INDRA UUID	Confidence	Citation Source	Citation Reference	Evidence	Subject	Predicate	Object
bd48bcd3-6649-4593-873f-85831bc2240b	1.0	PubMed	18701434	Our previous results demonstrated that ADN could impede Wnt and beta-catenin-signaling pathways in MDA-MB-231 human breast carcinoma cells [Wang, Y. et al. (2006) Adiponectin modulates the glycogen synthase kinase-3 beta and beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.	p(HGNC:ADIPOQ)	directlyIncreases	act(p(HGNC:GSK3B))
bd48bcd3-6649-4593-873f-85831bc2240b	1.0	PubMed	18606491	Activation of GSK3beta by adiponectin induces apoptosis and cell cycle arrest in MDAMB-231 human breast cancer cells, which is accompanied by suppressed intracellular accumulation of beta-catenin and its nuclear activities and reduced cyclin D1 levels.	p(HGNC:ADIPOQ)	directlyIncreases	act(p(HGNC:GSK3B))
3334ac97-193d-472d-a535-dab0868051b9	1.0	PubMed	24886245	Therefore, the role of AGK modulation of GSK-3beta activity in breast cancer cells is currently under investigation by our group.	p(HGNC:AGK)	directlyIncreases	act(p(HGNC:GSK3B))
22d9da63-0af4-4801-b7e9-5f44e7120106	1.0	PubMed	20840866	Current studies are in progress to delineate how SHP-1 promotes GSK3beta dependent beta-catenin degradation.In conclusion, the present study demonstrates that SHP-1 negatively regulates beta-catenin transcriptional activity by two mechanisms : 1 -- by dephosphorylating beta-catenin on Y86 and Y654, impairing with its capacity to interact with the basal transcriptional factor TBP and 2 -- by promoting beta-catenin degradation in a GSK3beta dependent manner.	p(UP:P29381)	directlyIncreases	act(p(HGNC:GSK3B))
eee41365-f3ef-43b8-b828-9d825569e3e4	1.0	PubMed	21890631	Depletion of AKAP220 induced a redistribution of GSK-3beta and an apparent decrease in the ability of these cells to move (XREF_FIG, S-V).	p(HGNC:AKAP11)	directlyIncreases	act(p(HGNC:GSK3B))
c2c89a9f-758e-481d-9922-c6545211cf7a	1.0	PubMed	15676208	No evidence text.	p(HGNC:AKT1, pmod(Ph, Ser, 473), pmod(Ph, Thr, 308), pmod(Ph, Tyr, 474))	directlyIncreases	act(p(HGNC:GSK3B))
6ae89c3c-578c-4027-9c8d-0da33e65321b	1.0	PubMed	20688159	Although GSK3beta can be directly phosphorylated by Akt and GSK3beta phosphorylation on Ser9 is often used as a marker for ectopic Akt expression, at least in MDA-MB-231 cells, forced expression of Akt1 did not increase GSK3beta phophorylation.	p(HGNC:AKT1)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	16051150	Dephosphorylation of Akt in response to DA leads to a reduction of kinase activity and a concomitant activation of its substrates glycogen synthase kinase 3 alpha and beta (GSK3alpha and GSK3beta) since both are negatively regulated by Akt ().	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	26119563	These in vitro and in vivo data together confirm the role of PI3K and Akt mediated GSK-3beta inactivation in EphB2 induced tau dephosphorylation.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	21821001	We therefore hypothesize that, in addition to galectin-3, Mcl-1 stabilization may also be regulated by galectin-3-regulated and Akt mediated GSK-3beta inactivation in surviving LY294002 treated cells.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	25931210	We observed that miR-429 attenuated PTEN expression induced the phosphorylation of AKT and inhibited the activity of GSK-3beta ().	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	23806081	PI3K and Akt is known to promote EMT by regulating the activity of GSK3beta, which targets Snail for degradation by suppressing NF-kappaB-dependent Snail expression [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	15689238	The binding of FGF2 to its receptor (FGFR1) induces several signalling cascades, such as MAPK mediated ERK activation and AKT mediated GSK3beta inactivation, both of which regulate cell survival.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	28143527	According to these findings, oncogenic signaling pathways related to AKT mediated GSK-3beta inactivation are speculated to be important for SHP2 activation as well as IFN-gamma hyporesponsiveness.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	22099458	For example, the Akt gene, which can directly regulate GSK3beta activity and downstream TCF/LEF signaling, is itself a schizophrenia risk gene and has been shown to be downregulated in postmortem brains of schizophrenia patients (XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	25499217	Mechanistic studies have suggested that Akt mediated Gsk-3beta inactivation plays a role in Mcl-1 phosphorylation and stabilization.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	21516346	It has been shown that during glucose deprivation, attenuated PI3K and PKB signals activate GSK3beta, which targets Mcl-1 to the proteasome [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24297051	Slit2 knockdown increased AKT phosphorylation, activated anti-apoptotic signaling, suppressed GSK3beta activity and induced beta-catenin activation.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	19429119	Inhibition of tau phosphorylation through inactivation of GSK-3beta by Akt has been well described [XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	21059203	On the other hand, it has been shown that Plexin-B1 inactivates PI3K, dephosphorylates AKT and activates GSK-3beta through R-Ras GAP activity.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	23043959	Akt induced inactivation of GSK-3beta by HS has been reported to contribute to the activation of heat shock factor-1 (HSF-1), the major transcriptional factor that regulates stress inducible synthesis of HSPs.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24011394	Thus increased MYCN levels via amplification or as the result of Akt mediated GSK-3beta inactivation would lead to DPYSL3 suppression in NB cells.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	18243161	Pharmacological inhibitor of PI3K, LY294002, abrogated this GSK-3beta inactivation downstream of LPS, suggesting that PI3K and Akt may negatively modulate GSK-3beta thereby inactivating p65 transactivation downstream of LPS.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	26017781	Although it is well known that Akt induces the inactivation of GSK-3beta via PI3K pathway, XREF_BIBR there are only a few reports concerning the TNF-alpha activation of Akt through its phosphorylation.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	25499972	Thus BAD inactivates AKT, which may activate GSK-3beta (XREF_FIG) causing reduction of beta-catenin (XREF_FIG).	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24571487	These findings suggest that Akt and GSK-3beta pathway aberrations are a general finding in cells with mTORC1 disrupted by Raptor silencing and that Akt phosphorylation leads to functional activation of Akt and GSK-3beta signaling.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	25412261	During Helicobacter pylori infection, PKB mediated GSK-3beta inactivation plays an essential role in Wnt signaling activation and cell proliferation XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	26320152	Inhibition of Akt (MK-2206) reversed the oxidant induced inactivation of GSK3beta.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	21308747	Moreover, SPH induced dephosphorylation of Akt at Ser (473) subsequently leads to the activation of GSK-3beta, caspase 3, PARP cleavage, and ultimately apoptosis.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	21143984	Akt mediates its downstream effects via phosphorylation and inactivation of GSK3beta ser9, with subsequently decreased phosphorylation of the GSK3beta target beta-catenin, resulting in increased beta-catenin nuclear translocation, binding to T-cell factor, and stimulation of gene expression related to cell proliferation and survival [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24735980	Akt is known to directly regulate GSK3beta by phosphorylation of its inhibitory serine residue (Ser 9).	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	21323578	Ubiquitously expressed hematological and neurological expressed 1 downregulates Akt mediated GSK3beta signaling, and its knockdown results in deregulated G2/M transition in prostate cells.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	19176518	To distinguish between these possibilities, we combined inhibition or knockdown of Akt1, Akt2, and Akt3, analyzing the canonical Akt targets Gsk3beta and tuberous sclerosis complex 2 (Tsc2) (XREF_BIBR) and the mTOR target rpS6 (XREF_FIG).	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	19371772	AKT positively regulates mTOR (activator of PGC-1alpha) by direct inhibition of the inhibitory complex TSC1/2 and by inhibition of the mTOR inhibitors AMPK (activator of PGC-1alpha) and GSK3b (regulator of PGC-1alpha turnover) [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24910204	Similarly, co-transfected Akt-myr (a constitutively active Akt mutant) with PCDH20 could also antagonize the active Akt induced GSK-3beta inactivation and Wnt and beta-catenin signalling pathway activation.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24910204	Our results suggest that PCDH20 induces Erks and Akt mediated activation of GSK-3beta, which in turn inhibits Wnt and beta-catenin signalling and leads to inhibition of HCC growth and migration.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24910204	PCDH20 inhibits Wnt signalling pathway through antagonizing ERK and Akt mediated activation of GSK-3beta.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	26252009	In conclusion, these findings suggest that inhibition of Akt signaling and activation of GSK-3beta partially contributes to the pro apoptotic effect of embelin in prostate cancer cells.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	25114899	Sensitization of Cancer Cells through Reduction of Total Akt and Downregulation of Salinomycin Induced pAkt, pGSk3beta, pTSC2, and p4EBP1 by Cotreatment with MK-2206.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	23440295	Akt and PKB mediated inactivation of GSK3-beta (through phosphorylation on its Ser9 residue) prevents GSK3-beta from phosphorylating MYCN on Thr58, which normally leads to proteasomal degradation of MYCN (XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24705253	The PI3K-AKT pathway modulates GSK-3beta activity 4 and accordingly, cells from patients with PIK3CA, PIK3R2 or AKT3 mutations similarly accumulated CCND2.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	25829335	Therefore, mTORC2 is also involved Akt induced GSK-3beta inhibition.The Signal Transducer and Activator of Transcription (STAT) protein regulates growth, survival and differentiation in cells as well as inflammation.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	24239461	As ERK, AKT, and GSK-3beta are important proteins in the generation of an antiapoptotic response in cells, the inactivation of ERK and AKT, and activation of GSK-3beta appears to be accountable for the death by apoptosis of T24 bladder carcinoma cells induced by boldine treatment.PI3K/AKT and MAPK and ERK pathways activation have been regarded as important key players in BC carcinogenesis.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	18769147	Here we show that inhibition of PI3-K and Akt induces a 40% decrease of cyclin D1 half-life as a result of accumulation of the dephosphorylated and active form of GSK-3beta within the nucleus, where this kinase can phosphorylate cyclin D1 on Thr286 thereby promoting its nuclear export.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	23300578	Based on these results, we confirmed that the knockdown of Pokemon in HepG2 cells suppressed the phosphorylation of ERK and Akt, thus activating GSK-3beta, which is the downstream target of Akt.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
77f5a763-cb07-4ac1-8dee-f9f355348430	1.0	PubMed	25643607	Inactivation of AKT signalling attenuated DVL1 mediated inhibition of GSK-3beta and accumulation of beta-catenin, in both A2780 and A2780 and Taxol cells.	p(FPLX:AKT)	directlyIncreases	act(p(HGNC:GSK3B))
f85c25ec-4452-483e-8bc2-9d1911e3286a	1.0	PubMed	21304492	Amer1 binds ck1gamma, recruits axin and gsk3beta to the plasma membrane and promotes complex formation between axin and lrp6.	p(HGNC:AMER1)	directlyIncreases	act(p(HGNC:GSK3B))
aa3e4b29-6716-4088-96fb-44ce8ce169fb	1.0	PubMed	26236947	Moreover, AMPK induced GSK3beta and SIRT1 activities were found to be responsible for inhibiting c-Myc-mediated upregulation of MTDH, as LiCl (an inhibitor of GSK3beta) and EX-527 (an inhibitor of SIRT1) reversed AICAR mediated downregulation of c-Myc and MTDH expressions.	p(FPLX:AMPK)	directlyIncreases	act(p(HGNC:GSK3B))
aa3e4b29-6716-4088-96fb-44ce8ce169fb	1.0	PubMed	26707164	We found that the binding between AMPK and beta-catenin occurs in the cytosolic fraction, and therefore concluded that the cancer cell antiproliferative effects of selenium are mediated by a GSK3beta independent AMPK and beta-catenin pathway, although AMPK mediated GSK3beta regulation was also observed.	p(FPLX:AMPK)	directlyIncreases	act(p(HGNC:GSK3B))
1088f8c7-8818-4bda-a874-4c9c7200f634	1.0	PubMed	22690042	Upregulation of GSK-3beta by APC and Reduction in Antiapoptotic Activity Following GSK-3beta-siRNA Treatment.	p(HGNC:APC)	directlyIncreases	act(p(HGNC:GSK3B))
1088f8c7-8818-4bda-a874-4c9c7200f634	1.0	PubMed	22690042	In this study, APC treatment was shown to elicit upregulation of GSK-3beta in normal HUVECs.	p(HGNC:APC)	directlyIncreases	act(p(HGNC:GSK3B))
af3ed8aa-f741-4429-b628-7145c47660a2	1.0	PubMed	16793187	However, apoE expression did not modulate the increased GSK-3beta activity observed in the Dab 1 deficient mice.	p(HGNC:APOE)	directlyIncreases	act(p(HGNC:GSK3B))
af3ed8aa-f741-4429-b628-7145c47660a2	1.0	PubMed	PMC7054571	ApoE4 and Abeta(1-42)-induced early activation of GSK-3beta could lead to apoptosis and tau hyperphosphorylation.	p(HGNC:APOE)	directlyIncreases	act(p(HGNC:GSK3B))
cefccb0a-bcdc-4e96-bccd-39ca2211e914	1.0	PubMed	14636889	Although the precise mechanism that leads to aberrant Akt and PKB signalling is unclear and currently under investigation, deregulation in the Akt and GSK3beta signal transduction cascade mediated by the familial Alzheimer 's disease mutants of amyloid precursor protein and presenilin may prove to be a critical event in the pathogenesis of Alzheimer 's disease, contributing to such events as hyperphosphorylation of tau, the major component of neurofibrillary tangles, and/or adversely affecting cellular functions such as cell adhesion, cell growth or replication or even cell death as reported by others.	p(HGNC:APP, var(p.?))	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	19700222	Although, Abeta accumulation has been causally implicated in the genesis of the cytoskeleton alterations (), there is not a clear understanding regarding the signal transduction pathways involved in the process.In AD, hyperphosphorylation appears to depend on the activity of the GSK3beta and Cdk5 kinases () and GSK3beta and Cdk5 activation is induced by Abeta neurotoxicity in neuronal cultures () However, the Abeta induced events upstream to the activation of these kinases are unknown.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	23026200	Conversely, Abeta has been reported to induce GSK-3beta activation, and reduction of Abeta levels might also reduces GSK-3beta activation on its own.We also observed a reduced association of GSK-3beta with PS1 in mice.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	25484286	In AD, elevated levels of Abeta could increase GSK3beta activity, which is thought to contribute to the pathogenesis of AD ().	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	25484286	Our data is consistent with the previous reports that Abeta could increase GSK3beta activity () and our results that GSK3beta could regulate BDNF dependent TrkB endocytosis.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	25491510	Supporting this hypothesis, a previous study demonstrated that sAPPalpha stimulates AKT and GSK3beta pathway in neuronal cells and consequently resulted in its neuroprotective effect [XREF_BIBR].	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	19090995	Similarly, Abeta can activate GSK3beta, leading to increased Abeta production [XREF_BIBR].	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	24086147	Because activation of calcineurin alone did not result in synaptotagmin aggregate accumulation, we further hypothesized that APP upregulation also enhances GSK-3beta activity through phosphorylation at Tyr216.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	24086147	Together, our data demonstrate that in addition to activating GSK-3beta by relieving inhibition through calcineurin, APP upregulation further enhances GSK-3beta activity through phosphorylation at Y214 in fly.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	24086147	We find that APP upregulation elevates calcineurin activity and GSK-3beta signaling, but Nebula co-upregulation corrects altered signaling to restore axonal transport.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	25963821	Tau reduction prevents Abeta induced axonal transport deficits by blocking activation of GSK3beta.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	25963821	Remarkably, tau ablation prevented the Abeta induced activation of GSK3beta, which in wild-type neurons occurred within 30 min of adding Abeta oligomers to the medium (XREF_FIG).	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	25963821	These data support a role for tau in regulating Abeta induced GSK3beta activation, which is critical for Abeta induced axonal transport deficits.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	25963821	Notably, we found that tau enables Abeta induced activation of GSK3beta, an important kinase in AD pathogenesis that negatively regulates kinesin based axonal transport (XREF_BIBR).	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	19587288	Finally, a recent finding strongly supports alpha7nAChR as a mediator of Abeta induced pathology in AD by demonstrating that both alpha7nAChR agonists and antagonists can modulate Abeta 1-42 -induced tau phosphorylation, possibly by involving GSK-3beta (XREF_BIBR).	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	4903491	Abeta (25-35) treatment activated tau protein kinase I/glycogen synthase kinase-3beta (TPKI and GSK-3beta) but not glycogen synthase kinase-3alpha (GSK-3alpha) or mitogen activated protein kinase (MAP kinase) in primary culture of hippocampal neurons.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	19782075	One of the key kinases that phoshorylates tau and particularly in is GSK-3beta (), and it is speculated that Abeta can stimulate the activity of GSK-3beta towards tau (see Discussion).	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	19782075	In light of this, it is therefore still possible that LiCl was acting by inhibiting endogenous when it prevented the Abeta mediated exacerbation of the tau longevity phenotype and that Abeta somehow stimulates GSK-3beta activity towards tau, but in a non-PI3K and PKB-dependent mechanism.An alternative mechanism by which Abeta could influence GSK-3beta activity towards its substrates is via the wnt / signal transduction pathway.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	19782075	It is likely, therefore, that in our model, if Abeta is increasing GSK-3beta activity, it is not doing so by acting on pathways such as the PI3K and PKB pathway which modulate the activity of GSK-3beta by altering its phosphorylation state.Instead we speculate that in the bigenic tau and Abeta flies, Abeta may be acting on GSK-3beta by antagonising endogenous signalling which usually controls the activity of GSK-3beta by regulating the complex it forms with its substrates.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	18494933	Aberrant processing of beta amyloid peptide (Abeta), which is thought to contribute to the development of AD, disrupts the Wnt signalling cascade, induces GSK-3beta activation, stimulates tau hyperphosphorylation and provokes neuronal cell damage [XREF_BIBR].	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	21876249	The present results now expand previous observations, and show that Abeta alone is sufficient to cause GSK3beta synthesis in cortical primary neurons : presumably via RCAN1 induction.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	21876249	A recent report by Terwel et al. (2008) [XREF_BIBR], showing that Abeta activates GSK3beta and aggravates tauopathy in mice, would seem to validate the significance of our findings.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	20032300	The mechanism by which Abeta induces cell cycle abnormalities evidently involves activation of GSK-3beta and the influx of Ca 2+, because blocking either of these two activities restores chromosome segregation to normal.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	20615469	Abeta activates GSK-3beta to phosphorylate tau ().	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	20615469	As shown in, lithium blocked the increase in GSK-3beta activity induced by Abeta.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	20615469	This inhibitory effect of lithium on Abeta activation of GSK-3beta was associated with reversal of Abeta suppression of tau 4R expression at both the mRNA and protein levels (A-D).	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	20615469	To study the mechanism of this Abeta action, we sought to establish the GSK-3beta-SC35 cascade based on the earlier observations that GSK-3beta is activated by Abeta () and GSK-3beta phosphorylates SC35 ().	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	20615469	The causal role of SC35 in Abeta activation of GSK-3beta to alter tau exon 10 splicing is supported by the finding that siRNA knockdown of SC35 blocked Abeta alteration of tau 4R mRNA expression.In an immunoprecipitation study, we noted that SC35-tau exon 10 interaction was enhanced following Abeta treatment.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	20615469	Thus, it is logical to consider that GSK-3beta action on SC35 is a downstream event following Abeta activation of GSK-3beta.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	In turn, treatment with Abeta activates GSK3beta in numerous conditions.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	However, there is little consensus about how Abeta mediates this activation and the phosphorylation and dephosphorylation processes resulting in GSK3beta activation and contributing to tau phosphorylation are still confused.The insulin and Akt signaling pathway is often suspected to be targeted in Abeta induced GSK3beta activation, supposing that reduced Ser9 phosphorylation could be the phosphorylation process implied in Abeta induced GSK3beta activation.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	In parallel, the hypothesis that Abeta mediated GSK3beta activation could be achieved through Tyr216 phosphorylation has emerged and an increase of pGSK3betaTyr216 (sometimes associated with a decrease of pGSK3betaSer9 and sometimes not) was noticed in numerous models of Abeta treatment.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	Here, using SH-SY5Y cells exposed to Abeta, we provided additional data to support that Abeta induced GSK3beta activation is mediated through Tyr216 phosphorylation and contributed to tau phosphorylation at PHF-1 epitope which translocated into the nucleus.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	Despite this, LiCl was unable to drop the pTau and Tau -5 in comparison with Abeta alone (B,) indicating that promoting Ser9 phosphorylation did not allow preventing tau phosphorylation at PHF-1 epitope in our conditions.To investigate the phosphorylation process involved in Abeta induced GSK3beta activation, SH-SY5Y cells were treated with Abeta in a time dependent manner.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	Despite this, LiCl was unable to drop the pTau and Tau -5 in comparison with Abeta alone (B,) indicating that promoting Ser9 phosphorylation did not allow preventing tau phosphorylation at PHF-1 epitope in our conditions.To investigate the phosphorylation process involved in Abeta induced GSK3beta activation, SH-SY5Y cells were treated with Abeta in a time dependent manner.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	These data are correlated with other reports which also described an increase in Tyr216 phosphorylation for Abeta induced GSK3beta activation in various and models of Alzheimer 's disease.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	Thus, depending on the literature, Abeta mediated GSK3beta activation could be achieved either by reduced Ser9 phosphorylation or by increased Tyr216 phosphorylation or both phenomena.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	27343974	As a consequence, any molecule targeting the Tyr216 phosphorylation site of GSK3beta could be of potential therapeutic interest.Here we provided further evidence to support that Abeta induced GSK3beta activation is performed through its Tyr216 phosphorylation, a phosphorylation state which could be able to participate to nuclear accumulation of pTau at PHF-1 epitope, an early event known to be implied in AD pathology.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
130044a7-02be-4640-8e15-8e42e3b32e23	1.0	PubMed	7054571	ApoE4 and Abeta (1-42)-induced early activation of GSK-3beta could lead to apoptosis and tau hyperphosphorylation.	p(HGNC:APP)	directlyIncreases	act(p(HGNC:GSK3B))
d3ba119f-3418-4415-a400-33eaae62e376	1.0	PubMed	22480520	In parallel and coordinated manner, beta-arrestin-1 and ETR forms a complex with axin, contributing to inactivate GSK-3beta and to stabilise beta-catenin ().	complex(p(HGNC:ARRB1), p(HGNC:AXIN1))	directlyIncreases	act(p(HGNC:GSK3B))
d0a87136-0b31-4331-9214-f24ed7274862	1.0	PubMed	22661511	In summary, AR mediates changes in p-GSK3beta, in part, via PKCalpha and beta and Akt during I/R.	p(HGNC:AR)	directlyIncreases	act(p(HGNC:GSK3B))
abbd9e11-f73c-42b6-9454-080c9303b775	1.0	PubMed	25970706	XREF_BIBR Thus, we hypothesized ATM may promote CAFs proliferation in a GSK3beta and beta-Catenin dependent manner.	p(HGNC:ATM)	directlyIncreases	act(p(HGNC:GSK3B))
be34e0fa-9ba4-4772-a8a6-ec86da13c0cd	1.0	PubMed	17283049	UV transiently increased GSK-3beta activity, and this increase could be blocked by caffeine or by ATR small interfering RNA, indicating ATR dependent activation of GSK-3beta.	p(HGNC:ATR)	directlyIncreases	act(p(HGNC:GSK3B))
1290a1a6-0d7d-4152-857d-07e3caf27b41	1.0	PubMed	19060929	We have used AKT specific inhibitor in presence and absence of AURKA and our results demonstrated a high level of phospho-GSK-3beta (S9) in the presence of AKT inhibitor in AURKA overexpressing cells, supporting our notion that AURKA can directly regulates GSK-3beta.	p(HGNC:AURKA)	directlyIncreases	act(p(HGNC:GSK3B))
cfa96507-4535-4e83-868a-e35dbe19ebfc	1.0	PubMed	5245188	Based on these data, we propose that the axin complex may directly regulate GSK-3beta enzymatic activity in vivo.	p(HGNC:AXIN1)	directlyIncreases	act(p(HGNC:GSK3B))
6ba24cbf-7801-4d62-bcea-cd8f64c7dc5b	1.0	PubMed	10911903	It has been found that a multiprotein complex assembled by the cytoplasmic component conductin induces degradation of cytoplasmic beta-catenin. The complex includes apc, the serine/threonine kinase gsk3 beta, and beta-catenin, which bind to conductin at distinct domains.	p(HGNC:AXIN2)	directlyIncreases	act(p(HGNC:GSK3B))
f6dd7e16-3338-4a35-95f7-50fa29c1ba53	1.0	PubMed	19107203	Although full-length Axin increases GSK3beta activity toward full-length beta-catenin through its scaffolding of GSK3beta and beta-catenin XREF_BIBR, the Axin GBD domain itself slightly inhibited GSK3beta (XREF_FIG), which is consistent with the reduced activity of Fratide bound GSK3beta XREF_BIBR.	p(FPLX:AXIN)	directlyIncreases	act(p(HGNC:GSK3B))
f6dd7e16-3338-4a35-95f7-50fa29c1ba53	1.0	PubMed	10647780	The fact that Axin does not increase the phosphorylation of a peptide substrate by GSK-3beta implies that Axin does not activate GSK-3beta activity.	p(FPLX:AXIN)	directlyIncreases	act(p(HGNC:GSK3B))
7d42f875-639d-47b3-a208-4896c58fbf47	1.0	PubMed	25062958	Adenosine and spermine NONOate both increased the ratio of phospho-GSK-3beta and total GSK-3beta, and these increases were abolished by either ODQ or Rp.	a(PUBCHEM:60961)	directlyIncreases	act(p(HGNC:GSK3B))
a2f0fcbb-224f-4293-ac15-9379968c71b1	1.0	PubMed	23049725	Because SARI is not a phosphatase, the mechanism of GSK-3beta activation by SARI may be mediated by a separate phosphatase associated within this complex.	p(HGNC:BATF2)	directlyIncreases	act(p(HGNC:GSK3B))
a2f0fcbb-224f-4293-ac15-9379968c71b1	1.0	PubMed	23049725	SARI Activates GSK-3beta By Regulating PP2A.	p(HGNC:BATF2)	directlyIncreases	act(p(HGNC:GSK3B))
a2f0fcbb-224f-4293-ac15-9379968c71b1	1.0	PubMed	23049725	Because SARI is not a phosphatase, the mechanism of GSK-3beta activation by SARI is likely mediated by a separate phosphatase associated with this complex.	p(HGNC:BATF2)	directlyIncreases	act(p(HGNC:GSK3B))
a2f0fcbb-224f-4293-ac15-9379968c71b1	1.0	PubMed	23049725	These data clearly indicate that PP2A is critical for SARI mediated GSK-3beta activation and MET responses.	p(HGNC:BATF2)	directlyIncreases	act(p(HGNC:GSK3B))
bbf0150b-0e73-4534-bb07-41711d5a6f64	1.0	PubMed	26861207	While assessing the specificity of Rsk inhibition, we noticed that phosphorylation of the Rsk substrate GSK3beta did not decline in cells treated with the Rsk inhibitor BI-D1870.	a(PUBCHEM:25023738)	directlyIncreases	act(p(HGNC:GSK3B))
a06b58b2-716f-498e-a4b6-ef70f999e60e	1.0	PubMed	21276221	As anticipated, the expression of Snail and phosphorylated GSK-3beta was up-regulated by Bmi-1 overexpression and down-regulated by Bmi-1 knockdown, but the levels of total GSK-3beta remained unaffected.	p(HGNC:BMI1)	directlyIncreases	act(p(HGNC:GSK3B, pmod(Ph)))
3b0a7725-071b-4237-806f-00170dec0e0c	1.0	PubMed	26452029	In addition, Bmi-1 also downregulated PTEN by associating the PTEN locus and consequently activated the Akt and GSK3beta pathway, ultimately induced EMT and cytoskeleton reconstruction, leading to enhanced invasiveness of cancer cells.	p(HGNC:BMI1)	directlyIncreases	act(p(HGNC:GSK3B))
3b0a7725-071b-4237-806f-00170dec0e0c	1.0	PubMed	21276221	The overexpression of Bmi-1 enhances the motility and invasiveness of immortalized HMECs, facilitates concurrent EMT like molecular changes, and promotes the stabilization of Snail and the activation of the Akt and GSK3beta pathway.	p(HGNC:BMI1)	directlyIncreases	act(p(HGNC:GSK3B))
3b0a7725-071b-4237-806f-00170dec0e0c	1.0	PubMed	21276221	Collectively, it appears that Bmi-1 induces the activation of Akt and the inactivation of GSK-3beta by phosphorylation, facilitates the stabilization and nuclear translocation of Snail, and finally results in the deregulation of EMT markers, thus promoting the migration and invasion of breast cancer cells.	p(HGNC:BMI1)	directlyIncreases	act(p(HGNC:GSK3B))
caf43b60-fde6-4c89-9c1d-9638a5055200	1.0	PubMed	19139264	BMP-2 increases beta-C via BMPRII dependent pERK1/2 inhibition of GSK3-beta.	p(HGNC:BMP2)	directlyIncreases	act(p(HGNC:GSK3B))
d45d0cc5-543f-45ed-8707-6942f51b8c63	1.0	PubMed	22739988	In addition, an IGF-1R tyrosine kinase inhibitor, BMS-536924, (XREF_SUPPLEMENTARY) also inhibited phospho-IGF-1Rbeta (Y1135), phospho-ATK (S473), and phospho-GSK3beta (S9) in a dose dependent manner in BRCA1-KD MCF7 cells (XREF_FIG).	a(PUBCHEM:68925359)	directlyIncreases	act(p(HGNC:GSK3B))
0c9a9eb8-7521-4b2e-81dc-20e50fa43ba1	1.0	PubMed	12941796	BP75, bromodomain containing M (r) 75,000 protein, binds dishevelled-1 and enhances Wnt signaling by inactivating glycogen synthase kinase-3 beta.	complex(p(HGNC:BRD7), p(HGNC:DVL1))	directlyIncreases	act(p(HGNC:GSK3B))
177b33cd-1fa9-47eb-b824-6a9b673e473c	1.0	PubMed	12123574	However, after transfection, Delta1 stimulated HES1 activation in GSK3beta null cells was still smaller in magnitude than in wild-type fibroblasts.	p(HGNC:GATD3A)	directlyIncreases	act(p(HGNC:GSK3B))
177b33cd-1fa9-47eb-b824-6a9b673e473c	1.0	PubMed	12123574	Moreover, NIC-myc was able to activate the HES1 promoter in both wild-type and GSK3beta null cells (data not shown).	p(HGNC:GATD3A)	directlyIncreases	act(p(HGNC:GSK3B))
177b33cd-1fa9-47eb-b824-6a9b673e473c	1.0	PubMed	26452029	Furthermore, we indicated that Bmi-1 mediated Hes1 induced cell proliferation and migration, downregulated PTEN and activated the Akt and GSK3beta pathway, consequently induced EMT and cytoskeleton reconstruction, ultimately leading to enhanced invasiveness of cancer cells.	p(HGNC:GATD3A)	directlyIncreases	act(p(HGNC:GSK3B))
48ecff8a-67a8-426b-bbfe-52575a4ec52f	1.0	PubMed	22096483	SP 600125 also enhanced G3 transfected cells expression of GSK-3beta (S9P) when treated with C2-ceramide (XREF_FIG).	a(PUBCHEM:5497136)	directlyIncreases	act(p(HGNC:GSK3B, var(p.Ser9Pro)))
67a0956b-6b7a-42ab-9fa6-b91614e42fa8	1.0	PubMed	6383745	Taking into account that GSK3beta phosphorylates MITF and increases the ability of MITF to bind its target sequence, our results indicate that activation of GSK3beta by cAMP facilitates MITF binding to the tyrosinase promoter, thereby leading to stimulation of melanogenesis.	a(CHEBI:17489)	directlyIncreases	act(p(HGNC:GSK3B))
1e3841ab-4cd5-4a87-85c2-c561479be0cd	1.0	PubMed	25969760	Thus, it has been shown that calpain cleaves the inhibitory domain of GSK3 generating two fragments of 40 and 30 kDa. This cleavage enhanced activity of the kinase	p(HGNC:CAPN1)	directlyIncreases	act(p(HGNC:GSK3B))
ccdaab9e-a596-484a-af00-a462b66bd909	1.0	PubMed	25969760	Thus, it has been shown that calpain cleaves the inhibitory domain of GSK3 generating two fragments of 40 and 30 kDa. This cleavage enhanced activity of the kinase	p(HGNC:CAPN2)	directlyIncreases	act(p(HGNC:GSK3B))
d9355ce6-c092-49eb-aebc-265fe7b511a6	1.0	PubMed	25969760	Thus, it has been shown that calpain cleaves the inhibitory domain of GSK3 generating two fragments of 40 and 30 kDa. This cleavage enhanced activity of the kinase	p(HGNC:CAPN3)	directlyIncreases	act(p(HGNC:GSK3B))
b2202072-842c-4cee-9ec3-e42cfd3a7313	1.0	PubMed	26621838	The increase of GSK3beta activity induced by NC1 (XIX), through a GSK3beta dephosphorylation process, could explain the effects of NC1 (XIX) on mTOR inhibition and could also explain its anti-tumor effects on SK-MEL-28 and other melanoma cell lines previously described [15, 16].	p(UP:O65572)	directlyIncreases	act(p(HGNC:GSK3B))
bd4b036b-ee37-41ff-9e9e-fa38597b14a2	1.0	PubMed	17873903	In conclusion, we revealed that CCDC85B induced degradation of beta-catenin is independent of GSK3beta and other p53 inducible products, Siah-1L, suggesting that CCDC85B constitutes the one of the frameworks of p53 induced multiple regulatory pathways for beta-catenin activity.	p(HGNC:CCDC85B)	directlyIncreases	act(p(HGNC:GSK3B))
40b10822-3fa6-412e-be66-a248c4b66f6e	1.0	PubMed	26022178	Phosphorylation at Ser21 in GSK-3alpha and at Ser9 in GSK-3beta induced by NKG2D, 2B4 or their combination were abrogated by co-crosslinking of CD94-NKG2A inhibitory receptor on NKL cells (D).	p(HGNC:CD244)	directlyIncreases	act(p(HGNC:GSK3B))
40b10822-3fa6-412e-be66-a248c4b66f6e	1.0	PubMed	26022178	Phosphorylation at Ser21 in GSK-3alpha and at Ser9 in GSK-3beta induced by combination of NKG2D and 2B4 were sensitive to the inhibitors of both PI3K (LY294002) and MEK (PD98059) that diminish phosphorylation of Akt and ERK, respectively (A).	p(HGNC:CD244)	directlyIncreases	act(p(HGNC:GSK3B))
5fbc39ca-2884-49f4-9f40-78d6c966472a	1.0	PubMed	27572267	GSK3beta CA mediated PD-L1 T180 and S184 phosphorylation was observed only in PD-L1 3NQ and 4NQ but not in WT and N35Q (XREF_FIG), further supporting the notion that glycosylation of PD-L1 prevents GSK3beta from binding to PD-L1 (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:CD274)	directlyIncreases	act(p(HGNC:GSK3B))
7a23099f-78f9-4a0b-8663-1721e0661d82	1.0	PubMed	25500144	These results demonstrate that EZH2 upregulation is required for CCRK induced hepatocarcinogenesis.We have recently identified GSK-3beta as a CCRK kinase target which mediates beta-catenin activation in liver and HCC cells.	p(HGNC:CDK20)	directlyIncreases	act(p(HGNC:GSK3B))
ed430bbd-6018-487c-87d8-f1ca2611a06e	1.0	PubMed	19591849	Interestingly, GSK3beta activation, like the cdk5 activation described previously, seemed to be mediated by intracellular calcium as BAPTA-AM also prevented enhanced GSK3beta phosphorylation after D1 receptor stimulation.	p(HGNC:CDK5)	directlyIncreases	act(p(HGNC:GSK3B))
3331bd58-4c72-4f55-a4ed-ba4837d39e31	1.0	PubMed	23085750	Here we report that GSK3beta regulates KLF6 protein activity through phosphorylation at amino acids 143, 147, 151 and 155, leading to the accumulation of KLF6 protein and augmented KLF6 mediated growth suppression by p21.	p(HGNC:CDKN1A)	directlyIncreases	act(p(HGNC:GSK3B))
e8bb227a-98ad-4249-a868-273a4414fd79	1.0	PubMed	24901984	Since the epitope contains Serine 9, which is kept unphosphorylated in the active form of GSK3beta XREF_BIBR, the CGR11 antibody is designed to preferentially target active GSK3beta.	p(HGNC:CGREF1)	directlyIncreases	act(p(HGNC:GSK3B))
2b00977c-81ba-4b2d-830e-42c7eabe8573	1.0	PubMed	23035100	Recent studies also show that CLASP2 is enriched in growth cones and supports axon regeneration by stabilizing the growing ends of axonal microtubules downstream of GSK3beta (XREF_BIBR).	p(HGNC:CLASP2)	directlyIncreases	act(p(HGNC:GSK3B))
ce5fe2d7-aea7-4d6e-ab62-220a78742931	1.0	PubMed	27232758	Loss of the CPD phosphorylation or mutation in the WD40 domain of FBW7 abolishes GSK3beta- and FBW7 dependent FAAP20 destruction, indicating that the GSK3beta-FBW7 proteolytic signaling axis regulates FAAP20 turnover.	p(HGNC:CPD)	directlyIncreases	act(p(HGNC:GSK3B))
d503c686-8995-4cc0-b925-dda6df4ab16b	1.0	PubMed	27049759	Although the functional consequence of CREB activity by GSK-3 is not still clear, our study strongly suggests that CREB positively regulates GSK-3alpha, not GSK-3beta, in lung cancer cells, thus providing a new concept of CREB-GSK-3alpha signaling.	p(FPLX:CREB)	directlyIncreases	act(p(HGNC:GSK3B))
26a6fcbd-94cb-458d-8ed1-7dcce44ce744	1.0	PubMed	14561750	Recombinant Csk phosphorylated and activated GSK-3beta in vitro, and GSK-3beta coprecipitated with Csk from cell lysates.	p(HGNC:CSK)	directlyIncreases	act(p(HGNC:GSK3B))
26a6fcbd-94cb-458d-8ed1-7dcce44ce744	1.0	PubMed	7005206	Recombinant Csk phosphorylated and activated GSK-3beta in vitro, and GSK-3beta coprecipitated with Csk from cell lysates.	p(HGNC:CSK)	directlyIncreases	act(p(HGNC:GSK3B))
093de6b3-f095-42d8-a641-7032e0eac9f3	1.0	PubMed	19293931	In the absence of secreted wnt ligands, cytosolic beta-catenin is phosphorylated at ser45 by the priming kinase casein kinase 1 (ck1). Consequently, glycogen synthase kinase 3 (gsk3), in complex with axin and adenomatous polyposis coli (apc), phosphorylates beta-catenin at thr41, ser37, and ser33  apc cooperates with axin to promote the phosphorylation of b-catenin by gsk3 [which requires priming phosphorylation by casein kinase 1, alpha-isoform (ck1alpha)]	p(HGNC:CSNK1A1)	directlyIncreases	act(p(HGNC:GSK3B))
093de6b3-f095-42d8-a641-7032e0eac9f3	1.0	PubMed	22083140	In the absence of secreted wnt ligands, cytosolic beta-catenin is phosphorylated at ser45 by the priming kinase casein kinase 1 (ck1). Consequently, glycogen synthase kinase 3 (gsk3), in complex with axin and adenomatous polyposis coli (apc), phosphorylates beta-catenin at thr41, ser37, and ser33  apc cooperates with axin to promote the phosphorylation of b-catenin by gsk3 [which requires priming phosphorylation by casein kinase 1, alpha-isoform (ck1alpha)]	p(HGNC:CSNK1A1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	17418091	It has been known that accumulation of free beta-catenin promoted the association of GSK3beta with APC and it led to phosphorylation of the 20 amino acid repeat region of APC.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	25931210	Intriguingly, knockdown of beta-catenin by siRNA resulted in no significant drop of miR-429 stimulated p-AKT activation (B), indicating that beta-catenin is the downstream effector of activated AKT and inhibited GSK-3beta, that plays its roles by way of relocation but not expression alteration.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	25150829	In this loop, beta-catenin activates PI3K and AKT signaling and consequently enhances P-GSK-3beta (Ser9) levels, which in turn further promotes beta-catenin.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	25499972	Phosphorylation of beta-catenin by GSK-3beta induces its degradation and GSK-3beta is inactivated by AKT and PKB phosphorylation [XREF_BIBR].	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	21179577	Several lines of evidence suggest that Abeta interferes with Wnt and beta-catenin signaling XREF_BIBR, XREF_BIBR, causing GSK-3beta activation, a kinase abnormally active in AD and involved in tau phosphorylation XREF_BIBR, XREF_BIBR.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	23049725	Activated GSK-3beta decreases nuclear beta-catenin accumulation and transcriptional activity, indicating the potent inhibitory function of SARI in Wnt-beta-catenin signaling.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	23768967	Phosphorylation of beta-catenin at this site then allows the destruction complex bound GSK-3beta to further phosphorylate beta-catenin at threonine 41, serine 37, and serine 33, subsequently allowing the ubiquitin ligase complex to recognize and poly-ubiquitinate beta-catenin, leading to its degradation at the proteasome.Wnt signaling is activated upon binding of Wnt ligands to Frizzled receptors and the low-density lipoprotein receptor related protein (LRP) on the surface of cells.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	24374173	We also observed that celecoxib inhibited exogenous PGE2 induced beta-catenin accumulation in the nucleus and inhibited activation of GSK-3beta; however, the mechanism of GSK-3beta inactivation by celecoxib is unknown.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	21965288	Downregulation of beta-catenin robustly potentiated the stimulus induced association of GSK-3beta with MRTF as early as 30 min after stimulation.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	19576885	Finally, we studied the phosphorylation state of beta-catenin : it has been shown that beta-catenin is a downstream target of GSK-3beta that is, in particular, regulated by Wnt signaling pathway.	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
00847e95-3d1c-4b20-991d-1dd0b7346bbb	1.0	PubMed	26274564	We next validated the role of GSK3beta Y216 in Wnt and beta-catenin signaling in GSK3beta knockout (KO) MEFs (mouse embryonic fibroblasts).	p(HGNC:CTNNB1)	directlyIncreases	act(p(HGNC:GSK3B))
c17688e2-a1ec-47e6-9d7c-5af6dd8ee9cc	1.0	PubMed	12660161	Retroviral transduction of VCIP induced cell aggregation and cell- cell interactions, modestly increased p120 catenin expression and promoted activation of the Fak, Akt and GSK3beta protein kinases.	p(HGNC:CTNND1)	directlyIncreases	act(p(HGNC:GSK3B))
c17688e2-a1ec-47e6-9d7c-5af6dd8ee9cc	1.0	PubMed	6715117	Retroviral transduction of VCIP induced cell aggregation and cell- cell interactions, modestly increased p120 catenin expression and promoted activation of the Fak, Akt and GSK3beta protein kinases.	p(HGNC:CTNND1)	directlyIncreases	act(p(HGNC:GSK3B))
bebe5ffd-9ac4-49e6-a671-393ba1e781a2	1.0	PubMed	23434321	These data support the model that CXCR4 promotes MPNST growth by activating the PI3K and AKT and the GSK-3beta and beta-catenin pathways.	p(HGNC:CXCR4)	directlyIncreases	act(p(HGNC:GSK3B))
be2e705f-721a-471e-8daf-e703adf2ab96	1.0	PubMed	23140583	In MCF-7 cells, Ca influx stimulated the GSK3beta, AKT, JNK, and Erk pathways (A).	a(CHEBI:29108)	directlyIncreases	act(p(HGNC:GSK3B))
9d43a3d3-3efa-4776-a328-bf0b65947692	1.0	PubMed	22087308	Together, these data suggest that DNA damage stress with simultaneous inhibition of the kinase activity causes degradation of Jak2 or Jak2-V617F by caspase cleavage and proteasomal degradation through GSK3beta activation, which is closely involved in synergistic induction of apoptosis in hematopoietic cells.	p(FPLX:Caspase)	directlyIncreases	act(p(HGNC:GSK3B))
6af3802d-0759-456e-8dad-fe9f326f65fc	1.0	PubMed	24038789	GSK3beta targets cyclin D1, cyclin E and Cdc25A for phosphorylation, signaling their ubiquitination, degradation and exit from cell cycle progression XREF_BIBR - XREF_BIBR.	p(FPLX:Cyclin)	directlyIncreases	act(p(HGNC:GSK3B))
089ae0c3-7186-461d-98bb-8b3b1f6f98fa	1.0	PubMed	21964756	The second construct, T498V S502A S505A T506V S510A (TSSTS), was based on our analysis of likely GSK3beta sites based on consensus sequence comparisons to other GSK3beta targets such as cyclin E (XREF_FIG).	p(FPLX:"Cyclin_E")	directlyIncreases	act(p(HGNC:GSK3B))
187b0e78-edad-404a-8d7d-e79252e19a48	1.0	PubMed	7255246	In the mouse striatum, increased DA neurotransmission arising either from administration of amphetamine or from the lack of the DA transporter results in inactivation of Akt and concomitant activation of GSK-3alpha and GSK-3beta.	a(CHEBI:18243)	directlyIncreases	act(p(HGNC:GSK3B))
187b0e78-edad-404a-8d7d-e79252e19a48	1.0	PubMed	21315744	In naive mice, we assessed METH induced conditioned place preference (CPP), dopamine (DA) D2 receptor density and the basal and METH induced activity of DISC1 partners, AKT and GSK-3beta in the ventral striatum.	a(CHEBI:18243)	directlyIncreases	act(p(HGNC:GSK3B))
31e8c0fb-1366-4005-a509-01d86b1ef726	1.0	PubMed	23029096	In contrast, decorin, by neutralizing the activity of EGFR and Met, relieves GSK3beta inactivation, and leads to non canonical GSK3beta evoked phosphorylation of beta-catenin as well as Myc at Thr58 XREF_BIBR, XREF_BIBR, thus leading to 26S proteasomal degradation.	p(HGNC:DCN)	directlyIncreases	act(p(HGNC:GSK3B))
c06bf411-b74b-4bfa-9d7c-4305a5b27acc	1.0	PubMed	23644467	Thus, we tested whether DDR2 activation could modulate GSK3beta activity downstream of ERK2.	p(HGNC:DDR2)	directlyIncreases	act(p(HGNC:GSK3B))
e012727f-33ce-419b-89fa-e9b1686cb059	1.0	PubMed	6180314	Abs against inactive (pSer (9)) and activity enhanced (pTyr (216)) GSK-3 beta showed marked increase of pSer (9) - and decrease of pTyr (216)-GSK-3 beta in both OVX + TP and OVX + (EB + TP) but not in sham-OVX + SO, OVX + SO, and OVX + EB.	p(HGNC:DDX41)	directlyIncreases	act(p(HGNC:GSK3B))
12e0ad65-b863-414b-9a6f-dbe2190539f9	1.0	PubMed	19154786	Since DIF-1 reduces phosphorylation of Thr668 and reports suggest that DIF-1 might activate GSK3beta [XREF_BIBR], we examined the effects of three structurally distinct GSK inhibitors (LiCl, kenpaullone and 1-azakenpaullone) on DIF-1 modulation of APP processing (XREF_FIG).	a(PUBCHEM:123886)	directlyIncreases	act(p(HGNC:GSK3B))
183351aa-ed1f-4dc4-bf20-e5f142e06335	1.0	PubMed	21642004	For example, a recent study suggests that DISC1 mediates neuronal progenitor cell proliferation by regulating GSK3beta and beta, a serine/threonine protein kinase (XREF_BIBR).	p(HGNC:DISC1)	directlyIncreases	act(p(HGNC:GSK3B))
183351aa-ed1f-4dc4-bf20-e5f142e06335	1.0	PubMed	25905630	ZNF804A is one of many genes coding for transcription factors, splicing regulators and chromatin remodeling proteins that have been implicated in SZ, BD, and ASD, including POU3F2, A2BP1, MYT1L, JARID2, TCF4, ARNT2, CHD8, SMARCA2, and beta-catenin (which is regulated by the lithium and DISC1 target GSK3beta) [XREF_BIBR - XREF_BIBR].	p(HGNC:DISC1)	directlyIncreases	act(p(HGNC:GSK3B))
183351aa-ed1f-4dc4-bf20-e5f142e06335	1.0	PubMed	19303846	Several lines of evidence suggest that DISC1 mediates this function by regulating GSK3beta.	p(HGNC:DISC1)	directlyIncreases	act(p(HGNC:GSK3B))
48710ee8-163d-4bbc-b13b-8c153808432c	1.0	PubMed	18494933	DKK-1 up-regulates GSK-3beta activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration.	p(HGNC:DKK1)	directlyIncreases	act(p(HGNC:GSK3B))
48710ee8-163d-4bbc-b13b-8c153808432c	1.0	PubMed	18494933	DKK-1 promotes activation of GSK-3beta, a key member of Wnt pathway implicated in tauopathy.	p(HGNC:DKK1)	directlyIncreases	act(p(HGNC:GSK3B))
48710ee8-163d-4bbc-b13b-8c153808432c	1.0	PubMed	18494933	In cortical neurons, APP induces the expression of the secreted DKK-1, which negatively modulates the canonical Wnt signalling pathway and thus activates the tauphosphorylating enzyme GSK-3beta.	p(HGNC:DKK1)	directlyIncreases	act(p(HGNC:GSK3B))
04eb2fc8-4659-4cc4-950d-9c6a141e9688	1.0	PubMed	22739727	Activation of Dvl induces the dissociation of GSK-3beta from Axin and leads to the inhibition of GSK-3beta.	p(FPLX:DVL)	directlyIncreases	act(p(HGNC:GSK3B))
04eb2fc8-4659-4cc4-950d-9c6a141e9688	1.0	PubMed	22415718	Downregulation of DVL increases GSK-3beta activity, and results from this same study showed that overexpressing GSK-3beta induced depressive like behavior.	p(FPLX:DVL)	directlyIncreases	act(p(HGNC:GSK3B))
3a88c87d-f622-40d0-8560-00f6722e37d5	1.0	PubMed	23555843	Thus, we tested the ability of EFV to induce activation of GSK3beta in isolated platelets, and observed a dose dependent decrease in the inhibitory phosphorylation of this kinase, indicating that EFV stimulates GSK3beta in platelets (XREF_FIG).	a(PUBCHEM:71464665)	directlyIncreases	act(p(HGNC:GSK3B))
b80dc4f9-6230-4437-9bfc-562f62e6ae92	1.0	PubMed	20140245	Gsk3beta inactivation is mediated mainly by two pathways : 1) activation of growth factor receptors by EGF, platelet derived growth factor or insulin, leading to activation of Akt, a protein kinase that phosphorylates and inactivates Gsk3beta, 2) activation of the Wnt pathway leading to inhibition of Gsk3beta.	p(HGNC:EGF)	directlyIncreases	act(p(HGNC:GSK3B))
b80dc4f9-6230-4437-9bfc-562f62e6ae92	1.0	PubMed	26710964	However, the activation of AKT and its target GSK3beta induced by EGF or serum was comparable in these stable cells.	p(HGNC:EGF)	directlyIncreases	act(p(HGNC:GSK3B))
520046bd-b491-4359-8db4-589f1dd3f585	1.0	PubMed	16959610	Finally, transfection of laforin substantially increased the enzymatic activity of GSK-3beta.	p(HGNC:EPM2A)	directlyIncreases	act(p(HGNC:GSK3B))
520046bd-b491-4359-8db4-589f1dd3f585	1.0	PubMed	16959610	Taken together, our data demonstrate that laforin is a critical regulator of Ser9 phosphorylation and of the enzymatic activity of GSK-3beta in vivo.An important issue is whether, by regulating GSK-3beta, laforin can modulate Wnt signaling.	p(HGNC:EPM2A)	directlyIncreases	act(p(HGNC:GSK3B))
639c02c9-2e11-490f-bcb9-e7a4287107b5	1.0	PubMed	22385658	The switch in Smad2,3 activity following inactivation of PI3K and Akt requires the activation of canonical Wnt signaling by Erk, which targets Gsk3beta.	p(FPLX:ERK)	directlyIncreases	act(p(HGNC:GSK3B))
639c02c9-2e11-490f-bcb9-e7a4287107b5	1.0	PubMed	21441955	These data suggest that ETS1 and ETS2 are the major ETS members mediating Ras and MAPK activation of GSK-3beta in PDA.	p(FPLX:ERK)	directlyIncreases	act(p(HGNC:GSK3B))
639c02c9-2e11-490f-bcb9-e7a4287107b5	1.0	PubMed	25712050	Hepatitis B Virus X Protein Stabilizes Cyclin D1 and Increases Cyclin D1 Nuclear Accumulation through ERK Mediated Inactivation of GSK-3beta.	p(FPLX:ERK)	directlyIncreases	act(p(HGNC:GSK3B))
639c02c9-2e11-490f-bcb9-e7a4287107b5	1.0	PubMed	19139264	Canonical beta-C-mediated signals require BMP-2 activation of phosphorylated ERK (pERK) to mediate GSK3-beta inactivation, whereas noncanonical signaling involves BMP-2 activation of phosphorylated Smad1 (pSmad1) to recruit Dvl and activate RhoA and Rac1.	p(FPLX:ERK)	directlyIncreases	act(p(HGNC:GSK3B))
639c02c9-2e11-490f-bcb9-e7a4287107b5	1.0	PubMed	24239461	As ERK, AKT, and GSK-3beta are important proteins in the generation of an antiapoptotic response in cells, the inactivation of ERK and AKT, and activation of GSK-3beta appears to be accountable for the death by apoptosis of T24 bladder carcinoma cells induced by boldine treatment.PI3K/AKT and MAPK and ERK pathways activation have been regarded as important key players in BC carcinogenesis.	p(FPLX:ERK)	directlyIncreases	act(p(HGNC:GSK3B))
639c02c9-2e11-490f-bcb9-e7a4287107b5	1.0	PubMed	16039586	Like HBX in hepatoma, HER2 and IGF-1 in breast cancer cells can also upregulate beta-catenin through inactivation of GSK-3beta via Ser9 phosphorylation by the Erk and RSK pathway.	p(FPLX:ERK)	directlyIncreases	act(p(HGNC:GSK3B))
8b9c7467-adf1-473d-bcdd-65d998948917	1.0	PubMed	6459568	Insulin like growth factor-1, okadaic acid, calyculin A, and lithium also protected cells from two other inducers of ER stress, tunicamycin and brefeldin A. Thus, ER stress activates GSK3beta through dephosphorylation of phospho-Ser-9, a prerequisite for caspase-3 activation, and this process is amenable to pharmacological intervention.	p(HGNC:ESR1)	directlyIncreases	act(p(HGNC:GSK3B))
8b9c7467-adf1-473d-bcdd-65d998948917	1.0	PubMed	25596749	ER stress activates GSK3beta to phosphorylate rictor at Ser1235 and subsequently reduces mTORC2 activity [XREF_BIBR].	p(HGNC:ESR1)	directlyIncreases	act(p(HGNC:GSK3B))
8b9c7467-adf1-473d-bcdd-65d998948917	1.0	PubMed	12228224	Insulin like growth factor-1, okadaic acid, calyculin A, and lithium also protected cells from two other inducers of ER stress, tunicamycin and brefeldin A. Thus, ER stress activates GSK3beta through dephosphorylation of phospho-Ser-9, a prerequisite for caspase-3 activation, and this process is amenable to pharmacological intervention.	p(HGNC:ESR1)	directlyIncreases	act(p(HGNC:GSK3B))
67c40b6c-4af0-45ed-b4bb-22938f159c61	1.0	PubMed	22480520	In parallel and coordinated manner, beta-arrestin-1 and ETR forms a complex with axin, contributing to inactivate GSK-3beta and to stabilise beta-catenin ().	complex(p(HGNC:AXIN1))	directlyIncreases	act(p(HGNC:GSK3B))
3513d236-a22a-4c44-9747-d41527195b47	1.0	PubMed	21441955	These data suggest that ETS1 and ETS2 are the major ETS members mediating Ras and MAPK activation of GSK-3beta in PDA.	p(FPLX:ETS)	directlyIncreases	act(p(HGNC:GSK3B))
e9465c35-c25e-40bb-b709-3f108b6e9991	1.0	PubMed	5120420	Mutant HOS which lacks the F-box blocked TNF alpha induced degradation of IkappaB as well as GSK3beta mediated degradation of beta-catenin.	p(HGNC:FBXW11, var(p.?))	directlyIncreases	act(p(HGNC:GSK3B))
e9465c35-c25e-40bb-b709-3f108b6e9991	1.0	PubMed	10321728	Mutant HOS which lacks the F-box blocked TNF alpha induced degradation of IkappaB as well as GSK3beta mediated degradation of beta-catenin.	p(HGNC:FBXW11, var(p.?))	directlyIncreases	act(p(HGNC:GSK3B))
05c65461-92ca-442b-8aae-8122462d5e48	1.0	PubMed	6380769	In primary rat neuronal and HT22 cells, FGF1 promoted a time dependent inactivation of GSK3beta by phosphorylation at serine 9.	p(HGNC:FGF1)	directlyIncreases	act(p(HGNC:GSK3B))
78cd83d8-0213-4b2a-ab6d-096086bf7468	1.0	PubMed	25088797	Furthermore, inhibitors were used to test the potential roles of PI3K and AKT signaling in the regulation of phosphorylated GSK-3beta induced by bFGF.	p(HGNC:FGF2)	directlyIncreases	act(p(HGNC:GSK3B, pmod(Ph)))
49e4ac97-ce14-4b1f-bcd1-d07cd93453bb	1.0	PubMed	25088797	It suggested that PI3K and AKT signaling pathway was responsible for the inhibition of GSK-3beta activity induced by bFGF treatment.	p(HGNC:FGF2)	directlyIncreases	act(p(HGNC:GSK3B))
49e4ac97-ce14-4b1f-bcd1-d07cd93453bb	1.0	PubMed	20643830	As expected, bFGF treatment of HSPCs increased p-ERK and p-GSK3-beta even further, in respect to untreated Sumf1 -/- cells; in turn, c/EBPalpha, GATA-1, and beta-catenin accumulated accordingly (XREF_FIG, lanes 2 and 5).	p(HGNC:FGF2)	directlyIncreases	act(p(HGNC:GSK3B))
49e4ac97-ce14-4b1f-bcd1-d07cd93453bb	1.0	PubMed	23349801	To examine how GFX influenced FGF-2 signaling in hPS cells, the phosphorylation of AKT, ERK-1/2, and GSK-3beta induced by FGF-2 with GFX was confirmed by western blotting analysis (XREF_SUPPLEMENTARY).	p(HGNC:FGF2)	directlyIncreases	act(p(HGNC:GSK3B))
ca471882-ed93-4db5-a98e-60b79de809f4	1.0	PubMed	7160451	In contrast to polystyrene, FN enabled radiation dependent induction of ILK and GSK-3beta in a PI3K independent manner.	p(HGNC:FN1)	directlyIncreases	act(p(HGNC:GSK3B))
0517a8ca-012c-4201-ad02-2f8d99070721	1.0	PubMed	9635432	The frat family consists of three members: frat-1, -2, and -3. It has been shown that different sites of frat-1 interact with gsk-3 and dvl-1 and that wnt-1 disintegrates the complex formation of frat-1, dvl-1, and axin, resulting in the activation of the wnt signaling pathway	p(HGNC:FRAT1)	directlyIncreases	act(p(HGNC:GSK3B))
56af069c-bcfc-4652-9a80-96f37ee2277d	1.0	PubMed	15708437	Moreover, insulin or insulin like growth factor-1 can trigger a rapid transient Fyn mediated activation of GSK-3beta, leading to increased tau phosphorylation in SH-SY5Y neuroblastoma cells, indicating that Fyn may be a key upstream regulator of tau phosphorylation.	p(HGNC:FYN)	directlyIncreases	act(p(HGNC:GSK3B))
56af069c-bcfc-4652-9a80-96f37ee2277d	1.0	PubMed	21281813	The Fyn tyrosine kinase can activate GSK-3beta, and because tau regulates intracellular localization of Fyn, it seems possible that absence of murine tau disturbs Fyn subcellular localization, leading to increased phosphorylation of Y216 GSK-3beta.	p(HGNC:FYN)	directlyIncreases	act(p(HGNC:GSK3B))
57bd88c8-181c-43f4-b6fc-2718b0cd1c5d	1.0	PubMed	27060477	GABA B R signaling repressed colorectal cancer cell proliferation by inhibiting activity of GSK-3beta.	a(PUBCHEM:119)	directlyIncreases	act(p(HGNC:GSK3B))
df018c10-a0f4-489b-a9c8-a1eb830934cd	1.0	PubMed	18216022	In contrast, GLP-1 agonists enhance Wnt signaling via GLP-1 receptor mediated activation of Akt and beta cell independent of GSK3beta.	p(HGNC:GCG)	directlyIncreases	act(p(HGNC:GSK3B))
ab87a697-e7e1-4f7d-a5bb-73fe385c2491	1.0	PubMed	PMC6619150	These results suggested that DIF-3 activates GSK-3beta to accelerate the proteolysis of cyclin D1 and that this mechanism is involved in the DIF-3-induced G(0)/G(1) arrest in mammalian cells.	p(HGNC:GGNBP2)	directlyIncreases	act(p(HGNC:GSK3B))
70c258d2-87bd-45dc-9bf5-693f2a7bd1ed	1.0	PubMed	21204008	Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3beta.	p(HGNC:GRN)	directlyIncreases	act(p(HGNC:GSK3B))
53890779-a567-44d4-8e82-a49364346f21	1.0	PubMed	19823589	The mammalian isoforms GSK3alpha and GSK3beta are functionally independent as GSK3alpha can not rescue the embryonically lethal phenotype of GSK3beta (-/-) mice XREF_BIBR.	p(HGNC:GSK3A)	directlyIncreases	act(p(HGNC:GSK3B))
53890779-a567-44d4-8e82-a49364346f21	1.0	PubMed	24984063	In fact, GSK3A is unable to rescue the lethal phenotype of GSK3B null mice : the animals die during embryogenesis as a result of liver degeneration caused by widespread hepatocyte apoptosis, where excessive TNF-alpha-mediated cell death occurs, due to reduced NFkB function XREF_BIBR.	p(HGNC:GSK3A)	directlyIncreases	act(p(HGNC:GSK3B))
53890779-a567-44d4-8e82-a49364346f21	1.0	PubMed	25875172	miR-375 overexpression downregulated GSK3alpha and beta levels and activity, and upregulated the inactive form of GSK3beta.	p(HGNC:GSK3A)	directlyIncreases	act(p(HGNC:GSK3B))
53890779-a567-44d4-8e82-a49364346f21	1.0	PubMed	18167338	Knockdown of GSK-3beta did not affect levels of GSK-3alpha (lane 3) demonstrating that stabilization of Cdc25A was due to loss of GSK-3beta rather than to loss of both GSK-3beta and GSK-3alpha.	p(HGNC:GSK3A)	directlyIncreases	act(p(HGNC:GSK3B))
cc2667f9-fcf8-4a30-ba3e-8dac0e0baeec	1.0	PubMed	24316184	Our observation that overexpression of WT-GSK3beta caused a slight increase in expression of COXII and VDAC () supports our hypothesis as GSK3 is reported to form stable complex with AMPK, and to phosphorylate AMPK independent of primed phosphorylation () so AMPK activity may become critically low by overexpression of WT-GSK3beta leading to a cellular metabolism shift toward anabolism.Collectively, the present study demonstrates that GSK3 is involved in 2-DG-mediated mitochondrial biogenesis through a proteolysis independent mechanism, and possibly through the regulation of transcription and translation processes in mitochondria.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AMPK))
f7b9df31-efc8-4c5b-85db-5aa2dd17b3fa	1.0	PubMed	21145761	As shown in D, overexpression of GSK3beta caused phosphorylation of wild-type TBK1 but not TBK1 (K38A), a kinase inactive mutant in which the ATP binding residue Lys38 was mutated to alanine.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1, var(p.Lys38Ala)))
2987993d-2482-4e18-9e00-87d3b9f5ec76	1.0	PubMed	21145761	We found that ablation of GSK3beta expression severely impaired virus triggered IkappaBalpha phosphorylation and degradation as well as NF-kappaB-mediated transcription.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
1e357180-ed94-4c31-badc-5815648fb6d9	1.0	PubMed	26274564	Reconstitution these MEFs with WT HA-GSK3beta and its phosphorylation mimetic mutant (HA-GSK3beta Y216E), but not GSK3beta Y216F mutant, also restored Wnt induced accumulation of beta-catenin, thus validating the positive role of GSK3beta Y216 phosphorylation in Wnt signaling.	p(HGNC:GSK3B, var(p.Tyr216Glu))	directlyIncreases	act(p(FPLX:Wnt))
760e568d-5810-4720-8c00-bae570e423dd	1.0	PubMed	26274564	Reconstitution these MEFs with WT HA-GSK3beta and its phosphorylation mimetic mutant (HA-GSK3beta Y216E), but not GSK3beta Y216F mutant, also restored Wnt induced accumulation of beta-catenin, thus validating the positive role of GSK3beta Y216 phosphorylation in Wnt signaling.	p(HGNC:GSK3B, var(p.Tyr216Phe))	directlyIncreases	act(p(FPLX:Wnt))
49902745-710a-4be1-b5a6-74d90cf540f1	1.0	PubMed	21145761	First, both the constitutively active mutant GSK3beta (S9A) and the inactive mutant GSK3beta (K85A) enhanced virus induced activation of IRF3 and the IFN-beta promoter as wild-type GSK3beta did in reporter assays.	p(HGNC:GSK3B, var(p.Lys85Ala))	directlyIncreases	act(p(HGNC:IFNB1))
49902745-710a-4be1-b5a6-74d90cf540f1	1.0	PubMed	21145761	Consistently, GSK3beta and its mutants GSK3beta (S9A) and GSK3beta (K85A) enhanced activation of the IFN-beta promoter and ISRE triggered by cytoplasmic poly (I : C) (A available online).	p(HGNC:GSK3B, var(p.Lys85Ala))	directlyIncreases	act(p(HGNC:IFNB1))
06ef9da1-900a-4517-8935-045cf5635f61	1.0	PubMed	21145761	First, both the constitutively active mutant GSK3beta (S9A) and the inactive mutant GSK3beta (K85A) enhanced virus induced activation of IRF3 and the IFN-beta promoter as wild-type GSK3beta did in reporter assays.	p(HGNC:GSK3B, var(p.Lys85Ala))	directlyIncreases	act(p(HGNC:IRF3))
33bf4837-eaaa-47c7-910d-cac584e575ea	1.0	PubMed	24929931	Expression of dominant negative GSK3beta (K85A) in the presence of G272V and model Hirano bodies lowered cell death to that expected of an additive effect of cell death induced by G272V+ model Hirano bodies alone.	p(HGNC:GSK3B, var(p.Lys85Ala))	directlyIncreases	act(bp(GO:"GO:0008219"))
56675571-f015-444d-aa42-828a71628779	1.0	PubMed	25528666	We firstly investigate the effect of GSK3beta K85M mutant on Sema3A induced axonal transport ().	p(HGNC:GSK3B, var(p.Lys85Met))	directlyIncreases	act(bp(GO:"GO:0006810"))
0c3776f7-ac93-4c51-ace4-6c02dbac3618	1.0	PubMed	25484286	However, overexpressing of GSK3beta S9A could significantly inhibit BDNF induced endogenous TrkB endocytosis, while overexpressing of GSK3beta R96A could significantly promote TrkB endocytosis (C, D), which confirmed our previous TrkB overexpression results.	p(HGNC:GSK3B, var(p.Arg96Ala))	directlyIncreases	act(p(HGNC:NTRK2))
4aa3229d-b693-47af-8dc4-8f20bfeae03e	1.0	PubMed	25484286	However, overexpressing of GSK3beta S9A could significantly inhibit BDNF induced endogenous TrkB endocytosis, while overexpressing of GSK3beta R96A could significantly promote TrkB endocytosis (C, D), which confirmed our previous TrkB overexpression results.	p(HGNC:GSK3B, var(p.Arg96Ala))	directlyIncreases	act(bp(GO:"GO:0006897"))
d37bf66b-a8e1-46d4-8199-8bfd241ef0d2	1.0	PubMed	21145761	First, both the constitutively active mutant GSK3beta (S9A) and the inactive mutant GSK3beta (K85A) enhanced virus induced activation of IRF3 and the IFN-beta promoter as wild-type GSK3beta did in reporter assays.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyIncreases	act(p(HGNC:IFNB1))
d37bf66b-a8e1-46d4-8199-8bfd241ef0d2	1.0	PubMed	21145761	Consistently, GSK3beta and its mutants GSK3beta (S9A) and GSK3beta (K85A) enhanced activation of the IFN-beta promoter and ISRE triggered by cytoplasmic poly (I : C) (A available online).	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyIncreases	act(p(HGNC:IFNB1))
3874c522-ea65-4bde-839e-a0b92b3486af	1.0	PubMed	21145761	First, both the constitutively active mutant GSK3beta (S9A) and the inactive mutant GSK3beta (K85A) enhanced virus induced activation of IRF3 and the IFN-beta promoter as wild-type GSK3beta did in reporter assays.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyIncreases	act(p(HGNC:IRF3))
16eb6880-840b-4f79-acae-ff763496f5d9	1.0	PubMed	24929931	In contrast, exogenous expression of GSK3beta (S9A) in the presence of 352WT or 352PHP causes significant potentiation of cell death compared to GSK3beta (S9A) alone.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyIncreases	act(bp(GO:"GO:0008219"))
16eb6880-840b-4f79-acae-ff763496f5d9	1.0	PubMed	24929931	Exogenous expression of GSK3beta (S9A) with either WT tau isoform or 352PHP in the presence of model Hirano bodies causes even further potentiation of cell death.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyIncreases	act(bp(GO:"GO:0008219"))
16eb6880-840b-4f79-acae-ff763496f5d9	1.0	PubMed	24929931	The effect of FTDP-17 mutant tau expression on cell death induced by GSK3beta (S9A) and model Hirano bodies was investigated.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyIncreases	act(bp(GO:"GO:0008219"))
16eb6880-840b-4f79-acae-ff763496f5d9	1.0	PubMed	24929931	GSK3beta (S9A) also significantly enhanced cell death in the presence of K18 or K18DeltaK280 compared to the sum of the expression of GSK3beta (S9A) and tau alone.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyIncreases	act(bp(GO:"GO:0008219"))
97bfa54d-a57b-4ac7-aff6-1bd0c7236a62	1.0	PubMed	22096483	G3DeltaEGF expressing cells also did not showed enhanced pJNK when treated with Docetaxel and enhanced GSK-3beta (S9P) when cultured in Doxorubicin as G3 expressing cells.	p(HGNC:GSK3B, var(p.Ser9Pro))	directlyIncreases	act(p(UP:P92208))
fead24f5-d497-4be7-a15a-986a6ca44f6a	1.0	PubMed	27283392	Mutations of GSK3beta phosphorylation sites Ser120 and Thr124 in RFX1 rescued the inhibition effect of GSK3beta.	p(HGNC:GSK3B, var(p.?))	directlyIncreases	act(p(HGNC:GSK3B))
fead24f5-d497-4be7-a15a-986a6ca44f6a	1.0	PubMed	27283392	Mutations of GSK3beta phosphorylation sites Ser120 and Thr124 in RFX1 rescued the inhibition effect of GSK3beta.	p(HGNC:GSK3B, var(p.?))	directlyIncreases	act(p(HGNC:GSK3B))
b6f2c67b-9d6a-4a89-b40c-e443d779701e	1.0	PubMed	24577092	Conversely, neutralizing mutations of the GSK3beta consensus enhanced MYOGENIN trans-activation of the muscle creatine kinase promoter, and also reduced the tumorigenic properties of ARMS cells (RH30) in a colony formation assay.	p(HGNC:GSK3B, var(p.?))	directlyIncreases	act(p(HGNC:MYOG))
5abf3604-5730-4162-bfca-6cd8e631fe23	1.0	PubMed	24577092	Conversely, neutralizing mutations of the GSK3beta consensus enhanced MYOGENIN trans-activation of the muscle creatine kinase promoter, and also reduced the tumorigenic properties of ARMS cells (RH30) in a colony formation assay.	p(HGNC:GSK3B, var(p.?))	directlyIncreases	act(a(PUBCHEM:586))
b28be6f8-c8ac-4912-9b2f-ab7beea608fd	1.0	PubMed	23273980	Consistently, expression of a kinase-inactive (KI) mutant of GSK3beta also led to beta-catenin-activated transcription in cells cultured with high glucose (F).	p(HGNC:GSK3B, var(p.?))	directlyIncreases	act(bp(GO:"GO:0006351"))
fb2f0262-fa21-40f4-a548-190d1bb3b6f5	1.0	PubMed	10653665	Thr 446 and Ser 450, which are phosphorylated by glycogen synthase kinase-3 (GSK-3).  Phosphorylation resulted in a 6-fold increase in V(max) and the conversion of citrate dependence from sigmoidal, displaying negative cooperativity, to hyperbolic.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ACLY))
fb2f0262-fa21-40f4-a548-190d1bb3b6f5	1.0	PubMed	10653665	Thr 446 and Ser 450, which are phosphorylated by glycogen synthase kinase-3 (GSK-3)	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ACLY))
b7de46b0-a02b-467f-9c07-16b7ebeb5fe1	1.0	PubMed	25219467	Cross talk of GSK-3beta and PP2A may also contribute to tau hyperphosphorylation in AD brain.	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF09793))
0bcba3fb-012c-4a62-b7ee-be09e5978d9e	1.0	PubMed	15910743	These data imply that modulation of GSK-3beta activity mediates the effect of AICAR on IL-2.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:18406))
f362f6cb-77a9-467f-9db3-684490da1b6d	1.0	PubMed	22814751	Inhibition of GSK-3beta reversed the inhibitory effects of Akt3 knockout and inhibitors of Akt or PI3K on platelet spreading, indicating that GSK-3beta is a downstream target of Akt in outside-in signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AKT3))
8c3a3203-b789-4a13-be17-aef050f86d49	1.0	PubMed	26945965	GSK-3beta (Ser9) is a downstream target of p-AKT and can inactivate a broad range of substrates, including beta-catenin, glycogen synthase, cyclin D1, Mcl-1, c-myc, c-jun, tau, notch and HIF-1.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT, pmod(Ph)))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	25645159	Activated Akt can induce phosphorylation of glycogen synthase kinase 3beta (GSK3beta), a key component of glycogen synthesis, at the serine residues and thus inactivate its kinase activity, which leads to glycogen production by activation of glycogen synthase [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	17316652	In agreement with this, in diabetic IMA () we found a pronounced decrease in the phosphorylation level of GSK3beta, which is a Akt effector, that mediates the Akt signal to cyclin D1.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	24391209	Activated Akt phosphorylates and inhibits the activity of glycogen synthase kinase-3beta (GSK3beta), a substrate for Akt (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	14636889	Swedish amyloid precursor protein 751 may mediate other specific signal (s) that lead to the inhibition of Akt and PKB activity.Knowing that GSK3beta is a direct target of Akt and PKB, we determined whether the inhibition of Akt and PKB activity by Swedish amyloid precursor protein 751 or by Wortmannin was translated to a downstream effect on GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	22705009	Activated Akt has been shown to be capable of phosphorylating and inactivating GSK3beta, leading to nuclear translocation and activation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	19492080	Activated Akt has been demonstrated to be capable of phosphorylating and inactivating GSK3-beta, leading to nuclear translocation and activation of beta-catenin XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	19492080	Together, these experiments demonstrate that Akt effects on mammary stem and progenitor cells are mediated by GSK3-beta and beta-catenin signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	18782353	These results confirm that GSK3beta is a downstream target of Akt, whereas PDK1 is upstream of Akt in the signalling pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	25889792	Next we aimed to identify the responsible transcription factor downstream of the PI3K and Akt signaling cascade which is activated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	23762398	In addition, the phosphorylation levels of certain Akt downstream targets such as GSK-3beta and Foxo1/3a were also decreased following NBS1 knockdown (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	21347395	Our result showed that the expression level of pAkt Serine 473 and pGSK3beta were increased in NT control clone upon insulin stimulation, indicating that insulin could successfully activate Akt and GSK3beta in BEL7402.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	26826001	The up-regulation of hepatic IGF-1R requires the activation of GSK-3beta and FoxO3a, and both GSK-3beta and FoxO3 are downstream targets of AKT.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	20933441	Receptor mediated activation of PI3K family kinases generates inositol phospholipids that activate the protein kinase Akt, which phosphorylates multiple substrates including Foxo transcription factors, glycogen synthase kinase (GSK3beta), and the mammalian target of rapamycin (mTOR).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	22922215	Therefore, IGF1 might activate PI3K and Akt signaling and its downstream mediators, such as GSK3beta and mTOR, to induce beta-catenin-dependent transcription including the transcription of Snail and Slug.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	20599907	As GSK3beta is the downstream target of Akt, we hypothesized that GSK3beta may also participate in the regulation of Smad3 mediated cellular function.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	20818790	Activated Akt then phosphorylates GSK-3beta, thus inactivating it and, in turn, preventing phosphorylation of tau protein.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	25247763	When compared to the kinase substrate databases described above, 16 proteins were known AKT substrates (Supplementary Data 7) including well studied molecules in AKT signaling such as GSK3A, GSK3B, AKT1S1, EPHA2 and PFKFB2.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	19176518	To distinguish between these possibilities, we combined inhibition or knockdown of Akt1, Akt2, and Akt3, analyzing the canonical Akt targets Gsk3beta and tuberous sclerosis complex 2 (Tsc2) (XREF_BIBR) and the mTOR target rpS6 (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	26267533	shRNA knockdown increased phospho-AKT (pAKT) and pAKT relative to total AKT and phospho-GSK3beta and GSK3beta following epidermal growth factor (EGF) stimulation, suggesting PIPP suppresses AKT signaling in breast cancer cells (H).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	11483158	Activated PKB then phosphorylates GSK3beta, inhibiting GSK3 kinase activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	24463007	Furthermore, phosphorylation of GSK3beta at Serine residue 9, mediated by AKT, was significantly increased, demonstrating downstream activity of AKT.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	15183529	The results are consistent to the previous findings with cultured cell lines or mouse primary cells that BAD and GSK-3beta are downstream targets of Akt.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	22728329	In HT-29 cells over expressing the EP4 receptor, PGE was linked predominantly to cAMP signaling, while in HEK293T cells programmed to ectopically express the EP2 receptor, PGE induced solely the phosphorylation of GSK-3beta activation of PKB and Akt.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	20548028	Activated Akt, in turn, phosphorylates and inactivates a serine/threonine kinase, glycogen synthase kinase-3beta (GSK3beta), at Ser9 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
d490c101-c7f7-4530-8e9e-bd83b92ebb68	1.0	PubMed	26797279	Our data showed that vIRF2 induces activation of PDK1 and Akt, but not GSK3beta, a downstream factor of the Akt signaling pathway (B).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AKT))
99b9bb16-c601-4fad-8d42-4f3e612fce7d	1.0	PubMed	26399460	In addition, the ALDH1 activity and sphere forming ability of CD44 (high) / ALDH1 (high) cells was significantly inhibited by GSK3beta knockdown.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ALDH1A1))
8ac1648f-ec2b-4952-88fb-0f51512a81b8	1.0	PubMed	22214783	This study demonstrated that suppression of GSK-3beta activity, through specific inhibitors, dramatically down-regulated Abeta generation in human SH-SY5Y and SH-SY5Y-AbetaPP695 cells by enhancing AMPK activity to down-regulate Abeta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AMPK))
3b84941b-ef1f-4757-9108-f7826e0ca9a9	1.0	PubMed	21737790	Phosphorylation of GSK-3beta suppresses opening of the mitochondrial permeability transition pore (mPTP) by binding to adenine nucleotide translocase (ANT) and thereby reducing the affinity of ANT for cyclophilin D 2.	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF03374))
9785d2b0-6f15-434f-84fd-b857826aa9c6	1.0	PubMed	18606491	GSK3beta directly modulates the activity of transcription factors, activator protein 1 (AP-1) and nuclear factor-kappaB (NF-kappaB).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AP1))
54635159-6e21-44a8-a193-23396599c0cf	1.0	PubMed	15652488	Inactivation of GSK-3beta by NT-3 and BDNF may induce the interaction of APC with microtubules, thereby stabilizing microtubules.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APC))
54635159-6e21-44a8-a193-23396599c0cf	1.0	PubMed	15327768	To assess if phosphorylation of 1504, 1507, and 1510 depends upon mutual priming of the APC R3 substrate by both kinases, unphosphorylated APC R3 was treated with CK1, GSK-3beta, or both CK1 and GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APC))
54635159-6e21-44a8-a193-23396599c0cf	1.0	PubMed	20519433	As before, loss of cell-cell adhesion increased the percent of HUVECs with APC clusters, whereas inhibition of GSK3beta and CKI decreased APC clusters (XREF_FIG E).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APC))
54635159-6e21-44a8-a193-23396599c0cf	1.0	PubMed	12554650	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APC))
54635159-6e21-44a8-a193-23396599c0cf	1.0	PubMed	15327768	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APC))
54635159-6e21-44a8-a193-23396599c0cf	1.0	PubMed	10698523	Gsk-3beta-dependent phosphorylation of apc.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APC))
b3498c99-c4ae-4563-85ae-8a654fe1bc86	1.0	PubMed	22214783	This study demonstrated that suppression of GSK-3beta activity, through specific inhibitors, dramatically down-regulated Abeta generation in human SH-SY5Y and SH-SY5Y-AbetaPP695 cells by enhancing AMPK activity to down-regulate Abeta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APP))
b3498c99-c4ae-4563-85ae-8a654fe1bc86	1.0	PubMed	23202730	We now report that specific inhibition of GSK3beta, but not GSK3alpha, reduced BACE1 mediated cleavage of APP and Abeta production by decreasing BACE1 gene transcription and expression.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APP))
b3498c99-c4ae-4563-85ae-8a654fe1bc86	1.0	PubMed	4351465	These findings suggest that GSK-3 beta activity may indirectly increase cellular maturation of APP, which may subsequently result in altered production of beta-amyloid protein.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APP))
b3498c99-c4ae-4563-85ae-8a654fe1bc86	1.0	PubMed	27343974	Studies have shown that Abeta production is promoted by active GSK3beta (sometimes GSK3alpha) and reduced by GSK3 inhibitors.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APP))
b3498c99-c4ae-4563-85ae-8a654fe1bc86	1.0	PubMed	22290178	Numerous reports have also convincingly established that GSK-3beta inhibition attenuates APP processing and inhibits hyperphosphorylated tau protein associated neurodegeneration in and AD models ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:APP))
442818b4-1711-463b-bef5-52ee6f81977c	1.0	PubMed	21887250	Further manipulation of GSK3beta showed that increased active GSK3beta by expressing its constitutive active mutant form enhanced HB9 expression, whereas inhibitory manipulations of GSK3beta by RNAi or inhibitors decreased HB9, confirming that GSK3beta was required for proper HB9 expression.	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:O04292))
d460ab13-1ae0-4dd3-8776-64e647f869f2	1.0	PubMed	17241872	Consistently, examination of protein expression by immunoblot revealed that the 54/58 SA mutant of Hath1 (54/58SA), but not the wild type, showed stable protein expression without inhibition of GSK3beta by BIO treatment.These data collectively indicated that the kinase activity of GSK3beta is critically required for the degradation of Hath1 in colon cancer cells and also that the 54th and 58th serine residues of the Hath1 protein are critically required for GSK3beta mediated Hath1 proteolysis.Former findings raised an important question as to how the kinase function of GSK3beta for Hath1 proteolysis is regulated by the upstream signaling events in colon cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ATOH1))
9d4c16d9-617a-4707-ac20-f82e0490f852	1.0	PubMed	23184735	GSK3beta catalyzes the transfer of gamma-phosphate of ATP to the unique substrate Ser/Thr residues with the assistance of two natural activating cofactors Mg (2+).	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:15422))
9d4c16d9-617a-4707-ac20-f82e0490f852	1.0	PubMed	18045539	In vitro phosphorylations were performed in two stages, and it was found that GSK3beta caused the incorporation of [gamma-P] ATP by Smad1 linker protein, but only after prephosphorylation by Erk and MAPK (K, compare lanes 2 and 4).	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:15422))
9d4c16d9-617a-4707-ac20-f82e0490f852	1.0	PubMed	5663271	Among the MT associated kinases, GSK3beta and cdk5 most readily contribute to the ATP induced " AD like " phosphorylation of tau.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:15422))
9d4c16d9-617a-4707-ac20-f82e0490f852	1.0	PubMed	22142472	Although NT-STK38 was slightly phosphorylated by GSK-3beta alone (C, lane 3), when NT-STK38 was first pretreated with PKA in the presence of non radioactive ATP and then treated with GSK-3beta in the presence of [gamma-P] ATP, GSK-3beta effectively phosphorylated it (C, lanes 4 and 5).	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:15422))
733bff2f-3cf4-4624-b67c-125df35b9735	1.0	PubMed	10581160	Axin residues T609 and S614 are physiological GSK3beta targets. Axin phosphorylation in the regulation of b-catenin stability. When active (left), GSK3b phosphorylates Axin as well as APC and b-catenin. The phosphorylated form of Axin binds strongly to b-catenin and promotes the phosphorylation of b-catenin by GSK3b, leading to strong interaction with b-TrCP	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AXIN1))
733bff2f-3cf4-4624-b67c-125df35b9735	1.0	PubMed	10581160	Axin residues T609 and S614 are physiological GSK3beta targets. Axin phosphorylation in the regulation of b-catenin stability. When active (left), GSK3b phosphorylates Axin as well as APC and b-catenin. The phosphorylated form of Axin binds strongly to b-catenin and promotes the phosphorylation of b-catenin by GSK3b, leading to strong interaction with b-TrCP	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AXIN1))
733bff2f-3cf4-4624-b67c-125df35b9735	1.0	PubMed	23579495	Phosphorylation by GSK3 kept Axin activated (open) for _-catenin interaction and poised for engagement of LRP6.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AXIN1))
733bff2f-3cf4-4624-b67c-125df35b9735	1.0	PubMed	10318824	From the binding experiments, we defined the domains of Axin that bind glycogen synthase kinase-3beta (GSK-3beta) and beta-catenin. We also examined the ability of each Axin mutant to inhibit lymphoid enhancer factor-1 (Lef-1) reporter activity in a cell line expressing high levels of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AXIN1))
733bff2f-3cf4-4624-b67c-125df35b9735	1.0	PubMed	9734785	Interaction with beta-catenin and GSK-3beta was required for the Axin-mediated beta-catenin reduction.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AXIN1))
733bff2f-3cf4-4624-b67c-125df35b9735	1.0	PubMed	20870744	In the canonical pathway, Wnt activation of Fzd results in disheveled (dsh)-mediated degradation of axin and GSK-3beta inhibition.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AXIN1))
733bff2f-3cf4-4624-b67c-125df35b9735	1.0	PubMed	12554650	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AXIN1))
733bff2f-3cf4-4624-b67c-125df35b9735	1.0	PubMed	15327768	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:AXIN1))
5a7fc550-53aa-445d-82d4-26d2035e25ee	1.0	PubMed	19107203	Whereas GSK3beta bound to LRP6 or 5 in the absence of Axin in yeast two-hybrid experiments XREF_BIBR, XREF_BIBR, GSK3beta dramatically increased the interaction of Axin with LRP6 or 5 in cells and in vitro XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AXIN))
5a7fc550-53aa-445d-82d4-26d2035e25ee	1.0	PubMed	19107203	Furthermore, we observed that an Axin fragment including the GBD was bound to the LRP6 miniCL fragment only when GSK3beta was co-incubated (XREF_FIG), demonstrating that GSK3beta mediates the association of the Axin fragment with the LRP6 intracellular region.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:AXIN))
7e1abe94-d749-45ec-880e-309eda72cf5a	1.0	PubMed	23202730	We now report that specific inhibition of GSK3beta, but not GSK3alpha, reduced BACE1 mediated cleavage of APP and Abeta production by decreasing BACE1 gene transcription and expression.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BACE1))
14c0f3f9-6448-4d1d-b78b-8b183353193a	1.0	PubMed	15525785	Glycogen synthase kinase-3beta phosphorylates bax and promotes its mitochondrial localization during neuronal apoptosis. Gsk-3beta directly phosphorylated bax(alpha) on ser163	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BAX))
14c0f3f9-6448-4d1d-b78b-8b183353193a	1.0	PubMed	25591548	Modulation of GSK3beta expression can markedly increase p53 dependent activation of Bax, leading to cytochrome c release and initiation of the intrinsic apoptotic pathway (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BAX))
571a6585-20a6-448a-8169-f89a80831496	1.0	PubMed	22262180	Gsk3b phosphorylates bcl2l12 at s156. Ectopic expression of gfp-fused bcl2l12 or bcl2l12a in u87mg cells leads to repression of apoptotic markers and protects against staurosporine (sts) insults, indicating an antiapoptotic role for both bcl2l12 and bcl2l12a. In contrast, no anti-apoptotic ability was seen in bcl2l12(s156a)	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BCL2L12))
df022cf7-0e07-4b8e-9edb-d0088d3a8a7e	1.0	PubMed	7260269	Addition of guanosine caused a rapid phosphorylation of Akt and PKB, and glycogen synthase kinase-3beta (GSK-3beta) and induced an upregulation of Bcl-2 mRNA and protein expression.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BCL2))
df022cf7-0e07-4b8e-9edb-d0088d3a8a7e	1.0	PubMed	24327518	It has also been shown that GSK-3beta contributes to the maintenance of active chromatin at Bcl-2 and XIAP promoters, allowing p65 binding and transcriptional activation of Bcl-2 and XIAP in cancer cells (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BCL2))
04262577-37cb-4b91-9239-024ea4133c20	1.0	PubMed	23243017	Parallel studies revealed that GSK3alpha or GSK3beta shRNA knockdown also significantly reduced BEZ235 and ABT-737-mediated caspase-3 and PARP cleavage (XREF_FIG), and cell death (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:71952))
abeba3a7-be29-4e96-9d0a-4400f600cc2a	1.0	PubMed	27537208	GSK3beta may up-regulate BK channels, an effect disrupted by Lithium or additional expression of PKB and possibly participating in the regulation of cell volume and excitability.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:439201))
17a4c45d-b06d-4afc-a764-3e26f6599dd9	1.0	PubMed	23442801	It suggests that gsk3_ activity is required for hbora-mediated mitotic entry through ser274 and ser278 phosphorylation	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BORA))
17a4c45d-b06d-4afc-a764-3e26f6599dd9	1.0	PubMed	23442801	It suggests that gsk3_ activity is required for hbora-mediated mitotic entry through ser274 and ser278 phosphorylation	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BORA))
9b51e827-bbf2-493f-a345-dd38f3880d29	1.0	PubMed	26935904	However, whether beta-TrCP is directly regulated by GSK-3beta has not yet been explored.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:BTRC))
f10eb8e2-3b44-4e02-9ccf-397471d5d040	1.0	PubMed	21887250	Since inhibiting the PI3K and Akt cascade resulted in decreased phosphorylation of GSK3beta Ser9 and increased MN differentiation from hNSCs, we then asked if the increase in HB9 expression was due to the increase in GSK3beta activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CA9))
8e6c6b41-701c-42a5-97e9-1f8a2d3fc90f	1.0	PubMed	23301033	Inhibition of PI3K and AKT or overexpression of PTEN or GSK-3beta failed to impair vIL-6 induction of angiogenesis and tumorigenesis in CAM and nude mice allograft models, indicating that vIL-6 might exert its biological function mainly via JAK and STAT signal rather than PI3K and AKT signal XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CALM1))
d91dcbc9-1366-43c6-a848-d83dd1f13c22	1.0	PubMed	25541373	Emerging evidence also suggests that GSK-3beta, is an important modulator of apoptosis, with the inactivation of GSK-3beta shown to mediate cAMP evoked neuroprotection from serum deprivation and a lowering of the KCl concentration in rat cerebellar granule neurons ().	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:17489))
4881bd3c-959b-459e-ac54-4debb2d22d31	1.0	PubMed	20962236	GSK-3beta inhibition prevented Tat induced increases in membrane DAT and membrane calpain activity, highlighting mechanisms by which GSK-3beta inhibitors may confer neuroprotective benefits for DAergic symptoms in HAND (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:CAPN))
4881bd3c-959b-459e-ac54-4debb2d22d31	1.0	PubMed	20962236	Tat increased PM DAT and calpain activity are blocked by the RyR antagonists ryanodine and dantrolene, the calpain inhibitor calpastatin, and by a specific inhibitor of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:CAPN))
883542a1-ad7a-4275-8522-be4a16dfcba4	1.0	PubMed	6459568	Activation of GSK3beta was obligatory for thapsigargin induced activation of caspase-3, because inhibition of GSK3beta by expression of dominant negative GSK3beta or by the GSK3beta inhibitor lithium blocked caspase-3 activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CASP3))
883542a1-ad7a-4275-8522-be4a16dfcba4	1.0	PubMed	23243017	Parallel studies revealed that GSK3alpha or GSK3beta shRNA knockdown also significantly reduced BEZ235 and ABT-737-mediated caspase-3 and PARP cleavage (XREF_FIG), and cell death (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CASP3))
883542a1-ad7a-4275-8522-be4a16dfcba4	1.0	PubMed	18540881	In SH-SY5Y neuroblastoma cells, overexpression of active JNK and GSK-3beta increased caspase-3 activation and cytotoxicity more than overexpression of tau alone.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CASP3))
883542a1-ad7a-4275-8522-be4a16dfcba4	1.0	PubMed	14523002	After DNA damage, mitochondrial GSK3beta co-immunoprecipitated with p53 and was activated, and inhibition of GSK3beta blocked cytochrome c release and caspase-3 activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CASP3))
883542a1-ad7a-4275-8522-be4a16dfcba4	1.0	PubMed	12228224	Activation of GSK3beta was obligatory for thapsigargin induced activation of caspase-3, because inhibition of GSK3beta by expression of dominant negative GSK3beta or by the GSK3beta inhibitor lithium blocked caspase-3 activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CASP3))
198023e5-18ef-432f-a5fa-a349974a58b6	1.0	PubMed	18606491	The intrinsic apoptotic signaling cascade can be induced by numerous stimuli that cause cell damage, such as DNA damage, oxidative stress and endoplasmic reticulum (ER) stress; GSK3beta promotes this cascade by facilitating signals that cause disruption of mitochondria and by regulating transcription factors that control the expression of anti- or pro apoptotic proteins.The extrinsic apoptotic pathway, on the other hand, is mediated by the activation of cell-surface death domain containing receptors (DRs) and initiates apoptosis by activating caspase-8.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CASP8))
3d02b8e4-b166-4776-99e0-7f5d0a4749eb	1.0	PubMed	25829335	Compatibly, Petit-Paitel et al. have depicted that either pharmacological or genetically inhibition of GSK-3beta (LiCl and kenpaullone, and RNA interference) could abrogate MPP+ mediated mitochondrial membrane potential changes and subsequent caspase-9 and -3 activations.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CASP9))
f64ab671-726f-45af-883a-a75e07c86341	1.0	PubMed	27057280	The downstream signals AKT and GSK-3beta mediated CCL21 induced the upregulation of Snail due to the fact that CCL21 treatment can obviously phosphorylate both AKT and GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CCL21))
519858a7-a101-4df5-8106-949ab4ebe34f	1.0	PubMed	27572267	To determine whether GSK3beta mediated PD-L1 destabilization affects cancer cell immunosuppression, we compared the immunosuppression activity of PD-L1 WT and 3SA both in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CD274))
d66193a7-565a-4575-adb1-b2abae369de3	1.0	PubMed	19734233	Our data support this concept, as the direct inactivation of GSK3beta in human memory CD4 + T cells via either pharmacological inhibition or genetic silencing augmented the cellular c-Jun levels present in memory CD4 + T cells upon TCR activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CD4))
15d50b0d-0e2a-4422-8041-60103cbfd9ce	1.0	PubMed	18167338	Here, we demonstrate that the ability of cells to efficiently degrade Cdc25A in response to genotoxic stress also requires GSK-3beta activity and that GSK-3beta cooperates with Chk1 to target Cdc25A for degradation in response to IR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDC25A))
15d50b0d-0e2a-4422-8041-60103cbfd9ce	1.0	PubMed	18167338	Endogenous Cdc25A also accumulated in cells treated with other GSK-3beta specific inhibitors, including 1-Azakenpaullone, SB216763, and SB415286 (data not shown) ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDC25A))
15d50b0d-0e2a-4422-8041-60103cbfd9ce	1.0	PubMed	18167338	If GSK-3beta promotes the turnover of Cdc25A in vivo, then treatment of cells with GSK-3beta-specific inhibitors is expected to prolong the half-life of Cdc25A.As seen in, both Cdc25A and beta-catenin were stabilized in cells treated with either LiCl (A) or GSK-3beta-specific siRNAs (B).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDC25A))
c8eef53f-46cd-4bed-8efb-9bc6d10b4a6a	1.0	PubMed	19107233	Recently, inhibition of the PI3K-Akt downstream target, GSK-3beta, by either inhibitor or siRNA treatment decreased cdc6 and cyclin E2 ex-pression, and this inhibition was suggested to be mediated through E2F in prostate cancer cells [36].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDC6))
704782e7-a3e9-4e7e-b797-9248f3903992	1.0	PubMed	19274078	Inhibition of GSK3beta with BIO stabilized beta-catenin, and like LiCl, reduced cadherin-11 mRNA and protein accumulation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDH11))
d4773b4d-f1da-49da-a75e-3a33fbc05d6a	1.0	PubMed	10671552	Phosphorylation of the E-cadherin Cytoplasmic Domain by CKII and GSK-3β Increases the Binding to β-catenin. pre-phosphorylation by CKII at Ser-855 and/or Ser-853 of E-cadherin is required before GSK-3β can phosphorylate at Ser-849.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDH1))
d4773b4d-f1da-49da-a75e-3a33fbc05d6a	1.0	PubMed	23959174	In a control experiment, we confirmed that ectopic expression of N-terminal Flag tagged Snail (Flag-Snail) induced E-cadherin suppression (XREF_FIG) and that expression of GSK3beta-HA inhibited the Snail mediated suppression of E-cadherin (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDH1))
541512d0-312e-4ee5-bb93-af022bfbd930	1.0	PubMed	22928011	Another mechanism by which Akt can promote cell proliferation is to phosphorylate and inactivate GSK3beta, thus protecting cyclin D1, enhancing CDK4 and CDK6 activity, and facilitate cell entry into S phase of the cell cycle XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDK4))
97e6d776-5b5e-4389-ab96-688e1fe19838	1.0	PubMed	22928011	Another mechanism by which Akt can promote cell proliferation is to phosphorylate and inactivate GSK3beta, thus protecting cyclin D1, enhancing CDK4 and CDK6 activity, and facilitate cell entry into S phase of the cell cycle XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDK6))
3411a2ef-14b0-4ddf-bcb0-f14e557e702a	1.0	PubMed	23085750	Based on transient transfection, GSK3beta augments the transactivation of a p21 promoter luciferase by KLF6.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDKN1A))
3411a2ef-14b0-4ddf-bcb0-f14e557e702a	1.0	PubMed	23085750	GSK3beta augmented the transactivation by wild-type KLF6, but not KLF6-4A, towards the p21 promoter, and increased p21 protein.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CDKN1A))
32b82450-6c0f-43a9-9513-018c9ad61499	1.0	PubMed	19956800	However, GSK3beta shares a 30% homology with CDK9 (unpublished data) and pharmacological GSK3beta inhibitors often also target CDKs and vice versa XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:CDK))
a272608b-c6dd-4e4b-9d4f-daf1570c211e	1.0	PubMed	21038412	The activated GSK-3beta not only repressed cell proliferation, but also activated C/EBPalpha, which maintained miR-122 levels and thereby enforced IGF-1R suppression.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CEBPA))
a272608b-c6dd-4e4b-9d4f-daf1570c211e	1.0	PubMed	10567568	Glycogen synthase kinase 3 (GSK3) phosphorylates T222 and T226, causing a conformational change in C/EBPα. GSK3-mediated phosphorylation does not, in itself, dramatically alter the activity of C/EBPα in our assays. phosphorylation of C/EBPalpha and other substrates by GSK3 may be required for adipogenesis, since treatment of differentiating preadipocytes with lithium inhibits their conversion to adipocytes.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CEBPA))
a272608b-c6dd-4e4b-9d4f-daf1570c211e	1.0	PubMed	10567568	Glycogen synthase kinase 3 (GSK3) phosphorylates T222 and T226, causing a conformational change in C/EBPα. GSK3-mediated phosphorylation does not, in itself, dramatically alter the activity of C/EBPα in our assays. phosphorylation of C/EBPalpha and other substrates by GSK3 may be required for adipogenesis, since treatment of differentiating preadipocytes with lithium inhibits their conversion to adipocytes.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CEBPA))
bf7f2c16-1a50-4c3e-b11f-fdd1f8857f47	1.0	PubMed	17601773	However, the acquisition of dna binding and transactivation capacity of c/ebpbeta is delayed until further phosphorylation (on ser(184) or thr(179)) by gsk3beta occurs.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CEBPB))
bf7f2c16-1a50-4c3e-b11f-fdd1f8857f47	1.0	PubMed	22369944	However, the acquisition of dna binding and transactivation capacity of c/ebpbeta is delayed until further phosphorylation (on ser(184) or thr(179)) by gsk3beta occurs.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CEBPB))
bf7f2c16-1a50-4c3e-b11f-fdd1f8857f47	1.0	PubMed	22355693	We found that expression of srebf1a depended on GSK3β activity and that GSK3β activity was necessary for C/EBPβ phosphorylation at Thr188	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CEBPB))
bf7f2c16-1a50-4c3e-b11f-fdd1f8857f47	1.0	PubMed	22369944	However, the acquisition of dna binding and transactivation capacity of c/ebpbeta is delayed until further phosphorylation (on ser(184) or thr(179)) by gsk3beta occurs.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CEBPB))
f9abdd7d-d9df-4dac-9ed2-f7c3fa5dbf27	1.0	PubMed	17991736	Here we report that CIITA represses collagen transcription through a phosphorylation-dependent interaction between its proline/serine/threonine domain and co-repressor molecules such as histone deacetylase (HDAC2) and Sin3B. Mutation of a serine (S373A) in CIITA, within a glycogen synthase kinase 3 (GSK3) consensus site, decreases repression of collagen transcription by blocking interaction with Sin3B	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CIITA))
2cbbd534-3c0c-48c1-97d7-c0f30ef39566	1.0	PubMed	26531156	It is speculated that the Cks1- and Cks2 regulated Akt and GSK-3beta signaling activity underlies the oncogenic activities of both Cks1 and Cks2.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CKS1B))
5ff1d5b5-b60e-4695-85ea-03ed24ee4aad	1.0	PubMed	26531156	It is speculated that the Cks1- and Cks2 regulated Akt and GSK-3beta signaling activity underlies the oncogenic activities of both Cks1 and Cks2.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CKS2))
53726a6d-2a1f-49c7-8d1f-6d2c3dd70a96	1.0	PubMed	23045552	Curiously, as in interphase, GSK3beta inhibition with lithium chloride also caused a slight reduction in CLASP2 band shift during mitosis, but in a less prominent way compared with that observed upon Cdk1 and/or Plk1 inhibition.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CLASP2))
6fadb234-794a-445c-bb98-b0ed77c15d07	1.0	PubMed	22174377	These findings are similar to the GSK3beta mediated phospho-ubiquitin clock previously described for the related coregulator SRC-3.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CLOCK))
1201612e-42b8-41ae-8317-e976c2902ab8	1.0	PubMed	25829335	GSK-3beta mediate some signaling pathway in the innate and adaptive CNS immune systems, and studies on innate immune system have shown that several signaling pathways in this system also regulates GSK-3beta activity.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:11006))
c27eef9f-c49c-4adb-9561-a2ac4c48cfa3	1.0	PubMed	16054087	Furthermore, siRNA mediated inactivation of GSK-3beta in HeLa and U2OS cells reduced the phosphorylation of T426 and S430 in endogenous SREBP1 (D), confirming that GSK-3beta targets the CPD motif in SREBP1.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CPD))
cafb811c-b98e-4a09-82eb-ac5728887b9d	1.0	PubMed	12162494	GSK-3 can phosphorylate CREB at S129  Transactivation of CREB is significantly reduced (p ≤ 0.05) by 86% for the S129A mutant	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CREB1))
f421a5af-6cb7-43a6-895b-547ef156922d	1.0	PubMed	19019440	The inactivation of GSK3-beta induces the release of CREB, which moves to the nuclear compartment and sequestrates CBP.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:CREB))
c9a7116a-ed4a-451c-9289-326dbbbbfc12	1.0	PubMed	16611631	Using in vitro kinase assays and pharmacological inhibition of gsk3 as described above for crmp2 and crmp4, it was found that thr509 (and presumably ser518 and thr514) of human crmp1 is phosphorylated by gsk3, following priming of ser522 by cdk5	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CRMP1))
c9a7116a-ed4a-451c-9289-326dbbbbfc12	1.0	PubMed	16611631	In summary, phosphorylation of thr509 of human crmp1 appears to be regulated by two mechanisms; direct phosphorylation by cdk5, or by priming of ser522 by cdk5 followed by sequential phosphorylation of ser518, thr514, and thr509 by gsk3.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CRMP1))
c9a7116a-ed4a-451c-9289-326dbbbbfc12	1.0	PubMed	16611631	Using in vitro kinase assays and pharmacological inhibition of gsk3 as described above for crmp2 and crmp4, it was found that thr509 (and presumably ser518 and thr514) of human crmp1 is phosphorylated by gsk3, following priming of ser522 by cdk5	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CRMP1))
f25b47a6-c4d6-4765-9c00-74fc76524120	1.0	PubMed	23820376	Because alleviated levels of GSK3beta eliminated G-CSFR and we hypothesized that GSK3 may phosphorylate G-CSFR in its CPDs for its recognition by Fbw7, we therefore assessed if GSK3beta mediated downregulation of G-CSFR is dependent on Fbw7.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CSF3R))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25749038	Less active GSK3beta enhanced activation of Wnt and beta-catenin pathway and resultant WISP1 expression; in turn, increased WISP1 expression further led to phosphorylation and inactivation of GSK3beta, which eventuated in a strong positive feedback loop of WISP1 expression and concomitant refractory radioresistance.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26739898	Phosphorylation and inactivation of GSK-3beta prevents beta-catenin degradation and results in cytosolic accumulation and eventual nuclear translocation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	23211630	Taken together, these results suggest that bFGF might increase proliferation of SH-SY5Y cells through the inactivation of GSK-3beta and following upregulation of beta-catenin pathway and that ROCK2 might mediate bFGF induced proliferation of SH-SY5Y cells through the activation of GSK-3beta and following downregulation of the beta-catenin pathway ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	24971537	Secreted Wnt ligands bind Frizzled and LRP5/6 transmembrane receptors to prevent degradation of beta-catenin in the cytoplasm by sequestering it away from the destruction complex consisting of APC (the adenomatous polyposis coli gene product), glycogen synthase kinase-3beta (GSK-3beta) and Axin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26211576	In this signal pathway, inactivation of GSK3beta allowing beta-catenin to translocate into the nucleus where it engages in the Tcf/Lef transcription factor complex and acts as master switch to activate transcription of a large number of target genes, including cyclinD1, c-myc, and CRDBP that regulate cells proliferation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	22496417	The local inactivation of GSK-3beta also seems to cause accumulation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	14636889	Specifically, we assessed GSK3beta mediated beta-catenin destabilization in the both the HEK293 and Alzheimer 's disease lymphoblast lines.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	24127488	It is likely that PKC, a downstream effector of PLCgamma2, phosphorylates and thus inactivates GSK3beta, a kinase that targets beta-catenin for ubiquitination and subsequent proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25632266	beta-catenin is upregulated by the AKT and GSK3beta pathway, which thereby triggers the cell cycle by enhancing cyclin D1 expression XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	21239435	It also attenuated GnRH-II induced trans-activation of a beta-catenin-dependent reporter gene, most likely because GSK3beta phosphorylation promotes translocation of beta-catenin to the nucleus.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	20615089	To address these shortcomings, the authors have taken a novel approach using chromatin immunoprecipitation enriched material annealed to microarrays (ChIP-chip) targeting genes in fetal brain tissue bound by beta-catenin, a transcription factor that is directly regulated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	24312415	Furthermore, beta-catenin protein was decreased by inhibition of phosphorylation of GSK3beta via mTORC1 activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	24143235	Since inactivation of GSK-3beta would inhibit degradation of beta-catenin (XREF_SUPPLEMENTARY), these data imply that a decrease in PTEN levels would transcriptionally activate MMP7 via GSK-3beta-beta-catenin-TCF pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	22640743	However, we observed that neither GSK-3beta nor Siah-1 siRNA treatment blocked degradation of beta-catenin during the activation of SIRT1.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	20826156	Our previous in vivo studies suggested that down-regulation of IKKalpha/beta/NF-kappaB results in Tyr phosphorylation of GSK3beta (and hence de-activation of GSK3beta), which can potentially activate beta-catenin (XREF_BIBR, XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	24726344	CPT-11 resistance reduced GSK3beta, p-GSK3beta, beta-catenin, COX-2 and Tbx3 (a gene target of Wnt and beta-catenin pathway) (44.14%, 77.31%, 64.85%, 89.82% and 57.1% decreased compare to parental LoVo cells, respectively) ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25847080	For example, as previously demonstrated in 3T3-L1 cells, the overexpression of Wnt1, Wnt10b or a GSK3beta mediated phosphorylation defective form of beta-catenin, inhibit adipogenesis (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25042702	WNT ligands lead, among other effects, to inhibition of GSK3-beta activity causing stabilization of nuclear beta-CATENIN, which acts as a potent transcriptional coactivator ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	19823589	beta-catenin is targeted for degradation upon phosphorylation by GSK3beta XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	7092328	We demonstrate that lack of Gadd45a not only prevents DeltaNp63alpha suppression and GSK3beta dephosphorylation but also prevents free cytoplasmic beta-catenin degradation after UV irradiation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	21325624	We also observed an increase in phosphorylation of the inhibitory Ser 9 residue of GSK-3beta, which has been proposed to enhance beta-catenin signaling by promoting the accumulation of beta-catenin protein levels, in a manner analogous to Wnt mediated GSK-3beta inactivation (Desbois-Mouthon et al., XREF_BIBR; Sharma et al., XREF_BIBR; Naito et al., XREF_BIBR; Mulholland et al., XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	21325624	Interestingly, despite the inhibition of GSK-3beta, we observed a decrease in the total levels of beta-catenin in stable Dsc2 knockdown cells, suggesting that Akt mediated GSK-3beta inhibition may promote the nuclear redistribution of beta-catenin and enhance beta-catenin-dependent transcription without inducing stabilization of total beta-catenin protein levels.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	19190323	Our data suggest that reduction in galectin-3 decreases GSK-3beta phosphorylation and increases GSK-3beta activity, which may mediate beta-catenin accumulation and Wnt signaling in colon cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	19237607	Our data show that NDRG2 introduction into SW620 cells induces a decrease in GSK-3beta phosphorylation, which increases its kinase activity (XREF_FIG) and subsequently induces beta-catenin downregulation (XREF_FIG and XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26755664	Inactivation of GSK-3beta stimulates beta-catenin, which in turn potentially regulates GSC differentiation and tumor progression via regulation of Notch pathway [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26485754	Silencing SFRP1, GSK3beta and TLE3 disrupted the repression efficacy of the miR-744-regulated Wnt / beta-catenin activity (XREF_SUPPLEMENTARY and Fig.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25218472	Here, we showed that downregulation of Tbeta4 by siRNA decreased the phosphorylation of GSK3beta, and decreased the expression and nuclear localization of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	20470940	A number of protein kinases have been shown to influence Wnt and beta-catenin signaling including GSK3beta, protein kinase C and casein kinase I and II.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26497855	The Wnt binds to its co-receptors of Frizzled to activate Dsh, which recruits glycogen synthase kinase-3 beta (GSK-3beta), promoting beta-catenin nuclear translocation and downstream gene expression, such as c-Myc.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	18552505	The localization of beta-catenin, which is involved in cell proliferation, and mediated by GSK-3beta activation was also demonstrated.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	19795391	Furthermore, when the WNT and beta-catenin pathway was activated in chondrocytic cells by WNT3a or SB216763, which inhibits the phosphorylation of GSK3beta, the mRNA levels of aggrecan and col2a1 were decreased, whereas that of mmp13 was increased.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	23768967	Axin is a member of the " destruction complex " - a protein complex which includes GSK-3beta that targets beta-catenin for degradation at the proteasome.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25412261	Inactivation of GSK-3beta increases not only the stability of CREB for IL-10 production but also enhances the activity of beta-catenin and Mcl-1 for cell growth and survival XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	24882689	Upon Wnt ligand binding to a receptor of the Frizzled family, GSK-3beta is inactivated, allowing beta-catenin to accumulate and to translocate into the nucleus to induce Wnt target gene expression together with TCF (T cell factor)/LEF (lymphoid enhancer factor) transcription factors.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	24881775	49 IGF pathway activation may enhance Wnt and beta-catenin signaling, as Akt mediated phosphorylation and inactivation of GSK3beta enhances beta-catenin stability.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25978974	The best studied of these is the canonical pathway, which involves the inhibition of Glycogen synthase kinase-3beta (GSK-3beta), which in turn blocks beta-catenin degradation in the cytosol, resulting in its accumulation and subsequent migration to the nucleus, where it forms transcription complexes with LEF and TCF, proteins that lead to the activation of several genes.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	21040406	SULF2 expression also increased phosphorylation of the anti-apoptotic Akt substrate GSK3beta and stimulated Wnt and beta-catenin signalling (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	28103279	DeltaN89-beta-catenin is a constitutively active form of beta-catenin, which is a stabilized form of beta-catenin as it lacks the GSK3beta phosphorylation site which targets beta-catenin for degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	20688159	Since cyclin D1 is a target of the transcription factor beta-catenin, we examined the transcriptional activity of beta-catenin using the TOPFLASH-luciferase reporter vector and phosphorylation of GSK3beta, which targets beta-catenin for degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	20504360	Akt phosphorylates and inactivates GSK3beta, allowing beta-catenin, a downstream effector of Wnt pathway to translocate into the nucleus where it binds to TCF-4.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	23911749	4) TNF-alpha induces hyper-phosphorylation of GSK3beta, i.e. the deactivated form of GSK3beta, which increases nuclear beta-catenin and Lef-1 accumulation, and eventually reduces the Runx2 associated osteogenesis in PDLSCs.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	23911749	Based on these observations, we speculated that in the inflammatory microenvironment, TNF-alpha induces hyper-phosphorylation of GSK3beta, which increases nuclear beta-catenin and Lef-1 accumulation, and eventually reduces the Runx2 associated osteogenesis in PDLSCs.Yet, how were GSK3beta activities affected by TNF-alpha?	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	17601533	Downregulation of beta-catenin is mediated through phosphorylation by GSK3beta, which targets beta-catenin for ubiquitination by the F-box protein beta-TrCP and Slimb and degradation by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25880337	AEG-1 interacts with Gsk-3beta and CKIdeltato activate Wnt and beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	5831527	LiCl, a potent inhibitor of Glycogen Synthase Kinase 3beta (GSK3beta) activity, abrogated the IL-6-induced inhibition of wild-type beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	22696062	It has not been shown directly before that a member of the cadherin family has an essential regulatory role in the control of normal human HF growth and cycling.Our data suggest that P-cadherin maintains human HFs in anagen through activation of canonical Wnt signaling and operates as a major molecular brake on HF regression (catagen) by inhibiting GSK3beta mediated beta-catenin degradation, thereby ensuring active canonical Wnt signaling ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	23889992	beta-Catenin is phosphorylated by GSK3beta and undergoes proteasomal degradation while phosphorylation of GSK3beta inactivates it and allows nuclear translocation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25909283	Fibulin-5 impedes Wnt and beta-catenin signaling by inhibiting extracellular signal regulated kinase (ERK) to activate glycogen synthase kinase-3 beta (GSK3beta), which downregulates beta-catenin and prevents its nuclear accumulation, leading to suppression of MMP-7 and c-Myc expression.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	19475691	Ordinarily, glycogen synthase kinase 3beta (GSK-3beta) constitutively phosphorylates and thereby targets beta-Catenin for degradation through the ubiquitin mediated proteosomal pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26274564	We have found that Wnt induced long-term beta-catenin stabilization is mediated by GSK3beta monoubiquitination through suppressing beta-catenin recruitment of beta-TrCP (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26274564	The results showed that reconstitution of the GSK3beta KO/GSK3alpha KD MEFs with WT Flag-GSK3alpha or Flag-GSK3alpha Y279E, but not GSK3alpha Y279F mutant restored Wnt induced accumulation of beta-catenin (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26274564	Overall, these results strongly support that FAK and PYK2 kinase contributes to APC driven intestinal tumorigenesis through phosphorylating GSK3beta Y216 to promote Wnt and beta-catenin signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	26274564	Our results has uncovered a previously unrealized role of GSK3beta Y216 phosphorylation : it triggers GSK3beta recruitment of beta-TrCP and subsequent GSK3beta monoubiquitination by beta-TrCP, an event required for Wnt induced inhibition of beta-catenin degradation, thus identifying phosphorylation of GSK3beta Y216 as an ' activator ' of the Wnt and beta-catenin pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	21247902	These results showed that NDRG2 diminishes the phosphorylation of GSK-3beta, which enhances its kinase activity, and subsequently down-regulates beta-catenin in SW620 cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	19784072	Mutations in the proteins of APC, axin, GSK-3beta, and CKI complex prevent proteasomal degradation of beta-catenin, thereby leading to translocation of beta-catenin into the nucleus and activation of beta-catenin and Tcf dependent transcription (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	25683913	The N-terminal phosphorylation of GSK-3beta, phosphorylation of beta-catenin at S552 and S675, and the induction of KLF5 collectively activate beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	24303084	Phosphorylation of GSK-3beta at serine 9 inactivates GSK-3beta activity and causes the stabilization and activation of beta-catenin signaling, which subsequently enhances P-gp expression [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	12554650	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	15327768	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	19238201	Wnt pathway activation (e.g., through Frizzled receptor) leads to GSK-3beta phosphorylation, which subsequently inhibits beta-catenin degradation by the APC-complex XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	23651923	Active Akt phosphorylates GSK-3beta promoting its inactivation and, therefore, inhibits beta-catenin degradation (B).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	16039586	Once treated with Erk inhibitor PD98059 or siRNA-Erk, phosphorylated Erk was reduced in the IGF-1-treated cells, and concurrently, downregulation of beta-catenin and inhibition of GSK-3beta (Ser9) phosphorylation were observed (E), suggesting that IGF-1-induced beta-catenin upregulation is mediated by the Erk and GSK-3beta pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
15478262-d0d8-42eb-84f7-17e2a2019e25	1.0	PubMed	22773696	Upon TGF-beta stimulation, GSK-3beta is phosphorylated and inactivated, allowing beta-catenin to translocate to the nucleus, where it activates transcription of genes involved in myofibroblastic differentiation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CTNNB1))
dcfc3dac-f604-4aaf-9018-94ac856f217b	1.0	PubMed	20454507	Active GSK3beta can induce mitochondrial release of cytochrome c, leading to the activation of the intrinsic apop-tosis pathway [5].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CYCS))
dcfc3dac-f604-4aaf-9018-94ac856f217b	1.0	PubMed	23922881	Active GSK3beta increases the cytochrome c release from mitochondria, which in turn activates successively caspase-9 and caspase-3.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CYCS))
dcfc3dac-f604-4aaf-9018-94ac856f217b	1.0	PubMed	24531650	In vivo, N-acetylcysteine ameliorated the d-GalN and LPS-induced hepatotoxicity and reduced GSK3beta activity; GSK3beta inhibition increased hepatic superoxide dismutase activity and the glutathione content, decreased malondialdehyde production in the liver tissues; while GSK3beta inhibition suppressed the JNK activation in the liver and decreased cytochrome c release from mitochondria.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CYCS))
dcfc3dac-f604-4aaf-9018-94ac856f217b	1.0	PubMed	26284974	Recently studies have showed that pharmacological inhibition of GSK3beta, such as lithium chloride (LiCl), is thought to block the opening of the mitochondrial permeability transition pore (mPTP) and attenuate cytochrome c release from mitochondria in cardiomyocytes.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CYCS))
dcfc3dac-f604-4aaf-9018-94ac856f217b	1.0	PubMed	14523002	After DNA damage, mitochondrial GSK3beta co-immunoprecipitated with p53 and was activated, and inhibition of GSK3beta blocked cytochrome c release and caspase-3 activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:CYCS))
08a023b2-1192-47bc-a81c-149f6fbb1f1f	1.0	PubMed	20547056	Later, Zaheer and colleagues found that overexpressed GMFB in neuroblastoma N18 cells by gene infection induced caspase dependent apoptosis mediated by GSK-3beta activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Caspase))
08a023b2-1192-47bc-a81c-149f6fbb1f1f	1.0	PubMed	6691199	Treatment with lithium, an inhibitor of GSK-3beta, inhibited caspase activation but did not prevent mitochondrial DNA damage or tau hyperphosphorylation, suggesting that the translocation of GSK-3beta may represent an upstream event that leads to caspase activation but is unrelated to tau hyperphosphorylation or mitochondrial DNA oxidative damage.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Caspase))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	25941117	In fact, MCF10A cells have a high GSK-3beta activity and proteasome inhibition increased the cyclin E/cyclin B ratio, arresting the cells in the G1/S phase.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	25941117	Similarly, proteasome inhibition in MCF7 cells that overexpressed a constitutive active form of GSK-3beta, increased the cyclin E/cyclin B ratio as did MCF10A cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	26121043	These findings suggest that the anti-proliferative effect of resibufogenin may be attributed to the degradation of cyclin D1 caused by the activation of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	21347341	To examine whether EBNA3C can block Cyclin D1 nuclear export, we tested the ability of EBNA3C to override GSK-3beta triggered Cyclin D1 nuclear export.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	19009649	Abrogation of EGF-R signalling in IHH-Fos by treatment with AG1478, a specific EGF-R tyrosine kinase inhibitor, prevented the phosphorylation of GSK-3beta induced by serum stimulation and decreased Cyclin D1 stability in the nucleus.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	19107233	Recently, inhibition of the PI3K-Akt downstream target, GSK-3beta, by either inhibitor or siRNA treatment decreased cdc6 and cyclin E2 ex-pression, and this inhibition was suggested to be mediated through E2F in prostate cancer cells [36].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	23383245	On the other side, GSK-3beta could also induce cyclin D1 proteolysis by direct phosphorylation of cyclin D1.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	23383245	Overall, inactivation of GSK-3beta and subsequent up-regulation of cyclin D1 have a critical role in cell cycle and HCC.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	15020233	As to the function of GSK-3beta, it has been reported that GSK-3beta induces cyclin D1 proteolysis.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	24038789	GSK3beta targets cyclin D1, cyclin E and Cdc25A for phosphorylation, signaling their ubiquitination, degradation and exit from cell cycle progression XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	9832503	Overexpression of an active, but not a kinase defective, form of GSK-3beta in mouse fibroblasts caused a redistribution of cyclin D1 from the cell nucleus to the cytoplasm.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	20548028	Phosphorylation of GSK3beta prolonged the half-life of cyclin D1.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	19767775	In the current work, we have identified a lysine residue within cyclin D1, near the GSK3beta phosphorylation site, that targets cyclin D1 for polyubiquitylation by the SCF Fbx4 and alphaB-crystallin ligase.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
7d0a5f95-ea3b-4c67-840e-dc95e8f7f5f6	1.0	PubMed	4921508	Overexpression of an active, but not a kinase defective, form of GSK-3beta in mouse fibroblasts caused a redistribution of cyclin D1 from the cell nucleus to the cytoplasm.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Cyclin))
28fdff1f-b82e-4cf3-abbb-efa77a70b06c	1.0	PubMed	21159948	Gsk3b phosphorylates dcx at the distinct site of ser327 and thereby contributes to dcx function in the restriction of axon branching. Together, our data define a jip3-regulated gsk3_/dcx signaling pathway that restricts axon branching in the mammalian brain.Gsk3_ induces the phosphorylation of dcx at ser327, which contributes to dcx function in the inhibition of axon branching and self-contact.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:DCX))
0d43f86b-1ac7-4921-8772-1a7e4ff2e7e7	1.0	PubMed	20634980	The present investigation identifies : i) Sphk-1 as a critical kinase involved in TLR mediated human beta-defensin 2 induction and modulation in HGECs; ii) activation of TLRs induces phosphorylation of Sphk-1 and its intracellular activity by enhanced conversion of S1P; and iii) activated PI3K suppresses GSK3-beta augmenting HBD-2 induction.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:DEFB4A))
0d43f86b-1ac7-4921-8772-1a7e4ff2e7e7	1.0	PubMed	20634980	Collectively, it is plausible to hypothesize that the modulation of Sphk-1 and GSK3-beta to induce and enhance HBD-2 production may help cells combat bacterial insult and thus they have potential therapeutic value.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:DEFB4A))
2206d4c7-2441-4629-8253-143b619b99a9	1.0	PubMed	25042702	In agreement with this, hPSCs in DE plus Ch condition did not upregulate DE markers EOMES, SOX17, and FOXA2, suggesting that strong GSK3-beta inhibition also prevented DE differentiation (G, H, and S4I).	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:151403))
7c971b37-5e06-4455-9087-a26bf221c30c	1.0	PubMed	25905630	ZNF804A is one of many genes coding for transcription factors, splicing regulators and chromatin remodeling proteins that have been implicated in SZ, BD, and ASD, including POU3F2, A2BP1, MYT1L, JARID2, TCF4, ARNT2, CHD8, SMARCA2, and beta-catenin (which is regulated by the lithium and DISC1 target GSK3beta) [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:DISC1))
34dfdbe6-aa2e-4d5b-ad53-d95f567bce7f	1.0	PubMed	23160194	Inhibition of GSK3beta in both DM1 cell culture and mouse models corrected cyclin D3 levels and reduced muscle weakness and myotonia in DM1 mice.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:11343137))
1d0630d0-1355-4f0e-8e02-c739a433b904	1.0	PubMed	19071090	Recently, it was shown that DNA damage caused by ionizing radiation induced phosphorylation of GSK-3beta by Akt.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D004249))
1d0630d0-1355-4f0e-8e02-c739a433b904	1.0	PubMed	6691199	Treatment with lithium, an inhibitor of GSK-3beta, inhibited caspase activation but did not prevent mitochondrial DNA damage or tau hyperphosphorylation, suggesting that the translocation of GSK-3beta may represent an upstream event that leads to caspase activation but is unrelated to tau hyperphosphorylation or mitochondrial DNA oxidative damage.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D004249))
5340e2bf-6f49-449e-a37e-b3fe9c1e2955	1.0	PubMed	26618897	In this paper we instead show that following GSK3beta inactivation, increased intracellular ROS trigger a DNA damage response which leads to an up-regulated expression of p21, the other CKI.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0000077"))
d0411d7a-3f81-4b07-953d-74fecd35bdcd	1.0	PubMed	26139537	Dynamin-1, which was thought to be neuron specific, is activated by the Akt and GSK3beta signaling cascade in non neuronal cells to trigger rapid, dysregulated CME.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:DNM1))
32a68155-c8fe-4702-9097-fe66600dbba9	1.0	PubMed	21179545	A rat CRMP4 triple alanine substitution mutant (L-CRMP4-AAA-V5) for the three carboxy terminal phospho-residues targeted by GSK3beta (Thr622, Thr627, Ser631) fails to undergo phosphorylation in response to nocodazole establishing the specificity of the antibody for phospho-CRMP4 (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:DPYSL3))
525e5959-c644-4a9a-b661-3edd4ba089eb	1.0	PubMed	17050006	Due to the localization of both amino acids in the E2F1 transactivation domain, we wanted to test whether GSK3beta modulates E2F1 transcriptional activity through interaction with this domain.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:E2F1))
525e5959-c644-4a9a-b661-3edd4ba089eb	1.0	PubMed	17050006	These results suggest that GSK3beta is able to modulate E2F1 transcriptional activity through its interaction with the transactivation domain.E2F1 has been described as primarily localized in the nucleus in cycling cells; whereas GSK3beta is localized mainly in the cytoplasma.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:E2F1))
525e5959-c644-4a9a-b661-3edd4ba089eb	1.0	PubMed	17050006	These results strongly suggest that phosphorylation of serine 403 and threonine 433 are not involved in the regulation of E2F transcriptional activity by GSK3beta.Our results indicate that direct modulation of E2F1 by GSK3beta is independent of its kinase activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:E2F1))
7237d162-ace4-4049-ab05-273782b31783	1.0	PubMed	19107233	Recently, inhibition of the PI3K-Akt downstream target, GSK-3beta, by either inhibitor or siRNA treatment decreased cdc6 and cyclin E2 ex-pression, and this inhibition was suggested to be mediated through E2F in prostate cancer cells [36].	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:P27958))
c90a40f3-e5cc-4388-8994-325e9a58f117	1.0	PubMed	21347395	Upon insulin stimulation, the pAkt Serine 473 and pGSK3beta levels were greatly elevated in NT control clone, but only increased marginally in E5 and E6 stable clones (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:P03126))
6aae1215-64e6-400f-8121-60db2d0a49cd	1.0	PubMed	28036276	Since GSK3beta is reported to be the main kinase that promotes FBW7 substrate phosphorylation followed by the E3 ligase complex recognition [XREF_BIBR], it is reasonable to hypothesize that Thr405 site may be a GSK3beta kinase site that mediate EglN2 protein stability regulation by FBW7.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:EGLN2))
923b5289-2468-4cd7-9284-2201f498b395	1.0	PubMed	23873439	XREF_BIBR Emerin is also targeted by the metabolically important kinase GSK3beta at unknown site (s) in vitro.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:EMD))
a21e9eff-8c0f-4aad-b3dc-56604b1f3cd7	1.0	PubMed	26197224	Our further results showed that ATX resulted in an increase in p-GSK-3beta (Ser9) whereas blockade of GSK-3beta activation by LiCl dramatically abrogated the neuroprotective effect of ATX, demonstrating that antioxidant capability of ATX might be mediated by the inactivation of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ENPP2))
de571768-e740-478b-82ec-7258db318f3e	1.0	PubMed	23874688	GSK3beta activity can be abrogated by direct phosphorylation on the Ser9 residue by phosphatidylinositol 3-kinase (PI3K)/Akt, mitogen activated protein kinase (MAPK)/p90RSK, or mammalian target of rapamycin and S6K upon a number of extracellular stimuli, such as insulin, epidermal growth factor, or fibroblast growth factor XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:ERK))
7336e7d9-8b14-408c-9bb2-fd3adf22e9eb	1.0	PubMed	16076840	The gsk-3 inhibitor lithium chloride was used to determine the role of gsk-3 in phosphorylation of ser-102, -104, and -106 and ser-118 in vivo and to explore the role of these serines in the regulation of eralpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of ser-104 and -106 and ser-118, which suggests these serine residues as targets for gsk-3 in vivo. Our results further suggest that eralpha phosphorylation by gsk-3 stabilizes eralpha under resting conditions and modulates eralpha transcriptional activity upon ligand binding. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin a-cdk2 complex.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ESR1))
7336e7d9-8b14-408c-9bb2-fd3adf22e9eb	1.0	PubMed	25829335	Accumulating evidences are also available showing that GSK-3beta activity is required for ER stress mediated apoptosis, and inhibitors of GSK-3beta can abrogate ER stress mediated cell damages.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ESR1))
7336e7d9-8b14-408c-9bb2-fd3adf22e9eb	1.0	PubMed	16076840	The gsk-3 inhibitor lithium chloride was used to determine the role of gsk-3 in phosphorylation of ser-102, -104, and -106 and ser-118 in vivo and to explore the role of these serines in the regulation of eralpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of ser-104 and -106 and ser-118, which suggests these serine residues as targets for gsk-3 in vivo. Our results further suggest that eralpha phosphorylation by gsk-3 stabilizes eralpha under resting conditions and modulates eralpha transcriptional activity upon ligand binding. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin a-cdk2 complex.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ESR1))
7336e7d9-8b14-408c-9bb2-fd3adf22e9eb	1.0	PubMed	16076840	The gsk-3 inhibitor lithium chloride was used to determine the role of gsk-3 in phosphorylation of ser-102, -104, and -106 and ser-118 in vivo and to explore the role of these serines in the regulation of eralpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of ser-104 and -106 and ser-118, which suggests these serine residues as targets for gsk-3 in vivo. Our results further suggest that eralpha phosphorylation by gsk-3 stabilizes eralpha under resting conditions and modulates eralpha transcriptional activity upon ligand binding. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin a-cdk2 complex.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ESR1))
7336e7d9-8b14-408c-9bb2-fd3adf22e9eb	1.0	PubMed	16076840	The gsk-3 inhibitor lithium chloride was used to determine the role of gsk-3 in phosphorylation of ser-102, -104, and -106 and ser-118 in vivo and to explore the role of these serines in the regulation of eralpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of ser-104 and -106 and ser-118, which suggests these serine residues as targets for gsk-3 in vivo. Our results further suggest that eralpha phosphorylation by gsk-3 stabilizes eralpha under resting conditions and modulates eralpha transcriptional activity upon ligand binding. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin a-cdk2 complex.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ESR1))
d9d241d7-7aa3-4fdb-b61a-a6af0df64c06	1.0	PubMed	23874688	GSK3beta inactivation promoted the stability of EZH2 protein in vitro.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:EZH2))
2b160426-3f6c-4dc3-acb6-f67ff916c35c	1.0	PubMed	21949350	Together, these data suggest a model of GSK-3beta and PAR-1 antagonism, in which kinases that inactivate GSK-3beta also enhance PAR-1 activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:F2R))
ffda0080-d584-404c-9ad0-5508f4b6e6bc	1.0	PubMed	21466834	The inhibition of GSK3beta activity significantly attenuated the rescuing effect of forskolin in thrombin challenged cells (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:F2))
8e566e1d-1341-4a71-8a9e-f7798aa11823	1.0	PubMed	21821001	We hypothesize that GSK-3beta upregulates galectin-3 indirectly via transcriptional regulation.GSK-3beta has a dual role in controlling cell fate.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:FATE1))
b19d69ec-5556-480f-9c7a-5f78b1d88c10	1.0	PubMed	21242966	Gsk3beta-mediated phosphorylation of fbx4 ser12 during the g1/s transition regulates fbx4 dimerization, which in turn governs fbx4-driven e3 ligase activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:FBXO4))
b19d69ec-5556-480f-9c7a-5f78b1d88c10	1.0	PubMed	18598945	Inhibition of GSK3beta activity through overexpression of RasV12 or GSK3beta knockdown resulted in an inhibition of Ser12 phosphorylation and decreased Fbx4 dimerization (C).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:FBXO4))
b6161696-b01d-485f-a561-f9c5a2084354	1.0	PubMed	24398687	Stability of the KLF5 is mediated by proteasomal degradation via phosphorylation by glycogen synthase kinase 3beta (GSK3beta) and recognition by F-box and WD repeat domain containing 7 (FBW7) of a phosphodegron sequence surrounding serine 303 in KLF5.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:FBXW7))
b375432d-4b55-45bc-ba8b-70784613008e	1.0	PubMed	21868755	Silencing of GSK3beta with two different siRNAs minimally decreased the levels of FLIP L in A549 cells; but reduced the levels of FLIP S to a greater extent in both H157 and A549 cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF00813))
c2e4d957-8ad8-4fc9-b4f0-2fe5b2f231c0	1.0	PubMed	24390485	FOXL2 posttranslational modifications mediated by GSK3beta determine the growth of granulosa cell tumours.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:FOXL2))
be1dc24f-0525-48fe-a306-6727450f4aaa	1.0	PubMed	26438629	Moreover, we reported that the anti-proliferative effect of silencing Sam68 was accompanied with up-regulated expression of cyclin dependent kinase inhibitors, p21 (Cip1) and p27 (Kip1), enhanced transactivation of FOXO factors (FOXO4), and dysreuglation of Akt and GSK-3beta signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:FOXO))
0867a1cf-d2c6-4413-bf57-4cb7abf0652f	1.0	PubMed	26934497	These results suggest that phosphorylation of GSK3B is essential, but not alone sufficient for PIM kinases to promote PC-3 cell migration.Murine FoxP3 and human PIM1 were produced as GST-fusion proteins in order to analyse whether also FoxP3 is a Pim substrate.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:FOXP3))
2e58c34b-ffe9-44e8-a1a2-ee52f0d1ea5d	1.0	PubMed	18702828	Briefly, GSK-3beta mediates Wnt and Fzd signaling cascades.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:FZD))
5cf740b9-218c-475e-befa-242219bf90b5	1.0	PubMed	15911064	ISO stimulation of the ANP promoter was mediated by stimulation of PI3K, activation of Akt, and inactivation of GSK3beta, allowing GATA-4 to migrate to the nucleus where it bound and transactivated the promoter.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GATA4))
fa79c527-83b1-46f1-924d-41816e1879ad	1.0	PubMed	22771494	These results indicate that GSK3beta is important for GR transactivation activity and that GSK3beta inhibition suppresses GC stimulated gene expression.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GC))
1465950d-b63d-4612-8c51-e777b3f5406f	1.0	PubMed	24606125	We identify Pit-1 as a putative GSK3-beta substrate, and the likely target of GSK3-beta mediated GH inhibition by SSTR3.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GH1))
d4f331fd-be3e-46f5-80ee-be14b633a730	1.0	PubMed	21095584	GSK-3beta phosphorylation targets the GLI proteins for specific cleavage ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GLI1))
007da0e4-c0ab-470b-b4ac-b7000dae7b4d	1.0	PubMed	21949350	GA fragmentation is also associated with decreased AKT activity and concomitant increased activity of GSK-3beta, which may itself induce GA fragmentation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:30778))
fffdff33-76dd-4d5b-abe6-5074882fdae5	1.0	PubMed	21436455	In animals fasted overnight, FGF19 induced phosphorylation of both GSK3alpha (Ser 21) and GSK3beta (Ser 9), which correlated with decreased phosphorylation of Ser 641 and Ser 645 on GS (XREF_FIG) and increased GS activity (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GLUL))
0a74684e-a408-4c5a-bf8f-3ea2f7f94f2b	1.0	PubMed	12054501	Kinase activities were monitored by immunoblotting with the Phospho-GSK-3alpha and beta (Ser21/9) antibody (Cell signal), which detects GSK-3 only when activated by phosphorylation at Ser21 of GSK-3alpha or Ser9 of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3A))
0a74684e-a408-4c5a-bf8f-3ea2f7f94f2b	1.0	PubMed	12054501	In our experiments, SGKL kinase activities were monitored by immunoblotting with the Phospho-GSK-3alpha and beta (Ser21/9) antibody which detects GSK-3 crosstide fusion protein only when activated by phosphorylation at Ser21 of GSK-3alpha or Ser9 of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3A))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	21347395	Our result showed that the expression level of pAkt Serine 473 and pGSK3beta were increased in NT control clone upon insulin stimulation, indicating that insulin could successfully activate Akt and GSK3beta in BEL7402.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	23727580	For example, mouse bone marrow macrophages isolated from heterozygous ROCK1 knockout mice exhibit enhanced phosphorylation of GSK3beta by cGMP dependent protein kinase II (cGKII) and Ca/calmodulin dependent protein kinase II (CaMKII) which inhibits GSK3beta activity, suggesting that ROCK1 may regulate the " destruction complex " assembly and activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	25499217	Phosphorylation of GSK-3beta by Akt inactivates GSK-3beta and concurrent Mcl-1 degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	23043959	Blockade of GSK-3beta inactivation by overexpression of constitutively active GSK-3beta or DN-Akt suppressed Hsp70 induction in heat treated inflammatory cells as well as human bronchial epithelial cells (data not shown), which is in accordance with previous report in human neuroblastoma cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	21325624	We also observed an increase in phosphorylation of the inhibitory Ser 9 residue of GSK-3beta, which has been proposed to enhance beta-catenin signaling by promoting the accumulation of beta-catenin protein levels, in a manner analogous to Wnt mediated GSK-3beta inactivation (Desbois-Mouthon et al., XREF_BIBR; Sharma et al., XREF_BIBR; Naito et al., XREF_BIBR; Mulholland et al., XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	17098228	Conversely, phosphorylation of GSK-3beta at Tyr 216 enhances GSK-3beta activity; however, the identity of the tyrosine kinase mediating Tyr 216 phosphorylation is unknown.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	16959610	This was consistent with the effect of laforin on Akt mediated phosphorylation of GSK-3beta at Ser9.The selective effect of laforin on phosphorylation of GSK-3beta at Ser9 raised the intriguing possibility that laforin may be the phosphatase of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	26822034	Here we show that phosphorylation of GSK3beta at Ser 389 / Thr 390 is specifically induced in response to DNA double-strand breaks (DSBs) and targets nuclear GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	20331603	Phosphorylation of the residue Tyrosine in 216 position results in the constitutive activity of GSK-3beta and believed to be important target for signal transduction.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	14570592	However, in the present study, we clearly demonstrate that GSK3_ is capable of catalysing the autophosphorylation of Tyr216 in vitro.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	18167338	Knockdown of GSK-3beta did not affect levels of GSK-3alpha (lane 3) demonstrating that stabilization of Cdc25A was due to loss of GSK-3beta rather than to loss of both GSK-3beta and GSK-3alpha.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	26711256	In vitro activity assays demonstrated that GSK-3beta phosphorylation mediated by PKCzeta enhanced GSK-3beta activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	21347395	Our result showed that the expression level of pAkt Serine 473 and pGSK3beta were increased in NT control clone upon insulin stimulation, indicating that insulin could successfully activate Akt and GSK3beta in BEL7402.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	23727580	For example, mouse bone marrow macrophages isolated from heterozygous ROCK1 knockout mice exhibit enhanced phosphorylation of GSK3beta by cGMP dependent protein kinase II (cGKII) and Ca/calmodulin dependent protein kinase II (CaMKII) which inhibits GSK3beta activity, suggesting that ROCK1 may regulate the " destruction complex " assembly and activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	25499217	Phosphorylation of GSK-3beta by Akt inactivates GSK-3beta and concurrent Mcl-1 degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	23043959	Blockade of GSK-3beta inactivation by overexpression of constitutively active GSK-3beta or DN-Akt suppressed Hsp70 induction in heat treated inflammatory cells as well as human bronchial epithelial cells (data not shown), which is in accordance with previous report in human neuroblastoma cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	21325624	We also observed an increase in phosphorylation of the inhibitory Ser 9 residue of GSK-3beta, which has been proposed to enhance beta-catenin signaling by promoting the accumulation of beta-catenin protein levels, in a manner analogous to Wnt mediated GSK-3beta inactivation (Desbois-Mouthon et al., XREF_BIBR; Sharma et al., XREF_BIBR; Naito et al., XREF_BIBR; Mulholland et al., XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	17098228	Conversely, phosphorylation of GSK-3beta at Tyr 216 enhances GSK-3beta activity; however, the identity of the tyrosine kinase mediating Tyr 216 phosphorylation is unknown.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	16959610	This was consistent with the effect of laforin on Akt mediated phosphorylation of GSK-3beta at Ser9.The selective effect of laforin on phosphorylation of GSK-3beta at Ser9 raised the intriguing possibility that laforin may be the phosphatase of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	26822034	Here we show that phosphorylation of GSK3beta at Ser 389 / Thr 390 is specifically induced in response to DNA double-strand breaks (DSBs) and targets nuclear GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	20331603	Phosphorylation of the residue Tyrosine in 216 position results in the constitutive activity of GSK-3beta and believed to be important target for signal transduction.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	14570592	However, in the present study, we clearly demonstrate that GSK3_ is capable of catalysing the autophosphorylation of Tyr216 in vitro.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	18167338	Knockdown of GSK-3beta did not affect levels of GSK-3alpha (lane 3) demonstrating that stabilization of Cdc25A was due to loss of GSK-3beta rather than to loss of both GSK-3beta and GSK-3alpha.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
f1de94ab-b364-4c36-a998-1da361690b56	1.0	PubMed	26711256	In vitro activity assays demonstrated that GSK-3beta phosphorylation mediated by PKCzeta enhanced GSK-3beta activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:GSK3B))
d7b3c0c6-ba8a-4535-a7a3-bbd067e939d1	1.0	PubMed	27566146	These data in total confirmed that the FBW7 CPD motif in SOX9 spans amino acids 236-240, that T236 is phosphorylated by GSK3beta, that FBW7 targets GSK3 phosphorylated SOX9 for degradation, and that FBW7 regulates SOX9 stability under normal physiological conditions.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:GSK3))
d7b3c0c6-ba8a-4535-a7a3-bbd067e939d1	1.0	PubMed	22142472	GSK-3 kinase reactions were initiated by the addition of 100U of GSK-3beta (New England BioLabs) to the beads in GSK-3 kinase buffer containing 0.37 MBq ml [gamma-P] ATP.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:GSK3))
ec43b29d-1407-4ddb-8c3d-f7c228a90454	1.0	PubMed	19682504	These sequences are targeted by multiple kinases including serum- and glucocorticoid induced kinase 1 (SGK1) and glycogen synthase kinase 3 beta (GSK3beta).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:GYS))
ec43b29d-1407-4ddb-8c3d-f7c228a90454	1.0	PubMed	21742036	Similarly, partial knockdown of neuronatin alpha decreased the level of pGSK-3beta and increased the phosphorylated form of glycogen synthase (E).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:GYS))
1bdd5909-7303-47d3-89b9-9c04874caee7	1.0	PubMed	25118933	In N2a cells, the overexpression of wide-type full-length Omi, but not S276C mutant Omi, reduced the endogenous GSK3beta abundance (XREF_FIG), as well as enhanced green fluorescent protein (EGFP)-, Flag- and HA tagged GSK3beta (XREF_SUPPLEMENTARY), whereas knockdown of Omi increased the abundances of GSK3beta in SH-SY5Y cells (XREF_FIG) and N2a cells (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:P69208))
e64ec00c-93c9-4f91-8846-a9a52a5bf661	1.0	PubMed	24086678	GSK3beta dependent phosphorylation may also enhance the activity of HDAC6 leading to decreased tubulin acetylation and an inhibition in mitochondrial motility XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:HDAC6))
e64ec00c-93c9-4f91-8846-a9a52a5bf661	1.0	PubMed	25150829	In this loop, both beta-catenin and GSK-3beta acted to up-regulate HDAC6 which led to decreased acetylated tubulin levels, thereby causing cilia defects.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:HDAC6))
e64ec00c-93c9-4f91-8846-a9a52a5bf661	1.0	PubMed	25150829	These data indicated HDAC6 was mediated by both beta-catenin and GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:HDAC6))
bd778826-ba6a-44f4-b35e-196410db1d2e	1.0	PubMed	25823824	For instance, in U2OS (human osteosarcoma) cells, the accumulation of the PHD2 and PHD3 proteins by hypoxia led to accelerated HIF-1 degradation after reoxygenation, while HIF-1 translation in RKO (human colon carcinoma) cells was inhibited by a decrease in GSK3beta under prolonged hypoxia [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:HIF1))
1ec23536-19e1-48ec-881d-394c6aa4560a	1.0	PubMed	19136008	We found that threonine 10 of h1.5 can be phosphorylated by glycogen synthase kinase-3 in vitro. We have generated an antiserum specific for human h1.5 phosphorylated at threonine 10. Immunofluorescence labeling of hela cells with this antiserum revealed that the phosphorylation at this site appears in prometaphase and disappears in telophase, and that this hyperphosphorylated form of h1.5 is mainly chromatin-bound in metaphase when chromatin condensation is maximal.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:HIST1H1B))
8756cb58-c7e6-4c12-afe0-dbff23570774	1.0	PubMed	23349801	AKT and GSK-3beta signaling may support self-renewal whereas PKC and GSK-3beta may promote cell differentiation of hPS cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:HPS1))
c0d89fab-07ff-44f6-8d91-f58e0efbd225	1.0	PubMed	5694272	Overexpression of GSK-3beta impaired heat shock induced activation of HSF-1, and also reduced HSP-70 production, which was partially restored by the GSK-3beta inhibitor lithium.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:HSF1))
dbce7373-26cb-43ae-8a2c-320895c30e1c	1.0	PubMed	23043959	Hsp70 induction by eHsp70 was mediated by Akt dependent inactivation of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:HSPA))
dbce7373-26cb-43ae-8a2c-320895c30e1c	1.0	PubMed	23043959	In order to evaluate whether GSK-3beta inactivation is sufficient to induce Hsp70 by rhHsp70, we next investigated if blocking of GSK-3beta inactivation abrogates Hsp70 induction by rhHsp70.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:HSPA))
dbce7373-26cb-43ae-8a2c-320895c30e1c	1.0	PubMed	23043959	In order to evaluate whether GSK-3beta inactivation is sufficient to induce Hsp70 by rhHsp70, we next investigated if blocking of GSK-3beta inactivation abrogates Hsp70 induction by rhHsp70.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:HSPA))
dbce7373-26cb-43ae-8a2c-320895c30e1c	1.0	PubMed	23043959	Blockade of GSK-3beta inactivation by overexpression of constitutively active GSK-3beta or DN-Akt suppressed Hsp70 induction in heat treated inflammatory cells as well as human bronchial epithelial cells (data not shown), which is in accordance with previous report in human neuroblastoma cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:HSPA))
dbce7373-26cb-43ae-8a2c-320895c30e1c	1.0	PubMed	23959174	HSF1 transcriptional activity is negatively regulated by GSK3beta XREF_BIBR, which suggests that RPN2 knockdown may promote GSK3beta induced downregulation of HSP70 (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:HSPA))
80708d28-eb75-4186-8c52-be94abd60f41	1.0	PubMed	23043959	Because Akt, GSK-3beta, and MAP kinases have been shown to be involved in HS induced HSP induction, we determined the impact of rhHsp70 on Akt, GSK-3beta, and MAP kinases.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:16654923))
9c1551bb-3d0e-4c86-a64b-ff9a6ec4e73e	1.0	PubMed	25118933	Thus, our data suggest that GSK3beta mediates Omi regulated PGC-1alpha abundance.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:HTRA2))
be40636e-2b67-4112-b347-b41f5f2c3a70	1.0	PubMed	21145761	Consistently, GSK3beta and its mutants GSK3beta (S9A) and GSK3beta (K85A) enhanced activation of the IFN-beta promoter and ISRE triggered by cytoplasmic poly (I : C) (A available online).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IFNB1))
be40636e-2b67-4112-b347-b41f5f2c3a70	1.0	PubMed	21145761	This effect is not cell type specific because knockdown of GSK3beta also inhibited SeV induced activation of the IFN-beta promoter in A549 and HeLa cells (A).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IFNB1))
be40636e-2b67-4112-b347-b41f5f2c3a70	1.0	PubMed	21145761	Reconstitution of GSK3beta but not GSK3alpha into MEFs by retrovirus mediated gene transfer significantly restored SeV induced activation of the IFN-beta promoter (E).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IFNB1))
be40636e-2b67-4112-b347-b41f5f2c3a70	1.0	PubMed	21145761	In the same experiments, wild-type GSK3beta but not GSK3beta (aa 221-420) (which did not interact with TBK1) restored SeV induced IFN-beta production ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IFNB1))
be40636e-2b67-4112-b347-b41f5f2c3a70	1.0	PubMed	23675467	GSK3beta (glycogen synthase kinase 3 beta) positively regulate IFNbeta production by promoting TBK1 self activation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IFNB1))
f71734f5-a0d8-416f-b048-f81b4fd72dd1	1.0	PubMed	27929056	GSK-3beta modulates NEMO protein stability.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IKBKG))
b1d03058-f76c-4262-b071-bf93e5b37858	1.0	PubMed	21145761	For example, knockdown of GSK3beta or treatment with GSK3beta inhibitors reduces TLR4- and TLR2 mediated release of interleukin-12 (IL-12) and increases the secretion of IL-10, respectively, indicating that GSK3beta is a crucial regulator for thebalance between pro- and anti-inflammatory cytokines ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IL10))
6be9bd80-45a6-4501-99ae-e36aa7654cc6	1.0	PubMed	25591548	GSK-3beta activation mediated the effects of IL-18 on TSCC cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IL18))
6be9bd80-45a6-4501-99ae-e36aa7654cc6	1.0	PubMed	25591548	The results confirmed that GSK-3beta mediated the effects of IL-18 on TSCC cells (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IL18))
f92aec02-16e5-4686-a77f-9c58c9b8d431	1.0	PubMed	12771992	In addition to this, we demonstrate that elevated ILK expression and increased MBP phosphotransferase activity coincide with effects on downstream targets of ILK signalling such as GSK3beta phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ILK))
f92aec02-16e5-4686-a77f-9c58c9b8d431	1.0	PubMed	25738875	In this study, the ectopic expression of PARVA activated and inhibited Akt and GSK3beta (the downstream mediators of ILK), respectively.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ILK))
30fc04fb-a1e8-440c-9ef7-42b20da0ce63	1.0	PubMed	21964756	However, the specific mechanism by which GSK3beta phosphorylation leads to the destruction of HIF-1alpha and its impact on hypoxia mediated angiogenic signaling remains unclear.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IMPACT))
6eb28c1e-0ec0-40d2-aae5-26dc4d05e0fe	1.0	PubMed	26402673	The phosphorylation of Akt (Ser473) and GSK3beta (Ser21/9), previously reported to mediate the activation of insulin signaling, was analyzed.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:INS))
6eb28c1e-0ec0-40d2-aae5-26dc4d05e0fe	1.0	PubMed	18178198	One mechanism whereby GSK3beta increases insulin resistance is by phosphorylating IRS-1 on Ser332, resulting in reduced tyrosine phosphorylation of IRS-1 by the insulin receptor and reduced signaling to downstream components (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:INS))
6eb28c1e-0ec0-40d2-aae5-26dc4d05e0fe	1.0	PubMed	23810379	Insulin dependent activation of downstream signals, such as AKT and GSK-3beta, was barely detectable in control knockout cells, whereas a robust activation was observed in normal p85alpha reconstituted cells (C and 5D).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:INS))
2afd1deb-0bb3-4746-b2c6-ce914e50dcf4	1.0	PubMed	21890631	Recent evidence suggests that GSK-3beta mediates regulation of IQGAP1 to control cell migration (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IQGAP1))
2afd1deb-0bb3-4746-b2c6-ce914e50dcf4	1.0	PubMed	20883816	A recent report suggests that GSK-3beta directly phosphorylates IQGAP1 within its C-terminal region (), thus it is plausible that GSK-3beta might directly regulate IQGAP1 transport through phosphorylation.beta-catenin, an important regulatory partner of IQGAP1, did not accumulate in the nucleus of cells after S phase arrest (M. Johnson, unpublished), indicating that IQGAP1 and beta-catenin can enter the nucleus independent of one another.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IQGAP1))
d6724c26-cc8d-4479-a870-e927a99d7282	1.0	PubMed	21145761	The present study establishes an important role for GSK3beta in virus triggered IFN induction and cellular antiviral response and provides a mechanistic explanation on how TBK1 is activated after viral infection.Overexpression of GSK3beta potentiated virus triggered activation of IRF3 and expression of the gene.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IRF3))
d6724c26-cc8d-4479-a870-e927a99d7282	1.0	PubMed	21145761	Overexpression of GSK3beta but not GSK3alpha potentiated SeV induced ISRE (interferon stimulated response element) activation (C) and IRF3 dimerization (D), which are hallmarks of IRF3 activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IRF3))
d6724c26-cc8d-4479-a870-e927a99d7282	1.0	PubMed	21145761	These results suggest that GSK3beta potentiates virus triggered activation of IRF3 as well as transcription of the gene.Because the kinase activity of GSK3beta is important for its functions in various signaling pathways, we next examined whether the effect of GSK3beta on virus triggered IRF3 activation is dependent on its kinase activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:IRF3))
7b8a5031-cbc1-46d8-af2a-2365eae87d30	1.0	PubMed	21887250	In addition, we found that inhibition of GSK3beta with GSK3beta-inhibitor VIII decreased both Olig2 and Isl1 (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ISL1))
387eb77c-5880-4061-8e51-d8e79985769c	1.0	PubMed	25344861	Furthermore, GSK-3beta inhibition led to strongly decreased expression of several integrin types including the cancer stem cell associated alpha2beta1 integrin.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Integrins))
387eb77c-5880-4061-8e51-d8e79985769c	1.0	PubMed	22863953	LDV exposure increased the change to the active VLA-4 configuration by 20-fold, and GSK3beta inhibition decreased activation of integrin beta1 by 60% +/- 6% (B).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Integrins))
0a01157d-1ce5-4644-ba90-c9c1adcc9d33	1.0	PubMed	20352103	It remains to determine whether, in our experimental model, JNK activation is modulated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:JNK))
0a01157d-1ce5-4644-ba90-c9c1adcc9d33	1.0	PubMed	24531650	In vivo, N-acetylcysteine ameliorated the d-GalN and LPS-induced hepatotoxicity and reduced GSK3beta activity; GSK3beta inhibition increased hepatic superoxide dismutase activity and the glutathione content, decreased malondialdehyde production in the liver tissues; while GSK3beta inhibition suppressed the JNK activation in the liver and decreased cytochrome c release from mitochondria.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:JNK))
a6b6916f-6b4f-4a72-84e1-bda7da6b706c	1.0	PubMed	18606491	GSK3beta directly modulates the activity of transcription factors, activator protein 1 (AP-1) and nuclear factor-kappaB (NF-kappaB).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:JUN))
2aa2d6d9-0e6b-4fa6-8c9e-06cf0e107927	1.0	PubMed	23301033	Inhibition of PI3K and AKT or overexpression of PTEN or GSK-3beta failed to impair vIL-6 induction of angiogenesis and tumorigenesis in CAM and nude mice allograft models, indicating that vIL-6 might exert its biological function mainly via JAK and STAT signal rather than PI3K and AKT signal XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:Q2HRC7))
24d77ecf-03d0-4b4e-bb0e-9cad5bbb7f9d	1.0	PubMed	25673709	Furthermore, the innate immune regulator STAT-5 and the kinase GSK3beta mediate the activation of Tip60 in HPV positive cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KAT5))
24d77ecf-03d0-4b4e-bb0e-9cad5bbb7f9d	1.0	PubMed	21658600	We demonstrate that gsk-3 phosphorylates serine 86 of the p53-acetyltransferase tip60. A tip60(s86a) mutant was less active to induce p53 k120 acetylation, histone 4 acetylation, and expression of puma	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KAT5))
9007d968-a8e3-498d-99f4-21d58a81b261	1.0	PubMed	27537208	BK channel activity in BKM513I+ Delta899-903 expressing oocytes was significantly increased by co-expression of GSK3beta, but not by co-expression of K85RGSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KCNMA1))
c747d9a3-3ed2-45f6-aba0-78bfcc39f62c	1.0	PubMed	26935904	Decreased VEGFR-2 caused by ROS was ameliorated by beta-TrCP siRNA, proteasome inhibitor MG132 and GSK-3beta activity inhibitor (lithium chloride and SB216763).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KDR))
c747d9a3-3ed2-45f6-aba0-78bfcc39f62c	1.0	PubMed	22711876	CKIdelta, but not GSK3beta, promoted the destruction of ectopically expressed VEGFR2 (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KDR))
ddad1310-e560-4dba-bfc2-75de9569deab	1.0	PubMed	23118350	As altered activities of GSK3beta and phosphatases are involved in tau aggregation and constitute hallmarks in AD, a GSK3beta and PP1 imbalance may also contribute to Kidins220 decreased clearance, accumulation and hampered neurotrophin signalling from early stages of the disease pathogenesis.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KIDINS220))
1f20fbda-7c97-45c4-8be1-c9c34f880823	1.0	PubMed	26106078	GSK-3beta signaling promotes HK2 dissociation from the OMM (XREF_BIBR), but Toxoplasma is not known to activate GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KIF2A))
20cc6f07-e963-4a64-abe8-3be1e168303b	1.0	PubMed	23085750	Previous studies have reported that GSK3beta targets KLF5 for proteosomal degradation, 19 which is in concordance with GSK3beta altering the stability of many of its substrates.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF5))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	24577092	However, GSK3beta has recently been shown to activate KLF6 43 and we recently identified that KLF6 enhances cell proliferation in myogenic cells through a TGFbeta and Smad3 dependent pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	23085750	Functionally, GSK3beta enhanced KLF6 mediated growth suppression, which was abrogated by the KLF6-4A phosphomutant.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	23085750	Inhibition of GSK3beta abrogates KLF6 protein increase.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	23085750	Taken together, these results are consistent with the hypothesis that GSK3beta increases total KLF6 protein.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	23085750	GSK3beta increases KLF6 mediated transactivation of p21 and growth suppression.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	23085750	Here we report that GSK3beta regulates KLF6 protein activity through phosphorylation at amino acids 143, 147, 151 and 155, leading to the accumulation of KLF6 protein and augmented KLF6 mediated growth suppression by p21.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	23085750	Moreover, GSK3beta primarily increases the phosphorylated isoform of KLF6, and mutation of the conserved GSK3beta phosphorylation site within KLF6 leads to selective loss of the higher molecular weight, hyperphosphorylated isoform of KLF6.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	23085750	We found that GSK3beta was able to increase all forms of KLF6 to some extent, although the mechanism of increase of KLF6-4A is not completely clear.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
accca0d5-6784-4074-870f-9a01c66df01b	1.0	PubMed	23085750	This study partially clarifies the post-translational regulation of KLF6 by phosphorylation, but further studies are required to fully characterize GSK3beta mediated KLF6 regulation, specifically the requirement for kinase priming to maximize phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:KLF6))
506046ea-509f-4541-8a62-97c12794d9db	1.0	PubMed	25390651	Activation of the mK ATP channel induced inhibitory phosphorylation of GSK-3beta and suppressed ROS production, LDH release and apoptosis after AA washout.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:LDH))
8a87148f-64ad-4d45-9a4e-13bb6f22878c	1.0	PubMed	23911749	4) TNF-alpha induces hyper-phosphorylation of GSK3beta, i.e. the deactivated form of GSK3beta, which increases nuclear beta-catenin and Lef-1 accumulation, and eventually reduces the Runx2 associated osteogenesis in PDLSCs.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:LEF1))
8a87148f-64ad-4d45-9a4e-13bb6f22878c	1.0	PubMed	23911749	Based on these observations, we speculated that in the inflammatory microenvironment, TNF-alpha induces hyper-phosphorylation of GSK3beta, which increases nuclear beta-catenin and Lef-1 accumulation, and eventually reduces the Runx2 associated osteogenesis in PDLSCs.Yet, how were GSK3beta activities affected by TNF-alpha?	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:LEF1))
fc2bf77e-211e-47ff-8d94-a10c02b5b5a5	1.0	PubMed	21821001	We hypothesize that GSK-3beta upregulates galectin-3 indirectly via transcriptional regulation.GSK-3beta has a dual role in controlling cell fate.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:LGALS3))
600c4818-28d5-438b-8356-8d78df878737	1.0	PubMed	22964642	Ectopic GSK-3beta Delta9 did not however increase Gal4 driven luciferase activity in cells expressing Gal4 (DBD)-Neh6 that lacked SDSGIS.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:LGALS4))
600c4818-28d5-438b-8356-8d78df878737	1.0	PubMed	22964642	By contrast, GSK-3beta Delta9 increased Gal4 driven luciferase activity from about 2.3-fold to 3.1-fold in cells expressing Gal4 (DBD)-Neh6that lacked DSAPGS.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:LGALS4))
c5739935-8cdb-4979-8397-6f77c4e2f0b8	1.0	PubMed	24391209	This observation unveils a novel pathway wherein miR-21 blunts LPS induced NFkappaB activation by silencing PTEN and GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:16412))
4585f13c-7da5-4546-a8c2-c466569eb1f5	1.0	PubMed	16890161	Expression of either FLAG-Axin or HA-GSK-3beta did not induce a mobility shift of LRP6-GFP, but their coexpression induced a marked shift (A).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:LRP6))
4585f13c-7da5-4546-a8c2-c466569eb1f5	1.0	PubMed	16341017	Glycogen synthase kinase 3 (gsk3), which is known for its inhibitory role in wnt through the promotion of beta-catenin phosphorylation and degradation, mediates the phosphorylation and activation of lrp6. We show that wnt induces sequential phosphorylation of lrp6 by gsk3 and casein kinase 1, and this dual phosphorylation promotes the engagement of lrp6 with the scaffolding protein axin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:LRP6))
7a392697-164f-4376-9001-336e675aba25	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAFA))
7a392697-164f-4376-9001-336e675aba25	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAFA))
7a392697-164f-4376-9001-336e675aba25	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAFA))
7a392697-164f-4376-9001-336e675aba25	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAFA))
319864cf-2d73-4f93-bdbd-9882b99e57f5	1.0	PubMed	18042454	We showed that c-maf and mafb, like mafa, are indeed phosphorylated by gsk-3/ we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAFB))
abeb0247-51a8-48d1-b931-8f948488951f	1.0	PubMed	18042454	We showed that c-maf and mafb, like mafa, are indeed phosphorylated by gsk-3/ we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAF))
634b28bf-3cfc-40b5-9845-894c86acebd9	1.0	PubMed	19146952	demonstrated that GSK-3beta, an important enzyme for glucose metabolism and transcriptional regulation, is able to activate MLK3 via direct phosphorylation on Ser798 and Ser793, which are located within its C-terminal domain.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAP3K11))
634b28bf-3cfc-40b5-9845-894c86acebd9	1.0	PubMed	17711861	The activation of MLK3 by GSK-3beta occurred via phosphorylation of MLK3 on two amino acid residues, Ser (789) and Ser (793), that are located within the C-terminal regulatory domain of MLK3.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAP3K11))
634b28bf-3cfc-40b5-9845-894c86acebd9	1.0	PubMed	24044867	XREF_BIBR, XREF_BIBR This is important because MLK3 can be activated as a result of direct phosphorylation by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAP3K11))
13370d9b-5d7e-4780-bc5e-080aaf880216	1.0	PubMed	27523474	As to breast cancer, it was demonstrated that miR-143 inhibited tumor growth through downregulating ERK5 and suppressing EMT induced by GSK3beta and Snail signaling ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAPK7))
9863d840-055f-4526-a6d1-12679d93b85e	1.0	PubMed	27023670	These results suggest that increases in the levels of phosphorylated tau mediated by GSK3beta and Sgg might contribute to Abeta42 induced detachment of tau from microtubules.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAPT, pmod(Ph)))
4958d392-1947-4664-a11b-7ac40894c3bc	1.0	PubMed	6489937	Here, we describe a new model in which adenovirus mediated gene expression of tau, DeltaMEKK, JNK3, and GSK-3beta in COS-7 cells produces most of the pathological phosphorylation epitopes of tau including AT100.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAPT))
4958d392-1947-4664-a11b-7ac40894c3bc	1.0	PubMed	26608845	Although one other study is consistent with ours in showing that decreasing GSK-3beta activity leads to increased levels of insoluble tau oligomers XREF_BIBR, many other studies, mostly in rodent models, have conversely found that increasing GSK-3beta activity promotes tau aggregation XREF_BIBR XREF_BIBR XREF_BIBR, and that inhibition of GSK-3beta reduces insoluble tau XREF_BIBR XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAPT))
4958d392-1947-4664-a11b-7ac40894c3bc	1.0	PubMed	17098228	These data indicate that the zinc induced pro apoptotic signals transmit through Akt and GSK-3beta, which then lead to their activation.The microtubule associated protein tau is known to be phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAPT))
4958d392-1947-4664-a11b-7ac40894c3bc	1.0	PubMed	5372392	These findings suggest that GSK-3beta modulates in a graded manner the ability of tau to control the microtubule dependent induction of cell processes.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MAPT))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	21821001	The activation of GSK-3beta by Akt inactivation induces Mcl-1 destabilization and then mitochondrial apoptosis upon growth factor withdrawal.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	25499217	Activation of GSK-3beta results in Mcl-1 degradation, while inactivation of GSK-3beta causes accumulation of Mcl-1 promoting chemo-resistance in a Mcl-1 dependent manner.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	25499217	Phosphorylation of GSK-3beta by Akt inactivates GSK-3beta and concurrent Mcl-1 degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	21516346	It has been shown that during glucose deprivation, attenuated PI3K and PKB signals activate GSK3beta, which targets Mcl-1 to the proteasome [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	25412261	Inactivation of GSK-3beta increases not only the stability of CREB for IL-10 production but also enhances the activity of beta-catenin and Mcl-1 for cell growth and survival XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	26822034	GSK3beta has been shown to increase Mcl-1 instability through phosphorylation on Ser 140 (ref.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	20920357	Intriguingly, it appeared that silencing of GSK-3alpha somehow favored whereas silencing of GSK-3beta protected against BZ induced AKT and, even more, MCL-1 degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	20920357	Moreover, our data suggest that GSK-3alpha might control AKT protein turnover, while GSK-3beta could modulate MCL-1 protein stability.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
2436462a-cc89-4df2-b4c2-3395c7d0c27e	1.0	PubMed	18606491	Activation of GSK3beta results in Mcl-1 degradation, while inactivation of GSK3beta causes accumulation of Mcl-1.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MCL1))
9cb6c8b4-7154-4e6a-918e-7747e191cf00	1.0	PubMed	18602000	However, GSK3beta, that is a negative regulator of Wnt signalling, could activate the function of MITF through phosphorylation at Ser298.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MITF))
3d2b63b9-df1d-45ee-9caa-1f9e1bb0597c	1.0	PubMed	21239435	We therefore conclude that GnRH-II stimulates the PI3K and Akt pathway, and the phosphorylation of GSK3beta, thereby enhancing the beta-catenin-dependent up-regulation of MT1-MMP production, which contributes to ovarian cancer metastasis.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MMP14))
45d2443d-b598-4a27-add8-0375738f86b0	1.0	PubMed	22707636	Inactivation of GSK-3beta by LiCl significantly increased MMP9 activity and EMT of RCC cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MMP9))
f8982f88-e208-44ec-9140-bf9725e68c4e	1.0	PubMed	24930764	Here, we showed that GSK3beta activation in MTA treated cells relies on mitochondrial ROS mediated inhibition of upstream Akt.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:439176))
995988e4-ca53-4239-896f-7436042f9386	1.0	PubMed	23416459	Phosphorylation and inactivation of GSK3beta, a serine threonine kinase that phosphorylates and destabilizes c-myc, promotes the regulation of MTDH by c-myc following Akt activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MTDH))
9165f18a-49fe-43c4-b40f-1b266608040c	1.0	PubMed	25851605	To obtain further support for this assumption, we studied the responses of the well established downstream targets of AKT, glycogen synthase kinase 3beta (GSK3beta) and S6 ribosomal protein (S6), downstream of the growth promoting mammalian target of rapamycin (mTOR) complex.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MTOR))
9165f18a-49fe-43c4-b40f-1b266608040c	1.0	PubMed	21329734	In contrast, GSK3beta inactivation may also activate mTOR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MTOR))
9165f18a-49fe-43c4-b40f-1b266608040c	1.0	PubMed	25115395	Thus it prompted us to speculate whether GSK3beta inactivation was required for Aur-A to activate mTOR signaling in breast cancer.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MTOR))
9165f18a-49fe-43c4-b40f-1b266608040c	1.0	PubMed	21737790	Inhibition of GSK-3beta increases, while activation of GSK-3beta inhibits mTOR activity during both ischemia and reperfusion phases.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MTOR))
32ec147e-b6f9-4780-9fbc-57ee442efe7a	1.0	PubMed	22833523	These data were consistent with Smk mediated inactivation of Akt (XREF_FIG) and GSK3beta (data not shown), since activation of Akt and GSK3beta signalling has been reported to promote SerP of MUC1-CT [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MUC1))
62990a2f-c3df-479f-b06e-ac82235d82ed	1.0	PubMed	25499223	These results led us to suggest the possibility that reactivation of Ras and AKT signaling by TSH and DUSP6 involves GSK3beta phosphorylation, which in turn induces c-Myc stabilization and represents as an overexpression of c-Myc.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MYC))
62990a2f-c3df-479f-b06e-ac82235d82ed	1.0	PubMed	17397930	Our recent study confirms that PI3K signaling in THR cells phosphorylates AKT and GSK3beta, which activates c-Myc, but not USF-1, resulting in increased expression ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MYC))
0b420588-e1b9-4f24-ada8-562914377cba	1.0	PubMed	26129946	In summary, our results indicate that inhibition of GSK-3beta reduces myocardin transcriptional activity, suggesting a role for GSK-3beta in myocardin transcriptional activity and smooth muscle differentiation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:MYOCD))
44f4e261-a9e4-44b3-ae5a-96020f51d434	1.0	PubMed	3982677	GSK-3 alpha and GSK-3 beta induce a partial retardation of a proportion of the transfected NF-H, but only cdk-5 alters the rate of electrophoretic migration to that of NF-H from brain.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NEFH))
014317b6-ab87-4d4d-9052-11cdf697c827	1.0	PubMed	22079596	Inhibition of GSK-3beta, in turn, promotes NFATc2 inhibition and degradation in cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NFATC2))
f2a7aa5f-6014-4df9-a1dc-e178872178bd	1.0	PubMed	22977251	Knockdown of glycogen synthase kinase 3beta (GSK3beta) significantly increased the depolarization induced nuclear localization of NFATc4.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NFATC4))
c588b4fa-e3bd-4e49-ba93-22bc8ad7bd06	1.0	PubMed	25651906	In contrast, the activation of the Ca 2+ signalling pathway by Ca 2+ ionophore A23187 failed to alter either the basal activity or the Wnt3a response of MyoD-PE-luc (XREF_FIG B), suggesting that NFAT, as reported previously [XREF_BIBR], might be indirectly activated by GSK3beta instead of the Ca 2+ signalling pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFAT))
c588b4fa-e3bd-4e49-ba93-22bc8ad7bd06	1.0	PubMed	21680901	Because the Akt and GSK3beta pathway can also activate Pim1 and NFAT in CASMC, we studied whether CML-BSA increases the Akt and GSK3beta pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFAT))
c588b4fa-e3bd-4e49-ba93-22bc8ad7bd06	1.0	PubMed	PMC6377119	We also examined possible insulin-like growth factor I (IGF-I) signaling of NFAT (nuclear factors of activated T cells)-inducible gene activity and possible modulation of NFAT activation by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFAT))
c588b4fa-e3bd-4e49-ba93-22bc8ad7bd06	1.0	PubMed	6377119	We also examined possible insulin like growth factor I (IGF-I) signaling of NFAT (nuclear factors of activated T cells)-inducible gene activity and possible modulation of NFAT activation by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFAT))
c588b4fa-e3bd-4e49-ba93-22bc8ad7bd06	1.0	PubMed	6377119	We also examined possible insulin like growth factor I (IGF-I) signaling of NFAT (nuclear factors of activated T cells)-inducible gene activity and possible modulation of NFAT activation by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFAT))
a3238135-86cf-4eb7-8ce8-cd71ac04a31a	1.0	PubMed	24887096	PLK2 mediated phosphorylation of GSK3B promotes the nuclear translocation of NRF2.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NFE2L2))
eb37e409-7345-4c65-bd9d-362b43e75c7d	1.0	PubMed	25881103	Blebbistatin enhanced Akt and GSK3beta phosphorylation and inhibited NF-kappaB p65 nuclear translocation and IkappaBalpha degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NFKBIA))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	22534782	Taken together, these results demonstrate that GSK-3beta activation stimulates NF-kappaB activity and that inhibition of the NF-kappaB pathway induces apoptosis in osteosarcoma cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	22534782	We conclude that GSK-3beta positively regulates the NF-kappaB pathway to promote oncogenic activities in osteosarcoma and that therapeutic targeting of the GSK-3beta and/or NF-kappaB pathways may be a promising strategy to enhance the therapeutic activity of anticancer drugs against osteosarcoma in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	22534782	Here, we provide evidence that GSK-3beta positively regulates the NF-kappaB pathway and is a promising therapeutic target in osteosarcoma, especially if GSK-3beta inhibition is combined with ADM and/or NF-kB inhibitors.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	22534782	Biological and pathological functions of GSK-3beta have been linked to the NF-kappaB pathway for a decade (XREF_BIBR), but the question of how GSK-3beta activates NF-kappaB signaling is poorly understood.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	22534782	To better understand the function of GSK-3beta in osteosarcoma, here, we sought to determine whether GSK-3beta can activate the NF-kappaB pathway to promote tumorigenicity and whether targeting of the GSK-3beta and/or NF-kappaB pathways might represent a promising strategy to enhance the therapeutic activity of anticancer drugs against osteosarcoma.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	25138042	Inhibition of either NF-kappaB or GSK3beta significantly abolishes the anti-apoptotic effect of 14-3-3zeta and Ser9 phosphorylated GSK3beta, suggesting that Ser9 phosphorylated GSK3beta actively antagonizes cell apoptosis in a NF-kappaB dependent manner.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	22243669	Giannopoulou M. et al. found in cultured renal tubular epithelium that hepatocyte growth factor (HGF) has a potent suppressive effect on NFkappaB activation, which was mediated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	20031160	In pancreatic cancer cells, GSK-3beta mediates regulation of NF-kappaB, controlling cellular survival and proliferation [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	16806170	In addition, only GSK-3beta can mediate the function of the transcription factor NF-kappaB, and GSK-3alpha can not compensate for the loss of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	15781227	Genetic disruption of GSK3beta abrogates NF-kappaB activation and NF-kappaB-mediated inflammatory responses to TNF-alpha or IL-1beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	15781227	reported that inhibition of GSK3beta abrogates NF-kappaB activation by TNF-alpha in human colon cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	18201972	Collectively, our findings suggest that HGF has a potent suppressive effect on NFkappaB activation, which is mediated by GSK3beta, an important signaling transducer controlling RelA and p65 phosphorylation specificity and directing the transcription of selective proinflammatory cytokines implicated in inflammatory kidney disease.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	7198827	We found that inhibition of GSK-3beta suppressed NF-kappaB activity, whereas reexpression of APC restored NF-kappaB activity in APC mutated cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	14991743	We found that inhibition of GSK-3beta suppressed NF-kappaB activity, whereas reexpression of APC restored NF-kappaB activity in APC mutated cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	24675460	The preceding results suggest that GSK-3beta, but not GSK-3alpha modulates a subset of NF-kappaB target genes.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	24675460	Our further studies show that GSK-3beta in the nucleus of pancreatic cancer cells contributes to TRAIL resistance by impacting binding of NF-kappaB dimers to a subset of NF-kappaB-responsive promoters, ultimately modulating the expression of specific anti-apoptotic NF-kappaB target genes such as BCL2L1.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	24675460	The preceding results not only show that GSK-3beta modulates the effects of NF-kappaB on a specific subset of its target genes, but also suggest that these effects occur after NF-kappaB enters the nucleus.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	21110852	These results indicate that inhibition of GSK-3beta downregulates the NF-kappaB activation pathway, leading to suppression of the expression of an NF-kappaB-regulated gene and promotion of apoptosis in ALL cells in vitro.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	21110852	Inhibition of GSK-3beta suppressed the binding of NF-kappaB to the DNA in ALL cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	21110852	Moreover, we found that GSK-3beta inhibition in ALL cells did not prevent NF-kappaB relocation from the cytoplasm to the nucleus, but the inhibition affected the transcriptional repression of NF-kappaB, as shown by EMSA analysis.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	26560046	Similarly, GSK3beta inhibition by AR-A014418 or siRNA in pancreatic cancer cell lines PANC-1 and MIA PaCa-2 reduced activation and nuclear accumulation of NFkappaB, which resulted in reduced cell growth and colony formation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	18243662	Hence, these results demonstrate that phosphorylation of Akt1 by IR is not through the mediation of DNA-PK and that wortmannin at the concentration used in this study has some specific inhibitory activity.For the confirmation of the involvement of GSK-3beta in the transcriptional control of IR induced NF-kappaB activation as seen above, cells were transiently transfected with a HA tagged GSK-3beta vector of either wild-type (wt) or catalytically inactive kinase dead mutant (kd).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	21145761	Although the exact mechanisms of GSK3beta mediated NF-kappaB activation in the virus triggered signaling pathways require further investigations, our studies suggest that GSK3beta regulates both virus triggered IRF3 and NF-kappaB activation pathways.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	21145761	In reporter assays, knockdown of GSK3beta dramatically inhibited SeV induced NF-kappaB activation (A).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	25829335	Moreover, inhibition of GSK-3beta also disrupts survival role of NF-kappaB transactivation and promote TNF-alpha mediated toxicity.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	19180470	Previous reports show that PI3K inhibits GSK-3beta through phosphorylation at Ser9 [XREF_BIBR; XREF_BIBR] and that inactivation of GSK-3beta can either increase NF-kappaB activity [XREF_BIBR; XREF_BIBR] or decrease NF-kappaB activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	19180470	Because LiCl inhibits GSK-3beta [XREF_BIBR - XREF_BIBR], the data suggested that active GSK-3beta increases NF-kappaB transactivation.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	19180470	GSK-3beta modulates the activity of NF-kappaB, which is a known regulator of TNF-alpha expression.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	19180470	An additional mechanism by which PI3K can limit the TNF-alpha production is through GSK-3beta modulating the NF-kappaB activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
716173b8-bedc-4be0-8cfa-9ac363024f34	1.0	PubMed	19180470	GSK-3beta can modulate the localization of NF-kappaB to the nucleus and effect expression of genes dependent on NF-kappaB activation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:NFkappaB))
f9e74c23-0a61-4099-a694-4b426a19a74a	1.0	PubMed	6402719	These studies reveal that GSK3beta modulates Notch1 signaling, possibly through direct phosphorylation of the intracellular domain of Notch, and that the activity of GSK3beta protects the intracellular domain from proteasome degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NOTCH1))
f9e74c23-0a61-4099-a694-4b426a19a74a	1.0	PubMed	17513037	GSK-3beta, a serine/threonine kinase and a component of the Wnt and wingless signaling cascade, modulates Notch1 signaling via the direct phosphorylation of Notch1-IC, and active GSK-3beta protects Notch1-IC against proteosomal degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NOTCH1))
f9e74c23-0a61-4099-a694-4b426a19a74a	1.0	PubMed	17513037	GSK-3beta modulates Notch1 signaling via the direct phosphorylation of Notch1-IC, and active GSK-3beta protects Notch1-IC against proteosomal degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NOTCH1))
f9e74c23-0a61-4099-a694-4b426a19a74a	1.0	PubMed	12123574	Here, we observed that gsk3beta was able to bind and phosphorylate notch1ic in vitro, and attenuation of gsk3beta activity reduced phosphorylation of notchic in vivo.Functionally, ligand-activated signaling through the endogenous notch1 receptor was reduced in gsk3beta fibroblasts, implying a positive role for gsk3beta in mammalian notch signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NOTCH1))
f9e74c23-0a61-4099-a694-4b426a19a74a	1.0	PubMed	25849484	In contrast, it has been shown in cell line models that GSK3beta positively modulates Notch signalling by protecting the intracellular domain of Notch1 (ICN1) from proteasome degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NOTCH1))
b6fd682b-780d-41cc-adff-f48e12fa7613	1.0	PubMed	16484495	We show here that gsk3beta phosphorylates and stabilizes the orphan nuclear receptor rev-erbalpha, a negative component of the circadian clock.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NR1D1))
b6fd682b-780d-41cc-adff-f48e12fa7613	1.0	PubMed	16484495	We show here that gsk3beta phosphorylates and stabilizes the orphan nuclear receptor rev-erbalpha, a negative component of the circadian clock.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NR1D1))
de9dc640-8b9f-4f96-a9bc-6c3ef13bb2c5	1.0	PubMed	15652488	Because the phosphorylation of GSK-3beta at Ser 9 is known to inactivate GSK-3beta, our findings suggest that NT-3 and BDNF decrease the phosphorylation levels of CRMP-2 at Thr 514 and increase nonphosphorylated active CRMP-2 via the PI3-kinase/Akt/GSK-3beta pathway.To examine the effect of NT-3 on the spatial distribution of phosphorylated CRMP-2 at Thr 514, hippocampal neurons were fixed at 3 DIV after the treatment of NT-3 for 30 min and then immunostained with anti-pT514 (phosphorylated CRMP-2, red) and anti-CRMP-2 antibodies (total CRMP-2, green;).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:NTF3))
9e487fa5-58e3-48a9-9134-6a6106d79f85	1.0	PubMed	22613765	Although some groups have shown that stimulation of GSK3beta results in neurite retractions, we found that activation of GSK3beta by the AICD actually enhances neurite outgrowth in PC12, Na cells and primary neurons.As a pathway that can promote cell growth, canonical Wnt signalling also contributes to suppressing NGF induced neurite differentiation.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:5360545))
d7c360da-4ccc-4c9f-ae5b-a00f9199bbed	1.0	PubMed	12123574	The present results show that Notch is directly modulated by GSK3beta activity and imply that its function may indeed be modulated by Wnt/wg signaling through its negative effect upon GSK3beta activity mediated by Disheveled.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Notch))
d7c360da-4ccc-4c9f-ae5b-a00f9199bbed	1.0	PubMed	26625202	==== RefsREFERENCES1 Clevers H The cancer stem cell : premises, promises and challenges Nat Med 2011 17 313 319 21386835 2 Takebe N Harris PJ Warren RQ Ivy SP Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways Nat Rev Clin Oncol 2011 8 97 106 21151206 3 Owens TW Naylor MJ Breast cancer stem cells Front Physiol 2013 4 225 23986719 4 Al-Hussaini H Subramanyam D Reedijk M Sridhar SS Notch signaling pathway as a therapeutic target in breast cancer Mol Cancer Ther 2011 10 9 15 20971825 5 Farnie G Clarke RB Spence K Pinnock N Brennan K Anderson NG Bundred NJ Novel cell culture technique for primary ductal carcinoma in situ : role of Notch and epidermal growth factor receptor signaling pathways J Natl Cancer Inst 2007 99 616 627 17440163 6 Reedijk M Odorcic S Chang L Zhang H Miller N McCready DR Lockwood G Egan SE High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival Cancer Res 2005 65 8530 8537 16166334 7 Capaccione KM Pine SR The Notch signaling pathway as a mediator of tumor survival Carcinogenesis 2013 34 1420 1430 23585460 8 Landor SK Mutvei AP Mamaeva V Jin S Busk M Borra R Gronroos TJ Kronqvist P Lendahl U Sahlgren CM Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms Proc Natl Acad Sci U S A 2011 108 18814 18819 22065781 9 Jin S Mutvei AP Chivukula IV Andersson ER Ramskold D Sandberg R Lee KL Kronqvist P Mamaeva V Ostling P Mpindi JP Kallioniemi O Screpanti I Non canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKalpha and IKKbeta Oncogene 2013 32 4892 4902 23178494 10 Bolos V Mira E Martinez-Poveda B Luxan G Canamero M Martinez-A C Manes S de la Pompa JL Notch activation stimulates migration of breast cancer cells and promotes tumor growth Breast Cancer Res 2013 15 R54 23826634 11 Simmons MJ Serra R Hermance N Kelliher MA NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere forming activity in vitro Breast Cancer Res 2012 14 R126 22992387 12 Osipo C Patel P Rizzo P Clementz AG Hao L Golde TE Miele L ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor Oncogene 2008 27 5019 5032 18469855 13 Rizzo P Miao H D'Souza G Osipo C Song LL Yun J Zhao H Mascarenhas J Wyatt D Antico G Hao L Yao K Rajan P Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches Cancer Res 2008 68 5226 5235 18593923 14 Aster JC Blacklow SC Targeting the Notch pathway : twists and turns on the road to rational therapeutics J Clin Oncol 2012 30 2418 2420 22585704 15 West AC Johnstone RW New and emerging HDAC inhibitors for cancer treatment J Clin Invest 2014 124 30 39 24382387 16 Barneda-Zahonero B Parra M Histone deacetylases and cancer Molec Oncol 2012 6 579 589 22963873 17 Smith KT Workman JL Introducing the acetylome Nature Biotechnol 2009 27 917 919 19816449 18 Salvador MA Wicinski J Cabaud O Toiron Y Finetti P Josselin E Lelievre H Kraus-Berthier L Depil S Bertucci F Collette Y Birnbaum D Charafe-Jauffret E The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression Clin Cancer Res 2013 19 6520 6531 24141629 19 Liao MJ Zhang CC Zhou B Zimonjic DB Mani SA Kaba M Gifford A Reinhardt F Popescu NC Guo W Eaton EN Lodish HF Weinberg RA Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity Cancer Res 2007 67 8131 8138 17804725 20 Grimshaw MJ Cooper L Papazisis K Coleman JA Bohnenkamp HR Chiapero-Stanke L Taylor-Papadimitriou J Burchell JM Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells Breast Cancer Res 2008 10 R52 18541018 21 Balasubramanian S Ramos J Luo W Sirisawad M Verner E Buggy JJ A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas Leukemia 2008 22 1026 1034 18256683 22 Hughes DP How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize Cancer Treat Res 2009 152 479 496 20213410 23 Matsumoto A Onoyama I Sunabori T Kageyama R Okano H Nakayama KI Fbxw7 dependent degradation of Notch is required for control of " stemness " and neuronal-glial differentiation in neural stem cells J Biol Chem 2011 286 13754 13764 21349854 24 Deshaies RJ Joazeiro CA RING domain E3 ubiquitin ligases Ann Rev Biochem 2009 78 399 434 19489725 25 Foltz DR Santiago MC Berechid BE Nye JS Glycogen synthase kinase-3 beta modulates notch signaling and stability Curr Biol 2002 12 1006 1011 12123574 26 Espinosa L Ingles-Esteve J Aguilera C Bigas A Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways J Biol Chem 2003 278 32227 32235 12794074 27 Ranganathan P Vasquez-Del Carpio R Kaplan FM Wang H Gupta A VanWye JD Capobianco AJ Hierarchical phosphorylation within the ankyrin repeat domain defines a phosphoregulatory loop that regulates Notch transcriptional activity J Biol Chem 2011 286 28844 28857 21685388 28 Wolfson NA Pitcairn CA Fierke CA HDAC8 substrates : Histones and beyond Biopolymers 2013 99 112 126 23175386 29 Lee H Sengupta N Villagra A Rezai-Zadeh N Seto E Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin mediated degradation Mol Cell Biol 2006 26 5259 5269 16809764 30 Karolczak-Bayatti M Sweeney M Cheng J Edey L Robson SC Ulrich SM Treumann A Taggart MJ Europe-Finner GN Acetylation of heat shock protein 20 (Hsp20) regulates human myometrial activity J Biol Chem 2011 286 34346 34355 21803775 31 Wilson BJ Tremblay AM Deblois G Sylvain-Drolet G Giguere V An acetylation switch modulates the transcriptional activity of estrogen related receptor alpha Mol Endocrinol 2010 24 1349 1358 20484414 32 Deardorff MA Bando M Nakato R Watrin E Itoh T Minamino M Saitoh K Komata M Katou Y Clark D Cole KE De Baere E Decroos C HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle Nature 2012 489 313 317 22885700 33 Oehme I Deubzer HE Wegener D Pickert D Linke JP Hero B Kopp-Schneider A Westermann F Ulrich SM von Deimling A Fischer M Witt O Histone deacetylase 8 in neuroblastoma tumorigenesis Clin Cancer Res 2009 15 91 99 19118036 34 Wu J Du C Lv Z Ding C Cheng J Xie H Zhou L Zheng S The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma Dig Dis Sci 2013 58 3545 3553 24077923 35 Kang Y Nian H Rajendran P Kim E Dashwood WM Pinto JT Boardman LA Thibodeau SN Limburg PJ Lohr CV Bisson WH Williams DE Ho E HDAC8 and STAT3 repress BMF gene activity in colon cancer cells Cell Death Dis 2014 5 e1476 25321483 36 Gao SM Chen CQ Wang LY Hong LL Wu JB Dong PH Yu FJ Histone deacetylases inhibitor sodium butyrate inhibits JAK2 and STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms Exp Hematol 2013 41 261 270 e264 23111066 37 Liu C Liu L Shan J Shen J Xu Y Zhang Q Yang Z Wu L Xia F Bie P Cui Y Zhang X Bian X Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification Cancer Lett 2013 339 60 69 23879963 38 Karagianni P Wong J HDAC3 : taking the SMRT-N-CoRrect road to repression Oncogene 2007 26 5439 5449 17694085	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Notch))
d7c360da-4ccc-4c9f-ae5b-a00f9199bbed	1.0	PubMed	25849484	In contrast, it has been shown in cell line models that GSK3beta positively modulates Notch signalling by protecting the intracellular domain of Notch1 (ICN1) from proteasome degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Notch))
fdbbf84f-1365-43cb-ab48-59e6161e3946	1.0	PubMed	21887250	In addition, we found that inhibition of GSK3beta with GSK3beta-inhibitor VIII decreased both Olig2 and Isl1 (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:OLIG2))
f166cc80-4f4d-4682-ab1a-46948af4e108	1.0	PubMed	23243017	Parallel studies revealed that GSK3alpha or GSK3beta shRNA knockdown also significantly reduced BEZ235 and ABT-737-mediated caspase-3 and PARP cleavage (XREF_FIG), and cell death (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PARP1))
f6a21933-75b4-4af7-8bc8-0e0cbb2ea0c5	1.0	PubMed	26797279	Our data showed that vIRF2 induces activation of PDK1 and Akt, but not GSK3beta, a downstream factor of the Akt signaling pathway (B).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PDPK1))
a53533f6-be60-4b07-a701-195e866dba70	1.0	PubMed	24681994	Attenuation of the microglia mediated inflammatory response targeted by GSK-3beta inhibition to prevent dopaminergic neuron degeneration in PD requires further investigation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D010300))
a53533f6-be60-4b07-a701-195e866dba70	1.0	PubMed	24681994	Attenuation of the microglia mediated inflammatory response targeted by GSK-3beta inhibition to prevent dopaminergic neuron degeneration in PD requires further investigation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D010300))
a53533f6-be60-4b07-a701-195e866dba70	1.0	PubMed	24115276	By contrast, GSK3B variants do appear to modulate PD risk in the context of additional genetic cues, but probably not in all populations.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D010300))
7c00d1d6-9576-43a3-a57c-e33d1796d752	1.0	PubMed	25632187	Interestingly, activation of the GSK3beta and beta-catenin pathway induced by Wnt3a resulted in up-regulation of P-gp, which was effectively abolished by beta-escin, indicating that beta-escin down-regulated P-gp expression in a GSK3beta dependent manner.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PGP))
963c77be-d26e-406b-8427-e3294865b4a2	1.0	PubMed	26845447	Therefore, we suspect that GSK3beta drives osteosarcoma progression either by its inhibition or by its activation, depending on its subcellular localization.To determine the effect of TSSC3 on osteosarcoma progression directly, we overexpressed TSSC3 in SaOS2 cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PHLDA2))
b3ea6e16-e52e-4a2b-b023-b4542cafd3e9	1.0	PubMed	25889792	Next we aimed to identify the responsible transcription factor downstream of the PI3K and Akt signaling cascade which is activated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PI3K))
b3ea6e16-e52e-4a2b-b023-b4542cafd3e9	1.0	PubMed	23383294	They may include regulation of activity and/or subcellular redistribution of known PI3K downstream targets such as the Vav, GSK-3b, and FOXO1, the importance of which in T cell S phase entry is established XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PI3K))
b3ea6e16-e52e-4a2b-b023-b4542cafd3e9	1.0	PubMed	27020460	However, it is not known whether GSK-3beta is a major target of the PI3K and AKT signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PI3K))
b3ea6e16-e52e-4a2b-b023-b4542cafd3e9	1.0	PubMed	22922215	Therefore, IGF1 might activate PI3K and Akt signaling and its downstream mediators, such as GSK3beta and mTOR, to induce beta-catenin-dependent transcription including the transcription of Snail and Slug.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PI3K))
b3ea6e16-e52e-4a2b-b023-b4542cafd3e9	1.0	PubMed	18328427	Activated PI3K leads to inhibition of glycogen synthase kinase 3-beta (GSK3beta) and induction of matrix metalloproteinases (MMPs).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PI3K))
b3ea6e16-e52e-4a2b-b023-b4542cafd3e9	1.0	PubMed	26219398	Accumulating evidence indicates that GSK3beta is a downstream target of the PI3K and AKT signaling pathway [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PI3K))
10300e19-9962-47f4-a6cf-3a936a1dd1a4	1.0	PubMed	21680901	Because the Akt and GSK3beta pathway can also activate Pim1 and NFAT in CASMC, we studied whether CML-BSA increases the Akt and GSK3beta pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PIM1))
10300e19-9962-47f4-a6cf-3a936a1dd1a4	1.0	PubMed	26934497	These results suggest that phosphorylation of GSK3B is essential, but not alone sufficient for PIM kinases to promote PC-3 cell migration.Murine FoxP3 and human PIM1 were produced as GST-fusion proteins in order to analyse whether also FoxP3 is a Pim substrate.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PIM1))
0b0f162b-4e35-4a12-be1e-f2f6c4d5d2ca	1.0	PubMed	19591849	Activation of PKA, cdk5 and GSK3beta will lead to tau phosphorylation.D1-stimulated PKA dependent phosphorylation of substrates is a relatively rapid event in neurons.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PKA, pmod(Ph)))
0628f9d2-bd4d-41fc-8d81-bf6afc2d0ffe	1.0	PubMed	22142472	Although NT-STK38 was slightly phosphorylated by GSK-3beta alone (C, lane 3), when NT-STK38 was first pretreated with PKA in the presence of non radioactive ATP and then treated with GSK-3beta in the presence of [gamma-P] ATP, GSK-3beta effectively phosphorylated it (C, lanes 4 and 5).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PKA))
a2ce4ef3-c685-44eb-8262-9900fd961a18	1.0	PubMed	20117169	This study also revealed that Zac1 is negatively regulated by the PI3K survival pathway and upregulated by GSK3beta through p53, suggesting that survival pathways may contribute to tumor progression also by downregulating this tumor suppressor.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PLAGL1))
4c404045-dc92-490d-9da7-dea49fe57737	1.0	PubMed	17991738	Pharmacologic inhibition of GSK-3beta prevents the disappearance of Noxa induced by sorafenib and enhances the down-modulation of Mcl-1.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PMAIP1))
db973cb9-b1bd-44b2-8f95-858b3948f4c9	1.0	PubMed	20178594	Furthermore, we demonstrated GSK-3beta transfection was able to interact with PMS2 and enhance PMS2 production in HeLa cells, and increased PMS2 production was responsible for enhanced chemosensitivity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PMS2))
db973cb9-b1bd-44b2-8f95-858b3948f4c9	1.0	PubMed	20178594	Our results provide the evidence that stabilization of PMS2 production by GSK-3beta was important to improve chemosensitization, indicating the significance of GSK-3beta-related PMS2 downregulation in the development of cervical carcinoma and in developing a potential strategy for chemotherapy.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PMS2))
db973cb9-b1bd-44b2-8f95-858b3948f4c9	1.0	PubMed	21571466	Inactivation of GSK-3beta might be important for NPC tumorgenesis through negatively regulating PMS2 production, and enhanced PMS2 production by GSK-3beta is beneficial for understanding the NPC tumorgenesis and developing potential strategy for future therapy.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PMS2))
9195ffe1-b5d9-417c-9dd6-3e3c161c56f5	1.0	PubMed	24901984	In summary, the morphological analyses reveal severe defects in nucleolar function and chromatin organization and together with the molecular analyses presented above support the conclusion that GSK3beta contributes to pol I transcription activation by indirectly inducing a permissive chromatin state.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:POLI))
8ecad8eb-dcc5-4b90-9586-899b73a7c68b	1.0	PubMed	19371772	AKT positively regulates mTOR (activator of PGC-1alpha) by direct inhibition of the inhibitory complex TSC1/2 and by inhibition of the mTOR inhibitors AMPK (activator of PGC-1alpha) and GSK3b (regulator of PGC-1alpha turnover) [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PPARGC1A))
8ecad8eb-dcc5-4b90-9586-899b73a7c68b	1.0	PubMed	26831453	The latter 's nuclear transcription activity is enhanced by Sirt1 dependent nuclear accumulation and is counter regulated by glycogen synthase kinase beta (GSK3beta), which targets PGC-1alpha for intranuclear proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PPARGC1A))
8ecad8eb-dcc5-4b90-9586-899b73a7c68b	1.0	PubMed	25118933	As GSK3beta is a kinase involved in PGC-1alpha degradation, we wonder whether GSK3beta mediates the downregulation of PGC-1alpha by Omi.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PPARGC1A))
18f93969-252e-4947-8d9f-d9bc3d844d36	1.0	PubMed	11320080	Protein phosphatase 1 (PP1) is complexed with inhibitor 2 (I-2) in the cytosol. In rabbit muscle extract PP1.I-2 is activated upon preincubation with ATP/Mg. This activation is caused by phosphorylation of I-2 on Thr(72) by glycogen synthase kinase 3 (GSK3).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PPP1R2))
e00815f3-e2f6-4722-83c2-a49210bc2f59	1.0	PubMed	26655089	A consequence of the reactivation of PP1 is the dephosphorylation of GSK3beta, which further activates PP1.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PPP1))
ffc3a06c-92f7-42ff-b80e-02010ec16253	1.0	PubMed	23428800	These results indicate that PTPA activates PP2A by regulatng the methylation and/or phosphorylation of PP2A.Glycogen synthase kinase-3beta (GSK-3beta) is a key tau kinase, GSK-3beta also inhibits PP2A.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PPP2))
ffc3a06c-92f7-42ff-b80e-02010ec16253	1.0	PubMed	25219467	Upregulation of GSK-3beta enhances PP2A activity through methylation of PP2A via PME-1 and/or LCMT-1; PP2A elevates GSK-3beta activity via reduction of its phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PPP2))
ffc3a06c-92f7-42ff-b80e-02010ec16253	1.0	PubMed	25219467	Specifically, targeting GSK-3beta might downregulate PP2A, resulting in an increase of tau phosphorylation at PP2A sensitive sites.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:PPP2))
d96b2e99-24c0-4593-be11-37746617b624	1.0	PubMed	18604201	Specifically, we have identified three phosphorylation sites within pkcepsilon that control its association with 14-3-3.kinase (ser 350), gsk3 (ser 346) and pkc itself (ser 368)	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:PRKCE))
30dc2391-8434-4e53-a135-e58ac0f33440	1.0	PubMed	26655089	Here we report that OLA1 is a GSK3beta interacting protein, and through its ATPase activity, inhibits the GSK3beta mediated activation of protein serine/threonine phosphatase 1 (PP1).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Phosphatase))
30dc2391-8434-4e53-a135-e58ac0f33440	1.0	PubMed	16959610	This was consistent with the effect of laforin on Akt mediated phosphorylation of GSK-3beta at Ser9.The selective effect of laforin on phosphorylation of GSK-3beta at Ser9 raised the intriguing possibility that laforin may be the phosphatase of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Phosphatase))
383dff5a-06e1-4605-b116-234f87ca10e2	1.0	PubMed	19754670	Our data reveal that PAF stimulation results in migration of THP-1, ND and DM monocytes through phosphorylation of AKT and GSK-3beta leading to Rac-1 activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RAC1))
5508f5cd-5e5e-4804-bed7-4493481d6a33	1.0	PubMed	14660640	Co-expression of GSK3beta and Rap1GAP in human embryonic kidney 293 cells stimulated proteasome dependent Rap1GAP turnover.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RAP1GAP))
a438bf7f-bdd6-4b89-afb1-e1ae216a8651	1.0	PubMed	18156211	We first showed that inhibition of GSK-3beta completely blocked rb sFRP-1-induced EC spreading on type I collagen ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RB1))
a77a0452-6f1b-4e0f-838b-1893321e5c77	1.0	PubMed	12063245	Consensus phosphorylation sites for p42/44 MAPK and GSK-3 are present in the SP repeat of MCIP1 at serine 112 and serine 108, respectively |Several endogenous proteins are capable of inhibiting the catalytic activity of calcineurin. Modulatory calcineurin interacting protein 1 (MCIP1) is unique among these proteins on the basis of its pattern of expression and its function in a negative feedback loop to regulate calcineurin activity. Here we show that MCIP1 can be phosphorylated by MAPK and glycogen synthase kinase-3 and that phosphorylated MCIP1 is a substrate for calcineurin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RCAN1))
7b9fa9d2-0060-4cc5-a6a8-a8addf4fef7e	1.0	PubMed	22707636	Inactivation of GSK-3beta by LiCl significantly increased MMP9 activity and EMT of RCC cells.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:10985033))
47ee0fae-84b8-4da4-be7e-7a2c8c5abea1	1.0	PubMed	17183360	Rela is phosphorylated at: ser276 by the catalytic subunit of protein kinase a (pkac), msk1 and msk2; at ser311 by the atypical pkczeta; at ser468 by ikkbeta, ikkepsilon and glycogen-synthase kinase-3beta (gsk3beta); at ser529 by ck2; and at ser536 by ikkbeta, ikkalfa, ikkepsilon, nf-kb activating kinase (nak, also known as tank-binding kinase-1 tbk1)) and rsk1 (also known as p90 ribosomal protein s6 kinase (p90s6k) .	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RELA))
47ee0fae-84b8-4da4-be7e-7a2c8c5abea1	1.0	PubMed	24327518	It has also been shown that GSK-3beta contributes to the maintenance of active chromatin at Bcl-2 and XIAP promoters, allowing p65 binding and transcriptional activation of Bcl-2 and XIAP in cancer cells (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RELA))
47ee0fae-84b8-4da4-be7e-7a2c8c5abea1	1.0	PubMed	16407239	Rela is phosphorylated at: ser276 by the catalytic subunit of protein kinase a (pkac), msk1 and msk2; at ser311 by the atypical pkczeta; at ser468 by ikkbeta, ikkepsilon and glycogen-synthase kinase-3beta (gsk3beta); at ser529 by ck2; and at ser536 by ikkbeta, ikkalfa, ikkepsilon, nf-kb activating kinase (nak, also known as tank-binding kinase-1 tbk1)) and rsk1 (also known as p90 ribosomal protein s6 kinase (p90s6k) .	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RELA))
333065a8-042a-48a7-8cb1-8b3d8c3b5820	1.0	PubMed	26514730	Similarly, WNT-5A induces migration in gastric cancer cells by activating PI3K and AKT pathway which phosphorylates and inactivates GSK-3beta and activates RhoA leading to cytoskeleton remodeling [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RHOA))
7782c0cc-f21c-49d5-9dec-00dadfdc9cda	1.0	PubMed	26824423	GSK-3beta also increases hnRNP A18 RNA binding activity and both, hnRNP A18 RNA binding domain and the RGG domain are required for maximal hnRNP A18 RNA binding activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF01877))
7782c0cc-f21c-49d5-9dec-00dadfdc9cda	1.0	PubMed	16513844	Furthermore, phosphorylation of hnRNP A18 by the hypoxia inducible kinase GSK3beta (XREF_BIBR) increases hnRNP A18 RNA binding activity in vitro and in RKO cells in response to UV radiation.	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF01877))
7782c0cc-f21c-49d5-9dec-00dadfdc9cda	1.0	PubMed	16513844	Our in vitro data (XREF_FIG) indicate that GSK3beta can increase hnRNP A18 RNA binding activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF01877))
7782c0cc-f21c-49d5-9dec-00dadfdc9cda	1.0	PubMed	16513844	These data suggest that phosphorylation of hnRNP A18 by GSK3beta following UV radiation exposure is necessary to increase hnRNP A18 RNA binding activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF01877))
c5b7ffa6-9b61-45c7-b67a-b3a4fc921a13	1.0	PubMed	26824423	GSK-3beta also increases hnRNP A18 RNA binding activity and both, hnRNP A18 RNA binding domain and the RGG domain are required for maximal hnRNP A18 RNA binding activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF08675))
57791a9c-04e6-4dbc-ad13-e55302b05e74	1.0	PubMed	20654575	While GSK3beta down-regulation increases TCF7L2 expression, there is no concomitant change in TCF7L2 mRNA isoforms, which demonstrate the dual effects of lithium on TCF7L2 expression via a GSK3beta dependent up-regulation and a GSK3beta independent modulation of RNA splicing.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008380"))
a1b8e225-54bb-40e5-ab81-ec8293e50f5e	1.0	PubMed	26618897	LiCl mediated GSK3beta inactivation in vitro resulted in increased mitochondrial ROS production, responsible for reduced cell proliferation, S phase transient arrest, and increase in cell senescence, size and granularity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ROS1))
a1b8e225-54bb-40e5-ab81-ec8293e50f5e	1.0	PubMed	26618897	With regards to the underlying molecular mechanisms, LiCl mediated GSK3beta inactivation increased mitochondrial ROS production that led to oxidative damage (increased 8-oxo-deoxyguanosine), DNA damage response (increased expression of gammaH2AX and growth arrest and DNA damage inducible protein 45beta (GADD45beta)) and cell senescence (transient S phase arrest, increased expression of the senescence marker p21, SA-beta galactosidase and PAS staining).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ROS1))
a1b8e225-54bb-40e5-ab81-ec8293e50f5e	1.0	PubMed	26618897	In this paper we instead show that following GSK3beta inactivation, increased intracellular ROS trigger a DNA damage response which leads to an up-regulated expression of p21, the other CKI.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ROS1))
a1b8e225-54bb-40e5-ab81-ec8293e50f5e	1.0	PubMed	24681994	Similar studies have indicated that GSK-3beta inhibition promotes mitochondrial biogenesis and prevents ROS production during ischemic cerebral damage (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ROS1))
a1b8e225-54bb-40e5-ab81-ec8293e50f5e	1.0	PubMed	25390651	Activation of the mK ATP channel induced inhibitory phosphorylation of GSK-3beta and suppressed ROS production, LDH release and apoptosis after AA washout.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ROS1))
a1b8e225-54bb-40e5-ab81-ec8293e50f5e	1.0	PubMed	25390651	A role of GSK-3beta translocated to mitochondria in ROS production is supported by the finding that selective expression of unregulated GSK-3beta in mitochondria significantly increased ROS production in SH-SY5Y cells XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ROS1))
6ec765c2-25b8-4355-8810-a6ba9cae54cf	1.0	PubMed	24899689	In striking contrast, we deleted GSK-3beta, an anti-fibrotic factor, and this led to markedly increased fibrosis, and increased scar expansion.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RPS4X))
13a7cbce-c8cd-4a6f-bea8-ce7fae97983f	1.0	PubMed	23583197	A recent study revealed that GSK3beta positively regulates S6K1, and thus use of drugs targeting GSK3beta to treat type 2 diabetes was suggested.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RPS6KB1))
33b65418-238c-4762-b277-803a3aa66b33	1.0	PubMed	24571487	To further confirm hyperactivation of Akt and GSK-3beta signaling in Raptor silenced NSCLC cells, siRNA against Raptor was introduced into A549, H460, H1299, and H2009 NSCLC cells (data not shown).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:RPTOR))
8b328fbe-35c7-43a8-a600-b38b14a138b4	1.0	PubMed	15652488	These observations raise the possibility that hyperphosphorylation of CRMP-2 is involved in the development of neurofibrillary tangles and plaque neurites.Inhibition of GSK-3beta prevents semaphorin-3A (Sema3A)-induced growth cone collapse.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SEMA3A))
8b328fbe-35c7-43a8-a600-b38b14a138b4	1.0	PubMed	22933777	To delineate how GSK3beta mediates Sema3A signaling, we here determined the substrates of GSK3beta involved.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SEMA3A))
8b328fbe-35c7-43a8-a600-b38b14a138b4	1.0	PubMed	25528666	These results suggest that GSK3beta is involved in Sema3A induced acceleration of antero- and retrograde axonal transport.We further examined the mechanism by which GSK3beta mediates Sema3A induced acceleration of axonal transport by using several GSK3beta mutants ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SEMA3A))
8b328fbe-35c7-43a8-a600-b38b14a138b4	1.0	PubMed	25528666	These results suggest that GSK3beta mediates Sema3A induced acceleration of axonal transport.We next examined which type substrates, unprimed or primed or both of GSK3beta are involved in Sema3A induced acceleration of axonal transport.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SEMA3A))
8b328fbe-35c7-43a8-a600-b38b14a138b4	1.0	PubMed	25528666	Since trafficking of signaling components that participate in neuronal polarization is necessary for the establishment of neuronal cell polarity, GSK3beta and Axin-1 may mediate the Sema3A actions contributing to the establishment of neuronal cell polarity in developing nerve system.TDZD-8 has been evaluated primarily as a cytoprotective agent in multiple rodent models for diseases such as septic and non septic shock, lung injury, arthritis, spinal cord injury, colitis, myotonic dystrophy and Alzheimer disease ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SEMA3A))
8b328fbe-35c7-43a8-a600-b38b14a138b4	1.0	PubMed	25528666	This result suggests that GSK3beta mediates Sema3A induced axonal transport through the phosphorylation of unprimed substrates, providing a contrast to the Sema3A signaling in the growth cones in which both primed and unprimed substrates of GSK3beta are involved ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SEMA3A))
c3254a3c-9ab8-4a85-b69f-98e91542817e	1.0	PubMed	22640743	These results indicate that suppression of GSK-3beta and Siah-1 expression does not prevent SIRT1 mediated degradation of beta-catenin in Panc-PAUF cells, considering that inhibition of GSK-3beta or Siah-1 stabilizes beta-catenin protein levels in colon cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SIRT1))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	25823663	Mechanistic studies revealed that Rab3D activated intracellular the AKT and GSK3beta signaling to induce the EMT process.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	23806081	In support of this, studies by Lester et al. [XREF_BIBR] demonstrated that uPAR activates diverse cell signaling pathways, including ERK and MAPK, Rac1, Akt and glycogen synthase kinase-3beta (GSK-3beta), that cooperatively induce EMT in hypoxic breast cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	23582741	For example, inactivation of GSK-3beta can increase migration in fibroblasts and induce EMT in nontumourigenic breast epithelial cells and lung epithelial cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	25462858	These findings suggested that GSK-3beta was able to relay signals from Akt and mediate transfer to snail.To further characterize the role of GSK-3beta participating in CXCR2 and CXCL5 axis induced EMT of HCC cells, a constitutively active mutant GSK-3beta (GSK-3betaS9A) was introduced into HCCLM3 and HepG2-CXCL5 cells which had high levels of both CXCR2 and CXCL5.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	26845447	In addition, downregulation promoted EMT is mediated by Snail, Wnt-beta-catenin and TCF, and GSK-3beta signaling pathways.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	27562816	Furthermore, it was found that activation of ERK or AKT and GSK-3beta signaling pathways was involved in FOXC2 promoting EMT in CDDP resistant ovarian cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	26452029	In addition, Bmi-1 also downregulated PTEN by associating the PTEN locus and consequently activated the Akt and GSK3beta pathway, ultimately induced EMT and cytoskeleton reconstruction, leading to enhanced invasiveness of cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	22707636	Inactivation of GSK-3beta by LiCl significantly increased MMP9 activity and EMT of RCC cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	26325518	Our data suggested that TXN might contribute to EMT modulated by PI3K and Akt / GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
51b20cae-ea10-464e-80da-79b3a0da738e	1.0	PubMed	25422594	GSK3beta is a repressor of beta-catenin and Snail able of inhibiting E-cadherin expression and subsequently promotes EMT and tumor progression.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001837"))
dca83400-909c-4f47-8a26-3172ddaf8966	1.0	PubMed	20962236	GSK-3beta inhibition prevented Tat induced increases in membrane DAT and membrane calpain activity, highlighting mechanisms by which GSK-3beta inhibitors may confer neuroprotective benefits for DAergic symptoms in HAND (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SLC6A3))
dca83400-909c-4f47-8a26-3172ddaf8966	1.0	PubMed	20962236	Tat increased PM DAT and calpain activity are blocked by the RyR antagonists ryanodine and dantrolene, the calpain inhibitor calpastatin, and by a specific inhibitor of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SLC6A3))
dceff808-df35-4a88-a6c8-1d1ff3e33b78	1.0	PubMed	17289590	GSK-3beta phosphorylation did not increase the ability of Smad1 to interact with Nup214 or Smurf1 under our assay conditions (C).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SMAD1))
526fbfaf-84d6-43c4-9a69-ffd303f2e907	1.0	PubMed	20599907	Together with Guo 's results, our findings reinforce the fact that GSK3beta can negatively modulate TGF-beta and Smad3 signaling and play critical roles in multiple biological processes.In summary, this study demonstrates that direct interaction of GSK3beta with Smad3 is associated with its negative regulatory role in TGF-beta1 and Angiotensin II signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SMAD3))
127c74de-e646-44e9-bc15-43f044ab81ce	1.0	PubMed	26863455	We discovered that the underlying mechanism, by which OLA1 regulates EMT, is related to OLA1 's inhibitory effect on GSK3beta, and the GSK3beta mediated Snail and E-cadherin signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI1))
127c74de-e646-44e9-bc15-43f044ab81ce	1.0	PubMed	23806081	PI3K and Akt is known to promote EMT by regulating the activity of GSK3beta, which targets Snail for degradation by suppressing NF-kappaB-dependent Snail expression [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI1))
127c74de-e646-44e9-bc15-43f044ab81ce	1.0	PubMed	23582741	These data are consistent with another report showing that GSK-3beta upregulates Snail and beta-catenin during gastrin induced migration in gastric cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI1))
127c74de-e646-44e9-bc15-43f044ab81ce	1.0	PubMed	26325518	The Akt and GSK-3beta signaling pathway can modulate stability of Snail [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI1))
127c74de-e646-44e9-bc15-43f044ab81ce	1.0	PubMed	26325518	Previous studies have showed that GSK-3beta is inhibited by TGF-beta through increased serine 9 phosphorylation and increased stabilization of Snail via the PI3K and AKT signaling network [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI1))
127c74de-e646-44e9-bc15-43f044ab81ce	1.0	PubMed	24901051	GSK3beta has been shown to inhibit EMT by targeting Snail for proteasomal degradation, thus releasing E-cadherin from transcriptional repression by Snail and promoting metastasis.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI1))
127c74de-e646-44e9-bc15-43f044ab81ce	1.0	PubMed	27057280	Previous studies have mentioned that AKT and GSK-3beta signaling pathway can modulate the stability of Snail [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI1))
127c74de-e646-44e9-bc15-43f044ab81ce	1.0	PubMed	22276203	SNAI1 exclusion from the nucleus and proteosomal degradation is mediated through its phosphorylation by GSK3beta XREF_BIBR and at this point it is unclear if a connection between both phosphorylation pathways exists.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI1))
680129f5-80d5-46d5-8cfa-8c9e9780d068	1.0	PubMed	23851495	To determine whether GSK3beta enhances Slug protein turnover through phosphorylation, we compared the half-life of wild-type Slug to that of the nonphosphorylatable Slug-4SA.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI2))
680129f5-80d5-46d5-8cfa-8c9e9780d068	1.0	PubMed	23851495	These results suggest that the activity of GSK3beta limits the intracellular concentration of Slug and modulates Slug protein turnover by direct phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI2))
680129f5-80d5-46d5-8cfa-8c9e9780d068	1.0	PubMed	23851495	Moreover, knockdown of CHIP led to the accumulation of the protein level of ectopically expressed Flag-Slug-WT, but not that of Flag-Slug-4SA, indicating that CHIP may participate in the GSK3beta mediated turnover of Slug (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SNAI2))
4f494bae-1803-4ada-979f-31a9efafa761	1.0	PubMed	27566146	Moreover, when cells were co-transfected with a reduced molar ratio of FBW7 to SOX9 (1:4) that did not deplete SOX9 levels substantially, overexpression of either wild-type GSK3beta or constitutively active GSK3beta caused a further reduction in SOX9, demonstrating that SOX9 destabilization mediated by FBW7 is enhanced by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SOX9))
4f494bae-1803-4ada-979f-31a9efafa761	1.0	PubMed	27566146	We could also detect P-T236 in overexpressed wild-type SOX9 that was decreased by GSK3beta inhibition.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SOX9))
01307fff-5b56-481d-8a10-b3e05c923851	1.0	PubMed	25728276	GSK-3beta increased the stability and transactivation activity of Osx through phosphorylation of the newly identified site.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SP7))
3250b808-ae0c-42f2-b413-4b39bd8671ec	1.0	PubMed	18055457	Astrin acts as a substrate for gsk3beta and is phosphorylated at thr-111, thr-937 ((s/t)p motif) and ser-974/thr-978 ((s/t)xxx(s/t)-p motif;p is a phosphorylatable residue). Inhibition of gsk3beta impairs spindle and kinetochore accumulation of astrin and spindle formation at mitosis, suggesting that astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by gsk3beta	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SPAG5))
3250b808-ae0c-42f2-b413-4b39bd8671ec	1.0	PubMed	18055457	Astrin acts as a substrate for gsk3beta and is phosphorylated at thr-111, thr-937 ((s/t)p motif) and ser-974/thr-978 ((s/t)xxx(s/t)-p motif;p is a phosphorylatable residue). Inhibition of gsk3beta impairs spindle and kinetochore accumulation of astrin and spindle formation at mitosis, suggesting that astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by gsk3beta	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SPAG5))
3250b808-ae0c-42f2-b413-4b39bd8671ec	1.0	PubMed	18055457	Astrin acts as a substrate for gsk3beta and is phosphorylated at thr-111, thr-937 ((s/t)p motif) and ser-974/thr-978 ((s/t)xxx(s/t)-p motif;p is a phosphorylatable residue). Inhibition of gsk3beta impairs spindle and kinetochore accumulation of astrin and spindle formation at mitosis, suggesting that astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by gsk3beta	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SPAG5))
3250b808-ae0c-42f2-b413-4b39bd8671ec	1.0	PubMed	18055457	Astrin acts as a substrate for gsk3beta and is phosphorylated at thr-111, thr-937 ((s/t)p motif) and ser-974/thr-978 ((s/t)xxx(s/t)-p motif;p is a phosphorylatable residue). Inhibition of gsk3beta impairs spindle and kinetochore accumulation of astrin and spindle formation at mitosis, suggesting that astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by gsk3beta	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SPAG5))
36f3d612-6904-4c62-b272-3c6cc90af0ef	1.0	PubMed	20648061	Interestingly, when Lkb1 was knocked down by in utero electroporation, S9 phosphorylated GSK3beta was not detectable at the tip of any neurites in cortical neurons despite the uniform distribution of GSK3beta 66, suggesting that GSK3beta could be a downstream target of LKB1 (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:STK11))
15ce8ee7-9188-4d8d-9f80-e3ee4a4dd338	1.0	PubMed	22142472	Knockdown of both GSK-3alpha and GSK-3beta stimulated the STK38 activity by 1.9-fold ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:STK38))
15ce8ee7-9188-4d8d-9f80-e3ee4a4dd338	1.0	PubMed	22142472	Knockdown of both GSK-3alpha and GSK-3beta stimulated the STK38 activity by 1.9-fold (Supplemental Fig. 2).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:STK38))
9d534740-065f-4996-bb13-83ca406d8bef	1.0	PubMed	23900341	We also demonstrated that AKT2 overexpression regulates the nuclear cytoplasmic distribution of exogenous Gli1 protein in neuroblastoma cells by relieving a GSK3beta mediated destabilization of SUFU, a negative regulator of Gli1 nuclear translocation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SUFU))
9d534740-065f-4996-bb13-83ca406d8bef	1.0	PubMed	23900341	To examine the possibility that AKT2 may decrease Gli1 activity by relieving GSK3beta mediated destabilization of SUFU, we assessed the expression of pGSK3beta and SUFU after AKT2 overexpression.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SUFU))
ac4adfee-1769-4085-8f75-914adb6bc3e7	1.0	PubMed	24391209	Inhibition of GSK3beta activity using a specific inhibitor, SB 216763, lowered the abundance of phospho-p65 as well as lowered phospho-IkappaB and phopsho-IKKbeta abundance (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:SYT1))
af138d17-2c4a-4718-bc8d-84483e7d1b15	1.0	PubMed	21949350	Activity of GSK-3beta is strongly upregulated due to TDP-43 expression, and reduced GSK-3beta dosage is also a common suppressor of Abeta42 and TDP-43 toxicity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TARDBP))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	21145761	This is consistent with the notion that IRF3 activation pathways triggered by various RLRs and TLRs converge at TBK1, which is targeted by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	21145761	GSK3beta promoted TBK1 dimerization and/or oligomerization and autophosphorylation at Ser172 independent of the kinase activity of GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	21145761	Because RIG-I, VISA, and MITA act upstream whereas IRF3 acts downstream of TBK1, the simplest explanation from these data is that GSK3beta targets TBK1.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	21145761	Although TBK1 and IKKepsilon have redundant roles in certain circumstances, knockdown of GSK3beta inhibited TBK1 but not IKKepsilon mediated ISRE activation (A).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	21145761	Consistently, GSK3beta potentiated TBK1- but not IKKepsilon mediated ISRE activation (D).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	21145761	These results suggest that GSK3beta specifically targets TBK1 but not IKKepsilon.We next examined whether GSK3beta is physically associated with TBK1 in untransfected cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	21145761	These data suggest that GSK3beta promotes TBK1 self association independent of its kinase activity.During our immunoprecipitation assays, we observed that transfection of GSK3beta caused a shift of TBK1 but not IKKepsilon to higher molecular weight bands (B and 5C).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	21145761	These data suggest that GSK3beta promotes TBK1 self association independent of its kinase activity.During our immunoprecipitation assays, we observed that transfection of GSK3beta caused a shift of TBK1 but not IKKepsilon to higher molecular weight bands (B and 5C).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
9f5e5250-66de-4797-9b8c-7aaa2f9cd7b6	1.0	PubMed	22945920	GSK-3beta promoted TBK1 dimerization and autophosphorylation in virus triggered type I IFN induction and cellular antiviral response (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TBK1))
b3ee5f3d-c658-49c7-a11a-eb02ed86d0e0	1.0	PubMed	24899689	Specifically, we found that GSK-3beta modulates canonical TGF-beta1 signaling through direct interactions with SMAD-3.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TGFB1))
cfa8589d-f99a-4191-88f8-74cf4e21eb9e	1.0	PubMed	23818587	Dysregulation of PAD4 mediated citrullination of nuclear GSK3beta activates TGF-beta signaling and induces epithelial-to-mesenchymal transition in breast cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:TGFB))
cfa8589d-f99a-4191-88f8-74cf4e21eb9e	1.0	PubMed	20599907	Together with Guo 's results, our findings reinforce the fact that GSK3beta can negatively modulate TGF-beta and Smad3 signaling and play critical roles in multiple biological processes.In summary, this study demonstrates that direct interaction of GSK3beta with Smad3 is associated with its negative regulatory role in TGF-beta1 and Angiotensin II signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:TGFB))
cfa8589d-f99a-4191-88f8-74cf4e21eb9e	1.0	PubMed	27162139	In this model, both PKCzeta and GSK3beta up-regulate TGFbeta signaling, which correlates well with several previous studies (XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:TGFB))
984d6140-9bf4-422a-a434-c36d87660ab8	1.0	PubMed	20848477	Blockade of GSK3-beta attenuates excessive proinflammatory TLR mediated immune responses.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:TLR))
c027ee22-a81d-469f-b309-3c8d5a23697c	1.0	PubMed	25218472	This indicates that GSK3beta is a negative mediator of Tbeta4 induced cell invasion and migration.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TMSB4X))
c937c443-d01e-41f8-9c6f-54a8db7c4801	1.0	PubMed	18846110	Knockdown of DDX3 or GSK3beta did not change TRAIL-R2 membrane localization, but tended to increase TRAIL-R1 in the membrane (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TNFRSF10A))
d12b44bf-9401-4581-b3eb-364bb05672c7	1.0	PubMed	18846110	In MDA-MB-231 cells resistant to TRAIL-R2-induced apoptosis, intact cIAP-1 remained associated with GSK3beta following stimulation of TRAIL-R2.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TNFRSF10B))
b75fc03f-42e8-41a8-a802-349e0b772912	1.0	PubMed	19218353	In the GSK3beta enhanced group +/- TNF, the unphosphorylated beta-catenin-Ser37/33 was similar to the control.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TNF))
b75fc03f-42e8-41a8-a802-349e0b772912	1.0	PubMed	19218353	In the GSK3beta enhanced group +/- TNF, the TOPflash and FOPflash activity ratio was similar to the control.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TNF))
b75fc03f-42e8-41a8-a802-349e0b772912	1.0	PubMed	19180470	The results suggest that CD16 cross linking activated PI3K and that active PI3K limited TNF-alpha production by inhibiting GSK-3beta activity, in part, by blocking the action of NF-kappaB.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TNF))
b75fc03f-42e8-41a8-a802-349e0b772912	1.0	PubMed	19180470	Moreover, the role that glycogen synthase kinase-beta (GSK-3beta) and NF-kappaB have modulating TNF-alpha production from activated monocytes was explored.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TNF))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	25591548	Modulation of GSK3beta expression can markedly increase p53 dependent activation of Bax, leading to cytochrome c release and initiation of the intrinsic apoptotic pathway (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	11483158	Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	21875573	Phosphorylation of Ser 33 by GSK3B activates transcription of a p53 dependent luciferase construct, whereas mutation of Ser 33 to alanine prevents activation of p53 by GSK3B, showing that phosphorylation of Ser 33 is sufficient for activation of p53.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	11483158	GSK3beta increased the transcriptional activity of the p53 protein in vivo.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	11483158	The present data indicates that transcriptional activation of p53 by GSK3beta requires both serines 33 and 37, but it does not allow us to determine if phosphorylation of serine 33 is dependent on phosphorylation of serine 37 in vivo.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	14523002	Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	14523002	GSK3beta activity was not required for p53 binding, but inhibition of GSK3beta stabilized the association, suggesting a transient interaction during which active GSK3beta promotes actions of p53.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	23554857	In addition, CDH17 knockdown increased P53 expression; a possible mechanism would be that CDH17 knockdown leads to reduced GSK-3beta phosphorylation, which in turn activates p53 dependent apoptosis and antagonizes tumor growth XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
a7bf4a68-0a25-4830-ae93-ef92b284ad0a	1.0	PubMed	5987862	GSK3beta increased the transcriptional activity of the p53 protein in vivo.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TP53))
b5f01795-c3ee-4951-b7a2-152dd3e55871	1.0	PubMed	23140583	The GSK3beta, JNK, and p38 pathways were activated TRPV6 specific in PC-3 cells (C and D).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TRPV6))
ad51b5ed-ea87-4939-8951-19484f271e0b	1.0	PubMed	16959574	Knockdown of endogenous GSK3alpha and GSK3beta by RNAi increased TSC2 mobility (F).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TSC2))
ad51b5ed-ea87-4939-8951-19484f271e0b	1.0	PubMed	16959574	Gsk3 inhibits the mtor pathway by phosphorylating tsc2 in a manner dependent on ampk-priming phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TSC2))
5d1535b3-9065-4fe1-a269-3e854d737b67	1.0	PubMed	6383745	We observed that GSK3beta regulated neither MITF promoter activity nor the intrinsic transcriptional activity of MITF but synergized with MITF to activate the tyrosinase promoter.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:TYR))
dd6689ae-9ad0-4c0e-9995-8834c509980d	1.0	PubMed	24587039	In addition to GFP, we also expressed GSK-3beta, Hsp70 or DsRed, any of which did not induce the Unc phenotype observed in the 0N4R/high and 4R fragment expressing worms (data not shown).	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:Q9SYB9))
97e4f213-69aa-4c1f-b5d8-8b2e8dea3857	1.0	PubMed	17397930	Our recent study confirms that PI3K signaling in THR cells phosphorylates AKT and GSK3beta, which activates c-Myc, but not USF-1, resulting in increased expression ().	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:USF1))
4a0b298d-b609-4a7a-bad8-ea3f2e58a2f2	1.0	PubMed	21345331	In addition, only Ser 68 and 72 are essential for the regulation of pVHL mediated MT stabilization by GSK-3beta as pVHL mutated on three other Ser and Thr residues failed to resist GSK-3beta effect.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:VHL))
abd668de-a124-4e9a-8f4d-e4d161a6f90d	1.0	PubMed	18955571	To examine whether GSK-3beta mediated VPA 's effect on APP processing in AD transgenic model mice, brain tissues of the double-transgenic mice were subjected to Western blot analysis for total GSK-3beta and phospho-GSK-3beta levels.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:39867))
a1debbaf-449c-4254-ae5c-94b73f7ea242	1.0	PubMed	18407462	Based on another finding indicating that Wnt5a upregulated PKA mediated phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) at serine 9 that caused inactivation of GSK-3beta and subsequently resulted in activation of the beta-catenin pathway, we have speculated that the Wnt5a anti-apoptotic activity may be partially mediated by PKA mediated phosphorylation of GSK-3beta and subsequent activation of the beta-catenin pathway.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:WNT5A))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	22385658	A mechanism underpinning these observations is suggested from our findings that Activin A/Smad2,3 promotes differentiation through activation of Erk signaling, through the subsequent repression of Gsk3beta and following activation of Wnt effectors such as beta-catenin and Snail.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	25749038	Less active GSK3beta enhanced activation of Wnt and beta-catenin pathway and resultant WISP1 expression; in turn, increased WISP1 expression further led to phosphorylation and inactivation of GSK3beta, which eventuated in a strong positive feedback loop of WISP1 expression and concomitant refractory radioresistance.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	23913826	Our study further showed that ERG is also able to induce Akt phosphorylation and GSK-3beta phosphorylation, which may further contribute to its ability to stabilize beta-catenin and activate Wnt signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	18702828	Briefly, GSK-3beta mediates Wnt and Fzd signaling cascades.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	24726344	CPT-11 resistance reduced GSK3beta, p-GSK3beta, beta-catenin, COX-2 and Tbx3 (a gene target of Wnt and beta-catenin pathway) (44.14%, 77.31%, 64.85%, 89.82% and 57.1% decreased compare to parental LoVo cells, respectively) ().	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	15507471	Upstream activation of Wnt signaling by the Wnt-2 and Wnt-3a ligands, stable overexpression of Wnt-2, as well as GSK-3beta inhibition by lithium, SB216763, and GSK-3beta dominant negative forms (K85R and R96E) conferred the invasive phenotype through several proinvasive pathways.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	19190323	Our data suggest that reduction in galectin-3 decreases GSK-3beta phosphorylation and increases GSK-3beta activity, which may mediate beta-catenin accumulation and Wnt signaling in colon cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	26485754	Silencing SFRP1, GSK3beta and TLE3 disrupted the repression efficacy of the miR-744-regulated Wnt / beta-catenin activity (XREF_SUPPLEMENTARY and Fig.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	26845447	It has been reported that nuclear GSK-3beta promotes cell survival and proliferation via positively regulating the NF-kappaB pathway, and a membrane associated form of GSK3beta, contrary to cytosolic GSK3beta, stimulates Wnt signaling via mediating LRP6 phosphorylation and activation.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	20470940	A number of protein kinases have been shown to influence Wnt and beta-catenin signaling including GSK3beta, protein kinase C and casein kinase I and II.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	19795391	Furthermore, when the WNT and beta-catenin pathway was activated in chondrocytic cells by WNT3a or SB216763, which inhibits the phosphorylation of GSK3beta, the mRNA levels of aggrecan and col2a1 were decreased, whereas that of mmp13 was increased.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	26844628	In that study, Klemm and colleagues found that the beta-catenin and E-cadherin genes were well expressed, whereas a very specific and limited pattern of Wnt target gene activation was observed with poor expression of not only LEF-1 and TCFs but also most of the known Wnts and many other Wnt targets including axins and GSK-3beta, but strong expression of cyclin D1 and c-Myc.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	21040406	SULF2 expression also increased phosphorylation of the anti-apoptotic Akt substrate GSK3beta and stimulated Wnt and beta-catenin signalling (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	25880337	AEG-1 interacts with Gsk-3beta and CKIdeltato activate Wnt and beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	26301867	However, in H1975 cells, Wnt modulators such as active beta-catenin, GATA-6 and p-GSK3beta were downregulated.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	26274564	Overall, these results strongly support that FAK and PYK2 kinase contributes to APC driven intestinal tumorigenesis through phosphorylating GSK3beta Y216 to promote Wnt and beta-catenin signaling.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	25940701	Thus, these findings suggest that DACH1 could suppress the hepatocellular carcinoma growth through inhibition on Wnt signaling, which might be mediated by phosphorylation of GSK3beta to suppress the activation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
8dd60b7d-8c13-4ceb-bc80-fa2244bb40bc	1.0	PubMed	23520519	To investigate this, we made use of the rat intestinal epithelial cell line IEC-18 because 112 CoN human cells are very hard to transfect, and we used a selective inhibitor of GSK3beta (" BIO ") to stimulate canonical Wnt signaling in these cells.	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:Wnt))
7fc0ede1-0c76-49b5-8bbd-3ba65da1d72f	1.0	PubMed	24327518	It has also been shown that GSK-3beta contributes to the maintenance of active chromatin at Bcl-2 and XIAP promoters, allowing p65 binding and transcriptional activation of Bcl-2 and XIAP in cancer cells (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:XIAP))
cd48c4f9-6574-4a5d-9630-5b8c317b5f21	1.0	PubMed	19141611	The Ser and Thr residues in the motif appear to be also phosphorylated by glycogen synthase kinase 3beta (GSK3beta) and the CKI family kinases, as GSK3beta and CKIepsilon could enhance the interaction of Zbed3 with Axin.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ZBED3))
20786c59-45cc-44a4-8085-a2a218fb953a	1.0	PubMed	22514281	Inhibition of GSK3beta by inhibitor SB216763 or down-regulation of GSK3beta by RNAi reduced the antiviral activity of ZAP.	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ZC3HAV1))
20786c59-45cc-44a4-8085-a2a218fb953a	1.0	PubMed	22514281	Glycogen synthase kinase 3beta (GSK3beta) modulates antiviral activity of zinc-finger antiviral protein (ZAP).	p(HGNC:GSK3B)	directlyIncreases	act(p(HGNC:ZC3HAV1))
ed56924c-d86e-4143-beec-e161e268e2ad	1.0	PubMed	16522681	In co-cultures of mouse mononuclear spleen cells and osteoblasts, inhibition of GSK3beta with LiCl or exposure to Wnt3a inhibited the formation of tartrate resistant acid phosphatase positive multinucleated cells compared with controls.	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF12689))
a0b33444-1895-4f3c-bcdd-951b6f134346	1.0	PubMed	6687293	Cdc42 dependent phosphorylation of GSK-3beta occurs specifically at the leading edge of migrating cells, and induces the interaction of adenomatous polyposis coli (Apc) protein with the plus ends of microtubules.	p(HGNC:GSK3B)	directlyIncreases	act(p(IP:IPR026818))
d7d719d4-8a0a-4ee7-86da-fcc86a22831d	1.0	PubMed	22863953	In the present study, we tested whether GSK3beta inhibition could attenuate monocyte adhesion and migration across monolayers of primary human brain endothelial cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0007155"))
abc78b99-8fc3-4b8b-9e3d-4a42d750d383	1.0	PubMed	23301033	Inhibition of PI3K and AKT or overexpression of PTEN or GSK-3beta failed to impair vIL-6 induction of angiogenesis and tumorigenesis in CAM and nude mice allograft models, indicating that vIL-6 might exert its biological function mainly via JAK and STAT signal rather than PI3K and AKT signal XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001525"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	20454507	Depending on the context and cell type under study, glycogen synthase kinase 3beta (GSK3beta) can promote cell survival or apoptosis after cytotoxic insults [4].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	21821001	The activation of GSK-3beta by Akt inactivation induces Mcl-1 destabilization and then mitochondrial apoptosis upon growth factor withdrawal.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	24136230	It is also known that GSK3beta overexpression induces increased apoptosis in vivo perturbing proliferation and maturation, resulting in the loss of immature neurons.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	25138042	Inhibition of either NF-kappaB or GSK3beta significantly abolishes the anti-apoptotic effect of 14-3-3zeta and Ser9 phosphorylated GSK3beta, suggesting that Ser9 phosphorylated GSK3beta actively antagonizes cell apoptosis in a NF-kappaB dependent manner.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	20547056	Later, Zaheer and colleagues found that overexpressed GMFB in neuroblastoma N18 cells by gene infection induced caspase dependent apoptosis mediated by GSK-3beta activation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	21795403	GSK3beta inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	12771992	A number of studies have shown that GSK3beta can modulate apoptosis (Frame and Cohen, 2001; King et al, 2001).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	20352103	Knockdown of GSK3beta expression increased apoptosis of adherent U937 (81 +/-4%, p < 0.01).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	20352103	Thus, alpha 5 beta 1 -mediated activation of GSK3beta modulates both extrinsic and intrinsic apoptosis signaling pathways XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	6132123	We demonstrate that expression of eIF2B mutants lacking the GSK-3beta phosphorylation or priming sites is sufficient to protect both Rat-1 and PC12 cells from apoptosis induced by overexpression of GSK-3beta, inhibition of PI 3-kinase, or growth factor deprivation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	25613377	Along this line, we further examined the activation of the AKT and GSK3beta and ERK pathway in an established pancreatic cell line (PANC-1), which expresses CD95 (48%) and is known to be resistant to CD95 induced apoptosis (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	19841191	The results provide a novel mechanism whereby active GSK3beta contributes to regulate apoptosis in DCs.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	24531650	GSK3beta inhibition attenuated oxidant stress induced hepatocyte apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	5437495	Expression of an inhibitory GSK3beta binding protein or a dominant interfering form of GSK3beta reduced neuronal apoptosis, suggesting that GSK3beta contributes to trophic factor withdrawal induced apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	5437495	Furthermore, overexpression of GSK3beta in neurons increased apoptosis, indicating that activation of this enzyme is sufficient to trigger programmed cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	22022450	This tactic was used instead of overexpressing GSK3 because previous studies have shown that overexpression of GSK3beta in astrocytes causes apoptosis XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	24681994	GSK-3beta activation promotes mitochondria mediated apoptosis by the upregulation of Bax expression levels (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	17098228	Overexpression of catalytically active GSK-3beta induces apoptosis in NGF differentiated PC12 cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	17098228	The activation of GSK-3beta has been shown to promote apoptosis in a remarkably wide variety of conditions, such as trophic factor withdrawal, PI-3K inhibition, and toxicity induced by ceramide, platelet activating factor, heat shock, and mitochondrial toxins.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	18437054	Selective GSK3beta inhibitiors and GSK3beta siRNA attenuated tetrandrine induced G (1) arrest and apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	23874688	Whereas overexpression of GSK3beta can induce apoptosis in several cell types, inactivation of GSK3beta has been found to reduce apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	25390651	Activation of the mK ATP channel induced inhibitory phosphorylation of GSK-3beta and suppressed ROS production, LDH release and apoptosis after AA washout.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	24025791	GSK3beta potentiates apoptosis through activation or increased expression of pro apoptotic proteins such as Bax.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	26284974	GSK3beta is a pro apoptotic kinase and the inhibitors of GSK3beta, such as LiCl, can attenuate mitochondrial dysfunction and cellular apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	27354597	Phosphorylation of glycogen synthase kinase 3beta (GSK3beta) by phosphatidyl-inositide 3-kinase (PI3K)/protein kinase B (AKT) or inhibition of GSK3beta with small-molecule inhibitor attenuates cell survival and proliferation and increases apoptosis in most cancer cell lines.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	27354597	Pharmacological inhibition of GSK3beta (using SB216763) reduced phosphorylation of GSK3beta, re-activated caspase dependent apoptosis, and blocked the expression of cancer stem cell markers and invasive characteristics in LPS stimulated drug treated cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	23851680	Moreover, pharmacological inhibition of GSK-3beta reduced hepatic endothelial cell apoptosis in mice passively administered anti-DENV NS1 Abs.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	26381174	However, suppression of GSK3alphabeta inhibited Cd induced autophagy and induced apoptosis, which could be reversed by overexpression of GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	25593505	Activation of GSK-3beta initiates apoptosis, while its inhibition is involved in anti-apoptotic signaling via the Wnt and beta-catenin pathway [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	5884164	Transient overexpression of GSK3beta was sufficient to induce apoptosis (control 7 +/- 1% vs. GSK3beta 28 +/- 2%, P < 0.0001).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	22690042	In summary, this study demonstrated that APC induced ER stress in HUVECs and attenuated LPS induced HUVEC apoptosis mediated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	18632640	Inhibition of GSK-3beta either by small molecules (SB216763 or SB415286) or by ectopic expression of kinase-inactive GSK-3beta before irradiation significantly attenuated radiation induced apoptosis in hippocampal neurons.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	18632640	GSK-3beta inhibition with SB216763 or SB415286 also decreased apoptosis in the subgranular zone of the hippocampus in irradiated mice, leading to improved cognitive function in irradiated animals.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	23538444	Netrin-1 protects hypoxia induced mitochondrial apoptosis through HSP27 expression via DCC- and integrin alpha6beta4 dependent Akt, GSK-3beta, and HSF-1 in mesenchymal stem cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	23538444	39 In this context, we investigated the role of GSK-3beta and HSF-1 on Ntn-1 effects in hypoxia induced UCB-MSC apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	22658458	25 Experimental studies demonstrated that the regulation of GSK-3beta activity by a small-molecule inhibitor induces a 10-fold increase in apoptosis mediated by 5-FU.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	20920357	GSK-3beta but not GSK-3alpha knock down caused basal MM cell apoptosis whereas GSK-3alpha but not GSK-3beta knock down was associated with a trend towards increased BZ induced apoptosis : this would suggest unexpected different roles of the two GSK-3 isoforms in MM cell survival.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	24802394	In this study, we focus on the role of AKT, JNK2, and GSK3beta kinase signaling pathways in HO induced PDLCs apoptosis to elucidate the mechanisms by which the relationship between XIAP and kinase signaling pathways acts in PDLCs survival.PDLs and bones were obtained from extracted human impacted third molars and associated maxillary alveolar bones at the Department of Orthodontics, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi, China.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	23943160	Furthermore, lithium, which is known to indirectly regulate GSK3beta through the PI3K and AKT pathway [XREF_BIBR, XREF_BIBR], can enhance GSK3beta activation and rescue the endometrial cancer cell lines from PPARbeta and delta induced apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	25829335	Moreover, evidences are published showing that deregulation of members of Bcl-2 family are also involved in GSK-3beta promoted mitochondrial apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	22039301	However, in studies conducted in both hematopoietic cells and in neuronal cells, it has been proposed that apoptosis induced by growth factor withdrawal or PI3K inhibition is mediated by GSK3beta (XREF_BIBR - XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	6362558	Based on these findings, we have proposed that part of the neuroprotectant properties of lithium is due to its ability to inhibit GSK-3beta, and thus block the facilitation of apoptosis produced by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	18606491	The intrinsic apoptotic signaling cascade can be induced by numerous stimuli that cause cell damage, such as DNA damage, oxidative stress and endoplasmic reticulum (ER) stress; GSK3beta promotes this cascade by facilitating signals that cause disruption of mitochondria and by regulating transcription factors that control the expression of anti- or pro apoptotic proteins.The extrinsic apoptotic pathway, on the other hand, is mediated by the activation of cell-surface death domain containing receptors (DRs) and initiates apoptosis by activating caspase-8.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	18606491	Activation of GSK3beta by adiponectin induces apoptosis and cell cycle arrest in MDAMB-231 human breast cancer cells, which is accompanied by suppressed intracellular accumulation of beta-catenin and its nuclear activities and reduced cyclin D1 levels.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	18606491	GSK3beta reactivation by exogenous expression of S9A GSK3beta mutant or treatment with LY294002 sensitizes hepatoma cells to etoposide- and camptothecin induced apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
1685df80-361c-4b4d-831f-33936b7bb491	1.0	PubMed	23554857	In addition, CDH17 knockdown increased P53 expression; a possible mechanism would be that CDH17 knockdown leads to reduced GSK-3beta phosphorylation, which in turn activates p53 dependent apoptosis and antagonizes tumor growth XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
e1928237-32ea-454b-ac0e-5e53660b75a6	1.0	PubMed	23559006	This finding is in line with a recent work, demonstrating that GSK-3beta inhibition promoted lysosomal biogenesis and autophagy protein degradation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006914"))
e1928237-32ea-454b-ac0e-5e53660b75a6	1.0	PubMed	20159967	GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006914"))
e1928237-32ea-454b-ac0e-5e53660b75a6	1.0	PubMed	21737790	Rapamycin abolished the inhibitory effects of dominant negative GSK-3beta on the number of GFP-LC3 dots after prolonged ischemia (XREF_FIG), and reduced the infarct size and AAR and the percentage of Hairpin-2 positive nuclei in Tg-DnGSK-3beta to the levels of those in NTg mice (XREF_FIG), indicating that GSK-3beta inhibition prevents autophagy through an mTOR dependent mechanism, and that GSK-3beta inhibition may enhance ischemic injury via mTOR dependent prevention of autophagy.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006914"))
e1928237-32ea-454b-ac0e-5e53660b75a6	1.0	PubMed	21737790	Importantly, the number of GFP-LC3 dots per microscopic field was significantly decreased after I/R in DnGSK-3beta and GFP-LC3 bigenic mice compared with that in GFP-LC3 transgenic mice (XREF_FIG), indicating that reperfusion induced autophagy was attenuated by GSK-3beta inhibition.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006914"))
e1928237-32ea-454b-ac0e-5e53660b75a6	1.0	PubMed	21737790	These findings suggest that GSK-3beta modulates autophagy through mTOR dependent mechanisms, thereby mediating survival and death of cardiomyocytes in a phase dependent manner.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006914"))
e1928237-32ea-454b-ac0e-5e53660b75a6	1.0	PubMed	21737790	Inhibition of GSK-3beta prevents autophagy through mTOR and is detrimental during ischemia.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006914"))
583e3408-36bb-4cae-8496-2e5f9b2a3ccd	1.0	PubMed	24316184	In agreement with our findings using SB216763, overexpression of GSK3beta-KD did not affect basal levels of COXII and VDAC expression (B) suggesting that GSK3beta activity does not contribute to mitochondrial biogenesis at basal condition.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0044085"))
fac86bb3-fff4-4516-ac8d-ffad8f1c93ac	1.0	PubMed	24930764	A very recent study supports this link between energetic metabolism and Akt pathway, since GSK3beta has been reported to potentiate mitochondria biosynthesis stimulation induced by a 2-Desoxy-Glucose-mediated inhibition of glycolysis [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0009058"))
f7a4f310-aaa4-4549-9635-0d36bbf8a7a4	1.0	PubMed	22810307	Inhibition of GSK3beta signaling prevents melanoma cell adhesion to fibroblasts and endothelial cells and transendothelial migration.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0007155"))
79f83175-aed9-4f7f-adf6-23693048bc09	1.0	PubMed	25632266	beta-catenin is upregulated by the AKT and GSK3beta pathway, which thereby triggers the cell cycle by enhancing cyclin D1 expression XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0007049"))
79f83175-aed9-4f7f-adf6-23693048bc09	1.0	PubMed	23851495	XREF_BIBR - XREF_BIBR Signaling pathways that inactivate GSK3beta, such as PI3K and Akt and MAPK, may promote the cell cycle, anti-apoptosis, and invasion, thus facilitating tumor progression.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0007049"))
79f83175-aed9-4f7f-adf6-23693048bc09	1.0	PubMed	18606491	In general, GSK3beta activation could cause cell cycle arrest by suppressing the expression of a number of critical cell cycle regulators, such as cyclin D1, cyclin E, c-Jun and c-Myc; these regulators are closely associated with cell transformation and tumor development.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0007049"))
79f83175-aed9-4f7f-adf6-23693048bc09	1.0	PubMed	18606491	Activation of GSK3beta by adiponectin induces apoptosis and cell cycle arrest in MDAMB-231 human breast cancer cells, which is accompanied by suppressed intracellular accumulation of beta-catenin and its nuclear activities and reduced cyclin D1 levels.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0007049"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	11986994	GSK3beta also is an important modulator of cell death, which may be a consequence of its regulatory effects on transcription factor activities.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	21821001	Numerous studies have shown that GSK-3beta promotes cell death through intrinsic mitochondrial damage.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	20159967	GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	20159967	Taken together, our study suggests that GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagic response and cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	17215111	However, activation of the Wnt/beta-catenin/TCF survival pathway by insulin, protein kinase C (PKC), agonists for PPARgamma, and inactivation of GSK-3beta all have the ability to protect primary cortical neurons to Abeta induced cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	24675460	In contrast, depletion of GSK-3beta, but not GSK-3alpha, sensitized PDA cell lines to TNFalpha induced cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	6311132	GSK3beta also is an important modulator of cell death, which may be a consequence of its regulatory effects on transcription factor activities.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	18208561	GSK3beta contributes to both cell death and survival.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	25390651	These results indicate that inactivation of GSK-3beta directly or indirectly by mK ATP channel activation facilitates recovery of DeltaPsi m by suppressing ROS production and mPTP opening, leading to cytoprotection from oxidant stress induced cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	23243017	Parallel studies revealed that GSK3alpha or GSK3beta shRNA knockdown also significantly reduced BEZ235 and ABT-737-mediated caspase-3 and PARP cleavage (XREF_FIG), and cell death (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	26822034	One of the mechanisms by which GSK3beta can mediate cell death is by phosphorylation of beta-catenin in the cytosol, leading to the rapid degradation of beta-catenin by APC complex XREF_BIBR XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	24929931	Hirano bodies differentially influence cell death induced by GSK3beta and tau.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	24929931	A role for the kinase GSK3beta is suggested by the finding that a dominant negative form of GSK3beta reduces this synergistic cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	24929931	However, model Hirano bodies had no effect on cell death induced by GSK3beta (S9A)/R5H tau or GSK3beta (S9A)/R406W tau.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	24929931	Similar to previous results, exogenous expression of GSK3beta (S9A)/441WT or GSK3beta (S9A)/P301L potentiated cell death compared to GSK3beta (S9A) alone.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	24929931	These results show that model Hirano bodies are not protective against cell death induced by GSK3beta and tau, and depending on the mutation, may further increase cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	17711861	Furthermore, the cell death induced by GSK-3beta was mediated by MLK3 in a manner dependent on its phosphorylation of the specific residues within the C-terminal domain by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
1109d154-6eca-4d20-b92a-598940dd23c6	1.0	PubMed	18606491	It has been suggested that GSK3beta promotes cell death caused by the intrinsic apoptotic pathway, but inhibits the death receptor mediated extrinsic apoptotic signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
5cb6bdd7-3779-4d32-a072-d23c67b8ef62	1.0	PubMed	22364879	The specific inhibition of GSK3beta activity by LiCl () prevented Myc degradation and consistently blocked the cell differentiation process, as revealed by the inhibition of the expression of CDX2 and SI.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
5cb6bdd7-3779-4d32-a072-d23c67b8ef62	1.0	PubMed	23349801	AKT and GSK-3beta signaling may support self-renewal whereas PKC and GSK-3beta may promote cell differentiation of hPS cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
fce7c484-6a6b-47d4-8685-98fc22d14edf	1.0	PubMed	22679108	In this report, GSK-3alpha and GSK-3beta actively promoted melanoma cell growth, despite phosphorylation at Ser21 or Ser9 in the majority of cell lines.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016049"))
fce7c484-6a6b-47d4-8685-98fc22d14edf	1.0	PubMed	26576547	PPP2R5D is a regulatory B subunit of PP2A and plays an important role in regulating key neuronal and developmental regulation processes such as PI3K and AKT and GSK3beta mediated cell growth, chromatin remodeling and gene transcriptional regulation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016049"))
fce7c484-6a6b-47d4-8685-98fc22d14edf	1.0	PubMed	24327518	In this study, it has clearly been shown that the pharmacological inhibition of GSK-3beta by treatment of 9-ING-41 caused cell growth inhibition with IC50 < 1muM.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016049"))
fce7c484-6a6b-47d4-8685-98fc22d14edf	1.0	PubMed	18804163	These findings suggest that TPO induced GSK-3beta is promoting cell growth through a beta-catenin-independent pathway, and that TPO and Wnt3a do not synergize in promoting cell growth in UT-7 and TPO cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016049"))
d33eb87d-6b7a-4202-b79f-8ec4e7ce1a55	1.0	PubMed	21890631	Recent evidence suggests that GSK-3beta mediates regulation of IQGAP1 to control cell migration (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016477"))
d33eb87d-6b7a-4202-b79f-8ec4e7ce1a55	1.0	PubMed	23408967	No consistent changes were observed in the levels of expression of these molecules (XREF_SUPPLEMENTARY, D), implying that EMT is unlikely to be the mechanism by which GSK3beta inhibition attenuates cancer cell migration and invasion.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016477"))
d33eb87d-6b7a-4202-b79f-8ec4e7ce1a55	1.0	PubMed	23408967	Inhibition of GSK3beta attenuated cancer cell migration and invasion in wound healing and transwell assays.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016477"))
d33eb87d-6b7a-4202-b79f-8ec4e7ce1a55	1.0	PubMed	23408967	Our study suggests that EMT may not be involved in the mechanism by which GSK3beta inhibition attenuates cancer cell migration and invasion.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016477"))
d33eb87d-6b7a-4202-b79f-8ec4e7ce1a55	1.0	PubMed	24312592	Therefore, although both GSK-3alpha and GSK-3beta could contribute to cell migration, the localized activity of GSK-3beta might play a key role in cell polarity formation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016477"))
d33eb87d-6b7a-4202-b79f-8ec4e7ce1a55	1.0	PubMed	22810307	Studies in colorectal and pancreatic cancer suggest that GSK3beta modulates cell migration and invasion through the regulation of focal adhesion assembly (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016477"))
d33eb87d-6b7a-4202-b79f-8ec4e7ce1a55	1.0	PubMed	25756394	We also found that Smad7 facilitates TGFbeta induced phosphorylation of p38 and GSK-3beta, resulting in GSK-3beta inactivation and beta-catenin accumulation and, in turn, APC recruitment to the microtubule plus end in the leading edge to direct cell migration (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016477"))
98e3ef69-eb06-4dad-9ec6-3e5ce3ce119a	1.0	PubMed	23851495	These data indicate that stabilized Slug-4SA, which abolishes GSK3beta mediated phosphorylation, can enhance cell motility and invasiveness.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0016477"))
e6bf0bbe-65df-4b65-9222-af70421be59e	1.0	PubMed	24312592	These results are consistent with an explanation that inhibition of GSK-3beta disrupted the cell polarity.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D016764))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	24577092	In addition, we confirmed that pharmacological inhibition of GSK3beta significantly reduced cell proliferation of PAX3-FOXO1 expressing cells (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	24577092	44 We therefore speculate that PAX3-FOXO1 and GSK3beta enhancement of cell proliferation may involve KLF6 as a downstream effector as it is also highly expressed in various RMS cell types.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	25053419	Moreover, knockdown of GSK3beta or FOXO1/3/4 leads to a decrease in cellular proliferation and abrogates IGF-I-induced hepatoma cell proliferation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	27060477	Further, inhibition of GSK-3beta activation could repress the cell proliferation which can be blocked by downregulation of GABA B R. Besides, we further confirmed that the promotion of cell proliferation caused by downregulation of GABR B R could be blocked by inhibition of NF-kappaB activation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	21441955	Moreover, there is increasing evidence that aberrant expression of GSK-3beta contributes to cell proliferation and survival in several human malignancies including pancreatic, colon, ovarian, prostate and renal cell cancer (XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	24675460	XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR Additionally, it has been observed that GSK-3beta overexpression contributes to PDA cell proliferation and survival, whereas GSK-3 inhibition reduces pancreatic cancer cell viability in vitro and suppresses tumor xenograft growth in vivo, at least partly, via downregulation of NF-kappaB activity.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	25645078	Phosphorylation of GSK3beta inhibits its activity and promotes cell proliferation and survival [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	23140583	GSK3beta, MAPKinase, and AKT signaling mediate cell proliferation in cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	25344882	Blocking GSK3b phosphorylation at Serine 9 attenuated cell proliferation while concomitantly stimulating apoptosis through activation of Caspase-3 in patient derived GSCs.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	26388612	In bladder cancer, GSK-3beta positively regulates cell proliferation and survival in vitro [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
dea45c1c-27d3-4bec-9e55-c6a53d2deac9	1.0	PubMed	24425879	Pharmacologic inhibition of GSK-3beta blocked cell proliferation in three different rodent insulinoma cell lines by arresting the cells in G2/M phase and caused apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	20454507	Depending on the context and cell type under study, glycogen synthase kinase 3beta (GSK3beta) can promote cell survival or apoptosis after cytotoxic insults [4].	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	21795403	These data demonstrate that by cooperatively activating Bcl2 and survivin, both c-Myb and LEF-1 are essential factors responsible for GSK3beta activity mediated cell survival in leukemia cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	21795403	Our results therefore reveal a novel mechanism by which GSK3beta stimulates cell survival and proliferation and suggest that the levels of c-Myb can be a determining factor in GSK3beta inhibition induced apoptosis of certain leukemia cell lines.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	20352103	Others and we have demonstrated that GSK3beta can upregulate cell survival through epigenetic and IkB independent control of NF-kappaB activity XREF_BIBR, XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	20352103	The alpha 5 beta 1 / GSK3beta pathway could modulate diverse signaling pathways controlling cell survival.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	20031160	GSK-3beta has previously been shown to mediate cell survival in pancreatic cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	20159967	GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	20159967	In this study, we attempted to determine how GSK-3beta promotes cell survival after serum depletion.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	20159967	Taken together, our study suggests that GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagic response and cell death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	23408967	We investigated whether GSK3beta contributes to cancer cell survival and proliferation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	22093618	Our previous studies suggest that GSK-3beta positively regulates NF-kappaB-mediated cancer cell survival, and therefore GSK-3 could be a potential therapeutic target in human cancer including RCC.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	22039301	For example, in a variety of cell types including eosinophils (XREF_BIBR), GSK3beta has been suggested to support cell survival downstream of the PI3K and AKT pathway.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	22039301	The data also indicate that the myeloproliferative capacity of the neoplastic HMC1.2 cells at least in part requires GSK3beta activity and that a small molecule inhibitor (CHIR 99021) of GSK3beta activity effectively reduces HMC1.2 cell survival (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	15820235	Activation of downstream PI3-K and PKB system and inhibition of GSK-3beta affect and modulate neuroprotective and antiapoptotic pathways of cell survival and growth, which may become dysfunctional in autism, because of Reelin deficiency.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
f0c927e3-eb23-4407-8c4f-969ad738c476	1.0	PubMed	18606491	Inhibition of GSK3beta decreases pancreatic cancer cell survival and proliferation, and arrests pancreatic tumor growth in established tumor xenografts.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D002470))
2729b209-0261-414f-be73-6fb7415b7def	1.0	PubMed	25691573	The enhancement of glycogenesis triggered by inactivated GSK3beta promotes cellular senescence and aging (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0090398"))
3dc4931c-26e7-46d0-a3bd-6044b6d92146	1.0	PubMed	23673211	Knockdown of GSK-3beta significantly increased the IC50 of cisplatin at 48h in A549 and DDP cells from 28.984 +/-1.404 muM to 73.590 +/-2.573 muM (< 0.01; B) and reduced the proportion of early apoptotic cells (Annexin V +/PI-) at 24h (C).	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:27899))
a273d530-8dc8-478f-a706-aeb7cdf65907	1.0	PubMed	26022178	GSK-3beta promotes inflammatory cytokine production by monocytes following TLR stimulation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001816"))
a273d530-8dc8-478f-a706-aeb7cdf65907	1.0	PubMed	24681994	Inhibition of GSK-3beta attenuates the microglia response to inflammatory stimuli and reduces cytokine production, thereby providing protection from inflammation induced toxicity (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0001816"))
0b56dc1b-08e3-4ed7-aef9-64fd065a971a	1.0	PubMed	24531650	GSK3beta inhibition blocks d-GalN and LPS-induced oxidative stress.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:2794221))
0b56dc1b-08e3-4ed7-aef9-64fd065a971a	1.0	PubMed	24531650	GSK3beta inhibition blocked d-GalN and LPS-induced oxidative stress and was capable of reducing the hepatocyte apoptosis induced by oxidant stress.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:2794221))
668572ed-e5e5-4cf7-8e5a-951e259643f3	1.0	PubMed	18508033	GSK3beta and endoplasmic reticulum stress mediate rotenone induced death of SK-N-MC neuroblastoma cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
668572ed-e5e5-4cf7-8e5a-951e259643f3	1.0	PubMed	17711861	Taken together, our data provide a direct link between GSK-3beta and MLK3 activation in a neuronal cell death pathway and identify MLK3 as a direct downstream target of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
668572ed-e5e5-4cf7-8e5a-951e259643f3	1.0	PubMed	15132987	Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
668572ed-e5e5-4cf7-8e5a-951e259643f3	1.0	PubMed	17475833	Unrestrained glycogen synthase kinase-3 beta activity leads to activated T cell death and can be inhibited by natural adjuvant.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008219"))
61c9c59b-6ab8-4462-8005-31785790f204	1.0	PubMed	26320152	In line with the CT99021 effect, knockdown of GSK3beta significantly inhibited the ability of dexamethasone to suppress CXCL8 expression, and the dexamethasone EC50 was increased from 22 to 100 nM.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:41879))
61c9c59b-6ab8-4462-8005-31785790f204	1.0	PubMed	26320152	GSK3beta modulates dexamethasone function in MonoMac6 cells.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:41879))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	22385658	Gsk3beta inactivation is therefore sufficient to promote differentiation, indicating that a major function of Erk is to regulate Gsk3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	26311646	Accordingly, GSK-3beta activity is higher in differentiated cells than undifferentiated cells, and physiological and pharmacological inhibitors of GSK-3beta promote the survival, proliferation and differentiation of NSCs ().	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	20154711	We also found activation of GSK-3beta during the course of cholera toxin induced differentiation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	20154711	These results indicate the requisite role of GSK-3beta in the differentiation of glioblastoma cells and suggest that GSK-3beta positively regulates the differentiation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	20154711	Overexpression of active GSK-3beta leads to differentiation of U87-MG glioblastoma cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	20154711	We next examined whether forced expression of GSK-3beta is sufficient to induce differentiation in U87-MG cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	20154711	These data indicate that overexpression of active GSK-3beta is necessary and sufficient to promote differentiation in U87-MG human glioblastoma cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	20154711	Conversely, overexpression of GSK-3beta enables glioblastoma cells to acquire differentiation ability.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	20154711	Our data provide strong evidence that GSK-3beta contributes to cellular differentiation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	19882709	Conversely, overexpression of a constitutively active form of human GSK-3beta (pcDNA3-GSK-3beta-S9A) mutant in resistant U251 glioma cells restores their differentiation capabilities.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	25042702	In agreement with this, hPSCs in DE plus Ch condition did not upregulate DE markers EOMES, SOX17, and FOXA2, suggesting that strong GSK3-beta inhibition also prevented DE differentiation (G, H, and S4I).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	24905466	This behaviour is in agreement with the fact that one the downstream targets of Akt most affected by IGFBP-3 treatment was GSK3beta, a factor whose activation by dephosphorylation triggers melanin synthesis and differentiation in melanocytes XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	24905466	In fact, GSK-3beta is known to promote melanin synthesis and melanocyte differentiation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
cd569132-b4eb-4bde-9167-274eeb99ef18	1.0	PubMed	21887250	Since inhibiting the PI3K and Akt cascade resulted in decreased phosphorylation of GSK3beta Ser9 and increased MN differentiation from hNSCs, we then asked if the increase in HB9 expression was due to the increase in GSK3beta activity.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0030154"))
11fdd793-5e1d-4806-a148-3836efd41298	1.0	PubMed	27470346	Mi-3646 was reported to contribute to docetaxel resistance in human breast cancer cells by GSK-3beta and beta-Catenin signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:4672))
1a786aa5-a888-4a26-8409-1ae43d6cc37c	1.0	PubMed	25056574	Activated Dsh then recruits GSK-3beta, releasing beta-catenin and promoting the nuclear translocation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:P51142))
1a786aa5-a888-4a26-8409-1ae43d6cc37c	1.0	PubMed	10959047	Activated Dsh in turn inhibits glycogen synthase kinase-3beta (GSK-3beta), probably by phosphorylation of an amino-terminal serine residue of GSK-3beta by protein kinase C (PKC).	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:P51142))
38ae9baf-f2c5-4b59-80de-643093410c6b	1.0	PubMed	28097141	Nevertheless, SB216763, an inhibitor of GSK-3beta, could reverse the effects of emodin except for ILK expression.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:42223))
abe386b6-14a7-485f-aff0-cc34096f62cb	1.0	PubMed	24558373	We then included chemical inhibitors for the PI3K, AKT and GSK3beta during estrogen stimulation and found that inhibition of the PI3K, AKT and GSK3beta attenuated estrogen stimulated growth of the stem and progenitor cells (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:50114))
8f4e4924-fbb7-4f9e-afd1-0a693f3f9155	1.0	PubMed	22810307	Using, WM793 melanoma cells expressing EGFP-FAK, and 1205Lu cells stained for total FAK, we demonstrated that NP309 treatment and siRNA knockdown of GSK3beta increased the number of large focal adhesions as shown by increased staining for FAK (XREF_FIG), paxillin and vinculin (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0051894"))
368a6148-f538-4e25-aa10-03276faf8420	1.0	PubMed	21466834	3.3 Inhibition of GSK3beta attenuates the effect of forskolin.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:47936))
368a6148-f538-4e25-aa10-03276faf8420	1.0	PubMed	21466834	The inhibition of GSK3beta activity significantly attenuated the rescuing effect of forskolin in thrombin challenged cells (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:47936))
f42bf72e-8e88-43a4-b0ac-b19e69f90429	1.0	PubMed	6639493	Wortmannin blocked heat-shock-induced Akt and GSK -3 beta phosphorylation, prevented 2-deoxyglucose uptake and abolished the heat-shock-induced glycogen synthesis.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:439177))
f42bf72e-8e88-43a4-b0ac-b19e69f90429	1.0	PubMed	21435438	The TRB3 inhibits the phosphorylation of Akt and GSK3beta, leading to increased phosphorylation levels of glycogen synthase and reduced hepatic glycogen synthesis.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:439177))
03cab782-9996-45a4-8d8b-8300c6107727	1.0	PubMed	25118933	In N2a cells, the overexpression of wide-type full-length Omi, but not S276C mutant Omi, reduced the endogenous GSK3beta abundance (XREF_FIG), as well as enhanced green fluorescent protein (EGFP)-, Flag- and HA tagged GSK3beta (XREF_SUPPLEMENTARY), whereas knockdown of Omi increased the abundances of GSK3beta in SH-SY5Y cells (XREF_FIG) and N2a cells (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF01353))
0c6222ee-899d-4d5b-ba05-747a8b51ffa1	1.0	PubMed	22039301	As GSK3beta has also been implicated in tumor growth (XREF_BIBR), we thus investigated whether, as for PI3K and mTOR, GSK3beta also contributes to the homeostasis of normal and neoplastic mast cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0042592"))
54c14c58-8364-4a70-9e3d-ea00b6f4ef9f	1.0	PubMed	21316358	The data of XREF_FIG indicate that GSK3beta inhibition prevents TNF-24.0 h induced increases in phospho-eNOS-Ser 1177 / eNOS and oxidized protein which supports the idea that GSK3beta inhibition prevents TNF induced lung inflammation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006954"))
54c14c58-8364-4a70-9e3d-ea00b6f4ef9f	1.0	PubMed	20848477	GSK3-beta blockade significantly reduced chronic intestinal inflammation and even abolished the colitis intensifying effects of CpG-ODN treatment.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006954"))
54c14c58-8364-4a70-9e3d-ea00b6f4ef9f	1.0	PubMed	27929056	The mechanism by which GSK3beta modulates inflammation has been shown to be mostly dependent on NF-kappaB XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006954"))
047a671d-e1dc-4817-a35d-fe13bdb4bbf1	1.0	PubMed	24681994	Attenuation of the microglia mediated inflammatory response targeted by GSK-3beta inhibition to prevent dopaminergic neuron degeneration in PD requires further investigation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006954"))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	24901051	GSK3beta ablation promotes cancer cell invasion, which is overcome by CD82 expression.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	23851495	XREF_BIBR - XREF_BIBR Signaling pathways that inactivate GSK3beta, such as PI3K and Akt and MAPK, may promote the cell cycle, anti-apoptosis, and invasion, thus facilitating tumor progression.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	25145299	CXCR4 and glycogen synthase kinase-3beta (GSK3beta) promote proliferation and invasion of pancreatic cancer.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	23874688	In this study, we also found that inactivation of GSK3beta and subsequent EZH2 overexpression promoted local invasion of NPC cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	23408967	Inhibition of GSK3beta significantly reduced the proliferation and survival of cancer cells, sensitized them to gemcitabine and ionizing radiation, and attenuated their migration and invasion.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	23408967	No consistent changes were observed in the levels of expression of these molecules (XREF_SUPPLEMENTARY, D), implying that EMT is unlikely to be the mechanism by which GSK3beta inhibition attenuates cancer cell migration and invasion.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	23408967	Inhibition of GSK3beta attenuated cancer cell migration and invasion in wound healing and transwell assays.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	23408967	Our study suggests that EMT may not be involved in the mechanism by which GSK3beta inhibition attenuates cancer cell migration and invasion.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	22810307	Studies in colorectal and pancreatic cancer suggest that GSK3beta modulates cell migration and invasion through the regulation of focal adhesion assembly (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	22810307	A further role for GSK3beta signaling in invasion was suggested by the ability of GSK3beta inhibitors and siRNA knockdown to block phosphorylation of FAK and increase the size of focal adhesions.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	22810307	GSK3beta inhibition blocks the migration and invasion of melanoma cell lines.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	25504636	Inhibition of GSK3beta attenuated the migration and invasion of glioblastoma cells in vitro and that of tumor cells in a mouse model of glioblastoma.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	22363707	Based on above conditions, the results of invasion assay were also shown that GSK3beta (CA)-introduced CL1-0 and LCRMP-1 cells (1015) could further promote cell invasion compared to control cells (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
b3bd5de8-5e46-4b34-ad10-73303a77e972	1.0	PubMed	22363707	Thus, we speculate that GSK3beta may positively promote regulation of actin cytoskeleton and tumor invasion.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
d19fbe2b-14ec-4071-9712-d0a08f204fdf	1.0	PubMed	23851495	These data indicate that stabilized Slug-4SA, which abolishes GSK3beta mediated phosphorylation, can enhance cell motility and invasiveness.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009361))
1e3081fb-92ab-484f-b326-1f7ba2a99dd8	1.0	PubMed	20926667	This phenomenon has been attributed to the propensity of these tau mutants to aggregate into filaments, leading to premature GSK3beta mediated release of kinesin from its cargoes, as with presenilin loss or mutation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(p(PFAM:PF00225))
39643d80-c4ac-4ff0-833e-76be07a53a3a	1.0	PubMed	20166136	Glycogen synthase kinase-3beta (GSK-3beta) phosphorylates Snail and promotes its export from the nucleus and subsequent degradation by the proteosome in the cytosol, while p21 activated kinase (PAK1) can also phosphorylate Snail at a different residue from GSK-3 beta to promote its nuclear localization and, thus, its activity as a transcription factor (XREF_BIBR - XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0051179"))
39643d80-c4ac-4ff0-833e-76be07a53a3a	1.0	PubMed	25218472	Here, we showed that downregulation of Tbeta4 by siRNA decreased the phosphorylation of GSK3beta, and decreased the expression and nuclear localization of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0051179"))
39643d80-c4ac-4ff0-833e-76be07a53a3a	1.0	PubMed	16984735	Inhibi-tion of GSK-3b stabilizes b-catenin expression, catalyzes its localization to the nucleus, and upregulates the downstream target gene cyclin D1 [59].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0051179"))
39643d80-c4ac-4ff0-833e-76be07a53a3a	1.0	PubMed	22977251	Knockdown of glycogen synthase kinase 3beta (GSK3beta) significantly increased the depolarization induced nuclear localization of NFATc4.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0051179"))
39643d80-c4ac-4ff0-833e-76be07a53a3a	1.0	PubMed	19180470	GSK-3beta can modulate the localization of NF-kappaB to the nucleus and effect expression of genes dependent on NF-kappaB activation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0051179"))
cb2aad57-c67d-4728-9ba3-8f3937eb9d20	1.0	PubMed	21422248	To rule out the possibility that the observed effects of rapamycin resulted from mTORC2 inhibition, we also monitored the levels of GSK3-beta (S9) in LPS stimulated wild-type and Rictor (essential component of mTORC2)-deficient mouse embryonic fibroblasts (MEFs).	p(HGNC:GSK3B)	directlyIncreases	act(p(FPLX:mTORC2))
5be2b37a-fb53-42aa-ab51-b0237b761e65	1.0	PubMed	24531650	In vivo, N-acetylcysteine ameliorated the d-GalN and LPS-induced hepatotoxicity and reduced GSK3beta activity; GSK3beta inhibition increased hepatic superoxide dismutase activity and the glutathione content, decreased malondialdehyde production in the liver tissues; while GSK3beta inhibition suppressed the JNK activation in the liver and decreased cytochrome c release from mitochondria.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:10964))
97580714-94ab-4ab2-8ef8-8365f0665348	1.0	PubMed	6782868	This work provides the basis for future studies of GSK-3 beta signaling in mammalian meiosis and spermatogenesis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0007126"))
b588f564-efdc-4755-a298-e935bfc7bc4f	1.0	PubMed	24905466	This behaviour is in agreement with the fact that one the downstream targets of Akt most affected by IGFBP-3 treatment was GSK3beta, a factor whose activation by dephosphorylation triggers melanin synthesis and differentiation in melanocytes XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:6325610))
b588f564-efdc-4755-a298-e935bfc7bc4f	1.0	PubMed	24905466	In fact, GSK-3beta is known to promote melanin synthesis and melanocyte differentiation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:6325610))
94fa8b81-0431-49c5-9708-bd31a2766bed	1.0	PubMed	23582741	In contrast, GSK-3beta was found to increase cancer cell metastasis by cooperating with h-prune and the small GTPase, Rac.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D009362))
505a2996-cbc9-481b-a6b9-fd267c1dc540	1.0	PubMed	25829335	Compatibly, Petit-Paitel et al. have depicted that either pharmacological or genetically inhibition of GSK-3beta (LiCl and kenpaullone, and RNA interference) could abrogate MPP+ mediated mitochondrial membrane potential changes and subsequent caspase-9 and -3 activations.	p(HGNC:GSK3B)	directlyIncreases	act(bp(MESH:D053078))
948e9aa3-1b7f-40cf-87c2-d13b9098ce09	1.0	PubMed	6639493	Wortmannin blocked heat-shock-induced Akt and GSK -3 beta phosphorylation, prevented 2-deoxyglucose uptake and abolished the heat-shock-induced glycogen synthesis.	p(HGNC:GSK3B)	directlyIncreases	act(a(PUBCHEM:9062))
acd7fb5b-d87e-49ae-99fe-7a8e5cf84212	1.0	PubMed	24374017	pAKT is also up-regulated by MUC4, and GSK-3beta is the target of pAKT which is the key element to regulate beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:P54644))
e5aa6b23-6073-4040-ab84-6425648ec596	1.0	PubMed	17925408	Adenoviral expression of constitutively active AKT and lithium chloride mediated inhibition of GSK3beta reduce the potentiated programmed cell death elicited by pleiotrophin.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006915"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	21821001	In leukemia, inhibiting GSK-3beta inhibits proliferation and mediates apoptosis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	23211630	Taken together, these results suggest that GSK-3beta and beta-catenin pathway might be involved in bFGF induced proliferation of SH-SY5Y cells and that ROCK might regulate GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	24136230	It is also known that GSK3beta overexpression induces increased apoptosis in vivo perturbing proliferation and maturation, resulting in the loss of immature neurons.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	21795403	Our results therefore reveal a novel mechanism by which GSK3beta stimulates cell survival and proliferation and suggest that the levels of c-Myb can be a determining factor in GSK3beta inhibition induced apoptosis of certain leukemia cell lines.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	21795403	In addition, in leukemia cells GSK3beta can enhance proliferation and/or survival (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	26311646	Accordingly, GSK-3beta activity is higher in differentiated cells than undifferentiated cells, and physiological and pharmacological inhibitors of GSK-3beta promote the survival, proliferation and differentiation of NSCs ().	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	20031160	In pancreatic cancer cells, GSK-3beta mediates regulation of NF-kappaB, controlling cellular survival and proliferation [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	25935310	However, further studies are needed to clarify whether CHP3 functions as an intracellular Ca sensor in response to Ca overload in the presence of physiological Mg.While germline knockout of GSK3beta results in embryonic lethality, cardiac specific gene ablation of GSK3beta promotes pressure overload- or myocardial infarction induced cardiomyocyte proliferation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	27060477	Huili Li and his laboratory had demonstrated that inhibition of GSK-3beta could suppress the proliferation of colorectal cells by the downregulation of activity of NF-kappaB and NF-kappaB-mediated target genes transcription, which may be of benefit for clinical outcome in patients suffering from colon cancer in future 8.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	27060477	Then, we found that wort (wortamannin, 10mumol/L -1), an agonist of GSK-3beta, could significantly block the proliferation repression caused by GABA B R signaling activation (Figs.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	27060477	GSK-3beta is proved to direct proliferation of breast cancer cells interplayed with histone H3 phosphorylation and DNA methylation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	19751734	Activation of the IGF-I receptor tyrosine kinase in human intestinal smooth muscle is augmented by alphaVbeta3 ligands and is coupled to Erk1/2 and p70S6 kinase activation, which jointly mediate IGF-I-stimulated proliferation, and to GSK-3beta activation, which mediates IGF-I-stimulated inhibition of apoptosis XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	23408967	We investigated whether GSK3beta contributes to cancer cell survival and proliferation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	23434321	Thus, we propose that the PI3K and GSK-3beta branch downstream of CXCR4 is sufficient to promote MPNST proliferation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	24038789	GSK3beta siRNA knockdown effectively decreased GSK3beta levels (XREF_FIG) and increased CSPC proliferation (XREF_FIG), supporting the effect of BIO on CSPC proliferation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	25145299	CXCR4 and glycogen synthase kinase-3beta (GSK3beta) promote proliferation and invasion of pancreatic cancer.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	23408967	Inhibition of GSK3beta significantly reduced the proliferation and survival of cancer cells, sensitized them to gemcitabine and ionizing radiation, and attenuated their migration and invasion.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	23408967	GSK3beta inhibition attenuated the survival and proliferation of cancer cells (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	19188159	Inhibition of GSK3beta activity by escalating doses of a small-molecule inhibitor (AR-A014418) or inhibition of its expression by RNA interference induced the apoptosis and attenuated the survival and proliferation of glioblastoma cells in vitro.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	22093618	We found nuclear accumulation of GSK-3beta as a new marker of RCC and demonstrated that GSK-3beta positively regulates NF-kappaB-mediated survival and proliferation of renal cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	18768676	Aberrant Akt2 and GSK3beta expression and activation could result in increased cell survival in PCOS follicles and contribute to the theca cell hypertrophy and abnormal follicular development and promote the proliferation of granulosa.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	18606491	Inhibition of GSK3beta activity by pharmacological inhibitors suppresses proliferation of the ovarian cancer cells and prevents the formation of tumors in nude mice generated by the inoculation of human ovarian cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	18606491	Inhibition of GSK3beta decreases pancreatic cancer cell survival and proliferation, and arrests pancreatic tumor growth in established tumor xenografts.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
442e0805-6e63-406c-b167-ca195927035c	1.0	PubMed	18606491	Other studies indicate that GSK3beta activation enhances the proliferation and survival of hepatocellular, prostate and lymphocytic leukemia cancer cells.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0008283"))
3f43967d-0c3e-4101-8d4d-9728f4671544	1.0	PubMed	23559006	This finding is in line with a recent work, demonstrating that GSK-3beta inhibition promoted lysosomal biogenesis and autophagy protein degradation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006508"))
33c70570-2bc8-420c-b776-e4ea7e846fa9	1.0	PubMed	23383245	On the other side, GSK-3beta could also induce cyclin D1 proteolysis by direct phosphorylation of cyclin D1.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006508"))
33c70570-2bc8-420c-b776-e4ea7e846fa9	1.0	PubMed	15020233	As to the function of GSK-3beta, it has been reported that GSK-3beta induces cyclin D1 proteolysis.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006508"))
33c70570-2bc8-420c-b776-e4ea7e846fa9	1.0	PubMed	18478343	The cytoplasmic level of beta-catenin is regulated by ubiquitin mediated proteolysis after it is targeted for phosphorylation by glycogen synthase kinase 3beta (GSK-3beta).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006508"))
33c70570-2bc8-420c-b776-e4ea7e846fa9	1.0	PubMed	17241872	Single transfection of APC2 or Wnt1 does not change E-box-dependent transcription activity in both SW480 and 293T cells, suggesting that the observed E-box-dependent transcriptional activity represents Hath1 mediated transcription.These data collectively indicated that GSK3beta mediated proteolysis of Hath1 protein observed in colon cancer cells is dependent on the aberrant activation of the canonical Wnt pathway and that GSK3beta reciprocally regulates Hath1 and beta-catenin protein stability in a Wnt dependent manner, directly leading to significant changes in transcriptional activity of the downstream target genes.It is well known that beta-catenin and TCF-dependent transcription often promotes cell proliferation, whereas Hath1 dependent transcription promotes cell differentiation.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006508"))
6d3db8cd-9a59-4163-9b1f-ea027053e8fe	1.0	PubMed	19244104	However, these effects involve blockade of the phosphatidylinositol-3-kinase (PI3K)/AKT/glycogen synthesis kinase 3 beta (GSK3beta)/mammalian target of rapamycin (mTOR) pathway (XREF_BIBR, XREF_BIBR - XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:9168))
6d3db8cd-9a59-4163-9b1f-ea027053e8fe	1.0	PubMed	18606491	Rapamycin is known to activate GSK3beta; it enhances a chemotherapy drug paclitaxel induced apoptosis in GSK3beta wild-type, but not in GSK3beta null breast cancer cells, indicating that GSK3beta mediates rapamycin induced chemosensitivity.	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:9168))
6d3db8cd-9a59-4163-9b1f-ea027053e8fe	1.0	PubMed	25797247	A previous study primarily using GSK3beta knockout MEFs has suggested that GSK3beta enhances rapamycin mediated growth inhibition and paclitaxel sensitization [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(a(CHEBI:9168))
91bb190f-55e2-4858-90b2-b3f1f1b06505	1.0	PubMed	26618897	GSK3beta inactivation induced chondrocyte senescence as assessed by the significant increase of SA-beta Gal activity [XREF_BIBR] after 5mM LiCl.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0090398"))
162d7d06-3ba0-49a2-8450-365be6ce1d12	1.0	PubMed	23301033	The above results showed that activation of PI3K and AKT resulted in the inhibition of GSK-3beta (XREF_FIG) indicating that GSK-3beta might mediate Tat induced enhancement of angiogenesis and tumorigenesis.	p(HGNC:GSK3B)	directlyIncreases	act(p(UP:P04608))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	20454507	Radiation induction of beta-catenin nuclear translocation correlates with the obser vation in vitro that GSK3beta phosphorylation modulates beta-catenin- dependent gene transcription.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	21821001	Notably, these transcription factors are potentially regulated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	22679108	GSK-3beta also modulates Mitf transcription factor activity via phosphorylation of Ser298 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	20615089	To address these shortcomings, the authors have taken a novel approach using chromatin immunoprecipitation enriched material annealed to microarrays (ChIP-chip) targeting genes in fetal brain tissue bound by beta-catenin, a transcription factor that is directly regulated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	25889792	Interestingly, GPNMB expression in melanoblasts and osteoclasts was shown to be dependent on MITF, and in human glioblastoma cells this transcription factor is activated by PI3K and Akt and GSK3beta signaling [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	16806170	In addition, only GSK-3beta can mediate the function of the transcription factor NF-kappaB, and GSK-3alpha can not compensate for the loss of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	19841191	We analyzed if GSK3beta was able to modulate the mobilizations of these transcription factors.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	21325624	Interestingly, despite the inhibition of GSK-3beta, we observed a decrease in the total levels of beta-catenin in stable Dsc2 knockdown cells, suggesting that Akt mediated GSK-3beta inhibition may promote the nuclear redistribution of beta-catenin and enhance beta-catenin-dependent transcription without inducing stabilization of total beta-catenin protein levels.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	21145761	RT-PCR experiments indicated that overexpression of GSK3beta potentiated transcription of virus induced downstream genes, such as,, and (B).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	21145761	These results suggest that GSK3beta potentiates virus triggered activation of IRF3 as well as transcription of the gene.Because the kinase activity of GSK3beta is important for its functions in various signaling pathways, we next examined whether the effect of GSK3beta on virus triggered IRF3 activation is dependent on its kinase activity.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	24901984	rDNA transcription activation is modulated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	18606491	The intrinsic apoptotic signaling cascade can be induced by numerous stimuli that cause cell damage, such as DNA damage, oxidative stress and endoplasmic reticulum (ER) stress; GSK3beta promotes this cascade by facilitating signals that cause disruption of mitochondria and by regulating transcription factors that control the expression of anti- or pro apoptotic proteins.The extrinsic apoptotic pathway, on the other hand, is mediated by the activation of cell-surface death domain containing receptors (DRs) and initiates apoptosis by activating caspase-8.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	18606491	GSK3beta directly modulates the activity of transcription factors, activator protein 1 (AP-1) and nuclear factor-kappaB (NF-kappaB).	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
60fe008d-4999-4624-a69f-c6f9ae29188f	1.0	PubMed	27683053	ILK can also directly phosphorylates GSK-3beta at Ser 9, inactivate it, and lead to activation of some transcription factors [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006351"))
a8f8fd96-73f0-4a57-9626-4fc2ee03bf92	1.0	PubMed	25823824	For instance, in U2OS (human osteosarcoma) cells, the accumulation of the PHD2 and PHD3 proteins by hypoxia led to accelerated HIF-1 degradation after reoxygenation, while HIF-1 translation in RKO (human colon carcinoma) cells was inhibited by a decrease in GSK3beta under prolonged hypoxia [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006412"))
9ca524bf-dc11-43bd-bcb0-493a676f8bc2	1.0	PubMed	25528666	These results suggest that GSK3beta is involved in Sema3A induced acceleration of antero- and retrograde axonal transport.We further examined the mechanism by which GSK3beta mediates Sema3A induced acceleration of axonal transport by using several GSK3beta mutants ().	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006810"))
9ca524bf-dc11-43bd-bcb0-493a676f8bc2	1.0	PubMed	25528666	We next investigated the effect of EGFP, GSK3beta-wt and GSK3beta-K85M on the Sema3A induced axonal transport ().	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006810"))
9ca524bf-dc11-43bd-bcb0-493a676f8bc2	1.0	PubMed	25528666	This result suggests that GSK3beta mediates Sema3A induced axonal transport through the phosphorylation of unprimed substrates, providing a contrast to the Sema3A signaling in the growth cones in which both primed and unprimed substrates of GSK3beta are involved ().	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006810"))
9ca524bf-dc11-43bd-bcb0-493a676f8bc2	1.0	PubMed	25528666	These results suggest that GSK3beta not only mediates Sema3A induced axonal transport but also is involved in the basal levels of axonal transport.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006810"))
9ca524bf-dc11-43bd-bcb0-493a676f8bc2	1.0	PubMed	25528666	On the contrary, our current studies and previous findings suggest that Cdk5 and GSK3beta positively regulate axonal transport elicited by Sema3A ().	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006810"))
9ca524bf-dc11-43bd-bcb0-493a676f8bc2	1.0	PubMed	20883816	A recent report suggests that GSK-3beta directly phosphorylates IQGAP1 within its C-terminal region (), thus it is plausible that GSK-3beta might directly regulate IQGAP1 transport through phosphorylation.beta-catenin, an important regulatory partner of IQGAP1, did not accumulate in the nucleus of cells after S phase arrest (M. Johnson, unpublished), indicating that IQGAP1 and beta-catenin can enter the nucleus independent of one another.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006810"))
9ca524bf-dc11-43bd-bcb0-493a676f8bc2	1.0	PubMed	14993907	GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila.	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006810"))
9ca524bf-dc11-43bd-bcb0-493a676f8bc2	1.0	PubMed	25796170	On the other hand, the activated Akt can phosphorylate GSK3beta, and lead to promotion of glucose transport ().	p(HGNC:GSK3B)	directlyIncreases	act(bp(GO:"GO:0006810"))
9492c90f-9953-40e6-84c1-f832d4f004fa	1.0	PubMed	11251183	The interaction between beta-catenin, GSK3beta and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer.	complex(p(HGNC:GSK3B), p(HGNC:APC))	directlyIncreases	act(bp(GO:"GO:0007165"))
add4332b-1b46-4df2-a914-bd9a6d44527f	1.0	PubMed	26359353	Since both GSK-3beta and Nur77 facilitate beta-catenin degradation, and we observed that NDRG1 enhance beta-catenin accumulation, we further hypothesized that NDRG1 interaction with GSK-3beta and Nur77 may impede beta-catenin degradation (allowing nuclear accumulation) in HCC cells.	complex(p(HGNC:GSK3B), p(HGNC:NDRG1))	directlyIncreases	act(p(HGNC:CTNNB1))
5f8d1ea6-5ccf-43cb-8d50-cd1f67b17dce	1.0	PubMed	25026278	Collectively, these data demonstrate that the binding of h-Prune and Gsk-3beta is sufficient to mediate the inhibition of beta-catenin degradation, thus leading to an enhancement of the free beta-catenin levels for its translocation into the nucleus and the activation of WNT signaling.	complex(p(HGNC:GSK3B), p(UP:Q86TP1))	directlyIncreases	act(p(HGNC:CTNNB1))
048f91f5-fe75-4b57-8ef2-39ecdd3ec287	1.0	PubMed	26940070	Previous reports have indicated that (i) CagA interacts with E-cadherin and disrupts E, cadherin, beta, and catenin complex formation, releasing beta-catenin from the E-cadherin and beta-catenin compelx into the cytoplasm; and (ii) CagA binds to GSK-3beta directly and depletes its activity, inhibiting the phosphorylation and proteasomal degradation of cytoplasmic beta-catenin.	complex(p(HGNC:GSK3B), p(HGNC:S100A8))	directlyIncreases	act(p(HGNC:CTNNB1))
221bd7db-b9d5-46fe-8580-9bb02557506b	1.0	PubMed	24022664	Together, the interaction between LKB1 and GSK3beta upregulates GSK3beta activity to suppress WNT induced cell proliferation in esophageal carcinoma cells.	complex(p(HGNC:GSK3B), p(HGNC:STK11))	directlyIncreases	act(p(HGNC:GSK3B))
221bd7db-b9d5-46fe-8580-9bb02557506b	1.0	PubMed	24022664	Together, the interaction between LKB1 and GSK3beta upregulates GSK3beta activity to suppress WNT induced cell proliferation in esophageal carcinoma cells.	complex(p(HGNC:GSK3B), p(HGNC:STK11))	directlyIncreases	act(p(HGNC:GSK3B))
a6845f6d-2a35-4000-8a5c-859149a95d4d	1.0	PubMed	14744935	ER stress induces GSK-3beta binding to p53 in the nucleus and enhances the cytoplasmic localization of the tumor suppressor.	complex(p(HGNC:GSK3B), p(HGNC:TP53))	directlyIncreases	act(bp(GO:"GO:0051179"))
4a8ae191-5c67-4d78-b215-d506eefa5370	1.0	PubMed	26940070	First, once CagA is injected into gastric cancer cells via the T4SS during infection, it directly binds to GSK-3beta and depletes its activity, inhibiting beta-catenin degradation.	complex(p(HGNC:GSK3B))	directlyIncreases	act(p(HGNC:CTNNB1))
c2bca093-629b-4570-bd83-bc7dd8aee458	1.0	PubMed	26359353	On the contrary, our observations demonstrate that NDRG1 is an oncogenic activator in HCC, possibly through its competitive binding with GSK-3beta and Nur77 which reduces beta-catenin degradation and enhances beta-catenin transcriptional activation of its downstream oncogenes.	complex(p(HGNC:GSK3B))	directlyIncreases	act(p(HGNC:CTNNB1))
c2bca093-629b-4570-bd83-bc7dd8aee458	1.0	PubMed	26359353	On the contrary, our observations demonstrate that NDRG1 is an oncogenic activator in HCC, possibly through its competitive binding with GSK-3beta and Nur77 which reduces beta-catenin degradation and enhances beta-catenin transcriptional activation of its downstream oncogenes.	complex(p(HGNC:GSK3B))	directlyIncreases	act(p(HGNC:CTNNB1))
b8173e1f-f8c9-4d91-9a96-af2e7c08633c	1.0	PubMed	17996206	On the other hand, in the cytosol, the axin, APC, and GSK3beta complex targets beta-catenin for phosphorylation and degradation.	complex(p(HGNC:GSK3B), p(HGNC:AXIN1), p(HGNC:APC))	directlyIncreases	act(p(HGNC:CTNNB1))
fc98dada-dccc-4180-9cf8-7ed44ef4f374	1.0	PubMed	21821713	Akt3 (-/-) platelets exhibit a significant reduction in thrombin induced phosphorylation of glycogen synthase kinase 3beta (GSK-3beta) at Ser9, which is known to inhibit GSK-3beta function.	p(FPLX:GYS)	directlyIncreases	act(p(HGNC:GSK3B))
5c678cff-4cba-4141-ba8d-869922ee9f8b	1.0	PubMed	14561750	Expression of Csk accentuated the activation of GSK-3beta by Galphaq (Q209L), whereas catalytically inactive Csk blocked GSK-3beta activation by Galphaq (Q209L).	p(FPLX:"G_q_alpha", var(p.Gln209Leu))	directlyIncreases	act(p(HGNC:GSK3B))
5c678cff-4cba-4141-ba8d-869922ee9f8b	1.0	PubMed	7005206	Expression of Csk accentuated the activation of GSK-3beta by Galphaq (Q209L), whereas catalytically inactive Csk blocked GSK-3beta activation by Galphaq (Q209L).	p(FPLX:"G_q_alpha", var(p.Gln209Leu))	directlyIncreases	act(p(HGNC:GSK3B))
c84f9039-0823-4a77-b1cc-a95da303043d	1.0	PubMed	PMC7005206	Expression of Csk accentuated the activation of GSK-3beta by Galphaq(Q209L), whereas catalytically inactive Csk blocked GSK-3beta activation by Galphaq(Q209L).	p(FPLX:"G_q_alpha")	directlyIncreases	act(p(HGNC:GSK3B))
c84f9039-0823-4a77-b1cc-a95da303043d	1.0	PubMed	PMC7005206	These results suggest that activation of Csk and GSK-3beta by Galphaq may contribute to the physiological and pathological effects of Gq-coupled receptors.	p(FPLX:"G_q_alpha")	directlyIncreases	act(p(HGNC:GSK3B))
d4c3b84f-e7fd-4f5c-95b3-081113f2521b	1.0	PubMed	6619150	These results suggested that DIF-3 activates GSK-3beta to accelerate the proteolysis of cyclin D1 and that this mechanism is involved in the DIF-3-induced G (0)/G (1) arrest in mammalian cells.	p(UP:Q5SV77)	directlyIncreases	act(p(HGNC:GSK3B))
696fa23b-905a-4fad-8133-4fe7567cda03	1.0	PubMed	20454507	(A) BxPC3 and Panc1 cells expressing NS or GSK3beta shRNA were treated with 2 Gy, and Western blot analysis for total and phosphorylated GSK3beta was performed.	a(PUBCHEM:92829)	directlyIncreases	act(p(HGNC:GSK3B))
600ac020-c4cd-47b7-be67-b19220e056c5	1.0	PubMed	24473773	In Hepa1-6, macroH2A1.1 over-expression induced, upon FFA treatment, dramatic changes in the expression of genes involved in carbohydrate metabolism when compared to macroH2A1.2 (downregulation of G6PC, GCK, MLXIPL, PDK4 and RBP4 and upregulation of PCK2 and GSK3B) or to FFA condition (upregulation of G6PC, GCK, MLXIPL and GSK3B and down-regulation of PCK2, PKLR and RBP4).	p(HGNC:H2AFY)	directlyIncreases	act(p(HGNC:GSK3B))
707f37c6-1614-4f3c-a41b-5756f2b8027f	1.0	PubMed	18201972	The action of HGF on proinflammatory NFkappaB activation was consistently mimicked by a selective GSK3beta inhibitor or GSK3beta knockdown by RNA interference but largely abrogated in cells expressing the mutant uninhibitable GSK3beta.	p(HGNC:HGF)	directlyIncreases	act(p(HGNC:GSK3B))
ccfdf238-b28e-4a72-ba15-99e0cc84cde8	1.0	PubMed	26739898	First, we determined whether HMGB1 induction of the PI3K and AKT and GSK-3beta signaling pathways was dependent upon beta-catenin activation.	p(HGNC:HMGB1)	directlyIncreases	act(p(HGNC:GSK3B))
be3a1450-315e-4c79-b9c4-a1db63c774c5	1.0	PubMed	22960426	In light of these observations, we explored the possibility that HNF4alpha DNA binding impairment is caused by TGFbeta induced inactivation of GSK3beta.	p(HGNC:HNF4A)	directlyIncreases	act(p(HGNC:GSK3B))
ce5d1ec2-637c-4f2d-960b-07e2d88af950	1.0	PubMed	23349801	GSK-3beta signaling might be stimulated also by other signal pathway in hPS cells.	p(HGNC:HPS1)	directlyIncreases	act(p(HGNC:GSK3B))
c1309fa2-3b16-451e-a5a3-dd7fdbe4702a	1.0	PubMed	22460328	Bip enhanced the association of GSK-3beta with tau during ER stress both in vivo and in vitro.	p(HGNC:HSPA5)	directlyIncreases	act(p(HGNC:GSK3B))
5167ed4f-c4da-4bf9-8e51-5338ebbfb387	1.0	PubMed	PMC6832922	Thus, a prolonged hypoxia activates GSK3beta, which results in decreased HIF-1alpha accumulation.	p(HGNC:HYOU1)	directlyIncreases	act(p(HGNC:GSK3B))
d0674b45-fc04-47bd-93ed-82d392e9962f	1.0	PubMed	5993296	Heat shock and staurosporine treatments increased nuclear GSK-3 beta prior to activation of caspase-9 and caspase-3, and this nuclear accumulation of GSK-3 beta was unaltered by pretreatment with a general caspase inhibitor.	p(PFAM:PF02985)	directlyIncreases	act(p(HGNC:GSK3B))
d0674b45-fc04-47bd-93ed-82d392e9962f	1.0	PubMed	11495916	Heat shock and staurosporine treatments increased nuclear GSK-3 beta prior to activation of caspase-9 and caspase-3, and this nuclear accumulation of GSK-3 beta was unaltered by pretreatment with a general caspase inhibitor.	p(PFAM:PF02985)	directlyIncreases	act(p(HGNC:GSK3B))
98f2978e-be07-4d0d-bea1-b97fcf2a1b89	1.0	PubMed	21160051	IFN-beta induces partial inactivation of GSK3-beta activity.	p(HGNC:IFNB1)	directlyIncreases	act(p(HGNC:GSK3B))
4307d859-064e-4554-873c-d158f3fe59fb	1.0	PubMed	19729319	Therefore, IGF-I stimulation of GSK3beta serine 9 phosphorylation, which inactivates GSK3beta, might partially reverse glucocorticoid induced proteolysis.An additional atrophy mechanism is thought to be mediated by IKK, which phosphorylates IRS-1 on serine 307 to reduce IGF-I stimulated signaling.	p(HGNC:IGF1)	directlyIncreases	act(p(HGNC:GSK3B))
7e87902e-96e6-4b99-8470-10a4f2d6f59d	1.0	PubMed	27929056	Since phosphorylation is an important step in NEMO regulation XREF_BIBR XREF_BIBR, we investigated whether NEMO is a target of GSK-3beta.	p(HGNC:IKBKG)	directlyIncreases	act(p(HGNC:GSK3B))
716d598c-6e65-4ecb-bf17-018dd73cf502	1.0	PubMed	25591548	In summary, IL-18 activated GSK3beta by site specific phosphorylation of Tyr216 residues to target intrinsic pathways and cyclin D1 expression, thus inhibiting TSCC cell growth by promoting apoptosis.	p(HGNC:IL18)	directlyIncreases	act(p(HGNC:GSK3B))
716d598c-6e65-4ecb-bf17-018dd73cf502	1.0	PubMed	25591548	Thus, future studies are to focus on how IL-18 expression can activate GSK3beta protein to possess IL-18 antitumor activity in TSCC cells.	p(HGNC:IL18)	directlyIncreases	act(p(HGNC:GSK3B))
eb6e9e65-02a7-41ed-94a7-1aa333bfb369	1.0	PubMed	22095718	The inhibition of IL-1 signaling significantly suppressed the activation of cdk5 and p25, GSK-3beta and p38-MAPK, all major kinases that phosphorylate tau in neurons.	p(FPLX:IL1)	directlyIncreases	act(p(HGNC:GSK3B))
30cb6de2-ce25-41a5-8c08-8b77975ba52e	1.0	PubMed	24742671	Glycogen synthase kinase (GSK)-3beta phosphorylates the IL-22R within a consensus phosphorylation signature at Ser (410) and Ser (414), and IL-22 treatment of cells triggers GSK-3beta inactivation.	p(HGNC:IL22RA1)	directlyIncreases	act(p(HGNC:GSK3B))
7e199b03-b802-4637-972d-0ecdc3fe26ee	1.0	PubMed	24742671	Glycogen synthase kinase (GSK)-3beta phosphorylates the IL-22R within a consensus phosphorylation signature at Ser (410) and Ser (414), and IL-22 treatment of cells triggers GSK-3beta inactivation.	p(HGNC:IL22)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	14990992	We investigated the role of endogenous cellular ILKAP in antagonizing ILK signaling of two key targets, PKB and GSK3beta.	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	11331582	Catalytically active, but not mutant ILKAP, strongly inhibited insulin like growth factor-1-stimulated GSK3beta phosphorylation on Ser9, but did not affect phosphorylation of PKB on Ser473, suggesting that ILKAP selectively affects ILK mediated GSK3beta signalling.	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	5873091	Catalytically active, but not mutant ILKAP, strongly inhibited insulin like growth factor-1-stimulated GSK3beta phosphorylation on Ser9, but did not affect phosphorylation of PKB on Ser473, suggesting that ILKAP selectively affects ILK mediated GSK3beta signalling.	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	7187588	We investigated the role of endogenous cellular ILKAP in antagonizing ILK signaling of two key targets, PKB and GSK3beta.	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	21196412	This increase in MMP-9 proteins was attributed to ILK mediated activation of GSK-3beta and AP-1 transcription factor (XREF_BIBR).	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	23707970	ILK siRNA suppresses downstream signaling target molecules p-Akt and p-GSK3 beta expressions.In order to explore the molecular mechanism of the inhibition of cell invasion and metastasis after knockdown of ILK, we detected the protein levels of the key EMT associated genes by Western blot.	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	23707970	The previous studies have shown that ILK inhibition could inhibit p-Akt, p-GSK3beta, beta-catenin, Snail as well as MMP9 and Twist.	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	22666394	ILK can also signal through a c-Jun-N-terminal kinase (JNK and c-Jun) signaling axis independently of the canonical signaling target GSK-3beta XREF_BIBR.	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
5d6c7660-4b6f-4206-93d2-c25885291a2b	1.0	PubMed	28097141	To further clarify that whether ILK targeted GSK-3beta to suppress EMT of EOC cells, we used GSK-3beta inhibitor (SB216763) to treat A2780 and SK-OV-3 cells for 6 hours.	p(HGNC:ILK)	directlyIncreases	act(p(HGNC:GSK3B))
49b00309-3a55-40ea-85f2-8c54a4a910a0	1.0	PubMed	25849484	Taken together, we suggest that, IM may activate Notch signalling by modulating the Wnt components Dishevelled and GSK3beta (XREF_FIG) or may activate Notch signalling by blocking the inhibitory action of BCR-ABL on its downstream substrate GSK3beta.	a(PUBCHEM:3386966)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	25645159	To assess the effect of HCV infection on insulin sensitivity, we examined the phosphorylation status of Akt and GSK3beta induced by insulin stimulation.	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	21347395	Our result showed that the expression level of pAkt Serine 473 and pGSK3beta were increased in NT control clone upon insulin stimulation, indicating that insulin could successfully activate Akt and GSK3beta in BEL7402.	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	5156719	To further evaluate the role of GSK3beta in insulin signaling, the GSK3beta inhibitor lithium was used to mimic the consequences of insulin stimulated GSK3beta inactivation.	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	23395167	Insulin stimulated activations of IRS-1, AKT and GSK3beta were significantly reduced in fibroblasts of LRP6 R611C mutation carriers compared to non carriers (XREF_FIG).	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	18178198	The difference in the absolute levels of insulin stimulated phospho (Ser9) GSK3beta between control and PCOS did not reach statistical significance (P = 0.077); however, the percent change was clearly different (2.4% increase in PCOS vs. 14% increase in controls, P = 0.0015).	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	PMC4986626	Thus, insulin rapidly and transiently activated GSK-3beta and modulated tau phosphorylation, alterations that may contribute to neuronal plasticity.	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	4986626	The increase in GSK-3beta tyrosine phosphorylation corresponded directly to an increase in the association of Fyn tyrosine kinase with GSK-3beta, and Fyn immunoprecipitated from cells treated with insulin for 1 min phosphorylated GSK-3beta to a significantly greater extent than Fyn immunoprecipitated from control cells.	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	4142852	Protein phosphatase 2A treatment partially reversed insulin induced GSK-3beta inactivation, but did not change GSK-3beta (delta9) inactivation.	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	24704462	GSK-3beta controls glucose metabolism and insulin action in skeletal muscles; overexpression of GSK-3beta results in development of insulin resistance in type II diabetes.	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	20399743	For example, a maximum inhibition value of 50% has been reported for GSK-3beta in myoblasts treated with EGF or insulin.	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
1bc06dc3-66c5-43e0-b60f-6a1f1a3008ee	1.0	PubMed	16039586	For instance, reduced GSK-3beta activity caused by insulin stimulation leads to beta-catenin accumulation in HepG2 cells and cardiomyocytes (), but not in human embryonic kidney 293 cells ().	p(HGNC:INS)	directlyIncreases	act(p(HGNC:GSK3B))
0c399dee-3fa1-4be1-a73d-502db4e2379f	1.0	PubMed	21145761	In reporter assays, wild-type GSK3beta, as well as GSK3beta (S9A) and GSK3beta (K85A), did not potentiate IFN-gamma-triggered activation of the IRF1 promoter (G), suggesting that GSK3beta plays a specific role in virus triggered IRF3 activation and IFN-beta induction.Because overexpression of GSK3beta potentiated virus triggered induction of IFN-beta, we next determined whether endogenous GSK3beta is required for virus induced signaling.	p(HGNC:IRF3)	directlyIncreases	act(p(HGNC:GSK3B))
63e88f4e-1b38-4c5f-b757-7fd01b5062ea	1.0	PubMed	20352103	This result suggests that the integrin dependent activation of GSK3beta could result from both increased PP2A and decreased PI 3-kinase/Akt activities XREF_BIBR.	p(FPLX:Integrins)	directlyIncreases	act(p(HGNC:GSK3B))
63e88f4e-1b38-4c5f-b757-7fd01b5062ea	1.0	PubMed	15940626	In contrast to insulin signaling, integrin linked kinase mediated inactivation of GSK-3beta through inhibitory phosphorylation does result in the stimulation of a Wnt signal.	p(FPLX:Integrins)	directlyIncreases	act(p(HGNC:GSK3B))
4839b9c8-c0ea-42c1-8cb3-4412a611a626	1.0	PubMed	19139264	Besides pERK1/2 (XREF_BIBR), BMPs can trigger Smad independent signaling using kinase pathways such as JNK, which could also target GSK3-beta for inhibition (XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(FPLX:JNK)	directlyIncreases	act(p(HGNC:GSK3B))
0cd5a82c-601d-47e4-90e6-36aa127cb9a4	1.0	PubMed	22018239	In a previous study, phosphorylation at Ser86 and Ser90 of TIP60 was shown to enhance its HAT activity in vitro using histones as substrates and in addition, GSK3beta and CDK1 and cyclin B were found to in vitro phosphorylate Ser86 and Ser90, respectively (XREF_BIBR; XREF_BIBR).	p(HGNC:KAT5)	directlyIncreases	act(p(HGNC:GSK3B))
847f3c37-db90-4f41-b11c-e754a5c6fc61	1.0	PubMed	22039301	In contrast, there was no significant difference in the phosphorylation of AKT (S 473) (XREF_FIG) following SCF stimulation in the GSK3beta knockdown cells compared to control cells.	p(HGNC:KITLG)	directlyIncreases	act(p(HGNC:GSK3B))
2db1b791-fed1-42fa-9074-097901ccfb7e	1.0	PubMed	23085750	Previous studies have reported that GSK3beta targets KLF5 for proteosomal degradation, 19 which is in concordance with GSK3beta altering the stability of many of its substrates.	p(HGNC:KLF5)	directlyIncreases	act(p(HGNC:GSK3B))
221d2ce5-0ce1-411a-9a68-656bd2b7a75b	1.0	PubMed	23085750	GSK3beta augmented the transactivation by wild-type KLF6, but not KLF6-4A, towards the p21 promoter, and increased p21 protein.	p(HGNC:KLF6)	directlyIncreases	act(p(HGNC:GSK3B))
75fc0c6d-718e-4291-a8c0-91b0cfd01272	1.0	PubMed	26022178	Phosphorylation at Ser21 in GSK-3alpha and at Ser9 in GSK-3beta induced by NKG2D, 2B4 or their combination were abrogated by co-crosslinking of CD94-NKG2A inhibitory receptor on NKL cells (D).	p(HGNC:KLRK1)	directlyIncreases	act(p(HGNC:GSK3B))
75fc0c6d-718e-4291-a8c0-91b0cfd01272	1.0	PubMed	26022178	Phosphorylation at Ser21 in GSK-3alpha and at Ser9 in GSK-3beta induced by combination of NKG2D and 2B4 were sensitive to the inhibitors of both PI3K (LY294002) and MEK (PD98059) that diminish phosphorylation of Akt and ERK, respectively (A).	p(HGNC:KLRK1)	directlyIncreases	act(p(HGNC:GSK3B))
86ba7f3d-a5e4-4a76-bc30-653b68a5e41d	1.0	PubMed	19190323	These data indicate that galectin-3 activates Wnt signaling by inactivating GSK-3beta.	p(HGNC:LGALS3)	directlyIncreases	act(p(HGNC:GSK3B))
971c5532-6273-446d-b151-5edebdfb5891	1.0	PubMed	27020460	LPS stimulation elevates GSK-3beta activity in platelets, resulting in platelet activation.	a(CHEBI:16412)	directlyIncreases	act(p(HGNC:GSK3B))
06610beb-db36-4495-a7f2-e7ca6b6a697d	1.0	PubMed	24165324	Furthermore, we found that LRRK2 mediated activation of GSK-3beta induces high phosphorylation of tau at Ser396 in SH-SY5Y cells.	p(HGNC:LRRK2)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	12900420	In some experiments, LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (a kinase involved in activating Akt) and tumor necrosis factor-alpha (TNF-alpha) were used to activate GSK-3beta.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	18243161	Pharmacological inhibitor of PI3K, LY294002, abrogated this GSK-3beta inactivation downstream of LPS, suggesting that PI3K and Akt may negatively modulate GSK-3beta thereby inactivating p65 transactivation downstream of LPS.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	25150829	To assess the role of PI3K and AKT signaling in regulating both beta-catenin and GSK3beta, MDCK cells expressing N-terminal APC fragments were treated with the PI3K inhibitor LY294002.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	26359353	LY294002 enhanced GSK-3beta activity as observed by decreased levels of GSK-3beta 9ser (the inactive form of GSK-3beta), whereas Cns-A up-regulated Nur77 expression and also its nuclear expression in all three HCC cell lines.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	26295469	The Akt inhibitor (LY294002), the ERK inhibitor (U0126) or the combination of LY294002 and U0126 reversed GSK3beta inactivation.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	6899864	In some experiments, LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (a kinase involved in activating Akt) and tumor necrosis factor-alpha (TNF-alpha) were used to activate GSK-3beta.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	26595527	Incubation with LY294002 activated GSK3B as judged by decreased phosphorylation of ser9-GSK3, but unlike AsPC-1 cells, this failed to induce degradation of cyclin E, consistent with the failure of MK-8776 to activate CDK2.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	21777419	Inhibition of PI3K activity (LY294002) in A431 tumor cells attenuated the TG2 induced activation of Akt and GSK-3beta, and suppressed the increases in Snail, MMP-9, and cell motility.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	25114899	LY294002, another Akt inhibitor [XREF_BIBR, XREF_BIBR, XREF_BIBR], was also found to reduce total Akt protein as well as activated Akt, pGSK3beta, pTSC2, and p4EBP1 in Sal treated cells.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
727ea4ac-452c-40df-9040-00b6d80ecc41	1.0	PubMed	19180470	LY294002 has been shown to cause the accumulation of endogenous GSK-3beta in its active form [XREF_BIBR].	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
139f0b6d-267b-4426-a375-2f238930a961	1.0	PubMed	17050006	In addition, LY 294002, an inhibitor of PI 3-kinase activity, was used to activate endogenous GSK3beta activity.	a(PUBCHEM:3973)	directlyIncreases	act(p(HGNC:GSK3B))
26f568ef-543d-4578-b0e3-6fffeb84b796	1.0	PubMed	19679347	Six hours or more of LiCl exposure significantly increased the content of inactive, phosphorylated GSK3beta (B).	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B, pmod(Ph)))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	26197224	Our further results showed that ATX resulted in an increase in p-GSK-3beta (Ser9) whereas blockade of GSK-3beta activation by LiCl dramatically abrogated the neuroprotective effect of ATX, demonstrating that antioxidant capability of ATX might be mediated by the inactivation of GSK-3beta.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	26618897	LiCl mediated GSK3beta inactivation in vitro resulted in increased mitochondrial ROS production, responsible for reduced cell proliferation, S phase transient arrest, and increase in cell senescence, size and granularity.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	26618897	With regards to the underlying molecular mechanisms, LiCl mediated GSK3beta inactivation increased mitochondrial ROS production that led to oxidative damage (increased 8-oxo-deoxyguanosine), DNA damage response (increased expression of gammaH2AX and growth arrest and DNA damage inducible protein 45beta (GADD45beta)) and cell senescence (transient S phase arrest, increased expression of the senescence marker p21, SA-beta galactosidase and PAS staining).	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	15911064	As expected, LiCl activated the hBNP promoter (D), presumably by inactivating GSK3beta.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	23334344	Interestingly, the MITF mRNA steady-state level was not reversed (and was even further downregulated) by LiCl mediated GSK3beta inhibition (), whereas phospho-beta-catenin IR in anagen VI HFs was normalized by LiCl in P-cadherin-silenced HFs ().	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	25062958	In contrast, although LiCl increased the phospho-GSK-3beta and total GSK-3beta ratio, this was unaffected by either ODQ or Rp.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	26560046	LiCl treatment resulted in a significant increase of both mRNA and protein levels of GSK3beta in CaSki cells, which was blunted by a knockdown of HPV16 E6/E7 with shRNA.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	26560046	We are currently investigating the exact mechanisms underlying HPV16 E6/E7 dependent GSK3beta mRNA level increase caused by LiCl.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	26560046	LiCl also increased GSK3beta transcripts in an HPV16 dependent manner in cervical cancer cells.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
92896bd0-0de7-4822-be09-64310da8ec14	1.0	PubMed	25927959	GSK3beta was also phosphorylated when HUVECs were treated with LiCl, a known inhibitor of GSK3beta.	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
f1853135-bb60-493e-82e8-af0e819a8df4	1.0	PubMed	17692821	Lithium increased the level of the phosphorylated form of GSK-3beta in HKC-8 cells, but had little effect on the total GSK-3beta level (B).	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:GSK3B))
20c3beee-40bc-4b2f-b69f-8db31148eb48	1.0	PubMed	15020233	In vitro kinase assay was carried out using a recombinant human active mek1 and we found that gsk-3beta was phosphorylated on tyr(216) by this kinase in a dose- and time-dependent manner. Further, the pretreatment of fibroblasts with u0126 inhibited serum-induced nuclear translocation of gsk-3beta. These results suggested that mek1/2 induces tyrosine phosphorylation of gsk-3beta and this cellular event might induce nuclear translocation of gsk-3beta.	p(HGNC:MAP2K1)	directlyIncreases	act(p(HGNC:GSK3B))
48f41093-19a4-4b32-b667-c812f4516c42	1.0	PubMed	18455992	In kinase assays, purified MAP3K10 increased the activity of GSK3beta, but had no effect on activities of CK1alpha and CK1epsilon against a casein substrate (G).	p(HGNC:MAP3K10)	directlyIncreases	act(p(HGNC:GSK3B))
f6436d22-e0ba-495d-ac39-578735dc8690	1.0	PubMed	18045539	In vitro phosphorylations were performed in two stages, and it was found that gsk3b caused the incorporation of [g-32p]atp by smad1 linker protein, but only after prephosphorylation by erk/mapk	p(HGNC:MAPK1)	directlyIncreases	act(p(HGNC:GSK3B))
703c8744-2aef-4c95-b8c5-d8b51dee3029	1.0	PubMed	25573097	It is therefore a likely site of synergistic modification to tau in its pathology along with phosphorylation of Thr.In this study, we demonstrate that phosphorylation of tau at Thr leads to the activation of GSK3beta, which then phosphorylates tau at Thr and which in turn leads to pathologic fibril formation.	p(HGNC:MAPT)	directlyIncreases	act(p(HGNC:GSK3B))
37faf0f2-dc85-413f-bec5-db96698ed815	1.0	PubMed	20417616	This observation suggests that HIC may restore the GSK-3-dependent regulation of beta-catenin stability by releasing GSK-3beta from LANA and negatively regulate LANA mediated beta-catenin-dependent transcription.	p(HGNC:MDFIC)	directlyIncreases	act(p(HGNC:GSK3B))
07fc8211-807d-465a-aa73-839c5abb359d	1.0	PubMed	19481076	This idea was supported by increased GSK-3beta content in transgenic chondrocytes treated with MG132 versus untreated transgenic cells (XREF_FIG, compare lane 4 with lane 3, lower panel).	a(CHEBI:75142)	directlyIncreases	act(p(HGNC:GSK3B))
07fc8211-807d-465a-aa73-839c5abb359d	1.0	PubMed	24901984	To start addressing this point, we prepared G1 lysates from GSK3beta -/- MEFs, untreated or treated with the proteasome inhibitor MG132, under which conditions the NM1 levels are rescued (see also XREF_FIG).	a(CHEBI:75142)	directlyIncreases	act(p(HGNC:GSK3B))
07fc8211-807d-465a-aa73-839c5abb359d	1.0	PubMed	24901984	To confirm that endogenous NM1 is a substrate for GSK3beta, we subjected lysates from G1 arrested GSK3beta -/- MEFs treated with MG132 to immunoprecipitations with anti-NM1 or anti-actin antibodies.	a(CHEBI:75142)	directlyIncreases	act(p(HGNC:GSK3B))
07fc8211-807d-465a-aa73-839c5abb359d	1.0	PubMed	24901984	We next synchronized GSK3beta -/- MEFs in G1 by serum starvation and treated with the proteasome inhibitor MG132.	a(CHEBI:75142)	directlyIncreases	act(p(HGNC:GSK3B))
a6c02227-0f66-4c6b-9459-5fa6f4fbc9b9	1.0	PubMed	22943878	MMP-2 and MMP-9 promote the migration and invasion of cells by activating the Akt and GSK-3beta pathway.	p(HGNC:MMP2)	directlyIncreases	act(p(HGNC:GSK3B))
de79b4e1-8914-4d36-8111-b9e9205e0d77	1.0	PubMed	22943878	MMP-2 and MMP-9 promote the migration and invasion of cells by activating the Akt and GSK-3beta pathway.	p(HGNC:MMP9)	directlyIncreases	act(p(HGNC:GSK3B))
7deef9fe-a3c1-4204-bd76-bb92d1766d29	1.0	PubMed	24930764	Then, to determine the role of GSK3beta in EB1 phosphorylation, A549 cells were treated with MTA combined with the GSK3beta specific inhibitor SB216763 during 6 h.	a(PUBCHEM:439176)	directlyIncreases	act(p(HGNC:GSK3B))
fc5a9c50-9618-48d7-9451-1ed935e5f7ce	1.0	PubMed	21737790	Furthermore, inhibition of mTOR signaling by rapamycin reversed the inhibitory effect of GSK-3beta inhibition on autophagy and, at the same time, abolished the effect of GSK-3beta inhibition on myocardial ischemic injury and reperfusion injury.	p(HGNC:MTOR)	directlyIncreases	act(p(HGNC:GSK3B))
6aef6ff5-5f02-481a-b3ef-1077b2bf65ad	1.0	PubMed	19996288	For example, the cytoplasmic tail of MUC1 was reported to enhance the invasion of MDA-MB-468 breast cancer cells expressing wild type GSK-3beta and beta-catenin (XREF_BIBR), suggesting possible interactions between these proteins.	p(HGNC:MUC1)	directlyIncreases	act(p(HGNC:GSK3B))
8cbb3fc6-c42d-4cf9-a479-2435fa5e9c2f	1.0	PubMed	21795403	GSK3beta inactivation increased c-Myb degradation, and overexpression of c-Myb could block the inhibitory effect of GSK3beta inactivation on cell proliferation.	p(HGNC:MYB)	directlyIncreases	act(p(HGNC:GSK3B))
4e23dd10-355b-4c05-9f3a-3991d6f18e48	1.0	PubMed	25310895	The proto-oncogene c-Myc was identified as a direct and functional target of miR-451, and overexpression of c-Myc which induced ERK dependent GSK-3beta inactivation and subsequent snail or MMPs activation was essential for acquisition of EMT phenotype.	p(HGNC:MYC)	directlyIncreases	act(p(HGNC:GSK3B))
4e23dd10-355b-4c05-9f3a-3991d6f18e48	1.0	PubMed	25435281	On the other hand, Ras dependent activation of the PI3K-AKT pathway tends to limit the phosphorylation of Myc at Thr58 by AKT mediated inhibition of GSK-3beta ().	p(HGNC:MYC)	directlyIncreases	act(p(HGNC:GSK3B))
4e23dd10-355b-4c05-9f3a-3991d6f18e48	1.0	PubMed	26164082	Here, both restoration of miR-451 and c-Myc downregulation could induce the decreased expression of p-GSK-3beta (Ser 9) protein, but no changes of total GSK-3beta protein.	p(HGNC:MYC)	directlyIncreases	act(p(HGNC:GSK3B))
d00885dc-8adc-46bb-a0af-98b4d12feeb4	1.0	PubMed	21329734	These results indicate that the mTOR signaling pathway is involved in visfatin induced GSK3beta inactivation and beta-catenin nuclear translocation.To explore the role of beta-catenin in visfatin induced angiogenesis, we used RNA interference to knock down beta-catenin expression in HUVECs.	p(HGNC:NAMPT)	directlyIncreases	act(p(HGNC:GSK3B))
d00885dc-8adc-46bb-a0af-98b4d12feeb4	1.0	PubMed	21329734	We therefore investigated the effect of visfatin induced inactivation of GSK3beta on mTOR activation using DIF-3 and LiCl to induce GSK3beta activation and inactivation, respectively ().	p(HGNC:NAMPT)	directlyIncreases	act(p(HGNC:GSK3B))
902a1045-ca81-47cc-8a21-67e693078438	1.0	PubMed	25003810	Snail knockdown, Smad1 knockdown, or Smad1 and Akt inhibition significantly reduced Nanog expression and rescued GSK3beta activity.	p(HGNC:NANOG)	directlyIncreases	act(p(HGNC:GSK3B))
98c97e84-1621-4ec3-b9aa-9da1a28fc3ec	1.0	PubMed	26418878	Using both HCT116 and HT29 cells, NDRG1 over-expression significantly (p < 0.001) increased the ratio of GSK3beta phosphorylation at Ser9 to total GSK3beta.	p(HGNC:NDRG1)	directlyIncreases	act(p(HGNC:GSK3B))
f68c655f-0865-4096-9d10-6c6c4da21cb4	1.0	PubMed	25153349	Recently, it has been reported in colon cancer cells that GSK-3beta induced by NDRG2 overexpression causes the transcriptional de-repression of E-cadherin through the proteasomal degradation of Snail.	p(HGNC:NDRG2)	directlyIncreases	act(p(HGNC:GSK3B))
f68c655f-0865-4096-9d10-6c6c4da21cb4	1.0	PubMed	25153349	We also observed an increase in GSK-3beta activity induced by NDRG2 overexpression in MDA-MB-231 cells, but treatment with MG132, a proteasome inhibitor, did not further increase the level of Snail accumulation in NDRG2 transfectants compared to mock control cells, suggesting that NDRG2 itself did not interfere with proteosomal activity (data not shown).	p(HGNC:NDRG2)	directlyIncreases	act(p(HGNC:GSK3B))
8fb6b99f-212c-49c6-ad63-1e72631629cf	1.0	PubMed	20140245	NEFH loss activates Akt, and further inhibits the activity of Gsk3beta, leading to expression of beta-catenin in ESCC.	p(HGNC:NEFH)	directlyIncreases	act(p(HGNC:GSK3B))
54a5de6f-6cf2-413b-ab43-0d2376b96c63	1.0	PubMed	24763737	Therefore, Nek6 deficiency promoted the activation of Akt and GSK-3beta signaling in vivo.	p(HGNC:NEK6)	directlyIncreases	act(p(HGNC:GSK3B))
54a5de6f-6cf2-413b-ab43-0d2376b96c63	1.0	PubMed	24763737	Conversely, the overexpression of Nek6 prevented Ang II induced hypertrophy in H9c2 cardiomyocytes and inhibited Akt and GSK-3beta signaling in vitro.	p(HGNC:NEK6)	directlyIncreases	act(p(HGNC:GSK3B))
adffca5a-07f5-45c3-ade3-34c5b473a785	1.0	PubMed	22534782	Next, we asked whether activation of the NF-kappaB pathway mediated the oncogenic effects of GSK-3beta in osteosarcoma.	p(FPLX:NFkappaB)	directlyIncreases	act(p(HGNC:GSK3B))
adffca5a-07f5-45c3-ade3-34c5b473a785	1.0	PubMed	21110852	Since NF-kappaB is a potential target of GSK3beta dependent cell survival pathway, we detected apoptotic cells as an Annexin-V + / 7-AAD + population within DMSO or SB216763 treated malignant cells cultured ex vivo from each of the 11 patients with ALL by using Annexin-V staining and flow cytometry.	p(FPLX:NFkappaB)	directlyIncreases	act(p(HGNC:GSK3B))
6bb06257-a25c-409b-b389-6804150ef823	1.0	PubMed	PMC7055472	Chick ciliary ganglion neurons in culture lack TrkA receptors but express p75NTR and also fail to show NGF-dependent GSK3beta phosphorylation of MAP1B, whereas in rat superior cervical ganglion neurons in culture, NGF activation of TrkA receptors elicits GSK3beta phosphorylation of MAP1B. Finally, inhibition of TrkA receptor tyrosine kinase activity in PC12 cells and superior cervical ganglion neurons with K252a potently and dose-dependently inhibits neurite elongation while concomitantly blocking GSK3beta phosphorylation of MAP1B. These results suggest that the activation of GSK3beta by NGF is mediated through the TrkA tyrosine kinase receptor and not through p75NTR receptors.	p(HGNC:NGF)	directlyIncreases	act(p(HGNC:GSK3B))
6bb06257-a25c-409b-b389-6804150ef823	1.0	PubMed	7055472	These results suggest that the activation of GSK3beta by NGF is mediated through the TrkA tyrosine kinase receptor and not through p75NTR receptors.	p(HGNC:NGF)	directlyIncreases	act(p(HGNC:GSK3B))
6bb06257-a25c-409b-b389-6804150ef823	1.0	PubMed	24367683	This data is consistent with previous reports [XREF_BIBR] and indicates that NGF does not activate GSK3beta in PC12 cells.	p(HGNC:NGF)	directlyIncreases	act(p(HGNC:GSK3B))
83d882da-08d0-4d31-8051-a9be2c5aeb80	1.0	PubMed	25062958	Adenosine and spermine NONOate both increased the ratio of phospho-GSK-3beta and total GSK-3beta, and these increases were abolished by either ODQ or Rp.	a(PUBCHEM:8158)	directlyIncreases	act(p(HGNC:GSK3B))
664958e6-4068-4220-b372-acd09450b324	1.0	PubMed	19286457	A human fibronectin peptide has been shown to reorganize alphavbeta3 and alphavbeta5 integrins, to dissociate the beta1ILK complex leading to inactivation of the ILK pathway.However the activation of GSK3beta by NOV may also depend on other mechanisms.	p(HGNC:NOV)	directlyIncreases	act(p(HGNC:GSK3B))
6b50dc6e-76cb-4022-a2e7-7a423788d21b	1.0	PubMed	25412261	Hepatitis C virus NS5A protein induces beta-catenin accumulation by inactivating GSK-3beta XREF_BIBR.	p(UP:Q89613)	directlyIncreases	act(p(HGNC:GSK3B))
a0977830-b700-46c0-bafa-160236277a67	1.0	PubMed	22965877	NUB1 modulation of GSK3beta reduces tau aggregation.	p(HGNC:NUB1)	directlyIncreases	act(p(HGNC:GSK3B))
6204d48c-b5b1-440c-bd8a-f50de833e721	1.0	PubMed	14644163	To examine the effect of GSK-3beta inactivation on HUVEC proliferation by lithium, HUVECs were treated with LiCl, or NaCl as control, at the indicated concentrations for 54-66 h. HUVEC proliferation was detected using BrdU ELISA.As shown in, lithium inhibited endothelial cell proliferation in a dose dependent way.	a(PUBCHEM:5234)	directlyIncreases	act(p(HGNC:GSK3B))
818afe27-1287-467c-aabf-bcf65af4533e	1.0	PubMed	22687243	We observed (i) that both AKT and GSK-3beta were modified by O-GlcNAc and (ii) that OGT expression increased and OGT knockdown decreased the O GlcNAcylation of AKT and GSK-3beta (XREF_FIG).	p(HGNC:OGT)	directlyIncreases	act(p(HGNC:GSK3B))
ad220aa9-a1be-403f-906b-e258fdcb8635	1.0	PubMed	PMC5209970	As the activation of platelet activating factor (PAF) receptors is critical for the induction of neuronal death by several candidate HIV-1 neurotoxins, we determined whether PAF can also activate GSK-3beta.	p(PFAM:PF15715)	directlyIncreases	act(p(HGNC:GSK3B))
ad220aa9-a1be-403f-906b-e258fdcb8635	1.0	PubMed	PMC5908701	Therefore, we investigated the biological effects following activation of GSK-3beta by PAF, and whether these effects were dependent on the culture conditions of the CGNs.	p(PFAM:PF15715)	directlyIncreases	act(p(HGNC:GSK3B))
ad220aa9-a1be-403f-906b-e258fdcb8635	1.0	PubMed	PMC5908701	We show here that activation of neuronal GSK-3beta by PAF is receptor-specific, with similar kinetics of activation in both monolayer cultures of CGNs that have ceased to migrate and reaggregate cultures of CGNs that are actively migrating.	p(PFAM:PF15715)	directlyIncreases	act(p(HGNC:GSK3B))
1deeb766-512b-4527-b8c6-670839baefbd	1.0	PubMed	PMC7005206	Recombinant Csk phosphorylated and activated GSK-3beta in vitro, and GSK-3beta coprecipitated with Csk from cell lysates.	p(HGNC:PAG1)	directlyIncreases	act(p(HGNC:GSK3B))
b1711e84-e297-4d73-873c-c41aa4129f2d	1.0	PubMed	25738875	In this study, we first discovered that PARVA can activate the GSK3beta -- AP-1-MMP9 pathway in lung cancer cells.	p(HGNC:PARVA)	directlyIncreases	act(p(HGNC:GSK3B))
2ce995e5-1289-4540-85fd-1b3c9b0acbb0	1.0	PubMed	22679108	The identification of this consensus motif is highly suggestive that PAX3 might be a target of GSK-3beta.	p(HGNC:PAX3)	directlyIncreases	act(p(HGNC:GSK3B))
750b4a1d-ec48-4ffb-a63d-b22a4bddd67e	1.0	PubMed	25172662	Though Snail1 and beta-catenin are both downstream molecular of GSK-3beta, the different modulation on GSK-3beta signaling by PCDH9 and PCDH20 suggested that different members of PCDH could play diverse roles as intracellular signaling regulators.	p(HGNC:PCDH20)	directlyIncreases	act(p(HGNC:GSK3B))
750b4a1d-ec48-4ffb-a63d-b22a4bddd67e	1.0	PubMed	24910204	We then investigated which signal pathway is involved in PCDH20 mediated activation of GSK-3beta.	p(HGNC:PCDH20)	directlyIncreases	act(p(HGNC:GSK3B))
750b4a1d-ec48-4ffb-a63d-b22a4bddd67e	1.0	PubMed	24910204	To elucidate whether Erk and Akt are responsible for PCDH20 mediated activation of GSK-3beta, we detected the level change of activated Akt and Erk first in HEK 293T cells transfected with PCDH20 expressing plasmid.	p(HGNC:PCDH20)	directlyIncreases	act(p(HGNC:GSK3B))
750b4a1d-ec48-4ffb-a63d-b22a4bddd67e	1.0	PubMed	24910204	Moreover, the involvement of Akt and Erk in PCDH20 induced GSK-3beta activation and consequently Wnt signalling pathway inactivation was supported by the following experiments : constitutively, active form of H-Ras (H-Ras-V12) could activate both Akt and Erk, while co-transfecting PCDH20 with H-Ras-V12 could partially block Akt and Erk, and subsequent Wnt signalling pathway activation induced by H-Ras-V12 in HEK 293T cells.	p(HGNC:PCDH20)	directlyIncreases	act(p(HGNC:GSK3B))
8c5b62f8-07b6-4dce-aafc-d9c3beb961b5	1.0	PubMed	25172662	By contrast, knockdown of endogenous PCDH9 expression resulted in the up-regulation of phospho-Akt and Erk in Hep3B and PLC/PRF/5 cells (A), suggesting strongly that PCDH9 might activate the GSK-3beta via modulating Erks and Akt activation.HCC development is clearly a multistep process involving both the activation of oncogenes and the silencing of tumor suppressor genes.	p(HGNC:PCDH9)	directlyIncreases	act(p(HGNC:GSK3B))
8c5b62f8-07b6-4dce-aafc-d9c3beb961b5	1.0	PubMed	25172662	Though Snail1 and beta-catenin are both downstream molecular of GSK-3beta, the different modulation on GSK-3beta signaling by PCDH9 and PCDH20 suggested that different members of PCDH could play diverse roles as intracellular signaling regulators.	p(HGNC:PCDH9)	directlyIncreases	act(p(HGNC:GSK3B))
08a24634-55e4-45bd-9b1b-96abbe08edfa	1.0	PubMed	10428053	As the activation of platelet activating factor (PAF) receptors is critical for the induction of neuronal death by several candidate HIV-1 neurotoxins, we determined whether PAF can also activate GSK-3beta.	p(HGNC:PCLAF)	directlyIncreases	act(p(HGNC:GSK3B))
08a24634-55e4-45bd-9b1b-96abbe08edfa	1.0	PubMed	10428053	Application of PAF to neuronal cultures activated GSK-3beta, and coincubation with lithium ameliorated PAF induced neuronal apoptosis.	p(HGNC:PCLAF)	directlyIncreases	act(p(HGNC:GSK3B))
08a24634-55e4-45bd-9b1b-96abbe08edfa	1.0	PubMed	15936090	In addition, PAF mediated activation of GSK3beta has been shown to enhance migration and negatively affect the survival of cerebellar granule cells.	p(HGNC:PCLAF)	directlyIncreases	act(p(HGNC:GSK3B))
08a24634-55e4-45bd-9b1b-96abbe08edfa	1.0	PubMed	5209970	As the activation of platelet activating factor (PAF) receptors is critical for the induction of neuronal death by several candidate HIV-1 neurotoxins, we determined whether PAF can also activate GSK-3beta.	p(HGNC:PCLAF)	directlyIncreases	act(p(HGNC:GSK3B))
08a24634-55e4-45bd-9b1b-96abbe08edfa	1.0	PubMed	5209970	Application of PAF to neuronal cultures activated GSK-3beta, and coincubation with lithium ameliorated PAF induced neuronal apoptosis.	p(HGNC:PCLAF)	directlyIncreases	act(p(HGNC:GSK3B))
08a24634-55e4-45bd-9b1b-96abbe08edfa	1.0	PubMed	5908701	Therefore, we investigated the biological effects following activation of GSK-3beta by PAF, and whether these effects were dependent on the culture conditions of the CGNs.	p(HGNC:PCLAF)	directlyIncreases	act(p(HGNC:GSK3B))
df90fa23-ca48-4e31-96b7-13e64e48eff0	1.0	PubMed	23922881	In the present study, we found that GSPB2 and overexpression of PIMT significantly attenuated the gly-LDL-induced decrease of phospho- GSK3beta.	p(HGNC:PCMT1)	directlyIncreases	act(p(HGNC:GSK3B))
a004d795-6725-4a07-bb0c-aa6f3aa8d92b	1.0	PubMed	18973553	Nuclear translocation of NF-kappaB, which lies downstream of GSK-3beta, however, remained unaffected in cells treated with PDGF.	p(FPLX:PDGF)	directlyIncreases	act(p(HGNC:GSK3B))
510a31c4-8182-4d5e-aa9a-738e41136f81	1.0	PubMed	22200892	While PDGF-BB activated p44 and p42 MAPK, SAPK and JNK, Akt and GSK-3beta, but not p38 MAPK (XREF_FIG), pretreatment with UVC significantly inhibited PDGF-BB-induced phosphorylation of Akt and GSK-3beta in these cells.	p(FPLX:"PDGF_BB")	directlyIncreases	act(p(HGNC:GSK3B))
60341e46-73e5-42a4-ad8d-7f2c019885e9	1.0	PubMed	23077641	In SH-SY5Y cells transfected with WT GSK3beta (XREF_FIG), as expected, PDGF-CC induced neuroprotection against Tat, however, in cells transfected with the serine mutant of GSK3beta (XREF_FIG), PDGF-CC failed to induce inactivation of GSK3beta, thereby resulting in failure of the ability of PDGF-CC to induce neuroprotection.	p(FPLX:"PDGF_CC")	directlyIncreases	act(p(HGNC:GSK3B))
60341e46-73e5-42a4-ad8d-7f2c019885e9	1.0	PubMed	23784143	PDGF-CC via its binding to the cognate receptor mediated inactivation of the downstream mediator (GSK3beta with its phosphorylation at Ser 9).	p(FPLX:"PDGF_CC")	directlyIncreases	act(p(HGNC:GSK3B))
ef222a20-7b04-4e61-9a11-53e4e9b1a819	1.0	PubMed	22279539	RKIP has been shown to inhibit the Raf-MEK-ERK, NFkappaB, GRK and activate the GSK3beta signaling pathways.	p(HGNC:PEBP1)	directlyIncreases	act(p(HGNC:GSK3B))
9f59db3f-c252-4279-9129-70d5712bdfea	1.0	PubMed	22276108	The activation of Akt can trigger many downstream signaling cascades, and in colon cancer PGE 2 has been shown to activate Akt and the downstream pathway of GSK-3beta and beta-catenin resulting in an increased proliferation, whereas an increased survival was due to Akt activation of PPARdelta XREF_BIBR, XREF_BIBR.	a(CHEBI:73965)	directlyIncreases	act(p(HGNC:GSK3B))
9f59db3f-c252-4279-9129-70d5712bdfea	1.0	PubMed	25266063	Stimulation of neuroblastoma cells with forskolin or PGE 2 increased p-GSK3beta (ser9) and elevated levels of unphosphorylated beta-catenin at the GSK3beta residues.	a(CHEBI:73965)	directlyIncreases	act(p(HGNC:GSK3B))
9f3b13f8-d428-4e21-83eb-8d604783aac5	1.0	PubMed	26183061	As previously reported, the stable overexpression of the constitutively active PI3K mutants PIK3CA p110alpha E545K or H1047R induced pAKT and pGSK3beta, with simultaneous stabilization of MKRN1 and destabilization of PTEN (XREF_FIG) XREF_BIBR XREF_BIBR.	p(FPLX:PI3K, var(p.?))	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	21160051	In addition, blockade of PI3K using LY294002 resulted in abrogation of the capacity of IFN-beta to reduce GSK3-beta activity (XREF_FIG).	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	23806081	PI3K and Akt is known to promote EMT by regulating the activity of GSK3beta, which targets Snail for degradation by suppressing NF-kappaB-dependent Snail expression [XREF_BIBR, XREF_BIBR].	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	21516346	It has been shown that during glucose deprivation, attenuated PI3K and PKB signals activate GSK3beta, which targets Mcl-1 to the proteasome [XREF_BIBR, XREF_BIBR].	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	18243161	Pharmacological inhibitor of PI3K, LY294002, abrogated this GSK-3beta inactivation downstream of LPS, suggesting that PI3K and Akt may negatively modulate GSK-3beta thereby inactivating p65 transactivation downstream of LPS.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	18243161	Pharmacological inhibitor of PI3K, LY294002, abrogated this GSK-3beta inactivation downstream of LPS, suggesting that PI3K and Akt may negatively modulate GSK-3beta thereby inactivating p65 transactivation downstream of LPS.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	21329734	Inhibition of PI3-kinase by the inhibitor LY293002 also inhibits visfatin induced activation of mTOR and visfatin induced inactivation of GSK3beta.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	16507111	Our data strongly suggests that PI3K activity links to the Notch signalling pathway through Akt mediated inactivation of GSK3beta, a known downstream effector of Akt.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	21777419	Inhibition of PI3K activity (LY294002) in A431 tumor cells attenuated the TG2 induced activation of Akt and GSK-3beta, and suppressed the increases in Snail, MMP-9, and cell motility.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	19734233	Inhibition of PI3K prevented the inactivation of GSK3beta by IL-12p70, as well as the subsequent ability of IL-12p70 to augment IL-10 levels by memory CD4 + T cells.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	19734233	In this regard, we show that IL-12 activates PI3K in human memory CD4 + T cells and that the subsequent PI3K mediated inactivation of the downstream kinase GSK3beta is required for IL-12 to promote IL-10 production from memory CD4 + T cells.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	5596638	Stimulation with NGF resulted in PI 3-kinase-dependent phosphorylation of GSK-3 beta and inhibition of its protein kinase activity, indicating that GSK-3 beta is targeted by PI 3-kinase/Akt in these neurons.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	18769147	Here we show that inhibition of PI3-K and Akt induces a 40% decrease of cyclin D1 half-life as a result of accumulation of the dephosphorylated and active form of GSK-3beta within the nucleus, where this kinase can phosphorylate cyclin D1 on Thr286 thereby promoting its nuclear export.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
3a4396ca-0cb9-4f86-ba01-c71893abb8d5	1.0	PubMed	19180470	The blockade of PI3K with LY294002 prevented the inactivation of GSK-3beta after the addition of anti-CD16.	p(FPLX:PI3K)	directlyIncreases	act(p(HGNC:GSK3B))
bcc5d4d9-7e0a-4789-af0c-f01d7df3b5a3	1.0	PubMed	19116273	APC also induced phosphorylation of Ser 9 in glycogen synthase kinase 3beta (GSK3beta), which was blocked by the PI3K inhibitor LY294002.	a(CHEBI:84801)	directlyIncreases	act(p(HGNC:GSK3B))
496f6f40-acbf-44bc-a436-03b45139a470	1.0	PubMed	23710442	DEX also facilitates the normal binding between CD2AP and p85, which activates PI3K, Akt, and GSK3beta and exerts antiapoptotic effects on podocytes.	complex(p(FPLX:"PI3K_p85"), p(HGNC:CD2AP))	directlyIncreases	act(p(HGNC:GSK3B))
ffc6b044-c69d-4dec-87b7-53f20254c0ec	1.0	PubMed	24001613	Our finding that Nir1 binding to CCL18 regulated PI3K and Akt activity and consequently promoted GSK3beta activity suggests that Nir1 binding to CCL18 may also contribute to the various functions and phenotypes modulated by PI3K and Akt and GSK3beta.	complex(p(HGNC:PITPNM3), p(HGNC:CCL18))	directlyIncreases	act(p(HGNC:GSK3B))
3a609651-5b4e-475a-9061-66c295aa787b	1.0	PubMed	21298039	Furthermore, a decrease in PKC activation leads to enhanced levels of phosphorylated tau through a reduced PKC mediated inhibition of GSK-3b XREF_BIBR.	p(FPLX:PKC)	directlyIncreases	act(p(HGNC:GSK3B))
3a609651-5b4e-475a-9061-66c295aa787b	1.0	PubMed	11903055	Overexpression of GSK-3 beta inhibited transactivation by hnRNP D, but stimulation of PKC negated the inhibitory effect of GSK-3 beta.	p(FPLX:PKC)	directlyIncreases	act(p(HGNC:GSK3B))
3a609651-5b4e-475a-9061-66c295aa787b	1.0	PubMed	25412261	Notably, PKC induced GSK-3beta inactivation facilitates the expression of IL-10 following LPS stimulation XREF_BIBR.	p(FPLX:PKC)	directlyIncreases	act(p(HGNC:GSK3B))
3a609651-5b4e-475a-9061-66c295aa787b	1.0	PubMed	6252558	Overexpression of GSK-3 beta inhibited transactivation by hnRNP D, but stimulation of PKC negated the inhibitory effect of GSK-3 beta.	p(FPLX:PKC)	directlyIncreases	act(p(HGNC:GSK3B))
291fcd45-093b-44b6-ade9-3018fb0ead94	1.0	PubMed	17671167	Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta dependent cell cell mechanical adhesion.	p(HGNC:PKD1)	directlyIncreases	act(p(HGNC:GSK3B))
a3548b29-765e-4cf5-99e0-76546e42da86	1.0	PubMed	18940913	Similarly, treatment with beta1P1 peptide, but not the scrambled control, inhibited uPA activation of ERK, Akt, GSK-3beta and Stat1 in WT cells (XREF_FIG), further confirming that uPAR-beta1-integrin interaction is crucial to uPA-uPAR signaling.	p(HGNC:PLAU)	directlyIncreases	act(p(HGNC:GSK3B))
17967863-2344-446a-8fcd-c0635c2c3fb5	1.0	PubMed	19472218	PLTP increases levels of inactive form of GSK3beta (pGSK3beta Ser9) in human neuronal cells.	p(HGNC:PLTP)	directlyIncreases	act(p(HGNC:GSK3B))
17967863-2344-446a-8fcd-c0635c2c3fb5	1.0	PubMed	19472218	These data suggest that PLTP increases the amount of the inactive form of GSK3beta in HCN2 cells.	p(HGNC:PLTP)	directlyIncreases	act(p(HGNC:GSK3B))
17967863-2344-446a-8fcd-c0635c2c3fb5	1.0	PubMed	19472218	In this study, we provide evidence that PLTP significantly reduces levels of tau phosphorylated at residues phosphorylated by GSK3beta, and increases levels of the inactive form of GSK3beta in vitro.	p(HGNC:PLTP)	directlyIncreases	act(p(HGNC:GSK3B))
e515ba75-b131-4f5d-99a2-3afde8e3c189	1.0	PubMed	26021267	Western blot analysis illustrated that periostin overexpression increased the expression of EMT associated factors, and periostin overexpression activated Akt and GSK-3beta, which could be inhibited using a PI3K inhibitor.	p(HGNC:POSTN)	directlyIncreases	act(p(HGNC:GSK3B))
a44b38e0-ff75-4667-8744-384f41b99464	1.0	PubMed	21316358	Similarly, in a variety of models for inflammation, SB216763 and TDZD-8 have been shown to increase phospho-GSK3beta-Ser 9 associated with decreased GSK3beta activity via yet to be described pathways (XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR); however, inhibition of GSK3beta-Ser 9 dependent activation of PP2a may prevent the feed-forward continued activation of GSK3beta.	p(HGNC:PPP2CA)	directlyIncreases	act(p(HGNC:GSK3B))
e28ec53c-0349-43da-81c2-1833017c2df6	1.0	PubMed	20352103	PP2A has been previously shown to reactivate GSK3beta through dephosphorylation of Ser 9 XREF_BIBR, XREF_BIBR.	p(FPLX:PPP2)	directlyIncreases	act(p(HGNC:GSK3B))
e28ec53c-0349-43da-81c2-1833017c2df6	1.0	PubMed	20352103	Indeed, inhibition of alpha 5 beta 1 and PP2A by siRNA or pharmacological drugs induced an increase of the Ser 9 phosphorylated inhibited form of GSK3beta.	p(FPLX:PPP2)	directlyIncreases	act(p(HGNC:GSK3B))
e28ec53c-0349-43da-81c2-1833017c2df6	1.0	PubMed	26655089	Inhibition of PP2A alone (by 2 nM Oka), however, did not inhibit or activate PP1 or GSK3beta.	p(FPLX:PPP2)	directlyIncreases	act(p(HGNC:GSK3B))
e28ec53c-0349-43da-81c2-1833017c2df6	1.0	PubMed	25219467	Upregulation of GSK-3beta enhances PP2A activity through methylation of PP2A via PME-1 and/or LCMT-1; PP2A elevates GSK-3beta activity via reduction of its phosphorylation.	p(FPLX:PPP2)	directlyIncreases	act(p(HGNC:GSK3B))
cb3dd2a8-d28c-4062-b5d5-d1b83727a3bc	1.0	PubMed	23026200	GSK-3beta activity might be modulated by PS1 and has been involved in APP processing.	p(HGNC:PSEN1)	directlyIncreases	act(p(HGNC:GSK3B))
cb3dd2a8-d28c-4062-b5d5-d1b83727a3bc	1.0	PubMed	6878925	Thus PS1 appears to modulate GSK3beta activity and the release of kinesin-I from MBOs at sites of vesicle delivery and membrane insertion.	p(HGNC:PSEN1)	directlyIncreases	act(p(HGNC:GSK3B))
cb3dd2a8-d28c-4062-b5d5-d1b83727a3bc	1.0	PubMed	12805290	Thus PS1 appears to modulate GSK3beta activity and the release of kinesin-I from MBOs at sites of vesicle delivery and membrane insertion.	p(HGNC:PSEN1)	directlyIncreases	act(p(HGNC:GSK3B))
cb3dd2a8-d28c-4062-b5d5-d1b83727a3bc	1.0	PubMed	12095675	Mutations in the presenilin 1 (PS1) gene seen in familial Alzheimer 's disease, increase the ability of PS1 to bind GSK-3beta ().	p(HGNC:PSEN1)	directlyIncreases	act(p(HGNC:GSK3B))
c7896a5c-da83-4c5e-893e-aba12779c2b3	1.0	PubMed	24391209	miR-21 silencing of PTEN inhibited GSK3beta implicated in NFkappaB activation and inducible TNFalpha expression.	p(HGNC:PTEN)	directlyIncreases	act(p(HGNC:GSK3B))
c7896a5c-da83-4c5e-893e-aba12779c2b3	1.0	PubMed	25409150	As expected, induction of PTEN downregulation led to activation of AKT and the downstream effectors PRAS40, GSK3beta and S6 in both T47D (XREF_FIG) and MCF7 (data not shown) cells under basal conditions.	p(HGNC:PTEN)	directlyIncreases	act(p(HGNC:GSK3B))
c7896a5c-da83-4c5e-893e-aba12779c2b3	1.0	PubMed	24143235	A constitutively high concentrations of nuclear beta-catenin was reported in PTEN-null prostate cancer cell lines, and a re-expression of PTEN in those cells resulted in activation of GSK-3beta and degradation of beta-catenin [XREF_BIBR].	p(HGNC:PTEN)	directlyIncreases	act(p(HGNC:GSK3B))
c7896a5c-da83-4c5e-893e-aba12779c2b3	1.0	PubMed	24143235	A constitutively high concentrations of nuclear beta-catenin was reported in PTEN-null prostate cancer cell lines, and a re-expression of PTEN in those cells resulted in activation of GSK-3beta and degradation of beta-catenin [XREF_BIBR].	p(HGNC:PTEN)	directlyIncreases	act(p(HGNC:GSK3B))
c7896a5c-da83-4c5e-893e-aba12779c2b3	1.0	PubMed	22864622	GSK-3beta also regulates the F-box protein FBXW7 to induce degradation of Aurora-A; this process is impaired in cancer, after loss of the tumor suppressor PTEN causes inhibition of AKT and GSK-3beta [XREF_BIBR].	p(HGNC:PTEN)	directlyIncreases	act(p(HGNC:GSK3B))
c7896a5c-da83-4c5e-893e-aba12779c2b3	1.0	PubMed	25596747	These results indicate that inhibition of PTEN by phosphorylation could activate PI3K and Akt signaling and subsequent GSK3beta inhibition, which in the end activate Wnt and beta-catenin signaling and promote the growth of colon tumor cells.	p(HGNC:PTEN)	directlyIncreases	act(p(HGNC:GSK3B))
5c200ee1-c683-40d3-b23c-46f779b48b6b	1.0	PubMed	25575814	We recently reported that COX-2 and PGE2 induces Akt and GSK-3beta and wnt signaling (beta-catenin and T-cell factor and lymphoid enhancer factor) to increase MIG-7 that inhibits protein phosphatase 2A (PP2A) to positively feedback on Akt and GSK-3beta signaling and sustain cancer cell migration and invasion [XREF_BIBR].	p(HGNC:PTGER4)	directlyIncreases	act(p(HGNC:GSK3B))
da84b876-93c2-4af2-a24f-62b66f659dff	1.0	PubMed	25575814	We recently reported that COX-2 and PGE2 induces Akt and GSK-3beta and wnt signaling (beta-catenin and T-cell factor and lymphoid enhancer factor) to increase MIG-7 that inhibits protein phosphatase 2A (PP2A) to positively feedback on Akt and GSK-3beta signaling and sustain cancer cell migration and invasion [XREF_BIBR].	p(HGNC:PTGS2)	directlyIncreases	act(p(HGNC:GSK3B))
6044ef67-18af-4d9b-b512-bbc35277baea	1.0	PubMed	23661004	PTP1B modulates GSK3beta and SKF mediated Nrf2 nuclear accumulation in APAP treated mouse hepatocytes.	p(HGNC:PTPN1)	directlyIncreases	act(p(HGNC:GSK3B))
6044ef67-18af-4d9b-b512-bbc35277baea	1.0	PubMed	23661004	These results suggest that PTP1B might activate this unknown kinase upstream from GSK3beta, probably by dephosphorylation, and thereby triggering the activation of the GSK3beta and Src-Fyn axis that ultimately leads to Nrf2 degradation.	p(HGNC:PTPN1)	directlyIncreases	act(p(HGNC:GSK3B))
6044ef67-18af-4d9b-b512-bbc35277baea	1.0	PubMed	23661004	Therefore, cytokine mediated increases in PTP1B expression might enhance the GSK3beta and Src-Fyn axis, resulting in increased Nrf2 tyrosine phosphorylation and a rapid nuclear exclusion.	p(HGNC:PTPN1)	directlyIncreases	act(p(HGNC:GSK3B))
296f2652-1806-428b-8eb4-d351ac6c3d47	1.0	PubMed	23100427	We found that lentiviral shRNAi knockdown of PTPRZ1 substantially augmented the GSK3beta inhibition associated, TCF regulated transcription of a luciferase reporter; this observation suggested the importance of PTPRZ1 as a brake on TCF dependent gene expression.	p(HGNC:PTPRZ1)	directlyIncreases	act(p(HGNC:GSK3B))
08008896-2132-480e-b919-118f2550b5da	1.0	PubMed	23661004	Protein tyrosine phosphatase 1B modulates GSK3beta and Nrf2 and IGFIR signaling pathways in acetaminophen induced hepatotoxicity.	p(FPLX:Phosphatase)	directlyIncreases	act(p(HGNC:GSK3B))
bcc4948d-ec1c-46c8-8e1e-53f1759926ef	1.0	PubMed	25941117	We have previously shown that acute proteasome inhibition produced a consistent and dose dependent inhibition of the GSK-3beta protein in the tumor cell line MCF7 but not in the normal mammary cell line MCF10A XREF_BIBR.	p(FPLX:Proteasome)	directlyIncreases	act(p(HGNC:GSK3B))
bcc4948d-ec1c-46c8-8e1e-53f1759926ef	1.0	PubMed	25401330	When CTNNB1 mutations occurred, the functional residues of beta-catenin may be affected so that the targets usually become invalid of priming phosphorylation by GSK-3beta and subsequent catalyzation by proteasome system XREF_BIBR.	p(FPLX:Proteasome)	directlyIncreases	act(p(HGNC:GSK3B))
9371415f-3db6-4176-8799-826c56a4e0f6	1.0	PubMed	20352103	Whether RACK1 directly regulates PP2A activity or targets GSK3beta and PP2A catalytic and regulatory subunits to specific locations is an open question.	p(HGNC:RACK1)	directlyIncreases	act(p(HGNC:GSK3B))
9371415f-3db6-4176-8799-826c56a4e0f6	1.0	PubMed	21725365	In leukemic progenitors from female but not male patients, the scaffolding protein RACK1, activated downstream of alpha (5) beta (1)-integrin engagement, was specifically upregulated and controlled GSK3beta activation through the phosphatase protein phosphatase 2A (PP2A).	p(HGNC:RACK1)	directlyIncreases	act(p(HGNC:GSK3B))
9371415f-3db6-4176-8799-826c56a4e0f6	1.0	PubMed	24000012	Our data collectively suggest that RACK1 contributes to THP1 cell proliferation through, at least partially, enhancing GSK3beta activity.	p(HGNC:RACK1)	directlyIncreases	act(p(HGNC:GSK3B))
831ea39c-ee59-498d-a961-6079b14555f7	1.0	PubMed	21441955	In fact, overexpression of dn-ETS not only reduced the basal GSK-3beta transcription with mutant K-Ras, but also abolished the Ras induced superactivation of GSK-3beta in pancreatic cancer cells with wild type Ras.	p(FPLX:RAS)	directlyIncreases	act(p(HGNC:GSK3B))
831ea39c-ee59-498d-a961-6079b14555f7	1.0	PubMed	21441955	These data suggest that ETS1 and ETS2 are the major ETS members mediating Ras and MAPK activation of GSK-3beta in PDA.	p(FPLX:RAS)	directlyIncreases	act(p(HGNC:GSK3B))
8c600fad-ed25-45c4-a02d-0346187ad571	1.0	PubMed	21876249	Induction of GSK3beta by RCAN1, however, had previously only been tested in a very artificial system, via overexpression of an RCAN1 transgene, with a tet-off inducible promoter, in PC12 cells [XREF_BIBR].	p(HGNC:RCAN1)	directlyIncreases	act(p(HGNC:GSK3B))
8c600fad-ed25-45c4-a02d-0346187ad571	1.0	PubMed	21680892	We propose that the mechanism by which stress can lead to these diseases involves the inhibition of calcineurin and the induction of GSK-3beta by RCAN1 proteins.	p(HGNC:RCAN1)	directlyIncreases	act(p(HGNC:GSK3B))
12aa78d0-f76b-4924-b864-365400f26b3c	1.0	PubMed	26935904	ROS activated GSK-3beta induces VEGFR-2 degradation in HUVECs.	p(HGNC:ROS1)	directlyIncreases	act(p(HGNC:GSK3B))
12aa78d0-f76b-4924-b864-365400f26b3c	1.0	PubMed	26935904	As is well known, phosphorylated GSK-3beta acts as an inactivated form, and decreased phosphorylated GSK-3beta upon exposure to GO, as shown in XREF_FIG, was noted; this signified that GSK-3beta was enhanced by excess ROS.	p(HGNC:ROS1)	directlyIncreases	act(p(HGNC:GSK3B))
12aa78d0-f76b-4924-b864-365400f26b3c	1.0	PubMed	21875573	For example, p38 alpha MAP kinase is activated by ROS during Ras oncogene induced malignant transformation, and activation of GSK3B by ROS is a critical step in autophagy induction by cadmium in MES-13 mesangial cells.	p(HGNC:ROS1)	directlyIncreases	act(p(HGNC:GSK3B))
8de467b6-a29a-4b8d-b0fb-f9a8a48db683	1.0	PubMed	23959174	RPN2 knockdown promoted GSK3beta mediated suppression of heat shock proteins that are essential for mtp53 stabilization.	p(HGNC:RPN2)	directlyIncreases	act(p(HGNC:GSK3B))
01038e13-f25a-44bc-8845-3872b5a5bd78	1.0	PubMed	17107957	Ectopic expression of R-Ras induced global inactivation of GSK-3beta and formation of multiple axons, whereas knockdown of endogenous R-Ras by RNA interference blocked GSK-3beta inactivation and axon formation.	p(HGNC:RRAS)	directlyIncreases	act(p(HGNC:GSK3B))
783cfa50-dae0-45dd-97ed-0d2cca6f653c	1.0	PubMed	16039586	Like HBX in hepatoma, HER2 and IGF-1 in breast cancer cells can also upregulate beta-catenin through inactivation of GSK-3beta via Ser9 phosphorylation by the Erk and RSK pathway.	p(FPLX:RSK)	directlyIncreases	act(p(HGNC:GSK3B))
4fb8ba9c-9a73-4eff-9c7d-7a7606fef2e7	1.0	PubMed	18606491	Rapamycin is known to activate GSK3beta; it enhances a chemotherapy drug paclitaxel induced apoptosis in GSK3beta wild-type, but not in GSK3beta null breast cancer cells, indicating that GSK3beta mediates rapamycin induced chemosensitivity.	a(CHEBI:9168)	directlyIncreases	act(p(HGNC:GSK3B))
5472c657-666f-4cd2-993a-497cd720b9ee	1.0	PubMed	24975844	S100A4 could increase GSK3beta kinase activity via the down-regulation of Akt1 activity, forming a negative feedback loop between S100A4 and beta-catenin.	p(HGNC:S100A4)	directlyIncreases	act(p(HGNC:GSK3B))
f87ecf8b-a0b9-4f5b-9876-3344853513f3	1.0	PubMed	22095718	Following 24 hr incubation, the highest concentration of S100B (5 muM) significantly reduced total beta-catenin levels, and S100B activated GSK-3beta in SH-SY5Y cells in a concentration dependent manner (XREF_FIG).	p(HGNC:S100B)	directlyIncreases	act(p(HGNC:GSK3B))
f87ecf8b-a0b9-4f5b-9876-3344853513f3	1.0	PubMed	22095718	S100B mediated activation of GSK-3beta in a cell culture model.	p(HGNC:S100B)	directlyIncreases	act(p(HGNC:GSK3B))
0baf734a-f472-479a-8f56-966090f08496	1.0	PubMed	22081448	Protein analysis of cell lysates harvested at day 21 revealed that treatment with either 10 or 30 microM SB415286 increased GSK3beta Serine 9 protein phosphorylation (XREF_FIG B).	a(PUBCHEM:4210951)	directlyIncreases	act(p(HGNC:GSK3B))
9d1931cc-6631-4e18-a30e-07c6c0a453b4	1.0	PubMed	25963821	Treating wild-type neuronal cultures with two distinct siRNAs targeting GSK3beta or with the selective GSK-3 inhibitor SB 415286 (XREF_BIBR; XREF_BIBR) prevented Abeta induced axonal transport deficits without affecting axonal transport in the absence of Abeta oligomers (XREF_FIG).	a(PUBCHEM:4210951)	directlyIncreases	act(p(HGNC:GSK3B))
eecbcfc8-c926-46f9-9621-0debc431c2c0	1.0	PubMed	26822034	Thus, DSBs generated in B cells undergoing CSR selectively cause the inactivation of nuclear GSK3beta through phosphorylation on Ser 389.	p(HGNC:SCARA3)	directlyIncreases	act(p(HGNC:GSK3B))
bcea5974-6c89-4945-a7cd-958ca91bf8a6	1.0	PubMed	25528666	These results suggest that GSK3beta is involved in Sema3A induced acceleration of antero- and retrograde axonal transport.We further examined the mechanism by which GSK3beta mediates Sema3A induced acceleration of axonal transport by using several GSK3beta mutants ().	p(HGNC:SEMA3A)	directlyIncreases	act(p(HGNC:GSK3B, var(p.?)))
25ff8385-8fa9-4cf7-a974-fc722c045d3e	1.0	PubMed	22933777	These results suggest that Sema3A induces the formation of GSK3beta, Axin-1, beta, and catenin complex, which regulates signaling cascade of Sema3A via an endocytotic mechanism.	p(HGNC:SEMA3A)	directlyIncreases	act(p(HGNC:GSK3B))
25ff8385-8fa9-4cf7-a974-fc722c045d3e	1.0	PubMed	25528666	We recently reported that Sema3A induces the formation of GSK3beta, Axin-1, beta, and catenin complex, which regulates signaling cascade of Sema3A via an endocytic mechanism ().	p(HGNC:SEMA3A)	directlyIncreases	act(p(HGNC:GSK3B))
aa1bb42c-ee67-46ac-ac8c-efd90e2a2c04	1.0	PubMed	23927957	Consistent with previous reports, we also found that a Wnt signalling antagonist such as sFRP1 restores GSK3beta activity, which phosphorylates the linker region of Smad3 and inhibited its transcriptional activity.	p(HGNC:SFRP1)	directlyIncreases	act(p(HGNC:GSK3B))
211efc3f-f4d5-4eec-9148-237bcc49b78c	1.0	PubMed	26456864	Inactivation of Shh activates GSK3beta activity leading to N-myc phosphorylation that enhances final degradation [XREF_BIBR].	p(HGNC:SHH)	directlyIncreases	act(p(HGNC:GSK3B))
860fdee2-0903-4f8e-8b8e-87dc649cf287	1.0	PubMed	24899689	To our surprise, SIS3 administration nearly abolished the detrimental phenotype of GSK-3beta deletion as evidenced by restored ventricular function and chamber dimensions (XREF_FIG).	p(UP:Q8GYT9)	directlyIncreases	act(p(HGNC:GSK3B))
8a179cad-7836-49cc-b1e3-248989e75e68	1.0	PubMed	23919497	We provide evidence for a mechanism where ZIP6 induced zinc influx inactivates GSK-3beta, enabling unphosphorylated Snail in the nucleus to down-regulate adherence genes such as E-cadherin, causing loss of cell adherence.	p(HGNC:SLC39A6)	directlyIncreases	act(p(HGNC:GSK3B))
537ea892-7ae3-4cee-81a1-e501801705bc	1.0	PubMed	18045539	In vitro phosphorylations were performed in two stages, and it was found that GSK3beta caused the incorporation of [gamma-P] ATP by Smad1 linker protein, but only after prephosphorylation by Erk and MAPK (K, compare lanes 2 and 4).	p(HGNC:SMAD1)	directlyIncreases	act(p(HGNC:GSK3B))
e85148de-3781-4c67-8159-e642ce8c4640	1.0	PubMed	26336990	Snail increased the phosphorylation level of GSK-3beta, the protein level of beta-catenin but decreased DAB2IP expression in SW480 cells, while reintroduction of beta-Trap in Snail expressing SW480 cells accelerated the degradation of Snail and subsequently induced up-regulation of DAB2IP, activation of GSK-3beta and down-regulation of beta-catenin (XREF_SUPPLEMENTARY).	p(HGNC:SNAI1)	directlyIncreases	act(p(HGNC:GSK3B))
1ab91bcd-3ca0-49b3-bce8-eb593f71180d	1.0	PubMed	27343974	Nevertheless, some studies have reported that alpha-synuclein, known to interact with Abeta potentiating its toxicity, activated GSK3beta through Tyr216 phosphorylation with parallel tau hyperphosphorylation at Ser396 and that specific inhibition of pGSK3betaTyr216 prevented tau phosphorylation.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:GSK3B))
1ab91bcd-3ca0-49b3-bce8-eb593f71180d	1.0	PubMed	25829335	On the other hand, by decreasing Ser9 phosphorylation and elevating Tyr216 phosphorylation, alpha-Synuclein stimulates GSK-3beta activity and inhibition of GSK-3beta abrogates alpha-Synuclein mediated neurotoxicity ().	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:GSK3B))
1ab91bcd-3ca0-49b3-bce8-eb593f71180d	1.0	PubMed	21445308	Moreover, in previous studies, we have found that alpha-Syn can recruit p-GSK-3beta through a direct physical protein : protein interaction to mediate the hyperphosphorylation of Tau, and that activation of p-GSK-3beta by alpha-Syn precedes formation of p-Tau in vitro XREF_BIBR.	p(HGNC:SNCA)	directlyIncreases	act(p(HGNC:GSK3B))
3f238483-0c13-4294-90e1-4afe2e20a235	1.0	PubMed	21927024	This finding may fit with a recent report that Sox2 could be a target of GSK3beta in Wnt dependent protein metabolism (XREF_BIBR).	p(HGNC:SOX2)	directlyIncreases	act(p(HGNC:GSK3B))
c7e1e557-59ec-4f15-b3b1-472a86374297	1.0	PubMed	26280346	Higher matrix stiffness upregulates OPN expression in HCC cells and activates the GSK3beta and beta-catenin signaling pathway in vitro.	p(HGNC:SPP1)	directlyIncreases	act(p(HGNC:GSK3B))
c7e1e557-59ec-4f15-b3b1-472a86374297	1.0	PubMed	26280346	Knock-down of integrin beta1 suppressed OPN expression and attenuated GSK3beta and beta-catenin pathway activation, as shown in XREF_FIG.	p(HGNC:SPP1)	directlyIncreases	act(p(HGNC:GSK3B))
f62e4dd0-9486-4b1c-bdda-54ef92ca2dae	1.0	PubMed	24606125	Because SSTR3 WT transfectants exhibit increased Pit-1 phosphorylation at serine residues as well as decreased occupancy of Pit-1 on the rGH promoter, the results suggest that GSK3-beta activation by constitutive SSTR3 activity may mediate GH inhibition through Pit-1 phosphorylation and thus inhibition of GH transcription.	p(HGNC:SSTR3)	directlyIncreases	act(p(HGNC:GSK3B))
f62e4dd0-9486-4b1c-bdda-54ef92ca2dae	1.0	PubMed	24606125	Because GSK3-beta phosphorylation at serine 9 inhibits kinase activity (XREF_BIBR), our results suggest that constitutive SSTR3 signaling increases GSK3-beta activity; appropriately, the classic GSK3-beta substrate beta-catenin exhibits increased phosphorylation at the characterized GSK3-beta target sites in ligand-free GpSSTR3 WT.	p(HGNC:SSTR3)	directlyIncreases	act(p(HGNC:GSK3B))
74df18fb-e81a-4981-a58f-4e311df6c7ae	1.0	PubMed	15731909	Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.	p(HGNC:STK11, var(p.?))	directlyIncreases	act(p(HGNC:GSK3B))
cbd9b069-56f0-44f7-bdbd-b6787e908a60	1.0	PubMed	20333643	LPLI could inhibit the activation of GSK-3beta, Bax, and caspase-3 induced by STS.	p(HGNC:STS)	directlyIncreases	act(p(HGNC:GSK3B))
832e56d2-7cff-401a-beea-9dbdc41a7bad	1.0	PubMed	25114899	Interestingly, we found that high concentration of Sal increased pAkt, pGSK3beta, pTSC2, and p4EBP1.	a(PUBCHEM:54675850)	directlyIncreases	act(p(HGNC:GSK3B))
832e56d2-7cff-401a-beea-9dbdc41a7bad	1.0	PubMed	25114899	In addition, Sal induced activation of GSK3beta, TSC2, and 4EBP1 was abolished by MK-2206 cotreatment.	a(PUBCHEM:54675850)	directlyIncreases	act(p(HGNC:GSK3B))
832e56d2-7cff-401a-beea-9dbdc41a7bad	1.0	PubMed	25114899	Cotreatment with MK-2206 Reduced Sal Activated GSk3beta, TSC2, and 4EBP1.	a(PUBCHEM:54675850)	directlyIncreases	act(p(HGNC:GSK3B))
832e56d2-7cff-401a-beea-9dbdc41a7bad	1.0	PubMed	25114899	Interestingly, as previously observed for pAkt (XREF_FIG), the high concentration of Sal also increased pGSK3beta, pTSC2, and p4EBP1 (XREF_FIG).	a(PUBCHEM:54675850)	directlyIncreases	act(p(HGNC:GSK3B))
832e56d2-7cff-401a-beea-9dbdc41a7bad	1.0	PubMed	25114899	Cotreatment with LY294002 Reduced Sal Activated GSk3beta, TSC2, and 4EBP1.	a(PUBCHEM:54675850)	directlyIncreases	act(p(HGNC:GSK3B))
99fb099c-14d9-47c8-9492-f9a194e4b1e2	1.0	PubMed	21949350	Finally, we report that mutant TDP-43 Q331K strongly increases GSK-3beta activity and that reducing GSK-3beta (sgg) expression strongly suppresses TDP-43 and Abeta42 toxicity.	p(HGNC:TARDBP, var(p.Gln331Lys))	directlyIncreases	act(p(HGNC:GSK3B))
99fb099c-14d9-47c8-9492-f9a194e4b1e2	1.0	PubMed	21949350	A very strong increase in GSK-3beta activity induced by TDP-43 Q331K was observed, as indicated by reduced levels of pGSK-3beta [Ser9].	p(HGNC:TARDBP, var(p.Gln331Lys))	directlyIncreases	act(p(HGNC:GSK3B))
7f5b3b43-4ec2-4b27-ad04-8bdb7028f859	1.0	PubMed	21949350	However, to our knowledge, this report is the first to demonstrate that mutant TDP-43 expression strongly induces GSK-3beta activity and that reduction in GSK-3beta and shaggy can suppress TDP-43 toxicity.	p(HGNC:TARDBP, var(p.?))	directlyIncreases	act(p(HGNC:GSK3B))
a4c8159b-0e5d-45ab-be11-88da142c76bf	1.0	PubMed	21145761	Because RIG-I, VISA, and MITA act upstream whereas IRF3 acts downstream of TBK1, the simplest explanation from these data is that GSK3beta targets TBK1.	p(HGNC:TBK1)	directlyIncreases	act(p(HGNC:GSK3B))
28a2293f-dbd3-4fab-846c-c785399ec6ec	1.0	PubMed	20654575	Lithium increases TCF7L2 mRNA levels in a GSK3beta dependent manner and induces a GSK3beta independent RNA-isoform switch favoring the expression of TCF7L2-short forms.	p(HGNC:TCF7L2)	directlyIncreases	act(p(HGNC:GSK3B))
66d4c89d-1687-46e3-bffe-22e0bc1a28ea	1.0	PubMed	25935310	Since CHP3 can activate both GSK3alpha and GSK3beta, it will be of interest to examine whether gene ablation of CHP3 can offset the distinct influences of GSK3alpha and beta and thus lead to cardiac hypertrophy in vivo.	p(HGNC:TESC)	directlyIncreases	act(p(HGNC:GSK3B))
08a89c1a-3e77-4f7e-bf4b-bf7e888fef6d	1.0	PubMed	24899689	XREF_BIBR, XREF_BIBR To determine the role of GSK-3beta on TGF-beta1 signaling, WT and GSK-3beta KO MEFs were treated with TGF-beta1 (10ng/ml) for 1h and phosphorylation of SMAD-3 at the C-terminus (Ser423/25) was determined.	p(HGNC:TGFB1)	directlyIncreases	act(p(HGNC:GSK3B))
10089fca-ddc0-4990-9f5e-32fa294836f1	1.0	PubMed	22496417	We found that TGFbeta stimulation led to phosphorylation and thereby activation of p38 and inactivation of GSK-3beta (XREF_FIG).	p(FPLX:TGFB)	directlyIncreases	act(p(HGNC:GSK3B))
10089fca-ddc0-4990-9f5e-32fa294836f1	1.0	PubMed	22496417	To further explore the importance of p38alpha for TGFbeta induced GSK-3beta inactivation and its effect on beta-catenin accumulation, we investigated wt and p38alpha -/- MEFs (XREF_BIBR).	p(FPLX:TGFB)	directlyIncreases	act(p(HGNC:GSK3B))
10089fca-ddc0-4990-9f5e-32fa294836f1	1.0	PubMed	22496417	Loss of Smad7 expression or p38 activation results in a loss of TGFbeta induced local inactivation of GSK-3beta in the leading edge of migrating cells, and as a consequence APC will not be recruited to the distal tip of polarized microtubules in cell extensions.	p(FPLX:TGFB)	directlyIncreases	act(p(HGNC:GSK3B))
10089fca-ddc0-4990-9f5e-32fa294836f1	1.0	PubMed	22496417	We also show that TGFbeta induces Smad7 and p38alpha dependent local inactivation of GSK-3beta, which leads to an accumulation of beta-catenin and increased levels of APC, facilitating cell protrusion in the leading edge of the migrating cell.	p(FPLX:TGFB)	directlyIncreases	act(p(HGNC:GSK3B))
10089fca-ddc0-4990-9f5e-32fa294836f1	1.0	PubMed	22496417	This is in line with our previous observation that p38 and Smad7 play important roles in TGFbeta induced accumulation of beta-catenin in PC-3U cells and TGFbeta induced inactivation of GSK-3beta (XREF_BIBR).	p(FPLX:TGFB)	directlyIncreases	act(p(HGNC:GSK3B))
10089fca-ddc0-4990-9f5e-32fa294836f1	1.0	PubMed	22960426	Moreover, the HNF4alpha 2-DE gel analysis revealed a number of TGFbeta induced GSK3beta independent HNF4alpha PTMs.	p(FPLX:TGFB)	directlyIncreases	act(p(HGNC:GSK3B))
b074408b-7147-43eb-92c7-5e7b4be37922	1.0	PubMed	20602916	Overexpression of TJP2 leads to a decrease in GSK-3beta Ser9 phosphorylation, thereby increasing GSK-3beta activity.	p(HGNC:TJP2)	directlyIncreases	act(p(HGNC:GSK3B))
70a497dc-3106-41da-9f17-ea7bf0422460	1.0	PubMed	20160039	Under non adherent conditions, talin1 stimulates FAK, Src and GSK3beta independent of integrin signaling and confers resistance to anoikis, leading to metastatic spread (XREF_SUPPLEMENTARY).	p(HGNC:TLN1)	directlyIncreases	act(p(HGNC:GSK3B))
25d82ff4-41d2-4027-bc14-a5e62ac2db70	1.0	PubMed	27354597	In this study, we investigated the role of phosphorylated GSK3beta activated by enhanced toll like receptor 4 (TLR4) expression in drug treated colon cancer cells as a model of post-chemotherapy cancer cells.	p(HGNC:TLR4)	directlyIncreases	act(p(HGNC:GSK3B, pmod(Ph)))
9293dc7a-4327-41d8-a82d-d546dfc882ea	1.0	PubMed	PMC7053081	Importantly, TRAIL stimulation increased GSK-3beta tyrosine phosphorylation at Y216, suggesting that GSK-3beta is activated by TRAIL.	p(HGNC:TNFSF10)	directlyIncreases	act(p(HGNC:GSK3B))
9293dc7a-4327-41d8-a82d-d546dfc882ea	1.0	PubMed	7053081	Importantly, TRAIL stimulation increased GSK-3beta tyrosine phosphorylation at Y216, suggesting that GSK-3beta is activated by TRAIL.	p(HGNC:TNFSF10)	directlyIncreases	act(p(HGNC:GSK3B))
9293dc7a-4327-41d8-a82d-d546dfc882ea	1.0	PubMed	26972480	We have firstly confirmed the regulatory role of GSK3beta on the protein level of c-FLIP in H1299 cells treated with TRAIL.	p(HGNC:TNFSF10)	directlyIncreases	act(p(HGNC:GSK3B))
9293dc7a-4327-41d8-a82d-d546dfc882ea	1.0	PubMed	26972480	H1299 cells after transfection of Flag-hnRNPK or knockdown of GSK3beta were treated with TRAIL (20ng/ml, 8hours) as indicated, then the cells were collected and stained with Alexa Fluor 488 Annexin-V/PI (HH-V13241, Invitrogen) following the manufacturer 's protocol.	p(HGNC:TNFSF10)	directlyIncreases	act(p(HGNC:GSK3B))
9293dc7a-4327-41d8-a82d-d546dfc882ea	1.0	PubMed	14617795	Importantly, TRAIL stimulation increased GSK-3beta tyrosine phosphorylation at Y216, suggesting that GSK-3beta is activated by TRAIL.	p(HGNC:TNFSF10)	directlyIncreases	act(p(HGNC:GSK3B))
752cfbf3-61cf-45d6-8792-5f3e8c91325d	1.0	PubMed	24391209	Finally, pharmacological inhibition of GSK3beta negated the ability of efferocytosis to blunt inducible TNFalpha expression supporting a key role of GSK3beta in the efferocytosis dependent resolution of inflammation pathway (XREF_FIG).	p(HGNC:TNF)	directlyIncreases	act(p(HGNC:GSK3B))
752cfbf3-61cf-45d6-8792-5f3e8c91325d	1.0	PubMed	21316358	In the SB216763+ TNF group, un-phospho-beta-catenin-Ser 33/37 was similar to Control, indicating prevention of TNF induced GSK3beta activation.	p(HGNC:TNF)	directlyIncreases	act(p(HGNC:GSK3B))
752cfbf3-61cf-45d6-8792-5f3e8c91325d	1.0	PubMed	21316358	The literature indicates multiple cell types and mechanisms for the TNF induced activation of GSK3beta in the lung.	p(HGNC:TNF)	directlyIncreases	act(p(HGNC:GSK3B))
752cfbf3-61cf-45d6-8792-5f3e8c91325d	1.0	PubMed	21316358	In summary, TNF induces the activation of GSK3beta associated with lung injury.	p(HGNC:TNF)	directlyIncreases	act(p(HGNC:GSK3B))
752cfbf3-61cf-45d6-8792-5f3e8c91325d	1.0	PubMed	12900420	In some experiments, LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (a kinase involved in activating Akt) and tumor necrosis factor-alpha (TNF-alpha) were used to activate GSK-3beta.	p(HGNC:TNF)	directlyIncreases	act(p(HGNC:GSK3B))
752cfbf3-61cf-45d6-8792-5f3e8c91325d	1.0	PubMed	23431386	TNFalpha Mediates Snail Stabilization via Activation of AKT and Inhibition of GSK-3beta.	p(HGNC:TNF)	directlyIncreases	act(p(HGNC:GSK3B))
752cfbf3-61cf-45d6-8792-5f3e8c91325d	1.0	PubMed	26017781	Western blotting revealed that TNF-alpha treatment induced the inactivation of GSK-3beta function through the phosphorylation of GSK-3beta.	p(HGNC:TNF)	directlyIncreases	act(p(HGNC:GSK3B))
752cfbf3-61cf-45d6-8792-5f3e8c91325d	1.0	PubMed	6899864	In some experiments, LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (a kinase involved in activating Akt) and tumor necrosis factor-alpha (TNF-alpha) were used to activate GSK-3beta.	p(HGNC:TNF)	directlyIncreases	act(p(HGNC:GSK3B))
41b595e6-dc9b-469c-80cf-063d457e8f1a	1.0	PubMed	12048243	This activation occurred by a phosphorylation independent mechanism involving direct binding of GSK3beta to p53, which was confined to the nucleus where p53 is localized, and mutated p53 (R175H) bound but did not activate GSK3beta.	p(HGNC:TP53, var(p.Arg175His))	directlyIncreases	act(p(HGNC:GSK3B))
41b595e6-dc9b-469c-80cf-063d457e8f1a	1.0	PubMed	6352228	This activation occurred by a phosphorylation independent mechanism involving direct binding of GSK3beta to p53, which was confined to the nucleus where p53 is localized, and mutated p53 (R175H) bound but did not activate GSK3beta.	p(HGNC:TP53, var(p.Arg175His))	directlyIncreases	act(p(HGNC:GSK3B))
b706ef41-d0d2-4b7b-81da-9b4eb8cee5e2	1.0	PubMed	18804163	These findings suggest that TPO induced GSK-3beta is promoting cell growth through a beta-catenin-independent pathway, and that TPO and Wnt3a do not synergize in promoting cell growth in UT-7 and TPO cells.	p(HGNC:TPO)	directlyIncreases	act(p(HGNC:GSK3B))
a4e19fd4-43ba-470b-bb32-76132ecf58c6	1.0	PubMed	25483191	We investigated if TRAF6 promotes the inactivation of GSK3beta, by phosphorylation on Ser9.	p(HGNC:TRAF6)	directlyIncreases	act(p(HGNC:GSK3B))
91882bb3-23b5-4205-91dc-43080f7013a9	1.0	PubMed	25639486	TRIM33 mediated destabilization is GSK-3beta and beta-TrCP independent.	p(HGNC:TRIM33)	directlyIncreases	act(p(HGNC:GSK3B))
91882bb3-23b5-4205-91dc-43080f7013a9	1.0	PubMed	25639486	We tested whether TRIM33 promoted beta-catenin degradation requires GSK-3beta or beta-TrCP.	p(HGNC:TRIM33)	directlyIncreases	act(p(HGNC:GSK3B))
00a0baf1-aab6-4517-aaa0-f309bf1f9d6d	1.0	PubMed	23140583	These results show that the overexpression of TRPV6 stimulates GSK3beta, MAPKinase, and AKT signaling and accelerates cell proliferation.In summary, we identified Numb1 as a novel regulator of TRPV6, and the results presented in this study Numb1 increase our understanding of the biological function of calcium signaling in cancer cells and development.	p(HGNC:TRPV6)	directlyIncreases	act(p(HGNC:GSK3B))
c4796519-edcc-48ff-8f56-1787b41aac93	1.0	PubMed	21441955	In fact, overexpression of dn-ETS not only reduced the basal GSK-3beta transcription with mutant K-Ras, but also abolished the Ras induced superactivation of GSK-3beta in pancreatic cancer cells with wild type Ras.	p(UP:Q8R4P5)	directlyIncreases	act(p(HGNC:GSK3B))
15000fcf-7fe4-4e38-a75e-ac782b6e5c91	1.0	PubMed	21118991	Overexpression of EDD enhances GSK-3beta 's and beta-catenin 's nuclear accumulation.	p(HGNC:UBR5)	directlyIncreases	act(p(HGNC:GSK3B))
15000fcf-7fe4-4e38-a75e-ac782b6e5c91	1.0	PubMed	21118991	These results indicate that EDD enhances the nuclear localization of both GSK-3beta and beta-catenin.	p(HGNC:UBR5)	directlyIncreases	act(p(HGNC:GSK3B))
bbc396c7-c00d-428c-bf64-e9812f790bdc	1.0	PubMed	25026278	Several studies demonstrated that Wnt3a induces endocytosis of Gsk-3beta into MVBs, thus leading to WNT pathway activation [XREF_BIBR, XREF_BIBR].	p(HGNC:WNT3A)	directlyIncreases	act(p(HGNC:GSK3B))
bbc396c7-c00d-428c-bf64-e9812f790bdc	1.0	PubMed	25632187	Interestingly, activation of the GSK3beta and beta-catenin pathway induced by Wnt3a resulted in up-regulation of P-gp, which was effectively abolished by beta-escin, indicating that beta-escin down-regulated P-gp expression in a GSK3beta dependent manner.	p(HGNC:WNT3A)	directlyIncreases	act(p(HGNC:GSK3B))
8e2548e8-f3da-4c93-804b-709b527a4bd9	1.0	PubMed	25691573	In addition, the beta-catenin pathway can be negatively regulated by Wnt5a signaling in a GSK3beta independent manner (XREF_BIBR, XREF_BIBR).	p(HGNC:WNT5A)	directlyIncreases	act(p(HGNC:GSK3B))
8e2548e8-f3da-4c93-804b-709b527a4bd9	1.0	PubMed	21078818	We demonstrate here that prototype canonical wnt3a and noncanonical wnt5a ligands specifically trigger completely unrelated endogenous coreceptors-lrp5/6 and ror1/2, respectively-through a common mechanism that involves their wnt-dependent coupling to the frizzled (fzd) coreceptor and recruitment of shared components, including dishevelled (dvl), axin, and glycogen synthase kinase 3 (gsk3)	p(HGNC:WNT5A)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	21325624	We also observed an increase in phosphorylation of the inhibitory Ser 9 residue of GSK-3beta, which has been proposed to enhance beta-catenin signaling by promoting the accumulation of beta-catenin protein levels, in a manner analogous to Wnt mediated GSK-3beta inactivation (Desbois-Mouthon et al., XREF_BIBR; Sharma et al., XREF_BIBR; Naito et al., XREF_BIBR; Mulholland et al., XREF_BIBR).	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	21325624	Furthermore, our results also suggest that inhibition of GSK-3beta by Akt may enhance beta-catenin signaling in a more distinct manner than Wnt mediated GSK-3beta inactivation, even though this component is shared by both Wnt and beta-catenin and Akt and beta-catenin pathways (see XREF_FIG).	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	23927957	Consistent with previous reports, we also found that a Wnt signalling antagonist such as sFRP1 restores GSK3beta activity, which phosphorylates the linker region of Smad3 and inhibited its transcriptional activity.	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	21179577	Several lines of evidence suggest that Abeta interferes with Wnt and beta-catenin signaling XREF_BIBR, XREF_BIBR, causing GSK-3beta activation, a kinase abnormally active in AD and involved in tau phosphorylation XREF_BIBR, XREF_BIBR.	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	23049725	For example, the S9 phosphorylation of GSK-3beta is not correlated with Wnt mediated GSK-3beta activity in certain cell types XREF_BIBR.	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	22613765	Therefore, the AICD may counteract Wnt signalling in a GSK3beta kinase activity dependent manner.	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	20624590	Given our results that DISC1 and Dixdc1 bind one another in vivo, and that DISC1 modifies the Wnt pathway in progenitor cells (XREF_BIBR), we hypothesized that Dixdc1 and DISC1 may functionally interact to modulate Wnt mediated GSK3beta and beta-catenin signaling and thereby regulate neural progenitor proliferation.	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	20624590	To measure Wnt mediated GSK3beta and beta-catenin activity, we utilized a luciferase reporter construct containing eight copies of the TCF/LEF binding site (8XSuperTOPFLASH), since beta-catenin stimulates transcription of genes containing TCF/LEF binding sites (XREF_BIBR; XREF_BIBR).	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	26274564	We next validated the role of GSK3beta Y216 in Wnt and beta-catenin signaling in GSK3beta knockout (KO) MEFs (mouse embryonic fibroblasts).	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0d3b4078-fd9e-4701-bdd4-4d11953aa079	1.0	PubMed	16039586	Although the molecular mechanism by which Wnt actually regulates GSK-3beta is not fully elucidated yet, one finding is that Wnt activated Dsh causes GSK-3beta dissociation from Axin (); the other is that Wnt stimulation leads to reduction of kinase activity of GSK-3beta ().	p(FPLX:Wnt)	directlyIncreases	act(p(HGNC:GSK3B))
0f1060ae-5d30-4300-8041-917023395771	1.0	PubMed	16039586	These data demonstrate that Erk docks to GSK-3beta at the DEF domain to bridge GSK-3beta and p90RSK together and phosphorylates GSK-3beta at the T residue.We next asked whether Erk docking to GSK-3beta and phosphorylating GSK-3beta have effects on the HBX mediated inactivation of GSK-3beta and upregulation of beta-catenin.	p(UP:Q64902)	directlyIncreases	act(p(HGNC:GSK3B))
ed0f2dca-4cf4-4bcb-b069-25919418471a	1.0	PubMed	27922666	Therefore, YB-1 may be a downstream target of ERK2 and GSK-3beta (XREF_BIBR, XREF_BIBR).	p(HGNC:YBX1)	directlyIncreases	act(p(HGNC:GSK3B))
8ff3de4b-3c8a-41ae-8369-d4cb3ee19d15	1.0	PubMed	15963640	The purpose of this study was to determine if 14-3-3zeta could act as a scaffolding protein to promote the interaction of GSK3beta with tau and subsequently, enhance GSK3beta mediated tau hyperphosphorylation.	p(HGNC:YWHAZ)	directlyIncreases	act(p(HGNC:GSK3B))
eb41cc45-fce9-48e1-a4ff-d6e4605bfd61	1.0	PubMed	19090997	AD : Alzheimer 's disease; AMPK : adenosine monophosphate activated protein kinase; BRSK1/2 : brain selective kinase 1/2; CD : common docking; GSK3beta : glycogene synthase kinase 3beta; MAP : microtubule associated protein; MARK : MAP-microtubule affinity regulating kinase; MELK : maternal embryonic leucine zipper kinase; SNF1 : sucrose non fermenting 1; UBA : ubiquitin associated.	a(PUBCHEM:6083)	directlyIncreases	act(p(HGNC:GSK3B))
a26792d5-2241-440f-8ce9-02244686379b	1.0	PubMed	19276348	Intriguingly, anandamide did not stimulate activity of GSK3beta (Plotnikov and Fuchs, unpublished data) indicating the existence of another kinase pathway that promotes Ser349 phosphorylation and PRLr degradation.	a(PUBCHEM:5281969)	directlyIncreases	act(p(HGNC:GSK3B))
b08233b6-c26d-42d3-be08-9b6becf9afff	1.0	PubMed	22096483	G3DeltaEGF expressing cells also did not showed enhanced pJNK when treated with Docetaxel and enhanced GSK-3beta (S9P) when cultured in Doxorubicin as G3 expressing cells.	p(UP:P92208)	directlyIncreases	act(p(HGNC:GSK3B, var(p.Ser9Pro)))
cdcfcf8d-5e00-4616-9b0b-c3a70df97429	1.0	PubMed	PMC6383745	Taking into account that GSK3beta phosphorylates MITF and increases the ability of MITF to bind its target sequence, our results indicate that activation of GSK3beta by cAMP facilitates MITF binding to the tyrosinase promoter, thereby leading to stimulation of melanogenesis.	a(CHEBI:17489)	directlyIncreases	act(p(HGNC:GSK3B))
82b6209a-17ec-4dbf-bd30-8d9338980292	1.0	PubMed	19591849	In the literature, GSK3beta is clearly activated by elevated intracellular calcium levels, leading to tau hyperphosphorylation ().	a(CHEBI:29108)	directlyIncreases	act(p(HGNC:GSK3B))
132eca68-5cd0-43b4-ab61-f97d06390ecc	1.0	PubMed	23846217	The results indicated that the activation of GSK3beta by celastrol was not a consequence of apoptosis.	a(PUBCHEM:122724)	directlyIncreases	act(p(HGNC:GSK3B))
7714ec4d-9bf9-4c93-b167-133df8615fa1	1.0	PubMed	26452029	Furthermore, we indicated that Bmi-1 mediated Hes1 induced cell proliferation and migration, downregulated PTEN and activated the Akt and GSK3beta pathway, consequently induced EMT and cytoskeleton reconstruction, ultimately leading to enhanced invasiveness of cancer cells.	bp(GO:"GO:0008283")	directlyIncreases	act(p(HGNC:GSK3B))
c70367ef-1928-41d6-a49f-9fdcf5ff71ff	1.0	PubMed	22087308	According to previous reports, GSK3beta is also activated by etoposide or ceramide, which may be mediated indirectly through PP2A activation XREF_BIBR, XREF_BIBR, XREF_BIBR.	a(CHEBI:17761)	directlyIncreases	act(p(HGNC:GSK3B))
cdf512b6-6dd7-4c53-9ed9-4430b49964ee	1.0	PubMed	23673211	Following the transfection for 48h, cells were collected for Western blot analysis of GSK-3beta protein or treated with 20muM cisplatin for 24h for subsequent flow cytometry and MTT analyses.After the indicated treatments, cells were washed three times with PBS and lysed in RIPA buffer (50mM Tris and HCl pH 8.0, 150mM NaCl, 1% Nonidet-P40, 1% Sodium deoxycholate, 0.1% SDS) with PMSF (100:1) on ice for a period of 30min.	a(CHEBI:27899)	directlyIncreases	act(p(HGNC:GSK3B))
187615c6-de3a-455e-bde7-3962bea4fe2a	1.0	PubMed	19481076	The protein levels of GSK-3beta in WT sternal chondrocytes treated with cycloheximide, a protein synthesis inhibitor, decreased gradually within 2 hours (XREF_FIG, E, upper panel, F, line WT); in contrast, the rate of decrease in GSK-3beta protein levels was significantly accelerated in transgenic chondrocytes with the same treatment (XREF_FIG, E, lower panel, F, line Col2-Sf2).	a(PUBCHEM:6197)	directlyIncreases	act(p(HGNC:GSK3B))
50cea04e-5c28-410d-aa69-c25391ac5c6a	1.0	PubMed	21315744	In naive mice, we assessed METH induced conditioned place preference (CPP), dopamine (DA) D2 receptor density and the basal and METH induced activity of DISC1 partners, AKT and GSK-3beta in the ventral striatum.	a(CHEBI:18243)	directlyIncreases	act(p(HGNC:GSK3B))
50cea04e-5c28-410d-aa69-c25391ac5c6a	1.0	PubMed	26979166	Excessive dopamine signaling via D2 receptors in the striatum causes an activation of GSK3beta via a multiprotein complex involving the D2 receptor, beta-arrestin, Akt, GSK3beta, and PP2A [XREF_BIBR, XREF_BIBR], while active GSK3beta results in diminished long-term potentiation (LTP) [XREF_BIBR - XREF_BIBR].	a(CHEBI:18243)	directlyIncreases	act(p(HGNC:GSK3B))
98c373c7-0a64-4a6c-b4b8-f1b000bdaf50	1.0	PubMed	25051360	More colonies were observed in MCF-7 and GSK-3beta (KD) cells than MCF-7 and GSK-3beta (WT) or MCF-7 and GSK-3beta (A9) cells when the cells were treated with doxorubicin.	a(CHEBI:28748)	directlyIncreases	act(p(HGNC:GSK3B))
d83c6d66-36e4-48d6-a87a-a401a8a4f218	1.0	PubMed	16039586	Although the molecular mechanism by which Wnt actually regulates GSK-3beta is not fully elucidated yet, one finding is that Wnt activated Dsh causes GSK-3beta dissociation from Axin (); the other is that Wnt stimulation leads to reduction of kinase activity of GSK-3beta ().	p(UP:P51142)	directlyIncreases	act(p(HGNC:GSK3B))
b0f33796-b80f-469a-845a-003db2456cde	1.0	PubMed	26252009	We examined whether embelin is able to enhance GSK-3beta stability and activity.	a(CHEBI:4778)	directlyIncreases	act(p(HGNC:GSK3B))
8a06ac94-6626-4f3f-b108-81270d592698	1.0	PubMed	20818790	XREF_BIBR - XREF_BIBR Although the mechanism whereby HIV-1 causes tau hyperphosphorylation in HAND brains has yet to be fully elucidated, based on our data we suggest that HIV envelope protein gp120 activates GSK-3beta by dephosphorylation, leading to tau hyperphosphorylation, which in turn may potentially contribute to the pathology of HAND.	p(UP:P04578)	directlyIncreases	act(p(HGNC:GSK3B))
ba5d5210-561c-43ba-9ce9-121e94b1ccbd	1.0	PubMed	22111711	62 On the other hand, estradiol can also initiate the Akt and GSK3beta and MAP kinase cascades in an ER dependent manner at the plasma membrane and cytoplasm, as well as a redox dependent cascade by an intrinsic antioxidant activity.	a(CHEBI:23965)	directlyIncreases	act(p(HGNC:GSK3B))
c11c8e04-075f-463e-bf6a-413d40df3248	1.0	PubMed	22087308	According to previous reports, GSK3beta is also activated by etoposide or ceramide, which may be mediated indirectly through PP2A activation XREF_BIBR, XREF_BIBR, XREF_BIBR.	a(CHEBI:4911)	directlyIncreases	act(p(HGNC:GSK3B))
843c54e3-93b3-44be-996d-716ff9f43890	1.0	PubMed	18803287	In parallel, gefitinib downregulated constitutively phosphorylated HER2 and HER3, and activated GSK3beta with a concomitant degradation of cyclin D1.	a(CHEBI:49668)	directlyIncreases	act(p(HGNC:GSK3B))
1e68b4c8-6496-4ce2-b5f6-188ac0ccdcd6	1.0	PubMed	25390651	Our recent study has shown that mitochondrial translocation of GSK-3beta triggered by exogenous hydrogen peroxide induced enhanced ROS production and that both mitochonrial translocation of GSK-3beta and ROS production were dependent on GSK-3beta kinase activity XREF_BIBR.	a(CHEBI:16240)	directlyIncreases	act(p(HGNC:GSK3B))
fafca4a6-c956-4d00-86e0-dfe4fd8cc5f1	1.0	PubMed	22262776	Specifically, GSK3beta activity and nuclear import were increased by imatinib mesylate (IM), a selective ABL inhibitor, but prevented by dasatinib that targets both BCR-ABL- and cytokine dependent MAPK and p60-SRC activity.	a(PUBCHEM:123596)	directlyIncreases	act(p(HGNC:GSK3B))
f572130f-7d82-4e05-9f70-2ec3c7fec057	1.0	PubMed	20169190	One of the key properties of LANA is to stimulate cells in the S phase entry XREF_BIBR by relocalizing GSK3-beta and stabilizing beta-catenin, thereby manipulating the GSK3beta, beta, and catenin complex.	p(UP:Q65DC4)	directlyIncreases	act(p(HGNC:GSK3B))
89b52259-86e1-491c-a0da-46fba3be502e	1.0	PubMed	15507471	Upstream activation of Wnt signaling by the Wnt-2 and Wnt-3a ligands, stable overexpression of Wnt-2, as well as GSK-3beta inhibition by lithium, SB216763, and GSK-3beta dominant negative forms (K85R and R96E) conferred the invasive phenotype through several proinvasive pathways.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:GSK3B))
89b52259-86e1-491c-a0da-46fba3be502e	1.0	PubMed	15507471	Upstream activation of Wnt signaling by the Wnt-2 and Wnt-3a ligands, stable overexpression of Wnt-2, as well as GSK-3beta inhibition by lithium, SB216763, and GSK-3beta dominant negative forms (K85R and R96E) conferred the invasive phenotype through several proinvasive pathways.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:GSK3B))
89b52259-86e1-491c-a0da-46fba3be502e	1.0	PubMed	23768967	Qu et al. further demonstrated the increased proliferation of neural precursor cells in response to the potent GSK-3beta inhibitors, SB216763 and SB415286, suggesting that GSK-3beta inhibition accounts for the proliferative effects induced by lithium treatment of neural precursor cells.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:GSK3B))
89b52259-86e1-491c-a0da-46fba3be502e	1.0	PubMed	19576885	However, the data indicated that lithium marginally inhibits GSK-3 activity in total protein extracts (membrane plus matrix fraction) but causes a two-fold increase in the active form of GSK-3beta in the flagella.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:GSK3B))
89b52259-86e1-491c-a0da-46fba3be502e	1.0	PubMed	18191226	In betaArr2-KO mice that are unable to scaffold this signaling complex, lithium fails to activate Akt, thus leading to a loss of indirect inhibition of GSK3beta by lithium and to a disruption of behavioral responses to this pharmacological agent.Our results identify the destabilization of beta-arrestin-mediated signaling complexes as a mechanism of action for a therapeutically effective drug, thereby providing an avenue for the development of pharmacological agents acting on GPCR signaling.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:GSK3B))
89b52259-86e1-491c-a0da-46fba3be502e	1.0	PubMed	23943160	Furthermore, lithium, which is known to indirectly regulate GSK3beta through the PI3K and AKT pathway [XREF_BIBR, XREF_BIBR], can enhance GSK3beta activation and rescue the endometrial cancer cell lines from PPARbeta and delta induced apoptosis.	a(PUBCHEM:28486)	directlyIncreases	act(p(HGNC:GSK3B))
90ddb931-0ce4-46b8-8970-2b6ec5383980	1.0	PubMed	19286457	The decrease of N-Myc amount caused by NOV was abolished in the presence of lithium chloride which is routinely used to inhibit GSK3-beta activity (), or by simultaneous addition of IGF-1 which was reported to stabilize N-Myc protein by triggering the inhibition of GSK3-beta activity through activation of the IGF-1R/PI3K/Akt pathway ().	a(PUBCHEM:433294)	directlyIncreases	act(p(HGNC:GSK3B))
c19faa2b-a5d8-4e07-b02a-8200ab41d61f	1.0	PubMed	21422248	Because the inhibition of mTORC1 suppressed the phospho inactivation of GSK3-beta (S9), we predicted that mTORC1 and GSK3 inhibition would mediate opposing effects on the levels of pro- and anti-inflammatory cytokines produced by LPS stimulated monocytes and, if GSK3 was downstream of mTORC1, that the inhibition of GSK3 would inhibit the inflammatory properties of rapamycin.	p(FPLX:mTORC1)	directlyIncreases	act(p(HGNC:GSK3B))
91094ad3-7140-42d3-adf4-88f3af971306	1.0	PubMed	4445512	The mechanism by which myo-inositol inhibits both dominant negative GSK-3 beta and lithium remains uncertain.	a(PUBCHEM:892)	directlyIncreases	act(p(HGNC:GSK3B))
a8881973-952f-415a-b8a7-96be7537fbb8	1.0	PubMed	15126504	17Beta-estradiol, a neuronal protective hormone, increased the binding of WOX1 and GSK-3beta with Tau.	a(PUBCHEM:5757)	directlyIncreases	act(p(HGNC:GSK3B))
26a8f1c8-73a5-4693-8d05-c5b561a09ada	1.0	PubMed	25483191	Moreover, active p38 causes inactivation of GSK-3beta, by phosphorylation on Ser9.	p(FPLX:p38)	directlyIncreases	act(p(HGNC:GSK3B))
26a8f1c8-73a5-4693-8d05-c5b561a09ada	1.0	PubMed	25483191	Treatment of PC-3U cells with the p38-inhibitor SB203580, resulted in an inhibition of TGFbeta induced phosphorylation of GSK-3beta on Ser9 (XREF_FIG), suggesting that p38 causes inactivation of GSK-3beta, consistent with previous observations.	p(FPLX:p38)	directlyIncreases	act(p(HGNC:GSK3B))
26a8f1c8-73a5-4693-8d05-c5b561a09ada	1.0	PubMed	22496417	Because we found that Smad7 directly associates with APC and is important for TGFbeta induced p38 activation and subsequent inactivation of GSK-3beta and accumulation of beta-catenin, we next examined the role of the Smad7 and APC complex for cell migration in a cell culture wound healing experiment.	p(FPLX:p38)	directlyIncreases	act(p(HGNC:GSK3B))
e24823a3-634e-42f4-9c38-1f4863855ab7	1.0	PubMed	25829335	In addition to these human evidences, in vivo and in vitro studies have demonstrated that 6-OHDA, a widely used agent in induction of PD models, significantly increases GSK-3beta activity.	a(PUBCHEM:4624)	directlyIncreases	act(p(HGNC:GSK3B))
e24823a3-634e-42f4-9c38-1f4863855ab7	1.0	PubMed	25829335	For instance, it has been shown that single intra-striatal injection of 6-OHDA increases the activity of GSK-3beta as well as caspase-3 cleavage in the substantia nigra, this 6-OHDA mediated activation of GSK-3beta is achieved via triggering of phosphorylation of tyrosine 216 residues (Tyr216).	a(PUBCHEM:4624)	directlyIncreases	act(p(HGNC:GSK3B))
93d01048-e4ba-4f86-abb6-2eb4c64fb1a6	1.0	PubMed	24132507	Western blot analysis showed that sodium palmitate activated GSK-3beta protein, which was indicated by dephosphorylation of GSK-3beta at Ser 9.	a(CHEBI:15756)	directlyIncreases	act(p(HGNC:GSK3B))
03e8f17d-4953-4fc2-a233-1979d66fedfa	1.0	PubMed	23710442	DEX also demonstrated a concentration dependent inhibition of PAN induced podocyte apoptosis and reversed PAN induced downregulation of p-Akt and p-GSK3beta.	p(UP:Q9YAC7)	directlyIncreases	act(p(HGNC:GSK3B))
03e8f17d-4953-4fc2-a233-1979d66fedfa	1.0	PubMed	23710442	DEX also demonstrated a concentration dependent inhibition of PAN induced podocyte apoptosis and reversed PAN induced downregulation of p-Akt and p-GSK3beta.	p(UP:Q9YAC7)	directlyIncreases	act(p(HGNC:GSK3B))
9a908658-8558-4be4-a3dc-019567c4b999	1.0	PubMed	19797085	In addition, we show that the beta-TrCP-mediated degradation requires phosphorylation of PHLPP1 by casein kinase I and glycogen synthase kinase 3beta (GSK-3beta), and activation of the phosphatidylinositol 3-kinase/Akt pathway suppresses the degradation of PHLPP1 by inhibiting the GSK-3beta activity.	a(PUBCHEM:53477912)	directlyIncreases	act(p(HGNC:GSK3B))
f8b2f5ae-fd95-448a-87a9-9197e149988f	1.0	PubMed	23043959	Blockade of GSK-3beta inactivation by overexpression of constitutively active GSK-3beta or DN-Akt suppressed Hsp70 induction in heat treated inflammatory cells as well as human bronchial epithelial cells (data not shown), which is in accordance with previous report in human neuroblastoma cells.	p(UP:P54644)	directlyIncreases	act(p(HGNC:GSK3B))
b412c612-f994-4907-b6e7-a2f66e26cbbe	1.0	PubMed	14636889	Although the precise mechanism that leads to aberrant Akt and PKB signalling is unclear and currently under investigation, deregulation in the Akt and GSK3beta signal transduction cascade mediated by the familial Alzheimer 's disease mutants of amyloid precursor protein and presenilin may prove to be a critical event in the pathogenesis of Alzheimer 's disease, contributing to such events as hyperphosphorylation of tau, the major component of neurofibrillary tangles, and/or adversely affecting cellular functions such as cell adhesion, cell growth or replication or even cell death as reported by others.	p(PFAM:PF01080)	directlyIncreases	act(p(HGNC:GSK3B))
35ca820f-c7e2-45a2-9659-f63a36d84466	1.0	PubMed	24132507	Western blot analysis showed that sodium palmitate activated GSK-3beta protein, which was indicated by dephosphorylation of GSK-3beta at Ser 9.	a(PUBCHEM:923)	directlyIncreases	act(p(HGNC:GSK3B))
a9dff152-1e6d-42a7-8d60-42b784db6442	1.0	PubMed	17991738	In this report, we show that sorafenib activates GSK-3beta in multiple subcellular compartments and that this activation undermines the lethality of the drug.	a(CHEBI:50924)	directlyIncreases	act(p(HGNC:GSK3B))
1ad2e1be-fa9b-4367-bc25-8506a13c842e	1.0	PubMed	25062958	Adenosine and spermine NONOate both increased the ratio of phospho-GSK-3beta and total GSK-3beta, and these increases were abolished by either ODQ or Rp.	a(PUBCHEM:1103)	directlyIncreases	act(p(HGNC:GSK3B))
13dfeca3-ac72-451d-8252-ea2a10ad3d96	1.0	PubMed	19698783	No caspase-3 was detected associated with immunoprecipitated GSK3beta from cells treated with staurosporine with or without lithium treatment (data not shown), indicating they do not directly associate.	a(PUBCHEM:44259)	directlyIncreases	act(p(HGNC:GSK3B))
13dfeca3-ac72-451d-8252-ea2a10ad3d96	1.0	PubMed	5993296	Heat shock and staurosporine treatments increased nuclear GSK-3 beta prior to activation of caspase-9 and caspase-3, and this nuclear accumulation of GSK-3 beta was unaltered by pretreatment with a general caspase inhibitor.	a(PUBCHEM:44259)	directlyIncreases	act(p(HGNC:GSK3B))
13dfeca3-ac72-451d-8252-ea2a10ad3d96	1.0	PubMed	11495916	Heat shock and staurosporine treatments increased nuclear GSK-3 beta prior to activation of caspase-9 and caspase-3, and this nuclear accumulation of GSK-3 beta was unaltered by pretreatment with a general caspase inhibitor.	a(PUBCHEM:44259)	directlyIncreases	act(p(HGNC:GSK3B))
d6fee080-ccfb-40e9-8743-0c467bb719c1	1.0	PubMed	23065461	Tat, albeit in neurons, activates GSK3beta, a negative regulator of beta-catenin that is part of the beta-catenin destruction complex, which phosphorylates and tags beta-catenin for proteasomal degradation (XREF_BIBR; XREF_BIBR).	p(UP:P04608)	directlyIncreases	act(p(HGNC:GSK3B))
d6fee080-ccfb-40e9-8743-0c467bb719c1	1.0	PubMed	23301033	Together these data suggest that Tat augments vIL-6-induced angiogenesis and tumorigenesis by activating PI3K and AKT and inactivating PTEN and GSK-3beta signals in both fibroblasts and endothelial cells mediated CAM model.	p(UP:P04608)	directlyIncreases	act(p(HGNC:GSK3B))
d6fee080-ccfb-40e9-8743-0c467bb719c1	1.0	PubMed	21514616	Tat induces GSK-3beta activity, which can be reversed by the addition of the GSK-3beta inhibitor lithium (XREF_BIBR).	p(UP:P04608)	directlyIncreases	act(p(HGNC:GSK3B))
d6fee080-ccfb-40e9-8743-0c467bb719c1	1.0	PubMed	23152614	We focused on Tat because : 1) Tat enhances activity of GSK3beta which would likely disrupt beta-catenin signaling (XREF_BIBR; XREF_BIBR), 2) Tat is secreted and is internalized by non infected cells (XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR), and 3) Tat has a well established role in promoting HIV neuropathogenesis by enhancing oxidative stress in target cells and inducing gliosis in astrocytes, contributing to neurodegeneration.	p(UP:P04608)	directlyIncreases	act(p(HGNC:GSK3B))
c38b2fd0-3a88-4b8f-a0eb-420fa5d0ae60	1.0	PubMed	18508033	ER stress was experimentally induced by tunicamycin and thapsigargin, but tunicamycin and thapsigargin did not activate GSK3beta in SK-N-MC cells.	a(CHEBI:9516)	directlyIncreases	act(p(HGNC:GSK3B))
c38b2fd0-3a88-4b8f-a0eb-420fa5d0ae60	1.0	PubMed	PMC7075376	Stimulation of apoptotic signaling by treatment with camptothecin or thapsigargin activated GSK3 beta in the nucleus and mitochondria, but not the cytosol, whereas inhibition of GSK3 beta by lithium treatment affected all three pools of GSK3 beta.	a(CHEBI:9516)	directlyIncreases	act(p(HGNC:GSK3B))
3e5bc956-3f6a-46e9-ae7e-aae9198211d5	1.0	PubMed	23077641	Platelet Derived Growth Factor CC Mediated Neuroprotection against HIV Tat Involves TRPC Mediated Inactivation of GSK 3beta.	p(UP:B0CEU2)	directlyIncreases	act(p(HGNC:GSK3B))
0ba90e9d-7801-41ee-93c7-a14b9c3ffd8b	1.0	PubMed	18508033	ER stress was experimentally induced by tunicamycin and thapsigargin, but tunicamycin and thapsigargin did not activate GSK3beta in SK-N-MC cells.	a(CHEBI:29699)	directlyIncreases	act(p(HGNC:GSK3B))
c5b4f661-0c61-432f-9793-f1a39a15d067	1.0	PubMed	26797279	Our data showed that vIRF2 induces activation of PDK1 and Akt, but not GSK3beta, a downstream factor of the Akt signaling pathway (B).	p(UP:Q2HR71)	directlyIncreases	act(p(HGNC:GSK3B))
f00ab2d0-62b8-4769-ac4f-79b9ae5f1bfe	1.0	PubMed	25219467	These findings are inconsistent with a previous study that reported activation of GSK-3beta by wartmannin led to an increase in PME-1 mRNA and a decreased in LCMT-1 mRNA ().	a(PUBCHEM:312145)	directlyIncreases	act(p(HGNC:GSK3B))
e0ed92a4-1f75-4730-9f11-9a8de5655665	1.0	PubMed	16293724	We show that PGE2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor, EP2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase Akt by free G protein betagamma subunits and the direct association of the G protein alphas subunit with the regulator of G protein signaling (RGS) domain of axin. This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:GSK3B, pmod(Ph))	directlyDecreases	act(p(HGNC:GSK3B))
b864c704-e0c7-4e5e-a877-9ebb7f93667a	1.0	PubMed	18045539	In vitro phosphorylations were performed in two stages, and it was found that gsk3b caused the incorporation of [g-32p]atp by smad1 linker protein, but only after prephosphorylation by erk/mapk	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	act(p(HGNC:GSK3B))
3e283ed7-b93c-4a3b-99b2-52d38f0301c1	1.0	PubMed	18451303	Here, we show that p38 mitogen-activated protein kinase (mapk) also inactivates gsk3beta by direct phosphorylation at its c terminus, and this inactivation can lead to an accumulation of beta-catenin.	p(HGNC:GSK3B, pmod(Ph, Ser, 389))	directlyDecreases	act(p(HGNC:GSK3B))
3e283ed7-b93c-4a3b-99b2-52d38f0301c1	1.0	PubMed	17726008	However p38alfa also inactivates gsk3b by direct phosphorilation of the c-terminal residue ser389. this non-canonicl p38 mapk-dependent phosphorilation of gsk3b seems to occur primarily in the brain and thymocytes.	p(HGNC:GSK3B, pmod(Ph, Ser, 389))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3_ or ser9 in gsk3_. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3alpha or ser9 in gsk3beta. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	9736715	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	12629168	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	17485554	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	17490631	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	17182785	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	20827300	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	15207235	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	16799642	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	17107957	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	11584304	S6k then phosphorylates the same serine residue on gsk3 that is targeted by pkb/akt (fig. 1), thereby inhibiting its activity.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	9373175	Evidence that the inhibition of glycogen synthase kinase-3_ by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	9373175	Evidence that the inhibition of glycogen synthase kinase-3_ by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	11584304	S6k then phosphorylates the same serine residue on gsk3 that is targeted by pkb/akt (fig. 1), thereby inhibiting its activity.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	14657655	Phospho-gsk3b-specific antibodies also revolved that lkb1 regulates gsk3b phosphorylation at a known inhibitory site, serine-9. This localized phosphorylation is cdc42 and pkc-zeta-dependent.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	12054501	Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	16543730	Phosphorylation of GSK3 by PKB or SGK1 inhibits GSK3 activity|estern blotting using an antibody specific for the PKB/SGK1 consensus phosphorylation site in GSK3a/beta (serine 21 and 9 respectively) revealed an increase in GSK3a/beta phosphorylation in human embryonic kidney 293 (HEK293) cells overexpressing wild type SGK1, constitutively active SGK1, but not catalytically inactive SGK1.|The effect of SGK1 was mimicked by PKB and SGK3.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	16914735	Gckr can phosphorylate an n-terminal recombinant fusion protein of gsk3_ and enhance the in vivo phosphorylation of gsk3_ on serine 9reduction of gckr expression inhibits wnt3a-induced phosphorylation of gsk3_ at serine 9 and decreases the accumulation of cytosolic _-catenin.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
1deefd89-f63d-4c9c-a29f-454f7a8249de	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3_ or ser9 in gsk3_. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	act(p(HGNC:GSK3B))
2b95e682-44b7-4be2-8a5d-9fb6adb8204e	1.0	PubMed	16039586	Erk, which is activated by hbx, associates with gsk-3beta through a docking motif ((291)fkfp) of gsk-3beta and phosphorylates gsk-3beta at the (43)thr residue, which primes gsk-3beta for its subsequent phosphorylation at ser9 by p90rsk, resulting in inactivation of gsk-3beta and upregulation of beta-catenin.	p(HGNC:GSK3B, pmod(Ph, Thr, 43))	directlyDecreases	act(p(HGNC:GSK3B))
2b95e682-44b7-4be2-8a5d-9fb6adb8204e	1.0	PubMed	16039586	Erk, which is activated by hbx, associates with gsk-3beta through a docking motif ((291)fkfp) of gsk-3beta and phosphorylates gsk-3beta at the (43)thr residue, which primes gsk-3beta for its subsequent phosphorylation at ser9 by p90rsk, resulting in inactivation of gsk-3beta and upregulation of beta-catenin.	p(HGNC:GSK3B, pmod(Ph, Thr, 43))	directlyDecreases	act(p(HGNC:GSK3B))
430b77c0-aebc-4fa8-b0f4-9d02e92654d9	1.0	PubMed	15020233	In vitro kinase assay was carried out using a recombinant human active mek1 and we found that gsk-3beta was phosphorylated on tyr(216) by this kinase in a dose- and time-dependent manner. Further, the pretreatment of fibroblasts with u0126 inhibited serum-induced nuclear translocation of gsk-3beta. These results suggested that mek1/2 induces tyrosine phosphorylation of gsk-3beta and this cellular event might induce nuclear translocation of gsk-3beta.	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))	directlyIncreases	act(p(HGNC:GSK3B))
430b77c0-aebc-4fa8-b0f4-9d02e92654d9	1.0	PubMed	20331603	Phosphorylation of the residue Tyrosine in 216 position results in the constitutive activity of GSK-3beta and believed to be important target for signal transduction.	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))	directlyIncreases	act(p(HGNC:GSK3B))
430b77c0-aebc-4fa8-b0f4-9d02e92654d9	1.0	PubMed	14570592	However, in the present study, we clearly demonstrate that GSK3_ is capable of catalysing the autophosphorylation of Tyr216 in vitro.	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))	directlyIncreases	act(p(HGNC:GSK3B))
430b77c0-aebc-4fa8-b0f4-9d02e92654d9	1.0	PubMed	15020233	In vitro kinase assay was carried out using a recombinant human active mek1 and we found that gsk-3beta was phosphorylated on tyr(216) by this kinase in a dose- and time-dependent manner. Further, the pretreatment of fibroblasts with u0126 inhibited serum-induced nuclear translocation of gsk-3beta. These results suggested that mek1/2 induces tyrosine phosphorylation of gsk-3beta and this cellular event might induce nuclear translocation of gsk-3beta.	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))	directlyIncreases	act(p(HGNC:GSK3B))
f2526896-9ba4-4f16-a6c6-7b0bf524a72e	1.0	PubMed	10911903	It has been found that a multiprotein complex assembled by the cytoplasmic component conductin induces degradation of cytoplasmic beta-catenin. The complex includes apc, the serine/threonine kinase gsk3 beta, and beta-catenin, which bind to conductin at distinct domains.	complex(p(HGNC:GSK3B), p(HGNC:AXIN2))	directlyIncreases	act(p(HGNC:GSK3B))
0884c2c3-a340-4b4c-a111-fde37fa773ff	1.0	PubMed	14657655	Phospho-gsk3b-specific antibodies also revolved that lkb1 regulates gsk3b phosphorylation at a known inhibitory site, serine-9. This localized phosphorylation is cdc42 and pkc-zeta-dependent.	complex(p(HGNC:GSK3B), p(HGNC:CDC42))	directlyDecreases	act(p(HGNC:GSK3B))
e8f40c75-3a3b-417d-8292-3641c3265952	1.0	PubMed	19293931	In the absence of secreted wnt ligands, cytosolic beta-catenin is phosphorylated at ser45 by the priming kinase casein kinase 1 (ck1). Consequently, glycogen synthase kinase 3 (gsk3), in complex with axin and adenomatous polyposis coli (apc), phosphorylates beta-catenin at thr41, ser37, and ser33  apc cooperates with axin to promote the phosphorylation of b-catenin by gsk3 [which requires priming phosphorylation by casein kinase 1, alpha-isoform (ck1alpha)]	complex(p(HGNC:GSK3B), p(HGNC:CSNK1A1))	directlyIncreases	act(p(HGNC:GSK3B))
e8f40c75-3a3b-417d-8292-3641c3265952	1.0	PubMed	22083140	In the absence of secreted wnt ligands, cytosolic beta-catenin is phosphorylated at ser45 by the priming kinase casein kinase 1 (ck1). Consequently, glycogen synthase kinase 3 (gsk3), in complex with axin and adenomatous polyposis coli (apc), phosphorylates beta-catenin at thr41, ser37, and ser33  apc cooperates with axin to promote the phosphorylation of b-catenin by gsk3 [which requires priming phosphorylation by casein kinase 1, alpha-isoform (ck1alpha)]	complex(p(HGNC:GSK3B), p(HGNC:CSNK1A1))	directlyIncreases	act(p(HGNC:GSK3B))
4a4d6692-ef94-4d4c-9643-fe96a97be775	1.0	PubMed	20837657	In canonical wnt signaling, dsh phosphorylation inhibits the apcaxingsk3 complex, leading to beta-catenin stabilization.	complex(p(HGNC:GSK3B), p(HGNC:DVL1))	directlyDecreases	act(p(HGNC:GSK3B))
89bd2aa0-d500-42cc-927c-5ea0f6434a7e	1.0	PubMed	9635432	The frat family consists of three members: frat-1, -2, and -3. It has been shown that different sites of frat-1 interact with gsk-3 and dvl-1 and that wnt-1 disintegrates the complex formation of frat-1, dvl-1, and axin, resulting in the activation of the wnt signaling pathway	complex(p(HGNC:GSK3B), p(HGNC:FRAT1))	directlyIncreases	act(p(HGNC:GSK3B))
68eea050-0646-4191-be7e-607ba42a6472	1.0	PubMed	11738041	The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.	complex(p(HGNC:GSK3B), p(HGNC:FRAT2))	directlyDecreases	act(p(HGNC:GSK3B))
696d6af2-4c17-495e-bacc-c9a662a510fa	1.0	PubMed	PMC3216082	Recombinant GSK-3 beta autophosphorylated on Ser, Thr, and Tyr residues although the enzyme already contained Tyr(P) as judged by its recognition by anti-Tyr(P) antibodies.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
0aff419c-cd70-4da6-8e1c-2aea222b472e	1.0	PubMed	PMC3216082	Recombinant GSK-3 beta autophosphorylated on Ser, Thr, and Tyr residues although the enzyme already contained Tyr(P) as judged by its recognition by anti-Tyr(P) antibodies.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr))
70e01b77-3ad2-411a-90a4-cbcd42ef59cb	1.0	PubMed	PMC3216082	Recombinant GSK-3 beta autophosphorylated on Ser, Thr, and Tyr residues although the enzyme already contained Tyr(P) as judged by its recognition by anti-Tyr(P) antibodies.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
15ca55f1-0f71-4295-b39d-766871ea62ad	1.0	PubMed	16507111	In contrast, expression of wild-type GSK3beta, which is inhibited by Akt activity, failed to significantly reduce reporter activity.	p(FPLX:AKT)	directlyDecreases	p(HGNC:GSK3B)
0cef1baa-2610-4cff-a950-0999e81ced13	1.0	PubMed	20457218	Overexpression of beta-arrestin 2 decreased the percentage of apoptosis and caspase-3 activation and attenuated resveratrol reduced levels of p-Akt and p-GSK3beta.	p(HGNC:ARRB2)	directlyDecreases	p(HGNC:GSK3B)
6dcb7392-4ddb-4130-855e-4aa05ed35408	1.0	PubMed	15652488	PI3-kinase inhibitor (wortmannin) inhibited NT-3- and BDNF induced decrements of the phosphorylation levels of CRMP-2 and increments of the phosphorylation levels of GSK-3beta and Akt.	p(HGNC:BDNF)	directlyDecreases	p(HGNC:GSK3B)
3b2ff107-d7c1-42e1-ba6d-17380ade182a	1.0	PubMed	19823589	Downregulation of Bmi1 reduced GSK3beta levels and induced the differentiation of malignant glial cells.	p(HGNC:BMI1)	directlyDecreases	p(HGNC:GSK3B)
3b2ff107-d7c1-42e1-ba6d-17380ade182a	1.0	PubMed	19823589	Screening of several key proteins controlling cell cycle, development, metabolism, apoptosis and growth, including Erk, Akt, GSK3beta, p16 and p14, Bcl-2, c-Myc, Nestin and Sox2, showed that downregulation of Bmi1 reduced GSK3beta protein levels and induced differentiation in cancer cells.	p(HGNC:BMI1)	directlyDecreases	p(HGNC:GSK3B)
5de298b7-3ec8-41e4-bc9b-1c347aa28446	1.0	PubMed	23076981	CD82 inhibits GSK-3beta and CK1alpha expression.	p(HGNC:CD82)	directlyDecreases	p(HGNC:GSK3B)
5de298b7-3ec8-41e4-bc9b-1c347aa28446	1.0	PubMed	23076981	The protein levels of GSK-3beta and CK1alpha were downregulated by CD82 and this effect was reverted by knocking down CD82.	p(HGNC:CD82)	directlyDecreases	p(HGNC:GSK3B)
1af7eed4-13b1-40be-96b7-93611fa7ea9d	1.0	PubMed	25305448	In our study, both mutated K-ras and CDK8 inhibited the expression of GSK-3beta and Axin2, thereby increasing the expression of both T-beta-catenin and N-beta-catenin.	p(HGNC:CDK8)	directlyDecreases	p(HGNC:GSK3B)
f5b44207-abad-4cb1-b435-1b54dd6361fe	1.0	PubMed	24501326	Furthermore, TNF-alpha-mediated downregulation of CDX2 was found to significantly decrease the mRNA levels of adenomatous polyposis coli (APC), axis inhibition protein 2 (AXIN2) and glycogen synthase kinase-3 beta (GSK3beta), whereas the mRNA levels of Wnt targets were significantly elevated in TNF-alpha-treated Caco-2 cells.	p(HGNC:CDX2)	directlyDecreases	p(HGNC:GSK3B)
da01e715-c593-4491-93c1-89cc7014c1e8	1.0	PubMed	21715663	No evidence text.	act(p(HGNC:CHRNA7), ma(tscript))	directlyDecreases	p(HGNC:GSK3B)
da01e715-c593-4491-93c1-89cc7014c1e8	1.0	PubMed	21715663	No evidence text.	act(p(HGNC:CHRNA7), ma(tscript))	directlyDecreases	p(HGNC:GSK3B)
54eee32e-c4d2-47b9-ab5f-730c2f887ade	1.0	PubMed	21715663	No evidence text.	act(p(HGNC:CHRNB2), ma(tscript))	directlyDecreases	p(HGNC:GSK3B)
54eee32e-c4d2-47b9-ab5f-730c2f887ade	1.0	PubMed	21715663	No evidence text.	act(p(HGNC:CHRNB2), ma(tscript))	directlyDecreases	p(HGNC:GSK3B)
62ae0b5a-daeb-4eee-902d-1f869dc4e73d	1.0	PubMed	25066487	In addition, miR-26a overexpression in CM 's decreased GSK3beta protein expression suggesting a role for GSK3beta in miR-26a-mediated apoptosis in cardiac myocytes.	a(PUBCHEM:23979)	directlyDecreases	p(HGNC:GSK3B)
24ad8870-58ec-4193-bff3-498899325ced	1.0	PubMed	27529071	Upregulation of beta-catenin expression in SCC-25 cells led to an overexpression of GSK-3beta and C-myc [XREF_BIBR], whereas downregulation of beta-catenin expression led to lower expression levels of GSK-3beta and C-myc.	p(HGNC:CTNNB1)	directlyDecreases	p(HGNC:GSK3B)
8e4762c7-ac93-4019-8bf5-e76616b24cdd	1.0	PubMed	25145299	Overexpression of CXCR4 promoted GSK3beta expression and silencing of CXCR4 suppressed GSK3beta expression.	p(HGNC:CXCR4)	directlyDecreases	p(HGNC:GSK3B)
d5282e45-cc4a-4fcb-8b0a-419ed7b2e6f5	1.0	PubMed	25940701	Ectopic expression of DACH1 significantly inhibited the p-GSK3beta levels without affecting total GSK3beta.	p(HGNC:DACH1)	directlyDecreases	p(HGNC:GSK3B)
9f17e62f-42a7-42fe-8af6-238c7e00f99d	1.0	PubMed	26646542	Importantly, the upregulation of DANCR significantly decreased the expression levels of p-GSK-3beta and beta-catenin expression indicating that lncRNA DANCR can inhibit the activation of the Wnt and beta-catenin signal pathway during the odontoblast like differentiation of hDPCs.	p(HGNC:DANCR)	directlyDecreases	p(HGNC:GSK3B)
0d082da8-0c0e-4288-9e53-1332bdf4c248	1.0	PubMed	23644467	DDR2 depletion in unstimulated cells decreased the level of inhibited GSK3beta, however when these cells were added to collagen I the level of pS9-GSK3beta increased to the same extent as in control cells (XREF_FIG).	p(HGNC:DDR2)	directlyDecreases	p(HGNC:GSK3B)
96fdf1ce-2b6c-47d6-9003-d3dec100b123	1.0	PubMed	28097141	Emodin Decreased the Expression of ILK, p-GSK-3beta, beta-Catenin, and Slug in A2780 and SK-OV-3 Cells.	a(PUBCHEM:25201450)	directlyDecreases	p(HGNC:GSK3B)
470c731a-3035-4497-a0cd-74e194ed18ad	1.0	PubMed	7220036	Folic acid treatment significantly reduced nuclear expression of beta-catenin (P < 0.05) and cellular expression of pGSK3beta (P < 0.01) when compared to placebo.	a(PUBCHEM:6037)	directlyDecreases	p(HGNC:GSK3B)
f9a88d52-9b55-42ce-9c20-f97198a818a5	1.0	PubMed	23582741	Expression of GSK-3beta S9A prevents the FasL induced increase in beta-catenin expression (a).	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	p(HGNC:CTNNB1)
2bc451b8-1cb8-48e1-aa91-24e6857805bf	1.0	PubMed	22096483	The increased expression of GSK-3beta (S9P) inhibits the expression of pSAPK and JNK, enhancing G3-cell survival.	p(HGNC:GSK3B, var(p.Ser9Pro))	directlyDecreases	p(FPLX:JNK)
80b7c2a3-705d-4c22-be63-129b66e3598f	1.0	PubMed	16982692	A significant decrease in MRP2 expression levels was observed following GSK3beta inhibition, which was correlated with the inhibited neurite outgrowth, while GSK3beta overexpression was found to increase MRP2 expression levels.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:ABCC2)
dcf8b954-c06a-4905-ad2b-2ee1738e97e7	1.0	PubMed	21658600	Knock-down of each GSK-3alpha or GSK-3beta expression partly reduced PUMA protein expression (XREF_FIG, lanes 2, 6, 8), indicating that both GSK-3 isoforms contribute to PUMA induction.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:BBC3)
4da874e9-e332-40cb-b1d7-fcff4dae546c	1.0	PubMed	27572267	Overexpression of both GSK3beta and beta-TrCP reduced PD-L1 4NQ (arrowhead) expression but not PD-L1 WT (black dot) when coexpressing PD-L1 WT and 4NQ together in the assay (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CD274)
d5873b0e-e923-42f3-a0f7-fedac8446c80	1.0	PubMed	26388612	These results showed that ectopic expression of GSK-3beta decreased the phosphorylation of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
617d0c84-7c2d-462e-903c-7fc9eb16f856	1.0	PubMed	26388612	Ectopic expression of GSK-3beta decreased the phosphorylation levels of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:HIF1A)
617d0c84-7c2d-462e-903c-7fc9eb16f856	1.0	PubMed	26388612	These results showed that ectopic expression of GSK-3beta decreased the phosphorylation of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:HIF1A)
617d0c84-7c2d-462e-903c-7fc9eb16f856	1.0	PubMed	26388612	Overexpression of GSK-3beta is sufficient to decrease HIF-1alpha level.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:HIF1A)
cd9bb9d4-0db8-41ce-ab8a-e5d1d0fdcf3f	1.0	PubMed	26388612	Ectopic expression of GSK-3beta decreased hemoglobin levels by 35% compared to the GFP group.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:Hemoglobin)
32977258-9ad9-46f3-8836-15e3d9276dfb	1.0	PubMed	21763505	As shown in f, overexpression of GSK-3beta decreased the protein expression of vIL-6.	p(HGNC:GSK3B)	directlyDecreases	p(UP:Q2HRC7)
4b7ab92a-cac0-40d8-b418-e5f01e72fc60	1.0	PubMed	6563209	Moreover, the amount of tau associated with microtubules was reduced by overexpression of GSK3beta but only when tau was phosphorylated at primed sites, as phosphorylation of tau by GSK3beta-R96A did not negatively regulate the association of tau with microtubules.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MAPT)
8724b86e-ad5a-48ef-b8ef-9cd314f042c2	1.0	PubMed	26388612	Ectopic expression of GSK-3beta decreased the phosphorylation levels of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MTOR)
0a7159a8-f0b3-4f49-8972-6bc908b77c86	1.0	PubMed	6906012	Consequently, the GSK-3 beta protein level increased, resulting in the destabilization of beta-catenin and the subsequent suppression of cyclin D1 and c-myc expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MYC)
0a7159a8-f0b3-4f49-8972-6bc908b77c86	1.0	PubMed	22025562	We found that GLIPR1 expression and CK1alpha expression led to similarly reduced c-Myc protein, but GSK3beta expression reduced c-Myc levels to a lesser extent (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MYC)
143ba76b-82e7-47aa-aa71-48c28435888d	1.0	PubMed	26157031	WT GSK3beta overexpression decreased PIAS1 protein levels in a dose dependent manner; however, PIAS1 protein levels decreased more markedly when we transfected cells with a constitutively activated GSK3beta hypermutant plasmid (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PIAS1)
b03cec61-af88-4c41-a092-fcb30e99da5e	1.0	PubMed	27162139	WT GSK3beta overexpression decreased PIAS4 protein levels in a dose dependent manner, and PIAS4 protein levels decreased more dramatically when we transfected cells with a constitutively activated GSK3beta hyper mutant plasmid (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PIAS4)
ea9f013c-becf-4f2b-ad53-255550a7fad7	1.0	PubMed	25219467	We found that GSK-3beta overexpression supressed PME-1 expression and that GSK-3beta knockdown promoted PME-1 expression at both messenger RNA (mRNA) and protein levels (, C and D).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PPME1)
ea9f013c-becf-4f2b-ad53-255550a7fad7	1.0	PubMed	25219467	Overexpression of GSK-3beta suppressed PME-1 expression, whereas its knockdown led to an increase in PME-1 level.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PPME1)
b63e6489-485f-4a74-8788-fc6e7138592a	1.0	PubMed	26388612	Ectopic expression of GSK-3beta decreased the phosphorylation levels of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:RPS6KB1)
b09d6088-8d23-4232-be98-1995dc26643a	1.0	PubMed	26542806	Furthermore, overexpression of either Fbw7alpha or GSK3beta was sufficient to down-regulate endogenous Runx2 expression and function; however, both failed to inhibit endogenous Runx2 when either of them was depleted in osteoblasts.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:RUNX2)
bd5f66b9-3083-4685-a79d-79b4116d3c0a	1.0	PubMed	20599907	Overexpression of GSK3beta reduces the amount of Smad3 in the nucleus and inhibits Smad3 mediated transcription and apoptosis may be the corporative effect of GSK3beta by phosphorylation of Smad3 at Thr66 to promote its degradation and interaction with Smad3 to sequester it outside the nucleus.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SMAD3)
66fd4ede-6b1f-42b1-8314-3c03126a23e7	1.0	PubMed	16601113	Using adenoviruses in lipopolysaccharide stimulated mice, overexpression of GSK-3beta significantly decreased TNF-alpha expression in lung and heart tissues (38 and 15%, respectively), further confirming the anti-inflammatory role of GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:TNF)
173a52e7-c891-421f-a2f9-0d4d04df1228	1.0	PubMed	26388612	Ectopic expression of GSK-3beta decreased the phosphorylation levels of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:VEGF)
173a52e7-c891-421f-a2f9-0d4d04df1228	1.0	PubMed	26388612	These results showed that ectopic expression of GSK-3beta decreased the phosphorylation of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:VEGF)
173a52e7-c891-421f-a2f9-0d4d04df1228	1.0	PubMed	26388612	Similarly, it was confirmed that VEGF mRNA expression in xenograft tumors were significantly decreased by GSK-3beta overexpression.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:VEGF)
64936c0e-94b9-4497-b3a8-af1fe2b421da	1.0	PubMed	25041379	As stated before, the phosphorylation of GSK-3beta at the serine 9 position inhibits GSK-3beta activity and causes an increase in beta-catenin levels, while phosphorylation at Tyr 216 increases GSK-3beta activity and decreases beta-catenin levels.	p(HGNC:GSK3B, pmod(Ph, 9))	directlyDecreases	p(HGNC:CTNNB1)
cb11136a-4da0-4911-878d-8b37f6e0656b	1.0	PubMed	23575666	Our results show that GSK-3beta phosphorylation attenuates C/EBPdelta levels in untreated macrophages.	p(HGNC:GSK3B, pmod(Ph))	directlyDecreases	p(HGNC:CEBPD)
df22d333-c097-47d7-9218-b498db2a2b3f	1.0	PubMed	25662052	We detected elevated levels of phosphorylated Akt in TG sham as the key regulator accountable for (i) increased concentration of phosphorylated GSK3beta, (ii) decreased overall beta-catenin content and (iii) simultaneously elevated levels of beta-catenin phosphorylated at Ser552.Still, regulation of beta-catenin signaling in failing myocardium must be further investigated using cell cultures that allow specific blockade of certain proteins.There is not only one exclusive signaling path mediating hypertrophy and activation of altered gene expression patterns in mammalian hearts.	p(HGNC:GSK3B, pmod(Ph))	directlyDecreases	p(HGNC:CTNNB1)
54ddb4df-1ec0-4860-bf36-8e8e61b1c39f	1.0	PubMed	25333257	In our previous study [XREF_BIBR], we showed that the nuclear expression and transcriptional activity of beta-catenin were increased by inhibitory phosphorylation of GSK-3beta at Ser 9 by FasL induced ERK1/2 MAPK signaling.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	p(HGNC:CTNNB1)
0c62a68c-937e-452c-a722-9c9800613f6d	1.0	PubMed	24915301	Conversely, phosphorylation of GSK3beta at Ser9 by AKT kinase or at Ser389 by p38 mitogen activated protein kinase (MAPK) could inactivate GSK3beta and increase cyclin D1 protein level by reducing degradation XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyDecreases	p(FPLX:Cyclin)
b7bd41ac-1bd5-49c2-b707-de38b29d8d6c	1.0	PubMed	23582741	Exogenous expression of GSK-3beta S9A, which can not be inactivated by phosphorylation at Ser9, in SW480 and AGS cells prevented the FasL induced changes in Snail and E-cadherin expression (c,).	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	p(HGNC:CDH1)
0c3d5389-7aed-4968-ab30-3345c6105351	1.0	PubMed	23582741	Exogenous expression of GSK-3beta S9A, which can not be inactivated by phosphorylation at Ser9, in SW480 and AGS cells prevented the FasL induced changes in Snail and E-cadherin expression (c,).	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	p(HGNC:SNAI1)
f692cb50-f359-4518-b396-4ab7d416d573	1.0	PubMed	22142472	The co-transfection of GSK-3beta (S9A) with STK38 also reduced the expression level of STK38 (A).	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	p(HGNC:STK38)
654fcc76-d8b1-43a8-87f5-82a996d09146	1.0	PubMed	25273023	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:ABCC1)
654fcc76-d8b1-43a8-87f5-82a996d09146	1.0	PubMed	25273023	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:ABCC1)
790aa80d-dbf6-4a93-9401-9030f697a65c	1.0	PubMed	22944069	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:ACHE)
551945c7-715a-4daa-8185-b50a5edce14a	1.0	PubMed	20110283	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:GDF15)
551945c7-715a-4daa-8185-b50a5edce14a	1.0	PubMed	17257745	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:GDF15)
20dc8ac9-6157-428e-ba51-73cc461f3dd0	1.0	PubMed	25246272	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:HMOX1)
20dc8ac9-6157-428e-ba51-73cc461f3dd0	1.0	PubMed	25246272	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:HMOX1)
ff20c891-1231-4809-95cc-f35ae1b0e286	1.0	PubMed	21821001	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:LGALS3)
ff20c891-1231-4809-95cc-f35ae1b0e286	1.0	PubMed	21821001	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:LGALS3)
ff20c891-1231-4809-95cc-f35ae1b0e286	1.0	PubMed	21821001	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:LGALS3)
8881b1da-6fad-4131-9870-853374db6ddb	1.0	PubMed	23164673	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:PARP1)
5b6e5a8b-b700-4b38-9345-37dcd07715e2	1.0	PubMed	23164673	No evidence text.	act(p(HGNC:GSK3B), ma(tscript))	directlyDecreases	p(HGNC:RELA)
cdd9f0c9-4179-489e-b1eb-35003ae3fed3	1.0	PubMed	18252708	GSK-3beta inhibition increased mRNA expression of alpha-actin and transactivation of nuclear factors of activated T cells and serum response factor.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:ACTA2)
4b164364-09a2-4117-801a-4077f488ab99	1.0	PubMed	18328427	Alternatively, inhibition of GSK3beta activity can directly increase AP-1 expression ().	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:AP1)
1564f333-f38e-4938-ad38-3efb621a6329	1.0	PubMed	23026200	deletion was also recently reported to affect APP trafficking to the neuronal surface.We observed a significant decrease of the active form of GSK-3beta (pY216) in mice that might have played a role in reduction of Abeta levels, because a reduction of GSK-3alpha and GSK-3beta activities were reported to reduce Abeta levels in APP mice, although the role of GSK-3 in modulation of APP processing is still a matter of investigation.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:APP)
00f89d5e-66b2-461a-9e41-9f19d149ed5c	1.0	PubMed	27043582	In this study, we found that inhibition of p38 by SB203580, JNK by SP600125, GSK3beta by LiCl, and IKK-alpha by BAY11-7082 attenuates PFF-A-induced ATF3 expression, which p38, JNK, GSK3beta, and IKK-alpha may be important kinases for activating ATF3 expression by PFF-A.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:ATF3)
67bd1ecc-b336-49f4-8bd7-e655e0f2dbf6	1.0	PubMed	24681994	Treatment with lithium, a pharmacological inhibitor of GSK-3beta, could suppress the pro apoptotic pathway by decreasing the expression levels of Bax, but promote anti-apoptotic signaling through increasing Bcl-2 expression (XREF_BIBR - XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:BAX)
ab86b2f8-e99a-4abc-9c14-abe845def8cc	1.0	PubMed	22286758	GSK3beta depletion also significantly reduced the levels of PUMA following sorafenib treatment in both HCT116 and RKO colon cancer cells (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:BBC3)
fb8a1019-8f93-495d-8925-5884a2203635	1.0	PubMed	21795403	Western analysis confirmed that the protein levels of Bcl2 and survivin also were inhibited by GSK3beta inactivation in Jurkat, K562, and RPMI-8226 cells (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:BCL2)
9d513781-be24-4d39-96d9-a5a00cafd134	1.0	PubMed	21795403	Western analysis confirmed that the protein levels of Bcl2 and survivin also were inhibited by GSK3beta inactivation in Jurkat, K562, and RPMI-8226 cells (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:BIRC5)
b23f7057-eded-4415-9c71-ba79e5fa9f7e	1.0	PubMed	26972480	As shown, knockdown of either GSK3beta or hnRNPK significantly increased the level of the cleaved Caspase 3 in Western blotting analyses and also the cell apoptotic rates in FACS assays, whereas the opposing effects were observed when cells were transfected by Flag-GSK3beta or Flag-hnRNPK (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CASP3)
679c7541-7ea4-4142-857a-f8120fb85107	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CCND1)
5b0316b6-2bc5-40b9-a3fe-9f818a3cb0c9	1.0	PubMed	20348946	Here, we report that casein kinase 1 alpha (ck1alpha) phosphorylates cdc25a on both s79 and s82 in a hierarchical manner requiring prior phosphorylation of s76 by chk1 or gsk-3beta. This facilitates beta-trcp binding and ubiquitin-mediated proteolysis of cdc25a	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CDC25A)
8318fad7-090f-4ab9-8251-e9be60e483f1	1.0	PubMed	17283049	Glycogen synthase kinase 3beta phosphorylates p21waf1/cip1 for proteasomal degradation after uv irradiationhere, we show that ser-114 phosphorylation of p21 protein by glycogen synthase kinase 3beta (gsk-3beta) is required for its degradation in response to uv irradiation	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CDKN1A)
7fea6fcf-076a-473d-8e40-1e0482661818	1.0	PubMed	23820376	The fact that increasing doses of GSK3beta or GSK3S9A persistently inhibits the expression of both G-CSFR and G-CSFR-T718 suggests that GSK3beta may phosphorylate G-CSFR probably in its CPDs marking it to be recognized by Fbw7 for efficient degradation.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CSF3R)
03f879c3-c71c-46a8-9bf4-91b714499823	1.0	PubMed	23824844	In adult lung fibroblasts inhibition of GSK-3beta modestly stimulates TGF-beta1-regulated CCN2 and CTGF expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTGF)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	20454507	GSK3beta silencing increased radiation induced beta-catenin target gene expression as measured by studies of AXIN2 and LEF1 transcript levels.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	19717166	More recently, it has been shown that an inhibitor of GSK-3beta, a peptide known as L803-MTS, not only inhibited GSK-3beta but also increased beta-catenin levels and produced antidepressant effects in an animal (mouse) model of depression ().	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	18986540	The activation of the coreceptors leads to stabilization of beta-catenin, indicated by the increase in presynaptic inputs when beta-catenin levels are increased either by inhibition of GSK3beta by LiCl or transfection of a constitutively active form of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	26359353	Desbois-Mouthon et al reported that inhibition of GSK-3beta through LiCl increased the amount of wild-type beta-catenin in cytosolic extracts without modifying the level of truncated beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	23334344	Interestingly, nonspecific GSK3beta inhibition by LiCl upregulated transcription of the prototypic beta-catenin target gene, Axin2 (), whereas the mRNA level of MITF remained low and LiCl treatment did not suffice to reverse the effect of P-cadherin silencing on MITF expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	7060443	GSK 3beta inhibition increased both NFkappaB and beta-catenin activity associated with decreased IkappaB and increased beta-catenin levels.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	18552505	Inhibition of GSK-3beta activity by pharmacological inhibitors rescued the expression and accumulation of beta-catenin in the nucleus and facilitated cell proliferation and growth following HBx induction.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	24993527	SiRNA oligonucleotides targeting GSK-3beta were used to silence endogenous GSK-3beta in HEK293T cells which, as expected, led to increased levels of active beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	25691573	Moreover, an RNA knockdown of GSK3beta using siRNA increased the levels of endogenous beta-catenin in normal glucose conditions but reduced the stability in the glucose deprived state (XREF_FIG D).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	22041457	To explore the possible regulatory effects of beta-catenin on the TGF-beta1 induced phenotypic change of dermal fibroblasts, an inhibitor of GSK-3beta, SB-216763, was used to increase cytoplasmic beta-catenin level.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	26274564	Reconstitution of the GSK3beta KO/GSK3alpha KD MEFs with WT HA-GSK3beta reduced the basal level of beta-catenin to the level comparable to WT MEFs (XREF_FIG, comparing lanes 1, 5 and 7), likely due to the restoration of GSK3 mediated phosphorylation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
b9e427ef-d3ed-4a7f-9e66-f2cf69c8b369	1.0	PubMed	24333432	Levels of beta-catenin, a putative GSK3beta target gene, were increased by GSK3beta inhibition.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1)
389717e1-5c9b-43e5-942c-2def761b2795	1.0	PubMed	22863953	Therefore, we investigated the effect of GSK3beta suppression on levels of phosphorylated and total cofilin in U937 cells and showed that GSK3beta inhibition increased the amount of phosphorylated cofilin, without a significant change in total cofilin ().	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:Cofilin, pmod(Ph))
dc7fa92b-d9c0-4f5b-af7d-277156650df9	1.0	PubMed	25591548	GSK-3beta protein also suppresses cyclin D1 transcription through inactivation of beta-catenin, the transcription factor of cyclin D1 (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:Cyclin)
dc7fa92b-d9c0-4f5b-af7d-277156650df9	1.0	PubMed	23383245	GSK-3beta could inhibit cyclin D1 gene transcription by inaction of its transcription factor beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:Cyclin)
dc7fa92b-d9c0-4f5b-af7d-277156650df9	1.0	PubMed	24038789	SDF1 mediated CK1alpha downregulation and increase in GSK3beta activity affected cell cycle through Bmi-1 downregulation, increased cyclin D1 phosphorylation, and decreased cyclin D1 levels.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:Cyclin)
dc7fa92b-d9c0-4f5b-af7d-277156650df9	1.0	PubMed	17437044	Further, the expression of cyclin D1 was down-regulated by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:Cyclin)
36f3fa2e-0840-4940-b0a0-32552f6129ee	1.0	PubMed	25941117	In this sense, cyclin E levels are negatively regulated by GSK-3beta, which phosphorylates it promoting its proteasomal degradation XREF_BIBR XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:"Cyclin_E")
68dba09c-f722-4b2c-a829-a91688695ddd	1.0	PubMed	24025791	Knockdown of GSK3beta, PI3K, and JAK2 significantly reduced DRP1 expression by 63.4% (< 0.01), 62.9% (< 0.01) and 50.7% (< 0.05), respectively (A and B).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:DNM1L)
941e35be-a215-49de-9ae4-67fa317aa046	1.0	PubMed	27232758	As for FBW7 overexpression, the introduction of exogenous GSK3beta in HeLa cells decreased the endogenous FAAP20 levels in a dose dependent manner.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:FAAP20)
941e35be-a215-49de-9ae4-67fa317aa046	1.0	PubMed	27232758	Furthermore, GSK3beta was able to decrease the cellular FAAP20 levels when overexpressed in wild-type, but not in FBW7 -/- HCT116 cells, indicating that GSK3beta requires downstream FBW7 to regulate the FAAP20 stability.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:FAAP20)
13033c3d-82bf-47c7-b362-1a9d0a4d94e7	1.0	PubMed	20541704	Its levels decreased almost 3 fold compared to much more modest or no decreases of other FOS or JUN family genes (XREF_SUPPLEMENTARY), as confirmed by quantitative PCR in cells treated with two different GSK-3 inhibitors (XREF_FIG), and consistent with observations that GSK-3beta deficiency substantially reduces FOS expression (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:"FOS_family")
a17d0ae5-bee1-4615-ab74-a3617e88fe13	1.0	PubMed	5921692	Overexpression of GSK3beta suppressed both basal and beta-adrenergic increases in nuclear expression of GATA4, whereas inhibition of GSK3beta by LiCl caused nuclear accumulation of GATA4, suggesting that GSK3beta negatively regulates nuclear expression of GATA4.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GATA4)
a17d0ae5-bee1-4615-ab74-a3617e88fe13	1.0	PubMed	5921692	These results suggest that GSK3beta negatively regulates nuclear expression of GATA4 by stimulating Crm1 dependent nuclear export.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GATA4)
56920d13-625c-4034-9551-d8771c01b2a4	1.0	PubMed	19244133	Inhibition of GSK3beta in 293T cells also increased protein levels of GLI1.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GLI1)
3f96a935-52a0-4bee-84eb-1027a518c2b3	1.0	PubMed	16611981	The degradation of Gli2 requires the phosphorylation of a cluster of numerous serine residues in its carboxyl terminus by protein kinase A and subsequently by casein kinase 1 and glycogen synthase kinase 3.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GLI2)
3f96a935-52a0-4bee-84eb-1027a518c2b3	1.0	PubMed	16611981	The degradation of Gli2 requires the phosphorylation of a cluster of numerous serine residues in its carboxyl terminus by protein kinase A and subsequently by casein kinase 1 and glycogen synthase kinase 3.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GLI2)
3f96a935-52a0-4bee-84eb-1027a518c2b3	1.0	PubMed	16611981	The degradation of Gli2 requires the phosphorylation of a cluster of numerous serine residues in its carboxyl terminus by protein kinase A and subsequently by casein kinase 1 and glycogen synthase kinase 3.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GLI2)
48ffdb7d-042f-4a41-8c7e-18e64b646bdc	1.0	PubMed	11955435	We show that these phosphoserines prime further phosphorylation at adjacent Glycogen Synthase Kinase 3 (GSK3) and Casein Kinase I (CK1) sites. Alteration of the GSK3 or CK1 sites prevents Ci-155 proteolysis and activates Ci in the absence of Hedgehog.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GLI3)
48ffdb7d-042f-4a41-8c7e-18e64b646bdc	1.0	PubMed	16885213	Gli2 and Gli3 (in vertebrates) are phosphorylated by protein kinase A and glycogen synthase kinase-3_ and are proteolytically processed	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GLI3)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	20205745	Moreover, downregulation of GSK3beta expression by specific GSK3beta siRNA also significantly enhanced and prolonged the phosphorylation of H2AX in response to irradiation and in G2/M phase cells (data not shown).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	21868755	In H358 cells, GSK3alpha siRNA reduced the levels of GSK3alpha only, whereas GSK3beta siRNA (# 1) reduced the levels of not only GSK3beta, but also GSK3alpha (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	25145299	Overexpression of CXCR4 promoted GSK3beta expression and silencing of CXCR4 suppressed GSK3beta expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	27470346	Collectively, all these findings suggested that miR-769 probably regulated cell growth through GSK3B.To further confirm the effect of GSK3B on human melanoma cell proliferation, specific siRNAs of GSK3B were used to suppress GSK3B expression in miR-769-in-transfected A375 cells, respectively (A).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	20519433	Because cycloheximide and GSK3beta and CKI inhibition effectively depleted the amount of GSK3beta and CKI-P-APC in cell extracts, it is likely the remaining APC at the lateral membrane is not phosphorylated by these kinases and corresponds to the faster migrating APC band on Western blots (XREF_FIG C).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	25528666	We confirmed that transfection of the GSK3beta siRNA into Neuro2A cells effectively reduced the expression levels of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	22039301	As shown in XREF_FIG, GSK3beta targeted shRNA substantially decreased the expression of GSK3beta in the HMC1.2 cells without reducing the expression of the internal controls, KIT and Syk.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	17241872	Transfection of GSK3beta specific siRNA into SW480 cells successfully decreased both mRNA and protein expression of GSK3beta in SW480 cells ().	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	25219467	These data demonstrated that GSK-3beta promotes PP2Ac methylation both invitro and invivo.To further confirm the role of GSK-3beta in PP2Ac methylation, we used siRNA to knockdown GSK-3beta expression specifically (A and B) and measured PP2Ac methylation.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	20205745	Moreover, downregulation of GSK3beta expression by specific GSK3beta siRNA also significantly enhanced and prolonged the phosphorylation of H2AX in response to irradiation and in G2/M phase cells (data not shown).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	21868755	In H358 cells, GSK3alpha siRNA reduced the levels of GSK3alpha only, whereas GSK3beta siRNA (# 1) reduced the levels of not only GSK3beta, but also GSK3alpha (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	25145299	Overexpression of CXCR4 promoted GSK3beta expression and silencing of CXCR4 suppressed GSK3beta expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	27470346	Collectively, all these findings suggested that miR-769 probably regulated cell growth through GSK3B.To further confirm the effect of GSK3B on human melanoma cell proliferation, specific siRNAs of GSK3B were used to suppress GSK3B expression in miR-769-in-transfected A375 cells, respectively (A).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	20519433	Because cycloheximide and GSK3beta and CKI inhibition effectively depleted the amount of GSK3beta and CKI-P-APC in cell extracts, it is likely the remaining APC at the lateral membrane is not phosphorylated by these kinases and corresponds to the faster migrating APC band on Western blots (XREF_FIG C).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	25528666	We confirmed that transfection of the GSK3beta siRNA into Neuro2A cells effectively reduced the expression levels of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	22039301	As shown in XREF_FIG, GSK3beta targeted shRNA substantially decreased the expression of GSK3beta in the HMC1.2 cells without reducing the expression of the internal controls, KIT and Syk.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	17241872	Transfection of GSK3beta specific siRNA into SW480 cells successfully decreased both mRNA and protein expression of GSK3beta in SW480 cells ().	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
14ac0286-c510-4907-a386-475473993169	1.0	PubMed	25219467	These data demonstrated that GSK-3beta promotes PP2Ac methylation both invitro and invivo.To further confirm the role of GSK-3beta in PP2Ac methylation, we used siRNA to knockdown GSK-3beta expression specifically (A and B) and measured PP2Ac methylation.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:GSK3B)
62a52fe9-de33-42c2-a37a-5f1049c74637	1.0	PubMed	21092141	Depletion of GSK3beta promotes the transcription of human c-Myb and represses the transcription of gamma-globin in K562 cells.	p(HGNC:GSK3B)	directlyDecreases	p(UP:Q45XH8)
30288134-4f9f-430a-a5a5-70d30d1c2a32	1.0	PubMed	24333432	As is reported in other tumors, our research found that in osteosarcoma inhibition of GSK3beta promoted the expression of HIF1alpha and its target genes, which was achieved by regulation of the HIF1alpha mRNA, rather than HIF1alpha protein stability.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:HIF1A)
30288134-4f9f-430a-a5a5-70d30d1c2a32	1.0	PubMed	24333432	Further experiments showed that inhibition of nucleolin could reduce HIF1alpha protein and mRNA levels, suggesting that regulation of HIF1alpha mRNA stability by GSK3beta could be mediated through the regulation of nucleolin.Current evidence suggests that in the MG63 osteosarcoma cell line, inhibition of GSK3beta could increase HIF1alpha protein levels and the expression of its target genes by increasing the stability of the HIF1alpha mRNA, not by affecting the HIF1alpha protein stability, and that this process could be mediated by nucleolin.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:HIF1A)
30288134-4f9f-430a-a5a5-70d30d1c2a32	1.0	PubMed	25396735	In contrast, the stability of HIF-1alpha is directly regulated by GSK-3beta-mediated phosphorylation : the inhibition or depletion of GSK-3beta increases HIF-1alpha levels, whereas the overexpression of GSK-3beta reduces HIF-1alpha levels XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:HIF1A)
30288134-4f9f-430a-a5a5-70d30d1c2a32	1.0	PubMed	18804163	We did examine two proteins that are known to be responsive to TPO and have been shown to be targets by GSK-3beta in other settings; however inhibition of GSK-3beta did not significantly increase protein levels of cyclin D1 or HIF-1alpha in UT-7 and TPO cells and therefore analysis of additional candidates is necessary.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:HIF1A)
843b3186-5588-4f3a-b831-a138d00d61a8	1.0	PubMed	26522589	Depleting RHAMM with shRNAs enhanced GSK3beta inhibitory phosphorylation but the GSK3beta inhibitor did not modulate RHAMM expression (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:HMMR)
3ce2fb81-abe7-4139-8626-41332bc607a8	1.0	PubMed	26022178	Using NK92 cell line, we observed that GSK-3beta knockdown also significantly enhanced the expression of IFN-gamma by CD16.NK-92 cells transduced to express CD16 receptor upon stimulation with K562 target cells and CD16 (Supplemental Fig. 4).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:IFNG)
daeadaba-dfcd-40ac-a88d-fe1829e7c1a1	1.0	PubMed	19734233	Furthermore, ectopic expression of a constitutively active form of GSK3beta attenuated the increased levels of IL-10 produced by CD4 + T cells stimulated in the presence of IL-12p70.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:IL10)
5f349fbd-4638-4ec5-9998-1e2d53335369	1.0	PubMed	23737552	In studying the activation of the C/EBP transcription factors, we found that IL-17-dependent phosphorylation of C/EBPbeta by GSK-3beta inhibits the expression of IL-17 target genes (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:IL17A)
5f349fbd-4638-4ec5-9998-1e2d53335369	1.0	PubMed	19244213	Collectively, these data show that ERK and GSK3beta repress or at least help to limit IL-17 target gene expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:IL17A)
78dc05a6-8560-4682-bf85-1a74cff03a23	1.0	PubMed	21700708	Inhibition of GSK-3beta by pharmacological inhibitors or siRNA mediated knockdown significantly prevented NO donor induced reduction in IRS-2 expression in beta-cells.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:IRS2)
e10a09cb-ef8d-4884-a743-70a95254d603	1.0	PubMed	21145761	Another study demonstrates that GSK3beta negatively regulates TLR4 mediated IFN-beta production by regulating c-Jun expression ().	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:JUN)
f38c92e0-481f-4031-bb89-16cc64d06c61	1.0	PubMed	23085750	Western blot demonstrated an increase in endogenous KLF6 hyperphosphorylated band intensity following both HA-GSK3beta and HA-GSK3beta-S9A transfection, whereas the dominant negative GSK3beta was unable to increase KLF6 protein levels (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:KLF6)
a81fe882-738f-4c38-8473-e47638f0771b	1.0	PubMed	24531650	As shown, H 2 O 2 or Antimycin A treatment can substantially increase the release of LDH from the human hepatocyte cells; in contrast, inhibition GSK3beta with SB216763 significantly decreased LDH levels of hepatocyte treated by H 2 O 2 or Antimycin A.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:LDH)
9aef6a27-091a-4499-8db5-6d009731cc7a	1.0	PubMed	22193544	This indicates that SH-SY5Y cell differentiation requires WWOX protein expression and lower pTau S396 and pTau S404 levels, possibly caused by the inhibition of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MAPT)
a4574540-5611-409b-b5aa-33569e6a2c27	1.0	PubMed	16543145	MCL-1 was phosphorylated by GSK-3 at a conserved GSK-3 phosphorylation site (S159). S159 phosphorylation of MCL-1 was induced by IL-3 withdrawal or PI3K inhibition and prevented by AKT or inhibition of GSK-3, and it led to increased ubiquitinylation and degradation of MCL-1.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MCL1)
a4574540-5611-409b-b5aa-33569e6a2c27	1.0	PubMed	26252009	Our data also confirmed that GSK-3beta activation by embelin mediated Akt inhibition suppresses Mcl-1 expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MCL1)
8900697d-a362-47f1-b757-d40d6419c89b	1.0	PubMed	26526575	Besides, GSK-3beta small interfering RNA (siRNA) transfection in ovarian cancer cells also downregulated GSK-3beta, cyclin D1, and MMP9 protein expression while upregulated p21 expression.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MMP9)
6f78b8e2-8a77-46d3-a8a1-c3398eff7e12	1.0	PubMed	11018017	Phosphorylation of Thr 58, likely mediated by GSK-3 but dependent on the prior phosphorylation of Ser 62, is associated with degradation of Myc.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MYC)
6f78b8e2-8a77-46d3-a8a1-c3398eff7e12	1.0	PubMed	16023596	Similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MYC)
6f78b8e2-8a77-46d3-a8a1-c3398eff7e12	1.0	PubMed	14563837	Conversely, overexpression of gsk-3 alpha or gsk-3 beta enhances thr-58 phosphorylation and ubiquitination of c-myc	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MYC)
e37befcb-9ed6-49fd-a6c1-de4805d7cc81	1.0	PubMed	25042702	Instead, these results are consistent with the model that GSK3-beta signaling inhibits NANOG expression via TCF7L1, which can also interfere with beta-CATENIN binding and function ().	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:NANOG)
e37befcb-9ed6-49fd-a6c1-de4805d7cc81	1.0	PubMed	25042702	This argues against the possibility that GSK3-beta inhibition impacts on NANOG expression by interfering with SMAD2 and SMAD3 signaling.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:NANOG)
badb487f-1914-4859-b1c4-f92091f1fc93	1.0	PubMed	24333432	The manner by which GSK3beta inhibition induces nucleolin expression remains to be elucidated.None.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:NCL)
849d05a3-1621-4b15-983d-25cb33871b7d	1.0	PubMed	22986745	They also show that GSK3B shRNA decreased the protein expression of NFAT1 and its downstream target Cox-2 (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:NFATC2)
c5a5f493-9738-4c93-a219-d1416d656a1a	1.0	PubMed	20599907	The Angiotensin II stimulated transcription of ANF mRNA in H9c2 cells was also reduced by GSK3beta and GSK3beta-K85A (B).	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:NPPA)
c5a5f493-9738-4c93-a219-d1416d656a1a	1.0	PubMed	5474925	Overexpression of GSK3beta inhibited ANF transcription, which was reversed by ISO.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:NPPA)
c5a5f493-9738-4c93-a219-d1416d656a1a	1.0	PubMed	16141410	Myocardin induced ANF transcription and increase in total protein amount were enhanced by GSK3beta blockade (10 mmol/L LiCl), indicating that GSK3beta inhibits myocardin.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:NPPA)
91696ad3-d171-4ff7-8a98-3a970fcb3a94	1.0	PubMed	20140245	However, PDH expression was decreased by PTEN or Gsk3beta siRNA transfection.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:PDH)
c6d3ae4e-0f80-480b-9442-13b205363cc5	1.0	PubMed	20140245	Gsk3beta knockdown slightly increased the expression of PK-M2 in N20 cells, but not in C2 cells (XREF_FIG, right), indicating differences in knockdown efficiency of Gsk3beta or the presence of Gsk3beta independent PK-M2 regulation in C2 cells.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PKM)
ebdea48e-0ccf-4a9f-b0d5-4113ac32dee5	1.0	PubMed	24901984	GSK3beta has therefore been suggested to suppress pol I transcription by repressing assembly of transcription-competent polymerase at rRNA gene promoter in transformed cells.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:POLI)
021affc6-a44a-4be0-9cdb-3199d4862085	1.0	PubMed	25118933	XREF_BIBR, XREF_BIBR GSK3beta reduces PGC-1alpha levels by phosphorylating PGC-1alpha and subsequently stimulating PGC-1alpha degradation by the ubiquitin-proteasomal system.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PPARGC1A)
49c387ca-709c-48fc-b4e6-af5110a50e8e	1.0	PubMed	25219467	In the present study, we found that GSK-3beta promoted PP2Ac methylation by suppressing PME-1 expression and phosphorylating LCMT-1, resulting in an increase of PP2A activity toward tau.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PPME1)
87f59d2b-9409-40eb-b4fa-a7c014850994	1.0	PubMed	16371352	Furthermore, inhibition of glycogen synthase kinase-3beta (GSK-3beta) by SB415286 induced expression of COX-2 mRNA and protein as well as the enzyme activity in the gastric cancer cells.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PTGS2)
87f59d2b-9409-40eb-b4fa-a7c014850994	1.0	PubMed	16371352	Our data show that inhibition of GSK-3beta stimulates COX-2 expression in gastric cancer cells, which seems to be primarily facilitated via an increase in mRNA stability and to a lesser extent through enhanced transcription.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PTGS2)
87f59d2b-9409-40eb-b4fa-a7c014850994	1.0	PubMed	5913763	Inhibition of GSK-3beta by lithium induced endogenous COX-2 protein expression and COX-2 promoter activity.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PTGS2)
87f59d2b-9409-40eb-b4fa-a7c014850994	1.0	PubMed	18606491	Inhibition of GSK3beta stimulates COX-2 expression in gastric cancer cells through increasing COX-2 mRNA stability, indicating GSK3beta is a negative regulator of COX-2.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PTGS2)
b13003b3-2376-4ce6-898b-52f3d9f4428e	1.0	PubMed	26758421	Moreover, the expression levels of FAK, p-FAK (Tyr397) and p-GSK3beta (Ser389) were largely reduced in the combination treatment group, but the expression of GSK3beta was up-regulated.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:PTK2)
d5c0e63d-65d4-4821-99ca-3bc0b687a2a1	1.0	PubMed	24901984	To confirm these results in living cells, GSK3beta +/+ MEFs and GSK3beta -/- MEFs were treated with DRB to selectively block RNA polymerase II transcription and then subjected to in situ run on assays.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:"RNApo_II")
a7dc0dcf-91df-4dd9-b182-a5241dafdab2	1.0	PubMed	23911749	Down-regulation of GSK3beta increased the combination of beta-catenin/Lef-1, but decreased Runx2 expression; while up-regulation of GSK3beta had the opposite effect.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:RUNX2)
cdb33a28-57a3-40d5-adb6-42bf17e3404a	1.0	PubMed	21964756	In that study, GSK3beta induced phosphorylation of an expressed fragment of HIF-1alpha containing the ODD domain, resulting in loss of PAI-1 transcription in response to hypoxia.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SERPINE1)
452e7ab2-7d06-46db-8943-e6256f901f37	1.0	PubMed	18408738	Overexpression of an active form of GSK-3beta reduced Skp2 expression, increased p27 Kip1 in the nucleus and increased p27 Kip1 binding to CDK2.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SKP2)
97f6408d-0b0a-4142-a88b-a5ffd6c8602b	1.0	PubMed	18172167	Mechanistically, axin facilitates gsk3-beta-mediated phosphorylation of smad3 at thr66, which triggers smad3 ubiquitination and degradation.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SMAD3)
86a4ae4d-12a9-43d2-b1bb-cd1f05ecd8ad	1.0	PubMed	23582741	GSK-3beta prevents Snail expression and activity by inhibiting its transcription and regulating its degradation and nuclear translocation.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SNAI1)
86a4ae4d-12a9-43d2-b1bb-cd1f05ecd8ad	1.0	PubMed	25088797	GSK-3beta activity inhibition decreases the ubiquitination of Snail and increases Snail transcription.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SNAI1)
86a4ae4d-12a9-43d2-b1bb-cd1f05ecd8ad	1.0	PubMed	25124796	To determine the way that Snail is accumulated, we demonstrate (1) that EGF promotes the stability of Snail via inhibiting the activity of glycogen synthase kinase 3 beta (GSK-3beta), (2) that protein kinase C (PKC) rather than the phosphatidylinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway is responsible for GSK-3beta inhibition and (3) that GSK-3beta inhibition promotes the transcription of Snail.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SNAI1)
86a4ae4d-12a9-43d2-b1bb-cd1f05ecd8ad	1.0	PubMed	23959174	While GSK3beta promotes ubiquitin-proteasome pathway mediated beta-catenin degradation XREF_BIBR and suppresses Snail expression at transcriptional and post-transcriptional levels XREF_BIBR XREF_BIBR, it is unclear how GSK3beta suppresses CSC tumorigenesis and metastasis.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SNAI1)
86a4ae4d-12a9-43d2-b1bb-cd1f05ecd8ad	1.0	PubMed	23959174	Several studies show that GSK3beta suppresses Snail expression at transcriptional and post-transcriptional levels XREF_BIBR XREF_BIBR, and the inhibition of GSK3beta by small molecules induces EMT and promotes CSC phenotypes in breast cancer XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SNAI1)
12af415b-3511-4c62-8079-87ef07e24275	1.0	PubMed	20101232	The GSK-3beta inactivation, in turn, repressed slug expression and increased E-cadherin.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SNAI2)
a4d45214-6d7c-414e-9b3b-65e9c7ceb512	1.0	PubMed	26461473	Furthermore, co-transfection of GSK3beta with Fbxw7alpha further reduced the protein level of SOX10 compared with Fbxw7alpha transfected alone.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SOX10)
e5fee953-6f16-4d39-9813-d5e897f7bebd	1.0	PubMed	22174377	Finally, knockdown of GSK3beta increased SRC-1 protein levels, mimicking the loss of phosphorylation at P1272S.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SRC)
206f010f-b6be-4c25-bb58-2bdf99cbcfc0	1.0	PubMed	19126544	Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SREBF1)
206f010f-b6be-4c25-bb58-2bdf99cbcfc0	1.0	PubMed	16825193	The transcription factor SREBP1 is degraded by the ubiquitin-proteasome system following phosphorylation of Thr426 and Ser430 in its phosphodegron. We now demonstrate that the glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of these residues in SREBP1 is enhanced in response to specific DNA binding	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SREBF1)
206f010f-b6be-4c25-bb58-2bdf99cbcfc0	1.0	PubMed	19126544	Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SREBF1)
206f010f-b6be-4c25-bb58-2bdf99cbcfc0	1.0	PubMed	19126544	Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SREBF1)
206f010f-b6be-4c25-bb58-2bdf99cbcfc0	1.0	PubMed	16825193	The transcription factor SREBP1 is degraded by the ubiquitin-proteasome system following phosphorylation of Thr426 and Ser430 in its phosphodegron. We now demonstrate that the glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of these residues in SREBP1 is enhanced in response to specific DNA binding	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:SREBF1)
3b50bfd6-a368-4ad3-a23e-7d34a08a1159	1.0	PubMed	17671694	We demonstrated that GSK-3beta negatively regulated the expression of p53.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:TP53)
b1454b6f-3d6b-4103-9e28-245c0ae5770c	1.0	PubMed	25593505	In the lens epithelial cells, inhibition of GSK-3beta leads to increased nuclear beta-catenin (XREF_FIG) and increased VEGF levels (XREF_FIG), thereby demonstrating, but not definitively proving, a direct association between beta-catenin and VEGF.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:VEGF)
16f9628c-3131-4324-b1f1-0e60452b7b2f	1.0	PubMed	22093618	Mechanistically, we found that depletion of GSK-3beta by re-expression of miR-199 downregulates expression of XIAP and Bcl-2 antiapoptotic molecules in renal cancer cells.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:XIAP)
48244bb4-521a-4e73-8912-25819e286a98	1.0	PubMed	25344861	Furthermore, we found that GSK-3beta inhibition led to a reduction of integrin alphav, alpha-2 and alpha6 expression, possibly mediated via the association of these integrins with F-actin [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	p(UP:P10995)
5b7afd89-b201-4b04-894e-e68569a48403	1.0	PubMed	25887375	Current data show that the inhibition of GSK3beta resulted in an increase in CREB phosphorylation, while almost completely eliminating IL-8 production, suggesting that the treatment with anti-LTbetaR mAb and LPS activates GSK3beta, which then decreases phospho-CREB levels.	p(HGNC:GSK3B)	directlyDecreases	p(UP:A1CIL1)
33a42aa2-2234-4051-91a2-afcb7537a5fb	1.0	PubMed	24853421	28 The western blotting revealed that the levels of p-ERK, p-AKT and p-GSK3beta were decreased by knocking down of HOXB7 and were increased by knockdown of TUG1 in SPC-A1 cells, respectively (XREF_FIG).	p(HGNC:HOXB7)	directlyDecreases	p(HGNC:GSK3B)
12153fa9-d398-4eaf-88b8-c6267d95d27d	1.0	PubMed	25118933	Overexpression of wide-type Omi, but not of S276C Omi, substantially represses the total level of GSK3beta.	p(HGNC:HTRA2)	directlyDecreases	p(HGNC:GSK3B)
34484a0a-6c56-4828-ac90-883725d03328	1.0	PubMed	25118933	Omi represses GSK3beta expression.	p(HGNC:HTRA2)	directlyDecreases	p(HGNC:GSK3B)
04dccbc3-a189-45ff-a93a-9233ad71c3e5	1.0	PubMed	16601113	We observed that tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) treatment of primary cultures of human microvascular cells reduced net endogenous active GSK-3beta protein levels while inducing inflammatory cytokine (IL-6 and monocyte chemoattractant protein-1 (MCP-1)) expression.	p(HGNC:IL1B)	directlyDecreases	p(HGNC:GSK3B)
9978bcbb-dcf3-4d37-b256-ccacae1d54c4	1.0	PubMed	22634610	No evidence text.	act(p(HGNC:INS), ma(tscript))	directlyDecreases	p(HGNC:GSK3B)
7d449af4-7b3f-4bd8-b0c7-f71286a6880d	1.0	PubMed	22096483	On the other hand, expression of pSAPK and JNK may also inhibit expression of GSK-3beta (S9P), and enhance cell apoptosis (XREF_FIG).	p(FPLX:JNK)	directlyDecreases	p(HGNC:GSK3B, var(p.Ser9Pro))
66740140-d51d-4288-b70a-752edf7d700a	1.0	PubMed	23383245	The anti-proliferative effect of betaKlotho might be linked with G1 to S phase arrest, which was mediated by Akt/GSK-3beta/cyclin D1 signaling, since forced expression betaKlotho reduced the phosphorylation level of Akt and GSK-3beta and induced down-regulation of cyclin D1.	p(HGNC:KLB)	directlyDecreases	p(HGNC:GSK3B)
a5f72962-ce41-42a5-8c4c-d98d8ac60c27	1.0	PubMed	25305448	In our study, both mutated K-ras and CDK8 inhibited the expression of GSK-3beta and Axin2, thereby increasing the expression of both T-beta-catenin and N-beta-catenin.	p(HGNC:KRAS)	directlyDecreases	p(HGNC:GSK3B)
15268600-02aa-4ea1-9294-54bff3c23373	1.0	PubMed	24303084	Knockdown of galectin-3 inhibits phosphorylation of GSK-3beta and increases GSK-3beta expression, which leads to beta-catenin phosphorylation and results in the degradation of beta-catenin by the proteasome [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:LGALS3)	directlyDecreases	p(HGNC:GSK3B)
15268600-02aa-4ea1-9294-54bff3c23373	1.0	PubMed	24303084	Western blotting and real-time PCR results showed that galectin-3 silencing resulted in decreased levels of phospho-GSK-3beta at serine 9 and increased GSK-3beta and GSK-3alpha expression.	p(HGNC:LGALS3)	directlyDecreases	p(HGNC:GSK3B)
4e096622-5724-490f-aeb6-63a0f76fe872	1.0	PubMed	21763505	We found that treatment of LY294002 downregulated the expression of vIL-6 and phosphorylation of PI3K and GSK-3beta (c).	a(PUBCHEM:3973)	directlyDecreases	p(HGNC:GSK3B)
4e096622-5724-490f-aeb6-63a0f76fe872	1.0	PubMed	25150829	LY294002 treatment decreased the levels of P-AKT (T308), P-GSK-3beta (Ser9) and beta-catenin (A).	a(PUBCHEM:3973)	directlyDecreases	p(HGNC:GSK3B)
4e096622-5724-490f-aeb6-63a0f76fe872	1.0	PubMed	23710442	Expression of p-GSK3beta was almost completely blocked by LY294002 (25mmol/L) for 1h (XREF_FIG).	a(PUBCHEM:3973)	directlyDecreases	p(HGNC:GSK3B)
6c2d368b-4901-4628-ab37-2b9928ffbea9	1.0	PubMed	19717166	Lithium and valproate also inhibit GSK-3beta activity and decrease GSK-3beta expression in rat brain and in hippocampus slices ().	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:GSK3B)
a215585f-1402-4867-9796-1dc8d1af36a7	1.0	PubMed	26882989	As expected, the inhibition of TAK1 significantly blocked the phosphorylation of IRS at Ser307, but increased the phosphorylated expression of AKT and GSK3beta, in both NTG and TRAF3-LTG mice (XREF_FIG), and the HFD triggered activation of MKK-JNK and NF-kappaB signalling was markedly inhibited by 5Z-7-ox treatment in vivo (XREF_FIG).	p(HGNC:MAP3K7)	directlyDecreases	p(HGNC:GSK3B)
e041ba75-08f4-41e0-b2bb-0bcfed72686b	1.0	PubMed	21127195	WT menin suppressed the phosphorylation of AKT at S473 by 30% and decreased p-GSK3beta level by 39% induced by overexpression of AKT1 (XREF_FIG).	p(HGNC:MEN1)	directlyDecreases	p(HGNC:GSK3B)
252a9317-7d34-464f-ae5d-bc5127e1827d	1.0	PubMed	25056574	In this study, we found that knockdown of Nestin expression significantly increased the levels of Axin, GSK-3beta, and APC, and the ratios of cytoplasmic to nuclear beta-catenin in breast CSC.	p(HGNC:NES)	directlyDecreases	p(HGNC:GSK3B)
c7c80bc3-0b83-4941-b4b1-cf455327b667	1.0	PubMed	23912036	NGF pre-treatment prevented the Vpr induced decrease in pGSK3beta and TrkA protein levels (XREF_FIG).	p(HGNC:NGF)	directlyDecreases	p(HGNC:GSK3B)
933e3358-fd07-4a56-b6f6-3e6a886ee17a	1.0	PubMed	26721203	The results demonstrated that NAC effectively inhibited ROS generation and concurrently downregulated the expression of Wnt signaling pathway regulatory proteins (Wnt2, phospho-Dvl, phospho-GSK-3beta, beta-catenin, Tcf4, and Lef1), and upregulated the expression of GSK-3beta and Dvl ().	a(CHEBI:7421)	directlyDecreases	p(HGNC:GSK3B)
937fa6ad-fd82-43cb-b250-4406a2159220	1.0	PubMed	27188386	No evidence text.	act(p(HGNC:NOG), ma(tscript))	directlyDecreases	p(HGNC:GSK3B)
937fa6ad-fd82-43cb-b250-4406a2159220	1.0	PubMed	27188386	No evidence text.	act(p(HGNC:NOG), ma(tscript))	directlyDecreases	p(HGNC:GSK3B)
59151224-ccc7-4ac9-841d-2c04950d54e7	1.0	PubMed	19286457	Moreover, the decreased levels of phosphorylated GSK3-beta and N-Myc induced by NOV were abolished when cells were pre-treated 15min with lithium chloride (C), which is routinely used to inhibit GSK3-beta activity ().	p(HGNC:NOV)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
169dc1c4-8013-409d-a7d5-d097fe2318b2	1.0	PubMed	26805761	VEGF or NRP-1 silencing attenuated the epithelial-mesenchymal transition (EMT) process and the activation of NF-kappaBp65, but enhanced GSK-3beta expression in MDA-MB-231 cells while NRP-1 over-expression reversed the effects in MCF-7 cells.	p(HGNC:NRP1)	directlyDecreases	p(HGNC:GSK3B)
994d6971-8b98-4bf0-909a-37bd4e2cf239	1.0	PubMed	15652488	PI3-kinase inhibitor (wortmannin) inhibited NT-3- and BDNF induced decrements of the phosphorylation levels of CRMP-2 and increments of the phosphorylation levels of GSK-3beta and Akt.	p(HGNC:NTF3)	directlyDecreases	p(HGNC:GSK3B)
def534c7-fc05-4eae-b5ca-7f39631a4a9e	1.0	PubMed	24929931	Furthermore, expression of CT-GFP in the presence of AICD and tau reduces the amount of GSK3beta to that of the control.	p(UP:P13259)	directlyDecreases	p(HGNC:GSK3B)
8dd6db8e-1209-44fc-9fff-8f516944f8c8	1.0	PubMed	22096483	Whereas only PD 98059 blocked G3 enhanced expression of GSK-3beta (S9P) (XREF_FIG).	a(PUBCHEM:4713)	directlyDecreases	p(HGNC:GSK3B, var(p.Ser9Pro))
95b255cd-0bc8-47e7-b843-1cb6f4937a77	1.0	PubMed	21743491	Consistent with the documented role of GSK-3beta for beta-catenin phosphorylation and degradation, we observed that PGE 2 treatment (for 24hours) decreased the levels of GSK-3beta and phospho-beta-catenin in human HCC cells.	a(CHEBI:73965)	directlyDecreases	p(HGNC:GSK3B)
4e670d95-d118-4878-b9aa-332a5765f1ed	1.0	PubMed	23943160	In our study, we observed that ligand activation of PPAR beta and delta decreased the phosphorylation levels of AKT and GSK3beta.	p(FPLX:PPAR)	directlyDecreases	p(HGNC:GSK3B)
14c61abc-52b5-4440-8d56-195ce259cba6	1.0	PubMed	21763505	As shown in b, overexpression of PTEN not only significantly decreased KSHV vIL-6 protein expression but also inhibited the phosphorylation level of downstream kinases PI3K and GSK-3beta.	p(HGNC:PTEN)	directlyDecreases	p(HGNC:GSK3B)
dfa30c73-591d-4548-a1a1-3af100656d16	1.0	PubMed	25003523	In contradistinction, silencing of PRL-1 protein level using siRNA interference caused down-regulation of expression of p-AKT (Ser 474), p-GSK3beta (Ser 9) and Snail transcriptional factor.	p(HGNC:PTP4A1)	directlyDecreases	p(HGNC:GSK3B)
12ad5099-1eff-410c-a38e-f4e3363d00a9	1.0	PubMed	23666756	The 2 muM dose of kallistatin reduced Wnt3a induced phosphorylated GSK-3beta levels.	p(HGNC:SERPINA4)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
48c1589e-2439-4e7d-bd39-da7dfee54f84	1.0	PubMed	25330231	Spns2 knockdown by Spns2i-A significantly increased levels of pGSK-3beta and pStat3 when compared to the controls (XREF_FIG), indicating that PI3K and Akt and Jak and Stat3 pathways were activated by Spns2 knockdown.	p(HGNC:SPNS2)	directlyDecreases	p(HGNC:GSK3B)
be9833c8-cbfa-484a-865e-21d479bfb904	1.0	PubMed	20725905	Knockdown of SULF2 decreased the levels of Wnt3a, phospho-GSK3beta and beta-catenin by Western immunoblotting (XREF_FIG), and the level of beta-catenin by immunocytochemistry (XREF_FIG).	p(HGNC:SULF2)	directlyDecreases	p(HGNC:GSK3B)
f976c9f4-f4a2-4179-b5c1-8a08210a07b5	1.0	PubMed	25935310	Inclusion of GST-CHP3 significantly reduced the phosphorylation level of GSK3beta (B), whereas GST had no effect, suggesting that CHP3 inhibited Akt induced phosphorylation of GSK3beta in vitro.To determine whether Ca binding was required for the function of CHP3, we prepared the HEK293 cells overexpressing CHP3-D123A-HA, an HA tagged Ca-unbound EF-hand CHP3 mutant.	p(HGNC:TESC)	directlyDecreases	p(HGNC:GSK3B)
57e2f543-859b-43ce-9645-359d7758a08f	1.0	PubMed	23673211	A more detailed analysis of subcellular extracts revealed that A549 and DDP cells had significantly increased cytoplasmic p-GSK-3beta in addition to reduced levels of p-GSK-3beta in the cytoplasm.	p(HGNC:TIMM8A)	directlyDecreases	p(HGNC:GSK3B)
7d310fb7-fd8f-4c1c-9708-44006fc89053	1.0	PubMed	26530498	Mechanistically, TIPE2 remarkably reduced the total levels of pAKT, pGSK3beta and beta-catenin as well as the nuclear level of beta-catenin in gastric cancer cells.	p(HGNC:TNFAIP8L2)	directlyDecreases	p(HGNC:GSK3B)
fb67b761-31db-492a-b183-c50914aa3b15	1.0	PubMed	16601113	We observed that tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) treatment of primary cultures of human microvascular cells reduced net endogenous active GSK-3beta protein levels while inducing inflammatory cytokine (IL-6 and monocyte chemoattractant protein-1 (MCP-1)) expression.	p(HGNC:TNF)	directlyDecreases	p(HGNC:GSK3B)
8dc48cd6-b6ef-4434-bf32-52f41c9fdbb5	1.0	PubMed	21613824	Troglitazone inhibited the constitutive expression of GSK-3beta and activation of NFkappaB.	a(PUBCHEM:5591)	directlyDecreases	p(HGNC:GSK3B)
2f07c03a-f48f-4f6c-88fe-19978fc059e1	1.0	PubMed	26805761	VEGF or NRP-1 silencing attenuated the epithelial-mesenchymal transition (EMT) process and the activation of NF-kappaBp65, but enhanced GSK-3beta expression in MDA-MB-231 cells while NRP-1 over-expression reversed the effects in MCF-7 cells.	p(FPLX:VEGF)	directlyDecreases	p(HGNC:GSK3B)
13df7d74-34d6-4587-a2e5-9f328b3ef749	1.0	PubMed	23846217	The result indicated that the protein level of GSK3beta was decreased by celastrol treatment.	a(PUBCHEM:122724)	directlyDecreases	p(HGNC:GSK3B)
8cecd4ea-b82d-4851-b4fb-e7ed1bc79789	1.0	PubMed	23673211	At the same time, cisplatin treatment decreased p-GSK-3beta levels in A549 and DDP cells, but raised it in A549 cells.	a(CHEBI:27899)	directlyDecreases	p(HGNC:GSK3B)
ad26a2bc-905d-465c-9a36-23a6295f816d	1.0	PubMed	20519433	Because cycloheximide and GSK3beta and CKI inhibition effectively depleted the amount of GSK3beta and CKI-P-APC in cell extracts, it is likely the remaining APC at the lateral membrane is not phosphorylated by these kinases and corresponds to the faster migrating APC band on Western blots (XREF_FIG C).	a(PUBCHEM:6197)	directlyDecreases	p(HGNC:GSK3B)
7e63458d-64e4-41d0-b581-bd250fb62d1d	1.0	PubMed	28097141	Besides, emodin decreased the expression of ILK, p-GSK-3beta, beta-catenin, and Slug.	a(CHEBI:42223)	directlyDecreases	p(HGNC:GSK3B)
7e6c3792-433a-49a6-9c45-6b3a6d6701e8	1.0	PubMed	24303084	Combined shGal-3 and epirubicin treatment significantly inhibited the mRNA expression level of galectin-3 and beta-catenin but increased the expression of GSK-3beta.	a(PUBCHEM:41867)	directlyDecreases	p(HGNC:GSK3B)
454bc3ca-d233-45dd-8ef0-7b4d49ca7ef5	1.0	PubMed	18687691	We found that isoflavone inhibited the phosphorylation of Akt and FOXO3a, regulated the phosphorylation of Src, and increased the expression of GSK-3beta, leading to the down-regulation of AR and its target gene PSA.	a(PUBCHEM:72304)	directlyDecreases	p(HGNC:GSK3B)
9c63a00e-bf04-41fb-8214-efc3f1cf9245	1.0	PubMed	16793187	Further, the lithium ion was shown to directly inhibit the activity of GSK-3beta overexpressed in NT2N cells, including a constitutively active construct whose serine 9 amino acid was substituted by alanine, as measured by a decreased incorporation of P into human recombinant tau.	a(PUBCHEM:28486)	directlyDecreases	p(HGNC:GSK3B)
ee645ada-da40-47dd-aec8-8eea48eba0d9	1.0	PubMed	26198711	Specifically, estrogen appeared to reduce GSK-3beta activity while progesterone decreased the expression of both GSK-3beta and tau [XREF_BIBR, XREF_BIBR].	a(CHEBI:17026)	directlyDecreases	p(HGNC:GSK3B)
39cc8eb0-2f5d-432d-8553-a9e0fefeb55d	1.0	PubMed	24853421	28 TUG1 knockdown could also increase the levels of p-ERK, p-AKT and p-GSK3beta.	p(UP:P25295)	directlyDecreases	p(HGNC:GSK3B)
b6a517e9-97f1-4ea7-a24a-71b2e2a211af	1.0	PubMed	19717166	Lithium and valproate also inhibit GSK-3beta activity and decrease GSK-3beta expression in rat brain and in hippocampus slices ().	a(PUBCHEM:3121)	directlyDecreases	p(HGNC:GSK3B)
3851a9bd-84f3-4443-88f5-fd0900d28844	1.0	PubMed	23912036	Further, we showed Vpr exposure decreased protein expression of the TrkA receptor and pGSK3beta (XREF_FIG), part of the PI3K pathway which regulates axonal outgrowth.	p(UP:P05928)	directlyDecreases	p(HGNC:GSK3B)
aa4011e2-3610-46ae-a836-bd293851f4df	1.0	PubMed	25219467	We found that OA treatment significantly increased GSK-3beta Ser9 phosphorylation (C), confirming the regulation of GSK-3beta Ser9 phosphorylation by PP2A.The previously mentioned results showed that GSK-3beta regulated PP2Ac methylation and inhibition of GSK-3beta significantly enhanced PP2Ac demethylation.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:PPP2C, pmod(Me))
aa4011e2-3610-46ae-a836-bd293851f4df	1.0	PubMed	25219467	But, by which GSK-3b regulates PME-1 expression remains to be studied.By using a series of pharmacologic and molecular biological approaches, we consistently found that upregulation of GSK-3beta promoted PP2Ac methylation and downregulation of GSK-3beta promoted PP2Ac demethylation.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:PPP2C, pmod(Me))
a9cf7507-039c-46fb-a842-262e738a05dc	1.0	PubMed	25219467	Reduction of PP2A may lead to increase in Ser9 phosphorylation of GSK-3beta and decrease in GSK-3beta activity, which may further promote PP2A demethylation and decrease PP2A activity.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:PPP2, pmod(Me))
2e411e02-3b41-48a6-9f0f-b334f2709317	1.0	PubMed	19429119	A previous study in differentiated hippocampal neurons and SY5Y cells has shown that AICAR induces dephosphorylation of Akt and GSK-3beta (pSer 9) [XREF_BIBR].	a(CHEBI:18406)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
b9e43add-546d-488e-a722-f9bfc106e7f0	1.0	PubMed	24086147	We find that APP and RNAi-CaNB co-overexpression in neurons, which was sufficient to restore calcineurin activity, completely prevented GSK-3beta dephosphorylation at Ser9 site.	p(HGNC:APP)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
1000515f-7bc8-4e44-8180-4ecce14bc2fb	1.0	PubMed	24188406	However, the protective effect of curcumin on dephosphorylation of GSK-3beta induced by Abeta is not directly related to cellular oxidative stress.	p(HGNC:APP)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
9737c5eb-fdfa-41af-8613-2267c8474de1	1.0	PubMed	24086147	Second, APP upregulation resulted in calcineurin dependent dephosphorylation of GSK-3beta at Ser9 site, a process thought to activate GSK-3beta kinase XREF_BIBR.	p(HGNC:APP)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
84c120b3-a611-4b5a-ae90-972842d034b5	1.0	PubMed	7237125	Addition of DHEA prevented phosphorylation of both Akt and glycogen synthase kinase-3 beta (GSK-3beta), downstream effector molecules of the phosphatidylinositol 3-kinase (PI3K) pathway.	a(PUBCHEM:5283451)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
d5019663-c564-4c86-aa3d-2f671ccb51f8	1.0	PubMed	23943160	Furthermore, we showed that PPARbeta and delta activation increased PTEN expression, which led to AKT and GSK3beta dephosphorylation, and increased beta-catenin phosphorylation associated with its degradation.	p(UP:P12551)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
40e38b6a-b9fd-41c2-a234-6be8662313a5	1.0	PubMed	26119563	Finally, we confirm that ephrinB1/Fc treatment induces tyrosine phosphorylation (activation) of EphB2, while deletion of the tyrosine kinase domain (VM) of EphB2 eliminates the receptor stimulation induced GSK-3beta inhibition and tau dephosphorylation.	p(HGNC:EPHB2)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
eac24948-b0bf-4d94-8117-fb34576b830b	1.0	PubMed	22578008	We and the Minassian laboratory showed that laforin dephosphorylates and inactivates GSK3beta at serine 9 in serum starved, growth factor stimulated cells [XREF_BIBR, XREF_BIBR].	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, 9))
eac24948-b0bf-4d94-8117-fb34576b830b	1.0	PubMed	22578008	This suggests that laforin dephosphorylates GSK3beta at serine 9 in a context dependent manner.	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, 9))
7630ea0c-4af2-482d-8be3-7879fc4755f5	1.0	PubMed	21887368	Laforin was also shown to dephosphorylate glycogen synthase kinase-3beta (GSK3beta) XREF_BIBR, XREF_BIBR, XREF_BIBR; however, ourselves and other groups have not observed dephosphorylation of GSK3beta by laforin XREF_BIBR, XREF_BIBR.	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
7630ea0c-4af2-482d-8be3-7879fc4755f5	1.0	PubMed	22364389	Other laboratories tested GSK3beta as a laforin substrate using in vivo and in vitro methods during targeted searches for a substrate, before the glucan phosphatase activity was discovered, and did not observe dephosphorylation of GSK3beta by laforin ([XREF_BIBR], [XREF_BIBR], [XREF_BIBR]).	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
d4dc0495-a12e-42c1-9921-b30718bbbae3	1.0	PubMed	16959610	As a third approach, we tested whether recombinant laforin can directly dephosphorylate GSK-3beta at Ser9 in vitro.	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d4dc0495-a12e-42c1-9921-b30718bbbae3	1.0	PubMed	16959610	Epm2a-encoded laforin is a phosphatase for GSK-3beta and an important repressor in the Wnt signaling pathway| only GSK-3β phosphorylation on Ser9 was affected by overexpression of laforin|Although GSK-3β is inactivated by phosphorylation at the Ser9 position, it is unclear if the inactivated enzyme can be reactivated by dephosphorylation.	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d4dc0495-a12e-42c1-9921-b30718bbbae3	1.0	PubMed	20453062	Some studies have suggested that laforin dephosphorylates GSK3-beta at Ser 9, thereby activating this enzyme (XREF_BIBR).	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
f51b9dc5-b047-4e63-a8ba-47adcbf5baa3	1.0	PubMed	22578008	We and the Minassian laboratory showed that laforin dephosphorylates and inactivates GSK3beta at serine 9 in serum starved, growth factor stimulated cells [XREF_BIBR, XREF_BIBR].	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser))
f51b9dc5-b047-4e63-a8ba-47adcbf5baa3	1.0	PubMed	22578008	This suggests that laforin dephosphorylates GSK3beta at serine 9 in a context dependent manner.	p(HGNC:EPM2A)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser))
33a9ee95-3c88-4d51-aab3-7b2024ef6d5d	1.0	PubMed	21450369	We also observed that inhibition of Erk1/2 caused a slight dephosphorylation of GSK-3beta at Ser9 (> 0.05, H).	p(FPLX:ERK)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
5aa52bf0-618b-4917-a1fb-089183d9ad8b	1.0	PubMed	24339928	They encompass the BCR-ABL1-mediated beta catenin phosphorylation at specific tyrosine residues (Y86 and Y654), resulting in its impaired recruitment by the Axin and glycogen synthase kinase 3 beta (GSK3b) destruction complex, BCR-ABL1-associated overexpression of growth arrest specific 2 (GAS2), reducing its degradation by the calpaine system, and GSK3b inactivation due to the prevalence of a GSK3b mis spliced isoform unable to phosphorylate beta catenin and/or to GSK3b de-phosphorylation by the Fas associated phosphatase 1 (Fap1) XREF_BIBR - XREF_BIBR.	p(HGNC:FAS)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
5aa52bf0-618b-4917-a1fb-089183d9ad8b	1.0	PubMed	24747551	beta-Catenin activation in CML is mostly contingent upon mechanisms hampering its degradation, including the BCR-ABL1-mediated phosphorylation at specific tyrosine residues (Y86 and Y654), which impairs the recruitment by the adenomatous polyposis coli (APC)/Axin/glycogen synthase kinase 3 beta (GSK3 beta) destruction complex, the overexpression of growth arrest specific 2 (GAS2), which reduces the calpain dependent degradation, and GSK3beta inactivation due to the prevalence of a GSK3beta mis spliced isoform unable to phosphorylate beta-catenin and/or to GSK3beta de-phosphorylation by the Fas associated phosphatase 1 (Fap1).	p(HGNC:FAS)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
d6f9cf1e-cf46-4585-ad1f-05ec083eb5dc	1.0	PubMed	PMC5329194	We propose a model in which inhibition of GSK3beta activity upon Wnt signaling leads to the dephosphorylation of GSK3beta sites in Axin, resulting in the release of beta-catenin from the phosphorylation complex.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:AXIN, pmod(Ph))
fed27ead-7cf0-4acf-98fc-e38832ada2b8	1.0	PubMed	26845447	In addition, siLRP5 reduced GSK-3beta dephosphorylation and increased levels of beta-catenin, CD44, and MMP7 by knockdown of () beta-catenin is also a component of the Wnt signaling pathway, which is associated with EMT.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CD44, pmod(Ph))
e9511b71-e8e2-4e4f-88d4-bb63afc9a27b	1.0	PubMed	6380695	Overexpression of GSK3beta did not affect BDNF induced phosphorylation of Akt, ERK1/2, or FKHRL1, but abolished CREB phosphorylation induced by BDNF.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:CREB, pmod(Ph))
f72dbeaa-43d6-4e83-a0a1-201065c0d4e2	1.0	PubMed	26845447	In addition, siLRP5 reduced GSK-3beta dephosphorylation and increased levels of beta-catenin, CD44, and MMP7 by knockdown of () beta-catenin is also a component of the Wnt signaling pathway, which is associated with EMT.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:CTNNB1, pmod(Ph))
034d8ffd-8589-4dbd-8ca0-8f9261169343	1.0	PubMed	15026145	Our long-term observations indicate an attenuation of insulin signaling that could be caused by a decrease in activity of one or more components of insulin signaling pathway upstream of PKB-alpha and PI-3 kinase.It is known that inhibition of GSK-3beta by insulin results from its phosphorylation at and N-terminus residue Ser by PKB and the inhibition of GSK-3beta subsequently promotes dephosphorylation and activation of glycogen synthase.	p(HGNC:GSK3B)	directlyDecreases	p(FPLX:GYS, pmod(Ph))
637c62b0-82e3-4528-aa32-9a3a7248cc32	1.0	PubMed	26845447	In addition, siLRP5 reduced GSK-3beta dephosphorylation and increased levels of beta-catenin, CD44, and MMP7 by knockdown of () beta-catenin is also a component of the Wnt signaling pathway, which is associated with EMT.	p(HGNC:GSK3B)	directlyDecreases	p(HGNC:MMP7, pmod(Ph))
56de482f-0dd1-4f2c-9945-a30413b43086	1.0	PubMed	16987514	The overexpression of I-2, which forms a stable complex with PP1 and inhibits PP1 activity, increased the basal phosphorylation of GSK3 at Ser21/9 and markedly blocked the KCl induced dephosphorylation of GSK3beta at Ser9, but only slightly blocked dephosphorylation of GSK3alpha at Ser21.	p(FPLX:GSK3, pmod(Ph))	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
94ba0b48-392d-4a43-8806-0f02325ea2fc	1.0	PubMed	6619150	Indeed, DIF-3 dephosphorylated Ser (9) and phosphorylated tyrosine on GSK-3beta, and it stimulated GSK-3beta activity in an in vitro kinase assay.	p(UP:Q5SV77)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser))
277d0c48-b389-474a-9e59-fdca93ba6509	1.0	PubMed	25959626	Shin reported that HO caused dephosphorylation of GSK3beta Ser9, resulting in the activation of GSK3beta ().	p(HGNC:HMOX1)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d389e29f-0494-439e-8089-8375236e4029	1.0	PubMed	26655089	I-2 complex, which in turn dephosphorylates and stimulates GSK3beta, thus forming a positive feedback loop.	p(UP:Q5EFR0)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
0ae5ef3a-8387-4cfd-a5d1-c496abfe5e93	1.0	PubMed	9373175	IGF-1 stimulation did not induce any tyrosine dephosphorylation of WT-GSK3beta or A9-GSK3beta.	p(HGNC:IGF1)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
0ae5ef3a-8387-4cfd-a5d1-c496abfe5e93	1.0	PubMed	4585508	IGF-1 stimulation did not induce any tyrosine dephosphorylation of WT-GSK3beta or A9-GSK3beta.	p(HGNC:IGF1)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
35098fbe-670b-46e0-b740-e4aaac086eb4	1.0	PubMed	7187588	Silencing of endogenous ILKAP by short interfering RNA (siRNA) stimulated GSK3beta phosphorylation at S9, with no effect on PKB S473 phosphorylation.	p(HGNC:ILKAP)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
dae34a91-9672-4ebe-9ed6-eb42cbf83e5b	1.0	PubMed	5873091	We propose that ILKAP regulates ILK1 activity, targeting ILK1 signalling of Wnt pathway components via modulation of GSK3beta phosphorylation.	p(HGNC:ILK)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
f23145e9-56c2-46b3-b1d2-2e6644cd63c7	1.0	PubMed	16987514	Inhibition of PP1 through I-2 overexpression increased the basal phosphorylation of GSK3alpha and GSK3beta, but only GSK3beta dephosphorylation induced by KCl treatment was blocked by I-2 overexpression.	a(PUBCHEM:4873)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
f23145e9-56c2-46b3-b1d2-2e6644cd63c7	1.0	PubMed	16987514	This could partly explain the differential effects of KCl induced GSK3alpha and GSK3beta dephosphorylation, but this mechanism will have to be tested in future studies.Activation of calcium signaling triggers a host of signaling cascades including the activation of both phosphatases and kinases.	a(PUBCHEM:4873)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
f2baf0cb-511d-4e91-b4d8-0d5f238257e5	1.0	PubMed	21821001	This suggested that inducible galectin-3 is anti-apoptotic because it stabilizes pro survival Bcl-2 family proteins.Western blotting showed that cisplatin, C-ceramide, and LY294002 caused the time dependent dephosphorylation of Akt (Ser473) and then the dephosphorylation of GSK-3alpha (Ser21) and GSK-3beta (Ser9) in K562 cells (A).	a(PUBCHEM:3973)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 21))
64b7216f-af00-42a2-8033-ef6bc4efd6bf	1.0	PubMed	21821001	This suggested that inducible galectin-3 is anti-apoptotic because it stabilizes pro survival Bcl-2 family proteins.Western blotting showed that cisplatin, C-ceramide, and LY294002 caused the time dependent dephosphorylation of Akt (Ser473) and then the dephosphorylation of GSK-3alpha (Ser21) and GSK-3beta (Ser9) in K562 cells (A).	a(PUBCHEM:3973)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
6abc793a-4c14-4999-b978-66a7f2b6a8e4	1.0	PubMed	6377119	LY-294002 (100 microM) and wortmannin (150 microM), specific inhibitors of phosphatidylinositol 3 '-kinase, attenuated IGF-I-induced GSK-3beta phosphorylation by 67 and 92%, respectively.	a(PUBCHEM:3973)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
06a5a51b-0cb6-4b9b-b6c8-a58355ec59b6	1.0	PubMed	26850078	Moreover, the MF induced MPT was attenuated by ROS scavenger (N-acetyl-L-cysteine, NAC) or GSK-3beta inhibitor, and NAC pretreatment prevented GSK-3beta dephosphorylation (Ser (9)) caused by MF exposure.	a(PUBCHEM:6992350)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
56cb3632-491d-4a01-a128-34ec27706e07	1.0	PubMed	26850078	Moreover, the MF induced MPT was attenuated by ROS scavenger (N-acetyl-L-cysteine, NAC) or GSK-3beta inhibitor, and NAC pretreatment prevented GSK-3beta dephosphorylation (Ser (9)) caused by MF exposure.	a(CHEBI:7421)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
bc1f49c2-360a-4e07-ae34-7dc681b877cd	1.0	PubMed	6719187	However, insulin or PDGF treatment did not impair phosphorylation of PKB and Akt and GSK-3beta, indicating that the proliferation defect is not due to absent or reduced ILK mediated phosphorylation of these substrates in vivo.	p(FPLX:PDGF)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
bbf776ca-466d-4997-917f-b20f35cb8c04	1.0	PubMed	5556769	These results suggest that PKNalpha and PKC directly inhibit GSK-3beta activity at least in part by phosphorylating Ser9 of GSK-3beta, and that they indirectly suppress GSK-3beta-stimulated phosphorylation of tau at amino acids Ser202 and Thr205 and Thr181, but enhanced phosphorylation at Thr231 through phosphorylation at other sites of tau.	p(FPLX:PKC)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
429c59b4-e4eb-45f8-af41-9ec36a7730a8	1.0	PubMed	23943160	Furthermore, we showed that PPARbeta and delta activation increased PTEN expression, which led to AKT and GSK3beta dephosphorylation, and increased beta-catenin phosphorylation associated with its degradation.	p(HGNC:PPARD)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
8a5ce0da-b886-4f11-9314-ef14835d4c94	1.0	PubMed	26972480	However, since the Ser9 phosphorylation state of GSK3beta was regulated both by its phosphorylation by PKC and its dephosphorylation by PP1 XREF_BIBR, it remained to verify if hnRNPK might also stimulate the dephosphorylation of GSK3beta by PP1.	p(FPLX:PPP1)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
8a5ce0da-b886-4f11-9314-ef14835d4c94	1.0	PubMed	26972480	To address this issue, we have treated H1299 cells with 100nM okadaic acid which inhibited the dephosphorylation of GSK3beta by PP1, and examined the effect of hnRNPK expression on the phosphorylation state of GSK3beta.	p(FPLX:PPP1)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
8a5ce0da-b886-4f11-9314-ef14835d4c94	1.0	PubMed	16987514	These findings are interesting because they suggest that under basal conditions, PP1 dephosphorylates both isoforms of GSK3; however, following KCl induced membrane depolarization, PP1 selectively dephosphorylates GSK3beta.	p(FPLX:PPP1)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
8a5ce0da-b886-4f11-9314-ef14835d4c94	1.0	PubMed	25219467	These results suggest that PP2A, but not PP1, catalyzes the dephosphorylation of GSK-3beta at Ser9.Then, we treated HEK-293FT cells with 100nM okadaic acid for 3hours to inhibit PP2A and determined the GSK-3beta phosphorylation.	p(FPLX:PPP1)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
a430fabb-a51f-442e-b193-a3f520e1c4cb	1.0	PubMed	16987514	Membrane depolarization could increase the association of PP1 and GSK3beta, such that inhibition of PP1 blocks GSK3beta Ser9 dephosphorylation.	p(FPLX:PPP1)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
46f77355-9cfa-47b2-b81d-1b44963715fd	1.0	PubMed	25219467	These results suggest that PP2A, but not PP1, catalyzes the dephosphorylation of GSK-3beta at Ser9.Then, we treated HEK-293FT cells with 100nM okadaic acid for 3hours to inhibit PP2A and determined the GSK-3beta phosphorylation.	p(FPLX:PPP2)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
63ace70d-3ec0-4687-a7d8-d2058c908d86	1.0	PubMed	23943160	Furthermore, we showed that PPARbeta and delta activation increased PTEN expression, which led to AKT and GSK3beta dephosphorylation, and increased beta-catenin phosphorylation associated with its degradation.	p(HGNC:PTEN)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
95b777e3-61d6-47d9-abc0-a1e507580223	1.0	PubMed	3265077	Here we have investigated which protein phosphatase activities can dephosphorylate recombinant tau phosphorylated with mitogen activated protein kinase, glycogen synthase kinase-3 beta, neuronal cdc2 like kinase, or cyclic AMP dependent protein kinase.	p(FPLX:Phosphatase)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
30fee586-b9da-4be9-8af4-6daee7f443f0	1.0	PubMed	7222190	U0126, a MEK1/2 inhibitor, inhibited tyrosine phosphorylation of GSK-3beta, suggesting that MEK1/2 was involved in the phosphorylation of Tyr (216) in GSK-3beta.	a(CHEBI:90693)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
873d3ec3-01e5-4c09-aa30-8e8bc29e8a7e	1.0	PubMed	26119563	Finally, we confirm that ephrinB1/Fc treatment induces tyrosine phosphorylation (activation) of EphB2, while deletion of the tyrosine kinase domain (VM) of EphB2 eliminates the receptor stimulation induced GSK-3beta inhibition and tau dephosphorylation.	a(PUBCHEM:6993039)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
83506c39-a273-4dea-a202-326f23845e65	1.0	PubMed	21821001	This suggested that inducible galectin-3 is anti-apoptotic because it stabilizes pro survival Bcl-2 family proteins.Western blotting showed that cisplatin, C-ceramide, and LY294002 caused the time dependent dephosphorylation of Akt (Ser473) and then the dephosphorylation of GSK-3alpha (Ser21) and GSK-3beta (Ser9) in K562 cells (A).	a(CHEBI:27899)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 21))
ab0cf582-02a7-4055-8631-a65aa944dbc6	1.0	PubMed	21821001	This suggested that inducible galectin-3 is anti-apoptotic because it stabilizes pro survival Bcl-2 family proteins.Western blotting showed that cisplatin, C-ceramide, and LY294002 caused the time dependent dephosphorylation of Akt (Ser473) and then the dephosphorylation of GSK-3alpha (Ser21) and GSK-3beta (Ser9) in K562 cells (A).	a(CHEBI:27899)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
960a3eff-1b67-4b54-a0f5-48f032112300	1.0	PubMed	21435438	Thus, dephosphorylation of GSK3beta by homocysteine may explain the inhibitory effect on glycogen synthesis.	a(PUBCHEM:778)	directlyDecreases	p(HGNC:GSK3B, pmod(Ph))
9d758ea9-c1c8-42a7-ae71-58696a8e49d9	1.0	PubMed	26318033	Overexpression of AKT3 increased the protein expression of total AKT, phospho-AKT S473, phospho-AKT T308, B-Raf, c-Myc, Skp2, cyclin E, GSK3beta, phospho-GSK3beta S9, phospho-mTOR S2448, and phospho-p70S6K T421 and S424, but decreased TSC1 (tuberous sclerosis 1) and TSC2 (tuberous Sclerosis Complex 2) proteins in PC-3 PCa cells.	p(HGNC:AKT3)	directlyIncreases	p(HGNC:GSK3B)
27534953-eed7-4126-9fbf-31564719ca6a	1.0	PubMed	25003523	Decrease of p-AKT (Ser 474) after exposure of the cells to ZSKT474 reduced expression of p-GSK3beta (Ser 9) and Snail and restored E-cadherin expression.	p(FPLX:AKT, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B)
a0cbb757-1933-4222-a829-7e3a27ff6015	1.0	PubMed	26211576	Downregulation of Akt increased the level of active GSK3beta and inhibited its non active form.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B)
a0cbb757-1933-4222-a829-7e3a27ff6015	1.0	PubMed	25757764	The knockdown of AKT by shRNA reduced p-GSK3beta and CTNNB1 expression in the cells, while the depletion of CTNNB1 impaired stem like phenotype of the cells.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B)
a0cbb757-1933-4222-a829-7e3a27ff6015	1.0	PubMed	18782353	As expected, Akt knock-down by Akt specific siRNA led to undetectable levels of GSK3beta (Ser 9) phosphorylation after H. pylori infection, but had no effect on H. pylori induced phosphorylation of PDK1 Ser 241.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B)
a0cbb757-1933-4222-a829-7e3a27ff6015	1.0	PubMed	23103626	Inhibition of Akt activity by the down-regulation of pAkt can decrease pGSK-3beta levels, while activation of Akt might phosphorylate GSK-3beta 31.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B)
d4a1b6b2-a2a8-4b76-9871-bf3a883cc0c8	1.0	PubMed	22690042	APC treatment elicited a rise in GSK-3beta expression, peaking after 6h APC treatment.	p(HGNC:APC)	directlyIncreases	p(HGNC:GSK3B)
287f1d7d-9614-4a80-a73d-88d351e2e663	1.0	PubMed	21876249	Glutathione and trolox, however, effectively prevented the Abeta induced increases in RCAN1 and GSK3beta expression, as well as the increased tau phosphorylation in our primary neurons (XREF_FIG).	p(HGNC:APP)	directlyIncreases	p(HGNC:GSK3B)
e8942b49-38e0-4990-8862-0fa658e39c4d	1.0	PubMed	20519433	Because cycloheximide and GSK3beta and CKI inhibition effectively depleted the amount of GSK3beta and CKI-P-APC in cell extracts, it is likely the remaining APC at the lateral membrane is not phosphorylated by these kinases and corresponds to the faster migrating APC band on Western blots (XREF_FIG C).	p(FPLX:CDKN)	directlyIncreases	p(HGNC:GSK3B)
147179c6-63d6-4ffb-bf40-a2d002fb8fa2	1.0	PubMed	19429245	In concordance with the previous study, we confirmed that GSK3beta was highly expressed in cultured alveolar epithelial cells, and further found that CSE inhibited GSK3beta by reducing the protein expression of GSK3beta and increasing the phosphorylated GSK3beta.	p(UP:Q9C942)	directlyIncreases	p(HGNC:GSK3B)
9b50b30f-7047-4916-814e-8802a55edd41	1.0	PubMed	23673211	These results were confirmed using Hoechst 33342 staining and fluorescence microscopy, which revealed a reduction in nuclear condensation and DNA fragmentation with co-treatment as compared to cells treated with cisplatin alone.To further confirm the involvement of the Wnt and beta-catenin signaling pathway in sensitization of A549 and DDP cells to cisplatin induced apoptosis, Wnt and beta-catenin signaling was disrupted using siRNA knockdown of GSK-3beta expression.	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B)
9fd9a3ae-20be-48f5-af8f-8520f8e024af	1.0	PubMed	21868755	DMC even at 15 microM increased the levels of p-GSK3beta in H157, H460 and Calu-1 cells, whereas it increased p-Akt levels only at 30 microM in these cell lines (XREF_SUPPLEMENTARY).	p(HGNC:CXCL17)	directlyIncreases	p(HGNC:GSK3B)
bfdd670a-e959-45eb-bae5-a283bb4f76ae	1.0	PubMed	25145299	Overexpression of CXCR4 promoted GSK3beta expression and silencing of CXCR4 suppressed GSK3beta expression.	p(HGNC:CXCR4)	directlyIncreases	p(HGNC:GSK3B)
9dd498c5-9798-43d1-a89d-e6698f08d183	1.0	PubMed	25145299	CXCR4 upregulated GSK3beta expression, at least in part, at the level of transcription.	p(HGNC:CXCR4)	directlyIncreases	p(HGNC:GSK3B)
9dd498c5-9798-43d1-a89d-e6698f08d183	1.0	PubMed	25145299	CXCR4 promotes GSK3beta expression via the Akt cell signaling pathway in pancreatic cancer cells.	p(HGNC:CXCR4)	directlyIncreases	p(HGNC:GSK3B)
9dd498c5-9798-43d1-a89d-e6698f08d183	1.0	PubMed	25145299	CXCR4 promotes GSK3beta expression in pancreatic cancer cells via the Akt pathway.	p(HGNC:CXCR4)	directlyIncreases	p(HGNC:GSK3B)
9dd498c5-9798-43d1-a89d-e6698f08d183	1.0	PubMed	25145299	Inhibition of CXCR4 suppresses GSK3beta expression.	p(HGNC:CXCR4)	directlyIncreases	p(HGNC:GSK3B)
9dd498c5-9798-43d1-a89d-e6698f08d183	1.0	PubMed	25145299	CXCR4 promoted GSK3beta expression and PANC-1 invasion by Akt signaling.	p(HGNC:CXCR4)	directlyIncreases	p(HGNC:GSK3B)
2771b4ba-7048-42e4-89f2-cd95c65eab31	1.0	PubMed	23673211	Cisplatin treatment increased total GSK-3beta and p-GSK-3beta expression in the nucleus of A549 and DDP cells while it decreased their expression in A549 cells (B, < 0.01, < 0.01).	a(CHEBI:27899)	directlyIncreases	p(HGNC:GSK3B)
2771b4ba-7048-42e4-89f2-cd95c65eab31	1.0	PubMed	23673211	Cisplatin treatment increased p-GSK-3beta levels in A549 and DDP cells, but reduced it in A549 cells.	a(CHEBI:27899)	directlyIncreases	p(HGNC:GSK3B)
3134adbb-d533-4550-8387-6f7dd7b29ba2	1.0	PubMed	25591548	GSK-3beta protein also suppresses cyclin D1 transcription through inactivation of beta-catenin, the transcription factor of cyclin D1 (XREF_BIBR).	p(FPLX:Cyclin)	directlyIncreases	p(HGNC:GSK3B)
3134adbb-d533-4550-8387-6f7dd7b29ba2	1.0	PubMed	23383245	GSK-3beta could inhibit cyclin D1 gene transcription by inaction of its transcription factor beta-catenin.	p(FPLX:Cyclin)	directlyIncreases	p(HGNC:GSK3B)
9269f485-23d6-4887-9e6e-996a89b8f542	1.0	PubMed	26336990	Indeed, DAB2IP KD induced high Ser9 (S9, negative regulatory site) phosphorylation level of GSK-3beta, nuclear translocation of beta-catenin and transcriptional activation of TCF/LEF.	p(HGNC:DAB2IP)	directlyIncreases	p(HGNC:GSK3B)
ebf3b383-8468-4c59-8f86-31ee638f13cc	1.0	PubMed	25773908	Furthermore, Embigin silencing led to a reduced expression of PI3K, GSK3-beta, and Snail and Slug.	p(HGNC:EMB)	directlyIncreases	p(HGNC:GSK3B)
9563c3e8-e659-404d-a960-12ba11a11a1a	1.0	PubMed	21441955	Overexpression of active K-Ras or H-Ras in BxPC-3 cells increases GSK-3beta protein expression by nearly two-fold, whereas treatment with U0126 prevents both ERK phosphorylation and Ras induced GSK-3beta expression as expected (XREF_FIG).	p(FPLX:ERK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B)
9dc76cd3-6b1e-44cb-81a4-f893576f4fdd	1.0	PubMed	22093618	Whether MAPK signaling cascade could lead to GSK-3beta overexpression in renal cancer remains to be investigated.In future, reintroduction of tumor suppressing miR-199a to patients with metastatic or locally advanced RCC can make a very attractive clinical tool.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B)
e4a4c179-64a2-4a53-9271-b1a815614ed9	1.0	PubMed	21441955	Lastly, we show that ETS2 cooperates with p300 histone acetyltransferase to remodel chromatin and promote GSK-3beta expression.	p(HGNC:ETS2)	directlyIncreases	p(HGNC:GSK3B)
3383a9e0-ecc9-43ab-999d-e5ff73349b32	1.0	PubMed	27060477	Inhibition of GABA B R activated GSK-3beta by reducing the phosphorylation level of GSK-3beta.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:GSK3B)
3383a9e0-ecc9-43ab-999d-e5ff73349b32	1.0	PubMed	27060477	Our study revealed that activation of GABA B R could increase the phosphorylation level of GSK-3beta which means GABA B R could regulate the activity of GSK-3beta.	a(PUBCHEM:119)	directlyIncreases	p(HGNC:GSK3B)
19ae2765-38cb-4584-a4a5-b25929d70963	1.0	PubMed	19531650	PGI and AMF overexpression up-regulated GSK-3beta expression and down-regulated its downstream target beta-catenin expression.	p(HGNC:GPI)	directlyIncreases	p(HGNC:GSK3B)
7607d312-f5b6-4f13-a48f-de124a7ba2b3	1.0	PubMed	20840866	However, our preliminary results indicate that the levels of GSK3beta phosphorylated on serine 9 are not modulated following SHP-1 overexpression (data not shown).	p(HGNC:GSK3B)	directlyIncreases	p(UP:P29381)
8313a84a-af2d-43e9-818c-d8cce037260b	1.0	PubMed	22640743	When Panc-Vec and Panc-PAUF cells were transfected with GSK-3beta siRNA alone, the resulting suppression of GSK-3beta levels mildly reduced beta-catenin expression (B).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
8313a84a-af2d-43e9-818c-d8cce037260b	1.0	PubMed	26388612	Ectopic expression of GSK-3beta decreased the phosphorylation levels of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
8313a84a-af2d-43e9-818c-d8cce037260b	1.0	PubMed	26388612	These results showed that ectopic expression of GSK-3beta decreased the phosphorylation of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
bd237329-3281-4bde-9616-393a9b6e3981	1.0	PubMed	6079836	Overexpression of gsk3beta mRNA rescued eyes and the wild-type fgf8 expression of homozygous mbl embryos.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FGF8)
0c4a8ac2-902e-45f9-abad-be928c7f4eac	1.0	PubMed	26388612	Ectopic expression of GSK-3beta decreased the phosphorylation levels of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A)
0c4a8ac2-902e-45f9-abad-be928c7f4eac	1.0	PubMed	26388612	These results showed that ectopic expression of GSK-3beta decreased the phosphorylation of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A)
8d298fe9-6848-419e-9f1a-6191be9491fc	1.0	PubMed	21320285	In contrast, a more recent study, showed that over-expression of GSK3beta or inhibition of GSK3beta expression or function, reduced or increased, respectively, TNF induced expression of IL-6, MCP-1 and VCAM-1 in microvascular endothelial cells [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(UP:P0CW71)
dd54153d-0ace-409d-868b-feae3c2a9b1e	1.0	PubMed	21320285	In contrast, a more recent study, showed that over-expression of GSK3beta or inhibition of GSK3beta expression or function, reduced or increased, respectively, TNF induced expression of IL-6, MCP-1 and VCAM-1 in microvascular endothelial cells [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:IL6)
4952c138-90c7-4772-b664-310a0bb8d30c	1.0	PubMed	24316184	Interestingly, COXII expression was slightly increased by overexpression of WT-GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:"MT-CO2")
4952c138-90c7-4772-b664-310a0bb8d30c	1.0	PubMed	24316184	Our observation that overexpression of WT-GSK3beta caused a slight increase in expression of COXII and VDAC () supports our hypothesis as GSK3 is reported to form stable complex with AMPK, and to phosphorylate AMPK independent of primed phosphorylation () so AMPK activity may become critically low by overexpression of WT-GSK3beta leading to a cellular metabolism shift toward anabolism.Collectively, the present study demonstrates that GSK3 is involved in 2-DG-mediated mitochondrial biogenesis through a proteolysis independent mechanism, and possibly through the regulation of transcription and translation processes in mitochondria.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:"MT-CO2")
ffb460a9-ce8e-4400-beca-567550070a09	1.0	PubMed	21320285	In contrast, a more recent study, showed that over-expression of GSK3beta or inhibition of GSK3beta expression or function, reduced or increased, respectively, TNF induced expression of IL-6, MCP-1 and VCAM-1 in microvascular endothelial cells [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VCAM1)
4178a5ed-2397-4fbc-ac0a-d50085101122	1.0	PubMed	24316184	Our observation that overexpression of WT-GSK3beta caused a slight increase in expression of COXII and VDAC () supports our hypothesis as GSK3 is reported to form stable complex with AMPK, and to phosphorylate AMPK independent of primed phosphorylation () so AMPK activity may become critically low by overexpression of WT-GSK3beta leading to a cellular metabolism shift toward anabolism.Collectively, the present study demonstrates that GSK3 is involved in 2-DG-mediated mitochondrial biogenesis through a proteolysis independent mechanism, and possibly through the regulation of transcription and translation processes in mitochondria.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VDAC1)
89352d16-1612-472f-9bd0-877a94ed350f	1.0	PubMed	26388612	Ectopic expression of GSK-3beta decreased the phosphorylation levels of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:VEGF)
89352d16-1612-472f-9bd0-877a94ed350f	1.0	PubMed	26388612	These results showed that ectopic expression of GSK-3beta decreased the phosphorylation of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:VEGF)
27931dcc-373d-4fde-9d5e-2559a89eeeb9	1.0	PubMed	25041379	As stated before, the phosphorylation of GSK-3beta at the serine 9 position inhibits GSK-3beta activity and causes an increase in beta-catenin levels, while phosphorylation at Tyr 216 increases GSK-3beta activity and decreases beta-catenin levels.	p(HGNC:GSK3B, pmod(Ph, 9))	directlyIncreases	p(HGNC:CTNNB1)
ed521d62-f4f3-4281-84f1-bb073b10aab4	1.0	PubMed	16987514	Overall, this study shows that the PP1/I -2 complex differentially regulates the phosphorylation of GSK3alpha and GSK3beta which downstream modulates SERCA2 levels.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:ATP2A2)
7606bbee-95d1-417f-afe4-ef4386c57581	1.0	PubMed	15668893	These results suggest that beta-catenin and MSI in ovarian carcinoma, like their in uterine counterpart, belong to 2 independent pathways.Increased beta-catenin expression caused by inactivating mutations in the GSK-3beta phosphorylation sites of beta-catenin or in APC results in the accumulation of beta-catenin in the nucleus and uncontrolled activation of target gene expression such as MMP-7, cyclin D1, Connexin 43, ITF2, c-myc, and PPAR-delta.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:CTNNB1)
7606bbee-95d1-417f-afe4-ef4386c57581	1.0	PubMed	26252009	Furthermore, inhibition of GSK-3beta phosphorylation clearly suppresses beta-catenin expression and resistance to apoptosis.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:CTNNB1)
7606bbee-95d1-417f-afe4-ef4386c57581	1.0	PubMed	6571200	The blockage of GSK-3beta phosphorylation markedly inhibited glycogen synthesis and decreased beta-catenin expression.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:CTNNB1)
6e6e7007-c6df-41db-8fb6-a9077b6595f6	1.0	PubMed	5474925	Furthermore, betaAR stimulated ANF transcription is predominantly mediated by activation of Akt and subsequent phosphorylation and inhibition of GSK3beta.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:NPPA)
5d0f4e95-3f9c-4cf2-a866-71b2bc4f270a	1.0	PubMed	25728838	This enhancement promoted the phosphorylation of GSK-3beta, leading to the stabilization and high concentration accumulation of beta-catenin in cytoplasm to activate the transcription of RUNX-2, and finally increased the osteogenesis of hUMSCs.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:RUNX2)
a19f170d-c047-483c-b33f-81a842ae84ff	1.0	PubMed	26538315	Another recent study showed increased SIRT2 expression in insulin resistant C2C12 skeletal muscle cells and that SIRT2 inhibition, by either pharmacological or genetic means, increased insulin stimulated glucose uptake and improved phosphorylation of Akt and GSK3beta under insulin-resistance conditions, suggesting that SIRT2 may negatively affect skeletal muscle glucose uptake.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:SIRT2)
6672bec7-11fd-4780-9cee-4e783d7bdabe	1.0	PubMed	21238544	Thus, GSK3beta activation may promote the phosphorylation of PS1 to enhance cleavage of IR, finally activating the transcription of Akt, which is a strong inhibitor of GSK3beta activity.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT)
86eb3359-d960-4d4b-ba67-75208cab8fd3	1.0	PubMed	21565291	By contrast, ARHGAP31 levels are augmented by GSK-3beta activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ARHGAP31)
d02595b9-9b94-41b0-b711-70ca968b3004	1.0	PubMed	27043582	As shown in XREF_FIG A, inhibition of p38, JNK, GSK3beta, and IKK-alpha attenuated the PFF-A-mediated ATF3 expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ATF3)
382c2ebd-82fc-49a0-820d-2a8903c01174	1.0	PubMed	21887250	Further manipulation of GSK3beta showed that increased active GSK3beta by expressing its constitutive active mutant form enhanced HB9 expression, whereas inhibitory manipulations of GSK3beta by RNAi or inhibitors decreased HB9, confirming that GSK3beta was required for proper HB9 expression.	p(HGNC:GSK3B)	directlyIncreases	p(UP:O04292)
ef8cdad8-8c33-4b99-af94-73ebee3ea281	1.0	PubMed	23202730	The regulation of BACE1 gene expression by GSK3beta was dependent on NF-kappaB signaling.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BACE1)
ef8cdad8-8c33-4b99-af94-73ebee3ea281	1.0	PubMed	23202730	These data provide evidence for regulation of BACE1 expression and AD pathogenesis by GSK3beta and that inhibition of GSK3 signaling can reduce Abeta neuropathology and alleviate memory deficits in AD model mice.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BACE1)
c8fe4bb0-b7e4-40f3-aecc-a5149a3f8715	1.0	PubMed	24675460	Nonetheless, inhibition of GSK-3beta function in MEFs or PDA cell lines impaired the expression of the NF-kappaB target genes Bcl-xL and cIAP2, but not IkappaBalpha.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BCL2L1)
c8fe4bb0-b7e4-40f3-aecc-a5149a3f8715	1.0	PubMed	24675460	Nuclear GSK-3beta contributes to Bcl-xL and cIAP2 expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BCL2L1)
c8fe4bb0-b7e4-40f3-aecc-a5149a3f8715	1.0	PubMed	24675460	XREF_BIBR, XREF_BIBR, XREF_BIBR In light of our direct experimental evidence that nuclear localized GSK-3beta can efficiently drive the expression of the NF-kappaB target genes BCL2L1 and BIRC3 in pancreatic cancer cells, it is of interest that many GSK-3beta substrates are nuclear transcription factors.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BCL2L1)
c8fe4bb0-b7e4-40f3-aecc-a5149a3f8715	1.0	PubMed	22039301	However, the expression of Bcl-xL and Bcl-2 were reduced by both SCF starvation and GSK3beta knockdown, with further reduction observed with the combination of these approaches.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BCL2L1)
29c16de3-cf1f-4a82-b2e8-1637f7fef20f	1.0	PubMed	22039301	However, the expression of Bcl-xL and Bcl-2 were reduced by both SCF starvation and GSK3beta knockdown, with further reduction observed with the combination of these approaches.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BCL2)
51c9abbf-73e4-48b6-bca5-d5ea9f74c0da	1.0	PubMed	24675460	Nuclear GSK-3beta contributes to Bcl-xL and cIAP2 expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BIRC3)
55ecae68-e012-4903-b10a-8b1f73c523ff	1.0	PubMed	24531650	In vitro, GSK3beta inhibition lessened hepatocytes apoptosis induced by H 2 O 2 or Antimycin A, as demonstrated by decreased LDH activity, and reduced cleavage of caspase-3 expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CASP3)
7674ca24-f08b-4ae9-8c36-77db2cac4711	1.0	PubMed	7243064	In the present study we examined the function of glycogen synthase kinase-3beta (GSK-3beta) on cAMP induced CCK gene transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCK)
835ff89f-7fbb-4754-912d-2987b766a7f4	1.0	PubMed	18167338	The PI-3K and AKT pathway negatively regulates both GSK-3beta and Chk1 and this, in turn, promotes cell-cycle advancement by elevating Cdc25A levels ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDC25A)
11c64340-a70d-4f4a-8004-2667810a45af	1.0	PubMed	26863455	These data suggested that in OLA1-knockdown cells, GSK3beta maintained active state in dephosphorylated form, which was consistent with decreased Snail and increased E-cadherin level.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH1)
11c64340-a70d-4f4a-8004-2667810a45af	1.0	PubMed	24586454	Inhibition of glycogen synthase kinase 3beta (GSK3beta) by Akt not only results in accumulation of several oncogenic proteins, including beta-catenin, c-myc, Snail, and cyclin D1 (CCND1), but also reduces expression of E-cadherin, a factor critical for contact inhibition XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH1)
3cc21921-e07e-4bc8-9527-efc19feeb605	1.0	PubMed	22810307	GSK3beta inhibition blocks melanoma cell and host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH2)
3cc21921-e07e-4bc8-9527-efc19feeb605	1.0	PubMed	22810307	Functionally, inhibition of GSK3beta signaling was found to suppress N-cadherin expression at the mRNA and protein levels and was associated with decreased expression of the transcription factor Slug.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH2)
3cc21921-e07e-4bc8-9527-efc19feeb605	1.0	PubMed	22810307	Here we present new data demonstrating that low constitutive levels of GSK3beta signaling contribute to the oncogenic behavior of melanoma by regulating both N-cadherin expression and focal adhesion complexes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH2)
3cc21921-e07e-4bc8-9527-efc19feeb605	1.0	PubMed	22810307	Inhibition of GSK3beta signaling in melanoma cells reduces N-cadherin expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH2)
e0758694-57b1-44b2-927a-785ef80b3699	1.0	PubMed	22928011	Knocking-down of XB130 reduced phosphorylation of p21Cip1 and WAF1, p27Kip1, FOXO3a and GSK3beta, increased p21Cip1 and WAF1protein levels and cleavages of caspase-8 and-9.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDKN1A)
f5d3f762-1a39-45ce-a552-d87e972ceb48	1.0	PubMed	21868755	As presented in XREF_FIG, expression of WT, particularly CA GSK3beta, but not KD GSK3beta, increased the levels of c-FLIP.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CFLAR)
f5d3f762-1a39-45ce-a552-d87e972ceb48	1.0	PubMed	21868755	Thus, it appears that activation of GSK3beta elevates c-FLIP levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CFLAR)
c2505190-e35b-42ed-af77-1fd7136f38aa	1.0	PubMed	23824844	These data identify a novel pathway in gingival fibroblasts in which inhibition of GSK-3beta attenuates CCN2 and CTGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTGF)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	22662165	All together, these data show that the oncogenic inactivation of GSK3beta by the delE746-A750 EGFR or E545K PIK3CA cancer proteins significantly increases nuclear beta-catenin pool in response to GD and enhances beta-catenin- and FOXO4 dependent expression of genes involved in antioxidant stress response.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	22470507	In colon cancer cells that express high levels of DACT1, we propose that DACT1 interacts with beta-catenin, after which DACT1 binds to and inhibits GSK-3beta, which results in the release of beta-catenin from the destruction complex, increased intracellular beta-catenin levels, and its subsequent accumulation in the nucleus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	25043531	It binds and stimulates the degradation of a complex formed by APC, Axin, and GSK3beta to inhibit beta-catenin degradation, thus elevating cytosolic levels of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	23727580	Specifically, our data show that enhanced ROCK activity is accompanied by reduced beta-catenin acetylation and phosphorylation by the ' destruction complex ' kinases CK1 and GSK3beta, which is likely to increase total beta-catenin levels through reducing its proteasomal degradation ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	19190323	Inactivation of GSK-3beta leads to reduced degradation of beta-catenin, and increased cellular beta-catenin levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	7060443	GSK 3beta inhibition increased both NFkappaB and beta-catenin activity associated with decreased IkappaB and increased beta-catenin levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	23434321	We also found reduced levels of activated beta-catenin, pGSK-3beta (Ser9) and pAKT (Ser473) in CXCR4 depleted MPNST tumor samples compared to control tumors (SMPNST allografts) (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	26560046	Our data presented a complicated picture regarding the effects of E6 and E7 oncoproteins of high-risk HPV on the regulation of GSK3beta (XREF_FIG), which in turn could modulate cellular beta-catenin levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	26252009	Previous report suggested that GSK-3beta modulates beta-catenin levels by phosphorylation of beta-catenin on Ser 33/37 and Thr 41 [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	26252009	Because it is suggested that Akt induces GSK-3beta phosphorylation on Ser 9 to promote GSK-3beta degradation through ubiquitin proteasome pathway, inhibition of Akt phosphorylation and activation by embelin partially contributes to the GSK-3beta activation and inhibition in the level of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	25909283	Knockdown of GSK3beta by siRNA in the stable fibulin-5-expressing A549 cells restored expression of beta-catenin, c-Myc, cyclin D1 and MMP-7, and invasive capacity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
6d8084a2-fe8b-4b9c-bf3d-a2aafac829de	1.0	PubMed	26165519	Inactivation of GSK-3beta is able to inhibit the degradation of beta-catenin, and increase the cellular levels of beta-catenin (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1)
498b9607-dec7-4a33-969e-8915605135e6	1.0	PubMed	23383245	The cyclin D1 expression level is mediated by Akt and GSK-3beta signaling.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin)
498b9607-dec7-4a33-969e-8915605135e6	1.0	PubMed	23434321	mTORC1 and GSK-3beta are important downstream effectors of phospho-AKT and our results show that in MPNSTs, CXCR4 depletion more strongly impacts GSK-3beta rather than mTOR through PI3-Kinase, and that GSK-3beta mediates cyclin D1 expression.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin)
498b9607-dec7-4a33-969e-8915605135e6	1.0	PubMed	25909283	Knockdown of GSK3beta by siRNA in the stable fibulin-5-expressing A549 cells restored expression of beta-catenin, c-Myc, cyclin D1 and MMP-7, and invasive capacity.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin)
498b9607-dec7-4a33-969e-8915605135e6	1.0	PubMed	24327518	Genetic depletion of GSK-3beta, on the other hand, increases cyclin D1 expression.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin)
498b9607-dec7-4a33-969e-8915605135e6	1.0	PubMed	24327518	Genetic depletion of GSK-3beta, on the other hand, increased cyclin D1 expression although inhibition of p21 degradation could still be clearly seen (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin)
498b9607-dec7-4a33-969e-8915605135e6	1.0	PubMed	18606491	Similarly, activation of GSK3beta by rapamycin also induces down-regulation of cyclin D1 expression, cell cycle arrest and the inhibition of anchorage dependent growth in breast cancer cells.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin)
3a64f12f-1c07-4412-9db3-873d566d53b5	1.0	PubMed	27060477	Silencing of GSK-3beta by shRNA prevented histone H3 phosphorylation and reduced DNMT1 expression so that can restrain breast cancer cell proliferation 27.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNMT1)
3a64f12f-1c07-4412-9db3-873d566d53b5	1.0	PubMed	24704462	In addition, GSK-3beta silencing under high glucose condition led to decrease in DNMT1 expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNMT1)
1f9a43b4-4a85-457f-bfc7-1b17c9521c74	1.0	PubMed	23874688	Since GSK3beta demonstrates a preference for pre-phosphorylated (primed) substrates by recognising the consensus sequence S/T-X-X-X-Phospho-S/T XREF_BIBR, XREF_BIBR and EZH2 contains the putative GSK-3beta phosphorylation motif ADHWDSKNVSCKNC (591), EZH2 may be a candidate substrate of GSK3beta, and GSK3beta inactivation may lead to excessive EZH2 expression in NPC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EZH2)
591b22f9-bda8-4e7e-a5f8-969edb5e54f6	1.0	PubMed	23783032	Suppression of endogenous GSK3beta by short hairpin RNA (shRNA) expression reduced the steady-state level of FANCL compared with control shRNA expression (XREF_FIG; n = 3).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FANCL)
591b22f9-bda8-4e7e-a5f8-969edb5e54f6	1.0	PubMed	23783032	Based on our previous publication (XREF_BIBR), we tested the role of GSK3beta, since we had observed that GSK3beta modulates the protein level of FANCL.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FANCL)
8666e9a1-9323-4cfa-beef-1398acce7525	1.0	PubMed	22662165	All together, these data show that the oncogenic inactivation of GSK3beta by the delE746-A750 EGFR or E545K PIK3CA cancer proteins significantly increases nuclear beta-catenin pool in response to GD and enhances beta-catenin- and FOXO4 dependent expression of genes involved in antioxidant stress response.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FOXO4)
7651d1d8-a2af-48ba-ac65-e342c3d0de06	1.0	PubMed	21868755	In H358 cells, GSK3alpha siRNA reduced the levels of GSK3alpha only, whereas GSK3beta siRNA (# 1) reduced the levels of not only GSK3beta, but also GSK3alpha (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3A)
a42b54a6-d156-4116-bbb5-1940aedbbc6e	1.0	PubMed	20008284	As before, GSK3beta knockdown significantly reduced GSK3beta expression in HuMCs (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B)
a42b54a6-d156-4116-bbb5-1940aedbbc6e	1.0	PubMed	24038789	GSK3beta siRNA knockdown effectively decreased GSK3beta levels (XREF_FIG) and increased CSPC proliferation (XREF_FIG), supporting the effect of BIO on CSPC proliferation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B)
a42b54a6-d156-4116-bbb5-1940aedbbc6e	1.0	PubMed	20008284	As before, GSK3beta knockdown significantly reduced GSK3beta expression in HuMCs (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B)
a42b54a6-d156-4116-bbb5-1940aedbbc6e	1.0	PubMed	24038789	GSK3beta siRNA knockdown effectively decreased GSK3beta levels (XREF_FIG) and increased CSPC proliferation (XREF_FIG), supporting the effect of BIO on CSPC proliferation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B)
54b04f58-d748-4c3d-8322-022b25edd9f5	1.0	PubMed	21377170	Moreover, it is possible that aberrant HDAC6 levels are induced by increased activity of GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HDAC6)
998e96e3-2c05-4374-98a4-816df317ed0c	1.0	PubMed	26388612	GSK-3beta inhibits beta-catenin and mTOR and p70S6K1 signal pathways, and down-regulates HIF-1 and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:HIF1)
f90545db-2c07-40e5-9738-30dc64c657ef	1.0	PubMed	21616478	In agreement with this idea, age dependent tau hyperphosphorylation in mice overexpressing low levels of p25 is mediated by GSK-3beta ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HRES1)
5488f20c-2eaf-4117-8e05-cbbdcc3aa818	1.0	PubMed	24923353	These results suggest that 14-3-3sigma induced HSF-1alpha and HSP70 expression and cell migration is mediated by the GSK-3beta and beta-catenin signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:HSPA)
5488f20c-2eaf-4117-8e05-cbbdcc3aa818	1.0	PubMed	24923353	Finally, 14-3-3sigma-induced HSF-1alpha and HSP70 expression is abolished by the knockdown of beta-catenin or activation of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:HSPA)
2e11f3dd-8e0f-47f0-ad95-c26901f78d0c	1.0	PubMed	25053419	Although kinase-dead GSK3beta can not up-regulate IGF-IR, the constitutively active GSK3beta induces IGF-IR expression in a FOXO dependent manner.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:IGF1R)
6053cd32-2e61-4e72-a499-471e657e4d8f	1.0	PubMed	23649588	GSK3beta inhibition also reduces the expression of stem cell markers such as Oct4, Sox2, and Nanog and upregulates expression of the differentiation markers Calgranulin B and Involucrin in the CD44 (high) / ESA (high) cell fraction.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:IVL)
2849c8cd-a9b5-4184-976b-573f26614229	1.0	PubMed	23085750	These findings suggested that the kinase activity of GSK3beta was necessary to increase KLF6 protein levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6)
2849c8cd-a9b5-4184-976b-573f26614229	1.0	PubMed	23085750	The addition of GSK3beta increased protein levels of both wild-type and phosphomutant KLF6, yet only KLF6-WT increased p21 protein levels (P < 0.05), while KLF6-4A had a minimal effect (P < 0.5) (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6)
2849c8cd-a9b5-4184-976b-573f26614229	1.0	PubMed	23085750	We further validate this effect by inhibiting GSK3beta, which reduces KLF6 protein levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6)
239e3cc9-5799-490e-b7bf-7434a85b9454	1.0	PubMed	27023670	Western blot analyses using a panel of anti-pan-tau, anti-non-phospho-tau, and anti-phospho-tau antibodies confirmed that knockdown of GSK3beta and Sgg significantly decreased tau phosphorylation levels at SP/TP sites (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT)
239e3cc9-5799-490e-b7bf-7434a85b9454	1.0	PubMed	27023670	These results suggest that knockdown of GSK3beta and Sgg significantly decreased tau phosphorylation levels at SP/TP sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT)
53b275d8-9076-44d5-864d-28e35222fb7f	1.0	PubMed	26459180	During differentiation induction, activation of MEK and ERK and PI3K and Akt pathways by ATRA leads to activation of p90RSK and inactivation of glycogen synthase kinase 3beta (GSK3beta), which increase Mcl-1 levels by increasing its translation and stability.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1)
53b275d8-9076-44d5-864d-28e35222fb7f	1.0	PubMed	26252009	These results suggest that Mcl-1 expression is modulated by GSK-3beta activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1)
8e8363ba-20ed-4343-b85b-3abe7eca0b6b	1.0	PubMed	23408967	GSK3beta inhibition decreased the active fractions of FAK and Rac1 and the expression and secretion of MMP-2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MMP2)
e871d326-9f16-4aca-8d48-4abf06a0f15e	1.0	PubMed	25909283	Knockdown of GSK3beta by siRNA in the stable fibulin-5-expressing A549 cells restored expression of beta-catenin, c-Myc, cyclin D1 and MMP-7, and invasive capacity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MMP7)
b3d91371-884c-4518-b483-dcb723495544	1.0	PubMed	21092141	Depletion of GSK3beta promotes the transcription of human c-Myb and represses the transcription of gamma-globin in K562 cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYB)
b3d91371-884c-4518-b483-dcb723495544	1.0	PubMed	21092141	However, depletion of GSK3beta upregulated the transcription of human c-Myb, resulting in transcriptional suppression of gamma-globin, one of the c-Myb target genes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYB)
2a86c77f-0c98-4327-bd5f-9655829a69c8	1.0	PubMed	25909283	Knockdown of GSK3beta by siRNA in the stable fibulin-5-expressing A549 cells restored expression of beta-catenin, c-Myc, cyclin D1 and MMP-7, and invasive capacity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC)
9c8a46bc-ac57-4588-9630-4accfc028d07	1.0	PubMed	23768967	Inhibition of GSK-3beta using both lithium and the specific GSK-3beta inhibitor SB216763 also reduces the expression of the progenitor markers Nestin and SOX2, while concurrently increasing expression of the differentiation markers, 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase, glial fibrillary acidic protein, and beta-tubulin III in a cell line dependent fashion.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NES)
9c8a46bc-ac57-4588-9630-4accfc028d07	1.0	PubMed	25144716	GSK-3beta inhibition has been previously shown to significantly reduce the stem like CD133 + fraction of a human GBM cell line, as well as the expression of the stem-cell markers, SOX-2 and nestin, while, in parallel, it increased the expression of differentiation markers, including glial fibrillary acidic protein, beta-tubulin III and 2 ', 3 '-cyclic nucleotide 3 '-phospohodiesterease.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NES)
affadffa-483c-4030-aefb-93fbeb458420	1.0	PubMed	12871932	GSK-3 beta forms an in vivo complex with and specifically phosphorylates NF-kappa B1/p105 at Ser-903 and Ser-907 in vitro. GSK-3 beta has a dual effect on p105: it stabilizes p105 under resting conditions and primes p105 for degradation upon tumor necrosis factor (TNF)-alpha treatment. Indeed, constitutive processing of p105 to p50 occurs at a higher rate in cells lacking GSK-3 beta with respect to wild-type cells and can be reduced upon reintroduction of GSK-3 beta by transfection. S903A and S907A point mutations impair p105 proteolysis in response to TNF-α.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKB1)
affadffa-483c-4030-aefb-93fbeb458420	1.0	PubMed	12871932	GSK-3 beta forms an in vivo complex with and specifically phosphorylates NF-kappa B1/p105 at Ser-903 and Ser-907 in vitro. GSK-3 beta has a dual effect on p105: it stabilizes p105 under resting conditions and primes p105 for degradation upon tumor necrosis factor (TNF)-alpha treatment. Indeed, constitutive processing of p105 to p50 occurs at a higher rate in cells lacking GSK-3 beta with respect to wild-type cells and can be reduced upon reintroduction of GSK-3 beta by transfection. S903A and S907A point mutations impair p105 proteolysis in response to TNF-α.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKB1)
45a26177-cc8b-4ad5-8ae2-23f6834499b8	1.0	PubMed	22534782	Inhibition of GSK-3beta partially decreased the expression of NF-kappaB pathway genes and yielded antitumor effects in mouse models of osteosarcoma.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFkappaB)
45a26177-cc8b-4ad5-8ae2-23f6834499b8	1.0	PubMed	24675460	Nonetheless, inhibition of GSK-3beta function in MEFs or PDA cell lines impaired the expression of the NF-kappaB target genes Bcl-xL and cIAP2, but not IkappaBalpha.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFkappaB)
45a26177-cc8b-4ad5-8ae2-23f6834499b8	1.0	PubMed	24675460	Our observation that GSK-3beta affects only a subset of NF-kappaB target genes, raised the possibility that GSK-3beta contributes to NF-kappaB target gene expression in a promoter- or chromatin context dependent manner.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFkappaB)
45a26177-cc8b-4ad5-8ae2-23f6834499b8	1.0	PubMed	24675460	XREF_BIBR, XREF_BIBR, XREF_BIBR In light of our direct experimental evidence that nuclear localized GSK-3beta can efficiently drive the expression of the NF-kappaB target genes BCL2L1 and BIRC3 in pancreatic cancer cells, it is of interest that many GSK-3beta substrates are nuclear transcription factors.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFkappaB)
45a26177-cc8b-4ad5-8ae2-23f6834499b8	1.0	PubMed	21110852	GSK-3beta inhibition significantly decreased the expression of the NF-kappaB target gene survivin.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFkappaB)
21aa1e76-f5f5-414b-b199-a061845ad6bd	1.0	PubMed	5474925	Kinase-inactive GSK3beta increased ANF transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NPPA)
9f879c1e-ea0b-485a-b43d-ede47ab2f6c2	1.0	PubMed	24903325	A recent report demonstrated that GSK3beta, the kinase that phosphorylates Pax3 at Ser201 (XREF_BIBR), promotes melanoma cell survival by regulating Pax3 protein levels (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3)
483285ac-a2c8-442c-82fd-58426e9d5642	1.0	PubMed	23428800	Moreover, we recently demonstrated that activation of glycogen synthase kinase-3beta (GSK-3beta) leads to inhibition of PP2A through accumulation of inhibitor-2 of PP2A (I), increase of the level of P-PP2A and reduction of PP2A protein and mRNA levels, decreasing Leu309 methylation by increasing PME-1 protein level and decreasing PPMT1 protein level 's and decreasing PP2A subunit protein level.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PPP2)
10310357-ca83-4be5-8a6d-7d3879fb5d2d	1.0	PubMed	21441955	Mutant Ras regulates GSK-3beta transcription via MAPK signaling.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:RAS, var(p.?))
85b92e30-78d2-446f-8943-4c996fc03d70	1.0	PubMed	25088797	GSK-3beta activity inhibition decreases the ubiquitination of Snail and increases Snail transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1)
85b92e30-78d2-446f-8943-4c996fc03d70	1.0	PubMed	23431386	Compared with control, down-regulation of GSK-3beta markedly elevated the levels of Snail expression (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1)
85b92e30-78d2-446f-8943-4c996fc03d70	1.0	PubMed	19411070	Downregulation of GSK-3beta partially elevated the level of Snail (lane 2 vs lane 1, XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1)
85b92e30-78d2-446f-8943-4c996fc03d70	1.0	PubMed	25935853	Increased FoxM1b levels induce EMT by activating AKT and subsequently increasing GSK-3beta, which enhanced Snail expression [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1)
85b92e30-78d2-446f-8943-4c996fc03d70	1.0	PubMed	23769744	Compared with the control group, down-regulation of GSK-3beta obviously elevated the expression level of Snail in PC3 cells (C).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1)
85b92e30-78d2-446f-8943-4c996fc03d70	1.0	PubMed	23572150	Further studies revealed that KCNN4 channels increased intracellular calcium levels and activated components of cell signaling downstream of calcium, including CaM-kinase II and glycogen synthase kinase-3 beta (GSK-3 beta), which increased Snail expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1)
85b92e30-78d2-446f-8943-4c996fc03d70	1.0	PubMed	23029025	Indeed, we showed that inactivation of GSK3beta by LiCl or by a specific GSK3beta inhibitor, AR-A014418, was sufficient to increase the levels of Snail in HCT116 cells XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1)
0a71b100-f665-4683-83d1-f6224488e366	1.0	PubMed	16174773	Inhibition of GSK3beta in primary neuronal cultures decreased the levels of endogenous synphilin-1, indicating that synphilin-1 is a physiologic substrate of GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCAIP)
56a516e6-9827-4b6b-948a-1651c90137ac	1.0	PubMed	24681994	GSK-3beta inhibition decreases alpha-synuclein protein expression and prevents cell death in a cellular model of PD, indicating that inhibition of GSK-3beta activity may be neuroprotective to dopaminergic neurons by attenuating the toxicity of alpha-synuclein overexpression (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCA)
58b2f90a-40e7-43f8-99c9-71c7eeeb3a08	1.0	PubMed	26095393	Inhibition of GSK3beta Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOST)
c18848c9-4bc0-44ce-8d76-d1c94c0a0c31	1.0	PubMed	19823589	Direct inhibition of GSK3beta by lithium chloride (LiCl), SB216763 and siRNA decreased Nestin and Sox2 levels and induced the cell differentiation markers CNPase, glial fibrillary acidic protein (GFAP) and beta-tubulin III.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX2)
c18848c9-4bc0-44ce-8d76-d1c94c0a0c31	1.0	PubMed	23768967	Inhibition of GSK-3beta using both lithium and the specific GSK-3beta inhibitor SB216763 also reduces the expression of the progenitor markers Nestin and SOX2, while concurrently increasing expression of the differentiation markers, 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase, glial fibrillary acidic protein, and beta-tubulin III in a cell line dependent fashion.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX2)
c18848c9-4bc0-44ce-8d76-d1c94c0a0c31	1.0	PubMed	25144716	GSK-3beta inhibition has been previously shown to significantly reduce the stem like CD133 + fraction of a human GBM cell line, as well as the expression of the stem-cell markers, SOX-2 and nestin, while, in parallel, it increased the expression of differentiation markers, including glial fibrillary acidic protein, beta-tubulin III and 2 ', 3 '-cyclic nucleotide 3 '-phospohodiesterease.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX2)
57be6b51-1bfe-4bba-8a5a-7c1722b18c48	1.0	PubMed	26280346	Higher matrix stiffness activates GSK3beta and beta-catenin signaling pathway mediated by integrin-beta1 to modulate OPN expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SPP1)
30232052-f54b-4d9b-9516-97c02d0a35ee	1.0	PubMed	25846563	Cell culture experiments using gastric cancer cell lines SNU-638 and SNU-668 revealed that STAT3 suppression did not affect pGSK-3beta expression, whereas GSK-3beta inhibition reduced pSTAT3 expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:STAT3)
966f642a-dfb0-4163-930d-7292be837cc4	1.0	PubMed	20654575	While GSK3beta down-regulation increases TCF7L2 expression, there is no concomitant change in TCF7L2 mRNA isoforms, which demonstrate the dual effects of lithium on TCF7L2 expression via a GSK3beta dependent up-regulation and a GSK3beta independent modulation of RNA splicing.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TCF7L2)
966f642a-dfb0-4163-930d-7292be837cc4	1.0	PubMed	20654575	These data are thus consistent with two inter related but independent lithium induced events : a GSK3beta dependent increase of TCF7L2 transcription and a GSK3beta independent effect on TCF7L2-RNA splicing.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TCF7L2)
b7097f48-d818-4778-a01c-c4ab91e9d3bf	1.0	PubMed	24391209	These findings support a role of GSK3beta in miR-21-PTEN mediated regulation of LPS induced NFkappaB activation and TNFalpha expression (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TNF)
b7097f48-d818-4778-a01c-c4ab91e9d3bf	1.0	PubMed	19180470	The inhibition of GSK-3beta with 20 and 50 mM concentrations of LiCl completely blocked TNF-alpha expression after treatment with anti-CD16 (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TNF)
4b797239-6516-40a0-b186-4908b943e368	1.0	PubMed	20399744	As shown in D, MyoD, myogenin, and MEF2 strongly bound to the TRIM72 promoter in C2C12 myotubes.By pharmaceutical and genetic approaches, we previously demonstrated that TRIM72 transcription is activated by the PI (3)-Akt pathway, but not by mTOR and GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TRIM72)
bb45010b-8d25-427e-96f8-35b06cc36f4a	1.0	PubMed	21441955	In fact, overexpression of dn-ETS not only reduced the basal GSK-3beta transcription with mutant K-Ras, but also abolished the Ras induced superactivation of GSK-3beta in pancreatic cancer cells with wild type Ras.	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q8R4P5)
674c8a70-f2b3-4ce6-8e3b-14832a1a91ba	1.0	PubMed	26388612	GSK-3beta inhibits beta-catenin and mTOR and p70S6K1 signal pathways, and down-regulates HIF-1 and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:VEGF)
83ab9cbb-e571-419b-8efc-2bee69fb582f	1.0	PubMed	22093618	We have recently demonstrated that GSK-3beta positively regulates NF-kappaB-mediated expression of XIAP and Bcl-2 antiapoptotic molecules in renal cancer cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:XIAP)
f736dc41-958e-4cda-bcca-f257ba45bce7	1.0	PubMed	24950457	The expression of other amuvatinib targets such as Rad51 and GSK3beta was uniform across both BRAF- and NRAS-mutant melanoma cell lines (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	a(PUBCHEM:11282283)
e3497ee0-6def-4586-adbb-8e1561864c21	1.0	PubMed	26778668	Interestingly, the downregulation of the Gsk3b and Fbw7 signaling pathway potentiated TNF related apoptosis by stabilizing MYC and increasing the expression of a death ligand receptor, which promoted cell death 103.	p(HGNC:GSK3B)	directlyIncreases	bp(GO:"GO:0008219")
cf93939f-0954-4418-9ef7-26be4e2be631	1.0	PubMed	24316184	In fact, our results that GSK3 inhibition reduced 2-DG-mediated upregulation of mitochondrial protein levels independent of protein degradation () but required mitochondrial protein synthesis (), and GSK3beta-KD overexpression reduced mitochondrial proteins upregulation by 2-DG () imply that GSK3 may promote protein synthesis (anabolic effect) following stress induced by 2-DG.	p(FPLX:GSK3)	directlyIncreases	p(HGNC:GSK3B)
99f155b8-0413-436c-820c-b3a011e2e235	1.0	PubMed	24333432	These data suggest that GSK3beta does not regulate HIF1alpha transcription.	p(HGNC:HIF1A)	directlyIncreases	p(HGNC:GSK3B)
b7f8925f-a8bc-4ff8-bf0b-8869f8089494	1.0	PubMed	21441955	Overexpression of active K-Ras or H-Ras in BxPC-3 cells increases GSK-3beta protein expression by nearly two-fold, whereas treatment with U0126 prevents both ERK phosphorylation and Ras induced GSK-3beta expression as expected (XREF_FIG).	p(HGNC:HRAS)	directlyIncreases	p(HGNC:GSK3B)
0e3030a2-d022-4e95-a115-65513656a8c9	1.0	PubMed	19682504	As shown in our study, GA induced inhibition of Hsp90 decreases total cellular levels of GSK3beta, thus supporting the idea that GSK3beta is indeed a direct client protein of Hsp90.In 2006, Lochhead et al. have shown that Hsp90 is necessary to form a functional GSK3beta transitional intermediate, whereby GA inhibits GSK3beta autophosphorylation, but it is not necessary for the mature kinase.	p(FPLX:HSP90)	directlyIncreases	p(HGNC:GSK3B)
e7a12312-3931-49a0-972c-0361a1e07c73	1.0	PubMed	21160051	The data from the current study demonstrated that IFN-beta stimulation of DC enhanced the phosphorylated levels of GSK3-beta (S9) and that preventing the phospho inactivation of GSK3-beta (S9) suppressed the ability of IFN-beta to induce IL-10 production by DC.	p(HGNC:IFNB1)	directlyIncreases	p(HGNC:GSK3B)
b80f9036-8f0c-4e83-99aa-1b10e5b34a21	1.0	PubMed	21562161	Active GSK3beta expression was modestly increased by IFN-gamma at 1 h posttreatment, but this induction was transient and returned to background level by 2 h (XREF_FIG).	p(HGNC:IFNG)	directlyIncreases	p(HGNC:GSK3B)
d6b52707-2bc3-426a-96dd-ffb293beafde	1.0	PubMed	19734233	Moreover, IL-12 also enhanced the levels of phospho-GSK3beta (S9), which is a phospho specific site that represses GSK3beta activity (XREF_FIG) (XREF_BIBR).	p(FPLX:IL12)	directlyIncreases	p(HGNC:GSK3B)
d6b52707-2bc3-426a-96dd-ffb293beafde	1.0	PubMed	19734233	Because the presence of IL-12 increased the levels of phospho-GSK3beta (S9), we next investigated whether the repression of GSK3beta activity was required for IL-12 to promote IL-10 production from human memory CD4 + T cells.	p(FPLX:IL12)	directlyIncreases	p(HGNC:GSK3B)
6e596c40-f92d-4d36-a2b5-45af7d3dec0b	1.0	PubMed	25591548	In the present study, we found that IL-18 overexpression was able to induce GSK-3beta expression and activation, whereas the selective GSK-3beta inhibitor KP antagonized the effects of IL-18 expression in TSCC cells.	p(HGNC:IL18)	directlyIncreases	p(HGNC:GSK3B)
ff63f8d2-ccbf-4ae5-a451-fea94e1125ce	1.0	PubMed	21347395	Consistently, ILK overexpression induced upregulation of pAkt Serine 473 and pGSK3beta levels in HEK293T cells.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B)
aa0148f8-f9b8-458f-9a36-ed3415ecc42b	1.0	PubMed	22570869	ILK siRNA suppresses downstream signaling target molecules p-AKT and p-GSK3beta expressions.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B)
aa0148f8-f9b8-458f-9a36-ed3415ecc42b	1.0	PubMed	28097141	Furthermore, ILK knockdown significantly decreased the levels of ILK, p-GSK-3beta, beta-catenin, and Slug in A2780 and SK-OV-3 cells, which were reinforced by emodin.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B)
bc1a6c0c-59da-411b-ae72-3bd95fe6250c	1.0	PubMed	22634610	No evidence text.	act(p(HGNC:INS), ma(tscript))	directlyIncreases	p(HGNC:GSK3B)
40cd8024-138d-4440-8424-bf6ed00d3020	1.0	PubMed	18178198	Basal and insulin stimulated levels of tyrosine phosphorylated GSK3beta were higher in PCOS than controls (XREF_FIG), consistent with a more active GSK3beta in the former.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
3bcbe5bc-0d83-4716-97ec-2bb3e1095c1f	1.0	PubMed	22096483	Selective JNK inhibitor SP 600125 enhanced G3 cells expression of GSK-3beta (S9P) when treated with serum free or C2-ceramide medium suggesting that expression of pSAPK and JNK inhibits expression of GSK-3beta (S9P), a pathway leading to cell apoptosis (XREF_FIG, XREF_FIG).	p(FPLX:JNK)	directlyIncreases	p(HGNC:GSK3B, var(p.Ser9Pro))
6d5971c4-ef07-4ae3-a482-c40cc123a210	1.0	PubMed	21441955	Overexpression of active K-Ras or H-Ras in BxPC-3 cells increases GSK-3beta protein expression by nearly two-fold, whereas treatment with U0126 prevents both ERK phosphorylation and Ras induced GSK-3beta expression as expected (XREF_FIG).	p(HGNC:KRAS)	directlyIncreases	p(HGNC:GSK3B)
b46fef31-b734-44b3-ad10-a93385f3a562	1.0	PubMed	24303084	Knockdown of galectin-3 inhibits phosphorylation of GSK-3beta and increases GSK-3beta expression, which leads to beta-catenin phosphorylation and results in the degradation of beta-catenin by the proteasome [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B)
b46fef31-b734-44b3-ad10-a93385f3a562	1.0	PubMed	24303084	Moreover, galectin-3 RNAi treatment significantly increased the mRNA level of GSK-3beta, Bax, caspase-3, and caspase-9; remarkably increased the Bax-to-Bcl-2 ratio; and upregulated the GSK-3beta and Bax protein expressions.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B)
48a69476-4837-4d7e-942b-739efb049f84	1.0	PubMed	25959626	On the other hand, LRP5 and LRP6 overexpressions were able to upregulate GSK3beta Ser9 protein levels and repress GSK3beta activity at all concentrations of HO.	p(HGNC:LRP5)	directlyIncreases	p(HGNC:GSK3B)
4ea16d00-47c5-4aff-a3dd-66225ea20e26	1.0	PubMed	25959626	On the other hand, LRP5 and LRP6 overexpressions were able to upregulate GSK3beta Ser9 protein levels and repress GSK3beta activity at all concentrations of HO.	p(HGNC:LRP6)	directlyIncreases	p(HGNC:GSK3B)
15566b8b-7f32-422e-a976-17dfe51b4782	1.0	PubMed	23612487	We also examined the effect of LY294002 and Akt inhibitor on the phosphorylation level of Ser9; LY294002 and Akt1/2 inhibitor markedly reduced the phosphorylation level of GSK-3beta at Ser9 up to below the basal level (D & F).	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B)
c73c91cb-b88f-4f0a-8d10-e90047032c06	1.0	PubMed	26336990	Unexpectedly, LiCL treatment obviously increased the phosphorylation level of GSK-3beta and the expressions of beta-catenin, Snail and transcriptional activity of TCF/LEF in Snail KD cells.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B)
8bf8a7e6-9f23-47b3-ba99-7834a74643b9	1.0	PubMed	26560046	HPV16 E6/E7 were required for LiCl induced increase of GSK3beta expression.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B)
8bf8a7e6-9f23-47b3-ba99-7834a74643b9	1.0	PubMed	26560046	Meanwhile, LiCl increased GSK3beta transcript levels and the proliferation of CaSki cells in a HPV16 dependent manner.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B)
8bf8a7e6-9f23-47b3-ba99-7834a74643b9	1.0	PubMed	26560046	The mRNA (XREF_FIG) and protein (XREF_FIG) levels of GSK3beta in CaSki cells were significantly increased by LiCl (10mM), which was abolished by E6/E7 knockdown (XREF_FIG).	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B)
8bf8a7e6-9f23-47b3-ba99-7834a74643b9	1.0	PubMed	26560046	A common GSK3beta inhibitor LiCl increased GSK3beta expression levels in CaSki cells, which was abolished by silencin HPV16 E6/E7 with shRNAs.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B)
8bf8a7e6-9f23-47b3-ba99-7834a74643b9	1.0	PubMed	26560046	The effect of LiCl on GSK3beta was HPV16 E6/E7 dependent as LiCl was failed to increase GSK3beta mRNA level in C33A cells.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B)
8bf8a7e6-9f23-47b3-ba99-7834a74643b9	1.0	PubMed	25691573	LiCl increased the levels of phospho-GSK3beta in the presence or absence of glucose.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B)
8bf8a7e6-9f23-47b3-ba99-7834a74643b9	1.0	PubMed	25869100	As expected, LiCl and SB415286 activated beta-catenin and TCF -1 signaling by increasing beta-catenin, p-GSK-3beta and TCF-1 levels.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B)
f9a74ccb-f275-46c8-a1fc-06d8220f68c4	1.0	PubMed	26882989	As expected, the inhibition of TAK1 significantly blocked the phosphorylation of IRS at Ser307, but increased the phosphorylated expression of AKT and GSK3beta, in both NTG and TRAF3-LTG mice (XREF_FIG), and the HFD triggered activation of MKK-JNK and NF-kappaB signalling was markedly inhibited by 5Z-7-ox treatment in vivo (XREF_FIG).	p(HGNC:MAP3K7)	directlyIncreases	p(HGNC:GSK3B)
95afea4f-8aa8-49e4-9f47-218dce161ec4	1.0	PubMed	21127195	WT menin suppressed the phosphorylation of AKT at S473 by 30% and decreased p-GSK3beta level by 39% induced by overexpression of AKT1 (XREF_FIG).	p(HGNC:MEN1)	directlyIncreases	p(HGNC:GSK3B)
e25eade4-ef1d-4f0c-ad4a-506dfc3e3d4a	1.0	PubMed	20140245	In contrast, the expression of Gsk3beta, and phosphorylation of beta-catenin Ser33/Ser37/Thr41 and beta-catenin Thr41 and Ser45 were increased by NEFH.	p(HGNC:NEFH)	directlyIncreases	p(HGNC:GSK3B)
c5428626-848b-4e6d-a2f0-4defcc33831b	1.0	PubMed	24763737	Western blotting results blotting that Nek6 deficiency markedly enhanced the phosphorylation level of Akt and GSK-3beta compared with WT controls after TAC (XREF_FIG).	p(HGNC:NEK6)	directlyIncreases	p(HGNC:GSK3B)
453f0b28-c31d-45d1-bc0a-e53b2f45d93c	1.0	PubMed	20144848	Whereas, NF-kappaB inhibition by TPCK (10muM) partially, but significantly suppressed both the snail-promoter activity and the phosphorylated GSK-3beta expression in c-myc-MCF10A cells (D).	p(FPLX:NFkappaB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
74839f41-1096-4931-a2e6-de75a5634ae3	1.0	PubMed	6138157	However, the expression of a novel GSK3beta isoform characterised by a reduced mobility on SDS gels is induced by NGF.	p(HGNC:NGF)	directlyIncreases	p(HGNC:GSK3B)
a31fe082-2be6-4dc6-b1b3-5bf4001157b2	1.0	PubMed	26721203	The results demonstrated that NAC effectively inhibited ROS generation and concurrently downregulated the expression of Wnt signaling pathway regulatory proteins (Wnt2, phospho-Dvl, phospho-GSK-3beta, beta-catenin, Tcf4, and Lef1), and upregulated the expression of GSK-3beta and Dvl ().	a(CHEBI:7421)	directlyIncreases	p(HGNC:GSK3B)
754184fc-ba4f-47a3-a4e1-801e583a7710	1.0	PubMed	21742036	Similarly, partial knockdown of neuronatin alpha decreased the level of pGSK-3beta and increased the phosphorylated form of glycogen synthase (E).	p(HGNC:NNAT)	directlyIncreases	p(HGNC:GSK3B)
86507c20-1b46-40b3-80fe-b91c0cff10f6	1.0	PubMed	5921692	We examined the mechanism by which GSK3beta regulates ANF transcription.	p(HGNC:NPPA)	directlyIncreases	p(HGNC:GSK3B)
86507c20-1b46-40b3-80fe-b91c0cff10f6	1.0	PubMed	5474925	Overexpression of GSK3beta inhibited ANF transcription, which was reversed by ISO.	p(HGNC:NPPA)	directlyIncreases	p(HGNC:GSK3B)
86507c20-1b46-40b3-80fe-b91c0cff10f6	1.0	PubMed	5474925	Kinase-inactive GSK3beta increased ANF transcription.	p(HGNC:NPPA)	directlyIncreases	p(HGNC:GSK3B)
21bf41e5-3476-4174-a385-3912559412ad	1.0	PubMed	19472218	Furthermore, inhibition of the phosphatidylinositol-3 kinase (PI3K) reversed the PLTP induced increase in levels of GSK3beta phosphorylated at serine 9 (pGSK3beta Ser9) and partially reversed the PLTP induced reduction in tau phosphorylation.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B)
21bf41e5-3476-4174-a385-3912559412ad	1.0	PubMed	27020460	These results reveal that inhibition of PI3K activity results in the secondary inhibition of Akt activity and subsequently suppresses GSK-3beta expression and phosphorylation.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B)
8bcf17cb-ca4c-479b-bfd3-a979db012c8b	1.0	PubMed	27020460	Further analysis showed that GSK-3beta expression and its phosphorylation level were both effectively suppressed by a PI3K inhibitor (LY294002) or an Akt inhibitor (SH-6).	a(CHEBI:84801)	directlyIncreases	p(HGNC:GSK3B)
06157847-b9f0-41e5-8468-f78d8198be65	1.0	PubMed	21763505	As shown in b, overexpression of PTEN not only significantly decreased KSHV vIL-6 protein expression but also inhibited the phosphorylation level of downstream kinases PI3K and GSK-3beta.	p(HGNC:PTEN)	directlyIncreases	p(HGNC:GSK3B)
359174e3-9c27-4f27-9749-cca146352c50	1.0	PubMed	21441955	Overexpression of active K-Ras or H-Ras in BxPC-3 cells increases GSK-3beta protein expression by nearly two-fold, whereas treatment with U0126 prevents both ERK phosphorylation and Ras induced GSK-3beta expression as expected (XREF_FIG).	p(FPLX:RAS, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B)
366e7147-cb36-4f06-b5d5-314a244e959f	1.0	PubMed	21876249	RCAN1 proteins then both inhibit calcineurin and induce expression of GSK3beta.	p(HGNC:RCAN1)	directlyIncreases	p(HGNC:GSK3B)
1447e332-c5f1-41b2-898d-4ebbd320a358	1.0	PubMed	21422248	Because we showed that rapamycin inhibited the phosphorylation of both GSK3-beta and S6K1 and that direct inhibition of S6K1 reduced the phosphorylated levels of GSK3-beta, we next wanted to discover whether S6K1 inhibition would mimic the effects of rapamycin on the levels of IL-10 and IL-12 produced by LPS stimulated monocytes.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:GSK3B)
591585af-a11f-4cf6-bacd-d42bce793311	1.0	PubMed	25869100	As expected, LiCl and SB415286 activated beta-catenin and TCF -1 signaling by increasing beta-catenin, p-GSK-3beta and TCF-1 levels.	a(PUBCHEM:4210951)	directlyIncreases	p(HGNC:GSK3B)
1fb36b44-2f5c-4b6f-a2b0-d1f933429e32	1.0	PubMed	26562529	Moreover, the down-regulated phosphorylation levels of Akt and GSK3beta by miR-543 overexpression were restored by SIRT1 overexpression, indicating that miR-543 depended on SIRT1 to function.	p(HGNC:SIRT1)	directlyIncreases	p(HGNC:GSK3B)
54fd7d87-28cc-4160-b223-7852e2b11a11	1.0	PubMed	25003810	Inhibition of Smad1 by siRNA markedly decreased the expression of Akt and GSK3beta phosphorylation and repression of Nanog expression in CL1-5 cells.	p(HGNC:SMAD1)	directlyIncreases	p(HGNC:GSK3B)
a9aaa824-8f0a-4121-b4c5-615356650bca	1.0	PubMed	21102582	Silencing of BRG1 remarkably reduced not only the phosphorylated forms of Akt and GSK-3beta levels, but also the total amount of cyclin D1 protein levels in DLD-1 cells, whereas transduction of BRG1 siRNA did not significantly decrease p-cyclin D1 levels (XREF_FIG).	p(HGNC:SMARCA4)	directlyIncreases	p(HGNC:GSK3B)
0aa2617d-8152-490d-ac2c-210a17fc024a	1.0	PubMed	26336990	Snail increased the phosphorylation level of GSK-3beta, the protein level of beta-catenin but decreased DAB2IP expression in SW480 cells, while reintroduction of beta-Trap in Snail expressing SW480 cells accelerated the degradation of Snail and subsequently induced up-regulation of DAB2IP, activation of GSK-3beta and down-regulation of beta-catenin (XREF_SUPPLEMENTARY).	p(HGNC:SNAI1)	directlyIncreases	p(HGNC:GSK3B)
5625f687-b650-417c-b59d-b5a7461390ef	1.0	PubMed	19679347	Moreover, increases in mRNA levels of the well documented target genes of Wnt and beta-catenin signalling such as c-myc, iNOS and beta-catenin itself were also observed [23,24], confirming the notion that GSK3beta regulates StarD7 transcription in JEG-3 cells via accumulation of beta-catenin (B).	p(HGNC:STARD7)	directlyIncreases	p(HGNC:GSK3B)
b707ba98-1d96-4c61-99ea-64c21a62b6b3	1.0	PubMed	25935310	Notably, knockdown of CHP3 slightly (19%) reduced the expression of GSK3beta (B) and may have thus shifted the equilibrium towards phosphorylation.	p(HGNC:TESC)	directlyIncreases	p(HGNC:GSK3B)
99f5b259-5375-4ff9-a99d-0115791d21a5	1.0	PubMed	23673211	These results were confirmed using Hoechst 33342 staining and fluorescence microscopy, which revealed a reduction in nuclear condensation and DNA fragmentation with co-treatment as compared to cells treated with cisplatin alone.To further confirm the involvement of the Wnt and beta-catenin signaling pathway in sensitization of A549 and DDP cells to cisplatin induced apoptosis, Wnt and beta-catenin signaling was disrupted using siRNA knockdown of GSK-3beta expression.	p(FPLX:Wnt)	directlyIncreases	p(HGNC:GSK3B)
f44ed958-06af-4cf2-a29b-e0a82ea1479e	1.0	PubMed	21868755	In Calu-1 cells, celecoxib increased the levels of p-GSK3beta or alpha/beta in a fashion similar to the p-Akt increase; however, in H358 cells, celecoxib increased p-GSK3 levels even at 1 h post treatment (XREF_FIG).	a(CHEBI:41423)	directlyIncreases	p(HGNC:GSK3B)
a6598e20-79b4-42cd-a3bb-561cbc0514f1	1.0	PubMed	23673211	These results were confirmed using Hoechst 33342 staining and fluorescence microscopy, which revealed a reduction in nuclear condensation and DNA fragmentation with co-treatment as compared to cells treated with cisplatin alone.To further confirm the involvement of the Wnt and beta-catenin signaling pathway in sensitization of A549 and DDP cells to cisplatin induced apoptosis, Wnt and beta-catenin signaling was disrupted using siRNA knockdown of GSK-3beta expression.	a(CHEBI:27899)	directlyIncreases	p(HGNC:GSK3B)
c77d0dd8-24d0-4921-83ea-5d50ad461be8	1.0	PubMed	24303084	We also found that epirubicin treatment increased the mRNA expression of galectin-3 and GSK-3beta but decreased the expression of beta-catenin.	a(PUBCHEM:41867)	directlyIncreases	p(HGNC:GSK3B)
5dd43318-2f62-43a9-8082-8f25d931e230	1.0	PubMed	18687691	We found that isoflavone inhibited the phosphorylation of Akt and FOXO3a, regulated the phosphorylation of Src, and increased the expression of GSK-3beta, leading to the down-regulation of AR and its target gene PSA.	a(PUBCHEM:72304)	directlyIncreases	p(HGNC:GSK3B)
7f0670fc-5519-4cd4-8bc9-305844c54edb	1.0	PubMed	16882987	However, progesterone induced a dose dependent increase in the expression of pGSK-3beta, which could be blocked by RU486.	a(CHEBI:17026)	directlyIncreases	p(HGNC:GSK3B)
fdc4a34f-cbc9-4f84-ad45-cb5d362d1082	1.0	PubMed	Other	No evidence text.	a(PUBCHEM:"CID:9549289")	directlyDecreases	act(p(HGNC:GSK3B))
d3d0e9b6-4e4a-4031-81c0-cb2e036df6f2	1.0	PubMed	18588978	These results suggested that either tau polymer is a less suitable substrate for GSK-3beta or that GSK-3beta is inhibited by ARA.	p(HGNC:ABCC6)	directlyDecreases	act(p(HGNC:GSK3B))
d3d0e9b6-4e4a-4031-81c0-cb2e036df6f2	1.0	PubMed	18588978	The reduction of phosphorylation levels is due to lower protein concentrations and a partial inhibition of GSK-3beta by ARA.	p(HGNC:ABCC6)	directlyDecreases	act(p(HGNC:GSK3B))
5e87ddf4-2b71-4750-ae85-9e82debcf7bd	1.0	PubMed	20599907	Indeed, we have observed that GSK3beta inhibits the nuclear translocation of Smad3 and reduces the amount of Smad3 in the nucleus upon TGF-beta1 and Angiotensin II stimulation.Increasing lines of evidence have shown that GSK3beta is an essential negative regulator of cardiac hypertrophy and the inactivation of GSK3beta by Angiotensin II is a critical mechanism in the Angiotensin II stimulation of cardiac hypertrophy ().	p(HGNC:AGT)	directlyDecreases	act(p(HGNC:GSK3B))
ab9599ad-928a-4c8a-b00a-dc754432496e	1.0	PubMed	19785987	Ajuba was shown to negatively regulate canonical Wnt signalling by enforcing the interaction of Gsk3beta with beta-catenin.	p(HGNC:AJUBA)	directlyDecreases	act(p(HGNC:GSK3B))
9ac42e5f-c0bf-4a59-9e0e-7723954c0610	1.0	PubMed	9373175	Evidence that the inhibition of glycogen synthase kinase-3_ by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9	p(HGNC:AKT1)	directlyDecreases	act(p(HGNC:GSK3B))
9ac42e5f-c0bf-4a59-9e0e-7723954c0610	1.0	PubMed	25218472	In parallel, activated AKT1 inhibited GSK3beta through phosphorylation, after which beta-catenin accumulated in the cytoplasm and translocated into the nucleus to play a role as an oncogenic transcriptional factor (C).	p(HGNC:AKT1)	directlyDecreases	act(p(HGNC:GSK3B))
9ac42e5f-c0bf-4a59-9e0e-7723954c0610	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:AKT1)	directlyDecreases	act(p(HGNC:GSK3B))
9ac42e5f-c0bf-4a59-9e0e-7723954c0610	1.0	PubMed	18391981	Although it was also reported that GSK-3beta is inactivated by protein kinase B at the spindle poles, functions and targets of GSK-3beta in the mitotic phase are unknown.	p(HGNC:AKT1)	directlyDecreases	act(p(HGNC:GSK3B))
f3ffdd1d-33d9-4bdb-8e46-a820719cb7cd	1.0	PubMed	16293724	We show that PGE2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor, EP2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase Akt by free G protein betagamma subunits and the direct association of the G protein alphas subunit with the regulator of G protein signaling (RGS) domain of axin. This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:AKT2)	directlyDecreases	act(p(HGNC:GSK3B))
f3ffdd1d-33d9-4bdb-8e46-a820719cb7cd	1.0	PubMed	25285168	The Glycogen synthase kinase 3-beta (GSK-3beta) may inhibit the translation of beta-catenin in Wnt and beta-catenin pathway by phosphorylation and degradation of beta-catenin XREF_BIBR, and the GSK-3beta is negatively regulated by AKT2 XREF_BIBR.	p(HGNC:AKT2)	directlyDecreases	act(p(HGNC:GSK3B))
f3ffdd1d-33d9-4bdb-8e46-a820719cb7cd	1.0	PubMed	26297988	Additionally, re-expression of AR increased the expression levels of Akt2, Akt3, PI3K p85, and phospho-PI3K p85 Tyr458 but decreased the abundance of GSK-3beta, phospho-GSK-3beta Ser9, matrix metalloproteinases-9 (MMP-9), vimentin, and beta-catenin proteins.	p(HGNC:AKT2)	directlyDecreases	act(p(HGNC:GSK3B))
f3ffdd1d-33d9-4bdb-8e46-a820719cb7cd	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:AKT2)	directlyDecreases	act(p(HGNC:GSK3B))
f3ffdd1d-33d9-4bdb-8e46-a820719cb7cd	1.0	PubMed	25059120	Akt2 mediates TGF-beta1-induced epithelial to mesenchymal transition by deactivating GSK3beta and snail signaling pathway in renal tubular epithelial cells.	p(HGNC:AKT2)	directlyDecreases	act(p(HGNC:GSK3B))
f3ffdd1d-33d9-4bdb-8e46-a820719cb7cd	1.0	PubMed	25059120	These findings revealed that knockdown of Akt2 antagonized TGF-beta1-induced EMT by inhibiting GSK3beta and Snail signaling pathway.	p(HGNC:AKT2)	directlyDecreases	act(p(HGNC:GSK3B))
c2a9e631-129f-4d81-802b-f8445bac7474	1.0	PubMed	26297988	Additionally, re-expression of AR increased the expression levels of Akt2, Akt3, PI3K p85, and phospho-PI3K p85 Tyr458 but decreased the abundance of GSK-3beta, phospho-GSK-3beta Ser9, matrix metalloproteinases-9 (MMP-9), vimentin, and beta-catenin proteins.	p(HGNC:AKT3)	directlyDecreases	act(p(HGNC:GSK3B))
c2a9e631-129f-4d81-802b-f8445bac7474	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:AKT3)	directlyDecreases	act(p(HGNC:GSK3B))
6f9353f5-a021-4d76-8585-e71d5f2488f2	1.0	PubMed	25617127	The phosphorylated AKT is activated and hence downregulates GSK3beta, blocks p53 expression, enhances the mTOR phosphorylation, elevates Bcl-2 expression and upregulates HIF-1alpha.	p(FPLX:AKT, pmod(Ph))	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	16051150	GSK3alpha and GSK3beta are both negatively regulated by Akt () and activated in response to DA receptor stimulation (), while PDK1 is a positive regulator of Akt responsible for the phosphorylation of the Thr308 residue ().	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	22765916	Moreover, GSK3b is inhibited by AKT, which, in turn, is regulated by PI3K and Dab1, an intracellular binding partner of Pcdh18 (;) and the reelin receptor ().	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	20454507	Akt serves to inhibit GSK3beta after irradiation in normal vascular endothelium [29], and administration of recombinant growth factors known to activate Figure 6.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26119563	PI3K and Akt mediated GSK-3beta inhibition is required for the EphB2 stimulation induced tau dephosphorylation.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26119563	To further verify the role of PI3K and Akt mediated GSK-3beta inhibition in EphB2 stimulation induced tau dephosphorylation, we first used wortmannin, a PI3K inhibitor, in SK-N-SH cells.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	23583197	Even if insulin effectively activates Akt, the total GSK3beta activity was not sufficiently suppressed by Akt in the muscle of the diabetic subject.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	23583197	Thus these observations indicated that the efficient inhibition of GSK3beta by Akt can be an important step to alleviate the insulin resistance.GSK3beta has been chosen as a potential therapeutic target in multiple diseases including type 2 diabetes mellitus.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	23583197	To resolve this unwanted side effect, we designed a GSK3beta inhibitory peptide that can be activated by Akt in response to insulin stimulation.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26211576	It has been postulated that Akt inhibit GSK3beta activation directly.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	27572267	Since activation of AKT by EGFR suppresses GSK3beta activity through Ser9 phosphorylation XREF_BIBR, inhibition of EGF signalling in BLBC cells creates a therapeutic benefit by reducing cancer cell immune escape via PD-L1 destabilization.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25003523	Reintroduction of PRL-1 in Huh7 and SK-hep1 HCC cell lines caused phosphorylation of AKT at ser 474, which subsequently inactivated GSK-3beta at ser 9 and elevated transcriptional factor Snail expression.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25360740	Thus, Akt activity leads to beta-catenin stabilization by suppressing the GSK3beta kinase, thereby preventing the proteosomal degradation of beta-catenin, consequently results increased expression of beta-catenin target genes XREF_BIBR.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	17949810	Although the total protein level of beta-catenin was decreased slightly in LY294002 treated cells, presumably as a result of reversing AKT mediated inhibition of GSK3-beta, beta-catenin tyrosine phosphorylation was relatively preserved.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	18350175	This is inhibited by growth factors through Akt dependent inactivation of GSK3beta.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25088797	PI3K and AKT signaling pathway is known to inhibit GSK-3beta activity and promote Snail protein stability.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25889792	Simultaneously, activated Akt inhibits GSK3beta by phosphorylation at serine 9.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25889792	In the present study we show for the first time that the concordant inhibition of the PI3K and Akt signaling pathway by the clinically used BCR-ABL TKI imatinib or nilotinib, Akt inhibitor MK2206 or the immunosuppressive cytokine IL-10 activates the downstream serine/threonine protein kinase GSK3beta, and subsequently the transcription factor MITF that is translocated into the cell nucleus.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	22099458	The finding that DISC1 directly inhibits GSK3beta is interesting given that the common mood stabilizer drug lithium, and the schizophrenia risk gene Akt, also inhibit GSK3beta which results in activation of canonical Wnt signaling, suggesting it may be an important target in psychiatric disease.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	PMC6380769	Moreover, FGF1 protection against glutamate toxicity was dependent on GSK3beta inactivation by the PI3K-Akt but was independent of ERK.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24777252	Upon M-CSF stimulation, Akt is activated by CSF-1R-PI3K and then inactivates GSK3beta, leading to the stabilization of CKIP-1 and beta-catenin proteins.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	18451303	Although the protein kinase Akt inhibits GSK3beta by phosphorylation at the N terminus, preventing Akt mediated phosphorylation does not affect the cell-survival pathway activated through the GSK3beta substrate beta-catenin.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	PMC7189068	Furthermore, androgen receptor phosphorylation was augmented by LY294002, an indirect inhibitor of protein kinase B/Akt that inhibits glycogen synthase kinase-3 beta.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	7088620	AM gene transfer increased phosphorylation of Akt and glycogen synthase kinase (GSK-3beta) but reduced GSK-3beta and caspase-3 activities in the heart.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25311367	When PI3K is phosphorylated and thus activated it phosphorylates AKT, which in turn inactivates GSK3beta by phosphorylating the S 9 residue on GSK3beta.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	23043959	Hsp70 induction by eHsp70 was mediated by Akt dependent inactivation of GSK-3beta.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26643256	GSK3beta is reported to regulate cell cycle analysis and apoptosis, Akt prevents the apoptotic activity of GSK3beta by phosphorylation [XREF_BIBR].	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	18243161	It has been shown that GSK-3beta was inactivated by Akt through phosphorylation on Ser9.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24085292	In addition, PIs induced Akt dependent inactivation of GSK-3beta.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	23431386	In the present work, we found that activation of upstream AKT signaling represses GSK-3beta activity.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	19818782	It was reported that galectin-3 mediates GSK-3beta phosphorylation by Akt, which also inactivates GSK-3beta.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25150829	Activation of phosphatidylinositol 3-kinase (PI3-kinase) gives rise to the phosphorylation and activation of AKT, which consequently inhibits GSK3beta activity by phosphorylation of Ser 9 ().	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21474066	In contrast, AKT is known to directly inhibit GSK3beta through inhibitory phosphorylation on serine 9 (XREF_BIBR).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21325624	Interestingly, despite the Akt mediated inhibition of GSK-3beta, total levels of beta-catenin were decreased in the stable Dsc2 knockdown cells compared with controls (Supplemental Figure 5D).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21325624	Furthermore, our results also suggest that inhibition of GSK-3beta by Akt may enhance beta-catenin signaling in a more distinct manner than Wnt mediated GSK-3beta inactivation, even though this component is shared by both Wnt and beta-catenin and Akt and beta-catenin pathways (see XREF_FIG).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21325624	Interestingly, despite the inhibition of GSK-3beta, we observed a decrease in the total levels of beta-catenin in stable Dsc2 knockdown cells, suggesting that Akt mediated GSK-3beta inhibition may promote the nuclear redistribution of beta-catenin and enhance beta-catenin-dependent transcription without inducing stabilization of total beta-catenin protein levels.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	10910956	In summary, the activation of Akt leads to increased survival, inhibition of GSK-3beta activity and post-translational stabilization of cyclin D1, all events responsible for disruption of the cell cycle G (1)/S restriction point in hepatocytes.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21559086	Activation of Akt inhibits Gsk-3beta and causing accumulation of cyclin D1 leading to loss of cell cycle regulation XREF_BIBR - XREF_BIBR.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	27218286	Abnormally high Akt activity suppresses GSK-3beta function, thereby accumulating the nuclear factor of activated T-cells cytoplasmic1 (NFATc1) in the nucleus, increasing DcR3 expression in IPF fibroblasts.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26456864	In this study, we showed that INSM1 possesses extra-nuclear activity to activate the PI3K and AKT signaling pathway that blocks GSK3beta activity.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21952626	However, functional redundancy of AKT suppression of GSK3beta has been shown in HCT116 cells by knockout studies (XREF_BIBR).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26356816	Given that we found distinct higher expressions of c-kit and AKT, we presumed that c-kit-activated AKT could inhibit Math1 degradation by inactivating GSK3beta and subsequently promote MUC2 secretion as well as CRMAC tumorigenesis [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24038789	SDF1 has been shown to stabilize beta-catenin levels in pancreatic islet cells that was proposed to occur via AKT dependent inhibition of GSK3beta activity 20.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24038789	SDF1 activation of AKT would be expected to decrease GSK3beta activity through phosphorylation of Ser9.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24680839	Akt also inactives GSK-3beta which promotes degradation of cyclin D1 -- Akt inhibition by myostatin serves to decrease cyclin D1 and inhibit cell proliferation in the G1 phase.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	22513362	As a result, it is possible that Aurora-A activates Akt followed by Akt inactivation of Gsk3beta resulting in the increase of Aurora-A levels.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	19729319	AKT also suppresses GSK3beta, an enzyme shown to have a direct inhibitory effect on eIF-2B, a known translational enhancer.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26279267	TIM-3 signaling can activate the ERK and AKT pathways (C and 3D), and both ERK and AKT signaling inhibits GSK3beta activity in cancer, resulting in promotion of nucleus translocation of beta-catenin ().	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26279267	Ligation of TIM-3 by Gal-9 induces phosphorylation of ERK and AKT, whose signaling can inhibit GSK3beta, a molecule responsible for degradation of beta-catenin by ubiquitination ().	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	PMC5654975	These data suggest that stimulation of glycogen synthase by insulin in HepG2 cells is mediated through the PI-3 kinase pathway by activating PKB and PP-1G and inactivating GSK-3beta.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	22814751	Taken together, our results reveal a novel outside-in signaling pathway involving sequential activation of Src, ADP secretion, P2Y12 and P2Y1 dependent activation of PI3K and Akt, and Akt mediated inhibition of GSK-3beta, leading to stimulation of platelet spreading (XREF_FIG).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25412261	Consistent with previous studies XREF_BIBR - XREF_BIBR, we observed that DENV induced synergistic activation of PKA and PKB inhibited GSK-3beta, leading to CREB mediated IL-10 production.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26320152	Oxidative stress induces PI3K and Akt dependent inhibition of GSK3beta activity in monocytes.Because of our hypothesis that oxidative stress induces glucocorticoid responsiveness, we next examined how GSK3beta activity is modulated in response to exogenous reactive oxygen species (ROS) in primary monocytes, as both H2O2 and CSE exposure reduce glucocorticoid sensitivity in monocytes (7, 30, 31).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24735980	Akt inhibits GSK3beta, a major candidate kinase involved in tau hyperphosphorylation [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24735980	The inhibition of GSK3beta by Akt kinases activity is counteracted by protein overexpression raising doubt on the effective role of GSK3beta in DS/AD as solely responsible for tau hyperphosphorylation occurring in DS.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25009285	The transcriptional activity of Snail is regulated by GSK-3beta, which is negatively regulated by PI3K and Akt (XREF_BIBR; XREF_BIBR).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	20847424	Akt downregulates the activities of GSK-3alpha and GSK-3beta by phosphorylating the former at Ser21 and the latter at Ser9 [XREF_BIBR].	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	22875023	Activation of AKT in tamoxifen resistant cells could thus rescue proteasomal degradation of these proteins by inhibiting GSK3beta.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	22810307	GSK3beta is negatively regulated by the serine/threonine kinase AKT through its phosphorylation at Ser9 (XREF_BIBR).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	22810307	Given that AKT inactivates GSK3beta signaling, the potentially oncogenic role of GSK3beta in melanoma has been little considered.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21887250	It is known that activation of the FGF and EGF receptors, FGFR and EGFR, respectively, could both lead to the activation of the PI3K and Akt pathway that negatively regulates GSK3beta XREF_BIBR.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21887250	Thus, GSK3beta is negatively regulated by Akt via Ser9 phosphorylation, with ELL priming evoking less GSK3beta activity than FL priming.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	22216350	GSK-3beta can be inactivated through the phosphorylation at S9 by Akt XREF_BIBR or by cAMP XREF_BIBR (XREF_FIG).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	26252009	Inhibition of Akt signaling and activation of GSK-3beta partially contributes to the pro apoptotic effect of embelin.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	19850036	Previous work showed that Akt inhibits GSK-3beta activity through the phosphorylation of serine 9 on GSK-3beta [XREF_BIBR].	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	5563192	In summary, the activation of Akt leads to increased survival, inhibition of GSK-3beta activity and post-translational stabilization of cyclin D1, all events responsible for disruption of the cell cycle G (1)/S restriction point in hepatocytes.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	23900341	AKT antagonizes GSK3beta signaling by direct phosphorylation.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24597671	Second, Zn supplement up-regulates Akt function that inactivates GSK-3beta by increasing its phosphorylation, leading to a significant reduction in Fyn nuclear translocation.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	20624590	For example, Akt inhibits GSK3beta activation, and its protein levels have been shown to be reduced in the brains of schizophrenia patients (XREF_BIBR).	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	15109499	Thus, activation of NFkappaB or maintaining NFkappaB inactive, complexed with IkappaB, did not influence expression.Since inhibition of GSK3beta by AKT leads to hypertrophy of myotubes, activation of GSK3beta might be a possible mechanism contributing to atrophy.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24428908	In contrast to p70S6K and 4E-BP1, GSK-3beta is negatively regulated by the PI3K and AKT signaling.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	16507111	Therefore, given that Akt phoshorylates and inactivates GSK3beta [XREF_BIBR], we hypothesised that Akt dependent inactivation of GSK3beta might be responsible for Notch potentiation.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	15940626	Consistent with this hypothesis, it has been shown that Akt inactivates GSK-3beta in 3T3 cells, but it does not enhance Wnt signaling unless there is a simultaneous Wnt signal present.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24705253	The PI3K-AKT pathway inactivates GSK-3beta by phosphorylation of the S9 residue 6, which should interfere with GSK-3beta dependent phosphorylation, ubiquitination, and proteasomal degradation of cyclin D2.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21284870	The activation of Akt phosphorylated and suppressed GSK-3beta, which is the major kinase for the phosphorylation of beta-catenin and Snail [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	5596638	Glycogen synthase kinase-3 beta (GSK-3 beta), which is inhibited upon phosphorylation by Akt, was recently shown to function during cell death induced by PI 3-kinase inhibitors.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21448462	PI3K and Akt mediated inhibition of GSK3beta has been demonstrated to be responsible for Snail expression by ROS such as H 2 O 2 XREF_BIBR.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	19389926	It is well accepted that Akt can inactivate GSK-3beta through phosphorylation at Ser9, resulting in stabilization of beta-catenin and activation of beta-catenin-dependent transcription.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	25883211	For example, EGFR activated PI3K and AKT leads to phosphorylation and subsequently inhibition of the beta-catenin suppressor GSK3beta, resulting in nuclear accumulation of beta-catenin [XREF_BIBR].	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	21384147	Phosphorylation of GSK3beta on Ser9 is a well described mechanism by which Akt inhibits GSK3beta activity.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	6088741	To test if glycogen synthase kinase-3beta (GSK3beta), a pro apoptotic kinase that is inhibited by Akt, is involved in regulating MPP induced apoptosis, overexpression of GSK3beta and lithium, a selective inhibitor of GSK3beta, were used to directly alter GSK3beta activity.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
a8da9b7a-5704-4306-bfac-201290dc433e	1.0	PubMed	24763737	Kida et al also reported that Akt activation mediates cell-cycle progression by phosphorylating and consequently inhibiting GSK-3beta XREF_BIBR, XREF_BIBR.	p(FPLX:AKT)	directlyDecreases	act(p(HGNC:GSK3B))
73bc1197-8eb5-4eb5-9647-ae50c1107cd2	1.0	PubMed	25422594	IGF-1 binds IGF1R to induce PI3K and activates AKT to repress GSK3beta.	complex(p(FPLX:AKT), p(HGNC:IGF1))	directlyDecreases	act(p(HGNC:GSK3B))
f58d920d-779e-4dec-99a6-b783dee947bd	1.0	PubMed	19531650	On the other hand, exogenous PGI and AMF signaling though gp78 inactivates GSK-3beta, resulting in up-regulation of beta-catenin expression, which increases cell growth.	p(HGNC:AMFR)	directlyDecreases	act(p(HGNC:GSK3B))
36278a75-f69c-4e13-9d2c-5970f8fe56fa	1.0	PubMed	19429119	AMPK has been reported to directly inactivate GSK-3beta through Ser 9 phosphorylation in hepatocytes [XREF_BIBR].	p(FPLX:AMPK)	directlyDecreases	act(p(HGNC:GSK3B))
497864d1-e6de-486a-9fae-6ef1f8c58256	1.0	PubMed	25564356	We also found that down-regulation of ANG remarkably reduced the phosphorylation of signaling targets AKT, GSK-3beta and mTOR.	p(HGNC:ANG)	directlyDecreases	act(p(HGNC:GSK3B))
f8ede966-cd0e-4d7f-930c-8ccb69d8cce0	1.0	PubMed	16930546	Mutations of APC or beta-catenin and activation of the Wnt signal inhibit GSK-3beta activity and induce beta-catenin stabilization.	p(HGNC:APC, var(p.?))	directlyDecreases	act(p(HGNC:GSK3B))
68f37b98-100b-4f37-864f-adbf49729906	1.0	PubMed	23127514	Mutations or deletions in AXN1/2 or APC genes inhibit the phosphorylating activity of GSK-3beta, thereby stabilizing cytoplasmic beta-catenin, and provoking aberrant cellular gene expression.	p(HGNC:APC)	directlyDecreases	act(p(HGNC:GSK3B))
68f37b98-100b-4f37-864f-adbf49729906	1.0	PubMed	20519433	Because GSK3beta and CKI inhibition reduced the level of both phosphorylated beta-catenin and APC in clusters, we could not exclude the possibility that the observed effect on cell migration was also due to the inhibition of GSK3beta and CKI-P-betacat, rather than APC.	p(HGNC:APC)	directlyDecreases	act(p(HGNC:GSK3B))
68f37b98-100b-4f37-864f-adbf49729906	1.0	PubMed	10959047	In addition, the ability of mutated (mt) APC to constitute a complex with and degrade free beta-catenin, in the presence of axin and GSK-3beta, is compromised, causing an increase in the cytosolic free beta-catenin.	p(HGNC:APC)	directlyDecreases	act(p(HGNC:GSK3B))
2c45987e-c7ff-40a9-8dff-8d86d96f7117	1.0	PubMed	23026200	Conversely, Abeta has been reported to induce GSK-3beta activation, and reduction of Abeta levels might also reduces GSK-3beta activation on its own.We also observed a reduced association of GSK-3beta with PS1 in mice.	p(HGNC:APP)	directlyDecreases	act(p(HGNC:GSK3B))
2c45987e-c7ff-40a9-8dff-8d86d96f7117	1.0	PubMed	27343974	However, there is little consensus about how Abeta mediates this activation and the phosphorylation and dephosphorylation processes resulting in GSK3beta activation and contributing to tau phosphorylation are still confused.The insulin and Akt signaling pathway is often suspected to be targeted in Abeta induced GSK3beta activation, supposing that reduced Ser9 phosphorylation could be the phosphorylation process implied in Abeta induced GSK3beta activation.	p(HGNC:APP)	directlyDecreases	act(p(HGNC:GSK3B))
cc559020-bb05-40bb-aaa2-cf6604a0ec57	1.0	PubMed	26297988	Additionally, re-expression of AR increased the expression levels of Akt2, Akt3, PI3K p85, and phospho-PI3K p85 Tyr458 but decreased the abundance of GSK-3beta, phospho-GSK-3beta Ser9, matrix metalloproteinases-9 (MMP-9), vimentin, and beta-catenin proteins.	p(HGNC:AR)	directlyDecreases	act(p(HGNC:GSK3B))
d385e435-8de6-411e-9e49-4a7ad9484b13	1.0	PubMed	26297988	We observed that re-expression of AR in PC-3 cells in the absence of androgen increased APC and E-cadherin but decreased GSK-3beta, phospho-GSK-3beta Ser9, NF-kappaB p50, Slug, N-cadherin, beta-catenin, vimentin, MMP-9, Snail, and phospho-RSK1 Thr359 and Ser363.	p(HGNC:AR)	directlyDecreases	act(p(HGNC:GSK3B))
d385e435-8de6-411e-9e49-4a7ad9484b13	1.0	PubMed	27343974	Our data firstly showed that AR markedly decreased the pGSK3betaTyr216 and GSK3beta (80%, P < 0.01) as a result for GSK3beta inhibition (A,).	p(HGNC:AR)	directlyDecreases	act(p(HGNC:GSK3B))
83dbad33-1788-43d9-9f76-dd83eb87d75d	1.0	PubMed	7010898	In this initial letter, some thienyl and phenyl alpha-halomethyl ketones are described as new non ATP competitive inhibitors of GSK-3beta.	a(CHEBI:15422)	directlyDecreases	act(p(HGNC:GSK3B))
83dbad33-1788-43d9-9f76-dd83eb87d75d	1.0	PubMed	6237018	Here, we describe the synthesis, biological evaluation, and SAR of the small heterocyclic thiadiazolidinones (TDZD) as the first non ATP competitive inhibitor of GSK-3beta.	a(CHEBI:15422)	directlyDecreases	act(p(HGNC:GSK3B))
8fd7abc9-40c5-4524-b2c5-ca94b06a4dff	1.0	PubMed	25115395	Aur-A activates mTOR activity by inhibiting GSK3beta under metabolic stress.	p(HGNC:AURKA)	directlyDecreases	act(p(HGNC:GSK3B))
da07f016-d8ea-42eb-b4d1-bb1ea1beb1ed	1.0	PubMed	11738041	A 25 amino acid sequence in Axin, identified as a GSK-3-interacting domain (GID), inhibits GSK-3beta and activates Wnt signaling.	p(FPLX:AXIN)	directlyDecreases	act(p(HGNC:GSK3B))
da07f016-d8ea-42eb-b4d1-bb1ea1beb1ed	1.0	PubMed	19331826	Phosphorylated glycogen synthase kinase (GSK3beta) which normally localizes to centrosomes and the negative end of spindles in mitotic L-EV cells, appeared to extend toward the positive end of the spindles in L-Axin cells (C), suggesting that ectopic Axin inactivates GSK3beta along mitotic spindles.	p(FPLX:AXIN)	directlyDecreases	act(p(HGNC:GSK3B))
f8ab343e-10a2-4b34-8f25-f3007f2e9049	1.0	PubMed	24993527	Indeed, our findings suggest a mechanism by which Aldolase may activate the Wnt pathway by inhibiting the affinity of GSK-3beta to Axin, perhaps acting as a competitive inhibitor.	p(PFAM:PF01081)	directlyDecreases	act(p(HGNC:GSK3B))
3603a236-e125-42cc-a59d-42a622923809	1.0	PubMed	25891085	Atorvastatin pretreatment also prevented AbetaO induced decreases in Akt and Erk1/2 kinase activity and the increases in GSK3beta and Cdk5 kinase activity.	a(PUBCHEM:60823)	directlyDecreases	act(p(HGNC:GSK3B))
846da448-1402-4015-923a-a8388ba1236e	1.0	PubMed	23049725	SARI inhibited GSK3beta activity though PP2A.	p(HGNC:BATF2)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	15652488	NT-3 and brain derived neurotrophic factor (BDNF) inhibit GSK-3beta via the phosphatidylinositol-3-kinase (PI3-kinase)/Akt (also known as PKB) pathway, and thereby reduce phosphorylation levels of CRMP-2 at Thr 514, leading to axon elongation and branching.It has been previously reported that the phosphorylation of CRMP-2 at Thr 514 by unidentified kinases induces the mobility shift of CRMP-2.	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	15652488	These findings suggest that NT-3 and BDNF inhibit GSK-3beta via the PI3-kinase and Akt pathway, thereby decreasing the phosphorylation levels of CRMP-2 at Thr 514.	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	15652488	It is also possible that NT-3 and BDNF inhibit GSK-3beta via the PAR-3/PAR-6/aPKC pathway, and NT-3 and BDNF increase the phosphatase activity toward CRMP-2 to accelerate the dephosphorylation of CRMP-2.	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	15652488	It is possible that NT-3 and BDNF inhibit GSK-3beta and thereby increase the stability of microtubules to enhance axon outgrowth through the dephosphorylation of MAP1B.	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	26311646	GSK-3beta protein and mRNA levels were significantly downregulated by BDNF upregulation, and this change was reversed by BDNF downregulation (B and B).	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	23077067	BDNF signaling through phosphatidylinositol 3-kinase (PI3K)-Akt also activates mTOR and represses GSK3beta, which was previously shown to reduce gephyrin clustering.	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	24992082	Brain derived neurotrophic factor, which is modulated by antidepressants and produces antidepressivelike activity in preclinical behavioral models, is able to inhibit GSK-3beta.	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	17628506	Brain derived neurotrophic factor (BDNF), which has shown antidepressant like effects in preclinical studies, is an inhibitor of GSK3B ().	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
3d19f45b-0dc5-4fff-892a-26fd8aa477ba	1.0	PubMed	20682308	BDNF inhibits GSK3B via increased serine 9 phosphorylation, and neural plasticity and survival by inhibition is regulated by -mediated signaling ().	p(HGNC:BDNF)	directlyDecreases	act(p(HGNC:GSK3B))
fc7c98bf-aaed-4c70-881e-12514b07d9b3	1.0	PubMed	19139264	In this study, we report that BMP-2, via BMPRII mediated inhibition of GSK3-beta, induces beta-catenin (beta-C) accumulation and transcriptional activity necessary for PAEC survival and proliferation.	p(HGNC:BMP2)	directlyDecreases	act(p(HGNC:GSK3B))
7f6de529-e383-402f-82f5-63261b2c0232	1.0	PubMed	23435375	Thus, BRAF may decrease the activity of GSK3-beta and therefore the degradation of Snail.	p(HGNC:BRAF)	directlyDecreases	act(p(HGNC:GSK3B))
c9052892-511f-4013-b39f-678a17016ddd	1.0	PubMed	23434765	More recently, beta-TrCP present in the cytosol is also shown to degrade GSK3beta phosphorylated Nrf2 [XREF_BIBR].	p(HGNC:BTRC)	directlyDecreases	act(p(HGNC:GSK3B))
c4fa6bcd-0f6e-4d81-9847-bd9ec8f13797	1.0	PubMed	PMC5694272	Thus, heat shock-induced activation of PI-3K and the inhibitory effect of GSK-3beta on HSF-1 activation and HSP-70 expression imply that Akt-induced inhibition of GSK-3beta contributes to the activation of HSF-1.	p(HGNC:C3orf58)	directlyDecreases	act(p(HGNC:GSK3B))
1c7e08e9-d433-4228-a1e3-80640f363021	1.0	PubMed	6530610	In contrast, inhibition of Ca2 +-dependent PKC isoforms activated GSK-3beta and offered no protection from Ab neurotoxicity.	p(HGNC:CA2)	directlyDecreases	act(p(HGNC:GSK3B))
848e8d99-1f20-47e6-a0c8-8546f7b99ea2	1.0	PubMed	20357815	Taken together, our results indicate that activation of the cAMP and PKA pathway can immediately inactivate GSK-3beta, which, in this study is shown to have a critical role in MMP-1 expression in human skin fibroblasts.We further investigated the effects of cAMP pathway and GSK-3 activity on MMP-1 expression but focused on their effects on MMP-1 expression after the activation of ERK and JNK by TNF-alpha had already occurred.	a(CHEBI:17489)	directlyDecreases	act(p(HGNC:GSK3B))
848e8d99-1f20-47e6-a0c8-8546f7b99ea2	1.0	PubMed	22216350	GSK-3beta can be inactivated through the phosphorylation at S9 by Akt XREF_BIBR or by cAMP XREF_BIBR (XREF_FIG).	a(CHEBI:17489)	directlyDecreases	act(p(HGNC:GSK3B))
848e8d99-1f20-47e6-a0c8-8546f7b99ea2	1.0	PubMed	25266063	cAMP activates PKA and thereby stabilizes beta-catenin either directly or indirectly by inhibiting GSK3beta, resulting in increased beta-catenin activity and neuroblastoma cell viability.	a(CHEBI:17489)	directlyDecreases	act(p(HGNC:GSK3B))
848e8d99-1f20-47e6-a0c8-8546f7b99ea2	1.0	PubMed	25266063	PGE 2 and cAMP promoted GSK3beta inhibition, phosphorylation of beta-catenin at the PKA target residue ser675, beta-catenin nuclear translocation and TCF dependent gene transcription.	a(CHEBI:17489)	directlyDecreases	act(p(HGNC:GSK3B))
c904a2cc-bfb9-43ae-be51-ea1d9762793b	1.0	PubMed	24915301	CCL19 and LiCl showed partly additive effect on the accumulation of cyclin D1 indicating the overlapping of the signaling pathways modulated by these two agents and suggesting CCL19 may inhibit GSK-3beta via AKT activation to up-regulate cyclin D1 protein (XREF_FIG).	p(HGNC:CCL19)	directlyDecreases	act(p(HGNC:GSK3B))
66ff7839-7204-4549-bf99-64db18b54059	1.0	PubMed	27057280	In this study, it was indicated that PI3K and AKT signaling pathway is responsible for CCL21 inhibited GSK-3beta activity and then Snail upregulation in HCT116 cells.	p(HGNC:CCL21)	directlyDecreases	act(p(HGNC:GSK3B))
cd0cbcec-1fad-44df-bc11-e8928882d7dc	1.0	PubMed	27572267	GSK3beta CA mediated PD-L1 T180 and S184 phosphorylation was observed only in PD-L1 3NQ and 4NQ but not in WT and N35Q (XREF_FIG), further supporting the notion that glycosylation of PD-L1 prevents GSK3beta from binding to PD-L1 (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:CD274)	directlyDecreases	act(p(HGNC:GSK3B))
cd0cbcec-1fad-44df-bc11-e8928882d7dc	1.0	PubMed	27572267	Restoration of Flag tagged GSK3beta WT and the CA form, but not KD in a low-GSK3beta background, reduced PD-L1 expression (XREF_SUPPLEMENTARY), PD-1 interaction (XREF_SUPPLEMENTARY) and the immunosuppressive activity, as measured by increased interleukin (IL) -2 expression through co-culture with T cells (XREF_SUPPLEMENTARY).	p(HGNC:CD274)	directlyDecreases	act(p(HGNC:GSK3B))
222d6cdf-35e2-4aa5-a6ae-f7f220b3b028	1.0	PubMed	14657655	Phospho-gsk3b-specific antibodies also revolved that lkb1 regulates gsk3b phosphorylation at a known inhibitory site, serine-9. This localized phosphorylation is cdc42 and pkc-zeta-dependent.	p(HGNC:CDC42)	directlyDecreases	act(p(HGNC:GSK3B))
222d6cdf-35e2-4aa5-a6ae-f7f220b3b028	1.0	PubMed	21952626	As Cdc42 dependent signals may suppress GSK3beta (XREF_BIBR), a context specific regulator of apoptosis (XREF_BIBR), we used pharmacological inhibitor studies to explore the role of GSK3beta in apoptosis of PTEN expressing or -deficient colorectal cells.	p(HGNC:CDC42)	directlyDecreases	act(p(HGNC:GSK3B))
222d6cdf-35e2-4aa5-a6ae-f7f220b3b028	1.0	PubMed	20849862	In searching for downstream signaling molecules through which active Cdc42 improves VEGF driven angiogenesis, we found that active Cdc42 strongly inhibited GSK-3beta, a serine threonine kinase that was initially identified as a phosphorylating inactivator of glycogen synthase.	p(HGNC:CDC42)	directlyDecreases	act(p(HGNC:GSK3B))
222d6cdf-35e2-4aa5-a6ae-f7f220b3b028	1.0	PubMed	20849862	Atypical PKC is one of the signaling intermediates that phosphorylate this residue; and, in astrocytes, cell polarity is controlled through Cdc42 mediated GSK-3beta inhibition by a complex consisting of Par6 and atypical PKC (XREF_BIBR).	p(HGNC:CDC42)	directlyDecreases	act(p(HGNC:GSK3B))
57406803-12fa-4da9-8838-5235182bf61f	1.0	PubMed	21130530	However, increased expression of CDK5 inhibits GSK3B activity.	p(HGNC:CDK5)	directlyDecreases	act(p(HGNC:GSK3B))
94d59e74-839b-49f7-9b46-c5f369dcc240	1.0	PubMed	23326460	And the expression of p21 was also significantly increased after RNA interference or blocking FAK and GSK3beta.	p(HGNC:CDKN1A)	directlyDecreases	act(p(HGNC:GSK3B))
a92c6704-bd82-4d51-8750-cad38fb0c02a	1.0	PubMed	25771860	ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3beta and beta-catenin signaling.	p(HGNC:CEBPD)	directlyDecreases	act(p(HGNC:GSK3B))
ea56eea0-6788-47f1-a650-4d939b8f63ed	1.0	PubMed	18167338	We observed elevated levels of Cdc25A in G1 cells that were treated with the GSK-3beta inhibitor, LiCl, and we observed that inhibition of GSK-3beta, but not Chk1, accelerated the rate of S phase entry.	p(HGNC:CHEK1)	directlyDecreases	act(p(HGNC:GSK3B))
38175db7-3a02-4b31-ba1e-9257cce91258	1.0	PubMed	Other	No evidence text.	a(PUBCHEM:"CID:53396311")	directlyDecreases	act(p(HGNC:GSK3B))
0ee4e4c8-e09f-48bd-ad7e-3a875f4b33e3	1.0	PubMed	Other	No evidence text.	a(PUBCHEM:"CID:9956119")	directlyDecreases	act(p(HGNC:GSK3B))
bf80d885-bafd-4bea-8fcf-7ff76478d552	1.0	PubMed	27020460	As expected, we found that the increase in GSK-3beta phosphorylation was inhibited in LPS stimulated platelets treated with CHIR99021 (XREF_FIG and XREF_SUPPLEMENTARY).	a(PUBCHEM:9956119)	directlyDecreases	act(p(HGNC:GSK3B))
f8ccd588-a89d-4a61-90dd-e1bfa7619a2c	1.0	PubMed	26595527	This degradation was also prevented by concurrent inhibition of GSK3B by CHIR-99021.	a(PUBCHEM:9956119)	directlyDecreases	act(p(HGNC:GSK3B))
2456770d-aaeb-4dbc-a051-01902b1b6fa9	1.0	PubMed	19019440	However, the lack of GSK3-beta phosphorylation in Jurkat cells transfected with the empty vector, despite the constitutive activation of Akt, suggests that c-mip inactivates GSK3-beta via an Akt independent pathway.	p(HGNC:CMIP)	directlyDecreases	act(p(HGNC:GSK3B))
2456770d-aaeb-4dbc-a051-01902b1b6fa9	1.0	PubMed	19019440	In contrast, treatment by Wortmannin neutralized the ability of c-mip to induce the phosphorylation of GSK3-beta, which suggests that c-mip inactivates GSK3-beta, by a PI3K dependent and Akt independent pathway.We next determined whether Wortmannin abolished the effect of c-mip on NF-kappaB inhibition.	p(HGNC:CMIP)	directlyDecreases	act(p(HGNC:GSK3B))
59c5d5fc-a665-41fd-b5ea-edbe5481091c	1.0	PubMed	24726344	CPT-11 resistance reduced GSK3beta, p-GSK3beta, beta-catenin, COX-2 and Tbx3 (a gene target of Wnt and beta-catenin pathway) (44.14%, 77.31%, 64.85%, 89.82% and 57.1% decreased compare to parental LoVo cells, respectively) ().	a(PUBCHEM:60837)	directlyDecreases	act(p(HGNC:GSK3B))
1078ceef-3282-4feb-a49c-1065c7c7bd92	1.0	PubMed	24606125	In addition, cAMP and PKA signaling in AtT-20 corticotroph cells is mediated through GSK3-beta; CRH dependent inhibition of GSK3-beta was effectively blocked upon activation of SSTR signaling (XREF_BIBR).	p(HGNC:CRH)	directlyDecreases	act(p(HGNC:GSK3B))
49fe8e02-02aa-48e5-ad53-f19b2b76eae5	1.0	PubMed	14561750	Expression of Csk accentuated the activation of GSK-3beta by Galphaq (Q209L), whereas catalytically inactive Csk blocked GSK-3beta activation by Galphaq (Q209L).	p(HGNC:CSK)	directlyDecreases	act(p(HGNC:GSK3B))
49fe8e02-02aa-48e5-ad53-f19b2b76eae5	1.0	PubMed	7005206	Expression of Csk accentuated the activation of GSK-3beta by Galphaq (Q209L), whereas catalytically inactive Csk blocked GSK-3beta activation by Galphaq (Q209L).	p(HGNC:CSK)	directlyDecreases	act(p(HGNC:GSK3B))
9843ade1-93df-4ef7-a619-dc891737f96a	1.0	PubMed	19576224	In contrast, over-expression of CSN1 as well as the N-terminal fragment of CSN1 reduced GSK3beta significantly and decreased Axin and Rbx1 moderately in Flag-pulldowns (e, right-hand panel).	p(HGNC:CSN1S1)	directlyDecreases	act(p(HGNC:GSK3B))
59b51cb8-e500-4c7f-a61d-1f9141efd62e	1.0	PubMed	19411070	Surprisingly, we found that the association of Snail with GSK-3beta was diminished in cells treated with TNFalpha or CSN2 compared with MG-132 treatment (XREF_FIG).	p(HGNC:CSN2)	directlyDecreases	act(p(HGNC:GSK3B))
22c5af0a-aaa6-4fbb-8f1f-68d8a667c0f9	1.0	PubMed	25749038	Wnt and beta-catenin pathway was reported to inhibit GSK3beta activity through an unknown mechanism [XREF_BIBR].	p(HGNC:CTNNB1)	directlyDecreases	act(p(HGNC:GSK3B))
22c5af0a-aaa6-4fbb-8f1f-68d8a667c0f9	1.0	PubMed	26744382	In the canonical Wnt and beta-catenin signalling pathway, Wnt ligands binding to Frizzled receptors activate Dvl to inhibit GSK-3beta, which stabilizes beta-catenin.	p(HGNC:CTNNB1)	directlyDecreases	act(p(HGNC:GSK3B))
22c5af0a-aaa6-4fbb-8f1f-68d8a667c0f9	1.0	PubMed	23243000	beta-Catenin accumulation in the nucleus requires not only its release from membrane complexes with VE-cadherin (XREF_FIG), but also decreased degradation in the cytoplasm by the ubiquitin and proteasome pathway involving GSK-3beta (XREF_BIBR; XREF_BIBR).	p(HGNC:CTNNB1)	directlyDecreases	act(p(HGNC:GSK3B))
22c5af0a-aaa6-4fbb-8f1f-68d8a667c0f9	1.0	PubMed	25150829	Moreover, we found knockdown of beta-catenin restored the activity of GSK3beta.	p(HGNC:CTNNB1)	directlyDecreases	act(p(HGNC:GSK3B))
22c5af0a-aaa6-4fbb-8f1f-68d8a667c0f9	1.0	PubMed	16930546	Mutations of APC or beta-catenin and activation of the Wnt signal inhibit GSK-3beta activity and induce beta-catenin stabilization.	p(HGNC:CTNNB1)	directlyDecreases	act(p(HGNC:GSK3B))
22c5af0a-aaa6-4fbb-8f1f-68d8a667c0f9	1.0	PubMed	25691573	Glucose Deprivation Promotes beta-Catenin Degradation in a GSK3beta independent Manner.	p(HGNC:CTNNB1)	directlyDecreases	act(p(HGNC:GSK3B))
22c5af0a-aaa6-4fbb-8f1f-68d8a667c0f9	1.0	PubMed	24374173	We also observed that celecoxib inhibited exogenous PGE2 induced beta-catenin accumulation in the nucleus and inhibited activation of GSK-3beta; however, the mechanism of GSK-3beta inactivation by celecoxib is unknown.	p(HGNC:CTNNB1)	directlyDecreases	act(p(HGNC:GSK3B))
22c5af0a-aaa6-4fbb-8f1f-68d8a667c0f9	1.0	PubMed	19238201	It has been suggested that GSK-3beta inhibition by LiCl releases beta-catenin from its fate of proteasome mediated destruction XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:CTNNB1)	directlyDecreases	act(p(HGNC:GSK3B))
5ddd9bbb-2ffa-470c-8547-574219785da9	1.0	PubMed	24412065	CA-LRP transfection induced GSK3beta sequestration in cells with downmodulated p120-catenin (A, lane 4); however, expression of GFP-p120-catenin S268,269 A (lane 8), but not that of the WT form (lane 6), impaired the accumulation of GSK3beta, Axin, and Dvl-2 into MVBs.	p(HGNC:CTNND1)	directlyDecreases	act(p(HGNC:GSK3B))
66a4cc7e-81f4-4511-9667-b79bdbfb6e9a	1.0	PubMed	24038789	SDF1 activation of AKT would be expected to decrease GSK3beta activity through phosphorylation of Ser9.	p(HGNC:CXCL12)	directlyDecreases	act(p(HGNC:GSK3B))
47dfb631-1c3c-4a58-bc2d-5857c6a3cf55	1.0	PubMed	25462858	Thus, we suggest that through activation of PI3K and Akt signaling, the CXCR2 and CXCL5 axis suppressed GSK-3beta activity; this resulted in a corresponding increase in the level of snail, which in turn led to the downregulation of E-cadherin and the subsequent EMT of HCC cells.Based on our in vitro and in vivo studies, we proceeded to measure relative expression levels of CXCR2, CXCL5, PI3K/Akt/GSK-3beta/Snail pathway components, and EMT markers in HCC samples.	p(HGNC:CXCL5)	directlyDecreases	act(p(HGNC:GSK3B))
43125df1-385d-45ac-80c4-af90475d61e2	1.0	PubMed	25462858	Thus, we suggest that through activation of PI3K and Akt signaling, the CXCR2 and CXCL5 axis suppressed GSK-3beta activity; this resulted in a corresponding increase in the level of snail, which in turn led to the downregulation of E-cadherin and the subsequent EMT of HCC cells.Based on our in vitro and in vivo studies, we proceeded to measure relative expression levels of CXCR2, CXCL5, PI3K/Akt/GSK-3beta/Snail pathway components, and EMT markers in HCC samples.	p(HGNC:CXCR2)	directlyDecreases	act(p(HGNC:GSK3B))
b2699062-a551-4827-9e61-b00f609ea6a9	1.0	PubMed	24038789	These in vitro results extend and support our in vivo findings where chronic AMD3100 antagonism of CXCR4 in a mouse myocardial infarction model decreased GSK3beta Y216 phosphorylation 18.	p(HGNC:CXCR4)	directlyDecreases	act(p(HGNC:GSK3B))
afc2b216-b3fe-492d-8fed-44f4c486f2ed	1.0	PubMed	22807997	Inhibition of GSK3-beta completely abrogates p22phox protein degradation, which demonstrates that without GSK3-beta signalling p22phox can not be processed by the proteasome.	p(HGNC:CYBA)	directlyDecreases	act(p(HGNC:GSK3B))
5eadf674-efe0-4652-87a3-9a18d080cccd	1.0	PubMed	23184735	Interestingly, the biological observation reveals that a non native Ca (2+) ion can inhibit the GSK3beta catalytic activity.	a(CHEBI:29108)	directlyDecreases	act(p(HGNC:GSK3B))
40eafabf-b2fc-421c-8a5b-90c8cdefc7fb	1.0	PubMed	24333432	Celecoxib inhibits beta-catenin by activating GSK3beta to have an anti-tumor effect in osteosarcoma.	a(PUBCHEM:2662)	directlyDecreases	act(p(HGNC:GSK3B))
61de6416-b0c1-45da-8334-b4cf424b1140	1.0	PubMed	25042702	Modest GSK3-beta inhibition by Ch (3muM) or inhibition of upstream WNT signaling (both canonical and noncanonical) by IWP2 during AnteriorPS induction prevented specification into beating, alpha-ACTININ cardiomyocyte clusters (D).	p(PFAM:PF00307)	directlyDecreases	act(p(HGNC:GSK3B))
a37da98b-8cc7-4469-a5ec-3428c706e4ef	1.0	PubMed	20548028	Inactivated GSK3beta stabilizes cyclin D1 that is required for the upregulation of the cell-cycle progression essential for angiogenesis.	p(FPLX:Cyclin)	directlyDecreases	act(p(HGNC:GSK3B))
d9fbb8e6-9935-4faf-a6cd-4509d85197d7	1.0	PubMed	26336990	Other groups previously reported that DAB2IP suppressed EMT by modulating GSK3beta and beta-catenin signaling pathway in prostate cancer [XREF_BIBR].	p(HGNC:DAB2IP)	directlyDecreases	act(p(HGNC:GSK3B))
ebe0e801-2cb0-48cc-86f6-ad5d1ae2a4a5	1.0	PubMed	22470507	These data further show that beta-catenin accumulates in the nucleus and at the plasma membrane as a result of the inhibition of GSK-3beta by DACT1.	p(HGNC:DACT1)	directlyDecreases	act(p(HGNC:GSK3B))
ebe0e801-2cb0-48cc-86f6-ad5d1ae2a4a5	1.0	PubMed	22470507	Moreover, based on our findings, we speculated that DACT1 inhibits GSK-3beta.	p(HGNC:DACT1)	directlyDecreases	act(p(HGNC:GSK3B))
ebe0e801-2cb0-48cc-86f6-ad5d1ae2a4a5	1.0	PubMed	22470507	We have also demonstrated DACT1 inhibits the activity of GSK-3beta via increasing the level of phosphorylated GSK-3beta at Ser9, which alters the subcellular location of beta-catenin.	p(HGNC:DACT1)	directlyDecreases	act(p(HGNC:GSK3B))
9dcdaa77-7d25-4aaa-8099-72131e63d77c	1.0	PubMed	23029096	In contrast, decorin, by neutralizing the activity of EGFR and Met, relieves GSK3beta inactivation, and leads to non canonical GSK3beta evoked phosphorylation of beta-catenin as well as Myc at Thr58 XREF_BIBR, XREF_BIBR, thus leading to 26S proteasomal degradation.	p(HGNC:DCN)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	26546129	Impaired DISC1 allowed inappropriate activation of GSK3beta in beta cells, and antagonizing GSK3beta (SB216763; IC50 = 34.3 nM) rescued the beta-cell defects.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	22099458	Common DISC1 polymorphisms disrupt Wnt and GSK3beta signaling and brain development.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	22099458	The finding that DISC1 directly inhibits GSK3beta is interesting given that the common mood stabilizer drug lithium, and the schizophrenia risk gene Akt, also inhibit GSK3beta which results in activation of canonical Wnt signaling, suggesting it may be an important target in psychiatric disease.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	22099458	We demonstrate using mouse, zebrafish, and human model systems that the DISC1 variants Ala83Val (A83V), Arg264Gln (R264Q), and Leu607Phe (L607F) disrupt canonical Wnt and GSK3beta signaling and neural progenitor cell proliferation.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	22832659	XREF_BIBR, XREF_BIBR Disc1 enhances Wnt and beta-catenin-dependent neural progenitor proliferation by inhibiting GSK-3beta, thereby inducing beta-catenin/TCF/LEF-dependent gene transcription.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	26553875	Indeed, DISC1 has been reported previously to inhibit GSK3beta (XREF_BIBR), which in turn phosphorylates kinesin light chains, causing uncoupling of motors from cargo (reviewed in Ref.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	19303846	We further narrowed down the DISC1-GSK3beta interaction domain and generated a DISC1 peptide that strongly inhibits GSK3beta In the context of the adult brain, DISC1 loss-of-function in the dentate gyrus resulted in reduced neural progenitor proliferation and elicited hyperactive and depressive behaviors in mice.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	19303846	Consistent with its ability to bind GSK3beta, the DISC1 fragment spanning residues 1-220 potently inhibited beta-catenin, axin, and GSK3beta phosphorylation at 0.5 microM, whereas none of the other DISC1 fragments, GST-p25, or GST-CASK proteins inhibited GSK3beta activity at this concentration (XREF_FIG).	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	19303846	If DISC1 inhibits GSK3beta activity, we speculated that the negative effects of DISC1 knockdown on proliferation should be alleviated by GSK3beta loss-of-function.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	19303846	Thus, increased GSK3beta activity caused by DISC1 loss-of-function is associated with schizophrenia- and depression like behaviors.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
145546e8-4356-4efd-9b1d-4ce000cf4ea5	1.0	PubMed	19303846	DISC1 inhibits GSK3beta by direct physical interaction.	p(HGNC:DISC1)	directlyDecreases	act(p(HGNC:GSK3B))
49181795-f3bb-4bda-8e83-7c4874558d60	1.0	PubMed	18641688	The endogenous protein interaction data suggest that in response to Wnt signaling, DOCK4 sequesters the beta-catenin degradation complex APC, Axin, and GSK3beta to facilitate the release and accumulation of beta-catenin in the cytosol.	p(HGNC:DOCK4)	directlyDecreases	act(p(HGNC:GSK3B))
2e30fe0a-a0f5-4b80-82ab-fe31e2332ede	1.0	PubMed	6935334	Administration of a D (1) dopamine receptor agonist inhibited GSK3beta activity in FCX and HP of control rabbits but not in cocaine offspring.	p(FPLX:DRD)	directlyDecreases	act(p(HGNC:GSK3B))
66d0d774-e17c-40ab-8995-64c5f48d1484	1.0	PubMed	20837657	In canonical wnt signaling, dsh phosphorylation inhibits the apcaxingsk3 complex, leading to beta-catenin stabilization.	p(HGNC:DVL1)	directlyDecreases	act(p(HGNC:GSK3B))
66d0d774-e17c-40ab-8995-64c5f48d1484	1.0	PubMed	21689639	Dishevelled-1 (Dvl-1) is activated upon Wnt stimulation and inhibits GSK3beta, leading to the accumulation of beta-catenin.	p(HGNC:DVL1)	directlyDecreases	act(p(HGNC:GSK3B))
66d0d774-e17c-40ab-8995-64c5f48d1484	1.0	PubMed	6182539	Dishevelled 1 (DVL1) is thought to act as a positive regulator of the wnt signalling pathway, and inhibits GSK3beta activity preventing beta-catenin degradation and thus allowing wnt target gene expression.	p(HGNC:DVL1)	directlyDecreases	act(p(HGNC:GSK3B))
66d0d774-e17c-40ab-8995-64c5f48d1484	1.0	PubMed	26071132	During developmental and homoeostatic events, the Wnt signalling mechanism can be regulated by Dishevelled (Dvl1) which inhibits GSK3beta activity and reduces the degree of beta-catenin degradation.	p(HGNC:DVL1)	directlyDecreases	act(p(HGNC:GSK3B))
66d0d774-e17c-40ab-8995-64c5f48d1484	1.0	PubMed	10647780	This result suggests that Dvl-1 inhibits the activity of GSK-3beta, which is consistent with genetic evidence in that Dishevelled acts negatively upstream of shaggy.	p(HGNC:DVL1)	directlyDecreases	act(p(HGNC:GSK3B))
66d0d774-e17c-40ab-8995-64c5f48d1484	1.0	PubMed	11803455	Dishevelled 1 (DVL1) is thought to act as a positive regulator of the wnt signalling pathway, and inhibits GSK3beta activity preventing beta-catenin degradation and thus allowing wnt target gene expression.	p(HGNC:DVL1)	directlyDecreases	act(p(HGNC:GSK3B))
66d0d774-e17c-40ab-8995-64c5f48d1484	1.0	PubMed	25643607	Inactivation of AKT signalling attenuated DVL1 mediated inhibition of GSK-3beta and accumulation of beta-catenin, in both A2780 and A2780 and Taxol cells.	p(HGNC:DVL1)	directlyDecreases	act(p(HGNC:GSK3B))
e37d1456-a79e-48a4-b17d-5e257757ab88	1.0	PubMed	22470507	Reports have shown that Dvl can inhibit the activity of GSK-3beta XREF_BIBR, XREF_BIBR.	p(FPLX:DVL)	directlyDecreases	act(p(HGNC:GSK3B))
e37d1456-a79e-48a4-b17d-5e257757ab88	1.0	PubMed	12464179	Activation of Dvl inhibits GSK-3beta within this complex leading to the stabilization and accumulation of beta-catenin in the cytoplasm.	p(FPLX:DVL)	directlyDecreases	act(p(HGNC:GSK3B))
e37d1456-a79e-48a4-b17d-5e257757ab88	1.0	PubMed	24340027	The canonical Wnt ligands bind to Fzd receptors and co-receptors LRP5 or LRP6, causing phosphorylation of Dvl, which inhibits GSK3beta from phosphorylating beta-catenin.	p(FPLX:DVL)	directlyDecreases	act(p(HGNC:GSK3B))
e37d1456-a79e-48a4-b17d-5e257757ab88	1.0	PubMed	PMC7164275	Inhibition of GSK-3beta by DVL increases beta-catenin stability and TCF transcriptional activation.	p(FPLX:DVL)	directlyDecreases	act(p(HGNC:GSK3B))
e37d1456-a79e-48a4-b17d-5e257757ab88	1.0	PubMed	10647780	Dvl antagonizes the action of GSK-3beta, perhaps by modulating its enzymatic activity.	p(FPLX:DVL)	directlyDecreases	act(p(HGNC:GSK3B))
e37d1456-a79e-48a4-b17d-5e257757ab88	1.0	PubMed	7164275	Inhibition of GSK-3beta by DVL increases beta-catenin stability and TCF transcriptional activation.	p(FPLX:DVL)	directlyDecreases	act(p(HGNC:GSK3B))
cde35cff-9a84-4a10-ba9f-74da9ead0040	1.0	PubMed	24391509	NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3beta Resulting in the Stabilization of MYCN in Human Neuroblastomas.	a(PUBCHEM:151403)	directlyDecreases	act(p(HGNC:GSK3B))
40fb9fcb-322a-4f51-80b8-6a1913e26d32	1.0	PubMed	22096483	Results demonstrated that G3 expressing cells enhanced GSK-3beta (S9P) expression when treated with a serum free medium, Doxorubicin or Epirubicin; they also expressed decreased GSK-3beta (S9P) and activated pSAPK and JNK when treated with C2-ceramide or Docetaxel.	a(PUBCHEM:148123)	directlyDecreases	act(p(HGNC:GSK3B, var(p.Ser9Pro)))
8e989910-a9c7-46fa-8c1d-7958ac27e0ed	1.0	PubMed	26086249	Co-depletion of E2F-1 reduced the activation of p53 and Bax, NF-kappaB, and GSK-3beta, and limited cell apoptosis.	p(HGNC:E2F1)	directlyDecreases	act(p(HGNC:GSK3B))
1ff88896-25b0-4f81-9d5c-597f7e667750	1.0	PubMed	25172557	Consistent with our hypothesis that E2 mediated inhibition of GSK3beta function can promote Nrf2 activity in our cells, experiments utilizing the GSK3beta inhibitor CT99021 showed that its effects were, like E2, stimulatory for Nrf2, both alone and in combination with tBHQ () Having shown that the PI3K pathway is essential for E2 induction of Nrf2 and HO1 expression, we directly assessed the ability of E2 to upregulate PI3K signaling.	p(UP:P27958)	directlyDecreases	act(p(HGNC:GSK3B))
893563fe-61fe-46b1-8322-cc2368f98c02	1.0	PubMed	23851495	Although E3 ligases, such as FBW7 and beta-trcp, often degrade the substrates of GSK3beta, their well characterized degradation sequences (degrons) are not found within Slug, Moreover, our preliminary data showed that knock-down of neither FBW7 (data not shown) nor beta-trcp affected the Slug protein level in lung cancer cell lines.	p(FPLX:"E3_Ub_ligase")	directlyDecreases	act(p(HGNC:GSK3B))
7c530a4c-e4c0-48f3-8749-0de4055c1250	1.0	PubMed	21347341	Increased stability and nuclear accumulation of Cyclin D1 in the presence of EBNA3C prompted us to examine whether EBNA3C can also negatively regulate GSK-3beta function linked to the stability of Cyclin D1.	p(UP:I1YP21)	directlyDecreases	act(p(HGNC:GSK3B))
7c530a4c-e4c0-48f3-8749-0de4055c1250	1.0	PubMed	21347341	Here, we show that EBNA3C stabilizes Cyclin D1 through inhibition of its poly-ubiquitination, and also increases its nuclear localization by blocking GSK3beta activity.	p(UP:I1YP21)	directlyDecreases	act(p(HGNC:GSK3B))
7f5086af-4fae-4ce4-b041-d92018c73f32	1.0	PubMed	22480520	In this context, ET-1 can drive inhibition of GSK-3beta to stabilise beta-catenin proteins to engage transcriptional programs that control EMT and increased cell invasion ().	p(HGNC:EDN1)	directlyDecreases	act(p(HGNC:GSK3B))
db7bce25-b0e3-46b5-bcd8-6c61950eb08b	1.0	PubMed	23555843	Inhibition of EFV induced Activation of GSK3beta via Valproic Acid Attenuates Release of sCD40L both in vitro and in vivo.	a(PUBCHEM:71464665)	directlyDecreases	act(p(HGNC:GSK3B))
cc1203c1-aa85-437d-afa0-026b6b10b4fe	1.0	PubMed	22662165	These data suggest that oncogenic EGFR and PI3K selectively inhibit GSK3beta during GD.	p(HGNC:EGFR)	directlyDecreases	act(p(HGNC:GSK3B))
cc1203c1-aa85-437d-afa0-026b6b10b4fe	1.0	PubMed	27572267	Together, these data suggest that activation of EGFR may inactivate GSK3beta and thereby stabilizes PD-L1 expression.	p(HGNC:EGFR)	directlyDecreases	act(p(HGNC:GSK3B))
cc1203c1-aa85-437d-afa0-026b6b10b4fe	1.0	PubMed	20734923	EGFR activated AKT and inactivated GSK3beta in EGFR +/PTEN+ GSCs.	p(HGNC:EGFR)	directlyDecreases	act(p(HGNC:GSK3B))
cc1203c1-aa85-437d-afa0-026b6b10b4fe	1.0	PubMed	25883211	For example, EGFR activated PI3K and AKT leads to phosphorylation and subsequently inhibition of the beta-catenin suppressor GSK3beta, resulting in nuclear accumulation of beta-catenin [XREF_BIBR].	p(HGNC:EGFR)	directlyDecreases	act(p(HGNC:GSK3B))
24996031-98e9-4e67-8f47-a8c0c174eb85	1.0	PubMed	23851495	46 We found that the treatment of elevated EGF caused the suppression of GSK3beta (through phosphorylation of Ser9) by the activation of Akt and a marked increase in Slug protein levels (XREF_FIG).	p(HGNC:EGF)	directlyDecreases	act(p(HGNC:GSK3B))
24996031-98e9-4e67-8f47-a8c0c174eb85	1.0	PubMed	24312592	EGF inhibited GSK-3beta through atypical PKC and MAPK pathways.	p(HGNC:EGF)	directlyDecreases	act(p(HGNC:GSK3B))
c1069360-0a42-4d05-b457-94f50f594caa	1.0	PubMed	28036276	Conversely, FBW7 overexpression leads to EglN2 downregulation in a GSK3beta dependent manner.	p(HGNC:EGLN2)	directlyDecreases	act(p(HGNC:GSK3B))
30854b22-ae95-4a68-b254-c3cc39b8eae5	1.0	PubMed	26119563	Stimulation of EphB2 inhibits GSK-3beta activity.	p(HGNC:EPHB2)	directlyDecreases	act(p(HGNC:GSK3B))
30854b22-ae95-4a68-b254-c3cc39b8eae5	1.0	PubMed	26119563	The data show that stimulation of EphB2 by ephrinB1/Fc inhibits GSK-3beta activity (XREF_FIG).	p(HGNC:EPHB2)	directlyDecreases	act(p(HGNC:GSK3B))
30854b22-ae95-4a68-b254-c3cc39b8eae5	1.0	PubMed	26119563	These data suggest that stimulation of EphB2 inhibits GSK-3beta.	p(HGNC:EPHB2)	directlyDecreases	act(p(HGNC:GSK3B))
30854b22-ae95-4a68-b254-c3cc39b8eae5	1.0	PubMed	26119563	These data suggest that PI3K and Akt activation mediates the EphB2 induced GSK-3beta inhibition.	p(HGNC:EPHB2)	directlyDecreases	act(p(HGNC:GSK3B))
30854b22-ae95-4a68-b254-c3cc39b8eae5	1.0	PubMed	26119563	By measuring directly GSK-3beta activity or the activity dependent phosphorylation of GSK-3beta at Ser9 (inhibitory) and Tyr216 (activation) XREF_BIBR, we found that stimulation of EphB2 inhibits GSK-3beta.	p(HGNC:EPHB2)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	22385658	Not only did Mek inhibition block differentiation in low PI3K and Akt activity, it also suppressed the inactivation of Gsk3beta (XREF_FIG), supporting the idea that Mek and Erk signaling inhibits Gsk3beta activity.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	22385658	Our data shows that Erk dependent inactivation of Gsk3beta signaling has a major role in destabilizing the pluripotent state.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	23583409	A previous study by Binhua P. Zhou and colleagues showed that not only the activation of MAPK and ERK pathway but also the activation of PI3K and Akt pathway suppressed the activity of GSK-3beta, which in turn stabilized the Snail level, an EMT inducer, ultimately resulting in EMT process.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	23582741	Since GSK-3beta activity is inhibited by Fas induced ERK and MAPK activation, beta-catenin, a substrate for GSK-3beta, may evade degradation and translocate into the nucleus to promote transcription of EMT associated genes.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	23582741	Our results show that GSK-3beta activity is inhibited by Fas induced ERK and MAPK activation, followed by increased nuclear expression of Snail and beta-catenin, which was almost completely blocked by expression of constitutively active GSK-3beta S9A.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	23644467	ERK can associate with and inactivate GSK3beta by acting as a scaffold for p90RSK and GSK3beta 30, and this ERK-p90RSK-GSK3beta pathway can be stimulated by RTKs such as HER2 XREF_BIBR, XREF_BIBR.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	18451303	Here, we show that p38 mitogen activated protein kinase (MAPK) also inactivates GSK3beta by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of beta-catenin.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	26279267	TIM-3 signaling can activate the ERK and AKT pathways (C and 3D), and both ERK and AKT signaling inhibits GSK3beta activity in cancer, resulting in promotion of nucleus translocation of beta-catenin ().	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	26279267	Ligation of TIM-3 by Gal-9 induces phosphorylation of ERK and AKT, whose signaling can inhibit GSK3beta, a molecule responsible for degradation of beta-catenin by ubiquitination ().	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	20849862	GSK-3beta is also inhibited by the PI-3 '-kinase pathway through PKB and Akt, and also by the MEK and ERK and p38 MAPK pathways, PKA, p90 RSK / MAPKAP kinase-1, and S6 kinase (XREF_BIBR; XREF_BIBR).	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	20634980	The increase in Sphk-1 activity may be due to the up regulated ERK 1/2 phosphorylation and agonist induced GSK3-beta inhibition.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
9952c3bf-a1dc-47b1-8ff4-3b140beef708	1.0	PubMed	23300578	Based on these results, we confirmed that the knockdown of Pokemon in HepG2 cells suppressed the phosphorylation of ERK and Akt, thus activating GSK-3beta, which is the downstream target of Akt.	p(FPLX:ERK)	directlyDecreases	act(p(HGNC:GSK3B))
94b6f182-01eb-459d-8fef-27ac8f9c924c	1.0	PubMed	25026278	This phenomenon whereby h-Prune provides protection against proteinase K degradation of Gsk-3beta was abolished when the membranes were solubilized with Triton X-100.	p(HGNC:"ERVK-10")	directlyDecreases	act(p(HGNC:GSK3B))
39090b2b-c101-4276-8b30-63f17690f74b	1.0	PubMed	20143409	In the blot shown, a small decrease in GSK-3beta phosphorylation was observed in samples treated with TM at 6 hr and samples treated with TG at 3 and 6 hr.	p(HGNC:"ERVK-18")	directlyDecreases	act(p(HGNC:GSK3B))
16867e26-5f11-421e-a6d1-bcdbd20724eb	1.0	PubMed	23582741	We demonstrate that Fas signalling inactivates GSK-3beta via ERK and MAPK signalling, leading to nuclear accumulation of Snail and beta-catenin, and, subsequently, downregulation of and upregulation of MMP9 and Vimentin, and ().	p(HGNC:FAS)	directlyDecreases	act(p(HGNC:GSK3B))
16867e26-5f11-421e-a6d1-bcdbd20724eb	1.0	PubMed	23582741	In this study, we demonstrate that Fas signalling inactivates GSK-3beta by ERK and MAPK signalling, leading to nuclear accumulation of Snail and beta-catenin, and, subsequently, downregulation of E-cadherin and upregulation of MMP9 and Vimentin, and.	p(HGNC:FAS)	directlyDecreases	act(p(HGNC:GSK3B))
757f3367-7df0-4ac8-9888-c3907dd8cc31	1.0	PubMed	25909283	Our results suggest that fibulin-5 antagonizes Wnt signaling by inhibiting ERK and indirectly activating GSK3beta to restrain beta-catenin in the cytoplasm, which prevents MMP-7 and c-Myc expression and lung cancer cell invasion and proliferation.	p(HGNC:FBLN5)	directlyDecreases	act(p(HGNC:GSK3B))
114cf310-c696-4558-93eb-5ee5a50a5810	1.0	PubMed	5202177	Basal GSK-3beta activity was decreased by approximately 40% in FF rats and remained unchanged after insulin treatment.	p(PFAM:PF01846)	directlyDecreases	act(p(HGNC:GSK3B))
72771432-d5a9-4b2a-a301-5d381db1887a	1.0	PubMed	6380769	On the other hand, infection with wild-type GSK3beta recombinant adenovirus associated virus increased activity of GSK3beta and cell death, both of which were reduced by FGF1 treatment.	p(HGNC:FGF1)	directlyDecreases	act(p(HGNC:GSK3B))
3f5e0f2a-1358-4d66-a817-17cd387c4bfc	1.0	PubMed	25088797	It indicated that bFGF inhibited the activity of GSK-3beta, which might be responsible for rapid Snail accumulation.	p(HGNC:FGF2)	directlyDecreases	act(p(HGNC:GSK3B))
3f5e0f2a-1358-4d66-a817-17cd387c4bfc	1.0	PubMed	25088797	In this study, it was demonstrated that PI3K and AKT signaling is responsible for bFGF inhibited activity of GSK-3beta then Snail up-regulation in PC-3 cells.	p(HGNC:FGF2)	directlyDecreases	act(p(HGNC:GSK3B))
5be2c188-64e8-4947-a2c7-e16c5ad4697e	1.0	PubMed	25088797	FGF signaling is mentioned to inhibit GSK-3beta activity via PI3K and AKT signaling network.	p(FPLX:FGF)	directlyDecreases	act(p(HGNC:GSK3B))
bf8b399d-1355-43bf-8d1b-67c6ddd2df2e	1.0	PubMed	20352103	We show here that in conditions of serum starvation, the fibronectin receptor alpha 5 beta 1 integrin, but not alpha 4 beta 1, induced activation of GSK3beta through Ser 9 dephosphorylation in adherent U937 cells.	p(HGNC:FN1)	directlyDecreases	act(p(HGNC:GSK3B))
652acc93-0dbd-4f4f-8c0a-6f254af3dd81	1.0	PubMed	19501598	XREF_BIBR In GSK-3beta the C-terminal insert is known to bind either the scaffold protein axin XREF_BIBR, which localizes GSK-3beta with its substrate beta-catenin, or with FRAT1 that disrupts GSK-3beta : axin binding.	p(HGNC:FRAT1)	directlyDecreases	act(p(HGNC:GSK3B))
f2ae4c25-341a-4b9a-9796-130df899a921	1.0	PubMed	11738041	The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.	p(HGNC:FRAT2)	directlyDecreases	act(p(HGNC:GSK3B))
d3d60fdf-0aa9-485e-ac73-8813d0a08158	1.0	PubMed	6227833	This was accompanied by GC mediated attenuation of GSK3beta Ser (9) inhibitory phosphorylation and increased GSK3beta kinase activity.	p(HGNC:GC)	directlyDecreases	act(p(HGNC:GSK3B))
d3d60fdf-0aa9-485e-ac73-8813d0a08158	1.0	PubMed	11877389	This was accompanied by GC mediated attenuation of GSK3beta Ser (9) inhibitory phosphorylation and increased GSK3beta kinase activity.	p(HGNC:GC)	directlyDecreases	act(p(HGNC:GSK3B))
b5a99bc2-7961-49a4-9770-6dff4a5af644	1.0	PubMed	26095393	We conclude that GSK3beta inhibition by GIN caused an uncoupling of BMP signaling and SOST expression, resulting in an increased BMP4 induced osteoblast differentiation.	p(PFAM:PF10764)	directlyDecreases	act(p(HGNC:GSK3B))
f9def60f-ad4c-4bc1-97cb-02d0960e48bf	1.0	PubMed	23202730	We now report that specific inhibition of GSK3beta, but not GSK3alpha, reduced BACE1 mediated cleavage of APP and Abeta production by decreasing BACE1 gene transcription and expression.	p(HGNC:GSK3A)	directlyDecreases	act(p(HGNC:GSK3B))
f9def60f-ad4c-4bc1-97cb-02d0960e48bf	1.0	PubMed	26022178	Moreover, cytotoxicity was significantly enhanced by the knockdown of GSK-3beta but not GSK-3alpha, particularly in response to combination of NKG2D and 2B4 (D).	p(HGNC:GSK3A)	directlyDecreases	act(p(HGNC:GSK3B))
79a44ef4-a152-41b5-a7fb-2a48e39a9221	1.0	PubMed	22193544	This study shows that the knockdown of GSK3beta expression through RNAi decreases Tau phosphorylation and increases the occurrence of SH-SY5Y cell differentiation.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
585491ad-7d54-4b60-a74e-2a785026858a	1.0	PubMed	25122124	GSK-3beta phosphorylation induces beta-TRCP-mediated ubiquitination, localization of Snail within the cytoplasm and subsequent proteasomal degradation of Snail XREF_BIBR.	p(HGNC:GSK3B, pmod(Ph))	directlyDecreases	act(p(HGNC:SNAI1))
87776f0f-5b0d-4a60-86f1-283d79a2b793	1.0	PubMed	20847424	Phosphorylation and inactivation of GSK-3beta, suppresses GSK-3beta-dependent phosphorylation of tau at residues overphosphorylated in AD and prevents apoptosis of confluent cells.	p(HGNC:GSK3B, pmod(Ph))	directlyDecreases	act(bp(GO:"GO:0006915"))
8b99f1ca-d381-486d-b1b6-2f9cabf5bcc1	1.0	PubMed	24498263	In its activated dephosphorylated form, GSK3beta promotes the degradation of cyclin D, and unphosphorylated GSK3beta suppresses Rb phosphorylation and prevents cell cycle progression XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B, pmod(Ph))	directlyDecreases	act(bp(GO:"GO:0007049"))
2a6b40ec-e992-4957-9ff5-3cd263edc2ee	1.0	PubMed	25528666	Overexpression of GSK3beta L128A mutant but not GSK3beta R96A mutant suppressed Sema3A induced acceleration of axonal transport in DRG neurons ().	p(HGNC:GSK3B, var(p.Leu128Ala))	directlyDecreases	act(bp(GO:"GO:0006810"))
451e85dd-dacf-48e8-a696-c49b8c4c516d	1.0	PubMed	23337503	Ser17 and Thr21 are critical sites of GSK3beta mediated phosphorylation, and inhibition of GSK3beta or S17A and T21A mutation enhances BMAL1 stability.	p(HGNC:GSK3B, var(p.Ser17Ala))	directlyDecreases	act(p(HGNC:ARNTL))
ecb90eae-0d5c-49b6-821d-2dfd791ac9ec	1.0	PubMed	23337503	Ser17 and Thr21 are critical sites of GSK3beta mediated phosphorylation, and inhibition of GSK3beta or S17A and T21A mutation enhances BMAL1 stability.	p(HGNC:GSK3B, var(p.Thr21Ala))	directlyDecreases	act(p(HGNC:ARNTL))
96539ffe-2e21-48d2-8d85-a6b6139ebe03	1.0	PubMed	24929931	Cell death due to tau+ AICD was suppressed by expression of GSK3beta (K85A) for 352PHP, G272V, P301L, R5H, and R406W, and K18.	p(HGNC:GSK3B, var(p.Lys85Ala))	directlyDecreases	act(bp(GO:"GO:0008219"))
17794676-f368-41fe-9b1a-f345f5f1bc50	1.0	PubMed	24929931	In support of this, expression of dominant negative GSK3beta (K85A) does not reduce cell death due to expression of AICD alone, or AICD and K18DeltaK280, as most GSK3beta phosphorylation sites are absent from this mutant.	p(HGNC:GSK3B, var(p.Lys85Ala))	directlyDecreases	act(bp(GO:"GO:0008219"))
17794676-f368-41fe-9b1a-f345f5f1bc50	1.0	PubMed	24929931	Further experiments show that expression of dominant negative GSK3beta (K85A) in the presence AICD and tau decreases levels of cell death to that expected from an additive effect of cell death induced by AICD+ tau alone.	p(HGNC:GSK3B, var(p.Lys85Ala))	directlyDecreases	act(bp(GO:"GO:0008219"))
9e4f3473-d642-42ba-84c0-47931490040e	1.0	PubMed	25528666	A kinase-dead GSK3beta K85M mutant markedly suppressed the basal levels of both antero- and retrograde transport ().	p(HGNC:GSK3B, var(p.Lys85Met))	directlyDecreases	act(bp(GO:"GO:0006810"))
63701f09-4533-48e8-8085-93a742cd5ed9	1.0	PubMed	25528666	Overexpression of GSK3beta L128A mutant but not GSK3beta R96A mutant suppressed Sema3A induced acceleration of axonal transport in DRG neurons ().	p(HGNC:GSK3B, var(p.Arg96Ala))	directlyDecreases	act(bp(GO:"GO:0006810"))
4adb83ef-c0d3-4df5-b92b-563e38956cb6	1.0	PubMed	25484286	However, overexpressing of GSK3beta S9A could significantly inhibit BDNF induced endogenous TrkB endocytosis, while overexpressing of GSK3beta R96A could significantly promote TrkB endocytosis (C, D), which confirmed our previous TrkB overexpression results.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:BDNF))
813dff70-3816-4d25-8cd2-06abc38032ee	1.0	PubMed	19289791	As expected, GSK3beta (S9A) expression completely disrupted MT association of WT CLASP2 (340-1,084).	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:CLASP2))
4df63028-0cab-4a24-8264-f008dc65838a	1.0	PubMed	23582741	We found that ectopic expression of GSK-3beta S9A significantly attenuated Fas induced migration, and the nuclear expression and transcriptional activity of Snail and beta-catenin.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:CTNNB1))
5ab41192-8e0e-4a7b-99d0-049561143c65	1.0	PubMed	20634980	Ectopic expression of constitutively active GSK-3beta (S9A) abrogated HBD-2 whereas kinase inactive GSK-3beta (R85A) induced higher amounts of HBD-2.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:DEFB4A))
5ab41192-8e0e-4a7b-99d0-049561143c65	1.0	PubMed	20634980	In this case constitutively active GSK3beta (S9A) inhibited HBD-2 possibly blocking the activation of ERK 1/2.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:DEFB4A))
79a5241e-5fdd-474a-ab8b-982a4e39cbf3	1.0	PubMed	23582741	We found that ectopic expression of GSK-3beta S9A significantly attenuated Fas induced migration, and the nuclear expression and transcriptional activity of Snail and beta-catenin.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:FAS))
7e554f8c-fe27-4332-8e0b-a64996ea1ca6	1.0	PubMed	23685991	Expression of constitutive active GSK3beta (S9A) represses LiCl mediated enhancement of IRF3 transactivation activity.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:IRF3))
dd76a0cb-4482-47f3-ab2c-3d42a22f3e57	1.0	PubMed	23685991	Expression of constitutive active GSK3beta (S9A) represses LiCl mediated enhancement of IRF3 transactivation activity.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(a(PUBCHEM:433294))
06828d59-e9e3-442a-bc5d-3fb6d59b88f0	1.0	PubMed	24423919	Consistently, a constitutively active form of GSK-3beta (S9A), which prevents phosphorylation and activates the kinase, did not inhibit the effect of Nur77 on inducing beta-catenin expression (XREF_FIG), suggesting a mechanism that relied upon PI3K and Akt but not GSK-3beta.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:NR4A1))
6961f49f-d06f-4a87-9f39-a38023a522ef	1.0	PubMed	25484286	Quantification of the fluorescence ratios showed that overexpression of GSK3beta S9A could significantly inhibit BDNF dependent TrkB endocytosis compared with the control group, whereas overexpression of GSK3beta R96A has an opposite effect (A, B), which confirmed our previous results that GSK3beta could regulate BDNF induced TrkB endocytosis.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:NTRK2))
b1cd2f1e-34f7-41db-b3ff-9110971fdda4	1.0	PubMed	23582741	We found that ectopic expression of GSK-3beta S9A significantly attenuated Fas induced migration, and the nuclear expression and transcriptional activity of Snail and beta-catenin.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:SNAI1))
b1cd2f1e-34f7-41db-b3ff-9110971fdda4	1.0	PubMed	23582741	Pretreatment with a pharmacological inhibitor of GSK-3beta (AR-A014418) increased Snail expression and beta-catenin nuclear translocation, whereas exogenous expression of GSK-3beta S9A abrogated Snail promoter induction.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:SNAI1))
16a2cdcf-8ef6-4ef2-b7aa-4287c56e1aa2	1.0	PubMed	22142472	Co-transfection of GSK-3beta (S9A) significantly reduced the HO stimulated wild-type STK38 kinase activity (A, lane 4), whereas the kinase activity of the STK38 mutant with alanine substitutions at all four residues (S6, T7, S10, and S11), the 4xA mutant, was not affected by GSK-3beta (S9A), suggesting that the GSK-3-mediated phosphorylation at S6 and T7 of STK38 is essential for limiting the full STK38 activity (A, lane 8).	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:STK38))
16a2cdcf-8ef6-4ef2-b7aa-4287c56e1aa2	1.0	PubMed	22142472	Our findings showed that overexpression of GSK-3beta (S9A) inhibited the HO stimulated activation of STK38, whereas the HO stiumulated STK38 activity of the 4xA mutant (S6A/T7A/S10A/S11A) was not affected by GSK-3beta (A), suggesting the involvement of specific phosphorylation events in GSK-3-mediated inhibition.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(p(HGNC:STK38))
d3207db5-bbe5-4d08-8d62-01854749116d	1.0	PubMed	25484286	Quantification of the fluorescence ratios showed that overexpression of GSK3beta S9A could significantly inhibit BDNF dependent TrkB endocytosis compared with the control group, whereas overexpression of GSK3beta R96A has an opposite effect (A, B), which confirmed our previous results that GSK3beta could regulate BDNF induced TrkB endocytosis.	p(HGNC:GSK3B, var(p.Ser9Ala))	directlyDecreases	act(bp(GO:"GO:0006897"))
2631a71c-aa56-46ee-b2b2-8a7c4e20de7f	1.0	PubMed	22096483	On the other hand, expression of pSAPK and JNK may also inhibit expression of GSK-3beta (S9P), and enhance cell apoptosis (XREF_FIG).	p(HGNC:GSK3B, var(p.Ser9Pro))	directlyDecreases	act(bp(GO:"GO:0006915"))
c0d35d26-9d69-41f3-9db0-35877d37bd5a	1.0	PubMed	17081987	Expression of this GSK3beta mutant dramatically reduced cyclin D1-FBX4 binding (B) as well as cyclin D1 phosphorylation (data not shown).	p(HGNC:GSK3B, var(p.?))	directlyDecreases	act(p(FPLX:Cyclin))
44f06cee-8856-46a0-9d03-5dc94140e4c6	1.0	PubMed	23185275	Instead, mutation of the GSK-3beta phosphorylation sites abolished CRMP-2 targeting to the primary cilium without affecting basal body localization.	p(HGNC:GSK3B, var(p.?))	directlyDecreases	act(p(HGNC:DPYSL2))
80762a49-ba60-4219-af14-940437b33a49	1.0	PubMed	18328427	Overexpression of a constitutively active GSK3beta mutant (GSK S9A) via lentiviral infection blocked CD95 induced migration of T98G cells (D).	p(HGNC:GSK3B, var(p.?))	directlyDecreases	act(p(HGNC:FAS))
d47e187d-c762-4d6a-841e-475bc3a6bd83	1.0	PubMed	24577092	Conversely, neutralizing mutations of the GSK3beta consensus enhanced MYOGENIN trans-activation of the muscle creatine kinase promoter, and also reduced the tumorigenic properties of ARMS cells (RH30) in a colony formation assay.	p(HGNC:GSK3B, var(p.?))	directlyDecreases	act(p(HGNC:KIDINS220))
4d719f69-f3a1-4b85-bf6e-309bcf478147	1.0	PubMed	22933777	Introduction of either GSK3beta mutants, GSK3beta-R96A, L128A, or K85M into chick dorsal root ganglion (DRG) neurons suppressed Sema3A induced growth cone collapse, thereby suggesting that unprimed as well as primed substrates are involved in Sema3A signaling.	p(HGNC:GSK3B, var(p.?))	directlyDecreases	act(p(HGNC:SEMA3A))
d65c8115-ba53-442d-9d25-130790ef4778	1.0	PubMed	20599907	In our study we find that GSK3beta-K85A, the kinase dead mutant of GSK3beta can inhibit the transcriptional activity of Smad3 and interact with Smad3 as well as the wild type, demonstrating that the interaction between Smad3 and GSK3beta and the inhibitory effect of GSK3beta on Smad3 are independent on the kinase activity of GSK3beta.	p(HGNC:GSK3B, var(p.?))	directlyDecreases	act(p(HGNC:SMAD3))
b96b50f1-6cb4-420d-95fc-697d3f075579	1.0	PubMed	25712050	HBx also prompted the nuclear accumulation of cyclin D1, and cotransfection of the constitutively active mutant of GSK-3beta along with HBx could reverse the nuclear accumulation and subsequent cell proliferation induced by HBx.	p(HGNC:GSK3B, var(p.?))	directlyDecreases	act(bp(GO:"GO:0008283"))
22c57359-a6a8-4193-89d9-eaf3aaea74f4	1.0	PubMed	25484286	Blocking GSK3beta phosphorylating Dyn1 could enhance the protective effects of BDNF in both neuronal and mouse models of AD.	p(HGNC:GSK3B)	directlyDecreases	act(p(PFAM:PF09793))
ef551a41-0a86-42d9-b912-a6c42752257e	1.0	PubMed	20599907	Both GSK3beta and GSK3beta-K85A inhibited Angiotensin II activation of ANF-luc in H9c2 cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:AGT))
759903e7-ad68-4830-9b81-ab0f2f7c22f2	1.0	PubMed	22209410	As expected TrkB.T1 overexpression alone decreased TrkB signaling, which is most clearly seen as suppression of Akt (protein kinase B) and glycogen synthase kinase 3beta (GSK-3beta) activity (measured as the ratio between the active, phosphorylated form and the total levels of the corresponding protein).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:AKT1))
b9ac7a96-e17c-403d-8e8d-4e925ccc91c2	1.0	PubMed	22814751	This is supported by the data that Akt3 -/- platelets spread on fibrinogen showed a significant reduction in GSK-3beta phosphorylation (XREF_FIG) and that GSK-3beta inhibition by SB216763 was sufficient to completely rescue the defect in Akt3 -/- platelet spreading.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:AKT3))
a54d87b9-34a3-4c12-b48f-1ca998fab5b3	1.0	PubMed	24930764	Here, we showed that GSK3beta activation in MTA treated cells relies on mitochondrial ROS mediated inhibition of upstream Akt.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AKT))
a54d87b9-34a3-4c12-b48f-1ca998fab5b3	1.0	PubMed	27105349	According to the data reported, titration of the classical Akt substrate GSK3beta suppressed the Akt kinase activity on another well characterized Akt substrate, H2B, but had no effect on a typical RS domain containing protein, SRSF1.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AKT))
a54d87b9-34a3-4c12-b48f-1ca998fab5b3	1.0	PubMed	22814751	Inhibition of GSK-3beta reversed the inhibitory effects of Akt3 knockout and inhibitors of Akt or PI3K on platelet spreading, indicating that GSK-3beta is a downstream target of Akt in outside-in signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AKT))
a54d87b9-34a3-4c12-b48f-1ca998fab5b3	1.0	PubMed	22814751	Inhibition of GSK-3beta reversed the inhibitory effects of Akt3 knockout and inhibitors of Akt or PI3K on platelet spreading, indicating that GSK-3beta is a downstream target of Akt in outside-in signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AKT))
a54d87b9-34a3-4c12-b48f-1ca998fab5b3	1.0	PubMed	20920357	Intriguingly, it appeared that silencing of GSK-3alpha somehow favored whereas silencing of GSK-3beta protected against BZ induced AKT and, even more, MCL-1 degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AKT))
a54d87b9-34a3-4c12-b48f-1ca998fab5b3	1.0	PubMed	24239461	As ERK, AKT, and GSK-3beta are important proteins in the generation of an antiapoptotic response in cells, the inactivation of ERK and AKT, and activation of GSK-3beta appears to be accountable for the death by apoptosis of T24 bladder carcinoma cells induced by boldine treatment.PI3K/AKT and MAPK and ERK pathways activation have been regarded as important key players in BC carcinogenesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AKT))
a54d87b9-34a3-4c12-b48f-1ca998fab5b3	1.0	PubMed	18804163	We conclude that GSK-3beta is phosphorylated and inhibited by TPO induced Akt, promoting survival and proliferation in megakaryocytic cells through a pathway that does not involve beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AKT))
674290d6-45df-483b-9ecd-f74392bb9895	1.0	PubMed	26440826	Further analysis revealed that Liver kinase B1 (LKB1) but not Calcium/calmodulin dependent protein kinase kinase beta (CaMKKbeta) is involved in AMPK activation and autophagy induction triggered by GSK-3beta inhibition.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AMPK))
674290d6-45df-483b-9ecd-f74392bb9895	1.0	PubMed	22419736	AK1 plays a role in Abeta (42)-induced impairment of AMPK activity and GSK3beta activation in the primary neurons.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AMPK))
5ba67c2c-1ae9-41bb-890d-a76c49cde023	1.0	PubMed	17437043	Taken together, we conclude that scratching caused a decrease in phosphorylation of GSK3beta, and that reduced phosphorylation of GSK3beta promoted APC protein to bind to the plus ends of microtubules and stabilize the growing ends.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:APC))
5ba67c2c-1ae9-41bb-890d-a76c49cde023	1.0	PubMed	16423286	Implicit in this model is the assumption that GSK3beta activity elsewhere in the cell normally suppresses the association of APC with microtubules.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:APC))
6be9bdbb-e612-4b71-943d-65b55132ffa7	1.0	PubMed	24610780	Our results show that the GSK3beta kinase inhibitors LiCl, SB 216763, and SB 415286 prevent copper responsive APP trafficking.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:APP))
aa7b791d-87c3-4fea-b730-7b76262cae69	1.0	PubMed	20049328	Gsk3beta phosphorylates bmal1 specifically on ser 17 and thr 21 and primes it for ubiquitylation. In the absence of gsk3beta-mediated phosphorylation, bmal1 becomes stabilized and bmal1 dependent circadian gene expression is dampened.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ARNTL))
aa7b791d-87c3-4fea-b730-7b76262cae69	1.0	PubMed	20049328	Gsk3beta phosphorylates bmal1 specifically on ser 17 and thr 21 and primes it for ubiquitylation. In the absence of gsk3beta-mediated phosphorylation, bmal1 becomes stabilized and bmal1 dependent circadian gene expression is dampened.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ARNTL))
675f3acf-a748-4b34-925b-2a5551dbd349	1.0	PubMed	18516299	Inhibition of GSK-3beta Activity Modulates AR Transcriptional Activity To determine the effects of a functional inhibition of GSK-3 on refractory LNCaP subline LNCaP-SSR were treated with different novel pharmacological inhibitors of GSK-3.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:AR))
5e263f2e-04d0-454a-894b-104a1e73dab2	1.0	PubMed	17241872	These results further confirmed that kinase activity of GSK3beta is critically required for Hath1 protein degradation in colon cancer cells.We next examined whether the 2 serine residues found in the putative GSK3beta target region (S54 and S58) are critically required for GSK3beta mediated Hath1 proteolysis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ATOH1))
155f79b1-1151-4c04-a92e-93487106acd8	1.0	PubMed	20122174	Knock-down of GSK-3beta inhibited Axin mediated degradation of beta-catenin and prevented downregulation of TCF-4 in both BE1 and A549 cells (P> 0.05, Figure XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AXIN))
155f79b1-1151-4c04-a92e-93487106acd8	1.0	PubMed	20122174	Knock-down or inhibition of GSK-3beta prevented Axin mediated downregulation of TCF-4.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:AXIN))
edf6e562-a977-463d-9c05-46836845e777	1.0	PubMed	25042702	In conclusion, whereas GSK3-beta inhibition strongly induced BRA and, ACTIVIN and BMP signaling induced them only moderately.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Activin))
a25ea8fa-16a2-4984-aec0-cbc355ad6623	1.0	PubMed	6443737	Angiogenesis was inhibited by GSK3beta activation in an in vivo Matrigel plug assay, whereas the inhibition of GSK3beta signaling enhanced capillary formation.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
a25ea8fa-16a2-4984-aec0-cbc355ad6623	1.0	PubMed	12167628	Angiogenesis was inhibited by GSK3beta activation in an in vivo Matrigel plug assay, whereas the inhibition of GSK3beta signaling enhanced capillary formation.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
c2226e42-1193-4689-afcd-68a65e3baac9	1.0	PubMed	22286758	Together, these results demonstrate that PUMA induction by sorafenib is mediated by ERK inhibition, relief of GSK3beta inhibition, and subsequent p65 activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BBC3))
c2226e42-1193-4689-afcd-68a65e3baac9	1.0	PubMed	21658600	Combined knock-down of GSK-3alpha and GSK-3beta by siRNA substantially diminished PUMA protein (XREF_FIG, compare lanes 2 and 4) and mRNA levels (XREF_SUPPLEMENTARY), and similar results were obtaind by shRNA mediated knockdown of GSK-3alpha and GSK-3beta (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BBC3))
d6a452ce-ce2f-41fe-9d9d-8e7bf2faa78b	1.0	PubMed	21795403	GSK3beta inactivation inhibits the activation of the survival genes Bcl2 and survivin by c-Myb and LEF-1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BCL2))
e81fbb1d-e94a-47e0-9d7f-2af5ac495295	1.0	PubMed	25484286	Blocking GSK3beta phosphorylating Dyn1 could enhance the protective effects of BDNF in both neuronal and mouse models of AD.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BDNF))
e81fbb1d-e94a-47e0-9d7f-2af5ac495295	1.0	PubMed	25484286	Our previous results revealed that inhibiting GSK3beta phosphorylating Dyn1 could enhance the neuroprotective effects of BDNF in vitro.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BDNF))
e81fbb1d-e94a-47e0-9d7f-2af5ac495295	1.0	PubMed	25484286	By cleavable surface biotinylation internalization assay, we found that BNDF induced biotinylated TrkB endocytosis in the AR-A014418 treated neurons was significantly increased compared with the control group (C, D), which suggested that inhibition of GSK3beta activity could promote BDNF dependent TrkB endocytosis.To exclude the nonspecific effects of AR-A014418, we used two GSK3beta mutants (S9A, R96A) to further testify our previous results.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BDNF))
e81fbb1d-e94a-47e0-9d7f-2af5ac495295	1.0	PubMed	16507111	To further reinforce this finding, expression of a constitutively-active GSK3beta construct (S9A), which is resistant to inactivation by Akt, prevented BDNF induction of Notch responsiveness.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BDNF))
4d8a544a-5e67-4722-b36f-c77e6592900f	1.0	PubMed	21795403	GSK3beta inactivation inhibits the activation of the survival genes Bcl2 and survivin by c-Myb and LEF-1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BIRC5))
a9d1e158-a075-4dae-ad00-8f4950427805	1.0	PubMed	25042702	In conclusion, whereas GSK3-beta inhibition strongly induced BRA and, ACTIVIN and BMP signaling induced them only moderately.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:BMP))
de00b79d-ba36-47d7-89b2-71fd4cd2a3a5	1.0	PubMed	26274564	We previously found that Wnt simulation induces monoubiquitination of GSK3beta by beta-TrCP, which is required for Wnt induced inhibition of beta-catenin recruitment of beta-TrCP and subsequent stabilization of beta-catenin (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BTRC))
de00b79d-ba36-47d7-89b2-71fd4cd2a3a5	1.0	PubMed	24451375	Rather, increased monoubiquitination of Gsk3beta and Gsk3beta-beta-TrCP association suppressed beta-catenin recruitment of beta-TrCP, leading to long-term inhibition of beta-catenin ubiquitination and degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:BTRC))
ddcf5a35-62ab-484c-b7fc-77c78223cb63	1.0	PubMed	19303846	While GSK3beta overexpression reduced the number of BrdU labeled cells (XREF_SUPPLEMENTARY), this was suppressed by DISC1 coexpression.	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:6035))
1e242d8d-e5e0-40db-8c7d-40a71d1e38a6	1.0	PubMed	21887250	Since inhibiting the PI3K and Akt cascade resulted in decreased phosphorylation of GSK3beta Ser9 and increased MN differentiation from hNSCs, we then asked if the increase in HB9 expression was due to the increase in GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CA9))
9784ae20-7ee6-4294-b94d-7738a1043bfd	1.0	PubMed	22778263	Cdk5 and gsk3 phosphorylate ser-129, ser-133, and ser-137. Mutation of ser-129, ser-133, and ser-137 increases autonomous activity with little change in ca2 /cam-dependent activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CAMKK2))
9784ae20-7ee6-4294-b94d-7738a1043bfd	1.0	PubMed	22778263	Cdk5 and gsk3 phosphorylate ser-129, ser-133, and ser-137. Mutation of ser-129, ser-133, and ser-137 increases autonomous activity with little change in ca2 /cam-dependent activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CAMKK2))
9784ae20-7ee6-4294-b94d-7738a1043bfd	1.0	PubMed	22778263	Cdk5 and gsk3 phosphorylate ser-129, ser-133, and ser-137. Mutation of ser-129, ser-133, and ser-137 increases autonomous activity with little change in ca2 /cam-dependent activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CAMKK2))
dd33e61a-ff63-41d1-bc01-8bcfbd3e1176	1.0	PubMed	20357815	These results suggest that GSK-3 activity and/or other factors that may be regulated by cAMP and PKA pathway are required at least up to 8hours post-treatment for efficient induction of MMP-1 by TNF-alpha in human skin fibroblasts.To examine whether cAMP mediated but ERK- and JNK independent suppression of MMP-1 expression was mainly mediated by inhibition of GSK-3beta, we transiently transfected human skin fibroblasts with the control vector only or the vector containing either the wild-type or a constitutively active form of GSK-3beta for 24hours.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:17489))
4e812600-6e56-413d-b241-47e55c9e6e4d	1.0	PubMed	7088620	AM gene transfer increased phosphorylation of Akt and glycogen synthase kinase (GSK-3beta) but reduced GSK-3beta and caspase-3 activities in the heart.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CASP3))
506d286d-0182-4a12-9cd3-d9b148d5f2d7	1.0	PubMed	16504004	Phosphorylation of cyclin d1 on a single threonine residue near the carboxyl terminus (thr-286) positively regulates proteasomal degradation of d1. Now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CCND1))
506d286d-0182-4a12-9cd3-d9b148d5f2d7	1.0	PubMed	9832503	Phosphorylation of cyclin d1 on a single threonine residue near the carboxyl terminus (thr-286) positively regulates proteasomal degradation of d1. Now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CCND1))
c715231b-33ef-4f09-8dce-b0eec3f0da76	1.0	PubMed	17486076	Glycogen synthase kinase-3beta and p38 phosphorylate cyclin d2 on thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CCND2))
39d820ca-aefa-4a33-babe-fa1185dc7461	1.0	PubMed	16331257	We have previously shown that both basal and camp-induced degradation of cyclin d3 in reh cells is dependent on thr-283 phosphorylation by glycogen synthase kinase-3beta (gsk-3beta).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CCND3))
895145e8-aedc-4c46-8508-f53e68787f05	1.0	PubMed	14536078	Our experiments suggest that gsk3 is the kinase primarily responsible for phosphorylation of cyclin e on t380	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CCNE1))
895145e8-aedc-4c46-8508-f53e68787f05	1.0	PubMed	14536078	Our experiments suggest that gsk3 is the kinase primarily responsible for phosphorylation of cyclin e on t380	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CCNE1))
d030fd83-5018-44f4-88ea-0aa5573b023a	1.0	PubMed	26022178	Similarly, GSK-3beta knockdown significantly enhanced the secretion of IFN-gamma via NKG2D and 2B4 combination and of MIP-1alpha in response to NKG2D, 2B4, or both (C).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CD244))
ca9055fd-8623-413c-b8f6-fcd904d323cf	1.0	PubMed	27572267	We show that glycogen synthase kinase 3beta (GSK3beta) interacts with PD-L1 and induces phosphorylation dependent proteasome degradation of PD-L1 by beta-TrCP.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CD274))
ca9055fd-8623-413c-b8f6-fcd904d323cf	1.0	PubMed	27572267	Non glycosylated PD-L1 with mutation of this motif (LSGKTT to LAGKTT, PD-L1 S176A) resisted to GSK3beta mediated PD-L1 degradation (XREF_SUPPLEMENTARY) as GSK3beta failed to degrade PD-L1 4NQ S176A mutant.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CD274))
ca9055fd-8623-413c-b8f6-fcd904d323cf	1.0	PubMed	27572267	In fact, the impact of GSK3beta mediated PD-L1 degradation can be found in both glycosylated and non glycosylated PD-L1 as both PD-L1 3SA and PD-L1 4NQ/3SA exhibit better stability (XREF_SUPPLEMENTARY) and lesser ubiquitination (XREF_SUPPLEMENTARY) in both WT and 4NQ backgrounds.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CD274))
7a63f79e-7f70-49ed-8bbb-9d520c538f20	1.0	PubMed	19050253	Furthermore, GSK3beta inactivated memory CD4 (+) T cells acquired the capacity to suppress the bystander proliferation of CD4 (+) T cells in an IL-10-dependent, cell contact independent manner.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CD4))
7a63f79e-7f70-49ed-8bbb-9d520c538f20	1.0	PubMed	19734233	Moreover, ectopic expression of a constitutively active form of GSK3beta abrogated the ability of IL-12p70 to increase IL-10 production by TCR stimulated CD4 + T cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CD4))
7a63f79e-7f70-49ed-8bbb-9d520c538f20	1.0	PubMed	19734233	In contrast, active GSK3beta in human memory CD4 + T cells was found to suppress the IL-10 recall response of human memory CD4 + T cells upon TCR stimulation (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CD4))
7070d98d-27ff-476b-b98e-e095f547a1b0	1.0	PubMed	18167338	Moreover, GSK-3beta inhibition also prolonged the half-life of Cdc25A in cells exposed to ionizing radiation (IR) (C and 2D).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDC25A))
7070d98d-27ff-476b-b98e-e095f547a1b0	1.0	PubMed	18167338	Several experiments were performed to determine if GSK-3beta negatively regulates Cdc25A in vivo.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDC25A))
7070d98d-27ff-476b-b98e-e095f547a1b0	1.0	PubMed	18167338	Taken together, these results suggest that GSK-3beta negatively regulates Cdc25A abundance in vivo.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDC25A))
e9861e6c-53ff-4660-b3ec-33918dcdfc3c	1.0	PubMed	20849862	Moreover, microtubule staining of MVECs in monolayer culture showed that GSK-3beta inhibitor-I enhanced microtubule polymerization similarly to active Cdc42 and rescued microtubule polymerization in cells transduced with DN Cdc42 (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDC42))
95d5eaa7-c5d4-4c47-938b-0aa55601456e	1.0	PubMed	19274078	Inactivation of GSK3beta with lithium chloride or the GSK3 inhibitor BIO and GSK3beta knockdown with siRNA repressed cadherin-11 mRNA and protein levels.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDH11))
ff3ee8b8-9a70-4e87-88cc-70e4584dbda9	1.0	PubMed	24901051	GSK3beta has been shown to inhibit EMT by targeting Snail for proteasomal degradation, thus releasing E-cadherin from transcriptional repression by Snail and promoting metastasis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDH1))
ff3ee8b8-9a70-4e87-88cc-70e4584dbda9	1.0	PubMed	25153349	Recently, it has been reported in colon cancer cells that GSK-3beta induced by NDRG2 overexpression causes the transcriptional de-repression of E-cadherin through the proteasomal degradation of Snail.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDH1))
fe8afe9d-fd5a-44fb-9b27-aae78b7ee70b	1.0	PubMed	19830702	GSKIP, an inhibitor of GSK3beta, mediates the N-cadherin and beta-catenin pool in the differentiation of SH-SY5Y cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDH2))
cbbd3794-4d19-49f2-9af9-6095923e85a1	1.0	PubMed	25149538	GSK3beta mediates CDK1 degradation induced by proteasome inhibition.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDK1))
cbbd3794-4d19-49f2-9af9-6095923e85a1	1.0	PubMed	25149538	To investigate whether GSK3beta mediates CDK1 degradation after LLnL treatment, we interfered HeLa cells and found that GSK3beta depletion impedes the lysosomal destruction of CDK1 (Fig XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDK1))
cbbd3794-4d19-49f2-9af9-6095923e85a1	1.0	PubMed	25149538	To investigate whether GSK3beta mediates CDK1 degradation after LLnL treatment, we interfered HeLa cells and found that GSK3beta depletion impedes the lysosomal destruction of CDK1 (Fig XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDK1))
119722e8-e3ab-468f-a5ae-9ba2c4c285ca	1.0	PubMed	23085750	GSK3beta increases KLF6 mediated transactivation of p21 and growth suppression.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CDKN1A))
38885bce-4e43-46dd-8b8d-fa0999d8896b	1.0	PubMed	26374165	Consistently, overexpression of GSK-3beta in HUVEC (confirmed by western blotting; XREF_SUPPLEMENTARY) led to diminished occupancy of C/EBPbeta at the EDIL3 promoter region relative to cells transfected with control vector (XREF_FIG, last two lanes).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CEBPB))
38885bce-4e43-46dd-8b8d-fa0999d8896b	1.0	PubMed	26374165	Consistently, overexpression of GSK-3beta in HUVEC (confirmed by western blotting; XREF_SUPPLEMENTARY) led to diminished occupancy of C/EBPbeta at the EDIL3 promoter region relative to cells transfected with control vector (XREF_FIG, last two lanes).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CEBPB))
34423032-a134-4bfb-a2a2-5d55bef97e14	1.0	PubMed	24155666	The discovery that GSK-3beta can promote the degradation of C/EBPdelta therefore opens up new avenues for investigation into the cross-talk between signaling pathways and the regulation of the innate immune response and inflammation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CEBPD))
7ced637d-7011-4b90-afcd-f25c473209bd	1.0	PubMed	18167338	Furthermore, Chk1 inhibition decreased T80A ubiquitination to the levelobserved for S76A (D, compare lanes 8 and 10), and inhibition of Chk1, but not GSK-3beta, extended the half-life of T80A (B).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CHEK1))
7ced637d-7011-4b90-afcd-f25c473209bd	1.0	PubMed	18167338	These results demonstrate that although T80A is insensitive to GSK-3beta inhibition in vivo, it retains sensitivity to Chk1 inhibition.To monitor the regulation of Cdc25A by GSK-3beta and Chk1 throughout the cell division cycle, synchronized cells were treated with LiCl to inhibit GSK-3beta or with Go6976 to inhibit Chk1, and Cdc25A levels were examined by western blotting (A).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CHEK1))
38b90aa8-c3ed-4af1-9b1b-164620576570	1.0	PubMed	23107073	Consistent with GSK3beta acting as a negative regulator of CLASP function, inhibition of GSK3beta activity enhances T. cruzi entry in a CLASP1 dependent manner and expression of constitutively active GSK3beta dampens infection.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CLASP1))
38b90aa8-c3ed-4af1-9b1b-164620576570	1.0	PubMed	23107073	While the majority of the work characterizing these interactions have been focused on CLASP2, homology between CLASP1 and CLASP2 and the conservation of putative GSK3beta phosphorylation sites, suggests that CLASP1 is also negatively regulated by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CLASP1))
38b90aa8-c3ed-4af1-9b1b-164620576570	1.0	PubMed	23107073	Consistent with a role for GSK3beta dependent inhibition of CLASP1, inhibition of GSK3beta activity enhances T. cruzi entry in a CLASP1 dependent manner, whereas expression of constitutively active GSK3beta dampens infection.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CLASP1))
b44e4143-cf9d-499b-a301-4f61ed386e91	1.0	PubMed	19289791	This indicates that GSK3beta phosphorylation of either motif is sufficient to inhibit the CLASP2 plus end tracking domain.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CLASP2))
b44e4143-cf9d-499b-a301-4f61ed386e91	1.0	PubMed	19289791	GSK3beta phosphorylation directly inhibits the CLASP2 plus end tracking domain.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CLASP2))
b44e4143-cf9d-499b-a301-4f61ed386e91	1.0	PubMed	19289791	Only complete phosphorylation of both GSK3beta motifs in the presence of elevated GSK3beta activity disrupted CLASP2 (340-1,084) plus end tracking, and it remains to be determined whether this occurs under physiological conditions.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CLASP2))
fc0e0488-216a-4ca9-80ed-a4455f38a0fa	1.0	PubMed	26822534	The ectopic upregulation of miR-224 dramatically inhibited the expression of GSK3beta and SFRP2 and enhanced CRC proliferation and invasion.	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q8L925))
13064383-0221-484b-9e14-2dd957f75665	1.0	PubMed	20008284	According to this model, GSK3beta inhibition would increase CREB activation allowing CREB to compete with the p65 subunit of NF-kappaB for binding to CBP.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:CREB))
13064383-0221-484b-9e14-2dd957f75665	1.0	PubMed	25887375	GSK3beta inactivates CREB via the direct phosphorylation of ser 129, as well as the indirect de-phosphorylation of ser 133.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:CREB))
13064383-0221-484b-9e14-2dd957f75665	1.0	PubMed	27049759	CREB DNA binding activity is inhibited by GSK-3beta overexpression and increased by lithium or sodium valproate which are GSK-3 inhibitors in human neuroblastoma cells [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:CREB))
13064383-0221-484b-9e14-2dd957f75665	1.0	PubMed	16756720	CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:CREB))
13064383-0221-484b-9e14-2dd957f75665	1.0	PubMed	17628506	Active GSK3B strongly inhibits CREB activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:CREB))
5af6ac7b-814f-4f31-9282-88ed2955f106	1.0	PubMed	23959174	Snail expression is suppressed by glycogen synthase kinase-3beta (GSK3beta) at transcriptional and post-transcriptional levels XREF_BIBR XREF_BIBR, and the inhibition of GSK3beta by small molecules induces EMT and promotes CSC phenotypes in breast cancer XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D014411))
5af6ac7b-814f-4f31-9282-88ed2955f106	1.0	PubMed	23959174	Several studies show that GSK3beta suppresses Snail expression at transcriptional and post-transcriptional levels XREF_BIBR XREF_BIBR, and the inhibition of GSK3beta by small molecules induces EMT and promotes CSC phenotypes in breast cancer XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D014411))
5af6ac7b-814f-4f31-9282-88ed2955f106	1.0	PubMed	23959174	While GSK3beta promotes ubiquitin-proteasome pathway mediated beta-catenin degradation XREF_BIBR and suppresses Snail expression at transcriptional and post-transcriptional levels XREF_BIBR XREF_BIBR, it is unclear how GSK3beta suppresses CSC tumorigenesis and metastasis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D014411))
5af6ac7b-814f-4f31-9282-88ed2955f106	1.0	PubMed	25056574	While we did not define the precise molecular mechanisms by which Nestin promoted the Wnt and beta-catenin activation in breast CSC, our data clearly indicated that spontaneous Wnt and beta-catenin activation was crucial for Nestin to promote CSC proliferation, which was negatively regulated by GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D014411))
20ae71f3-1e45-4dd3-ab1b-07f9f94dcc9d	1.0	PubMed	23820376	Because alleviated levels of GSK3beta eliminated G-CSFR and we hypothesized that GSK3 may phosphorylate G-CSFR in its CPDs for its recognition by Fbw7, we therefore assessed if GSK3beta mediated downregulation of G-CSFR is dependent on Fbw7.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CSF3R))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	16293724	This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	23151663	Beta-catenin phosphorylation in vivo is sequentially carried out by two distinct kinases, ckialfa and gsk-3. Ckialfa phosphorylation of s45 proceeds and is required for subsequent gsk-3 phosphorylation of t41, s37, and s33 one key substrate of gsk3 is the transcriptional co-activator beta catenin, whichis inactivated by gsk3 mediated phosphorylation and targeted for proteasomal degradation in unstimulated cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	11955436	Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19303846	DISC1 inhibits GSK3beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19303846	DISC1 inhibits GSK3beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	16293724	This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	11955436	Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22470507	Previous studies have shown that the inhibition of GSK-3beta promoted the accumulation of beta-catenin in the nucleus XREF_BIBR and at the plasma membrane XREF_BIBR, XREF_BIBR, which our data confirmed.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25721268	When the Wnt pathway is activated, cytoplasmic beta-catenin is no longer degraded by GSK3beta, and large amount of beta-catenin translocates to the nucleus, where it interacts with lymphoid enhancer and T-cell transcription factors (TCF/LEF) and cAMP response element binding protein binding protein (CBP), thereby regulating the transcription of genes such as E-cadherin, MMP or VEGF XREF_BIBR XREF_BIBR XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	23151663	Beta-catenin phosphorylation in vivo is sequentially carried out by two distinct kinases, ckialfa and gsk-3. Ckialfa phosphorylation of s45 proceeds and is required for subsequent gsk-3 phosphorylation of t41, s37, and s33 one key substrate of gsk3 is the transcriptional co-activator beta catenin, whichis inactivated by gsk3 mediated phosphorylation and targeted for proteasomal degradation in unstimulated cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19303846	DISC1 inhibits GSK3beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	16293724	This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	23720015	GSK3beta promotes the ubiquitin-proteasome degradation of beta-catenin by phosphorylating three specific amino acids, Ser33/Ser37/Thr41, on beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26001136	Canonical Wnt signaling was repressed following miR-148a expression, as indicated by the marked reduction of Wnt1 protein (XREF_FIG, Day 0), increased phosphorylation of GSK-3beta (p-GSK-3beta) (XREF_FIG, Day 10), and reduced nuclear beta-catenin (XREF_FIG, Day 10).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26888362	A multi protein complex that includes adenomatous polyposis coli (APC) and glycogen synthase kinase-3 beta (GSK3 beta) promotes the degradation of beta-catenin thus controls the levels of free beta-catenin in cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25152363	Previous studies have shown that inhibition of glycogen synthase kinase 3 (GSK3beta) signaling induces beta-catenin transcriptional activity resulting in cell cycle progression [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	6070273	We conclude that PS1 negatively regulates the stability and transcriptional activity of beta-catenin at different levels in the Wnt pathway, that the effect on transcriptional activity appears to be independent of the GSK-3beta mediated degradation of beta-catenin, and that mutations in PS1 differentially affect the stability and transcriptional activity of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25026278	The simplest explanation would be that there is a cooperative effect between h-Prune and the other drugs used here, for the inhibition of beta-catenin degradation by Gsk-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	24136230	Using LiCl as a well-known chemical activator of the Wnt pathway, XREF_BIBR, XREF_BIBR which negatively regulates GSK3beta inhibition of beta-catenin, 37 it was possible to rescue the adverse phenotype in nipblb-MO-injected embryos at all levels : anatomical cephalic structures appeared morphologically normal, the programmed cell death levels were restored to physiological levels seen in controls, and Ccnd1 protein levels were increased.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	27572267	Inhibition of GSK3beta allows beta-catenin to translocate to the nucleus, form complexes with T-cell factor and lymphoid enhancer factor and thereby activates target gene expression XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25360740	This implies that GSK3beta independent or suppressed regulation might play a prominent role in EGF induced beta-catenin transactivation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22692453	In order to maintain IEC homeostasis, intracellular Wingless-Int (Wnt) signaling cascades act to regulate glycogen synthase kinase 3beta (GSK3beta)-dependent proteosomal degradation of beta-catenin XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22692453	GSK3- beta is then free to inhibit beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22692453	However, GBP-1 appears to represses beta- catenin through a different mechanism, as GSK3-beta and proteasomal inhibition was unable to rescue the loss of beta-catenin and TCF activity (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19148484	The loss of APC and GSK3-beta did not lead to augmentation of the Wnt target protein cyclin D1 or the Wnt oncoprotein beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25285168	The Glycogen synthase kinase 3-beta (GSK-3beta) may inhibit the translation of beta-catenin in Wnt and beta-catenin pathway by phosphorylation and degradation of beta-catenin XREF_BIBR, and the GSK-3beta is negatively regulated by AKT2 XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25532422	The process of generation of HPV-16-associated cervical tumorigenesis is synergized with GSK3beta inactivation and overactivation of Wnt and beta-catenin pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	18986540	In our cultures, application of LiCl, an inhibitor of GSK3beta, produced a strong increase in the intensity of ' active ' beta-catenin in both the nucleus and soma, verifying the effectiveness of the antibody (Additional file XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	21383695	Degradation of beta-catenin was inhibited by pretreatment of a proteasomal inhibitor, MG132 or lactacystin (XREF_FIG), but inhibition of GSK3beta had almost no effect on TNF induced beta-catenin degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26631736	Lithium chloride inhibition of GSK-3beta increased nuclear beta-catenin content and normalized nuclear PPAR-gamma in Ob-MSCs.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	5329194	We propose a model in which inhibition of GSK3beta activity upon Wnt signaling leads to the dephosphorylation of GSK3beta sites in Axin, resulting in the release of beta-catenin from the phosphorylation complex.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25500144	Moreover, inhibition of p-GSK3beta by a dominant-inhibitory S9A-GSK-3beta mutant impaired not only CCRK induced beta-catenin activation, but also EZH2 and H3K27me3 (A, right).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19823589	In the Wnt and beta-catenin pathway GSK3beta mediates beta-catenin degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	23673211	Our previous studies showed that the decreased cytoplasmic levels of activated GSK-3beta resulted in activation of Wnt and beta-catenin signaling and increased expression of survivin, a target gene of the Wnt and beta-catenin signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	23673211	Inhibition of cytoplasmic GSK-3beta activity may activate the Wnt and beta-catenin signaling pathway and subsequent upregulate its target genes, including survivin, and may play a critical role in the development of cisplatin resistance in NSCLC.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25150829	In turn, repression of GSK3beta led to up-regulated beta-catenin levels (A).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26359353	Both GSK-3beta and Nur77 mediate beta-catenin degradation, suggesting a role of NDRG1 in beta-catenin regulation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19237607	Our data show that NDRG2 introduction into SW620 cells induces a decrease in GSK-3beta phosphorylation, which increases its kinase activity (XREF_FIG) and subsequently induces beta-catenin downregulation (XREF_FIG and XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19190323	These results suggest that galectin-3 mediates Wnt signaling, at least in part, by regulating GSK-3beta phosphorylation and activity via the PI3K and AKT pathway, and thus the degradation of beta-catenin in colon cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25431208	In SW480 cells, GSK3beta does not degrade beta-catenin due to a lack of APC [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	27129219	LiCl and SB415286 are specific inhibitors of GSK3beta, which can inhibit Wnt and beta-catenin signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	20064927	beta-Catenin can be degraded by GSK3beta dependent and GSK3beta independent proteasomal pathways (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	5120420	Mutant HOS which lacks the F-box blocked TNF alpha induced degradation of IkappaB as well as GSK3beta mediated degradation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	24403311	Inhibition of GSK3beta rescues Wnt and beta-catenin pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	24403311	The promoting effect of alpha6A on the expression of the active and nuclear form of beta-catenin and the fact that inhibition of GSK3beta could rescue the activity of the Wnt and beta-catenin pathway suggest that alpha6A could interfere with a signalling event upstream to GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	24403311	Indeed, based on the observations that down-regulation of alpha6A levels results in a reduction of the relative amounts of both active (evaluated as the non GSK3beta phosphorylated form) and nuclear beta-catenin, whereas the pharmacological inhibition of GSK3beta restored the activity of the Wnt and beta-catenin pathway as evaluated by TOPflash assays and the modulation of specific target genes including LGR5 and CCD2, we suggest that alpha6A interferes with the activity of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26862060	The LecB induced inhibitory phosphorylation of GSK-3beta would be expected to cause an accumulation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26862060	These experiments argue for an importance of GSK-3beta activity for LecB induced beta-catenin degradation, whereas the inhibitory effect of Akt on GSK-3beta may be blocked or circumvented by LecB.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26547035	Previous studies have shown that GSK-3beta degrades multifunctional oncogenic beta-catenin through phosphorylation in cytoplasm and that the phosphorylation and accumulation of beta-catenin are important for tumorigenesis and cancer progression.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25499972	Thus BAD inactivates AKT, which may activate GSK-3beta (XREF_FIG) causing reduction of beta-catenin (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25426554	On the other hand, treatment with LiCl, a potent inhibitor of GSK3beta dependent degradation of beta-catenin resulted in a substantial and comparable induction of the transcriptional response in all cases.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25412261	Indeed, the quantitative data of Western blotting showed that GSK-3beta was significantly (P < 0.01) inhibited by phosphorylation at Ser9 XREF_BIBR in DENV infected THP-1 cells (XREF_FIG, upper panel); this GSK-3beta inhibition was also accompanied by an accumulation of beta-catenin and Mcl-1 protein, substrates that are negatively regulated by GSK-3beta XREF_BIBR, XREF_BIBR (XREF_FIG, lower panel).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	18606491	In a mouse model of mammary tumorigenesis, inhibition of GSK3beta by overexpression of kinase-inactive GSK3beta in mouse mammary glands promotes mammary tumorigenesis; this is accompanied by the over-expression of beta-catenin and cyclin D1, supporting that GSK3beta inhibition causes dysregulation of the Wnt and beta-catenin pathway which results in tumor promotion.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	24882689	Upon Wnt ligand binding to a receptor of the Frizzled family, GSK-3beta is inactivated, allowing beta-catenin to accumulate and to translocate into the nucleus to induce Wnt target gene expression together with TCF (T cell factor)/LEF (lymphoid enhancer factor) transcription factors.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25662052	Eventually inhibition of GSK3beta causes accumulation of beta-catenin in cytoplasm and its passover to the nucleus.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	21118991	Next, we tested the effect of GSK-3beta repression on EDD induced beta-catenin activity using the luciferase pTOPFLASH and pFOPFLASH assay (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25691573	Taken together, our results demonstrated a molecular mechanism by which glucose deprivation could induce the GSK3beta independent degradation of beta-catenin protein, leading to autophagy.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25691573	In addition, the beta-catenin pathway can be negatively regulated by Wnt5a signaling in a GSK3beta independent manner (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25691573	Specifically, Wnt5a was reported to promote GSK3beta independent degradation of beta-catenin in the regulation of limb development (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	20849862	Thus, the relationship between GSK-3beta inhibition and stability of beta-catenin also warrants further investigation in the context of VEGF and pathological neovascularization.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	21321938	Following phosphorylation on Ser9, GSK3beta is degraded by the proteasome pathway, thus releasing beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	24910204	Our results suggest that PCDH20 induces Erks and Akt mediated activation of GSK-3beta, which in turn inhibits Wnt and beta-catenin signalling and leads to inhibition of HCC growth and migration.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22115830	However, in the presence of Wnt ligand, GSK3beta is inhibited resulting in accumulation of cytoplasmic beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19850036	GSK-3beta has been shown to promote degradation of beta-Catenin through N-terminal phosphorylation on serine 33, serine 37 and threonine 41 leading to beta-Catenin ubiquitination, and subsequent targeting to the proteosome where it is degraded [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22735579	This connection is further reinforced by the observation that the molecular interaction between the Peg3 N-terminal domain and beta-catenin is the basis for the GSK3beta independent antagonism of beta-catenin signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26219398	In this study, knocking down TACC3 increased p-GSK3beta levels, which then suppressed beta-catenin activation, leading to reduced c-Myc and cyclin D1 levels.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	17950943	In addition, glycogen synthase kinase-3beta (GSK-3beta) contributes to the degradation of beta-catenin and represses beta-catenin and Tcf signaling, while the activity of NF-kappaB is enhanced by GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	23911749	The inhibition of GSK3beta in turn induced the nuclear accumulation of beta-catenin (A) and transactivation of Tcf/Lef (B).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26723972	As a result, the complex of GSK-3beta, APC and axin2 failed to degrade beta-catenin, which was the key substance in the Wnt signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19429245	After co-transfected GSK3betaS9A with the Tcf luciferase reporter plasmids followed by CSE treatment, we examined the luciferase activity of pGL3-OT and found that beta-catenin and Tcf transcription activity induced by CSE was abolished by GSK3beta over-expression () (9285 +/-2945 in GSK3betaS9A+ CSE treatment group 20,764 +/-1801 in CSE treatment group, < 0.01).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19429245	These indicated that the over-expression of active GSK3beta promoted the degradation of beta-catenin in alveolar epithelial cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19429245	We demonstrated that active GSK3beta significantly inhibited beta-catenin and TCF transcriptional activity induced by CSE.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	20492734	For example, expressions of beta-catenin proteins decreased in the brains of schizophrenia patients, presumably due to aberrant regulation of beta-catenin degradation mediated by activated GSK-3beta [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	27012187	Because the components AXIN and GSK3beta induce the degradation of beta-catenin, the interaction between hnRNP-K and beta-catenin, AXIN2, and GSK3beta suggested that hnRNP-K might protect beta-catenin from degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	27012187	Because AXIN2 and GSK3beta increase the degradation of beta-catenin, the interaction between hnRNP-K and beta-catenin, AXIN2, and GSK3beta suggest that hnRNP-K may protect beta-catenin from degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	20140245	These results indicate that PDH induction and PKM2 repression by NEFH are mediated through Gsk3beta mediated degradation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	20140245	These results suggest that Gsk3beta dependent degradation of beta-catenin contributes at least part to the tumor suppressive role of NEFH.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	19830702	GSKIP, an inhibitor of GSK3beta, mediates the N-cadherin and beta-catenin pool in the differentiation of SH-SY5Y cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	21411632	The membrane association of Axin and GSK3beta disrupts the beta-catenin destruction complex, resulting in accumulation of beta-catenin in the nucleus, where it triggers target gene activation by displacing transcriptional repressors from DNA bound lymphoid enhancer factor (LEF)/T-cell factor (TCF) (Behrens et al., XREF_BIBR; Brunner et al., XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	12969793	Our results suggest that the phosphorylation of GSK-3beta at Ser9 could have contributed to the reduced ability of GSK-3beta to cause the degradation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	15454084	In the absence of Wnt signaling, beta-catenin is synthesized but rapidly degraded due to phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26341138	For example, downregulation of GSK3B significantly suppresses metastasis by inactivating the Wnt and beta-catenin axis at the epithelial-mesenchymal transition (EMT) in HCC cells () and TGF-beta affect the EMT via distinct mechanisms ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22028766	As shown in XREF_FIG, Ser 9 phosphorylation of GSK3beta was significantly decreased in the shNRP-2 cells, indicating that in these cells there were increased levels of active GSK3beta protein, which promotes beta-catenin degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25909283	Fibulin-5 impedes Wnt and beta-catenin signaling by inhibiting extracellular signal regulated kinase (ERK) to activate glycogen synthase kinase-3 beta (GSK3beta), which downregulates beta-catenin and prevents its nuclear accumulation, leading to suppression of MMP-7 and c-Myc expression.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22710759	beta-catenin is degraded by GSK3beta, an enzyme inactivated via phosphorylation of its serine 9 residue by upstream kinase Akt (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26274564	We previously found that Wnt simulation induces monoubiquitination of GSK3beta by beta-TrCP, which is required for Wnt induced inhibition of beta-catenin recruitment of beta-TrCP and subsequent stabilization of beta-catenin (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	21247902	These results showed that NDRG2 diminishes the phosphorylation of GSK-3beta, which enhances its kinase activity, and subsequently down-regulates beta-catenin in SW620 cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	7164275	Inhibition of GSK-3beta by DVL increases beta-catenin stability and TCF transcriptional activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	17972518	Glycogen synthase kinase-3beta (GSK3beta), serine/threonine protein kinase, has been reported to repress the Wnt and beta-catenin pathway and regulate the balance between cellular proliferation and apoptosis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25829335	Studies have demonstrated that GSK-3beta also is involved in the regulation of TGF-beta, as inhibition of GSK-3beta promotes beta-catenin signaling, which causes TGFbeta1 to antagonize the production of a number of pro inflammatory cytokines.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25829335	In addition, recent studies show that inhibition of GSK-3beta increased the anti-inflammatory effects of Tregs simply by increasing beta-catenin stages in response to TGFbeta1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25829335	On the other hand, GSK-3beta plays role as a negative regulator for tumorigenesis processes, over-inhibition of GSK-3beta activity could cause the wnt and beta-catenin signaling pathway to be over-activated and potentially promoting oncogenesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25940701	Thus, these findings suggest that DACH1 could suppress the hepatocellular carcinoma growth through inhibition on Wnt signaling, which might be mediated by phosphorylation of GSK3beta to suppress the activation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25940701	Thus, these findings suggest that DACH1 could suppress the hepatocellular carcinoma growth through inhibition on Wnt signaling, which might be mediated by phosphorylation of GSK3beta to suppress the activation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	22535304	In the absence of Wnt signaling, beta-catenin is constantly degraded in cytoplasm due to phosphorylation by GSK3beta (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	23605563	This is consistent with previous reports showing that : i) GSK3beta activity is required to enable PPARgamma dependent beta-catenin degradation during pre-adipocyte differentiation [XREF_BIBR]; ii) inhibition of GSK3beta activity, restricted to the early step of differentiation, is sufficient to impair adipogenic differentiation of human adipose derived stem cells [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	10321728	Mutant HOS which lacks the F-box blocked TNF alpha induced degradation of IkappaB as well as GSK3beta mediated degradation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	20815877	This protein is an inhibitor of GSK-3beta, thus preventing the degradation of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	10581160	We propose a model in which inhibition of GSK3beta activity upon Wnt signaling leads to the dephosphorylation of GSK3beta sites in Axin, resulting in the release of beta-catenin from the phosphorylation complex.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	17601559	beta-Catenin is degraded through the ubiquitin proteasome pathway after dissociation of the complex by phosphorylation of GSK-3beta (through the Wnt signaling protein Dishevelled).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26522132	Since GSK-3beta induces beta-catenin proteasomal degradation via Ser33/37 phosphorylation, these results are in line with an impaired degradation of beta-catenin, which levels we found to be increased.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	26522132	It is known that GSK3beta inhibition promotes beta-catenin stabilization and transcriptional activity, including EGFR gene expression ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25596747	These results indicate that inhibition of PTEN by phosphorylation could activate PI3K and Akt signaling and subsequent GSK3beta inhibition, which in the end activate Wnt and beta-catenin signaling and promote the growth of colon tumor cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25422594	GSK3beta is a repressor of beta-catenin and Snail able of inhibiting E-cadherin expression and subsequently promotes EMT and tumor progression.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	11955436	Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	16039586	GSK-3beta inhibition can be caused by a number of growth factors including IGF-1, EGF, PDGF, FGF-2, HGF, TGF-beta, TNF-alpha, etc. (), and one virus protein, the latent membrane protein 2A of Epstein-Barr virus (), has been reported to increase beta-catenin stabilization through Ser9 phosphorylation of GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	16039586	However, in certain cell types inhibition of GSK-3beta via Ser9 phosphorylation is not sufficient to induce beta-catenin accumulation (), suggesting that the consequences of changed GSK-3beta activity on beta-catenin stabilization are cell type dependent.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	25883211	For example, EGFR activated PI3K and AKT leads to phosphorylation and subsequently inhibition of the beta-catenin suppressor GSK3beta, resulting in nuclear accumulation of beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	23273980	Thus, LiCl and Wnt-3a induce cytosolic beta-catenin accumulation, but nuclear accumulation requires high glucose in addition.Both LiCl and Wnt-3a induce Ser9 phosphorylation of GSK3betato inhibit GSK3beta driven beta-catenin degradation and lead to beta-catenin cytosolic accumulation (time courses, B and S2C).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
4b214161-9b91-4254-af34-1dc7b90713b8	1.0	PubMed	17822871	In our study, when the Wnt pathway was activated by LiCl through inhibiting GSK3beta mediated beta-catenin degradation, we observed an antagonising effect in TCF activation in N3IC cells compared to control cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CTNNB1))
5d7890c7-5e8f-4500-9aa4-c631f8430701	1.0	PubMed	22807997	Inhibition of GSK3-beta completely abrogates p22phox protein degradation, which demonstrates that without GSK3-beta signalling p22phox can not be processed by the proteasome.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CYBA))
5d7890c7-5e8f-4500-9aa4-c631f8430701	1.0	PubMed	22807997	Inhibition of GSK3-beta completely abrogates p22phox protein degradation, which demonstrates that without GSK3-beta signalling p22phox can not be processed by the proteasome.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:CYBA))
b354b352-70d3-49d5-bedf-79a3b67f3b52	1.0	PubMed	26318034	Furthermore, cells expressing CXCR4 became susceptible to Nef-M1-induced inhibition of p-GSK-3beta and vimentin expression (mesenchymal signature) and Nef-M1 induced elevation of E cadherin (epithelial signature).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cadherin))
459d46ae-f5db-4193-96e9-ed1d1be4de9d	1.0	PubMed	4954427	Cell cycle inhibition by GSK-3beta is not mediated by the level of beta-catenin or by a direct effect on either the MAP kinase pathway or translation of mos and cyclin B1.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007049"))
ba87f9a5-f497-4fb1-8c6b-f454ec2cb2aa	1.0	PubMed	21110852	Cell death induced by GSK-3beta inhibition in ALL cells was mediated by a downregulation of NF-kappaB p65 transcriptional activity.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008219"))
c5423c75-3f86-4e61-aaf7-539b59977c99	1.0	PubMed	19148484	The loss of APC and GSK3-beta did not lead to augmentation of the Wnt target protein cyclin D1 or the Wnt oncoprotein beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cyclin))
c5423c75-3f86-4e61-aaf7-539b59977c99	1.0	PubMed	6506800	Thus, inhibition of GSK3beta activity appears to trigger nuclear accumulation of cyclin D1 and cell cycle progression.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cyclin))
c5423c75-3f86-4e61-aaf7-539b59977c99	1.0	PubMed	24463355	40 AKT mediated phosphorylation of GSK3beta was shown to inhibit nuclear export and proteasomal degradation of cyclin D1.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cyclin))
c5423c75-3f86-4e61-aaf7-539b59977c99	1.0	PubMed	26121043	It is known that glycogen synthase kinase-3beta (GSK-3beta) induces the proteasomal degradation of cyclin D1.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cyclin))
c5423c75-3f86-4e61-aaf7-539b59977c99	1.0	PubMed	12364325	Thus, inhibition of GSK3beta activity appears to trigger nuclear accumulation of cyclin D1 and cell cycle progression.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cyclin))
c5423c75-3f86-4e61-aaf7-539b59977c99	1.0	PubMed	25311367	Cyclin D1 is a cell-cycle regulator downstream of GSK3beta and is inhibited by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cyclin))
c5423c75-3f86-4e61-aaf7-539b59977c99	1.0	PubMed	23383245	The anti-proliferative effect of betaKlotho might be linked with G1 to S phase arrest, which was mediated by Akt/GSK-3beta/cyclin D1 signaling, since forced expression betaKlotho reduced the phosphorylation level of Akt and GSK-3beta and induced down-regulation of cyclin D1.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cyclin))
c5423c75-3f86-4e61-aaf7-539b59977c99	1.0	PubMed	24121026	GSK3beta, a well-known main target of pAkt, normally phosphorylates and promotes the degradation of cyclin D1 ().	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Cyclin))
8087641c-4388-474e-b10c-c4ec13065f74	1.0	PubMed	21305049	It is also known that treatment of prenatal DA progenitors with inhibitors of the beta-catenin kinase GSK3beta enhances DA neurogenesis XREF_BIBR and that transplantation of rodent fetal neural stem cells treated with Wnt5a results in enhanced survival, differentiation and functional integration of stem cell derived DA neurons in an animal model of Parkinson 's disease XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:18243))
f8242e0c-4247-40a4-8193-b0a365dc0f0c	1.0	PubMed	23717519	Inhibition of GSK3beta is expected to increase REDD1 stability.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DDIT4))
1d2654b9-cb13-43fc-a8d1-196b188ba5cd	1.0	PubMed	20634980	Interestingly, inhibition of GSK-3beta by SB 216763 or by RNA interference, augmented HBD-2 induction.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DEFB4A))
1d2654b9-cb13-43fc-a8d1-196b188ba5cd	1.0	PubMed	20634980	In the present investigation, we identified the involvement of Sphk-1 in the induction of beta-defensin 2 in human gingival epithelial cells (HGECs) and also found that the inhibition of kinase glycogen synthase kinase-3beta (GSK3-beta) augments HBD-2, all of which may have therapeutic application.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DEFB4A))
1d2654b9-cb13-43fc-a8d1-196b188ba5cd	1.0	PubMed	20634980	GSK-3beta inhibition augments HBD-2 in oral keratinocytes.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DEFB4A))
1d2654b9-cb13-43fc-a8d1-196b188ba5cd	1.0	PubMed	20634980	The silencing of GSK-3beta significantly increased the induction of HBD-2 in the presence of FSL-1 demonstrating that the inhibition of GSK3-beta either by siRNA or by pharmacological inhibition can augment HBD-2 induction in HGECs (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DEFB4A))
1d2654b9-cb13-43fc-a8d1-196b188ba5cd	1.0	PubMed	20634980	GSK3-beta over-expression downregulated HBD-2 induction.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DEFB4A))
1d2654b9-cb13-43fc-a8d1-196b188ba5cd	1.0	PubMed	20634980	Since we noted dramatic upregulation of HBD-2 following inhibition of GSK3 by a potent selective inhibitor SB 216763 and also by siRNA, we tested if the overexpression of GSK3-beta downregulates HBD-2.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DEFB4A))
1d2654b9-cb13-43fc-a8d1-196b188ba5cd	1.0	PubMed	20634980	To our surprise, the inhibition of GSK3-beta augmented both HBD-2 and proinflammatory cytokines like IL-6, TNFalpha and IL-1beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DEFB4A))
1d2654b9-cb13-43fc-a8d1-196b188ba5cd	1.0	PubMed	20634980	In support of this, transient silencing of GSK3beta up-regulated agonist induced HBD-2.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DEFB4A))
b253e057-f25f-46dc-84c5-fb0848479829	1.0	PubMed	22415718	Furthermore, inhibiting GSK-3beta rescued the negative effects of DISC1 knockdown on proliferation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DISC1))
c2255a60-45db-4050-bb16-43f09e28fc46	1.0	PubMed	26139537	CRISPR-Cas9n-mediated knockout and reconstitution studies establish that dynamin-1 is activated by Akt and GSK3beta signaling in H1299 non small lung cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DNM1))
252360f8-5670-4e90-920f-0b2b928f6135	1.0	PubMed	17716861	However, herein, Gsk3beta inhibition caused DNMT1 increase before beta-catenin increase (B).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DNMT1))
1f5887d9-c261-496f-af04-434a873d87b3	1.0	PubMed	15652488	Ser-518 is also a potential phosphorylation site of CRMP-2 by GSK-3_.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DPYSL2))
1f5887d9-c261-496f-af04-434a873d87b3	1.0	PubMed	23185275	In this work we demonstrate that CRMP-2 is critically involved in primary cilium formation and that GSK-3beta modulates primary cilium targeting of CRMP-2 : specific inhibition of GSK-3beta results in a reduction of the level of phosphorylated pCRMP-2 at the basal body and an enhanced localization of CRMP-2 at the primary cilium.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DPYSL2))
1f5887d9-c261-496f-af04-434a873d87b3	1.0	PubMed	15652488	Here, we showed that glycogen synthase kinase-3beta (gsk-3beta) phosphorylated crmp-2 at thr-514 and inactivated it	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DPYSL2))
1f5887d9-c261-496f-af04-434a873d87b3	1.0	PubMed	20506281	Phosphorylation of T514 by GSK-3beta, or of T555 by Rho Kinase, disrupts the interaction of CRMP2 with tubulin heterodimers preventing increases in axon length and branching [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DPYSL2))
04666e66-36da-4596-929d-29de5330bc0b	1.0	PubMed	16611631	Together, these results suggest that crmp4 is able to increase neurite formation and elongation in neurons, although not as potently as crmp2, and that this process is regulated by ser522/ser518/thr514/thr509 phosphorylation in both cases. We demonstrate that cdk5 primes crmp2 and crmp4 for subsequent phosphorylation by gsk3, whereas dyrk2, phosphorylates and primes only crmp4 in vitro	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DPYSL3))
04666e66-36da-4596-929d-29de5330bc0b	1.0	PubMed	16611631	Primary rat cortical neurons were treated with purvalanol, a more potent inhibitor of cdk5 and dyrk2 than roscovitine (25). Phosphorylation was monitored using antibodies that specifically recognize crmp2 when phosphorylated at thr514/thr509, or crmp4 when phosphorylated at thr509. Loss of phosphorylation of ser522 will prevent subsequent phosphorylation of ser518/thr514/thr509 by gsk3. Together, these results suggest that crmp4 is able to increase neurite formation and elongation in neurons, although not as potently as crmp2, and that this process is regulated by ser522/ser518/thr514/thr509 phosphorylation in both cases. We demonstrate that cdk5 primes crmp2 and crmp4 for subsequent phosphorylation by gsk3, whereas dyrk2, phosphorylates and primes only crmp4 in vitro	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DPYSL3))
04666e66-36da-4596-929d-29de5330bc0b	1.0	PubMed	16611631	Together, these results suggest that crmp4 is able to increase neurite formation and elongation in neurons, although not as potently as crmp2, and that this process is regulated by ser522/ser518/thr514/thr509 phosphorylation in both cases. We demonstrate that cdk5 primes crmp2 and crmp4 for subsequent phosphorylation by gsk3, whereas dyrk2, phosphorylates and primes only crmp4 in vitro	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DPYSL3))
04666e66-36da-4596-929d-29de5330bc0b	1.0	PubMed	16611631	Together, these results suggest that crmp4 is able to increase neurite formation and elongation in neurons, although not as potently as crmp2, and that this process is regulated by ser522/ser518/thr514/thr509 phosphorylation in both cases. We demonstrate that cdk5 primes crmp2 and crmp4 for subsequent phosphorylation by gsk3, whereas dyrk2, phosphorylates and primes only crmp4 in vitro	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:DPYSL3))
37969daf-87a3-4ef7-9523-fdb1a0c5099e	1.0	PubMed	18606491	It has been suggested that GSK3beta promotes cell death caused by the intrinsic apoptotic pathway, but inhibits the death receptor mediated extrinsic apoptotic signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:"Death_receptor"))
cb4eb92c-e544-4c6e-8b77-43f0155afce2	1.0	PubMed	21145761	GSK3beta has been shown to inhibit E2F1 transcriptional activity and neural cell differentiation independent of its kinase activity ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:E2F1))
352da6d8-e271-40b2-9715-55901d016e47	1.0	PubMed	26119563	A previous study demonstrates that activation of GSK-3beta can down-regulate EphB2 and ephrinB1 in intestinal epithelial cells XREF_BIBR, while our current paper is the first to show that stimulation of EphB2 and ephrinB1 inactivates GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EFNB1))
9d1e99b7-8c1c-4046-80a6-fef593a1bd18	1.0	PubMed	24312592	Up- or down-regulation of GSK-3beta inhibited EGF stimulated cell invasion.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EGF))
b9b90eb2-e2d9-4f2b-bee1-2d3dbfefa191	1.0	PubMed	21798082	Akt also promotes protein synthesis by phosphorylating and inactivating gsk3b, thus releasing the gsk3b-dependent inhibition of the eukariotic translation initiation factor 2b (eif2b).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF2B1))
e8e978d0-a6dd-48fc-ac74-d6162a8d6e41	1.0	PubMed	21798082	Akt also promotes protein synthesis by phosphorylating and inactivating gsk3b, thus releasing the gsk3b-dependent inhibition of the eukariotic translation initiation factor 2b (eif2b).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF2B2))
10586743-2985-49d8-bfda-99df265da018	1.0	PubMed	21798082	Akt also promotes protein synthesis by phosphorylating and inactivating gsk3b, thus releasing the gsk3b-dependent inhibition of the eukariotic translation initiation factor 2b (eif2b).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF2B3))
f64c3d86-a895-4442-8d54-882a1b4c237a	1.0	PubMed	21798082	Akt also promotes protein synthesis by phosphorylating and inactivating gsk3b, thus releasing the gsk3b-dependent inhibition of the eukariotic translation initiation factor 2b (eif2b).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF2B4))
9f252cd9-79d7-40f7-8ea0-f9968d7cce16	1.0	PubMed	21798082	Akt also promotes protein synthesis by phosphorylating and inactivating gsk3b, thus releasing the gsk3b-dependent inhibition of the eukariotic translation initiation factor 2b (eif2b).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF2B5))
9f252cd9-79d7-40f7-8ea0-f9968d7cce16	1.0	PubMed	11500362	We identify multiple phosphorylation sites in the largest, catalytic, subunit (epsilon) of mammalian eIF2B. Glycogen synthase kinase 3 (GSK3) is responsible for phosphorylating Ser535. This regulatory phosphorylation event requires both the fourth site (Ser539) and a distal region, which acts to recruit GSK3 to eIF2Bepsilon in vivo.   eIF2Bϵ from mammals or insects is a substrate for glycogen synthase kinase 3 (GSK3), and this inhibits the activity of eIF2B	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF2B5))
9f252cd9-79d7-40f7-8ea0-f9968d7cce16	1.0	PubMed	12133000	The largest (epsilon) subunit of eIF2B is a substrate for glycogen synthase kinase (GSK)-3 in vitro, and phosphorylation by GSK3 inhibits the activity of eIF2B. The site of phosphorylation has previously been identified as Ser(535).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF2B5))
9f252cd9-79d7-40f7-8ea0-f9968d7cce16	1.0	PubMed	18701453	Gsk3_ phosphorylates eif2b_ at ser-539 (ser-535 in the rat sequence) and inactivates it	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF2B5))
35419afd-d49a-449c-9195-d935513b07fc	1.0	PubMed	23584478	Glycogen synthase kinase-3_ positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1We found that GSK-3_ phosphorylates and inactivates 4E-BP1, thereby increasing eIF4E-dependent protein synthesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF4EBP1))
35419afd-d49a-449c-9195-d935513b07fc	1.0	PubMed	18701453	We found that gsk-3Beta phosphorylates and inactivates 4e-bp1, thereby increasing eif4e-dependent protein synthesis. upon stimulation, 4e-bp1 is phosphorylated on several threonine and serine residues, including thr-37/46 (36). This results in dissolution of the complex, freeing eif4e to bind with mrna cap to promote translation initiation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF4EBP1))
35419afd-d49a-449c-9195-d935513b07fc	1.0	PubMed	18701453	We found that gsk-3Beta phosphorylates and inactivates 4e-bp1, thereby increasing eif4e-dependent protein synthesis. upon stimulation, 4e-bp1 is phosphorylated on several threonine and serine residues, including thr-37/46 (36). This results in dissolution of the complex, freeing eif4e to bind with mrna cap to promote translation initiation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EIF4EBP1))
3dbcb24c-e721-44d8-aa6d-9786920e55d5	1.0	PubMed	19150350	GSK-3beta inhibition augments EpCAM + HCC cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EPCAM))
2a567d0e-9256-4e03-9b3e-f7497db7d2f1	1.0	PubMed	26119563	To further confirm the role of GSK-3beta inhibition in EphB2 induced tau dephosphorylation, we simultaneously transfected GSK-3beta with EphB2 plasmids into HEK293-tau cells before ephrinB1/Fc treatment.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EPHB2))
2a567d0e-9256-4e03-9b3e-f7497db7d2f1	1.0	PubMed	26119563	A previous study demonstrates that activation of GSK-3beta can down-regulate EphB2 and ephrinB1 in intestinal epithelial cells XREF_BIBR, while our current paper is the first to show that stimulation of EphB2 and ephrinB1 inactivates GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EPHB2))
536d0505-3f3a-4b41-b924-8616e1a88507	1.0	PubMed	20634980	This data is in agreement with Rehani et al. (2008) who show that ERK 1/2 activation is mediated by the inhibition of GSK-3beta XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:ERK))
536d0505-3f3a-4b41-b924-8616e1a88507	1.0	PubMed	22039301	Downregulation of GSK3beta inhibits SHP2 and ERK1/2 but not PI3K activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:ERK))
536d0505-3f3a-4b41-b924-8616e1a88507	1.0	PubMed	24239461	As ERK, AKT, and GSK-3beta are important proteins in the generation of an antiapoptotic response in cells, the inactivation of ERK and AKT, and activation of GSK-3beta appears to be accountable for the death by apoptosis of T24 bladder carcinoma cells induced by boldine treatment.PI3K/AKT and MAPK and ERK pathways activation have been regarded as important key players in BC carcinogenesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:ERK))
1fa9c175-4362-42d6-aa67-a82a5c97bec6	1.0	PubMed	25500144	Moreover, inhibition of p-GSK3beta by a dominant-inhibitory S9A-GSK-3beta mutant impaired not only CCRK induced beta-catenin activation, but also EZH2 and H3K27me3 (A, right).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EZH2))
1fa9c175-4362-42d6-aa67-a82a5c97bec6	1.0	PubMed	23874688	Therefore, our finding showed inhibition of GSK3beta activity can promote EZH2 overproduction by increasing the stability of EZH2 protein.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:EZH2))
7191abb5-9ace-422c-8f34-210193634afb	1.0	PubMed	27232758	Conversely, siRNA mediated knockdown of GSK3beta increased the half-life of FAAP20 compared with the control, indicating that GSK3beta is necessary for proper degradation of FAAP20 inside cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:FAAP20))
7191abb5-9ace-422c-8f34-210193634afb	1.0	PubMed	27232758	To further understand the GSK3beta signaling that mediates FAAP20 degradation, we generated a phospho specific antibody that recognizes phosphorylation at serine 113 of FAAP20.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:FAAP20))
7191abb5-9ace-422c-8f34-210193634afb	1.0	PubMed	27232758	Therefore, we evaluated whether FAAP20 degradation is modulated by AKT dependent GSK3beta regulation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:FAAP20))
9583f743-92dd-419b-9c9c-b44a43502589	1.0	PubMed	27232758	Overexpression of GSK3beta and FBW7 was sufficient to destabilize FAAP20, impair FANCD2 activation mediated by the FA core complex, and disrupt DNA ICL repair, supporting the idea that SCF FBW7 -dependent proteolysis directly regulates the FA pathway via regulating FAAP20 degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:FANCD2))
bba49d55-ce72-4564-b11c-10497a59348e	1.0	PubMed	22405651	Notably, Gsk3beta levels and Cyclin E binding to Cdk2 were unaffected by depletion of Glmn or Fbw7 (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:FBXW7))
e58a596c-194b-474d-86bd-e499d967fef2	1.0	PubMed	27060477	Activation of GSK-3beta blocked the function of GABA B R signaling on repressing cell proliferation.	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:119))
70d04203-811d-4c96-a29f-cfc085f7073f	1.0	PubMed	15911064	showed that GSK3beta negatively regulated GATA-4.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GATA4))
70d04203-811d-4c96-a29f-cfc085f7073f	1.0	PubMed	5921692	Overexpression of GSK3beta suppressed both basal and beta-adrenergic increases in nuclear expression of GATA4, whereas inhibition of GSK3beta by LiCl caused nuclear accumulation of GATA4, suggesting that GSK3beta negatively regulates nuclear expression of GATA4.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GATA4))
09b2be2d-85dc-4eb4-86f8-1ed37bea9f4b	1.0	PubMed	25428377	Our studies revealed that miR-29s expression is downregulated in GC and they could repress the AKT2 expression and the inactivation of AKT and GSK3beta leading to inhibit the GC cells invasion.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GC))
f3a01a21-a084-415a-ab94-8a86fe0d9d31	1.0	PubMed	24606125	Moreover, SSTR3 dependent GH transcriptional inhibition was rescued by inhibition of GSK3-beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GH1))
f3a01a21-a084-415a-ab94-8a86fe0d9d31	1.0	PubMed	24606125	Because SSTR3 WT transfectants exhibit increased Pit-1 phosphorylation at serine residues as well as decreased occupancy of Pit-1 on the rGH promoter, the results suggest that GSK3-beta activation by constitutive SSTR3 activity may mediate GH inhibition through Pit-1 phosphorylation and thus inhibition of GH transcription.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GH1))
a8b2b6f6-5788-4dd7-819b-3d5ea3de63b3	1.0	PubMed	19615554	Shh, Wnt and BMP pathways can interact, with GSK-3beta stimulating degradation of Gli effectors and Shh up-regulating BMP4 in the ureteric bud, providing evidence for complex modulation of signaling pathways.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GLI1))
add6fee2-2849-4f6c-a25c-c08283e34efc	1.0	PubMed	22405651	Notably, Gsk3beta levels and Cyclin E binding to Cdk2 were unaffected by depletion of Glmn or Fbw7 (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GLMN))
de01d6a7-bc5b-4e23-8a51-4f730d05877b	1.0	PubMed	23164509	In addition, Akt inhibits by phosphorylation the activity of glycogen synthase kinase-3beta (GSK-3beta), and since GSK-3beta inhibits GS also by phosphorylation, suppression of GSK-3beta leads to activation of glycogen synthesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GLUL))
de01d6a7-bc5b-4e23-8a51-4f730d05877b	1.0	PubMed	24704462	Inhibition of GSK-3beta results in activation of GS, increases glucose uptake and stimulates glycogen synthesis in human skeletal muscle.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GLUL))
45f918c5-2522-40a2-b53d-9007d83f6f1f	1.0	PubMed	23077067	BDNF signaling through phosphatidylinositol 3-kinase (PI3K)-Akt also activates mTOR and represses GSK3beta, which was previously shown to reduce gephyrin clustering.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GPHN))
45f918c5-2522-40a2-b53d-9007d83f6f1f	1.0	PubMed	23408424	Identification of gsk3_ as the kinase targeting ser-270 /phosphorylation at ser-270 promotes gephyrin processing by calpain	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GPHN))
26f00d99-5a0d-438d-8fcb-fb8ca524e1ae	1.0	PubMed	24984063	In order to chemically inhibit GSK3A, but not GSK3B, enzymatic activity we first screened a number of commercially available inhibitors (XREF_SUPPLEMENTARY); in fact, being the ATP binding pockets of GSK3A and GSK3B very similar, most inhibitors block the activity of both isoforms XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3A))
26f00d99-5a0d-438d-8fcb-fb8ca524e1ae	1.0	PubMed	25797247	Small interfering RNA (siRNA)-mediated knockdown of GSK3alpha, GSK3beta or both were confirmed with Western blotting.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3A))
4cb813d0-1db8-4215-8406-44f714248d08	1.0	PubMed	19429245	However, the mechanism about how CSE resulted in the injury of alveolar epithelial cells remains unclear.Our previous study in mouse inhalation () showed that the cigarette smoke could decrease the GSK3beta expression and increase the inactive phosphorylated GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B, pmod(Ph)))
4cb813d0-1db8-4215-8406-44f714248d08	1.0	PubMed	19429245	However, the mechanism about how CSE resulted in the injury of alveolar epithelial cells remains unclear.Our previous study in mouse inhalation () showed that the cigarette smoke could decrease the GSK3beta expression and increase the inactive phosphorylated GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B, pmod(Ph)))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	22470507	DACT1 mediates the subcellular localization of beta-catenin via increasing the level of phosphorylated GSK-3beta at Ser9 to inhibit the activity of GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	15652488	Because the phosphorylation of GSK-3beta at Ser 9 is known to inactivate GSK-3beta, our findings suggest that NT-3 and BDNF decrease the phosphorylation levels of CRMP-2 at Thr 514 and increase nonphosphorylated active CRMP-2 via the PI3-kinase/Akt/GSK-3beta pathway.To examine the effect of NT-3 on the spatial distribution of phosphorylated CRMP-2 at Thr 514, hippocampal neurons were fixed at 3 DIV after the treatment of NT-3 for 30 min and then immunostained with anti-pT514 (phosphorylated CRMP-2, red) and anti-CRMP-2 antibodies (total CRMP-2, green;).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	6459568	Activation of GSK3beta was obligatory for thapsigargin induced activation of caspase-3, because inhibition of GSK3beta by expression of dominant negative GSK3beta or by the GSK3beta inhibitor lithium blocked caspase-3 activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	6009512	Treatment of these cells with either insulin or phenylephrine (PE), an alpha1-adrenergic receptor agonist, induced Ser 9 phosphorylation of GSK-3beta and inhibited GSK-3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	7088620	AM gene transfer increased phosphorylation of Akt and glycogen synthase kinase (GSK-3beta) but reduced GSK-3beta and caspase-3 activities in the heart.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	23673211	Thus, suppression of GSK-3beta activity induced by phosphorylation of GSK-3beta at serine 9 may account for CP70 resistance to cisplatin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	19190323	Our data suggest that reduction in galectin-3 decreases GSK-3beta phosphorylation and increases GSK-3beta activity, which may mediate beta-catenin accumulation and Wnt signaling in colon cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	26456864	We identified a novel positive-feedback loop mechanism via the INSM1 transcription factor that activated the PI3K and AKT signaling pathway, which subsequently induced phosphorylation of GSK3beta kinase and blocked GSK3beta kinase activity to stabilize N-myc.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	25959626	On the other hand, LRP5 and LRP6 overexpressions were able to upregulate GSK3beta Ser9 protein levels and repress GSK3beta activity at all concentrations of HO.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	24086147	Interestingly, phosphorylation of GSK-3beta at Ser9 can both inhibit GSK-3beta activity and override the increase in activity even when phosphorylated at Tyr216 XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	18500637	In general, the data suggest that phosphorylation levels of GSK3beta are reduced in schizophrenia, resulting in increased GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	19729319	In fact, phosphorylation of serine 9 in GSK3beta downregulates GSK3beta activity, and this phosphorylation reaction occurs as a result of IGF-I stimulated AKT activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	23874688	However, when GSK3beta activity was inhibited after cells were transfected with GSK3beta-KD or treated with lithium, both p-GSK3beta (Ser9) and EZH2 were significantly upregulated in CNE-1 and CNE-2 cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	22814751	Akt is known to phosphorylate GSK-3beta, which negatively regulates GSK-3beta function.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	19411070	To examine whether the stabilization of Snail by TNFalpha is mediated by regulation of GSK-3beta activity, we treated Snail and HEK293 cells with the PI3K inhibitor LY294002 to activate GSK-3beta prior to TNFalpha treatment (loss of GSK-3beta phosphorylation at Serine 9 enhances GSK-3beta activity).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	27405982	Because the phosphorylation of GSK3beta at Ser9 inhibits the kinase activity of GSK3beta [XREF_BIBR], the PMA induced phosphorylation of GSK3beta may decrease the possibility for NFAT phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	21887250	In order to verify that Akt was actually involved in the regulation of HB9, we inhibited Akt directly using several inhibitors, and found that Akt inhibition increased HB9 levels, which correlated with a decrease in GSK3beta phosphorylation at Ser9, a modification that decreases GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	11483158	Phosphorylation of GSK3beta by PKB inhibits GSK3beta kinase activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	26252009	Because it is suggested that Akt induces GSK-3beta phosphorylation on Ser 9 to promote GSK-3beta degradation through ubiquitin proteasome pathway, inhibition of Akt phosphorylation and activation by embelin partially contributes to the GSK-3beta activation and inhibition in the level of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	23911749	TNF-alpha induces the phosphorylation of glycogen synthase kinase 3beta (GSK3beta), i.e. inhibition of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	18167338	Immunohistochemistry was performed with a Cdc25A specific antibody and an antibody that recognizes GSK-3beta when it is phosphorylated on serine 9 (p-GSK-3beta), a modification that inactivates GSK-3beta ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	23612487	Subsequently, we examined the effect of S1P on GSK-3beta, whose activity is inhibited by the phosphorylation of GSK-3beta at Ser9 in the PI3K and Akt signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	17150190	To verify whether Akt pathway was involved in hCSC proliferation, we examined the activation of Akt in hCSCs and found that EGF and bFGF treatment of hCSCs caused a rapid activation of Akt (A) and also augmented sustained phosphorylation of GSK-3beta, which is one of the downstream targets of Akt, to inactivate GSK-3beta function (B).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	19734233	Moreover, IL-12 also enhanced the levels of phospho-GSK3beta (S9), which is a phospho specific site that represses GSK3beta activity (XREF_FIG) (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	6380695	BDNF also increased serine (9) -phosphorylation of GSK3beta, which inhibits GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	24303084	Phosphorylation of GSK-3beta at serine 9 inactivates GSK-3beta activity and causes the stabilization and activation of beta-catenin signaling, which subsequently enhances P-gp expression [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	12228224	Activation of GSK3beta was obligatory for thapsigargin induced activation of caspase-3, because inhibition of GSK3beta by expression of dominant negative GSK3beta or by the GSK3beta inhibitor lithium blocked caspase-3 activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	18606491	In a mouse model of mammary tumorigenesis, inhibition of GSK3beta by overexpression of kinase-inactive GSK3beta in mouse mammary glands promotes mammary tumorigenesis; this is accompanied by the over-expression of beta-catenin and cyclin D1, supporting that GSK3beta inhibition causes dysregulation of the Wnt and beta-catenin pathway which results in tumor promotion.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	25738875	Previous studies have shown that overexpression of ILK results in the phosphorylation of Akt and PKB and GSK3beta [XREF_BIBR] and that the phosphorylation of GSK3beta at Ser9 inhibits the activity of GSK3beta followed by activation of the activator protein 1 (AP-1) transcription factor complex [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	16797529	Phosphorylation of GSK3beta by P-Akt inhibits GSK3beta activity, leading to an overall decrease in glycogen synthesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	22470507	DACT1 mediates the subcellular localization of beta-catenin via increasing the level of phosphorylated GSK-3beta at Ser9 to inhibit the activity of GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	15652488	Because the phosphorylation of GSK-3beta at Ser 9 is known to inactivate GSK-3beta, our findings suggest that NT-3 and BDNF decrease the phosphorylation levels of CRMP-2 at Thr 514 and increase nonphosphorylated active CRMP-2 via the PI3-kinase/Akt/GSK-3beta pathway.To examine the effect of NT-3 on the spatial distribution of phosphorylated CRMP-2 at Thr 514, hippocampal neurons were fixed at 3 DIV after the treatment of NT-3 for 30 min and then immunostained with anti-pT514 (phosphorylated CRMP-2, red) and anti-CRMP-2 antibodies (total CRMP-2, green;).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	6459568	Activation of GSK3beta was obligatory for thapsigargin induced activation of caspase-3, because inhibition of GSK3beta by expression of dominant negative GSK3beta or by the GSK3beta inhibitor lithium blocked caspase-3 activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	6009512	Treatment of these cells with either insulin or phenylephrine (PE), an alpha1-adrenergic receptor agonist, induced Ser 9 phosphorylation of GSK-3beta and inhibited GSK-3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	7088620	AM gene transfer increased phosphorylation of Akt and glycogen synthase kinase (GSK-3beta) but reduced GSK-3beta and caspase-3 activities in the heart.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	23673211	Thus, suppression of GSK-3beta activity induced by phosphorylation of GSK-3beta at serine 9 may account for CP70 resistance to cisplatin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	19190323	Our data suggest that reduction in galectin-3 decreases GSK-3beta phosphorylation and increases GSK-3beta activity, which may mediate beta-catenin accumulation and Wnt signaling in colon cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	26456864	We identified a novel positive-feedback loop mechanism via the INSM1 transcription factor that activated the PI3K and AKT signaling pathway, which subsequently induced phosphorylation of GSK3beta kinase and blocked GSK3beta kinase activity to stabilize N-myc.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	25959626	On the other hand, LRP5 and LRP6 overexpressions were able to upregulate GSK3beta Ser9 protein levels and repress GSK3beta activity at all concentrations of HO.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	24086147	Interestingly, phosphorylation of GSK-3beta at Ser9 can both inhibit GSK-3beta activity and override the increase in activity even when phosphorylated at Tyr216 XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	18500637	In general, the data suggest that phosphorylation levels of GSK3beta are reduced in schizophrenia, resulting in increased GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	19729319	In fact, phosphorylation of serine 9 in GSK3beta downregulates GSK3beta activity, and this phosphorylation reaction occurs as a result of IGF-I stimulated AKT activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	23874688	However, when GSK3beta activity was inhibited after cells were transfected with GSK3beta-KD or treated with lithium, both p-GSK3beta (Ser9) and EZH2 were significantly upregulated in CNE-1 and CNE-2 cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	22814751	Akt is known to phosphorylate GSK-3beta, which negatively regulates GSK-3beta function.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	19411070	To examine whether the stabilization of Snail by TNFalpha is mediated by regulation of GSK-3beta activity, we treated Snail and HEK293 cells with the PI3K inhibitor LY294002 to activate GSK-3beta prior to TNFalpha treatment (loss of GSK-3beta phosphorylation at Serine 9 enhances GSK-3beta activity).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	27405982	Because the phosphorylation of GSK3beta at Ser9 inhibits the kinase activity of GSK3beta [XREF_BIBR], the PMA induced phosphorylation of GSK3beta may decrease the possibility for NFAT phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	21887250	In order to verify that Akt was actually involved in the regulation of HB9, we inhibited Akt directly using several inhibitors, and found that Akt inhibition increased HB9 levels, which correlated with a decrease in GSK3beta phosphorylation at Ser9, a modification that decreases GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	11483158	Phosphorylation of GSK3beta by PKB inhibits GSK3beta kinase activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	26252009	Because it is suggested that Akt induces GSK-3beta phosphorylation on Ser 9 to promote GSK-3beta degradation through ubiquitin proteasome pathway, inhibition of Akt phosphorylation and activation by embelin partially contributes to the GSK-3beta activation and inhibition in the level of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	23911749	TNF-alpha induces the phosphorylation of glycogen synthase kinase 3beta (GSK3beta), i.e. inhibition of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	18167338	Immunohistochemistry was performed with a Cdc25A specific antibody and an antibody that recognizes GSK-3beta when it is phosphorylated on serine 9 (p-GSK-3beta), a modification that inactivates GSK-3beta ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	23612487	Subsequently, we examined the effect of S1P on GSK-3beta, whose activity is inhibited by the phosphorylation of GSK-3beta at Ser9 in the PI3K and Akt signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	17150190	To verify whether Akt pathway was involved in hCSC proliferation, we examined the activation of Akt in hCSCs and found that EGF and bFGF treatment of hCSCs caused a rapid activation of Akt (A) and also augmented sustained phosphorylation of GSK-3beta, which is one of the downstream targets of Akt, to inactivate GSK-3beta function (B).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	19734233	Moreover, IL-12 also enhanced the levels of phospho-GSK3beta (S9), which is a phospho specific site that represses GSK3beta activity (XREF_FIG) (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	6380695	BDNF also increased serine (9) -phosphorylation of GSK3beta, which inhibits GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	24303084	Phosphorylation of GSK-3beta at serine 9 inactivates GSK-3beta activity and causes the stabilization and activation of beta-catenin signaling, which subsequently enhances P-gp expression [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	12228224	Activation of GSK3beta was obligatory for thapsigargin induced activation of caspase-3, because inhibition of GSK3beta by expression of dominant negative GSK3beta or by the GSK3beta inhibitor lithium blocked caspase-3 activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	18606491	In a mouse model of mammary tumorigenesis, inhibition of GSK3beta by overexpression of kinase-inactive GSK3beta in mouse mammary glands promotes mammary tumorigenesis; this is accompanied by the over-expression of beta-catenin and cyclin D1, supporting that GSK3beta inhibition causes dysregulation of the Wnt and beta-catenin pathway which results in tumor promotion.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	25738875	Previous studies have shown that overexpression of ILK results in the phosphorylation of Akt and PKB and GSK3beta [XREF_BIBR] and that the phosphorylation of GSK3beta at Ser9 inhibits the activity of GSK3beta followed by activation of the activator protein 1 (AP-1) transcription factor complex [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
280b6ac1-83dd-4eb2-a556-425c0535bf95	1.0	PubMed	16797529	Phosphorylation of GSK3beta by P-Akt inhibits GSK3beta activity, leading to an overall decrease in glycogen synthesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GSK3B))
3c99dc1f-ecda-4e54-a770-70d7cb8e3b47	1.0	PubMed	24316184	This is in line with and findings that showed that GSK3 inhibition by pharmacological inhibitors of GSK3 (Indirubin) and expression of GSK3beta-KD did not affect mitochondrial biogenesis in primary bovine aortic endothelial cells, and inhibition of GSK3beta using GSK3beta siRNA did not alter mitochondria DNA content in HepG2 cells, respectively.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GSK3))
3c99dc1f-ecda-4e54-a770-70d7cb8e3b47	1.0	PubMed	21422248	The small interfering RNA mediated knockdown of GSK3-beta or pharmacological inhibition of GSK3 using a panel of different GSK3 selective inhibitors suppressed the production of IL-1beta, IL-6, TNF, and IL-12, whereas the production of IL-10 was increased in TLR2-, TLR4-, TLR5-, and TLR9 stimulated monocytes (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GSK3))
3c99dc1f-ecda-4e54-a770-70d7cb8e3b47	1.0	PubMed	23077590	AKT phosphorylates GSK3 on serine 9 for GSK3beta or 21 for GSK3alpha, thereby inactivating GSK3 XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GSK3))
3c99dc1f-ecda-4e54-a770-70d7cb8e3b47	1.0	PubMed	11483158	Activated PKB then phosphorylates GSK3beta, inhibiting GSK3 kinase activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GSK3))
3c99dc1f-ecda-4e54-a770-70d7cb8e3b47	1.0	PubMed	23383112	GSK3 is a constitutively active kinase in resting cells and phosphorylation of GSK3beta and alpha on Ser9/21 reduces GSK3 activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GSK3))
3c99dc1f-ecda-4e54-a770-70d7cb8e3b47	1.0	PubMed	18221734	Contrary to the inhibitory regulation by serine phosphorylation, GSK3 activity is increased by phosphorylation of Tyr in GSK3beta and Tyr in GSK3alpha ().	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GSK3))
b8909f9d-787b-4211-a326-512347a59856	1.0	PubMed	14593110	Glycogen synthase kinase-3 (gsk-3) phosphorylates four serine residues in the cooh terminus of glycogen synthase. Phosphorylation of one of these residues, ser640 (site 3a), causes strong inactivation of glycogen synthase	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GYS1))
b8909f9d-787b-4211-a326-512347a59856	1.0	PubMed	6772446	Glycogen synthase kinase-3 phosphorylates three serine residues on glycogen synthase (sites 3a, 3b and 3c) which are all located in the same nine-amino-acid segment of the polypeptide chain. The sequence in this region is: Arg-Tyr-Pro-Arg-Pro-Ala-Ser(P)-Val-Pro-Pro-Ser(P)-Pro-Ser-Leu-Ser(P)-Arg-.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GYS1))
b8909f9d-787b-4211-a326-512347a59856	1.0	PubMed	6772446	Glycogen synthase kinase-3 phosphorylates three serine residues on glycogen synthase (sites 3a, 3b and 3c) which are all located in the same nine-amino-acid segment of the polypeptide chain. The sequence in this region is: Arg-Tyr-Pro-Arg-Pro-Ala-Ser(P)-Val-Pro-Pro-Ser(P)-Pro-Ser-Leu-Ser(P)-Arg-.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GYS1))
b8909f9d-787b-4211-a326-512347a59856	1.0	PubMed	6772446	Glycogen synthase kinase-3 phosphorylates three serine residues on glycogen synthase (sites 3a, 3b and 3c) which are all located in the same nine-amino-acid segment of the polypeptide chain. The sequence in this region is: Arg-Tyr-Pro-Arg-Pro-Ala-Ser(P)-Val-Pro-Pro-Ser(P)-Pro-Ser-Leu-Ser(P)-Arg-.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GYS1))
b8909f9d-787b-4211-a326-512347a59856	1.0	PubMed	11427888	Glycogen synthase has multiple serines (residues 640, 644, 648 and 652) separated by three residues, and those Ser residues are phosphorylated sequentially by GSK3 from the C-terminal end after Ser 656 has been phosphorylated by casein kinase II.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GYS1))
b8909f9d-787b-4211-a326-512347a59856	1.0	PubMed	11427888	Glycogen synthase has multiple serines (residues 640, 644, 648 and 652) separated by three residues, and those Ser residues are phosphorylated sequentially by GSK3 from the C-terminal end after Ser 656 has been phosphorylated by casein kinase II.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GYS1))
b8909f9d-787b-4211-a326-512347a59856	1.0	PubMed	11427888	Glycogen synthase has multiple serines (residues 640, 644, 648 and 652) separated by three residues, and those Ser residues are phosphorylated sequentially by GSK3 from the C-terminal end after Ser 656 has been phosphorylated by casein kinase II.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GYS1))
b8909f9d-787b-4211-a326-512347a59856	1.0	PubMed	11427888	Glycogen synthase has multiple serines (residues 640, 644, 648 and 652) separated by three residues, and those Ser residues are phosphorylated sequentially by GSK3 from the C-terminal end after Ser 656 has been phosphorylated by casein kinase II.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:GYS1))
b28904c9-904f-4e4b-9931-bf1b18fb9614	1.0	PubMed	22209410	As expected TrkB.T1 overexpression alone decreased TrkB signaling, which is most clearly seen as suppression of Akt (protein kinase B) and glycogen synthase kinase 3beta (GSK-3beta) activity (measured as the ratio between the active, phosphorylated form and the total levels of the corresponding protein).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GYS))
b28904c9-904f-4e4b-9931-bf1b18fb9614	1.0	PubMed	21435438	The GSK3beta can phosphorylate and thereby inactivate glycogen synthase, resulting in reduced glycogenesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GYS))
b28904c9-904f-4e4b-9931-bf1b18fb9614	1.0	PubMed	12182887	As GSK-3beta can inactivate glycogen synthase through phosphorylation, we quantified the glycogen level in the cerebrum and cerebellum of both wild type and transgenic mice.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:GYS))
c9bb6e81-78cc-431b-97c7-f9dcc7e8cea2	1.0	PubMed	PMC5014345	Instead, a MnSO4-dependent glucose transfer to glycoproteins, inhibited by glycogen and UDP-pyridoxal (which do not affect glycogenin), and unaffected by CDP (a potent inhibitor of glycogenin), was consistently detected.	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q8JTH0))
54eddfcf-7772-4c09-804d-4e6ec6b958db	1.0	PubMed	24802406	Chemical inhibition of activated Gsk3beta allows HDAC2 deficient adults to become sensitive to hypertrophic stimulation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HDAC2))
54eddfcf-7772-4c09-804d-4e6ec6b958db	1.0	PubMed	17322895	Chemical inhibition of activated Gsk3beta allowed Hdac2 deficient adults to become sensitive to hypertrophic stimulation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HDAC2))
0c7b0c29-c730-48ea-8c00-0e28ed611158	1.0	PubMed	21118993	The double mutation of serines 298/302 into alanines, but also the sole mutation of serine 302, abolishes hdac4 phosphorylation by gsk3_we have shown that cells lacking gsk3_ are unable to degrade hdac4 after serum starvation	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HDAC4))
0c7b0c29-c730-48ea-8c00-0e28ed611158	1.0	PubMed	21118993	The double mutation of serines 298/302 into alanines, but also the sole mutation of serine 302, abolishes hdac4 phosphorylation by gsk3_we have shown that cells lacking gsk3_ are unable to degrade hdac4 after serum starvation	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HDAC4))
e227709a-3fc8-4e84-b067-ec692fdf9bc5	1.0	PubMed	21964756	Indirect activation of GSK3beta by suppressing PI3K activity also reduced the HIF-1alpha stabilization response to hypoxia (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HIF1A))
e227709a-3fc8-4e84-b067-ec692fdf9bc5	1.0	PubMed	17325032	We found that the inhibition or depletion of GSK-3 induced HIF-1alpha whereas the overexpression of GSK-3beta reduced HIF-1alpha.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HIF1A))
e227709a-3fc8-4e84-b067-ec692fdf9bc5	1.0	PubMed	24333432	Daniela Flugel reported that GSK3beta regulated HIF1alpha via three key amino residues in the ODD domain in the HepG2 cell line and mutation analysis revealed that GSK3beta degraded HIF1alpha in a VHL independent way.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HIF1A))
e227709a-3fc8-4e84-b067-ec692fdf9bc5	1.0	PubMed	24333432	Our results suggest that GSK3beta negatively regulates HIF1alpha in the MG63 osteosarcoma cell line.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HIF1A))
e227709a-3fc8-4e84-b067-ec692fdf9bc5	1.0	PubMed	24333432	Inhibition of GSK3beta increased HIF1alpha accumulation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HIF1A))
e227709a-3fc8-4e84-b067-ec692fdf9bc5	1.0	PubMed	24333432	To sum up, GSK3beta negatively regulated HIF1alpha protein by affecting its mRNA stability in the MG63 osteosarcoma cell line.Nucleolin is a multifunctional phosphorylated protein that plays a critical role in DNA and RNA metabolism, and its expression is rather extensive.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HIF1A))
e227709a-3fc8-4e84-b067-ec692fdf9bc5	1.0	PubMed	18804163	Therefore, we examined if inhibition of GSK-3beta using TPO or BIO can promote the accumulation of HIF-1alpha in the nucleus of UT-7 and TPO cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HIF1A))
71a71d59-a942-44f6-863c-ea7f505b5d91	1.0	PubMed	6832922	In conclusion, hypoxia induced a biphasic effect on HIF-1alpha stabilization with accumulation in early hypoxia, which depends on an active PI3K and Akt pathway and an inactive GSK3beta, whereas prolonged hypoxia results in the inactivation of Akt and activation of GSK3beta, which then down-regulates the HIF-1 activity through down-regulation of HIF-1alpha accumulation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:HIF1))
71a71d59-a942-44f6-863c-ea7f505b5d91	1.0	PubMed	12764143	In conclusion, hypoxia induced a biphasic effect on HIF-1alpha stabilization with accumulation in early hypoxia, which depends on an active PI3K and Akt pathway and an inactive GSK3beta, whereas prolonged hypoxia results in the inactivation of Akt and activation of GSK3beta, which then down-regulates the HIF-1 activity through down-regulation of HIF-1alpha accumulation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:HIF1))
b00cb514-31d0-4149-b55e-d70074620fc4	1.0	PubMed	26935904	Accordingly, in the present study we hypothesized that redundant ROS downregulated VEGFR-2 through beta-TrCP-induced UPS dependent VEGFR-2 degradation, which was likely mediated by GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HMBS))
7314b79d-90d3-4a2b-98cd-9c2edfc1dc2f	1.0	PubMed	16551619	Pharmacological inhibitors (LiCl and PDZD-8) and genetic variants of GSK-3beta (constitutively active and dominant negative mutants) indicated that PI3K and Akt activates and GSK-3beta inhibits the antioxidant response elements of the ho1 promoter and pointed Nrf2 as directly involved in this process.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HMOX1))
bc538882-00eb-499c-ab43-33c7a0a1f86e	1.0	PubMed	22960426	A 2-DE analysis with nuclear extracts from MMH hepatocytes treated for 5h with the GSK3beta inhibitor BIO, showed that GSK3beta inhibition causes a loss of negative charges to HNF4alpha, similar to what observed after TGFbeta treatment (C).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HNF4A))
bc538882-00eb-499c-ab43-33c7a0a1f86e	1.0	PubMed	22960426	In particular, by means of a chemical inhibitor and constitutive active mutant, we demonstrated that (1) TGFbeta induced HNF4alpha functional impairment is mediated by GSK3beta inactivation; and (2) GSK3beta inhibition causes HNF4alpha post-translational modifications that correlate with its DNA binding impairment.Recently, Wang have performed an extensive quantitative mass spectrometry (MS)-based analysis of cytokine mediated HNF4alpha serine and threonine phosphorylation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HNF4A))
c219fb5f-3718-481d-8add-4192bd9f29a6	1.0	PubMed	11903055	In kinase assays pka phosphorylated ser-87 of hnrnp d, whereas glycogen synthase kinase-3 beta (gsk-3 beta) phosphorylated ser-83, but only if ser-87 had been pre-phosphorylated by pka. Phosphorylation of ser-87 enhanced, whereas phosphorylation of ser-83 repressed, transactivation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HNRNPD))
c219fb5f-3718-481d-8add-4192bd9f29a6	1.0	PubMed	11903055	In kinase assays pka phosphorylated ser-87 of hnrnp d, whereas glycogen synthase kinase-3 beta (gsk-3 beta) phosphorylated ser-83, but only if ser-87 had been pre-phosphorylated by pka. Phosphorylation of ser-87 enhanced, whereas phosphorylation of ser-83 repressed, transactivation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HNRNPD))
47f22127-fc2b-4dce-8e3a-b6025db88b0f	1.0	PubMed	23349801	PI3K and AKT promotes cell self-renewal whereas the MEK/ERK-1/2, PKC/ERK-1/2 and PKC and GSK-3beta pathways down-regulate hPS cell self-renewal.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HPS1))
b9bd2038-6ff0-4393-bf49-d06d2ab822f2	1.0	PubMed	24923353	Although the molecular mechanism of HSF-1 's transcriptional regulation is not well elucidated, some evidence indicates that the activation of glycogen synthase kinase-3beta (GSK-3beta) signaling attenuates HSF-1 activity [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HSF1))
b9bd2038-6ff0-4393-bf49-d06d2ab822f2	1.0	PubMed	8940068	Ser-303 is phosphorylated by glycogen synthase kinase 3 (GSK3) through a mechanism dependent on primary phosphorylation of Ser-307 by MAPK. Secondary phosphorylation of Ser-303 by GSK3 may thus repress the activity of HSF-1, and its requirement for priming by MAPK phosphorylation of Ser-307 provides a potential link between the MAPK cascade and HSF-1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HSF1))
b9bd2038-6ff0-4393-bf49-d06d2ab822f2	1.0	PubMed	8940068	Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HSF1))
b9bd2038-6ff0-4393-bf49-d06d2ab822f2	1.0	PubMed	23959174	HSF1 transcriptional activity is negatively regulated by GSK3beta XREF_BIBR, which suggests that RPN2 knockdown may promote GSK3beta induced downregulation of HSP70 (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:HSF1))
f8129224-fb86-4d18-ad22-2fa0c65495ae	1.0	PubMed	5694272	Overexpression of GSK-3beta impaired heat shock induced activation of HSF-1, and also reduced HSP-70 production, which was partially restored by the GSK-3beta inhibitor lithium.	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q5UQ49))
f8129224-fb86-4d18-ad22-2fa0c65495ae	1.0	PubMed	4866111	Transient increases in the expression of GSK-3beta facilitate the disappearance of HSF-1 punctate granules and reduce hsp-70 transcription after heat shock.	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q5UQ49))
88bb130d-3054-457a-b547-67e86153b258	1.0	PubMed	27232758	Overexpression of GSK3beta and FBW7 was sufficient to destabilize FAAP20, impair FANCD2 activation mediated by the FA core complex, and disrupt DNA ICL repair, supporting the idea that SCF FBW7 -dependent proteolysis directly regulates the FA pathway via regulating FAAP20 degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(PFAM:PF00463))
551dd28c-9e50-4aa7-89b7-fb0310e17da2	1.0	PubMed	21145761	Because deletion of GSK3beta markedly impaired but did not completely abolish IRF3 activation and IFN-beta induction after SeV infection, it is also possible that GSK3beta is involved in an amplification cascade of virus induced interferon induction through a virally induced complex rather than being required for the first wave of production of virus induced interferons.In addition to virus triggered RLR mediated IRF3 activation pathways, our study also demonstrated that GSK3beta is required for TLR3- and TLR4 mediated IFN-beta induction.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IFNB1))
551dd28c-9e50-4aa7-89b7-fb0310e17da2	1.0	PubMed	21145761	Knockdown of GSK3beta markedly inhibited activation of ISRE and the IFN-beta promoter triggered by poly (I : C) and poly (dA : dT) transfected into 293 cells (F and 2G).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IFNB1))
bda05891-d5d4-4cf0-837f-9e00adb5cd9e	1.0	PubMed	7186553	Sustained stimulation by IGF-1 caused cardiac hypertrophy in protein synthesis and cellular morphology, and overexpression of unphosphorylatable GSK-3beta (Ad GSK-3beta S9A) repressed these hypertrophic effects of IGF-1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IGF1))
bf5121b9-111b-4d85-841b-e917dbba7b1a	1.0	PubMed	21160051	IFN-beta-mediated suppression of GSK3-beta promoted IL-10, because IL-10 production by IFN-beta-stimulated dendritic cells (DC) expressing an active GSK3-beta knockin was severely reduced, whereas pharmacological or genetic inhibition of GSK3-beta augmented IL-10 production.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IL10))
bf5121b9-111b-4d85-841b-e917dbba7b1a	1.0	PubMed	21160051	In addition, a knockdown in the cellular levels of GSK3-beta protein significantly (p < 0.01) increased IL-10 production by human DC stimulated with IFN-beta compared with control cells stimulated with IFN-beta (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IL10))
bf5121b9-111b-4d85-841b-e917dbba7b1a	1.0	PubMed	25412261	DENV infection also caused glycogen synthase kinase (GSK)-3beta inactivation in a PKA/PI3K/PKB regulated manner, and inhibition of GSK-3beta significantly increased DENV induced IL-10 production following CREB activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IL10))
bf5121b9-111b-4d85-841b-e917dbba7b1a	1.0	PubMed	22140263	Thus, GSK-3beta negatively regulates myeloid cell IL-10 production in response to leishmania.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IL10))
bf5121b9-111b-4d85-841b-e917dbba7b1a	1.0	PubMed	19734233	Because direct inactivation of GSK3beta led to the increased cellular levels of c-Jun, taken together with our findings that the repression of GSK3beta activity by IL-12 was necessary for IL-12 to induce IL-10 production from human memory CD4 + T cells, we next investigated if the stimulation of human memory CD4 + T cells in the presence of exogenous IL-12 increased the frequency of cells containing detectable levels of c-Jun protein.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IL10))
bf5121b9-111b-4d85-841b-e917dbba7b1a	1.0	PubMed	19734233	In contrast, active GSK3beta in human memory CD4 + T cells was found to suppress the IL-10 recall response of human memory CD4 + T cells upon TCR stimulation (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IL10))
a3cfce3f-5d14-4003-b4df-2ae3535b0777	1.0	PubMed	19244213	Consistently, GSK3beta overexpression inhibits IL-17 signaling to a C/EBP dependent reporter, and GSK3beta deficient cells fail to induce phosphorylation at T179.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IL17A))
a3cfce3f-5d14-4003-b4df-2ae3535b0777	1.0	PubMed	26374165	Pharmacological inhibition of GSK-3beta with SB216763 (but not of the other investigated molecules by appropriate inhibitors) significantly reversed the IL-17 inhibitory effect on Del-1 mRNA and protein expression (XREF_FIG, respectively).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IL17A))
7e82d30a-15ed-4756-a2b8-dad30b288d96	1.0	PubMed	20956547	Consistent with inhibition of GSKbeta by Akt and GSK3beta dependent degradation of the prosurvival factor MCL1 (XREF_BIBR), bPTEN and SHIP -/- B cells expressed elevated amounts of MCL1 compared with WT, bPTEN -/-, or bSHIP -/- B cells at all time points examined (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:INPP5D))
34b905f2-00c8-49e3-84c6-a6861b2b1baf	1.0	PubMed	26402673	We found that a deficiency in PTP1B O GlcNAcylation resulted in an increase in insulin stimulated phosphorylation of Akt and GSK3beta, and hence might reverse the downstream events of insulin signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:INS))
34b905f2-00c8-49e3-84c6-a6861b2b1baf	1.0	PubMed	23583197	Therefore, the peptide developed in this study is expected to have reduced side effects in diverse types of normal cells, compared to constitutively active GSK3beta inhibitors.Release of insulin from the pancreatic beta-cell is stimulated by an elevated blood glucose level, and the insulin release is stopped when the blood glucose level is back to the normal.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:INS))
a47088f6-a94e-4585-a282-e22ee0c12d46	1.0	PubMed	20883816	We discovered that inhibition of GSK-3beta increased the proportion of NIH 3T3 cells displaying nuclear IQGAP1 by up to 300%, with similar results in NRK52e cells (C and D).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IQGAP1))
e3077488-1bb9-40c0-843e-b04007cb9b7d	1.0	PubMed	21145761	Knockdown of GSK3beta did not significantly inhibit IFN-gamma-induced activation of the IRF1 promoter (E), suggesting that GSK3beta is specifically involved in virus triggered IRF3 activation and IFN-beta expression.We further determined whether GSK3beta is involved in intracellular dsRNA- or dsDNA triggered signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IRF1))
fb4328ef-1691-47a1-b28d-b91ad08388a2	1.0	PubMed	21145761	Because deletion of GSK3beta markedly impaired but did not completely abolish IRF3 activation and IFN-beta induction after SeV infection, it is also possible that GSK3beta is involved in an amplification cascade of virus induced interferon induction through a virally induced complex rather than being required for the first wave of production of virus induced interferons.In addition to virus triggered RLR mediated IRF3 activation pathways, our study also demonstrated that GSK3beta is required for TLR3- and TLR4 mediated IFN-beta induction.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:IRF3))
4f9383e8-4410-468a-a78e-b9173115f266	1.0	PubMed	23874688	Inhibition of GSK 3beta Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
6e4c48c6-c72e-4c92-9371-41233b30b302	1.0	PubMed	17726008	Inhibition of GSK3beta kinase activity with SB216763 results in enhanced MEKK4 kinase activity and increased JNK and p38 activation, indicating that an active state of GSK3beta is required for binding and inhibition of MEKK4 dimerization.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:JNK))
6e4c48c6-c72e-4c92-9371-41233b30b302	1.0	PubMed	17726008	However, unlike TRAF4, Axin, and GADD45, GSK3beta inhibits MEKK4 activity and prevents its activation of JNK and p38.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:JNK))
69e333ea-4ca8-4789-bbfb-271133dde185	1.0	PubMed	4445512	Lithium treatment also leads to activation of an AP-1-luciferase reporter in Xenopus embryos, consistent with previous observations that GSK-3 beta inhibits c-jun activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:JUN))
69e333ea-4ca8-4789-bbfb-271133dde185	1.0	PubMed	16023596	The c-jun and c-myc oncogenic transcription factors are highly unstable proteins due to polyubiquitination. Similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation.Phosphorylation of Thr-239 and Ser-243 is required for Fbw7-mediated c-Jun disappearance	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:JUN))
69e333ea-4ca8-4789-bbfb-271133dde185	1.0	PubMed	16023596	The c-jun and c-myc oncogenic transcription factors are highly unstable proteins due to polyubiquitination. Similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation.Phosphorylation of Thr-239 and Ser-243 is required for Fbw7-mediated c-Jun disappearance	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:JUN))
69e333ea-4ca8-4789-bbfb-271133dde185	1.0	PubMed	1846781	Phosphorylation of recombinant human c-jun proteins in vitro by gsk-3 decreases their dna-binding activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:JUN))
69e333ea-4ca8-4789-bbfb-271133dde185	1.0	PubMed	24027432	Moreover, only simultaneous enforcement of COP1 and constitutively active GSK3beta (GSK3betaS9A) expression was able to effectively downregulate c-Jun in invasive breast cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:JUN))
69e333ea-4ca8-4789-bbfb-271133dde185	1.0	PubMed	24027432	To conclude, our study suggests that COP1 and GSK3beta cooperate to promote c-Jun degradation and, hence, subsequent inhibition of breast tumor progression and metastasis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:JUN))
9aaf2b60-82bf-4642-bb9c-bc4811def566	1.0	PubMed	25541373	Emerging evidence also suggests that GSK-3beta, is an important modulator of apoptosis, with the inactivation of GSK-3beta shown to mediate cAMP evoked neuroprotection from serum deprivation and a lowering of the KCl concentration in rat cerebellar granule neurons ().	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:4873))
25d937d3-1e26-4f67-85f9-a7a52b850314	1.0	PubMed	26935904	Accordingly, in the present study we hypothesized that redundant ROS downregulated VEGFR-2 through beta-TrCP-induced UPS dependent VEGFR-2 degradation, which was likely mediated by GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KDR))
25d937d3-1e26-4f67-85f9-a7a52b850314	1.0	PubMed	26935904	ROS activated GSK-3beta induces VEGFR-2 degradation in HUVECs.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KDR))
1645ec4d-f3dc-4930-940e-3941eadd1fac	1.0	PubMed	24577092	Manipulation of GSK3beta and MYOGENIN activity reduces tumorigenic properties of ARMS derived RH30 cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KIDINS220))
1645ec4d-f3dc-4930-940e-3941eadd1fac	1.0	PubMed	23118350	Using AD brain necropsies, glycogen synthase kinase 3-beta (GSK3beta)-transgenic mice and cell models of AD related neurodegeneration, we show that GSK3beta phosphorylation decreases Kidins220 susceptibility to calpain proteolysis, while protein phosphatase 1 (PP1) action has the opposite effect.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KIDINS220))
ec792409-462c-4693-ab37-bbceacd93f18	1.0	PubMed	20008284	Similarly, the close correlation between GSK3beta knockdown and reduction in SCF induced chemotaxis in the GSK3beta knockdown-HuMCs, also provides evidence for a pre-requisite role for GSK3beta in the SCF induced chemotactic response.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KITLG))
af2177a8-c16a-4b72-a601-4de5df2f86b0	1.0	PubMed	26822034	Thus, WT Mcl-1 will still be degraded by GSK3beta Ser 389 Ala in KI B cells, but the mMcl-1 mutant should be protected from degradation.	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:4875))
35302373-47ed-4255-aa83-dca8afaf61cb	1.0	PubMed	24398687	Stability of the klf5 is mediated by proteasomal degradation via phosphorylation by glycogen synthase kinase 3_ (gsk3_) and recognition by f-box and wd repeat domain-containing 7 (fbw7) of a phosphodegron sequence surrounding serine 303 in klf5	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KLF5))
02777a94-8869-456d-89e9-177c5f062ea9	1.0	PubMed	23085750	Taken together, however, these results indicate that GSK3beta enhances the growth-suppressive activity of KLF6 at least in part through phosphorylation, thereby enhancing KLF6 mediated transactivation of p21.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KLF6))
05bd3392-ff20-410c-9780-4e5192175f7c	1.0	PubMed	26022178	Similarly, GSK-3beta knockdown significantly enhanced the secretion of IFN-gamma via NKG2D and 2B4 combination and of MIP-1alpha in response to NKG2D, 2B4, or both (C).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KLRK1))
bd834607-9eaf-413d-807e-defca386dc56	1.0	PubMed	20541704	Activated AKT, which physiologically inhibits GSK-3, also decreased cell proliferation, and GSK-3beta knockdown increased sensitivity to GSK-3 inhibitors (XREF_SUPPLEMENTARY) phenocopying the responses of MLL transformed cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:KMT2A))
f6fc7ae6-576b-47cb-b682-304d330240e1	1.0	PubMed	25390651	Activation of the mK ATP channel induced inhibitory phosphorylation of GSK-3beta and suppressed ROS production, LDH release and apoptosis after AA washout.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:LDH))
8dd07734-c8cd-4e04-8a78-def3b9c29395	1.0	PubMed	21689639	Furthermore, transfection of GSK3beta attenuated Lef1- and beta-catenin-induced promoter activity (B).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:LEF1))
1a4f6733-6553-477b-b42f-cb4d95e93505	1.0	PubMed	18243161	Pharmacological inhibitor of PI3K, LY294002, abrogated this GSK-3beta inactivation downstream of LPS, suggesting that PI3K and Akt may negatively modulate GSK-3beta thereby inactivating p65 transactivation downstream of LPS.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:16412))
7ced2d85-0020-412c-8574-5d0c3af0b56b	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAFA))
7ced2d85-0020-412c-8574-5d0c3af0b56b	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAFA))
7ced2d85-0020-412c-8574-5d0c3af0b56b	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAFA))
7ced2d85-0020-412c-8574-5d0c3af0b56b	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAFA))
ac19e192-df23-43a6-b068-2f1862471bf0	1.0	PubMed	18042454	We showed that c-maf and mafb, like mafa, are indeed phosphorylated by gsk-3/ we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAFB))
4a88cc35-0763-4fad-abb2-76110e2681ce	1.0	PubMed	18042454	We showed that c-maf and mafb, like mafa, are indeed phosphorylated by gsk-3/ we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAF))
79109b40-55c9-45e7-acf0-a1c3651462f7	1.0	PubMed	23029358	The active form of GSK3beta directly interacts with the N-terminus of MAML1 to inhibit MAML1 transcriptional activity XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAML1))
79109b40-55c9-45e7-acf0-a1c3651462f7	1.0	PubMed	19740771	We found that gsk3beta inhibits maml1 transcriptional activity by directly targeting the n-terminal domain of maml1	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAML1))
3b60dc6f-b48e-4958-9af4-ee0de45c2e03	1.0	PubMed	5123939	Inhibition of GSK-3 beta leads to a decrease in a phosphorylated form of microtubule associated protein-1B (MAP-1B), a protein involved in microtubule assembly, and a concomitant decrease in the level of stable microtubules.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAP1B))
3b60dc6f-b48e-4958-9af4-ee0de45c2e03	1.0	PubMed	19576885	Thus, inhibition of GSK-3beta activity by lithium induces the release of MAP1B from the microtubules.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAP1B))
23b041c0-ee92-46e5-8af9-90986a59b040	1.0	PubMed	25115395	Western blot analysis showed that reconstitution of GSK3beta activity, to a large extent, repressed mTOR activation by Aur-A overexpression, as well as increased LC3 conversion during nutrient deprivation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:MAP1LC3))
b3b2ec6b-db8f-4991-a78e-2a26c3c6b981	1.0	PubMed	21880738	Overexpression of GSK3beta-WT or the S9A mutant was unable to antagonize MLK3 induced stabilization, suggesting this to be independent of GSK3beta pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAP3K11))
4e39c6f0-8048-4947-9e4e-a3461562aaf4	1.0	PubMed	24348429	It is also an antagonist of GSK3beta (glycogen synthase kinase 3 beta), which inhibits MEKK4 kinase (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAP3K4))
4e39c6f0-8048-4947-9e4e-a3461562aaf4	1.0	PubMed	17726008	Gsk3beta binding to mekk4 blocks mekk4 dimerization that is required for mekk4 activation, effectively inhibiting mekk4 stimulation of the jnk and p38 mapk pathways	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAP3K4))
4e39c6f0-8048-4947-9e4e-a3461562aaf4	1.0	PubMed	17726008	MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAP3K4))
4e39c6f0-8048-4947-9e4e-a3461562aaf4	1.0	PubMed	17726008	However, unlike TRAF4, Axin, and GADD45, GSK3beta inhibits MEKK4 activity and prevents its activation of JNK and p38.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAP3K4))
fd74e458-d59a-489a-8976-64b442331bd0	1.0	PubMed	17726008	Here we show that similar to the interaction with traf4 and axin, the kinase domain of mekk4 interacts with the multifunctional serine/threonine kinase gsk3beta. Gsk3beta binding to mekk4 blocks mekk4 dimerization that is required for mekk4 activation, effectively inhibiting mekk4 stimulation of the jnk and p38 mapk pathways	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPK14))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	21949350	We also demonstrate that GSK-3beta (shaggy) is a common suppressor of tau, Abeta42 and TDP-43 toxicity, and that GSK-3beta activity is strongly upregulated due to mutant TDP-43 expression.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	21215781	Gsk3b phosphorylates tau at t231tau phosphorylation at t231, s235 and s262 also contributes to the dissociation of tau from microtubules	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20308788	Abnormal hyperphosphorylation of tau appears to be crucial in neurofibrillary degeneration in alzheimer's disease (ad). Gsk-3beta phosphorylated tau at many sites, with ser199, thr205, and ser396 being the most favorable sites in cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	21443865	GSK3B might modulate tau mRNA splicing and then reduce the ability of tau to bind to microtubules ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20308788	Abnormal hyperphosphorylation of tau appears to be crucial in neurofibrillary degeneration in alzheimer's disease (ad). Gsk-3beta phosphorylated tau at many sites, with ser199, thr205, and ser396 being the most favorable sites in cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	17078951	Here, we found that prephosphorylation by pka promotes gsk-3beta-catalyzed tau phosphorylation at thr181, ser199, ser202, thr205, thr217, thr231, ser396 and ser422	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	17078951	Here, we found that prephosphorylation by pka promotes gsk-3beta-catalyzed tau phosphorylation at thr181, ser199, ser202, thr205, thr217, thr231, ser396 and ser422	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	21215781	Tau pseudophosphorylation at specific sites such as s262, s293, s324 and s356 was reported to induce tau conformational change and attenuate tau binding to microtubules (fischer et al., 2009). Then, newly soluble tau proteins are targeted by post-translational modifications that directly or indirectly alter tau conformation, promoting tau dimerization in an anti-parallel manner. Stable tau dimers form tau oligomers, which continue in the aggregation process	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	9771888	Tau is phosphorylated by gsk-3 at several sites found in alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by a-kinase.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	9771888	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	9832145	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
972a28c4-c91b-4b64-91f8-5c5f99eea329	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MAPT))
fba971ae-9c6d-4dec-bad5-fbc9ef89e20d	1.0	PubMed	21821001	GSK-3beta negatively regulates Mcl-1 to facilitate growth-factor withdrawal induced mitochondrial apoptosis : Mcl-1, an apoptotic substrate of GSK-3beta, was degraded through GSK-3beta-mediated phosphorylation followed by proteasome mediated degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MCL1))
fba971ae-9c6d-4dec-bad5-fbc9ef89e20d	1.0	PubMed	17991738	Pharmacologic inhibition of GSK-3beta prevents the disappearance of Noxa induced by sorafenib and enhances the down-modulation of Mcl-1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MCL1))
fba971ae-9c6d-4dec-bad5-fbc9ef89e20d	1.0	PubMed	25412261	Indeed, the quantitative data of Western blotting showed that GSK-3beta was significantly (P < 0.01) inhibited by phosphorylation at Ser9 XREF_BIBR in DENV infected THP-1 cells (XREF_FIG, upper panel); this GSK-3beta inhibition was also accompanied by an accumulation of beta-catenin and Mcl-1 protein, substrates that are negatively regulated by GSK-3beta XREF_BIBR, XREF_BIBR (XREF_FIG, lower panel).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MCL1))
fba971ae-9c6d-4dec-bad5-fbc9ef89e20d	1.0	PubMed	26822034	GSK3beta also promotes the degradation of Mcl-1 through phosphorylation on Ser 159 (mouse Ser 140) XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MCL1))
fba971ae-9c6d-4dec-bad5-fbc9ef89e20d	1.0	PubMed	20956547	Consistent with inhibition of GSKbeta by Akt and GSK3beta dependent degradation of the prosurvival factor MCL1 (XREF_BIBR), bPTEN and SHIP -/- B cells expressed elevated amounts of MCL1 compared with WT, bPTEN -/-, or bSHIP -/- B cells at all time points examined (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MCL1))
fba971ae-9c6d-4dec-bad5-fbc9ef89e20d	1.0	PubMed	16543145	We investigated the role of glycogen synthase kinase-3 (gsk-3), which is inactivated by akt, for its role in the regulation of apoptosis. Upon il-3 withdrawal, protein levels of mcl-1 decreased but were sustained by pharmacological gsk-3, which prevented cytochrome c release and apoptosis. Mcl-1 was phosphorylated by gsk-3 at a conserved gsk-3 phosphorylation site (s159). S159 phosphorylation of mcl-1 was induced by il-3 withdrawal or pi3k inhibition and prevented by akt or gsk-3, and it led to increased ubiquitinylation and degradation of mcl-1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MCL1))
1f360d70-bf2b-4ba0-8199-760eed6b6371	1.0	PubMed	21628454	Zoledronic acid disrupts this NFATc2 stabilization pathway through two mechanisms, namely GSK-3beta inhibition and induction of HDM2 activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MDM2))
1f8dda37-fe41-4444-af8f-88ce20aafd5b	1.0	PubMed	10587587	The same serine was found to be phosphorylated in vivo, and expression of dominant negative GSK3beta selectively suppressed the ability of MITF to transactivate the tyrosinase promoter.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MITF))
1f8dda37-fe41-4444-af8f-88ce20aafd5b	1.0	PubMed	23334344	Interestingly, the MITF mRNA steady-state level was not reversed (and was even further downregulated) by LiCl mediated GSK3beta inhibition (), whereas phospho-beta-catenin IR in anagen VI HFs was normalized by LiCl in P-cadherin-silenced HFs ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MITF))
1f8dda37-fe41-4444-af8f-88ce20aafd5b	1.0	PubMed	5320311	The same serine was found to be phosphorylated in vivo, and expression of dominant negative GSK3beta selectively suppressed the ability of MITF to transactivate the tyrosinase promoter.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MITF))
1aca4476-dedc-417c-b5a4-3ef1d8004baa	1.0	PubMed	24425879	Here we show that gsk-3_ inactivates the proapoptotic activity of hlxb9 by phosphorylating hlxb9 at ser-78/ser-80 (phlxb9).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MNX1))
1aca4476-dedc-417c-b5a4-3ef1d8004baa	1.0	PubMed	24425879	Here we show that gsk-3_ inactivates the proapoptotic activity of hlxb9 by phosphorylating hlxb9 at ser-78/ser-80 (phlxb9).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MNX1))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	23874688	GSK3beta activity can be abrogated by direct phosphorylation on the Ser9 residue by phosphatidylinositol 3-kinase (PI3K)/Akt, mitogen activated protein kinase (MAPK)/p90RSK, or mammalian target of rapamycin and S6K upon a number of extracellular stimuli, such as insulin, epidermal growth factor, or fibroblast growth factor XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21329734	In other words, activation of mTOR signaling by visfatin contributes to GSK3beta inactivation in human endothelial cells.In contrast, GSK3beta inhibition can result in mTOR activation according to Inoki et al..	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	25115395	Pharmacological inhibition of GSK3beta activity caused mTOR signaling activation and autophagy induction in both SKBR-3 and BT-549 cells (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	25115395	Western blot analysis showed that reconstitution of GSK3beta activity, to a large extent, repressed mTOR activation by Aur-A overexpression, as well as increased LC3 conversion during nutrient deprivation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	25115395	Here we showed that reconstitution of GSK3beta kinase activity repressed mTOR signaling with the presence of Aur-A overexpression.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	25115395	However, reconstitution of GSK3beta activity did not totally attenuate mTOR activation by Aur-A, suggesting Aur-A might regulate mTOR signaling cascade by other mechanisms besides suppressing GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	26301867	Canonical Wnt and mTOR pathways can be negatively regulated by the serine/threonine kinase GSK3beta [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21592956	We found that Ser 9 phosphorylation of the Akt substrate GSK3beta in both human platelets and adipocytes was unaffected by inhibition of mTOR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21737790	Suppression of GSK-3beta activation significantly attenuated suppression of mTOR during ischemia, indicating a causative role of GSK-3beta activation in mediating mTOR inhibition.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21737790	Suppression of mTOR by GSK-3beta was reversed when TSC2 was down-regulated, indicating that GSK-3beta regulates mTOR through TSC2 in cardiomyocytes.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21737790	Constitutive activation of GSK-3beta inhibited activation of mTOR during reperfusion, suggesting that phosphorylation and suppression of GSK-3beta plays an essential role in mediating mTOR activation during reperfusion as well.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21737790	Both at baseline and after 2 hours of ischemia, the phosphorylation level of p70 S6 kinase (S6K), a downstream target phosphorylated by mTOR, in Tg-DnGSK-3beta mice (XREF_FIG) was increased, but that in betaKI mice was decreased (XREF_FIG), compared with that of WT mice, indicating that inhibition of GSK-3beta increased, but activation of GSK-3beta inhibited mTOR activity after prolonged ischemia.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21737790	Importantly, ischemia decreased the phosphorylation level of S6K in NTg and WT mice, indicating that dephosphorylation of GSK-3beta by ischemia might inhibit mTOR activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21737790	These results suggest that inhibition of GSK-3beta increases mTOR activity, while activation of GSK-3beta decreases mTOR activity during I/R.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21737790	These results suggest that inhibition of GSK-3beta increases mTOR activity, while activation of GSK-3beta decreases mTOR activity during I/R.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
f72538f6-e266-4f4e-8742-0ddd5d921303	1.0	PubMed	21737790	These results suggest that GSK-3beta down-regulates mTOR through TSC2 dependent mechanisms in cardiomyocytes.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTOR))
32cc60c6-f5c6-4eb1-8807-34a0e1fa5f5c	1.0	PubMed	24318128	Interestingly, we found that CKIdelta, but not GSK3beta, efficiently promoted the degradation of MTSS1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MTSS1))
ab9e6fde-a992-4d60-8634-c229db43ee1b	1.0	PubMed	24316184	Additionally, the COXII and VDAC induction effect by 2-DG was suppressed by GSK3beta-KD overexpression while promoted by WT-GSK3beta overexpression confirming the involvement of GSK3 in 2-DG-induced mitochondrial biogenesis ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:"MT-CO2"))
c1c4f906-f053-4302-a47c-6e797836bcae	1.0	PubMed	9819408	GSK3beta binds directly to an STDRSPYE site in MUC1 and phosphorylates the serine adjacent to proline. Phosphorylation of MUC1 by GSK3beta decreases binding of MUC1 to beta-catenin in vitro and in vivo.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MUC1))
da8e207a-51b9-498e-b61c-bbe9bafb466c	1.0	PubMed	21795403	GSK3beta inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYB))
da8e207a-51b9-498e-b61c-bbe9bafb466c	1.0	PubMed	21795403	GSK3beta inactivation increased c-Myb degradation, and overexpression of c-Myb could block the inhibitory effect of GSK3beta inactivation on cell proliferation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYB))
b00366fc-9539-47d7-8150-31596d5518bb	1.0	PubMed	24391509	MYCN directly transactivates both NCYM and MYCN mRNA, whereas NCYM stabilizes MYCN protein by inhibiting the activity of GSK3beta, a kinase that promotes MYCN degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYCN))
7a00360e-e4d0-44bb-b1de-45445fdb3dcd	1.0	PubMed	22364879	The specific inhibition of GSK3beta activity by LiCl () prevented Myc degradation and consistently blocked the cell differentiation process, as revealed by the inhibition of the expression of CDX2 and SI.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYC))
7a00360e-e4d0-44bb-b1de-45445fdb3dcd	1.0	PubMed	23768967	GSK-3beta phosphorylation acts to cause the degradation of the Myc protein - a process critical for cell cycle exit in cerebellar neural precursors.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYC))
7a00360e-e4d0-44bb-b1de-45445fdb3dcd	1.0	PubMed	25310895	Likewise, the expression of Ser-9-phosphorylated GSK-3beta, an inactive form of kinase, was found to be significantly downregulated in miR-451-overexpressed or c-Myc-downregulated docetaxel resistant LAD cells, and overexpression of GSK-3beta could reverse the effects of miR-451 upregulation or c-Myc downregulation on the activity of snail promoter.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYC))
7a00360e-e4d0-44bb-b1de-45445fdb3dcd	1.0	PubMed	17397930	In human neuroblastoma SH-SY5Y cells, inhibition of GSK3beta by lithium causes increased Myc nuclear protein levels ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYC))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
f4ed21b0-ad77-4b16-bcd5-5ff4264093e3	1.0	PubMed	16141410	Myocardin induced ANF transcription and increase in total protein amount were enhanced by GSK3beta blockade (10 mmol/L LiCl), indicating that GSK3beta inhibits myocardin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOCD))
a3d8e331-6f78-4231-a3bd-88c556937794	1.0	PubMed	24577092	We report here that PAX3-FOXO1 enhances glycogen synthase kinase 3beta (GSK3beta) activity which in turn represses MYOGENIN activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOG))
a3d8e331-6f78-4231-a3bd-88c556937794	1.0	PubMed	24577092	On the basis of the in silico prediction of a single consensus phosphorylation site for GSK3beta on the MYOGENIN protein and also high levels of GSK3beta activity in these cells, we determined that MYOGENIN function is potently repressed by GSK3beta activity in ARMS.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOG))
a3d8e331-6f78-4231-a3bd-88c556937794	1.0	PubMed	24577092	MYOGENIN trans-activation function is repressed by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOG))
a3d8e331-6f78-4231-a3bd-88c556937794	1.0	PubMed	24577092	XREF_BIBR, XREF_BIBR, XREF_BIBR Thus, our observations reported here, that MYOGENIN function in ARMS is repressed by inappropriate sustained signaling by the kinase GSK3beta, may be of considerable significance for understanding the etiology of this disease.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOG))
a3d8e331-6f78-4231-a3bd-88c556937794	1.0	PubMed	24577092	In PAX3-FOXO1 expressing ARMS cells, our data indicate that sustained GSK3beta activity represses MYOGENIN function, contributing to the transformed, proliferative phenotype of these cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:MYOG))
6700d311-fa76-48ba-b8b4-624f577db01d	1.0	PubMed	15005626	Gsk3 beta-dependent phosphorylation of the alpha nac coactivator regulates its nuclear translocation and proteasome-mediated degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NACA))
51e01476-21a9-4004-b29b-43fedbc5143f	1.0	PubMed	7191837	We demonstrated that the inhibition of GSK3beta activity by treatment of cells with the inhibitor 5-iodo-indirubin-3 '-monoxime, as well as with a dominant negative GSK3beta mutant, induced the accumulation of alphaNAC in the nuclei of cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NACA))
01ab2658-b97a-4ff3-8511-6c1a66a9eb00	1.0	PubMed	24333432	We found that inhibition of GSK3beta could increase nucleolin protein and mRNA levels.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NCL))
9e36e411-b9b8-454a-b25a-40cd55f682a8	1.0	PubMed	21798082	Gsk3b is able to phosphorylate nebulin at two ser sites in the c-terminal region of nebulin localized to the z-disk, thus preventing the interaction of nebulin with neuronal wiscott-aldrich syndrome protein (nwasp), a ubiquitously expressed member of the wasp family, which is involved in actin assembly.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NEB))
fd516587-85fb-491c-8202-ca16a5ce9d7c	1.0	PubMed	12130654	Gsk3beta was shown to phosphorylate at ser-493 in vitro by phosphopeptide mapping and site-directed mutagenesis, and in vivo in hek293 cells. The role of ser-493 phosphorylation is also a question to be addressed in the future. Because the e-segment appears to be involved in filament formation (27, 42), phosphorylation in that region may also play a regulatory role in filament formation. Secondary structure prediction suggests that phosphorylation of ser-493 in combination with following the pro residue interrupts _-helix of the e-segment	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NEFH))
29d55d4c-c14f-4637-b47f-2b013251354f	1.0	PubMed	25056574	We found that treatment with LGK974, an inhibitor of the PORCN related Wnt and beta-catenin signaling pathway, significantly inhibited the formation of Nestin high -mediated mammospheres; however, treatment with SB216763, an inhibitor of GSK-3beta, significantly enhanced the formation of Nestin low -mediated mammospheres in vitro (P < 0.05 for both, Figure XREF_FIG D).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NES))
b491312f-8e51-4be3-a373-d83b75123fc1	1.0	PubMed	4922297	GSK3beta, which inhibits NeuroD function in vivo, blocks both Ngn1 induced and NeuroD induced neuronal differentiation, while Notch signaling inhibits only Ngn1 induced neuronal differentiation, confirming that NeuroD is downstream of Ngn1 and insensitive to Notch inhibition.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NEUROD1))
b491312f-8e51-4be3-a373-d83b75123fc1	1.0	PubMed	4925516	On the basis of these data we propose that GSK3beta inhibits the function of NeuroD and therefore prevents neuronal differentiation at a relatively late stage in the developmental pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NEUROD1))
2b06c150-cb44-4e83-9695-e9938e391954	1.0	PubMed	22986745	al. reported that silencing GSK3B decreased the NFAT1 transcriptional activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFATC2))
2b06c150-cb44-4e83-9695-e9938e391954	1.0	PubMed	26022178	Thus, such an enhancement of NFAT1 activation by GSK-3beta inhibition might be accounted for by a dual mechanism : reduced nuclear export of NFAT1 and/or its increased nuclear import.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFATC2))
2b06c150-cb44-4e83-9695-e9938e391954	1.0	PubMed	15276472	Gsk3 was previously shown to directly phosphorylate the n-terminal regulatory domain of nfatc1, thus antagonizing the action of calcineurin and inhibiting nuclear shuttling of nfat.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFATC2))
a5c64564-f1d9-4cac-89e3-5932f8d1b046	1.0	PubMed	26022178	Accumulating evidences suggest that GSK-3beta functions as a NFAT kinase and thereby inhibits NFAT activation through direct phosphorylation of NFAT at conserved serine residues necessary for nuclear export.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFAT))
a5c64564-f1d9-4cac-89e3-5932f8d1b046	1.0	PubMed	26496802	We propose that pharmacological inhibition of DYRK1A and GSK3B can drive supra-physiological levels of NFAT activation and an increase in beta-cell proliferation beyond that achievable even under conditions of increased glucose load XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFAT))
2060fdde-73aa-4be6-97d2-56f73527b83e	1.0	PubMed	23623971	Both Fbw7 and GSK3beta-CA reduced Nrf1 in HEK293 cells (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFE2L1))
2060fdde-73aa-4be6-97d2-56f73527b83e	1.0	PubMed	23623971	Glycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (nrf1) and inhibits pro-survival function of nrf1	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFE2L1))
bc388169-a75b-4f87-b6a6-c96b0abc3d9f	1.0	PubMed	26262608	Nrf2 protein degradation could be mediated by the phosphorylation of GSK-3beta and beta-TrCP.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFE2L2))
bc388169-a75b-4f87-b6a6-c96b0abc3d9f	1.0	PubMed	26197224	GSK-3beta phosphorylation at Ser9 is thought to play a pivotal role in regulation GSK-3beta activity, which can inactivate Nrf2 ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFE2L2))
bc388169-a75b-4f87-b6a6-c96b0abc3d9f	1.0	PubMed	26197224	Over-activation of GSK-3beta can inactivate Nrf2 ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFE2L2))
f2257cc7-24ff-4177-9278-d16e17e1911b	1.0	PubMed	22864569	In WT cells, treatment with the pharmacological GSK3beta-inhibitor BIO increased the levels of p100, whereas ectopic expression of active GSK3beta together with Fbw7 reduced p100 levels efficiently (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NFKB2))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	12398896	As beta-catenin is a major downstream target of GSK-3beta, depletion of GSK-3beta may lead to an elevated beta-catenin expression and suppressed NF-kappaB activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	27060477	Repression of GSK-3beta lead to upregulation of cell proliferation could be rescued by inhibition of GABA B R. Further, inhibition of GSK-3beta could inhibit NF-kappaB so that to suppress the cancer cell proliferation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	21110852	Genetic depletion of GSK-3beta by RNA interference suppresses basal NF-kappaB transcriptional activity, leading to decreased pancreatic cancer cell proliferation and survival [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	22216350	Moreover, Akt could act, at least in part, through IKKalpha to activate canonical NF-kappaB activity XREF_BIBR and GSK3beta could suppress NF-kappaB activity by inhibiting IKK and stabilizing IkappaB XREF_BIBR (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	27929056	Our finding is in accordance with a recent study demonstrating that inhibition of GSK-3beta in quiescent cells resulted in activation of NF-kappaB through degradation of IkappaBalpha XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	27929056	These data indicate that loss of GSK-3beta results in defective NF-kappaB signalling in response to TNFalpha stimulation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	21145761	Knockdown of GSK3beta also inhibited NF-kappaB activation mediated by overexpression of VISA and TRIF, suggesting that GSK3beta is important for both RIG-I and MDA5 and TLR3 mediated NF-kappaB activation (C).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	21514616	GSK-3beta inhibition through lithium or indirubin treatment blocked NF-kB inhibition, the suppressive binding of RelA to HDAC3, and neuronal apoptosis (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	21514616	GSK-3beta can directly inhibit NF-kB through phosphorylation of RelA at serine 468, resulting in an inactivate form of NF-kB (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	25829335	Inactivation of GSK-3beta by the PI3K and Akt signaling pathway also participate in the regulation of inflammatory pathways, as it has been shown that Akt induced inhibition of GSK-3beta negatively modulate the NF-kappaB pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	18606491	In colon and pancreatic cancer cells, GSK3beta positively regulates NF-kappaB and inactivation of GSK3beta inhibits NF-kappaB activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	18606491	However, GSK3beta is reported to inhibit NF-kappaB activity in neuronal cells and astrocytes.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	19180470	We suggest from our work that inactivation of GSK-3beta will decrease NF-kappaB activity by preventing nuclear localization of NF-kappaB.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	19180470	Previous reports show that PI3K inhibits GSK-3beta through phosphorylation at Ser9 [XREF_BIBR; XREF_BIBR] and that inactivation of GSK-3beta can either increase NF-kappaB activity [XREF_BIBR; XREF_BIBR] or decrease NF-kappaB activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	19180470	The inactivation of GSK-3beta inhibited the NF-kappaB activity, a transcription factor that functions in TNF-alpha expression.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
4a323934-810c-42fb-b13a-20dd4546c338	1.0	PubMed	25327559	The observation that stable but not acute silencing of GSK-3beta increased NFkappaB activity prompted us to determine the effects of acute silencing on NFkappaB dependent transcription.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:NFkappaB))
cc59171e-b073-4449-be52-4da2b1978327	1.0	PubMed	12794074	We show that gsk-3beta directly binds at c-terminal of the notch2 ankyrin repeats and phosphorylates thr-2068 and/or ser-2070, thr-2074, and thr-2093.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NOTCH2))
cc59171e-b073-4449-be52-4da2b1978327	1.0	PubMed	12794074	We show that gsk-3beta directly binds at c-terminal of the notch2 ankyrin repeats and phosphorylates thr-2068 and/or ser-2070, thr-2074, and thr-2093.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NOTCH2))
cc59171e-b073-4449-be52-4da2b1978327	1.0	PubMed	12794074	We show that gsk-3beta directly binds at c-terminal of the notch2 ankyrin repeats and phosphorylates thr-2068 and/or ser-2070, thr-2074, and thr-2093.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NOTCH2))
cc59171e-b073-4449-be52-4da2b1978327	1.0	PubMed	19000719	beta-catenin can be phosphorylated by GSK3beta and regulated by the proteosome dependent degradation machinery, and Notch2 is also associated with GSK3beta, which inhibits the Notch2 activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NOTCH2))
cc59171e-b073-4449-be52-4da2b1978327	1.0	PubMed	12794074	Ser-2093 is efficiently phosphorylated by GSK-3β and, to a minor extent, residues Thr-2068 and/or Ser-2070 and Thr-2074 of Notch2 are also targets for GSK-3β-dependent phosphorylation. We also find that GSK-3β-dependent phosphorylation of Notch2 is inhibiting transcriptional activation of different Notch target genes.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NOTCH2))
cc59171e-b073-4449-be52-4da2b1978327	1.0	PubMed	12794074	Ser-2093 is efficiently phosphorylated by GSK-3β and, to a minor extent, residues Thr-2068 and/or Ser-2070 and Thr-2074 of Notch2 are also targets for GSK-3β-dependent phosphorylation. We also find that GSK-3β-dependent phosphorylation of Notch2 is inhibiting transcriptional activation of different Notch target genes.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NOTCH2))
cc59171e-b073-4449-be52-4da2b1978327	1.0	PubMed	12794074	Ser-2093 is efficiently phosphorylated by GSK-3β and, to a minor extent, residues Thr-2068 and/or Ser-2070 and Thr-2074 of Notch2 are also targets for GSK-3β-dependent phosphorylation. We also find that GSK-3β-dependent phosphorylation of Notch2 is inhibiting transcriptional activation of different Notch target genes.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NOTCH2))
cc59171e-b073-4449-be52-4da2b1978327	1.0	PubMed	12794074	Ser-2093 is efficiently phosphorylated by GSK-3β and, to a minor extent, residues Thr-2068 and/or Ser-2070 and Thr-2074 of Notch2 are also targets for GSK-3β-dependent phosphorylation. We also find that GSK-3β-dependent phosphorylation of Notch2 is inhibiting transcriptional activation of different Notch target genes.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NOTCH2))
a25acb0a-5251-4efd-bc38-e86cbdfaba53	1.0	PubMed	20599907	Both GSK3beta and GSK3beta-K85A inhibited Angiotensin II activation of ANF-luc in H9c2 cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NPPA))
b7b9cc48-66ff-4acc-bcc7-7ba0bb0bed48	1.0	PubMed	22209410	As expected TrkB.T1 overexpression alone decreased TrkB signaling, which is most clearly seen as suppression of Akt (protein kinase B) and glycogen synthase kinase 3beta (GSK-3beta) activity (measured as the ratio between the active, phosphorylated form and the total levels of the corresponding protein).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NTRK2))
f9f00183-36f3-41a9-9792-b59ddef8409e	1.0	PubMed	24412473	Moreover, these interesting findings led to a possible pattern of protein regulation in which a protein can be positively regulated by c-Src and negatively regulated by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:NUP214))
23330367-9290-4819-a398-5d39ad9e207d	1.0	PubMed	16507111	To further reinforce this finding, expression of a constitutively-active GSK3beta construct (S9A), which is resistant to inactivation by Akt, prevented BDNF induction of Notch responsiveness.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Notch))
23330367-9290-4819-a398-5d39ad9e207d	1.0	PubMed	16507111	As observed with T-cells, inhibition of GSK3beta with lithium chloride strongly enhanced the level of Notch signalling in a dose dependent manner.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Notch))
23330367-9290-4819-a398-5d39ad9e207d	1.0	PubMed	16507111	Whilst our data agrees with that of Espinosa et al. [XREF_BIBR], that is that GSK3beta activity inhibits Notch signalling, data from the Nye laboratory in GSK3beta deficient murine embryonic fibroblasts demonstrates that GSK3beta phosphorylates and stabilises Notch-IC, leading to enhanced signalling [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Notch))
81af7be0-b625-4cf3-b56d-1ce7a8d49c29	1.0	PubMed	26655089	Based on our cell based inhibitor tests and in vitro reconstitution assays, we propose here a positive feedback loop that consists of PP1, its inhibitor I-2, GSK3beta, the kinase that inhibits the inhibitor, and additionally, an intrinsic suppressor for the entire loop - OLA1.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:OLA1))
8a07d08f-af9e-4447-8d0d-17c53be20c02	1.0	PubMed	5556769	Incubating GSK-3beta with PKNalpha or PKC subtypes inhibited subsequent GSK-3beta-induced AT8 and AT270 immunoreactivity.	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q9SI18))
8fdc4749-aa84-434d-8003-a312641748d3	1.0	PubMed	22679108	Knockdown of either GSK-3alpha or GSK-3beta in 537 cells reduced the amount of PAX3 protein to 70.2% and 51.8% of the siScramble control, respectively (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PAX3))
6e3488a7-ea9b-4e37-b48a-ed72e741139b	1.0	PubMed	23853095	We conclude that PASK phosphorylates and inactivates GSK3beta, thereby preventing PDX-1 serine phosphorylation and alleviating GSK3beta mediated PDX-1 protein degradation in pancreatic beta-cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PDHX))
8b510226-d5c4-4a87-9324-91e23b451569	1.0	PubMed	PMC3997457	In cholinergic neurons, betaA impaired acetylcholine synthesis without affecting choline acetyltransferase activity, which suggests that PDH is inactivated by betaA-induced TPKI/GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:PDH))
e5ca71f0-89d7-4717-9075-d972c41b2687	1.0	PubMed	22815195	Our data suggest that rs334558 variant in GSK3beta reduces the risk of PD in a Han Chinese population from mainland China.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D010300))
e5ca71f0-89d7-4717-9075-d972c41b2687	1.0	PubMed	25829335	Accumulating evidences have revealed that GSK-3beta and alpha-Synuclein have a mutual interaction with each other, on the one hand, GSK-3beta is a determining factor in the expression and aggregation of alpha-Synuclein, as it is reported that PD features such as alpha-Synuclein aggregation and tau hyperphosphorylation induced by rotenone or MPP+ could be reversed by GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D010300))
5e4b54ad-a55f-4311-8d8f-f365b9f354d3	1.0	PubMed	19797085	In addition, we show that the beta-trcp-mediated degradation requires phosphorylation of phlpp1 by casein kinase i and glycogen synthase kinase 3beta (gsk-3beta), and activation of the phosphatidylinositol 3-kinase/akt pathway suppresses the degradation of phlpp1 by inhibiting the gsk-3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PHLPP1))
8428cc82-6612-4851-882b-78fe88ef1cb8	1.0	PubMed	22814751	Inhibition of GSK-3beta reversed the inhibitory effects of Akt3 knockout and inhibitors of Akt or PI3K on platelet spreading, indicating that GSK-3beta is a downstream target of Akt in outside-in signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:PI3K))
8428cc82-6612-4851-882b-78fe88ef1cb8	1.0	PubMed	22039301	Downregulation of GSK3beta inhibits SHP2 and ERK1/2 but not PI3K activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:PI3K))
c6d6e012-c6b6-4873-9672-6a6dbc640f7f	1.0	PubMed	27162139	Moreover, a half-life study suggested that WT GSK3beta ectopic expression decreased PIAS4 half-life to ~ 4 h, whereas the more potent GSK3beta hyper mutant further decreased PIAS4 half-life to ~ 2 h (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PIAS4))
994df045-778f-41b9-9223-a5ae2278322a	1.0	PubMed	25118933	The mitochondrial biogenesis factor PGC-1alpha is downregulated and the kinase GSK3beta that promotes PGC-1alpha degradation is increased in mnd2 mice.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PPARGC1A))
994df045-778f-41b9-9223-a5ae2278322a	1.0	PubMed	25118933	XREF_BIBR, XREF_BIBR Thus, abnormal increases of GSK3beta activity or abundance are able to induce PGC-1alpha degradation, subsequently leading to neurodegeneration.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PPARGC1A))
984fde30-7bf0-43b1-9cdf-eb0754b550a1	1.0	PubMed	17433504	The underlying mechanism for this discrepancy is currently not understood.Taken together, we have found in the present study that activation of GSK-3beta inhibits the activity of PP-2A through up-regulating I, and the up-regulation of I may involve the post-transcription machinery mediated by hnRNP A18.There are no actual or potential conflicts of interest including any financial, personal or other relationships with other people or organizations within 3 years of beginning the work submitted that could inappropriately influence (bias) our work.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PPP2CA))
984fde30-7bf0-43b1-9cdf-eb0754b550a1	1.0	PubMed	17433504	These data strongly suggest that activation of GSK-3beta increases the expression of I and thus inhibits the activity of PP-2A.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PPP2CA))
ad53f634-a0ec-4b25-b81f-f6b2e5161bb8	1.0	PubMed	22732552	We have reported that glycogen synthase kinase-3beta (GSK-3beta) inhibits PP2A via upregulating the phosphorylation of PP2A catalytic subunit (PP2A (C)).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:PPP2))
ad53f634-a0ec-4b25-b81f-f6b2e5161bb8	1.0	PubMed	23428800	These results indicate that PTPA activates PP2A by regulatng the methylation and/or phosphorylation of PP2A.Glycogen synthase kinase-3beta (GSK-3beta) is a key tau kinase, GSK-3beta also inhibits PP2A.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:PPP2))
ad53f634-a0ec-4b25-b81f-f6b2e5161bb8	1.0	PubMed	23428800	Recently, we have reported that activation of GSK-3beta, a crucial tau kinase that is activated in the AD brain, inhibits PP2A through upregulating I, increasing the inhibitory tyrosine 307 phosphorylation and decreasing the expression of PP2A.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:PPP2))
ad53f634-a0ec-4b25-b81f-f6b2e5161bb8	1.0	PubMed	25219467	These results suggest that PP2A, but not PP1, catalyzes the dephosphorylation of GSK-3beta at Ser9.Then, we treated HEK-293FT cells with 100nM okadaic acid for 3hours to inhibit PP2A and determined the GSK-3beta phosphorylation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:PPP2))
d80d5073-cef3-413c-9c0c-28b31c968d2e	1.0	PubMed	17360711	We demonstrate that phosphorylation of serines 353 and 357 by glycogen synthase kinase-3beta (gsk3beta) induces a structural change of the hydrophilic loop of ps1the structural change of ps1 reduces the interaction with beta-catenin leading to decreased phosphorylation and ubiquitination of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PSEN1))
d80d5073-cef3-413c-9c0c-28b31c968d2e	1.0	PubMed	17360711	We demonstrate that phosphorylation of serines 353 and 357 by glycogen synthase kinase-3beta (gsk3beta) induces a structural change of the hydrophilic loop of ps1the structural change of ps1 reduces the interaction with beta-catenin leading to decreased phosphorylation and ubiquitination of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PSEN1))
24622828-d033-45d5-ac86-2c10ae2f0f51	1.0	PubMed	16107342	Gsk3beta Phosphorylates pten at thr-366 in intact cells phosphorylation of pten at thr-366 reduces the activity of pten in cells	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PTEN))
6c2a2f9c-21d5-4bb8-b14f-eecd34c032b8	1.0	PubMed	24726344	However, COX-2 is negatively regulated by GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PTGS2))
6c2a2f9c-21d5-4bb8-b14f-eecd34c032b8	1.0	PubMed	18708588	Our data are further supported by a study that showed UVB reduced activity of GSK-3beta and that overexpression of GSK-3beta reduced COX-2 induction by UVB XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PTGS2))
b204b18c-3a1f-4558-8682-4a5ab418c6cb	1.0	PubMed	26274564	If FAK and PYk2 regulates Wnt and beta-catenin through their kinase activity by phosphorylating GSK3beta Y216, there should be differences in the time courses of FAK and PYK2 inhibitor mediated suppression of FAK and PYK2 kinase activity, GSK3beta Y216 phosphorylation and beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PTK2B))
9932fddb-8f23-492f-8cca-8bb523c2c2e0	1.0	PubMed	26274564	If FAK and PYk2 regulates Wnt and beta-catenin through their kinase activity by phosphorylating GSK3beta Y216, there should be differences in the time courses of FAK and PYK2 inhibitor mediated suppression of FAK and PYK2 kinase activity, GSK3beta Y216 phosphorylation and beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PTK2))
5fa6489d-90c3-4c1b-807f-9f301e5a41b3	1.0	PubMed	22606260	As menin is a known primary affected tumour suppressor in parathyroid tumours, it is possible that its dysfunction would cause a disinhibition of GSK3beta mediated degradation of PRLr, hence stabilizing the long and DeltaS1 isoforms.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PTP4A3))
d5122f01-7310-4cbe-a26c-112aa9f5ae1a	1.0	PubMed	22039301	Downregulation of GSK3beta inhibits SHP2 and ERK1/2 but not PI3K activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PTPN11))
380b1b1d-c780-4320-b41b-1bd082ee8def	1.0	PubMed	21757741	Glycogen synthase kinase-3beta (GSK3beta) negatively regulates PTTG1 and human securin protein stability, and GSK3beta inactivation correlates with securin accumulation in breast tumors.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:PTTG1))
13f8605f-de32-488c-b37e-62d574f1e713	1.0	PubMed	27572267	We show that glycogen synthase kinase 3beta (GSK3beta) interacts with PD-L1 and induces phosphorylation dependent proteasome degradation of PD-L1 by beta-TrCP.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Proteasome))
857d9de6-e559-4dba-a787-3dd9f15c6b62	1.0	PubMed	24142875	Here, we showed that rnpc1 is phosphorylated at ser195 by glycogen synthase kinase 3 (gsk3). We also provided evidence that ser195 phosphorylation converts rnpc1 from a repressor to an activator of p53.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:RBM38))
1a4f3d18-889a-4669-ae90-af3aa0cac522	1.0	PubMed	21056029	Since GSK-3beta can repress basal p65 transcriptional activity, it is possible that LiCl mediated GSK-3beta inhibition might activate the transcriptional activity as well.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:RELA))
e8f1dc6b-a91f-4617-824f-143c09884111	1.0	PubMed	16513844	Moreover, down regulation of GSK3beta prevented the activation of hnRNP A18 RNA binding activity upon UV exposure (XREF_FIG, lane 4).	p(HGNC:GSK3B)	directlyDecreases	act(p(PFAM:PF01877))
04d02894-05e7-486e-b2aa-d9dad6340d22	1.0	PubMed	21078818	We identify ror2 ser 864 as a critical residue phosphorylated by gsk3 and required for noncanonical receptor activation by wnt5a, analogous to the priming phosphorylation of low-density receptor-related protein 6 (lrp6) in response to wnt3a.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ROR2))
956f122e-849b-4174-ac9f-2abb99e8be7f	1.0	PubMed	25390651	Activation of the mK ATP channel induced inhibitory phosphorylation of GSK-3beta and suppressed ROS production, LDH release and apoptosis after AA washout.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ROS1))
956f122e-849b-4174-ac9f-2abb99e8be7f	1.0	PubMed	25390651	ROS production induced by AA, an inhibitor of complex III, was suppressed by inactivation of GSK-3beta (XREF_FIG), indicating that this kinase enhanced ROS prodcution.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ROS1))
956f122e-849b-4174-ac9f-2abb99e8be7f	1.0	PubMed	25390651	The mechanism by which inactivation of GSK-3beta suppresses ROS production remains unclear.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ROS1))
316cc3f1-7fe4-43f1-a0c3-f24134f6da4a	1.0	PubMed	24899689	CF specific deletion of GSK-3beta increases post-MI scar circumference and fibrosis.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:RPS4X))
4489396c-3cb4-46a5-aab1-86500d227264	1.0	PubMed	23911749	4) TNF-alpha induces hyper-phosphorylation of GSK3beta, i.e. the deactivated form of GSK3beta, which increases nuclear beta-catenin and Lef-1 accumulation, and eventually reduces the Runx2 associated osteogenesis in PDLSCs.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:RUNX2))
4489396c-3cb4-46a5-aab1-86500d227264	1.0	PubMed	23911749	Based on these observations, we speculated that in the inflammatory microenvironment, TNF-alpha induces hyper-phosphorylation of GSK3beta, which increases nuclear beta-catenin and Lef-1 accumulation, and eventually reduces the Runx2 associated osteogenesis in PDLSCs.Yet, how were GSK3beta activities affected by TNF-alpha?	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:RUNX2))
17570169-86c3-4655-881f-b9c8545a4829	1.0	PubMed	20932480	Psf is directly phosphorylated by gsk3, thus promoting interaction of psf with trap150, which prevents psf from binding cd45 pre-mrna. / threonine phosphorylation of psf by gsk3 primarily occurs on residue t687	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SFPQ))
17570169-86c3-4655-881f-b9c8545a4829	1.0	PubMed	20932480	We conclude that t687 is the primary site of threonine phosphorylation in psf. Gsk3 directly phosphorylates the splicing regulatory protein psf. In this phosphorylated form, psf is sequestered in a complex with trap150, precluding it from binding the ess1 sequence in cd45 alternatively spliced exons. Upon t?_Cell stimulation, reduced gsk3 activity leads to reduced psf phosphorylation, thereby releasing psf from trap150 and allowing it to participate in activation-induced cd45 exon skipping	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SFPQ))
39565aa2-bd0d-4e79-a104-064185a33208	1.0	PubMed	19615554	Shh, Wnt and BMP pathways can interact, with GSK-3beta stimulating degradation of Gli effectors and Shh up-regulating BMP4 in the ureteric bud, providing evidence for complex modulation of signaling pathways.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SHH))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	25172662	These results suggest that PCDH9 expression can modulate GSK-3beta kinase activity.To verify whether the activation of GSK-3beta is required for PCDH9 to inhibit EMT, SNU-449 cells were treated with the GSK-3beta inhibitor lithium chloride (LiCl) and the expression of EMT markers were analyzed.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	17692821	Based on all of these findings taken together, we concluded that inactivation of GSK-3beta inhibits degradation of Snail1 protein in renal epithelial cells.The results of the present study demonstrate that Snail1 mediates renal tubular EMT in renal fibrosis and that the Snail1 level is regulated at the transcription and protein degradation levels.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	24901051	GSK3beta has been shown to inhibit EMT by targeting Snail for proteasomal degradation, thus releasing E-cadherin from transcriptional repression by Snail and promoting metastasis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	23785295	Specifically, inhibition of GSk-3beta (which was confirmed by an increase in the level of inhibitory phosphorylation of GSK-3beta at Ser9) with LiCl, activated EMT and resulted in E-cadherin down-regulation, Snail1 accumulation and increased levels of beta-catenin (XREF_FIG); concomitantly, E-cadherin was down-regulated following GSk-3beta inhibition by LiCl (XREF_FIG) or exogenous expression of vimentin (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	26716415	Subsequently, the activated GSK3beta inhibits EMT regulatory proteins, such as Snail or Slug, under a certain conditions [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	20978190	Wnt signals are also known to induce EMT, which is also negatively regulated by GSK-3beta (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	23408967	No consistent changes were observed for the expression of EMT related molecules in cancer cells treated with GSK3beta inhibitor, in contrast to a previous study that found GSK3beta inhibits EMT by phosphorylating and destabilizing snail, a transcriptional repressor of E-cadherin XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	23959174	Snail expression is suppressed by glycogen synthase kinase-3beta (GSK3beta) at transcriptional and post-transcriptional levels XREF_BIBR XREF_BIBR, and the inhibition of GSK3beta by small molecules induces EMT and promotes CSC phenotypes in breast cancer XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	23959174	Several studies show that GSK3beta suppresses Snail expression at transcriptional and post-transcriptional levels XREF_BIBR XREF_BIBR, and the inhibition of GSK3beta by small molecules induces EMT and promotes CSC phenotypes in breast cancer XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	18606491	GSK3beta plays an important role in EMT most likely through the modulation of Wnt, Hedgehog and Snail (a zinc-finger transcriptional repressor) pathways; inhibition of GSK3beta promotes the development of EMT.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
baee5876-5d25-4a55-9cc6-c8db099952a3	1.0	PubMed	27523474	As to breast cancer, it was demonstrated that miR-143 inhibited tumor growth through downregulating ERK5 and suppressing EMT induced by GSK3beta and Snail signaling ().	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001837"))
b8ba522a-4f57-478c-94cb-ac0d733188a8	1.0	PubMed	18045539	Phosphorylation at the gsk3 sites represses the transcriptional activity of smad1 by enhancing proteasomal degradation of psmad1cter	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SMAD1))
e27f8393-6bc4-4696-a22e-d73dd31a33e7	1.0	PubMed	20599907	These results indicated that GSK3beta negatively regulated Smad3 mediated transcriptional responses.We determined the regulatory role of GSK3beta and Smad3 in the transcription of atrial natriuretic factor (ANF), one of the hypertrophic marker genes.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SMAD3))
fb0470e0-3fd6-48e3-b371-26470a6bf9f9	1.0	PubMed	23166798	In particular, inhibition of GSK3beta causes the upregulation of the transcriptional regulators Sp1, SNAIL, and SMAD XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:SMAD))
fb0470e0-3fd6-48e3-b371-26470a6bf9f9	1.0	PubMed	24060635	Thus, GSK3beta activity is probably sufficient to inhibit Smad signaling, explaining why LY292004 had no effect on BMP2 response (A and B).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:SMAD))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	26506239	The enhancement of GSK-3beta activity by NDRG2 overexpression causes the proteasomal degradation of Snail followed by the transcriptional de-repression of E-cadherin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	23919497	GSK-3beta (glycogen synthase kinase 3beta) deactivates Snail by phosphorylation, promoting nuclear export and priming it for ubiquitination by beta-TrCP (beta transducing repeat containing protein; also known as BTRC] and subsequent degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	23919497	As GSK-3beta deactivates Snail by phosphorylation [XREF_BIBR] we tested transfected cells for activated GSK-3alpha and beta by FACS analysis (XREF_FIG D) and showed a significant reduction in activated GSK-3alpha and beta present in ZIP6 transfected cells compared with controls.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	24571487	We postulated that inhibitory phosphorylation of GSK-3beta at Ser9 by Akt might cause the increase in Snail, Zeb2, and Twist mRNA.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	21585337	These data suggest that inhibition of GSK-3beta allows Snail to induce EndMT.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	21585337	The signaling kinase GSK-3beta has been shown to control Snail activity by impairing its function, and inhibitory phosphorylation of GSK-3beta promotes Snail transcriptional activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	21585337	Therefore, inhibitory phosphorylation of GSK-3beta by kinases such as AKT, a downstream signaling molecule from PI3K [XREF_BIBR], is sufficient to prevent GSK-3beta-dependent inhibition of Snail.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	21585337	Our data show that inhibition of GSK-3beta by TGF-beta2-induced PI3K signaling or by direct inhibition with LiCl allows Snail to function to induce EndMT.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	23959174	RPN2 stabilized mtp53 by inactivation of glycogen synthase kinase-3beta (GSK3beta) which suppresses Snail, a master regulator of epithelial to mesenchymal transition.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	16169465	Accordingly, inhibition of GSK-3beta activity by the PI3K and AKT, MAPK, and Wnt signaling pathways promotes Snail stabilization and activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	17664334	These GSK-3beta activities limit the ability of Snail to function as an E-cadherin transcriptional repressor (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	23900729	The enhancement of glycogen synthase kinase 3beta (GSK-3beta) activity by NDRG2 overexpression caused proteasomal degradation of Snail transcription factor followed by transcriptional de-repression of E-cadherin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	25422594	GSK3beta is a repressor of beta-catenin and Snail able of inhibiting E-cadherin expression and subsequently promotes EMT and tumor progression.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
a6c069b9-c5d1-4046-9288-eb29ccf71189	1.0	PubMed	19861116	Furthermore, Gsk-3beta inhibition results in the upregulation of Snai1 and downregulation of E-cadherin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI1))
7e8da756-fd2c-420d-b676-07ff3a400361	1.0	PubMed	23851495	GSK3beta controls epithelial-mesenchymal transition and tumor metastasis by CHIP mediated degradation of Slug.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI2))
7e8da756-fd2c-420d-b676-07ff3a400361	1.0	PubMed	23851495	These results suggest that the activity of GSK3beta limits the intracellular concentration of Slug and modulates Slug protein turnover by direct phosphorylation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI2))
7e8da756-fd2c-420d-b676-07ff3a400361	1.0	PubMed	23851495	This repression was alleviated in the presence of constitutively-active GSK3beta (GSK3beta-CA), but coexpression of kinase-inactive GSK3beta (GSK3beta-KD) enhanced the repression activity of Slug (XREF_FIG), supporting the notion that GSK3beta-KD acts as a dominant negative form of the normal enzyme.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI2))
7e8da756-fd2c-420d-b676-07ff3a400361	1.0	PubMed	23851495	Interestingly, among these 20 patients with a low Slug protein level and a low expression of GSK3beta-pSer9, CHIP was highly expressed in 12 (60%) of the samples (XREF_SUPPLEMENTARY), implicating that high CHIP expression may facilitate GSK3beta mediated Slug degradation in vivo.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI2))
7e8da756-fd2c-420d-b676-07ff3a400361	1.0	PubMed	23851495	Moreover, up to 60% of patients with a low Slug level and a low GSK3beta-pSer9 level have a high expression of CHIP, implying that CHIP may participate in the GSK3beta mediated Slug degradation in NSCLC.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI2))
7e8da756-fd2c-420d-b676-07ff3a400361	1.0	PubMed	23851495	We thus speculated that other E3 ligases might be involved in GSK3beta mediated Slug degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI2))
7e8da756-fd2c-420d-b676-07ff3a400361	1.0	PubMed	23851495	Wu et al. has indicated that beta-trcp participates in the GSK3beta mediated degradation of Slug in breast cancer.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNAI2))
c2408276-4d0e-4246-98ad-c31ac53bd4ce	1.0	PubMed	16174773	Synphilin-1 s556a mutant, which is less phosphorylated by gsk3beta, formed more inclusion bodies than wild type synphilin-1. Mutation analysis showed that ser556 is a major gsk3beta phosphorylation site in synphilin-1	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNCAIP))
48f807e1-c16a-462b-af0b-9b400148621e	1.0	PubMed	25829335	On the other hand, by decreasing Ser9 phosphorylation and elevating Tyr216 phosphorylation, alpha-Synuclein stimulates GSK-3beta activity and inhibition of GSK-3beta abrogates alpha-Synuclein mediated neurotoxicity ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SNCA))
5f0e4fce-b736-4bda-9dec-bf2f3ec43523	1.0	PubMed	27566146	Based on our findings that inhibition of GSK3beta prevents DNA damage induced SOX9 degradation, and that FBW7 targets SOX9 for degradation after DNA damage, we reasoned that phosphorylation of SOX9 by GSK3beta is required for FBW7 mediated SOX9 degradation.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SOX9))
8d9f04c6-9308-4dee-9d6d-dec22c27216a	1.0	PubMed	23166798	In particular, inhibition of GSK3beta causes the upregulation of the transcriptional regulators Sp1, SNAIL, and SMAD XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SP1))
b92cca3a-e2ca-4df8-b3a8-540e3f222ee1	1.0	PubMed	24606125	Moreover, SSTR3 dependent GH transcriptional inhibition was rescued by inhibition of GSK3-beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:SSTR3))
2d1381c8-fa4e-40ee-be62-79372ba2841f	1.0	PubMed	22577147	Finally, pharmacological inhibition of GSK-3beta induces a redistribution of stathmin 3, but not stathmin 2, from the periphery toward the Golgi region of neurons.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:STMN2))
bb09476c-3898-44bb-8d0e-8bb58176f080	1.0	PubMed	22577147	Finally, pharmacological inhibition of GSK-3beta induces a redistribution of stathmin 3, but not stathmin 2, from the periphery toward the Golgi region of neurons.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:STMN3))
2efecfb2-640a-4247-9c0e-8f6ad0cb1cd2	1.0	PubMed	26219398	Compared with the negative control, TACC3 down-regulation led to decreased GSK3beta (Ser 9) phosphorylation and beta-catenin down-regulation, whereas total GSK3beta-levels remained unchanged.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TACC3))
6fb5dcf5-d28f-4b6d-9f73-5dd07cd9f9b9	1.0	PubMed	21949350	Finally, we report that mutant TDP-43 Q331K strongly increases GSK-3beta activity and that reducing GSK-3beta (sgg) expression strongly suppresses TDP-43 and Abeta42 toxicity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TARDBP))
6fb5dcf5-d28f-4b6d-9f73-5dd07cd9f9b9	1.0	PubMed	21949350	GSK-3beta suppresses Abeta42 and TDP-43 toxicity, and mutant TDP-43 induces increased GSK-3beta phosphorylation activation state.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TARDBP))
2d046461-2217-4ffd-830a-f39fd2fe4bac	1.0	PubMed	20122174	Knock-down of GSK-3beta inhibited Axin mediated degradation of beta-catenin and prevented downregulation of TCF-4 in both BE1 and A549 cells (P> 0.05, Figure XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TCF4))
2d046461-2217-4ffd-830a-f39fd2fe4bac	1.0	PubMed	20122174	Knock-down or inhibition of GSK-3beta prevented Axin mediated downregulation of TCF-4.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TCF4))
2030a64f-cbbe-4b57-a6e0-9637f91bd6b2	1.0	PubMed	22692453	However, GBP-1 appears to represses beta- catenin through a different mechanism, as GSK3-beta and proteasomal inhibition was unable to rescue the loss of beta-catenin and TCF activity (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:"TCF_LEF"))
2030a64f-cbbe-4b57-a6e0-9637f91bd6b2	1.0	PubMed	5096923	Thus, inhibition of GSK-3beta is insufficient to activate Tcf dependent transcription in T lymphocytes.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:"TCF_LEF"))
2030a64f-cbbe-4b57-a6e0-9637f91bd6b2	1.0	PubMed	17950943	In addition, glycogen synthase kinase-3beta (GSK-3beta) contributes to the degradation of beta-catenin and represses beta-catenin and Tcf signaling, while the activity of NF-kappaB is enhanced by GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:"TCF_LEF"))
2030a64f-cbbe-4b57-a6e0-9637f91bd6b2	1.0	PubMed	23911749	The inhibition of GSK3beta in turn induced the nuclear accumulation of beta-catenin (A) and transactivation of Tcf/Lef (B).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:"TCF_LEF"))
2030a64f-cbbe-4b57-a6e0-9637f91bd6b2	1.0	PubMed	19429245	After co-transfected GSK3betaS9A with the Tcf luciferase reporter plasmids followed by CSE treatment, we examined the luciferase activity of pGL3-OT and found that beta-catenin and Tcf transcription activity induced by CSE was abolished by GSK3beta over-expression () (9285 +/-2945 in GSK3betaS9A+ CSE treatment group 20,764 +/-1801 in CSE treatment group, < 0.01).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:"TCF_LEF"))
2030a64f-cbbe-4b57-a6e0-9637f91bd6b2	1.0	PubMed	19429245	We demonstrated that active GSK3beta significantly inhibited beta-catenin and TCF transcriptional activity induced by CSE.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:"TCF_LEF"))
2030a64f-cbbe-4b57-a6e0-9637f91bd6b2	1.0	PubMed	7164275	Inhibition of GSK-3beta by DVL increases beta-catenin stability and TCF transcriptional activation.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:"TCF_LEF"))
ff09021e-75a0-4589-8ca3-f7f2338452f8	1.0	PubMed	16297654	All constructs that phosphorylated a downstream Akt substrate, GSK-3beta, also suppressed TGF-beta responses, whereas all kinase-dead or kinase inactive mutants were either ineffective or enhanced TGF-beta responses.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:TGFB))
ca072707-f7e2-48e4-a3f1-4ef0ed7d7885	1.0	PubMed	19218353	In the GSK3beta inhibited groups (i.e., SB-216763 and kdGSK3beta) +/- TNF, the unphosphorylated beta-catenin-Ser37/33 was similar to the TNF group.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TNF))
ca072707-f7e2-48e4-a3f1-4ef0ed7d7885	1.0	PubMed	19218353	In the GSK3beta inhibited groups (i.e., SB-216763 and kdGSK3beta) +/- TNF, the TOPflash and FOPflash activity ratio was similar to the TNF group.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TNF))
ca072707-f7e2-48e4-a3f1-4ef0ed7d7885	1.0	PubMed	24489933	In cardiomyocytes during LPS stimulation, GSK3-beta functions to suppress TNF-alpha expression XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TNF))
ca072707-f7e2-48e4-a3f1-4ef0ed7d7885	1.0	PubMed	25829335	Moreover, inhibition of GSK-3beta also disrupts survival role of NF-kappaB transactivation and promote TNF-alpha mediated toxicity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TNF))
cbf22089-fc8b-473b-b860-0a8afe83f614	1.0	PubMed	23554857	In addition, CDH17 knockdown increased P53 expression; a possible mechanism would be that CDH17 knockdown leads to reduced GSK-3beta phosphorylation, which in turn activates p53 dependent apoptosis and antagonizes tumor growth XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TP53))
2284fdc9-dc14-40e8-bffe-fa6a52c1b030	1.0	PubMed	18804163	Similarly, expression of a constitutively active version of beta-catenin did not increase cell growth either in the absence or presence of TPO, suggesting that the effects of GSK-3beta inhibition downstream of TPO signaling are distinct from those induced by Wnt3a and independent of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TPO))
5a71860b-04af-4f85-9284-b2c2c10c2f78	1.0	PubMed	26318033	Overexpression of AKT3 increased the protein expression of total AKT, phospho-AKT S473, phospho-AKT T308, B-Raf, c-Myc, Skp2, cyclin E, GSK3beta, phospho-GSK3beta S9, phospho-mTOR S2448, and phospho-p70S6K T421 and S424, but decreased TSC1 (tuberous sclerosis 1) and TSC2 (tuberous Sclerosis Complex 2) proteins in PC-3 PCa cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TSC1))
d7bd9de9-dcb8-497b-ba02-613c6c92862c	1.0	PubMed	22771494	Knockdown of GSK3beta but not GSK3alpha reduced endogenous GILZ induction in response to dexamethasone and GR dependent reporter gene activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TSC22D3))
07934456-b6f1-4cd2-8b9d-c1c6a731877e	1.0	PubMed	26318033	Overexpression of AKT3 increased the protein expression of total AKT, phospho-AKT S473, phospho-AKT T308, B-Raf, c-Myc, Skp2, cyclin E, GSK3beta, phospho-GSK3beta S9, phospho-mTOR S2448, and phospho-p70S6K T421 and S424, but decreased TSC1 (tuberous sclerosis 1) and TSC2 (tuberous Sclerosis Complex 2) proteins in PC-3 PCa cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TSC2))
31691004-7186-4a94-bd15-6e013648be89	1.0	PubMed	24571487	We postulated that inhibitory phosphorylation of GSK-3beta at Ser9 by Akt might cause the increase in Snail, Zeb2, and Twist mRNA.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:TWIST1))
e50f6a84-ffdf-4402-8675-b711ea10f5e6	1.0	PubMed	24316184	Additionally, the COXII and VDAC induction effect by 2-DG was suppressed by GSK3beta-KD overexpression while promoted by WT-GSK3beta overexpression confirming the involvement of GSK3 in 2-DG-induced mitochondrial biogenesis ().	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:VDAC1))
99a99ac9-764a-4f65-9b02-e4d9452317f2	1.0	PubMed	21964756	Our data show that loss of GSK3beta promotes VEGF production through HIF-1alpha stabilization, but the observed stimulation of endothelial tube maturation may be a result of a combination of factors secreted into the media that will be explored in future studies.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:VEGF))
99a99ac9-764a-4f65-9b02-e4d9452317f2	1.0	PubMed	20849862	We did not investigate intermediate kinases responsible for inhibiting GSK-3beta downstream of Cdc42 but instead focused on investigating the significance of GSK-3beta inhibition for Cdc42 mediated improvement of VEGF driven angiogenesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:VEGF))
99a99ac9-764a-4f65-9b02-e4d9452317f2	1.0	PubMed	26388612	Here we demonstrate that GSK-3beta inhibits VEGF mRNA and protein levels by RT-PCR and ELISA assay.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:VEGF))
363d0edf-03f3-4caf-8bf9-a42d341911c3	1.0	PubMed	24333432	Daniela Flugel reported that GSK3beta regulated HIF1alpha via three key amino residues in the ODD domain in the HepG2 cell line and mutation analysis revealed that GSK3beta degraded HIF1alpha in a VHL independent way.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:VHL))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	17987039	However, it remains to be seen whether the induction of Wnt signalling either by GSK3beta inhibition, or by antibody administration may affect the metastatic potential of OS cells since Wnt signalling and/or beta-catenin upregulation has been shown to be a key regulator of migration in prostate tumours, multiple myeloma cells and also in OS cells (Iwaya et al, 2003; Qiang et al, 2005; Hall et al, 2006).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	19148484	The loss of APC and GSK3-beta did not lead to augmentation of the Wnt target protein cyclin D1 or the Wnt oncoprotein beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	25532422	The process of generation of HPV-16-associated cervical tumorigenesis is synergized with GSK3beta inactivation and overactivation of Wnt and beta-catenin pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	22825252	This situation also applies in primed cells, but, in addition, a separate pool of Gsk3beta is required to suppress canonical Wnt signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	23673211	Our previous studies showed that the decreased cytoplasmic levels of activated GSK-3beta resulted in activation of Wnt and beta-catenin signaling and increased expression of survivin, a target gene of the Wnt and beta-catenin signaling pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	23673211	Inhibition of cytoplasmic GSK-3beta activity may activate the Wnt and beta-catenin signaling pathway and subsequent upregulate its target genes, including survivin, and may play a critical role in the development of cisplatin resistance in NSCLC.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	22328737	Inhibition of glycogen synthase kinase-3beta (GSK-3beta) activated canonical Wnt signalling and exacerbated experimental tissue fibrosis 30 In the current study, we specifically targeted beta-catenin and indeed found that fibroblast specific stabilisation of beta-catenin resulted in rapid and progressive fibrosis with prominent dermal thickening, differentiation of resting fibroblasts into myofibroblasts and increased accumulation of collagens.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	27129219	LiCl and SB415286 are specific inhibitors of GSK3beta, which can inhibit Wnt and beta-catenin signaling.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	24403311	Inhibition of GSK3beta rescues Wnt and beta-catenin pathway.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	24403311	The promoting effect of alpha6A on the expression of the active and nuclear form of beta-catenin and the fact that inhibition of GSK3beta could rescue the activity of the Wnt and beta-catenin pathway suggest that alpha6A could interfere with a signalling event upstream to GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	24403311	Indeed, based on the observations that down-regulation of alpha6A levels results in a reduction of the relative amounts of both active (evaluated as the non GSK3beta phosphorylated form) and nuclear beta-catenin, whereas the pharmacological inhibition of GSK3beta restored the activity of the Wnt and beta-catenin pathway as evaluated by TOPflash assays and the modulation of specific target genes including LGR5 and CCD2, we suggest that alpha6A interferes with the activity of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	20971552	Our results indicate a functional specificity of exogenous APC interference for HBx mediated Wnt activation, which further supports the idea that APC and HBx interaction is involved in HBx mediated beta-catenin and Wnt activation.We proposed that antagonizing Wnt signal downstream of GSK3beta and APC would effectively abrogate HBx activation of Wnt signals.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	23768967	Although GSK-3beta inhibition is known to activate pro proliferative Wnt signaling, responses to GSK-3beta inhibition is known to vary between cell lines, with some authors reporting an increase and others a decrease in proliferative response.It is likely that in some of these cancer models that hyperactivation of proliferative pathways such as PI3K and EGFR may saturate Wnt targets, making further activation difficult to detect.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	24910204	Our results suggest that PCDH20 induces Erks and Akt mediated activation of GSK-3beta, which in turn inhibits Wnt and beta-catenin signalling and leads to inhibition of HCC growth and migration.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	5775972	Ectopic expression of GSK3beta, which inhibits beta-catenin-mediated Wnt signaling, also induced cardiogenesis in ventral mesoderm.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	19435525	LiCl, Wnt signal activator by GSK-3beta inhibition, significantly increased reporter activities in wild-type Tcf1 containing constructs, but were without effect in mutant Tcf1 containing constructs in HEK/293 cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	26301867	Canonical Wnt and mTOR pathways can be negatively regulated by the serine/threonine kinase GSK3beta [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	26341138	For example, downregulation of GSK3B significantly suppresses metastasis by inactivating the Wnt and beta-catenin axis at the epithelial-mesenchymal transition (EMT) in HCC cells () and TGF-beta affect the EMT via distinct mechanisms ().	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	10330403	It had been assumed that Wnt caused beta-catenin stabilization by inhibiting GSK3beta activity (for review see XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	17972518	Glycogen synthase kinase-3beta (GSK3beta), serine/threonine protein kinase, has been reported to repress the Wnt and beta-catenin pathway and regulate the balance between cellular proliferation and apoptosis.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	15940626	This finding suggests that inhibition of GSK-3beta by PI3-K and Akt may further stimulate Wnt signaling if there is an active Wnt signal already present.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	25829335	On the other hand, GSK-3beta plays role as a negative regulator for tumorigenesis processes, over-inhibition of GSK-3beta activity could cause the wnt and beta-catenin signaling pathway to be over-activated and potentially promoting oncogenesis.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	18606491	In a mouse model of mammary tumorigenesis, inhibition of GSK3beta by overexpression of kinase-inactive GSK3beta in mouse mammary glands promotes mammary tumorigenesis; this is accompanied by the over-expression of beta-catenin and cyclin D1, supporting that GSK3beta inhibition causes dysregulation of the Wnt and beta-catenin pathway which results in tumor promotion.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
03221e60-8cf4-474c-806b-1463eadec208	1.0	PubMed	25596747	These results indicate that inhibition of PTEN by phosphorylation could activate PI3K and Akt signaling and subsequent GSK3beta inhibition, which in the end activate Wnt and beta-catenin signaling and promote the growth of colon tumor cells.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:Wnt))
df4d35c9-472c-4665-9b6b-07a19632eb1e	1.0	PubMed	20971552	Our results indicate a functional specificity of exogenous APC interference for HBx mediated Wnt activation, which further supports the idea that APC and HBx interaction is involved in HBx mediated beta-catenin and Wnt activation.We proposed that antagonizing Wnt signal downstream of GSK3beta and APC would effectively abrogate HBx activation of Wnt signals.	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q157B2))
aa0a8ade-9fd2-4cff-a3e2-0d56ccb308ae	1.0	PubMed	16039586	Furthermore, transfection of constitutively active GSK-3beta (S9AGSK-3beta) into HepG2-X and Hep3B-X cells resulted in a significant suppression of transcriptional activity of beta-catenin (E) as compared to wild-type GSK-3beta, indicating that constitutively active GSK-3beta can reverse HBX upregulated beta-catenin activity.	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q64902))
5ba0e3d5-9163-4a28-8327-8cee952e767a	1.0	PubMed	26001115	Inhibition of GSK3beta phosphorylation increases ZAP 's ability to repress target mRNA translation without increased mRNA degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ZC3HAV1))
0c6db49d-1744-4a15-9d48-b1f4d930db8d	1.0	PubMed	24571487	We postulated that inhibitory phosphorylation of GSK-3beta at Ser9 by Akt might cause the increase in Snail, Zeb2, and Twist mRNA.	p(HGNC:GSK3B)	directlyDecreases	act(p(HGNC:ZEB2))
7317175e-1c55-481c-b58a-152ca94cbd51	1.0	PubMed	20352103	alpha 5 siRNA as well as GSK3beta siRNA, but not alpha 4 siRNA, abolished the adhesion dependent resistance to TNFalpha (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007155"))
7317175e-1c55-481c-b58a-152ca94cbd51	1.0	PubMed	19754670	We provide evidence that inhibition of GSK-3beta signalling augments monocyte activity (adhesion, migration and transmigration).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007155"))
7317175e-1c55-481c-b58a-152ca94cbd51	1.0	PubMed	22810307	Pharmacological and genetic ablation of GSK3beta signaling inhibited the adhesion of melanoma cells to both endothelial cells and fibroblasts and prevented transendothelial migration, an effect rescued by the forced overexpression of N-cadherin.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007155"))
3eb94499-988b-4d8d-864b-5451c81da396	1.0	PubMed	23328640	Hyperoxia exposure in the presence of the placebo increased GSK-3beta phosphorylation, which was correlated with increased inflammation, decreased alveolarization and angiogenesis, and increased pulmonary vascular remodeling and PH. However, treatment with SB216763 decreased phosphorylation of NF-kappaB p65, expression of monocyte chemotactic protein-1, and lung inflammation during hyperoxia.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
3eb94499-988b-4d8d-864b-5451c81da396	1.0	PubMed	20849862	Nonetheless, they are in agreement regarding the conclusion that inhibition of GSK-3beta can support angiogenesis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
3eb94499-988b-4d8d-864b-5451c81da396	1.0	PubMed	26388612	Moreover, overexpression of GSK-3beta inhibited angiogenesis and tumor growth in vivo.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
3eb94499-988b-4d8d-864b-5451c81da396	1.0	PubMed	26388612	GSK-3beta inhibits tumor angiogenesis in vivo.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
3eb94499-988b-4d8d-864b-5451c81da396	1.0	PubMed	26388612	These results demonstrate that GSK-3beta inhibit tumor induced angiogenesis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
3eb94499-988b-4d8d-864b-5451c81da396	1.0	PubMed	26388612	In conclusion, our current study demonstrates that p-GSK-3beta (Ser9) levels are positively related with higher glioma grades; ectopic expression of GSK-3beta is sufficient to inhibit angiogenesis and tumor growth; we further identify Wnt and beta-catenin and mTOR/p70S6K1/HIF-1a/VEGF pathways are involved in GSK-3beta-inhibited angiogenesis and tumor growth.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
3eb94499-988b-4d8d-864b-5451c81da396	1.0	PubMed	26388612	The functional analysis reveals that ectopic expression of GSK-3beta suppressed angiogenesis and tumor growth in vivo.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001525"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	22534782	Because GSK-3beta regulates cell survival partially through the NF-kappaB pathway in osteosarcoma cell lines and because NF-kappaB inhibitors such as pyrrolidine dithiocarbamate (PDTC), parthenolide (PARTH), and Bay 11-7085 (BAY) have been successfully used in preclinical studies in mouse models (XREF_BIBR, XREF_BIBR - XREF_BIBR), we investigated whether apoptosis could be increased by the inhibition of both NF-kappaB and GSK-3beta in osteosarcoma.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	22534782	Next, we sought to determine whether inhibition of GSK-3beta would induce apoptosis in osteosarcoma cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	22534782	LiCl mediated inhibition of GSK-3beta also induced apoptosis in U20S and U2OS and MTX300 cells, as indicated by caspase-3 cleavage on western blots (XREF_FIG and Supplementary Figure 2, A, available online).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	22534782	GSK-3beta inhibition by LiCl did enhance the apoptosis of U2OS or ZOS cells induced by ADM, MTX, or DDP in vitro (eg, for U2OS, the percentage of viable cells at 72 hours with 20 mM LiCl = 44%, with 4 ng/mL ADM = 75%, with both = 27%; difference, both vs ADM = 48%, 95% CI = 36% to 61%; P <.01; XREF_FIG and Supplementary Figure 3, A-D, available online).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	22534782	Silencing of GSK-3beta expression also acted additively with ADM, MTX, and DDP to promote apoptosis of U2OS cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	22534782	Likewise, GSK-3beta inhibition by GSK-3beta inhibitor IX augmented the apoptosis of U2OS or ZOS cells induced by chemotherapeutic drugs, such as ADM, in vitro.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	22534782	Because GSK-3beta inhibition induced apoptosis in osteosarcoma, we examined the effect of LiCl treatment on apoptosis related proteins in U2OS cells using an antibody array.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	21821001	In leukemia, inhibiting GSK-3beta inhibits proliferation and mediates apoptosis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	21821001	Furthermore, PI staining and then flow cytometry showed that inhibiting GSK-3beta with TDZD-8 or shGSK-3beta significantly (< 0.05) increased cisplatin-, C-ceramide-, and LY294002 induced cell apoptosis (B and C).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	21795403	Taken together, GSK3beta inactivation suppresses the transcriptional activation of apoptosis related genes Bcl2 and survivin by c-Myb and LEF-1.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	20031160	Previously it has been shown that GSK-3beta inhibition leads to apoptosis through NF-kappaB [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	24367688	Indeed, inhibition of GSK-3beta activity has been shown to trigger apoptosis only in human pancreatic cancer cells but not in human non transformed pancreatic epithelial cells through JNK pathway [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	18437054	Selective GSK3beta inhibitiors and GSK3beta siRNA attenuated tetrandrine induced G (1) arrest and apoptosis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	23874688	Whereas overexpression of GSK3beta can induce apoptosis in several cell types, inactivation of GSK3beta has been found to reduce apoptosis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	24969626	Furthermore, IMD 1-53 exerts potent cardioprotective effects against oxidative stress, inhibiting endoplasmic reticulum stress via PI3 kinase-Akt signaling, and activating cardioprotective Akt and GSK-3beta signaling, decreasing mitochondrial mediated myocardial apoptosis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	21110852	GSK-3beta inhibition leads to suppression of NF-kappaB transcriptional activity and induces apoptosis through the transcriptional downregulation of the survivin gene.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	21110852	Pharmacologic inhibition of GSK-3beta induced apoptosis in ALL cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	21110852	These results confirmed that GSK-3beta suppression leads to ALL apoptosis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	21110852	To further evaluate whether GSK-3beta inhibition specifically induced apoptosis in ALL cells, we examined the effect of GSK-3beta inhibitors on normal BMMC.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	21110852	Pharmacologic inhibition of GSK-3beta induced apoptosis in ALL cells, so we further investigated whether inhibition of GSK-3beta affects NF-kappaB-mediated expression of the antiapoptotic gene survivin in cells from 10 patients with ALL.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	25390651	Activation of the mK ATP channel induced inhibitory phosphorylation of GSK-3beta and suppressed ROS production, LDH release and apoptosis after AA washout.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	27049759	Tivantinib showed higher potency for GSK-3alpha more than for GSK-3beta and the inhibition of GSK-3alpha or GSK-3beta expression caused apoptosis in lung cancer cells [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	19188159	Inhibition of GSK3beta activity by escalating doses of a small-molecule inhibitor (AR-A014418) or inhibition of its expression by RNA interference induced the apoptosis and attenuated the survival and proliferation of glioblastoma cells in vitro.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	5884164	GSK3beta induced apoptosis was significantly attenuated by GLUT1 overexpression (GSK3beta 29 +/- 3% vs. GLUT1 + GSK3beta 6 +/- 1%, n = 12, P < 0.001), suggesting that the antiapoptotic effect of enhanced glucose metabolism is linked to the inactivation of GSK3beta.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	25504636	We previously reported that inhibition of GSK3beta compromises the survival and proliferation of glioblastoma cells, induces their apoptosis, and sensitizes them to temozolomide and radiation.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	26088648	In our study, miR-26b elevated the expression of beta-catenin and CyclinD1 by lowering GSK-3beta expression, which in-turn activated Wnt/GSK-3beta/beta-catenin pathway, inhibited RAFLS apoptosis and led to increased secretion of TNF-alpha, IL-1beta and IL-6.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	22039301	GSK3beta knockdown increases SCF withdrawal induced apoptosis in HuMCs.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	23554857	In addition, CDH17 knockdown increased P53 expression; a possible mechanism would be that CDH17 knockdown leads to reduced GSK-3beta phosphorylation, which in turn activates p53 dependent apoptosis and antagonizes tumor growth XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
28f0d470-052b-4f1b-9691-a70594dde865	1.0	PubMed	24425879	Pharmacologic inhibition of GSK-3beta blocked cell proliferation in three different rodent insulinoma cell lines by arresting the cells in G2/M phase and caused apoptosis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006915"))
e2c6c601-d57e-4773-adf8-fa916c16fc0c	1.0	PubMed	25941117	Importantly, as we and other have previously demonstrated pharmacological inhibition of GSK-3beta activity induced early autophagy activation XREF_BIBR XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006914"))
e2c6c601-d57e-4773-adf8-fa916c16fc0c	1.0	PubMed	25115395	Pharmacological inhibition of GSK3beta activity caused mTOR signaling activation and autophagy induction in both SKBR-3 and BT-549 cells (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006914"))
e2c6c601-d57e-4773-adf8-fa916c16fc0c	1.0	PubMed	26440826	Further analysis revealed that Liver kinase B1 (LKB1) but not Calcium/calmodulin dependent protein kinase kinase beta (CaMKKbeta) is involved in AMPK activation and autophagy induction triggered by GSK-3beta inhibition.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006914"))
9464aa0d-10b7-48f8-b982-3b5d9534c055	1.0	PubMed	23559006	This finding is in line with a recent work, demonstrating that GSK-3beta inhibition promoted lysosomal biogenesis and autophagy protein degradation.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0044085"))
9464aa0d-10b7-48f8-b982-3b5d9534c055	1.0	PubMed	24681994	Similar studies have indicated that GSK-3beta inhibition promotes mitochondrial biogenesis and prevents ROS production during ischemic cerebral damage (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0044085"))
9464aa0d-10b7-48f8-b982-3b5d9534c055	1.0	PubMed	25118933	Inhibition of GSK3beta by SB216763 or overexpression of PGC-1alpha can restore mitochondrial biogenesis in mnd2 mice or Omi-knockdown N2a cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0044085"))
9464aa0d-10b7-48f8-b982-3b5d9534c055	1.0	PubMed	25118933	Thus, our data suggest that inhibition of GSK3beta and overexpression of PGC-1alpha significantly restore mitochondrial biogenesis that is influenced by Omi deficiency.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0044085"))
9464aa0d-10b7-48f8-b982-3b5d9534c055	1.0	PubMed	25118933	Inhibition of GSK3beta and overexpression of PGC-1alpha restore mitochondrial biogenesis influenced by Omi.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0044085"))
9464aa0d-10b7-48f8-b982-3b5d9534c055	1.0	PubMed	25118933	As GSK3beta is effective on PGC-1alpha abundance at the downstream of Omi, we wonder whether the inhibition of GSK3beta is able to restore mitochondrial biogenesis in vivo and in vitro.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0044085"))
9464aa0d-10b7-48f8-b982-3b5d9534c055	1.0	PubMed	25118933	As inhibition of GSK3beta is able to restore mitochondrial biogenesis influenced by Omi in vivo and in vitro, we wonder whether there is a functional improvement in mnd2 mice after SB216763 treatment.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0044085"))
9464aa0d-10b7-48f8-b982-3b5d9534c055	1.0	PubMed	25118933	An inhibition of GSK3beta promotes mitochondrial biogenesis during ischemia cerebral injury.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0044085"))
a86a60b2-12a7-45d1-9a45-e3256b444706	1.0	PubMed	16987514	Previously, it was shown that overexpression of GSK3beta in mouse hearts impaired the re-uptake of calcium into the ER.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:29108))
9113eafd-2681-418f-ae21-2589eba834dc	1.0	PubMed	21868755	In agreement, we found in this study that siRNA mediated silencing of GSK3beta enhanced the ability of celecoxib to downregulate c-FLIP (i.e., FLIP L).	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:41423))
6da9fc11-5a02-4869-bd5e-045c6491970e	1.0	PubMed	20519433	In combination, however, GSK3beta and CKI inhibition blocked the effect of loss of cell-cell adhesion and significantly reduced the percent of cells with APC clusters (XREF_FIG E).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0016337"))
dd04c73e-5112-4b1a-ab4f-a6fd80476f69	1.0	PubMed	22525275	Phosphorylation of GSK3beta deactivates the protein kinase and thereby complements the effects of MDM2 stabilization by promoting cell cycle progression (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007049"))
dd04c73e-5112-4b1a-ab4f-a6fd80476f69	1.0	PubMed	6506800	Thus, inhibition of GSK3beta activity appears to trigger nuclear accumulation of cyclin D1 and cell cycle progression.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007049"))
dd04c73e-5112-4b1a-ab4f-a6fd80476f69	1.0	PubMed	12364325	Thus, inhibition of GSK3beta activity appears to trigger nuclear accumulation of cyclin D1 and cell cycle progression.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007049"))
dd04c73e-5112-4b1a-ab4f-a6fd80476f69	1.0	PubMed	24038789	Increased CSPC proliferation with BIO inhibition of GSK3beta activity and siRNA knockdown suggests that increased GSK3beta activity would attenuate cell cycle progression.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007049"))
36d6bfd0-1dc1-4595-93b1-92a9f2a5eca8	1.0	PubMed	20159967	Under full culture conditions (10% FBS), GSK-3beta inhibition with chemical inhibitors or siRNAs failed to induce cell death in human prostate cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008219"))
36d6bfd0-1dc1-4595-93b1-92a9f2a5eca8	1.0	PubMed	27221474	In this study, we showed that GSK-3beta inhibits ROS induced hepatocellular carcinoma cell death by suppressing ASK1.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008219"))
36d6bfd0-1dc1-4595-93b1-92a9f2a5eca8	1.0	PubMed	24675460	In contrast to TRAIL, only GSK-3beta suppression led to sensitization of TNFalpha induced cell death in PDA, an effect recapitulated in GSK-3beta-null MEFs.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008219"))
36d6bfd0-1dc1-4595-93b1-92a9f2a5eca8	1.0	PubMed	25829335	In line with these results, a recent study has reported that GSK-3beta downrgulation by short hairpin RNA (shRNA) interference partially abrogates 6-OHDA induced SH-SY5Y apoptotic cell death.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008219"))
b8dbe869-c991-4a73-8d34-2b8d87193188	1.0	PubMed	18167338	These results demonstrate that although T80A is insensitive to GSK-3beta inhibition in vivo, it retains sensitivity to Chk1 inhibition.To monitor the regulation of Cdc25A by GSK-3beta and Chk1 throughout the cell division cycle, synchronized cells were treated with LiCl to inhibit GSK-3beta or with Go6976 to inhibit Chk1, and Cdc25A levels were examined by western blotting (A).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007049"))
c309d141-78c0-4093-8cb3-9fc77ef80955	1.0	PubMed	21964756	A previous study also using SK-OV-3 cells found that constitutively active GSK3beta increased cell growth and GSK3beta inhibition reduced cell growth [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0016049"))
c309d141-78c0-4093-8cb3-9fc77ef80955	1.0	PubMed	26274564	In SW480 cells, KD of both GSK3alpha and GSK3beta greatly inhibited cell growth in soft agar (XREF_FIG) and in nude mice (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0016049"))
c309d141-78c0-4093-8cb3-9fc77ef80955	1.0	PubMed	18804163	Therefore, TPO- and BIO induced inhibition of GSK-3beta promotes cell growth in UT-7 and TPO cells that is mediated by a beta-catenin-independent pathway, and the targets of GSK-3beta in this pathway do not appear to be either HIF-1alpha or cyclin D.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0016049"))
8994b5ae-51b2-4408-aec5-0801099008fd	1.0	PubMed	24901051	As it has been shown that GSK3beta can inhibit cell migration, 31 we examined whether CD82 has a role in GSK3beta mediated inhibition of cell invasion.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0016477"))
8994b5ae-51b2-4408-aec5-0801099008fd	1.0	PubMed	24312592	As shown in XREF_FIG, both uniformly up- or down-regulating intracellular GSK3beta inhibited cell migration.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0016477"))
8994b5ae-51b2-4408-aec5-0801099008fd	1.0	PubMed	25756394	It remains unclear whether p-Par6 is implicated in PKCzeta activation or has a role in GSK-3beta inactivation in prostate cancer cell migration.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0016477"))
a7517a20-d639-4a78-8d7f-dfe854c8736f	1.0	PubMed	27060477	In order to detect the regulatory mechanism of GSK-3beta on the proliferation, we further found that the repression of cell proliferation caused by inhibition of GSK-3beta by SB216763 could be blocked by Phorbol-12-myristate-13-acetate (PMA) (200nmol/L -1) which is the agonist of NF-kappaB.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
a7517a20-d639-4a78-8d7f-dfe854c8736f	1.0	PubMed	27060477	MK-2206 2HCl also restored the cell proliferation which was repressed by the GSK-3beta signaling inhibitor SB216763.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
a7517a20-d639-4a78-8d7f-dfe854c8736f	1.0	PubMed	26243309	The activated GSK3beta inhibited cell proliferation by c-Jun phosphorylation at Ser243, which facilitated destabilization and degradation of c-Jun through the ubiquitination mediated proteasomal degradation pathway.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
a7517a20-d639-4a78-8d7f-dfe854c8736f	1.0	PubMed	21038412	The activated GSK-3beta not only repressed cell proliferation, but also activated C/EBPalpha, which maintained miR-122 levels and thereby enforced IGF-1R suppression.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
a7517a20-d639-4a78-8d7f-dfe854c8736f	1.0	PubMed	27470346	The results of colony formation assays and anchorage independent growth assay both revealed that suppression of GSK3B in cells transfected with miR-769-in dramatically increased cell proliferation of human melanoma A375 cells (B and C).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
a7517a20-d639-4a78-8d7f-dfe854c8736f	1.0	PubMed	21595894	In a novel way, our results reveal that, when targeted by siRNA, phosphoinositide dependent kinase (PDK) (PDPK1) and p90Rsk (RPS6KA2), which are known positive regulators of transcription factor CREB1 (cyclic adenosine monophosphate responsive element binding protein 1), decreased cell proliferation, whereas inhibitor of nuclear factor kappaB kinase subunit (IKK) (CHUK) and glycogen synthase kinase 3 (GSK3) (GSK3B), which are known inhibitors of transcription factors NF-kappaB and c-Myc, significantly increased cell proliferation.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
048a870c-cdb1-4e84-8599-ac26dcbc688e	1.0	PubMed	11986994	GSK3beta facilitates apoptosis, and lithium 's inhibition of GSK3beta supports cell survival.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
048a870c-cdb1-4e84-8599-ac26dcbc688e	1.0	PubMed	6585168	Our recent findings suggest that inhibition of GSK3beta promotes PC12 cell survival after NGF-W.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
048a870c-cdb1-4e84-8599-ac26dcbc688e	1.0	PubMed	6311132	GSK3beta facilitates apoptosis, and lithium 's inhibition of GSK3beta supports cell survival.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
048a870c-cdb1-4e84-8599-ac26dcbc688e	1.0	PubMed	23408967	In contrast to our result, a recent study reported that siRNA mediated GSK3beta silencing promotes pancreatic cancer cell survival following irradiation via stabilization and activation of beta-catenin XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
048a870c-cdb1-4e84-8599-ac26dcbc688e	1.0	PubMed	20847424	Inhibition of GSK-3beta promotes cell survival through a variety of mechanisms including a reduced degradation of beta-catenin, which then translocates into the nucleus and activates the transcription of protective genes [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
048a870c-cdb1-4e84-8599-ac26dcbc688e	1.0	PubMed	27354597	Phosphorylation of glycogen synthase kinase 3beta (GSK3beta) by phosphatidyl-inositide 3-kinase (PI3K)/protein kinase B (AKT) or inhibition of GSK3beta with small-molecule inhibitor attenuates cell survival and proliferation and increases apoptosis in most cancer cell lines.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
048a870c-cdb1-4e84-8599-ac26dcbc688e	1.0	PubMed	18804163	Inhibition of GSK-3beta through BIO or lithium chloride promotes TPO independent cell survival and growth.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
451c8dd7-ca8a-4cf7-af6f-0b44253b5382	1.0	PubMed	22179823	ALK inhibition also resulted in decreased cell viability, which was rescued by GSK3beta inhibition.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
451c8dd7-ca8a-4cf7-af6f-0b44253b5382	1.0	PubMed	22179823	We provide evidence that NPM-ALK results in stabilization of Mcl-1 and CDC25A through GSK3beta inhibition, which in turn enhances cell viability, proliferation and oncogenic potential.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
451c8dd7-ca8a-4cf7-af6f-0b44253b5382	1.0	PubMed	23408967	Depletion of GSK3beta by RNA interference attenuated cell viability and proliferation in all cancer cell lines (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
451c8dd7-ca8a-4cf7-af6f-0b44253b5382	1.0	PubMed	23729362	Downregulation of GSK3B in various drug resistant p53-null colon cancer cell lines abolished cell viability and colony growth after drug addition without affecting cell proliferation or cell cycle in untreated cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D002470))
f59293ee-5592-4320-947b-64414b4abb8a	1.0	PubMed	23673211	Thus, differences in GSK-3beta activity and its subcellular distribution were observed between A549 and DDP cells and its parental cell line.To assess the relationship between GSK-3beta inactivation in the cytoplasm and cisplatin resistance, similar analyses were carried out in the presence of cisplatin.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:27899))
f59293ee-5592-4320-947b-64414b4abb8a	1.0	PubMed	23673211	Thus, exogenous inhibition of GSK-3beta by LiCl enhanced cisplatin resistance.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:27899))
f59293ee-5592-4320-947b-64414b4abb8a	1.0	PubMed	23673211	These data further confirmed that endogenous inhibition of GSK-3beta by siRNA also enhanced cisplatin resistance.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:27899))
f59293ee-5592-4320-947b-64414b4abb8a	1.0	PubMed	18606491	Conversely, reactivation of GSK3beta by expressing a constitutively active S9A GSK3beta mutant reverses cisplatin resistance and enhances sensitivity of ovarian cancer cells to cisplatin.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:27899))
9907f050-f625-4635-a157-a6cecb8d4ddb	1.0	PubMed	23107073	CLASP recruitment to microtubule plus-ends and its interaction with EB1 and IQGAP are negatively regulated by GSK3beta dependent phosphorylation at multiple sites (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q4U0G1))
9907f050-f625-4635-a157-a6cecb8d4ddb	1.0	PubMed	23107073	CLASP binding to microtubules and to IQGAP is negatively regulated by the serine/threonine kinase GSK3beta where chemical inhibition of GSK3beta enhances CLASP localization to microtubules and stabilizes microtubules at the leading edge of migrating cells (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q4U0G1))
9907f050-f625-4635-a157-a6cecb8d4ddb	1.0	PubMed	15955847	Our FRAP experiments indicate that GSK3beta inhibition increased the association of CLASP with MT lattices compared with lamella MT lattice bound CLASP in control cells, and constitutively active GSK3beta (S9A) reduced CLASP plus end tracking below the control cell level.	p(HGNC:GSK3B)	directlyDecreases	act(p(UP:Q4U0G1))
86e9ac15-12df-4be9-bf98-537354e5ea83	1.0	PubMed	26056233	Inhibition of GSK3beta, a negative Wnt regulator (XREF_BIBR), enhances wound healing and collagen deposition (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:3815))
794b018c-3152-43a0-9cc8-3ee0062d61ed	1.0	PubMed	24577092	PAX3-FOXO1 activation of GSK3beta antagonizes muscle creatine kinase promoter activation.	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:586))
794b018c-3152-43a0-9cc8-3ee0062d61ed	1.0	PubMed	27978525	Kinetic analysis revealed that GSK3beta significantly decreased the maximal creatine transport rate.	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:586))
743f6dea-7873-45b7-9e93-b04a9a0ea60f	1.0	PubMed	5596638	Similarly, expression of Frat1 or kinase deficient GSK-3 beta reduced death caused by inhibiting Akt.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008219"))
f445963b-a64f-47b0-8f8d-3706924ef9bf	1.0	PubMed	26320152	Not surprisingly, therefore, the effect of GSK3beta inhibition on enhancing the expression of LPS induced inflammatory genes was more marked in the presence of dexamethasone.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:41879))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	22385658	By itself, Gsk3beta inhibition with BIO up-regulates differentiation markers but is unaffected by Mek inhibition (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	19823589	Downregulation of Bmi1 reduced GSK3beta levels and induced the differentiation of malignant glial cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	19823589	Screening of several key proteins controlling cell cycle, development, metabolism, apoptosis and growth, including Erk, Akt, GSK3beta, p16 and p14, Bcl-2, c-Myc, Nestin and Sox2, showed that downregulation of Bmi1 reduced GSK3beta protein levels and induced differentiation in cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	25752456	Our results indicated that inhibition of GSK3beta by specific inhibitors, SB216763 or TDZD-8, promoted the differentiation of iTreg and increased their suppressive activity.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	25752456	In contrast, overexpression of GSK3beta significantly inhibited iTreg differentiation.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	25752456	Furthermore, GSK3beta inhibition enhanced iTreg differentiation through the TGF-beta and Smad3 pathway.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	25752456	Taken together, this study demonstrates that inhibition of GSK3beta enhances human iTreg differentiation and its suppressive activity, and provides a rationale to target GSK3beta as a novel immunotherapeutic strategy.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	21887250	Since inhibiting the PI3K and Akt cascade resulted in decreased phosphorylation of GSK3beta Ser9 and increased MN differentiation from hNSCs, we then asked if the increase in HB9 expression was due to the increase in GSK3beta activity.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	21145761	GSK3beta has been shown to inhibit E2F1 transcriptional activity and neural cell differentiation independent of its kinase activity ().	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	22775567	Inhibition of GSK-3beta enhances neural differentiation in unrestricted somatic stem cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	22775567	Thus, inhibition of GSK-3beta in USSCs enhances their neural differentiation, which suggests a positive role of the Wnt and beta-catenin signalling pathway towards neural fate.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	4925516	On the basis of these data we propose that GSK3beta inhibits the function of NeuroD and therefore prevents neuronal differentiation at a relatively late stage in the developmental pathway.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	19830702	GSKIP, an inhibitor of GSK3beta, mediates the N-cadherin and beta-catenin pool in the differentiation of SH-SY5Y cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	20735988	Recently, inhibition of GSK-3beta using small molecules has been shown to enhance neuronal differentiation in human fetal mesencephalic NPC-line ReNcell VM.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
a94075b5-67d2-4259-aa13-978183f453c6	1.0	PubMed	23605563	This is consistent with previous reports showing that : i) GSK3beta activity is required to enable PPARgamma dependent beta-catenin degradation during pre-adipocyte differentiation [XREF_BIBR]; ii) inhibition of GSK3beta activity, restricted to the early step of differentiation, is sufficient to impair adipogenic differentiation of human adipose derived stem cells [XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0030154"))
34236130-586c-4954-afc4-cd7533c7cdc3	1.0	PubMed	21725365	GSK3beta inhibition restored sensitivity to etoposide, and impaired the clonogenic capacities of adherent leukemic progenitors from female patients.	p(HGNC:GSK3B)	directlyDecreases	act(a(CHEBI:4911))
a253bb0d-8494-445b-b44d-636cf4f7a984	1.0	PubMed	22810307	Inhibition of GSK3beta increases the size of focal adhesions.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0051894"))
a253bb0d-8494-445b-b44d-636cf4f7a984	1.0	PubMed	22810307	Our results mirrored those observed in HeLa cells where inhibition of GSK3beta using both siRNA and pharmacological inhibitors impaired cell motility and increased the size and number of focal adhesions (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0051894"))
01039afe-84c2-468e-9dcc-a6f98b396b35	1.0	PubMed	21466834	GSK3beta inhibition in control or forskolin treated cells caused slight increase in ERM phosphorylation at the cell boundaries compared to cells without addition of the GSK3beta inhibitor (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:47936))
7aa56fdf-8d56-4c1b-9388-0e4e9acaf436	1.0	PubMed	23408967	The above results led us to address whether GSK3beta inhibition could enhance the effects of gemcitabine and ionizing radiation.	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:60750))
0566c49a-c590-4e0c-87d4-bf95be9dbf2e	1.0	PubMed	24704462	Inhibition of GSK-3beta results in activation of GS, increases glucose uptake and stimulates glycogen synthesis in human skeletal muscle.	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:439177))
7aad06f0-063f-425e-8047-13313f567589	1.0	PubMed	21334395	Therefore, a defect in GSK3beta phosphorylation in cirrhotic immune cells may deregulate the inflammatory response to LPS.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006954"))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	21239435	The phosphatidylinositol 3 kinase (PI3K)/Akt pathway is involved in beta-catenin-dependent signaling, and pretreatment of these human ovarian cancer cells with a PI3K and Akt inhibitor, LY294002, attenuated GnRH-II-stimulated phosphorylation of GSK3beta and inhibited GnRH-II-induced invasion.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	24901051	While GSK3beta knockdown markedly promoted cell invasion, concomitant CD82 expression partially, but significantly, reverted cell invasion to lower levels (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	23851495	Glycogen synthase kinase 3 beta (GSK3beta) is highly inactivated in epithelial cancers and is known to inhibit tumor migration and invasion.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	26297988	Down-regulation of beta-catenin abundance and GSK-3beta phosphorylation were correlated to reduce cellular migration and invasion in PC-3 and DU-145 prostate cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	25218472	Inhibition of GSK3beta activity significantly increased cell invasion in parental and control siRNA treated cells, and was restored in Tbeta4 downregulated cells (B).	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	25218472	Inhibition of GSK3beta activity by LiCl treatment significantly increased invasion in parental and control siRNA treated cells, and restored invasion in Tbeta4 downregulated cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	24312592	Over-expressing wild-type or constitutively active forms of GSK-3beta also inhibited the cell invasion.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	26822534	The ectopic upregulation of miR-224 dramatically inhibited the expression of GSK3beta and SFRP2 and enhanced CRC proliferation and invasion.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
e3f41657-6654-484a-a60e-2dc2a5e105a7	1.0	PubMed	25428377	Our studies revealed that miR-29s expression is downregulated in GC and they could repress the AKT2 expression and the inactivation of AKT and GSK3beta leading to inhibit the GC cells invasion.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009361))
4ed1dd42-8cdf-4ef4-aecf-1294ba424073	1.0	PubMed	23021822	However, this association between the GSK-3beta polymorphisms and therapeutic response to lithium is supported by data from animal studies which showed that the inhibition of GSK-3beta underlies the therapeutic effect of lithium for the treatment of mood disorders ().	p(HGNC:GSK3B)	directlyDecreases	act(a(PUBCHEM:28486))
f9f5206a-83a9-4a76-a55f-382fa900c864	1.0	PubMed	23107073	CLASP binding to microtubules and to IQGAP is negatively regulated by the serine/threonine kinase GSK3beta where chemical inhibition of GSK3beta enhances CLASP localization to microtubules and stabilizes microtubules at the leading edge of migrating cells (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0051179"))
f9f5206a-83a9-4a76-a55f-382fa900c864	1.0	PubMed	19180470	We suggest from our work that inactivation of GSK-3beta will decrease NF-kappaB activity by preventing nuclear localization of NF-kappaB.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0051179"))
749ffada-6a2b-4fbc-b74d-549fccb19142	1.0	PubMed	24481845	We found that mTORC1 activation by GSK-3beta inhibition reduces reperfusion injury by limiting exaggerated activation of autophagy, which is maladaptive 110.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:mTORC1))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	24901051	GSK3beta has been shown to inhibit EMT by targeting Snail for proteasomal degradation, thus releasing E-cadherin from transcriptional repression by Snail and promoting metastasis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	23959174	While GSK3beta promotes ubiquitin-proteasome pathway mediated beta-catenin degradation XREF_BIBR and suppresses Snail expression at transcriptional and post-transcriptional levels XREF_BIBR XREF_BIBR, it is unclear how GSK3beta suppresses CSC tumorigenesis and metastasis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	26341138	For example, downregulation of GSK3B significantly suppresses metastasis by inactivating the Wnt and beta-catenin axis at the epithelial-mesenchymal transition (EMT) in HCC cells () and TGF-beta affect the EMT via distinct mechanisms ().	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	25909283	Furthermore, knockdown of GSK3beta in H1752 cells by shRNA was sufficient to promote lung metastasis of H1752 tumors.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	25909283	Furthermore, knockdown of beta-catenin suppresses metastasis of H460 tumors, while knockdown of GSK3beta promotes metastasis of fibulin-5-expressing H1752 tumors.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	24886245	Phosphorylation mediated suppression of GSK3beta promotes breast tumor initiation and metastasis, and reduced phosphorylation of GSK3beta efficiently inhibit cancer stem cell like phenotypes in breast cancer [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	24027432	active GSK3beta suppress breast cancer cell metastasis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	25277196	Mechanistic investigations suggested through downregulation of GSK3B, CTNNB1, SNAI2, and CDH2, CLDN3 could significantly suppress metastasis by inactivating the Wnt and beta-catenin-epithelial mesenchymal transition (EMT) axis in HCC cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
2047bf6c-b967-4e7f-8224-c60d2ca146f5	1.0	PubMed	26781467	Mechanistically, TUFM knockdown activated AMPK and phosphorylated GSK3beta and increased the nuclear accumulation of beta-catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009362))
f5204ad2-ac35-41fb-9a06-009d92491994	1.0	PubMed	26440826	We have shown that inhibition of GSK-3beta activity triggered a profound autophagic response and subsequent necrotic cell death after serum deprivation in prostate cancer cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(MESH:D009336))
a32f481e-9732-419a-ae0c-6c3c7bb78e83	1.0	PubMed	17726008	Inhibition of GSK3beta kinase activity with SB216763 results in enhanced MEKK4 kinase activity and increased JNK and p38 activation, indicating that an active state of GSK3beta is required for binding and inhibition of MEKK4 dimerization.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:p38))
a32f481e-9732-419a-ae0c-6c3c7bb78e83	1.0	PubMed	17726008	However, unlike TRAF4, Axin, and GADD45, GSK3beta inhibits MEKK4 activity and prevents its activation of JNK and p38.	p(HGNC:GSK3B)	directlyDecreases	act(p(FPLX:p38))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	22179823	We provide evidence that NPM-ALK results in stabilization of Mcl-1 and CDC25A through GSK3beta inhibition, which in turn enhances cell viability, proliferation and oncogenic potential.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	4929257	Lithium chloride (LiCl), a direct inhibitor of GSK-3beta, can alone stimulate granule cell proliferation and enhance proliferation induced by IGF-I.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	21795403	Consistent with results published in the literature, we could not detect endogenous c-Myb expression in HEK293 cells (Supplemental Figure S3) (XREF_BIBR; XREF_BIBR), which might explain why the proliferation of these cells is not inhibited by GSK3beta (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	25051360	Thus at least with regards to mammary epithelial cells GSK-3beta activity appears to limit proliferation and suppress the stem like cell population.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	26063791	Restoration of GSK3B expression blocked proliferation of normal oral epithelial cell lines carrying shRNA to GRHL3 (cell no., Day 8 : Scramble ctl, 616 +/-21.8 x 10 (3) vs GRHL3-kd, 1194 +/-44 X 10 (3), P <.001; GRHL3-kd vs GRHL3-kd + GSK3B, 800 +/-98.84 X 10 (3), P =.003) and human HNSCC cells.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	24038789	Further, beta-catenin and GSK3beta knockdown increased proliferation as would be predicted.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	23408967	Depletion of GSK3beta by RNA interference attenuated cell viability and proliferation in all cancer cell lines (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	27354597	Phosphorylation of glycogen synthase kinase 3beta (GSK3beta) by phosphatidyl-inositide 3-kinase (PI3K)/protein kinase B (AKT) or inhibition of GSK3beta with small-molecule inhibitor attenuates cell survival and proliferation and increases apoptosis in most cancer cell lines.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	26822534	The ectopic upregulation of miR-224 dramatically inhibited the expression of GSK3beta and SFRP2 and enhanced CRC proliferation and invasion.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	23349842	Interestingly, a selective inhibitor of GSK3beta, LiCl (20 mM), markedly suppressed the inhibitory effect of proliferation by homocysteine (XREF_FIG).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	25056574	While we did not define the precise molecular mechanisms by which Nestin promoted the Wnt and beta-catenin activation in breast CSC, our data clearly indicated that spontaneous Wnt and beta-catenin activation was crucial for Nestin to promote CSC proliferation, which was negatively regulated by GSK-3beta.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	19967550	The results of the BrdU assay suggested that knockdown of GSK-3beta with the RNAi adenovirus may stimulate the proliferation of HUVECs.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	26496802	Inhibition of DYRK1A and GSK3B induces human beta-cell proliferation.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	26496802	Overexpression of Gsk3b only partially inhibited aminopyrazine induced beta-cell proliferation (XREF_FIG), and beta-cells can proliferate and function normally in the absence of beta catenin XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	26496802	Consistent with a critical role for Dyrk1a inhibition, and confirming that Gsk3b inhibition is insufficient to drive full beta-cell proliferation, GNF6324 was completely inactive in both rat and human beta-cell proliferation assays (XREF_FIG and XREF_FIG, XREF_SUPPLEMENTARY), but capable of inducing nuclear localization of beta-catenin (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	26496802	However, our findings demonstrate that dual inhibition of GSK3B and DYRK1A more robustly stimulates beta-cell proliferation, even when compared directly with harmine or 5-IT (XREF_FIG; XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	26496802	We propose that pharmacological inhibition of DYRK1A and GSK3B can drive supra-physiological levels of NFAT activation and an increase in beta-cell proliferation beyond that achievable even under conditions of increased glucose load XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	18804163	Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
60e7c7bd-f0cd-430e-b966-e765584e3cf7	1.0	PubMed	18804163	Inhibition of GSK-3beta promotes survival and proliferation in megakaryocytic cells, but not through the action of beta-catenin.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0008283"))
c096da01-e82d-448f-a9e9-ba088fe4e810	1.0	PubMed	26262608	Nrf2 protein degradation could be mediated by the phosphorylation of GSK-3beta and beta-TrCP.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006508"))
c096da01-e82d-448f-a9e9-ba088fe4e810	1.0	PubMed	22679108	GSK-3beta phosphorylation can lead to protein degradation, such as with beta-catenin (XREF_BIBR).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006508"))
c096da01-e82d-448f-a9e9-ba088fe4e810	1.0	PubMed	22807997	Inhibition of GSK3-beta completely abrogates p22phox protein degradation, which demonstrates that without GSK3-beta signalling p22phox can not be processed by the proteasome.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006508"))
fac1405e-3ffe-4100-a85e-5e8782de316a	1.0	PubMed	19729319	GSK3beta might partially mediate glucocorticoid effects, because expression of dominant negative GSK3beta prevents glucocorticoid induced proteolysis.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006508"))
f17a1426-08d7-4767-b52b-452f9c0eec6d	1.0	PubMed	21964756	Indirect activation of GSK3beta by suppressing PI3K activity also reduced the HIF-1alpha stabilization response to hypoxia (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0001666"))
bddade06-4f12-49db-86e6-4ebebf320b60	1.0	PubMed	25486988	The lower GSK-3beta expression generated by Abeta immunotherapy shows evidence of a modification of the signalling pathway induced by GSK-3beta leading to the overall reduction of tau, supporting the contention that in humans, GSK-3beta unifies Abeta and tau related neuropathology.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0007165"))
57072ef3-34ed-4319-a6e0-c1cb6b1df922	1.0	PubMed	23100427	GSK3beta inhibition increased TCF dependent transcription.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006351"))
57072ef3-34ed-4319-a6e0-c1cb6b1df922	1.0	PubMed	23100427	We first asked whether fetal human OPCs could activate Wnt and beta-catenin pathway signaling, by assessing whether GSK3beta inhibition increased TCF dependent transcription, using a TCF dependent luciferase reporter.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006351"))
57072ef3-34ed-4319-a6e0-c1cb6b1df922	1.0	PubMed	5096923	Thus, inhibition of GSK-3beta is insufficient to activate Tcf dependent transcription in T lymphocytes.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006351"))
57072ef3-34ed-4319-a6e0-c1cb6b1df922	1.0	PubMed	22140263	One of the transcription factors that is negatively regulated by GSK-3beta is CREB, which itself positively regulates IL-10 expression.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006351"))
57072ef3-34ed-4319-a6e0-c1cb6b1df922	1.0	PubMed	4866111	Transient increases in the expression of GSK-3beta facilitate the disappearance of HSF-1 punctate granules and reduce hsp-70 transcription after heat shock.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006351"))
57072ef3-34ed-4319-a6e0-c1cb6b1df922	1.0	PubMed	19429245	After co-transfected GSK3betaS9A with the Tcf luciferase reporter plasmids followed by CSE treatment, we examined the luciferase activity of pGL3-OT and found that beta-catenin and Tcf transcription activity induced by CSE was abolished by GSK3beta over-expression () (9285 +/-2945 in GSK3betaS9A+ CSE treatment group 20,764 +/-1801 in CSE treatment group, < 0.01).	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006351"))
57072ef3-34ed-4319-a6e0-c1cb6b1df922	1.0	PubMed	6362558	GSK-3beta itself inhibits the activation of several transcription factors, which are important cell survival factors, such as heat shock factor 1.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006351"))
57072ef3-34ed-4319-a6e0-c1cb6b1df922	1.0	PubMed	23900729	The enhancement of glycogen synthase kinase 3beta (GSK-3beta) activity by NDRG2 overexpression caused proteasomal degradation of Snail transcription factor followed by transcriptional de-repression of E-cadherin.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006351"))
58f4c64f-10b4-4f7d-8288-02a43f4c9628	1.0	PubMed	25285168	The Glycogen synthase kinase 3-beta (GSK-3beta) may inhibit the translation of beta-catenin in Wnt and beta-catenin pathway by phosphorylation and degradation of beta-catenin XREF_BIBR, and the GSK-3beta is negatively regulated by AKT2 XREF_BIBR.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006412"))
22fd710a-f26d-46ba-8cbd-8a9ee4b60e1b	1.0	PubMed	28057765	We recently demonstrated that dynein is a GSK-3beta substrate and that inhibition of GSK-3beta promotes dynein dependent transport.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006810"))
22fd710a-f26d-46ba-8cbd-8a9ee4b60e1b	1.0	PubMed	27978525	Kinetic analysis revealed that GSK3beta significantly decreased the maximal creatine transport rate.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006810"))
22fd710a-f26d-46ba-8cbd-8a9ee4b60e1b	1.0	PubMed	24086147	Calcineurin activity assay showed an unexpected decrease in calcineurin activity (0.74 +/-0.06 fold of control) in these flies, suggesting that constitutive GSK-3beta activation in the absence of calcineurin activation is sufficient to disrupt axonal transport potentially through phosphorylation of KLC.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006810"))
22fd710a-f26d-46ba-8cbd-8a9ee4b60e1b	1.0	PubMed	24086147	However, GSK-3beta activation may also perturb general axonal transport by influencing motor activity or binding of motors to the microtubule tract.	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006810"))
22fd710a-f26d-46ba-8cbd-8a9ee4b60e1b	1.0	PubMed	25528666	Knockdown of either Axin-1 or GSK3beta suppressed Sema3A induced bidirectional axonal transport ().	p(HGNC:GSK3B)	directlyDecreases	act(bp(GO:"GO:0006810"))
615d68de-750a-4ebc-92e7-6caaf011dae6	1.0	PubMed	23768967	In general though, enough GSK-3beta is bound to Axin to prevent accumulation of beta-catenin even in the presence of active Akt.	complex(p(HGNC:GSK3B), p(HGNC:AXIN1))	directlyDecreases	act(p(HGNC:CTNNB1))
30d6ea60-ca88-48f3-8c2b-9db6767beae3	1.0	PubMed	4862567	Axin interacts with beta-catenin, GSK-3beta and APC, and negatively regulates the Wnt signalling pathway, presumably by regulating the level of beta-catenin.	complex(p(HGNC:GSK3B), p(HGNC:AXIN1))	directlyDecreases	act(p(FPLX:Wnt))
e9559e14-f72f-4163-ba21-de859fe5422b	1.0	PubMed	4862567	Axin interacts with beta-catenin, GSK-3beta and APC, and negatively regulates the Wnt signalling pathway, presumably by regulating the level of beta-catenin.	complex(p(HGNC:GSK3B), p(HGNC:AXIN1))	directlyDecreases	act(bp(GO:"GO:0007165"))
f111bbe3-b98b-4490-9731-65f36e318ccb	1.0	PubMed	22513362	Since FBXW7 appears to mediate ubiquitination of Aurora-A in a GSK3beta dependent manner, we investigated whether disruption of the interactions between FBXW7 and Aurora-A and GSK3beta and Aurora-A would block proteasome dependent degradation of Aurora-A.	complex(p(HGNC:GSK3B))	directlyDecreases	act(p(FPLX:Proteasome))
a1eb83fc-78e7-4d4b-a542-2f07e0915882	1.0	PubMed	22513362	Since FBXW7 appears to mediate ubiquitination of Aurora-A in a GSK3beta dependent manner, we investigated whether disruption of the interactions between FBXW7 and Aurora-A and GSK3beta and Aurora-A would block proteasome dependent degradation of Aurora-A.	complex(p(HGNC:GSK3B), p(HGNC:FBXW7))	directlyDecreases	act(p(FPLX:Proteasome))
e1ddd2ab-df82-424c-aecc-aebc91b042d0	1.0	PubMed	17726008	GSK3beta binding to MEKK4 blocks MEKK4 dimerization that is required for MEKK4 activation, effectively inhibiting MEKK4 stimulation of the JNK and p38 MAPK pathways.	complex(p(HGNC:GSK3B), p(HGNC:MAP3K4))	directlyDecreases	act(p(HGNC:MAP3K4))
fd424f8b-569e-49d0-ad6b-ece7a17c1fb9	1.0	PubMed	22965877	We reveal that NUB1 interacted with both tau and GSK3beta to disrupt their interaction, and abolished recruitment of GSK3beta to tau inclusions.	complex(p(HGNC:GSK3B), p(HGNC:NUB1))	directlyDecreases	act(p(HGNC:GSK3B))
fd424f8b-569e-49d0-ad6b-ece7a17c1fb9	1.0	PubMed	22965877	We reveal that NUB1 interacted with both tau and GSK3beta to disrupt their interaction, and abolished recruitment of GSK3beta to tau inclusions.	complex(p(HGNC:GSK3B), p(HGNC:NUB1))	directlyDecreases	act(p(HGNC:GSK3B))
1fb53b81-ee43-4f7d-a419-02a139b9ea49	1.0	PubMed	26655089	OLA1 binds with GSK3beta and inhibits the GSK3 mediated reactivation of PP1.	complex(p(HGNC:GSK3B), p(HGNC:OLA1))	directlyDecreases	act(p(FPLX:PPP1))
1cc279b5-d1f9-4dbf-a098-e5e93b4464d9	1.0	PubMed	18593713	A Smad7-Axin interaction disassociates GSK-3beta and beta-catenin from Axin, as well as inhibits the recruitment of Smurf2, an E3 ligase, to beta-catenin, thus protecting beta-catenin from phosphorylation and degradation.	complex(p(HGNC:GSK3B))	directlyDecreases	act(p(HGNC:SMURF2))
8927a276-b38f-4239-a33b-ff7d31121689	1.0	PubMed	6704417	LANA stabilizes beta-catenin by binding to the negative regulator GSK-3beta, causing a cell cycle dependent nuclear accumulation of GSK-3beta.	complex(p(HGNC:GSK3B), p(UP:Q65DC4))	directlyDecreases	act(p(HGNC:GSK3B))
8927a276-b38f-4239-a33b-ff7d31121689	1.0	PubMed	6704417	LANA stabilizes beta-catenin by binding to the negative regulator GSK-3beta, causing a cell cycle dependent nuclear accumulation of GSK-3beta.	complex(p(HGNC:GSK3B), p(UP:Q65DC4))	directlyDecreases	act(p(HGNC:GSK3B))
16670d3a-891c-4e2b-9a49-fca38255c6ca	1.0	PubMed	6704417	LANA stabilizes beta-catenin by binding to the negative regulator GSK-3beta, causing a cell cycle dependent nuclear accumulation of GSK-3beta.	complex(p(HGNC:GSK3B), p(UP:Q65DC4))	directlyDecreases	act(bp(GO:"GO:0007049"))
801ee53d-1877-44d6-bc88-5c800f823327	1.0	PubMed	26984280	Based on these bioinformatics results, we hypothesized that NIFK overexpression downregulates CK1alpha, thereby decreasing the levels of the APC, AXIN, CK1alpha, CTNNbeta, and GSK3beta complex, which in turn increases intracellular beta-catenin protein stability.	complex(p(HGNC:GSK3B), p(HGNC:APC), p(HGNC:AXIN1))	directlyDecreases	act(p(HGNC:CTNNB1))
87588c3b-670a-4f88-b88d-ffec4cd95119	1.0	PubMed	7088620	AM gene transfer increased phosphorylation of Akt and glycogen synthase kinase (GSK-3beta) but reduced GSK-3beta and caspase-3 activities in the heart.	p(FPLX:GYS)	directlyDecreases	act(p(HGNC:GSK3B))
87588c3b-670a-4f88-b88d-ffec4cd95119	1.0	PubMed	23911749	TNF-alpha induces the phosphorylation of glycogen synthase kinase 3beta (GSK3beta), i.e. inhibition of GSK3beta.	p(FPLX:GYS)	directlyDecreases	act(p(HGNC:GSK3B))
e66aeb6a-5ee3-45ff-9abf-6b70bbf4e520	1.0	PubMed	20399743	Therefore, beta-Catenin expression or function might be an interesting target for clinical investigations.Previous results from our laboratory have shown that activation of Galphaq in oocytes inhibits GSK-3beta and stabilizes beta-Catenin, suggesting that Galphaq positively regulates the canonical Wnt pathway.	p(FPLX:"G_q_alpha")	directlyDecreases	act(p(HGNC:GSK3B))
e66aeb6a-5ee3-45ff-9abf-6b70bbf4e520	1.0	PubMed	20399743	Our previous results have shown that activation of Galphaq inhibits GSK-3beta in oocytes.	p(FPLX:"G_q_alpha")	directlyDecreases	act(p(HGNC:GSK3B))
e66aeb6a-5ee3-45ff-9abf-6b70bbf4e520	1.0	PubMed	20399743	Expression of the wild type or the activated Galphaq decreased GSK-3beta activity by 20-30% while expression of the control gene () had no effect (data not shown).	p(FPLX:"G_q_alpha")	directlyDecreases	act(p(HGNC:GSK3B))
e66aeb6a-5ee3-45ff-9abf-6b70bbf4e520	1.0	PubMed	20399743	As shown in, expression of the activated Galphaq (GalphaqQL) reduced GSK-3beta activity by 50%.	p(FPLX:"G_q_alpha")	directlyDecreases	act(p(HGNC:GSK3B))
e66aeb6a-5ee3-45ff-9abf-6b70bbf4e520	1.0	PubMed	20399743	The levels of inhibition of GSK-3beta by Galphaq (or GalphaqQL) are similar to those reported by other groups who have used a similar assay to study other regulators of GSK-3beta.	p(FPLX:"G_q_alpha")	directlyDecreases	act(p(HGNC:GSK3B))
e66aeb6a-5ee3-45ff-9abf-6b70bbf4e520	1.0	PubMed	20399743	On the other hand, since the efficiency of transient transfection methods is not 100%, the levels of inhibition of GSK-3beta by Galphaq (or GalphaqQL) might be expected to have been higher than those we observed.	p(FPLX:"G_q_alpha")	directlyDecreases	act(p(HGNC:GSK3B))
e66aeb6a-5ee3-45ff-9abf-6b70bbf4e520	1.0	PubMed	20399743	We conclude that activation of Galphaq significantly inhibits GSK-3beta and therefore that it is very likely that Galphaq mediated accumulation of beta-Catenin is due to inhibition of GSK-3beta.	p(FPLX:"G_q_alpha")	directlyDecreases	act(p(HGNC:GSK3B))
5d85b913-c006-45c6-be60-a73c2c0e2fd8	1.0	PubMed	25504627	Moreover, re-expression of HDAC8 attenuated miR-21-3p-mediated suppression of cardiac hypertrophy by enhancing phospho-Akt and phospho-Gsk3beta expression.	p(HGNC:HDAC8)	directlyDecreases	act(p(HGNC:GSK3B))
e128be18-bd85-4d0f-bfb8-3da15ba22b2c	1.0	PubMed	26739898	We also observed that GSK3beta inhibition by HMGB1 was transient, whereas nuclear translocation and accumulation of beta-catenin was sustained for up to 3h and 24h, respectively.	p(HGNC:HMGB1)	directlyDecreases	act(p(HGNC:GSK3B))
20d68327-aa44-4cb8-b896-072271ea83c5	1.0	PubMed	18801366	Indeed, HO treatment of HCC cells activated Akt and suppressed GSK3beta through phosphorylation of Ser 9; treatment with LY294002, a PI3K inhibitor, blocked this effect ().	p(HGNC:HMOX1)	directlyDecreases	act(p(HGNC:GSK3B))
185add87-0714-4255-9826-ee0d5d25d530	1.0	PubMed	19303846	Consistent with its ability to bind GSK3beta, the DISC1 fragment spanning residues 1-220 potently inhibited beta-catenin, axin, and GSK3beta phosphorylation at 0.5 microM, whereas none of the other DISC1 fragments, GST-p25, or GST-CASK proteins inhibited GSK3beta activity at this concentration (XREF_FIG).	p(HGNC:HRES1)	directlyDecreases	act(p(HGNC:GSK3B))
9af60625-2fe1-4f93-8446-caf8498644a2	1.0	PubMed	23043959	Akt induced inactivation of GSK-3beta by HS has been reported to contribute to the activation of heat shock factor-1 (HSF-1), the major transcriptional factor that regulates stress inducible synthesis of HSPs.	a(PUBCHEM:6992830)	directlyDecreases	act(p(HGNC:GSK3B))
9af60625-2fe1-4f93-8446-caf8498644a2	1.0	PubMed	23043959	HS rapidly activated Akt and ERK, and inactivated GSK-3beta.	a(PUBCHEM:6992830)	directlyDecreases	act(p(HGNC:GSK3B))
9af60625-2fe1-4f93-8446-caf8498644a2	1.0	PubMed	23043959	HS inactivated GSK-3beta via Akt activation, resulting in the activation of HSF-1.	a(PUBCHEM:6992830)	directlyDecreases	act(p(HGNC:GSK3B))
668a1da7-c96d-4967-8fd2-60497d2aabf1	1.0	PubMed	25118933	We next investigated whether Omi downregulates GSK3beta in vitro.	p(HGNC:HTRA2)	directlyDecreases	act(p(HGNC:GSK3B))
668a1da7-c96d-4967-8fd2-60497d2aabf1	1.0	PubMed	25118933	In N2a cells, the overexpression of wide-type full-length Omi, but not S276C mutant Omi, reduced the endogenous GSK3beta abundance (XREF_FIG), as well as enhanced green fluorescent protein (EGFP)-, Flag- and HA tagged GSK3beta (XREF_SUPPLEMENTARY), whereas knockdown of Omi increased the abundances of GSK3beta in SH-SY5Y cells (XREF_FIG) and N2a cells (XREF_SUPPLEMENTARY).	p(HGNC:HTRA2)	directlyDecreases	act(p(HGNC:GSK3B))
668a1da7-c96d-4967-8fd2-60497d2aabf1	1.0	PubMed	25118933	In N2a cells, the overexpression of wide-type full-length Omi, but not S276C mutant Omi, reduced the endogenous GSK3beta abundance (XREF_FIG), as well as enhanced green fluorescent protein (EGFP)-, Flag- and HA tagged GSK3beta (XREF_SUPPLEMENTARY), whereas knockdown of Omi increased the abundances of GSK3beta in SH-SY5Y cells (XREF_FIG) and N2a cells (XREF_SUPPLEMENTARY).	p(HGNC:HTRA2)	directlyDecreases	act(p(HGNC:GSK3B))
3c534425-d165-4693-839e-c6cac7febaf1	1.0	PubMed	21160051	The findings from the current study demonstrated that the ability of IFN-beta to suppress GSK3-beta was a critical intracellular signaling event required for IFN-beta to induce IL-10 from DC.	p(HGNC:IFNB1)	directlyDecreases	act(p(HGNC:GSK3B))
850a4fb2-b270-4578-a18f-4b0ca31c5abd	1.0	PubMed	20504360	IGF-1R knockdown using siRNA suppressed the levels of IGF-1R protein and concomitantly suppressed the downstream kinases, pAkt and pGSK3beta, and cyclin D1.	p(HGNC:IGF1R)	directlyDecreases	act(p(HGNC:GSK3B))
932b2b91-72cd-4b7d-8ecf-03f53256b3d8	1.0	PubMed	17846171	Because IGF-1 signaling inactivates GSK-3beta and promotes protein synthesis (XREF_BIBR), we examined whether inhibition of IGF-1R activity could reduce p53 and mdm2 translation through activation of GSK-3beta.	p(HGNC:IGF1)	directlyDecreases	act(p(HGNC:GSK3B))
932b2b91-72cd-4b7d-8ecf-03f53256b3d8	1.0	PubMed	23619527	Recent evidence showed that both lithium and IGF-1 inhibit GSK-3beta in breast cancer cells through two different mechanisms : IGF-1 activates the PI3K and AKT and extracellular signal regulated kinases (ERK) pathways while lithium directly inhibits GSK-3beta through a magnesium-competitive mechanism.	p(HGNC:IGF1)	directlyDecreases	act(p(HGNC:GSK3B))
932b2b91-72cd-4b7d-8ecf-03f53256b3d8	1.0	PubMed	7237125	Further IGF-I was able to sustain Akt activity and thus preventing GSK-3beta activation in the presence of DHEA.	p(HGNC:IGF1)	directlyDecreases	act(p(HGNC:GSK3B))
932b2b91-72cd-4b7d-8ecf-03f53256b3d8	1.0	PubMed	19729319	Therefore, IGF-I stimulation of GSK3beta serine 9 phosphorylation, which inactivates GSK3beta, might partially reverse glucocorticoid induced proteolysis.An additional atrophy mechanism is thought to be mediated by IKK, which phosphorylates IRS-1 on serine 307 to reduce IGF-I stimulated signaling.	p(HGNC:IGF1)	directlyDecreases	act(p(HGNC:GSK3B))
932b2b91-72cd-4b7d-8ecf-03f53256b3d8	1.0	PubMed	6377119	IGF-I suppressed the kinase activity of GSK-3beta.	p(HGNC:IGF1)	directlyDecreases	act(p(HGNC:GSK3B))
932b2b91-72cd-4b7d-8ecf-03f53256b3d8	1.0	PubMed	17264150	In addition, we show that IGF-1 also signals to myotubes to stimulate protein metabolism via Akt by (1) activating the mTOR-p70S6K-S6 pathway and inhibiting GSK-3beta, both involved in the control of protein translation, and (2) inhibiting the Foxo1-atrogin-1 protein degradation pathway.	p(HGNC:IGF1)	directlyDecreases	act(p(HGNC:GSK3B))
1e9e9103-cc12-454b-ba2f-6203244b2249	1.0	PubMed	19734233	These data demonstrate that the IL-12-mediated production of IL-10 is dependent on the ability of IL-12 to inactivate GSK3beta.	p(HGNC:IL10)	directlyDecreases	act(p(HGNC:GSK3B))
a06c887c-ca74-494a-884c-541705118bff	1.0	PubMed	19734233	The inactivation of GSK3beta by IL-12 was shown to lead to the increased levels of the transcription factor c-Jun.	p(FPLX:IL12)	directlyDecreases	act(p(HGNC:GSK3B))
9699e727-678c-40c5-a692-bde020dfac88	1.0	PubMed	21321938	Thus IL-18 induced GSK3beta degradation and the subsequent release of beta-catenin might activate NF-kappaB and induce kappaB dependent pro mitogenic gene expression in VSMC.	p(HGNC:IL18)	directlyDecreases	act(p(HGNC:GSK3B))
c3ab922a-a144-4c0c-a8f9-cb46a1746233	1.0	PubMed	19701245	The nature of tumor induced IL-1beta release from macrophages and the mechanism whereby IL-1beta inactivates GSK3beta and leads to enhanced beta-catenin and TCF4 transcriptional activity remain, for now, unknown.	p(HGNC:IL1B)	directlyDecreases	act(p(HGNC:GSK3B))
c3ab922a-a144-4c0c-a8f9-cb46a1746233	1.0	PubMed	23029025	Macrophages and IL1beta inactivate GSK3beta in both HCT116 and Hke-3 cells (XREF_FIG) and, consistently, stabilize Snail independently of the presence kRas mutations in tumor cells XREF_BIBR.	p(HGNC:IL1B)	directlyDecreases	act(p(HGNC:GSK3B))
c3ab922a-a144-4c0c-a8f9-cb46a1746233	1.0	PubMed	22095718	Since IL-1beta regulates the expression and secretion of a key AD-relevant cytokine, S100B, from astrocytes (XREF_BIBR - XREF_BIBR), and since S100B has been shown to promote tau pathology by disrupting a substrate of GSK-3beta, beta-catenin, in neuronal stem cell culture (XREF_BIBR), we hypothesized that S100B might mediate the reduction in GSK-3beta activity that we observed.	p(HGNC:IL1B)	directlyDecreases	act(p(HGNC:GSK3B))
1725f55a-433e-47f5-9d73-b47bfac13db9	1.0	PubMed	17273789	IL-6 treatment decreased active MAPK and pERK and glycogen synthase kinase 3beta (GSK3beta) expression and GSK3beta kinase activity.	p(HGNC:IL6)	directlyDecreases	act(p(HGNC:GSK3B))
ea383354-5587-4d71-a557-910295149de0	1.0	PubMed	12771992	In addition to this, inhibition of GSK3beta by ILK could tip the scale in favour of enhanced growth.	p(HGNC:ILK)	directlyDecreases	act(p(HGNC:GSK3B))
ea383354-5587-4d71-a557-910295149de0	1.0	PubMed	23237804	In fact, inactivation of GSK3beta by ILK leads to induction of the ranscription complex beta, catenin, and Lymphoid Enhancer Factor-1 (LEF1) [XREF_BIBR], which in turn leads to increased regulation of multiple pro survival genes.	p(HGNC:ILK)	directlyDecreases	act(p(HGNC:GSK3B))
ea383354-5587-4d71-a557-910295149de0	1.0	PubMed	17563721	In addition to the PI3K pathway, GSK-3b can be directly inhibited by ILK phosphorylation in a PI3K dependent manner (reviewed in [XREF_BIBR]).	p(HGNC:ILK)	directlyDecreases	act(p(HGNC:GSK3B))
ea383354-5587-4d71-a557-910295149de0	1.0	PubMed	19286457	Binding of CCN proteins to specific integrin receptors stimulates the activity of Integrin Linked Kinase (ILK) which in turn inhibits GSK3-beta activity either directly or indirectly through stimulation of Akt ().	p(HGNC:ILK)	directlyDecreases	act(p(HGNC:GSK3B))
ea383354-5587-4d71-a557-910295149de0	1.0	PubMed	27683053	ILK knockdown activates GSK-3beta.	p(HGNC:ILK)	directlyDecreases	act(p(HGNC:GSK3B))
95bb97b6-de61-42df-a9cc-d512874fe0f3	1.0	PubMed	PMC4445512	The mechanism by which myo-inositol inhibits both dominant negative GSK-3 beta and lithium remains uncertain.	p(HGNC:IMPA1)	directlyDecreases	act(p(HGNC:GSK3B))
3339fb21-15c3-4682-8349-382029244251	1.0	PubMed	26456864	In parallel, INSM1 is capable of activating PI3K and AKT and inhibits GSK3beta kinase, which is responsible for Thr58 and Thr50 of C-myc and N-myc phosphorylation that triggers the degradation of Myc protein.	p(HGNC:INSM1)	directlyDecreases	act(p(HGNC:GSK3B))
c5c0d550-fc1a-4e42-91cf-593f4bef0331	1.0	PubMed	21737790	Since the activity of GSK-3beta is negatively regulated by S9 phosphorylation, GSK-3beta is activated by prolonged ischemia, but is inhibited by I/R.	bp(MESH:D011839)	directlyDecreases	act(p(HGNC:GSK3B))
8c095492-1500-4707-9c1a-d6fa06ae2a10	1.0	PubMed	21238544	Moreover, under the same condition, we observed that IR ICD reduced GSK3beta activity, promoted GSK3beta S9 phosphorylation, as well as enhanced Akt levels (F, G).	p(HGNC:INSR)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	24411062	Insulin related molecules may represent another consequence of drug mechanism of action as insulin inhibits GSK3beta via the phosphatidylinositol 3-kinase/protein kinase B signalling pathway ().	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	18443205	Silencing of IKKbeta had no effect on basal or insulin stimulated GSK3beta Ser 9 and prevented the TNF-alpha-induced increase in GSK3beta phosphorylation.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	25336918	XREF_BIBR Since GSK3beta can be suppressed by insulin and some other activators of the PI3K signaling pathway, this intriguing finding suggests that GSK3beta phosphorylation on PTEN is likely to be involved in the negative feedback loop of the PI3K signaling pathway.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	19429119	Insulin inactivates GSK-3beta in this manner, through phosphorylation by protein kinase B (Akt) [XREF_BIBR].	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	21862343	Thus, GSK3beta plays a vital role in glucose homeostasis and is inactivated by insulin through the insulin receptor-insulin receptor substrates (IRS)-Akt pathway.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	18768676	In PCOS adipocytes, GSK3beta tyrosine phosphorylation is increased and insulin stimulated serine phosphorylation is decreased (XREF_BIBR), which could result in an overactive GSK3beta that is less able to be suppressed by insulin, possibly explaining impaired insulin stimulated glycogen synthesis.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	15026145	Our long-term observations indicate an attenuation of insulin signaling that could be caused by a decrease in activity of one or more components of insulin signaling pathway upstream of PKB-alpha and PI-3 kinase.It is known that inhibition of GSK-3beta by insulin results from its phosphorylation at and N-terminus residue Ser by PKB and the inhibition of GSK-3beta subsequently promotes dephosphorylation and activation of glycogen synthase.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	15940626	In contrast, insulin signaling inhibits GSK-3beta by the downstream activation of PI3-K and Akt and PKB, which results in the phosphorylation of GSK-3beta at serine 9.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	8250835	The results suggest that ser-9 phosphorylation underlies the reported gsk3 beta inhibition by insulin and that gsk3 may represent a point of convergence of two major growth-factor-stimulated protein kinase cascades.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
d7770f2e-f85f-498f-994c-7b00e307d920	1.0	PubMed	PMC3741895	The results suggest that Ser-9 phosphorylation underlies the reported inhibition of GSK3 beta by insulin and that GSK3 may represent a point of convergence of two major growth-factor-stimulated protein kinase cascades.	p(HGNC:INS)	directlyDecreases	act(p(HGNC:GSK3B))
df5646e6-e0fa-417f-a32a-a8d5686387eb	1.0	PubMed	Other	No evidence text.	a(PUBCHEM:"CID:5359405")	directlyDecreases	act(p(HGNC:GSK3B))
48b994ab-7a54-4b12-b3c0-b9f881ed31ba	1.0	PubMed	24577092	Electrical stimulation of ARMS derived RH30 cells reduces GSK3beta activity through Akt (PKB).	p(HGNC:KIDINS220)	directlyDecreases	act(p(HGNC:GSK3B))
08de7760-305d-4925-9a5b-e5215f4a9c9a	1.0	PubMed	15940626	Expression of oncogenic K- does not block the interaction of GSK-3beta with the Axin scaffold, so the inhibition of GSK-3beta by K- is unlikely to be mediated by Frat.In summary, we have identified a unique interaction between 2 oncogenic pathways commonly mutated in colon cancer.	p(UP:P31282)	directlyDecreases	act(p(HGNC:GSK3B))
08de7760-305d-4925-9a5b-e5215f4a9c9a	1.0	PubMed	15940626	These data showed that K- does not inhibit GSK-3beta by disrupting its interaction with Axin.GSK-3beta is a negative regulator of Wnt signaling.	p(UP:P31282)	directlyDecreases	act(p(HGNC:GSK3B))
08de7760-305d-4925-9a5b-e5215f4a9c9a	1.0	PubMed	15940626	In addition, kinase assays revealed that K- inhibited the activity of GSK-3beta by 21% in Caco-2 cells (=.025) and 34% in HeLa cells (=.024), confirming that phosphorylation at serine 9 was not necessary for K -- mediated inhibition of GSK-3beta.	p(UP:P31282)	directlyDecreases	act(p(HGNC:GSK3B))
08de7760-305d-4925-9a5b-e5215f4a9c9a	1.0	PubMed	15940626	These data showed that K- also blocks the activity of GSK-3beta when it is part of the Axin scaffold.	p(UP:P31282)	directlyDecreases	act(p(HGNC:GSK3B))
08de7760-305d-4925-9a5b-e5215f4a9c9a	1.0	PubMed	15940626	K- inhibited GSK-3beta activity by 49% (=.0002).	p(UP:P31282)	directlyDecreases	act(p(HGNC:GSK3B))
08de7760-305d-4925-9a5b-e5215f4a9c9a	1.0	PubMed	15940626	However, the combination of SB216763 and K- inhibited GSK-3beta activity by 89% (=.00007), indicating that inhibition of GSK-3beta by SB216763 is only partial and the addition of K- further inhibits kinase activity.	p(UP:P31282)	directlyDecreases	act(p(HGNC:GSK3B))
4b58a3e7-aa4f-4deb-85b6-53f3a06797f4	1.0	PubMed	19429119	One such target, of relevance to Alzheimer 's disease (AD), may be GSK-3beta, which has been shown to be inactivated by Leptin.	p(HGNC:LEP)	directlyDecreases	act(p(HGNC:GSK3B))
4b58a3e7-aa4f-4deb-85b6-53f3a06797f4	1.0	PubMed	19429119	Interestingly, Leptin has been reported to inactivate GSK-3beta in mouse cortical neurons [XREF_BIBR].	p(HGNC:LEP)	directlyDecreases	act(p(HGNC:GSK3B))
d53a8fee-17c7-45b6-9fd0-fd79e68f9a4d	1.0	PubMed	23575666	LPS signalling inhibits GSK-3beta through the PI3K and AKT pathway 26.	a(CHEBI:16412)	directlyDecreases	act(p(HGNC:GSK3B))
d53a8fee-17c7-45b6-9fd0-fd79e68f9a4d	1.0	PubMed	23575666	Therefore, inhibition of GSK-3beta by LPS stabilises C/EBPdelta.	a(CHEBI:16412)	directlyDecreases	act(p(HGNC:GSK3B))
d53a8fee-17c7-45b6-9fd0-fd79e68f9a4d	1.0	PubMed	22520842	In human alveolar macrophages, bacterial lipopolysaccharide (LPS) exposure activates PI3-K and Akt, inactivates GSK-3beta, and causes accumulation of beta-catenin in the nucleus of any cell and expression of genes that require nuclear beta-catenin for their activation [XREF_BIBR].	a(CHEBI:16412)	directlyDecreases	act(p(HGNC:GSK3B))
624df0a1-c0c1-4a0f-b9c0-7a03d378ab4f	1.0	PubMed	25959626	On the other hand, LRP5 and LRP6 overexpressions were able to upregulate GSK3beta Ser9 protein levels and repress GSK3beta activity at all concentrations of HO.	p(HGNC:LRP5)	directlyDecreases	act(p(HGNC:GSK3B))
d90d6ead-3099-40a7-8dd6-65164efc0e60	1.0	PubMed	25959626	Our finding that overexpression of LRP5 and LRP6 inhibited GSK3beta activity resulting in decreased level of phosphorylated tau suggests that LRP5 and LRP6 protect cells from tau hyperphosphorylation through modulating GSK3beta activity.Although LRP5 and LRP6 are highly homologous and both serve as the co-receptors for Wnt cascade, numerous reports suggest that their role in regulating Wnt signaling may not be equivalent ().	p(HGNC:LRP5)	directlyDecreases	act(p(HGNC:GSK3B))
f1fe4d28-69a0-4596-a783-048fd4ff7e32	1.0	PubMed	25959626	On the other hand, LRP5 and LRP6 overexpressions were able to upregulate GSK3beta Ser9 protein levels and repress GSK3beta activity at all concentrations of HO.	p(HGNC:LRP6)	directlyDecreases	act(p(HGNC:GSK3B))
8f4824a5-914e-413e-a8d1-03c2e4d238c6	1.0	PubMed	19107203	Based on steady-state kinetic analyses XREF_BIBR, the dually phosphorylated LRP6 peptide competitively inhibits GSK3beta with an apparent inhibition constant (K i) of 13 microM.	p(HGNC:LRP6, pmod(Ph))	directlyDecreases	act(p(HGNC:GSK3B))
1df8add0-0e74-457f-86f9-af667310028b	1.0	PubMed	21957254	It is believed that inhibition of GSK3b by LRP6 occurs independently of P-Ser9 (XREF_BIBR), so that PDGF likely stimulates GSK3b Ser9 phosphorylation in OPCs through a different pathway.	p(HGNC:LRP6)	directlyDecreases	act(p(HGNC:GSK3B))
1df8add0-0e74-457f-86f9-af667310028b	1.0	PubMed	19711366	Previously, we showed that the free LRP6 intracellular domain (LRP6-ICD) can activate the Wnt and beta-catenin pathway in a beta-catenin and TCF/LEF -1 dependent manner, as well as interact with and attenuate GSK3beta activity.	p(HGNC:LRP6)	directlyDecreases	act(p(HGNC:GSK3B))
1df8add0-0e74-457f-86f9-af667310028b	1.0	PubMed	25959626	Our finding that overexpression of LRP5 and LRP6 inhibited GSK3beta activity resulting in decreased level of phosphorylated tau suggests that LRP5 and LRP6 protect cells from tau hyperphosphorylation through modulating GSK3beta activity.Although LRP5 and LRP6 are highly homologous and both serve as the co-receptors for Wnt cascade, numerous reports suggest that their role in regulating Wnt signaling may not be equivalent ().	p(HGNC:LRP6)	directlyDecreases	act(p(HGNC:GSK3B))
1df8add0-0e74-457f-86f9-af667310028b	1.0	PubMed	16365045	In vitro assays using immunoprecipitated proteins demonstrated that the C terminus of LRP6 significantly attenuated the activity of GSK3beta.	p(HGNC:LRP6)	directlyDecreases	act(p(HGNC:GSK3B))
1df8add0-0e74-457f-86f9-af667310028b	1.0	PubMed	19107203	The LRP6 PPPSPxS motif can inhibit GSK3beta both toward beta-catenin and glycogen synthase.	p(HGNC:LRP6)	directlyDecreases	act(p(HGNC:GSK3B))
89b220d9-94b7-4be2-99c8-654b6cc9c151	1.0	PubMed	19116273	APC also induced phosphorylation of Ser 9 in glycogen synthase kinase 3beta (GSK3beta), which was blocked by the PI3K inhibitor LY294002.	a(PUBCHEM:3973)	directlyDecreases	act(p(HGNC:GSK3B))
89b220d9-94b7-4be2-99c8-654b6cc9c151	1.0	PubMed	25003810	Moreover, LY294002 pretreatment prevented Akt hyperactivation and reactivated GSK3beta without altering Smad1 activation.	a(PUBCHEM:3973)	directlyDecreases	act(p(HGNC:GSK3B))
89b220d9-94b7-4be2-99c8-654b6cc9c151	1.0	PubMed	26295469	The Akt inhibitor (LY294002), the ERK inhibitor (U0126) or the combination of LY294002 and U0126 reversed GSK3beta inactivation.	a(PUBCHEM:3973)	directlyDecreases	act(p(HGNC:GSK3B))
06b23cdf-4cfc-4d52-b012-425dff0ca98a	1.0	PubMed	20333643	LPLI could inhibit the activation of GSK-3beta, Bax, and caspase-3 induced by STS.	p(HGNC:LYPLA1)	directlyDecreases	act(p(HGNC:GSK3B))
585002cb-7d7a-4e05-b227-28556875a9fa	1.0	PubMed	26336990	To dissect whether the positive feedback between DAB2IP and Snail modulates Snail stability via proteasome dependent ubiquitination mediated by GSK3beta in SW480 cells, we treated Snail KD cells with LiCL (inhibitor of GSK-3beta) or MG132 (a proteasome inhibitor).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
585002cb-7d7a-4e05-b227-28556875a9fa	1.0	PubMed	23846217	The capacity of LiCL to inhibit GSK3beta is shown in XREF_SUPPLEMENTARY.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
585002cb-7d7a-4e05-b227-28556875a9fa	1.0	PubMed	23846217	LiCL at 1, 2 or 5mM all could inhibit GSK3beta.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	21056029	Since GSK-3beta can repress basal p65 transcriptional activity, it is possible that LiCl mediated GSK-3beta inhibition might activate the transcriptional activity as well.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	12123574	A decreased relative amount of P was apparent in the Notch1IC band when either the dominant negative GSK3beta was cotransfected or the cells were treated with the GSK3beta inhibitor LiCl.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	12123574	The stability of the NotchIC protein was assessed in pulse-chase experiments with transfected NIC-myc in which GSK3beta activity was reduced by either cotransfection of DN GSK3beta or by the addition of LiCl ().	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22534782	Consistent with these results, caspase-3 activity assays also showed that inhibition of GSK-3beta by LiCl or by GSK-3beta-specific siRNA was accompanied by statistically significantly increased caspase-3 cleavage (eg, caspase-3 activity in U2OS cells treated for 72 hours with 20 mM LiCl = 2.97-fold compared with control, in untreated cells = 1 (referent); difference = 1.97-fold, 95% CI = 0.71- to 3.24-fold; P =.002; XREF_FIG, Supplementary Figure 2, A, available online).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22534782	GSK-3beta inhibition by LiCl did enhance the apoptosis of U2OS or ZOS cells induced by ADM, MTX, or DDP in vitro (eg, for U2OS, the percentage of viable cells at 72 hours with 20 mM LiCl = 44%, with 4 ng/mL ADM = 75%, with both = 27%; difference, both vs ADM = 48%, 95% CI = 36% to 61%; P <.01; XREF_FIG and Supplementary Figure 3, A-D, available online).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	9546672	In the extract, the kinases responsible for generating the AT100 epitope are GSK-3beta and PKA, which can be inhibited by their specific inhibitors LiCl and RII, respectively.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22999923	Our results revealed that silencing of p53 significantly decreased the level of Akt phosphorylation (< 0.05 compared with blank control, A and B), suggesting PI3K and Akt but not Wnt and beta-catenin signaling pathway might be involved in regulating cell proliferation.To investigate the association between PTEN and GSK-3beta in glioma cells, SWO-38 cells were treated with GSK-3beta inhibitor LiCl.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20031160	LiCl, which is commonly used to treat mood disorders, has been shown to inhibit GSK-3beta.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20031160	LiCl can directly inhibit GSK-3beta by reversibly competing with Mg 2+ and can also inhibit GSK-3beta through Ser9 phosphorylation [XREF_BIBR, XREF_BIBR].	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20031160	LiCl has been shown to cause GSK-3beta inhibition and growth suppression in neuroendocrine tumors [XREF_BIBR].	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20031160	LiCl has previously been shown to inhibit GSK-3beta.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	7019262	Inhibition of GSK3beta by LiCl blocks L6 myogenesis, indicating that ILK mediated inhibition of GSK3beta is not sufficient for differentiation.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22364879	We treated differentiating Caco-2 cells with lithium chloride (LiCl), which selectively inhibits GSK3beta activity ().	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22364879	The specific inhibition of GSK3beta activity by LiCl () prevented Myc degradation and consistently blocked the cell differentiation process, as revealed by the inhibition of the expression of CDX2 and SI.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	5997277	Cells expressing wild-type or mutant PS1 were treated with LiCl, which inhibits GSK 3beta, or transfected with beta-catenin constructs that lack the GSK 3beta phosphorylation sites.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	25979842	To confirm the mechanisms responsible for the GSK-3beta-dependent degradation of c-Jun, control shRNA and CD44 shRNA cells were treated with lithium chloride (LiCl), which inhibits GSK-3beta activity.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22262180	GSK3beta regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	6180953	Importantly, although genistein and LiCl each inhibit GSK-3beta activity, neither prevented the phosphorylation of serine 133 induced by PTH.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	23395167	We then treated LRP6 knockdown 3T3L1 cells with GSK3beta antagonist LiCl for 24h to rescue IR expression.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22863953	Inhibition of GSK3beta by LiCl or activation of the Wnt-beta-catenin pathway results in decreased monocyte migration across endothelial monolayers.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	21772333	To investigate the integrity of Wnt signalling in MCF10AT and Rama37 cells, we tested the Top and Fop glow reporter activity in Rama37 and MCF10AT cells treated with lithium chloride (LiCl), which inhibits GSK-3beta and thereby increases the stability of beta-catenin (XREF_BIBR), or sodium chloride (NaCl) as a control.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	19429119	As expected, LiCl inhibited GSK-3beta activity (first bar from right) under the conditions used (K i = 2 mM) [XREF_BIBR].	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	24367688	In our previous study, we found that lithium chloride (LiCl), which inhibited glycogen synthase kinase 3beta (GSK-3beta) activity in vivo and vitro, and mimicked the biochemical effect of Wnt signaling by leading to stabilization of beta-catenin protein, up-regulated Notch3 signaling, and Notch3 siRNA weakened the effects of LiCl on the cell cycle of NSCLC cell lines [XREF_BIBR].	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20008284	Treatment of monocytes with GSK3beta inhibitors such as LiCl and/or SB216763, or with GSK3beta targeted siRNA, has been reported to inhibit TLR2-, 4-, 5-, and 9 dependent release of IL-1beta, IL-6, TNF-alpha, IL-12, and IFN-gamma but to enhance TLR dependent production of IL-10 (XREF_BIBR).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	16712787	LiCl is an inhibitor of GSK-3beta that has a critical role in the degradation of beta-catenin, and thus can act as an effective Wnt signaling activator.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	23673211	Moreover, LiCl inhibits GSK-3beta activity by phosphorylation at serine 9, resulting in beta-catenin accumulation.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	23673211	Thus, exogenous inhibition of GSK-3beta by LiCl enhanced cisplatin resistance.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	18243161	Moreover, LPS induced p65 transactivation activity was shown to be inhibited when GSK-3beta was inactivated by LiCl, a known specific GSK-3beta inhibitor.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	26618897	Insulin shares with LiCl the ability to inactivate GSK3beta through the PI3K and Akt pathway [XREF_BIBR, XREF_BIBR] although LiCl is able to inactivate GSK3beta through multiple mechanisms [XREF_BIBR].	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	26618897	GSK3beta inactivation by either LiCl or SB216763 also led to glycogen accumulation : the number of PAS positive cells was significantly higher at 24 hours for both 5mM LiCl and 10muM SB216763 (XREF_FIG and XREF_SUPPLEMENTARY).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	14644163	The change in the distribution of endothelial cells was not so obvious when using LiCl; however, LiCl not only inhibits the activity of GSK-3beta but also alters the PKC and PI3K and PKB pathways.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	27129219	LiCl and SB415286 are specific inhibitors of GSK3beta, which can inhibit Wnt and beta-catenin signaling.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	5921692	Overexpression of GSK3beta suppressed both basal and beta-adrenergic increases in nuclear expression of GATA4, whereas inhibition of GSK3beta by LiCl caused nuclear accumulation of GATA4, suggesting that GSK3beta negatively regulates nuclear expression of GATA4.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	15492040	Curiously, however, long-term inhibition of GSK3beta by LiCl (over 6 h at 10 mM) generates a pool of beta-catenin that binds TCF and cadherin-GST proteins equally well (XREF_FIG B, lanes 3-6).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	21295697	Wounds on WT skin were treated with either lithium chloride (LiCl) which directly inhibits GSK3beta, or Wortmannin, which activates GSK3beta by inhibiting an upstream regulator, phosphoinositol-3 kinase (PI3K).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	4688889	In the extract, the kinases responsible for generating the AT100 epitope are GSK-3beta and PKA, which can be inhibited by their specific inhibitors LiCl and RII, respectively.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	17157329	LiCl is an inhibitor of GSK3beta that has a critical role in the degradation of beta-catenin, and thus can act as a potent Wnt activator ().	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	16930546	We also determined the effects of LiCl on PRA1 related TCF and beta-catenin signaling, because the treatment of LiCl is known to inhibit GSK3beta and mimic Wnt signaling via the stabilization of beta-catenin.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22665063	In vitro, the inhibition of GSK3beta by LiCl has been shown to prevent the migration of neural crest cells from explanted chicken neural tubes onto fibronectin coated dishes (XREF_BIBR), which suggests an involvement of beta-catenin; however, other cellular targets may be affected by LiCl.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	25390651	Interestingly, despite its transient effect on GSK-3beta during the early phase of AA treatment, nicorandil improved recovery of DeltaPsi m similarly to inactivation of GSK-3beta by LiCl throughout the AA treatment period (XREF_FIG).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	21238544	For this purpose, either Akt inhibitor IV or LiCl, which activates or inhibits GSK3beta respectively, was added to change the phosphorylation status of PS1 in APPswe and N-cad-CHO cells (E).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22859938	Application of LiCl in our experiment was shown to successfully block GSK-3beta activity by increasing phosphorylation of GSK-3beta at ser9.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	19100874	The canonical Wnt signalling pathway can be activated with, e.g., LiCl treatment, which inhibits GSK3beta, or by overexpressing beta-catenin in the cell culture models.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	26560046	As conventional wisdom believed that LiCl could only inhibit the kinase activity of GSK3beta XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR, it was surprising that LiCl increased GSK3beta mRNA level in HPV16 positive cervical cancer cells, which might have resulted from increased E6/E7 transcriptional activity by LiCl or GSK3beta inactivation causing the activation of other signal pathway which cooperated with E6/E7.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22707636	Inactivation of GSK-3beta by LiCl significantly increased MMP9 activity and EMT of RCC cells.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	17331723	Wnt signaling, activated by transfection of Wnt3a, LRP6, and Dishevelled and by LiCl mediated inhibition of GSK-3beta, was blocked by cotransfection of Gli3R.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	15135146	LiCl inhibits GSK-3beta activity, thereby mimicking Wnt signaling via the beta-catenin pathway.Several of the Wnt components whose expression was found to be altered by DBP in this study activate signal transduction via the beta-catenin pathway.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22810307	Treatment of the WM793, 1205Lu and WM9 melanoma cell lines with the GSK3beta inhibitors NP309, LiCl and siRNA knockdown of GSK3beta inhibited the motile behavior of melanoma cells in a scratch wound assay (XREF_FIG : XREF_SUPPLEMENTARY).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	21726809	To investigate this possibility, HEK293A cells were transiently transfected with wild-type parafibromin or parafibromin-Y290/293/315F vector together with a beta-catenin expression vector; transfected cells were incubated in the presence of 25mM LiCl, which inhibits GSK3beta and thereby prevents beta-catenin degradation.Relative to wild-type parafibromin, the phospho resistant parafibromin-Y290/293/315F displayed a marked increase in the ability to form a complex with beta-catenin (A).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	6377119	LiCl, which inhibits GSK-3beta, removed the block by cGSK-3beta on IGF-I-inducible NFAT responsive reporter gene activity.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	26252009	As treatment with LiCl did not recover embelin mediated decrease in GSK-3beta phosphorylation, LiCl may inhibit GSK-3beta activity but not change GSK-3beta phosphorylation.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	23349842	It has been shown that LiCl not only inhibits the activity of GSK3beta, but also activates the activity of Akt through PI3K XREF_BIBR.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	23844215	LiCl is an inhibitor of GSK-3beta that blocks the phosphorylation and subsequent degradation of beta-catenin, thereby resulting in the stabilization of beta-catenin [XREF_BIBR].	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20032300	The data of XREF_FIG, A and B, show that pretreating normal splenocytes with BAPTA, which chelates extracellular Ca 2+ and thus inhibits, for instance, calpain activation, or with LiCl, which inhibits GSK-3beta, prevents Abeta from inducing chromosome mis segregation.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	23911749	Both LiCl and Wnt3a can inhibit the activity of GSK3beta and trigger the Wnt and beta-catenin pathway.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	18167338	LiCl was used to inhibit GSK-3beta (lanes 5-8), and Go6976 () was used to inhibit Chk1 (lanes 13-16).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	27343974	As attempted, LiCl, known to inhibit GSK3beta through Ser9 phosphorylation, significantly extended the pGSK3betaSer9 and GSK3beta (95%, P < 0.01) (A,) without any change in the pGSK3betaTyr216 and GSK3beta (A,).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	27343974	First, LiCl is known to inhibit GSK3beta through the PI3K and Akt survival pathway.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	19274078	Taken together these experiments indicate that inhibition of GSK3beta by LiCl or BIO influences cadherin-11 mRNA and protein levels by mechanisms largely independent of transcriptional repression.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	17156427	The MICE assay results also demonstrated significantly reduced AAH immunoreactivity in cells treated with the Akt inhibitor, Roscovitine, or PD98059, and increased AAH protein in cells treated with LiCl, which inhibits GSK-3beta.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20631314	Although at the dose used in our studies, LiCl induces beta-catenin by inhibiting GSK-3beta, lithium may have effects that are independent of beta-catenin.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20122174	beta-catenin expression was upregulated when LiCl blocked GSK-3beta activity in A549 cells.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	19180470	Because LiCl inhibits GSK-3beta [XREF_BIBR - XREF_BIBR], the data suggested that active GSK-3beta increases NF-kappaB transactivation.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	27015268	The same result was observed at 24 h after application of LiCl (XREF_FIG), which inhibits GSK3beta and leads to activation of the Wnt signaling pathway.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	21986938	Lithium chloride (LiCl), which inhibits GSK3beta and consequently stabilizes free cytosolic beta-catenin (XREF_BIBR, XREF_BIBR) (XREF_SUPPLEMENTARY), was added to the cells for 6 hr prior to ATE-i2-b4 treatment.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20508033	Transcriptional activation of beta-catenin was stimulated with 20 mmol/L LiCl, which blocks GSK3beta enzymatic activity.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	20508033	As GSK3beta inhibition by LiCl may also interfere with the signaling of other pathways such as Shh, we made use of a Lef-1-beta-catenin fusion construct (LefDeltaN-betaCTA), conferring dominant activation of beta-catenin-dependent signaling without interfering with the endogenous beta-catenin pool.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	12470641	LiCl inhibits GSK3beta kinase activity resulting in the stabilization, accumulation, and nuclear translocation of beta-catenin.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	11504726	Cells expressing wild-type or mutant PS1 were treated with LiCl, which inhibits GSK 3beta, or transfected with beta-catenin constructs that lack the GSK 3beta phosphorylation sites.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	23273980	Thus, LiCl or Wnt-3a inhibits GSK3beta, inducing cytosolic accumulation of beta-catenin, which allows high glucose to induce nuclear beta-catenin accumulation, and neither cytosolic nor nuclear beta-catenin accumulation relies on Akt activation.Importantly, glucose induced nuclear accumulation of beta-catenin (A) occurred between 1hr and 4hr, matched the time required for transcriptional induction as shown in E, and was specific to high glucose, in that using glutamine as an alternative carbon source did not substitute for glucose in promoting nuclear accumulation of beta-catenin (C).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	17822871	It has been demonstrated previously that LiCl activates the Wnt and TCF pathway by blocking GSK3beta activity resulting in intracellular beta-catenin accumulation and nuclear translocation.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
600d9ab7-197d-496f-8a6b-b87ed0cf1323	1.0	PubMed	22823957	LiCl inhibits GSK3-beta, resulting in beta-catenin stabilization and its consequent nuclear translocation.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
949f231b-1cfe-439c-9d05-882df1817f46	1.0	PubMed	23211630	Li is an inhibitor of GSK-3beta ().	a(PUBCHEM:7010534)	directlyDecreases	act(p(HGNC:GSK3B))
949f231b-1cfe-439c-9d05-882df1817f46	1.0	PubMed	23768967	Ding et al. also demonstrated that unbound GSK-3beta and Axin bound GSK-3beta participated in different signaling pathways (GSK-3beta in PI3-K and insulin signaling, Axin bound GSK-3beta in Wnt signaling), indicating the wide ranging effects of GSK-3beta activity within a cell.Almost 20years ago the mood stabilizing drug lithium (Li), often used to treat manic depression, was found to inhibit GSK-3beta.	a(PUBCHEM:7010534)	directlyDecreases	act(p(HGNC:GSK3B))
949f231b-1cfe-439c-9d05-882df1817f46	1.0	PubMed	24150227	Among its molecular targets, Li inhibits GSK3beta, 11 a feature of the drug that may account for the effects on both mood and the clock.	a(PUBCHEM:7010534)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	6204504	Lithium treatment significantly inhibited BMP-2 stimulation of chondrogenesis as well as GSK-3beta enzymatic activity, and decreased the levels of N-cadherin protein and mRNA.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	4051147	Lithium potently inhibits GSK-3 beta activity (Ki = 2 mM), but is not a general inhibitor of other protein kinases.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	19717166	Lithium inhibits GSK-3beta at therapeutic concentrations ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	19717166	Lithium also inhibits GSK-3beta in human neuroblastoma cells ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	17692821	Lithium inhibits GSK-3beta, in part, by increasing the phosphorylated form of GSK-3beta.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	20654575	Lithium inhibits GSK3beta and thereby activates beta-catenin and TCF7 transcriptional activities in different immortalized and cancer cells [XREF_BIBR].	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	6005951	Lithium, the primary therapeutic agent for bipolar mood disorder, is a selective inhibitor of GSK3beta.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	23114888	Lithium, which inhibits GSK3beta, leading to beta-catenin activation can reverse Abeta-toxicity in small animal models.Wnt 3A can also exert the same neuroprotective effect in animal models of AD.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	21671254	Lithium inhibits GSK3-beta directly by competing with Mg 2+ and, indirectly, through phosphatase inhibition, PP2A, then increasing phosphorylation at S 9 (XREF_BIBR).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	11835406	Lithium treatment significantly inhibited BMP-2 stimulation of chondrogenesis as well as GSK-3beta enzymatic activity, and decreased the levels of N-cadherin protein and mRNA.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	6396718	Lithium directly inhibits GSK-3beta in contrast to VPA, which inhibits GSK-3beta indirectly by an as-yet-unknown pathway.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	27537208	GSK3beta is inhibited by the antidepressant Lithium.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	20599907	Lithium is an ATP-noncompetitive inhibitor of GSK3beta ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	17628506	Lithium induced GSK3B inhibition has a neuroprotective effect, clinically, preclinically and in animal models ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
ee92bd4a-7092-4478-b340-cbe78de7f10d	1.0	PubMed	18191226	Lithium can inhibit GSK3beta both directly () and indirectly by enhancing Akt activity ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
05fab431-75ee-47a6-a8ff-2e19c7f46fda	1.0	PubMed	16523202	Lithium chloride is an inhibitor of GSK3beta and its consequent ability to stabilise beta-catenin has been exploited widely to mimic Wnt signalling since this property was characterised (Klein and Melton, 1996).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
05fab431-75ee-47a6-a8ff-2e19c7f46fda	1.0	PubMed	26631736	Lithium chloride inhibition of GSK-3beta increased nuclear beta-catenin content and normalized nuclear PPAR-gamma in Ob-MSCs.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
05fab431-75ee-47a6-a8ff-2e19c7f46fda	1.0	PubMed	21952626	Lithium chloride (LiCl) treatment suppresses GSK3beta (XREF_BIBR).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
05fab431-75ee-47a6-a8ff-2e19c7f46fda	1.0	PubMed	21986938	Lithium chloride (LiCl), which inhibits GSK3beta and consequently stabilizes free cytosolic beta-catenin (XREF_BIBR, XREF_BIBR) (XREF_SUPPLEMENTARY), was added to the cells for 6 hr prior to ATE-i2-b4 treatment.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
2d470885-9b9f-45e9-a136-100bcdaf3802	1.0	PubMed	25003996	Our data showed that phos-GSK3beta (Ser9) was indeed decreased in SW620 transfected with shMACC1, which meant that GSK3beta activity was increased by MACC1 knockdown.	p(HGNC:MACC1)	directlyDecreases	act(p(HGNC:GSK3B))
2d470885-9b9f-45e9-a136-100bcdaf3802	1.0	PubMed	25003996	The expression pattern of phos-GSK3beta was similar to that of beta-catenin, leading us to postulate that the beta-catenin degradation is attributed to the increased GSK3beta activity induced by MACC1 knockdown.	p(HGNC:MACC1)	directlyDecreases	act(p(HGNC:GSK3B))
e446b925-2ada-41d6-a1bb-96cc567bd4f4	1.0	PubMed	16815997	In the absence of wnt, macf1 associated with a complex that contained axin, betBeta-catenin, gsk3beta, and apc. Upon wnt stimulation, macf1 appeared to be involved in the translocation and subsequent binding of the axin complex to lrp6 at the cell membrane. Macf1 is involved in the translocation of the complex containing axin, Beta-catenin, and gsk3_ but not apc from the cytosol to the cell membrane, where axin and macf1 bind to lrp-5/6. Subsequently, gsk3_ is inactivated by phosphorylation, axin is degraded, and Beta-catenin is released and enters the nucleus, where it can activate the wnt-responsive genes.	p(HGNC:MACF1)	directlyDecreases	act(p(HGNC:GSK3B))
622cacb6-3986-4ac4-8861-5bd169f4582b	1.0	PubMed	16914735	Gckr can phosphorylate an n-terminal recombinant fusion protein of gsk3_ and enhance the in vivo phosphorylation of gsk3_ on serine 9reduction of gckr expression inhibits wnt3a-induced phosphorylation of gsk3_ at serine 9 and decreases the accumulation of cytosolic _-catenin.	p(HGNC:MAP4K5)	directlyDecreases	act(p(HGNC:GSK3B))
007a9353-cae9-4696-9418-04dffc0cc4b9	1.0	PubMed	18451303	Here, we show that p38 mitogen-activated protein kinase (mapk) also inactivates gsk3beta by direct phosphorylation at its c terminus, and this inactivation can lead to an accumulation of beta-catenin.	p(HGNC:MAPK14)	directlyDecreases	act(p(HGNC:GSK3B))
007a9353-cae9-4696-9418-04dffc0cc4b9	1.0	PubMed	17726008	However p38alfa also inactivates gsk3b by direct phosphorilation of the c-terminal residue ser389. this non-canonicl p38 mapk-dependent phosphorilation of gsk3b seems to occur primarily in the brain and thymocytes.	p(HGNC:MAPK14)	directlyDecreases	act(p(HGNC:GSK3B))
ecbe1460-bb82-4ba3-bc04-d58118caea1b	1.0	PubMed	16039586	Erk, which is activated by hbx, associates with gsk-3beta through a docking motif ((291)fkfp) of gsk-3beta and phosphorylates gsk-3beta at the (43)thr residue, which primes gsk-3beta for its subsequent phosphorylation at ser9 by p90rsk, resulting in inactivation of gsk-3beta and upregulation of beta-catenin.	p(HGNC:MAPK1)	directlyDecreases	act(p(HGNC:GSK3B))
ecbe1460-bb82-4ba3-bc04-d58118caea1b	1.0	PubMed	23644467	Therefore, ERK2 was required to inhibit GSK3beta in unstimulated cells.	p(HGNC:MAPK1)	directlyDecreases	act(p(HGNC:GSK3B))
c8207241-baa5-4b75-9709-36097456b83a	1.0	PubMed	16039586	Erk, which is activated by hbx, associates with gsk-3beta through a docking motif ((291)fkfp) of gsk-3beta and phosphorylates gsk-3beta at the (43)thr residue, which primes gsk-3beta for its subsequent phosphorylation at ser9 by p90rsk, resulting in inactivation of gsk-3beta and upregulation of beta-catenin.	p(HGNC:MAPK3)	directlyDecreases	act(p(HGNC:GSK3B))
aa46658c-eb70-4fd3-ae71-476c3317c7d9	1.0	PubMed	11696419	The expression of PBP increases tau phosphorylation in the human HEK293T fibroblast cell line but decreases GSK-3beta activity.	p(HGNC:MAPT)	directlyDecreases	act(p(HGNC:GSK3B))
c1c747e9-dfd0-416b-9aa0-493987d91ac5	1.0	PubMed	22965877	We reveal that NUB1 interacted with both tau and GSK3beta to disrupt their interaction, and abolished recruitment of GSK3beta to tau inclusions.	complex(p(HGNC:MAPT), p(HGNC:NUB1))	directlyDecreases	act(p(HGNC:GSK3B))
37c683b4-4fa3-40e2-a8d1-f82b3e9fa5fd	1.0	PubMed	21270272	We recently also showed that inactivation of GSK-3beta by overexpression of cardiac MT gene results in an improvement of cardiac glucose metabolism in the diabetic hearts along with a significant suppression of cardiac nitrosative damage, inflammation, and remodeling (XREF_BIBR).	p(HGNC:MCAT)	directlyDecreases	act(p(HGNC:GSK3B))
f3ca5612-1cb9-4259-8928-c610cd731ee1	1.0	PubMed	17387146	A variant of Mcl-1 (Mcl-1-3A), which abolishes the phosphorylations by GSK-3beta and then can not be ubiquitinated by beta-TrCP, is much more stable than wild-type Mcl-1 and able to block the proapoptotic function of GSK-3beta and enhance chemoresistance.	p(HGNC:MCL1)	directlyDecreases	act(p(HGNC:GSK3B))
399e5561-5f4b-4db9-a433-9e5de806a8c6	1.0	PubMed	20417616	However, HIC (but not HICDeltaC) expression significantly decreased GSK-3beta precipitation with LANA (B, lanes 7 and 8).	p(HGNC:MDFIC)	directlyDecreases	act(p(HGNC:GSK3B))
14086421-e326-4ec1-ae25-a929e8b56ea9	1.0	PubMed	22385658	Not only did Mek inhibition block differentiation in low PI3K and Akt activity, it also suppressed the inactivation of Gsk3beta (XREF_FIG), supporting the idea that Mek and Erk signaling inhibits Gsk3beta activity.	p(FPLX:MEK)	directlyDecreases	act(p(HGNC:GSK3B))
14086421-e326-4ec1-ae25-a929e8b56ea9	1.0	PubMed	20849862	GSK-3beta is also inhibited by the PI-3 '-kinase pathway through PKB and Akt, and also by the MEK and ERK and p38 MAPK pathways, PKA, p90 RSK / MAPKAP kinase-1, and S6 kinase (XREF_BIBR; XREF_BIBR).	p(FPLX:MEK)	directlyDecreases	act(p(HGNC:GSK3B))
ba3855aa-1b46-4075-a927-1150c940108a	1.0	PubMed	26336990	To dissect whether the positive feedback between DAB2IP and Snail modulates Snail stability via proteasome dependent ubiquitination mediated by GSK3beta in SW480 cells, we treated Snail KD cells with LiCL (inhibitor of GSK-3beta) or MG132 (a proteasome inhibitor).	a(CHEBI:75142)	directlyDecreases	act(p(HGNC:GSK3B))
ba3855aa-1b46-4075-a927-1150c940108a	1.0	PubMed	24901984	The results show a marked increase in the levels of endogenous NM1 polyubiquitination in lysates of GSK3beta silenced HeLa cells treated with MG132 (XREF_FIG, lanes 3 and 6).	a(CHEBI:75142)	directlyDecreases	act(p(HGNC:GSK3B))
ba3855aa-1b46-4075-a927-1150c940108a	1.0	PubMed	19861116	Gsk-3beta and beta-Trcp dependent degradation can be inhibited by the addition of MG132, a proteasome inhibitor.	a(CHEBI:75142)	directlyDecreases	act(p(HGNC:GSK3B))
757e0e7d-7539-421a-a34b-d1b358a9f2e9	1.0	PubMed	23334344	Interestingly, the MITF mRNA steady-state level was not reversed (and was even further downregulated) by LiCl mediated GSK3beta inhibition (), whereas phospho-beta-catenin IR in anagen VI HFs was normalized by LiCl in P-cadherin-silenced HFs ().	p(HGNC:MITF)	directlyDecreases	act(p(HGNC:GSK3B))
c73d01b5-89b6-4d51-a0e8-bdefa4b5344f	1.0	PubMed	24899689	MI induced GSK-3beta inhibition was further confirmed by analyzing the GSK-3beta upstream effector, P-AKT (P-AKT473, P-AKT308), and the downstream targets (Cyclin D1, c-Myc), 3 wks post-MI (XREF_SUPPLEMENTARY).	a(PUBCHEM:892)	directlyDecreases	act(p(HGNC:GSK3B))
89a5da73-2b87-44d1-813c-8012391f4686	1.0	PubMed	20682799	These results suggest that MTA1s and MTA1 promotes WNT signaling at multiple levels by inhibiting two known regulators of Wnt pathway namely Six3, as well as GSK3-beta (XREF_FIG).	p(HGNC:MTA1)	directlyDecreases	act(p(HGNC:GSK3B))
5e3a0e1f-6363-4d1c-8248-3fe103d54c1d	1.0	PubMed	21329734	Inhibition of PI3-kinase by the inhibitor LY293002 also inhibits visfatin induced activation of mTOR and visfatin induced inactivation of GSK3beta.	p(HGNC:MTOR)	directlyDecreases	act(p(HGNC:GSK3B))
5e3a0e1f-6363-4d1c-8248-3fe103d54c1d	1.0	PubMed	21737790	Furthermore, inhibition of mTOR signaling by rapamycin reversed the inhibitory effect of GSK-3beta inhibition on autophagy and, at the same time, abolished the effect of GSK-3beta inhibition on myocardial ischemic injury and reperfusion injury.	p(HGNC:MTOR)	directlyDecreases	act(p(HGNC:GSK3B))
72170373-803a-48be-a06a-814755789c95	1.0	PubMed	24391509	Thus, these results suggest that GSK3beta inhibition by NCYM stabilizes the MYCN protein both in vitro and in vivo.	p(HGNC:MYCNOS)	directlyDecreases	act(p(HGNC:GSK3B))
72170373-803a-48be-a06a-814755789c95	1.0	PubMed	24391509	Further studies are required to evaluate the role of NCYM mediated inhibition of GSK3beta activity on MYCN stability.	p(HGNC:MYCNOS)	directlyDecreases	act(p(HGNC:GSK3B))
70f22f72-a91b-410d-b094-00ce67140d56	1.0	PubMed	25435281	On the other hand, Ras dependent activation of the PI3K-AKT pathway tends to limit the phosphorylation of Myc at Thr58 by AKT mediated inhibition of GSK-3beta ().	p(HGNC:MYC)	directlyDecreases	act(p(HGNC:GSK3B))
70f22f72-a91b-410d-b094-00ce67140d56	1.0	PubMed	26164082	Here, we showed that both miR-451 upregulation and c-Myc downregulation induced the decreased expression of p-Erk1/2, p-GSK-3beta, MMP-2 and MMP-9 proteins, the decreased expression of total or nuclear snail proteins, and eventually the reduced activity of snail promoter.	p(HGNC:MYC)	directlyDecreases	act(p(HGNC:GSK3B))
03c50d59-c8b0-4fb3-b877-c7d5efb61443	1.0	PubMed	PMC4445512	The mechanism by which myo-inositol inhibits both dominant negative GSK-3 beta and lithium remains uncertain.	p(UP:Q9JIF9)	directlyDecreases	act(p(HGNC:GSK3B))
300c63bb-cde3-41ef-8741-198890c9398e	1.0	PubMed	21329734	We have now demonstrated for the first time that visfatin activates mTOR signaling and inactivates GSK3beta signaling in human endothelial cells, thereby enhancing VEGF and cyclin D1 expression in these cells.The mTOR protein is a serine/threonine kinase that plays a key role in cell growth and homeostasis.	p(HGNC:NAMPT)	directlyDecreases	act(p(HGNC:GSK3B))
db303d0f-97ae-4d47-b03a-4bd9f342b2c5	1.0	PubMed	25003810	Snail knockdown, Smad1 knockdown, or Smad1 and Akt inhibition significantly reduced Nanog expression and rescued GSK3beta activity.	p(HGNC:NANOG)	directlyDecreases	act(p(HGNC:GSK3B))
f321ecd5-a961-4b6e-97e9-012ddc04f582	1.0	PubMed	26359353	Consistently, our study also demonstrated that suppression of NDRG1 caused GSK-3beta activation only through a decrease in wild-type beta-catenin without any effects on truncated beta-catenin.	p(HGNC:NDRG1)	directlyDecreases	act(p(HGNC:GSK3B))
f321ecd5-a961-4b6e-97e9-012ddc04f582	1.0	PubMed	26852918	Previous studies also indicated that NDRG1 could suppress GSK-3beta activity, which plays a key regulatory role in controlling G1 related proteins in hypoxia XREF_BIBR XREF_BIBR.	p(HGNC:NDRG1)	directlyDecreases	act(p(HGNC:GSK3B))
80dc375f-2286-4ce9-a690-502cb0593f5f	1.0	PubMed	24763737	Therefore, Nek6 overexpression inhibited Akt and GSK-3beta signaling in vitro.	p(HGNC:NEK6)	directlyDecreases	act(p(HGNC:GSK3B))
5dc9e2af-0356-4830-bb74-34ac8d955848	1.0	PubMed	17959258	Nerve growth factor (NGF) promotes axonal elongation via the p75 neurotrophin receptor (p75NTR) and also inactivates GSK-3beta.	p(HGNC:NGF)	directlyDecreases	act(p(HGNC:GSK3B))
8379b912-afb3-436b-aa26-6e349a1b58ca	1.0	PubMed	24531650	NAC, an antioxidant, protects mice from liver injury and decreases GSK3beta activity.	a(CHEBI:7421)	directlyDecreases	act(p(HGNC:GSK3B))
f1f9380c-6866-4249-8b61-e04fc858d019	1.0	PubMed	21742036	We found that overexpression of neuronatin inactivated GSK-3beta through phosphorylation at Ser9.	p(HGNC:NNAT)	directlyDecreases	act(p(HGNC:GSK3B))
0a82928c-c6e3-4498-b5e5-a2e0b0a1dcc4	1.0	PubMed	25062958	3.6 eNOS activation and NO inhibit GSK-3beta by activating cGMP dependent protein kinase.	p(HGNC:NOS3)	directlyDecreases	act(p(HGNC:GSK3B))
c94ca0e5-d819-44c4-918a-62e989c2a2dc	1.0	PubMed	17030184	We observed that the NO donor GTN inhibited GSK-3beta, induced its dissociation from beta-catenin, and decreased the expression of CKI alpha.	a(CHEBI:16480)	directlyDecreases	act(p(HGNC:GSK3B))
c94ca0e5-d819-44c4-918a-62e989c2a2dc	1.0	PubMed	25062958	3.6 eNOS activation and NO inhibit GSK-3beta by activating cGMP dependent protein kinase.	a(CHEBI:16480)	directlyDecreases	act(p(HGNC:GSK3B))
1ac22e24-d956-4920-8256-5bc4fe4314fd	1.0	PubMed	21671254	Studies in SH-SY5Y cells have shown that inhibition of PP-2A and PP-1 leads to tau hyperphosphorylation at specific sites and up-regulation of the activities of cdc2 kinase, CDK5, and MAPK, but not of GSK3-beta (XREF_BIBR).	p(HGNC:NPY4R)	directlyDecreases	act(p(HGNC:GSK3B))
e25f49a9-b727-47e2-9e70-48417847d9a8	1.0	PubMed	19711366	PHOSPHORYLATION OF THE LRP6-ICD PPP (S/T) P MOTIF IS NOT REQUIRED TO INHIBIT GSK3beta ACTIVITY IN VITRO.	p(HGNC:NR4A2)	directlyDecreases	act(p(HGNC:GSK3B))
9547bf43-14cf-46a8-9d8c-24240ef42b00	1.0	PubMed	22110662	Recently, the nonstructural 5A (NS5A) protein of HCV has been shown to inactivate GSK3beta activity and subsequently increase accumulation of beta-catenin in hepatoma cells XREF_BIBR.	p(UP:Q89613)	directlyDecreases	act(p(HGNC:GSK3B))
9547bf43-14cf-46a8-9d8c-24240ef42b00	1.0	PubMed	19726098	We further showed that NS5A increased the beta-catenin stability by disrupting GSK3beta from complex formation with its beta-catenin substrate.	p(UP:Q89613)	directlyDecreases	act(p(HGNC:GSK3B))
070b5ad4-abf4-464d-89c0-afa861ae0bb0	1.0	PubMed	15652488	These findings suggest that NT-3 and BDNF inhibit GSK-3beta via the PI3-kinase and Akt pathway, thereby decreasing the phosphorylation levels of CRMP-2 at Thr 514.	p(HGNC:NTF3)	directlyDecreases	act(p(HGNC:GSK3B))
070b5ad4-abf4-464d-89c0-afa861ae0bb0	1.0	PubMed	15652488	It is also possible that NT-3 and BDNF inhibit GSK-3beta via the PAR-3/PAR-6/aPKC pathway, and NT-3 and BDNF increase the phosphatase activity toward CRMP-2 to accelerate the dephosphorylation of CRMP-2.	p(HGNC:NTF3)	directlyDecreases	act(p(HGNC:GSK3B))
070b5ad4-abf4-464d-89c0-afa861ae0bb0	1.0	PubMed	15652488	It is possible that NT-3 and BDNF inhibit GSK-3beta and thereby increase the stability of microtubules to enhance axon outgrowth through the dephosphorylation of MAP1B.	p(HGNC:NTF3)	directlyDecreases	act(p(HGNC:GSK3B))
070b5ad4-abf4-464d-89c0-afa861ae0bb0	1.0	PubMed	15652488	Inactivation of GSK-3beta by NT-3 and BDNF may induce the interaction of APC with microtubules, thereby stabilizing microtubules.	p(HGNC:NTF3)	directlyDecreases	act(p(HGNC:GSK3B))
d40198d6-c2fb-46fe-ad23-358ff454caf5	1.0	PubMed	22965877	Strikingly, NUB1 induced GSK3beta degradation.	p(HGNC:NUB1)	directlyDecreases	act(p(HGNC:GSK3B))
f4c093cb-d2e0-4bf9-8ff1-fff6e3e0aedf	1.0	PubMed	19107203	Our data indicate that the miniCL protein can inhibit GSK3beta independently of AKT activity when this LRP6 fragment is overexpressed in the cytoplasm, implying that it can act as a general inhibitor of GSK3beta.	p(HGNC:NUP214)	directlyDecreases	act(p(HGNC:GSK3B))
3f0f0674-8226-4935-b766-2c12af44e576	1.0	PubMed	24531650	In a murine model induced by d-galactosamine (d-GalN) (700mg/kg) and LPS (10mug/kg), N-acetylcysteine (300mg/kg) or SB216763 (25mg/kg) was used to inhibit oxidative stress or GSK3beta activity, respectively.	a(PUBCHEM:12035)	directlyDecreases	act(p(HGNC:GSK3B))
3f0f0674-8226-4935-b766-2c12af44e576	1.0	PubMed	24531650	In vivo, N-acetylcysteine ameliorated the d-GalN and LPS-induced hepatotoxicity and reduced GSK3beta activity; GSK3beta inhibition increased hepatic superoxide dismutase activity and the glutathione content, decreased malondialdehyde production in the liver tissues; while GSK3beta inhibition suppressed the JNK activation in the liver and decreased cytochrome c release from mitochondria.	a(PUBCHEM:12035)	directlyDecreases	act(p(HGNC:GSK3B))
82ff99ce-1218-4c77-a727-3345185b8d1b	1.0	PubMed	26863455	The study also showed that OLA1 is a GSK3beta interacting protein, and knockdown of OLA1 causes an under-phosphorylated yet hyperactive GSK3beta, promoting degradation of its substrate Snail, and thus preserving the expression of E-cadherin.	p(HGNC:OLA1)	directlyDecreases	act(p(HGNC:GSK3B))
82ff99ce-1218-4c77-a727-3345185b8d1b	1.0	PubMed	26863455	Importantly, we further found that the OLA1 mediated GSK-3beta inhibition is independent of either TGFbeta-Smad signaling or Akt phosphorylation but via a direct action on GSK3beta.	p(HGNC:OLA1)	directlyDecreases	act(p(HGNC:GSK3B))
2eaab546-db12-4c81-a8de-b3f0f6ac1d1c	1.0	PubMed	25619831	In the same model, P2X7 silencing or antagonist administration reduced the activity of PI3K and Akt and increased that of GSK3beta, leading to a decrease in cellular glycogen stores.	p(HGNC:P2RX7)	directlyDecreases	act(p(HGNC:GSK3B))
64393fec-4787-4e38-afca-ed266feee7ab	1.0	PubMed	15132987	Blocking GSK3beta activity by selective inhibitors (lithium, TDZD-8, and L803-mts) prevented 6-OHDA-induced cleavage of caspase-3 and poly (ADP-ribose) polymerase (PARP), DNA fragmentations and cell death.	p(HGNC:PARP1)	directlyDecreases	act(p(HGNC:GSK3B))
2c0fc2a8-545a-480b-b99d-9684f1341f33	1.0	PubMed	25738875	To determine whether PARVA can inhibit GSK3beta and activate AP-1, we performed Western blot analysis.	p(HGNC:PARVA)	directlyDecreases	act(p(HGNC:GSK3B))
2c0fc2a8-545a-480b-b99d-9684f1341f33	1.0	PubMed	25738875	In this study, the ectopic expression of PARVA activated and inhibited Akt and GSK3beta (the downstream mediators of ILK), respectively.	p(HGNC:PARVA)	directlyDecreases	act(p(HGNC:GSK3B))
0531a454-bd9c-4d87-8aaa-573fe35ca1de	1.0	PubMed	9373175	Coexpression of WT-GSK3beta in 293 cells with either PKB alpha (also known as AKT) or PDK1 (the ' upstream ' activator of PKB) mimicked the IGF-1- or insulin induced phosphorylation of Ser 9 and inactivation of GSK3beta.	p(HGNC:PDPK1)	directlyDecreases	act(p(HGNC:GSK3B))
0531a454-bd9c-4d87-8aaa-573fe35ca1de	1.0	PubMed	4585508	Coexpression of WT-GSK3beta in 293 cells with either PKB alpha (also known as AKT) or PDK1 (the ' upstream ' activator of PKB) mimicked the IGF-1- or insulin induced phosphorylation of Ser 9 and inactivation of GSK3beta.	p(HGNC:PDPK1)	directlyDecreases	act(p(HGNC:GSK3B))
90c07348-ab18-45f1-bc29-7a7b4e4c8a30	1.0	PubMed	26716415	Therefore, RKIP dependent suppression of the ERK or GSK3beta pathways might be associated with the inhibitory role of RKIP in cancer metastasis.	p(HGNC:PEBP1)	directlyDecreases	act(p(HGNC:GSK3B))
9a54b7d8-f42c-4776-9007-ad5f5e2cf811	1.0	PubMed	21743491	In summary, this study shows that mPGES-1 and its enzymatic product, PGE 2, inhibits GSK-3beta and induces the formation of EGR1, beta, and catenin complex which interacts with TCF4 and LEF1 transcription factors, leading to beta-catenin activation and upregulation of its downstream genes in human HCC cells (illustrated in XREF_FIG).	a(CHEBI:73965)	directlyDecreases	act(p(HGNC:GSK3B))
9a54b7d8-f42c-4776-9007-ad5f5e2cf811	1.0	PubMed	25266063	In non small cell lung cancer and colorectal cancer, PGE 2 enhances beta-catenin nuclear localization and inhibits GSK3beta by phosphorylation which is dependent on cAMP and kinase activity of PKA [XREF_BIBR, XREF_BIBR].	a(CHEBI:73965)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	22662165	These data suggest that oncogenic EGFR and PI3K selectively inhibit GSK3beta during GD.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	26739898	We observed that treatment of airway epithelial cells with HMGB1 resulted in inactivation of GSK3beta by PI3K dependent AKT phosphorylation, which caused cytoplasmic accumulation of beta-catenin and its subsequent translocation to the nucleus.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	21821001	GSK-3beta is negatively regulated by the PI-3 kinase and Akt mediated phosphorylation of serine residue.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	25088797	PI3K and AKT signaling pathway is known to inhibit GSK-3beta activity and promote Snail protein stability.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	25889792	In the present study we show for the first time that the concordant inhibition of the PI3K and Akt signaling pathway by the clinically used BCR-ABL TKI imatinib or nilotinib, Akt inhibitor MK2206 or the immunosuppressive cytokine IL-10 activates the downstream serine/threonine protein kinase GSK3beta, and subsequently the transcription factor MITF that is translocated into the cell nucleus.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	PMC6380769	Moreover, FGF1 protection against glutamate toxicity was dependent on GSK3beta inactivation by the PI3K-Akt but was independent of ERK.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	25336918	XREF_BIBR Since GSK3beta can be suppressed by insulin and some other activators of the PI3K signaling pathway, this intriguing finding suggests that GSK3beta phosphorylation on PTEN is likely to be involved in the negative feedback loop of the PI3K signaling pathway.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	12900420	In some experiments, LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (a kinase involved in activating Akt) and tumor necrosis factor-alpha (TNF-alpha) were used to activate GSK-3beta.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	15942663	Therefore, PI3K mediated GSK-3beta inhibition could be a mechanism by which cancer cells escape from chemotherapy induced apoptosis.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	20602916	Consistent with the hypothesis that GSK-3beta can regulate hair cell survival, inhibition of PI3 kinase signaling, which can negatively regulate GSK-3beta, blocked the ability of dexamethasone to protect cells from ototoxicity in a rat model of trauma induced hearing loss.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	26456864	In this study, we showed that INSM1 possesses extra-nuclear activity to activate the PI3K and AKT signaling pathway that blocks GSK3beta activity.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	26320152	Oxidative stress induces PI3K and Akt dependent inhibition of GSK3beta activity in monocytes.Because of our hypothesis that oxidative stress induces glucocorticoid responsiveness, we next examined how GSK3beta activity is modulated in response to exogenous reactive oxygen species (ROS) in primary monocytes, as both H2O2 and CSE exposure reduce glucocorticoid sensitivity in monocytes (7, 30, 31).	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	23994577	VPA also caused phosphorylation of Akt and glycogen synthase kinase-3beta (GSK3beta) at concentrations ranging from 0.6 mM to 5mM in SH-SY5Y cells, suggesting activation of the PI3K pathway known to inhibit GSK3beta through Akt phosphorylation.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	25009285	The transcriptional activity of Snail is regulated by GSK-3beta, which is negatively regulated by PI3K and Akt (XREF_BIBR; XREF_BIBR).	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	21887250	It is known that activation of the FGF and EGF receptors, FGFR and EGFR, respectively, could both lead to the activation of the PI3K and Akt pathway that negatively regulates GSK3beta XREF_BIBR.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	20849862	GSK-3beta is also inhibited by the PI-3 '-kinase pathway through PKB and Akt, and also by the MEK and ERK and p38 MAPK pathways, PKA, p90 RSK / MAPKAP kinase-1, and S6 kinase (XREF_BIBR; XREF_BIBR).	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	6899864	In some experiments, LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (a kinase involved in activating Akt) and tumor necrosis factor-alpha (TNF-alpha) were used to activate GSK-3beta.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	25135221	On the other direction, PI3K activation inducing Akt activity () will inhibit GSK3beta, allowing beta-catenin cytoplasmic accumulation and nuclear translocation.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	22799764	PI 3 K/Akt pathway could inactivate the Gsk3-beta and FOXO transcription factors, thus inhibit cyclin D1 while induce p27 and p21 in the regulation of cell-cycle entry [XREF_BIBR].	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	24428908	In contrast to p70S6K and 4E-BP1, GSK-3beta is negatively regulated by the PI3K and AKT signaling.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	19734233	The differential ability to induce PI3K and subsequent inactivation of GSK3beta observed between IL-12 and IL-23 explains why IL-12, but not IL-23, was able to promote IL-10 production from human memory CD4 + T cells.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	15940626	This finding suggests that inhibition of GSK-3beta by PI3-K and Akt may further stimulate Wnt signaling if there is an active Wnt signal already present.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	18606491	We demonstrate that activation of PI3K and PKC inhibits GSK3beta activity by stimulating pGSK3beta (Ser9).	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	19180470	Previous reports show that PI3K inhibits GSK-3beta through phosphorylation at Ser9 [XREF_BIBR; XREF_BIBR] and that inactivation of GSK-3beta can either increase NF-kappaB activity [XREF_BIBR; XREF_BIBR] or decrease NF-kappaB activity [XREF_BIBR].	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	19180470	PI3K can inactivate GSK-3beta, an enzyme shown to stimulate nuclear localization and transactivation of NF-kappaB [XREF_BIBR; XREF_BIBR].	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	21448462	PI3K and Akt mediated inhibition of GSK3beta has been demonstrated to be responsible for Snail expression by ROS such as H 2 O 2 XREF_BIBR.	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	25883211	For example, EGFR activated PI3K and AKT leads to phosphorylation and subsequently inhibition of the beta-catenin suppressor GSK3beta, resulting in nuclear accumulation of beta-catenin [XREF_BIBR].	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
5df19282-bee8-4094-8d3e-32f9b25b3ae9	1.0	PubMed	25219467	Activation of PI3K pathway suppresses GSK-3beta activity via Ser9 phosphorylation by AKT ().	p(FPLX:PI3K)	directlyDecreases	act(p(HGNC:GSK3B))
ce07692a-3002-48d5-96f8-0efc8f4f718f	1.0	PubMed	26119563	To confirm the role of GSK-3beta inhibition in EphB2 and ephrinB1 induced tau dephosphorylation, we used wortmannin (a PI3K inhibitor that can indirectly activate GSK-3beta) XREF_BIBR or overexpression of wild type GSK-3beta.	a(CHEBI:84801)	directlyDecreases	act(p(HGNC:GSK3B))
73383d07-4142-4a6e-a543-10a3e5913bc3	1.0	PubMed	26297988	Additionally, re-expression of AR increased the expression levels of Akt2, Akt3, PI3K p85, and phospho-PI3K p85 Tyr458 but decreased the abundance of GSK-3beta, phospho-GSK-3beta Ser9, matrix metalloproteinases-9 (MMP-9), vimentin, and beta-catenin proteins.	p(FPLX:"PI3K_p85")	directlyDecreases	act(p(HGNC:GSK3B))
58102d62-e5d6-4e9c-9127-dbef5b6db72b	1.0	PubMed	22212451	Further, knockdown of p85alpha in cultured acinar cells to 30% of its original level caused a significant decrease in IGF-1-induced activation of the PI3K downstream signaling factors mTOR, p70S6K, and GSK3beta, which are important for regulating cell growth and cell cycling.	p(HGNC:PIK3R1)	directlyDecreases	act(p(HGNC:GSK3B))
82ac7634-1726-4b6e-bbb9-c936b623ff76	1.0	PubMed	22184106	Furthermore, Pin1 promotes protein turnover of APP by inhibiting GSK3beta activity.	p(HGNC:PIN1)	directlyDecreases	act(p(HGNC:GSK3B))
92dc7966-25e3-4d65-82cf-3f6b55bf4f3e	1.0	PubMed	20007971	It is widely expressed and facilitates phosphorylation and thus inactivation of GSK3beta by PKA.	p(FPLX:PKA)	directlyDecreases	act(p(HGNC:GSK3B))
92dc7966-25e3-4d65-82cf-3f6b55bf4f3e	1.0	PubMed	12147701	A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta) and mediates protein kinase A dependent inhibition of GSK-3beta.	p(FPLX:PKA)	directlyDecreases	act(p(HGNC:GSK3B))
92dc7966-25e3-4d65-82cf-3f6b55bf4f3e	1.0	PubMed	20357815	Taken together, our results indicate that activation of the cAMP and PKA pathway can immediately inactivate GSK-3beta, which, in this study is shown to have a critical role in MMP-1 expression in human skin fibroblasts.We further investigated the effects of cAMP pathway and GSK-3 activity on MMP-1 expression but focused on their effects on MMP-1 expression after the activation of ERK and JNK by TNF-alpha had already occurred.	p(FPLX:PKA)	directlyDecreases	act(p(HGNC:GSK3B))
92dc7966-25e3-4d65-82cf-3f6b55bf4f3e	1.0	PubMed	25412261	Consistent with previous studies XREF_BIBR - XREF_BIBR, we observed that DENV induced synergistic activation of PKA and PKB inhibited GSK-3beta, leading to CREB mediated IL-10 production.	p(FPLX:PKA)	directlyDecreases	act(p(HGNC:GSK3B))
92dc7966-25e3-4d65-82cf-3f6b55bf4f3e	1.0	PubMed	26088133	Interestingly, GSK3beta can be released from the multienzyme complex in response to PKA phosphorylation on serine 9, which suppresses GSK3beta activity.	p(FPLX:PKA)	directlyDecreases	act(p(HGNC:GSK3B))
d8cf0a09-3bad-4b5c-8178-ab777bb4ffed	1.0	PubMed	24127488	It is likely that PKC, a downstream effector of PLCgamma2, phosphorylates and thus inactivates GSK3beta, a kinase that targets beta-catenin for ubiquitination and subsequent proteasomal degradation.	p(FPLX:PKC)	directlyDecreases	act(p(HGNC:GSK3B))
d8cf0a09-3bad-4b5c-8178-ab777bb4ffed	1.0	PubMed	18391982	We further demonstrated that the functional regulation of p53 by triptolide was mediated by an intranuclear association of p53 with glycogen synthase kinase-3beta (GSK3beta), which was inactivated by protein kinase C (PKC).	p(FPLX:PKC)	directlyDecreases	act(p(HGNC:GSK3B))
d8cf0a09-3bad-4b5c-8178-ab777bb4ffed	1.0	PubMed	23349801	GFX inhibited FGF-2-induced phosphorylation of glycogen synthase kinase-3beta (GSK-3beta), suggesting that FGF-2 induced PKC and then PKC inhibited the activity of GSK-3beta.	p(FPLX:PKC)	directlyDecreases	act(p(HGNC:GSK3B))
d8cf0a09-3bad-4b5c-8178-ab777bb4ffed	1.0	PubMed	25292215	The Cdc42 pathway relies on phosphorylation of kinase GSK3beta on Ser 9 by an a typical protein kinase C (aPKC), which inhibits GSK3beta and reverses its inhibitory effect on APC (XREF_BIBR).	p(FPLX:PKC)	directlyDecreases	act(p(HGNC:GSK3B))
d8cf0a09-3bad-4b5c-8178-ab777bb4ffed	1.0	PubMed	18606491	We demonstrate that activation of PI3K and PKC inhibits GSK3beta activity by stimulating pGSK3beta (Ser9).	p(FPLX:PKC)	directlyDecreases	act(p(HGNC:GSK3B))
d8cf0a09-3bad-4b5c-8178-ab777bb4ffed	1.0	PubMed	19901516	Stabilization of beta-catenin can result from direct inhibition of GSK3beta by PKC and ERK, and transformation of mammary epithelial cells resulting from increased beta-catenin and TCF signaling has been linked to PKCalpha activation downstream of PDK1.	p(FPLX:PKC)	directlyDecreases	act(p(HGNC:GSK3B))
31461520-5660-48ab-b35c-ea9f0fed5c8c	1.0	PubMed	23806081	Our finding that uPAR regulates PI3K and Akt activity, and consequently inhibits GSK3beta activity, suggests that the uPAR pathway may also contribute to various functions and phenotypes modulated by PI3K and Akt and GSK3beta.	p(HGNC:PLAUR)	directlyDecreases	act(p(HGNC:GSK3B))
af8facc7-830a-4a33-aae1-3ad78b032b6f	1.0	PubMed	24127488	It is likely that PKC, a downstream effector of PLCgamma2, phosphorylates and thus inactivates GSK3beta, a kinase that targets beta-catenin for ubiquitination and subsequent proteasomal degradation.	p(HGNC:PLCG2)	directlyDecreases	act(p(HGNC:GSK3B))
47f44222-7f9f-4dc5-be59-0828e42c7521	1.0	PubMed	20178594	We found a statistically significant negative correlation between pGSK-3beta (inactivation of GSK-3beta) and PMS2 in cervical carcinoma (P = 0.001), while pGSK-3beta did not show a statistically significant correlation with MLH1 and MSH2 immunoreactivity (data not shown).	p(HGNC:PMS2)	directlyDecreases	act(p(HGNC:GSK3B))
8b0c4fa7-2d4b-4b37-98aa-164aa1e372be	1.0	PubMed	18794809	Wnt and beta-catenin signaling was decreased by POX in that phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) was decreased on the one hand and phosphorylation of beta-catenin was increased on the other.	p(PFAM:PF07526)	directlyDecreases	act(p(HGNC:GSK3B))
5ab6b379-e56c-486e-994c-6c22e47db2f6	1.0	PubMed	26046374	[XREF_BIBR] This implies that PPARgamma agonists may inactivate GSK-3beta through other upstream mediators alongside or independently through direct inhibition.	p(HGNC:PPARG)	directlyDecreases	act(p(HGNC:GSK3B))
49a502cc-191d-41c4-bdac-577159d2dbd6	1.0	PubMed	11696419	The expression of PBP increases tau phosphorylation in the human HEK293T fibroblast cell line but decreases GSK-3beta activity.	p(HGNC:PPBP)	directlyDecreases	act(p(HGNC:GSK3B))
aca8b60f-66d1-4e07-b9d8-c4a4b4f00052	1.0	PubMed	11696419	The fact that PBP also binds presenilin and significantly decreases the activity of GSK-3beta in human cells suggests that a large complex between these molecules may exist in which the very large 240-kd PBP plays a central role.	complex(p(HGNC:PPBP), p(PFAM:PF01080))	directlyDecreases	act(p(HGNC:GSK3B))
f3501b87-b097-4991-a02c-9cbf2798ed51	1.0	PubMed	22732552	Knockdown of PME-1 or PPMT1 eliminated the effects of GSK-3beta on PP2A (C).	p(HGNC:PPME1)	directlyDecreases	act(p(HGNC:GSK3B))
76f394cb-4aa9-424f-b15b-9eeda5547aad	1.0	PubMed	PMC5654975	These data suggest that stimulation of glycogen synthase by insulin in HepG2 cells is mediated through the PI-3 kinase pathway by activating PKB and PP-1G and inactivating GSK-3beta.	p(HGNC:PPP1CC)	directlyDecreases	act(p(HGNC:GSK3B))
fcc8e8d0-f0df-48b4-af01-ae2e04a9281a	1.0	PubMed	26655089	Here we report that OLA1 is a GSK3beta interacting protein, and through its ATPase activity, inhibits the GSK3beta mediated activation of protein serine/threonine phosphatase 1 (PP1).	p(FPLX:PPP1)	directlyDecreases	act(p(HGNC:GSK3B))
656f167a-a1ac-4434-9f55-f13a915ca40b	1.0	PubMed	21671254	Studies in SH-SY5Y cells have shown that inhibition of PP-2A and PP-1 leads to tau hyperphosphorylation at specific sites and up-regulation of the activities of cdc2 kinase, CDK5, and MAPK, but not of GSK3-beta (XREF_BIBR).	p(HGNC:PPP2CA)	directlyDecreases	act(p(HGNC:GSK3B))
846c295c-bbd1-4880-9c0e-734c18147090	1.0	PubMed	21806989	Knockdown and overexpression of I 2 PP2A in the brain have been found to decrease and increase GSK-3beta activity, respectively [XREF_BIBR, XREF_BIBR].	p(FPLX:PPP2)	directlyDecreases	act(p(HGNC:GSK3B))
846c295c-bbd1-4880-9c0e-734c18147090	1.0	PubMed	12086851	Here, we report that DeltaNp63 associates with the B56alpha regulatory subunit of protein phosphatase 2A (PP2A) and glycogen synthase kinase 3beta (GSK3beta), leading to a dramatic inhibition of PP2A mediated GSK3beta reactivation.	p(FPLX:PPP2)	directlyDecreases	act(p(HGNC:GSK3B))
846c295c-bbd1-4880-9c0e-734c18147090	1.0	PubMed	6380675	Here, we report that DeltaNp63 associates with the B56alpha regulatory subunit of protein phosphatase 2A (PP2A) and glycogen synthase kinase 3beta (GSK3beta), leading to a dramatic inhibition of PP2A mediated GSK3beta reactivation.	p(FPLX:PPP2)	directlyDecreases	act(p(HGNC:GSK3B))
846c295c-bbd1-4880-9c0e-734c18147090	1.0	PubMed	25219467	To understand whether inhibition of GSK-3b caused by inhibition of PP2A with OA affects PP2Ac methylation, we determined the methylation of PP2Ac in previously mentioned OA treated cell samples by Western blots.	p(FPLX:PPP2)	directlyDecreases	act(p(HGNC:GSK3B))
08d7318d-28df-457c-a628-972fe60e5f9c	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3alpha or ser9 in gsk3beta. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:PRKACA)	directlyDecreases	act(p(HGNC:GSK3B))
a2b237a9-0152-42bf-b2a4-f830d8ae0209	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3_ or ser9 in gsk3_. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:PRKCA)	directlyDecreases	act(p(HGNC:GSK3B))
a2b237a9-0152-42bf-b2a4-f830d8ae0209	1.0	PubMed	19218353	The data indicate that TNF induces endothelial activation that is modulated by a PKCalpha dependent inhibition of GSK3beta.	p(HGNC:PRKCA)	directlyDecreases	act(p(HGNC:GSK3B))
19408bfc-b4a9-4ef3-bb01-c68f5edbc2ff	1.0	PubMed	26522132	In light of these evidences, our finding of an enhanced cell proliferation after PRKCD silencing might be linked to the demonstrated increased beta-catenin expression.We also demonstrated that PRKCD silencing increases phosphorylated GSK-3beta (Ser9), resulting in an inactivation of this enzyme ().	p(HGNC:PRKCD)	directlyDecreases	act(p(HGNC:GSK3B, pmod(Ph)))
f12906a3-ce41-4b68-8f53-d30433d6f250	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3_ or ser9 in gsk3_. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:PRKCH)	directlyDecreases	act(p(HGNC:GSK3B))
91b82715-cce1-4899-b29e-fcfd69c185dd	1.0	PubMed	14657655	Phospho-gsk3b-specific antibodies also revolved that lkb1 regulates gsk3b phosphorylation at a known inhibitory site, serine-9. This localized phosphorylation is cdc42 and pkc-zeta-dependent.	p(HGNC:PRKCZ)	directlyDecreases	act(p(HGNC:GSK3B))
5eacc9ad-4fd9-439a-aecf-8867df0fa83c	1.0	PubMed	18561034	Parkin attenuates four-repeat human tau, but not mutant P301L, hyperphosphorylation in the presence of intracellular Abeta (1-42), or alpha-synuclein and decreases GSK-3beta activity in amyloid stressed M17 human neuroblastoma cells.	p(HGNC:PRKN)	directlyDecreases	act(p(HGNC:GSK3B))
126d11f1-21d9-47d3-930a-97b73656bca7	1.0	PubMed	25908095	Furthermore, we find that REGgamma activates Wnt and beta-catenin signalling by degrading GSK-3beta in vitro and in cells, increasing levels of CyclinD1 and c-Myc, the downstream targets of beta-catenin.	p(HGNC:PSME3)	directlyDecreases	act(p(HGNC:GSK3B))
80a0b253-8f81-4f14-afa4-6d86e5bea7a6	1.0	PubMed	25931210	We observed that miR-429 attenuated PTEN expression induced the phosphorylation of AKT and inhibited the activity of GSK-3beta ().	p(HGNC:PTEN)	directlyDecreases	act(p(HGNC:GSK3B))
9e407b22-022c-4cab-8559-ec85d87bd1a1	1.0	PubMed	20975834	PTEN can block beta-catenin accumulation and signaling by favoring retention of active GSK3beta and inactive PKB and Akt kinase in some XREF_BIBR, XREF_BIBR, but not all experimental systems XREF_BIBR, XREF_BIBR.	p(HGNC:PTEN)	directlyDecreases	act(p(HGNC:GSK3B))
9e407b22-022c-4cab-8559-ec85d87bd1a1	1.0	PubMed	25431208	In contrast, the downregulation of OTUB1 in SW620 cells increased PTEN expression and decreased p-AKT and p-GSK3beta (S9) levels.	p(HGNC:PTEN)	directlyDecreases	act(p(HGNC:GSK3B))
607ac081-e770-4821-ae8e-d945db5fdb3a	1.0	PubMed	24374173	PGE2 has been reported to inactivate GSK3beta and induce a consequent intracellular accumulation of beta-catenin.	p(HGNC:PTGER4)	directlyDecreases	act(p(HGNC:GSK3B))
5c209e11-50fd-4e0a-bc99-3a48deee3265	1.0	PubMed	21743491	In summary, this study shows that mPGES-1 and its enzymatic product, PGE 2, inhibits GSK-3beta and induces the formation of EGR1, beta, and catenin complex which interacts with TCF4 and LEF1 transcription factors, leading to beta-catenin activation and upregulation of its downstream genes in human HCC cells (illustrated in XREF_FIG).	p(HGNC:PTGES)	directlyDecreases	act(p(HGNC:GSK3B))
d477c120-d29a-4004-bf96-11ee83597a14	1.0	PubMed	16293724	We show that pge2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (g protein)coupled receptor, ep2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase akt by free g protein bg subunits and the direct association of the g protein as subunit with the regulator of g protein signaling (rgs) domain of axin. This leads to the inactivation and release of glycogen synthase kinase 3b from its complex with axin, thereby relieving the inhibitory phosphorylation of b-catenin and activating its signaling pathway.	p(HGNC:PTGS2)	directlyDecreases	act(p(HGNC:GSK3B))
1502c286-139a-41e1-8967-a594ffc14f91	1.0	PubMed	23326460	As shown in XREF_FIG, the FAK pathway was suppressed dramatically after RNA interference or blocking FAK and GSK3beta.	p(HGNC:PTK2)	directlyDecreases	act(p(HGNC:GSK3B))
086ae197-eb4b-4e0d-abf7-3d59a4174b02	1.0	PubMed	23519466	We also found Fap1 dependent inactivation of Gsk3beta and consequent stabilization of betacatenin in these cells.	p(HGNC:PTPN13)	directlyDecreases	act(p(HGNC:GSK3B))
086ae197-eb4b-4e0d-abf7-3d59a4174b02	1.0	PubMed	26147002	Moreover, it is promoted by the deregulated transcription of genes encoding factors critical for beta-catenin inactivation, including growth arrest specific 2 (GAS2, which reduces the calpain dependent degradation of beta-catenin), and by the prevalence of GSK-3beta mis spliced, functionally inactive isoforms unable to phosphorylate beta-catenin and/or Fas associated phosphatase 1 (Fap1, which inactivates GSK-3beta through de-phosphorylation) [XREF_BIBR - XREF_BIBR].	p(HGNC:PTPN13)	directlyDecreases	act(p(HGNC:GSK3B))
acd17688-db0e-4831-b54c-726599338489	1.0	PubMed	23100427	PTPRZ1 inhibition potentiated GSK3beta regulated beta-catenin translocation.	p(HGNC:PTPRZ1)	directlyDecreases	act(p(HGNC:GSK3B))
288c6e55-c550-4a82-a4c0-4eb5e88f1a94	1.0	PubMed	6701132	Such Akt and GSK3beta activation was abrogated completely by wortmannin, an inhibitor of PI-3 kinase, and greatly by pertussis toxin, a G protein inhibitor.	p(FPLX:"Pertussis_toxin")	directlyDecreases	act(p(HGNC:GSK3B))
127c16c6-2af1-4585-a98a-92afc2e989a9	1.0	PubMed	22144179	Further, experiments with GSK-3beta and Fbw7 deficient cells revealed that GSK-3beta and Fbw7 dependent HIF-1alpha degradation can be antagonized by ubiquitin specific protease 28 (USP28).	p(FPLX:Protease)	directlyDecreases	act(p(HGNC:GSK3B))
911b7053-7b6d-4d7a-a32c-7df56e49db7e	1.0	PubMed	20519433	Clusters were enriched in GSK3beta and CKI-P-APC and GSK3beta and CKI-P-betacat, which were rapidly degraded by the proteasome.	p(FPLX:Proteasome)	directlyDecreases	act(p(HGNC:GSK3B))
911b7053-7b6d-4d7a-a32c-7df56e49db7e	1.0	PubMed	21321938	Following phosphorylation on Ser9, GSK3beta is degraded by the proteasome pathway, thus releasing beta-catenin.	p(FPLX:Proteasome)	directlyDecreases	act(p(HGNC:GSK3B))
c3bdc8ed-0a31-4d3e-818b-664687d5d038	1.0	PubMed	PMC7189068	Furthermore, androgen receptor phosphorylation was augmented by LY294002, an indirect inhibitor of protein kinase B/Akt that inhibits glycogen synthase kinase-3 beta.	p(FPLX:RAC)	directlyDecreases	act(p(HGNC:GSK3B))
8bd1d777-ffb0-4d13-affc-d821c89ea6e3	1.0	PubMed	22385658	Immunoblot analysis shows that cRaf activated Erk1,2 and inactivated Gsk3beta (XREF_FIG).	p(HGNC:RAF1)	directlyDecreases	act(p(HGNC:GSK3B))
87aa7363-ec03-49eb-9c67-8d923c14dc01	1.0	PubMed	19276348	Constitutive oncogenic signaling downstream of the Ras pathway inactivates GSK3beta through phosphorylation of GSK3beta on Ser9.	p(FPLX:RAS)	directlyDecreases	act(p(HGNC:GSK3B))
a314b89b-b55b-4051-91fd-d66aa694c0a8	1.0	PubMed	25657336	Caki-1, a metastatic RCC cell line, showed higher expression of molecular EMT markers, including Snail and Zeb1, but decreased activity of GSK3beta.	a(PUBCHEM:10985033)	directlyDecreases	act(p(HGNC:GSK3B))
90790496-7692-4736-8f0f-4e83e2e0432a	1.0	PubMed	24151146	Since, phosphorylation of Ser9 was associated with an inactive form of GSK-3beta, results demonstrated a Reg4 mediated inhibition of GSK-3beta activity.	p(HGNC:REG4)	directlyDecreases	act(p(HGNC:GSK3B))
a96cca11-f67b-45e3-8b4a-411b146338d8	1.0	PubMed	17614163	Tau phosphorylation involves various kinases, such as cyclin dependent kinase 5 (CDK-5) or glycogen synthase kinase 3beta (GSK-3beta), an enzyme whose activity is inhibited by reelin through a mechanism involving the presence of LRP8 (); (ii) reelin modulates synaptic plasticity and LTP through a mechanism involving the presence of exon 19 of ().	p(HGNC:RELN)	directlyDecreases	act(p(HGNC:GSK3B))
cea04b5a-0920-40b0-bd1f-904dc8fb6aa9	1.0	PubMed	21448462	In addition, hypoxia also induces Snail translocation into the nucleus through ROS dependent inhibition of GSK-3beta XREF_BIBR, XREF_BIBR.	p(HGNC:ROS1)	directlyDecreases	act(p(HGNC:GSK3B))
cea04b5a-0920-40b0-bd1f-904dc8fb6aa9	1.0	PubMed	25396735	XREF_BIBR provided evidence that hypoxia dependent changes occur through a biphasic mechanism involving a very early and reactive oxygen species (ROS)-dependent inhibition of GSK-3beta followed by early Snail 1 nuclear translocation, also involving the nuclear translocation of beta-catenin.	p(HGNC:ROS1)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	The present study suggests that the stabilization of mtp53 (R280K and del126-133) in breast cancer depends on RPN2 inhibition of GSK3beta mediated inactivation of HSP70 and HSP90 that are essential factors for the stabilization and oncogenic activities of mtp53.	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	RPN2 knockdown promoted GSK3beta mediated inactivation of heat shock proteins.	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	RPN2 antagonizes GSK3beta function via physical interaction.	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	These results indicate that RPN2 knockdown promotes GSK3beta activation, and such activation is associated with the suppression of CSC phenotypes (XREF_FIG and XREF_FIG).	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	To further investigate whether RPN2 antagonizes GSK3beta activity via physical interaction, we examined the E-cadherin expression in 293T cells.	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	These results indicate that RPN2 inhibits the nuclear localization and activation of GSK3beta via a physical interaction with its N-terminal region, and partially provide a molecular mechanism by which E-cadherin negative fraction acquires drug resistance.	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	HSF1 transcriptional activity is negatively regulated by GSK3beta XREF_BIBR, which suggests that RPN2 knockdown may promote GSK3beta induced downregulation of HSP70 (XREF_SUPPLEMENTARY).	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	These results strongly suggest that the formation of RPN2 and GSK3beta protein complexes inhibits the function of GSK3beta, and that RPN2 knockdown induces the destabilization of mtp53 by GSK3beta mediated inactivation of heat shock proteins, leading to CSC phenotypic suppression.	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	Since RPN2 knockdown promoted GSK3beta mediated inactivation of heat shock proteins that are essential for mtp53 stabilization XREF_BIBR XREF_BIBR, we examined the expression and stability of mtp53 in MCF7-ADR and MM231-LN cells that express a p53 deletion mutant (p53 deletion 126-133) XREF_BIBR and a p53 point mutant (p53R280K) XREF_BIBR, respectively (XREF_FIG).	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
0414a3b0-00ec-403a-a8b4-374e8268aee8	1.0	PubMed	23959174	We also demonstrated that RPN2 antagonized GSK3beta function via physical interaction, and identified N-terminal amino acids 56-85 of GSK3beta as important for its interaction with RPN2 (XREF_FIG).	p(HGNC:RPN2)	directlyDecreases	act(p(HGNC:GSK3B))
ef9e4a91-f686-4b5b-9297-b6f10fb52248	1.0	PubMed	11584304	S6k then phosphorylates the same serine residue on gsk3 that is targeted by pkb/akt (fig. 1), thereby inhibiting its activity.	p(HGNC:RPS6KA1)	directlyDecreases	act(p(HGNC:GSK3B))
475eebfc-8494-4ba8-bc74-81ee94b44bd8	1.0	PubMed	22095718	We next set out to test whether reduced IL-1beta-induced S100B secretion from astrocytes mediated the activation of GSK-3beta in neurons in vitro, as observed in our in vivo model.	p(HGNC:S100B)	directlyDecreases	act(p(HGNC:GSK3B))
3363643f-6cde-4ffe-b3fd-1df572a54505	1.0	PubMed	18955571	The S 9 phosphorylation (pGSK-3beta S9) inhibits GSK-3beta activity, whereas the Y 216 phosphorylation (pGSK-3beta Y216) up-regulates GSK-3beta activity.	p(UP:Q2Y0E2, pmod(Ph))	directlyDecreases	act(p(HGNC:GSK3B))
6b0db346-65e7-4dca-a783-39acac30a157	1.0	PubMed	12781867	Although higher levels of inhibitor are required, LCK, GSK3beta, PKBalpha and PDK1 are all inhibited by SB203580, effects which could impinge on the phosphorylation of eIF4E.	a(CHEBI:90705)	directlyDecreases	act(p(HGNC:GSK3B))
4b216ff2-7737-4fe8-bd3e-568a6911750d	1.0	PubMed	27129219	LiCl and SB415286 are specific inhibitors of GSK3beta, which can inhibit Wnt and beta-catenin signaling.	a(PUBCHEM:4210951)	directlyDecreases	act(p(HGNC:GSK3B))
4b216ff2-7737-4fe8-bd3e-568a6911750d	1.0	PubMed	25829335	Persistently, in vitro studies are also available indicating that GSK-3beta inhibitors are protective against PD mimetics; for instance it has been shown that inhibition of GSK-3beta activity either directly by SB415286 or indirectly by tacrine (2)-ferulic acid could decrease 6-OHDA mediated neurotoxicity in PC-12 cells.	a(PUBCHEM:4210951)	directlyDecreases	act(p(HGNC:GSK3B))
90330d5a-76c7-4e7c-a914-105878a15403	1.0	PubMed	20190034	GSK-3beta inhibition by lithium or SB-216763 increased cell size, protein synthesis, and contractile protein expression.	a(PUBCHEM:176158)	directlyDecreases	act(p(HGNC:GSK3B))
90330d5a-76c7-4e7c-a914-105878a15403	1.0	PubMed	21254166	First, pharmacological inhibition of GSK3beta by SB-216763 protected cells against the suppressive effect of AR42 on topoIIalpha expression (XREF_FIG).	a(PUBCHEM:176158)	directlyDecreases	act(p(HGNC:GSK3B))
90330d5a-76c7-4e7c-a914-105878a15403	1.0	PubMed	25875172	To directly demonstrate that a reduction in GSK3 activity is involved in redifferentiation, we employed the GSK3 inhibitor SB-216763, which inhibits both GSK-3alpha and GSK-3beta activity [XREF_BIBR].	a(PUBCHEM:176158)	directlyDecreases	act(p(HGNC:GSK3B))
90330d5a-76c7-4e7c-a914-105878a15403	1.0	PubMed	19549530	For the inhibition of GSK3beta and protein synthesis, cells were treated with SB-216763 at 10 mumol/L for 24 hours and cycloheximide at 0.5 mug/mL (Sigma) for 12 hours.	a(PUBCHEM:176158)	directlyDecreases	act(p(HGNC:GSK3B))
90330d5a-76c7-4e7c-a914-105878a15403	1.0	PubMed	20634980	Interestingly, inhibition of GSK-3beta by SB 216763 or by RNA interference, augmented HBD-2 induction.	a(PUBCHEM:176158)	directlyDecreases	act(p(HGNC:GSK3B))
34669205-992b-40a7-9cce-04061db35945	1.0	PubMed	21980345	Thus, the specificity, the potency, and the sustainability of the ' knock-out ' punch of nimesulide on PEL cells could be attributed to additive anti-viral effects by the blockade of KSHV latency genes LANA-1 and vFLIP, anti-inflammatory and anti-survival properties by the down-regulation of VEGF-C, Akt1/2, and GSK-3beta, anti-PEL specific properties by down-regulating syndecan-1, VDR, and aquaporin-3 as well as anti-cancer properties by the activation of G1 arrest and apoptosis (XREF_FIG).	p(HGNC:SDC1)	directlyDecreases	act(p(HGNC:GSK3B))
7ea2137a-9f69-4836-8354-b00a0041b22e	1.0	PubMed	12054501	Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction	p(HGNC:SGK3)	directlyDecreases	act(p(HGNC:GSK3B))
7ea2137a-9f69-4836-8354-b00a0041b22e	1.0	PubMed	16543730	Phosphorylation of GSK3 by PKB or SGK1 inhibits GSK3 activity|estern blotting using an antibody specific for the PKB/SGK1 consensus phosphorylation site in GSK3a/beta (serine 21 and 9 respectively) revealed an increase in GSK3a/beta phosphorylation in human embryonic kidney 293 (HEK293) cells overexpressing wild type SGK1, constitutively active SGK1, but not catalytically inactive SGK1.|The effect of SGK1 was mimicked by PKB and SGK3.	p(HGNC:SGK3)	directlyDecreases	act(p(HGNC:GSK3B))
141e6f67-499b-488d-8a4b-c2fa6676afd8	1.0	PubMed	21276221	In addition, repression of Bmi-1 reverses the expression of EMT markers and inhibits the Akt and GSK3beta pathway.	bp(GO:"GO:0001837")	directlyDecreases	act(p(HGNC:GSK3B))
141e6f67-499b-488d-8a4b-c2fa6676afd8	1.0	PubMed	21284870	We further showed that EMT activated Akt and suppressed the function of GSK-3beta, which is required for the stabilization and nuclear translocation of beta-catenin, and thus results in the transcription of CD44.	bp(GO:"GO:0001837")	directlyDecreases	act(p(HGNC:GSK3B))
df3223f8-f772-4f10-9fed-a5dacb69d298	1.0	PubMed	19481076	Smurf2 Induces Degradation of GSK-3beta and Upregulates beta-Catenin in Chondrocytes : A Potential Mechanism for Smurf2 Induced Degeneration of Articular Cartilage.	p(HGNC:SMURF2)	directlyDecreases	act(p(HGNC:GSK3B))
087de153-3659-4508-afee-7a58dd36087c	1.0	PubMed	20634980	Hence increasing HBD-2 by modulating the kinase activity of Sphk-1 and kinase inactivation of GSK3-beta can be seen as a valuable intervention against viral attack.	p(HGNC:SPHK1)	directlyDecreases	act(p(HGNC:GSK3B))
087de153-3659-4508-afee-7a58dd36087c	1.0	PubMed	20634980	The present investigation identifies : i) Sphk-1 as a critical kinase involved in TLR mediated human beta-defensin 2 induction and modulation in HGECs; ii) activation of TLRs induces phosphorylation of Sphk-1 and its intracellular activity by enhanced conversion of S1P; and iii) activated PI3K suppresses GSK3-beta augmenting HBD-2 induction.	p(HGNC:SPHK1)	directlyDecreases	act(p(HGNC:GSK3B))
f813e018-f630-49e7-a889-241259a4f496	1.0	PubMed	22262776	Specifically, GSK3beta activity and nuclear import were increased by imatinib mesylate (IM), a selective ABL inhibitor, but prevented by dasatinib that targets both BCR-ABL- and cytokine dependent MAPK and p60-SRC activity.	p(HGNC:SRC)	directlyDecreases	act(p(HGNC:GSK3B))
f813e018-f630-49e7-a889-241259a4f496	1.0	PubMed	24412473	Li, Y et al. demonstrated that c-Src decreases the interaction of MUC1 and GSK3beta [XREF_BIBR].	p(HGNC:SRC)	directlyDecreases	act(p(HGNC:GSK3B))
c7c69bc9-b470-4b4b-a39c-db5bf2359646	1.0	PubMed	18598779	BIO induced a strong activation of the reporter in HEK293T and NT2/D1 cells (A) but was ineffective in Hela cells (data not shown) suggesting that Hela cells lack important factors necessary for a functional canonical Wnt pathway.Activation of the reporter by BIO was reduced twofold by SRY in HEK293T cells (A, left panel) suggesting that SRY inhibits the Wnt-canonical-signaling pathway downstream of GSK3beta in these cells.	p(HGNC:SRY)	directlyDecreases	act(p(HGNC:GSK3B))
8301c708-ab30-4d17-b088-a0b6268ec54f	1.0	PubMed	22087308	Thus, these data suggest that STAT5A1 * 6, or possibly activated endogenous STAT5, may inhibit GSK3beta through the PI3K and Akt pathway to prevent the Jak2 downregulation under DNA damage stress.	p(FPLX:STAT5)	directlyDecreases	act(p(HGNC:GSK3B))
acb291ea-f8bc-4de1-baf5-5fa2e4718548	1.0	PubMed	14657655	Phospho-gsk3b-specific antibodies also revolved that lkb1 regulates gsk3b phosphorylation at a known inhibitory site, serine-9. This localized phosphorylation is cdc42 and pkc-zeta-dependent.	p(HGNC:STK11)	directlyDecreases	act(p(HGNC:GSK3B))
a44d3dc7-da6b-4c5f-98b6-428f49bd8b39	1.0	PubMed	21435461	The two molecules inhibit GSK-3beta through different mechanisms : lithium directly inhibits GSK-3beta by competing with magnesium but not with substrate or ATP, whereas Sb-216763 inhibits GSK-3beta in an ATP-competitive manner.	a(PUBCHEM:176158)	directlyDecreases	act(p(HGNC:GSK3B))
9ad6a0f1-181d-4998-8b7b-4a39ef23d856	1.0	PubMed	23644467	ERK2 then interacted with and phosphorylated Snail1 on S82 and S104 and inhibited GSK3beta activity, with both effects contributing to stabilization of Snail1 protein.	complex(p(HGNC:MAPK1))	directlyDecreases	act(p(HGNC:GSK3B))
16c6df5e-57d9-4ae2-9f9a-44b06397c517	1.0	PubMed	23463670	Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt and GSK3beta dependent protein degradation.	a(CHEBI:50924)	directlyDecreases	act(p(HGNC:GSK3B))
eade9dea-f02f-436d-aeaf-bb0510fe2c33	1.0	PubMed	21949350	Finally, we report that mutant TDP-43 Q331K strongly increases GSK-3beta activity and that reducing GSK-3beta (sgg) expression strongly suppresses TDP-43 and Abeta42 toxicity.	p(HGNC:TARDBP, var(p.Gln331Lys))	directlyDecreases	act(p(HGNC:GSK3B))
ece7e373-9d86-4e0d-892d-24bc1103d144	1.0	PubMed	20516119	We investigated whether Taspase1 disrupts the GSK3beta signaling and thereby extends the MCL-1 half-life.	p(HGNC:TASP1)	directlyDecreases	act(p(HGNC:GSK3B))
2013cf36-7b4b-46cc-8ec3-681ba44e9c1d	1.0	PubMed	22496417	Moreover, we observed a reduced TGFbeta induced inactivation of GSK-3beta in p38alpha -/- MEFs and in PC-3U cells in which p38alpha was silenced with siRNA or treated with the p38 inhibitor SB203580, demonstrating that p38alpha plays an important role for inactivation of GSK-3beta.	p(FPLX:TGFB)	directlyDecreases	act(p(HGNC:GSK3B))
2013cf36-7b4b-46cc-8ec3-681ba44e9c1d	1.0	PubMed	26325518	Previous studies have showed that GSK-3beta is inhibited by TGF-beta through increased serine 9 phosphorylation and increased stabilization of Snail via the PI3K and AKT signaling network [XREF_BIBR].	p(FPLX:TGFB)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	23431386	As shown in XREF_FIG, the association of Snail with GSK-3beta was diminished in cells treated with TNFalpha, compared with cells treated with MG-132.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	23431386	Based on our findings, we proposed a model in which TNFalpha up-regulates Snail via activation of AKT signaling and thereby inhibits GSK-3beta activity.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	23431386	TNFalpha also inhibits the association of Snail and GSK-3beta.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	23431386	On the one hand, TNFalpha activates AKT signaling and subsequently represses GSK-3beta activity.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	26017781	It appeared that TNF-alpha suppressed the enzyme activity of GSK-3beta via Akt phosphorylation of GSK-3beta.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	22707636	In addition, TNF-alpha treatment inhibited glycogen synthase kinase 3beta (GSK-3beta) activity through serine 9 phosphorylation mediated by the phosphatidylinositol 3-kinase/protein kinase B (PI3K and Akt) pathway in RCC cells.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	23769744	As shown in B, the expression of p-GSK-3beta increased in a time dependent manner upon TNFalpha treatment, suggesting that TNFalpha indeed inhibit the activity of GSK-3beta in PC3 cells.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	23769744	In this study, we found that TNFalpha activates AKT signaling pathway and represses downstream GSK-3beta activity.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	23769744	Finally, we demonstrated that TNFalpha activates AKT signaling and subsequently represses GSK-3beta activity to stabilize Snail.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	19576224	In contrast, over-expression of CSN1 as well as the N-terminal fragment of CSN1 reduced GSK3beta significantly and decreased Axin and Rbx1 moderately in Flag-pulldowns (e, right-hand panel).	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
9d3b508e-eec1-4058-971f-9e0bf17e6045	1.0	PubMed	25846459	In this study, we demonstrated that miR-29a regulates tumor necrosis factor-alpha (TNF-alpha) mediated bone loss mainly by targeting DKK1 and GSK3beta, thus activating the Wnt and beta-catenin pathway.	p(HGNC:TNF)	directlyDecreases	act(p(HGNC:GSK3B))
821ee7e6-1e04-4f88-a955-5e4e1a51f52a	1.0	PubMed	22999923	The phosphorylation of GSK-3beta at Ser9 was barely detectable under normal conditions in SWO-38 cells, while its level was increased in mutant p53 depleted SWO-38 cells (< 0.05 compared with blank control, A and B), suggesting the down-regulation of R280T mutant p53 may decrease the activity of GSK-3beta.	p(HGNC:TP53, var(p.Arg280Thr))	directlyDecreases	act(p(HGNC:GSK3B))
955e7ce9-75d9-49ce-b9e9-a06bd8885c97	1.0	PubMed	11483158	Mutation of either serine 33 or serine 37 of p53 to alanine blocked the ability of GSK3beta to regulate p53 transcriptional activity.	p(HGNC:TP53)	directlyDecreases	act(p(HGNC:GSK3B))
955e7ce9-75d9-49ce-b9e9-a06bd8885c97	1.0	PubMed	5987862	Mutation of either serine 33 or serine 37 of p53 to alanine blocked the ability of GSK3beta to regulate p53 transcriptional activity.	p(HGNC:TP53)	directlyDecreases	act(p(HGNC:GSK3B))
e8c0283b-3d6a-442c-9ad7-e2f5e9b489c2	1.0	PubMed	18804163	Therefore, we asked if TPO and Wnt3a can both inhibit GSK-3beta in megakaryocytic cells, and if they can act synergistically to promote cell growth.	p(HGNC:TPO)	directlyDecreases	act(p(HGNC:GSK3B))
e8c0283b-3d6a-442c-9ad7-e2f5e9b489c2	1.0	PubMed	18804163	We hypothesized that TPO signaling only inhibits one pool of GSK-3beta in UT-7 and TPO cells, whereas a separate pool could be acted on by another pathway, such as the Wnt pathway.	p(HGNC:TPO)	directlyDecreases	act(p(HGNC:GSK3B))
b6157c88-88d6-40a8-9084-5a4b944694c4	1.0	PubMed	21284870	Together, our results indicate that expression of Twist can induce the activation of Akt and the suppression of GSK-3beta, which results in the stabilization of beta-catenin and Snail in Hela and MCF7 cells.	p(HGNC:TWIST1)	directlyDecreases	act(p(HGNC:GSK3B))
bfdcc159-f4d7-4720-8787-7e30d52dcb57	1.0	PubMed	22513362	Furthermore, based on our results that Pten negatively regulates Aurora-A through AKT and GSK3beta, together with the recent report by Taga et.	p(PFAM:PF12561)	directlyDecreases	act(p(HGNC:GSK3B))
f63622f0-2ab8-4f12-8bfe-548458549cc0	1.0	PubMed	21441955	In fact, overexpression of dn-ETS not only reduced the basal GSK-3beta transcription with mutant K-Ras, but also abolished the Ras induced superactivation of GSK-3beta in pancreatic cancer cells with wild type Ras.	p(UP:Q8R4P5)	directlyDecreases	act(p(HGNC:GSK3B))
a92a875d-6163-4196-a7ab-606047a0996a	1.0	PubMed	15689238	However, the ERK inhibitor U0126 significantly decreased GSK3beta activity.	a(CHEBI:90693)	directlyDecreases	act(p(HGNC:GSK3B))
a92a875d-6163-4196-a7ab-606047a0996a	1.0	PubMed	26295469	The Akt inhibitor (LY294002), the ERK inhibitor (U0126) or the combination of LY294002 and U0126 reversed GSK3beta inactivation.	a(CHEBI:90693)	directlyDecreases	act(p(HGNC:GSK3B))
ebddd1d0-7ac9-40a8-aff4-d698d687143a	1.0	PubMed	21928107	Furthermore, our results showed that USP22 deletion also caused down-regulation of Akt and GSK3beta activity, which can also contribute to the reduction of cyclin D2.	p(HGNC:USP22)	directlyDecreases	act(p(HGNC:GSK3B))
291d26bc-409b-4a0b-8f27-9add4c3ba81e	1.0	PubMed	22144179	Further, experiments with GSK-3beta and Fbw7 deficient cells revealed that GSK-3beta and Fbw7 dependent HIF-1alpha degradation can be antagonized by ubiquitin specific protease 28 (USP28).	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:GSK3B))
291d26bc-409b-4a0b-8f27-9add4c3ba81e	1.0	PubMed	26542806	Taken together, these data demonstrate that Fbw7alpha negatively regulates osteogenesis by targeting Runx2 for ubiquitin mediated degradation in a GSK3beta dependent manner and thus provides a plausible explanation for GSK3beta mediated bone loss as described before.	p(FPLX:Ubiquitin)	directlyDecreases	act(p(HGNC:GSK3B))
9ab9bb12-8fdd-42d2-a09c-079e183b867e	1.0	PubMed	18350175	In addition, the interaction between VDAC and HK II was reported to be inhibited by GSK3beta mediated VDAC phosphorylation, and stimulated by Akt dependent inactivation of GSK3beta XREF_BIBR, and this would protect from cell death.	p(HGNC:VDAC1)	directlyDecreases	act(p(HGNC:GSK3B))
f5fbc248-8e02-49b4-b1a6-fac5ae3ef42c	1.0	PubMed	21345331	In addition, only Ser 68 and 72 are essential for the regulation of pVHL mediated MT stabilization by GSK-3beta as pVHL mutated on three other Ser and Thr residues failed to resist GSK-3beta effect.	p(HGNC:VHL)	directlyDecreases	act(p(HGNC:GSK3B))
cbaff240-7583-42d1-9e42-695186bdda26	1.0	PubMed	6396718	Recent studies suggest that lithium and VPA inhibit GSK-3beta, a serine/threonine kinase involved in the insulin and WNT signaling pathways.	a(CHEBI:39867)	directlyDecreases	act(p(HGNC:GSK3B))
cbaff240-7583-42d1-9e42-695186bdda26	1.0	PubMed	6396718	In vitro kinase assays show that therapeutic concentrations of VPA do not inhibit GSK-3beta but that therapeutic concentrations of lithium partially inhibit GSK-3beta activity.	a(CHEBI:39867)	directlyDecreases	act(p(HGNC:GSK3B))
cbaff240-7583-42d1-9e42-695186bdda26	1.0	PubMed	6396718	Lithium directly inhibits GSK-3beta in contrast to VPA, which inhibits GSK-3beta indirectly by an as-yet-unknown pathway.	a(CHEBI:39867)	directlyDecreases	act(p(HGNC:GSK3B))
cbaff240-7583-42d1-9e42-695186bdda26	1.0	PubMed	18955571	Collectively, these data suggest that VPA negatively regulates GSK-3beta activity.	a(CHEBI:39867)	directlyDecreases	act(p(HGNC:GSK3B))
cbaff240-7583-42d1-9e42-695186bdda26	1.0	PubMed	18955571	VPA can inhibit GSK-3beta, resulting in increased beta-catenin protein levels (XREF_BIBR, XREF_BIBR).	a(CHEBI:39867)	directlyDecreases	act(p(HGNC:GSK3B))
91d321ce-7675-4c18-be63-4eac117eafce	1.0	PubMed	19576885	Valproate inhibits GSK-3beta activity at 1mM concentration, but we could not detect any changes of primary cilium lengths using this inhibitor at concentrations from 1.56 mM up to 12.5 mM (A).	a(PUBCHEM:3121)	directlyDecreases	act(p(HGNC:GSK3B))
76a3c143-03bd-435f-9914-776b339d18ad	1.0	PubMed	25749038	Since WISP1 activation of Akt kinase has been reported previously [XREF_BIBR, XREF_BIBR], we therefore proposed that WISP1 inhibited GSK3beta activity possibly through activation of Akt.	p(HGNC:WISP1)	directlyDecreases	act(p(HGNC:GSK3B))
b1657b8d-3b7d-4da0-86d4-4149cc563a1a	1.0	PubMed	12398896	A recent report demonstrates that Wnt-1, which inhibits GSK-3beta and increases beta-catenin, can inhibit cellular sensitivity to apoptosis induced by two anticancer agents, vincristine (VCR) and vinblastine (VBL).	p(HGNC:WNT1)	directlyDecreases	act(p(HGNC:GSK3B))
d9b1d297-ddfe-44f0-94d1-132832da572a	1.0	PubMed	15507471	Upstream activation of Wnt signaling by the Wnt-2 and Wnt-3a ligands, stable overexpression of Wnt-2, as well as GSK-3beta inhibition by lithium, SB216763, and GSK-3beta dominant negative forms (K85R and R96E) conferred the invasive phenotype through several proinvasive pathways.	p(HGNC:WNT2)	directlyDecreases	act(p(HGNC:GSK3B))
2aecb175-bbf7-42b9-b650-eee881b99f49	1.0	PubMed	15507471	Upstream activation of Wnt signaling by the Wnt-2 and Wnt-3a ligands, stable overexpression of Wnt-2, as well as GSK-3beta inhibition by lithium, SB216763, and GSK-3beta dominant negative forms (K85R and R96E) conferred the invasive phenotype through several proinvasive pathways.	p(HGNC:WNT3A)	directlyDecreases	act(p(HGNC:GSK3B))
2aecb175-bbf7-42b9-b650-eee881b99f49	1.0	PubMed	23824844	In contrast, inhibition of GSK-3beta by Wnt3a does not inhibit, but modestly stimulates, CCN2 and CTGF levels in primary human adult lung fibroblasts and is beta-catenin dependent, consistent with previous studies performed in other cell models.	p(HGNC:WNT3A)	directlyDecreases	act(p(HGNC:GSK3B))
2aecb175-bbf7-42b9-b650-eee881b99f49	1.0	PubMed	23911749	Both LiCl and Wnt3a can inhibit the activity of GSK3beta and trigger the Wnt and beta-catenin pathway.	p(HGNC:WNT3A)	directlyDecreases	act(p(HGNC:GSK3B))
2aecb175-bbf7-42b9-b650-eee881b99f49	1.0	PubMed	24412065	Transfection of this mutant was not only unable to rescue the inhibition caused by p120-catenin depletion on the Wnt3a induced GSK3beta uptake in MVBs but also prevented the effect of CA-LRP, which did not require p120-catenin.	p(HGNC:WNT3A)	directlyDecreases	act(p(HGNC:GSK3B))
2aecb175-bbf7-42b9-b650-eee881b99f49	1.0	PubMed	18804163	Therefore, we asked if TPO and Wnt3a can both inhibit GSK-3beta in megakaryocytic cells, and if they can act synergistically to promote cell growth.	p(HGNC:WNT3A)	directlyDecreases	act(p(HGNC:GSK3B))
2aecb175-bbf7-42b9-b650-eee881b99f49	1.0	PubMed	23273980	Thus, LiCl or Wnt-3a inhibits GSK3beta, inducing cytosolic accumulation of beta-catenin, which allows high glucose to induce nuclear beta-catenin accumulation, and neither cytosolic nor nuclear beta-catenin accumulation relies on Akt activation.Importantly, glucose induced nuclear accumulation of beta-catenin (A) occurred between 1hr and 4hr, matched the time required for transcriptional induction as shown in E, and was specific to high glucose, in that using glutamine as an alternative carbon source did not substitute for glucose in promoting nuclear accumulation of beta-catenin (C).	p(HGNC:WNT3A)	directlyDecreases	act(p(HGNC:GSK3B))
a518be58-e8be-4641-aea7-5e4fe4afe2a8	1.0	PubMed	25691573	Specifically, Wnt5a was reported to promote GSK3beta independent degradation of beta-catenin in the regulation of limb development (XREF_BIBR).	p(HGNC:WNT5A)	directlyDecreases	act(p(HGNC:GSK3B))
39846d5c-c2ee-468a-8d3f-256a37e3ed53	1.0	PubMed	22193544	In this study, we demonstrated that WWOX enhances retinoic acid (RA)-mediated neurite outgrowth and identified a novel mechanism through which WWOX promotes neurite outgrowth by interacting with and suppressing GSK3beta kinase activity in the presence of RA.	p(HGNC:WWOX)	directlyDecreases	act(p(HGNC:GSK3B))
39846d5c-c2ee-468a-8d3f-256a37e3ed53	1.0	PubMed	22193544	GSK3beta kinase activity is negatively regulated by WWOX.	p(HGNC:WWOX)	directlyDecreases	act(p(HGNC:GSK3B))
39846d5c-c2ee-468a-8d3f-256a37e3ed53	1.0	PubMed	22193544	The microtubule assembly will eventually be promoted by Tau when GSK3beta is inhibited by WWOX during RA stimulated neuronal cell differentiation.	p(HGNC:WWOX)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	25749038	Wnt and beta-catenin pathway was reported to inhibit GSK3beta activity through an unknown mechanism [XREF_BIBR].	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	5534018	Wnt signaling inhibits GSK3beta activity and this blocks degradation, allowing beta-catenin to accumulate and signal.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	5523997	Wnt stimulation inactivates glycogen-synthase kinase-3beta (GSK-3) with subsequent stabilization of beta-catenin, which after heterodimerizing with lymphocyte enhancer factor-1 and T-cell factor cofactors stimulates transcription.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	24901051	Activation of Wnt signaling inhibits GSK3beta activity, leading to nuclear beta-catenin accumulation and increased gene expression, including oncogenes such as cyclin D1 and Myc.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	12408868	Wnt signaling inhibits GSK3beta activity.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	26744382	In the canonical Wnt and beta-catenin signalling pathway, Wnt ligands binding to Frizzled receptors activate Dvl to inhibit GSK-3beta, which stabilizes beta-catenin.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	25679396	Canonical Wnt signaling promotes degradation of GSK-3beta by ubiquitin-proteasome system, which in turn leads to accumulation of Slug (Snail2).	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	5344212	Neither Wnt nor dishevelled causes depletion but instead they reduce GSK3beta specific activity.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	22123293	Besides inducing beta-catenin-dependent regulation of target genes, the suppression of Gsk3beta by Wnt also leads to beta-catenin-independent up-regulation of mTOR activity.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	12000790	Wnt signaling is considered to prevent GSK-3beta from phosphorylating beta-catenin, thus causing its stabilization.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	19524533	Activation of Wnt signaling pathway inhibits GSK3beta and stabilizes unphosphorylated beta-catenin that accumulates in the nucleus, binds to T-cell factor (TCF) family of transcription factors and promotes target gene expression.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	10477752	Wnt signaling inhibits the activity of GSK3beta (Cook et al. 1996) and leads to the stabilization of cytoplasmic hypophosphorylated beta-catenin, which is able to interact with lymphocyte enhancer factor 1/T-cell factor (Lef-1 and Tcf) transcription factors and the complex can act as a transcriptional coactivator in the nucleus (Behrens et al. 1996; Huber et al. 1996; Molenaar et al. 1996; Papkoff et al. 1996).	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	12408825	Binding of Wnt to its receptor prevents GSK-3beta from phosphorylating beta-catenin.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	23874688	Wnt signalling inactivates GSK3beta through the phosphorylation of the Ser9 residue and prevents it from phosphorylating beta-catenin, thus stabilising beta-catenin in the cytoplasm XREF_BIBR.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	16930546	Mutations of APC or beta-catenin and activation of the Wnt signal inhibit GSK-3beta activity and induce beta-catenin stabilization.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	20519433	Activation of Wnt signaling inhibits GSK3beta, leading to accumulation of nonphosphorylated beta-catenin, which binds Tcf/Lef family of transcription factors and induces target gene expression.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	21575861	Thus, GSK3beta inhibition by autocrine Wnt activation could in theory lead to increased CDC25A protein stabilization.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	19100874	Activation of Wnt pathway inhibits GSK3beta activity leading to cytosolic accumulation and nuclear import of beta-catenin.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	6329679	Wnt signaling is considered to prevent GSK-3beta from phosphorylating beta-catenin, thus causing its stabilization.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	23312883	If the APC is mutated or GSK3beta activity is blocked by Wnt signaling, beta-catenin will not be degraded and will translocate into nucleus leading to the activaton of beta-catenin dependent transcription.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	27333045	It was reported that the Wnt signaling pathway inhibits GSK3beta and stabilizes beta-catenin, which translocates to the nucleus to engage LEF and TCF transcription factors, resulting in induction of a gene expression program that promotes EMT (XREF_BIBR).	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	16815294	Activation of the Wnt signaling pathway inactivates GSK-3beta and leads to accumulation of beta-catenin.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	22556133	The interaction of Wnt with its receptor on the plasma membrane of most mammalian cells inhibits the activity of GSK-3beta.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	19124717	Wnt signals block GSK-3beta activity thereby stabilizing beta-catenin, which then translocates to the nucleus and interacts with TCF and lymphocyte enhancer binding factor (LEF) to promote gene transcription (XREF_BIBR - XREF_BIBR).	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	25848952	However, Wnt has also been shown to promote mTOR activity by preventing the activation of the TSC complex through two mechanisms : the inhibition of GSK3beta, which is a known activator of the TSC complex, and the activation of the small GTPase Rac1 [XREF_BIBR].	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	14672538	Activation of the Wingless and Wnt signaling pathway inhibits GSK3beta and stabilizes beta-catenin [XREF_BIBR, XREF_BIBR].	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	22086512	XREF_BIBR However, WNT activation inhibits GSK-3beta, and beta-catenin is then able to avoid degradation and accumulate in the cytoplasm.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	10021369	Wnt signalling decreases the activity of GSK-3beta.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	26501139	It has been well established that activation of the canonical Wnt pathway inhibits GSK-3beta from phosphorylating beta-catenin, resulting in the accumulation of active beta-catenin polypeptide species that translocate into the nucleus.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	19107203	It is well established that Wnt signaling reduces GSK3beta activity during development of the Xenopus embryo XREF_BIBR, and that the suppressed activity of GSK3beta induces a second body axis in the Xenopus embryo in the response to Wnt XREF_BIBR.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	20708603	Activation of Wnt signaling inhibits GSK3beta, leading to accumulation of non phosphorylated beta-catenin, which binds Tcf/Lef family of transcription factors and induces target gene expression.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	15454084	Wnt signaling inhibits the kinase activity of GSK3beta, allowing beta-catenin to accumulate in the cytoplasm and to translocate to the nucleus.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	23612487	Activation of the Wnt signaling pathway induces the stabilization of cytoplasmic beta-catenin by inhibiting GSK-3beta, followed by the accumulation in the cytoplasm and therefore translocation into the nucleus to regulate the expression of its target genes in collaboration with TCF and lymphoid enhancer binding factor (LEF).	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	25265336	Wnt signaling inactivates GSK3beta through the phosphorylation of Ser9 residue and prevents it from phosphorylating beta-catenin, thus stabilizing GSK3beta in the cytoplasm XREF_BIBR.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	19784072	If the APC is mutated or GSK-3beta activity is blocked by Wnt signaling, beta-catenin will not be phosphorylated, and will translocate into the nucleus (XREF_BIBR).	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	18606491	Activation of Wnt signaling inhibits GSK3beta and stabilizes cytoplasmic beta-catenin, qualifying beta-catenin as a proto-oncogene.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	18606491	Wnt signaling inactivates GSK3beta and prevents it from phosphorylating beta-catenin, thus stabilizing beta-catenin in the cytoplasm.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	24244294	Wnt signals inhibit GSK3beta kinase activity to stop degradation and force a rapid increase in the levels of free, cytosolic beta-catenin, and very soon thereafter, translocates into the nucleus where it binds to TCF/Lef transcription factors XREF_BIBR, XREF_BIBR.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	18419788	16 In contrast, Wnt signalling activation inhibits GSK-3beta, resulting in beta-catenin accumulation in the nucleus which activates the transcription of target genes.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	18804163	GSK-3beta can also be inhibited by Wnt signaling through a distinct mechanism, leading to reduced phosphorylation and accumulation of the transcription factor beta-catenin.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	18804163	In contrast to its regulation by Ser9 phosphorylation, Wnt signaling negatively regulates GSK-3beta activity by disrupting a protein complex that juxtaposes GSK-3beta with its substrate in this pathway, beta-catenin.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
dbd6f0f6-9220-445a-a200-b43fc56f2ece	1.0	PubMed	17822871	When the Wnt pathway is activated by a Wnt ligand or chemical compounds inactivate GSK3beta, the intracellular pool of beta-catenin accumulates and translocates to the nucleus where it activates the transcription factor T-cell factor (TCF), thereby regulating the expression of downstream Wnt target genes.	p(FPLX:Wnt)	directlyDecreases	act(p(HGNC:GSK3B))
77eb2ad6-7d4b-4844-98d8-46382a55c053	1.0	PubMed	19298526	The binding of Wnt to Frizzled activates Dishevelled (Dsh), often antagonizes GSK-3beta activities, and leads to the stabilization of beta-catenin [XREF_BIBR].	complex(p(FPLX:Wnt), p(PFAM:PF01534))	directlyDecreases	act(p(HGNC:GSK3B))
ce90dcdb-4d7d-4f76-8a95-c7de48489120	1.0	PubMed	19475691	Similarly, HBx expression has recently been shown to inhibit GSK-3beta activity as well, which allows beta-catenin to accumulate in the cytoplasm of HCC cells (XREF_BIBR).	p(UP:Q157B2)	directlyDecreases	act(p(HGNC:GSK3B))
da5da3fd-3388-4661-ae10-39e75849cc20	1.0	PubMed	3997457	In cholinergic neurons, betaA impaired acetylcholine synthesis without affecting choline acetyltransferase activity, which suggests that PDH is inactivated by betaA induced TPKI and GSK-3beta.	a(PUBCHEM:187)	directlyDecreases	act(p(HGNC:GSK3B))
d4e68913-a16b-4fe2-a2c6-3422bc9b270e	1.0	PubMed	24374173	We also observed that celecoxib inhibited exogenous PGE2 induced beta-catenin accumulation in the nucleus and inhibited activation of GSK-3beta; however, the mechanism of GSK-3beta inactivation by celecoxib is unknown.	a(CHEBI:41423)	directlyDecreases	act(p(HGNC:GSK3B))
ffee8e3b-6cce-4ddd-b7f4-bb498b5f826f	1.0	PubMed	22262776	Specifically, GSK3beta activity and nuclear import were increased by imatinib mesylate (IM), a selective ABL inhibitor, but prevented by dasatinib that targets both BCR-ABL- and cytokine dependent MAPK and p60-SRC activity.	a(CHEBI:49375)	directlyDecreases	act(p(HGNC:GSK3B))
14cfae91-dd95-48d7-8cfa-105f984f2f61	1.0	PubMed	28097141	Our findings verified that emodin could inhibit the EMT via ILK and GSK-3beta signaling pathway in EOC cells.	a(CHEBI:42223)	directlyDecreases	act(p(HGNC:GSK3B))
44f3ad83-8e7b-4c46-b955-48dc1927008d	1.0	PubMed	PMC6396718	Our results support the idea that both mood stabilizers inhibit GSK-3beta in developing neurons through different pathways.	a(CHEBI:77966)	directlyDecreases	act(p(HGNC:GSK3B))
bb1a3e79-dc13-4804-951b-0c658f9bf87e	1.0	PubMed	6180953	Importantly, although genistein and LiCl each inhibit GSK-3beta activity, neither prevented the phosphorylation of serine 133 induced by PTH.	a(CHEBI:28088)	directlyDecreases	act(p(HGNC:GSK3B))
3de821de-1bf7-4e5f-902f-12d71b25923c	1.0	PubMed	17959258	Nerve growth factor (NGF) promotes axonal elongation via the p75 neurotrophin receptor (p75NTR) and also inactivates GSK-3beta.	p(UP:Q776B5)	directlyDecreases	act(p(HGNC:GSK3B))
f3962db8-e6f9-40c0-8809-619df4f984d2	1.0	PubMed	25340789	Moreover, although it is well-known that during latency LANA-1 inhibits GSK-3beta XREF_BIBR, we saw no effect of de novo infection on GSK-3beta activity (XREF_SUPPLEMENTARY), making this pathway unlikely to be involved in Nrf2 activation at the observed stage of infection.	p(UP:Q65DC4)	directlyDecreases	act(p(HGNC:GSK3B))
94cad4fc-fb6e-4186-808f-1f428d0be623	1.0	PubMed	12592400	LANA stabilizes beta-catenin by binding to the negative regulator GSK-3beta, causing a cell cycle dependent nuclear accumulation of GSK-3beta.	complex(p(UP:Q65DC4), p(HGNC:GSK3B))	directlyDecreases	act(p(HGNC:GSK3B))
fecf5ba3-9b2f-4bde-93f9-53230f7b3675	1.0	PubMed	22520842	In human alveolar macrophages, bacterial lipopolysaccharide (LPS) exposure activates PI3-K and Akt, inactivates GSK-3beta, and causes accumulation of beta-catenin in the nucleus of any cell and expression of genes that require nuclear beta-catenin for their activation [XREF_BIBR].	a(CHEBI:16412)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	4445512	Our data indicate that this activation of the wnt pathway is a consequence of inhibition of GSK-3 beta by lithium.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	4445512	Using a novel assay for GSK-3 beta in oocytes, we show that lithium inhibits GSK-3 beta from species as diverse as Dictyostelium discoideum and Xenopus laevis, providing a biochemical mechanism for the action of lithium on the development of these organisms.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	5169198	Further, lithium which inhibits the cytoplasmic kinase GSK3beta and hence influences beta-catenin levels did cause differentiation of NTERA2 cells.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	20190034	GSK-3beta inhibition by lithium or SB-216763 increased cell size, protein synthesis, and contractile protein expression.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	15456937	Our studies propose a new mechanism by which lithium indirectly inhibits GSK-3beta via phosphatidylinositol 3 kinase- dependent activation of PKC-alpha.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	23185275	In a previous study, we showed that GSK-3beta activity can be inhibited by lithium, causing elongation of primary cilia XREF_BIBR.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	4051147	In support of this hypothesis, lithium treatment phenocopies loss of GSK-3 beta function in Xenopus and Dictyostelium.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	19717166	It has been shown by many investigators that lithium, a mood stabilizing drug, inhibits GSK-3beta activity and that the neurotrophic and beneficial effects of lithium may be related to its effect on GSK-3beta ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	19717166	This observation does not support the hypothesis that lithium produces its therapeutic effects by inhibiting GSK-3beta.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	17692821	Since lithium is known to inhibit GSK-3beta, we examined Snail1 expression after GSK-3beta activity was inhibited with lithium.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	20654575	To determine the involvement of lithium induced GSK3beta inhibition on TCF7L2-RNA expression and patterns, GSK3beta down-regulation by specific si-RNA duplexes was undertaken as previously described [XREF_BIBR].	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	22099458	The finding that DISC1 directly inhibits GSK3beta is interesting given that the common mood stabilizer drug lithium, and the schizophrenia risk gene Akt, also inhibit GSK3beta which results in activation of canonical Wnt signaling, suggesting it may be an important target in psychiatric disease.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	6079836	Heterozygous mbl embryos showed increased sensitivity to inhibition of GSK3beta by lithium or dn Xgsk3beta that led to the loss of eyes.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	23619527	Recent evidence showed that both lithium and IGF-1 inhibit GSK-3beta in breast cancer cells through two different mechanisms : IGF-1 activates the PI3K and AKT and extracellular signal regulated kinases (ERK) pathways while lithium directly inhibits GSK-3beta through a magnesium-competitive mechanism.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	6613937	The latter finding, along with previous reports that lithium directly inhibits GSK3beta, reveals the possibly unique situation where a single target, GSK3beta, is inhibited by two independent mechanisms, directly and by phosphorylation following lithium administration, and further, that two mood stabilizers have inhibitory effects on GSK3beta.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	6396718	Recent studies suggest that lithium and VPA inhibit GSK-3beta, a serine/threonine kinase involved in the insulin and WNT signaling pathways.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	6396718	In vitro kinase assays show that therapeutic concentrations of VPA do not inhibit GSK-3beta but that therapeutic concentrations of lithium partially inhibit GSK-3beta activity.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	27978525	Moreover, GSK3beta is inhibited by the antidepressant lithium.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	25041379	It was first shown by Klein and Menton (XREF_BIBR) that lithium causes inhibition of GSK-3beta activity.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	25041379	It was shown by Gould et al. (XREF_BIBR) that lithium treatment inhibited GSK-3beta in brain of rats.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	25041379	The initial evidence was provided by the observation of Klein and Melton (XREF_BIBR) and other investigators (XREF_BIBR, XREF_BIBR, XREF_BIBR) indicating that lithium causes an inhibition of GSK-3beta activity both in vitro and in vivo.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	20015462	The discovery that lithium directly inhibits GSK-3beta by possibly competing with magnesium for association with the kinase introduced the idea that this effect may be involved in the therapeutic mechanism of lithium in mood disorders ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	17433504	On the contrary, inhibition of GSK-3beta by lithium (a general inhibitor) and SB216763 (a specific GSK-3beta inhibitor) suppressed the immunoreactivity of I with increases of PP-2A activity and decreases of tau phosphorylation.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	23768967	Ding et al. also demonstrated that unbound GSK-3beta and Axin bound GSK-3beta participated in different signaling pathways (GSK-3beta in PI3-K and insulin signaling, Axin bound GSK-3beta in Wnt signaling), indicating the wide ranging effects of GSK-3beta activity within a cell.Almost 20years ago the mood stabilizing drug lithium (Li), often used to treat manic depression, was found to inhibit GSK-3beta.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	24992082	Our finding that GSK3B haplotype 1 (T-A) was associated with a higher lithium response may suggest that patients with the T allele of -50 T/C (rs334558), which gives greater transcriptional activity, are more affected by lithium, which inhibits GSK-3beta activity.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	22615875	Moreover, GSK3beta inhibition by lithium treatment showed that MENA mRNA levels increase concurrently with the cytosolic accumulation of beta-catenin (XREF_FIG).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	17397930	In human neuroblastoma SH-SY5Y cells, inhibition of GSK3beta by lithium causes increased Myc nuclear protein levels ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	16987514	reported that NMDA treatment of cortical and hippocampal neurons caused the dephosphorylation of Ser9 on GSK3beta via the activation of PP1 which was blocked by lithium treatment.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	16026766	These effects were reversed by administration of lithium, which inhibited GSK3beta and significantly reduced dopamine dependent locomotor behavior.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	20226637	From a pharmacological perspective, is a prime candidate gene for bipolar disorder (BD, MIM 125480) because lithium inhibits GSK3beta in vitro () and because GSK3beta inhibitors reverse the neuroanatomical and behavioral abnormalities induced by expression silencing in mice ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	21514616	Tat induces GSK-3beta activity, which can be reversed by the addition of the GSK-3beta inhibitor lithium (XREF_BIBR).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	17628506	Antidepressants, lithium and other mood stabilizers may restore adequate signaling by inhibiting GSK3B and thereby inducing increased transcription factor activity.The patients in this study were participants of GAP phases 2 and 3 which aimed at evaluating the efficacy of algorithm guided treatments and investigating treatment options more tailored to the individual needs of a patient ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	19576885	In particular, GSK-3beta phosphorylates MAPs, participating in regulation of microtubule stability.It was shown that inhibition of GSK-3beta by lithium affects the formation and possibly the length of flagella in.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	19576885	Given that microtubule binding of MAP1B leads to microtubule stabilization, microtubule disassociation of MAP1B after lithium treatment could possibly decrease microtubule stability raising the question as to how lithium inhibition of GSK-3beta activity could promote growth of the primary cilium.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	24677591	Recent data support further evidences for the GSK3B protein as the target of lithium therapy in vivo and demonstrates that lithium disrupts the stabilizing effect of the GSK3B protein on the beta, arrestin-2, Akt, and PP2A complex (XREF_BIBR).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	20624590	This is interesting given that one of the actions of lithium, the most common mood disorder drug, is to inhibit GSK3beta (XREF_BIBR; XREF_BIBR) and activate TCF/LEF dependent gene transcription (XREF_BIBR).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	23640485	This increase in SmgGDS when GSK-3beta is inactivated by SB216763 or lithium is consistent with the presence of several putative GSK-3beta phosphorylation sites in SmgGDS identified by the eukaryotic linear motif program (http://elm.eu.org).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	26476274	Alternatively, lithium inhibition of GSK3B stabilizes Cav1.2 by reducing protein turnover (), suggesting another way that lithium could amplify Ca signals.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	19286457	Finally, the anti-proliferative action of NOV was abolished when GSK3-beta activity was blocked by lithium or SB216763, a selective ATP-competitive inhibitor of GSK3 (D) ().	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	21435461	The two molecules inhibit GSK-3beta through different mechanisms : lithium directly inhibits GSK-3beta by competing with magnesium but not with substrate or ATP, whereas Sb-216763 inhibits GSK-3beta in an ATP-competitive manner.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	19688630	In relation to the treatment of HAND, the mood stabilizers lithium and sodium valproate have both been shown to inhibit GSK3beta activity (XREF_BIBR; XREF_BIBR).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	26979166	It should be noted though that GSK3beta inhibition by lithium in these models is just a symptomatic treatment and does not stop the underlying pathological processes.	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
0550b506-2340-40b9-8f9b-6995b2a05bec	1.0	PubMed	22415718	Interestingly, lithium, which inhibits GSK-3beta and enhances beta-catenin stability, has been shown to protect rat neurons from Abeta induced damage (XREF_BIBR; XREF_BIBR).	a(PUBCHEM:28486)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	21056029	However, lithium chloride (LiCl) treatment inactivates GSK3beta mimicking Wnt activation, leading to beta-catenin accumulation and translocation to the nucleus.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	20454507	Previous studies have shown that lithium chloride (LiCl) is a pharmacological inhibitor of GSK3beta, with inhibition correlating with increased phosphorylation of GSK3beta at serine 9 [18].	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	22364879	We treated differentiating Caco-2 cells with lithium chloride (LiCl), which selectively inhibits GSK3beta activity ().	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	25979842	To confirm the mechanisms responsible for the GSK-3beta-dependent degradation of c-Jun, control shRNA and CD44 shRNA cells were treated with lithium chloride (LiCl), which inhibits GSK-3beta activity.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	21772333	To investigate the integrity of Wnt signalling in MCF10AT and Rama37 cells, we tested the Top and Fop glow reporter activity in Rama37 and MCF10AT cells treated with lithium chloride (LiCl), which inhibits GSK-3beta and thereby increases the stability of beta-catenin (XREF_BIBR), or sodium chloride (NaCl) as a control.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	24367688	In our previous study, we found that lithium chloride (LiCl), which inhibited glycogen synthase kinase 3beta (GSK-3beta) activity in vivo and vitro, and mimicked the biochemical effect of Wnt signaling by leading to stabilization of beta-catenin protein, up-regulated Notch3 signaling, and Notch3 siRNA weakened the effects of LiCl on the cell cycle of NSCLC cell lines [XREF_BIBR].	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	23673211	Previous study indicated that cisplatin resistance in ovarian cancer had been attributed to inhibition of GSK-3beta by lithium chloride and it is possible that a mechanism is responsible for regulating the expression of p53 negatively.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	21952626	Pharmacological inhibition of GSK3beta by lithium chloride treatment mimicked effects of Cdc42 in promotion of PARP cleavage and/or apoptosis.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	15492040	Short-term inhibition of GSK3beta by lithium chloride (LiCl; under 4 h at 10 mM) mimics the Wnt effect on beta-catenin, i.e., beta-catenin preferentially binds TCF-GST greater than cad-GST (XREF_FIG B, lanes 1 and 2).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	21295697	Wounds on WT skin were treated with either lithium chloride (LiCl) which directly inhibits GSK3beta, or Wortmannin, which activates GSK3beta by inhibiting an upstream regulator, phosphoinositol-3 kinase (PI3K).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	24314188	Mouse neuroblastoma cells, treated by lithium chloride to inhibit GSK-3beta, accumulate beta-catenin protein and differentiate morphologically.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	18806787	Wnt signaling was activated using Wnt-3a ligand or lithium chloride (an inhibitor of GSK-3beta that mimics Wnt activation) and inhibited using Wnt-3a plus DKK1, a competitive antagonist of Wnt-3a (XREF_FIG and XREF_SUPPLEMENTARY).	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	6270308	In addition, when GSK-3beta activity was inhibited by lithium chloride, both c-fos promoter activity and protein levels increased.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	19286457	Moreover, the decreased levels of phosphorylated GSK3-beta and N-Myc induced by NOV were abolished when cells were pre-treated 15min with lithium chloride (C), which is routinely used to inhibit GSK3-beta activity ().	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
fdc2a8aa-5275-4080-a4fd-0cbe81c87223	1.0	PubMed	19928349	XREF_BIBR To examine the dynamic nature of proteins bound to the c-myc enhancer element, various transcription coregulators were immunoprecipitated from mouse myoblast cells (C2C12) treated with lithium chloride (an inhibitor of GSK3beta in the destruction complex) to increase beta-catenin levels.	a(PUBCHEM:433294)	directlyDecreases	act(p(HGNC:GSK3B))
dce7564a-a4e6-47cc-92b0-b199dc9dca5f	1.0	PubMed	23640485	Because it is known that the reduced mevalonate biosynthesis is one of the mechanisms of activation of the PI3K and Akt pathway by statins, 28 we hypothesized that statins activate PI3K and Akt pathway through mevalonate, which in turn inhibits GSK-3beta.	a(PUBCHEM:449)	directlyDecreases	act(p(HGNC:GSK3B))
5b4464b4-9b04-465e-8bb0-1218cea2ca5f	1.0	PubMed	21524889	Consistent with above findings, we also found that minoxidil inactivates GSK3beta, an upstream effector of beta-catenin, leading to activation of beta-catenin pathway (a).	a(PUBCHEM:4201)	directlyDecreases	act(p(HGNC:GSK3B))
96a88b41-d5e7-4c2b-994c-2b2d47a0baf5	1.0	PubMed	25396735	XREF_BIBR provided evidence that hypoxia dependent changes occur through a biphasic mechanism involving a very early and reactive oxygen species (ROS)-dependent inhibition of GSK-3beta followed by early Snail 1 nuclear translocation, also involving the nuclear translocation of beta-catenin.	a(CHEBI:25806)	directlyDecreases	act(p(HGNC:GSK3B))
1a4b115e-a7e5-4f29-902a-d879655bedad	1.0	PubMed	22496417	p38 MAPK has also been shown to inactivate GSK-3beta directly by a phosphorylation at Ser 389 (XREF_BIBR), and a report by XREF_BIBR) suggests that Wnt induced inactivation of GSK-3beta is a result of p38 dependent phosphorylation at Ser 9.	p(FPLX:p38)	directlyDecreases	act(p(HGNC:GSK3B))
1a4b115e-a7e5-4f29-902a-d879655bedad	1.0	PubMed	22496417	p38 MAPK has also been shown to inactivate GSK-3beta directly by a phosphorylation at Ser 389 (XREF_BIBR), and a report by XREF_BIBR) suggests that Wnt induced inactivation of GSK-3beta is a result of p38 dependent phosphorylation at Ser 9.	p(FPLX:p38)	directlyDecreases	act(p(HGNC:GSK3B))
1a4b115e-a7e5-4f29-902a-d879655bedad	1.0	PubMed	20849862	GSK-3beta is also inhibited by the PI-3 '-kinase pathway through PKB and Akt, and also by the MEK and ERK and p38 MAPK pathways, PKA, p90 RSK / MAPKAP kinase-1, and S6 kinase (XREF_BIBR; XREF_BIBR).	p(FPLX:p38)	directlyDecreases	act(p(HGNC:GSK3B))
714b9892-3c59-4b0a-bfc6-41f53b25f20d	1.0	PubMed	23710442	PAN Induced Suppression of p-GSK3beta.	p(UP:Q9YAC7)	directlyDecreases	act(p(HGNC:GSK3B))
714b9892-3c59-4b0a-bfc6-41f53b25f20d	1.0	PubMed	23710442	PAN decreases podocyte p-GSK3beta at 12.5 mug/mL, and expression progressively decreased as PAN concentrations increased (50, 70, and 100mug/mL).	p(UP:Q9YAC7)	directlyDecreases	act(p(HGNC:GSK3B))
10744d65-eb07-4d09-901b-11616b4030cd	1.0	PubMed	6362558	These include the phosphatidylinositol 3-kinase/Akt cell survival pathway, which inhibits GSK-3beta activity.	a(PUBCHEM:53477912)	directlyDecreases	act(p(HGNC:GSK3B))
3928e495-035b-4eff-b6eb-f2b0750c383c	1.0	PubMed	25360740	Based on previous reports XREF_BIBR and our findings reported here, we suggest that mimicking TNFalpha mediated inflammation XREF_BIBR in prostate cells results in a significant increase in pAkt (S473), which consequently inhibits GSK3beta kinase activity by increasing the phosphorylation from (S9) residue (XREF_FIG).	p(UP:P54644)	directlyDecreases	act(p(HGNC:GSK3B))
3928e495-035b-4eff-b6eb-f2b0750c383c	1.0	PubMed	23301033	As expected, AKT-DN also reduced the level of the phosphorylated form of GSK-3beta compared to the vector control (XREF_FIG).	p(UP:P54644)	directlyDecreases	act(p(HGNC:GSK3B))
e8d39250-c146-4be5-9ea3-33ce6217403a	1.0	PubMed	20152177	Active aPKC regulates the cortical recruitment of Dlg1 and inactivates GSK3beta through serine 9 phosphorylation, leading to the association of Adenomatous Polyposis Coli (APC) with microtubule plus ends at the leading edge and subsequent centrosome polarization and nuclear translocation ().	p(UP:Q19266)	directlyDecreases	act(p(HGNC:GSK3B))
e8d39250-c146-4be5-9ea3-33ce6217403a	1.0	PubMed	25518939	At the leading edge of migrating cells, activated aPKC inactivates GSK-3beta, thereby allowing several MT associated proteins, such as adenomatous polyposis coli (APC), to accumulate at and stabilize MTs; this is followed by the formation of an asymmetric MT network.	p(UP:Q19266)	directlyDecreases	act(p(HGNC:GSK3B))
e8d39250-c146-4be5-9ea3-33ce6217403a	1.0	PubMed	25292215	The Cdc42 pathway relies on phosphorylation of kinase GSK3beta on Ser 9 by an a typical protein kinase C (aPKC), which inhibits GSK3beta and reverses its inhibitory effect on APC (XREF_BIBR).	p(UP:Q19266)	directlyDecreases	act(p(HGNC:GSK3B))
95f73be3-0137-4a85-b3e8-09d7b1713abb	1.0	PubMed	20926667	Interestingly, loss of presenilin has also been shown to increase GSK3beta kinase activity, leading to GSK3beta mediated phosphorylation of the motor protein kinesin to promote its release from its membrane bound cargoes during anterograde axonal transport (XREF_BIBR; XREF_BIBR).	p(PFAM:PF01080)	directlyDecreases	act(p(HGNC:GSK3B))
faba5f4a-2f2d-4ca9-b250-9032927cf4f5	1.0	PubMed	23211630	Taken together, these results show that Y27632 decreases bFGF induced proliferation of SH-SY5Y cells.Lithium (Li), commonly used as a mood stabilizer, is a specific inhibitor of GSK-3beta ().	bp(GO:"GO:0008283")	directlyDecreases	act(p(HGNC:GSK3B))
501bed29-fb3f-4855-bb77-b8581acfb58d	1.0	PubMed	19688630	In relation to the treatment of HAND, the mood stabilizers lithium and sodium valproate have both been shown to inhibit GSK3beta activity (XREF_BIBR; XREF_BIBR).	a(PUBCHEM:923)	directlyDecreases	act(p(HGNC:GSK3B))
ab04aad2-c5b1-4667-a065-9160ff8fef5e	1.0	PubMed	26766591	GSK-3beta deletion was induced by tamoxifen.	a(CHEBI:41774)	directlyDecreases	act(p(HGNC:GSK3B))
dde63192-6288-46ac-81fc-fe444f0128bc	1.0	PubMed	23301033	Mechanistic studies indicated Tat activates PI3K and AKT, and inactivates PTEN and GSK-3beta in vIL-6 expressing cells.	p(UP:P04608)	directlyDecreases	act(p(HGNC:GSK3B))
f679731f-8ca4-47ed-8639-2d864fff2554	1.0	PubMed	22102280	We report here that tideglusib inhibits GSK-3beta irreversibly, as demonstrated by the lack of recovery in enzyme function after the unbound drug has been removed from the reaction medium and the fact that its dissociation rate constant is non significantly different from zero.	a(PUBCHEM:11313622)	directlyDecreases	act(p(HGNC:GSK3B))
469171c1-1b53-4eed-98ff-6298187c1523	1.0	PubMed	5245188	In contrast to full-length axin, which has been shown to antagonize Wnt signaling, the GID inhibits GSK-3beta in vivo and activates Wnt signaling.	p(UP:Q8UET6)	directlyDecreases	act(p(HGNC:GSK3B))
0700d46c-7431-4713-851b-3d51cba394cc	1.0	PubMed	19688630	In relation to the treatment of HAND, the mood stabilizers lithium and sodium valproate have both been shown to inhibit GSK3beta activity (XREF_BIBR; XREF_BIBR).	a(PUBCHEM:3121)	directlyDecreases	act(p(HGNC:GSK3B))
c30a785c-8802-49d5-be10-f68327e1c2b6	1.0	PubMed	PMC6396718	Recent studies suggest that lithium and VPA inhibit GSK-3beta, a serine/threonine kinase involved in the insulin and WNT signaling pathways.	a(CHEBI:39867)	directlyDecreases	act(p(HGNC:GSK3B))
c30a785c-8802-49d5-be10-f68327e1c2b6	1.0	PubMed	PMC6396718	Lithium directly inhibits GSK-3beta in contrast to VPA, which inhibits GSK-3beta indirectly by an as-yet-unknown pathway.	a(CHEBI:39867)	directlyDecreases	act(p(HGNC:GSK3B))
27cb9f88-d2ab-424a-84e7-b309656a2118	1.0	PubMed	25041379	It was later shown by other investigators (XREF_BIBR) that valproic acid treatment, an anticonvulsant and a mood stabilizing drug, also directly inhibited GSK-3beta activity.	a(PUBCHEM:3121)	directlyDecreases	act(p(HGNC:GSK3B))
27cb9f88-d2ab-424a-84e7-b309656a2118	1.0	PubMed	21384147	In particular, lithium exerts a consistent inhibition of GSK3beta leading to beta-catenin stabilization while valproic acid inhibition of GSK3beta is cell-type-dependent and thus its effects on beta-catenin levels may also be cell-type-dependent (XREF_BIBR).	a(PUBCHEM:3121)	directlyDecreases	act(p(HGNC:GSK3B))
9da80b4f-ce44-4bca-92b0-f5ac1c53d62f	1.0	PubMed	PMC6376961	Treatment of HEK-293 cells with zinc enhanced glycogen synthase activity and increased the intracellular levels of beta-catenin, providing evidence for inhibition of endogenous GSK-3beta by zinc.	a(CHEBI:27363)	directlyDecreases	act(p(HGNC:GSK3B))
43ef6a28-67de-43cd-b75f-d971d7bf2639	1.0	PubMed	27696293	The messenger RNA (mRNA) expression, protein expression, and promoter methylation of the RECK gene, as well as the expression of GSK3beta, phospho and total beta-catenin, and c-myc, were measured by RT-PCR, bisulphate modification-PCR, immunohistochemistry, and Western blot analysis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RECK, pmod(Me))
5fbe95ef-e5d0-4c48-886a-004e7abe47cc	1.0	PubMed	25219467	Upregulation of GSK-3beta promotes the methylation of PP2Ac and increases its phosphatase activity toward tau, whereas downregulation of PP2Ac elevates Ser9 phosphorylation of GSK-3beta and inhibits the kinase activity.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PPP2C, pmod(Me))
5fbe95ef-e5d0-4c48-886a-004e7abe47cc	1.0	PubMed	25219467	These data demonstrated that GSK-3beta promotes PP2Ac methylation both invitro and invivo.To further confirm the role of GSK-3beta in PP2Ac methylation, we used siRNA to knockdown GSK-3beta expression specifically (A and B) and measured PP2Ac methylation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PPP2C, pmod(Me))
5fbe95ef-e5d0-4c48-886a-004e7abe47cc	1.0	PubMed	25219467	In the present study, we found that GSK-3beta promoted PP2Ac methylation by suppressing PME-1 expression and phosphorylating LCMT-1, resulting in an increase of PP2A activity toward tau.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PPP2C, pmod(Me))
b2b4141b-bab9-4bc0-99db-81dad93f989b	1.0	PubMed	25219467	These results suggest that the methylation of PP2A by GSK-3beta depends on its kinase activity.To learn the role of PP2A on Ser9 phosphorylation of GSK-3beta, we overexpressed PP2Ac tagged with HA in HEK-293FT cells and then measured phosphorylation of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PPP2, pmod(Me))
b2b4141b-bab9-4bc0-99db-81dad93f989b	1.0	PubMed	25219467	In this study we found that GSK-3beta promoted PP2A methylation and consequently increased PP2A activity.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PPP2, pmod(Me))
d42d9a8c-3c3f-4b6c-aa57-f70086f26030	1.0	PubMed	25219467	We found that OA treatment significantly increased GSK-3beta Ser9 phosphorylation (C), confirming the regulation of GSK-3beta Ser9 phosphorylation by PP2A.The previously mentioned results showed that GSK-3beta regulated PP2Ac methylation and inhibition of GSK-3beta significantly enhanced PP2Ac demethylation.	p(FPLX:PPP2C)	directlyIncreases	p(HGNC:GSK3B, pmod(Me))
d42d9a8c-3c3f-4b6c-aa57-f70086f26030	1.0	PubMed	25219467	But, by which GSK-3b regulates PME-1 expression remains to be studied.By using a series of pharmacologic and molecular biological approaches, we consistently found that upregulation of GSK-3beta promoted PP2Ac methylation and downregulation of GSK-3beta promoted PP2Ac demethylation.	p(FPLX:PPP2C)	directlyIncreases	p(HGNC:GSK3B, pmod(Me))
57e108df-f2ae-44c9-ad54-77f9e4c72f54	1.0	PubMed	25219467	In the present study, by using pharmacologic and molecular biological approaches, we clearly demonstrated both in cultured cell and invivo that 3beta promotes PP2A methylation and inhibition of GSK-3beta led to demethylation of PP2Ac.By phosphorylation prediction analysis, PME-1 and LCMT-1 are putative phosphor proteins.	p(FPLX:PPP2)	directlyIncreases	p(HGNC:GSK3B, pmod(Me))
ca75312e-76b1-4a76-a8c3-1e5fed7d29d9	1.0	PubMed	24813896	In agreement with these results, adiponectin treatment alone did not stimulate the tyrosine phosphorylation of IRbeta and IRS1 or the serine/threonine phosphorylation of Akt and GSK3beta (XREF_FIG).	p(HGNC:ADIPOQ)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b664ebf9-e077-4bc4-815d-aa3a4ca8bedc	1.0	PubMed	7088620	AM gene transfer increased phosphorylation of Akt and glycogen synthase kinase (GSK-3beta) but reduced GSK-3beta and caspase-3 activities in the heart.	bp(MESH:D000650)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
694739f9-9d25-43ac-b1f5-44750f047570	1.0	PubMed	18930955	In presenilin-1 familial AD mutations, the PI3K and Akt pathway is inhibited, thus promoting GSK-3beta activity and tau phosphorylation, and in turn promoting tau pathology (XREF_BIBR).	p(PFAM:PF09793, var(p.?))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c7ad7f35-5875-40d2-83d0-82c85397642f	1.0	PubMed	26446840	A subsequent study showed that XB130 modulates phosphorylation of the PI3K and Akt downstream targets p21Cip1 and WAF1, p27Kip1, FOXO3a, and GSK3beta and activation of caspase 8 and 9, thereby regulating cell proliferation and survival in WRO and TPC-1 human thyroid cancer cells and A549 human lung cancer cells (XREF_BIBR; XREF_BIBR).	p(HGNC:AFAP1L2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
fd4989a8-1280-43a4-aadc-24e70b68696d	1.0	PubMed	18782353	In agreement with the consensus that GSK3beta is located downstream of PI3K and Akt in the signalling pathway, pre-treatment of AGS cells with pharmacologic PI3K inhibitor completely blocked H. pylori induced phosphorylation of GSK3beta (XREF_FIG).	a(PUBCHEM:135103)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0197eae5-eabc-4799-9f9e-4e7e42878912	1.0	PubMed	20599907	In our study, we found that Angiotensin II stimulated the phosphorylation of GSK3beta (Ser9) in H9c2 cells (A).	p(HGNC:AGT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
44bf0df7-5eb4-4c36-a737-67bf4fb9a2de	1.0	PubMed	15910743	In accordance with its inhibitory effect on NF-AT (), AICAR significantly reduced phosphorylations of GSK-3beta at serine 9 in PMA/Io activated Jurkat cells (D).	a(CHEBI:18406)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
4c5187c0-9572-455f-90c2-4112add44787	1.0	PubMed	19429119	Leptin or AICAR treatment of these cells significantly increased the levels of GSK-3beta phosphorylation (pSer 9) (lanes 3-4, 6-7) compared to vehicle (lane 2) and untransfected controls (lane 1).	a(CHEBI:18406)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4c5187c0-9572-455f-90c2-4112add44787	1.0	PubMed	19429119	However, both Leptin and AICAR treatments significantly (p < 0.05) blocked these increases (lanes 6-7) presumably by increasing GSK-3beta phosphorylation and thereby leading to its inactivation.	a(CHEBI:18406)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4c5187c0-9572-455f-90c2-4112add44787	1.0	PubMed	15910743	Importantly, AICAR did reduce phosphorylation of GSK-3beta in these cells.	a(CHEBI:18406)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4c5187c0-9572-455f-90c2-4112add44787	1.0	PubMed	15910743	In cells stimulated with PMA/Io, GSK-3beta is phosphorylated at Ser9, which abrogates its enzyme activity; by reducing phosphorylation of GSK-3beta, AICAR restores its ability to phosphorylate NF-AT.	a(CHEBI:18406)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8dccc47d-25c0-4950-bb90-5d79bb27ff7b	1.0	PubMed	15910743	In accordance with its inhibitory effect on NF-AT (), AICAR significantly reduced phosphorylations of GSK-3beta at serine 9 in PMA/Io activated Jurkat cells (D).	a(CHEBI:18406)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
4338528d-564b-4a78-baca-56d5ad23896a	1.0	PubMed	26415504	Notably, AIF knockdown appeared to reduce Akt-S473 and GSK-3beta phosphorylations in the PC3 cells, suggesting that additional factors impinge on the functional connections between AIF, Akt, and GSK3-3beta in the PTEN deficient cells.	p(HGNC:AIFM1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a286b3ac-058e-4343-9188-75f6ecfa8af3	1.0	PubMed	21890631	It was shown that AKAP220 mediated anchoring of PKA facilitates phosphorylation of GSK-3beta on serine 9 to suppress the activity of this kinase (XREF_BIBR).	p(HGNC:AKAP11)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
01d4d650-8e0b-4985-b79c-035840e04009	1.0	PubMed	21890631	It was shown that AKAP220 mediated anchoring of PKA facilitates phosphorylation of GSK-3beta on serine 9 to suppress the activity of this kinase (XREF_BIBR).	p(HGNC:AKAP11)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
150f134f-ac2b-4177-a947-4923915d1d6e	1.0	PubMed	10729337	No evidence text.	p(HGNC:AKT1, pmod(Ph, Ser, 473), pmod(Ph, Thr, 308), pmod(Ph, Tyr, 474))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
150f134f-ac2b-4177-a947-4923915d1d6e	1.0	PubMed	15207235	No evidence text.	p(HGNC:AKT1, pmod(Ph, Ser, 473), pmod(Ph, Thr, 308), pmod(Ph, Tyr, 474))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
e45550b7-5057-4311-add7-f899f7270da2	1.0	PubMed	9582355	No evidence text.	p(HGNC:AKT1, pmod(Ph, Ser, 473), pmod(Ph, Thr, 308))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
26d9480e-0feb-4b05-b28d-641682ccf9bf	1.0	PubMed	8524413	No evidence text.	p(HGNC:AKT1, pmod(Ph, Thr, 308))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
01502bd4-9549-4f7d-baa2-0fba4c7951d2	1.0	PubMed	21334395	It has been shown that AKT2 preferentially phosphorylates GSK3alpha while AKT1 and AKT3 phosphorylate GSK-3beta.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
01502bd4-9549-4f7d-baa2-0fba4c7951d2	1.0	PubMed	21334395	AKT2 preferentially phosphorylates GSK3alpha while AKT1 and AKT3 phosphorylate GSK3beta.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
01502bd4-9549-4f7d-baa2-0fba4c7951d2	1.0	PubMed	19841191	In keeping with its prosurvival role, stimulation of CCR7 induced phosphorylation and inhibition of GSK3beta, which was mediated by the prosurvival regulator Akt1, but it was independent of ERK1/2, a key regulator of chemotaxis.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
01502bd4-9549-4f7d-baa2-0fba4c7951d2	1.0	PubMed	24838891	Interestingly, Akt1 plays a predominant role in the phosphorylation of GSK3beta in LNCaP cells.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
01502bd4-9549-4f7d-baa2-0fba4c7951d2	1.0	PubMed	10385529	No evidence text.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
01502bd4-9549-4f7d-baa2-0fba4c7951d2	1.0	PubMed	18523275	No evidence text.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
01502bd4-9549-4f7d-baa2-0fba4c7951d2	1.0	PubMed	15353558	No evidence text.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
01502bd4-9549-4f7d-baa2-0fba4c7951d2	1.0	PubMed	26294429	Reduced Akt1 activity decreases inhibitory phosphorylation of GSK-3beta, resulting in increased phosphorylation of VDAC.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
612f426c-2365-42e9-b275-6af093519da4	1.0	PubMed	9373175	Evidence that the inhibition of glycogen synthase kinase-3_ by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
612f426c-2365-42e9-b275-6af093519da4	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
612f426c-2365-42e9-b275-6af093519da4	1.0	PubMed	19166821	No evidence text.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b28cf060-76e6-4851-a5c2-bc7cfdd5f2a5	1.0	PubMed	15026145	PKB-alpha inactivates and phosphorylates GSK-3beta at Ser.	p(HGNC:AKT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
6f6f73ff-9084-4efd-bc12-626b6d360324	1.0	PubMed	21045156	Phosphorylation of GSK3beta and expression of various cyclins were also restored by expression of constitutively active AKT2 (XREF_FIG).	p(HGNC:AKT2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6f6f73ff-9084-4efd-bc12-626b6d360324	1.0	PubMed	23900341	AKT2 overexpression increased phosphorylation of GSK3beta in BE (2)-C cells transfected either with vector control of pcDNA-His-GLI1.	p(HGNC:AKT2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d9070ac1-1a3d-4d5d-83f5-fdb5483004dc	1.0	PubMed	9712142	No evidence text.	p(HGNC:AKT2, pmod(Ph, Ser, 474), pmod(Ph, Thr, 309))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
8d2618cf-f22b-4c03-b072-7f30f1fa1032	1.0	PubMed	16293724	We show that PGE2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor, EP2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase Akt by free G protein betagamma subunits and the direct association of the G protein alphas subunit with the regulator of G protein signaling (RGS) domain of axin. This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:AKT2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8d2618cf-f22b-4c03-b072-7f30f1fa1032	1.0	PubMed	24434510	8 On the other hand, Akt2 phosphorylation of Gsk3beta causes its inactivation, thereby removing its inhibitory effect on differentiation and hypertrophy.	p(HGNC:AKT2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8d2618cf-f22b-4c03-b072-7f30f1fa1032	1.0	PubMed	25059120	Knockdown of Akt2 using siRNAs or the PI3K inhibitor Ly294002 inhibited TGF-beta1-induced phosphorylation of GSK3beta and expression of Snail1.	p(HGNC:AKT2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
71a73261-8acc-4768-92c7-ced7fb9044c2	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:AKT2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
afc6f975-65a8-49ba-ab48-78b7c92daa4c	1.0	PubMed	21334395	It has been shown that AKT2 preferentially phosphorylates GSK3alpha while AKT1 and AKT3 phosphorylate GSK-3beta.	p(HGNC:AKT3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
afc6f975-65a8-49ba-ab48-78b7c92daa4c	1.0	PubMed	21334395	AKT2 preferentially phosphorylates GSK3alpha while AKT1 and AKT3 phosphorylate GSK3beta.	p(HGNC:AKT3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
afc6f975-65a8-49ba-ab48-78b7c92daa4c	1.0	PubMed	22814751	Because Akt3 -/- has reduced GSK-3beta phosphorylation, which presumably results in increased GSK-3beta activity, we sought to determine whether the spreading defect of Akt3 -/- platelets could be corrected by treatment with GSK-3beta inhibitor SB216763.	p(HGNC:AKT3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
aaddc07e-d182-4dd6-bc95-22ce7dc4ca42	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:AKT3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
9b741bdd-181a-4cb6-bfd1-52802ec6a34b	1.0	PubMed	25889792	Activating signals such as growth factors or TLR stimulation lead to phosphorylation of Akt that causes phosphorylation and thereby inhibition of GSK3beta.	p(FPLX:AKT, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9b741bdd-181a-4cb6-bfd1-52802ec6a34b	1.0	PubMed	26714756	Therefore, we speculate that in the presence of FTY720, there is a decrease in S1P 1 -mediated phosphorylation of Akt, which in turn decreases GSK3beta phosphorylation.	p(FPLX:AKT, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d3e8e6ab-1a4b-4576-9369-4a00df5a929d	1.0	PubMed	25979842	Serine 9 of GSK-3beta is phosphorylated by Akt, and GSK-3beta inactivation after phosphorylation of serine 9 is thought to be related to tumorigenesis.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
d3e8e6ab-1a4b-4576-9369-4a00df5a929d	1.0	PubMed	23768967	Subsequently, activated Akt phosphorylates GSK-3beta at serine 9, leading to the autoinhibition of GSK-3beta by binding of the N-terminal domain to a positively charged pocket in its catalytic site as a pseudosubstrate ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
d3e8e6ab-1a4b-4576-9369-4a00df5a929d	1.0	PubMed	24463007	Furthermore, phosphorylation of GSK3beta at Serine residue 9, mediated by AKT, was significantly increased, demonstrating downstream activity of AKT.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
d3e8e6ab-1a4b-4576-9369-4a00df5a929d	1.0	PubMed	19274078	Akt phosphorylates GSK3beta on serine 9 and GSK3alpha on serine 21 to inhibit their kinase activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	21435438	On activation, Akt phosphorylates and inactivates GSK3beta.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	22389405	Phosphorylation of GSK-3beta (inactivated) by activated Akt inhibits ubiquitylation of beta-catenin, leading to its nuclear translocation, which then induces the expression of MUC5AC and cyclin D1.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26141684	It is less possible that Akt is affected by midostaurin because this drug did not attenuate the phosphorylation of GSK-3beta by Akt, whereas it immediately inhibited the reaction medicated by PKC as indicated in this study.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	22340730	Second, increased Akt activation results in phosphorylation and inhibition of GSK3beta, resulting in decreased phosphorylation of PHLPP1 at serine 847.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	21986318	XREF_BIBR, XREF_BIBR) Cytoplasmic beta-catenin is degraded after it was phosphorylated by GSK3beta, which was shown to be phosphorylated and inactivated by Akt.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	25220377	This system may also underlie, at least in part, the mechanism behind the ability of hepatic insulin signaling to promote SREBP transcriptional activity because engagement of the insulin receptor promotes Akt dependent phosphorylation of GSK-3beta, a modification that inhibits its kinase activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	18487214	Although Akt activation leads to GSK-3beta phosphorylation and the subsequent expression of beta-catenin, activation of this pathway by 1-azakenpaullone was insufficient to stimulate the motile phenotype.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	19492080	It has also been reported that Akt may regulate Wnt signaling through Akt phosphorylation and inactivation of GSK3-beta, which in turn mediates beta-catenin degradation XREF_BIBR or, directly by phosphorylating beta-catenin on serine 552, promoting the nuclear translocation of beta-catenin XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	20648549	In conjunction with these changes, Akt transgenic mice showed elevations in phosphorylation of GSK3beta, Bad, FoxO, mammalian target of rapamycin (mTOR) and mTOR downstream signaling (e.g., eIF4G, eIF4E and S6K) both in the absence and presence of TPA treatment [XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	17949810	Since AKT directly phosphorylates and inhibits the activity of GSK3-beta thereby stabilizing beta-catenin levels, we wished to determine whether it played a role in KIT dependent tyrosine phosphorylation of beta-catenin.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26121043	GSK-3beta is phosphorylated and inactivated by Akt and p38 MAPK [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23103626	We hypothesize that the reduced phosphorylation of GSK-3beta, mediated by the inhibition of Akt signaling, contributes to enhanced beta-catenin degradation.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	25499217	Phosphorylation of GSK-3beta by Akt inactivates GSK-3beta and concurrent Mcl-1 degradation.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26514730	Similarly, WNT-5A induces migration in gastric cancer cells by activating PI3K and AKT pathway which phosphorylates and inactivates GSK-3beta and activates RhoA leading to cytoskeleton remodeling [XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	25622682	To explore the specific mechanism involved, we assessed the expression of total and phosphorylated Akt and GSK-3beta in hBM-MSC-conditioned ALCs, as previous studies have shown that PI3K and Akt signaling can promote GSK-3beta phosphorylation which then stabilizes beta-catenin [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	19019440	In our Jurkat cell line, constitutively active Akt was unable to phosphorylate GSK3-beta, in the absence of c-mip, but the inhibition of PI3K abolished the phosphorylation of GSK3-beta induced by c-mip.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	17190838	After activation, Akt phosphorylates GSK3beta and inhibits its activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23867821	We found that the inhibition of AKT reduced the phosphorylation of PRAS40, FOXO3a and GSK-3beta ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26643256	Akt phosphorylates GSK3beta and blocks its kinase activity, thereby allowing cyclin D1 to accumulate which could inhibit cells into S period from G1 phase.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23431386	Taken together, these results demonstrated that TNFalpha up-regulated Snail in HCT116 cells by activating AKT signaling that lead to the phosphorylation of GSK-3beta and subsequently stabilize Snail.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	27978525	GSK3beta is phosphorylated and thus inhibited by PKB and Akt.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23383245	Akt phosphorylates and inactivates GSK-3beta resulting in stabilization of cyclin D1 XREF_BIBR - XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26456864	We identified a novel positive-feedback loop mechanism via the INSM1 transcription factor that activated the PI3K and AKT signaling pathway, which subsequently induced phosphorylation of GSK3beta kinase and blocked GSK3beta kinase activity to stabilize N-myc.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	24038789	These results also demonstrate AKT activation by SDF1 does not directly regulate GSK3beta phosphorylation or activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26017781	It appeared that TNF-alpha suppressed the enzyme activity of GSK-3beta via Akt phosphorylation of GSK-3beta.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	18328427	PI3K activates AKT and PKB, which in turn is able to phosphorylate GSK3beta, leading to its inactivation.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	19071090	Recently, it was shown that DNA damage caused by ionizing radiation induced phosphorylation of GSK-3beta by Akt.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	24662006	There is evidence that PTEN and the TSC complex are negative regulators of the PI3K pathway, that Gsk3beta can be directly phosphorylated and inactivated by AKT, and that TSC is an upstream regulator of the mTOR/S6 signaling pathway ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	22814751	Akt dependent phosphorylation of GSK-3beta is a downstream mechanism of integrin outside-in signaling.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	22814751	In this study, we show that (1) Akt, as a downstream effector of PI3K, plays an important role in mediating integrin outside-in signaling leading to platelet spreading; (2) Akt promotes platelet spreading by phosphorylating and inhibiting GSK-3beta; and (3) activation of PI3K-Akt-GSK-3beta pathway is downstream from SFK and requires platelet secretion of ADP and ADP receptor signaling.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	20818790	Furthermore, inhibiting Akt activation using the PI3K inhibitor LY294002 completely prevented EPO+IGFI-I-induced Akt phosphorylation and GSK-3beta phosphorylation compared to control (see XREF_FIG), confirming the involvement of the PI3K/Akt/GSK-3beta pathway.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26320152	These redox sensitive p38 MAPK, ERK-1/2, and PI3K and Akt pathways can all induce GSK3beta phosphorylation (8, 15) and have been implicated in glucocorticoid insensitivity in COPD (5).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	25412261	In addition, we demonstrated that PKB phosphorylates GSK-3beta and decreases its activity, enhancing CREB stability and inducing IL-10 production, consistent with previous studies XREF_BIBR - XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	22137028	It is reported that Akt activates NFAT by phosphorylating and inactivating glycogen synthase kinase-3 beta, which phosphorylates NFAT and inhibits its nuclear import and DNA binding ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	18243662	Phosphorylation of GSK-3beta by Akt has also been reported in irradiated vascular endothelium.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	18243662	Thus, our data seem to be in contradiction to a recent finding of Viniegra et al. demonstrating that increased phosphorylation of GSK-3beta by activated Akt could be mediated through ATM in response to ionizing radiation.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	18280241	For example, RSK and Akt can phosphorylate GSK-3beta, tRNA methylase METTL1, andp27Kip1 at the same position ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	11483158	Phosphorylation of GSK3beta by PKB inhibits GSK3beta kinase activity [XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23301033	On the other hand, activated AKT phosphorylates and inactivates GSK-3beta to decrease phosphorylation of cyclin D1, and accordingly, triggering cell proliferation XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	18458160	First, GST-GSK3beta was phosphorylated by Akt, confirming that this Akt kinase activity was sufficient.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26714756	These results indicate that FTY720 inhibits beta-catenin accumulation by reducing Akt mediated inactivation and phosphorylation of GSK3beta.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23164509	In parallel, Akt can negatively regulate GSK-3beta activity and its phosphorylation, and in turn the activation of GSK-3beta brings the detachment of HK II by acting on VDAC.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	24157255	Activated Akt subsequently phosphorylated and suppressed GSK-3beta, which is the major kinase responsible for beta-catenin phosphorylation.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23349842	Akt phosphorylates GSK3beta to make it inactive XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23107073	Thus, localized activation of class I A PI-3 kinases and PIP 3 accumulation at the T. cruzi invasion site (XREF_BIBR) may influence the microtubule and IQGAP binding activity of CLASPs following Akt dependent phosphorylation of GSK3beta.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	20688159	Although GSK3beta can be directly phosphorylated by Akt and GSK3beta phosphorylation on Ser9 is often used as a marker for ectopic Akt expression, at least in MDA-MB-231 cells, forced expression of Akt1 did not increase GSK3beta phophorylation.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	20504360	Akt phosphorylates and inactivates GSK3beta, allowing beta-catenin, a downstream effector of Wnt pathway to translocate into the nucleus where it binds to TCF-4.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23029096	Thus, upstream activation of these signaling pathways leads to inactivating phosphorylation of GSK-3beta by PI3K and Akt to allow for translocation of active beta-catenin and Myc into the nucleus where, through association with various nuclear co-activator complexes, enable induction of a large number of genes including Myc itself XREF_BIBR, XREF_BIBR, and AP4, a transcriptional repressor of p21 XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	25714029	GSK3beta and Bad were the downstream substrates of AKT and can be phosphorylated by activated AKT.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	26538315	While SIRT2 overexpression in 3T3-L1 preadipocytes and HeLa cells enhanced insulin induced Akt activation and phosphorylation of its downstream targets GSK3beta and p70S6 kinase, pharmacological or genetic SIRT2 inhibition causes the opposite effect.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	25622907	Activation of PI3K-Akt and subsequent phosphorylation of GSK-3beta is significant here as a wealth of literature exists, across multiple tumor types, confirming the importance of GSK-3beta phosphorylation in stabilizing Snail so that it can translocate to nucleus and participate in transcriptional regulation.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	21447180	The phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is a major regulator of GSK-3beta where AKT phosphorylates and inactivates GSK-3beta [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23724143	However, phosphorylation of GSK-3beta by AKT inhibits this activity and thus directly influencing the stability of PHLPP1, resulting in a negative feedback loop to control AKT activation XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	21435438	The GSK3beta is a major downstream target of Akt, which can phosphorylate GSK3beta to make it inactive.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	25796170	On the other hand, the activated Akt can phosphorylate GSK3beta, and lead to promotion of glucose transport ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	22087308	Under these conditions, the PI3K and Akt pathway downstream of Jak2 is downregulated, thus reducing the inhibitory phosphorylation of GSK3beta.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	22087308	It was also noted that treatment of cells with etoposide or doxorubicin significantly reduced the inhibitory phosphorylation of GSK3beta, a target of Akt activated downstream of PI3K, particularly in the absence of Epo (XREF_FIG).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	24975844	The phosphorylation of Akt was also decreased in S100A4 overexpressing cell lines, indicating that decreased GSK3beta phosphorylation is mediated by decreased Akt kinase activity (B).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	18801732	Furthermore, AMPK mediated GSK3beta phosphorylation was inhibited by an Akt specific inhibitor in HepG2 cells, suggesting involvement of the Akt pathway.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	20018240	Inhibitory phosphorylation of GSK-3beta (by Akt and ILK) is essential for functional activation of NF-kappaB, Snail, and LEF-1 (XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	19303846	Growth factors such as insulin activate AKT, which in turn phosphorylates GSK3beta at Ser9, an inhibitory phosphorylation site (XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	18804163	GSK-3beta is phosphorylated and inhibited by Akt as part of the PI3K pathway.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	23651923	Active Akt phosphorylates GSK-3beta promoting its inactivation and, therefore, inhibits beta-catenin degradation (B).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	24498263	Abnormalities in the serine/threonine protein kinase, Akt, are closely related to the proliferative status of cells and induce phosphorylation of GSK3beta XREF_BIBR, XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1c92dd5e-808f-4184-be4a-1964b518fd8b	1.0	PubMed	16797529	Phosphorylation of GSK3beta by P-Akt inhibits GSK3beta activity, leading to an overall decrease in glycogen synthesis.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	21035499	Akt phosphorylates GSK-3beta at Ser 9, leading to inactivation of its kinase activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	25172662	Both Akt and Erks can phosphorylate GSK-3beta at the crucial Ser9 residue.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	15652488	Activated Akt phosphorylates GSK-3beta at Ser 9 and inactivates its kinase activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	22496417	The Ser/Thr kinases Akt, protein kinase A, and protein kinase C phosphorylate GSK-3beta on Ser 9, leading to its inactivation (XREF_BIBR; XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	18262492	Active Akt phosphorylates, among other targets, GSK3beta on Ser 9.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	18782353	As expected, Akt knock-down by Akt specific siRNA led to undetectable levels of GSK3beta (Ser 9) phosphorylation after H. pylori infection, but had no effect on H. pylori induced phosphorylation of PDK1 Ser 241.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	26121043	Ser 9 of GSK-3beta is phosphorylated by Akt and Thr 390 is phosphorylated by p38 MAPK, respectively.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	25979842	Since S9 of GSK-3beta is phosphorylated by Akt, we also examined the phosphorylation of Akt at S473, a hallmark of Akt activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	21334395	On the other hand, within the first minutes of LPS exposure, TLR4 activates phosphatidylinositol 3-kinase (PI3K) and its mediator AKT which induces phosphorylation of GSK3beta on Ser9 ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	21665151	Akt phosphorylates GSK3beta on Ser9, thereby creating a competitive pseudosubstrate that blocks substrate phosphorylation (XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	25622682	We also analyzed the expression of pho-Akt and pho-GSK-3beta in ALCs conditioned by hBM-MSCs, and found that both pho-Akt and pho-GSK-3beta increased before the accumulation of beta-catenin, which was consistent with previous studies showing that PI3K activated Akt can phosphorylate GSK-3beta at Ser 9, thereby inactivating GSK-3beta and triggering related signaling pathways [XREF_BIBR - XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	25491510	APP-kd cells displayed mitigated AKT activation which leads to decreased inhibitory phosphorylation of GSK3beta (Ser9) and FOXO1 (T24).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	23243000	We show that apo (a) increases phosphorylation of both sites for a full activation of Akt (XREF_FIG), which can then phosphorylate GSK-3beta at Ser 9 (XREF_FIG).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	21450369	These results indicate that activation of GSK-3 rather than Erk1/2 and p38 may play a pivotal role in the AGE induced tau hyperphosphorylation.It is well known that Akt can phosphorylate GSK-3beta at Ser9 and thus inhibit the kinase ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	19190323	It has been demonstrated that in response to certain growth stimuli XREF_BIBR, XREF_BIBR - XREF_BIBR, PI3K activated AKT can phosphorylate GSK-3beta at Ser9, leading to inactivation of GSK-3beta and augmentation of beta-catenin-TCF4 transcriptional activity XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	18675921	In the PI3K pathway Akt phosphorylates GSK3beta at Ser9 and blocks GS3Kbeta driven degradation of beta catenin.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	21887250	Since inhibiting the PI3K and Akt cascade resulted in decreased phosphorylation of GSK3beta Ser9 and increased MN differentiation from hNSCs, we then asked if the increase in HB9 expression was due to the increase in GSK3beta activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	24910204	It is well known that Erk and Akt can phosphorylate GSK-3beta at the Ser9 residue and inactivate its kinase activation [XREF_BIBR, XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	26252009	As shown in XREF_FIG, we found that embelin strongly prevented the phosphorylation of GSK-3beta on Ser 9 by Akt activation.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	26252009	Because it is suggested that Akt induces GSK-3beta phosphorylation on Ser 9 to promote GSK-3beta degradation through ubiquitin proteasome pathway, inhibition of Akt phosphorylation and activation by embelin partially contributes to the GSK-3beta activation and inhibition in the level of beta-catenin.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	22547702	We next used a selective Akt inhibitor to determine if Ser 9 phosphorylation of GSK3-beta was modulated by Akt activation (XREF_FIG B).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	19107203	Suppression of GS phosphorylation normally occurs when GSK3beta is phosphorylated at Ser9 by AKT as a part of the insulin and IGF -1 signaling pathway XREF_BIBR.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	25172557	Phosphorylation of GSK3beta at ser9 is exclusively mediated by the action of Akt.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	18191226	In turn, activated Akt phosphorylates GSK3beta, a constitutively active kinase, on the Ser 9 residue and renders it inactive ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	24366069	Interestingly, all these kinases have implications in the regulation of NRF2 stability and/or induction : i) the MEK inhibitor AZD6244, that inhibits MEK-ERK pathway (XREF_BIBR), reduced the K-Ras G12D -mediated Nrf2 induction in primary murine cells (XREF_BIBR); ii) AKT phosphorylates GSK3beta (S9) (XREF_BIBR, XREF_BIBR) to inhibit its kinase activity that phosphorylates NRF2 and induces its degradation by beta-TrCP-dependent ubiquitination (XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	24975844	Since Ser9 of GSK3beta is phosphorylated by Akt, we also examined the phosphorylation at Ser473, which is a hallmark for Akt kinase activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	19303846	Growth factors such as insulin activate AKT, which in turn phosphorylates GSK3beta at Ser9, an inhibitory phosphorylation site (XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	26374165	In this regard, we have shown that Akt is critical for the ability of RvD1 and RvD2 to induce Ser9 phosphorylation of GSK-3beta, thereby abrogating its inhibitory phosphorylation of C/EBPbeta and allowing unhindered expression of Del-1.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	27683053	Akt phosphorylates GSK-3beta at Ser 9, leading to inactivation of its kinase activity, and ILK can phosphorylate GSK-3beta at Ser 9 in Akt independent way [XREF_BIBR].	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bf3fb783-6ef7-40c1-bb4a-37f83588b227	1.0	PubMed	16039586	To prevent interference by Akt, which is also able to phosphorylate GSK-3beta at Ser9, the above 12 tumor tissues were preselected to be negative for phosphorylated Akt by IHC ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	24391209	Phosphorylation of GSK3beta by AKT at the N-terminal region serine 9 renders GSK3beta inactive (XREF_BIBR).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	14636889	Indeed, phosphorylation of the N-terminal serine 9 residue, a negative regulation site, of GSK3beta by Akt and PKB, is important for the inhibition of GSK3beta during insulin dependent glycogen synthesis and neuronal survival mediated through Akt.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	25979842	Serine 9 of GSK-3beta is phosphorylated by Akt, and GSK-3beta inactivation after phosphorylation of serine 9 is thought to be related to tumorigenesis.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	24815315	For instance, the binding of BDNF to the TrkB receptor activates PI3K and Akt pathway that leads to the phosphorylation of the N-terminal serine of glycogen synthase kinase-3 beta (GSK3beta) and a decrease of its activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	17050006	Binding experiments were conducted in the presence of FCS; conditions in which GSK3beta is phosphorylated at serine 9 by PKB.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	20357815	In addition, studies have reported that PKA and PKC, in addition to PKB and Akt, can phosphorylate GSK-3beta at serine 9 in some cell lines, leading to the inactivation of GSK-3beta activity (;).	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	23768967	Subsequently, activated Akt phosphorylates GSK-3beta at serine 9, leading to the autoinhibition of GSK-3beta by binding of the N-terminal domain to a positively charged pocket in its catalytic site as a pseudosubstrate ().	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	20934407	Moreover, both PKC and AKT activity can phosphorylate GSK-3beta at Ser, indicating an overlap in these signaling pathways.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	24463007	Furthermore, phosphorylation of GSK3beta at Serine residue 9, mediated by AKT, was significantly increased, demonstrating downstream activity of AKT.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	19726098	In response to insulin stimulation, phosphatidylinositol 3-kinase-activated Akt phosphorylates GSK3beta at Ser, which leads to inactivation of GSK3beta and augmentation of beta-catenin-TCF and LEF -1 transcriptional activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9d37e359-4bce-4a69-8ff4-ee6506a55b00	1.0	PubMed	19274078	Akt phosphorylates GSK3beta on serine 9 and GSK3alpha on serine 21 to inhibit their kinase activity.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
93658c61-c829-4b2b-9ec4-8844f45ce6c1	1.0	PubMed	26121043	Ser 9 of GSK-3beta is phosphorylated by Akt and Thr 390 is phosphorylated by p38 MAPK, respectively.	p(FPLX:AKT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr, 390))
81f46fcd-65b4-4017-bcff-666e6e5c0f05	1.0	PubMed	18801732	Although a previous study found TORC2 phosphorylation to be involved in the suppression of AMPK mediated CRE transcriptional activity, we herein present evidence that glycogen synthase kinase 3beta (GSK3beta) phosphorylation induced by AMPK also plays an important role.	p(FPLX:AMPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
81f46fcd-65b4-4017-bcff-666e6e5c0f05	1.0	PubMed	25778901	Therefore, the inhibitory phosphorylation of GSK3beta by AMPK contributes to mitochondrial protection.	p(FPLX:AMPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ddfbb3f8-9e81-456b-9f14-a53c51bc2696	1.0	PubMed	26274564	Our findings indicate that : loss of functional APC induces the expression of FAK and PYK2, elevated FAK and PYK2 phosphorylates GSK3beta Y216 to stabilize beta-catenin, which initiates and supports intestinal tumorigenesis (XREF_FIG).	p(HGNC:APC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
e4210516-a1bf-4551-a5d8-1e7737da12af	1.0	PubMed	21143984	T24 cell proliferation, MMP2 expression, Akt ser473 and thr308 phosphorylation, GSK3beta tyr216 phosphorylation, and beta-catenin ser45 and thr41 phosphorylation were all decreased by APF, whereas p53 expression, and beta-catenin ser33,37/thr41 phosphorylation, were increased by APF treatment in non electroporated and non target siRNA transfected cells.	p(UP:P22324)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
a1896320-7f6c-4e61-a3f4-471fa819d895	1.0	PubMed	26637371	Abeta suppresses the phosphorylation of GSK-3beta, leading to tau phosphorylation.	p(HGNC:APP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a1896320-7f6c-4e61-a3f4-471fa819d895	1.0	PubMed	21460223	On the contrary, several oligomeric Abeta forms, present in the soluble fractions of aged PS1xAPP mice, inhibited the induced phosphorylation of Akt and GSK-3beta and decreased the neuronal survival.	p(HGNC:APP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ffd3287d-9cdd-47a8-a3df-e9a2854cec7c	1.0	PubMed	24188406	The results indicated that curcumin inhibits Abeta induced tau phosphorylation at Thr231 and Ser396, over-expression of HDAC6, and decrease in phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) at Ser9.	p(HGNC:APP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
7522dbc4-178f-4814-9b64-593ffe07d90a	1.0	PubMed	22661511	Our objective was to investigate if AR mediates I/R injury by influencing phosphorylation of glycogen synthase kinase-3beta (p-GSK3beta).	p(HGNC:AR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
35d91a63-7eab-4186-92ef-f306e43c65b0	1.0	PubMed	25390651	Activation of the mK ATP channel induced inhibitory phosphorylation of GSK-3beta and suppressed ROS production, LDH release and apoptosis after AA washout.	a(CHEBI:15422)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
697ddacc-7883-4062-a86b-3bf6181c51fd	1.0	PubMed	19060929	The knockdown of AURKA reversed the phosphorylation of GSK-3beta and the beta-catenin protein levels.	p(HGNC:AURKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
697ddacc-7883-4062-a86b-3bf6181c51fd	1.0	PubMed	19060929	Furthermore, the in vitro kinase assay demonstrated phosphorylation of GSK-3beta by AURKA in a concentration dependent manner (XREF_FIG).	p(HGNC:AURKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
697ddacc-7883-4062-a86b-3bf6181c51fd	1.0	PubMed	19060929	These results confirm that AURKA can directly bind to and phosphorylate GSK-3beta.	p(HGNC:AURKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cf2b07ec-8412-47ea-961d-532073954a4a	1.0	PubMed	19060929	The recombinant human AURKA protein phosphorylated the GSK-3beta protein at Ser 9 in a concentration dependent manner, in vitro.	p(HGNC:AURKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
cf2b07ec-8412-47ea-961d-532073954a4a	1.0	PubMed	25115395	Previously, we and others showed that Aur-A phosphorylated GSK3beta at Ser9, thus inhibiting its kinase activity [XREF_BIBR, XREF_BIBR].	p(HGNC:AURKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
924bb321-8361-4eb8-aea2-ff2618b6126c	1.0	PubMed	23349801	From our previous report that activin A acts synergistically with FGF-2 in stimulating the phosphorylation of ERK-1/2 XREF_BIBR, we speculated that activin A may increase the phosphorylation of GSK-3beta synergistically with FGF-2.	p(FPLX:"Activin_A")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
924bb321-8361-4eb8-aea2-ff2618b6126c	1.0	PubMed	23349801	Addition of increasing concentrations of activin A with FGF-2 increased phosphorylation of both GSK-3beta and ERK-1/2 in a dose dependent manner in H9 hES cells (XREF_FIG, XREF_SUPPLEMENTARY).	p(FPLX:"Activin_A")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
924bb321-8361-4eb8-aea2-ff2618b6126c	1.0	PubMed	23349801	Addition of activin A increased phosphorylation of GSK-3beta and extracellular signal regulated kinase-1/2 (ERK-1/2) synergistically with FGF-2 whereas activin A alone did not.	p(FPLX:"Activin_A")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
924bb321-8361-4eb8-aea2-ff2618b6126c	1.0	PubMed	23349801	Addition of activin A increased phosphorylation of GSK-3beta and ERK-1/2 synergistically with FGF-2 whereas activin A alone did not induce phosphorylation of GSK-3beta.	p(FPLX:"Activin_A")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
72f0f8b1-3e72-4a81-b146-74b096f7b63e	1.0	PubMed	26136077	The CPP-BH3 BIM (I155R and E158S) peptide reduced the phosphorylation of GSK3beta, but not Akt itself (XREF_FIG), indicating that this peptide could have acted as a substrate of Akt.	p(HGNC:BCL2L11, var(p.Ile155Arg))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6be4e376-ea93-40fa-b504-59570dc170f5	1.0	PubMed	26136077	The CPP-BH3 BIM (I155R and E158S) peptide reduced the phosphorylation of GSK3beta, but not Akt itself (XREF_FIG), indicating that this peptide could have acted as a substrate of Akt.	p(HGNC:BCL2L11, var(p.Glu158Ser))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4c20139e-8375-4167-86b6-f640a9eebe93	1.0	PubMed	PMC6380695	BDNF also increased serine(9) -phosphorylation of GSK3beta, which inhibits GSK3beta activity.	p(HGNC:BDNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4c20139e-8375-4167-86b6-f640a9eebe93	1.0	PubMed	6380695	BDNF also increased serine (9) -phosphorylation of GSK3beta, which inhibits GSK3beta activity.	p(HGNC:BDNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
afa5080f-b6df-4a0d-942d-4a2451f0da41	1.0	PubMed	24387108	BEZ235 inhibited Akt, GSK3beta, and P70S6K phosphorylation at submicromolar range, consistent with its growth-inhibitory effects.	a(CHEBI:71952)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f8f77a0a-b828-409f-af3c-4080cb6a877e	1.0	PubMed	26452029	In addition, we overexpressed Bmi-1 in SW480 cells and inhibited Bmi-1 in HCT116 cells, and found Bmi-1 could promote cell growth (XREF_SUPPLEMENTARY) and activate Akt and GSK3beta phosphorylation (XREF_SUPPLEMENTARY).	p(HGNC:BMI1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
811a9654-c6b4-4bfb-9e78-eff861b6af36	1.0	PubMed	20190034	Unlike epidermal growth factor, BMP-4, TGF-beta1, 5-HT, and ET-1 each increased smooth muscle cell size, contractile protein expression, fractional cell shortening, and GSK-3beta phosphorylation.	p(HGNC:BMP4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
87b0c34e-cf50-423e-bdb6-b1e66583067a	1.0	PubMed	25738875	Previous studies have shown that PIP induces the phosphorylation of Akt and PKB and GSK3beta, and the enforced expression of ILK induces the phosphorylation of Akt and GSK3beta [XREF_BIBR, XREF_BIBR].	a(CHEBI:28765)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6e3ccc69-d805-42e3-acde-f3bd0533b295	1.0	PubMed	25347529	The logic was based on some interesting observations, such as, beta-TrCP committed to degrade the GSK3beta phosphorylated DNA methyl transferase 1 (DNMT1) is prevented by tobacco specific carcinogen NNK induced beta-TrCP translocation to the cytoplasm with the help of heterogeneous nuclear ribonucleoprotein U (hnRNP-U) XREF_BIBR.	p(HGNC:BTRC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c1e3003f-2bc6-4c22-90da-8cc15eb8e39c	1.0	PubMed	26522589	These findings suggest that depleting Bub1 decreased RHAMM expression, which, in turn, enhanced inhibitory phosphorylation of GSK3beta.	p(HGNC:BUB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d1a1a735-6f21-43b2-964d-66fae48063db	1.0	PubMed	26452029	We then silenced Bmi-1 expression in Hes1 expressing SW620 cells using RNAi, and found inhibition of Bmi-1 abrogated Hes1 protection of colon cancer cells from apoptosis and reduced the accelerated cell growth in vitro and in vivo, we also found Akt activation and GSK3beta phosphorylation induced by Hes1.	p(HGNC:GATD3A)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d1a1a735-6f21-43b2-964d-66fae48063db	1.0	PubMed	26452029	Here, results indicated that Hes1 downregulated PTEN, and promoted Akt activation and GSK3beta phosphorylation in colon cancer cells.	p(HGNC:GATD3A)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
3b3da113-a6ad-452e-985e-6b1cdfc05256	1.0	PubMed	20357815	Therefore, we were interested in whether cAMP could also phosphorylate GSK-3beta at serine 9 in human skin fibroblasts.	a(CHEBI:17489)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
3b3da113-a6ad-452e-985e-6b1cdfc05256	1.0	PubMed	20357815	However, the phosphorylation of GSK-3beta at serine 9 by cAMP was significantly reduced by pretreatment with H-89, indicating that cAMP phosphorylates GSK-3beta at serine 9 via PKA in human skin fibroblasts ().	a(CHEBI:17489)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
c154fb71-4cdb-47cc-baac-4471a0bf4db4	1.0	PubMed	20357815	Therefore, we were interested in whether cAMP could also phosphorylate GSK-3beta at serine 9 in human skin fibroblasts.	a(CHEBI:17489)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
c154fb71-4cdb-47cc-baac-4471a0bf4db4	1.0	PubMed	20357815	However, the phosphorylation of GSK-3beta at serine 9 by cAMP was significantly reduced by pretreatment with H-89, indicating that cAMP phosphorylates GSK-3beta at serine 9 via PKA in human skin fibroblasts ().	a(CHEBI:17489)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
a29c4614-0dc6-49b4-8648-aba2ff481917	1.0	PubMed	27057280	The downstream signals AKT and GSK-3beta mediated CCL21 induced the upregulation of Snail due to the fact that CCL21 treatment can obviously phosphorylate both AKT and GSK-3beta.	p(HGNC:CCL21)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a29c4614-0dc6-49b4-8648-aba2ff481917	1.0	PubMed	27057280	The results revealed that CCL21 significantly phosphorylated AKT and GSK-3beta but not other molecules in HCT116 cells (XREF_FIG).	p(HGNC:CCL21)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a29c4614-0dc6-49b4-8648-aba2ff481917	1.0	PubMed	27057280	Consistent with our suppose, LY 294002 also reversed CCL21 induced Snail upregulation (XREF_FIG) and GSK-3beta phosphorylation (XREF_FIG).	p(HGNC:CCL21)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6da22a86-2242-40f0-bd2e-eb8d07a369db	1.0	PubMed	19841191	They also suggest that upon stimulation of CCR7, Akt mediated phosphorylation and inhibition of GSK3beta may be required to allow complete translocations of FOXO and NF-kappaB that confer DCs an extended survival.	p(HGNC:CCR7)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9e87d39e-3ac0-49a8-b545-eadd0712991c	1.0	PubMed	26022178	Using a model of NK cell activation through combination of NKG2D and 2B4 that couple to different signaling adaptors, we found that an inhibitory phosphorylation of GSK-3beta at Ser9 was induced in common by the engagement of NKG2D, 2B4, or their combination.	p(HGNC:CD244)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
9e87d39e-3ac0-49a8-b545-eadd0712991c	1.0	PubMed	26022178	Stimulation of either NKG2D or 2B4 alone induced GSK-3beta phosphorylation at Ser9 largely through the PI3K and Akt- or MEK and ERK dependent pathway, respectively.	p(HGNC:CD244)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
f09595fe-218c-47ed-8ccd-a79ec232bfcf	1.0	PubMed	23649588	Examining CD44 regulated signal pathways in these cells we show that CD44, and also RHAMM, act to inhibit phosphorylation of glycogen synthase kinase 3beta (GSK3beta).	p(HGNC:CD44)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d68b9f11-6edc-4eae-86f4-8a7696e14618	1.0	PubMed	25979842	We found that CD44 knock-down decreased phosphorylation of GSK-3beta at S9 indicating an increase in the active form of GSK-3beta, which could then induce degradation of c-Jun (A).	p(HGNC:CD44)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
cfe12621-b620-480d-a975-af03a8660fc3	1.0	PubMed	20658693	In contrast, phosphorylation of Gsk3beta by a Cdc42 dependent mechanism promotes Apc microtubule interactions and thus leads to cell shape changes that accompany cellular migration (XREF_BIBR; XREF_BIBR).	p(HGNC:CDC42)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cfe12621-b620-480d-a975-af03a8660fc3	1.0	PubMed	PMC6687293	Cdc42-dependent phosphorylation of GSK-3beta occurs specifically at the leading edge of migrating cells, and induces the interaction of adenomatous polyposis coli (Apc) protein with the plus ends of microtubules.	p(HGNC:CDC42)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cfe12621-b620-480d-a975-af03a8660fc3	1.0	PubMed	6687293	Cdc42 dependent phosphorylation of GSK-3beta occurs specifically at the leading edge of migrating cells, and induces the interaction of adenomatous polyposis coli (Apc) protein with the plus ends of microtubules.	p(HGNC:CDC42)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e648626c-0695-4a64-a6f8-948a56fcf09e	1.0	PubMed	19676131	33 Herein, CDH17 knockdown in HCC decreased GSK-3beta phosphorylation, accompanied by a concomitant reduction of cyclin D1 and induction of Rb.	p(HGNC:CDH17)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e648626c-0695-4a64-a6f8-948a56fcf09e	1.0	PubMed	23554857	Herein, CDH17 knockdown decreased beta-catenin and GSK-3beta phosphorylation, accompanied by a concomitant increase of Rb and reduction of Cyclin D1 in gastric cancer.	p(HGNC:CDH17)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e648626c-0695-4a64-a6f8-948a56fcf09e	1.0	PubMed	23554857	In addition, CDH17 knockdown increased P53 expression; a possible mechanism would be that CDH17 knockdown leads to reduced GSK-3beta phosphorylation, which in turn activates p53 dependent apoptosis and antagonizes tumor growth XREF_BIBR.	p(HGNC:CDH17)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2bb9b489-f585-4530-a78b-b6ec07f88ce2	1.0	PubMed	25500144	Taken together, these findings demonstrate that CCRK phosphorylates GSK-3beta to activate a beta-catenin/TCF/E2F1 transcriptional cascade for EZH2 up-regulation.	p(HGNC:CDK20)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b5e625af-2176-4fe6-aa74-69ad529a7028	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:CDK4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f87e50d3-77bc-4c77-a9f0-1b882811360c	1.0	PubMed	20166136	Glycogen synthase kinase-3beta (GSK-3beta) phosphorylates Snail and promotes its export from the nucleus and subsequent degradation by the proteosome in the cytosol, while p21 activated kinase (PAK1) can also phosphorylate Snail at a different residue from GSK-3 beta to promote its nuclear localization and, thus, its activity as a transcription factor (XREF_BIBR - XREF_BIBR).	p(HGNC:CDKN1A)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a4b4e840-3589-4e0b-80ae-924752c71e4e	1.0	PubMed	26531156	Depletion of either Cks1 or Cks2 promotes AKT and GSK-3beta phosphorylation in HepG2 cells.	p(HGNC:CKS1B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a4b4e840-3589-4e0b-80ae-924752c71e4e	1.0	PubMed	26531156	The results revealed that depletion of either Cks1 or Cks2 reduced AKT and GSK-3beta phosphorylation (XREF_FIG).	p(HGNC:CKS1B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
79a23da4-f9bb-44a9-8196-f42674131c64	1.0	PubMed	26531156	Depletion of either Cks1 or Cks2 promotes AKT and GSK-3beta phosphorylation in HepG2 cells.	p(HGNC:CKS2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
79a23da4-f9bb-44a9-8196-f42674131c64	1.0	PubMed	26531156	The results revealed that depletion of either Cks1 or Cks2 reduced AKT and GSK-3beta phosphorylation (XREF_FIG).	p(HGNC:CKS2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9f9c1654-a324-4aad-a187-fc6277b84913	1.0	PubMed	19019440	On the other hand, the overexpression of c-mip induced the phosphorylation of GSK3-beta and thus its inactivation.	p(HGNC:CMIP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0293e421-680f-4b8e-8f3b-9309dd5f7146	1.0	PubMed	19019440	In our Jurkat cell line, constitutively active Akt was unable to phosphorylate GSK3-beta, in the absence of c-mip, but the inhibition of PI3K abolished the phosphorylation of GSK3-beta induced by c-mip.	p(HGNC:CMIP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ed02a074-92dd-44fd-9c9b-118d97c9eb97	1.0	PubMed	27020460	As described above, we found that exogenous CO may effectively abolish the significant elevations in PI3K, Akt and GSK-3beta production and phosphorylation in LPS stimulated platelets.	a(CHEBI:17245)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ed02a074-92dd-44fd-9c9b-118d97c9eb97	1.0	PubMed	27020460	However, exogenous CO administration clearly inhibited GSK-3beta phosphorylation, indicating that exogenous CO directly or indirectly inhibits GSK-3beta activation.	a(CHEBI:17245)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c104c6a0-f978-4b15-9d9d-211d08ec6069	1.0	PubMed	10493495	In addition, CR-1 was found to induce the phosphorylation of GSK-3beta.	p(HGNC:CR1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c104c6a0-f978-4b15-9d9d-211d08ec6069	1.0	PubMed	10493495	Phosphorylation of AKT and GSK-3beta by CR-1 can be blocked by LY294002, a specific inhibitor of PI3K, thus leading to apoptosis.	p(HGNC:CR1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c104c6a0-f978-4b15-9d9d-211d08ec6069	1.0	PubMed	5256753	In addition, CR-1 was found to induce the phosphorylation of GSK-3beta.	p(HGNC:CR1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c104c6a0-f978-4b15-9d9d-211d08ec6069	1.0	PubMed	5256753	Phosphorylation of AKT and GSK-3beta by CR-1 can be blocked by LY294002, a specific inhibitor of PI3K, thus leading to apoptosis.	p(HGNC:CR1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4fe5d6b2-77b9-4f84-a958-4235e042d895	1.0	PubMed	21976528	In cultured neurons, CRF 1 activation initiates CREB signaling which leads to phosphorylation of GSK3beta (XREF_BIBR; XREF_BIBR).	p(FPLX:CREB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2a7d578d-de8e-4c84-bce9-1a43db657918	1.0	PubMed	25238260	Also, Western blot analysis revealed that CTHRC1 could promote the phosphorylation of GSK-3beta at Ser9.	p(HGNC:CTHRC1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
c78f99c2-0be0-4b4d-8fca-a1eb84967c92	1.0	PubMed	18463684	However, phosphorylation of GSK-3beta was suppressed by LY294002 treatment and the total amount of beta-catenin and its targets c-Myc and cyclin-D1 decreased ().	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c78f99c2-0be0-4b4d-8fca-a1eb84967c92	1.0	PubMed	17822871	Inactivation of Notch by siRNA in cells led to a significant increase in TCF activation; and over-expression of Notch reduced the ectopic Wnt and TCF activation that was induced by over-expression of a degradation resistant beta-catenin lacking the GSK3beta phosphorylation site.	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2078da33-d076-4103-8c14-8b7230851af5	1.0	PubMed	19682504	Similar to other Hsp90 client proteins, total GSK3beta protein is decreased, along with the phosphorylation of the GSK3beta target beta-catenin in the presence of GA..	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2078da33-d076-4103-8c14-8b7230851af5	1.0	PubMed	25218472	Overexpression and mutations in the regulatory region of beta-catenin prevent GSK3beta dependent phosphorylation, which in turn leads to stabilization of beta-catenin and an interaction between beta-catenin and T-cell factor (TCF)/lymphocyte enhancer factor (LEF).	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2078da33-d076-4103-8c14-8b7230851af5	1.0	PubMed	21143984	Akt mediates its downstream effects via phosphorylation and inactivation of GSK3beta ser9, with subsequently decreased phosphorylation of the GSK3beta target beta-catenin, resulting in increased beta-catenin nuclear translocation, binding to T-cell factor, and stimulation of gene expression related to cell proliferation and survival [XREF_BIBR, XREF_BIBR].	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2078da33-d076-4103-8c14-8b7230851af5	1.0	PubMed	18641688	Wnt stimulation results in the inhibition of GSK3beta mediated beta-catenin phosphorylation and activation of GSK3beta mediated phosphorylation of Axin and the Wnt co-receptor LRP5/6 (XREF_BIBR).	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2078da33-d076-4103-8c14-8b7230851af5	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2078da33-d076-4103-8c14-8b7230851af5	1.0	PubMed	16039586	Moreover, in breast cancer cell line MDA-MB-231 and hepatoma cell line Hep3B, growth factor IGF-1 can lead to beta-catenin upregulation and phosphorylation of Erk and GSK-3beta (Ser9).	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d5769504-a373-4404-9f32-843636d45172	1.0	PubMed	26219398	Compared with the negative control, TACC3 down-regulation led to decreased GSK3beta (Ser 9) phosphorylation and beta-catenin down-regulation, whereas total GSK3beta-levels remained unchanged.	p(HGNC:CTNNB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
f745eb21-49e6-48e6-be5e-66aadb803030	1.0	PubMed	6895213	Addition of SDF-1 to a human neuronal cell line induces phosphorylation of p44 and p42 MAP kinase and GSK3beta.	p(HGNC:CXCL12)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
480f89fb-97d6-4cea-acdc-1f73fefd3c1e	1.0	PubMed	24038789	Conversely, SDF1 treatment increased GSK3beta Y216 phosphorylation as would be expected based on the effect of chronic AMD3100 in vivo (XREF_FIG).	p(HGNC:CXCL12)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
480f89fb-97d6-4cea-acdc-1f73fefd3c1e	1.0	PubMed	24038789	As SDF1 mediated CK1alpha downregulation is shown above to markedly attenuate beta-catenin phosphorylation to facilitate its increased stability and SDF1 leads to increased GSK3beta Y216 phosphorylation that increases activity, we were interested in determining whether direct inhibition of GSK3beta would have an impact on proliferation.	p(HGNC:CXCL12)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
480f89fb-97d6-4cea-acdc-1f73fefd3c1e	1.0	PubMed	24038789	SDF1 also increased GSK3beta Y216 phosphorylation responsible for increased activity.	p(HGNC:CXCL12)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
480f89fb-97d6-4cea-acdc-1f73fefd3c1e	1.0	PubMed	24038789	SDF1 also increased GSK3beta Y216 phosphorylation to facilitate increased activity.	p(HGNC:CXCL12)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
ec725f2d-3cd9-4998-baa9-40ac4c7b5edd	1.0	PubMed	25462858	In addition, we found that suppression of Akt activation by LY294002 remarkably attenuated CXCR2 and CXCL5 axis elicited GSK-3beta phosphorylation and snail expression in HCC cells ().	p(HGNC:CXCL5)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a6e50e29-6e51-4fc2-984c-2fa583e48154	1.0	PubMed	17412687	Down-regulation of endogenous XB130 with siRNA reduced c-Src activity, IL-8 production, EGF induced phosphorylation of Akt and GSK3beta, and altered cell cycles in human lung epithelial cells.	p(HGNC:CXCL8)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2951e716-0b67-4ee2-89bd-22dba492d1eb	1.0	PubMed	25462858	In addition, we found that suppression of Akt activation by LY294002 remarkably attenuated CXCR2 and CXCL5 axis elicited GSK-3beta phosphorylation and snail expression in HCC cells ().	p(HGNC:CXCR2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8c15d427-2866-487f-a439-9c47ded9dbb2	1.0	PubMed	23949225	Moreover, the wild-type but not the mutated CXXC4 reduced the amount of beta-catenin and inhibited the phosphorylation of GSK-3beta (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:CXXC4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8c15d427-2866-487f-a439-9c47ded9dbb2	1.0	PubMed	23949225	In contrast, knockdown of CXXC4 increased the phosphorylation of GSK-3beta (XREF_FIG and XREF_SUPPLEMENTARY), indicating that CXXC4 functions to inhibit wnt signaling by stabilizing the destruction complex of beta-catenin.	p(HGNC:CXXC4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
96d71c4f-d4cb-497a-a7b0-c661ef19dc91	1.0	PubMed	22491319	As phosphorylation of GSK3beta is known to result in inactivation of its kinase activity and CYLD deficiency enhances GSK3beta phosphorylation, it is logical that CYLD may induce GSK3beta kinase activity by inhibiting its phosphorylation and thereby promoting GSK3beta-CHIP-mediated Smad3 protein degradation.	p(HGNC:CYLD)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f1fc9850-eb55-4d74-b374-5b3aa2a67d14	1.0	PubMed	21640770	As it is shown in, HCV core protein expression promotes a slight GSK3beta phosphorylation, having conversely no effect on GSK3beta total level.	p(UP:Q64897)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
db334ab6-0af8-4596-9a53-47a20d1903e7	1.0	PubMed	18328427	Inhibition of caspases by the general caspase inhibitor zVAD-fmk did not prevent GSK3beta phosphorylation (B).	p(FPLX:Caspase)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
5485766b-5a0f-471a-ac8b-2e566fafa36d	1.0	PubMed	20018240	Collagen I fibrils interact with alpha2beta1 Integrin (XREF_BIBR) causing ILK induced phosphorylation of Akt, IkappaB, and GSK-3beta.	p(PFAM:PF01391)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
5e72a5da-a571-4c35-b745-55b13a06e33c	1.0	PubMed	25940701	In vitro experiments indicated that DACH1 decreased the phosphorylation of GSK3beta, leading to an increasing of phosphorylated beta-catenin, and then inactive Wnt pathways to repress cell proliferation and migration.	p(HGNC:DACH1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
5063ad7a-382c-419b-a813-cf6860af893d	1.0	PubMed	26547035	We observed that DAPT induced NOTCH1 inhibition upregulated ILK1 activation and increased GSK-3beta phosphorylation by ILK1 (C).	a(PUBCHEM:5311272)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c4f026c5-151e-4f06-8894-3f9e553b6ac1	1.0	PubMed	20952497	In conclusion, at both hD (2L) and hD3 receptors, DA elicited a G (i/o) - and Ca (2) +/calmodulin-dependent phosphorylation of Akt and GSK-3beta via transactivation of insulin like growth factor 1 receptor.	a(CHEBI:18243)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c4f026c5-151e-4f06-8894-3f9e553b6ac1	1.0	PubMed	21315744	We found impairment in METH induced CPP, decreased DA D2 receptor density and altered METH induced phosphorylation of AKT and GSK-3beta in naive DISC1 female mice.	a(CHEBI:18243)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a13716fd-fb3f-4366-854d-e3412b36aeae	1.0	PubMed	19589360	Interestingly, mDia2 was shown to directly bind PKCepsilon and PKCeta and mediate the GSK3beta phosphorylation.	p(HGNC:DIAPH3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
16e9479f-b3ac-45d4-90ec-1c229e51440b	1.0	PubMed	18494933	Moreover, inhibitors of JNK phosphorylation block DKK-1 expression, and prior studies have shown that DKK-1 overex-pression promotes GSK-3beta activity and tau hyperphosphorylation.	p(HGNC:DKK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
16e9479f-b3ac-45d4-90ec-1c229e51440b	1.0	PubMed	16919965	In order to determine whether recombinant DKK1 protein could directly induce GSK3beta activation and Tau phosphorylation, we applied recombinant DKK1 to neuronal cultures and measured levels of P-GSK3beta and phosphorylated Tau (detected with PHF-1 antibodies).	p(HGNC:DKK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
16e9479f-b3ac-45d4-90ec-1c229e51440b	1.0	PubMed	18494933	S100B induction of both DKK-1 and pppTau expression in neurons raises the possibility that S100B promotes DKK-1 expression, and thereby disrupts the canonical Wnt pathway (increased GSK-3beta phosphorylation and enhanced beta-catenin degradation), leading to tau protein hyperphosphorylation.	p(HGNC:DKK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
16e9479f-b3ac-45d4-90ec-1c229e51440b	1.0	PubMed	18494933	Under these same experimental conditions, DKK-1 siRNA almost completely abolished GSK-3beta phosphorylation, beta-catenin degradation, tau protein hyperphosphorylation (XREF_FIG).	p(HGNC:DKK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c76bd774-2180-4a01-9752-faf16399f6fe	1.0	PubMed	26822034	Phosphorylation of GSK3beta on Ser 389 is induced by DSB.	bp(MESH:D053903)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 389))
f43f2b02-40a8-4ea4-b0a5-cc5302dffc6d	1.0	PubMed	PMC6556728	Furthermore, forskolin and 8-Br-cAMP phosphorylated GSK-3beta at serine 9 in intestinal proglucagon-producing cells, and both lithium and forskolin induced the accumulation of free beta-catenin in these cell lines.	p(HGNC:DUOX1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
809458dc-4c38-45e3-8787-23c09d8e57fd	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(FPLX:DVL)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
989cfb91-1acd-47b6-ab0d-57738a65a860	1.0	PubMed	6649932	These results showed that ECS could induce biphasic changes in the Ser 9 phosphorylation of GSK-3beta in the rat brain, suggesting some similarities, as well as differences, in the actions of mood stabilizers and ECS in the signal transduction mechanisms of the brain.	a(PUBCHEM:247304)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d4778ee2-3772-4b39-b84f-4f48992f16fe	1.0	PubMed	20190034	Unlike epidermal growth factor, BMP-4, TGF-beta1, 5-HT, and ET-1 each increased smooth muscle cell size, contractile protein expression, fractional cell shortening, and GSK-3beta phosphorylation.	p(HGNC:EDN1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c8aa917b-f1e4-4b06-a925-52b320f011d1	1.0	PubMed	21315744	Mutant DISC1 significantly delayed METH ED produced sensitization and affected drug induced phosphorylation of AKT and GSK-3beta in female mice.	a(PUBCHEM:99716)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4996a167-1fa7-432f-b14a-83a25457ffed	1.0	PubMed	25164010	To investigate the mechanism of beta-catenin stabilization, we first examined whether EGFR mutants enhance GSK3beta phosphorylation.	p(HGNC:EGFR, var(p.?))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9ab020d6-2c56-421a-baa2-91914851c557	1.0	PubMed	19009649	Abrogation of EGF-R signalling in IHH-Fos by treatment with AG1478, a specific EGF-R tyrosine kinase inhibitor, prevented the phosphorylation of GSK-3beta induced by serum stimulation and decreased Cyclin D1 stability in the nucleus.	p(HGNC:EGFR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9ab020d6-2c56-421a-baa2-91914851c557	1.0	PubMed	20302655	EGFR signal- induced phosphorylation of beta-catenin and GSK-3beta.	p(HGNC:EGFR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9ab020d6-2c56-421a-baa2-91914851c557	1.0	PubMed	17972518	Epithelial growth factor receptor (EGFR) might phosphorylate GSK3beta into inactive phosphorylated GSK3beta-ser9 (P-GSK3beta-ser9).	p(HGNC:EGFR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f36287bc-0f25-4a40-a0f6-de264587f459	1.0	PubMed	25130271	Mechanistically, we found that Hsp27 is required for EGF induced AKT and GSK3beta phosphorylation and beta-catenin nuclear translocation.	p(HGNC:EGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f36287bc-0f25-4a40-a0f6-de264587f459	1.0	PubMed	26547035	Moreover, expression of NOTCH1-IC remarkably decreased EGF induced stimulation of GSK-3beta phosphorylation by ILK1 (B).	p(HGNC:EGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f36287bc-0f25-4a40-a0f6-de264587f459	1.0	PubMed	25622907	To do so, we measured EGF stimulated GSK-3beta phosphorylation in the presence or absence of a well established PI3K pathway inhibitor, Ly294002.	p(HGNC:EGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f36287bc-0f25-4a40-a0f6-de264587f459	1.0	PubMed	17150190	To verify whether Akt pathway was involved in hCSC proliferation, we examined the activation of Akt in hCSCs and found that EGF and bFGF treatment of hCSCs caused a rapid activation of Akt (A) and also augmented sustained phosphorylation of GSK-3beta, which is one of the downstream targets of Akt, to inactivate GSK-3beta function (B).	p(HGNC:EGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1939f5f7-4a05-41ab-8e11-bd772a5f9bc9	1.0	PubMed	26243309	Aschantin inhibited epidermal growth factor (EGF)-induced full activation of Akt by phosphorylation at Ser473 and Thr308, resulting in inhibition of the mTORC2 and Akt and Akt/mTORC1/p70S6K signaling pathways and activation of GSK3beta by abrogation of Akt mediated GSK3beta phosphorylation at Ser9.	p(HGNC:EGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b61729c2-a716-4e44-963f-7eb99434596d	1.0	PubMed	20302655	EGF treatment increased phosphorylation of beta-catenin (tyrosine) and GSK-3beta (Ser-(9), resulting in a loss of beta-catenin association with E-cadherin.	p(HGNC:EGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
daca5753-1b80-4d27-b9d1-f5e5d2963752	1.0	PubMed	21029237	The goal of this work was to determine if PKR could concurrently trigger GSK-3beta activation, tau phosphorylation and apoptosis.	p(HGNC:EIF2AK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
daca5753-1b80-4d27-b9d1-f5e5d2963752	1.0	PubMed	21029237	Our results demonstrate that neuronal PKR co-localizes with GSK-3beta and tau in AD brains and is able to modulate GSK-3beta activation, tau phosphorylation and apoptosis in neuroblastoma cells exposed to tunicamycin or Abeta.	p(HGNC:EIF2AK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f16b7704-e3a8-45bb-b609-2d32fc607f46	1.0	PubMed	26988917	In addition, eIF3f decreased the phosphorylation of GSK-3beta and expression of Elk-1 and Egr-1, downstream factors of Akt and ERK, respectively.	p(HGNC:EIF3F)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
5d7dbd67-bdb6-48df-818c-6788d6fecebc	1.0	PubMed	25078664	Consistent with the above results, we observed that combined knockdown of Galphai1 and Galphai3 in MEFs largely inhibited the phosphorylation of AKT (473S) and GSK-3beta (9S), as well as 4E-BP1 (65S) and S6 (235/236S) by KGF.	p(HGNC:EIF4EBP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 66))
2b637066-d082-4240-80ce-3796af4f1974	1.0	PubMed	26119563	We found that deletion of PDZ domain did not affect the EphB2 stimulation induced phosphorylation levels of PI3K and GSK-3beta and tau proteins (XREF_FIG), whereas deletion of VM kinase domain almost abolished the EphB2 activation induced alterations of PI3K and GSK-3beta and tau phosphorylation (XREF_FIG).	p(HGNC:EPHB2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0922a0ec-0a23-49f9-90e3-8a4d6d0f5c90	1.0	PubMed	23913826	Interestingly, western blot analysis revealed that AKT and GSK-3beta phosphorylation were indeed drastically increased by ERG overexpression, being consistent with the accumulation of active beta-catenin (XREF_FIG).	p(HGNC:ERG)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4c213ab2-7adf-4948-a36e-86cc4cb29f27	1.0	PubMed	23913826	Our study further showed that ERG is also able to induce Akt phosphorylation and GSK-3beta phosphorylation, which may further contribute to its ability to stabilize beta-catenin and activate Wnt signaling.	p(HGNC:ERG)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	25344802	In addition to ERalpha-pathway, MTA1s also cooperate with the Wnt1 pathway by stimulating Wnt1 signaling via promoting ERK dependent phosphorylation of GSK-3beta and nuclear translocation of beta-catenin and through stimulation of the Wnt1 target genes in breast cancer cells [XREF_BIBR, XREF_BIBR].	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	25909283	Transfecting A549 and H1299 cells with dominant negative (DN) ERK, but not wild-type ERK, also inhibited GSK3beta phosphorylation and c-Myc expression.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	20710043	We found that MTA1s upregulates ERK signaling which could, in-turn, lead to phosphorylation and inactivation of GSK3-beta and stabilization of beta-catenin.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	16039586	As Erk interacts with GSK-3beta, we then ask whether Erk may phosphorylate GSK-3beta.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	16039586	To further confirm phosphorylation of T, we constructed mutants of GSK-3beta at T and generated antibody against the phosphorylation site of GSK-3beta, Thr43, to examine whether Erk could phosphorylate GSK-3beta in vivo.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	16039586	Mutation of GSK-3beta T significantly inhibited the phosphorylation of GSK-3beta by Erk (lane 3, E and 4F) even though it still interacted with Erk (lane 3, C).	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	16039586	Furthermore, consistent with our hypothesis, mutating the Erk docking motif (DEF domain) of GSK-3beta, which impaired the association of GSK-3beta with Erk (lane 2, C), also significantly inhibited the phosphorylation of GSK-3beta by Erk (lane 2, E).	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	16039586	These data demonstrate that Erk docks to GSK-3beta at the DEF domain to bridge GSK-3beta and p90RSK together and phosphorylates GSK-3beta at the T residue.We next asked whether Erk docking to GSK-3beta and phosphorylating GSK-3beta have effects on the HBX mediated inactivation of GSK-3beta and upregulation of beta-catenin.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	16039586	Another important finding is identification of a mechanism to elucidate accurately how the Erk and p90RSK pathway phosphorylates and inactivates GSK-3beta.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
183471a5-2eba-4f5b-b455-452a326d8a43	1.0	PubMed	16039586	In addition, we noticed that in WI-38 fibroblast cells, TGF-beta-mediated upregulation of beta-catenin also required Erk phosphorylation and Ser9 phosphorylation of GSK-3beta ().	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
bc1bfba7-4345-4966-8de4-a53b47239f4d	1.0	PubMed	25172662	Both Akt and Erks can phosphorylate GSK-3beta at the crucial Ser9 residue.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bc1bfba7-4345-4966-8de4-a53b47239f4d	1.0	PubMed	24910204	It is well known that Erk and Akt can phosphorylate GSK-3beta at the Ser9 residue and inactivate its kinase activation [XREF_BIBR, XREF_BIBR].	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
fa8b937d-46c0-4d93-a0c1-5e29ef88e992	1.0	PubMed	26022178	In addition, ERK associates with and phosphorylates GSK-3beta at Thr43, which primes GSK-3beta for its subsequent phosphorylation at Ser9 by RSK, a kinase downstream of ERK activation, thus underscoring the importance of ERK pathway in GSK-3beta inactivation.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr, 43))
fa8b937d-46c0-4d93-a0c1-5e29ef88e992	1.0	PubMed	21531565	ERK phosphorylates GSK3beta at Thr43, which primes GSK3beta for subsequent phosphorylation and inactivation by RSK (Ser9) (XREF_FIG, [XREF_BIBR]).	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr, 43))
fa8b937d-46c0-4d93-a0c1-5e29ef88e992	1.0	PubMed	25683913	ERK phosphorylates GSK-3beta at Thr43 that primes GSK-3beta for phosphorylation at Ser9.	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr, 43))
fa8b937d-46c0-4d93-a0c1-5e29ef88e992	1.0	PubMed	16039586	Moreover, the phosphorylation level of GSK-3beta at Thr43 is significantly higher in the HepG2-X and IGF-1-treated HepG2 cells in which Erk is also highly phosphorylated compared to HepG2 cells (lanes 4 and 2 versus lane 3, G), while Erk and MAPK inhibitor PD98059 can dramatically inhibit GSK-3beta phosphorylation at Thr43 in the HepG2-X and IGF-1-treated HepG2 cells (lanes 5 and 1 versus lanes 4 and 2, G).	p(FPLX:ERK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr, 43))
2062d263-254a-4e0e-9604-1d953221cf44	1.0	PubMed	24498263	Abnormalities in the serine/threonine protein kinase, Akt, are closely related to the proliferative status of cells and induce phosphorylation of GSK3beta XREF_BIBR, XREF_BIBR.	p(HGNC:ERN1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
84f88169-1c44-42bc-91eb-aafd35c31f2f	1.0	PubMed	25600807	The activation of ER stress induced by PA can impede the insulin signaling pathway, which is indicated by insulin stimulated phosphorylation of Akt and GSK3beta, consequent expression of downstream target-genes and glucose intake.	p(HGNC:ESR1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0806118d-720d-4ea7-b78b-717a759d4071	1.0	PubMed	22253748	Enzastaurin inhibited GSK3beta phosphorylation and induced beta-catenin expression in both wild type and mutant cell lines (XREF_SUPPLEMENTARY), consistent with its known mechanism of activity.	a(PUBCHEM:176167)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f52b2432-0397-4274-a247-9b1db9e61b41	1.0	PubMed	21320285	Since previous studies have shown that thrombin receptor activation causes Ser9 phosphorylation of GSK-3beta in platelets, and that GSK-3beta blockade amplifies induced platelet activation (15), we reasoned that inhibiting this pathway in platelets could indirectly exaggerate the platelet dependent stimulation of monocyte tissue factor expression.	p(HGNC:F2R)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
a0682501-1639-44f8-887f-e4a4f6b25456	1.0	PubMed	25909283	Inhibition of the Wnt pathway by fibulin-5 requires the RGD motif, as the mutant fibulin-5 lacking the RGD motif (DeltaRGD) was unable to suppress the MMP-7 reporter, GSK3beta Ser9 phosphorylation, or c-Myc and cyclin D1 expression in A549 and H1299 cells.	p(HGNC:FBLN5, var(p.?))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d957e589-62be-40f1-9cf1-4f853a686dec	1.0	PubMed	17150190	To verify whether Akt pathway was involved in hCSC proliferation, we examined the activation of Akt in hCSCs and found that EGF and bFGF treatment of hCSCs caused a rapid activation of Akt (A) and also augmented sustained phosphorylation of GSK-3beta, which is one of the downstream targets of Akt, to inactivate GSK-3beta function (B).	p(HGNC:FGF2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
01facce4-aad0-40ff-81e0-73453f338afe	1.0	PubMed	25088797	Mechanically, bFGF treatment increased phosphorylation of GSK-3beta at Ser9 residues, leading to the inhibition of GSK-3beta activity and increase in stabilization of Snail.	p(HGNC:FGF2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
01f56004-c296-450e-964a-bb34a4978b37	1.0	PubMed	25078664	Consistent with the above results, we observed that combined knockdown of Galphai1 and Galphai3 in MEFs largely inhibited the phosphorylation of AKT (473S) and GSK-3beta (9S), as well as 4E-BP1 (65S) and S6 (235/236S) by KGF.	p(HGNC:FGF7)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
9dfa59a5-4135-478f-b96a-99e8003998ee	1.0	PubMed	19732725	We found that overexpression of FKBP51 decreased the phosphorylation of GSK-3beta (pSer9GSK-3beta) and FOXO1 (pThr24 FoxO1) (XREF_FIG, lower panels), which was consistent with decreased Akt phosphorylation.	p(HGNC:FKBP4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9dfa59a5-4135-478f-b96a-99e8003998ee	1.0	PubMed	19732725	As we demonstrated earlier, overexpression of FKBP51 alone decreased Akt Ser473 phosphorylation and downstream GSK-3beta phosphorylation.	p(HGNC:FKBP4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
41cb987c-0835-4da1-bc68-ae41b225242c	1.0	PubMed	19732725	In contrast, downregulation of FKBP51 significantly increased the phosphorylation of GSK-3beta and FOXO1 (XREF_FIG, lower panels).	p(HGNC:FKBP4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
5b8116d1-0778-41ce-9e5d-03377aabfc48	1.0	PubMed	21471285	Linifanib inhibits phosphorylation of AKT, and GSK3beta in Ba/F3 FLT3 ITD mutant cells and IL-3 rescues phosphorylation of GSK3beta.	p(HGNC:FLT3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cc31c417-ff83-47c1-8daf-cbe11a7d2784	1.0	PubMed	25266063	Forskolin and PGE 2 induced phosphorylation of beta-catenin (ser675), p-GSK3beta (ser9) and concomitant higher levels of active, unphosphorylated, beta-catenin.	a(PUBCHEM:47936)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
361bd360-9062-4d50-8186-bb4d54acc52d	1.0	PubMed	25078664	Gab1 deficiency severely impaired KGF induced phosphorylation of AKT (473S), GSK-3beta (9S), and S6 (235/236S) in MEFs and KGFR (, upper panel and), indicating that Gab1 is required for KGF induced AKT-mTORC1 activation.	p(HGNC:GAB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
5f55c33c-0f81-4320-bc64-02c5016d0f88	1.0	PubMed	7092328	We demonstrate that lack of Gadd45a not only prevents DeltaNp63alpha suppression and GSK3beta dephosphorylation but also prevents free cytoplasmic beta-catenin degradation after UV irradiation.	p(HGNC:GADD45A)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c0327d8c-477b-4dd4-a134-326a3ca8377f	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:GAPDH)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b3e3379d-21e2-44a2-be92-03933564b375	1.0	PubMed	16914735	No evidence text.	p(HGNC:GCKR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
3943b498-4a2a-492c-bba5-b7dec0c5fbaa	1.0	PubMed	21239435	We therefore conclude that GnRH-II stimulates the PI3K and Akt pathway, and the phosphorylation of GSK3beta, thereby enhancing the beta-catenin-dependent up-regulation of MT1-MMP production, which contributes to ovarian cancer metastasis.	p(HGNC:GNRH2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1abecaac-5541-4a23-bf7f-9130e16a7f8e	1.0	PubMed	20443868	GRK5 overexpression in HCAECs significantly suppressed both acute and late activation of Akt and extracellular signal related kinase (ERKs) as well as the phosphorylation of GSK-3beta, an endogenous substrate of Akt.	p(HGNC:GRK5)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e13c0a39-0a1e-4b86-b933-6ec1e2882a22	1.0	PubMed	25219467	Overexpression of GSK-3beta in transgenic mice leads to tau hyperphosphorylation and AD like tau pathology ().	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF09793, pmod(Ph))
de492c25-e24c-4816-bba8-f0e992c37292	1.0	PubMed	20738806	Recently, Tang et al. showed that Smad7 directly binds beta-catenin, effectively sequestering it, resulting in a loss of both GSK3beta directed beta-catenin phosphorylation and subsequent ubiquitin mediated degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
9197e604-a35e-42e9-8754-8fb4f20e5705	1.0	PubMed	20708687	In contrast, inhibition of GSK-3 resulted in enhanced eEF-2 phosphorylation, whereas overexpression of either GSK-3alpha or GSK-3beta reduced eEF-2 phosphorylation compared with the levels in untreated cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EEF2, pmod(Ph))
d23aa419-9267-40a9-a841-6c1caa7fd941	1.0	PubMed	27221474	Moreover, GSK-3beta expression clearly inhibited H2O2 induced phosphorylation of ASK1 in HepG2 cells, in association with a decrease in ASK1 protein level.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP3K5, pmod(Ph))
8ed2581e-73f7-4571-8d52-dab350db44b9	1.0	PubMed	22193544	This study shows that the knockdown of GSK3beta expression through RNAi decreases Tau phosphorylation and increases the occurrence of SH-SY5Y cell differentiation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8ed2581e-73f7-4571-8d52-dab350db44b9	1.0	PubMed	16420965	Since the transfection rate of transient expressional systems is varying, it is difficult to quantify the increased levels of GSK-3beta mediated Tau phosphorylation in double transfected cells ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
8ed2581e-73f7-4571-8d52-dab350db44b9	1.0	PubMed	25219467	In the cases of Ser199 and Ser396, which are favorite sites of GSK-3beta and not PP2A, overexpression of GSK-3beta significantly increased tau phosphorylation at these sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
6c87f02a-1d9b-4e59-b213-b87ba172a11a	1.0	PubMed	16420965	They demonstrated by both sequential immunofluorescence and immunoblotting that over-expression of GSK-3beta had caused increased Tau phosphorylation at Ser396 and Ser404.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
6c87f02a-1d9b-4e59-b213-b87ba172a11a	1.0	PubMed	25219467	We found that overexpression of GSK-3beta increased tau phosphorylation at Ser199, Thr205, and Ser396 (A).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
0d5652f3-b30f-4fbb-b721-129f9c98d718	1.0	PubMed	25219467	We found that overexpression of GSK-3beta increased tau phosphorylation at Ser199, Thr205, and Ser396 (A).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
eccbbed4-4b9f-4ac6-be01-1d4832989f2e	1.0	PubMed	16420965	They demonstrated by both sequential immunofluorescence and immunoblotting that over-expression of GSK-3beta had caused increased Tau phosphorylation at Ser396 and Ser404.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
58d72b91-057c-49bd-a8f4-044f37042456	1.0	PubMed	25219467	We found that overexpression of GSK-3beta increased tau phosphorylation at Ser199, Thr205, and Ser396 (A).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
dc5fa5a5-e385-4868-90ee-26f1e454e183	1.0	PubMed	26388612	These results showed that ectopic expression of GSK-3beta decreased the phosphorylation of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MTOR, pmod(Ph))
1f1a8ebc-7268-4056-8680-87133535af89	1.0	PubMed	14563837	Conversely, overexpression of GSK-3 alpha or GSK-3 beta enhances Thr 58 phosphorylation and ubiquitination of c-Myc.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Thr, 58))
1f1a8ebc-7268-4056-8680-87133535af89	1.0	PubMed	7013582	Conversely, overexpression of GSK-3 alpha or GSK-3 beta enhances Thr 58 phosphorylation and ubiquitination of c-Myc.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Thr, 58))
8c331beb-4e9c-4eaf-a54a-2a07bd10d1c2	1.0	PubMed	17574025	In addition, expression of either GSK3alpha or GSK3beta enhanced SRC-3 phosphorylation at S505 (B).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NCOA3, pmod(Ph, Ser, 505))
c906d29f-f047-405b-9b45-a90fd72dc0f0	1.0	PubMed	21145761	We found that ablation of GSK3beta expression severely impaired virus triggered IkappaBalpha phosphorylation and degradation as well as NF-kappaB-mediated transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKBIA, pmod(Ph))
2446edba-bceb-4cc2-a8ba-c765b8d185dc	1.0	PubMed	26388612	These results showed that ectopic expression of GSK-3beta decreased the phosphorylation of mTOR and p70S6K1; and inhibited beta-catenin, HIF-1alpha and VEGF expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RPS6KB1, pmod(Ph))
19a004c3-08a2-4f10-93e5-f49d4e83c336	1.0	PubMed	23851495	Noticeably, phosphorylation of wild-type Slug also occurred in vivo and was enhanced by the co-expression of constitutively-active GSK3beta (GSK3beta-CA) as determined by the in vivo kinase assay (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
de568cba-e1a3-4170-a889-947ac81ef86c	1.0	PubMed	21145761	As shown in D, overexpression of GSK3beta caused phosphorylation of wild-type TBK1 but not TBK1 (K38A), a kinase inactive mutant in which the ATP binding residue Lys38 was mutated to alanine.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TBK1, pmod(Ph))
61482e5c-0e17-4882-a32e-0c610e1cd7fc	1.0	PubMed	14636889	We wanted to understand whether dephosphorylation of GSK3beta through down-regulation of Akt and PKB, presumably by the Swedish amyloid precursor protein gene, could activate GSK3beta and subsequently lead to hyperphosphorylation of tau.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
42dff81f-3a7e-4b52-a4ca-b62cf5349da7	1.0	PubMed	25360740	However, increased Wnt signaling and activating phosphorylation of Akt (S473) results in inhibitory phosphorylation of GSK3beta (S9).	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(FPLX:AKT, pmod(Ph, Ser, 473))
ea6087ea-27a7-41f0-a755-52e2f90eff14	1.0	PubMed	24955581	In this study, increased phosphorylation of GSK-3beta, reduced phosphorylation of beta-catenin, and nuclear translocation of beta-catenin were observed in CD24 + cells, compared with parental or CD24 - cells (XREF_FIG).	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
ea6087ea-27a7-41f0-a755-52e2f90eff14	1.0	PubMed	19726098	The phosphorylated GSK3beta is inactive and hence unable to phosphorylate beta-catenin, resulting in accumulation of beta-catenin in cells.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
08677607-fbdf-477c-a0be-19b5b7f2af4c	1.0	PubMed	22976805	Activation of Akt phosphorylates GSK3beta preventing phosphorylation of cyclin D1 which leads to accumulation and nuclear localisation of cyclin D1, activation of CDK4/6 and cell cycle progression.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
cc22bde2-d4b2-4a9d-a066-d022c03ccae9	1.0	PubMed	20847424	Phosphorylation and inactivation of GSK-3beta, suppresses GSK-3beta-dependent phosphorylation of tau at residues overphosphorylated in AD and prevents apoptosis of confluent cells.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e8cbae69-7f34-4662-83f9-2f90d4cb22b0	1.0	PubMed	24498263	In its activated dephosphorylated form, GSK3beta promotes the degradation of cyclin D, and unphosphorylated GSK3beta suppresses Rb phosphorylation and prevents cell cycle progression XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:RB1, pmod(Ph))
07686f42-735a-4fa6-91a3-dd549d708b42	1.0	PubMed	23707970	Both ILK and Akt are known to phosphorylate and inactivate GSK3beta, which in turn suppresses phosphorylation of Snail and leading to EMT.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
888d3ba5-a5db-4820-b498-d94223ec346a	1.0	PubMed	25935310	Consistent with the array analysis, we confirmed with immunoblotting that knockdown of CHP3 increased GSK3alpha phosphorylation at Ser21 by 1.7-fold and GSK3beta phosphorylation at Ser9 by 3.5-fold in NRVMs (B).	p(HGNC:GSK3B, pmod(Ph, Ser, 9))	directlyIncreases	p(HGNC:GSK3A, pmod(Ph, Ser, 21))
1449b1e0-f23c-4d86-a81f-cb34e4898fe8	1.0	PubMed	14985354	No evidence text.	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))	directlyIncreases	p(HGNC:AR, pmod(Ph))
43269df8-a428-4104-b180-5160f203b559	1.0	PubMed	24038789	Thus BIO inhibition of GSK3beta Y216 phosphorylation would significantly attenuate its activity and attenuate beta-catenin phosphorylation leading to its stabilization.	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
63a675b6-f612-4c3b-9d9b-d43a8f88bc88	1.0	PubMed	11389840	In addition, since LS174T cells express only mutant beta catenin, which can not be phosphorylated by GSK3beta (S45F) (R.W., unpublished result), this observation provides further support for our finding that Siah-1 downregulates beta-catenin independently of GSK3beta mediated phosphorylation.	p(HGNC:GSK3B, var(p.Ser45Phe))	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5a7991c4-6f58-402c-91ad-13a670d63a3e	1.0	PubMed	19289791	In contrast, mutation of the GSK3beta phosphorylation sites in 9xS/A CLASP2 (340-1,362) rescued MT binding (XREF_FIG).	p(HGNC:GSK3B, var(p.?))	directlyIncreases	p(HGNC:CLASP2, pmod(Ph))
f7c0ebdc-436d-485f-85b1-3a24edb6e6ff	1.0	PubMed	17949810	In colorectal cancer, truncation or loss of the APC protein or mutation of the GSK-3beta phosphorylation sites in beta-catenin are thought to be critical mechanisms underlying beta-catenin cytoplasmic and nuclear accumulation, promoting the expression of beta-catenin-regulated pro proliferative and survival genes.	p(HGNC:GSK3B, var(p.?))	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
f7c0ebdc-436d-485f-85b1-3a24edb6e6ff	1.0	PubMed	6276376	Loss of the APC gene promotes abnormal accumulation of beta-catenin, and mutation of GSK-3 beta phosphorylation sites in the beta-catenin gene can have a similar effect.	p(HGNC:GSK3B, var(p.?))	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
ecc68a32-fefa-468b-a6a6-ce2b4a34a613	1.0	PubMed	27929056	However, during our investigations on the signalling interaction between GSK-3beta and NEMO we were surprised to find that mutations of GSK-3beta phosphorylation sites in NEMO leads to a strong reduction of NEMO protein level and, consequently, reduction of NF-kappaB activation.	p(HGNC:GSK3B, var(p.?))	directlyIncreases	p(HGNC:IKBKG, pmod(Ph))
26256943-7678-48dc-8c88-473789057d8f	1.0	PubMed	17156427	The mechanism of this effect is under investigation, but preliminary results suggest that GSK-3beta phosphorylation of AAH protein leads to its degradation [Cheng, Tong, and de la Monte, Unpublished].	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q6FCU0, pmod(Ph))
77df459f-d739-4832-b580-42814f6d082a	1.0	PubMed	10653665	Thr 446 and Ser 450, which are phosphorylated by glycogen synthase kinase-3 (GSK-3)	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ACLY, pmod(Ph, Ser, 451))
1917e2c0-b38b-451b-9ac2-9d5c58519ec6	1.0	PubMed	10653665	Thr 446 and Ser 450, which are phosphorylated by glycogen synthase kinase-3 (GSK-3).  Phosphorylation resulted in a 6-fold increase in V(max) and the conversion of citrate dependence from sigmoidal, displaying negative cooperativity, to hyperbolic.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ACLY, pmod(Ph, Thr, 447))
9f135b2c-541b-405f-8614-622bbf83d64f	1.0	PubMed	20607601	At the G 1 / S boundary, cyclin D1 is phosphorylated by GSK3beta followed by nuclear export to the cytoplasm, where cyclin D1 is recognized by SCF Fbx4 and alphaB-crystallin ligase, ubiquitinated, and targeted to the 26S proteasome.	p(HGNC:GSK3B)	directlyIncreases	bp(GO:"GO:0051318", pmod(Ph))
f49b0fc3-37d5-4752-9208-64e1bdfda23e	1.0	PubMed	18391981	AIP was phosphorylated by GSK-3beta, and an AIP mutant in which the GSK-3beta phosphorylation site was mutated could bind and downregulate Aurora-A more efficiently.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AIP, pmod(Ph))
a703d3e5-12dd-4787-a33a-237779db9bb4	1.0	PubMed	19785987	have recently shown that Ajuba, a LD containing protein of the Zyxin family closely related to Wtip, is phosphorylated by Gsk3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AJUBA, pmod(Ph))
a09bc059-c3e7-4466-9c5c-e3da5c5ba158	1.0	PubMed	23703635	The over-expression of RI reduces the phosphorylation of the ILK downstream signaling targets p-Akt and p-GSK3beta in T24 cells.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph), pmod(Ph, Thr, 24))
a42f269b-1b06-470c-8d66-5600692f9be5	1.0	PubMed	26604643	These results suggest that Huh7.5 cells either infected with HCV or ectopically expressing HCV NS5A alone have the potential to induce insulin resistance by the phosphorylation of IRS-1 at serine residue (Ser (307)) followed by decreased phosphorylation of Akt Thr (308), Fox01 Ser (256) and GSK3beta Ser (9), the downstream players of the insulin signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph, 9))
2553df97-f5b2-4a0b-a514-7c95666ced97	1.0	PubMed	18486982	Insulin induced tyrosine phosphorylation of IRS-1 and IRS-1 association with PI3K were normal in cells expressing HCV proteins, but serine phosphorylation of Akt and PKB and GSK3beta were impaired (A).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph))
2553df97-f5b2-4a0b-a514-7c95666ced97	1.0	PubMed	25053419	GSK3beta knockdown or GSK3 inhibitor suppresses IGF-I-induced IGF-IR, Akt, and ERK1/2 phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph))
2553df97-f5b2-4a0b-a514-7c95666ced97	1.0	PubMed	22539113	In addition, silencing of GSK-3beta, but not GSK-3alpha, reduced Akt phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph))
2553df97-f5b2-4a0b-a514-7c95666ced97	1.0	PubMed	23349801	FGF-2 significantly stimulated the phosphorylation of AKT, ERK-1/2, and GSK-3beta in H9 cells in 15 minutes (XREF_FIG) as described previously XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph))
2553df97-f5b2-4a0b-a514-7c95666ced97	1.0	PubMed	23349801	Neither BMP-4 nor activin A in the absence of FGF-2 induced the phosphorylation of AKT, ERK-1/2, or GSK-3beta in 201B7 iPS cells (XREF_FIG, XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph))
2553df97-f5b2-4a0b-a514-7c95666ced97	1.0	PubMed	22837212	LMP2A also induced phosphorylation of the Akt target GSK3beta, a Wnt signaling mediator that has been shown to regulate the activity of focal adhesion kinase (FAK), a tyrosine kinase activated by clustering and ligand interaction of integrins.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph))
2553df97-f5b2-4a0b-a514-7c95666ced97	1.0	PubMed	22001647	However, p38 inhibition affected neither Akt phosphorylation nor phosphorylation of the Akt target GSK3beta following H 2 O 2 (XREF_FIG; see right panel for quantification).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph))
bdbc6cbd-5eb0-4bb6-a848-e38a0cac9bdf	1.0	PubMed	26604643	These results suggest that Huh7.5 cells either infected with HCV or ectopically expressing HCV NS5A alone have the potential to induce insulin resistance by the phosphorylation of IRS-1 at serine residue (Ser (307)) followed by decreased phosphorylation of Akt Thr (308), Fox01 Ser (256) and GSK3beta Ser (9), the downstream players of the insulin signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph, Ser))
c5cd3d37-01a3-4c71-a70e-58a1acc8e584	1.0	PubMed	26604643	These results suggest that Huh7.5 cells either infected with HCV or ectopically expressing HCV NS5A alone have the potential to induce insulin resistance by the phosphorylation of IRS-1 at serine residue (Ser (307)) followed by decreased phosphorylation of Akt Thr (308), Fox01 Ser (256) and GSK3beta Ser (9), the downstream players of the insulin signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph, Thr))
ac65e2cb-1062-41d2-915f-07b6ce5bc30e	1.0	PubMed	22837212	LMP2A also induced phosphorylation of the Akt target GSK3beta, a Wnt signaling mediator that has been shown to regulate the activity of focal adhesion kinase (FAK), a tyrosine kinase activated by clustering and ligand interaction of integrins.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AKT, pmod(Ph, Tyr))
19d7d68e-14ad-4820-947f-6cd3acb7fa94	1.0	PubMed	11166179	To determine whether phosphorylation of APC by GSK3beta also affects APC binding to microtubules, we compared the ability of completely dephosphorylated APC4 protein or APC4 protein phosphorylated by GSK3beta to bundle microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ANAPC4, pmod(Ph), pmod(Ph))
5d8ed445-60da-460d-9769-77371c7fa066	1.0	PubMed	11166179	To determine whether phosphorylation of APC by GSK3beta also affects APC binding to microtubules, we compared the ability of completely dephosphorylated APC4 protein or APC4 protein phosphorylated by GSK3beta to bundle microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ANAPC4, pmod(Ph))
ee2fa689-cb95-445f-a83d-497301136416	1.0	PubMed	21145761	For example, phosphorylation of c-Jun, AP-1, or CREB by GSK3beta negatively regulates the DNA binding activities of these transcription factors ().	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AP1, pmod(Ph))
7c3e1c77-3c48-47ad-bbab-f80fa35b3bc5	1.0	PubMed	10698523	In addition, the heterodimeric form of protein phosphatase 2A (PP2A) directly bound to Axin, and PP2A complexed with Axin dephosphorylated APC phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph), pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	20658693	Phosphorylation of Apc by Gsk3beta which promotes binding to beta-catenin in the cytoplasmic destruction complex, also reduces Apc microtubule binding affinity and hence migration (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	21689639	beta-Catenin complexed with APC and Axin can be phosphorylated by GSK3beta, which leads to its degradation via the proteasome dependent pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	19531650	In the absence of Wnt signals, beta, catenin, and APC complex is phosphorylated by GSK-3beta and targeted for ubiquitin and proteasome mediated degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	19711366	As a negative regulator, cytosolic GSK3beta (and GSK3alpha) phosphorylates beta-catenin to promote its degradation, phosphorylates APC to increase its binding to beta-catenin [XREF_BIBR] and phosphorylates axin in the destruction complex which stabilizes axin and increases its affinity for beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	12771992	It is possible that ILK mediated inhibition of GSK3beta could destabilise the formation of the ' destruction complex ' since phosphorylation of axin and APC by GSK3beta is said to favour the formation of the complex (reviewed in Fodde et al, 2001).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	24342833	A study by Ikeda et al. showed that the presence of beta-catenin modulated the phosphorylation of APC by GSK3beta within the Axin scaffold.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	24342833	Based on this argument, we propose that -GlcNAcylation of Ser 23 can putatively restrict GSK3beta phosphorylation of APC, impeding adequate delivery of beta-catenin to the destruction complex and hence its phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	11348595	Phosphorylation of APC by GSK-3beta enhances APC, beta, and catenin complex formation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	16753179	Phosphorylation of APC by CK1epsilon and GSK-3beta enhances its ability to bind and down-regulate beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	16753179	The cleaved protein was further purified by Q-Sepharose HP column (Amersham Pharmacia) and Superdex-200 size-exclusion column (Amersham Pharmacia) and finally changed to 1x PBS buffer for NMR study.Phosphorylated APC samples were prepared using purified APC fragments extensively phosphorylated by CK1-delta and GSK-3beta (New England Biolabs).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	15327768	Phosphorylation of APC by CK1epsilon and GSK-3beta enhances its ability to bind to and to downregulate beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	23302090	In endothelial cells, phosphorylation of APC by GSK3beta and CK1 is required for APC and phosphorylated beta-catenin to be associated with microtubules in clusters at protrusion ends and for cell migration [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	15063782	Within that complex, Axin acts as structural scaffold, enhancing the phosphorylation of APC by GSK3beta and thus APC 's affinity for beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	20519433	CKI and GSK3beta also phosphorylate APC (XREF_BIBR; XREF_BIBR), but consequences of this phosphorylation on APC function (s) are not well understood.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	20519433	GSK3beta and CKI Phosphorylate APC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	20519433	However, because lambda phosphatase caused both APC bands to collapse into a third faster migrating species (XREF_FIG B) and only the slowest migrating APC band is phosphorylated by GSK3beta and CKI (XREF_FIG C), another, as yet unidentified kinase may phosphorylate APC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	20519433	A Complex of APC and beta-Catenin at the Lateral Membrane Is Phosphorylated by GSK3beta and CKI.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	20519433	In MDCK Cells APC Localizes to Clusters, But Not to the Lateral Plasma Membrane, and Is Phosphorylated by GSK3beta and CKI.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	20519433	It was previously shown that phosphorylation of APC by GSK3beta inhibited interaction of APC with microtubules in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	21311754	Cdc42 controls cell polarity through the spatial regulation of GSK-3beta (glycogen synthase kinase-3beta) phosphorylation of APC XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	11007961	Obviously, physiological signaling requires an appropriate balance between GSK3beta catalysed phosphorylation of APC complex components including beta-catenin, axin, and APC, and PP2A catalysed dephosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	11166179	Binding of APC to beta-catenin is enhanced by GSK3beta phosphorylation of APC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	11166179	To determine whether phosphorylation of APC by GSK3beta also affects APC binding to microtubules, we compared the ability of completely dephosphorylated APC4 protein or APC4 protein phosphorylated by GSK3beta to bundle microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	PMC5774816	The interaction of APC with microtubules is decreased by phosphorylation of APC by GSK3 beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	15955847	GSK3beta also phosphorylates neuronal MAPs (XREF_BIBR) and APC (XREF_BIBR; XREF_BIBR; XREF_BIBR), and there are interesting parallels between APC and CLASPs.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	10647780	GSK-3beta directly phosphorylates APC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	10647780	Indeed, PP2A bound to Axin dephosphorylates APC and Axin phosphorylated by GSK-3beta in the Axin complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	10330403	It has been shown that phosphorylation of APC by GSK3beta (XREF_BIBR) can be stimulated by Axin in vitro (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	10330403	This suggests that binding of APC and GSK3beta to Axin promotes the phosphorylation of APC in vivo, presumably by GSK3beta (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	10330403	It previously has been shown that GSK3beta can phosphorylate APC in vitro (XREF_BIBR), that Axin promotes this event (XREF_BIBR), and that this phosphorylation enhances the ability of APC to bind to beta-catenin (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	10698523	These results indicate that APC complexed with Axin is effectively phosphorylated by GSK-3beta and that beta-catenin may modulate this phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	10698523	Gsk-3beta-dependent phosphorylation of apc.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
91635130-5c7a-4d25-a0c9-f57e9655c9dc	1.0	PubMed	10959047	When in complex, GSK-3beta acts in concert with axin to phosphorylate beta-catenin and APC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APC, pmod(Ph))
4b44b0a1-422e-4d10-8847-54cb4c96b227	1.0	PubMed	24112793	Additional evidence has suggested that modulation of GSK3beta activity reduces APP phosphorylation and amyloid load (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APP, pmod(Ph))
4b44b0a1-422e-4d10-8847-54cb4c96b227	1.0	PubMed	25546412	Phosphorylation of APP by Cdk5 and GSK-3beta (glycogen synthase kinase-3beta) at T668 and S655 [XREF_BIBR] affects its sorting into Golgi vesicles [XREF_BIBR, XREF_BIBR, XREF_BIBR] and the balance between APP trafficking and cleavage [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APP, pmod(Ph))
4b44b0a1-422e-4d10-8847-54cb4c96b227	1.0	PubMed	22184106	A point mutation either at Thr 330, the Pin1 binding site in GSK3beta, or at Thr 668, the GSK3beta phosphorylation site in APP, abolished the regulation of GSK3beta activity, Thr 668 phosphorylation, and APP stability by Pin1, resulting in reduced non amyloidogenic APP processing and increased APP levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APP, pmod(Ph))
4b44b0a1-422e-4d10-8847-54cb4c96b227	1.0	PubMed	27077117	The GSK-3beta activity is increased in AD and MCI patients, and activation of GSK-3beta causes tau hyperphosphorylation and Abeta overproduction (XREF_BIBR, XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APP, pmod(Ph))
ec7568a1-9f46-4f91-82f5-153a2c9e251a	1.0	PubMed	19154786	The proline directed kinase GSK3beta and cell cycle dependent kinase cdk5 have both been shown to phosphorylate APP at Thr668 [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APP, pmod(Ph, Thr, 743))
ec7568a1-9f46-4f91-82f5-153a2c9e251a	1.0	PubMed	23402899	Previous studies also suggest that GSK-3beta also stimulates phosphorylation of APP at Thr668, which promotes Abeta production (;).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APP, pmod(Ph, Thr, 743))
ec7568a1-9f46-4f91-82f5-153a2c9e251a	1.0	PubMed	8764598	The sole site of phosphorylation in APPcyt by GSK-3beta was determined by phosphoamino acid analysis and phosphorylation of APPcyt mutant peptides to be Thr743 (numbering as for APP770).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:APP, pmod(Ph, Thr, 743))
3a0c88ce-c069-48e5-88ab-c1e8adcfd8be	1.0	PubMed	21179498	GSK-3beta phosphorylates PER2, CRY2, REV-ERBalpha, CLOCK, and BMAL1 for functional regulation XREF_BIBR - XREF_BIBR, and pharmacological and RNAi based inhibition of GSK-3beta causes period shortening in cultured cells XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ARNTL, pmod(Ph))
3a0c88ce-c069-48e5-88ab-c1e8adcfd8be	1.0	PubMed	24728990	It is known that GSK3beta phosphorylates BMAL1, promoting its ubiquitination and degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ARNTL, pmod(Ph))
3a0c88ce-c069-48e5-88ab-c1e8adcfd8be	1.0	PubMed	19946213	A key role of GSK-3beta in this regulation is further confirmed by results of a complimentary study demonstrating that GSK-3beta can also directly phosphorylate BMAL1 (P. Sassone-Corsi, personal communication).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ARNTL, pmod(Ph))
2cac714f-1279-418f-9534-1429b8a1f7ab	1.0	PubMed	20049328	Gsk3beta phosphorylates bmal1 specifically on ser 17 and thr 21 and primes it for ubiquitylation. In the absence of gsk3beta-mediated phosphorylation, bmal1 becomes stabilized and bmal1 dependent circadian gene expression is dampened.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ARNTL, pmod(Ph, Ser, 17))
697c4dbc-f9f0-4f64-8385-cfbe0d7eb69a	1.0	PubMed	20049328	Gsk3beta phosphorylates bmal1 specifically on ser 17 and thr 21 and primes it for ubiquitylation. In the absence of gsk3beta-mediated phosphorylation, bmal1 becomes stabilized and bmal1 dependent circadian gene expression is dampened.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ARNTL, pmod(Ph, Thr, 21))
adb1c690-6cb6-4814-9d05-b5d8a3fb966d	1.0	PubMed	24275493	Interestingly, it has been shown that the GSK3beta kinase phosphorylates and stabilizes both ERalpha (XREF_BIBR, XREF_BIBR) and AR (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AR, pmod(Ph))
adb1c690-6cb6-4814-9d05-b5d8a3fb966d	1.0	PubMed	PMC7189068	In particular, we showed that glycogen synthase kinase-3 beta phosphorylates the androgen receptor, thereby inhibiting androgen receptor-driven transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AR, pmod(Ph))
adb1c690-6cb6-4814-9d05-b5d8a3fb966d	1.0	PubMed	7189068	In particular, we showed that glycogen synthase kinase-3 beta phosphorylates the androgen receptor, thereby inhibiting androgen receptor driven transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AR, pmod(Ph))
adb1c690-6cb6-4814-9d05-b5d8a3fb966d	1.0	PubMed	14985354	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AR, pmod(Ph))
adb1c690-6cb6-4814-9d05-b5d8a3fb966d	1.0	PubMed	14985354	In particular, we showed that glycogen synthase kinase-3 beta phosphorylates the androgen receptor, thereby inhibiting androgen receptor driven transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AR, pmod(Ph))
5bc6a0fa-1dda-4d52-a67b-bee4a09f0f88	1.0	PubMed	17241872	However, the present study could not provide precise evidence to understand whether Hath1 is directly phosphorylated by GSK3beta or how changes of GSK3beta target are sequentially regulated between Hath1 and beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ATOH1, pmod(Ph))
798553f9-56bc-4a5f-a7c4-176d4a7134c9	1.0	PubMed	17434145	As ataxin-3 interacts with GSK 3beta (), we further determine whether GSK 3beta phosphorylates ataxin-3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ATXN3, pmod(Ph))
798553f9-56bc-4a5f-a7c4-176d4a7134c9	1.0	PubMed	17434145	For mapping the site (s) in ataxin-3 that is phosphorylated by GSK 3beta, we analyzed the potential phosphorylation motifs in ataxin-3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ATXN3, pmod(Ph))
798553f9-56bc-4a5f-a7c4-176d4a7134c9	1.0	PubMed	17434145	Interestingly, GSK 3beta differentially phosphorylates normal ataxin-3 relative to expanded ataxin-3 (A).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ATXN3, pmod(Ph))
798553f9-56bc-4a5f-a7c4-176d4a7134c9	1.0	PubMed	17434145	As phospho dead mutant of ataxin-3-Q80 enhances its aggregation ability and GSK 3beta differentially phosphorylates normal ataxin-3 relative to expanded ataxin-3, it is therefore possible that differential phosphorylation of normal and expanded ataxin-3 may exist in MJD brain.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ATXN3, pmod(Ph))
ff5f1b79-8391-4456-8134-178243b93062	1.0	PubMed	17434145	As shown in C, conversion of the S256 to alanine in ataxin-3 completely abolished its phosphorylation by GSK 3beta, whereas other mutants were still phosphorylated by GSK 3beta, suggesting that GSK 3beta phosphorylates ataxin-3 at serine 256.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ATXN3, pmod(Ph, Ser, 256))
ff5f1b79-8391-4456-8134-178243b93062	1.0	PubMed	17434145	In our present study, we demonstrate that GSK 3beta phosphorylates ataxin-3 at serine 256.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ATXN3, pmod(Ph, Ser, 256))
93f1c0a9-f69b-4cd1-b5d1-e03ad0fb3eff	1.0	PubMed	22864622	AURKAIP1 phosphorylation by GSK-3beta decreases its ability to downregulate Aurora-A, suggesting GSK-3beta positively regulates Aurora-A expression in early mitosis [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AURKAIP1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	19711366	As a negative regulator, cytosolic GSK3beta (and GSK3alpha) phosphorylates beta-catenin to promote its degradation, phosphorylates APC to increase its binding to beta-catenin [XREF_BIBR] and phosphorylates axin in the destruction complex which stabilizes axin and increases its affinity for beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	22933777	The phosphorylation of Axin-1 by GSK3beta accelerates the association of Axin-1 with beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	12771992	It is possible that ILK mediated inhibition of GSK3beta could destabilise the formation of the ' destruction complex ' since phosphorylation of axin and APC by GSK3beta is said to favour the formation of the complex (reviewed in Fodde et al, 2001).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	23579495	Phosphorylation by GSK3 kept Axin activated (open) for _-catenin interaction and poised for engagement of LRP6.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	26025668	The predicted GSK3beta phosphorylation sites in AXIN1 are conserved in AXIN2 (XREF_FIG C).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	25528666	We have previously reported that phosphorylation of Axin-1 by GSK3beta contributes to intracellular signaling of Sema3A to induce growth cone collapse ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	25528666	In this study, we show that the phosphorylation of Axin-1 by GSK3beta is also involved in intracellular signaling of Sema3A that induce acceleration of axonal transport.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	25528666	We have previously reported that sequential phosphorylation of CRMP2 by Cdk5 and GSK3beta and phosphorylation of Axin-1 by GSK3beta mediates growth cone collapse response to Sema3A ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	25528666	We recently reported that phosphorylation of Axin-1 by GSK3beta is necessary for Sema3A induced growth cone collapse ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	10581160	A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf mediated gene expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
b595f4b4-0fb9-4914-8d3d-d54b06f6128e	1.0	PubMed	19901516	XREF_BIBR - XREF_BIBR Conversely, GSK3beta activation phosphorylates beta-catenin and axin to target beta-catenin for ubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph))
bf90082a-64ce-4a3e-a901-26d3b9d0ffff	1.0	PubMed	10581160	Axin residues T609 and S614 are physiological GSK3beta targets. Axin phosphorylation in the regulation of b-catenin stability. When active (left), GSK3b phosphorylates Axin as well as APC and b-catenin. The phosphorylated form of Axin binds strongly to b-catenin and promotes the phosphorylation of b-catenin by GSK3b, leading to strong interaction with b-TrCP	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph, Ser, 486))
a734e7c6-4c79-419b-b5a3-d0108c393cf0	1.0	PubMed	10581160	Axin residues T609 and S614 are physiological GSK3beta targets. Axin phosphorylation in the regulation of b-catenin stability. When active (left), GSK3b phosphorylates Axin as well as APC and b-catenin. The phosphorylated form of Axin binds strongly to b-catenin and promotes the phosphorylation of b-catenin by GSK3b, leading to strong interaction with b-TrCP	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN1, pmod(Ph, Thr, 481))
a7ecee7c-15a5-489a-9f49-f74dd17dd89c	1.0	PubMed	PMC4688250	Axil was phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN2, pmod(Ph))
a7ecee7c-15a5-489a-9f49-f74dd17dd89c	1.0	PubMed	4688250	Axil was phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN2, pmod(Ph))
a7ecee7c-15a5-489a-9f49-f74dd17dd89c	1.0	PubMed	9566905	Axil was phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:AXIN2, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	21689639	beta-Catenin complexed with APC and Axin can be phosphorylated by GSK3beta, which leads to its degradation via the proteasome dependent pathway.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	PMC5588784	In the Axin complex, GSK-3beta efficiently phosphorylates beta-catenin, which is then ubiquitinated and degraded by proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	PMC5588784	Axam inhibited the complex formation of Dvl with Axin and the activity of Dvl to suppress GSK-3beta-dependent phosphorylation of Axin.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	23768967	Axin, a GSK-3beta substrate and binding partner, is phosphorylated by GSK-3beta allowing it to subsequently bind and increase GSK-3beta phosphorylation, ultimately leading to the degradation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	15063782	Likewise, GSK3beta phosphorylates Axin, which increases Axin 's stability and its affinity for beta-catenin, thereby enhancing the stability of the degradation complex.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	15063782	In that way, Axin phosphorylation by GSK3beta serves as a key determinant of beta-catenin stability and turnover.In the present study, we provide several pieces of evidence that cyclin and CDK2 also can regulate the interaction between beta-catenin and Axin.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	PMC5078401	Because GSK-3beta also phosphorylates Axin in the complex, the physiological significance of the phosphorylation of Axin was examined.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	PMC5078401	Dvl-1, which was genetically shown to function upstream of GSK-3beta, inhibited the phosphorylation of Axin by GSK-3beta in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	5078401	Because GSK-3beta also phosphorylates Axin in the complex, the physiological significance of the phosphorylation of Axin was examined.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	5078401	Dvl-1, which was genetically shown to function upstream of GSK-3beta, inhibited the phosphorylation of Axin by GSK-3beta in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	19107203	To further test whether the dually phosphorylated PPPSPxS peptide can act as a general inhibitor of GSK3beta, we tested its effect on GSK3beta mediated phosphorylation of an Axin fragment (mouse Axin amino acids 512-650), in which Ser614 is the only site phosphorylated by GSK3beta in vitro and in vivo XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	19107203	As shown in XREF_FIG, the phosphorylated PPPSPxS peptides inhibited GSK3beta mediated phosphorylation of the Axin fragment as efficiently as on the primed beta-catenin N-terminal fragment substrate.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	10647780	Furthermore, Dvl-1 inhibits the phosphorylation of Axin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	10647780	Indeed, PP2A bound to Axin dephosphorylates APC and Axin phosphorylated by GSK-3beta in the Axin complex.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	18641688	Axin phosphorylation by GSK3beta has also been reported in Wnt and beta-catenin signaling (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
a17161db-d6f8-4601-a945-586f46e6eb70	1.0	PubMed	16981698	Similar to Axin GID (381-405) and FRATtide, synthesized GSKIPtide is also shown to compete with and/or block the phosphorylation of Axin and beta-catenin by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:AXIN, pmod(Ph))
6fa236a9-5fa9-4c0d-9e0e-2e1680a68fdc	1.0	PubMed	15525785	Glycogen synthase kinase-3beta phosphorylates bax and promotes its mitochondrial localization during neuronal apoptosis. Gsk-3beta directly phosphorylated bax(alpha) on ser163	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BAX, pmod(Ph, Ser, 163))
e6b71a1a-2ea7-415e-94ac-d58d1777dcfd	1.0	PubMed	22262180	In short, we established a model to demonstrate that GSK3b interacts with and phosphorylates BCL2L12 and might also affect BCL2L12A to modulate the apoptosis signaling pathway in glioblastoma.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BCL2L12, pmod(Ph))
6c8cb5df-8ae5-4a88-a7f3-6c7a0458ec77	1.0	PubMed	22262180	In vitro kinase and l-phosphatase assays showed that GSK3b phosphorylates BCL2L12 at S156, while this site is absent on BCL2L12A.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BCL2L12, pmod(Ph, Ser, 156))
6c8cb5df-8ae5-4a88-a7f3-6c7a0458ec77	1.0	PubMed	22262180	Gsk3b phosphorylates bcl2l12 at s156. Ectopic expression of gfp-fused bcl2l12 or bcl2l12a in u87mg cells leads to repression of apoptotic markers and protects against staurosporine (sts) insults, indicating an antiapoptotic role for both bcl2l12 and bcl2l12a. In contrast, no anti-apoptotic ability was seen in bcl2l12(s156a)	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BCL2L12, pmod(Ph, Ser, 156))
47881760-33ff-4fc2-b08b-427bc5eb5ad3	1.0	PubMed	23442801	It suggests that gsk3_ activity is required for hbora-mediated mitotic entry through ser274 and ser278 phosphorylation	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BORA, pmod(Ph, Ser, 274))
fb4b4813-fb26-4399-a227-c8bd56bbed64	1.0	PubMed	23442801	It suggests that gsk3_ activity is required for hbora-mediated mitotic entry through ser274 and ser278 phosphorylation	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BORA, pmod(Ph, Ser, 278))
908542b3-faf5-40a8-b384-be55c61272e4	1.0	PubMed	25340789	Specifically, it has been shown that GSK-3beta mediates phosphorylation of certain serine residues on the Neh6 domain of Nrf2, increasing its affinity for another E3 ubiquitin ligase, beta-TrCP, which is believed to mediate Nrf2 ubiquitination and proteasomal degradation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:BTRC, pmod(Ph, Ser))
ba83592a-1b30-47ae-b771-d0026e87dc87	1.0	PubMed	15752768	Our data showed that GSK3beta, but not PKA, phosphorylates CABYR through its extensin like domain (A) demonstrating that GSK3beta interacts with and phosphorylates CABYR through its extensin like domain.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CABYR, pmod(Ph))
ba83592a-1b30-47ae-b771-d0026e87dc87	1.0	PubMed	15752768	To explore which sites of CABYR could be truly phosphorylated by GSK3beta, we performed kinase assays with GSK3beta and several serial His tagged fusion proteins were tested.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CABYR, pmod(Ph))
ba83592a-1b30-47ae-b771-d0026e87dc87	1.0	PubMed	15752768	Although prior phosphorylation of a pre-phosphorylated substrate by a distinct protein kinase is required for the phosphorylation by GSK3beta, our data showed that mutations of CABYR-379 either at Thr or Ser or double mutant Thr and Ser did not affect phosphorylation (C), suggesting that phosphorylation of CABYR by GSK3beta does not require prior phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CABYR, pmod(Ph))
ba83592a-1b30-47ae-b771-d0026e87dc87	1.0	PubMed	15752768	Our data also show that GSK3beta is able to phosphorylate CABYR variants, suggesting that phosphorylation may play a role for more CABYR functions in different tissues other than testis sperm capacitation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CABYR, pmod(Ph))
0a083f46-b9b6-4761-988d-29f30ca5c13a	1.0	PubMed	15752768	GSK3β interacts with and phosphorylates CABYR in vitro. GSK3β interacts with and phosphorylates CABYR in vitro.  the functional extent of the CABYR phosphorylation sites to participate in cellular processes through GSK3β remains to be investigated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CABYR, pmod(Ph, Ser, 155))
b2afebaf-2769-4d76-8eb6-71c36e9504e1	1.0	PubMed	15752768	GSK3β interacts with and phosphorylates CABYR in vitro. GSK3β interacts with and phosphorylates CABYR in vitro.  the functional extent of the CABYR phosphorylation sites to participate in cellular processes through GSK3β remains to be investigated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CABYR, pmod(Ph, Thr, 151))
6cc29f6f-8485-4514-b9ad-44ebb64e6efe	1.0	PubMed	22778263	Cdk5 and gsk3 phosphorylate ser-129, ser-133, and ser-137. Mutation of ser-129, ser-133, and ser-137 increases autonomous activity with little change in ca2 /cam-dependent activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CAMKK2, pmod(Ph, Ser, 129))
98d4594a-aea2-4142-a702-5156ae0311d6	1.0	PubMed	22778263	Cdk5 and gsk3 phosphorylate ser-129, ser-133, and ser-137. Mutation of ser-129, ser-133, and ser-137 increases autonomous activity with little change in ca2 /cam-dependent activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CAMKK2, pmod(Ph, Ser, 133))
d45b4be1-2d3d-48e5-8a65-b4e88603c1a4	1.0	PubMed	22778263	Cdk5 and gsk3 phosphorylate ser-129, ser-133, and ser-137. Mutation of ser-129, ser-133, and ser-137 increases autonomous activity with little change in ca2 /cam-dependent activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CAMKK2, pmod(Ph, Ser, 137))
e06fe199-0f98-40ba-84a9-40250d7be351	1.0	PubMed	PMC5741954	For example, phosphorylation of nuclear cyclin D1 could increase its rate of nuclear export relative to nuclear import; alternatively, phosphorylation of cytoplasmic cyclin D1 by GSK-3beta could inhibit nuclear import.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCND1, pmod(Ph))
7bdca27a-420a-43eb-958b-f93e13cee95b	1.0	PubMed	16504004	Phosphorylation of cyclin d1 on a single threonine residue near the carboxyl terminus (thr-286) positively regulates proteasomal degradation of d1. Now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCND1, pmod(Ph, Thr, 286))
7bdca27a-420a-43eb-958b-f93e13cee95b	1.0	PubMed	9832503	Phosphorylation of cyclin d1 on a single threonine residue near the carboxyl terminus (thr-286) positively regulates proteasomal degradation of d1. Now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover now, we demonstrate that glycogen synthase kinase-3beta (gsk-3beta) phosphorylates cyclin d1 specifically on thr-286, thereby triggering rapid cyclin d1 turnover.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCND1, pmod(Ph, Thr, 286))
7bdca27a-420a-43eb-958b-f93e13cee95b	1.0	PubMed	23552696	Active AKT, a common mediator of cell survival signals induced by radiation through multiple intracellular signaling pathways,11, 12 suppresses apoptosis. AKT positively regulates cyclin D1 expression through inactivation of glycogen synthase kinase 3_ (GSK3_). The AKT-mediated phosphorylation of glycogen synthase kinase 3_ on serine9 decreases its kinase activity for Thr286 of cyclin D1, which inhibits the nuclear export and the cytoplasmic proteasomal degradation of cyclin D1	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCND1, pmod(Ph, Thr, 286))
7bdca27a-420a-43eb-958b-f93e13cee95b	1.0	PubMed	PMC5741954	GSK-3beta-dependent phosphorylation of cyclin D1 at Thr-286 promotes the nuclear-to-cytoplasmic redistribution of cyclin D1 during S phase of the cell cycle, but how phosphorylation regulates redistribution has not been resolved.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCND1, pmod(Ph, Thr, 286))
02072a56-23f0-469a-9227-78386ee0fc9f	1.0	PubMed	24134204	CCND1 (cyclin D1), a key regulator of the mammalian G1-S-phase transition, is phosphorylated on Thr (286) by GSK3beta (glycogen synthase kinase 3beta) to promote its degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCND1, pmod(Ph, Thr))
b9aeaa08-9397-49e4-81b8-efd08bec382b	1.0	PubMed	17486076	Glycogen synthase kinase-3beta and p38 phosphorylate cyclin d2 on thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCND2, pmod(Ph, Thr, 280))
6e860af4-2d45-4002-91ac-d451a7cdca9c	1.0	PubMed	16331257	We have previously shown that both basal and camp-induced degradation of cyclin d3 in reh cells is dependent on thr-283 phosphorylation by glycogen synthase kinase-3beta (gsk-3beta).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCND3, pmod(Ph, Thr, 283))
2a65f5a3-a750-49ee-87a6-64ba8ec9a2b6	1.0	PubMed	14536078	Our experiments suggest that gsk3 is the kinase primarily responsible for phosphorylation of cyclin e on t380	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCNE1, pmod(Ph, Thr, 395))
cbf8d1cc-8a8e-44c9-b420-ab6ff41c9c2c	1.0	PubMed	14536078	Our experiments suggest that gsk3 is the kinase primarily responsible for phosphorylation of cyclin e on t380	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CCNE1, pmod(Ph, Thr, 77))
8c8a4d1d-845d-43c4-b0cd-832d2f594611	1.0	PubMed	27572267	GSK3beta binds to and phosphorylates PD-L1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CD274, pmod(Ph))
8c8a4d1d-845d-43c4-b0cd-832d2f594611	1.0	PubMed	27572267	GST-PD-L1 was strongly phosphorylated by GSK3beta CA (constitutively active, GSK3beta S9A) but not GSK3beta kinase dead (KD, GSK3beta S85A), and site directed mutation of the consensus motif on PD-L1 (S176A, T180A and S184A) completely abolished PD-L1 phosphorylation (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CD274, pmod(Ph))
b6679b97-74ac-4c76-95c7-8be840a540ed	1.0	PubMed	18167338	In addition, we demonstrate that Cdc25A phosphorylation by GSK-3beta requires prior phosphorylation of Cdc25A on T80, and this can be catalyzed by Plk-3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDC25A, pmod(Ph))
b6679b97-74ac-4c76-95c7-8be840a540ed	1.0	PubMed	18167338	In addition, GSK-3beta bound to and phosphorylated Cdc25A on a key regulatory site, S76.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDC25A, pmod(Ph))
b6679b97-74ac-4c76-95c7-8be840a540ed	1.0	PubMed	18167338	However, efficient phosphorylation of Cdc25A by GSK-3beta required that Cdc25A first be phosphorylated on a priming site, T80.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDC25A, pmod(Ph))
14d5158c-e0dc-4b1e-91ba-3b6765337721	1.0	PubMed	18167338	Next, kinase reactions were carried out in vitro to determine if GSK-3beta directly phosphorylates Cdc25A on S76.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDC25A, pmod(Ph, Ser, 76))
14d5158c-e0dc-4b1e-91ba-3b6765337721	1.0	PubMed	18167338	However, prior phosphorylation of Cdc25A by Plk-3 significantly enhanced the ability of GSK-3beta to phosphorylate Cdc25A on S76 in vitro (top panel, lane 3).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDC25A, pmod(Ph, Ser, 76))
14d5158c-e0dc-4b1e-91ba-3b6765337721	1.0	PubMed	18167338	We demonstrate that GSK-3beta phosphorylates Cdc25A on S76 to facilitate the binding of the E3 ubiquitin ligase, SCF.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDC25A, pmod(Ph, Ser, 76))
14d5158c-e0dc-4b1e-91ba-3b6765337721	1.0	PubMed	20348946	Here, we report that casein kinase 1 alpha (ck1alpha) phosphorylates cdc25a on both s79 and s82 in a hierarchical manner requiring prior phosphorylation of s76 by chk1 or gsk-3beta. This facilitates beta-trcp binding and ubiquitin-mediated proteolysis of cdc25a	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDC25A, pmod(Ph, Ser, 76))
50a29001-c88c-46a7-97bf-6240ebd26ab7	1.0	PubMed	10671552	Thus, phosphorylation of the E-cadherin cytoplasmic domain by CKII and GSK-3beta appears to modulate the affinity between beta-catenin and E-cadherin, ultimately modifying the strength of cell-cell adhesion.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH1, pmod(Ph))
50a29001-c88c-46a7-97bf-6240ebd26ab7	1.0	PubMed	PMC5381817	Thus, phosphorylation of the E-cadherin cytoplasmic domain by CKII and GSK-3beta appears to modulate the affinity between beta-catenin and E-cadherin, ultimately modifying the strength of cell-cell adhesion.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH1, pmod(Ph))
50a29001-c88c-46a7-97bf-6240ebd26ab7	1.0	PubMed	5381817	Thus, phosphorylation of the E-cadherin cytoplasmic domain by CKII and GSK-3beta appears to modulate the affinity between beta-catenin and E-cadherin, ultimately modifying the strength of cell-cell adhesion.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH1, pmod(Ph))
01044a60-f898-4441-9697-a20e7999498c	1.0	PubMed	24063632	Casein kinase 2 (CK2) and glycogen synthase kinase 3beta (GSK3beta) phosphorylate human E-cadherin at Ser838, Ser853, and Ser855, which enhances the interaction with beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH1, pmod(Ph, Ser, 838))
50555b36-acb6-47c3-b6e2-25ad4192166b	1.0	PubMed	10671552	Phosphorylation of the E-cadherin Cytoplasmic Domain by CKII and GSK-3β Increases the Binding to β-catenin. pre-phosphorylation by CKII at Ser-855 and/or Ser-853 of E-cadherin is required before GSK-3β can phosphorylate at Ser-849.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH1, pmod(Ph, Ser, 847))
f3f9323d-b953-46e1-9963-4e8835db4b6c	1.0	PubMed	24063632	Casein kinase 2 (CK2) and glycogen synthase kinase 3beta (GSK3beta) phosphorylate human E-cadherin at Ser838, Ser853, and Ser855, which enhances the interaction with beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDH1, pmod(Ph, Ser, 853))
aee860e1-a5d5-4d05-84f9-c1f3abb358f7	1.0	PubMed	15063782	Analysis of the amino acid sequence revealed that this region contains three possible CDK2 consensus phosphorylation sequences (S/TP), Thr609-Pro610, Ser614-Pro615, and Ser621-Pro622, which, interestingly, are also known to be phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDK2, pmod(Ph))
013a05aa-0529-455f-a5d9-6e83cebfcdf4	1.0	PubMed	17283049	These data show that GSK-3beta is activated by UV irradiation through the ATR signaling pathway and phosphorylates p21 at ser 114 for its degradation by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDKN1A, pmod(Ph, Ser, 114))
013a05aa-0529-455f-a5d9-6e83cebfcdf4	1.0	PubMed	17283049	Glycogen synthase kinase 3beta phosphorylates p21waf1/cip1 for proteasomal degradation after uv irradiationhere, we show that ser-114 phosphorylation of p21 protein by glycogen synthase kinase 3beta (gsk-3beta) is required for its degradation in response to uv irradiation	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDKN1A, pmod(Ph, Ser, 114))
e13bb654-2321-4906-9449-34cb0b9530c3	1.0	PubMed	23408967	Whereas GSK3beta phosphorylates and stabilizes p27 Kip1 in normal cells XREF_BIBR, it down-regulates p27 Kip1 in leukemia cells and selectively maintains the survival and proliferation of these cells XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDKN1B, pmod(Ph))
1e3037a3-261e-4cd8-baf4-13917679f882	1.0	PubMed	16027724	GSK-3, p38 and CDK2 can phosphorylate Cdx2 through the 4S motif in vitro, but only CDK2 was shown to be active in vivo. the compound mutant 4S>A (serines 281, 285, 289 and 293 replaced by alanines)	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDX2, pmod(Ph, Ser, 283))
7f897cd9-12ac-4d87-99fe-ea51cd8620dd	1.0	PubMed	16027724	GSK-3, p38 and CDK2 can phosphorylate Cdx2 through the 4S motif in vitro, but only CDK2 was shown to be active in vivo. the compound mutant 4S>A (serines 281, 285, 289 and 293 replaced by alanines)	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDX2, pmod(Ph, Ser, 287))
4faf5fc7-8596-450d-b305-41f5cf58fec4	1.0	PubMed	16027724	GSK-3, p38 and CDK2 can phosphorylate Cdx2 through the 4S motif in vitro, but only CDK2 was shown to be active in vivo. the compound mutant 4S>A (serines 281, 285, 289 and 293 replaced by alanines)	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDX2, pmod(Ph, Ser, 291))
69558077-26da-47e9-842c-f52b6446c245	1.0	PubMed	16027724	GSK-3, p38 and CDK2 can phosphorylate Cdx2 through the 4S motif in vitro, but only CDK2 was shown to be active in vivo. the compound mutant 4S>A (serines 281, 285, 289 and 293 replaced by alanines)	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDX2, pmod(Ph, Ser, 295))
ef026778-f511-48e4-820e-8efa38700f85	1.0	PubMed	10567568	Glycogen synthase kinase 3 (GSK3) phosphorylates T222 and T226, causing a conformational change in C/EBPα. GSK3-mediated phosphorylation does not, in itself, dramatically alter the activity of C/EBPα in our assays. phosphorylation of C/EBPalpha and other substrates by GSK3 may be required for adipogenesis, since treatment of differentiating preadipocytes with lithium inhibits their conversion to adipocytes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPA, pmod(Ph, Thr, 226))
0243d605-8b15-4ed5-9e62-bf891c9bf6da	1.0	PubMed	10567568	Glycogen synthase kinase 3 (GSK3) phosphorylates T222 and T226, causing a conformational change in C/EBPα. GSK3-mediated phosphorylation does not, in itself, dramatically alter the activity of C/EBPα in our assays. phosphorylation of C/EBPalpha and other substrates by GSK3 may be required for adipogenesis, since treatment of differentiating preadipocytes with lithium inhibits their conversion to adipocytes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPA, pmod(Ph, Thr, 230))
ba2d3154-67e0-4441-9327-88bae48e88e2	1.0	PubMed	23737552	In studying the activation of the C/EBP transcription factors, we found that IL-17-dependent phosphorylation of C/EBPbeta by GSK-3beta inhibits the expression of IL-17 target genes (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph))
ba2d3154-67e0-4441-9327-88bae48e88e2	1.0	PubMed	23737552	Phosphorylation of C/EBPbeta by GSK-3beta is mediated through the CBAD and is associated with dampened IL-17R signaling (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph))
ba2d3154-67e0-4441-9327-88bae48e88e2	1.0	PubMed	19244213	In that setting, phosphorylation of C/EBPbeta by GSK3beta decreases its capacity to bind DNA, at least in vitro, thereby reducing its ability to regulate transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph))
ba2d3154-67e0-4441-9327-88bae48e88e2	1.0	PubMed	20110283	The phosphorylation and interaction of C/EBPbeta with GSK3beta and ATF3 are decreased by the inhibition of the GSK3beta and Protein Kinase C pathways.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph))
ba2d3154-67e0-4441-9327-88bae48e88e2	1.0	PubMed	26374165	For instance, CBAD is required for glycogen synthase kinase-3beta (GSK-3beta)-mediated inhibitory phosphorylation of C/EBPbeta that suppresses its transcriptional activity XREF_BIBR XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph))
ba2d3154-67e0-4441-9327-88bae48e88e2	1.0	PubMed	26374165	This finding is consistent with earlier reports that phosphorylation of C/EBPbeta by GSK-3beta inhibits its DNA binding capacity and transcription of target genes XREF_BIBR XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph))
778706e7-5df8-4da1-8ee3-c83c355054f2	1.0	PubMed	17601773	However, the acquisition of dna binding and transactivation capacity of c/ebpbeta is delayed until further phosphorylation (on ser(184) or thr(179)) by gsk3beta occurs.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph, Ser, 231))
778706e7-5df8-4da1-8ee3-c83c355054f2	1.0	PubMed	22369944	However, the acquisition of dna binding and transactivation capacity of c/ebpbeta is delayed until further phosphorylation (on ser(184) or thr(179)) by gsk3beta occurs.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph, Ser, 231))
423626a1-1391-47c5-9b1e-66dc4349dadf	1.0	PubMed	22369944	However, the acquisition of dna binding and transactivation capacity of c/ebpbeta is delayed until further phosphorylation (on ser(184) or thr(179)) by gsk3beta occurs.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph, Thr, 226))
7e74b641-41fe-4cf6-904a-6dfaa3bf1146	1.0	PubMed	22355693	We found that expression of srebf1a depended on GSK3β activity and that GSK3β activity was necessary for C/EBPβ phosphorylation at Thr188	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPB, pmod(Ph, Thr, 235))
1959efd0-6c9b-4f7f-9c97-d94edcf6af8e	1.0	PubMed	24155666	This negative feedback loop depends on GSK-3beta 's phosphorylation of C/EBPdelta, which is inhibited by LPS.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPD, pmod(Ph))
1959efd0-6c9b-4f7f-9c97-d94edcf6af8e	1.0	PubMed	23575666	Indeed, in vitro kinase assays with recombinant activated GSK-3beta confirmed that GSK-3beta directly phosphorylated C/EBPdelta (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPD, pmod(Ph))
1959efd0-6c9b-4f7f-9c97-d94edcf6af8e	1.0	PubMed	23575666	Phosphorylation of C/EBPdelta by GSK-3beta is required for its degradation by FBXW7alpha.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPD, pmod(Ph))
1959efd0-6c9b-4f7f-9c97-d94edcf6af8e	1.0	PubMed	23993701	This novel finding highlights the importance of CEBPD in activated astrocytes and neuroinflammatory diseases.Different from neurons, astrocytic CEBPD is phosphorylated by GSK3beta and consequently activates the expression of,, and by binding to their promoter regions.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPD, pmod(Ph))
96ecc6ac-b0fc-4b02-921c-34bf7ca35087	1.0	PubMed	23993701	After inducing CEBPD expression with IL-1beta in astrocytes, we identified that GSK3beta phosphorylates Ser167 of CEBPD; furthermore, the phosphorylation of astrocytic CEBPD contributes to the activation and migration of microglia and macrophages.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPD, pmod(Ph, Ser, 167))
96ecc6ac-b0fc-4b02-921c-34bf7ca35087	1.0	PubMed	23993701	In this study, GSK3beta can phosphorylate Ser167 and Thr171 of CEBPD in an invitro kinase assay.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPD, pmod(Ph, Ser, 167))
b4162066-d752-4dae-9fa4-b4b5db6082c8	1.0	PubMed	23993701	In this study, GSK3beta can phosphorylate Ser167 and Thr171 of CEBPD in an invitro kinase assay.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CEBPD, pmod(Ph, Thr, 171))
ef9340c3-16de-4d7e-9799-d078c3dec312	1.0	PubMed	17991736	Here we report that CIITA represses collagen transcription through a phosphorylation-dependent interaction between its proline/serine/threonine domain and co-repressor molecules such as histone deacetylase (HDAC2) and Sin3B. Mutation of a serine (S373A) in CIITA, within a glycogen synthase kinase 3 (GSK3) consensus site, decreases repression of collagen transcription by blocking interaction with Sin3B	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CIITA, pmod(Ph, Ser, 373))
f5640bbb-3640-443b-9d5b-5e6bb397c01e	1.0	PubMed	19289791	Because we were not able to achieve sufficient GSK3beta phosphorylation of CLASP2 protein in vitro, we instead compared MT binding of WT 6xHis-CLASP2 (340-650) and a construct in which the GSK3beta motif between S594 and S610 was replaced with phosphomimetic aspartate residues (5xS/D; XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLASP2, pmod(Ph))
f5640bbb-3640-443b-9d5b-5e6bb397c01e	1.0	PubMed	19289791	Consistent with these data, we were unable to immunoprecipitate EB1 with longer CLASP2 constructs (not depicted), which may be more efficiently phosphorylated by endogenous GSK3beta levels than EGFP-CLASP2 (512-650) (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLASP2, pmod(Ph))
f5640bbb-3640-443b-9d5b-5e6bb397c01e	1.0	PubMed	19289791	We currently do not know whether CLASP2 phosphorylation by GSK3beta requires priming phosphorylation, but it is intriguing that both C-terminal residues of the functional GSK3beta motifs (S610 and S576) are near perfect matches to the Cdk consensus (S/T) PX (K/R) (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLASP2, pmod(Ph))
f5640bbb-3640-443b-9d5b-5e6bb397c01e	1.0	PubMed	19289791	GSK3beta phosphorylates CLASP2 in the MT plus end tracking domain.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLASP2, pmod(Ph))
f5640bbb-3640-443b-9d5b-5e6bb397c01e	1.0	PubMed	15955847	Indeed, GSK3beta phosphorylated CLASP2 protein in vitro, and GSK3beta inhibition in PtK1 cells resulted in a noticeable downshift of CLASPs on immunoblots of cell extracts.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLASP2, pmod(Ph))
f5640bbb-3640-443b-9d5b-5e6bb397c01e	1.0	PubMed	22182509	AKAP220 also binds GSK-3beta, which phosphorylates CLASP2 to prevent its interaction with IQGAP1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLASP2, pmod(Ph))
54279b7c-e5de-4fc4-b9bd-047629402148	1.0	PubMed	25733387	GSK-3beta phosphorylation of the serine and serine residues of Clasp2 is critical for binding to the region between amino acids 1503 and 1667 of IQGAP1 ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLASP2, pmod(Ph, Ser))
99bb1bff-4986-40b2-9792-06328dd7116e	1.0	PubMed	21179498	GSK-3beta phosphorylates PER2, CRY2, REV-ERBalpha, CLOCK, and BMAL1 for functional regulation XREF_BIBR - XREF_BIBR, and pharmacological and RNAi based inhibition of GSK-3beta causes period shortening in cultured cells XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLOCK, pmod(Ph))
99bb1bff-4986-40b2-9792-06328dd7116e	1.0	PubMed	24875049	Recently it was shown that GSK3beta is able to phosphorylate and destabilize CLOCK XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLOCK, pmod(Ph))
99bb1bff-4986-40b2-9792-06328dd7116e	1.0	PubMed	19946213	To demonstrate the intracellular phosphorylation of CLOCK by GSK-3beta, cells were co-transfected with expression plasmids for either CLOCK or phospho deficient mutant (S427A) and ectopic GSK-3beta, either the active (CA) or kinase-dead (KD) form.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLOCK, pmod(Ph))
99bb1bff-4986-40b2-9792-06328dd7116e	1.0	PubMed	19946213	As seen in XREF_FIG, GSK-3beta (CA) increased CLOCK phosphorylation while GSK-3beta (KD) decreased it.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLOCK, pmod(Ph))
99bb1bff-4986-40b2-9792-06328dd7116e	1.0	PubMed	19946213	To test whether GSK-3beta directly phosphorylates CLOCK, we performed an in vitro kinase assay using recombinant GSK-3beta and IP-CLOCK as a substrate.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CLOCK, pmod(Ph))
108169dd-b64c-4829-9995-359530a3a1a1	1.0	PubMed	27232758	The serine 113 of the CPD motif is phosphorylated by GSK3beta, which in turn is recognized by the F-box protein FBW7, leading to proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CPD, pmod(Ph))
108169dd-b64c-4829-9995-359530a3a1a1	1.0	PubMed	16054087	In addition, the CPD in cyclin E is also phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CPD, pmod(Ph))
108169dd-b64c-4829-9995-359530a3a1a1	1.0	PubMed	26461473	Furthermore, mutation of SOX10 CPD (SOX10-2A) abrogated their interaction, indicating that GSK3beta interacts specifically with SOX10 and that this interaction depends on the potential GSK3beta phosphorylation motif in CPD.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CPD, pmod(Ph))
108169dd-b64c-4829-9995-359530a3a1a1	1.0	PubMed	23820376	Like other known substrates, through its WD domain Fbw7 physically interacts with CPD motifs of G-CSFR that are apparently phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CPD, pmod(Ph))
199bb027-8532-487a-b7b6-ef476783bd82	1.0	PubMed	12162494	GSK-3 can phosphorylate CREB at S129  Transactivation of CREB is significantly reduced (p ≤ 0.05) by 86% for the S129A mutant	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CREB1, pmod(Ph, Ser, 129))
a837ae76-68cc-444d-9ee9-87c143f5716c	1.0	PubMed	21145761	For example, phosphorylation of c-Jun, AP-1, or CREB by GSK3beta negatively regulates the DNA binding activities of these transcription factors ().	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:CREB, pmod(Ph))
b3f3ddd8-e84e-495e-845c-ef678a5af202	1.0	PubMed	PMC6180953	We propose that GSK-3beta phosphorylates CREB at serine 129 and thus is required for the increased transcriptional activity of CREB in response to PTH.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:CREB, pmod(Ph, Ser, 129))
b3f3ddd8-e84e-495e-845c-ef678a5af202	1.0	PubMed	6180953	We propose that GSK-3beta phosphorylates CREB at serine 129 and thus is required for the increased transcriptional activity of CREB in response to PTH.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:CREB, pmod(Ph, Ser, 129))
b3f3ddd8-e84e-495e-845c-ef678a5af202	1.0	PubMed	25412261	Activated PKB phosphorylates and activates CREB at Ser133, but it also phosphorylates and inactivates GSK-3beta, which stabilizes CREB (GSK-3beta phosphorylates CREB at Ser129, causing CREB downregulation) XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:CREB, pmod(Ph, Ser, 129))
b3f3ddd8-e84e-495e-845c-ef678a5af202	1.0	PubMed	21044077	Glycogen Synthase Kinase-3beta (GSK3beta), a kinase implicated in neurodegenerative and psychiatric disorders, phosphorylates CREB at Ser 129.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:CREB, pmod(Ph, Ser, 129))
b3f3ddd8-e84e-495e-845c-ef678a5af202	1.0	PubMed	27043582	GSK3beta phosphorylates CREB at Ser129 and subsequently induces CREB transcriptional activity [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:CREB, pmod(Ph, Ser, 129))
61953f3f-b9d1-4fbe-b742-afb35b251bf7	1.0	PubMed	25887375	As seen in C, GSK3beta inhibition resulted in the increased phosphorylation of CREB (ser 133).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:CREB, pmod(Ph, Ser, 133))
861a91b1-1451-4b0d-8279-733d0c5e4253	1.0	PubMed	16611631	Using in vitro kinase assays and pharmacological inhibition of gsk3 as described above for crmp2 and crmp4, it was found that thr509 (and presumably ser518 and thr514) of human crmp1 is phosphorylated by gsk3, following priming of ser522 by cdk5	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CRMP1, pmod(Ph, Ser, 518))
d9e503bb-6c9b-4353-9145-0cea552c6a22	1.0	PubMed	16611631	In summary, phosphorylation of thr509 of human crmp1 appears to be regulated by two mechanisms; direct phosphorylation by cdk5, or by priming of ser522 by cdk5 followed by sequential phosphorylation of ser518, thr514, and thr509 by gsk3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CRMP1, pmod(Ph, Thr, 509))
5fd4a5c3-f61b-430a-b5a1-0596c2ae2a92	1.0	PubMed	16611631	Using in vitro kinase assays and pharmacological inhibition of gsk3 as described above for crmp2 and crmp4, it was found that thr509 (and presumably ser518 and thr514) of human crmp1 is phosphorylated by gsk3, following priming of ser522 by cdk5	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CRMP1, pmod(Ph, Thr, 514))
d5537958-f85f-4b46-ba64-32707a137134	1.0	PubMed	21179498	GSK-3beta phosphorylates PER2, CRY2, REV-ERBalpha, CLOCK, and BMAL1 for functional regulation XREF_BIBR - XREF_BIBR, and pharmacological and RNAi based inhibition of GSK-3beta causes period shortening in cultured cells XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CRY2, pmod(Ph))
0387e834-2498-449c-9888-78f019eca4ef	1.0	PubMed	23820376	This process is promoted by GSK3beta which presumably phosphorylates G-CSFR in its potential CPDs and thus facilitates its recognition by Fbw7 for subsequent ubiquitin-proteasome degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CSF3R, pmod(Ph))
0387e834-2498-449c-9888-78f019eca4ef	1.0	PubMed	23820376	The presence of five such similar motifs in G-CSFR encouraged us to hypothesize that GSK3beta might also phosphorylate G-CSFR within putative CPD motifs for Fbw7 recognition and subsequent degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CSF3R, pmod(Ph))
0387e834-2498-449c-9888-78f019eca4ef	1.0	PubMed	23820376	The fact that increasing doses of GSK3beta or GSK3S9A persistently inhibits the expression of both G-CSFR and G-CSFR-T718 suggests that GSK3beta may phosphorylate G-CSFR probably in its CPDs marking it to be recognized by Fbw7 for efficient degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CSF3R, pmod(Ph))
90478a6c-9ab5-498b-b1e1-0f376e04d25b	1.0	PubMed	19576224	To see whether GSK3beta dependent phosphorylation of CSN1 has any impact on CSN based supercomplex formation, CSN1 or the N-terminal fragment were over-expressed in Flag-CSN2-B8 cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CSN1S1, pmod(Ph))
462fda9d-6ec6-4385-80ed-21406f4eab4b	1.0	PubMed	24975844	These results suggest that GSK3beta activity could lead to the degradation of beta-catenin via a proteasome mediated mechanism.Since GSK3beta phosphorylates beta-catenin at serine 33, mutant beta catenin S33Y, which can not be phosphorylated by GSK3beta, and hence is resistant to phosphorylation dependent degradation, was transfected with S100A4 into 293T cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph), var(p.Ser33Tyr))
97418682-6b3b-433c-a8ae-f6f2ebd982ed	1.0	PubMed	20126258	The T41A mutant of beta-catenin used in reporter studies can not be phosphorylated by GSK-3beta XREF_BIBR and is therefore constitutively stabilized and activated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph), var(p.Thr41Ala))
c36f9267-b3d4-4d70-8133-4dd8cacdae90	1.0	PubMed	20215423	GSK-3beta phosphorylates beta-catenin at threonine 41, serine 37, and serine 33 residues, thereby facilitating its ubiquitination and proteosomal degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 33))
c36f9267-b3d4-4d70-8133-4dd8cacdae90	1.0	PubMed	16942611	CKI, which is recruited to the destruction complex by the axin binding protein diversin [XREF_BIBR], phosphorylates beta-catenin at serine 45, an important priming step required by GSK-3beta to mediate beta-catenin phosphorylation at threonine 41, serine 37 and serine 33.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 33))
c36f9267-b3d4-4d70-8133-4dd8cacdae90	1.0	PubMed	11389839	Unlike beta-TrCP, however, which requires GSK3beta mediated phosphorylation of beta-catenin on serine 33 and serine 37, Ebi interacts with beta-catenin independently of these phosphorylation sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 33))
c36f9267-b3d4-4d70-8133-4dd8cacdae90	1.0	PubMed	24975844	These results suggest that GSK3beta activity could lead to the degradation of beta-catenin via a proteasome mediated mechanism.Since GSK3beta phosphorylates beta-catenin at serine 33, mutant beta catenin S33Y, which can not be phosphorylated by GSK3beta, and hence is resistant to phosphorylation dependent degradation, was transfected with S100A4 into 293T cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 33))
3266490b-a287-40ac-b6c8-4da2eff73220	1.0	PubMed	20215423	GSK-3beta phosphorylates beta-catenin at threonine 41, serine 37, and serine 33 residues, thereby facilitating its ubiquitination and proteosomal degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 37))
3266490b-a287-40ac-b6c8-4da2eff73220	1.0	PubMed	16942611	CKI, which is recruited to the destruction complex by the axin binding protein diversin [XREF_BIBR], phosphorylates beta-catenin at serine 45, an important priming step required by GSK-3beta to mediate beta-catenin phosphorylation at threonine 41, serine 37 and serine 33.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 37))
3266490b-a287-40ac-b6c8-4da2eff73220	1.0	PubMed	11389839	Unlike beta-TrCP, however, which requires GSK3beta mediated phosphorylation of beta-catenin on serine 33 and serine 37, Ebi interacts with beta-catenin independently of these phosphorylation sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 37))
94636adc-6954-4a03-a65f-7b0783aa852f	1.0	PubMed	20215423	GSK-3beta phosphorylates beta-catenin at threonine 41, serine 37, and serine 33 residues, thereby facilitating its ubiquitination and proteosomal degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 41))
94636adc-6954-4a03-a65f-7b0783aa852f	1.0	PubMed	16942611	CKI, which is recruited to the destruction complex by the axin binding protein diversin [XREF_BIBR], phosphorylates beta-catenin at serine 45, an important priming step required by GSK-3beta to mediate beta-catenin phosphorylation at threonine 41, serine 37 and serine 33.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, 41))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21056029	Phosphorylation of beta-catenin by GSK3beta leads to its degradation by the ubiquitin dependent proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26564738	The activated GSK-3beta then phosphorylates beta-catenin and promotes its binding to APC, which blocks Wnt pathway and EMT via ubiquitination XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC6269314	In conclusion, we have found that the Arg(96) mutant has a dominant-negative effect on GSK-3beta-dependent phosphorylation of beta-catenin and that targeting of beta-catenin for degradation requires prior priming through phosphorylation of Ser(45).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23954131	In the absence of Wnt signaling, beta-catenin is phosphorylated by CK1 and GSK3beta, subsequently resulting in the polyubiquitination and degradation of beta-catenin by the 26S proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22470507	The interaction of GSK-3beta with axin in the complex facilitates efficient phosphorylation of beta-catenin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21035499	beta-catenin is phosphorylated in its N-terminal domain by GSK-3beta, which leads to its degradation by the ubiquitination ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26739898	In normal epithelium, beta-catenin is associated with E-cadherin, and any free cytosolic beta-catenin is phosphorylated by GSK3beta and targeted for ubiquitin dependent degradation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21689639	In the absence of Wnt, beta-catenin is phosphorylated and degraded by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22110662	Phosphorylation of beta-catenin by GSK-3beta causes its degradation through the ubiquitin-proteasome system.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22534782	Phosphorylation of beta-catenin by GSK-3beta results in ubiquitin mediated degradation of beta-catenin, reducing translocation of beta-catenin into the nucleus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25873176	In so doing, TGIF could conceivably hinder beta-Catenin phosphorylation by GSK3beta, and its subsequent degradation by betaTRCP.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	11136974	In the current view, phosphorylation of beta-catenin by GSK-3beta (glycogen synthase kinase-3beta) regulates the turnover of beta-catenin (reviewed by).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	11136974	Active Wnt signaling inhibits the phosphorylation of beta-catenin by GSK-3beta by a mostly unknown mechanism, thus preventing the degradation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24447505	(XREF_BIBR, XREF_BIBR) Wnt signaling suppresses phosphorylation of beta-catenin by GSK-3beta, leading to the accumulation of beta-catenin in nuclei.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25026278	In the WNT and beta-catenin pathway, the N-terminal phosphorylation of beta-catenin by GSK-3beta is a key control point for ubiquitin dependent beta-catenin degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	17987039	Inhibition of GSK3beta decreases phosphorylation of beta-catenin, preventing its degradation by the ubiquitin mediated pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	14706341	beta-catenin is phosphorylated in its N-terminal domain by GSK-3beta, which leads to its degradation mediated by the SCF/ubiquitin/proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC5534018	In the prevailing model in the literature, GSK3beta-dependent phosphorylation of these sites targets beta-catenin for ubiquitin-mediated degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23085750	In hepatocytespecific APC knockout mice, beta-catenin is no longer phosphorylated by GSK3beta, leading to increased levels of beta-catenin protein and subsequent hepatocyte proliferation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18281035	In the absence of Wnt family proteins in the Wnt-beta-catenin pathway, beta-catenin is complexed with Axin and GSK3beta, and beta-catenin phosphorylated by GSK3beta is degraded by the ubiquitin-proteasome system.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24923353	GSK-3beta phosphorylates beta-catenin and subsequently facilitates beta-catenin ubiquitination and degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	27572267	For example, GSK3beta phosphorylates beta-catenin, incorporating beta-TrCP for protein degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19481076	beta-catenin levels are normally limited through continuous proteasome mediated degradation of phosphorylated beta-catenin, which is catalyzed by the enzyme GSK-3beta in a " destruction complex " brought together by Axin and APC [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21986318	XREF_BIBR, XREF_BIBR) Cytoplasmic beta-catenin is degraded after it was phosphorylated by GSK3beta, which was shown to be phosphorylated and inactivated by Akt.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23648139	When Wnt pathway is activated, beta-catenin phosphorylation by GSK-3beta is inhibited.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22095064	A key underlying mechanism was shown to be the loss the ability of DISC1 to interact with and inhibit glycogen synthase kinase-3beta (GSK3beta) (XREF_FIG), which in turn phosphorylates beta-catenin and mediates its degradation 87.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26592459	The serine/threonine kinase GSK3beta, which mediates phosphorylation of beta-catenin and boosts thereby its degradation, represents an important hub in Wnt and Notch signaling crosstalk ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23913826	In the canonical Wnt and beta-catenin pathway, the binding of Wnts such as WNT3A to the receptors activates a signaling cascade that prevents phosphorylation of cytoplasmic beta-catenin by GSK-3beta and results in its cytoplasmic accumulation followed by nuclear translocation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22496417	Active GSK-3beta phosphorylates beta-catenin, marking it for proteasomal degradation, thereby preventing accumulation of beta-catenin (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18835279	The N terminus of beta-catenin can either be phosphorylated by GSK3beta and then degraded sequentially by the proteasome, or it binds simultaneously to alpha-catenin and E-cadherin, having a crucial role in cell adhesion.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24735796	In the absence of Wnt signaling, beta-catenin is phosphorylated by GSK-3beta and degraded via proteasome activation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24735796	The binding of a Wnt ligand to its receptor, composed by a member of the Frizzled (Fzd) family and low-density lipoprotein-receptor-related proteins (LRP5 or LRP6), recruits the cytoplasmic adapter protein disheveled (Dvl) to the destruction complex through interaction with axin, inhibiting beta-catenin phosphorylation by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25660336	These mutations were single-base substitutions that were located within the critical serine residues for GSK-3beta phosphorylation of beta-catenin (codons 29-48).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	14636889	GSK3beta dependent phosphorylation of beta-catenin has been demonstrated in a complex with Axin, a negative regulator of Wnt and Wingless signalling.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19711366	As a negative regulator, cytosolic GSK3beta (and GSK3alpha) phosphorylates beta-catenin to promote its degradation, phosphorylates APC to increase its binding to beta-catenin [XREF_BIBR] and phosphorylates axin in the destruction complex which stabilizes axin and increases its affinity for beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19711366	In the absence of the Wnt ligand, GSK3beta phosphorylates cytosolic beta-catenin at Thr 41 and Ser 33/37 in the destruction complex priming beta-catenin for ubiquitinylation and degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19711366	The ability of LRP6-ICD to functionally affect GSK3beta mediated phosphorylation of beta-catenin independent of axin has recently been demonstrated in vitro [XREF_BIBR; XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	6660510	Quantitative analysis suggests that the interaction of GSK3beta with the axin scaffold enhances phosphorylation of beta-catenin by> 20 000-fold.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	27871173	CK1 and GSK3beta sequentially phosphorylate beta-catenin, which results in recognition by the E3 ubiquitin protein ligase beta-TrCP and subsequent ubiquitin dependent proteasomal degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23646120	In its inactive state, Gsk3b fails to phosphorylate Ctnnb1, leading to its cytoplasmic accumulation and subsequent transport to the nucleus where it affects transcription of several Wnt-target genes including c-Myc and Axin2 XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	11348595	Phosphorylation of beta-catenin by GSK-3beta occurs in a multiprotein complex that includes the tumor suppressor Adenomatous Polyposis Coli (APC) and Axin, both of which bind to beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15905022	Phosphorylation of beta-catenin by GSK-3beta leads to proteosomal degradation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23582741	beta-Catenin can be phosphorylated by GSK-3beta at specific N-terminal residues (Ser 33/37) and subsequently targeted towards the ubiquitin-proteasomal degradation pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23582741	Furthermore, immunoprecipitation assay showed that GSK-3beta phosphorylated a less amount of beta-catenin after Fas activation, and that this is ERK and MAPK dependent (d).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22364879	When cells arrest their growth upon commitment to differentiation, the active and dephosphorylated glycogen synthase kinase 3beta (GSK3beta), as part of a large protein complex comprising APC and axin, phosphorylates beta-catenin to be degraded.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24736394	In the absence of Wnt ligands, cytoplasmic beta-catenin is constitutively phosphorylated by CK1 and GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24736394	Therefore, the mutant 4 beta-catenin was not phosphorylated by CK1 and GSK-3beta, and degraded by proteasome mediated pathway, which leads to stabilized beta-catenin and a constitutively active beta-catenin and TCF transcriptional activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24736394	First, beta-catenin phosphorylated by CK1 and GSK-3beta could be subjected to the ubiquitin dependent degradation E3 ubiquitin ligase beta-TrCP mediates in the canonical pathway XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC5121045	Axin promotes the phosphorylation of beta-catenin by GSK-3beta, leading to beta-catenin degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16696969	GSK-3beta phosphorylates beta-catenin and thereby marks it for degradation by the ubiquitin proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	5121045	Axin promotes the phosphorylation of beta-catenin by GSK-3beta, leading to beta-catenin degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25639486	In the canonical Wnt pathway, phosphorylation of beta-catenin by GSK-3beta followed by binding with beta-TrCP results in beta-catenin degradation 3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	17697341	Phosphorylation of beta-catenin by GSK-3beta then targets beta-catenin for proteolysis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24607787	This complex promotes phosphorylation of beta-catenin by casein kinase 1 (Ck1) and GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21949350	GSK-3beta phosphorylates the transcription factor Armadillo and beta-catenin, which targets it for degradation (XREF_BIBR); thus a reduction in sgg may suppress tau toxicity by allowing increased Armadillo to activate transcription of target genes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	14662741	APC regulates beta-catenin levels by forming a complex with beta-catenin, Axin, and GSK3beta that leads to the phosphorylation of beta-catenin and its degradation through ubiquitin mediated proteolysis (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20654575	In this pathway, inhibition of beta-catenin phosphorylation by GSK3beta triggers beta-catenin stabilization and its accumulation in the cytoplasm and subsequently in the nucleus where beta-catenin acts as co-activator for the TCF7 and LEF1 transcription factors.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25051360	In contrast, other cases GSK-3beta acts as a tumor suppressor and induces beta-catenin phosphorylation and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26940070	Next, GSK3beta kinase phosphorylates the N-terminus of beta-catenin at the Ser33/37/Thr41 residues and targets it for degradation via the ubiquitin-proteasome system.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25733387	The direct interaction of beta-catenin and APC and indirect recruitment of the Axin, GSK3beta, CK1, SCF, beta, and TrCP complex to the IQGAP1 scaffold demonstrate that under steady state, casein kinase 1 (CK1) phosphorylates GSK3beta, which in turn constitutively phosphorylates beta-catenin and directs it for degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22640743	CK-1alpha and GSK-3beta phosphorylate beta-catenin on Ser 45 and Ser 33/37/Thr -41 sites, respectively, leading to its ubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25262469	beta-catenin stabilization and stimulation of beta-catenin and TCF signaling required the catalytic activity of E6AP, the kinase activity of GSK3beta, and the phosphorylation of beta-catenin by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25305448	Axin2, a Wnt signaling upstream gene of beta-catenin, efficiently supports the GSK3beta dependent phosphorylation of beta-catenin in normal cells, which subsequently marks the posttranslationally modified protein for beta-TrCP-dependent ubiquitination and proteosomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12554650	Quantitative analysis suggests that the interaction of GSK3beta with the axin scaffold enhances phosphorylation of beta-catenin by> 20 000-fold.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24901051	29 GSK3beta phosphorylates the cotranscriptional activator beta-catenin, thus targeting it for ubiquitination and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21383695	beta-catenin is phosphorylated by GSK3beta, which targets it for proteasome degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20043299	Cytoplasmic levels of beta-catenin are regulated by a degradative complex composed of axin, adenomatous polyposis coli (APC) tumor suppressor, and GSK3-beta which phosphorylates beta-catenin for ubiquitination and degradation by the proteasome [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22025562	In the canonical Wnt signaling pathway, GSK3beta phosphorylation of beta-catenin promotes proteasomal targeting and degradation of beta-catenin (XREF_BIBR - XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC7217280	FGF2 increases beta-catenin signaling through several different mechanisms including increased expression of beta-catenin mRNA, increased nuclear translocation of beta-catenin, increased phosphorylation of GSK-3beta, and tyrosine phosphorylation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25491510	GSK3beta is known to suppress beta-catenin-dependent oncogenic signaling pathway by phosphorylating beta-Catenin [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23337036	CK1 and GSK3beta sequentially phosphorylate beta-catenin, leading to its ubiquitination and subsequent proteasome mediated degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20093106	In the absence of the Wnt ligand, cytosolic beta-catenin that is associated with a multiprotein complex consisting of Axin, adenomatous polyposis coli (APC), and glycogen synthase kinase 3beta (GSK3beta) is constitutively phosphorylated by GSK3beta and degraded by the ubiquitin-proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20093106	Binding of Wnt ligand to Frizzled and LRP5 and LRP6 inhibits the phosphorylation of beta-catenin by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19249679	These results are consistent with the possibility that ATDC may interfere with GSK-3beta- dependent phosphorylation of beta-catenin by the destruction complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19249679	Activated Dvl binds to the Axin and GSK3beta complex and antagonizes GSK-3beta dependent phosphorylation of beta-catenin in a manner not dissimilar to what we observed with ATDC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19249679	Interaction of GSK3beta with Axin in the complex facilitates efficient phosphorylation of beta-catenin by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19249679	When Wnt binds to the frizzled and LRP co-receptors at the cell surface, a cytoplasmic protein, Dvl, antagonizes GSK-3beta dependent phosphorylation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19471023	This destruction complex enhances the phosphorylation of CTNNB1 by GSK3beta (glycogen synthase kinase 3beta), thus targeting it for ubiquitin mediated degradation by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20173740	Of note, this suppression of E-cadherin expression also led to a reduction of beta-catenin phosphorylation by GSK-3beta through unknown regulatory mechanisms, thereby enabling the liberated beta-catenin to escape proteasome mediated degradation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23784889	GSK-3beta phosphorylates beta-catenin, which marks ubiquitin dependent degradation by the proteasome, thereby maintaining low levels of free cytoplasmic beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC5521612	Glycogen synthase kinase-3 beta (GSK-3 beta) phosphorylated beta-catenin slightly in the presence of either APC-(1211-2075) or Axin(delta)(beta)(-catenin), in which the beta-catenin-binding site is deleted, and greatly in the presence of both proteins.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC5521612	The enhancement of the GSK-3 beta-dependent phosphorylation of beta-catenin was eliminated by the APC-binding site of Axin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25164084	When Wnt signals are absent, free beta-catenin forms a complex with GSK3beta, APC and Axin in the cytoplasm, and is phosphorylated by CK1 and GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	5521612	The enhancement of the GSK-3 beta dependent phosphorylation of beta-catenin was eliminated by the APC binding site of Axin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	5521612	These results indicate that the complex formation of APC and Axin enhances the phosphorylation of beta-catenin by GSK-3 beta, leading to the down-regulation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC5588784	In the Axin complex, GSK-3beta efficiently phosphorylates beta-catenin, which is then ubiquitinated and degraded by proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	5588784	In the Axin complex, GSK-3beta efficiently phosphorylates beta-catenin, which is then ubiquitinated and degraded by proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25560280	We confirmed that this effect was not due to direct inhibition by PF3758309 of GSK3beta, which phosphorylates beta-catenin at S33/37 (online).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23673211	CK1 and GSK-3beta phosphorylate beta-catenin, resulting in its subsequent polyubiquitination and degradation and therefore maintenance of very low levels in the cytoplasm.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23673211	beta-catenin is subsequently phosphorylated by GSK-3beta, which targets it for ubiquitination and proteolytic degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23673211	Activation of Wnt and beta-catenin signaling inhibits formation of the multi protein complex, and phosphorylation of beta-catenin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23490077	In the absence of Wnt signal, GSK-3beta and casein kinase 1 (CK1) phosphorylate beta-catenin XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15642117	This signal antagonizes the phosphorylation of beta-catenin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23431386	Only cytosolic beta-catenin can be phosphorylated by GSK-3-beta XREF_BIBR, so the alteration of beta-catenin in whole cell lysate is not distinct with TNFalpha treatment.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23243000	In addition to disruption of VE-cadherin and beta-catenin complexes, treatment of vascular EC with apo (a) attenuates the phosphorylation of beta-catenin at Ser 33,-37/Thr-41 by GSK-3beta (XREF_FIG), thus causing a decrease in the degradation of cytoplasmic beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19589401	As expected, phosphorylation of beta-catenin (Ser33/37/Thr41) by GSK3beta decreased when RCJ cells were treated with WT FGF9 for 24 hr, and subsequently total beta-catenin and its downstream target c-Myc were significantly induced.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23600975	XREF_BIBR Wnt binds to frizzled-type receptors and activates disheveled, which downregulates the destruction complex comprising axin, adenomatous polyposis coli (APC), casein kinase 1 (CK1), and glycogen synthase kinase 3beta (GSK-3beta) that would normally phosphorylate beta-catenin, marking it for degradation by the multiprotein ubiquitin and proteasome complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24721736	This complex promotes phosphorylation of beta-catenin by casein kinase 1alpha (CK1alpha) and GSK-3beta, marking it for ubiquitylation and subsequent proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24721736	beta-catenin is tightly regulated and its levels and activity are attenuated mainly by GSK-3beta that binds and phosphorylates beta-catenin, marking it for degradation by the proteasome ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	14644163	LiCl, a chemical inhibitor of GSK-3beta, can mimic the canonical pathway by inhibiting GSK-3beta phosphorylation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19237607	Under normal conditions, free beta-catenin is rapidly phosphorylated by GSK-3beta and subsequently degraded in the ubiquitin-proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26110841	GSK3beta inhibits Wnt signaling by promoting phosphorylation and degradation of beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25431208	GSK-3beta phosphorylates the N-terminal domain of beta-catenin, resulting in the ubiquitylation and degradation of beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20668165	Consistent with the increased abundance of beta-catenin in the cytosol (XREF_FIG A), the extent of phosphorylation of beta-catenin by GSK3beta was decreased in Wnt3a stimulated C2C12 cells that had been depleted of PDZRN3 (XREF_FIG B).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	6752950	Wnt pathway mutations result in biochemical mechanisms yielding inefficient phosphorylation of beta-catenin by GSK3beta due to APC, beta-catenin and/or axin mutations.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	17098228	Although GSK-3beta also phosphorylates beta-catenin, targeting it for ubiquitination and degradation by proteasomal degradation, beta-catenin does not appear to be the critical substrate by which GSK-3beta triggers neuronal cell death.In summary, Akt promotes zinc induced neuronal apoptosis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26282852	beta-catenin is phosphorylated by GSK3beta, so glycogen production has an inverse relationship with phosphorylated beta-catenin levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22739727	In this complex, Axin acts as a scaffold protein, upon which adenomatous polyposis coli (APC) tumor suppressor protein, glycogen synthase kinase 3beta (GSK-3beta) and casein kinase 1alpha (CK1alpha) bind to facilitate the sequential phosphorylation of beta-catenin by kinase CK1alpha and GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19000719	beta-catenin can be phosphorylated by GSK3beta and regulated by the proteosome dependent degradation machinery, and Notch2 is also associated with GSK3beta, which inhibits the Notch2 activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22123293	Normally Gsk3beta phosphorylates beta-catenin, marking it for ubiquitin mediated degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24403311	These results suggest that in these CRC cells, depletion of the alpha6A integrin variant interferes with the Wnt and beta-catenin pathway by enhancing the phosphorylation of beta-catenin by GSK3beta, targeting it to proteasome degradation and consequently reducing its accumulation in the nucleus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26392741	The direct inhibition of GSK-3beta catalytic activity prevents phosphorylation of the downstream substrates, beta-catenin and HIF-1alpha.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20971552	In the absence of a Wnt signal, beta-catenin is phosphorylated by GSK3beta and targeted for degradation through the ubiquitin-proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15492040	Moreover, cells transfected with a form of beta-catenin that can not be phosphorylated by GSK3beta and casein kinase (CK1; S/T> A point mutants at residues 33, 37, 41 and 45) exhibit binding selectivity similar to cells transfected with wild-type beta-catenin (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15327768	In the absence of a Wnt, casein kinase 1alpha (CK1alpha) and glycogen synthase kinase-3beta (GSK-3beta) phosphorylate cytosolic beta-catenin, thereby flagging it for recognition and destruction by the ubiquitin and proteosome machinery.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15327768	The observation of scaffolding on the phosphorylation of beta-catenin by CK1epsilon and GSK-3beta makes it likely that axin has a similar effect on the modification of APC.Mutagenesis studies and a recent crystal structure of an axin peptide bound to beta-catenin demonstrate that axin binds to beta-catenin at a site on repeats 3-5 that overlaps that of the phosphorylated APC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25546293	XREF_BIBR, XREF_BIBR In this complex, beta-catenin is constitutively phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12000790	Normally, cytoplasmic beta-catenin associates with APC and axin and is continuously phosphorylated by GSK-3beta, marking it for proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20470940	In the absence of Wnt signaling, beta-catenin is phosphorylated by GSK-3beta, which leads to its rapid degradation by the ubiquitin pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19887615	In the absence of Wnt signaling, beta-catenin (contained within a multiprotein complex of axin, APC and GSK3beta) is phosphorylated by GSK3beta and subsequently degraded by ubiquitin dependent proteolysis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24384091	Phosphorylation of MUC1-C by EGFR or SRC leads to the increase of cytoplasmic and nuclear beta-catenin levels, notably by increasing MUC1 and beta-catenin complexes and blocking the GSK3beta phosphorylation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19941816	GSK-3beta phosphorylates the N-terminal domain of beta-catenin, which leads to beta-catenin degradation via the SCF/ubiquitin/proteasome pathway (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19060929	The phosphorylation of beta-catenin (Ser33/37/Thr41) by GSK-3beta is known to target beta-catenin towards degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19060929	The phosphorylation of beta-catenin by the kinase active GSK-3beta leads to ubiquitination and proteosomal degradation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19060929	The phospho-GSK-3beta is kinase inactive and can not phosphorylate beta-catenin, thus leading to a more stable beta-catenin with its accumulation and subsequent nuclear localization which was detected as shown in XREF_FIG.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21851818	beta-catenin is sequentially phosphorylated by CK1 and GSK-3beta, which leads to ubiquitination and subsequent proteolytic degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16942611	Not surprisingly, the critical serine/threonine residues of beta-catenin that are phosphorylated by GSK-3beta are mutational ' hot spots ' in many cancers.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18806787	Constitutively, in Wnt-off phase, beta-catenin is phosphorylated by GSK-3beta, binds to the destruction complex in the cytosol and gets degraded.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	11389840	In the absence of Wnt signaling, the cytoplasmic level of beta-catenin is kept low through interaction with a protein complex comprised of APC, Axin, protein phosphatase 2A (PP2A), and glycogen synthase kinase 3beta (GSK3beta), where beta-catenin is phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19524533	In the absence of Wnt stimulus, glycogen synthase kinase 3beta (GSK3beta) phosphorylates beta-catenin in an N-terminal sequence that serves as a phosphodegron that is recognized by the beta-TrCP1 ubiquitin ligase (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26431491	Mutated CTNNB1 expresses stabilized beta-catenin, which can not be phosphorylated by GSK3beta [XREF_BIBR], leading to further activation of the mTOR pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22469663	However, increased phosphorylation of 4B3-bindable beta-catenin at both Ser33/Ser37/Thr41 and Thr41 and Ser45 in the presence of two different GSK3beta inhibitors suggests that GSK3beta does not directly phosphorylate the N-terminal tail of 4B3-bindable beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23326460	In the absence of the Wnt signaling, beta-catenin is tightly regulated by a multiprotein degradation complex, in which beta-catenin is phosphorylated by GSK3beta, leading to its degradation via the ubiquitin-proteasome pathway XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20711340	Phosphorylation of beta-catenin by GSK3beta targets beta-catenin to ubiquitination and proteasome degradation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26166436	In the canonical Wnt and beta-catenin signaling pathway, GSK-3beta phosphorylates the amino terminal region of beta-catenin, with subsequent beta-catenin ubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25499972	Phosphorylation of beta-catenin by GSK-3beta induces its degradation and GSK-3beta is inactivated by AKT and PKB phosphorylation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18328427	Phosphorylation of beta-catenin by GSK3beta targets it for proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18328427	Inhibition of GSK3beta, as reported here, allows unphosphorylated beta-catenin to accumulate and translocate into the nucleus, where it functions as a cofactor for transcription factors of the TCF/Lef family ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21087614	Scaffolding of APC, GSK3beta, and beta-catenin by Axin dramatically enhances GSK3beta mediated phosphorylation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23408967	In normal cells, the known function of GSK3beta in mediating Wnt and beta-catenin signaling depends on cell membrane associated fraction of GSK3beta that antagonizes the phosphorylation of beta-catenin by cytoplasmic GSK3beta, a key step initiating beta-catenin degradation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25359619	LiCl treatment, which has been previously reported to up-regulate the Wnt signaling pathway by inhibiting GSK3-beta phosphorylation of beta-catenin [XREF_BIBR], significantly stimulated the Gli2 and PTHrP promoter regions in RWGT2 cells (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20519433	Sequential phosphorylation of beta-catenin by CKI and GSK3beta leads to ubiquitination and degradation of beta-catenin by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20519433	A Complex of APC and beta-Catenin at the Lateral Membrane Is Phosphorylated by GSK3beta and CKI.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20837771	Phosphorylation of beta-catenin by GSK-3beta leads to beta-TrCP binding, which results in beta-catenin degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22615875	In the absence of Wnt ligand, cytosolic beta-catenin levels are down-regulated via a degradation complex including CK1alpha, GSK3beta, Axin, APC, and PP2A in which processive phosphorylation of beta-catenin by CK1alpha and GSK3beta leads to its ubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24151146	However, following induction of Wnt signaling GSK-3beta activity is inhibited resulting in reduced phosphorylation of beta-Catenin at Ser33/37/Thr41 residues leading to its subsequent release from its destruction protein complex and its further transportation to the nucleus, where it associates with DNA binding factors to activate target genes involved in the regulation of cell division [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	27529071	In the absence of Wnt signaling, beta-catenin is phosphorylated by GSK-3beta and targeted for degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24993527	As GSK-3beta phosphorylates beta-catenin, thus targeting the latter for degradation we examined whether expression of ALDOC and ALDOB change the phosphorylation levels of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24501426	Note that beta-catenin phosphorylated by Nek2 (XREF_FIG, B and C, lane 4) migrated more slowly in SDS-PAGE than beta-catenin phosphorylated by GSK3beta and CK1 (XREF_FIG, B and C, lane 2), which is likely due to the additional Nek2 phosphorylation sites in the beta-catenin N-terminus (XREF_FIG and Supplemental FigureS1).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23076981	Inhibition of beta-catenin phosphorylation (Ser33, Ser37, Thr41 and Ser45) by CD82 also suggests that beta-catenin may be differently phosphorylated by GSK-3beta and CK1alpha.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24501426	It is well known that GSK3beta phosphorylation of beta-catenin at S33/S37/T41 targets beta-catenin for ubiquitination by the E3 ligase, beta-TrCP, and subsequent degradation by the proteasome (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24501426	To test directly whether GSK3beta caused S33/S37/T41 beta-catenin phosphorylation at centrosomes during mitosis, we used variants of the HCT116 cell line in which the wild-type beta-catenin allele had been deleted and the other beta-catenin allele contained an in-frame deletion of serine 45 (18 -/DeltaS45) (XREF_BIBR); DeltaS45 inhibits GSK3beta specific phosphorylation of S33/S37/T41 on beta-catenin because the CK1alpha priming phosphorylation on S45 is deleted (Supplemental FigureS4; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24501426	Because we used a cell line, HCT116 18 -/DeltaS45, expressing only DeltaS45 beta-catenin for the centrosome preparations, we conclude that phosphorylation of S33/S37/T41 beta-catenin at mitotic centrosomes is not caused by GSK3beta activity (see also XREF_FIG and Supplemental FigureS4).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24501426	Only Par WT/DeltaS45 and 85 WT/- cells treated with 20 mM LiCl had a small (~ 20%) reduction in fluorescence intensity of phospho-S33/S37/T41 reactivity at mitotic spindle poles (XREF_FIG), which could be caused by inhibition of GSK3beta phosphorylation of wild-type beta-catenin in these cells (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24501426	To test directly whether GSK3beta independent S33/S37/T41 phosphorylation of beta-catenin occurred at centrosomes, we enriched centrosomes from HCT116 18 -/DeltaS45 cells in which the wild-type beta-catenin allele was deleted and the other allele contained a beta catenin mutant with the in-frame deletion of S45; S45 is the CK1 priming site required for subsequent GSK3beta phosphorylation of S33/S37/T41 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC6329679	Normally, cytoplasmic beta-catenin associates with APC and axin and is continuously phosphorylated by GSK-3beta, marking it for proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26029888	The beta-catenin stability is regulated by a destruction complex, formed by axin, adenomatous polyposis complex (APC), casein kinase 1 and glycogen synthase kinase-3beta (GSK-3 beta) that phosphorylates beta-catenin at its N-terminus and leads to its ubiquitylation and subsequent proteasomal degradation [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	6329679	Normally, cytoplasmic beta-catenin associates with APC and axin and is continuously phosphorylated by GSK-3beta, marking it for proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12057932	Mutations that affect GSK-3B phosphorylation of beta-catenin prevent ubiquitination and degradation, resulting in cytoplasmic accumulation and nuclear translocation of beta-catenin, which accounts for the immunoreactivity observed in this study.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12057932	Mutations in the gene encoding beta-catenin typically affect the phosphorylation site thereby inhibiting GSK-3B phosphorylation of beta-catenin that prevents ubiquitination and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24882689	GSK-3beta phosphorylates beta-catenin, targeting it for ubiquitination by an SCF (Skp1 and F-box)-CRL (cullin RING ubiquitin E3 ligase) that harbors beta-TrCP1 (beta-transducin repeat containing protein 1) as an F-box protein.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21303971	beta-catenin phosphorylation by GSK-3beta results in binding beta-TRCP and HOS and its ubiquitylation by SCF beta-TRCP leading to proteasomic degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25662052	Binding of a secreted Wnt protein to the frizzled receptor promotes intracellular signaling through various proteins, one of which is GSK3beta that in turn phosphorylates beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21118991	GSK-3beta and CK1 phosphorylate beta-catenin at several serine/threonine residues (Kimelman and Xu, XREF_BIBR), and the phosphorylated protein is then recognized and ubiquitinated by E3 ligases.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21118991	Although GSK-3beta levels were unchanged by EDD overexpression, GSK-3beta phosphorylation of beta-catenin seemed to be important for EDD 's function, as the GFP-S33A-beta-catenin protein was hardly affected by EDD (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21118991	Furthermore, in COLO320 and SW480 cells, where GSK-3beta can not phosphorylate beta-catenin, silencing of EDD had no effect on beta-catenin and TCF-mediated transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21118991	Although GSK-3beta is a negative regulator of the Wnt pathway (Kimelman and Xu, XREF_BIBR), our results show that GSK-3beta is involved in EDD mediated activation of beta-catenin and that phosphorylation of beta-catenin by GSK-3beta is required for its EDD induced ubiquitination.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24162018	APC acts as a scaffold, binding beta-catenin and recruiting CK1alpha and GSK3beta to phosphorylate beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23525311	GSK3beta phosphorylates beta-catenin and thereby targets it for recognition by ubiquitination and consequent degradation (XREF_BIBR - XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12027456	The levels of beta-catenin within a cell are regulated via phosphorylation of the N terminus of beta-catenin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC4688250	These results indicate that Axil negatively regulates the Wnt signaling pathway by mediating GSK-3beta-dependent phosphorylation of beta-catenin, thereby inhibiting axis formation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15279902	In the absence of Wnt signaling, beta-catenin is constitutively phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16815294	This result indicates that the canonical Wnt and beta-catenin pathway enhances monocyte adhesion to endothelial cells.Without activation of the Wnt signaling pathway, a cytosolic pool of beta-catenin is phosphorylated by GSK-3beta and degraded by ubiquitin mediated proteosome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21743491	The regulation of beta-catenin activity occurs via a cytoplasmatic multiprotein complex containing GSK-3beta that phosphorylates beta-catenin, leading to its proteosomal degradation (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25691573	Finally, phosphorylation resistance mutants of beta-catenin (S33F, S37A, and T41A) that had abolished GSK3beta dependent phosphorylation of beta-catenin at Ser 33 or -37 and Thr 41, which is required for beta-catenin degradation, were also employed in analysis (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26714756	Inactivation of GSK3beta allows unphosphorylated beta-catenin to accumulate, translocate into the nucleus, and activate gene transcription by replacing co-repressor molecules bound to TCF-1 [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26714756	The active unphosphorylated GSK3beta phosphorylates beta-catenin, resulting in its proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19124717	In the absence of Wnt-ligand binding to Frizzled receptor, GSK-3beta phosphorylates beta-catenin targeting it to the ubiquitin dependent degradation pathway (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19124717	We suggest that Erk mediated phosphorylation of GSK-3beta at ser9 blocked phosphorylation and degradation of beta-catenin (XREF_BIBR), allowing its accumulation during beta-selection.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	11389839	Suppression of GSK3beta reduces phosphorylation of beta-catenin, thus eliminating binding of F box protein beta-TrCP and resulting in accumulation of beta-catenin due to reduced ubiquitin mediated proteolysis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18223684	The regulation of beta-catenin activity is thought to occur via a cytoplasmatic multiprotein complex that includes the serine/threonine kinase glycogen synthase kinase-3beta (GSK-3beta) that phosphorylates beta-catenin, marking it for degradation by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18223684	Using colorectal cell lines that express a mutant form of beta-catenin, which can not be phosphorylated by GSK-3beta and ectopically expressed mutant beta catenin protein, we show that nuclear GSK-3beta functions in a mechanism that does not involve beta-catenin phosphorylation to reduce the levels of Wnt signalling.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23056346	Similarly, erioflorin (8 h, 5 microM) stabilized the beta-TrCP-target beta-catenin, which is phosphorylated by the glycogen synthase kinase 3beta (GSK3beta) XREF_BIBR, from serum deprivation induced degradation (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24910204	It is known that phosphorylation of beta-catenin by GSK-3beta initiates its degradation by a multiprotein ' destruction complex ' [XREF_BIBR]; therefore, we examined whether PCDH20 reduced beta-catenin protein level via activation of GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	11007961	On the contrary, beta-catenin, which remains anchored to APC and axin, is phosphorylated by GSK3beta and undergoes ubiquitin mediated proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	14672538	Axin (Axil and conductin) binds to form a complex with APC, beta-catenin, and GSK3beta to promote beta-catenin phosphorylation and subsequent binding with slim (beta-TrCP) which mediates its ubiquitination and degradation in the proteasome [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25650440	In the absence of Wnt ligand, a complex of cytosolic proteins, which is referred to as the destruction complex and includes adenomatous polyposis coli (APC), AXIN, glycogen synthase kinase beta (GSK3B), casein kinase 1alpha (CSNK1A) and betaTrCP1 and betaTrCP2 (BTRC and FBXW11), sequentially phosphorylates and ubiquitinates beta-catenin, resulting in its proteasomal degradation (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24157255	Because GSK-3beta can phosphorylate beta-catenin and lead to degradation of its proteasome, this result was consistent with our finding that beta-catenin was stabilised due to the significantly reduced phosphorylation level.We showed that -induced E-cadherin downregulation and beta-catenin accumulation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12297048	GSK-3beta alone phosphorylated recombinant beta-catenin at residues 33/37/41 poorly.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12297048	For in vitro phosphorylation of GST-beta-catenin by PS1 immune complexes or by purified GSK-3beta or PKA for detection of P-45 and P-33/37/41 beta-catenin, PSN2 immune precipitates or purified enzymes were incubated with 40 ng of recombinant GST-beta-catenin in kinase buffer (50 mM HEPES [pH 7.4], 20 mM MgCl, 5 mM DTT, and protease and phosphatase inhibitors) in the presence of 200 muM ATP for the indicated times at 30degreesC, after which the proteins were fractionated on SDS-PAGE and probed for either P-45 or P-33/37/41 beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22240482	The results of interaction analyses in vitro and in vivo, together with the finding that RACK1 promoted the phosphorylation of beta-catenin (), supported the notion that RACK facilitates GSK3beta dependent phosphorylation of beta-catenin within the destruction complex.To extend the function of RACK1 involved in the destruction complex, we next asked whether RACK1 might influence the stability of the beta-catenin destruction complex, which was disrupted on the stimulation of Wnt ligands.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22240482	On the stimulation of Wnt3a, Dvl2 bound to Axin and GSK3beta complex and antagonized GSK3beta dependent phosphorylation of beta-catenin by disrupting beta-catenin destruction complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC7251397	Axin, a negative regulator of Wnt, forms a complex with glycogen synthase kinase 3beta, beta-catenin, and adenomatous polyposis coli and promotes GSK3beta-dependent phosphorylation of beta-catenin, thereby stimulating degradation of the beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25593505	GSK3-beta, when active, phosphorylates beta-catenin and targets it for degradation through the ubiquitin pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25593505	GSK-3beta, as a part of the destruction complex consisting of the scaffolding proteins Axin and adenomatous polyposis coli (APC), leads to phosphorylation and degradation of beta-catenin by the ubiquitin and proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24403055	beta-catenin associates with the DC, is phosphorylated by CK1-alpha and GSK3beta XREF_BIBR - XREF_BIBR, and subsequently ubiquitinated and degraded XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	14970870	In this complex, beta-catenin is phosphorylated by GSK-3beta and then targeted by beta-transducin repeat containing protein (beta-TrCP) to proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25135221	It has been reported that GSK3beta activity phosphorylates beta-catenin precluding its nuclear translocation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23029025	In the absence of Wnt signaling beta-catenin is phosphorylated by GSK3beta, resulting in its ubiquitination and subsequent degradation in the proteasome XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23911749	In the absence of Wnt ligands, cytoplasmic beta-catenin is phosphorylated by GSK3beta, thus resulting in the degradation of beta-catenin through the ubiquitin-proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23911749	GSK3beta can phosphorylate beta-catenin, thus resulting in the degradation of beta-catenin through the ubiquitin-proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	7251397	Axin, a negative regulator of Wnt, forms a complex with glycogen synthase kinase 3beta, beta-catenin, and adenomatous polyposis coli and promotes GSK3beta dependent phosphorylation of beta-catenin, thereby stimulating degradation of the beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24726140	In addition, the level of GSK3beta, which phosphorylates beta-catenin on Ser-33/Ser-37/Thr-41 was increased in rCTHRC1 treated primary GIST cells (, and).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	17601533	This inhibition of signaling is mediated by enhanced phosphorylation of beta-catenin by GSK3beta and is independent of APC, as N-terminally truncated versions of Axin that lack the RGS domain retain inhibitory activity ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19924227	In the absence of wnt signaling, cytoplasmic beta-catenin is recruited to a complex containing axin, APC and GSK-3beta, which is then able to phosphorylate beta-catenin, triggering its ubiquitin dependent degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20004015	When this occurs, GSK3beta is unable to phosphorylate beta-catenin and instead, non phosphorylated beta-catenin accumulates in the cytoplasm, translocates into the nucleus, and modulates gene transcription [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20538055	The key kinase of the Wnt pathway GSK3beta that phosphorylates beta-catenin to initiate its degradation is known to be inhibited by lithium.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19679347	Without Wnt signalling, beta-catenin is phosphorylated by a complex containing GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19589360	In the absence of Wnt, beta-catenin is phosphorylated by the axin, APC, and GSK3beta complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20140245	APC protein targets beta-catenin for destruction by interaction with beta-catenin XREF_BIBR, which requires phosphorylation of beta-catenin by Gsk3beta on 3 serines and one threonine residue, all of which are encoded in exon 3 of the beta-catenin gene XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20140245	However, when KYSE140 cells were transfected with a beta catenin mutant (pCI-beta-cat-S33Y) that has a defect in Gsk3beta dependent phosphorylation of beta-catenin, NEFH could not suppress mt-beta-catenin expression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20140245	Phosphorylation of beta-catenin by Gsk3beta targets beta-catenin to ubiquitination and proteasome degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19107203	In the absence of Wnt, beta-catenin is phosphorylated by GSK3beta in a complex that includes Axin, GSK3beta, and beta-catenin XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19107203	Very recently, it was reported that an intracellular region of LRP6, which contains the Ser/Thr rich cluster and the five PPPSPxS motifs, inhibits the phosphorylation of beta-catenin by GSK3beta, and that an intact PPPSPxS motif is required XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19107203	Cselenyi et al. (2008) found that the recombinant, nonphosphorylated LRP6 intracellular region at ~ 4 microM can inhibit beta-catenin phosphorylation by GSK3beta, but not Tau, another GSK3beta substrate, which led these authors to propose that GSK3beta phosphorylates LRP6 and that the phosphorylated species somehow specifically interferes with the beta-catenin-GSK3beta interaction rather than inhibiting the kinase.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19107203	It was previously suggested that the roles of phosphorylated PPPSPxS motif are to recruit beta-catenin XREF_BIBR and Axin XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR, which would lead to inhibition of beta-catenin phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26388612	It is reported that GSK3beta is able to phosphorylate beta-catenin, thus marking the protein for degradation [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15082903	In the absence of Wnt signaling, the cytoplasmic level of beta-catenin is kept low through interaction with a protein complex comprised of adenomatous polyposis coli (APC), Axin, protein phosphatase 2A (PP2A), and glycogen synthase kinase 3beta (GSK3beta), where beta-catenin is phosphorylated by GSK3beta (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24499657	GSK3beta and CKI phosphorylate beta-catenin, which is subsequently ubiquitinated by ubiquitin ligase protein (betaTrCP) and degraded in the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10647780	It is notable that Wnt signaling affects Axin through Dvl, and inhibits the phosphorylation of beta-catenin by GSK-3beta, resulting in the stabilization of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22041457	In the absence of Wnt ligand, beta-catenin is phosphorylated by GSK-3beta and targeted for degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16772034	Phosphorylation of beta-catenin by GSK-3beta leads to ubiquitination of beta-catenin and degradation in proteasomes [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10647780	Axin greatly enhances the phosphorylation of beta-catenin by GSK-3beta under conditions in which these three proteins form a complex ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10647780	Therefore, it is thought that the phosphorylation of beta-catenin by GSK-3beta regulates the stability of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10647780	However, it has been reported that GSK-3beta does not significantly phosphorylate beta-catenin in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10647780	Axin may function by placing beta-catenin in the vicinity of GSK-3beta, thereby enhancing the phosphorylation of beta-catenin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10647780	Axil also enhances the phosphorylation of beta-catenin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10647780	Thus, the phosphorylation of beta-catenin by GSK-3beta and its ubiquitination are enhanced in the Axin complex.The observations that Axin promotes the phosphorylation and ubiquitination of beta-catenin suggest that Axin is involved in the regulation of the stability of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23889992	beta-Catenin is phosphorylated by GSK3beta and undergoes proteasomal degradation while phosphorylation of GSK3beta inactivates it and allows nuclear translocation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20708603	Sequential phosphorylation of beta-catenin by CKI and GSK3beta leads to ubiquitination and degradation of beta-catenin by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22028766	In an active complex, GSK3beta phosphorylates beta-catenin, tagging it for recognition by beta-trCP, polyubiquitinylation, and subsequent degradation by the proteasome complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22028766	Posttranslational modifications are known to play a critical role in the regulation of beta-catenin turnover, and beta-catenin is sequentially phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19726098	It is well known that beta-catenin is phosphorylated at codons 33, 37, 41, and 45 by GSK3beta and CKI.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19726098	It is possible that NS5A may either form a structural barrier between beta-catenin and GSK3beta or inhibit APC, Axin, and GSK3beta complex formation such that GSK3beta can no longer phosphorylate beta-catenin and perform subsequent ubiquitinylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24561281	In the absence of Wnt ligands, glycogen synthase kinase 3beta (GSK3beta) phosphorylates the canonical Wnt signal mediator beta-catenin, in a destruction complex with axin, casein kinase 1-alpha and adenomatous polyposis coli.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25193114	While Wnt signal is absent, beta-catenin is phosphorylated by the CK1 and GSK3beta, and consequently degraded through the ubiquitin-proteasome pathway, and the signal transduction is off, TCF/LEF interacts with Groucho transcription repressor preventing gene transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16956801	This interaction results in inhibition of GSK3beta dependent phosphorylation of beta-catenin, leading to stabilization of beta-catenin and activation of TCF and LEF1 mediated transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10330403	Subsequent studies have shown that Axin is part of a complex including these two proteins as well as APC and that it promotes the phosphorylation of beta-catenin by GSK3beta and its subsequent degradation (XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10330403	In the presence of a Wnt signal, GSK3beta phosphorylation of beta-catenin is inhibited, free beta-catenin is stabilized, accumulates in the cytoplasm, and is imported into the nucleus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10330403	This observation is consistent with the hypothesis that the binding of PP2A to the Axin complex may negatively regulate the phosphorylation of beta-catenin by GSK3beta (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10330403	Modulation of the Wnt pathway has a striking effect on beta-catenin levels; in the absence of a Wnt signal, constitutively active GSK3beta phosphorylates beta-catenin and causes its rapid turnover, whereas Wnt signaling induces stabilization of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10330403	We have hypothesized that the binding of PP2A to the Axin complex might counteract the phosphorylation of beta-catenin by GSK3beta (XREF_BIBR) that could account for the increased ventralization activity in the absence of this domain.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20399743	According to the current model, in the absence of Wnt ligands, GSK-3beta and Casein kinase1 phosphorylate beta-Catenin in a protein complex that also contains Axin and APC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25266063	beta-catenin not phosphorylated by GSK3beta is stable and translocates to the nucleus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26274564	The loss of functional APC results in less efficient GSK3 (two isoforms in mammals, GSK3alpha and GSK3beta)-mediated phosphorylation of beta-catenin, leading to reduced degradation of beta-catenin, thus mimicking Wnt stimulation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26274564	Reconstitution of the GSK3beta KO/GSK3alpha KD MEFs with WT HA-GSK3beta reduced the basal level of beta-catenin to the level comparable to WT MEFs (XREF_FIG, comparing lanes 1, 5 and 7), likely due to the restoration of GSK3 mediated phosphorylation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25658088	the The beta-catenin- dependent pathway or canonical pathway, is activated by Wnt-ligand binding to frizzled receptors (FZD) followed by cytosolic accumulation of beta-catenin through prevention of glycogen syntheses kinase three beta (GSK-3beta) mediated phosphorylation of the beta-catenin Ser/Thr domain.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19727391	In the absence of pathway activation by WNT ligands or small molecule inhibitors of GSK3, beta-catenin is sequentially phosphorylated by CK1 and GSK3beta XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19784072	Non sequestered free beta-catenin is rapidly phosphorylated by GSK-3beta in the APC, axin, GSK-3beta, and CKI complex, and subsequently degraded by the ubiquitin-proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26088648	GSK-3beta directly regulates beta-catenin availability in the nucleus, depending on the intensity of the Wnt signaling pathway, by phosphorylating beta-catenin in the cytosol and targeting it for ubiquitin dependent proteolysis [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18641688	When bound to this complex, beta-catenin is constitutively phosphorylated by GSK3beta, which serves as an earmark for its ubiquitin mediated degradation (XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23617586	This prevents the phosphorylation of beta-catenin by GSK3B, and leads to its binding to the nuclear transcription factors, TCF7, LEF1, TCF7L1 and TCF7L2, leading to the activation of more than 60 different genes involved in growth regulation and differentiation, as well as GLP-1 expression [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18478343	The phosphorylation of beta-catenin by GSK-3beta occurs in the context of a structural complex that includes Axin and APC [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15940626	The cellular levels of beta-catenin are controlled by ubiquitin mediated proteasomal degradation, and this process is initiated when GSK-3beta phosphorylates beta-catenin on the Axin scaffold.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	6342218	The levels of beta-catenin within a cell are regulated via phosphorylation of the N terminus of beta-catenin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	27316454	It has been reported that the GSK-3beta consensus phosphorylation site in beta-catenin is necessary for ubiquitination.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21284870	GSK-3beta phosphorylates beta-catenin and triggers its ubiquitination and degradation by beta-Trcp.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21284870	As GSK-3beta can phosphorylate beta-catenin and result in its proteasome degradation, this result was consistent with our finding that beta-catenin was stabilized because of the significantly reduced level of phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25829335	Consistently, phosphorylation of beta-catenin by GSK-3beta is shown to disrupt interaction between beta-catenin and NF-kappaB and promotes inflammation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23602568	As part of this complex, GSK3B phosphorylates beta-catenin, leading to its subsequent ubiquitination and proteasomal degradation ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	15896469	It has been recognised that, under physiological condition, the excess beta-catenin in cytoplasm is phosphorylated by functional interactions of GSK-3beta, Axin, Conductin and APC, and subjected to degradation by the ubiquitin proteasome system.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24975844	It is well known that GSK3beta phosphorylates beta-catenin, leading to the ubiquitination and degradation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24975844	beta-Catenin expression was decreased by S100A4 co-expression in 293T transient transfection system, but beta-catenin S33Y expression was not changed by S100A4, indicating that the S100A4 induced down-regulation of beta-catenin was indeed mediated by the phosphorylation of beta-catenin by GSK3beta (A).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24303084	Knockdown of galectin-3 inhibits phosphorylation of GSK-3beta and increases GSK-3beta expression, which leads to beta-catenin phosphorylation and results in the degradation of beta-catenin by the proteasome [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	23094051	In the pathway inactive state, GSK-3beta and APC, both present in the cytosolic protein complex, phosphorylate cytosolic beta-catenin, which then becomes ubiquitinated for subsequent cytoplasmic degradation XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18606491	Phosphorylation of beta-catenin by active GSK3beta targets beta-catenin for ubiquitin mediated proteasomal degradation and maintains a low level of cytoplasmic beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	26337424	In the absence of Wnt ligands, Axin/APC/GSK3beta/beta-catenin together form a multiprotein destruction complex in which beta-catenin is phosphorylated by GSK3beta and subsequently degraded by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21536751	In this pathway, in the absence of ligands, the constitutively active kinase GSK-3beta phosphorylates beta-catenin within a destruction complex, addressing it for degradation through the proteasome pathway (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20122174	Under normal circumstances, GSK-3beta phosphorylates excess beta-catenin facilitating its degradation, resulting in the dynamic balance between beta-catenin generation and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19238201	Since exogenous wild type beta-catenin is subject to GSK-3beta-mediated destruction, and is not easily incorporated into AJ (A. I. Barth, Stanford University, personal communication), we used a beta-catenin construct that can not be phosphorylated by GSK-3beta due to point mutations at four important phosphorylation sites XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22535304	In the absence of Wnt signals GSK3beta phosphorylates beta-catenin, which leads to its degradation via the ubiquitination.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25003996	Phosphorylation of beta-catenin by GSK-3beta results in ubiquitin mediated degradation of beta-catenin, reducing translocation of beta-catenin into the nucleus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25003996	Phosphorylation of beta-catenin by GSK-3beta results in ubiquitin mediated degradation of beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	24130899	Activation of the canonical Wnt pathway leads to the stabilization of the cytoplasmic pool of beta -catenin, which is otherwise phosphorylated by glycogen synthase kinase-3 beta (GSK-3 beta) and subsequently degraded by the ubiquitin-proteosome pathway [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20126258	Phosphorylation of beta-catenin by GSK-3beta targets it for degradation via the beta-TrCP ubiquitin ligase-proteasome pathway XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18221734	Although the majority of GSK3 substrates require pre-phosphorylation, a number of GSK3beta substrates do not, including beta-catenin which is phosphorylated by GSK3beta at Ser/Ser/Thr and can thus serve as a marker of GSK3beta activation ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20957670	Wnt signaling dissociates the beta-catenin destruction complex consisting of axin, adenomatous polyposis coli (APC) and glycogen synthase kinase 3beta (GSK3beta), which leads to phosphorylation of beta-catenin for ubiquitination and proteosomal degradation in the cytoplasm (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC4693828	Taken together with our recent observations that Axin directly interacts with glycogen synthase kinase-3beta (GSK-3beta) and beta-catenin and that it promotes GSK-3beta-dependent phosphorylation of beta-catenin, these results suggest that Axin, APC, GSK-3beta, and beta-catenin make a tetrameric complex, resulting in the regulation of the stabilization of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20336693	In the absence of Wnt signaling, beta-catenin is phosphorylated by GSK-3beta, which targets it for proteasomal degradation; in contrast, dephosphorylated beta-catenin is stable and transcriptionally active.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	27543871	The levels of beta-catenin within a cell are regulated via phosphorylation of the N terminus of beta-catenin by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	20347274	SB216763 is believed to activate beta-catenin pathway by inhibiting GSK3beta, which phosphorylates beta-catenin leading to its degradation by the proteasomal pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	PMC5020760	We found that the binding of beta-TrCP to beta-catenin was direct and dependent upon the WD40 repeat sequences in beta-TrCP and on phosphorylation of the GSK3beta sites in beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25217103	These data indicate that Aurora-A overexpression promotes beta-catenin dissociation from cell-cell contacts, nuclear translocation, and activates transcription of its targeted genes.It is known that GSK-3beta phosphorylates the cytoplasmic beta-catenin and facilitates its proteasomal degradation ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	27683053	beta-catenin is phosphorylated in its N-terminal domain by GSK-3beta, which leads to its degradation by ubiquitination [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12860119	Activation of Wnt signaling inhibits the phosphorylation of beta-catenin by GSK-3beta, resulting in a release of beta-catenin to the cytoplasm and nucleus.Although the nuclear localization of Par14 in mammalian cells is well known, the mechanism by which Par14 is transported to or retained in the nucleus has not yet been determined.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25661872	Under normal circumstances, beta-catenin is phosphorylated by GSK3beta and quickly degraded by the ubiquitin and proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	18804163	Therefore, in this context the inability of GSK-3beta to phosphorylate beta-catenin is not due to inhibition of its kinase activity, but rather secondary to the lack of association with substrate.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16981698	Similar to Axin GID (381-405) and FRATtide, synthesized GSKIPtide is also shown to compete with and/or block the phosphorylation of Axin and beta-catenin by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16039586	The current model suggests that Axin and adenomatous polyposis coli (APC) gene products serve as scaffolds to facilitate the phosphorylation of beta-catenin by GSK-3beta (), and phosphorylated beta-catenin is targeted to degradation by the ubiquitin-proteasome system ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16039586	Mutations within the binding site of either Axin or APC, or the GSK-3beta phosphorylation site of beta-catenin, result in the inability of GSK-3beta to phosphorylate beta-catenin ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16039586	It is known that phosphorylation of beta-catenin by GSK-3beta causes its degradation by the ubiquitin-proteasome system; therefore, we examined whether the stabilization of beta-catenin in HBX transfectants may result from inhibition of GSK-3beta activity to phosphorylate beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16039586	Although CK1 is known to be required as a priming kinase for GSK-3beta phosphorylation of beta-catenin in vivo (), in vitro beta-catenin can be directly phosphorylated at S33, S37, and T41 residues by GSK-3beta without priming by CK1 () ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	16039586	The kinase assay indicated that the ability of GSK-3beta to phosphorylate beta-catenin was significantly lower in HepG2-X and Hep3B-X cells as compared to HepG2 and Hep3B cells (C).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	21858154	Another mechanism of Wnt and beta-catenin inhibition in colon cancer has been proposed by Kaler and cols. : 1,25 (OH) 2 D 3 decreases the synthesis and secretion by THP-1 macrophages of interleukin-1beta, a cytokine that activates the Wnt and beta-catenin pathway in colon cancer cells through the blockade of beta-catenin phosphorylation by GSK-3beta XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12049819	Phosphorylation of beta-catenin by GSK3beta results in its ubiquitination and subsequent degradation by proteosomes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	12049819	The GSK3beta phosphorylation site in beta-catenin consists of a stretch of three serines and one threonine, each separated by three residues (SXXXSXXXTXXXS).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	10959047	When in complex, GSK-3beta acts in concert with axin to phosphorylate beta-catenin and APC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22570728	Mechanistically, beta-catenin is phosphorylated by GSK3beta and then ubiquitinated by E3 ligase beta-Trcp for degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	25883211	Phosphorylated p68 in turn facilitates beta-catenin nuclear translocation by blocking phosphorylation of beta-catenin by GSK-3beta and displacing Axin from beta-catenin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	22773696	In the cytoplasm, beta-catenin is phosphorylated on the NH (2) terminus by constitutively active GSK-3beta, favoring its degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
5df7070b-826e-4ccd-a6bc-51e3c8319ef1	1.0	PubMed	19901516	XREF_BIBR - XREF_BIBR Conversely, GSK3beta activation phosphorylates beta-catenin and axin to target beta-catenin for ubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	16293724	This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	23151663	Beta-catenin phosphorylation in vivo is sequentially carried out by two distinct kinases, ckialfa and gsk-3. Ckialfa phosphorylation of s45 proceeds and is required for subsequent gsk-3 phosphorylation of t41, s37, and s33 one key substrate of gsk3 is the transcriptional co-activator beta catenin, whichis inactivated by gsk3 mediated phosphorylation and targeted for proteasomal degradation in unstimulated cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	19303846	DISC1 inhibits GSK3beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	21035499	beta-catenin is phosphorylated by GSK-3beta at Ser 33; Ser 37 and Thr 47 within the N-terminal domain, which leads to its degradation by the ubiquitin and proteasome pathway (B).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	25360740	The inhibition of GSK3beta suppresses the phosphorylation of beta-catenin at S33, ultimately resulting in its cytoplasmic accumulation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	18070361	GSK-3beta constitutively phosphorylates beta-catenin at Ser 33, Ser 37, and Thr 41 (S33/37/T41) residues, triggering ubiquitinylation by a Cullin-1-containing E3 ligase (also known as the SCF complex) before proteasomal degradation [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	26905812	Accordingly, GSK3beta dependent phosphorylation of beta-catenin on Thr41, Ser33 and Ser37, which precedes proteosomal degradation XREF_BIBR, was increased in the presence of SS18-SSX1 (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	20302655	GSK-3beta phosphorylates cytosolic beta-catenin at Ser 33, Ser 37, and Thr 41 prior to beta-catenin degradation, but phosphorylation of GSK-3beta at Ser 9 inhibits its kinase activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	23243000	In addition to disruption of VE-cadherin and beta-catenin complexes, treatment of vascular EC with apo (a) attenuates the phosphorylation of beta-catenin at Ser 33,-37/Thr-41 by GSK-3beta (XREF_FIG), thus causing a decrease in the degradation of cytoplasmic beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	9233789	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	11955436	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	26189775	In this complex, beta-catenin is phosphorylated at S45 by CKIalpha, and subsequently by GSK3beta at residues S33, S37, and T41.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	20137080	In non stimulated cells, the protein level of free beta-catenin is kept low by a so called destruction complex consisting mainly of the tumor suppressor adenomatous polyposis coli (APC) and Axin, which build a scaffold on which the serine/threonine kinases casein kinase 1alpha (CK1alpha) and glycogen synthase kinase 3beta (GSK3beta) function to phosphorylate beta-catenin on N-terminal residues Ser 45 (CK1alpha) and Ser 33, Ser 37, and Thr 41 (GSK3beta) [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	23076981	Consequently, GSK-3beta phosphorylates beta-catenin at Thr41, Ser37 and Ser33 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	23076981	GSK-3beta phosphorylates beta-catenin at residues Ser33, Ser37 and Thr41 (XREF_BIBR), thereby targeting it for ubiquitination by beta-TrCP and subsequent degradation in the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	21562161	Following casein kinase 1 mediated phosphorylation of beta-catenin at serine 45, GSK3beta phosphorylates beta-catenin at Thr 41, Ser 33, and Ser 37, which tags beta-catenin for ubiquitination by betaTrCP and proteomic degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	11955436	Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	27683053	beta-catenin is phosphorylated by GSK-3beta at Ser 33, Ser 37, and Thr 47 within the N-terminal domain, which leads to its degradation by the ubiquitin and proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	16039586	Although CK1 is known to be required as a priming kinase for GSK-3beta phosphorylation of beta-catenin in vivo (), in vitro beta-catenin can be directly phosphorylated at S33, S37, and T41 residues by GSK-3beta without priming by CK1 () ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
33775fa3-eeae-4d54-9fd8-65ffe01fae4d	1.0	PubMed	18644116	This complex promotes the degradation of beta-catenin through multiple, hierarchical phosphorylation events that, once beta-catenin is phosphorylated at Ser 37 and Ser 33 by GSK3beta, is recognized by beta transducing repeat containing protein (beta-Trcp) and targeted for proteasomal degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 33))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	11955436	Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	19303846	DISC1 inhibits GSK3beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	16293724	This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	21035499	beta-catenin is phosphorylated by GSK-3beta at Ser 33; Ser 37 and Thr 47 within the N-terminal domain, which leads to its degradation by the ubiquitin and proteasome pathway (B).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	18070361	GSK-3beta constitutively phosphorylates beta-catenin at Ser 33, Ser 37, and Thr 41 (S33/37/T41) residues, triggering ubiquitinylation by a Cullin-1-containing E3 ligase (also known as the SCF complex) before proteasomal degradation [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	26905812	Accordingly, GSK3beta dependent phosphorylation of beta-catenin on Thr41, Ser33 and Ser37, which precedes proteosomal degradation XREF_BIBR, was increased in the presence of SS18-SSX1 (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	20302655	GSK-3beta phosphorylates cytosolic beta-catenin at Ser 33, Ser 37, and Thr 41 prior to beta-catenin degradation, but phosphorylation of GSK-3beta at Ser 9 inhibits its kinase activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	9233789	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	11955436	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	26189775	In this complex, beta-catenin is phosphorylated at S45 by CKIalpha, and subsequently by GSK3beta at residues S33, S37, and T41.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	27098453	CK1alpha initially phosphorylates beta-catenin at serine 45 (S45) of the N-terminal region, and GSK-3beta subsequently phosphorylates beta-catenin at threonine 41 (T41), serine 37 (S37), and serine 33 (S33) 3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	20137080	In non stimulated cells, the protein level of free beta-catenin is kept low by a so called destruction complex consisting mainly of the tumor suppressor adenomatous polyposis coli (APC) and Axin, which build a scaffold on which the serine/threonine kinases casein kinase 1alpha (CK1alpha) and glycogen synthase kinase 3beta (GSK3beta) function to phosphorylate beta-catenin on N-terminal residues Ser 45 (CK1alpha) and Ser 33, Ser 37, and Thr 41 (GSK3beta) [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	23076981	Consequently, GSK-3beta phosphorylates beta-catenin at Thr41, Ser37 and Ser33 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	23076981	GSK-3beta phosphorylates beta-catenin at residues Ser33, Ser37 and Thr41 (XREF_BIBR), thereby targeting it for ubiquitination by beta-TrCP and subsequent degradation in the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	21562161	Following casein kinase 1 mediated phosphorylation of beta-catenin at serine 45, GSK3beta phosphorylates beta-catenin at Thr 41, Ser 33, and Ser 37, which tags beta-catenin for ubiquitination by betaTrCP and proteomic degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	27683053	beta-catenin is phosphorylated by GSK-3beta at Ser 33, Ser 37, and Thr 47 within the N-terminal domain, which leads to its degradation by the ubiquitin and proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	16039586	Although CK1 is known to be required as a priming kinase for GSK-3beta phosphorylation of beta-catenin in vivo (), in vitro beta-catenin can be directly phosphorylated at S33, S37, and T41 residues by GSK-3beta without priming by CK1 () ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	18644116	This complex promotes the degradation of beta-catenin through multiple, hierarchical phosphorylation events that, once beta-catenin is phosphorylated at Ser 37 and Ser 33 by GSK3beta, is recognized by beta transducing repeat containing protein (beta-Trcp) and targeted for proteasomal degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
e589322a-0833-4e88-8009-3cdd8d8ea1c5	1.0	PubMed	25366337	Additionally, Ser 33 and Ser 37 phosphorylation of beta-catenin by GSK3B was also increased.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 37))
45b9ac4d-043f-46fb-b489-7ad5116d45c6	1.0	PubMed	22640743	CK-1alpha and GSK-3beta phosphorylate beta-catenin on Ser 45 and Ser 33/37/Thr -41 sites, respectively, leading to its ubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 45))
45b9ac4d-043f-46fb-b489-7ad5116d45c6	1.0	PubMed	9233789	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 45))
45b9ac4d-043f-46fb-b489-7ad5116d45c6	1.0	PubMed	11955436	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 45))
45b9ac4d-043f-46fb-b489-7ad5116d45c6	1.0	PubMed	26189775	In this complex, beta-catenin is phosphorylated at S45 by CKIalpha, and subsequently by GSK3beta at residues S33, S37, and T41.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 45))
45b9ac4d-043f-46fb-b489-7ad5116d45c6	1.0	PubMed	23721711	Phosphorylation of beta-catenin by casein kinase I and GSK3beta on Ser45 and subsequently on Ser33/37, Thr41, respectively, leads to its ubiquitination and proteosomal degradation (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 45))
45b9ac4d-043f-46fb-b489-7ad5116d45c6	1.0	PubMed	24501426	GSK3beta and its priming kinase, casein kinase 1 (CK1), phosphorylate beta-catenin at residues S33/S37/T41 and S45, respectively, leading to binding of the E3 ligase beta-TrCP, which marks beta-catenin for ubiquitination and then degradation by the proteasome (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 45))
45b9ac4d-043f-46fb-b489-7ad5116d45c6	1.0	PubMed	20140245	Both Gsk3beta and casein kinase-1 (CK1) phosphorylate beta-catenin at Ser33/Ser37/Thr41 and at Thr41 and Ser45, respectively, leading to the degradation of beta-catenin through the ubiquitin pathway XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 45))
ce231581-193a-4df4-9ed1-5ef94ca07694	1.0	PubMed	22216350	beta-catenin could be phosphorylated by GSK3beta at S33/S37/T41 or by other kinases as PKA at S675 and Akt at S552 XREF_BIBR (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 552))
6ed9933c-c9d2-4865-8500-4d1c9609bf57	1.0	PubMed	22216350	beta-catenin could be phosphorylated by GSK3beta at S33/S37/T41 or by other kinases as PKA at S675 and Akt at S552 XREF_BIBR (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser, 675))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	20454507	Active GSK3beta phosphorylates beta-catenin, a tran-scription factor involved in survival and proliferation, at serine 33, which primes beta-catenin for ubiquitination and subsequent proteosome mediated degradation [6].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	22470507	In the absence of Wnt ligands, cytoplasmic levels of beta-catenin are regulated by the destruction complex that contains axin, APC, and glycogen synthase kinase-3beta (GSK-3beta), where beta-catenin is phosphorylated by GSK-3beta at multiple serine and threonine residues in its N terminus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	20215423	GSK-3beta phosphorylates beta-catenin at threonine 41, serine 37, and serine 33 residues, thereby facilitating its ubiquitination and proteosomal degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	19249679	Axin and APC are believed to facilitate efficient phosphorylation of beta-catenin by GSK3beta at multiple serine and threonine residues in its N-terminus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	26056085	In the absence of Wnt stimulation, serine phosphorylation of beta-catenin by GSK-3beta targets it for ubiquitination degradation, thus blocking transcriptional activation of the Wnt responsive genes [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	27098453	CK1alpha initially phosphorylates beta-catenin at serine 45 (S45) of the N-terminal region, and GSK-3beta subsequently phosphorylates beta-catenin at threonine 41 (T41), serine 37 (S37), and serine 33 (S33) 3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	16942611	CKI, which is recruited to the destruction complex by the axin binding protein diversin [XREF_BIBR], phosphorylates beta-catenin at serine 45, an important priming step required by GSK-3beta to mediate beta-catenin phosphorylation at threonine 41, serine 37 and serine 33.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	23100427	The signaling of Wnt ligands through their Frizzled receptors promotes the cytosolic accumulation and nuclear translocation of beta-catenin, via the sequestration and inhibition of glycogen synthase kinase 3beta (GSK3beta), which would otherwise phosphorylate beta-catenin on serine to initiate its proteosomal destruction (XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	11389839	Unlike beta-TrCP, however, which requires GSK3beta mediated phosphorylation of beta-catenin on serine 33 and serine 37, Ebi interacts with beta-catenin independently of these phosphorylation sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	21447180	When this destruction complex is intact, GSK-3beta phosphorylates the amino terminal serine and threonine residues of beta-catenin and targets it towards degradation by proteasomal machinery [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	24975844	These results suggest that GSK3beta activity could lead to the degradation of beta-catenin via a proteasome mediated mechanism.Since GSK3beta phosphorylates beta-catenin at serine 33, mutant beta catenin S33Y, which can not be phosphorylated by GSK3beta, and hence is resistant to phosphorylation dependent degradation, was transfected with S100A4 into 293T cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
0c42e5ed-0568-4409-a87b-4fa3a258ec06	1.0	PubMed	12049819	It has been demonstrated convincingly that phosphorylation of beta-catenin by the serine threonine kinase GSK3beta is crucial for destabilization of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Ser))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	11955436	Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	23151663	Beta-catenin phosphorylation in vivo is sequentially carried out by two distinct kinases, ckialfa and gsk-3. Ckialfa phosphorylation of s45 proceeds and is required for subsequent gsk-3 phosphorylation of t41, s37, and s33 one key substrate of gsk3 is the transcriptional co-activator beta catenin, whichis inactivated by gsk3 mediated phosphorylation and targeted for proteasomal degradation in unstimulated cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	19303846	DISC1 inhibits GSK3beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	16293724	This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	19711366	In the absence of the Wnt ligand, GSK3beta phosphorylates cytosolic beta-catenin at Thr 41 and Ser 33/37 in the destruction complex priming beta-catenin for ubiquitinylation and degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	18070361	GSK-3beta constitutively phosphorylates beta-catenin at Ser 33, Ser 37, and Thr 41 (S33/37/T41) residues, triggering ubiquitinylation by a Cullin-1-containing E3 ligase (also known as the SCF complex) before proteasomal degradation [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	26905812	Accordingly, GSK3beta dependent phosphorylation of beta-catenin on Thr41, Ser33 and Ser37, which precedes proteosomal degradation XREF_BIBR, was increased in the presence of SS18-SSX1 (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	20302655	GSK-3beta phosphorylates cytosolic beta-catenin at Ser 33, Ser 37, and Thr 41 prior to beta-catenin degradation, but phosphorylation of GSK-3beta at Ser 9 inhibits its kinase activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	9233789	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	11955436	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	26189775	In this complex, beta-catenin is phosphorylated at S45 by CKIalpha, and subsequently by GSK3beta at residues S33, S37, and T41.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	24403311	Wnt and beta-catenin activity was first evaluated by determining the level of GSK3beta phosphorylation of beta-catenin at ser37 and thr41 using an active beta-catenin antibody.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	27098453	CK1alpha initially phosphorylates beta-catenin at serine 45 (S45) of the N-terminal region, and GSK-3beta subsequently phosphorylates beta-catenin at threonine 41 (T41), serine 37 (S37), and serine 33 (S33) 3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	20137080	In non stimulated cells, the protein level of free beta-catenin is kept low by a so called destruction complex consisting mainly of the tumor suppressor adenomatous polyposis coli (APC) and Axin, which build a scaffold on which the serine/threonine kinases casein kinase 1alpha (CK1alpha) and glycogen synthase kinase 3beta (GSK3beta) function to phosphorylate beta-catenin on N-terminal residues Ser 45 (CK1alpha) and Ser 33, Ser 37, and Thr 41 (GSK3beta) [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	23076981	Consequently, GSK-3beta phosphorylates beta-catenin at Thr41, Ser37 and Ser33 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	20140245	Both Gsk3beta and casein kinase-1 (CK1) phosphorylate beta-catenin at Ser33/Ser37/Thr41 and at Thr41 and Ser45, respectively, leading to the degradation of beta-catenin through the ubiquitin pathway XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	20140245	Interestingly, decrease of Gsk3beta phosphorylation and increase of beta-catenin phosphorylation at Ser33/Ser37/Thr41 and at Thr41 and Ser45 were caused only by API-2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	21562161	Following casein kinase 1 mediated phosphorylation of beta-catenin at serine 45, GSK3beta phosphorylates beta-catenin at Thr 41, Ser 33, and Ser 37, which tags beta-catenin for ubiquitination by betaTrCP and proteomic degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	22415718	GSK-3beta phosphorylates beta-catenin at sites Ser33/37 and Thr41 marking it for degradation by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
8771d525-c7e2-41be-b845-4b0d77772a01	1.0	PubMed	16039586	Although CK1 is known to be required as a priming kinase for GSK-3beta phosphorylation of beta-catenin in vivo (), in vitro beta-catenin can be directly phosphorylated at S33, S37, and T41 residues by GSK-3beta without priming by CK1 () ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr, 41))
e10860c7-a00e-4568-9523-a7267f54018c	1.0	PubMed	22470507	In the absence of Wnt ligands, cytoplasmic levels of beta-catenin are regulated by the destruction complex that contains axin, APC, and glycogen synthase kinase-3beta (GSK-3beta), where beta-catenin is phosphorylated by GSK-3beta at multiple serine and threonine residues in its N terminus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr))
e10860c7-a00e-4568-9523-a7267f54018c	1.0	PubMed	26214021	Wnt pathway is known as a " destruction complex " in which Axin and adenomatous polypopsis coli (APC) form a scaffold facilitating beta-catenin phosphorylated by CK1a and GSK3beta at serine and threonine residues in its amino-terminal region [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr))
e10860c7-a00e-4568-9523-a7267f54018c	1.0	PubMed	20215423	GSK-3beta phosphorylates beta-catenin at threonine 41, serine 37, and serine 33 residues, thereby facilitating its ubiquitination and proteosomal degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr))
e10860c7-a00e-4568-9523-a7267f54018c	1.0	PubMed	27098453	CK1alpha initially phosphorylates beta-catenin at serine 45 (S45) of the N-terminal region, and GSK-3beta subsequently phosphorylates beta-catenin at threonine 41 (T41), serine 37 (S37), and serine 33 (S33) 3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr))
e10860c7-a00e-4568-9523-a7267f54018c	1.0	PubMed	16942611	CKI, which is recruited to the destruction complex by the axin binding protein diversin [XREF_BIBR], phosphorylates beta-catenin at serine 45, an important priming step required by GSK-3beta to mediate beta-catenin phosphorylation at threonine 41, serine 37 and serine 33.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr))
e10860c7-a00e-4568-9523-a7267f54018c	1.0	PubMed	21447180	When this destruction complex is intact, GSK-3beta phosphorylates the amino terminal serine and threonine residues of beta-catenin and targets it towards degradation by proteasomal machinery [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr))
e10860c7-a00e-4568-9523-a7267f54018c	1.0	PubMed	12049819	It has been demonstrated convincingly that phosphorylation of beta-catenin by the serine threonine kinase GSK3beta is crucial for destabilization of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Thr))
4cae573d-e2ff-4640-98d0-c3e7533c9413	1.0	PubMed	18620091	Mutant Ron kinase caused tyrosine phosphorylation of beta-catenin thereby increasing its stability and preventing degradation by the axin and GSK-3beta complex ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ph, Tyr))
9422faaa-48a8-46ac-9506-26cf1a019f76	1.0	PubMed	12885254	GSK3beta selectively phosphorylates p120 on S252 and T310 in Vitro	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNND1, pmod(Ph, Ser, 252))
7d05404a-7c3e-4d93-9478-9a48b3fd862a	1.0	PubMed	12885254	GSK3beta selectively phosphorylates p120 on S252 and T310 in Vitro	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNND1, pmod(Ph, Thr, 310))
63c39d96-1617-42fd-8d5b-9ba801b2bd25	1.0	PubMed	24412473	Phosphorylation of delta-catenin by Akt and GSK3beta has been studied in various cell lines.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNND2, pmod(Ph))
63c39d96-1617-42fd-8d5b-9ba801b2bd25	1.0	PubMed	24412473	We previously reported that GSK3beta phosphorylates delta-catenin and negatively regulates its stability via ubiquitination and proteosome mediated proteolysis [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNND2, pmod(Ph))
196520d0-2fd2-415e-b2e3-f7a67805ded4	1.0	PubMed	27316454	In the process of ubiquitination, delta-catenin is firstly phosphorylated by GSK-3beta mainly at Thr, and the phosphorylated delta-catenin can then be ubiquitinated at the C-terminus via interaction with beta-TrCP-1, an E3 ubiquitin ligase.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNND2, pmod(Ph, Thr))
92887f2c-54c5-4062-9385-db51538486a4	1.0	PubMed	17681942	Unexpectedly, we found that low serum conditions increased phosphorylation of endogenous CTPS1 and this phosphorylation was inhibited by the glycogen synthase kinase 3 (GSK3) inhibitor indirubin-3 '-monoxime and GSK3beta short interfering RNAs, demonstrating the involvement of GSK3 in phosphorylation of endogenous human CTPS1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTPS1, pmod(Ph))
21603ae1-96c9-4f20-bbed-bd198c932e16	1.0	PubMed	24170547	Phosphorylation of Cyclin D1 by GSK3beta at threonine 286 enhances its ubiquitination and proteasomal degradation preventing its interaction with CDK4, and CDK4 dependent RB phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph), pmod(Ph, Asp, 1))
591435b3-3076-4430-befe-6c8cb66f4458	1.0	PubMed	19338781	Similarly, it has been demonstrated previously that Pin1 directly binds to phosphorylated cyclin D1 that has been phosphorylated by glycogen synthase kinase-3beta (GSK-3beta) and thereby prevents its nuclear export and ubiquitin mediated degradation of cyclin D1.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph), pmod(Ph))
361016d2-7160-4d50-82ef-9cf8287b55be	1.0	PubMed	24170547	Phosphorylation of Cyclin D1 by GSK3beta at threonine 286 enhances its ubiquitination and proteasomal degradation preventing its interaction with CDK4, and CDK4 dependent RB phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph), pmod(Ph, Thr, 286))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	26274615	Furthermore, phosphorylation of cyclin D1 by GSK-3beta promotes its export by facilitating its association with CRM1 and the abrogation of phosphorylation results in its nuclear localization, thus promoting subcutaneous tumor formation in SCID mice [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	24806449	XREF_BIBR Inhibition of DYRK1A but not GSK3beta reduced Cyclin D1 phosphorylation and increased its protein level (XREF_FIG) Thus, DYRK1A phosphorylates Cyclin D1 independently of GSK3beta in SH-SY5Y cells.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	21317297	Earlier it was shown that GSK-3beta phosphorylates cyclin D1 at T286, which is required for nuclear export during the S phase of the cell cycle and subsequent proteolysis (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	22814742	It has been well characterized that GSK3beta mediates cyclin D1 phosphorylation at threonine 286 position, which plays a key role in the nuclear export of cyclin D1 and the subsequent ubiquitin dependent proteolysis (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	21242966	Ubiquitylation of cyclin D1 requires phosphorylation of both cyclin D1 and Fbx4 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	26121043	It has been reported that GSK-3beta phosphorylates cyclin D1 at Thr 286 and causes subsequent proteasomal degradation [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	21347341	During late G1 and S phases, Cyclin D1 is phosphorylated on Thr 286 by GSK3beta, which triggers nuclear export and proteasomal degradation through E3 ubiquitin ligase, SCF FBX4-alphaB crystallin XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	15353558	GSK-3beta may also phosphorylate cyclin D1 (XREF_BIBR) and c-Myc (XREF_BIBR), promoting their protein degradation and contributing to cell cycle arrest.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	25591548	Phosphorylation of cyclin D1 protein on Thr286 by GSK-3beta protein facilitated cyclin D1 binding to CRM1, a nuclear protein that mediates protein nuclear export, for exclusion of cyclin D1 protein from the nucleus and proteasomal degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	19412162	Phosphorylation of cyclin D1 at threonine 286 can be mediated by glycogen synthase kinase 3beta (GSK3beta) XREF_BIBR, XREF_BIBR and through a MAP kinase pathway XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	19903334	The phosphorylation of cyclin D1 residue threonine 286 (T286) by GSK3beta greatly enhances its degradation by the ubiquitin- 26S proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	24038789	Further, SDF1 dependent GSK3beta Y216 phosphorylation increases GSK3beta phosphorylation of cyclin D1 signaling its export from the nucleus, ubiquitinization, and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	24038789	SDF1 mediated CK1alpha downregulation and increase in GSK3beta activity affected cell cycle through Bmi-1 downregulation, increased cyclin D1 phosphorylation, and decreased cyclin D1 levels.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	17205132	Glycogen synthase kinase-3beta (GSK3beta) can phosphorylate cyclin D1 at Thr286, promoting nuclear-to-cytoplasmic redistribution of cyclin D1 XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	17050006	GSK3beta phosphorylates cyclin D1 which increases cyclin D1 degradation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	18598945	At the G1/S boundary, cyclin D1 is phosphorylated by GSK3beta at the residue Thr286 followed by CRM1 dependent nuclear export to the cytoplasm, where cyclin D1 is recognized by SCF ligase, ubiquitinated, and targeted to the 26S proteasome ().	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	5741954	For example, phosphorylation of nuclear cyclin D1 could increase its rate of nuclear export relative to nuclear import; alternatively, phosphorylation of cytoplasmic cyclin D1 by GSK-3beta could inhibit nuclear import.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	5741954	D1-T286A, a cyclin D1 mutant that can not be phosphorylated by GSK-3beta, remains nuclear throughout the cell cycle, a consequence of its reduced binding to CRM1.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	17081987	At the G1/S phase transition, cyclin D1 is phosphorylated at Thr286 by GSK3beta, exported from the nucleus, and degraded in the cytoplasm ().	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	17081987	We hypothesized that, following G0 release, FBX4 would not limit cyclin D1 accumulation until the G1/S phase transition when GSK3beta phosphorylates cyclin D1, inducing its cytoplasmic redistribution.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	16843438	Glycogen synthase kinase 3beta (GSK-3beta) catalyzes the phosphorylation of cyclin D1 on Thr286 and redirects the protein from the nucleus to the cytoplasm.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	20347627	Nuclear export requires phosphorylation of cyclin D1 at Thr286 by GSK-3beta, which in turn allows Cmr1 nuclear exportin to shuttle cyclin D1 out of the nucleus.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	18167338	GSK-3beta phosphorylates cyclin D1 and c-Myc to promote their destruction in G1.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	21852138	At the molecular level, the kinase GSK-3beta phosphorylates the Thr286-Pro motif of cyclin D1 to allow binding to CRM1, which controls cyclin D1 turnover and localization by shuttling nuclear cyclin D1 to the cytoplasm leading to degradation [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	20607601	Our results suggest that cyclin D1 may be phosphorylated by GSK3beta in response to a 3D collagen environment, resulting in its inactivation by nuclear export.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	9832503	Now, we demonstrate that glycogen synthase kinase-3beta (GSK-3beta) phosphorylates cyclin D1 specifically on Thr 286, thereby triggering rapid cyclin D1 turnover.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	20548028	Thus, inactive GSK3beta fails to phosphorylate cyclin D1 and prevents its proteosomal degradation and, consequently, promotes endothelial cell survival and proliferation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	20548028	GSK3beta phosphorylates cyclin D1 at Thr286, thereby triggering its proteasomal degradation and cell-cycle arrest (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	19767775	At the G1/S boundary, cyclin D1 is phosphorylated at Thr 286 by GSK-3beta, triggering cyclin D1 nuclear export and subsequent ubiquitin dependent proteolysis (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	4921508	Now, we demonstrate that glycogen synthase kinase-3beta (GSK-3beta) phosphorylates cyclin D1 specifically on Thr 286, thereby triggering rapid cyclin D1 turnover.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	18804163	Both cyclins D1 and D3 are known to regulate cell cycling in megakaryocytic cells [XREF_BIBR - XREF_BIBR], and it has been previously shown that active GSK-3beta can phosphorylated cyclin D1 and target it for nuclear export and degradation [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
e166a1b0-6546-479e-abe4-a03c2a4c4d7a	1.0	PubMed	17046823	Involvement of GSK-3beta and DYRK1B in differentiation inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 1))
15d3f3cb-a3a6-4b83-a75a-7b68b58ff3a4	1.0	PubMed	11750880	However, further work in this field is necessary, as the D-type cyclin in megakaryocytes is primarily cyclin D3 and as of yet there are no reports of GSK-3beta phosphorylation of cyclin D3.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 3))
15d3f3cb-a3a6-4b83-a75a-7b68b58ff3a4	1.0	PubMed	15252116	We demonstrate that elevation of intracellular levels of cAMP promotes degradation of cyclin D3 in proteasomes, and that this occurs via glycogen synthase kinase-3beta (GSK-3beta)-mediated phosphorylation of cyclin D3 at Thr 283.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Asp, 3))
f3bc9a74-7859-4935-ae20-814d662eb24f	1.0	PubMed	21242966	Ubiquitylation of cyclin D1 requires phosphorylation of both cyclin D1 and Fbx4 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph))
f3bc9a74-7859-4935-ae20-814d662eb24f	1.0	PubMed	26121043	Cyclin D1 in the nucleus is phosphorylated by GSK-3beta and subsequently exported to cytoplasm [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph))
f3bc9a74-7859-4935-ae20-814d662eb24f	1.0	PubMed	25596745	For example, it has been shown that GSK3beta dependent phosphorylation of cyclin E1 controls the binding of the E3 ligase Fbw7 to cyclin E1, resulting in cyclin E1 degradation via the ubiquitin-proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph))
f3bc9a74-7859-4935-ae20-814d662eb24f	1.0	PubMed	18598945	The SCF complexes were immunoprecipitated from the lysates using M2 agarose and incubated with purified GST tagged cyclin D1 phosphorylated in vitro by recombinant GSK3beta (5U), E1, E2 (UbcH5A), ATP, and ubiquitin for the indicated times at 37degreesC.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph))
f3bc9a74-7859-4935-ae20-814d662eb24f	1.0	PubMed	24705253	Murine cyclin D2 can be phosphorylated on p.Thr280 in vitro by GSK-3beta, rendering Ccnd2 susceptible to ubiquitin and proteasome dependent degradation 4.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph))
c2477c65-5ce8-4749-a358-2e5c3abe5019	1.0	PubMed	15252116	We demonstrate that elevation of intracellular levels of cAMP promotes degradation of cyclin D3 in proteasomes, and that this occurs via glycogen synthase kinase-3beta (GSK-3beta)-mediated phosphorylation of cyclin D3 at Thr 283.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 283))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	21317297	Earlier it was shown that GSK-3beta phosphorylates cyclin D1 at T286, which is required for nuclear export during the S phase of the cell cycle and subsequent proteolysis (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	22814742	It has been well characterized that GSK3beta mediates cyclin D1 phosphorylation at threonine 286 position, which plays a key role in the nuclear export of cyclin D1 and the subsequent ubiquitin dependent proteolysis (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	26121043	It has been reported that GSK-3beta phosphorylates cyclin D1 at Thr 286 and causes subsequent proteasomal degradation [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	21347341	During late G1 and S phases, Cyclin D1 is phosphorylated on Thr 286 by GSK3beta, which triggers nuclear export and proteasomal degradation through E3 ubiquitin ligase, SCF FBX4-alphaB crystallin XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	19412162	Phosphorylation of cyclin D1 at threonine 286 can be mediated by glycogen synthase kinase 3beta (GSK3beta) XREF_BIBR, XREF_BIBR and through a MAP kinase pathway XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	19903334	The phosphorylation of cyclin D1 residue threonine 286 (T286) by GSK3beta greatly enhances its degradation by the ubiquitin- 26S proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	17205132	Glycogen synthase kinase-3beta (GSK3beta) can phosphorylate cyclin D1 at Thr286, promoting nuclear-to-cytoplasmic redistribution of cyclin D1 XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	18598945	At the G1/S boundary, cyclin D1 is phosphorylated by GSK3beta at the residue Thr286 followed by CRM1 dependent nuclear export to the cytoplasm, where cyclin D1 is recognized by SCF ligase, ubiquitinated, and targeted to the 26S proteasome ().	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	19071090	Cyclin D1 is phosphorylated by GSK-3beta at threonine 286 and moves to the cytosol; ubiquitination by the SCF complex and proteasomal degradation follow.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	17081987	At the G1/S phase transition, cyclin D1 is phosphorylated at Thr286 by GSK3beta, exported from the nucleus, and degraded in the cytoplasm ().	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	16843438	Glycogen synthase kinase 3beta (GSK-3beta) catalyzes the phosphorylation of cyclin D1 on Thr286 and redirects the protein from the nucleus to the cytoplasm.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	20347627	Nuclear export requires phosphorylation of cyclin D1 at Thr286 by GSK-3beta, which in turn allows Cmr1 nuclear exportin to shuttle cyclin D1 out of the nucleus.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	9832503	Now, we demonstrate that glycogen synthase kinase-3beta (GSK-3beta) phosphorylates cyclin D1 specifically on Thr 286, thereby triggering rapid cyclin D1 turnover.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	20548028	GSK3beta phosphorylates cyclin D1 at Thr286, thereby triggering its proteasomal degradation and cell-cycle arrest (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	19767775	At the G1/S boundary, cyclin D1 is phosphorylated at Thr 286 by GSK-3beta, triggering cyclin D1 nuclear export and subsequent ubiquitin dependent proteolysis (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
b4ae7a0f-e70f-4a3f-b640-37edf6f03233	1.0	PubMed	4921508	Now, we demonstrate that glycogen synthase kinase-3beta (GSK-3beta) phosphorylates cyclin D1 specifically on Thr 286, thereby triggering rapid cyclin D1 turnover.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ph, Thr, 286))
6ebe2038-2efa-44f1-852c-58cc4f9b0823	1.0	PubMed	26418899	Under the condition of lacking of growth signals, GSK-3beta is able to be activated to phosphorylate Cyclin D and promote its degration.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:"Cyclin_D", pmod(Ph))
58bbd918-4beb-46fa-970c-20175d376471	1.0	PubMed	23717519	Of note, Katiyar et al. reported that GSK3beta dependent phosphorylation of REDD1 causes a faster migration in SDS gels XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DDIT4, pmod(Ph))
58bbd918-4beb-46fa-970c-20175d376471	1.0	PubMed	23717519	Thus, we found that mutation of the reported GSK3beta phosphorylation sites in REDD1 to alanine or aspartate did not affect REDD1 protein levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DDIT4, pmod(Ph))
a757baef-00b2-4314-8453-e009585412f0	1.0	PubMed	23717519	It has been reported that GSK3beta phosphorylates REDD1 at residues Thr23 and Thr25, resulting in REDD1 recruitment to the Cullin 4a-beta-Trcp E3 ligase complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DDIT4, pmod(Ph, Thr, 23))
f88c393b-885f-4994-8e2d-bcd63b3124cb	1.0	PubMed	23717519	It has been reported that GSK3beta phosphorylates REDD1 at residues Thr23 and Thr25, resulting in REDD1 recruitment to the Cullin 4a-beta-Trcp E3 ligase complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DDIT4, pmod(Ph, Thr, 25))
ea9685be-c632-4715-9f30-4158b8d0ce5a	1.0	PubMed	23185298	Given our previous report that GSK3beta interacts with and phosphorylates Drp1 XREF_BIBR, XREF_BIBR, we attempted to identify the functional consequences of GSK3beta mediated phosphorylation of Drp1 at the Ser693 site in addition to Ser616 and Ser637 located within the GED domain.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNM1L, pmod(Ph))
ea9685be-c632-4715-9f30-4158b8d0ce5a	1.0	PubMed	23185298	In this experiment, we found that the fragments with respect to Drp1 634-690 and Drp1 691-736 are two relatively small peptides serving as phosphorylating substrates of GSK3beta and that Drp1 444-736 can also be phosphorylated by GSK3beta (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNM1L, pmod(Ph))
ea9685be-c632-4715-9f30-4158b8d0ce5a	1.0	PubMed	23185298	We suggested S693D as a phosphomimetic mutant may act as Drp1 phosphorylated by GSK3beta and resulted in this Drp1 mutant unable to be targeted to mitochondrial membrane (refers to XREF_FIG, the model).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNM1L, pmod(Ph))
40d1db42-301e-4e2f-aa75-058f78344320	1.0	PubMed	23185298	Here we demonstrate that Drp1 is phosphorylated by GSK3beta at Ser693 and by PKA at Ser637 leading mitochondria to undergo rapid elongation through the attenuation of GTPase activity, down-regulating cytochrome c release, capase-3, -7 and PARP activation (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNM1L, pmod(Ph, Ser, 637))
dfe1aaab-e709-4751-a047-c15df885e4de	1.0	PubMed	23185298	Here we demonstrate that Drp1 is phosphorylated by GSK3beta at Ser693 and by PKA at Ser637 leading mitochondria to undergo rapid elongation through the attenuation of GTPase activity, down-regulating cytochrome c release, capase-3, -7 and PARP activation (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNM1L, pmod(Ph, Ser, 693))
8c306ac1-87d4-4d33-8c09-7e1ecf05499b	1.0	PubMed	25347529	The logic was based on some interesting observations, such as, beta-TrCP committed to degrade the GSK3beta phosphorylated DNA methyl transferase 1 (DNMT1) is prevented by tobacco specific carcinogen NNK induced beta-TrCP translocation to the cytoplasm with the help of heterogeneous nuclear ribonucleoprotein U (hnRNP-U) XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNMT1, pmod(Ph))
8c306ac1-87d4-4d33-8c09-7e1ecf05499b	1.0	PubMed	22317856	They found that in a human lung cell line, glycogen synthase kinase 3beta (GSK3beta) phosphorylated DNMT1 to recruit beta-transducin repeat containing protein (betaTrCP), resulting in DNMT1 degradation, and that NNK activated AKT, inhibiting GSK3beta function and thereby attenuating DNMT1 degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNMT1, pmod(Ph))
8c306ac1-87d4-4d33-8c09-7e1ecf05499b	1.0	PubMed	20093774	We determined that in a human lung cell line, glycogen synthase kinase 3beta (GSK3beta) phosphorylated DNMT1 to recruit beta-transducin repeat containing protein (betaTrCP), resulting in DNMT1 degradation, and that NNK activated AKT, inhibiting GSK3beta function and thereby attenuating DNMT1 degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DNMT1, pmod(Ph))
ff556eeb-36f5-474f-8ae9-34ccf332b933	1.0	PubMed	18641688	DOCK4 is phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DOCK4, pmod(Ph))
ff556eeb-36f5-474f-8ae9-34ccf332b933	1.0	PubMed	18641688	Furthermore, we observe that DOCK4 is phosphorylated by GSK3beta, which enhances Wnt induced Rac activation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DOCK4, pmod(Ph))
ff556eeb-36f5-474f-8ae9-34ccf332b933	1.0	PubMed	18641688	These data indicate that DOCK4 is phosphorylated by GSK3beta during Wnt and beta-catenin signaling.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DOCK4, pmod(Ph))
ff556eeb-36f5-474f-8ae9-34ccf332b933	1.0	PubMed	18641688	To test if Axin is a scaffold for DOCK4 phosphorylation by GSK3beta, GST fused C terminus of DOCK4 was coexpressed with GSK3beta in the presence or absence of Axin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DOCK4, pmod(Ph))
ff556eeb-36f5-474f-8ae9-34ccf332b933	1.0	PubMed	18641688	This analysis allowed us to map 10 specific residues (nine serines and one threonine) in the C terminus of DOCK4 that are phosphorylated by GSK3beta (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DOCK4, pmod(Ph))
ff556eeb-36f5-474f-8ae9-34ccf332b933	1.0	PubMed	18641688	Taken together, these data provide biochemical evidence that DOCK4 is phosphorylated by GSK3beta in the presence of Axin in Wnt and beta-catenin signaling.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DOCK4, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	15652488	We found that GSK-3beta phosphorylated CRMP-2 that was prephosphorylated by Cdk5 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	15652488	We examined whether CRMP-2 is phosphorylated by GSK-3beta in hippocampal neurons during axon outgrowth.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	15652488	Here, we tried to prepare CRMP-2 phosphorylated by GSK-3beta in vitro but found that the stoichiometry of the phosphorylation was less than 40%.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	15652488	GSK-3beta alone did not phosphorylate CRMP-2 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	15652488	We found that treatment of Cdk inhibitor (olomoucine) decreased the phosphorylation levels of CRMP-2 in COS7 cells (data not shown) and hippocampal neurons (Supplemental Figure S1B) and that GSK-3beta phosphorylated CRMP-2 that was prephosphorylated by Cdk5 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	15652488	To examine whether GSK-3beta phosphorylates CRMP-2, COS7 cells were cotransfected with GSK-3beta wild-type (wt) and CRMP-2 wt and subjected to immunoblot analysis with anti-CRMP-2 antibody.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	23185275	In this study, we show that GSK-3beta inhibition reduces CRMP-2 phosphorylation and enhances CRMP-2 localization to the primary cilium.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	25285016	XREF_BIBR, XREF_BIBR Similarly, in dorsal root ganglion cells, Sema3A induces phosphorylation of CRMP2 by GSK-3beta after priming by Cdk5, which reduces the ability of CRMP2 to bind tubulin, thereby destabilizing microtubule structure and impairing cell migration.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
d9117fb0-32c1-42ed-8ffb-2e03571b6a81	1.0	PubMed	25528666	We have previously reported that sequential phosphorylation of CRMP2 by Cdk5 and GSK3beta and phosphorylation of Axin-1 by GSK3beta mediates growth cone collapse response to Sema3A ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph))
10194eac-f976-4b4c-9d79-956c8199042b	1.0	PubMed	15652488	Ser-518 is also a potential phosphorylation site of CRMP-2 by GSK-3_.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Ser, 518))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	These results indicate that GSK-3beta can phosphorylate CRMP-2 at Thr 514 after CRMP-2 is phosphorylated by Cdk5.We then evaluated each phosphorylation site (Thr 514, Ser 518, and Ser 522).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	These results suggest that GSK-3beta phosphorylates CRMP-2 at Thr 514 after CRMP-2 is phosphorylated by Cdk5 in hippocampal neurons.To investigate the spatial distribution of phosphorylated CRMP-2 at Thr 514, hippocampal neurons were fixed at 3 DIV and then immunostained with anti-pT514 (phosphorylated CRMP-2, red) and anti-CRMP-2 antibodies (total CRMP-2, green;).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	Taken together, these results suggest that NT-3 decreases the phosphorylation levels of CRMP-2 and increases nonphosphorylated active CRMP-2 to promote axon outgrowth and branching.In the present study, we found that CRMP-2 was phosphorylated at Thr 514 by GSK-3beta in vitro and in vivo (; Supplemental Figure S1C).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	Therefore, it is likely that Cdk5 phosphorylates CRMP-2 at Ser 522, whereby GSK-3beta phosphorylates CRMP-2 at Thr 514 in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	However, it remains unknown whether GSK-3beta is involved in neuronal polarity and, if so, what the target substrates of GSK-3beta are.We report here that GSK-3beta phosphorylates CRMP-2 at Thr 514, inactivates the CRMP-2 activity, and participates in neuronal polarization through CRMP-2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	Considering the consensus sequences of GSK-3beta, we speculated that CRMP-2 was phosphorylated by GSK-3beta at Thr 514.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	These results suggest that GSK-3beta phosphorylates CRMP-2 at Thr 514.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	Next, we examined whether GSK-3beta phosphorylates CRMP-2 at Thr 514 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
a9f5c48f-1807-4afe-a761-c6b5e55440ee	1.0	PubMed	15652488	Here, we showed that glycogen synthase kinase-3beta (gsk-3beta) phosphorylated crmp-2 at thr-514 and inactivated it	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL2, pmod(Ph, Thr, 514))
6cab463e-0b42-4eab-bd5b-1e78f35185da	1.0	PubMed	21179545	To determine the importance of CRMP4 phosphorylation in chromosomal alignment, we depleted endogenous CRMP4 protein using CRMP4 siRNA, and assessed whether a CRMP4 mutant that is not phosphorylated by GSK3beta, L-CRMP4-AAA-V5, could rescue the chromosomal misalignment phenotype.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL3, pmod(Ph), var(p.?))
6fab636e-5349-41bb-b1be-ec6f1295f680	1.0	PubMed	16611631	Together, these results suggest that crmp4 is able to increase neurite formation and elongation in neurons, although not as potently as crmp2, and that this process is regulated by ser522/ser518/thr514/thr509 phosphorylation in both cases. We demonstrate that cdk5 primes crmp2 and crmp4 for subsequent phosphorylation by gsk3, whereas dyrk2, phosphorylates and primes only crmp4 in vitro	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL3, pmod(Ph, Ser, 518))
ded61388-d68f-431a-af3a-27b6c3830092	1.0	PubMed	16611631	Primary rat cortical neurons were treated with purvalanol, a more potent inhibitor of cdk5 and dyrk2 than roscovitine (25). Phosphorylation was monitored using antibodies that specifically recognize crmp2 when phosphorylated at thr514/thr509, or crmp4 when phosphorylated at thr509. Loss of phosphorylation of ser522 will prevent subsequent phosphorylation of ser518/thr514/thr509 by gsk3. Together, these results suggest that crmp4 is able to increase neurite formation and elongation in neurons, although not as potently as crmp2, and that this process is regulated by ser522/ser518/thr514/thr509 phosphorylation in both cases. We demonstrate that cdk5 primes crmp2 and crmp4 for subsequent phosphorylation by gsk3, whereas dyrk2, phosphorylates and primes only crmp4 in vitro	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL3, pmod(Ph, Ser, 522))
7c961658-c63c-4cad-86ae-1ec8f8927a3e	1.0	PubMed	16611631	Together, these results suggest that crmp4 is able to increase neurite formation and elongation in neurons, although not as potently as crmp2, and that this process is regulated by ser522/ser518/thr514/thr509 phosphorylation in both cases. We demonstrate that cdk5 primes crmp2 and crmp4 for subsequent phosphorylation by gsk3, whereas dyrk2, phosphorylates and primes only crmp4 in vitro	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL3, pmod(Ph, Thr, 509))
67ba0175-5770-4628-98e0-345cab97c54f	1.0	PubMed	16611631	Together, these results suggest that crmp4 is able to increase neurite formation and elongation in neurons, although not as potently as crmp2, and that this process is regulated by ser522/ser518/thr514/thr509 phosphorylation in both cases. We demonstrate that cdk5 primes crmp2 and crmp4 for subsequent phosphorylation by gsk3, whereas dyrk2, phosphorylates and primes only crmp4 in vitro	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DPYSL3, pmod(Ph, Thr, 514))
ae05688a-05ac-4421-9918-b4bdf7be7003	1.0	PubMed	25699712	Interestingly, GSK3beta can phosphorylate Drosha at S300 and S302 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DROSHA, pmod(Ph, Ser, 300))
2c15a202-c023-4f0f-af3e-77962973b8da	1.0	PubMed	25699712	Interestingly, GSK3beta can phosphorylate Drosha at S300 and S302 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:DROSHA, pmod(Ph, Ser, 302))
48369eb3-8f54-485c-95ca-56d20683a214	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:DVL, pmod(Ph))
29dba77f-340c-4430-9ae2-5a55bec8f9e3	1.0	PubMed	25484286	To specifically block GSK3beta phosphorylating Dyn1, we introduced a cell-permeable peptide, TAT-Dyn1SpS, which contained the same sequence of Dyn1 (amino acids 767-786) with the Ser 778 mutated into p-Ser to provide a docking site for GSK3beta, while TAT-Con containing the reverse sequence of Dyn1 (amino acids 767-786) with the Ser 778 mutated into p-Ser was used as a control (A).	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q9C1M7, pmod(Ph))
29dba77f-340c-4430-9ae2-5a55bec8f9e3	1.0	PubMed	25484286	We found that TAT-Dyn1SpS but not TAT-Con could enhance BDNF induced Akt but not Erk1/2 activation (G, I), which suggested that inhibiting GSK3beta dependent phosphorylation of Dyn1 could promote BDNF induced Akt activation.	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q9C1M7, pmod(Ph))
29dba77f-340c-4430-9ae2-5a55bec8f9e3	1.0	PubMed	25484286	We found that TAT-Dyn1SpS instead of TAT-Con could decrease GSK3beta-Dyn1 interaction and phosphorylation of Ser 774 on Dyn1 (A-C), which suggested that TAT-Dyn1SpS could inhibit phosphorylation of Dyn1 induced by GSK3beta in vivo.Next, we testified whether TAT-Dyn1SpS could affect the BDNF downstream signaling activation and the cleaved caspase-3 levels in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q9C1M7, pmod(Ph))
ac8192b1-d932-4c8b-8e86-6a194d883ca2	1.0	PubMed	25596745	For example, it has been shown that GSK3beta dependent phosphorylation of cyclin E1 controls the binding of the E3 ligase Fbw7 to cyclin E1, resulting in cyclin E1 degradation via the ubiquitin-proteasome pathway.	p(HGNC:GSK3B)	directlyIncreases	a(PUBCHEM:5870, pmod(Ph))
34949cbe-1745-47e8-922f-60a0cd92b62b	1.0	PubMed	20447425	To validate the specificity of the antibody, we studied its immunoreactivity against a recombinant E2F1 phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph))
34949cbe-1745-47e8-922f-60a0cd92b62b	1.0	PubMed	17050006	We used a GST fusion protein containing the putative GSK3beta phosphorylation sites in human E2F1 transactivation domain (amino acids 380-437) with none, one, or two point mutations, respectively.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph))
34949cbe-1745-47e8-922f-60a0cd92b62b	1.0	PubMed	17050006	As shown in B, GSK3beta phosphorylates E2F1 at the active domain, in accordance with the localization of both amino acids within this domain.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph))
34949cbe-1745-47e8-922f-60a0cd92b62b	1.0	PubMed	17050006	Whether GSK3beta phosphorylates E2F1 was also analyzed in cells overexpressing GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph))
34949cbe-1745-47e8-922f-60a0cd92b62b	1.0	PubMed	17050006	These results suggest a predominant role of cdk7 in the effect of GSK3beta on E2F1 phosphorylation.The phosphorylation of E2F1 by GSK3beta suggested that the two proteins physically interact.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph))
34949cbe-1745-47e8-922f-60a0cd92b62b	1.0	PubMed	17050006	Our results suggest that GSK3beta does not phosphorylate E2F1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph))
34949cbe-1745-47e8-922f-60a0cd92b62b	1.0	PubMed	17050006	We can not exclude a possible phosphorylation of E2F1 by GSK3beta since different kinetic behavior in the phosphorylation of E2F1 by cdk7 and GSK3beta and/or limited sensitivity of the assay can not formally be ruled out.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph))
4d5db5de-90be-47b2-ad78-fb08a605183f	1.0	PubMed	20447425	We previously reported that GSK3beta is able to phosphorylate E2F1 at Ser403 and Ser433.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph, Ser, 403))
4d5db5de-90be-47b2-ad78-fb08a605183f	1.0	PubMed	20447425	Several previous studies had demonstrated that GSK3beta, p38 MAP kinase and cdk7 were able to phosphorylate E2F1 at Ser403.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph, Ser, 403))
4d5db5de-90be-47b2-ad78-fb08a605183f	1.0	PubMed	20447425	Although the indirect data presented in these studies suggested that GSK3beta was not able to phosphorylate E2F1, no real E2F1 Ser403 phosphorylation detection was evaluated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph, Ser, 403))
4d5db5de-90be-47b2-ad78-fb08a605183f	1.0	PubMed	20447425	Neither GSK3beta nor p38 MAP kinase that are shown to phosphorylate E2F1 on Ser403, are involved in this phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ph, Ser, 403))
d8c91942-10e8-42fc-8d11-316250b906a3	1.0	PubMed	27566146	In order to identify the E3 ligase that may meditate the ubiquitination of SOX9 leading to its proteasomal degradation after DNA damage, we screened the F-box protein family of E3 ligases, which typically require their target proteins to first be phosphorylated by GSK3beta (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:"E3_Ub_ligase", pmod(Ph))
5757ab81-2bba-42de-9e57-fd9f7fa293c1	1.0	PubMed	24917152	Consistently, in vitro kinase assays demonstrated that Cdk5, but not GSK3beta, directly phosphorylates EFhd2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EFHD2, pmod(Ph))
ef9e8974-2f27-4497-a8a5-a7e641fb2db4	1.0	PubMed	28036276	Although our data show that FBW7 promotes EglN2 degradation in a GSK3beta kinase dependent manner, we have not observed the GSK3beta kinase induced EglN2 Thr405 site phosphorylation when performing the in vitro kinase assay with GST tagged EglN2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EGLN2, pmod(Ph, Thr, 405))
e56dd57d-3e09-4fed-83d1-20ded5b16415	1.0	PubMed	12133000	The largest (epsilon) subunit of eIF2B is a substrate for glycogen synthase kinase (GSK)-3 in vitro, and phosphorylation by GSK3 inhibits the activity of eIF2B. The site of phosphorylation has previously been identified as Ser(535).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EIF2B5, pmod(Ph, Ser, 535))
55c25ec2-ebfe-42af-85c8-9c9947bda987	1.0	PubMed	11500362	We identify multiple phosphorylation sites in the largest, catalytic, subunit (epsilon) of mammalian eIF2B. Glycogen synthase kinase 3 (GSK3) is responsible for phosphorylating Ser535. This regulatory phosphorylation event requires both the fourth site (Ser539) and a distal region, which acts to recruit GSK3 to eIF2Bepsilon in vivo.   eIF2Bϵ from mammals or insects is a substrate for glycogen synthase kinase 3 (GSK3), and this inhibits the activity of eIF2B	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EIF2B5, pmod(Ph, Ser, 540))
55c25ec2-ebfe-42af-85c8-9c9947bda987	1.0	PubMed	18701453	Gsk3_ phosphorylates eif2b_ at ser-539 (ser-535 in the rat sequence) and inactivates it	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EIF2B5, pmod(Ph, Ser, 540))
01c2e3d4-020c-4a21-bf02-23e5e065eda0	1.0	PubMed	18701453	We found that gsk-3Beta phosphorylates and inactivates 4e-bp1, thereby increasing eif4e-dependent protein synthesis. upon stimulation, 4e-bp1 is phosphorylated on several threonine and serine residues, including thr-37/46 (36). This results in dissolution of the complex, freeing eif4e to bind with mrna cap to promote translation initiation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EIF4EBP1, pmod(Ph, Thr, 37))
4957b432-25ee-42e5-adba-536c555fdaae	1.0	PubMed	23584478	Glycogen synthase kinase-3_ positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1We found that GSK-3_ phosphorylates and inactivates 4E-BP1, thereby increasing eIF4E-dependent protein synthesis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EIF4EBP1, pmod(Ph, Thr, 46))
4957b432-25ee-42e5-adba-536c555fdaae	1.0	PubMed	18701453	We found that gsk-3Beta phosphorylates and inactivates 4e-bp1, thereby increasing eif4e-dependent protein synthesis. upon stimulation, 4e-bp1 is phosphorylated on several threonine and serine residues, including thr-37/46 (36). This results in dissolution of the complex, freeing eif4e to bind with mrna cap to promote translation initiation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EIF4EBP1, pmod(Ph, Thr, 46))
42fb32d9-2279-4306-83af-23f6b5e56ca5	1.0	PubMed	25053419	GSK3beta knockdown or GSK3 inhibitor suppresses IGF-I-induced IGF-IR, Akt, and ERK1/2 phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:ERK, pmod(Ph))
42fb32d9-2279-4306-83af-23f6b5e56ca5	1.0	PubMed	8764598	Using conditions in vitro under which two proline directed protein kinases, glycogen synthase kinase-3beta (GSK-3beta) and mitogen activated protein kinase (MAPK), were able to hyperphosphorylate tau, GSK-3beta but not MAPK phosphorylated recombinant APPcyt.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:ERK, pmod(Ph))
42fb32d9-2279-4306-83af-23f6b5e56ca5	1.0	PubMed	26022178	Moreover, phosphorylation of ERK, which is a downstream of PLC-gamma activation, and of Akt was also significantly augmented by GSK-3beta knockdown (B and C).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:ERK, pmod(Ph))
42fb32d9-2279-4306-83af-23f6b5e56ca5	1.0	PubMed	4146386	Using conditions in vitro under which two proline directed protein kinases, glycogen synthase kinase-3beta (GSK-3beta) and mitogen activated protein kinase (MAPK), were able to hyperphosphorylate tau, GSK-3beta but not MAPK phosphorylated recombinant APPcyt.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:ERK, pmod(Ph))
42fb32d9-2279-4306-83af-23f6b5e56ca5	1.0	PubMed	21898401	GSK-3beta knockdown blocked the IFN-alpha-induced phosphorylation of extracellular signal regulated kinase (ERK) 1/2 (Thr202 and Tyr204) and signal transducer and transactivator (STAT) 1.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:ERK, pmod(Ph))
b08360d3-aec1-4392-b66e-18edd350c8de	1.0	PubMed	26547929	Western blot results revealed that in both cell lines, restoration of miR-9 could block the phosphorylation of AKT (Ser473) and ERK (Thr202 and Tyr204) as well as GSK-3beta (Ser9).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:ERK, pmod(Ph, Ser, 9))
d99d5127-0d81-41ce-8a21-403de051b6e3	1.0	PubMed	24275493	Interestingly, it has been shown that the GSK3beta kinase phosphorylates and stabilizes both ERalpha (XREF_BIBR, XREF_BIBR) and AR (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ESR1, pmod(Ph))
b208b275-8fe3-4dae-a8ef-e41c08591001	1.0	PubMed	16076840	The gsk-3 inhibitor lithium chloride was used to determine the role of gsk-3 in phosphorylation of ser-102, -104, and -106 and ser-118 in vivo and to explore the role of these serines in the regulation of eralpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of ser-104 and -106 and ser-118, which suggests these serine residues as targets for gsk-3 in vivo. Our results further suggest that eralpha phosphorylation by gsk-3 stabilizes eralpha under resting conditions and modulates eralpha transcriptional activity upon ligand binding. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin a-cdk2 complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ESR1, pmod(Ph, Ser, 102))
b522b5bb-75f3-4021-a7b5-383dbe10c6d8	1.0	PubMed	16076840	The gsk-3 inhibitor lithium chloride was used to determine the role of gsk-3 in phosphorylation of ser-102, -104, and -106 and ser-118 in vivo and to explore the role of these serines in the regulation of eralpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of ser-104 and -106 and ser-118, which suggests these serine residues as targets for gsk-3 in vivo. Our results further suggest that eralpha phosphorylation by gsk-3 stabilizes eralpha under resting conditions and modulates eralpha transcriptional activity upon ligand binding. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin a-cdk2 complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ESR1, pmod(Ph, Ser, 104))
97f60702-1cda-4e97-beb3-8c16d5b42f0e	1.0	PubMed	16076840	The gsk-3 inhibitor lithium chloride was used to determine the role of gsk-3 in phosphorylation of ser-102, -104, and -106 and ser-118 in vivo and to explore the role of these serines in the regulation of eralpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of ser-104 and -106 and ser-118, which suggests these serine residues as targets for gsk-3 in vivo. Our results further suggest that eralpha phosphorylation by gsk-3 stabilizes eralpha under resting conditions and modulates eralpha transcriptional activity upon ligand binding. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin a-cdk2 complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ESR1, pmod(Ph, Ser, 106))
68582355-0c76-40d3-a501-eac73b97223e	1.0	PubMed	17609434	Furthermore, in vitro kinase assay depicted that GSK-3beta phosphorylates ERalpha at Ser 118.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ESR1, pmod(Ph, Ser, 118))
68582355-0c76-40d3-a501-eac73b97223e	1.0	PubMed	16076840	The gsk-3 inhibitor lithium chloride was used to determine the role of gsk-3 in phosphorylation of ser-102, -104, and -106 and ser-118 in vivo and to explore the role of these serines in the regulation of eralpha function. Treatment of cells with lithium chloride resulted in dephosphorylation of ser-104 and -106 and ser-118, which suggests these serine residues as targets for gsk-3 in vivo. Our results further suggest that eralpha phosphorylation by gsk-3 stabilizes eralpha under resting conditions and modulates eralpha transcriptional activity upon ligand binding. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin a-cdk2 complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ESR1, pmod(Ph, Ser, 118))
a882c251-1c2a-43a1-88f0-18cce610573a	1.0	PubMed	4997431	In addition, Eve was phosphorylated and inactivated by purified GSK-3 beta plus casein kinase II.	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF01878, pmod(Ph))
74edc96f-37e8-4516-aa5c-0d558a475066	1.0	PubMed	27232758	Phosphorylation of the FAAP20 degron motif by GSK3beta provides a platform for recognition and polyubiquitination of FAAP20 by FBW7, and its subsequent degradation by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FAAP20, pmod(Ph))
74edc96f-37e8-4516-aa5c-0d558a475066	1.0	PubMed	27232758	In addition, pharmacological inhibition of GSK3beta activity delayed both endogenous and exogenous FAAP20 degradation, indicating that GSK3beta dependent phosphorylation of FAAP20 is required for regulating FAAP20 stability.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FAAP20, pmod(Ph))
778482d5-c403-4252-9f8b-1cf5e6b8af4b	1.0	PubMed	27232758	However, treatment with GSK3beta inhibitor in the presence of MG132 abrogated the phospho-signal, whereas the FAAP20 levels were elevated, indicating that GSK3beta phosphorylates the Ser113 of FAAP20, leading to FAAP20 degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FAAP20, pmod(Ph, Ser, 113))
19e0cb61-0e97-48b5-84f4-2b049c3c33b5	1.0	PubMed	23783032	We generated a T178A point mutation at a putative GSK3beta phosphorylation site in FANCL identified by the NetPhosK1.0 and KinasePhos programs (XREF_FIG, top, left).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FANCL, pmod(Ph))
9e86f60b-8bc4-4de8-ba39-1e9146e03e4f	1.0	PubMed	23542741	Targeting is facilitated by GSK3beta phosphorylation of Fbxl2, this provides a phosphodegron molecular signal for Fbxo3 recruitment to Fbxl2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FBXL2, pmod(Ph))
2bb3562d-9900-4159-9702-3a976757e4c0	1.0	PubMed	21242966	Ubiquitylation of cyclin D1 requires phosphorylation of both cyclin D1 and Fbx4 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FBXO4, pmod(Ph))
2bb3562d-9900-4159-9702-3a976757e4c0	1.0	PubMed	18598945	Phosphorylation of Fbx4 by GSK3beta was also confirmed with recombinant proteins in an in vitro kinase assay (A).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FBXO4, pmod(Ph))
2bb3562d-9900-4159-9702-3a976757e4c0	1.0	PubMed	18598945	Altogether, we provide evidence that cancer derived mutations that target the GSK3beta phosphorylation site in Fbx4 and affect its dimerization have reduced activity toward cyclin D1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FBXO4, pmod(Ph))
2f9a82bc-2ef4-47e3-a3a9-b8e398080460	1.0	PubMed	21242966	Taken together, these results suggest a model wherein Fbx4 is first phosphorylated at S12 by GSK3beta predominantly at the G1/S transition and subsequently binds 14-3-3epsilon in a phospho-S12 dependent manner.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FBXO4, pmod(Ph, Ser, 12))
2f9a82bc-2ef4-47e3-a3a9-b8e398080460	1.0	PubMed	21242966	Gsk3beta-mediated phosphorylation of fbx4 ser12 during the g1/s transition regulates fbx4 dimerization, which in turn governs fbx4-driven e3 ligase activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FBXO4, pmod(Ph, Ser, 12))
de19cda5-4919-4eeb-b99d-d4f335473728	1.0	PubMed	21964756	Possible FBW7 interaction sites within the oxygen dependent degradation (ODD) domain of HIF-1alpha were identified through homology with other FBW7 targets that are phosphorylated by GSK3beta (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FBXW7, pmod(Ph))
5784593c-1a35-49a4-a4c6-de465291e94f	1.0	PubMed	19185849	Deletion of Rictor in MEFs ablates Akt S473 phosphorylation, and this partly impairs the ability of Akt to phosphorylate FoxO, but not TSC2 or GSK3beta suggesting that in these cells Akt retains activity (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:FOXO, pmod(Ph))
1dd18149-66a2-4bea-8378-8dec34a79459	1.0	PubMed	23434765	GSK3beta under the control of AKT and PI3K, phosphorylates Fyn leading to Fyn nuclear localization.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:FYN, pmod(Ph))
61b45301-98c6-4a3e-97f2-c6d4cb6721ff	1.0	PubMed	23673211	After the Wnt ligand binds to its receptor, Frizzled (Fz), its co-receptor, low-density lipoprotein receptor related protein 5/6 (LRP5/6), is phosphorylated by CK1 and GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:FZD, pmod(Ph))
3cbbb965-c85f-4c56-b2e4-847655836ea2	1.0	PubMed	PMC5921692	GSK3beta physically associates with GATA4 and phosphorylates GATA4 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GATA4, pmod(Ph))
3cbbb965-c85f-4c56-b2e4-847655836ea2	1.0	PubMed	5921692	GSK3beta physically associates with GATA4 and phosphorylates GATA4 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GATA4, pmod(Ph))
3cbbb965-c85f-4c56-b2e4-847655836ea2	1.0	PubMed	26946174	For example, phosphorylation of S105 by ERK and p38 MAPK, and of S419/410 by protein kinase C (PKC) potentiated GATA4 's function, whereas glycogen synthase kinase 3 beta (GSK 3b) phosphorylated the N-terminal domain of GATA4 (2-205 aa), which decreased its nuclear occupancy, and subsequently repressed the GATA4 dependent gene activation program.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GATA4, pmod(Ph))
1888c4a2-e6ed-4437-b0eb-ca9995a15b4d	1.0	PubMed	22206674	This decrease was partially attenuated by pretreatment with Ro-31-8220 or U0126, indicating a PKC- or MEK dependent pathway, respectively.It has been shown that the phosphorylation of GCMa by GSK-3beta induces its degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GCM1, pmod(Ph))
1888c4a2-e6ed-4437-b0eb-ca9995a15b4d	1.0	PubMed	26992674	Glycogen synthase kinase-3beta (GSK-3beta) is activated by suppressed PI3K-Akt signaling in hypoxic conditions; GSK-3beta then phosphorylates GCM1 and enhances its ubiquitination and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GCM1, pmod(Ph))
4d2c7cc0-2209-4c25-a01d-5aed9bf504ed	1.0	PubMed	20855292	We demonstrated that GSK-3beta mediates phosphorylation of GCM1 on Ser322, which is recognized by the F-box protein, FBW2, to promote GCM1 ubiquitination and degradation (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GCM1, pmod(Ph, Ser, 322))
c3b75d34-d32e-4907-bc20-19ed2d0bc215	1.0	PubMed	22034075	It has been reported that PKA and GSK-3beta (glycogen synthase kinase 3beta) induced Gli protein phosphorylation, leading to proteolytic degradation of Gli protein proteolysis [XREF_BIBR], and disruption of Hh signaling causes metabolic bone diseases [XREF_BIBR; XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI1, pmod(Ph))
597c0d7a-cbc2-4ce7-b6f9-0573c3072f8a	1.0	PubMed	16611981	The degradation of Gli2 requires the phosphorylation of a cluster of numerous serine residues in its carboxyl terminus by protein kinase A and subsequently by casein kinase 1 and glycogen synthase kinase 3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI2, pmod(Ph, Ser, 820))
13854215-390e-4746-986b-c45f2daff7f7	1.0	PubMed	16611981	The degradation of Gli2 requires the phosphorylation of a cluster of numerous serine residues in its carboxyl terminus by protein kinase A and subsequently by casein kinase 1 and glycogen synthase kinase 3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI2, pmod(Ph, Ser, 832))
fa7e98a7-b5b5-4714-b9f5-e81cf12ac676	1.0	PubMed	16611981	The degradation of Gli2 requires the phosphorylation of a cluster of numerous serine residues in its carboxyl terminus by protein kinase A and subsequently by casein kinase 1 and glycogen synthase kinase 3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI2, pmod(Ph, Ser, 863))
3d8f398a-deb4-4f67-9a4d-562db75f032d	1.0	PubMed	16705181	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI3, pmod(Ph, Ser, 1006), pmod(Ph, Ser, 849), pmod(Ph, Ser, 861), pmod(Ph, Ser, 865), pmod(Ph, Ser, 877), pmod(Ph, Ser, 907), pmod(Ph, Ser, 980))
2a9b9e38-166c-4ee0-a098-9d8a4b36d504	1.0	PubMed	16705181	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI3, pmod(Ph, Ser, 1006), pmod(Ph, Ser, 849), pmod(Ph, Ser, 865), pmod(Ph, Ser, 873), pmod(Ph, Ser, 877), pmod(Ph, Ser, 907), pmod(Ph, Ser, 980))
16ddcf85-7ea7-4d7c-a139-a6401a81a277	1.0	PubMed	16705181	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI3, pmod(Ph, Ser, 1006), pmod(Ph, Ser, 849), pmod(Ph, Ser, 865), pmod(Ph, Ser, 877), pmod(Ph, Ser, 903), pmod(Ph, Ser, 907), pmod(Ph, Ser, 980))
9a3d5d79-88a7-45b6-84cc-5bbb4914ce4a	1.0	PubMed	11955435	We show that these phosphoserines prime further phosphorylation at adjacent Glycogen Synthase Kinase 3 (GSK3) and Casein Kinase I (CK1) sites. Alteration of the GSK3 or CK1 sites prevents Ci-155 proteolysis and activates Ci in the absence of Hedgehog.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI3, pmod(Ph))
9a3d5d79-88a7-45b6-84cc-5bbb4914ce4a	1.0	PubMed	16885213	Gli2 and Gli3 (in vertebrates) are phosphorylated by protein kinase A and glycogen synthase kinase-3_ and are proteolytically processed	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI3, pmod(Ph))
9a3d5d79-88a7-45b6-84cc-5bbb4914ce4a	1.0	PubMed	27621083	In the absence of pathway activation, sequential phosphorylation of Gli3, and to a lesser extent of Gli2, by PKA, CKI and GSK3beta induces ubiquitin dependent limited proteolysis to generate a transcriptionally repressive form, GliR (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLI3, pmod(Ph))
c164f24d-79e8-4d6d-a714-a45358e9b026	1.0	PubMed	25390651	Inhibition of GSK-3beta activity by LiCl was confirmed by the results that LiCl increased Ser9-phospho-GSK-3beta level, reflecting suppression of a GSK-3beta activity dependent phosphatase, and reduced phosphorylation of glycogen synthase (GS), a downstream target of GSK-3beta (XREF_FIG, lower panel).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GLUL, pmod(Ph))
3cc0c158-2660-40c8-b8a9-840763f86105	1.0	PubMed	23408424	Identification of gsk3_ as the kinase targeting ser-270 /phosphorylation at ser-270 promotes gephyrin processing by calpain	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GPHN, pmod(Ph, Ser, 270))
d941dc20-efab-458b-95c9-2bf64874f6ba	1.0	PubMed	16984735	Moreover, a selective PKCb inhibitor, LY379196, reduced NT mediated GSK-3b (but not GSK-3a) phosphorylation, suggesting a role for PKCb1 in the NT mediated phosphorylation of GSK-3b and an undefined kinase in the NT mediated phosphorylation of GSK-3a.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3A, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	21471285	Linifanib inhibits phosphorylation of AKT, and GSK3beta in Ba/F3 FLT3 ITD mutant cells and IL-3 rescues phosphorylation of GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	21422248	Immunoprecipitation and in vitro kinase assays demonstrated that GSK3-beta associated with a downstream target of mTORC1, p85S6K, and phosphorylated GSK3-beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	PMC5551276	At the protein level, we observed an up-regulation of both GSK-3beta and phosphorylated GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	23768967	Axin, a GSK-3beta substrate and binding partner, is phosphorylated by GSK-3beta allowing it to subsequently bind and increase GSK-3beta phosphorylation, ultimately leading to the degradation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	26822034	To determine the function of the phosphorylation of GSK3beta at Ser 389 / Thr 390 relative to classical Ser 9 phosphorylation, we generated GSK3beta-KI mice where Ser 389 of GSK3beta was replaced with Ala to prevent the C-terminal phosphorylation of GSK3beta (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	21585337	Lithium chloride (LiCl), a chemical inhibitor of GSK-3beta, increased GSK-3beta phosphorylation in our cultures (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	19289791	However, most importantly, mutation of the first GSK3beta motif that is not phosphorylated by physiological GSK3beta levels preferentially rescued plus end tracking.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	19429245	The results showed that GSK3beta protein level decreased and phosphorylated GSK3beta level increased in a dose dependent manner, respectively ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	19107203	Thus, the phosphorylated LRP6 motif is a much stronger inhibitor of GSK3beta than the phosphorylated N-terminal fragment of GSK3beta (K i ~ 700 microM), which is a known pseudosubstrate inhibitor of GSK3beta XREF_BIBR (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	23912036	Primary antibodies anti-TrkA receptor (RTA : 1:1000), anti-p75 receptor (REX : 1:1000), GSK3-beta, and phosphorylated GSK3beta (Sigma Aldrich, 1:1000) and a mouse anti-beta-actin antibody (Promega, 1:1000) as a loading control.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	18641688	Wnt stimulation results in the inhibition of GSK3beta mediated beta-catenin phosphorylation and activation of GSK3beta mediated phosphorylation of Axin and the Wnt co-receptor LRP5/6 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	21471285	Linifanib inhibits phosphorylation of AKT, and GSK3beta in Ba/F3 FLT3 ITD mutant cells and IL-3 rescues phosphorylation of GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	21422248	Immunoprecipitation and in vitro kinase assays demonstrated that GSK3-beta associated with a downstream target of mTORC1, p85S6K, and phosphorylated GSK3-beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	PMC5551276	At the protein level, we observed an up-regulation of both GSK-3beta and phosphorylated GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	23768967	Axin, a GSK-3beta substrate and binding partner, is phosphorylated by GSK-3beta allowing it to subsequently bind and increase GSK-3beta phosphorylation, ultimately leading to the degradation of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	26822034	To determine the function of the phosphorylation of GSK3beta at Ser 389 / Thr 390 relative to classical Ser 9 phosphorylation, we generated GSK3beta-KI mice where Ser 389 of GSK3beta was replaced with Ala to prevent the C-terminal phosphorylation of GSK3beta (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	21585337	Lithium chloride (LiCl), a chemical inhibitor of GSK-3beta, increased GSK-3beta phosphorylation in our cultures (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	19289791	However, most importantly, mutation of the first GSK3beta motif that is not phosphorylated by physiological GSK3beta levels preferentially rescued plus end tracking.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	19429245	The results showed that GSK3beta protein level decreased and phosphorylated GSK3beta level increased in a dose dependent manner, respectively ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	19107203	Thus, the phosphorylated LRP6 motif is a much stronger inhibitor of GSK3beta than the phosphorylated N-terminal fragment of GSK3beta (K i ~ 700 microM), which is a known pseudosubstrate inhibitor of GSK3beta XREF_BIBR (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	23912036	Primary antibodies anti-TrkA receptor (RTA : 1:1000), anti-p75 receptor (REX : 1:1000), GSK3-beta, and phosphorylated GSK3beta (Sigma Aldrich, 1:1000) and a mouse anti-beta-actin antibody (Promega, 1:1000) as a loading control.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	18641688	Wnt stimulation results in the inhibition of GSK3beta mediated beta-catenin phosphorylation and activation of GSK3beta mediated phosphorylation of Axin and the Wnt co-receptor LRP5/6 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c633b685-c1a8-442c-a700-8c946d403293	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
752a4ebb-7d5a-423b-9ddf-5d726e5c60f3	1.0	PubMed	16987514	Furthermore, they reported that inhibition of GSK3beta by lithium reduced I-2 phosphorylation and increased GSK3beta Ser9 phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
752a4ebb-7d5a-423b-9ddf-5d726e5c60f3	1.0	PubMed	16987514	Furthermore, they reported that inhibition of GSK3beta by lithium reduced I-2 phosphorylation and increased GSK3beta Ser9 phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
dbfb3c34-4324-4d55-b4e5-7b4484d8efc6	1.0	PubMed	20454507	Silencing of GSK3beta prevented radiation induced GSK3beta serine phosphorylation in response to a 2-Gy radiation and produced radioresistance (REFs of 0.82 in BxPC3 and 0.60 in Panc1, P <.05; Figure 2B) similarly to pharmacological inhibition of GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
dbfb3c34-4324-4d55-b4e5-7b4484d8efc6	1.0	PubMed	20454507	Silencing of GSK3beta prevented radiation induced GSK3beta serine phosphorylation in response to a 2-Gy radiation and produced radioresistance (REFs of 0.82 in BxPC3 and 0.60 in Panc1, P <.05; Figure 2B) similarly to pharmacological inhibition of GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
5110ea0c-255d-4c80-a1d2-37f05fe8d92e	1.0	PubMed	20331603	Phosphorylation of the residue Tyrosine in 216 position results in the constitutive activity of GSK-3beta and believed to be important target for signal transduction.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
5110ea0c-255d-4c80-a1d2-37f05fe8d92e	1.0	PubMed	14570592	However, in the present study, we clearly demonstrate that GSK3_ is capable of catalysing the autophosphorylation of Tyr216 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
5110ea0c-255d-4c80-a1d2-37f05fe8d92e	1.0	PubMed	20331603	Phosphorylation of the residue Tyrosine in 216 position results in the constitutive activity of GSK-3beta and believed to be important target for signal transduction.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
5110ea0c-255d-4c80-a1d2-37f05fe8d92e	1.0	PubMed	14570592	However, in the present study, we clearly demonstrate that GSK3_ is capable of catalysing the autophosphorylation of Tyr216 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
299e0429-2329-4620-8046-b2c610495488	1.0	PubMed	22837212	LMP2A also induced phosphorylation of the Akt target GSK3beta, a Wnt signaling mediator that has been shown to regulate the activity of focal adhesion kinase (FAK), a tyrosine kinase activated by clustering and ligand interaction of integrins.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
299e0429-2329-4620-8046-b2c610495488	1.0	PubMed	22837212	LMP2A also induced phosphorylation of the Akt target GSK3beta, a Wnt signaling mediator that has been shown to regulate the activity of focal adhesion kinase (FAK), a tyrosine kinase activated by clustering and ligand interaction of integrins.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
64c14c9d-8cef-40e9-ba5f-d8938d1054d7	1.0	PubMed	11483158	GST protein alone incubated with DNA-PK was not phosphorylated by GSK3beta (data not shown).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:GST, pmod(Ph))
64c14c9d-8cef-40e9-ba5f-d8938d1054d7	1.0	PubMed	19107203	Prior to the binding reaction, the GST fused LRP6 fragments were phosphorylated by GSK3beta and CK1 and transferred to a PVDF membrane.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:GST, pmod(Ph))
476ea863-ac50-41b9-930c-d19125ef0d00	1.0	PubMed	14593110	Glycogen synthase kinase-3 (gsk-3) phosphorylates four serine residues in the cooh terminus of glycogen synthase. Phosphorylation of one of these residues, ser640 (site 3a), causes strong inactivation of glycogen synthase	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GYS1, pmod(Ph, Ser, 641))
476ea863-ac50-41b9-930c-d19125ef0d00	1.0	PubMed	6772446	Glycogen synthase kinase-3 phosphorylates three serine residues on glycogen synthase (sites 3a, 3b and 3c) which are all located in the same nine-amino-acid segment of the polypeptide chain. The sequence in this region is: Arg-Tyr-Pro-Arg-Pro-Ala-Ser(P)-Val-Pro-Pro-Ser(P)-Pro-Ser-Leu-Ser(P)-Arg-.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GYS1, pmod(Ph, Ser, 641))
476ea863-ac50-41b9-930c-d19125ef0d00	1.0	PubMed	11427888	Glycogen synthase has multiple serines (residues 640, 644, 648 and 652) separated by three residues, and those Ser residues are phosphorylated sequentially by GSK3 from the C-terminal end after Ser 656 has been phosphorylated by casein kinase II.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GYS1, pmod(Ph, Ser, 641))
9b3f36db-4ac3-482a-8ac1-90f2e170ae2f	1.0	PubMed	6772446	Glycogen synthase kinase-3 phosphorylates three serine residues on glycogen synthase (sites 3a, 3b and 3c) which are all located in the same nine-amino-acid segment of the polypeptide chain. The sequence in this region is: Arg-Tyr-Pro-Arg-Pro-Ala-Ser(P)-Val-Pro-Pro-Ser(P)-Pro-Ser-Leu-Ser(P)-Arg-.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GYS1, pmod(Ph, Ser, 645))
9b3f36db-4ac3-482a-8ac1-90f2e170ae2f	1.0	PubMed	11427888	Glycogen synthase has multiple serines (residues 640, 644, 648 and 652) separated by three residues, and those Ser residues are phosphorylated sequentially by GSK3 from the C-terminal end after Ser 656 has been phosphorylated by casein kinase II.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GYS1, pmod(Ph, Ser, 645))
2086d7a8-319b-4b49-99ad-2ac867da85e7	1.0	PubMed	6772446	Glycogen synthase kinase-3 phosphorylates three serine residues on glycogen synthase (sites 3a, 3b and 3c) which are all located in the same nine-amino-acid segment of the polypeptide chain. The sequence in this region is: Arg-Tyr-Pro-Arg-Pro-Ala-Ser(P)-Val-Pro-Pro-Ser(P)-Pro-Ser-Leu-Ser(P)-Arg-.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GYS1, pmod(Ph, Ser, 649))
2086d7a8-319b-4b49-99ad-2ac867da85e7	1.0	PubMed	11427888	Glycogen synthase has multiple serines (residues 640, 644, 648 and 652) separated by three residues, and those Ser residues are phosphorylated sequentially by GSK3 from the C-terminal end after Ser 656 has been phosphorylated by casein kinase II.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GYS1, pmod(Ph, Ser, 649))
2c9dc2f9-49b8-4e37-a89c-7f40f18031c6	1.0	PubMed	11427888	Glycogen synthase has multiple serines (residues 640, 644, 648 and 652) separated by three residues, and those Ser residues are phosphorylated sequentially by GSK3 from the C-terminal end after Ser 656 has been phosphorylated by casein kinase II.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GYS1, pmod(Ph, Ser, 653))
4fdfffdb-a888-4a83-9bf7-a61435687384	1.0	PubMed	24399733	Interestingly, ursolic acid suppressed the expression of Wnt5alpha and beta and beta-catenin, and enhanced the phosphorylation of glycogen synthase kinase 3 beta (GSK3beta).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:GYS, pmod(Ph))
4fdfffdb-a888-4a83-9bf7-a61435687384	1.0	PubMed	25390651	Inhibition of GSK-3beta activity by LiCl was confirmed by the results that LiCl increased Ser9-phospho-GSK-3beta level, reflecting suppression of a GSK-3beta activity dependent phosphatase, and reduced phosphorylation of glycogen synthase (GS), a downstream target of GSK-3beta (XREF_FIG, lower panel).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:GYS, pmod(Ph))
4fdfffdb-a888-4a83-9bf7-a61435687384	1.0	PubMed	21821713	Akt3 (-/-) platelets exhibit a significant reduction in thrombin induced phosphorylation of glycogen synthase kinase 3beta (GSK-3beta) at Ser9, which is known to inhibit GSK-3beta function.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:GYS, pmod(Ph))
4fdfffdb-a888-4a83-9bf7-a61435687384	1.0	PubMed	23097631	Loss of either CLDN3 or CLDN4 resulted in down-regulation of E-cadherin mRNA and protein, increased inhibitory phosphorylation of glycogen synthase kinase-3beta (GSK-3beta), and activation of beta-catenin pathway signaling as evidenced by increases in nuclear beta-catenin, the dephosphorylated form of the protein, and transcriptional activity of beta-catenin and T-cell factor (TCF).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:GYS, pmod(Ph))
dd5a6644-55f1-4cfc-b22f-6742e7722c24	1.0	PubMed	20205745	Moreover, downregulation of GSK3beta expression by specific GSK3beta siRNA also significantly enhanced and prolonged the phosphorylation of H2AX in response to irradiation and in G2/M phase cells (data not shown).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:H2AFX, pmod(Ph))
89629cf2-aaac-4080-826a-9322de41b103	1.0	PubMed	18358501	The mutation frequency of in the GSK-3beta phosphorylation sites in HCCs ranges from 0% to 44%, with higher mutation rate identified in HCV associated HCC.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HCCS, pmod(Ph))
eedc15b6-bd01-49ec-a4bb-0a625c230869	1.0	PubMed	21118993	Next we investigated whether GSK3beta could directly phosphorylate HDAC4.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HDAC4, pmod(Ph))
eedc15b6-bd01-49ec-a4bb-0a625c230869	1.0	PubMed	21118993	We have shown that cells lacking GSK3beta are unable to degrade HDAC4 after serum starvation and that GSK3beta can phosphorylate HDAC4 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HDAC4, pmod(Ph))
54647f30-6d12-462a-8c0c-79432f89403f	1.0	PubMed	21118993	The double mutation of serines 298/302 into alanines, but also the sole mutation of serine 302, abolishes hdac4 phosphorylation by gsk3_we have shown that cells lacking gsk3_ are unable to degrade hdac4 after serum starvation	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HDAC4, pmod(Ph, Ser, 298))
13cc13d2-d91f-475b-81f7-a27c294462fc	1.0	PubMed	21118993	The double mutation of serines 298/302 into alanines, but also the sole mutation of serine 302, abolishes hdac4 phosphorylation by gsk3_we have shown that cells lacking gsk3_ are unable to degrade hdac4 after serum starvation	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HDAC4, pmod(Ph, Ser, 302))
7f763899-7526-4576-b53b-589c80842365	1.0	PubMed	26392741	The direct inhibition of GSK-3beta catalytic activity prevents phosphorylation of the downstream substrates, beta-catenin and HIF-1alpha.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A, pmod(Ph))
7f763899-7526-4576-b53b-589c80842365	1.0	PubMed	26392741	Our data are, in part, explained by the work of Flugel et al. [XREF_BIBR], who demonstrated that the inhibition of GSK-3beta catalytic activity prevents phosphorylation of HIF-1alpha, thus preventing its degradation and increasing HIF-1alpha intracellular levels.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A, pmod(Ph))
7f763899-7526-4576-b53b-589c80842365	1.0	PubMed	21964756	This study used an ovarian cancer cell model to test the hypothesis that HIF-1alpha phosphorylation by GSK3beta in hypoxia leads to interaction with FBW7 and ubiquitin dependent degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A, pmod(Ph))
7f763899-7526-4576-b53b-589c80842365	1.0	PubMed	21964756	Specifically, phosphorylation of HIF-1alpha by GSK3beta, as mediated through PI3K activity, was shown to negatively regulate HIF-1alpha stability [XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A, pmod(Ph))
7f763899-7526-4576-b53b-589c80842365	1.0	PubMed	24333432	C shows that the knock down of GSK3beta significantly increased the mRNA expression of VEGF (a) and Glut1 (b), suggesting that inhibition of GSK3beta enhanced HIF1alpha protein expression and the expression of its target genes in osteosarcoma cells.Previous studies have shown that GSK3beta phosphorylates three amino acid residues in the ODD domain of HIF1alpha, mediating a VHL independent proteasomal degradation of HIF1alpha.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A, pmod(Ph))
7f763899-7526-4576-b53b-589c80842365	1.0	PubMed	18804163	In addition, HIF-1alpha is phosphorylated by GSK-3beta, and this phosphorylation reduces its accumulation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A, pmod(Ph))
b25aa26a-fe79-4760-9ccc-92b0d9254344	1.0	PubMed	19136008	We found that threonine 10 of h1.5 can be phosphorylated by glycogen synthase kinase-3 in vitro. We have generated an antiserum specific for human h1.5 phosphorylated at threonine 10. Immunofluorescence labeling of hela cells with this antiserum revealed that the phosphorylation at this site appears in prometaphase and disappears in telophase, and that this hyperphosphorylated form of h1.5 is mainly chromatin-bound in metaphase when chromatin condensation is maximal.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIST1H1B, pmod(Ph, Thr, 11))
5104e021-b006-443f-95eb-db3ad4ddf414	1.0	PubMed	11903055	In kinase assays pka phosphorylated ser-87 of hnrnp d, whereas glycogen synthase kinase-3 beta (gsk-3 beta) phosphorylated ser-83, but only if ser-87 had been pre-phosphorylated by pka. Phosphorylation of ser-87 enhanced, whereas phosphorylation of ser-83 repressed, transactivation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HNRNPD, pmod(Ph, Ser, 83))
5104e021-b006-443f-95eb-db3ad4ddf414	1.0	PubMed	11903055	In kinase assays pka phosphorylated ser-87 of hnrnp d, whereas glycogen synthase kinase-3 beta (gsk-3 beta) phosphorylated ser-83, but only if ser-87 had been pre-phosphorylated by pka. Phosphorylation of ser-87 enhanced, whereas phosphorylation of ser-83 repressed, transactivation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HNRNPD, pmod(Ph, Ser, 83))
826b1f61-d6b5-4a62-bd37-4095bb29502c	1.0	PubMed	16513844	The presence of GSK3beta phosphorylation sites in hnRNP A18 RGG domain and the fact that it co-immunoprecipitates with GSK3beta, but not GSK3alpha (data not shown), also support that hnRNP A18 is a bona fide oxidative stress responsive GSK3beta substrate.	p(HGNC:GSK3B)	directlyIncreases	p(UP:P21522, pmod(Ph))
0d621a1a-2b76-4bdb-9232-eccbb856f797	1.0	PubMed	25720964	As we demonstrated earlier, the FBXW7 : HSF1 interaction and substrate degradation requires phosphorylation of HSF1 by GSK3beta and ERK1 (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HSF1, pmod(Ph))
ca51c2d7-e48e-42ee-9694-5fcd89cc1317	1.0	PubMed	8940068	Ser-303 is phosphorylated by glycogen synthase kinase 3 (GSK3) through a mechanism dependent on primary phosphorylation of Ser-307 by MAPK. Secondary phosphorylation of Ser-303 by GSK3 may thus repress the activity of HSF-1, and its requirement for priming by MAPK phosphorylation of Ser-307 provides a potential link between the MAPK cascade and HSF-1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HSF1, pmod(Ph, Ser, 303))
ca51c2d7-e48e-42ee-9694-5fcd89cc1317	1.0	PubMed	8940068	Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HSF1, pmod(Ph, Ser, 303))
1e38e710-1262-4d9f-800b-3c5598bf4310	1.0	PubMed	20668436	GSK3beta dependent phosphorylation of 5-HT1B receptors appears to be required for agonist induced decrease in cAMP production.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HTR1B, pmod(Ph))
08a519e5-6c28-4a34-83e9-5a0177e4f880	1.0	PubMed	22727668	We found that, while GSK3beta was able to suppress H2B phosphorylation, it enhanced the associated kinase activity towards the SR protein SRSF1 (XREF_SUPPLEMENTARY), which is consistent with the reported effect of GSK3beta in phosphorylating primed SR proteins (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:"Histone_H2B", pmod(Ph))
5b03a6f6-3d9d-4a5f-82d1-763930292251	1.0	PubMed	27060477	Silencing of GSK-3beta by shRNA prevented histone H3 phosphorylation and reduced DNMT1 expression so that can restrain breast cancer cell proliferation 27.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:"Histone_H3", pmod(Ph))
5b03a6f6-3d9d-4a5f-82d1-763930292251	1.0	PubMed	24704462	In addition, silencing of GSK-3beta by siRNA prevents phosphorylation of histone H3, thereby, down-regulating the expression of metastatic genes.In conclusion, hyperglycemia induces proliferation in MDA-MB-231 cells by involving cross-talk between GSK-3beta activation, histone H3 phosphorylation and DNA methylation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:"Histone_H3", pmod(Ph))
2116fe06-e5bd-4bfa-8a46-81279d50be14	1.0	PubMed	24704462	We observed that GSK-3beta silencing under high glucose condition prevented phosphorylation of histone H3 at Ser 10.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:"Histone_H3", pmod(Ph, Ser, 10))
2116fe06-e5bd-4bfa-8a46-81279d50be14	1.0	PubMed	24704462	Interestingly, inactivation of GSK-3beta by specific siRNA attenuates the phosphorylation of histone H3 at Ser 10, indicating that GSK-3beta might be involved in the phosphorylation of histone H3.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:"Histone_H3", pmod(Ph, Ser, 10))
5421ea4d-0371-40f8-8c92-14d284026b18	1.0	PubMed	26655089	However, I-2 phosphorylation by GSK3beta is a relatively transient event [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q5EFR0, pmod(Ph))
5421ea4d-0371-40f8-8c92-14d284026b18	1.0	PubMed	16987514	Furthermore, they reported that inhibition of GSK3beta by lithium reduced I-2 phosphorylation and increased GSK3beta Ser9 phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q5EFR0, pmod(Ph))
7e267c8a-68dd-4e05-9576-14a76fb3209a	1.0	PubMed	22200892	PDGF-BB caused phosphorylation of p44 and p42 MAPK, SAPK and JNK, Akt and GSK-3beta, but not p38 MAPK in AsPC1 and BxPC3 cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:IFI44, pmod(Ph))
ca32c326-ba55-46eb-8edf-0213b54ff90b	1.0	PubMed	25053419	GSK3beta knockdown or GSK3 inhibitor suppresses IGF-I-induced IGF-IR, Akt, and ERK1/2 phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:IGF1R, pmod(Ph))
76ccc467-c1bf-4e52-8bdc-2698998e7cf4	1.0	PubMed	23703635	The over-expression of RI reduces the phosphorylation of the ILK downstream signaling targets p-Akt and p-GSK3beta in T24 cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ILK, pmod(Ph))
40803ca9-c6db-45ec-aba8-f12795009258	1.0	PubMed	20655470	Third, the InsR is abundant in osteoblasts and treatment of osteoblasts with insulin increases phosphorylation of the InsR and its downstream targets AKT, GSK3beta, FoxO1 and p70S6K (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:INSR, pmod(Ph))
0cbba8da-1bc3-4b28-8c57-a2efa840d6e1	1.0	PubMed	23685991	Invitro, both GSK3alpha and GSK3beta phosphorylate IRF3 at the linker region.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:IRF3, pmod(Ph))
0cbba8da-1bc3-4b28-8c57-a2efa840d6e1	1.0	PubMed	21145761	Consistently, knockdown of GSK3beta markedly inhibited SeV induced IRF3 phosphorylation and dimerization (D).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:IRF3, pmod(Ph))
61405e6a-49fd-45a6-b4c1-6153b89c3141	1.0	PubMed	25935310	However, JNK is phosphorylated by GSK3beta in cardiomyocytes.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:JNK, pmod(Ph))
c0a25aa3-0d27-445b-a6e6-25038101efa8	1.0	PubMed	25483191	XREF_BIBR Active GSK3beta phosphorylates c-Jun, thereby marking it for proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:JUN, pmod(Ph))
c0a25aa3-0d27-445b-a6e6-25038101efa8	1.0	PubMed	21145761	For example, phosphorylation of c-Jun, AP-1, or CREB by GSK3beta negatively regulates the DNA binding activities of these transcription factors ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:JUN, pmod(Ph))
c0a25aa3-0d27-445b-a6e6-25038101efa8	1.0	PubMed	19734233	Because GSK3beta can phosphorylate and destabilize c-Jun, unrepressed GSK3beta likely functions to suppress the endogenous levels of c-Jun in TCR stimulated human memory CD4 + T cells (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:JUN, pmod(Ph))
c0a25aa3-0d27-445b-a6e6-25038101efa8	1.0	PubMed	1324914	Here it is shown that glycogen synthase kinase-3 beta (GSK-3 beta), a serine/threonine kinase that specifically targets the inhibitory c-Jun phosphorylation sites, is phosphorylated in vitro by particular forms of PKC (alpha, beta 1, gamma greater than beta 2; not epsilon).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:JUN, pmod(Ph))
4090fa13-bc80-4024-b6a2-1a95720309d4	1.0	PubMed	16023596	The c-jun and c-myc oncogenic transcription factors are highly unstable proteins due to polyubiquitination. Similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation.Phosphorylation of Thr-239 and Ser-243 is required for Fbw7-mediated c-Jun disappearance	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:JUN, pmod(Ph, Ser, 243))
f146930f-4fc7-40f4-a623-063634fe110f	1.0	PubMed	1846781	Phosphorylation of recombinant human c-jun proteins in vitro by gsk-3 decreases their dna-binding activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:JUN, pmod(Ph, Ser, 249))
1ba753b9-9700-4ed2-800e-bf33a398904b	1.0	PubMed	16023596	The c-jun and c-myc oncogenic transcription factors are highly unstable proteins due to polyubiquitination. Similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation.Phosphorylation of Thr-239 and Ser-243 is required for Fbw7-mediated c-Jun disappearance	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:JUN, pmod(Ph, Thr, 239))
f6f284f0-c89e-4b2e-a4d5-145f7451f438	1.0	PubMed	24481845	Autophagy is also regulated during energy deprivation through mTORC1 independent mechanisms, such as AMPK dependent Ulk1 phosphorylation 41, phosphorylation and activation of TIP60 by GSK-3beta, which in turn activates Ulk1 108, and production of ROS by Nox4 in the endoplasmic reticulum 109.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KAT5, pmod(Ph))
3d76f7df-826f-40ee-b677-6956a226f343	1.0	PubMed	21658600	We demonstrate that gsk-3 phosphorylates serine 86 of the p53-acetyltransferase tip60. A tip60(s86a) mutant was less active to induce p53 k120 acetylation, histone 4 acetylation, and expression of puma	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KAT5, pmod(Ph, Ser, 86))
dbcd98ee-febf-45bf-896a-bceaa07295e9	1.0	PubMed	26935904	Taking this into consideration, we predict that GSK-3beta phosphorylated VEGFR-2 at sites within the DSG (X) n S motif.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KDR, pmod(Ph))
741c1bfa-f635-40a4-98cb-840f73850bd8	1.0	PubMed	22094641	In SH-SY5Y neural cells, GSK-3beta phosphorylated KLC1, a change associated to decreased association of KLC1 with its cargoes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLC1, pmod(Ph))
1faf9296-8ce8-43e8-ac88-de8eb32a8535	1.0	PubMed	22797700	Glycogen synthase kinase 3beta (GSK3beta)-mediated phosphorylation of KLF13 triggers the ubiquitination of KLF13 by the E3 ligase Fbw7gamma, resulting in KLF13 protein degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF13, pmod(Ph))
30494102-bd81-4c9b-9166-c27c5027ecf6	1.0	PubMed	24398687	Stability of the klf5 is mediated by proteasomal degradation via phosphorylation by glycogen synthase kinase 3_ (gsk3_) and recognition by f-box and wd repeat domain-containing 7 (fbw7) of a phosphodegron sequence surrounding serine 303 in klf5	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF5, pmod(Ph, Ser, 303))
1840718a-0de7-4383-9c6b-bc803f744ced	1.0	PubMed	23085750	GSK3beta phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6, pmod(Ph))
1840718a-0de7-4383-9c6b-bc803f744ced	1.0	PubMed	23085750	These data establish that GSK3beta directly phosphorylates KLF6, which augments its induction of p21 and resultant growth suppression.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6, pmod(Ph))
1840718a-0de7-4383-9c6b-bc803f744ced	1.0	PubMed	23085750	GSK3beta interacts with and phosphorylates KLF6 in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6, pmod(Ph))
1840718a-0de7-4383-9c6b-bc803f744ced	1.0	PubMed	23085750	To examine whether KLF6 is phosphorylated by GSK3beta, GST tagged KLF6 was expressed in bacteria, and then purified by glutathione affinity chromatography.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6, pmod(Ph))
1840718a-0de7-4383-9c6b-bc803f744ced	1.0	PubMed	23085750	This finding was validated using in vivo kinase assays with the addition of [32 P] orthophosphate in cell culture to confirm phosphorylation of KLF6 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6, pmod(Ph))
1840718a-0de7-4383-9c6b-bc803f744ced	1.0	PubMed	23353867	On a regulatory level, glycogen synthase kinase (GSK3) activation promotes hepatocyte lipoapoptosis, a key feature of NAFLD, and we previously demonstrated that GSK3beta directly phosphorylates KLF6, and thus increases its growth suppressor properties in vitro [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KLF6, pmod(Ph))
d219a5ef-c93c-4881-8e7f-64e4fed47165	1.0	PubMed	15327768	Using these priming rules and the crystallographically observed phosphoserine positions, an ordered phosphorylation of APC R3 by CK1 and GSK-3beta becomes apparent.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:KRT1, pmod(Ph, Arg, 3))
545963ef-a0fa-41c8-83fc-bb14859a844f	1.0	PubMed	25219467	There are 2 Thr and Ser residues followed by proline in LCMT-1, which could be phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LCMT1, pmod(Ph))
545963ef-a0fa-41c8-83fc-bb14859a844f	1.0	PubMed	25219467	To determine whether GSK-3beta can phosphorylate LCMT-1, we immunopurified HA tagged LCMT-1 from HEK-293FT cells using anti-HA and incubated it with recombinant GSK-3beta in a reaction mixture containing P-ATP at 30 degreesC for 30minutes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LCMT1, pmod(Ph))
545963ef-a0fa-41c8-83fc-bb14859a844f	1.0	PubMed	25219467	We found that GSK-3beta was able to phosphorylate LCMT-1 and autophosphorylate as well (A).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LCMT1, pmod(Ph))
545963ef-a0fa-41c8-83fc-bb14859a844f	1.0	PubMed	25219467	In the present study, we found that GSK-3beta promoted PP2Ac methylation by suppressing PME-1 expression and phosphorylating LCMT-1, resulting in an increase of PP2A activity toward tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LCMT1, pmod(Ph))
545963ef-a0fa-41c8-83fc-bb14859a844f	1.0	PubMed	25219467	In the present study, we found that GSK-3beta interacted with and phosphorylated LCMT-1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LCMT1, pmod(Ph))
217c26b9-af65-4cd8-aed6-875220a880e5	1.0	PubMed	25219467	Therefore, it is likely that LCMT-1 is phosphorylated by GSK-3beta at Ser142 and/or Thr205; however, this remains to be determined in future studies.Tau phosphorylation is complicatedly regulated by kinases andphosphatases.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LCMT1, pmod(Ph, Ser, 142))
f6fb6c7b-f0ca-4b39-bc69-76a75b4a0ca2	1.0	PubMed	25219467	Therefore, it is likely that LCMT-1 is phosphorylated by GSK-3beta at Ser142 and/or Thr205; however, this remains to be determined in future studies.Tau phosphorylation is complicatedly regulated by kinases andphosphatases.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LCMT1, pmod(Ph, Thr, 205))
358727d5-6dfd-4ba5-958b-89f7421d78ed	1.0	PubMed	19923321	Zhou and colleagues proposed a slightly different model where GSK3beta initially phosphorylates Snail1 in the nucleus at serines 119, 115, 111, and 107, promoting its nuclear export to the cytoplasm where GSK3beta further phosphorylates the DB serines (S96 and S100), eliciting ubiquitination and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LEPR, pmod(Ph, Ser, 100))
23971a51-668f-4c0d-b53d-2ee807b5947b	1.0	PubMed	22986745	Others have shown that galectin-3 can complex with and be phosphorylated by CK1 and GSK3B (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LGALS3, pmod(Ph))
23971a51-668f-4c0d-b53d-2ee807b5947b	1.0	PubMed	20600357	Shimura et al demonstrated that phosphorylation of galectin-3 by GSK-3beta is mediated by Axin [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LGALS3, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	26739898	LRP6 phosphorylation by GSK-3beta and casein kinase 1 resulted in LRP6 recruitment of axin to the plasma membrane and activation of beta-catenin XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	24721736	The cytoplasmic tail of LRP6 is then phosphorylated by CK1alpha and GSK-3beta, which are sequestered together with Axin away from the " beta-catenin destruction complex " rendering its disassembly.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	19801552	As shown in XREF_FIG A, GRK5 (lane 2) was a more effective kinase on LRP6-CT than GSK3beta (lane 3), and the stoichiometry of LRP6-CT phosphorylation by GRK5 and GSK3beta were ~ 1.2 and 0.3 phosphate and molecule under identical conditions (kinase and substrate molarity ratio is 1:5), respectively.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	19801552	In addition, phosphorylation of LRP6-CT by GSK3beta was inhibited by a GSK3beta inhibitor TWS119 (XREF_BIBR), which also partially inhibited GRK5 activity in our experiments (supplemental Fig.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	23703864	These trigger translocation of Axin to the cell surface and CDY dependent phosphorylation of LRP6 by CK and GSK3-beta leading to inactivation of GSK3-beta and stabilization of beta-catenin (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	24265322	Several kinases including GSK3beta, CK1gamma, MAPKs, cyclin dependent kinase, or G protein coupled receptor kinases phosphorylating Lrp6 have been identified (XREF_BIBR - XREF_BIBR); however, the relative contribution of individual kinases is still a matter of debate.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	25500543	In presence of Wnt, LRP6 is phosphorylated within the PPPS/TP motifs by GSK3beta and multiple CK1 members, providing docking sites to bind Axin1 and GSK3, thereby sequestering both proteins away from the beta-catenin destruction complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	19107203	It was recently reported that injection of a recombinant portion of the LRP6 cytoplasmic region containing the Ser/Thr rich cluster and the five PPPSPxS motifs induced a second body axis as effectively as the phosphorylated PPPSPxS peptide in the absence of the exogenously added Wnt ligand, even when the LRP6 protein was not prephosphorylated by GSK3beta and CK1 XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	19107203	Cselenyi et al. (2008) found that the recombinant, nonphosphorylated LRP6 intracellular region at ~ 4 microM can inhibit beta-catenin phosphorylation by GSK3beta, but not Tau, another GSK3beta substrate, which led these authors to propose that GSK3beta phosphorylates LRP6 and that the phosphorylated species somehow specifically interferes with the beta-catenin-GSK3beta interaction rather than inhibiting the kinase.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
6725f677-ef1e-472e-9e88-31ec89c37ccb	1.0	PubMed	20399743	When the Wnt ligand binds to the Frizzled and LRP6 receptors, CK1 and GSK-3beta phosphorylate LRP6 and thus dissociate Axin from the complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph))
4e524cbc-3cf4-4e61-b22e-b68981f77143	1.0	PubMed	16341017	Glycogen synthase kinase 3 (gsk3), which is known for its inhibitory role in wnt through the promotion of beta-catenin phosphorylation and degradation, mediates the phosphorylation and activation of lrp6. We show that wnt induces sequential phosphorylation of lrp6 by gsk3 and casein kinase 1, and this dual phosphorylation promotes the engagement of lrp6 with the scaffolding protein axin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:LRP6, pmod(Ph, Ser, 1490))
07f60f73-70b9-494c-ae44-d563e4f3d893	1.0	PubMed	21295697	GSK3beta Phosphorylation of ACF7 Regulates Bulge SC Migration and Skin Wound Repair In Vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MACF1, pmod(Ph))
07f60f73-70b9-494c-ae44-d563e4f3d893	1.0	PubMed	21295697	In vitro kinase (IVK) assays further showed that ACF7 is a substrate for active GSK3beta, and that GSK3beta phosphorylates ACF7 (CT) but not ACF7-NT (N-terminal domain of ACF7, serving as a control) (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MACF1, pmod(Ph))
07f60f73-70b9-494c-ae44-d563e4f3d893	1.0	PubMed	21295697	To assess whether our identification of GSK3beta phosphorylation sites in ACF7 (CT) was correct, we replaced the predicted GSK3beta targeted serines with alanines and repeated our phosphorylation assays in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MACF1, pmod(Ph))
07f60f73-70b9-494c-ae44-d563e4f3d893	1.0	PubMed	21295697	Phosphorylation of ACF7 by GSK3beta Inhibits Microtubule Binding.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MACF1, pmod(Ph))
07f60f73-70b9-494c-ae44-d563e4f3d893	1.0	PubMed	21295697	The Polarization of MTs along Actin-Focal Adhesion Networks is Abrogated When ACF7 is Phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MACF1, pmod(Ph))
07f60f73-70b9-494c-ae44-d563e4f3d893	1.0	PubMed	21295697	These findings were consistent with the phospho dependent decreased affinity of ACF7 for MTs that we observed in vitro and revealed a marked correlation between GSK3beta phosphorylation of ACF7 and a severing of the ACF7-MT connection.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MACF1, pmod(Ph))
07f60f73-70b9-494c-ae44-d563e4f3d893	1.0	PubMed	21295697	GSK3beta Phosphorylation of ACF7 Must Be Dynamic to Govern Polarization and Directed Movement in Cultured HF-SCs.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MACF1, pmod(Ph))
07f60f73-70b9-494c-ae44-d563e4f3d893	1.0	PubMed	21295697	Consistent with these data, the majority of ACF7 phosphorylated by GSK3beta was localized in the cell body and not at the leading edge of HF-SCs (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MACF1, pmod(Ph))
0e8345fe-dbca-4476-be3d-cba1b6b257b9	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFA, pmod(Ph, Ser, 49))
0e8345fe-dbca-4476-be3d-cba1b6b257b9	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFA, pmod(Ph, Ser, 49))
609f5997-d77b-4d18-b094-31fb5cf970a6	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFA, pmod(Ph, Ser, 61))
609f5997-d77b-4d18-b094-31fb5cf970a6	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFA, pmod(Ph, Ser, 61))
b2f01416-aebb-475f-bf04-a1932e77886f	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFA, pmod(Ph, Thr, 53))
b2f01416-aebb-475f-bf04-a1932e77886f	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFA, pmod(Ph, Thr, 53))
a9dd9588-25d3-435d-af85-84df8006b4d8	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFA, pmod(Ph, Thr, 57))
a9dd9588-25d3-435d-af85-84df8006b4d8	1.0	PubMed	18042454	We also demonstrate that gsk-3 triggers mafa sequential phosphorylation on residues s61, t57, t53, and s49 /we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity./ Taken together, these results suggest that, in contrast to what can be expected from ubiquitination/degradation, gsk-3-mediated mafa phosphorylation increases its transactivating ability, thereby controlling its biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFA, pmod(Ph, Thr, 57))
15b8ead9-04d5-4263-a1d0-71a289b940a2	1.0	PubMed	18042454	We showed that c-maf and mafb, like mafa, are indeed phosphorylated by gsk-3/ we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFB, pmod(Ph))
15b8ead9-04d5-4263-a1d0-71a289b940a2	1.0	PubMed	18042454	We showed that c-maf and mafb, like mafa, are indeed phosphorylated by gsk-3/ we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAFB, pmod(Ph))
48077e5c-6034-4a5b-8a06-5914a621cdd2	1.0	PubMed	18042454	We showed that c-maf and mafb, like mafa, are indeed phosphorylated by gsk-3/ we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAF, pmod(Ph))
48077e5c-6034-4a5b-8a06-5914a621cdd2	1.0	PubMed	18042454	We showed that c-maf and mafb, like mafa, are indeed phosphorylated by gsk-3/ we demonstrated that phosphorylation by gsk-3 is conserved among the large maf proteins. It couples ubiquitination/degradation and transcriptional activation and modulates maf biological activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAF, pmod(Ph))
ffc82c28-93db-4b83-94ae-af22121c422c	1.0	PubMed	19740771	We found that gsk3beta inhibits maml1 transcriptional activity by directly targeting the n-terminal domain of maml1	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAML1, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	15652488	The phosphorylation of MAP1B by GSK-3beta suppresses detyrosination of microtubules and decreases the numbers of stable microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	PMC7055472	Similarly, NGF fails to activate GSK3beta phosphorylation of MAP1B in PC12 cells that lack TrkA receptors but express p75NTR receptors (PC12 nnr).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	PMC7055472	Chick ciliary ganglion neurons in culture lack TrkA receptors but express p75NTR and also fail to show NGF-dependent GSK3beta phosphorylation of MAP1B, whereas in rat superior cervical ganglion neurons in culture, NGF activation of TrkA receptors elicits GSK3beta phosphorylation of MAP1B. Finally, inhibition of TrkA receptor tyrosine kinase activity in PC12 cells and superior cervical ganglion neurons with K252a potently and dose-dependently inhibits neurite elongation while concomitantly blocking GSK3beta phosphorylation of MAP1B. These results suggest that the activation of GSK3beta by NGF is mediated through the TrkA tyrosine kinase receptor and not through p75NTR receptors.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	7055472	We show here that brain derived neurotrophic factor, which activates p75NTR but not TrkA receptors, does not stimulate GSK3beta phosphorylation of MAP1B in PC12 cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	7055472	Similarly, NGF fails to activate GSK3beta phosphorylation of MAP1B in PC12 cells that lack TrkA receptors but express p75NTR receptors (PC12 nnr).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	7055472	Chick ciliary ganglion neurons in culture lack TrkA receptors but express p75NTR and also fail to show NGF dependent GSK3beta phosphorylation of MAP1B, whereas in rat superior cervical ganglion neurons in culture, NGF activation of TrkA receptors elicits GSK3beta phosphorylation of MAP1B.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	7055472	Finally, inhibition of TrkA receptor tyrosine kinase activity in PC12 cells and superior cervical ganglion neurons with K252a potently and dose-dependently inhibits neurite elongation while concomitantly blocking GSK3beta phosphorylation of MAP1B.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	6138157	Expression of this isoform and the GSK3beta phosphorylated isoform of MAP1B (MAP1B-P) are induced in parallel in response to NGF.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	6138157	Additionally, GSK3beta from PC12 cells not exposed to NGF can not phosphorylate MAP1B in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	20886841	Like tau, MAP1B is phosphorylated by glycogen synthase kinase-3 beta in growing axons XREF_BIBR, whereas regulators of MAP1A phosphorylation remain to be elucidated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	19607922	GSK-3beta phosphorylates MAP1B at both primed () and nonprimed () sites but whether one or both spliced isoforms are involved is unknown.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	19607922	Since the loss of detyrosinated microtubules in COS-7 cells co-transfected with GSK-3beta and MAP1B is dependent on GSK-3beta phosphorylation of MAP1B (), the present findings suggest that, when transfected into COS-7 cells, GSK-3beta1 and GSK-3beta2 are equally efficient at phosphorylating MAP1B, in contrast to their relative activities in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	19576885	GSK-3beta is constitutively active in cells under basal conditions, phosphorylates MAP1B, promotes MAP1B binding to microtubules and causes stabilization of microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	PMC4681734	In vitro phosphorylation assays show that MAP-1B-P is generated by direct phosphorylation of MAP-1B by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	20864408	Lithium inhibits the activity of GSK-3beta, which in turn inhibits the phosphorylation of microtubule-associated-protein 1B (Map1B).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	PMC6955627	Furthermore, this function is regulated by phosphorylation of MAP1B by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
31e7cb90-8284-4b6c-96e6-3a37c96f78af	1.0	PubMed	6955627	Recent findings suggest that glycogen synthase kinase 3beta (GSK-3beta) phosphorylation of MAP1B may act as a molecular switch to regulate microtubule stability during axonogenesis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP1B, pmod(Ph))
ebb15285-1d7b-4802-952b-6caa58b32773	1.0	PubMed	10826493	Hence, we have studied the phosphorylation of MAP2 by GSK3b in co-transfected COS-1 cells to analyze possible effects on MT organization.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP2, pmod(Ph))
ebb15285-1d7b-4802-952b-6caa58b32773	1.0	PubMed	10826493	GSK3b phosphorylates MAP2 in situ at least at the site recognized by antibody 305 We recently demonstrated that MAP2 was phosphorylated in vitro by GSK3 at Thr 1620 and Thr 1623, which are located in the proline rich region and are recognized by antibody 305 (Sa ' nchez et al., 1996).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP2, pmod(Ph))
ebb15285-1d7b-4802-952b-6caa58b32773	1.0	PubMed	PMC5495184	We have found that GSK3beta phosphorylates MAP2C in co-transfected cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP2, pmod(Ph))
ebb15285-1d7b-4802-952b-6caa58b32773	1.0	PubMed	20615438	Decreased activity of GSK-3beta reduces the phosphorylation of microtubule associated protein 2 (MAP2) ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAP2, pmod(Ph))
7b34cb96-ce22-4b13-9391-7bc39251b8c0	1.0	PubMed	18263590	Using a human peripheral primitive neuroectodermal tumor cell line, SK-N-MC, we demonstrated FGF2 stimulated phosphorylation of ERK1 and ERK2 (pERK1/2) and GSK3beta (pGSK3beta (Tyr 216)), all of which were primarily retained in the cytoplasm.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPK1, pmod(Ph))
3d068bfb-96c5-4b85-a55b-ac68a185c22a	1.0	PubMed	18263590	Using a human peripheral primitive neuroectodermal tumor cell line, SK-N-MC, we demonstrated FGF2 stimulated phosphorylation of ERK1 and ERK2 (pERK1/2) and GSK3beta (pGSK3beta (Tyr 216)), all of which were primarily retained in the cytoplasm.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPK3, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	10826493	Lovestone, S., Hartley, C. L., Pearce, J., Anderton, B. H. (1996) : Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells : The effects on the organization and stability of microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	10826493	Wagner, U., Utton, M., Gallo, J. M., Miller, C. C. J. (1996) : Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	21985244	Because the expression of alpha-SN is promoted by oxidative stress, the accumulation of alpha-SN induced by such stress may directly induce the hyperphosphorylation of tau by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	21985244	Furthermore, we found that heat shock protein 70 (Hsp70) suppresses the alpha-SN-induced phosphorylation of tau by GSK-3beta through its direct binding to alpha-SN, suggesting that Hsp70 acts as a physiological suppressor of alpha-SN-mediated tau hyperphosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC7110675	GSK3beta phosphorylates both primed and unprimed sites on tau, but only primed phosphorylation events significantly decrease the ability of tau to bind microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	22193544	As shown in XREF_FIG, GSK3beta can phosphorylate Tau in vitro, and this phosphorylation is completely abolished in the presence of excess WWOX, but not GST or WWOX L404A.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	22193544	Furthermore, evidence shows that the phosphorylation of Tau by GSK3beta affects the ability of Tau to promote microtubule formation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	16919965	We have previously shown that inhibition of GSK3beta by lithium and a specific GSK3beta inhibitor, and of DKK1 expression by antisense oligonucleotides, can decrease Abeta mediated PHF-1 induction in cultured neurons (), consistent with an involvement of DKK1 and of inhibition of Wnt signaling in Abeta mediated Tau phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	27023670	Western blot analyses using a panel of anti-pan-tau, anti-non-phospho-tau, and anti-phospho-tau antibodies confirmed that knockdown of GSK3beta and Sgg significantly decreased tau phosphorylation levels at SP/TP sites (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	27023670	These results suggest that knockdown of GSK3beta and Sgg significantly decreased tau phosphorylation levels at SP/TP sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC6557700	Phosphorylation of tau by GSK3beta decreases tau-microtubule interactions.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC6557700	The results clearly demonstrate that axin is a negative regulator of tau phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC6557700	This negative regulation of GSK3beta-mediated tau phosphorylation is due to the fact that axin efficiently binds GSK3beta but not tau and thus sequesters GSK3beta away from tau, as an axin mutant that does not bind GSK3beta did not inhibit tau phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	14636889	Indeed, of the proline directed kinases, GSK3beta is the major contributor to the phosphorylation of tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	6557700	Phosphorylation of tau by GSK3beta decreases tau-microtubule interactions.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	6557700	The results clearly demonstrate that axin is a negative regulator of tau phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	11516996	Second, hyperphosphorylation of tau protein by GSK3b, CDK5 and other kinases lead to its dissociation from microtubules and formation of intracellular tau aggregates in a paired helical filament conformation (called neurofibrillary tangles).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	6917811	These abnormalities were associated with activation of kinases that phosphorylate tau, including glycogen synthase kinase 3beta (GSK-3beta), mitogen activated protein kinase (MAPK), and cyclin dependent kinase 5 (Cdk-5).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	21156028	Phosphorylation of tau by both DYRK1A and GSK-3beta enhances both self aggregation and fibril formation in vitro [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	19573950	To emphasize the role of phosphorylation, a recent study indicated that GSK3beta phosphorylation of tau is sufficient to produce tau filaments ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	9565682	However, in intact cells, tau is already phosphorylated by endogenous kinases at the same sites as CDK5 and p23, so that GSK-3beta could phosphorylate tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	9565682	GSK-3beta was able to phosphorylate tau in specific sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	21949350	However, our laboratory observed that GSK-3beta phosphorylation of tau was independent of phosphorylation by PAR-1 (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	17317006	We showed that within the complex, 14-3-3zeta binds to tau and GSK3beta and mediates GSK3beta catalyzed tau phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	25484286	In our study, a cell-permeable peptide-TAT-Dyn1SpS could decrease the GSK3beta induced phosphorylation of Dyn1, but not Tau phosphorylation, which suggested that TAT-Dyn1SpS could specifically block GSK3beta phosphorylating Dyn1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	8764598	Using conditions in vitro under which two proline directed protein kinases, glycogen synthase kinase-3beta (GSK-3beta) and mitogen activated protein kinase (MAPK), were able to hyperphosphorylate tau, GSK-3beta but not MAPK phosphorylated recombinant APPcyt.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	8764598	The ability of GSK-3beta to phosphorylate APPcyt and tau provides a putative link between the two lesions and indicates a critical role of GSK-3beta in the pathogenesis of Alzheimer 's disease.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	19429119	GSK-3beta phosphorylates tau at select epitopes, thereby leading to tau hyperphosphorylation which increasesthe propensity for the formation of oligomeric tau [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	26751496	Although both NCLK and GSK-3beta phosphorylate tau on multiple epitopes, including the PHF epitopes, GSK-3beta can phosphorylate tau on additional epitopes not phosphorylated by NCLK and has been suggested to play a dominant role in tau phosphorylation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	20602916	In addition, phosphorylation of tau or kinesin by GSK-3beta can disrupt microtubules or intracellular protein transport, respectively, which can also contribute to apoptosis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	19472218	These data suggest that PLTP reduces GSK3beta dependent phosphorylation of tau in HCN2 cells in vitro, without affecting levels of total tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	26608845	As expected, GSK-3beta inhibition significantly reduced tau phosphorylation at several of these sites except at the ser262 site (htau-Li and htau-AR lanes in XREF_FIG and XREF_FIG where reduction in phosphorylation in drug treated hTau 0N3R flies is quantified as a percentage of phosphorylation in untreated hTau 0N3R flies).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC3244209	Both GSK-3 alpha and GSK-3 beta phosphorylated tau to produce a PHF-like state of phosphorylation but the MAP kinases failed to induce such a transformation in tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	24113872	Results showed that both antibodies are highly specific for tau peptides phosphorylated at their respective epitopes with minimal reactivity to non phosphorylated tau peptide, non phosphorylated C-terminal tau [C ' Tau] and C ' Tau phosphorylated by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	3244209	Both GSK-3 alpha and GSK-3 beta phosphorylated tau to produce a PHF like state of phosphorylation but the MAP kinases failed to induce such a transformation in tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	17098228	Tau hyper-phosphorylation by GSK-3beta is followed by increased formation of neurofibrillary tangles.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	17098228	The current study supports this model and shows that tau phosphorylation by GSK-3beta plays an important role in the transmission of zinc induced cytotoxic signals in H19-7 cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	25959626	However, it remains unclear how GSK3beta activity is regulated to modulate tau phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	20096481	A number of protein kinases have been studied in investigating the molecular mechanism of tau phosphorylation, and among them, GSK-3beta is one of the most implicated kinases in the abnormal hyperphosphorylation of tau (); interestingly, TTBK1 is a kinase that increases the subsequent phosphorylation of tau by GSK-3beta in vivo ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	16446437	This binding is also significantly decreased by GSK3beta phosphorylation of tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	22965877	Moreover, NUB1 reduced GSK3beta mediated phosphorylation of tau and aggregation of tau in intracellular inclusions.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC5445794	The PSEN1 binding protein glycogen synthase kinase-3 beta (GSK-3 beta) has been considered as a key protein in AD pathogenesis since GSK-3 beta phosphorylates tau and hyperphosphorylated tau is a main component of neurofibrillary tangles associated to AD.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	5445794	The PSEN1 binding protein glycogen synthase kinase-3 beta (GSK-3 beta) has been considered as a key protein in AD pathogenesis since GSK-3 beta phosphorylates tau and hyperphosphorylated tau is a main component of neurofibrillary tangles associated to AD.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC5962927	Furthermore, we show that human dvl-1 and wnt-1 also reduce the phosphorylation of tau by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	5962927	Furthermore, we show that human dvl-1 and wnt-1 also reduce the phosphorylation of tau by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	21238544	Moreover, aberrantly activated GSK3beta phosphorylates Tau, which leads to NFTs ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC5714647	As certain muscarinic receptors are linked to PKC, we examined the effect of a range of agonists on GSK-3beta phosphorylation of tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	5714647	As certain muscarinic receptors are linked to PKC, we examined the effect of a range of agonists on GSK-3beta phosphorylation of tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	19782075	Though these results suggest that Abeta could be exacerbating the tau phenotypes by suppressing endogenous signalling and thus increasing GSK-3beta phosphorylation of tau in the tau and Abeta flies, further work needs to be done to ascertain that this is indeed the case.We have shown that Abeta co-expression significantly exacerbates the neuronal dysfunction phenotypes that are seen following expression of human tau in a model of AD.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC5881045	Glycogen synthase kinase 3 beta (GSK3 beta) phosphorylates the microtubule associated protein tau at sites that are aberrantly phosphorylated in AD.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC5881045	This would suggest that the aberrant phosphorylation of tau by GSK3 beta in AD is not due to sequence variations in the gene or its promoter.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	21130530	Phosphorylation of tau by GSK3B occurs surrounding the MT binding domain and it can also modify 4 residues inside this domain, thereby decreasing tau and MT interaction and favoring tau self aggregation ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	24929931	These results show that the ability of specific mutant tau proteins to induce cell death in the presence of AICD or CT-GFP is due to GSK3beta phosphorylation of tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	16365045	In situ, LRP6 significantly decreased GSK3beta mediated phosphorylation of tau at both primed and unprimed sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	16420965	In association with other kinases and molecules, GSK-3beta can phosphorylate Tau more extensively and can even generate AD specific epitopes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	4146386	Using conditions in vitro under which two proline directed protein kinases, glycogen synthase kinase-3beta (GSK-3beta) and mitogen activated protein kinase (MAPK), were able to hyperphosphorylate tau, GSK-3beta but not MAPK phosphorylated recombinant APPcyt.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	4146386	The ability of GSK-3beta to phosphorylate APPcyt and tau provides a putative link between the two lesions and indicates a critical role of GSK-3beta in the pathogenesis of Alzheimer 's disease.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC6368214	Furthermore, manipulation of other wingless signaling molecules downstream from shaggy demonstrated that components of the Wnt signaling pathway modulate neurodegeneration induced by tau pathology in vivo but suggested that tau phosphorylation by GSK-3beta differs from canonical Wnt effects on beta-catenin stability and TCF activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	6368214	Furthermore, manipulation of other wingless signaling molecules downstream from shaggy demonstrated that components of the Wnt signaling pathway modulate neurodegeneration induced by tau pathology in vivo but suggested that tau phosphorylation by GSK-3beta differs from canonical Wnt effects on beta-catenin stability and TCF activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	18588978	We conclude that the phosphorylation of tau by GSK-3beta either prior to or following polymerization promotes polymer and polymer interactions that result in stable clusters of tau filaments.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	6177083	Glycogen synthase kinase-3beta (GSK3beta) is able to phosphorylate tau in a cellular context which could play a role in the formation of these NFT.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	16793187	The targeted inhibition of GSK-3beta activity in order to prevent the hyperphosphorylation of tau may have unintended adverse consequences due to inhibition of other necessary functions.The relevance of abnormalities of reelin-signal transduction to psychosis in general, and schizophrenia in particular is supported by human postmortem studies, and evaluation of the heterozygous reeler deficient mouse ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC5252098	Recent studies have shown that GSK-3beta phosphorylates the microtubule-associated protein tau in vitro and in cell culture.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	20032300	Interestingly, activated calpain cleaves Tau, inactivating it, and yielding a toxic fragment, and GSK-3beta phosphorylates Tau at AD-PHF-relevant sites and is itself involved in chromosome segregation (XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	20032300	These findings are linked, for Ca 2+ is necessary for the Abeta induced cleavage and inactivation of Tau and GSK-3beta for Abeta induced phosphorylation and inactivation of Tau and both for Abeta toxicity (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	4691443	Combined tau protein kinase II (TPK II), which consists of CDK5 and its activator (p23), and glycogen synthase kinase-3beta (GSK-3beta) phosphorylate tau to the PHF-form in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	25387847	GSK3beta also phosphorylates tau and might be the integration point of Abeta and tau induced toxicity [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	20648061	As with CRMP2 and APC, Tau phosphorylation by GSK3beta abolishes its binding to microtubules and thus impairs microtubule assembly 89.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	20648061	Interestingly, in Drosophila, MARK acts as a priming kinase, triggering subsequent Tau phosphorylation by GSK3beta 95, suggesting that inactivation of MARK2 and GSK3beta at the axonal tip together reduce Tau phosphorylation downstream of Par3, Par6, and PKCsigma complex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	5252098	Recent studies have shown that GSK-3beta phosphorylates the microtubule associated protein tau in vitro and in cell culture.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	12421363	Phosphorylation of tau by GSK3beta decreases tau-microtubule interactions.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	19107203	This result is consistent with the observation that the intracellular region of LRP6 decreased GSK3beta phosphorylation of an unprimed substrate Tau protein and the primed substrate full-length beta-catenin in vitro XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	19107203	Cselenyi et al. (2008) found that the recombinant, nonphosphorylated LRP6 intracellular region at ~ 4 microM can inhibit beta-catenin phosphorylation by GSK3beta, but not Tau, another GSK3beta substrate, which led these authors to propose that GSK3beta phosphorylates LRP6 and that the phosphorylated species somehow specifically interferes with the beta-catenin-GSK3beta interaction rather than inhibiting the kinase.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	12421363	The results clearly demonstrate that axin is a negative regulator of tau phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	27343974	Anyway, our results showed that tau phosphorylation was largely prevented by GSK3beta inhibition, especially when Tyr216 phosphorylation was prevented but not when Ser9 phosphorylation was promoted.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	10486203	Recent studies have shown that GSK-3beta phosphorylates the microtubule associated protein tau in vitro and in cell culture.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	20679343	Here, we use an in vitro phosphorylation assay and NMR spectroscopy to characterize in a qualitative and quantitative manner the phosphorylation of Tau by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	23525328	GAB2 and GSK3B (rs6438552, AA genotype) have been shown to increase Tau phosphorylation (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	23525328	Because the inactivation of GSK3B prevents Tau hyperphosphorylation in neurons (XREF_BIBR), it is reasonable to assume that any decrease in GAB2 expression and/or function would increase Tau phosphorylation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	16043125	Many studies link activation of GSK3beta and neuropsychiatric disorders, exemplified by Alzheimer 's disease, on the basis of GSK3beta mediated phosphorylation of tau, one of the hallmarks of this disease (reviewed in).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC6563209	GSK3beta phosphorylation of tau negatively regulates tau-microtubule interactions; however the differential effects of phosphorylation at primed and unprimed epitopes on tau is unknown.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC6563209	Both GSK3beta and GSK3beta-R96A phosphorylated tau efficiently in situ.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC6563209	Prephosphorylating tau with cdk5/p25 impaired the ability of GSK3beta-R96A to phosphorylate tau, whereas GSK3beta-R96A phosphorylated recombinant tau to a significantly greater extent than GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC6563209	Moreover, the amount of tau associated with microtubules was reduced by overexpression of GSK3beta but only when tau was phosphorylated at primed sites, as phosphorylation of tau by GSK3beta-R96A did not negatively regulate the association of tau with microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	24498342	Nevertheless, because of inherent higher GSK3beta activity in biGT mice, the anticipated higher levels of AT180 and AT8 reflecting more extensive phosphorylation of protein Tau by GSK3beta was not substantiated by the experimental observations.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	24498342	This unexpected extra axonal damage by increased phosphorylation of protein Tau by GSK3beta, is proposed to disable surrounding oligodendrocytes in maintaining myelination of TA axons in biGT mice.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	17078951	PKA modulates GSK-3beta- and cdk5 catalyzed phosphorylation of tau in site- and kinase specific manners.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	16428884	Glycogen synthase kinase-3beta (GSK-3beta) phosphorylates tau protein, and increased GSK-3beta expression has been associated with neurofibrillary tangles.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	24165324	Since LRRK2 is detected in tau positive inclusions in brain tissue affected by various neurodegenerative disorders, including PD, LRRK2 stimulated phosphorylation of tau by GSK-3beta may be involved in development of pathological features in the initial stage of PD.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	Other	sparser:Unknown	Therefore, endogenous ILK protects against GSK-3beta-induced aberrant tau phosphorylation via inhibition of GSK-3beta activity in N1E-115 cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	PMC4186664	These results suggest that phosphorylation of tau by GSK-3 beta modulates its ability to organise microtubules into ordered arrays such as are found in axons.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	20599975	In particular, it was found that Tau that was hyperphosphorylated by GSK-3beta was especially potent in inhibiting proteasomal activity in vitro (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	4186664	These results suggest that phosphorylation of tau by GSK-3 beta modulates its ability to organise microtubules into ordered arrays such as are found in axons.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	21453448	Once activated, p-GSK-3beta causes the hyperphosphorylation of Tau.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
dafe3024-087c-42e6-9402-97b3e4e2f7fd	1.0	PubMed	25219467	We speculate that GSK-3beta phosphorylates tau directly and indirectly via upregulation of PP2A methylation and activity, resulting in an increase at phosphorylation on GSK-3beta target- and PP2A insensitive-sites (such as Ser199 and Ser396) and a decrease at non-GSK-3beta target- and PP2A sensitive-sites (such as Ser262/356).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph))
e5c92101-0571-45ce-8d7c-659ddd22c747	1.0	PubMed	25484286	Moreover, we found that TAT-Dyn1SpS could not affect GSK3beta phosphorylating Ser 396 on Tau (C, D), which demonstrated the specific effect of TAT-Dyn1SpS on GSK3beta phosphorylating Ser 774 residue of Dyn1.Next, we testified whether TAT-Dyn1SpS could affect the BDNF dependent TrkB endocytosis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
e5c92101-0571-45ce-8d7c-659ddd22c747	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
e5c92101-0571-45ce-8d7c-659ddd22c747	1.0	PubMed	24165324	Furthermore, we found that LRRK2 mediated activation of GSK-3beta induces high phosphorylation of tau at Ser396 in SH-SY5Y cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 396))
2ddbbdf8-1c5b-4bda-83fa-7f21d99420b6	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 400))
0f7a734d-84fe-49e2-bee3-52a85919d5fc	1.0	PubMed	9771888	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 512))
6cbbc701-f8d5-4684-9e4a-5a05f40127d9	1.0	PubMed	9832145	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 515))
a0571028-4ad0-4559-b95c-86cc9e4d519e	1.0	PubMed	24268883	Finally, tau can be phosphorylated at serine 199 by GSK3beta and serine 202 by GSK3beta, and Cdk5, 2 putative tau kinases (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
a0571028-4ad0-4559-b95c-86cc9e4d519e	1.0	PubMed	20308788	Abnormal hyperphosphorylation of tau appears to be crucial in neurofibrillary degeneration in alzheimer's disease (ad). Gsk-3beta phosphorylated tau at many sites, with ser199, thr205, and ser396 being the most favorable sites in cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
a0571028-4ad0-4559-b95c-86cc9e4d519e	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 516))
404dac56-9454-413d-b590-bafd61eb9b7f	1.0	PubMed	24268883	Finally, tau can be phosphorylated at serine 199 by GSK3beta and serine 202 by GSK3beta, and Cdk5, 2 putative tau kinases (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
404dac56-9454-413d-b590-bafd61eb9b7f	1.0	PubMed	17078951	Here, we found that prephosphorylation by pka promotes gsk-3beta-catalyzed tau phosphorylation at thr181, ser199, ser202, thr205, thr217, thr231, ser396 and ser422	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
404dac56-9454-413d-b590-bafd61eb9b7f	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 519))
5817a922-b98a-4d31-808c-ab8bc22654bf	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 531))
eb791948-9178-4ab4-acc8-38743e5e98c3	1.0	PubMed	21215781	Tau pseudophosphorylation at specific sites such as s262, s293, s324 and s356 was reported to induce tau conformational change and attenuate tau binding to microtubules (fischer et al., 2009). Then, newly soluble tau proteins are targeted by post-translational modifications that directly or indirectly alter tau conformation, promoting tau dimerization in an anti-parallel manner. Stable tau dimers form tau oligomers, which continue in the aggregation process	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
eb791948-9178-4ab4-acc8-38743e5e98c3	1.0	PubMed	9771888	Tau is phosphorylated by gsk-3 at several sites found in alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by a-kinase.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 579))
26d8e914-afaf-44d5-ab5f-62b1d7b4b2d9	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 713))
9b4a2e49-e09d-4bba-b94c-1287be3fac0a	1.0	PubMed	12387894	Sequencing of 32P-labeled trypsin phosphopeptides from tau prephosphorylated by A-kinase (using unlabeled ATP) and further phosphorylated by GSK-3 in the presence of [gamma-32P]ATP revealed that Ser-195, Ser-198, Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-262, Ser-356 and Ser-404 are phosphorylated, whereas if tau is not prephosphorylated by A-kinase, GSK-3 phosphorylates it at Thr-181, Ser-184, Ser-262, Ser-356 and Ser-400. These data suggest that (i) prephosphorylation of tau by A-kinase makes additional and different sites accessible for phosphorylation by GSK-3; (ii) phosphorylation of tau at these additional sites further inhibits the biological activity of tau in its ability to bind to microtubules and promote microtubule assembly.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 717))
2d95a5c8-d8ab-463e-a154-37dc7b5826ff	1.0	PubMed	20679343	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-? Peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated tau protein. Tau is mostly found in a hyperphosphorylated form in these tangleswe find that three residues can be phosphorylated (ser-396, ser-400, and ser-404) by gsk3?	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
2d95a5c8-d8ab-463e-a154-37dc7b5826ff	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Ser, 721))
237fe23c-799b-458a-9cd6-e08e481e14c9	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 498))
3ec80ee6-cb7f-426a-8c58-2e81a0929dee	1.0	PubMed	20308788	Abnormal hyperphosphorylation of tau appears to be crucial in neurofibrillary degeneration in alzheimer's disease (ad). Gsk-3beta phosphorylated tau at many sites, with ser199, thr205, and ser396 being the most favorable sites in cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
3ec80ee6-cb7f-426a-8c58-2e81a0929dee	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 522))
b53498e9-9fb5-4bed-b99a-e0c1130da93b	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 529))
2933f149-706a-4035-a721-e477745f3a39	1.0	PubMed	17078951	Here, we found that prephosphorylation by pka promotes gsk-3beta-catalyzed tau phosphorylation at thr181, ser199, ser202, thr205, thr217, thr231, ser396 and ser422	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
2933f149-706a-4035-a721-e477745f3a39	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 534))
73d611dc-e175-4904-9334-a71d33fec26a	1.0	PubMed	PMC7110675	These results strongly indicate that phosphorylation of Thr231 in tau by GSK3beta plays a critical role in regulating tau's ability to bind and stabilize microtubules.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
73d611dc-e175-4904-9334-a71d33fec26a	1.0	PubMed	21215781	Gsk3b phosphorylates tau at t231tau phosphorylation at t231, s235 and s262 also contributes to the dissociation of tau from microtubules	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
73d611dc-e175-4904-9334-a71d33fec26a	1.0	PubMed	12387894	We found that cdk5 phosphorylated tau(441) at Thr-181, Ser-199, Ser-202, Thr-205, Thr-212, Ser-214, Thr-217, Thr-231, Ser-235, Ser-396, and Ser-404, but not at Ser-262, Ser-400, Thr-403, Ser-409, Ser-413, or Ser-422. GSK-3beta phosphorylated all the cdk5-catalyzed sites above except Ser-235.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MAPT, pmod(Ph, Thr, 548))
04e1b7cb-06fc-42d2-8742-1ba17e9618e1	1.0	PubMed	16257959	Our further findings led us to conclude that GSK-3beta phosphorylates MARK2 on Ser 212, one of the two reported phosphorylation sites (Thr 208 and Ser 212) found in the activation loop of MARK2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MARK2, pmod(Ph, Ser, 212))
7091f523-8bc8-4f8d-b67c-aa9fea4c2545	1.0	PubMed	17387146	Here, we report that glycogen synthase kinase 3 (GSK-3) was required for Mcl-1 degradation, and we identified a novel mechanism for proteasome mediated Mcl-1 turnover in which GSK-3beta associates with and phosphorylates Mcl-1 at one consensus motif ((155) STDG (159) SLPS (163) T; phosphorylation sites are in italics), which will lead to the association of Mcl-1 with the E3 ligase beta-TrCP, and beta-TrCP then facilitates the ubiquitination and degradation of phosphorylated Mcl-1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph))
7091f523-8bc8-4f8d-b67c-aa9fea4c2545	1.0	PubMed	25499217	In presence of PI3K and Akt signaling axis, Akt induces post-translational modification of Gsk-3beta, which phosphorylates its cognate substrate Mcl-1 at a conserved GSK-3 phosphorylation site (Ser159) promoting its ubiquitination and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph))
7091f523-8bc8-4f8d-b67c-aa9fea4c2545	1.0	PubMed	19118303	In the absence of intracellular glucose, GSK3beta is activated and thus can phosphorylate the anti-apoptotic molecule Mcl1, thereby mediating its degradation XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph))
7091f523-8bc8-4f8d-b67c-aa9fea4c2545	1.0	PubMed	21852138	Phosphorylation of Mcl-1 by GSK-3beta can recruit the E3 ligase, beta-Trcp, for Mcl-1 degradation which leads to cellular apoptosis, tumor suppression and chemosensitization [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph))
7091f523-8bc8-4f8d-b67c-aa9fea4c2545	1.0	PubMed	20516119	For example, the PI3K and AKT pathway inhibits GSK3beta mediated phosphorylation of MCL-1 and thereby prevents beta-TrCP-mediated ubiquitylation and proteasomal degradation of MCL-1 (XREF_BIBR - XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph))
d906a268-6c28-4d67-a43a-20fa6c93b33b	1.0	PubMed	26822034	Thus, preventing phosphorylation of Mcl-1 on Ser 140 by nuclear GSK3beta could be a key mechanism to prolong survival during the repair of DSBs.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph, Ser, 159))
d906a268-6c28-4d67-a43a-20fa6c93b33b	1.0	PubMed	22024133	For example, phosphorylation of Mcl-1 at T92 and T163 mediated by ERK prolongs the half-life of Mcl-1 protein (XREF_BIBR, XREF_BIBR), while phosphorylation of Mcl-1 at S159 mediated by GSK-3beta promotes Mcl-1 ubiquitination and degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph, Ser, 159))
d906a268-6c28-4d67-a43a-20fa6c93b33b	1.0	PubMed	24681994	Additionally, GSK-3beta phosphorylates Mcl-1 on Ser159, resulting in the destabilization of this protein and the blockage of the Mcl-1-dependent integrity of the mitochondrial membrane (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph, Ser, 159))
d906a268-6c28-4d67-a43a-20fa6c93b33b	1.0	PubMed	16543145	MCL-1 was phosphorylated by GSK-3 at a conserved GSK-3 phosphorylation site (S159). S159 phosphorylation of MCL-1 was induced by IL-3 withdrawal or PI3K inhibition and prevented by AKT or inhibition of GSK-3, and it led to increased ubiquitinylation and degradation of MCL-1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph, Ser, 159))
d906a268-6c28-4d67-a43a-20fa6c93b33b	1.0	PubMed	27517746	Glycogen synthase kinase 3 (GSK3beta) is a key regulator in tumorigenesis and mediates phosphorylation of Mcl-1 at Ser159 [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph, Ser, 159))
d906a268-6c28-4d67-a43a-20fa6c93b33b	1.0	PubMed	16543145	We investigated the role of glycogen synthase kinase-3 (gsk-3), which is inactivated by akt, for its role in the regulation of apoptosis. Upon il-3 withdrawal, protein levels of mcl-1 decreased but were sustained by pharmacological gsk-3, which prevented cytochrome c release and apoptosis. Mcl-1 was phosphorylated by gsk-3 at a conserved gsk-3 phosphorylation site (s159). S159 phosphorylation of mcl-1 was induced by il-3 withdrawal or pi3k inhibition and prevented by akt or gsk-3, and it led to increased ubiquitinylation and degradation of mcl-1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ph, Ser, 159))
8de2bcbf-1087-4621-989a-ed921293748c	1.0	PubMed	PMC6383745	Taking into account that GSK3beta phosphorylates MITF and increases the ability of MITF to bind its target sequence, our results indicate that activation of GSK3beta by cAMP facilitates MITF binding to the tyrosinase promoter, thereby leading to stimulation of melanogenesis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MITF, pmod(Ph))
8de2bcbf-1087-4621-989a-ed921293748c	1.0	PubMed	6383745	Taking into account that GSK3beta phosphorylates MITF and increases the ability of MITF to bind its target sequence, our results indicate that activation of GSK3beta by cAMP facilitates MITF binding to the tyrosinase promoter, thereby leading to stimulation of melanogenesis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MITF, pmod(Ph))
f0be3f5e-6a08-478a-9c81-cbd5f3dfc26a	1.0	PubMed	24425879	GSK-3beta protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MNX1, pmod(Ph))
6c0fe5f7-6de9-46da-acc8-ef54496bef16	1.0	PubMed	24425879	Here we show that GSK-3beta inactivates the proapoptotic activity of HLXB9 by phosphorylating HLXB9 at Ser-78 and Ser-80 (pHLXB9).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MNX1, pmod(Ph, Ser, 77))
6c0fe5f7-6de9-46da-acc8-ef54496bef16	1.0	PubMed	24425879	Here we show that gsk-3_ inactivates the proapoptotic activity of hlxb9 by phosphorylating hlxb9 at ser-78/ser-80 (phlxb9).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MNX1, pmod(Ph, Ser, 77))
b352a9b2-bdf5-476f-a477-6f1000d81185	1.0	PubMed	24425879	Here we show that GSK-3beta inactivates the proapoptotic activity of HLXB9 by phosphorylating HLXB9 at Ser-78 and Ser-80 (pHLXB9).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MNX1, pmod(Ph, Ser, 79))
b352a9b2-bdf5-476f-a477-6f1000d81185	1.0	PubMed	24425879	Here we show that gsk-3_ inactivates the proapoptotic activity of hlxb9 by phosphorylating hlxb9 at ser-78/ser-80 (phlxb9).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MNX1, pmod(Ph, Ser, 79))
70df8fa4-912e-4d76-89d6-9a89f6dfaef3	1.0	PubMed	9819408	Phosphorylation of MUC1 by GSK3beta decreases binding of MUC1 to beta-catenin in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MUC1, pmod(Ph))
70df8fa4-912e-4d76-89d6-9a89f6dfaef3	1.0	PubMed	19782069	MUC1 is also phosphorylated by GSK-3beta ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MUC1, pmod(Ph))
70df8fa4-912e-4d76-89d6-9a89f6dfaef3	1.0	PubMed	19782069	So it is plausible that MUC1 in RhoB overexpressed prostate cancer cells might be predominantly phosphorylated by GSK-3beta, abrogating its suppressive effect on MMP1 transcription.In the literature, there have been no solid data studying the relevance of RhoB and clinical cancer.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MUC1, pmod(Ph))
70df8fa4-912e-4d76-89d6-9a89f6dfaef3	1.0	PubMed	PMC4914118	Phosphorylation of MUC1 by GSK3beta decreases binding of MUC1 to beta-catenin in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MUC1, pmod(Ph))
70df8fa4-912e-4d76-89d6-9a89f6dfaef3	1.0	PubMed	4914118	Phosphorylation of MUC1 by GSK3beta decreases binding of MUC1 to beta-catenin in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MUC1, pmod(Ph))
f5debeeb-d281-4d61-b291-505438b70f8b	1.0	PubMed	9819408	GSK3beta binds directly to an STDRSPYE site in MUC1 and phosphorylates the serine adjacent to proline. Phosphorylation of MUC1 by GSK3beta decreases binding of MUC1 to beta-catenin in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MUC1, pmod(Ph, Ser, 1227))
ba7ed0b7-8ff8-4eed-8cf2-ed9334d64cd9	1.0	PubMed	19022564	On the cellular membrane, phosphorylation of LRP by GSK-3beta and casein kinase I-gamma recruits axin to the plasma membrane, where it is inactivated and/or targeted for degradation, resulting in the beta-catenin stability.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MVP, pmod(Ph))
ba7ed0b7-8ff8-4eed-8cf2-ed9334d64cd9	1.0	PubMed	23029137	Binding of Wnt proteins to the cell surface receptor complex Fz and LRP facilitates the phosphorylation of the cytoplasmic tail of LDL receptor related protein (LRP) cytoplasmic tail by GSK-3beta XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MVP, pmod(Ph))
6f96348e-8a3b-4166-bee1-3b638837c058	1.0	PubMed	22266851	Indeed, PI3K activation in NBs enhances PKB and AKT activation leading to the stabilization of MYCN levels as a result of decreased GSK-3beta phosphorylation of MYCN which leads to degradation of the oncoprotein (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYCN, pmod(Ph))
644f2054-026a-4237-8e54-d6e41a21f033	1.0	PubMed	22364879	Degradation through this pathway requires sequential phosphorylation of Myc on serine 62 by ERK and on threonine 58 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, 62))
402d3836-1fae-4860-bf41-b65db41fb412	1.0	PubMed	26474287	These include JQ1, which inhibits the Myc associated chromatin remodeling enzyme Brd4 and the synthetic lethal compound dihydroartemisinin, which activates the Ser/Thr kinase GSK3beta that in turn phosphorylates and de-stabilizes Myc [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph))
402d3836-1fae-4860-bf41-b65db41fb412	1.0	PubMed	22025562	GSK3beta phosphorylation of c-Myc creates a recognition motif for E3 ubiquitin ligase Fbw7, leading to subsequent ubiquitination and proteasome mediated c-Myc degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph))
402d3836-1fae-4860-bf41-b65db41fb412	1.0	PubMed	22735579	This is mediated in part by relieving RTK inhibition of GSK3beta, which in turn phosphorylates Myc at specific sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph))
61701e22-a661-4fa7-b948-d38506e82640	1.0	PubMed	26751215	The ERK and GSK-3beta can phosphorylate c-Myc at Ser62 and Thr58, respectively.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Ser, 62))
f8ff8ab7-4adf-4dd4-a2ba-3a14b454d25e	1.0	PubMed	22364879	Degradation through this pathway requires sequential phosphorylation of Myc on serine 62 by ERK and on threonine 58 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Ser))
3abfeb2e-56c4-461c-848a-5158d7bff721	1.0	PubMed	26751215	The ERK and GSK-3beta can phosphorylate c-Myc at Ser62 and Thr58, respectively.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Thr, 58))
3abfeb2e-56c4-461c-848a-5158d7bff721	1.0	PubMed	11018017	Phosphorylation of Thr 58, likely mediated by GSK-3 but dependent on the prior phosphorylation of Ser 62, is associated with degradation of Myc.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Thr, 58))
3abfeb2e-56c4-461c-848a-5158d7bff721	1.0	PubMed	16023596	Similar to c-myc, we report here that phosphorylation of c-jun by gsk3 creates a high-affinity binding site for the e3 ligase fbw7, which targets c-jun for polyubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Thr, 58))
3abfeb2e-56c4-461c-848a-5158d7bff721	1.0	PubMed	14563837	Conversely, overexpression of gsk-3 alpha or gsk-3 beta enhances thr-58 phosphorylation and ubiquitination of c-myc	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Thr, 58))
3abfeb2e-56c4-461c-848a-5158d7bff721	1.0	PubMed	22735579	Phosphorylation of Thr58 on Myc by GSK3beta is known to evoke Myc degradation via the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Thr, 58))
3abfeb2e-56c4-461c-848a-5158d7bff721	1.0	PubMed	16210249	Small inhibitory RNA induced silencing of GSK3beta prevents phosphorylation of MYC on T58, thereby inhibiting recognition of MYC by the E3 ubiquitin ligase component FBW7.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ph, Thr, 58))
c949caf7-39b6-48c1-8189-939da6fab871	1.0	PubMed	PMC6138157	Expression of this isoform and the GSK3beta-phosphorylated isoform of MAP1B (MAP1B-P) are induced in parallel in response to NGF.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYL1, pmod(Ph))
f26eed44-99ba-4f55-b51a-8e3ec37e87bf	1.0	PubMed	17046230	Glycogen synthase kinase 3beta (GSK-3beta), a known suppressor of cardiac hypertrophy, phosphorylates myocardin and inhibits its transcriptional activity [].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph))
702a9405-43e1-4db3-a02b-20373e9ec6d7	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph, Ser, 451))
4468be6c-38d4-404b-b36a-1aa2369fc50c	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph, Ser, 455))
79341b95-fa44-41cc-be7c-c7f2dd52346a	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph, Ser, 459))
9c4d646b-30b4-4c2f-987e-931b609a9ce9	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph, Ser, 463))
adf590db-b7c4-479e-bd08-f5a9ec61db76	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph, Ser, 626))
c635ce3f-627e-4910-baef-8da0b7081de7	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph, Ser, 630))
f4134e73-6333-4622-944d-6999f5722de0	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph, Ser, 634))
1eaa4cd5-8e1b-484b-9b87-46dc4e471fa3	1.0	PubMed	16141410	In vitro and in vivo (HEK 293 cells) kinase assays with synthetic peptides and full-length myocardin demonstrated that myocardin was a primed GSK3beta substrate, with serines 455 to 467 and 624 to 636 being the major GSK3beta phosphorylation sites.  GSK3β phosphorylation at the sites identified inhibits myocardin intrinsic transcriptional activity	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOCD, pmod(Ph, Ser, 638))
011346d5-9e26-4caf-8ca0-db2cf7e07996	1.0	PubMed	24577092	GSK3beta directly phosphorylates MYOGENIN in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYOG, pmod(Ph))
f0febf67-55f5-4a33-9fc5-ee29fdda9734	1.0	PubMed	15005626	Gsk3 beta-dependent phosphorylation of the alpha nac coactivator regulates its nuclear translocation and proteasome-mediated degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NACA, pmod(Ph, Thr, 2022))
ce0aec52-503d-442f-8a9a-01e0d8cf3d2d	1.0	PubMed	7191837	We conclude that GSK3beta dependent phosphorylation of alphaNAC was the signal that directed the protein to the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NACA, pmod(Ph))
ce0aec52-503d-442f-8a9a-01e0d8cf3d2d	1.0	PubMed	PMC7191837	We conclude that GSK3beta-dependent phosphorylation of alphaNAC was the signal that directed the protein to the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NACA, pmod(Ph))
2191142a-3058-44a2-8c4f-2ae3be92dc75	1.0	PubMed	24879152	XREF_BIBR Altogether, our results show that GSK3A and GSK3B phosphorylate NBR1 in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NBR1, pmod(Ph))
70852f05-525d-49ac-bac3-cf7a0e11e26f	1.0	PubMed	21708134	NDRG1 has been reported as a substrate for the protein kinases PKA, PKC & CaMKII and recently we showed that NDRG1 was specifically phosphorylated at its C-terminus by SGK1, but not other AGC kinases, a priming event for subsequent phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NDRG1, pmod(Ph))
0a3ec7c6-ae5f-4916-b681-48043b2aca80	1.0	PubMed	20416281	NDRG1 and Cap43 is phosphorylated at threonine (Thr) 328, serine (Ser) 330, Thr346, Thr356 and Thr366 by SGK1, and further phosphorylated at Ser342, Ser352 and Ser362 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NDRG1, pmod(Ph, Ser, 342))
74578687-6a86-4eb8-a246-73a3d8bf04f2	1.0	PubMed	20416281	NDRG1 and Cap43 is phosphorylated at threonine (Thr) 328, serine (Ser) 330, Thr346, Thr356 and Thr366 by SGK1, and further phosphorylated at Ser342, Ser352 and Ser362 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NDRG1, pmod(Ph, Ser, 352))
e9af8f0b-2e46-4756-af7c-2689462a9a0e	1.0	PubMed	20416281	NDRG1 and Cap43 is phosphorylated at threonine (Thr) 328, serine (Ser) 330, Thr346, Thr356 and Thr366 by SGK1, and further phosphorylated at Ser342, Ser352 and Ser362 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NDRG1, pmod(Ph, Ser, 362))
30c945c1-4bd8-46ce-9612-8172858493b5	1.0	PubMed	21798082	Gsk3b is able to phosphorylate nebulin at two ser sites in the c-terminal region of nebulin localized to the z-disk, thus preventing the interaction of nebulin with neuronal wiscott-aldrich syndrome protein (nwasp), a ubiquitously expressed member of the wasp family, which is involved in actin assembly.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NEB, pmod(Ph))
d4f58787-52e3-434f-9e8a-511428192435	1.0	PubMed	3982677	Our results demonstrate that whereas GSK-3 alpha, GSK-3 beta, and cdk-5 will all phosphorylate NF-H, they generate different antibody reactivity profiles.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NEFH, pmod(Ph))
e2d5cf4b-7c40-4f8f-a3e1-4c2021e558fc	1.0	PubMed	12130654	Gsk3beta was shown to phosphorylate at ser-493 in vitro by phosphopeptide mapping and site-directed mutagenesis, and in vivo in hek293 cells. The role of ser-493 phosphorylation is also a question to be addressed in the future. Because the e-segment appears to be involved in filament formation (27, 42), phosphorylation in that region may also play a regulatory role in filament formation. Secondary structure prediction suggests that phosphorylation of ser-493 in combination with following the pro residue interrupts _-helix of the e-segment	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NEFH, pmod(Ph, Ser, 503))
e2eab86c-6358-4940-a19c-82e71ff61438	1.0	PubMed	9072970	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 233), pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 294))
e2eab86c-6358-4940-a19c-82e71ff61438	1.0	PubMed	12351631	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 233), pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 294))
907a7823-7791-4ae0-bfc7-5b3b11482f5e	1.0	PubMed	9072970	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 237), pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 294))
907a7823-7791-4ae0-bfc7-5b3b11482f5e	1.0	PubMed	12351631	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 237), pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 294))
92e9a8af-2e29-4017-8f11-9b5a9aa7a1fa	1.0	PubMed	9072970	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 278), pmod(Ph, Ser, 294))
92e9a8af-2e29-4017-8f11-9b5a9aa7a1fa	1.0	PubMed	12351631	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 278), pmod(Ph, Ser, 294))
81cf5371-a064-4882-b1cb-0cf5333160c3	1.0	PubMed	9072970	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 282), pmod(Ph, Ser, 294))
81cf5371-a064-4882-b1cb-0cf5333160c3	1.0	PubMed	12351631	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 282), pmod(Ph, Ser, 294))
b0e50d0f-269b-4243-af1b-cc7b8f8e1ea2	1.0	PubMed	9072970	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 286), pmod(Ph, Ser, 294))
b0e50d0f-269b-4243-af1b-cc7b8f8e1ea2	1.0	PubMed	12351631	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 286), pmod(Ph, Ser, 294))
2294f728-13d8-43c2-a731-9a24f9f2a7e8	1.0	PubMed	9072970	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 290), pmod(Ph, Ser, 294))
2294f728-13d8-43c2-a731-9a24f9f2a7e8	1.0	PubMed	12351631	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 290), pmod(Ph, Ser, 294))
8e9bf0fe-7877-4fc6-af9e-12db04cafb08	1.0	PubMed	9072970	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 294), pmod(Ph, Ser, 299))
8e9bf0fe-7877-4fc6-af9e-12db04cafb08	1.0	PubMed	12351631	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph, Ser, 245), pmod(Ph, Ser, 269), pmod(Ph, Ser, 294), pmod(Ph, Ser, 299))
ad0f7893-a879-41b5-a28f-54ac85efbb92	1.0	PubMed	20865272	Phosphorylation of NFATc1 by nuclear GSK3beta and casein kinase (XREF_BIBR) unmasks the nuclear export signal (NES) on NFATc1-P, allowing NFATc1-P to be transported out of the nucleus, and obscures the NLS on NFATc1-P (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph))
ad0f7893-a879-41b5-a28f-54ac85efbb92	1.0	PubMed	16513844	Actually phosphorylation of the transcription factor NFATc by GSK3beta induces its transport out of the nucleus (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC1, pmod(Ph))
f532d706-3d7e-47f6-bdc2-60c433dd2fbb	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 110), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
f532d706-3d7e-47f6-bdc2-60c433dd2fbb	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 110), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
f532d706-3d7e-47f6-bdc2-60c433dd2fbb	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 110), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
2a313bf9-5879-4fe3-a6ef-1a5e9ab3f2ba	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 171), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
2a313bf9-5879-4fe3-a6ef-1a5e9ab3f2ba	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 171), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
2a313bf9-5879-4fe3-a6ef-1a5e9ab3f2ba	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 171), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
c2b731b2-c586-4d52-89e0-72831e443503	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 172), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
c2b731b2-c586-4d52-89e0-72831e443503	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 172), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
c2b731b2-c586-4d52-89e0-72831e443503	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 172), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
258c4761-7947-4b03-8300-3f3025a60eff	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 174), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
258c4761-7947-4b03-8300-3f3025a60eff	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 174), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
258c4761-7947-4b03-8300-3f3025a60eff	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 174), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
bb990f18-020f-49f6-823e-a185448267d2	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 175), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
bb990f18-020f-49f6-823e-a185448267d2	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 175), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
bb990f18-020f-49f6-823e-a185448267d2	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 175), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
44115838-bb62-4664-8dfe-442915113c26	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 177), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
44115838-bb62-4664-8dfe-442915113c26	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 177), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
44115838-bb62-4664-8dfe-442915113c26	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 177), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
52cbd2db-2c02-4c93-b300-95ba9ae121ad	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 180), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
52cbd2db-2c02-4c93-b300-95ba9ae121ad	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 180), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
52cbd2db-2c02-4c93-b300-95ba9ae121ad	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 180), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
ee9b074a-bbdd-4daa-98fa-7b6a7bd4b562	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 213), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
ee9b074a-bbdd-4daa-98fa-7b6a7bd4b562	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 213), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
ee9b074a-bbdd-4daa-98fa-7b6a7bd4b562	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 213), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
4d877e81-2b25-4a25-a478-106825613ed5	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 217), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
4d877e81-2b25-4a25-a478-106825613ed5	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 217), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
4d877e81-2b25-4a25-a478-106825613ed5	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 217), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
c46225c1-60b7-488b-909b-2cf040d13821	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 221), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
c46225c1-60b7-488b-909b-2cf040d13821	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 221), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
c46225c1-60b7-488b-909b-2cf040d13821	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 221), pmod(Ph, Ser, 243), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
5a5590ae-7c1e-4871-9a24-67b6c7791bd7	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 268), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
5a5590ae-7c1e-4871-9a24-67b6c7791bd7	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 268), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
5a5590ae-7c1e-4871-9a24-67b6c7791bd7	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 268), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
e8b84af9-b265-40c2-a48b-f2fa87575bbe	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 274), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
e8b84af9-b265-40c2-a48b-f2fa87575bbe	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 274), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
e8b84af9-b265-40c2-a48b-f2fa87575bbe	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 274), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
82b8c8e3-7b67-425d-bd85-66d16c06d38b	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 276), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
82b8c8e3-7b67-425d-bd85-66d16c06d38b	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 276), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
82b8c8e3-7b67-425d-bd85-66d16c06d38b	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 276), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
26e06506-1a26-4709-bb73-2d4d6731bd09	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 280), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
26e06506-1a26-4709-bb73-2d4d6731bd09	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 280), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
26e06506-1a26-4709-bb73-2d4d6731bd09	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 280), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
eeb69c95-6b3c-48e0-a8a5-bef02fd8c47c	1.0	PubMed	15121840	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 326), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
eeb69c95-6b3c-48e0-a8a5-bef02fd8c47c	1.0	PubMed	11030334	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 326), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
eeb69c95-6b3c-48e0-a8a5-bef02fd8c47c	1.0	PubMed	10788511	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph, Ser, 243), pmod(Ph, Ser, 326), pmod(Ph, Ser, 53), pmod(Ph, Ser, 56))
9616f887-1b5c-4cd6-a80c-906c1c61f78e	1.0	PubMed	15276472	Gsk3 was previously shown to directly phosphorylate the n-terminal regulatory domain of nfatc1, thus antagonizing the action of calcineurin and inhibiting nuclear shuttling of nfat.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC2, pmod(Ph))
effc37b7-a615-495a-8a74-09787f39325a	1.0	PubMed	12244165	We find that in the presence but not the absence of EC, NFAT1 can be detected in the nuclei of CsA treated T cells within 8 h of triggering, reaching a maximal level of 60% of control by 24 h. Glycogen synthase kinase-3beta (GSK-3beta), which rephosphorylates NFAT and promotes nuclear export, is inhibited by EC costimulation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFAT, pmod(Ph))
effc37b7-a615-495a-8a74-09787f39325a	1.0	PubMed	22518286	In the nucleus, GSK3beta phosphorylates NFAT, thereby promoting its nuclear export [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFAT, pmod(Ph))
effc37b7-a615-495a-8a74-09787f39325a	1.0	PubMed	22137028	It is reported that Akt activates NFAT by phosphorylating and inactivating glycogen synthase kinase-3 beta, which phosphorylates NFAT and inhibits its nuclear import and DNA binding ().	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFAT, pmod(Ph))
effc37b7-a615-495a-8a74-09787f39325a	1.0	PubMed	6498275	We find that in the presence but not the absence of EC, NFAT1 can be detected in the nuclei of CsA treated T cells within 8 h of triggering, reaching a maximal level of 60% of control by 24 h. Glycogen synthase kinase-3beta (GSK-3beta), which rephosphorylates NFAT and promotes nuclear export, is inhibited by EC costimulation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:NFAT, pmod(Ph))
e88c382b-b040-4a20-b13a-0fc083e7acaa	1.0	PubMed	23623971	Glycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (nrf1) and inhibits pro-survival function of nrf1	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFE2L1, pmod(Ph, Ser, 379))
15eafc3b-f63b-41e1-ab36-d1033d59d3d0	1.0	PubMed	22215675	Interestingly, a recent study demonstrated that NRF2 is phosphorylated by GSK3beta in the central Neh6 domain (DSGIS, residues 334-338), creating an SCF BTRC destruction motif similar to that of beta-catenin (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFE2L2, pmod(Ph))
15eafc3b-f63b-41e1-ab36-d1033d59d3d0	1.0	PubMed	24943846	Indeed, phosphatase treatment resulted in the disappearance of the slowest migrating Nrf2 species (Supplemental Figure S1B), which is consistent with previous reports suggesting that Nrf2 is phosphorylated by PKC, GSK-3beta, CK2, and JNK (XREF_BIBR; XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFE2L2, pmod(Ph))
1d6ecd85-86cc-4fc7-aa8b-40e80297f561	1.0	PubMed	26254094	Nrf2 is also phosphorylated by GSK3beta at Ser335, Ser338, Ser342, and Ser347 in the Neh6 domain, creating a phosphodegron to which beta-TrCP is recruited.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFE2L2, pmod(Ph, Ser, 347))
c1d2c256-3c34-4750-aacc-5ebd4cbdd907	1.0	PubMed	25340789	Specifically, it has been shown that GSK-3beta mediates phosphorylation of certain serine residues on the Neh6 domain of Nrf2, increasing its affinity for another E3 ubiquitin ligase, beta-TrCP, which is believed to mediate Nrf2 ubiquitination and proteasomal degradation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFE2L2, pmod(Ph, Ser))
4cd7d771-9b09-4ac6-bb49-3cfb46601275	1.0	PubMed	17693123	Additionally GSK-3beta phosphorylates p105 at serine 903 and 907 which primes p105 for proteolytic degradation in response to TNFalpha stimulation () ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKB1, pmod(Ph, 907))
76f65315-3f7c-402d-9aa9-7abe4bd5e859	1.0	PubMed	25829335	Accordingly it has been shown that GSK-3beta phosphorylate p105 precursor of the NF-kappaB p50 subunit and this in turn promote TNF-alpha induced phosphorylation and degradation of IkappaB by the IkappaB kinase (IKK), thereby, GSK-3beta regulates the promoter specific recruitment of NF-kappaB, and by this means it plays an essential role in gene transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKB1, pmod(Ph))
f494b9b1-49f0-4e29-8c11-d8a133313025	1.0	PubMed	12871932	GSK-3 beta forms an in vivo complex with and specifically phosphorylates NF-kappa B1/p105 at Ser-903 and Ser-907 in vitro. GSK-3 beta has a dual effect on p105: it stabilizes p105 under resting conditions and primes p105 for degradation upon tumor necrosis factor (TNF)-alpha treatment. Indeed, constitutive processing of p105 to p50 occurs at a higher rate in cells lacking GSK-3 beta with respect to wild-type cells and can be reduced upon reintroduction of GSK-3 beta by transfection. S903A and S907A point mutations impair p105 proteolysis in response to TNF-α.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKB1, pmod(Ph, Ser, 903))
f494b9b1-49f0-4e29-8c11-d8a133313025	1.0	PubMed	17693123	Additionally GSK-3beta phosphorylates p105 at serine 903 and 907 which primes p105 for proteolytic degradation in response to TNFalpha stimulation () ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKB1, pmod(Ph, Ser, 903))
7470d87f-a956-47b2-a963-4fc074665a87	1.0	PubMed	12871932	GSK-3 beta forms an in vivo complex with and specifically phosphorylates NF-kappa B1/p105 at Ser-903 and Ser-907 in vitro. GSK-3 beta has a dual effect on p105: it stabilizes p105 under resting conditions and primes p105 for degradation upon tumor necrosis factor (TNF)-alpha treatment. Indeed, constitutive processing of p105 to p50 occurs at a higher rate in cells lacking GSK-3 beta with respect to wild-type cells and can be reduced upon reintroduction of GSK-3 beta by transfection. S903A and S907A point mutations impair p105 proteolysis in response to TNF-α.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKB1, pmod(Ph, Ser, 907))
5945b484-5508-4790-9fe4-df3f1c199901	1.0	PubMed	22864569	Our data suggests that a pool of p100 is constitutively phosphorylated by GSK3beta, ubiquitinated by Fbw7 and degraded independently of stimulation of the NF-kappaB pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKB2, pmod(Ph))
c8d27238-f1a8-4230-99d3-fa907654333c	1.0	PubMed	22534782	We may speculate that GSK-3beta may phosphorylate IkappaBalpha to release p65 and p50 into the nucleus to affect target gene expression because IkappaBalpha may be phosphorylated by GSK-3beta, as previously proposed (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKBIA, pmod(Ph))
c8d27238-f1a8-4230-99d3-fa907654333c	1.0	PubMed	22534782	We may speculate that GSK-3beta may phosphorylate IkappaBalpha to release p65 and p50 into the nucleus to affect target gene expression because IkappaBalpha may be phosphorylated by GSK-3beta, as previously proposed (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKBIA, pmod(Ph))
c8d27238-f1a8-4230-99d3-fa907654333c	1.0	PubMed	27929056	It was postulated that GSK-3beta phosphorylates IkappaBalpha directly and, this way, induces its degradation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFKBIA, pmod(Ph))
9d9935ab-4122-4bfd-821c-3fde3eb74228	1.0	PubMed	17383637	Our research showed that hNinein is possibly phosphorylated by PKA, Aurora A and GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NIN, pmod(Ph))
9d9935ab-4122-4bfd-821c-3fde3eb74228	1.0	PubMed	20596670	Using a kinase assay, AIBp interacts with the Aurora-A kinase domain functions as a positive regulator, whereas AIBp binding to hNinein appears to block the phosphorylation of hNinein by both Aurora-A and GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NIN, pmod(Ph))
9d9935ab-4122-4bfd-821c-3fde3eb74228	1.0	PubMed	15147888	In kinase assay, CGI-99 binds to hNinein and completely blocks the phosphorylation of hNinein by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NIN, pmod(Ph))
8abce35a-7a7e-4a6c-820e-083ff5c3878a	1.0	PubMed	12123574	Here, we observed that gsk3beta was able to bind and phosphorylate notch1ic in vitro, and attenuation of gsk3beta activity reduced phosphorylation of notchic in vivo.Functionally, ligand-activated signaling through the endogenous notch1 receptor was reduced in gsk3beta fibroblasts, implying a positive role for gsk3beta in mammalian notch signaling.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH1, pmod(Ph))
c81dd470-5f85-4771-8f90-6bd9a97c3a93	1.0	PubMed	PMC6887733	In this study, we show that GSK-3 beta is able to bind and phosphorylate Notch2 in vitro and in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph))
fb6dd742-d9f6-4a49-9373-5ebc0b3e183f	1.0	PubMed	12794074	We show that gsk-3beta directly binds at c-terminal of the notch2 ankyrin repeats and phosphorylates thr-2068 and/or ser-2070, thr-2074, and thr-2093.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Ser, 2070))
fb6dd742-d9f6-4a49-9373-5ebc0b3e183f	1.0	PubMed	12794074	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Ser, 2070))
fb6dd742-d9f6-4a49-9373-5ebc0b3e183f	1.0	PubMed	12794074	Ser-2093 is efficiently phosphorylated by GSK-3β and, to a minor extent, residues Thr-2068 and/or Ser-2070 and Thr-2074 of Notch2 are also targets for GSK-3β-dependent phosphorylation. We also find that GSK-3β-dependent phosphorylation of Notch2 is inhibiting transcriptional activation of different Notch target genes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Ser, 2070))
b55a25e0-a891-442d-a21a-5e8cf7f60337	1.0	PubMed	12794074	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Ser, 2093))
b55a25e0-a891-442d-a21a-5e8cf7f60337	1.0	PubMed	12794074	Ser-2093 is efficiently phosphorylated by GSK-3β and, to a minor extent, residues Thr-2068 and/or Ser-2070 and Thr-2074 of Notch2 are also targets for GSK-3β-dependent phosphorylation. We also find that GSK-3β-dependent phosphorylation of Notch2 is inhibiting transcriptional activation of different Notch target genes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Ser, 2093))
5dcd2369-ac8b-4730-a8c9-d8d5d0818c8b	1.0	PubMed	12794074	We show that gsk-3beta directly binds at c-terminal of the notch2 ankyrin repeats and phosphorylates thr-2068 and/or ser-2070, thr-2074, and thr-2093.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Thr, 2068))
5dcd2369-ac8b-4730-a8c9-d8d5d0818c8b	1.0	PubMed	12794074	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Thr, 2068))
5dcd2369-ac8b-4730-a8c9-d8d5d0818c8b	1.0	PubMed	12794074	Ser-2093 is efficiently phosphorylated by GSK-3β and, to a minor extent, residues Thr-2068 and/or Ser-2070 and Thr-2074 of Notch2 are also targets for GSK-3β-dependent phosphorylation. We also find that GSK-3β-dependent phosphorylation of Notch2 is inhibiting transcriptional activation of different Notch target genes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Thr, 2068))
7dc48b9b-5368-488f-94a3-6a9dec4fc1de	1.0	PubMed	12794074	We show that gsk-3beta directly binds at c-terminal of the notch2 ankyrin repeats and phosphorylates thr-2068 and/or ser-2070, thr-2074, and thr-2093.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Thr, 2074))
7dc48b9b-5368-488f-94a3-6a9dec4fc1de	1.0	PubMed	12794074	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Thr, 2074))
7dc48b9b-5368-488f-94a3-6a9dec4fc1de	1.0	PubMed	12794074	Ser-2093 is efficiently phosphorylated by GSK-3β and, to a minor extent, residues Thr-2068 and/or Ser-2070 and Thr-2074 of Notch2 are also targets for GSK-3β-dependent phosphorylation. We also find that GSK-3β-dependent phosphorylation of Notch2 is inhibiting transcriptional activation of different Notch target genes.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NOTCH2, pmod(Ph, Thr, 2074))
98411495-be91-4d1e-a5d1-11fc32c74f63	1.0	PubMed	16484495	We show here that gsk3beta phosphorylates and stabilizes the orphan nuclear receptor rev-erbalpha, a negative component of the circadian clock.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NR1D1, pmod(Ph, Ser, 55))
1770430f-b317-4a74-8a56-07d57a8641fd	1.0	PubMed	16484495	We show here that gsk3beta phosphorylates and stabilizes the orphan nuclear receptor rev-erbalpha, a negative component of the circadian clock.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NR1D1, pmod(Ph, Ser, 59))
19bfa51c-7d0a-4bc7-8e38-84ab9603d024	1.0	PubMed	18838540	We found hormone-dependent GR phosphorylation on serine 404 by GSK-3beta [ ]Cells expressing a GR that is incapable of GSK-3beta phosphorylation had a redirection of the global transcriptional response to hormone, including the activation of additional signaling pathways, in part due to the altered ability of unphosphorylatable GR to recruit transcriptional cofactors CBP/p300 and the p65 (RelA) subunit of NF-kappaB	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NR3C1, pmod(Ph, Ser, 404))
19bfa51c-7d0a-4bc7-8e38-84ab9603d024	1.0	PubMed	18838540	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NR3C1, pmod(Ph, Ser, 404))
866fbf73-7554-456d-9886-2ff93fca65ef	1.0	PubMed	26840408	GSK3beta suppresses Nur77 activity by phosphorylating Nur77 in colorectal cancer [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NR4A1, pmod(Ph))
b17e0dd3-50a2-437d-8535-bf06421d6440	1.0	PubMed	12123574	Consistent with the evidence of GSK3beta dependent phosphorylation of Notch (presented above), these data indicate that GSK3beta activity regulates the phosphorylation of Notch1IC polypeptides in vivo.The Notch1IC domain is likely to be a direct substrate for GSK3beta phosphorylation because it contains several conserved consensus sites for GSK3beta, three of which show a bi- or tripartite site for ordered phosphorylation (S-X-S-X-S/T) similar to sites found in glycogen synthase and beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Notch, pmod(Ph))
b17e0dd3-50a2-437d-8535-bf06421d6440	1.0	PubMed	15546612	GSK-3beta, which can phosphorylate Notch in the nucleus, was not present with the ICD at the promoter (data not shown).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Notch, pmod(Ph))
b17e0dd3-50a2-437d-8535-bf06421d6440	1.0	PubMed	PMC6887733	Together, our results suggest that cross-talk between Notch and Wnt pathways may be partially mediated by specific regulation of GSK-3 beta-dependent Notch phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Notch, pmod(Ph))
142ed7d1-b4ab-4cbb-9f8d-35cbda37abb1	1.0	PubMed	3356642	Phosphorylation of p90rsk by both GSK-3 alpha and GSK-3 beta isoforms was predominantly on threonine residues.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:P90RSK, pmod(Ph, Thr))
0ac04be8-6fcf-42fc-8e1d-39da4fdc6045	1.0	PubMed	22200892	PDGF-BB caused phosphorylation of p44 and p42 MAPK, SAPK and JNK, Akt and GSK-3beta, but not p38 MAPK in AsPC1 and BxPC3 cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PA2G4, pmod(Ph))
e5306f74-48a5-4906-b6c9-afa5dd05dd6f	1.0	PubMed	22679108	GSK-3beta phosphorylates PAX3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph))
e5306f74-48a5-4906-b6c9-afa5dd05dd6f	1.0	PubMed	22679108	We further found that PAX3 directly interacted with and was phosphorylated in vitro on a number of residues by GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph))
e5306f74-48a5-4906-b6c9-afa5dd05dd6f	1.0	PubMed	22679108	GSK-3beta interacted with and phosphorylated PAX3, which was correlated with PAX3 levels in melanoma cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph))
e5306f74-48a5-4906-b6c9-afa5dd05dd6f	1.0	PubMed	22679108	These findings demonstrate that GSK-3beta phosphorylates PAX3 within the first series of GSK-3beta recognition motifs.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph))
e5306f74-48a5-4906-b6c9-afa5dd05dd6f	1.0	PubMed	22679108	GSK-3beta phosphorylates PAX3 and is correlated with PAX3 levels in melanoma.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph))
e5306f74-48a5-4906-b6c9-afa5dd05dd6f	1.0	PubMed	21440083	Therefore, these results demonstrate that purified GSK3beta phosphorylates Pax3 when Pax3 is phosphorylated at serine 205 by CK2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph))
e5306f74-48a5-4906-b6c9-afa5dd05dd6f	1.0	PubMed	21440083	Further, the inability of GST-Pax3 to be radioactively phosphorylated by GSK3beta when the required priming site is absent [GST-Pax3 (S205A)] or the site of GSK3beta phosphorylation is absent [GST-Pax3 (S201A)] demonstrates that serine 201 is the only site of phosphorylation by purified GSK3beta on Pax3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph))
246e8fd3-c726-443e-ac59-2a8736406afe	1.0	PubMed	22679108	The ubiquitously expressed CK2 often provides the priming phosphorylation for GSK-3, however, we found that GSK-3beta alone was sufficient to phosphorylate PAX3 at both Ser205 and Ser197 and Ser201 in-vitro (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph, Ser, 197))
1d56ab96-9864-4aac-ae04-b1ba9b72bd0a	1.0	PubMed	22679108	The ubiquitously expressed CK2 often provides the priming phosphorylation for GSK-3, however, we found that GSK-3beta alone was sufficient to phosphorylate PAX3 at both Ser205 and Ser197 and Ser201 in-vitro (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph, Ser, 201))
1d56ab96-9864-4aac-ae04-b1ba9b72bd0a	1.0	PubMed	24903325	A recent report demonstrated that GSK3beta, the kinase that phosphorylates Pax3 at Ser201 (XREF_BIBR), promotes melanoma cell survival by regulating Pax3 protein levels (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph, Ser, 201))
1d56ab96-9864-4aac-ae04-b1ba9b72bd0a	1.0	PubMed	21440083	Further, in the absence of priming by CK2, GSK3beta alone was unable to phosphorylate Pax3 at serine 201 (XREF_FIG, lane 2, middle panel).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph, Ser, 201))
1d56ab96-9864-4aac-ae04-b1ba9b72bd0a	1.0	PubMed	21440083	Taken together, these results demonstrate that purified GSK3beta can phosphorylate Pax3 at serine 201 only after phosphorylation of serine 205 by CK2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph, Ser, 201))
26c77764-a647-4018-8535-bf9e46ee5d75	1.0	PubMed	22679108	The ubiquitously expressed CK2 often provides the priming phosphorylation for GSK-3, however, we found that GSK-3beta alone was sufficient to phosphorylate PAX3 at both Ser205 and Ser197 and Ser201 in-vitro (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PAX3, pmod(Ph, Ser, 205))
9d973d3d-a4b8-4b2a-8e8b-2703b9c622a1	1.0	PubMed	3997457	PDH was phosphorylated and inactivated by TPKI and GSK-3beta in vitro and also in betaA treated hippocampal cultures, resulting in mitochondrial dysfunction, which would contribute to neuronal death.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PDH, pmod(Ph))
829550b2-c606-42e2-8243-a1611b36664b	1.0	PubMed	21179498	GSK-3beta phosphorylates PER2, CRY2, REV-ERBalpha, CLOCK, and BMAL1 for functional regulation XREF_BIBR - XREF_BIBR, and pharmacological and RNAi based inhibition of GSK-3beta causes period shortening in cultured cells XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PER2, pmod(Ph))
e0e4fced-0c9e-4aa4-9396-80da03f8a709	1.0	PubMed	23724143	GSK-3beta can phosphorylate PHLPP1 leading to its ubiquitination and subsequent degradation via beta-TrCP XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PHLPP1, pmod(Ph))
82c4a624-d063-496a-89f6-e7020f2005aa	1.0	PubMed	19797085	In addition, we show that the beta-trcp-mediated degradation requires phosphorylation of phlpp1 by casein kinase i and glycogen synthase kinase 3beta (gsk-3beta), and activation of the phosphatidylinositol 3-kinase/akt pathway suppresses the degradation of phlpp1 by inhibiting the gsk-3beta activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PHLPP1, pmod(Ph, Ser, 1359))
88fb06cb-d711-43a1-a09c-76c7bdb3bd5a	1.0	PubMed	18471882	After recruitment, Akt is activated by phosphorylation at Ser473 and in turn phosphorylates several downstream targets of the PI3K pathway, including the constitutively active serine threonine kinase glycogen synthase kinase-3beta (GSK3beta).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PI3K, pmod(Ph))
29389cae-d5f3-41ab-bbae-9f6650a87964	1.0	PubMed	26157031	We further observed that GSK3beta directly phosphorylated WT PIAS1, but not S13A, S17A, or S13 and S17A mutant PIAS1, in an in vitro kinase assay (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PIAS1, pmod(Ph, Ser, 13), var(p.Ser17Ala))
19eb7591-30cd-4cdc-a03a-023fbb216e00	1.0	PubMed	26157031	We found that GSK3b phosphorylation of PIAS1 provided a phosphodegron for HECTD2 targeting.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PIAS1, pmod(Ph))
aef217f5-eb38-4b80-a3d6-9acc8c34f614	1.0	PubMed	26157031	We further observed that GSK3beta directly phosphorylated WT PIAS1, but not S13A, S17A, or S13 and S17A mutant PIAS1, in an in vitro kinase assay (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PIAS1, pmod(Ph, Ser, 13))
59fae246-5b25-499e-a8a0-ec21441c1a45	1.0	PubMed	27162139	Under TGFbeta stimulation, two kinases, PKCzeta and GSK3beta, phosphorylate PIAS4 and FIEL1, respectively.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PIAS4, pmod(Ph))
3b00faff-17e9-4600-ac49-a895b96a709e	1.0	PubMed	24777252	In resting macrophages, CKIP-1 was phosphorylated at Serine 342 by constitutively active GSK3beta, the downstream target of Akt.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PLEKHO1, pmod(Ph, Ser, 342))
0f9e18dc-2921-4d17-8ab0-a27ab28d30b0	1.0	PubMed	19472218	Similar, but attenuated results were obtained for tau phosphorylated at serine 199 and 202, residues also phosphorylated by GSK3beta, with PLTP reducing pTau Ser199, 202 by ~ 20% (data not shown).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PLTP, pmod(Ph, 202))
748384ed-6c23-4b20-b65a-42fcedf3e3b0	1.0	PubMed	24606125	Furthermore, treatment of cells with a highly specific chemical GSK3-beta inhibitor, CHIR99021 (XREF_BIBR), caused dose dependent rebound of rGH promoter activity in GpSSTR3 WT, further indicating that GH inhibition by SSTR3 is mediated at least in part through GSK3-beta activation and perhaps by enhanced Pit-1 phosphorylation by GSK3-beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:POU1F1, pmod(Ph))
055d3178-1bfd-456c-92fe-446fd1d91657	1.0	PubMed	25118933	Within them, GSK3beta, which can phosphorylate PGC-1alpha and promote its ubiquitin mediated degradation (XREF_SUPPLEMENTARY), XREF_BIBR, XREF_BIBR was upregulated significantly in mnd2 mouse brain and spinal cord compared with that in wide-type mice (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PPARGC1A, pmod(Ph))
055d3178-1bfd-456c-92fe-446fd1d91657	1.0	PubMed	25118933	XREF_BIBR, XREF_BIBR GSK3beta reduces PGC-1alpha levels by phosphorylating PGC-1alpha and subsequently stimulating PGC-1alpha degradation by the ubiquitin-proteasomal system.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PPARGC1A, pmod(Ph))
0886f142-0116-4f22-84fb-c1241e2bcfe4	1.0	PubMed	25445707	Two proposed signaling factors include GSK3-beta and p53.Based on a previous work by Juhaszova et al. showing that GSK3-beta mediates regulatory signaling of the MPT pore, Rasola and collaborators proposed that CypD is phosphorylated by GSK3-beta as a final step in a complex signaling cascade starting in the cytosol with ERK.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PPIF, pmod(Ph))
2db0fb01-336a-4ac6-bf64-6bceccf61a45	1.0	PubMed	11320080	Protein phosphatase 1 (PP1) is complexed with inhibitor 2 (I-2) in the cytosol. In rabbit muscle extract PP1.I-2 is activated upon preincubation with ATP/Mg. This activation is caused by phosphorylation of I-2 on Thr(72) by glycogen synthase kinase 3 (GSK3).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PPP1R2, pmod(Ph, Thr, 73))
09d52046-955e-4a42-b8e7-12f00d0296c1	1.0	PubMed	26655089	It is hypothesized that GSK3beta phosphorylates inhibitor 2 (I-2) of PP1 at Thr 72 and activates the PP1.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:PPP1, pmod(Ph, Thr, 72))
e3b30380-0031-454d-89a3-1a6163dbebd0	1.0	PubMed	23277198	GSK3beta Phosphorylates Newly Identified Site in the Pro Ala Rich Region of Cardiac Myosin Binding Protein C and Alters Cross-Bridge Cycling Kinetics in Human.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PRH1, pmod(Ph, Ala))
097fa557-539f-4b1e-9fca-f5a03d030b68	1.0	PubMed	20350291	GSK3-beta phosphorylates PKCepsilon at Ser 346 whereas Ser 368 is autophosphorylated [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PRKCE, pmod(Ph, Ser, 346))
097fa557-539f-4b1e-9fca-f5a03d030b68	1.0	PubMed	18604201	Specifically, we have identified three phosphorylation sites within pkcepsilon that control its association with 14-3-3.kinase (ser 350), gsk3 (ser 346) and pkc itself (ser 368)	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PRKCE, pmod(Ph, Ser, 346))
38b229e0-8c24-4875-b624-512fb580e933	1.0	PubMed	20350291	GSK3-beta phosphorylates PKCepsilon at Ser 346 whereas Ser 368 is autophosphorylated [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PRKCE, pmod(Ph, Ser, 368))
606bff78-e920-4996-b955-27c0ff869e4c	1.0	PubMed	22606260	GSK3beta is able to phosphorylate ser349 of the prolactin receptor XREF_BIBR, a residue existing only in the long and DeltaS1 isoforms.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PRLR, pmod(Ph, Ser, 349))
dc127b30-c2b7-4207-98b9-73bb3fff43aa	1.0	PubMed	21238544	Importantly, we and other groups previously reported that PS1, a causative molecule of familial AD, was also phosphorylated by GSK3beta at serine 353, 357 residues ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PSEN1, pmod(Ph, 357))
d92afaaf-778d-42e5-9335-c68d34d20a83	1.0	PubMed	21238544	These results suggest that up-regulated GSK3beta activity could enhance PS1 phosphorylation in AD affected brains.Since IR is one of key regulators of GSK3beta activity, we analyzed the functional relationship between PS1 and gamma-secretase activity and IR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PSEN1, pmod(Ph))
d92afaaf-778d-42e5-9335-c68d34d20a83	1.0	PubMed	21238544	Thus, GSK3beta activation may promote the phosphorylation of PS1 to enhance cleavage of IR, finally activating the transcription of Akt, which is a strong inhibitor of GSK3beta activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PSEN1, pmod(Ph))
733c209b-c6d4-45ed-8381-fbe6815d53b4	1.0	PubMed	21238544	Importantly, we and other groups previously reported that PS1, a causative molecule of familial AD, was also phosphorylated by GSK3beta at serine 353, 357 residues ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PSEN1, pmod(Ph, Ser, 353))
733c209b-c6d4-45ed-8381-fbe6815d53b4	1.0	PubMed	17360711	We demonstrate that phosphorylation of serines 353 and 357 by glycogen synthase kinase-3beta (gsk3beta) induces a structural change of the hydrophilic loop of ps1the structural change of ps1 reduces the interaction with beta-catenin leading to decreased phosphorylation and ubiquitination of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PSEN1, pmod(Ph, Ser, 353))
d62d7f66-b8ef-4fdc-9f44-bc7a0789e0b4	1.0	PubMed	17360711	We demonstrate that phosphorylation of serines 353 and 357 by glycogen synthase kinase-3beta (gsk3beta) induces a structural change of the hydrophilic loop of ps1the structural change of ps1 reduces the interaction with beta-catenin leading to decreased phosphorylation and ubiquitination of beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PSEN1, pmod(Ph, Ser, 357))
fc46e94b-90cd-40fb-9dcb-0b6215748791	1.0	PubMed	16107342	More importantly, prior phosphorylation of PTEN at Ser 370 by CK2 strongly increased its phosphorylation at Thr 366 by GSK3beta, suggesting that the two may synergize.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTEN, pmod(Ph, Ser, 370))
fc46e94b-90cd-40fb-9dcb-0b6215748791	1.0	PubMed	22902055	Another study by Nick et al. showed that PTEN was phosphorylated on thr 366 and ser 370 by CK2 and GSK 3beta respectively, and mutation of these phophorylation sites did not alter the phosphatase activity of PTEN either or.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTEN, pmod(Ph, Ser, 370))
70289229-9975-4cee-87b4-ca80cf287cf4	1.0	PubMed	16107342	Gsk3beta Phosphorylates pten at thr-366 in intact cells phosphorylation of pten at thr-366 reduces the activity of pten in cells	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTEN, pmod(Ph, Thr, 366))
70289229-9975-4cee-87b4-ca80cf287cf4	1.0	PubMed	19208634	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTEN, pmod(Ph, Thr, 366))
70289229-9975-4cee-87b4-ca80cf287cf4	1.0	PubMed	22902055	Another study by Nick et al. showed that PTEN was phosphorylated on thr 366 and ser 370 by CK2 and GSK 3beta respectively, and mutation of these phophorylation sites did not alter the phosphatase activity of PTEN either or.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTEN, pmod(Ph, Thr, 366))
dad19b8a-bfb0-412d-838c-c3de7608573e	1.0	PubMed	22810307	GSK3beta inhibition blocks melanoma cell and host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTK2, pmod(Ph))
fc432ef0-5e58-439b-9b5d-56be51bc66ba	1.0	PubMed	22810307	A comprehensive mass spectrometry based analysis of FAK phosphorylation demonstrated that GSK3beta inhibition increased the phosphorylation of FAK at Ser 843, an inhibitory phosphorylation site (XREF_BIBR) (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTK2, pmod(Ph, Ser, 843))
e342cf8a-e0cc-4263-931e-c5861c3d1bca	1.0	PubMed	24021281	The primary antibodies used were against : Active beta-catenin (Clone 8E7; Millipore, Billerica, MA, USA), Total beta-catenin (gift from Dr. James Wahl, University of Nebraska Medical Center), pGSK3beta (Serine; Cell Signaling Technology), Total GSK3beta (Cell Signaling Technology), Akt (Cell Signaling Technology), pAkt (Serine; Cell Signaling Technology), COX-2 (Cayman Chemical), FAK (Cell Signaling Technology), phosphorylated FAK (Ser Santa Cruz Biotechnology, Inc..	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTK2, pmod(Ph, Ser))
9ea41925-8e4e-491c-afb3-dba21d3dca35	1.0	PubMed	19276348	We sought to investigate the consequences of impaired PRLr phosphorylation on Ser349 in human mammary epithelial cells by expressing PRLr S349A mutant that can not be phosphorylated by GSK3beta (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTP4A3, pmod(Ph), var(p.Ser349Ala))
5425411b-bee8-4a22-92d9-eb8d96afc5fb	1.0	PubMed	21757741	Here, we demonstrate that glycogen synthase kinase-3beta (GSK3beta) phosphorylates securin to promote its proteolysis via SCF (betaTrCP) E3 ubiquitin ligase.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PTTG1, pmod(Ph))
0879d386-e3bf-4207-896f-19ff0aa64f45	1.0	PubMed	22193544	Consistent with our observations of Tau phosphorylation, WT but not mutant WWOX inhibits GSK3beta phosphorylation of GS-1 (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:PUDP, pmod(Ph))
bc49df09-913d-438a-b263-177f9c499dff	1.0	PubMed	24134204	In HEK (human embryonic kidney) -293 and PANC-1 cells (which exhibit DYRK1B amplification) DYRK1B drives Thr (286) phosphorylation and proteasome dependent turnover of CCND1 and this is abolished by AZ191 or DYRK1B RNAi, but not by GSK3beta inhibitors or GSK3beta RNAi.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Proteasome, pmod(Ph))
37e1bd20-17e0-4c8f-afc7-cd4a7cc80045	1.0	PubMed	14660640	Glycogen synthase kinase 3beta (GSK3beta) phosphorylated Rap1GAP immunoprecipitated from thyroid cells, and GSK3beta inhibitors prevented phosphorylation and degradation of endogenous Rap1GAP.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RAP1GAP, pmod(Ph))
d9712a69-1c53-4ce0-b3ce-8bd761c8bcb3	1.0	PubMed	24290981	CK1alpha, but not CK2, GSK3beta, or CDK1 (kinases involved in the phosphorylation of other substrates of betaTrCP), phosphorylated the degron of RAPGEF2 invitro, as shown by the recognition by our phosphospecific antibody (I).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RAPGEF2, pmod(Ph))
efd08dcf-ea49-498d-86fc-e1324b7aa043	1.0	PubMed	24709419	In this degradation process, glycogen synthase kinase-3 beta (GSK-3beta)-mediated phosphorylation of RAS has been reported to prime its binding with beta-TrCP1 [28].	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:RAS, pmod(Ph))
388432ce-fb9a-4011-b016-d0dd4e9e8904	1.0	PubMed	23408967	One possible mechanism is suggested by our observation that GSK3beta inhibition decreased Rb phosphorylation, thus restoring its function against E2F.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RB1, pmod(Ph))
388432ce-fb9a-4011-b016-d0dd4e9e8904	1.0	PubMed	24170547	Phosphorylation of Cyclin D1 by GSK3beta at threonine 286 enhances its ubiquitination and proteasomal degradation preventing its interaction with CDK4, and CDK4 dependent RB phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RB1, pmod(Ph))
0b611ea8-a6fd-4fec-9049-556c101c358a	1.0	PubMed	24142875	Here, we showed that rnpc1 is phosphorylated at ser195 by glycogen synthase kinase 3 (gsk3). We also provided evidence that ser195 phosphorylation converts rnpc1 from a repressor to an activator of p53.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RBM38, pmod(Ph, Ser, 195))
ad5a9a99-3853-4810-b962-bf2a26b165a2	1.0	PubMed	25144594	In contrast, the MEK5-MEKK3-BMK signaling cascade, GSK-3beta, and TAK1 phosphorylate RCAN1 and suppress its inhibition effect on calcineurin activity XREF_BIBR, XREF_BIBR - XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RCAN1, pmod(Ph))
316b10fd-e011-4c1f-be06-aa727e07f926	1.0	PubMed	25753203	For instance, GSK-3beta- and ERK mediated phosphorylations at the Ser 108 and Ser 112 of RCAN1 activate calcineurin signaling.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RCAN1, pmod(Ph, Ser, 163))
316b10fd-e011-4c1f-be06-aa727e07f926	1.0	PubMed	12063245	Consensus phosphorylation sites for p42/44 MAPK and GSK-3 are present in the SP repeat of MCIP1 at serine 112 and serine 108, respectively |Several endogenous proteins are capable of inhibiting the catalytic activity of calcineurin. Modulatory calcineurin interacting protein 1 (MCIP1) is unique among these proteins on the basis of its pattern of expression and its function in a negative feedback loop to regulate calcineurin activity. Here we show that MCIP1 can be phosphorylated by MAPK and glycogen synthase kinase-3 and that phosphorylated MCIP1 is a substrate for calcineurin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RCAN1, pmod(Ph, Ser, 163))
6d39f652-c856-4383-bf5c-ec2c84fdfc8c	1.0	PubMed	25753203	For instance, GSK-3beta- and ERK mediated phosphorylations at the Ser 108 and Ser 112 of RCAN1 activate calcineurin signaling.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RCAN1, pmod(Ph, Ser, 167))
096c73d9-651f-44fb-9d1b-01fa64ca2002	1.0	PubMed	22534782	In addition, GSK-3beta may phosphorylate p65 to enhance the transcriptional activity of p65, as shown in pancreatic cancer (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RELA, pmod(Ph))
096c73d9-651f-44fb-9d1b-01fa64ca2002	1.0	PubMed	22615844	It has been reported that GSK-3beta can phosphorylate the C-terminal domain (residues354-551) of p65 in vitro XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RELA, pmod(Ph))
096c73d9-651f-44fb-9d1b-01fa64ca2002	1.0	PubMed	PMC6352943	The p65 sequence revealed four potential GSK-3 phosphorylation sites within its COOH-terminal transactivation domains and recombinant GSK-3beta phosphorylated glutathione S-transferase (GST)-p65(354-551), but not GST-p65(1-305) in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RELA, pmod(Ph))
41af4c13-a0b2-4e5b-bbd9-05808b5fc01e	1.0	PubMed	19345186	Phosphorylation of Serine 468 (S468) in p65 is associated with negative regulation of NF-kappaB signaling (XREF_BIBR) and can be mediated by GSK3beta, which is activated following TLR4 stimulation in human monocytes (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RELA, pmod(Ph, Ser, 468))
41af4c13-a0b2-4e5b-bbd9-05808b5fc01e	1.0	PubMed	19345186	Therefore, we hypothesized that S468 phosphorylation of p65 by GSK3beta might provide the docking site for tethering of Nurr1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RELA, pmod(Ph, Ser, 468))
41af4c13-a0b2-4e5b-bbd9-05808b5fc01e	1.0	PubMed	17183360	Rela is phosphorylated at: ser276 by the catalytic subunit of protein kinase a (pkac), msk1 and msk2; at ser311 by the atypical pkczeta; at ser468 by ikkbeta, ikkepsilon and glycogen-synthase kinase-3beta (gsk3beta); at ser529 by ck2; and at ser536 by ikkbeta, ikkalfa, ikkepsilon, nf-kb activating kinase (nak, also known as tank-binding kinase-1 tbk1)) and rsk1 (also known as p90 ribosomal protein s6 kinase (p90s6k) .	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RELA, pmod(Ph, Ser, 468))
41af4c13-a0b2-4e5b-bbd9-05808b5fc01e	1.0	PubMed	16407239	Rela is phosphorylated at: ser276 by the catalytic subunit of protein kinase a (pkac), msk1 and msk2; at ser311 by the atypical pkczeta; at ser468 by ikkbeta, ikkepsilon and glycogen-synthase kinase-3beta (gsk3beta); at ser529 by ck2; and at ser536 by ikkbeta, ikkalfa, ikkepsilon, nf-kb activating kinase (nak, also known as tank-binding kinase-1 tbk1)) and rsk1 (also known as p90 ribosomal protein s6 kinase (p90s6k) .	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RELA, pmod(Ph, Ser, 468))
4fb52154-c309-437f-b858-1c1a61ad815c	1.0	PubMed	21217772	Most importantly, as demonstrated by in vitro kinase assays, human RelB is inducibly phosphorylated by GSK-3beta, indicating a direct substrate-enzyme relationship.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RELB, pmod(Ph))
1a38eeea-1420-4256-8895-5cb01146ee16	1.0	PubMed	21343617	We found that during cellular stress, GSK-3beta phosphorylated the mTORC2 component rictor at serine 1235, a modification that interfered with the binding of Akt to mTORC2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RICTOR, pmod(Ph, Ser, 1235))
2bef8561-df02-4bc5-b45c-ef543dfdf653	1.0	PubMed	17986005	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ROR2, pmod(Ph))
0137e780-55d4-4803-9768-8ddb232076e6	1.0	PubMed	21078818	We identify ror2 ser 864 as a critical residue phosphorylated by gsk3 and required for noncanonical receptor activation by wnt5a, analogous to the priming phosphorylation of low-density receptor-related protein 6 (lrp6) in response to wnt3a.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ROR2, pmod(Ph, Ser, 864))
3612b42e-96a3-4fa2-b263-a6b14164c7b7	1.0	PubMed	21228102	GSK3beta inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RPS6KB1, pmod(Ph))
6c634bc6-132e-46c7-be85-0ed8f1c431d9	1.0	PubMed	19734454	Similarly, the GSK3beta dependent phosphorylation of Runx2 at S369-S373-S377 (S280-S284-S288 of human type I Runx2) (XREF_FIG) was shown to inhibit Runx2 transactivation activity (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:RUNX2, pmod(Ph))
a54bda30-c881-481c-9724-5ca3c999d607	1.0	PubMed	23277198	GSK3beta Phosphorylates Newly Identified Site in the Pro Ala Rich Region of Cardiac Myosin Binding Protein C and Alters Cross-Bridge Cycling Kinetics in Human.	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF05062, pmod(Ph, Ala))
9154684f-865d-41f4-b645-d7c1c33ead3f	1.0	PubMed	15975092	S1 phosphorylation was observed to decrease in wounded cell monolayers, while GSK3beta underwent inactivation and later was observed to increase to the original level within 24 h. Direct phosphorylation of S1, requiring pre-phosphorylation of Ser 726 in the +4 position, was demonstrated using purified GSK3 and a synthetic peptide containing FAK residues 714-730.	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF00575, pmod(Ph))
415ff86d-7d95-4ed1-83ca-1a90c008bd3b	1.0	PubMed	20932480	Psf is directly phosphorylated by gsk3, thus promoting interaction of psf with trap150, which prevents psf from binding cd45 pre-mrna. / threonine phosphorylation of psf by gsk3 primarily occurs on residue t687	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SFPQ, pmod(Ph))
a6b5145e-9b7e-40e4-9dee-630195c8e9e9	1.0	PubMed	20932480	We conclude that t687 is the primary site of threonine phosphorylation in psf. Gsk3 directly phosphorylates the splicing regulatory protein psf. In this phosphorylated form, psf is sequestered in a complex with trap150, precluding it from binding the ess1 sequence in cd45 alternatively spliced exons. Upon t?_Cell stimulation, reduced gsk3 activity leads to reduced psf phosphorylation, thereby releasing psf from trap150 and allowing it to participate in activation-induced cd45 exon skipping	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SFPQ, pmod(Ph, Thr, 687))
c4a00ef3-2a9a-4ff7-aedc-9927d71da1e6	1.0	PubMed	18348280	However, overexpression and knockdown of GSK-3beta in LKB1 defective HeLa cells suggests that GSK-3beta alone may not be able to phosphorylate or activate SIK1, indicating that LKB1 may play a crucial role by phosphorylating SIK1 at Thr182, possibly as an initiator of the autophosphorylation cascade, and GSK-3beta may phosphorylate SIK1 at Thr182 by recognizing the priming autophosphorylation at Ser186 in cultured cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SIK1, pmod(Ph))
96cfaa71-cc52-4701-b7ec-5cba969693a4	1.0	PubMed	18348280	However, overexpression and knockdown of GSK-3beta in LKB1 defective HeLa cells suggests that GSK-3beta alone may not be able to phosphorylate or activate SIK1, indicating that LKB1 may play a crucial role by phosphorylating SIK1 at Thr182, possibly as an initiator of the autophosphorylation cascade, and GSK-3beta may phosphorylate SIK1 at Thr182 by recognizing the priming autophosphorylation at Ser186 in cultured cells.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SIK1, pmod(Ph, Thr, 182))
306f1ddd-cfb0-433e-b013-2588a167d8ca	1.0	PubMed	26047580	In the absence of WNT, GSK3beta specifically phosphorylates the dually phosphorylated form of Smad1, leaving Smad1 susceptible to ubiquitination by Smurf1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD1, pmod(Ph))
306f1ddd-cfb0-433e-b013-2588a167d8ca	1.0	PubMed	18045539	Phosphorylation at the gsk3 sites represses the transcriptional activity of smad1 by enhancing proteasomal degradation of psmad1cter	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD1, pmod(Ph))
306f1ddd-cfb0-433e-b013-2588a167d8ca	1.0	PubMed	17289590	GSK-3beta did not phosphorylate Smad1 [EPSM] or Smad1 [GPSM], in which putative GSK-3 sites were mutated (S191A, T202V, and S210A) (B).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD1, pmod(Ph))
296bb3d2-5ecb-4f2f-9b45-69fb407f778a	1.0	PubMed	23077590	Because we have demonstrated that GSK3 is involved in the phosphorylation of two downstream effectors of transforming growth factor beta (TGFbeta), Smad2 and Smad3, at their linker domain, our aim was to determine whether riluzole could induce GSK3beta mediated linker phosphorylation of Smad2 and Smad3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD2, pmod(Ph))
296bb3d2-5ecb-4f2f-9b45-69fb407f778a	1.0	PubMed	23077590	In addition, in vitro kinase assays confirmed that GSK3beta could phosphorylate Smad2 and Smad3 at the cluster of serines 245/250/255 and serine 204 respectively.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD2, pmod(Ph))
e194f646-35bd-41c9-a910-039c9a66591e	1.0	PubMed	23077590	Because we have demonstrated that GSK3 is involved in the phosphorylation of two downstream effectors of transforming growth factor beta (TGFbeta), Smad2 and Smad3, at their linker domain, our aim was to determine whether riluzole could induce GSK3beta mediated linker phosphorylation of Smad2 and Smad3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD3, pmod(Ph))
e194f646-35bd-41c9-a910-039c9a66591e	1.0	PubMed	23077590	In addition, in vitro kinase assays confirmed that GSK3beta could phosphorylate Smad2 and Smad3 at the cluster of serines 245/250/255 and serine 204 respectively.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD3, pmod(Ph))
e194f646-35bd-41c9-a910-039c9a66591e	1.0	PubMed	22617150	Non activated Smad3 can also be phosphorylated in its MH1 domain by GSK3-beta in association with the scaffolding protein Axin.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD3, pmod(Ph))
b2bb7428-4b23-4a92-9b60-c430bd10eae1	1.0	PubMed	23077590	In addition, siRNA knock-down of GSK3alpha and GSK3beta inhibited the riluzole induced phosphorylation of Smad2 (S245/250/255) and Smad3 (S204) (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD3, pmod(Ph, Ser, 204))
4799e8ae-d02f-4d82-a655-76fabca7f503	1.0	PubMed	20599907	As we are preparing for this manuscript, Guo et al. report that GSK3beta can mediate phosphorylation of Smad3 at Thr66 to promote Smad3 degradation ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD3, pmod(Ph, Thr, 66))
4799e8ae-d02f-4d82-a655-76fabca7f503	1.0	PubMed	18172167	Mechanistically, axin facilitates gsk3-beta-mediated phosphorylation of smad3 at thr66, which triggers smad3 ubiquitination and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SMAD3, pmod(Ph, Thr, 66))
9cf25418-d159-4af3-b6dd-d2e815deb814	1.0	PubMed	19914168	The Smad linker is also phosphorylated by G1 cyclin dependent kinases during the cell cycle (XREF_BIBR) and by GSK3beta complementing MAPK action (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:SMAD, pmod(Ph, Gly, 1))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	26863455	In subsequent studies, we explored possible upstream factors that mediated the effect of OLA1 on E-cadherin, including Snail, the transcriptional suppressor of E-cadherin, and GSK-3beta, a kinase that phosphorylates Snail and so enables its degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	20166136	Glycogen synthase kinase-3beta (GSK-3beta) phosphorylates Snail and promotes its export from the nucleus and subsequent degradation by the proteosome in the cytosol, while p21 activated kinase (PAK1) can also phosphorylate Snail at a different residue from GSK-3 beta to promote its nuclear localization and, thus, its activity as a transcription factor (XREF_BIBR - XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	25088797	GSK-3beta binds to and phosphorylates Snail to induce its cytoplasmic translocation and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	26336990	Snail is highly unstable and GSK-3beta binds to and phosphorylates Snail at two consensus motifs to dually regulate the function of this protein.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	26336990	Inhibition of GSK-3beta suppresses the phosphorylation of Snail and thus induces the protein stabilization and nuclear localization of Snail, which leads to EMT [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	26336990	Inhibition of GSK-3beta suppressed the phosphorylation of Snail and thus induced the protein stabilization and nuclear localization of Snail, which led to EMT [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	26183398	We thus analyzed the effect of EMT induction on TRPS1 and Cath-D expression in ER + MCF7 cells that were stably transfected with a Snail variant (6SA) that can not be phosphorylated by GSK-3 beta and thus induces EMT [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	25314079	GSK-3beta can phosphorylate Snail and promotes its polyubiquitination and degradation ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	22128911	Glycogen synthase kinase 3beta (GSK-3beta) is known to induce Snail phosphorylation and degradation through the E3 ubiquitin ligase beta-TrCP1 [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	23435375	GSK3-beta phosphorylates Snail and induces its subsequent polyubiquitination and proteasomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	15448698	We show that GSK-3beta binds to and phosphorylates Snail at two consensus motifs to dually regulate the function of this protein.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	19887480	For example, GSK-3beta phosphorylation of the Snail nuclear export signal and destruction box induces its cytoplasmic export and ubiquitin mediated proteasomal degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	27323966	It is known that Snail can be phosphorylated by GSK3beta, a downstream protein of PI3K and AKT pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	19379710	Phosphorylation of Snail by GSK-3beta facilitates its proteasomal degradation [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
e3b5b3fd-b9da-4976-9dc7-841aa29cbb45	1.0	PubMed	24565133	Earlier studies have shown that GSK-3beta (glycogen synthase kinase-3 beta) phosphorylates SNAI1 and promotes its export from the nucleus and subsequent degradation by the proteasome in the cytosol [XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph))
f56a77c5-48a6-42a0-a72a-f4c9e85d0cf9	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 100))
f56a77c5-48a6-42a0-a72a-f4c9e85d0cf9	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 100))
4db53087-2460-4aac-9427-e305638e9659	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 104))
4db53087-2460-4aac-9427-e305638e9659	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 104))
4e262039-89ed-4874-8432-7bc92e1dfe66	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 107))
4e262039-89ed-4874-8432-7bc92e1dfe66	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 107))
d930feda-08c2-4989-bcb4-8937a0d5e14a	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 111))
d930feda-08c2-4989-bcb4-8937a0d5e14a	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 111))
e4a71b46-3809-4908-863c-b957a1d4ef4d	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 115))
e4a71b46-3809-4908-863c-b957a1d4ef4d	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 115))
6051231e-41fe-4234-8fbb-7cde57a2c392	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 119))
6051231e-41fe-4234-8fbb-7cde57a2c392	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 119))
d6451e65-11a8-4773-aace-4c1ee506960d	1.0	PubMed	20305697	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 96))
d6451e65-11a8-4773-aace-4c1ee506960d	1.0	PubMed	15448698	Snail is a well-known zn-finger transcription factor that promotes emt by repressing e-cadherin expression. It is known that snail is phosphorylated by gsk3beta and degraded by beta-trcp-mediated ubiquitination. A variant of snail (snail-6sa), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce emt	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser, 96))
8506e1a1-5399-4477-a507-5c5be158ee27	1.0	PubMed	22276203	For example, the kinase GSK3beta phosphorylates SNAI1 at several serine residues in its NES (nuclear export sequence) and its destruction box leading to SNAI1 nuclear export, ubiquitination and degradation XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ph, Ser))
29c08d0a-ac0f-4e2a-9160-f4fdd4397727	1.0	PubMed	27283392	STUB1 can promote ubiquitination of Slug, a zinc-finger-containing transcriptional repressor only when it is phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
29c08d0a-ac0f-4e2a-9160-f4fdd4397727	1.0	PubMed	23851495	To clarify whether GSK3beta mediates Slug phosphorylation directly, we performed the in vitro kinase assay using recombinant GSK3beta and GST tagged Slug purified from Escherichia coli (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
29c08d0a-ac0f-4e2a-9160-f4fdd4397727	1.0	PubMed	23851495	GSK3beta dose-dependently phosphorylated Slug and the phosphorylation sites were further determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) (XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
29c08d0a-ac0f-4e2a-9160-f4fdd4397727	1.0	PubMed	23851495	We found that phosphorylation on GST-S104A and GST-S100/104A mutants was equivalently reduced while that on GST-S92/96A was obviously retained, indicating that Slug was sequentially phosphorylated by GSK3beta (XREF_FIG, XREF_SUPPLEMENTARY).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
29c08d0a-ac0f-4e2a-9160-f4fdd4397727	1.0	PubMed	23851495	These data suggest that Slug interacts with GSK3beta and is phosphorylated by GSK3beta at four sequential sites.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
29c08d0a-ac0f-4e2a-9160-f4fdd4397727	1.0	PubMed	23851495	Phosphorylation of Slug by GSK3beta promotes CHIP binding and ubiquitin mediated proteolysis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
29c08d0a-ac0f-4e2a-9160-f4fdd4397727	1.0	PubMed	23851495	In summary, the finding that GSK3beta phosphorylates Slug through the CHIP pathway to mediate Slug degradation may offer new therapeutic targets to prevent cancer metastasis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
29c08d0a-ac0f-4e2a-9160-f4fdd4397727	1.0	PubMed	23011797	In the absence of Wnt signaling, Slug is phosphorylated by GSK3beta and subsequently undergoes beta-Trcp1-dependent ubiquitination and proteosomal degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI2, pmod(Ph))
3d8d5640-bf4b-4a58-a1da-d380ebb77255	1.0	PubMed	16174773	Additionally, synphilin-1 S556A mutant, which is less phosphorylated by GSK3beta, formed more inclusion bodies than wild type synphilin-1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCAIP, pmod(Ph), var(p.Ser556Ala))
6db1d244-a3a8-47ea-aaac-739435c76a3c	1.0	PubMed	16174773	We now show that synphilin-1 is phosphorylated by GSK3beta within amino acids 550-659 and that this phosphorylation is significantly decreased by pharmacological inhibition of GSK3beta and suppression of GSK3beta expression by small interfering RNA duplex.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCAIP, pmod(Ph))
6db1d244-a3a8-47ea-aaac-739435c76a3c	1.0	PubMed	16174773	Mutation analysis showed that Ser556 is a major GSK3beta phosphorylation site in synphilin-1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCAIP, pmod(Ph))
6db1d244-a3a8-47ea-aaac-739435c76a3c	1.0	PubMed	16174773	Activation of GSK3beta during endoplasmic reticulum stress and the specific phosphorylation of synphilin-1 by GSK3beta place synphilin-1 as a possible mediator of endoplasmic reticulum stress and proteasomal dysfunction observed in Parkinson disease.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCAIP, pmod(Ph))
6db1d244-a3a8-47ea-aaac-739435c76a3c	1.0	PubMed	25829335	In addition, GSK-3beta also phosphorylates synphilin-1 (alpha-Synuclein-interacting protein) and decreases its ubiquitylation, mediated degradation, therefore it is suggested that this phosphorylation of synphilin-1 and alpha-synuclein or direct activation of intrinsic cascades might be implicated in the GSK-3beta induced toxicity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCAIP, pmod(Ph))
33ff9f76-d7d7-428b-a2fd-da8cc127d39e	1.0	PubMed	16174773	Synphilin-1 s556a mutant, which is less phosphorylated by gsk3beta, formed more inclusion bodies than wild type synphilin-1. Mutation analysis showed that ser556 is a major gsk3beta phosphorylation site in synphilin-1	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCAIP, pmod(Ph, Ser, 556))
9cced6ef-14b0-45ba-ac34-6e0e35e794d6	1.0	PubMed	26461473	Besides, GSK3beta phosphorylates SOX10 at CPD domain and facilitates Fbxw7alpha mediated SOX10 degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX10, pmod(Ph))
9cced6ef-14b0-45ba-ac34-6e0e35e794d6	1.0	PubMed	26461473	This process is promoted by glycogen synthase kinase 3beta (GSK3beta)-mediated phosphorylation of SOX10 at the CPD motif.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX10, pmod(Ph))
719b1df5-eba3-4088-87ca-5e71a1bdb341	1.0	PubMed	27566146	SOX9 is phosphorylated by GSK3beta, facilitating the binding of SOX9 to the F-box protein FBW7alpha, an E3 ligase that functions in the DNA damage response pathway.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX9, pmod(Ph))
719b1df5-eba3-4088-87ca-5e71a1bdb341	1.0	PubMed	27566146	There had been no prior reports that GSK3beta phosphorylates SOX9 or regulates SOX9 stability, but GSK3beta is involved in the regulation of p21 and MYC degradation after UV irradiation (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX9, pmod(Ph))
719b1df5-eba3-4088-87ca-5e71a1bdb341	1.0	PubMed	27566146	Based on our findings that inhibition of GSK3beta prevents DNA damage induced SOX9 degradation, and that FBW7 targets SOX9 for degradation after DNA damage, we reasoned that phosphorylation of SOX9 by GSK3beta is required for FBW7 mediated SOX9 degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX9, pmod(Ph))
719b1df5-eba3-4088-87ca-5e71a1bdb341	1.0	PubMed	27566146	To test if GSK3beta directly phosphorylates SOX9 within the FBW7 consensus binding motif, we performed an in vitro kinase assay using a purified fragment of WT or CPD-mutant SOX9 and recombinant human GSK3.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX9, pmod(Ph))
719b1df5-eba3-4088-87ca-5e71a1bdb341	1.0	PubMed	27566146	Failure of GSK3beta to phosphorylate SOX9 prevents the binding of FBW7 to the consensus CPD site on SOX9, located within the K2 transactivation domain, and prevents the degradation of SOX9 both under normal conditions and after DNA damage.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SOX9, pmod(Ph))
f88edd14-db5d-4d3f-9c21-0478a3df6330	1.0	PubMed	18055457	Astrin acts as a substrate for gsk3beta and is phosphorylated at thr-111, thr-937 ((s/t)p motif) and ser-974/thr-978 ((s/t)xxx(s/t)-p motif;p is a phosphorylatable residue). Inhibition of gsk3beta impairs spindle and kinetochore accumulation of astrin and spindle formation at mitosis, suggesting that astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by gsk3beta	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SPAG5, pmod(Ph, Ser, 974))
0419d970-9334-414f-8900-0ae988b7f308	1.0	PubMed	18055457	Astrin acts as a substrate for gsk3beta and is phosphorylated at thr-111, thr-937 ((s/t)p motif) and ser-974/thr-978 ((s/t)xxx(s/t)-p motif;p is a phosphorylatable residue). Inhibition of gsk3beta impairs spindle and kinetochore accumulation of astrin and spindle formation at mitosis, suggesting that astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by gsk3beta	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SPAG5, pmod(Ph, Thr, 111))
346f740b-3590-4901-9fb8-87b525b7ba9e	1.0	PubMed	18055457	Astrin acts as a substrate for gsk3beta and is phosphorylated at thr-111, thr-937 ((s/t)p motif) and ser-974/thr-978 ((s/t)xxx(s/t)-p motif;p is a phosphorylatable residue). Inhibition of gsk3beta impairs spindle and kinetochore accumulation of astrin and spindle formation at mitosis, suggesting that astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by gsk3beta	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SPAG5, pmod(Ph, Thr, 937))
37d2f9fb-c4ab-410f-9a3f-63b338960b8f	1.0	PubMed	18055457	Astrin acts as a substrate for gsk3beta and is phosphorylated at thr-111, thr-937 ((s/t)p motif) and ser-974/thr-978 ((s/t)xxx(s/t)-p motif;p is a phosphorylatable residue). Inhibition of gsk3beta impairs spindle and kinetochore accumulation of astrin and spindle formation at mitosis, suggesting that astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by gsk3beta	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SPAG5, pmod(Ph, Thr, 978))
8ca74925-a12a-4870-a144-4730a2a27861	1.0	PubMed	5155387	The major nucleoporin p62 can be phosphorylated in vitro by protein kinase A and glycogen synthase kinase (GSK)-3alpha but not by cyclin B/cdc2 or GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SQSTM1, pmod(Ph))
a4370e54-e12b-47c2-86f4-3fb1200b0013	1.0	PubMed	23661004	Activated GSK3beta phosphorylates and activates Src kinase family (SKF) members in the cytosol, allowing their nuclear translocation and subsequent tyrosine phosphorylation of Nrf2 at Tyr568, ultimately resulting in Nrf2 nuclear exclusion and degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SRC, pmod(Ph))
a4370e54-e12b-47c2-86f4-3fb1200b0013	1.0	PubMed	23434765	It is noteworthy that active GSK3beta phosphorylates Src A sub-family members including Fyn that enter in the nucleus leading to phosphorylation of Nrf2Tyr568, nuclear export and degradation of Nrf2 [XREF_BIBR - XREF_BIBR, XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SRC, pmod(Ph))
b68c614e-a9fd-4fb4-97f1-c496c66d9d68	1.0	PubMed	24425205	XREF_BIBR, XREF_BIBR Previous reports have shown that SREBP1 is phosphorylated by glycogen synthase kinase-3 beta (GSK-3beta), which leads to F-box and WD repeat domain-containing7 (FBXW7)-dependent ubiquitination of SREBP1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SREBF1, pmod(Ph))
b684f486-e85f-420a-9741-e72d84135128	1.0	PubMed	19126544	Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SREBF1, pmod(Ph, Ser, 430))
b684f486-e85f-420a-9741-e72d84135128	1.0	PubMed	16825193	The transcription factor SREBP1 is degraded by the ubiquitin-proteasome system following phosphorylation of Thr426 and Ser430 in its phosphodegron. We now demonstrate that the glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of these residues in SREBP1 is enhanced in response to specific DNA binding	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SREBF1, pmod(Ph, Ser, 430))
15904b2c-09e6-4c60-a489-d7dcf5d5b4f4	1.0	PubMed	19126544	Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SREBF1, pmod(Ph, Ser, 434))
6e0e4a28-cef8-4a73-8dbb-2bc5f11bd6fc	1.0	PubMed	16825193	The transcription factor SREBP1 is degraded by the ubiquitin-proteasome system following phosphorylation of Thr426 and Ser430 in its phosphodegron. We now demonstrate that the glycogen synthase kinase (GSK)-3beta-dependent phosphorylation of these residues in SREBP1 is enhanced in response to specific DNA binding	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SREBF1, pmod(Ph, Thr, 426))
6e0e4a28-cef8-4a73-8dbb-2bc5f11bd6fc	1.0	PubMed	19126544	Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SREBF1, pmod(Ph, Thr, 426))
1c9eba65-3ef0-40bc-afb3-1180eeb91071	1.0	PubMed	21333649	GSK-3beta and Dyrk1A phosphorylate SC35 and modulate its function in the alternative splicing of tau exon 10 ([XREF_BIBR] and our unpublished data).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SRSF2, pmod(Ph))
1c9eba65-3ef0-40bc-afb3-1180eeb91071	1.0	PubMed	PMC7062099	Furthermore, immunoprecipitated SC35 is phosphorylated by recombinant GSK-3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SRSF2, pmod(Ph))
1c9eba65-3ef0-40bc-afb3-1180eeb91071	1.0	PubMed	20615469	Direct phosphorylation of SC35 by GSK-3beta was not examined in the present study but has been reported previously ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SRSF2, pmod(Ph))
1c9eba65-3ef0-40bc-afb3-1180eeb91071	1.0	PubMed	20615469	To study the mechanism of this Abeta action, we sought to establish the GSK-3beta-SC35 cascade based on the earlier observations that GSK-3beta is activated by Abeta () and GSK-3beta phosphorylates SC35 ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SRSF2, pmod(Ph))
1c9eba65-3ef0-40bc-afb3-1180eeb91071	1.0	PubMed	20615469	GSK-3beta phosphorylation of SC35 has been shown to alter tau exon 10 splicing ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SRSF2, pmod(Ph))
677acab5-a51b-43e0-9def-9a57c84305ec	1.0	PubMed	21898401	GSK-3beta knockdown blocked the IFN-alpha-induced phosphorylation of extracellular signal regulated kinase (ERK) 1/2 (Thr202 and Tyr204) and signal transducer and transactivator (STAT) 1.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:STAT, pmod(Ph))
2d9f6ec2-4afc-4c64-96f6-08eeb8edae82	1.0	PubMed	22142472	However, when STK38 (K118A) was phosphorylated first with PKA using unlabeled ATP, followed by a separate kinase reaction using GSK-3beta with radiolabeled ATP, the label was incorporated into STK38 (K118A); this demonstrated that GSK-3beta successfully phosphorylated the STK38 (A, lane 3).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:STK38, pmod(Ph))
8c811420-d701-4383-8433-21edc7aff026	1.0	PubMed	22142472	STK38 may be subjected to multiple post-translational modifications in response to HO.Second, we demonstrated that GSK-3beta interacted with STK38 (C and D), that GSK-3beta phosphorylated residues S6 and T7 of STK38 (and did so efficiently following PKA pretreatment), and that mutations at two priming phosphorylation sites (S10 and S11) attenuated the phosphorylation of two other sites S6/T7 by GSK-3 ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:STK38, pmod(Ph, Ser, 6))
615864a1-febe-4445-aa28-96a4e3ca4920	1.0	PubMed	22142472	Together, these results indicated that GSK-3beta phosphorylates STK38 at S6 and T7, and does so efficiently when S10 and S11 of STK38 are prephosphorylated by a priming kinase, such as PKA.To investigate whether GSK-3 regulates STK38 activity, we examined the effects of GSK-3 overexpression on the HO stimulated STK38 activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:STK38, pmod(Ph, Thr, 7))
615864a1-febe-4445-aa28-96a4e3ca4920	1.0	PubMed	22142472	STK38 may be subjected to multiple post-translational modifications in response to HO.Second, we demonstrated that GSK-3beta interacted with STK38 (C and D), that GSK-3beta phosphorylated residues S6 and T7 of STK38 (and did so efficiently following PKA pretreatment), and that mutations at two priming phosphorylation sites (S10 and S11) attenuated the phosphorylation of two other sites S6/T7 by GSK-3 ().	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:STK38, pmod(Ph, Thr, 7))
6674cea4-7bc7-498c-8f51-95e231bb7b47	1.0	PubMed	27283392	Besides, GSK3beta can also phosphorylate the chaperone protein of STUB1, and influence the binding of Hsp70 and Hsp90 to STUB1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:STUB1, pmod(Ph))
dd89d145-2c49-4dab-9857-1584018ccfad	1.0	PubMed	21317289	Here, we report that Sufu is phosphorylated at Ser 342 and Ser 346 by GSK3beta and cAMP dependent protein kinase A (PKA), respectively, and phosphorylation at this dual site stabilizes Sufu against Shh signaling induced degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SUFU, pmod(Ph, Ser, 342))
b90e9e7e-e547-4288-bcda-c1153b80ac2f	1.0	PubMed	21317289	Here, we report that Sufu is phosphorylated at Ser 342 and Ser 346 by GSK3beta and cAMP dependent protein kinase A (PKA), respectively, and phosphorylation at this dual site stabilizes Sufu against Shh signaling induced degradation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SUFU, pmod(Ph, Ser, 346))
de558874-a7f7-4018-a510-3c41f927f396	1.0	PubMed	17908237	Extensive phosphorylation of T4 by GSK3beta resulted in increased GFP intensity.	p(HGNC:GSK3B)	directlyIncreases	a(PUBCHEM:5819, pmod(Ph))
aedaf916-d18f-4ca1-a6db-f16632511832	1.0	PubMed	15546612	GSK-3beta can phosphorylate the ICD TAD in the nucleus; however, little is known of other protein kinase (s) that may contribute to turnover of the Notch ICD in the nucleus.We previously showed that MAM is not only required for Notch transcription but also induces phosphorylation of CBP and p300 and hyperphosphorylation and degradation of the Notch ICD in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF13400, pmod(Ph))
e27b4477-2eba-407b-b106-efe8b71fedce	1.0	PubMed	21145761	GSK3beta failed to cause phosphorylation of TBK1 (S172A) whereas in the same experiments GSK3beta mediated phosphorylation of wild-type TBK1 and a randomized serine mutant, TBK1 (S716A) (C).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TBK1, pmod(Ph), var(p.Ser172Ala))
900009cd-00f5-40a3-a4a8-16f8b80c8a5d	1.0	PubMed	21145761	To determine whether GSK3beta promotes TBK1 autophosphorylation or trans-phosphorylation at Ser172, we transfected 293 cells with Flag tagged wild-type or mutant TBK1, HA tagged wild-type TBK1 and GSK3beta, or control plasmid.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TBK1, pmod(Ph))
c1bcd809-dc7c-4526-8499-452315296b49	1.0	PubMed	21145761	These results suggest that GSK3beta promotes autophosphorylation but not trans-phosphorylation of TBK1 at Ser172.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TBK1, pmod(Ph, Ser, 172))
44f26200-5430-46e0-ab21-ebf658c63573	1.0	PubMed	PMC5927078	Lowered sgg activity decreased TIMELESS phosphorylation, and it was found that GSK-3 beta specifically phosphorylates TIMELESS in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TIMELESS, pmod(Ph))
44f26200-5430-46e0-ab21-ebf658c63573	1.0	PubMed	5927078	Lowered sgg activity decreased TIMELESS phosphorylation, and it was found that GSK-3 beta specifically phosphorylates TIMELESS in vitro.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TIMELESS, pmod(Ph))
f8c048df-c74a-4716-b01c-c3b41dfddc35	1.0	PubMed	19107203	Thus, the phosphorylated LRP6 motif is a much stronger inhibitor of GSK3beta than the phosphorylated N-terminal fragment of GSK3beta (K i ~ 700 microM), which is a known pseudosubstrate inhibitor of GSK3beta XREF_BIBR (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TNF, pmod(Ph))
e6a6644d-6aa3-4237-8e40-1a1f678fe5b7	1.0	PubMed	11483158	Here, we show that GSK3beta, but not GSK3alpha, can phosphorylate serine 33 of p53 in vitro when serine 37 is already phosphorylated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, 33))
e6a6644d-6aa3-4237-8e40-1a1f678fe5b7	1.0	PubMed	11483158	This implies that the phosphorylation of serine 33 of p53 by GSK3beta would be decreased in cells exposed to DNA damage, but elevated in cells growth arrested in Go.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, 33))
e6a6644d-6aa3-4237-8e40-1a1f678fe5b7	1.0	PubMed	11483158	GSK3beta dependent phosphorylation of p53 at serine 33 may be part of other p53-regulatory pathways, such as oncogene activation or apoptosis, which are not directly activated by DNA-damage.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, 33))
e6a6644d-6aa3-4237-8e40-1a1f678fe5b7	1.0	PubMed	11483158	This would be predicted to block phosphorylation of serine 33 of p53 by GSK3beta, decreasing p53 transcriptional activity and therefore reducing the transcription of p53 regulated growth and pro apoptotic proteins.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, 33))
e6a6644d-6aa3-4237-8e40-1a1f678fe5b7	1.0	PubMed	11483158	This study demonstrates that GSK3beta, but not GSK3alpha, can directly phosphorylate serine 33 of p53 when serine 37 of p53 is already phosphorylated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, 33))
67a1a4ed-4de6-4e50-8ebe-e03532fd46f5	1.0	PubMed	11483158	Next, we set out to identify the exact amino-acid (s) within the p53 protein which were phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph))
67a1a4ed-4de6-4e50-8ebe-e03532fd46f5	1.0	PubMed	11483158	Similarly, mutation of serine 37, which abolishes the DNA-PK phosphorylation site, blocks phosphorylation of p53 by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph))
67a1a4ed-4de6-4e50-8ebe-e03532fd46f5	1.0	PubMed	11483158	However, when cells were exposed to Ionizing Radiation, GSK3beta kinase activity was inhibited rather than enhanced, implying decreased GSK3beta dependent phosphorylation of p53 after DNA damage.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph))
67a1a4ed-4de6-4e50-8ebe-e03532fd46f5	1.0	PubMed	11483158	Thus GSK3beta may phosphorylate and activate p53 in vivo.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph))
af3cb6fc-38ae-48bd-8c1f-930c97bcffd4	1.0	PubMed	14744935	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, Ser, 315))
c35e02d1-0d7c-4f99-b53a-03725fbb5f85	1.0	PubMed	11483158	Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, Ser, 33))
d1e6a084-b4bf-4292-89d8-7a193a2e33dc	1.0	PubMed	14744935	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, Ser, 376))
530cb106-17c7-486e-a812-0648062b8fab	1.0	PubMed	11483158	Here, we show that GSK3beta, but not GSK3alpha, can phosphorylate serine 33 of p53 in vitro when serine 37 is already phosphorylated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, Ser))
530cb106-17c7-486e-a812-0648062b8fab	1.0	PubMed	11483158	This implies that the phosphorylation of serine 33 of p53 by GSK3beta would be decreased in cells exposed to DNA damage, but elevated in cells growth arrested in Go.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, Ser))
530cb106-17c7-486e-a812-0648062b8fab	1.0	PubMed	11483158	GSK3beta dependent phosphorylation of p53 at serine 33 may be part of other p53-regulatory pathways, such as oncogene activation or apoptosis, which are not directly activated by DNA-damage.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, Ser))
530cb106-17c7-486e-a812-0648062b8fab	1.0	PubMed	11483158	This would be predicted to block phosphorylation of serine 33 of p53 by GSK3beta, decreasing p53 transcriptional activity and therefore reducing the transcription of p53 regulated growth and pro apoptotic proteins.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, Ser))
530cb106-17c7-486e-a812-0648062b8fab	1.0	PubMed	11483158	This study demonstrates that GSK3beta, but not GSK3alpha, can directly phosphorylate serine 33 of p53 when serine 37 of p53 is already phosphorylated.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TP53, pmod(Ph, Ser))
74c948a0-eace-4034-bb3b-0ee36f43161d	1.0	PubMed	16959574	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TSC2, pmod(Ph, Ser, 1379), pmod(Ph, Ser, 1387))
3319faf9-e5dd-4d63-bd6e-f15e8fd20478	1.0	PubMed	16959574	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TSC2, pmod(Ph, Ser, 1383), pmod(Ph, Ser, 1387))
1a2bd5cf-4040-4052-a57f-cd9c6a5b5723	1.0	PubMed	16959574	Gsk3 inhibits the mtor pathway by phosphorylating tsc2 in a manner dependent on ampk-priming phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TSC2, pmod(Ph))
1a2bd5cf-4040-4052-a57f-cd9c6a5b5723	1.0	PubMed	22556133	This is a mechanism of action analogous to that observed for AMPK mediated mTOR inhibition, and it appears that the phosphorylation of TSC2 by GSK-3beta is dependent on prior phosphorylation of the substrate by AMPK at the S1345 residue (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TSC2, pmod(Ph))
1a2bd5cf-4040-4052-a57f-cd9c6a5b5723	1.0	PubMed	22001647	We speculate that inactivation of GSK3beta by Akt in cells exposed to ROS (XREF_FIG) may impair the GSK3beta dependent phosphorylation of TSC2.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TSC2, pmod(Ph))
1a2bd5cf-4040-4052-a57f-cd9c6a5b5723	1.0	PubMed	21737790	GSK-3beta phosphorylates and activates TSC2, which in turn inhibits mTOR 11, where GSK-3beta is required for mTOR regulation by energy starvation 11.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:TSC2, pmod(Ph))
bd2d6b05-bc04-4557-8312-ef3b9a2663b9	1.0	PubMed	24901984	UBF phosphorylation by GSK3beta promotes UBF degradation by the ubiquitin-proteasome system, concomitantly with differentiation of myeloid cells XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:UBTF, pmod(Ph))
7c224ed3-d18d-45dd-bb64-90ed838fb9c3	1.0	PubMed	18350175	Following the current model, VDAC phosphorylation by GSK3beta prompts HK II detachment from VDAC and induces apoptosis.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VDAC1, pmod(Ph))
7c224ed3-d18d-45dd-bb64-90ed838fb9c3	1.0	PubMed	21179577	GSK-3beta phosphorylates VDAC, causing HKII release from mitochondria in HeLa cells XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VDAC1, pmod(Ph))
7c224ed3-d18d-45dd-bb64-90ed838fb9c3	1.0	PubMed	26294429	Because activated glycogen synthase kinase-3beta (GSK-3beta) phosphorylates VDAC in the mitochondrial outer membrane of HeLa cells, preventing VDAC association with hexokinase (XREF_BIBR), we speculated that in vascular cells, activation of GSK-3beta by transient hyperglycemia could be a critical element in a multicomponent feedback loop that would maintain persistently increased ROS production during subsequent periods of normoglycemia.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VDAC1, pmod(Ph))
7c224ed3-d18d-45dd-bb64-90ed838fb9c3	1.0	PubMed	26294429	To demonstrate that the increased VDAC phosphorylation and subsequent dissociation of HK-II was mediated by GSK-3beta, a cell-permeable peptide inhibitor of the kinase was used.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VDAC1, pmod(Ph))
6439c0d2-07a1-4267-928c-21ff03e691df	1.0	PubMed	26294429	VDAC threonine phosphorylation by GSK-3beta causes detachment of HK-II from VDAC (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VDAC1, pmod(Ph, Thr))
5b8cec0f-fed9-4691-b74c-5d8e94980bc3	1.0	PubMed	16198352	Phosphorylation of cold shock domain and Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:VEGF, pmod(Ph))
6a3fbe3c-619c-4204-b5da-a120fe432652	1.0	PubMed	20637892	Thereby, it was shown that GSK-3beta phosphorylates VHL on serine 68 only when VHL was previously phosphorylated at serine 72.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VHL, pmod(Ph, 68))
2b426fbc-80fa-46b6-9b57-d11d945bf3ce	1.0	PubMed	20637892	Thereby, it was shown that GSK-3beta phosphorylates VHL on serine 68 only when VHL was previously phosphorylated at serine 72.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:VHL, pmod(Ph, Ser))
9356ccbf-817b-48c9-9aec-5ed62fc266d0	1.0	PubMed	22999923	GSK-3beta phosphorylates several components of the Wnt signaling pathway, including beta-catenin.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Wnt, pmod(Ph))
9356ccbf-817b-48c9-9aec-5ed62fc266d0	1.0	PubMed	24451373	Significantly, levels of Aha1, Hsp90 ATPase activity, Akt, and GSK3beta phosphorylation and expression of Wnt target genes were increased in the colons of p53-null as compared with p53 wild type mice.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Wnt, pmod(Ph))
9356ccbf-817b-48c9-9aec-5ed62fc266d0	1.0	PubMed	24561281	In the absence of Wnt ligands, glycogen synthase kinase 3beta (GSK3beta) phosphorylates the canonical Wnt signal mediator beta-catenin, in a destruction complex with axin, casein kinase 1-alpha and adenomatous polyposis coli.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Wnt, pmod(Ph))
d45af3ad-4bb9-4fa4-9973-30d1907fb737	1.0	PubMed	21170361	YBX1 can also be phosphorylated directly via ERK and by GSK3beta XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:YBX1, pmod(Ph))
d45af3ad-4bb9-4fa4-9973-30d1907fb737	1.0	PubMed	16198352	We find both dbpA and dbpB are phosphorylated by ERK2 and GSK3beta in vitro, and the binding of dbpB to single-strand VEGF HRR DNA is regulated by this phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:YBX1, pmod(Ph))
9924bd05-bccd-422f-8658-b7eeaf3f98de	1.0	PubMed	16198352	We find both dbpA and dbpB are phosphorylated by ERK2 and GSK3beta in vitro, and the binding of dbpB to single-strand VEGF HRR DNA is regulated by this phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:YBX3, pmod(Ph))
0801340e-c329-41e0-aa2c-d05e04e25fd1	1.0	PubMed	22514281	These results indicate that phosphorylation of ZAP by GSK3beta modulates ZAP activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ZC3HAV1, pmod(Ph))
0801340e-c329-41e0-aa2c-d05e04e25fd1	1.0	PubMed	26001115	In addition to pADPr [XREF_BIBR], Sun et al. [XREF_BIBR] reported phosphorylation of ZAP by GSK3beta, and Charron et al. [XREF_BIBR] found that S farnesylation at the C-terminus of ZAP-L enhanced its restriction of Sindbis virus.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ZC3HAV1, pmod(Ph))
e1a37f7e-0e94-4ca9-99ac-18af8980df5d	1.0	PubMed	22514281	GSK3beta sequentially phosphorylated Ser 270, Ser 266, Ser 262, and Ser 257 of rat ZAP.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ZC3HAV1, pmod(Ph, Ser, 257))
b80d7d24-e658-4570-9f9e-8af65787e769	1.0	PubMed	22514281	GSK3beta sequentially phosphorylated Ser 270, Ser 266, Ser 262, and Ser 257 of rat ZAP.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ZC3HAV1, pmod(Ph, Ser, 267))
c0ec9b2d-f2b6-4761-8d30-c475fb6f7ea5	1.0	PubMed	22514281	GSK3beta sequentially phosphorylated Ser 270, Ser 266, Ser 262, and Ser 257 of rat ZAP.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:ZC3HAV1, pmod(Ph, Ser, 271))
b4770d08-7196-4b0a-a072-0686400bd335	1.0	PubMed	PMC5881045	This would suggest that the aberrant phosphorylation of tau by GSK3 beta in AD is not due to sequence variations in the gene or its promoter.	p(HGNC:GSK3B)	directlyIncreases	p(UP:B6EMS7, pmod(Ph))
59c3651b-424c-4c47-a8af-f62bdb206477	1.0	PubMed	22832527	GSK3B, in addition to its many functions in cell signaling, also modulates presynaptic vesicle release by phosphorylating the voltage dependent calcium channels and reducing intracellular Ca 2+ levels.	p(HGNC:GSK3B)	directlyIncreases	a(CHEBI:29108, pmod(Ph))
8627c5a9-8d84-4e86-a6e2-90f0ae66667f	1.0	PubMed	19289791	Because CLASP2 contains several potential GSK3beta phosphorylation motifs (XREF_FIG), we used truncated CLASP2 constructs to define the parts of the CLASP molecule phosphorylated by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q4U0G1, pmod(Ph))
8627c5a9-8d84-4e86-a6e2-90f0ae66667f	1.0	PubMed	19289791	CLASP phosphorylation by GSK3beta.	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q4U0G1, pmod(Ph))
8627c5a9-8d84-4e86-a6e2-90f0ae66667f	1.0	PubMed	21782439	In migrating epithelial cells, the localization of CLASP to MT plus ends and MT lattice is spatially regulated by GSK3beta kinase, which phosphorylates CLASP at multiple sites near these domains.	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q4U0G1, pmod(Ph))
af38d138-37b8-4e1e-a758-f36f629e661f	1.0	PubMed	22350414	CK1alpha and GSK-3beta mediate the degradation of beta-catenin molecules by phosphorylating specific amino N terminal residues (Ser45 by CK1alpha, and Thr41, Ser 37, and Ser33 by GSK-3beta in this sequential order), thereby marking the protein and rendering it as recognizable by beta-transducin repeat containing protein (beta-TrCP), a component of the E3 ubiquitin ligase, leading to its degradation by the 26S proteasome complex (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q91854, pmod(Ph))
26289f0e-ec81-4077-895d-5efa35f1bcc4	1.0	PubMed	14636889	In fact, GSK3beta has been identified as tau protein kinase 1 and specifically impairs tau microtubule function by hyperphosphorylating paired helical filament tau.	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF00038, pmod(Ph))
6ee3fe67-3444-4f64-b7e2-3e57a0cd3479	1.0	PubMed	20602916	In addition, phosphorylation of tau or kinesin by GSK-3beta can disrupt microtubules or intracellular protein transport, respectively, which can also contribute to apoptosis.	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF00225, pmod(Ph))
6ee3fe67-3444-4f64-b7e2-3e57a0cd3479	1.0	PubMed	6878925	In vivo, GSK3beta phosphorylates kinesin light chains (KLC) and causes the release of kinesin-I from membrane bound organelles (MBOs), leading to a reduction in kinesin-I driven motility (Morfini et al., 2002b).	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF00225, pmod(Ph))
6ee3fe67-3444-4f64-b7e2-3e57a0cd3479	1.0	PubMed	12805290	In vivo, GSK3beta phosphorylates kinesin light chains (KLC) and causes the release of kinesin-I from membrane bound organelles (MBOs), leading to a reduction in kinesin-I driven motility (Morfini et al., 2002b).	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF00225, pmod(Ph))
6ee3fe67-3444-4f64-b7e2-3e57a0cd3479	1.0	PubMed	20926667	Loss of presenilin in vitro and expression of PS1 familial AD mutations in vivo impair fast axonal transport through dysregulation of GSK3beta, a prominent tau kinase that also phosphorylates the motor protein kinesin to promote its release of cargo vesicles (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF00225, pmod(Ph))
e140face-445b-441f-b1cb-28b05f2c74e2	1.0	PubMed	21343617	We found that during cellular stress, GSK-3beta phosphorylated the mTORC2 component rictor at serine 1235, a modification that interfered with the binding of Akt to mTORC2.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:mTORC2, pmod(Ph, Ser, 1235))
b5144dd0-8d07-48fd-b22c-12e82b9d89e7	1.0	PubMed	19286457	Indeed, GSK3-beta directly stimulates the hyperphosphorylation of the N-Myc protein leading to its subsequent degradation ().	p(HGNC:GSK3B)	directlyIncreases	p(UP:P24793, pmod(Ph))
bbbff9db-6b1d-43de-a353-103240dd5e57	1.0	PubMed	25699712	Thus, it appears that phosphorylation of S300 by GSK3beta and p38 MAPK is involved in opposing processes.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:p38, pmod(Ph, Ser, 300))
706bad76-74f8-4061-be29-4783c5f599ea	1.0	PubMed	25347529	The logic was based on some interesting observations, such as, beta-TrCP committed to degrade the GSK3beta phosphorylated DNA methyl transferase 1 (DNMT1) is prevented by tobacco specific carcinogen NNK induced beta-TrCP translocation to the cytoplasm with the help of heterogeneous nuclear ribonucleoprotein U (hnRNP-U) XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(PFAM:PF02458, pmod(Ph))
755994ed-f24c-4637-bf5b-11a0a553e0f5	1.0	PubMed	15975092	GSK3 (glycogen synthase kinase 3) inhibitors decreased S1 phosphorylation, and siRNA (short interfering RNA) silencing indicated further the involvement of GSK3beta.	p(FPLX:GSK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1190fd61-d018-4a3b-8f6b-564ca66516c9	1.0	PubMed	22905262	beta-catenin degradation is initiated following phosphorylation by glycogen synthase kinase 3 beta (GSK3beta) XREF_BIBR, XREF_BIBR, a kinase counteracting cardiac hypertrophy XREF_BIBR, inhibiting apoptosis and fibrosis and thus increasing cardiac contractility XREF_BIBR, XREF_BIBR.	p(FPLX:GYS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9c273c4a-f4e4-4fd9-8f7f-92b91a10ae43	1.0	PubMed	14561750	Galphaq (Q209L)-AA, a mutant that can not activate PLCbeta, also induced GSK-3beta activation and phosphorylation of Tyr216.	p(FPLX:"G_q_alpha")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9c273c4a-f4e4-4fd9-8f7f-92b91a10ae43	1.0	PubMed	7005206	Galphaq (Q209L)-AA, a mutant that can not activate PLCbeta, also induced GSK-3beta activation and phosphorylation of Tyr216.	p(FPLX:"G_q_alpha")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
3447ac3a-5b24-46a6-9515-0f825f0a9ae9	1.0	PubMed	6619150	Indeed, DIF-3 dephosphorylated Ser (9) and phosphorylated tyrosine on GSK-3beta, and it stimulated GSK-3beta activity in an in vitro kinase assay.	p(UP:Q5SV77)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
13b723dd-6bb1-47c5-8160-06fae3494967	1.0	PubMed	16806170	HB-EGF caused a transient increase in GSK-3alpha and GSK-3beta phosphorylation and a concomitant decrease in their respective kinase activities, suggesting partial initial inactivation, followed by their dephosphorylation and reactivation prior to the onset of cell migration.	p(HGNC:HBEGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cc3f325f-91cd-4990-89a6-2ea4c9eb7a3c	1.0	PubMed	15781227	In HKC, HGF treatment immediately elicited inhibitory phosphorylation of GSK3alpha and GSK3beta (), as probed by a specific antibody against phosphorylated GSK3alpha (S21) and GSK3beta (S9).	p(HGNC:HGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
94b83532-756d-46ba-b2a8-c19b1096ecda	1.0	PubMed	23649588	Examining CD44 regulated signal pathways in these cells we show that CD44, and also RHAMM, act to inhibit phosphorylation of glycogen synthase kinase 3beta (GSK3beta).	p(HGNC:HMMR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
94b83532-756d-46ba-b2a8-c19b1096ecda	1.0	PubMed	26522589	These findings suggest that depleting Bub1 decreased RHAMM expression, which, in turn, enhanced inhibitory phosphorylation of GSK3beta.	p(HGNC:HMMR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f3e73922-3b7e-4a49-8681-836f98bd60db	1.0	PubMed	26197224	C shows that LiCl effectively reduced the phosphorylation of Akt and GSK-3beta as well as HO-1 expression in HT22 cells exposed to ATX.	p(HGNC:HMOX1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
44adc9aa-5709-4e69-99a3-4d2b01027d35	1.0	PubMed	26197224	Using Western blotting, we found that glutamate treatment decreased the phosphorylation of Akt and GSK-3beta (Ser9) as well as HO-1 expression in HT22 cells.	p(HGNC:HMOX1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
16316a2c-688b-4fcd-9c43-053d5d277d99	1.0	PubMed	26972480	In our preliminary studies, we have observed that the overexpression of Flag-hnRNPK dramatically reduced the Ser9 phosphorylation of GSK3beta in several kinds of cells, including H1299 cells (data not shown).	p(HGNC:HNRNPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b5044469-7a7b-44d8-b994-b27629c24f79	1.0	PubMed	26972480	As contrast, when using rottlerin that is an inhibitor against the non classic PKC delta subtype, hnRNPK siRNA still significantly stimulated the Ser9 phosphorylation of GSK3beta (XREF_FIG).	p(HGNC:HNRNPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b5044469-7a7b-44d8-b994-b27629c24f79	1.0	PubMed	26972480	Based on the regulation of GSK3beta Ser9 phosphorylation by hnRNPK as described hereinabove, and the stabilization of c-FLIP by GSK3beta reported by others XREF_BIBR, we searched to know if there was any link between these two events which might be part of the mechanisms involving these three proteins in the resistance of the TRAIL induced apoptosis.	p(HGNC:HNRNPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b5044469-7a7b-44d8-b994-b27629c24f79	1.0	PubMed	26972480	How to cite this article : Gao, X. et al. hnRNPK inhibits GSK3beta Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.	p(HGNC:HNRNPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b5044469-7a7b-44d8-b994-b27629c24f79	1.0	PubMed	26972480	hnRNPK inhibits GSK3beta Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.	p(HGNC:HNRNPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b5044469-7a7b-44d8-b994-b27629c24f79	1.0	PubMed	26972480	This suggests that hnRNPK might inhibit the Ser9 phosphorylation of GSK3beta and thereby regulate the TRAIL induced apoptosis in H1299 cells.	p(HGNC:HNRNPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
3348a801-d0f0-4450-abd8-80331155a2f7	1.0	PubMed	22315307	Moreover, Hsp60 impaired insulin stimulated phosphorylation of GSK3alpha and GSK3beta (XREF_FIG).	p(HGNC:HSPD1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e5760266-d0ab-4c5a-98a1-0cbe8ad22fb7	1.0	PubMed	17016438	Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines.	p(HGNC:IGF1R)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
eb5b5b26-e91f-469e-8f48-7b58c07515ab	1.0	PubMed	26801096	Phosphorylation of GSK3beta, a downstream target of Akt, was stimulated by IGF-1 and GSK690693 inhibited this IGF stimulated phosphorylation.	p(HGNC:IGF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
eb5b5b26-e91f-469e-8f48-7b58c07515ab	1.0	PubMed	19323791	This suggested that the IGF-I signaling pathway in Guam and Kii ALS patients might function to phosphorylate GSK-3beta to protect neurons from ALS degeneration.	p(HGNC:IGF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
eb5b5b26-e91f-469e-8f48-7b58c07515ab	1.0	PubMed	25935310	Whereas IGF-1 induced a significant increase in the phosphorylation of GSK3beta in control cardiomyocytes, overexpression of CHP3-GFP abolished the increased phosphorylation of GSK3beta (A).	p(HGNC:IGF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
eb5b5b26-e91f-469e-8f48-7b58c07515ab	1.0	Other	sparser:Unknown	LY-294002 (100 microM) and wortmannin (150 microM), specific inhibitors of phosphatidylinositol 3'-kinase, attenuated IGF-I-induced GSK-3beta phosphorylation by 67 and 92%, respectively.	p(HGNC:IGF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
eb5b5b26-e91f-469e-8f48-7b58c07515ab	1.0	PubMed	22767591	In these cells, IGF-I stimulation induced tyrosine phosphorylation of IGF-IR and IRS-1/2, but mutated IGF-IR failed to bind PI3K and to induce maximal phosphorylation of GSK3beta and cell proliferation in response to IGF-I.	p(HGNC:IGF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d1fa7f31-ecd2-40e3-8a84-70b8741f50f4	1.0	PubMed	26637371	IGF-I stimulation was reported to induce prolonged phosphorylation of GSK-3beta (at Ser 9) via the PI3K pathway [XREF_BIBR].	p(HGNC:IGF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
c58c5ff4-fd44-41a2-8ca4-e4f3ab8804e4	1.0	PubMed	18675921	Protein analyses revealed IGF2 administration activated phosphorylation of Akt and GSK3beta in the PI3K pathway.	p(HGNC:IGF2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c58c5ff4-fd44-41a2-8ca4-e4f3ab8804e4	1.0	PubMed	18675921	IGF2 driven phosphorylation of Akt protein and GSK3beta protein.	p(HGNC:IGF2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c58c5ff4-fd44-41a2-8ca4-e4f3ab8804e4	1.0	PubMed	18675921	IGF2 driven phosphorylation of Akt and GSK3beta in the PI3K pathway was shown and inhibition of PI3K by LY294002 revealed that upregulation of Aggrecan mRNA and Versican mRNA was mediated by PI3K.	p(HGNC:IGF2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1329ecdc-c1b4-40b3-9339-500d0e7d556a	1.0	PubMed	18443205	Here, we report that IKKbeta silencing prevents the TNF-alpha-mediated increase in GSK3beta phosphorylation; however, the functional consequence requires further investigation.	p(HGNC:IKBKB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1e7ef5c4-6031-4d17-ac5d-6cecc2c73810	1.0	PubMed	27929056	The kinase forms a complex with wild-type NEMO while point mutations of NEMO at the specific serines abrogated GSK-3beta binding and subsequent phosphorylation of NEMO resulting in its destabilization.	p(HGNC:IKBKG, var(p.?))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a93c1985-5fa2-4d19-910e-c4e2eb6846c3	1.0	PubMed	25889792	Imatinib, nilotinib, Akt inhibitor or IL-10 prevent phosphorylation of GSK3beta in moDC.	p(HGNC:IL10)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
64a25bce-a493-45aa-be4b-3d6d31df03b4	1.0	PubMed	21321938	Both IL-18 and WISP1 induced GSK3beta phosphorylation and degradation, beta-catenin nuclear translocation and TCF-LEF activation.	p(HGNC:IL18)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
64a25bce-a493-45aa-be4b-3d6d31df03b4	1.0	PubMed	21321938	IL-18 induces Akt dependent GSK3beta phosphorylation.	p(HGNC:IL18)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
64a25bce-a493-45aa-be4b-3d6d31df03b4	1.0	PubMed	21321938	Together, these results indicate that IL-18 mediates GSK3beta phosphorylation and degradation via PI3K and Akt (XREF_FIG).	p(HGNC:IL18)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0f480aca-7887-4a30-bd15-26b13bd6906c	1.0	PubMed	21321938	IL-18 rapidly induced GSK3beta phosphorylation at Ser9 in the VSMC, an effect that was significantly inhibited by the GSK3beta inhibitor SB 216763 and LiCl (XREF_FIG).	p(HGNC:IL18)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
a2587487-4708-4a4b-a3d4-da7e335b753d	1.0	PubMed	21471285	Linifanib inhibits phosphorylation of AKT, and GSK3beta in Ba/F3 FLT3 ITD mutant cells and IL-3 rescues phosphorylation of GSK3beta.	p(HGNC:IL3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a2587487-4708-4a4b-a3d4-da7e335b753d	1.0	PubMed	21471285	We also hypothesized that since IL-3 rescues the effects of Linifanib induced apoptosis, that apoptosis in ITD mutant cell lines is occurring through the same pathway as IL-3 withdrawal induced apoptosis by inhibiting PI3K activation, reducing AKT phosphorylation, and reducing phosphorylation of GSK3beta.	p(HGNC:IL3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
54278844-9e24-4019-8473-2f4ac305c3fb	1.0	PubMed	14990992	Silencing of endogenous ILKAP by short interfering RNA (siRNA) stimulated GSK3beta phosphorylation at S9, with no effect on PKB S473 phosphorylation.	p(HGNC:ILKAP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
dcdbb175-a200-4dfb-b941-124144d10562	1.0	PubMed	19463178	The over-expression of wt-ILK in a number of cell types can lead to phosphorylation of Akt and GSK3-beta while the active mutant ca-ILK has been shown to constitutively phosphorylate Akt [XREF_BIBR - XREF_BIBR].	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	9736715	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	12629168	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	17485554	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	17490631	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	17182785	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	20827300	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	15207235	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	16799642	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
df2bc094-40ee-49fa-9875-7d64119dda46	1.0	PubMed	17107957	No evidence text.	p(HGNC:ILK, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	6724389	These findings suggest that Ilk regulates actin reorganization in chondrocytes and modulates chondrocyte growth independently of phosphorylation of Pkb and Akt and GSK3-beta.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	22570869	In addition, down-regulation of ILK also could inhibit phosphorylation of Akt and GSK3beta, reduce the expressions of MMP-2 and MMP-9.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	21347395	BEL7402 ILK knockdown stable clones were treated with insulin to stimulate phosphorylation of Akt and its downstream effector GSK3beta.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	23011394	We found that GSK3beta phosphorylation by ILK-1 was higher in cells cultured on LN compared to CIV and FN.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	16357176	Transfection of dominant negative ILK or exposure to an ILK inhibitor suppresses the ET-1-induced phosphorylation of GSK-3beta as well as Snail and beta-catenin protein stability, activity, and invasiveness, indicating that ET-1/ET (A) R induced EMT promoting effects depend on ILK.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	PMC6846931	These findings suggest a novel pathway that makes direct phosphorylation of GSK-3beta by ILK feasible after irradiation.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	6846931	These findings suggest a novel pathway that makes direct phosphorylation of GSK-3beta by ILK feasible after irradiation.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	26531674	ILK shRNA suppressed the phosphorylation of downstream signaling targets Akt and GSk-3beta.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	20978190	TGF-betas also signal ILK, MAPK and PI3K pathway, and activated ILK can directly phosphorylate downstream target GSK-3beta to inactivate (XREF_BIBR).	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	11331582	We propose that ILKAP regulates ILK1 activity, targeting ILK1 signalling of Wnt pathway components via modulation of GSK3beta phosphorylation.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	26547035	GSK-3beta phosphorylation by ILK1 was markedly decreased in NOTCH1-IC-expressing cells (A).	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	26547035	Moreover, expression of NOTCH1-IC remarkably decreased EGF induced stimulation of GSK-3beta phosphorylation by ILK1 (B).	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	26547035	GSK-3beta phosphorylation by ILK1 was upregulated in cells transfected with shRNA.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	19952891	ILK can also phosphorylate and inhibit GSK3beta, leading to the stabilization and translocation of beta-catenin to the nucleus and activation of gene expression (XREF_FIG) [XREF_BIBR].	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	23707970	Our results were in agreement with the previous studies.Furthermore, we demonstrated that down-regulation of ILK also could inhibit phosphorylation of Akt and GSK3beta in tongue cancer cells and.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	20018240	ILK also causes inhibitory phosphorylation of GSK-3beta, a kinase that prevents functional activation of both Snail and LEF-1.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	20018240	Inhibitory phosphorylation of GSK-3beta (by Akt and ILK) is essential for functional activation of NF-kappaB, Snail, and LEF-1 (XREF_BIBR; XREF_BIBR; XREF_BIBR).	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	28097141	In oral squamous cell carcinoma cells, knockdown of ILK inhibited EMT by suppressing the phosphorylation of downstream signaling targets Akt and GSK-3beta [XREF_BIBR].	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	PMC6771184	ILK directly phosphorylates GSK-3beta and inhibits its activity.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	6771184	ILK directly phosphorylates GSK-3beta and inhibits its activity.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	26006229	Activated PI3K stimulates ILK activity, which stimulates the phosphorylation of two downstream targets, AKT and GSK-3beta.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	25738875	Lastly, we found that PARVA forms a complex with SGK1 and ILK to enhance the phosphorylation of ILK, which led to the phosphorylation of Akt and GSK3beta.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7c755c5a-c217-4cca-955e-d67ef980dc9a	1.0	PubMed	25738875	In addition, inhibition of the kinase activity of ILK using the ILK inhibitor T315 [XREF_BIBR] significantly reduced the invasive ability and the extent of GSK3beta phosphorylation in the PARVA overexpressing transfectants in a dose dependent manner (XREF_FIG).	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
325dc514-9909-464e-8bf9-8285bc7471fa	1.0	PubMed	21035499	ILK also directly phosphorylates GSK-3beta at Ser 9, inactivating it and leading to activation of some transcription factors ().	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
325dc514-9909-464e-8bf9-8285bc7471fa	1.0	PubMed	21035499	GSK can also interact with ILK, and ILK can phosphorylate GSK-3beta at Ser 9 in Akt independent way ().	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
325dc514-9909-464e-8bf9-8285bc7471fa	1.0	PubMed	16799642	No evidence text.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
325dc514-9909-464e-8bf9-8285bc7471fa	1.0	PubMed	26547035	These results suggested that NOTCH1-IC regulates ILK1 phosphorylation by interacting with PAK1, but not by direct regulation of PAK1 activation.Previous reports have shown that ILK1 phosphorylates GSK-3beta at Ser9 and that the phosphorylation of GSK3beta inhibits its activity.	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
325dc514-9909-464e-8bf9-8285bc7471fa	1.0	PubMed	27683053	ILK can also directly phosphorylates GSK-3beta at Ser 9, inactivate it, and lead to activation of some transcription factors [XREF_BIBR].	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
325dc514-9909-464e-8bf9-8285bc7471fa	1.0	PubMed	27683053	Akt phosphorylates GSK-3beta at Ser 9, leading to inactivation of its kinase activity, and ILK can phosphorylate GSK-3beta at Ser 9 in Akt independent way [XREF_BIBR].	p(HGNC:ILK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
194e860b-a935-434d-8db5-f6154d9fd7c7	1.0	PubMed	21737790	Ischemia alone significantly reduced S9 phosphorylation of GSK-3beta, but I/R increased S9 phosphorylation of GSK-3beta in the mouse heart (XREF_FIG).	bp(MESH:D011839)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
e204f263-8e24-41ce-a805-c6a30b86ab63	1.0	PubMed	18243662	Given that transcriptional activation of NF-kappaB and the increased phosphorylation of GSK-3beta in response to IR could be detected both in ATM deficient cells and in normal cells (A), their possible association was examined using the PI3K inhibitors, wortmannin and LY294002.	p(HGNC:INSR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e204f263-8e24-41ce-a805-c6a30b86ab63	1.0	PubMed	18243662	Although the data are expressed in fold induction, the level of actual activation was similar in both cell types (data not shown), confirming the suggestion that GSK-3 phosphorylation could be induced independently of ATM, and that transcriptional activation of NF-kappaB by IR could be mediated through GSK-3 phosphorylation even without ATM expression.Given that IR increased the phosphorylation of GSK-3beta and NF-kappaB transcriptional activation as described above, we examined whether another potent DNA damaging agent, camptothecin (CPT), could also induce the similar signaling in both cell types.	p(HGNC:INSR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b98cff08-3a90-4ccf-a000-6d7745229357	1.0	PubMed	6390865	In addition, neuronal cultures generated from ethanol exposed pups had reduced levels of insulin stimulated Akt, GSK-3beta, and BAD phosphorylation, and increased levels of non phosphorylated (activated) GSK-3beta and BAD protein expression.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d4202160-bc1d-478e-b249-628976dbf5b5	1.0	PubMed	18178198	PCOS adipocytes displayed higher tyrosine phosphorylation and lower insulin stimulated serine phosphorylation of GSK3beta, suggesting GSK3beta overactivity.	p(HGNC:INS, pmod(Ph, Tyr))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
599ff689-5cee-4b84-9743-4daa6a18fb4a	1.0	PubMed	26538315	Another recent study showed increased SIRT2 expression in insulin resistant C2C12 skeletal muscle cells and that SIRT2 inhibition, by either pharmacological or genetic means, increased insulin stimulated glucose uptake and improved phosphorylation of Akt and GSK3beta under insulin-resistance conditions, suggesting that SIRT2 may negatively affect skeletal muscle glucose uptake.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph), pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	26402673	Interestingly, the addition of 100 nM insulin for 20 minutes upregulated phosphorylation of Akt and GSK3beta, whereas it downregulated total cellular O-GlcNAc levels and O GlcNAcylation, specifically on PTP1B.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	26402673	We found that a deficiency in PTP1B O GlcNAcylation resulted in an increase in insulin stimulated phosphorylation of Akt and GSK3beta, and hence might reverse the downstream events of insulin signaling.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	26402673	As a phosphatase, PTP1B can inhibit insulin stimulated IR autophosphorylation and phosphorylation of IRS, Akt, and GSK3beta, thereby terminating the insulin signaling.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	18443205	Conversely, TNF-alpha exposure has also been shown to prevent insulin stimulated phosphorylation of GSK3beta in HEPG2 cells (XREF_BIBR).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	22687243	We took the same approach as used for HEK-293FT cells and observed that insulin stimulation for 5-60 min increased phosphorylation of AKT and GSK-3beta markedly (XREF_FIG).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	Other	sparser:Unknown	One pathway inhibits insulin-induced GSK-3beta phosphorylation by blocking insulin activation of Akt.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	Other	sparser:Unknown	Insulin-induced GSK-3beta phosphorylation is mediated by the phosphatidylinositol 3-kinase/Akt signaling pathway.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	Other	sparser:Unknown	Furthermore, insulin-induced GSK-3beta phosphorylation was mediated by both PI 3-kinase-PKB and the TC10-Par6-atypical PKC signaling pathways.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	22315307	Moreover, Hsp60 impaired insulin stimulated phosphorylation of GSK3alpha and GSK3beta (XREF_FIG).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	12504077	PTP1B ASO treatment induced an increase on insulin stimulated GSK3alpha and GSK3beta phosphorylation ().	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	24813896	On the other hand, we have demonstrated that disruption in appl1 gene expression in mice had a marked effect not only on insulin stimulated serine/threonine phosphorylation of Akt and GSK3beta but also on insulin stimulated tyrosine phosphorylation of IRS1/2 in different insulin target tissues such as liver, skeletal muscle, and adipose tissue.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	17335965	In C2C12 cells, however, Par6alpha overexpression inhibited insulin dependent phosphorylation of both GSK3alpha and GSK3beta, and a decreased GSK3alpha and beta phosphorylation leads to a stronger phosphorylation and inhibition of glycogen synthase and glycogen synthesis ().	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	5199268	Similarly, in 3T3-L1 adipocytes, only insulin stimulated phosphorylation of Akt 's endogenous substrate, GSK-3beta.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	15026145	Further, The phosphorylation of GSK-3beta by TNF-alpha and insulin parallels those of PKB-alpha, indicating that downstream effects of TNF-alpha and insulin are mediated through this enzyme.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	12670870	However, insulin or PDGF treatment did not impair phosphorylation of PKB and Akt and GSK-3beta, indicating that the proliferation defect is not due to absent or reduced ILK mediated phosphorylation of these substrates in vivo.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	21460223	Using N2a and primary neuronal cell cultures, we demonstrated that soluble amyloid precursor protein-alpha (sAPPalpha), the predominant APP derived fragment in young PS1xAPP mice, acting through IGF-1 and/or insulin receptors, activated the PI3K and Akt pathway, phosphorylated the GSK-3beta activity, and in consequence, exerted a neuroprotective action.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	26538315	While SIRT2 overexpression in 3T3-L1 preadipocytes and HeLa cells enhanced insulin induced Akt activation and phosphorylation of its downstream targets GSK3beta and p70S6 kinase, pharmacological or genetic SIRT2 inhibition causes the opposite effect.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	24815187	Insulin increased phosphorylation of Akt, GSK3beta and S6RP in E-VSMC, while responses of Tcad +-VSMC were attenuated (A-C).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	18467643	After angiotensin II or TNFalpha treatment, JNK activation was augmented in Nox2 but not Nox4 transfected cells, whereas insulin augmented phosphorylation of p38MAPK, Akt, and GSK3beta specifically in Nox4 overexpressing cells and JNK specifically in Nox2 overexpressing cells.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	26562529	Conversely, the inhibition of the miR-543 up-regulated the insulin stimulated phosphorylation of the Akt and GSK3beta (E and F).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	21435438	studies have demonstrated that homocysteine thiolactone disrupts insulin signaling by inhibiting insulin stimulated phosphatidylinositol 3-kinase activity and phosphorylation of GSK3beta and glycogen synthesis in HTC hepatoma cells.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	6719187	However, insulin or PDGF treatment did not impair phosphorylation of PKB and Akt and GSK-3beta, indicating that the proliferation defect is not due to absent or reduced ILK mediated phosphorylation of these substrates in vivo.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	21464990	Both inhibitors caused a significant reduction in the insulin stimulated phosphorylation of IRS-1, Akt2, and GSK3beta (XREF_FIG).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	21464990	We also found a significant reduction in the insulin stimulated phosphorylation of GSK3beta, a substrate of Akt2, in the mtDNA depleted hepatocytes compared to control hepatocytes (XREF_FIG).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	26700654	As expected insulin stimulated phosphorylation of Akt and GSK3beta and PEDF inhibited these critical nodes with increasing concentration (a).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
775abcef-be13-4d14-af5b-977bdeb7c208	1.0	PubMed	7219296	However, long-term pretreatments of cells with TNF-alpha reduced insulin stimulated phosphorylation of PKB-alpha and GSK-3 beta.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a338895c-a4ed-4035-9d50-d8a3475208ee	1.0	PubMed	19720798	After overnight incubation with chemerin, skeletal muscle cells showed a marked decrease in insulin stimulated Akt phosphorylation at Ser473, GSK3alpha phosphorylation at Ser21, and GSK3beta phosphorylation at Ser9 (XREF_FIG A and B).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 21))
c33c5b22-f7e9-449d-8efe-127d721f212a	1.0	PubMed	18443205	Insulin increased phosphorylation of GSK3beta Ser 9 (XREF_FIG) and AS160 (XREF_FIG) in primary cultures of human skeletal muscle.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
c33c5b22-f7e9-449d-8efe-127d721f212a	1.0	PubMed	19720798	After overnight incubation with chemerin, skeletal muscle cells showed a marked decrease in insulin stimulated Akt phosphorylation at Ser473, GSK3alpha phosphorylation at Ser21, and GSK3beta phosphorylation at Ser9 (XREF_FIG A and B).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
c33c5b22-f7e9-449d-8efe-127d721f212a	1.0	PubMed	4142852	It is known that Ser 9 of GSK-3beta is phosphorylated in response to insulin and that the phosphorylation of this amino acid residue causes inactivation of GSK-3beta.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
c33c5b22-f7e9-449d-8efe-127d721f212a	1.0	PubMed	23605563	Insulin can, in fact, induce GSK3beta (ser9) phosphorylation and inhibition via the activation of the phosphoinositide 3 kinase and protein kinase B pathway (reviewed in [XREF_BIBR]).	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
820c0a9d-f3ec-418c-9b0d-9c358cebcd35	1.0	PubMed	18178198	Alternatively, and in contrast to the controls, GSK3beta serine phosphorylation in response to insulin did not change in PCOS (XREF_FIG), suggestive of resistance to the effect of insulin to serine phosphorylate, and thus downregulate, GSK3beta activity.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
820c0a9d-f3ec-418c-9b0d-9c358cebcd35	1.0	PubMed	15026145	Both TNF-alpha and insulin increased the phosphorylation of Ser residue of GSK-3beta but the phosphorylation was significantly higher in the presence of insulin as compared to TNF-alpha.	p(HGNC:INS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
3636b798-d841-4e4e-b096-247927a1c1a5	1.0	PubMed	25889792	Imatinib, nilotinib, Akt inhibitor or IL-10 prevent phosphorylation of GSK3beta in moDC.	a(PUBCHEM:5291)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
10796d8d-cdbc-48dc-9706-cff57ad26371	1.0	PubMed	15940626	Furthermore, GSK-3beta is also regulated by integrin linked kinase, which can directly phosphorylate GSK-3beta at serine 9 and serine 21 to inhibit its activity.	p(FPLX:Integrins)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 21))
9229cb1f-2b7f-420d-ab3f-7ddc100e5900	1.0	PubMed	15940626	Furthermore, GSK-3beta is also regulated by integrin linked kinase, which can directly phosphorylate GSK-3beta at serine 9 and serine 21 to inhibit its activity.	p(FPLX:Integrins)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
ae50a9d7-cfec-4783-8094-4db5dc2d08df	1.0	PubMed	19190323	XREF_BIBR found that integrin linked kinase modulates prolonged PI3K dependent effects on Wnt signaling by elevating GSK-3beta phosphorylation.	p(FPLX:Integrins)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ae50a9d7-cfec-4783-8094-4db5dc2d08df	1.0	PubMed	22814751	Akt inhibitors and Akt3 knockout also diminished integrin dependent phosphorylation of glycogen synthase kinase-3beta (GSK-3beta).	p(FPLX:Integrins)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ba9e3d79-ab97-4b6c-9e09-1b68fb9b2267	1.0	PubMed	15940626	Furthermore, GSK-3beta is also regulated by integrin linked kinase, which can directly phosphorylate GSK-3beta at serine 9 and serine 21 to inhibit its activity.	p(FPLX:Integrins)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
fe445795-87c0-4f6d-b26f-dbfd74bd3aee	1.0	PubMed	22087308	Under these conditions, the PI3K and Akt pathway downstream of Jak2 is downregulated, thus reducing the inhibitory phosphorylation of GSK3beta.	p(HGNC:JAK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
688cbe3b-d458-41ef-969b-f654c772a10e	1.0	PubMed	21779383	JNK activation induces Dickopff-1 expression that in turn promotes GSK3beta phosphorylation and tau hyperphosphorylation XREF_BIBR, XREF_BIBR.	p(FPLX:JNK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1ddcc20b-8d4d-4711-b08e-57548669e8d4	1.0	PubMed	22039301	Nevertheless, the inability of SCF alone to further enhance the observed constitutive phosphorylation of GSK3beta at Y 216, again suggests that GSK3beta may be constitutively active in the resting state in HuMCs and that this activity can not be further enhanced through KIT activation.	p(HGNC:KITLG)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1ddcc20b-8d4d-4711-b08e-57548669e8d4	1.0	PubMed	22039301	Although it is apparent that SCF can induce the phosphorylation of GSK3beta at the inhibitory site (S 9), this was not associated with a decrease in the phosphorylation of GS at S 641 which we have demonstrated requires the presence of GSK3beta for optimal phosphorylation in mast cells (XREF_BIBR).	p(HGNC:KITLG)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
fe7153c6-5167-403f-aa71-acbb8cf919ad	1.0	PubMed	22039301	To provide further support for this conclusion, we investigated whether inhibitors of known signaling processes downstream of KIT block the constitutive phosphorylation of GS and GSK3beta, including PP2, a Src family tyrosine kinase inhibitor also capable of inhibiting KIT phosphorylation (XREF_BIBR); U71322, a PLCgamma 1 inhibitor {Kuehn, 2008 # 44}; and wortmannin, a selective PI3K inhibitor (XREF_BIBR).	p(HGNC:KIT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8c82c53a-0b95-4ce1-9db4-89ef77c27dff	1.0	PubMed	23383245	Consistent with this, we showed that betaKlotho overexpression reduced the phosphorylation of Akt and subsequent phosphorylation of GSK-3beta, indicating Akt inactivation and GSK-3beta activation respectively.	p(HGNC:KLB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9d35b620-db96-4330-870f-ced0a557b180	1.0	PubMed	26022178	Stimulation of either NKG2D or 2B4 alone induced GSK-3beta phosphorylation at Ser9 largely through the PI3K and Akt- or MEK and ERK dependent pathway, respectively.	p(HGNC:KLRK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
9d35b620-db96-4330-870f-ced0a557b180	1.0	PubMed	26022178	Using a model of NK cell activation through combination of NKG2D and 2B4 that couple to different signaling adaptors, we found that an inhibitory phosphorylation of GSK-3beta at Ser9 was induced in common by the engagement of NKG2D, 2B4, or their combination.	p(HGNC:KLRK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
5d15067d-2be2-468c-8693-fccb516bbde0	1.0	PubMed	25591548	To further verify the inhibitory effect of activated GSK-3beta on tongue cancer, we used the selective GSK-3beta inhibitor kenpaullone (KP) to treat IL-18-transfected CRL1623 cells and found that KP reduced GSK-3beta phosphorylation and its activation, in turn inhibiting the activity of caspase-3 and -7 (XREF_FIG).	a(PUBCHEM:171204)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
beebf820-8a23-41f0-b050-a22035da952b	1.0	PubMed	25733387	The direct interaction of beta-catenin and APC and indirect recruitment of the Axin, GSK3beta, CK1, SCF, beta, and TrCP complex to the IQGAP1 scaffold demonstrate that under steady state, casein kinase 1 (CK1) phosphorylates GSK3beta, which in turn constitutively phosphorylates beta-catenin and directs it for degradation.	p(HGNC:KRT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7459e66b-6193-4a14-9ce6-8e650d686694	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:KRT7)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
64c71cd8-34fc-4a28-92ce-d1962a3d3e15	1.0	PubMed	15940626	We first sought to determine whether K- may phosphorylate and inactivate GSK-3beta.	p(UP:P31282)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c6618278-d023-490a-a0d7-cc7600064f1d	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:LEF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
37a76e77-cd5f-4f99-a208-b2241d675d11	1.0	PubMed	19429119	Leptin or AICAR treatment of these cells significantly increased the levels of GSK-3beta phosphorylation (pSer 9) (lanes 3-4, 6-7) compared to vehicle (lane 2) and untransfected controls (lane 1).	p(HGNC:LEP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
37a76e77-cd5f-4f99-a208-b2241d675d11	1.0	PubMed	19429119	However, both Leptin and AICAR treatments significantly (p < 0.05) blocked these increases (lanes 6-7) presumably by increasing GSK-3beta phosphorylation and thereby leading to its inactivation.	p(HGNC:LEP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
37a76e77-cd5f-4f99-a208-b2241d675d11	1.0	PubMed	22270359	Mechanistically, leptin stimulates phosphorylation of glycogen synthase kinase 3beta (GSK3beta) via Akt activation resulting in a substantial decrease in the formation of the GSK3beta, LKB1, and Axin complex that leads to increased accumulation of beta-catenin.	p(HGNC:LEP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
37a76e77-cd5f-4f99-a208-b2241d675d11	1.0	PubMed	22270359	Leptin treatment also increases Wnt1 expression that contributes to GSK3beta phosphorylation.	p(HGNC:LEP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
37a76e77-cd5f-4f99-a208-b2241d675d11	1.0	PubMed	22270359	Inhibition of Wnt1 abrogates leptin stimulated GSK3beta phosphorylation.	p(HGNC:LEP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
37a76e77-cd5f-4f99-a208-b2241d675d11	1.0	PubMed	22270359	We also discovered that leptin increases the expression of an important modifier of Wnt1 signaling, MTA1, which is integral to leptin mediated regulation of the Wnt and beta-catenin pathway as silencing of MTA1 inhibits leptin induced Wnt1 expression, GSK3beta phosphorylation, and beta-catenin activation.	p(HGNC:LEP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	23103626	Silencing Gal-3 inhibits phosphorylation of Akt and GSK-3beta.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	25622682	We also showed, for the first time, that gal-3 modulated beta-catenin signaling by regulating GSK-3beta phosphorylation and the PI3K and Akt pathway in hBM-MSC-conditioned ALCs.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	25622682	Taken together, these results demonstrated that gal-3 reduced degradation of beta-catenin by promoting phosphorylation of Akt and GSK-3beta.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	21958686	In pancreatic cancer, this is linked to Akt regulation by galectin-3, which in turn modulates GSK-3beta phosphorylation and beta-catenin degradation by suppression of the beta-catenin and Wnt signaling pathway [XREF_BIBR].	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	19818782	It was reported that galectin-3 mediates GSK-3beta phosphorylation by Akt, which also inactivates GSK-3beta.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	19190323	These results suggest that galectin-3 mediates Wnt signaling, at least in part, by regulating GSK-3beta phosphorylation and activity via the PI3K and AKT pathway, and thus the degradation of beta-catenin in colon cancer cells.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	19190323	We have demonstrated, for the first time, that galectin-3 modulates beta-catenin levels and Wnt signaling by regulating GSK-3beta phosphorylation and activity though PI3K and AKT pathway.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	19190323	Our data suggest that reduction in galectin-3 decreases GSK-3beta phosphorylation and increases GSK-3beta activity, which may mediate beta-catenin accumulation and Wnt signaling in colon cancer cells.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	19190323	In the current study, we demonstrated that galectin-3 up-regulates beta-catenin expression and its nuclear accumulation and augments Wnt signaling in human colon cancer cells by regulating GSK-3beta phosphorylation and activity though PI3K and AKT pathway.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	19190323	Down-regulation of galectin-3 decreased AKT phosphorylation, and the PI3K inhibitor LY294002 blocked GSK-3beta phosphorylation and TCF4 transcriptional activity induced by galectin-3 in colon cancer cells.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	19190323	In addition, we have demonstrated for the first time that galectin-3 modulates beta-catenin levels and Wnt signaling by regulating the activity and phosphorylation of GSK-3beta via PI3K and AKT pathway.	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d97a5d9a-5320-4a85-b982-26a5b9927961	1.0	PubMed	24303084	Knockdown of galectin-3 inhibits phosphorylation of GSK-3beta and increases GSK-3beta expression, which leads to beta-catenin phosphorylation and results in the degradation of beta-catenin by the proteasome [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
fa90d036-cd26-4d7a-8e57-0cfcbbea31c7	1.0	PubMed	19190323	In contrast, increased galectin-3 in RKO-gl3 cells led to increased phosphorylation of AKT and GSK-3beta (at serine 9) and an increase in beta-catenin levels (XREF_FIG right panel).	p(HGNC:LGALS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
5ce7939c-7ba5-4696-9a4a-f41150bcaabe	1.0	PubMed	23815230	Western blot analysis showed that LGI3 induced focal adhesion kinase activation, Akt phosphorylation, and glycogen synthase kinase 3beta (GSK3beta) phosphorylation in these cells.	p(HGNC:LGI3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0aa60921-ec73-4ddd-87fa-89b018143bab	1.0	PubMed	25683913	Knockdown of KLF5 did not affect phosphorylation of beta-catenin or GSK-3beta by LPA (B).	p(HGNC:LPA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0aa60921-ec73-4ddd-87fa-89b018143bab	1.0	PubMed	15837931	Moreover, LPA activates the main signaling events in the beta-catenin pathway : phosphorylation of glycogen synthase kinase 3beta (GSK3beta), nuclear translocation of beta-catenin, transcriptional activation of T cell factor (Tcf)/lymphoid-enhancer factor (Lef), and expression of target genes.	p(HGNC:LPA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d269fae9-b999-41fb-8a3e-7a553583abc6	1.0	PubMed	21334395	These findings suggest that an under-expression of AKT1 may play a role in the low LPS induced phosphorylation of GSK3beta in cirrhotic immune cells (C).	a(CHEBI:16412)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d269fae9-b999-41fb-8a3e-7a553583abc6	1.0	PubMed	19646728	GSK3beta, a multifunctional kinase implicated in HIV mediated neuropathogenesis (XREF_BIBR), was phosphorylated (therefore inactivated) by PIC or LPS (pSer9-GSK3beta), while IFNs had minimal effects (XREF_FIG).	a(CHEBI:16412)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d269fae9-b999-41fb-8a3e-7a553583abc6	1.0	PubMed	22547702	LPS phosphorylates GSK3-beta via the PI (XREF_BIBR) K-Akt pathway in macrophages.	a(CHEBI:16412)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d269fae9-b999-41fb-8a3e-7a553583abc6	1.0	PubMed	25829335	Consistently, it has reported that inhibition of S6K in LPS stimulated monocytes decreases GSK-3beta phosphorylation and increases release of proinflammatory cytokines.	a(CHEBI:16412)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d269fae9-b999-41fb-8a3e-7a553583abc6	1.0	PubMed	26157031	LPS drastically increased PIAS1 phosphorylation and GSK3beta binding (XREF_FIG).	a(CHEBI:16412)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
543f0f15-b8bd-4a9c-92a8-f5edcd914ea3	1.0	PubMed	21422248	Compared with nonstimulated cells, LPS induced the phosphorylation of GSK3-beta (S9), and this was accompanied by a reduction in the phosphorylation of the GSK3 specific substrate glycogen synthase (S641) (XREF_FIG).	a(CHEBI:16412)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
543f0f15-b8bd-4a9c-92a8-f5edcd914ea3	1.0	PubMed	22547702	LPS stimulation of BMDMs induced phosphorylation of Akt (Ser 473) and GSK3-beta (Ser 9) at multiple time points (XREF_FIG A).	a(CHEBI:16412)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
74a8dc23-3fe2-4302-8738-296b952337b8	1.0	PubMed	25959626	Upon binding to Wnt ligand, LRP5 and LRP6 inhibit GSK3beta phosphorylation by recruiting Axin to plasma membrane and subsequently facilitate the accumulation of beta-catenin and transcription of downstream target genes ().	p(HGNC:LRP5)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1a44416a-8994-41fb-a230-58687640c1dc	1.0	PubMed	25959626	In addition, LRP5 and LRP6 overexpression phosphorylated GSK3beta at Serine (Ser) 9 residue and inhibited its activity, leading to reduced tau phosphorylation.	p(HGNC:LRP5)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
38cd3c6c-2811-440b-a973-660ce3d18014	1.0	PubMed	25959626	Upon binding to Wnt ligand, LRP5 and LRP6 inhibit GSK3beta phosphorylation by recruiting Axin to plasma membrane and subsequently facilitate the accumulation of beta-catenin and transcription of downstream target genes ().	p(HGNC:LRP6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2b54fe8a-f393-4d55-b87c-6f2b9c63878c	1.0	PubMed	25959626	In addition, LRP5 and LRP6 overexpression phosphorylated GSK3beta at Serine (Ser) 9 residue and inhibited its activity, leading to reduced tau phosphorylation.	p(HGNC:LRP6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
455834aa-89d0-480b-bf5b-2adf6fbc73c4	1.0	PubMed	23910058	Molecularly, LY294002 treatment down-regulated AEG-1 expression, AKT and GSK3beta phosphorylation, and expression of cyclinD1, CDK4, VEGF and Bcl2, but up-regulated Bax and c-Myc expression.	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
455834aa-89d0-480b-bf5b-2adf6fbc73c4	1.0	PubMed	21763505	We found that treatment of LY294002 downregulated the expression of vIL-6 and phosphorylation of PI3K and GSK-3beta (c).	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
455834aa-89d0-480b-bf5b-2adf6fbc73c4	1.0	PubMed	19190323	Down-regulation of galectin-3 decreased AKT phosphorylation, and the PI3K inhibitor LY294002 blocked GSK-3beta phosphorylation and TCF4 transcriptional activity induced by galectin-3 in colon cancer cells.	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
455834aa-89d0-480b-bf5b-2adf6fbc73c4	1.0	PubMed	25003810	Unlike Akt and GSK3beta phosphorylation, which were completely inhibited by LY294002, Smad1 phosphorylation did not respond to LY294002, suggesting that Smad1 is an upstream factor for Snail induced Akt activation (or GSK3beta inactivation).	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
455834aa-89d0-480b-bf5b-2adf6fbc73c4	1.0	PubMed	25596747	The application of the PI3K and Akt inhibitor, LY294002, inhibited the LL-37-induced accumulation of unphosphorylated beta-catenin, as well as the phosphorylation of GSK3beta in SW480 cells.	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
045c5a2b-e92e-4838-8081-325e9789e2d9	1.0	PubMed	17098228	LY294002 also suppressed GSK-3beta phosphorylation at Ser and Tyr residues (A and B).	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
373311e6-0d84-4c73-a984-16650aab0d98	1.0	PubMed	17098228	LY294002 also suppressed GSK-3beta phosphorylation at Ser and Tyr residues (A and B).	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
f42a6d7b-74e1-4153-8b5c-4ea27ecd6f99	1.0	PubMed	23349801	Addition of the PI3K inhibitor LY-294002 with FGF-2 completely inhibited AKT phosphorylation and significantly reduced GSK-3beta phosphorylation (XREF_FIG, XREF_SUPPLEMENTARY).	a(PUBCHEM:3973)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a892da64-8ad5-4576-8c1f-6abb4a57a167	1.0	PubMed	20454507	We determined the concentration of LiCl needed to increase GSK3beta phosphorylation and found that 30 mM was associated with phosphorylation in BxPC3 and Panc1 cells.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a892da64-8ad5-4576-8c1f-6abb4a57a167	1.0	PubMed	20093106	LiCl inhibits GSK3beta phosphorylation, which normally leads to ubiquitination and proteolytic degradation of beta-catenin in the cytosol.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a892da64-8ad5-4576-8c1f-6abb4a57a167	1.0	PubMed	18243662	On the other hand, LiCl promoted the phosphorylation of GSK-3beta, possibly leading to the ATM dependent increase in p53 phosphorylation and subsequent apoptosis of MRC5CV1 cells.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a892da64-8ad5-4576-8c1f-6abb4a57a167	1.0	PubMed	18243662	As shown in A, LiCl significantly increased the phosphorylation of GSK-3beta in both the cells, AT5BIVA and MRC5CV1.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a892da64-8ad5-4576-8c1f-6abb4a57a167	1.0	PubMed	21585337	Lithium chloride (LiCl), a chemical inhibitor of GSK-3beta, increased GSK-3beta phosphorylation in our cultures (XREF_FIG).	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a892da64-8ad5-4576-8c1f-6abb4a57a167	1.0	PubMed	22028766	LiCl has been reported to induce the inhibitory Ser 9 phosphorylation of GSK3beta while having no effect on other protein kinases.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
456b5847-968b-4bcc-8d28-d8c40a82e498	1.0	PubMed	20447425	To this end, we used SB216762, an ATP-competitive inhibitor of GSK3beta activity, and LiCl, which promotes the phosphorylation and inactivation of GSK3beta at Ser 9.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
456b5847-968b-4bcc-8d28-d8c40a82e498	1.0	PubMed	21952626	In the present study, LiCl treatment enhanced GSK3beta Ser9 phosphorylation, increased PARP cleavage and PI labelled apoptosis, thus indicating an anti-apoptotic role for GSK3beta in the colorectal epithelial model systems.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
456b5847-968b-4bcc-8d28-d8c40a82e498	1.0	PubMed	23348690	GSK3beta inhibitor LiCl, which stimulates phosphorylation of GSK3beta (Ser 9), was sufficient to restore the expression of Snail, thus leading to decreased E-cadherin expression in TACC3 depleted U2OS cells ().	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
4e2f40d0-0f85-41a8-a151-ea6534c2414e	1.0	PubMed	6613937	Lithium treatment increased the Ser 9 phosphorylation of GSK3beta both in cells and in mouse brain after chronic administration, but did not alter the phosphorylation of Akt.	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
c5c86a45-c7ae-4b54-a793-b94c72ebc56d	1.0	PubMed	20708687	Lithium enhanced serine phosphorylation of GSK-3beta (B) as previously described (), thus verifying the effect of lithium on GSK-3.	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
77ff6ccd-2f8c-4a64-b4b2-51b2c4aa6adf	1.0	PubMed	21585337	Lithium chloride (LiCl), a chemical inhibitor of GSK-3beta, increased GSK-3beta phosphorylation in our cultures (XREF_FIG).	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b71830d4-9066-4020-87d1-b88e72088a96	1.0	PubMed	15020233	These results raised the possibility that MEK1/2 phosphorylate the tyrosine residues of GSK-3alpha/beta.We then examined whether MEK1 is able to directly phosphorylate GSK-3beta by an in vitro kinase assay in a cell-free system.	p(HGNC:MAP2K1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b71830d4-9066-4020-87d1-b88e72088a96	1.0	PubMed	23208494	MEK1 and RSK2 failed to augment the half-life of GLI2 lacking GSK-3beta phosphorylation sites, indicating that MEK-RSK stabilizes GLI2 by controlling targeting GSK-3beta-mediated phosphorylation and ubiquitination of GLI2.	p(HGNC:MAP2K1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
63fcf589-38ea-4d89-a87b-d30232bc878a	1.0	PubMed	15020233	In vitro kinase assay was carried out using a recombinant human active mek1 and we found that gsk-3beta was phosphorylated on tyr(216) by this kinase in a dose- and time-dependent manner. Further, the pretreatment of fibroblasts with u0126 inhibited serum-induced nuclear translocation of gsk-3beta. These results suggested that mek1/2 induces tyrosine phosphorylation of gsk-3beta and this cellular event might induce nuclear translocation of gsk-3beta.	p(HGNC:MAP2K1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
0082b76c-f9ee-42be-971c-9f6a50abeea1	1.0	PubMed	15020233	Western blot analysis using an anti-phosphotyrosine antibody PY-20 () and an anti-phospho-Tyr-GSK-3alpha and beta () showed that GSK-3beta was phosphorylated on tyrosine by the active MEK1 in a dose dependent manner.	p(HGNC:MAP2K1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
2a99223d-0931-4f51-b9c9-7370ff44d300	1.0	PubMed	PMC3741895	MAPKAP kinase-1 and p70S6K phosphorylated the same tryptic peptide on GSK3 beta, and the site of phosphorylation was identified as the serine located nine residues from the N-terminus of the protein.	p(HGNC:MAP2K4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7486033f-ccba-41f6-9642-1b25fd4b6bca	1.0	PubMed	16914735	Gckr can phosphorylate an n-terminal recombinant fusion protein of gsk3_ and enhance the in vivo phosphorylation of gsk3_ on serine 9reduction of gckr expression inhibits wnt3a-induced phosphorylation of gsk3_ at serine 9 and decreases the accumulation of cytosolic _-catenin.	p(HGNC:MAP4K5)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
235bd710-8b34-4fb0-9ebb-0fcb7cea0cf9	1.0	PubMed	18451303	Here, we show that p38 mitogen-activated protein kinase (mapk) also inactivates gsk3beta by direct phosphorylation at its c terminus, and this inactivation can lead to an accumulation of beta-catenin.	p(HGNC:MAPK14)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 389))
235bd710-8b34-4fb0-9ebb-0fcb7cea0cf9	1.0	PubMed	17726008	However p38alfa also inactivates gsk3b by direct phosphorilation of the c-terminal residue ser389. this non-canonicl p38 mapk-dependent phosphorilation of gsk3b seems to occur primarily in the brain and thymocytes.	p(HGNC:MAPK14)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 389))
868b21c7-58de-4d4e-a8e2-2e0f587db1db	1.0	PubMed	18045539	In vitro phosphorylations were performed in two stages, and it was found that gsk3b caused the incorporation of [g-32p]atp by smad1 linker protein, but only after prephosphorylation by erk/mapk	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
868b21c7-58de-4d4e-a8e2-2e0f587db1db	1.0	PubMed	16039586	Reaction products were resolved by SDS-PAGE, and P labeled proteins were visualized by autoradiography.Mass spectral analysis of the in vitro phosphorylated GSK-3beta by Erk2 was performed as described ().	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b8d57b0f-020f-4032-8d97-982fa73148b8	1.0	PubMed	16039586	Erk, which is activated by hbx, associates with gsk-3beta through a docking motif ((291)fkfp) of gsk-3beta and phosphorylates gsk-3beta at the (43)thr residue, which primes gsk-3beta for its subsequent phosphorylation at ser9 by p90rsk, resulting in inactivation of gsk-3beta and upregulation of beta-catenin.	p(HGNC:MAPK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr, 43))
98e0cfd8-bdf1-4541-aad8-351612575767	1.0	PubMed	16039586	Erk, which is activated by hbx, associates with gsk-3beta through a docking motif ((291)fkfp) of gsk-3beta and phosphorylates gsk-3beta at the (43)thr residue, which primes gsk-3beta for its subsequent phosphorylation at ser9 by p90rsk, resulting in inactivation of gsk-3beta and upregulation of beta-catenin.	p(HGNC:MAPK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr, 43))
b03dde6b-f45a-491e-b17f-79adc0bd4f9f	1.0	PubMed	18782353	Pre-treatment of cells with pharmacologic mitogen activated protein kinase kinase (MEK) inhibitor also blocked the phosphorylation of GSK3beta, suggesting that Erk is involved in the regulation of H. pylori induced GSK3beta phosphorylation and that Erk is located upstream of GSK3 or influencing H. pylori induced GSK3 inactivation.	p(FPLX:MAPK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
11a2d3a7-4441-455f-bff0-2cea70fb4bb8	1.0	PubMed	11959122	Modelling Alzheimer specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
11a2d3a7-4441-455f-bff0-2cea70fb4bb8	1.0	PubMed	6691199	Tau phosphorylation and nuclear translocation of NF-kappaB and GSK-3beta were also observed.	p(HGNC:MAPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4a3bd911-f5b6-4199-bab2-2e02fac9af47	1.0	PubMed	25390651	Activation of the mK ATP channel induced inhibitory phosphorylation of GSK-3beta and suppressed ROS production, LDH release and apoptosis after AA washout.	p(HGNC:MDK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6717cd35-85f4-4e9c-a6e3-80f588569f11	1.0	PubMed	18782353	Pre-treatment of cells with pharmacologic mitogen activated protein kinase kinase (MEK) inhibitor also blocked the phosphorylation of GSK3beta, suggesting that Erk is involved in the regulation of H. pylori induced GSK3beta phosphorylation and that Erk is located upstream of GSK3 or influencing H. pylori induced GSK3 inactivation.	p(FPLX:MEK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6717cd35-85f4-4e9c-a6e3-80f588569f11	1.0	PubMed	PMC7222190	These results suggested that MEK1/2 induces tyrosine phosphorylation of GSK-3beta and this cellular event might induce nuclear translocation of GSK-3beta.	p(FPLX:MEK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6717cd35-85f4-4e9c-a6e3-80f588569f11	1.0	PubMed	7222190	This is the first report to suggest that MEK1/2 phosphorylates not only ERK1/2 but also GSK-3beta.	p(FPLX:MEK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6717cd35-85f4-4e9c-a6e3-80f588569f11	1.0	PubMed	15020233	If MEK1/2 could phosphorylate GSK-3beta, GSK-3beta molecules should be physically associated with MEK1/2.	p(FPLX:MEK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c9a7b202-e1c6-4300-918c-e3127e6ee425	1.0	PubMed	7222190	These results suggested that MEK1/2 induces tyrosine phosphorylation of GSK-3beta and this cellular event might induce nuclear translocation of GSK-3beta.	p(FPLX:MEK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
c9a7b202-e1c6-4300-918c-e3127e6ee425	1.0	PubMed	15020233	Although we could not determine the functional role of Tyr phosphorylation of GSK-3beta induced by MEK1/2, we hypothesize that the phosphorylation of GSK-3beta might play an important role to degrade cyclin D1 to promote cell cycle progression.In summary, our results suggested that MEK1/2 induces Tyr phosphorylation on GSK-3beta and triggers GSK-3beta nuclear translocation.	p(FPLX:MEK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
a46fd5ce-74d8-414f-8e82-cb92f0554eb5	1.0	PubMed	26844702	Reduction of c-Met by miR-433 suppressed the activating phosphorylation of AKT and the inhibitory phosphorylation of GSK-3beta, leading to the nuclear accumulation of Snail and increased expression of E-cadherin.	p(HGNC:MET)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
92947a30-3761-4ffb-aace-4a5ddf1881c5	1.0	PubMed	22879939	Concomitant with Akt phosphorylation, TGFbeta increased phosphorylation of GSK3beta, which was prevented by expression of miR-21 Sponge (XREF_FIG and XREF_SUPPLEMENTARY).	p(HGNC:MIR21)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6462b1b2-66b9-4d4e-b4c4-69c4b7f1fa02	1.0	PubMed	24899689	In the border zone, MI induced maximal GSK-3beta phosphorylation at day 3 post-MI, which slowly declined at later time points (day 7 and day 21) (XREF_FIG).	a(PUBCHEM:892)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
37ba03b0-a8c9-476c-99d3-45b289e6bccc	1.0	PubMed	24981175	The allosteric Akt inhibitor MK2206 reduced Akt, GSK-3beta, S6 kinase, and 4E-BP1 phosphorylation by ~ 80% and purine synthesis by 73% in cells expressing endogenous Akt (XREF_FIG, XREF_SUPPLEMENTARY) (XREF_BIBR).	a(PUBCHEM:24964624)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
65d5f277-9dcb-4e7e-a2fe-7b25943f73d0	1.0	PubMed	25390651	Phosphorylation of GSK-3beta in mitochondria by nicorandil was inhibited by MPG (XREF_FIG), indicating that ROS generated by mK ATP channel activation XREF_BIBR, XREF_BIBR mediated GSK-3beta phosphorylation.	p(HGNC:MPG)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8fab91c6-eb0f-4ae4-947f-1ecc0064b8c9	1.0	PubMed	22687243	As expected, depletion of B-27 down-regulated phosphorylation of AKT and GSK-3beta, whereas insulin treatment activated the phosphorylation dramatically (XREF_FIG).	p(HGNC:MRAP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
3e39365b-ab36-441e-9f58-82c6efc40d71	1.0	PubMed	22768080	MTDH overexpression promotes phosphorylation of Akt and GSK3beta XREF_BIBR, and affects many additional Akt downstream genes that are crucial for cellular proliferation, survival and apoptosis.	p(HGNC:MTDH)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d006ee0d-5f60-4131-8613-0f0a074c0c81	1.0	PubMed	25880337	We further investigated that AEG-1 could activate Wnt and beta-catenin signaling by inducing GSK-3beta (glycogensynthasekinase 3beta) phosphorylation via CKIdelta (casein kinase Idelta), consequently enhancing EMT status.	p(HGNC:MTDH)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8d09710f-1bf8-42b2-ab08-f816e5205eb9	1.0	PubMed	25791428	Interestingly overexpression of mTor in SH-SY-5Y cell has been previously shown by us to suppress PP2A activity, the main tau phosphatase with concomitant increase in S6K phosphorylation at Thr 389 site and increase in GSK-3beta phosphorylation at Ser9 site, contributing to increased tau phosphorylation at certain sites.	p(HGNC:MTOR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
2a244802-231b-4a8c-9a17-b2d89e68d1a7	1.0	PubMed	23525311	The upregulation of beta-catenin observed in our study via gene and protein expression analyses may also have been influenced by the oncoprotein MUC1, which interacts directly with beta-catenin to block GSK3beta mediated phosphorylation and consequent beta-catenin degradation (XREF_BIBR).	p(HGNC:MUC1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9e085d1b-3269-4edb-b636-e704c25de3f1	1.0	PubMed	24391509	NCYM promoted phosphorylation of GSK3beta at serine 9 possibly via the activation of mTOR-S6K signaling, that might have led to the constitutive inactivation of GSK3beta in vivo.	p(HGNC:MYCNOS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
60214fe6-d450-4823-a63c-c3085e1efe23	1.0	PubMed	24391509	To investigate the mechanism by which NCYM promotes the phosphorylation of GSK3beta, we analyzed the phosphorylation status of the known upstream kinases for GSK3beta, AKT XREF_BIBR and S6K XREF_BIBR.	p(HGNC:MYCNOS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
60214fe6-d450-4823-a63c-c3085e1efe23	1.0	PubMed	24391509	These results suggest that NCYM promotes the phosphorylation of GSK3beta via the activation of mTOR-S6K signaling.	p(HGNC:MYCNOS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
592f92e0-df69-4f32-b261-1bb46ecb6edf	1.0	PubMed	24391509	NCYM promoted phosphorylation of GSK3beta at serine 9 possibly via the activation of mTOR-S6K signaling, that might have led to the constitutive inactivation of GSK3beta in vivo.	p(HGNC:MYCNOS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
2a21ab87-b24c-4f65-8b3b-9babd5f395fc	1.0	PubMed	24603331	As shown in XREF_FIG, phosphorylation of GSK-3beta was notably enhanced by MyD88 overexpression and dramatically decreased by MyD88 knockdown in hepatoma cells.	p(HGNC:MYD88)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
47fe9283-54c2-4f8a-822e-153ae8075135	1.0	PubMed	24603331	Suppression of Akt activation by DN-Akt remarkably attenuated MyD88 elicited GSK-3beta phosphorylation and Snail expression in hepatoma cells (XREF_FIG).	p(HGNC:MYD88)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b40634df-19e2-4208-ad73-86f92051860f	1.0	PubMed	21329734	In addition, visfatin time- and dose-dependently increased mTOR phosphorylation at Ser 2448 and GSK3beta phosphorylation at Ser 9, thereby activating mTOR and deactivating GSK3beta ().	p(HGNC:NAMPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b40634df-19e2-4208-ad73-86f92051860f	1.0	PubMed	21329734	Because we observed that visfatin increases the phosphorylation of GSK3beta at Ser 9 residue (), thereby inactivating it, and p70S6K has been reported to regulate GSK3beta phosphorylation, we investigated whether the mTOR signaling pathway is involved in visfatin induced phosphorylation of GSK3beta.	p(HGNC:NAMPT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
e564725b-b56e-4fdb-93ee-14492037b535	1.0	PubMed	25398386	Using the human hepatocellular carcinoma cell line HepG2, we also showed that Nck1 depletion by siRNA promotes insulin signaling, as represented by increased levels of pY IRS-1, Akt phosphorylation on Ser 473, GSK3beta phosphorylation on Ser 9 and glycogen synthesis in response to insulin [XREF_BIBR].	p(HGNC:NCK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
fcd4904f-f768-4f61-9877-d06053b58172	1.0	PubMed	22174377	A SNP in steroid receptor coactivator-1 disrupts a GSK3beta phosphorylation site and is associated with altered tamoxifen response in bone.	p(HGNC:NCOA1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
25b7d3be-fb19-4372-b26e-cb37bd7dc244	1.0	PubMed	26418878	Using both HCT116 and HT29 cells, NDRG1 over-expression significantly (p < 0.001) increased the ratio of GSK3beta phosphorylation at Ser9 to total GSK3beta.	p(HGNC:NDRG1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
50841b2d-3dc9-4edd-b4c3-01d5a1d9f192	1.0	PubMed	26418878	These observations suggest that NDRG1 can promote GSK3beta phosphorylation at Ser9, leading to inhibition of beta-catenin phosphorylation at Ser33/37, Thr4.	p(HGNC:NDRG1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
3a4859d9-ba02-4cc2-b087-65f74c9eeab6	1.0	PubMed	23068607	Intracellular coexpression showed that NDRG2 and PRA1 synergistically downregulate T-cell factor (TCF) promoter activity and GSK3beta phosphorylation.	p(HGNC:NDRG2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
3a4859d9-ba02-4cc2-b087-65f74c9eeab6	1.0	PubMed	19237607	Our data show that NDRG2 introduction into SW620 cells induces a decrease in GSK-3beta phosphorylation, which increases its kinase activity (XREF_FIG) and subsequently induces beta-catenin downregulation (XREF_FIG and XREF_FIG).	p(HGNC:NDRG2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
3a4859d9-ba02-4cc2-b087-65f74c9eeab6	1.0	PubMed	21247902	These results showed that NDRG2 diminishes the phosphorylation of GSK-3beta, which enhances its kinase activity, and subsequently down-regulates beta-catenin in SW620 cells.	p(HGNC:NDRG2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ad034551-9638-4fd8-a614-df667cb72ff0	1.0	PubMed	21270272	The in vitro finding was further supported by in vivo results showing that diabetes inhibits cardiac Akt and GSK-3beta phosphorylation, effects that were prevented by enhanced expression of Nrf2 with Dh404 (XREF_FIG).	p(HGNC:NFE2L2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c9e13ef6-1f8e-4683-bab5-c6fbbc1faf45	1.0	PubMed	PMC7055472	Chick ciliary ganglion neurons in culture lack TrkA receptors but express p75NTR and also fail to show NGF-dependent GSK3beta phosphorylation of MAP1B, whereas in rat superior cervical ganglion neurons in culture, NGF activation of TrkA receptors elicits GSK3beta phosphorylation of MAP1B. Finally, inhibition of TrkA receptor tyrosine kinase activity in PC12 cells and superior cervical ganglion neurons with K252a potently and dose-dependently inhibits neurite elongation while concomitantly blocking GSK3beta phosphorylation of MAP1B. These results suggest that the activation of GSK3beta by NGF is mediated through the TrkA tyrosine kinase receptor and not through p75NTR receptors.	p(HGNC:NGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
aa7816e6-bb39-4867-a5e2-98cbc15c0ca9	1.0	PubMed	25062958	25 We here show that activation of eNOS or exogenous application of spermine NONOate, increases phosphorylation of GSK-3beta and that this is attenuated following inhibition of sGC or PKG.	a(PUBCHEM:8158)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
439058aa-0ac1-488b-9d0c-58ac7d17cd79	1.0	PubMed	25062958	25 We here show that activation of eNOS or exogenous application of spermine NONOate, increases phosphorylation of GSK-3beta and that this is attenuated following inhibition of sGC or PKG.	p(HGNC:NOS3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ed6f3e8c-bdc9-4f9f-a4e3-93fecd9ebdbc	1.0	PubMed	26547035	We observed that DAPT induced NOTCH1 inhibition upregulated ILK1 activation and increased GSK-3beta phosphorylation by ILK1 (C).	p(HGNC:NOTCH1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
af0ec382-ac94-4baf-a1e2-744e07de4901	1.0	PubMed	23538444	To examine whether or not Ntn-1 has a role in the regulation of Akt related glycogen synthase kinase-3beta (GSK-3beta) phosphorylation and heat shock factor-1 (HSF-1) expression, we assessed whether Ntn-1 induces GSK-3beta phosphorylation and HSF-1 expression.	p(HGNC:NTN1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
af0ec382-ac94-4baf-a1e2-744e07de4901	1.0	PubMed	23538444	As shown in XREF_FIG, Ntn-1 reversed the hypoxia induced decrease of GSK-3beta phosphorylation, which was blocked by Akt inhibitor.	p(HGNC:NTN1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1617ddbd-7a8a-4199-852f-00160e494b60	1.0	PubMed	25210182	Finally, chemical inhibition of TrkB signaling increases apoptosis in HTLV-1-infected T cells and reduces phosphorylation of glycogen synthase kinase 3beta (GSK-3beta), a downstream target in the signaling pathway.	p(HGNC:NTRK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f35a45a1-adee-45c0-a6ba-c96c409d13a8	1.0	PubMed	24810113	Moreover, another in vitro studies [XREF_BIBR] showed that IGF-1R inhibitor (NVP-AEW541) in BsB8 cells significantly downregulated GSK3b mediated phosphorylation and N-Myc to induce a G1-phase arrest.	a(PUBCHEM:11476171)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
136004f5-fcc3-48f6-bc22-64090f6ad81b	1.0	PubMed	25219467	As expected, OA treatment increased GSK-3beta phosphorylation at Ser9 (B) and upregulated DM-PP2Ac as well (C).	a(CHEBI:44658)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
2d7896d3-0427-402a-9733-6cc211ff5dde	1.0	PubMed	26686692	MbetaCD and Cav-1 siRNA knockdown increased OM induced AMPK, Akt, GSK3beta, and CREB phosphorylation, which were reversed by Ara-A, a specific AMPK inhibitor.	p(HGNC:OCM)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a364f13a-5be0-40bd-b840-932c03f2d01e	1.0	PubMed	22687243	Knockdown of OGT significantly decreased phosphorylation of GSK-3beta at Ser9 when the cells were cultured under both media and with or without insulin stimulation.	p(HGNC:OGT)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
442bf889-0110-4729-bf62-da5fcbc3918f	1.0	PubMed	19701245	Coculture of tumor cells with THP1 macrophages, like treatment with IL-1beta, resulted in phosphorylation of GSK3beta and treatment with 1,25 (OH) 2 D 3 prevented THP-1 mediated phosphorylation of GSK3beta and induction of c-myc (XREF_FIG, right panel).	a(PUBCHEM:961)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1ffb6ab4-94fc-4d6e-881b-9e0d60c449ad	1.0	PubMed	22814751	P2Y12 -/- mouse platelets treated with A3P5P further inhibited phosphorylation of Akt, as well as GSK-3beta (XREF_FIG).	p(HGNC:P2RY12)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
61e71c37-2015-4fc8-ad22-9d9d37fad7b3	1.0	PubMed	16039586	Another important finding is identification of a mechanism to elucidate accurately how the Erk and p90RSK pathway phosphorylates and inactivates GSK-3beta.	p(FPLX:P90RSK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c57fc044-48d2-44bf-ab07-99e21693423a	1.0	PubMed	16039586	On one hand, Erk phosphorylates and activates p90RSK, and on the other hand, Erk serves as an adaptor and priming kinase through binding to the DEF domain of GSK-3beta and phosphorylating GSK-3beta at the T residue, to facilitate phosphorylation of GSK-3beta by p90RSK on Ser9, which leads to the inactivation of GSK-3beta.	p(FPLX:P90RSK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
445feccc-fb7a-4d9b-86d8-6e4005304915	1.0	PubMed	PMC7005206	Recombinant Csk phosphorylated and activated GSK-3beta in vitro, and GSK-3beta coprecipitated with Csk from cell lysates.	p(HGNC:PAG1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
dc7c46db-5773-40de-b194-038f4384fae8	1.0	PubMed	25738875	PARVA promotes invasiveness by phosphorylating ILK and GSK3beta.	p(HGNC:PARVA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cbe43f01-fd32-473f-85e8-a5d568f27420	1.0	PubMed	23853095	In vitro, PASK directly phosphorylates GSK3beta on its inactivating phosphorylation site Ser (9).	p(HGNC:PASK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
cbe43f01-fd32-473f-85e8-a5d568f27420	1.0	PubMed	23853095	We conclude that PASK phosphorylates and inactivates GSK3beta, thereby preventing PDX-1 serine phosphorylation and alleviating GSK3beta mediated PDX-1 protein degradation in pancreatic beta-cells.	p(HGNC:PASK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
d90b8027-419c-441c-a89a-24fce3ef6153	1.0	PubMed	19754670	These results show that PAF phosphorylates GSK-3beta at serine 9 in monocytes confirming that AKT-GSK-3beta axis is a critical intermediary pathway.	p(HGNC:PCLAF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
f15329f5-abc8-425e-8404-43b4cd8231be	1.0	PubMed	19754670	These results show that PAF phosphorylates GSK-3beta at serine 9 in monocytes confirming that AKT-GSK-3beta axis is a critical intermediary pathway.	p(HGNC:PCLAF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
4fd5f1ae-95d5-4932-8509-30ff2526d719	1.0	PubMed	21957254	In OPCs, PDGF stimulated phosphorylation of GSK3beta and the Wnt co-receptor LRP6, and enhanced beta-catenin-dependent gene expression.	p(FPLX:PDGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4fd5f1ae-95d5-4932-8509-30ff2526d719	1.0	PubMed	12670870	However, insulin or PDGF treatment did not impair phosphorylation of PKB and Akt and GSK-3beta, indicating that the proliferation defect is not due to absent or reduced ILK mediated phosphorylation of these substrates in vivo.	p(FPLX:PDGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
368b5027-f32d-476b-91ab-1e758baf50bf	1.0	PubMed	21957254	It is believed that inhibition of GSK3b by LRP6 occurs independently of P-Ser9 (XREF_BIBR), so that PDGF likely stimulates GSK3b Ser9 phosphorylation in OPCs through a different pathway.	p(FPLX:PDGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
368b5027-f32d-476b-91ab-1e758baf50bf	1.0	PubMed	21957254	Taken together, these observations indicate that PDGF stimulates the phosphorylation of LRP6 through MEK activation, and GSK3beta phosphorylation at Ser9 likely through Akt activation, both of which lead to beta-catenin accumulation and catenin associated transcriptional response.	p(FPLX:PDGF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
c2a1f390-bc47-407d-9643-4852de908fa9	1.0	PubMed	23077641	In cells pretreated with the inhibitor of PI3 kinase, PDGF-CC failed to induce phosphorylation of GSK3beta at serine 9 (XREF_FIG), thereby suggesting that PI3K and Akt pathway was up-stream of GSK3beta.	p(FPLX:"PDGF_CC")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
b96054fd-cc7d-4da0-a62e-35b2efe9fd53	1.0	PubMed	23077641	In cells pretreated with the inhibitor of PI3 kinase, PDGF-CC failed to induce phosphorylation of GSK3beta at serine 9 (XREF_FIG), thereby suggesting that PI3K and Akt pathway was up-stream of GSK3beta.	p(FPLX:"PDGF_CC")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
ef829ad6-7500-4958-a60e-a9085bbff0a6	1.0	PubMed	26716415	RKIP also stimulates glycogen synthase kinase 3beta (GSK3beta) signaling by blocking the inhibitory phosphorylation of GSK3beta.	p(HGNC:PEBP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
285ff951-d04c-48f0-963a-ddd873acf384	1.0	PubMed	22340730	Further supporting the high degree of substrate specificity, knockdown of PHLPP1 versus PHLPP2 affects different subsets of Akt substrates : PHLPP1 knockdown results in increased phosphorylation of GSK (glycogen synthase kinase) 3alpha and beta, MDM2 (murine double minute 2), and TSC2 (tuberous sclerosis complex 2)/tuberin, whereas PHLPP2 knockdown increases the phosphorylation of GSK3beta, FoxO (Forkhead Box O) 1, p27, and TSC2 [XREF_BIBR].	p(HGNC:PHLPP2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d5463cc6-0dbf-4648-9650-ae8d1002dbc2	1.0	PubMed	PMC5634202	Herein, we report that glycogen synthase kinase-3beta (GSK-3beta), a protein kinase previously implicated in processes as diverse as development and tumorigenesis, is inactivated by hypertrophic stimuli via a phosphoinositide 3-kinase-dependent protein kinase that phosphorylates GSK-3beta on ser 9.	p(UP:P25848)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
ddd8af99-247f-4d1b-96f0-63765e98d995	1.0	PubMed	PMC5596638	Stimulation with NGF resulted in PI 3-kinase-dependent phosphorylation of GSK-3 beta and inhibition of its protein kinase activity, indicating that GSK-3 beta is targeted by PI 3-kinase/Akt in these neurons.	p(PFAM:PF00454)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
89171623-7064-43d6-ae4b-5bdac23be2a1	1.0	PubMed	23765252	Constitutive activation of AKT by PI3K signaling, by PTEN and PI3K mutations, leads to the phosphorylation of GSK3beta targeting it for degradation, and thus allowing free beta-catenin to translocate to the nucleus 52.	p(FPLX:PI3K, var(p.?))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	26441085	Following phosphorylation, Dab1 proteins recruit the p85alpha subunit of phosphatidylinositol-3 kinase (PI3K), in turn, stimulating phosphorylation of AKT (protein kinase B), glycogen synthase kinase 3beta (GSK3beta) and CrkL, and consequent activation of a host of cellular responses.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	26514730	Similarly, WNT-5A induces migration in gastric cancer cells by activating PI3K and AKT pathway which phosphorylates and inactivates GSK-3beta and activates RhoA leading to cytoskeleton remodeling [XREF_BIBR].	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	25622682	To explore the specific mechanism involved, we assessed the expression of total and phosphorylated Akt and GSK-3beta in hBM-MSC-conditioned ALCs, as previous studies have shown that PI3K and Akt signaling can promote GSK-3beta phosphorylation which then stabilizes beta-catenin [XREF_BIBR, XREF_BIBR].	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	19019440	In our Jurkat cell line, constitutively active Akt was unable to phosphorylate GSK3-beta, in the absence of c-mip, but the inhibition of PI3K abolished the phosphorylation of GSK3-beta induced by c-mip.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	7144423	Furthermore, insulin induced GSK-3beta phosphorylation was mediated by both PI 3-kinase-PKB and the TC10-Par6-atypical PKC signaling pathways.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	26456864	We identified a novel positive-feedback loop mechanism via the INSM1 transcription factor that activated the PI3K and AKT signaling pathway, which subsequently induced phosphorylation of GSK3beta kinase and blocked GSK3beta kinase activity to stabilize N-myc.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	21964756	Activation of the phosphoinositide 3 kinase (PI3K) pathway has been linked to stabilization of HIF-1alpha protein through AKT mediated phosphorylation and inactivation of glycogen synthase kinase beta (GSK3beta) [XREF_BIBR; XREF_BIBR].	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	27020460	These results reveal that inhibition of PI3K activity results in the secondary inhibition of Akt activity and subsequently suppresses GSK-3beta expression and phosphorylation.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	26320152	These redox sensitive p38 MAPK, ERK-1/2, and PI3K and Akt pathways can all induce GSK3beta phosphorylation (8, 15) and have been implicated in glucocorticoid insensitivity in COPD (5).	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	23029096	Thus, upstream activation of these signaling pathways leads to inactivating phosphorylation of GSK-3beta by PI3K and Akt to allow for translocation of active beta-catenin and Myc into the nucleus where, through association with various nuclear co-activator complexes, enable induction of a large number of genes including Myc itself XREF_BIBR, XREF_BIBR, and AP4, a transcriptional repressor of p21 XREF_BIBR.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	18678710	Addition of a small molecule inhibitor against phosphoinositide-3 kinase (PI3K) prevented increased phosphorylation of IkappaB, p70S6K, AKT, and GSK-3beta.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	19584164	In vitro, PI3K inhibition diminished hepatoblastoma cell growth being accompanied by reduced AKT and GSK-3beta phosphorylation.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	5596638	Stimulation with NGF resulted in PI 3-kinase-dependent phosphorylation of GSK-3 beta and inhibition of its protein kinase activity, indicating that GSK-3 beta is targeted by PI 3-kinase/Akt in these neurons.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	22087308	Under these conditions, the PI3K and Akt pathway downstream of Jak2 is downregulated, thus reducing the inhibitory phosphorylation of GSK3beta.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	17653089	Inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, using LY294002, prevented both H2-relaxin-mediated phosphorylation of Akt and GSK-3beta and translocation of beta-catenin/AR into the nucleus.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4beb6ef0-cc07-48a8-ab9d-90691bdbbffd	1.0	PubMed	25596747	The application of the PI3K and Akt inhibitor, LY294002, inhibited the LL-37-induced accumulation of unphosphorylated beta-catenin, as well as the phosphorylation of GSK3beta in SW480 cells.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
377b6181-9188-452f-9287-0bba832df228	1.0	PubMed	23559006	20 PI produced both a higher GSK-3beta phosphorylation on Ser9 and accumulation of LC3II in MCF10A-NeuT cells.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
377b6181-9188-452f-9287-0bba832df228	1.0	PubMed	21160051	Thus, we next determined whether the ability of the PI3K pathway to mediate the phosphorylation and inactivation of GSK3-beta (S9) affected the levels of IL-10 produced by IFN-beta-stimulated DC.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
377b6181-9188-452f-9287-0bba832df228	1.0	PubMed	26119563	We found that simultaneous inhibition of PI3K almost abolished the ephrinB1/Fc induced GSK-3beta phosphorylation at Ser9 and tau dephosphorylation (XREF_FIG), suggesting that PI3K and Akt plays a crucial role in ephrinB1/Fc induced GSK-3beta inhibition and tau dephosphorylation.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
377b6181-9188-452f-9287-0bba832df228	1.0	PubMed	21887250	Since inhibiting the PI3K and Akt cascade resulted in decreased phosphorylation of GSK3beta Ser9 and increased MN differentiation from hNSCs, we then asked if the increase in HB9 expression was due to the increase in GSK3beta activity.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
6649f227-1b58-475a-afa3-b96deecc025f	1.0	PubMed	24815315	For instance, the binding of BDNF to the TrkB receptor activates PI3K and Akt pathway that leads to the phosphorylation of the N-terminal serine of glycogen synthase kinase-3 beta (GSK3beta) and a decrease of its activity.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
6649f227-1b58-475a-afa3-b96deecc025f	1.0	PubMed	19472218	Furthermore, inhibition of the phosphatidylinositol-3 kinase (PI3K) reversed the PLTP induced increase in levels of GSK3beta phosphorylated at serine 9 (pGSK3beta Ser9) and partially reversed the PLTP induced reduction in tau phosphorylation.	p(FPLX:PI3K)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
1e8f0bb3-22fd-4be0-8f10-8a1091d2d1d1	1.0	PubMed	20008284	Similarly, the mTORC1 inhibitor, rapamycin, failed to block the phosphorylation of GSK3beta (S 9, Y 216) (XREF_FIG) despite a marked inhibition of GSK3beta (S 9 only) by the PI3K inhibitor wortmannin.	a(CHEBI:84801)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1e8f0bb3-22fd-4be0-8f10-8a1091d2d1d1	1.0	PubMed	19190323	Down-regulation of galectin-3 decreased AKT phosphorylation, and the PI3K inhibitor LY294002 blocked GSK-3beta phosphorylation and TCF4 transcriptional activity induced by galectin-3 in colon cancer cells.	a(CHEBI:84801)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1e8f0bb3-22fd-4be0-8f10-8a1091d2d1d1	1.0	PubMed	23349801	Addition of the PI3K inhibitor LY-294002 with FGF-2 completely inhibited AKT phosphorylation and significantly reduced GSK-3beta phosphorylation (XREF_FIG, XREF_SUPPLEMENTARY).	a(CHEBI:84801)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1e8f0bb3-22fd-4be0-8f10-8a1091d2d1d1	1.0	PubMed	19117013	pAkt and pGSK-3beta phosphorylation were reduced by either PI3K inhibitor, and the inhibitory effects of Wortmannin were more pronounced than the effects of LY294002 over these concentrations and is shown in XREF_FIG.	a(CHEBI:84801)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ade4c2bc-d04e-4f4e-8461-42bcf04877dc	1.0	PubMed	22271581	Cyclin G1 overexpression enhanced Akt activation through interaction with p85 (regulatory subunit of phosphoinositide 3-kinase [PI3K]), which led to subsequent phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) and stabilization of Snail, a critical EMT mediator.	p(FPLX:"PI3K_p85")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
31ba8eaf-f076-4e2e-9580-b43dca5943e3	1.0	PubMed	19646728	GSK3beta, a multifunctional kinase implicated in HIV mediated neuropathogenesis (XREF_BIBR), was phosphorylated (therefore inactivated) by PIC or LPS (pSer9-GSK3beta), while IFNs had minimal effects (XREF_FIG).	a(PUBCHEM:7672)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
728fb007-1e72-4696-ab7a-024782098763	1.0	PubMed	20582532	Expression of p110beta and p110gamma induces much lower levels of phosphorylation of AKT, S6K, 4E-BP and GSK3beta.	p(HGNC:PIK3CB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e26a08ec-a65e-48a7-8bce-4dc072862368	1.0	PubMed	20582532	Expression of p110beta and p110gamma induces much lower levels of phosphorylation of AKT, S6K, 4E-BP and GSK3beta.	p(HGNC:PIK3CG)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c39e586e-d3fd-4ba2-961b-46aefc24015f	1.0	PubMed	26934497	However, unlike the other above mentioned PIM targets, active GSK3B and FOXP3 have tumour-suppressive and anti-migratory activities that are abrogated by PIM dependent phosphorylation of Ser in GSK3B or Ser in FOXP3.	p(PFAM:PF16765)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
e23d802b-af2d-4a66-a9cc-452412f8b3ff	1.0	PubMed	25899925	Notably, we found that mutant G309D PINK1 significantly reduced phosphorylation of GSK3beta at serine 9, suggesting that alterations in GSK3beta activity play an essential role in mutant G309D PINK1 induced tau phosphorylation at the PHF-1 site.	p(HGNC:PINK1, var(p.Gly309Asp))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
0cd556da-923a-4d66-8c41-c75ec625c358	1.0	PubMed	25899925	Notably, we found that mutant G309D PINK1 significantly reduced phosphorylation of GSK3beta at serine 9, suggesting that alterations in GSK3beta activity play an essential role in mutant G309D PINK1 induced tau phosphorylation at the PHF-1 site.	p(HGNC:PINK1, var(p.Gly309Asp))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
56c1b6e5-f292-40e7-aa16-bf894274716d	1.0	PubMed	22488590	In BRCA1-KD MCF7 cells, treatment of PI-103, a PI3K and mTOR inhibitor, abolished phosphorylation of AKT and its substrate GSK3beta, in a dose dependent manner (XREF_FIG and XREF_SUPPLEMENTARY).	a(PUBCHEM:9884685)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0901a3dc-866b-4a53-be97-e67c4d4600dd	1.0	PubMed	21890631	We postulated that these regulatory events could be mediated by AKAP220 anchored PKA, especially because PKA phosphorylation of serine 9 on GSK-3beta inhibits the latter enzyme (XREF_BIBR, XREF_BIBR).	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
0901a3dc-866b-4a53-be97-e67c4d4600dd	1.0	PubMed	18407462	Based on another finding indicating that Wnt5a upregulated PKA mediated phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) at serine 9 that caused inactivation of GSK-3beta and subsequently resulted in activation of the beta-catenin pathway, we have speculated that the Wnt5a anti-apoptotic activity may be partially mediated by PKA mediated phosphorylation of GSK-3beta and subsequent activation of the beta-catenin pathway.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
0901a3dc-866b-4a53-be97-e67c4d4600dd	1.0	PubMed	20357815	In addition, studies have reported that PKA and PKC, in addition to PKB and Akt, can phosphorylate GSK-3beta at serine 9 in some cell lines, leading to the inactivation of GSK-3beta activity (;).	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	17681085	Among other substrates PKA phosphorylates GSK-3beta.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	12147701	It has been reported that PKA phosphorylates GSK-3beta, thereby decreasing its activity.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	20357815	Among them, we focused on GSK-3beta, which had been shown to be phosphorylated at serine 9 and therefore inactivated by PKA (;).	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	PMC6434811	It has been reported that PKA phosphorylates GSK-3beta, thereby decreasing its activity.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	6434811	It has been reported that PKA phosphorylates GSK-3beta, thereby decreasing its activity.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	5680785	The increased phosphorylation of GSK-3beta by protein kinase A (PKA) occurs at serine 9, the same site phosphorylated by Akt.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	5680785	These data suggest that activated PKA directly phosphorylates GSK-3beta and inhibits its apoptotic activity in neurons.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	22182509	As cAMP levels rise, PKA phosphorylates and suppresses GSK-3beta activity.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	25266063	PKA can phosphorylate beta-catenin and GSK3beta (see introduction).	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	PMC5680785	The increased phosphorylation of GSK-3beta by protein kinase A (PKA) occurs at serine 9, the same site phosphorylated by Akt.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	PMC5680785	Purified PKA is able to phosphorylate recombinant GSK-3beta in vitro.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
22d55615-696a-494f-83e1-4fbd26af7190	1.0	PubMed	PMC5680785	These data suggest that activated PKA directly phosphorylates GSK-3beta and inhibits its apoptotic activity in neurons.	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6dc7c7b0-7766-4c9e-86ff-e1335bf475f0	1.0	PubMed	22496417	The Ser/Thr kinases Akt, protein kinase A, and protein kinase C phosphorylate GSK-3beta on Ser 9, leading to its inactivation (XREF_BIBR; XREF_BIBR).	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
019018ff-ea8d-4482-9c44-5608eaae3fcd	1.0	PubMed	21890631	We postulated that these regulatory events could be mediated by AKAP220 anchored PKA, especially because PKA phosphorylation of serine 9 on GSK-3beta inhibits the latter enzyme (XREF_BIBR, XREF_BIBR).	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
019018ff-ea8d-4482-9c44-5608eaae3fcd	1.0	PubMed	20357815	In addition, studies have reported that PKA and PKC, in addition to PKB and Akt, can phosphorylate GSK-3beta at serine 9 in some cell lines, leading to the inactivation of GSK-3beta activity (;).	p(FPLX:PKA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
fcc880b9-4e04-4ef2-81fe-fe848847271d	1.0	PubMed	22807997	We show that PKC412 inhibition of FLT3-ITD signalling prevents phosphorylation of GSK3-beta in both MV4-11and MOLM-13 cell lines (XREF_FIG).	a(PUBCHEM:9829523)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
21b5c683-7cf2-4d22-836f-6a9ba6e619e3	1.0	PubMed	7144423	Furthermore, insulin induced GSK-3beta phosphorylation was mediated by both PI 3-kinase-PKB and the TC10-Par6-atypical PKC signaling pathways.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
21b5c683-7cf2-4d22-836f-6a9ba6e619e3	1.0	PubMed	6635560	Inhibition of protein kinase C (PKC) s with GF109203X abrogated GSK-3beta phosphorylation by PLCgamma1.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
21b5c683-7cf2-4d22-836f-6a9ba6e619e3	1.0	PubMed	25927959	When HUVECs were depleted of PKC by lengthy treatment (48h) with PMA, the high concentration glucose induced phosphorylation of GSK3beta was significantly reduced, suggesting that PKC mediates high concentration glucose induced GSK3beta phosphorylation.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
21b5c683-7cf2-4d22-836f-6a9ba6e619e3	1.0	PubMed	16984735	Our results also indicate that PKC activation increases the phosphorylation of GSK-3b, implying a pathway that may be involved in physiological functions mediated by NT.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
21b5c683-7cf2-4d22-836f-6a9ba6e619e3	1.0	PubMed	1324914	Phosphorylation of GSK-3 beta by PKC results in its specific inactivation.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d1a3f51b-0cc4-414c-8a45-d9b5d9967822	1.0	PubMed	25138042	We show that 14-3-3zeta enhances Ser9 phosphorylation of GSK3beta by PKC.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d1a3f51b-0cc4-414c-8a45-d9b5d9967822	1.0	PubMed	22496417	The Ser/Thr kinases Akt, protein kinase A, and protein kinase C phosphorylate GSK-3beta on Ser 9, leading to its inactivation (XREF_BIBR; XREF_BIBR).	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d1a3f51b-0cc4-414c-8a45-d9b5d9967822	1.0	PubMed	26972480	Taken together, these results suggest that hnRNPK is capable to inhibit the Ser9 phosphorylation of GSK3beta by PKC, probably via steric hindrance caused by its interaction with GSK3beta.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d1a3f51b-0cc4-414c-8a45-d9b5d9967822	1.0	PubMed	26972480	Consistently, whilst the Ser9 phosphorylation of GSK3beta by PKC has been well documented in the literature XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR, no report concerning the physical interaction between PKC and GSK3beta could be found.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d1a3f51b-0cc4-414c-8a45-d9b5d9967822	1.0	PubMed	26972480	We find that hnRNPK is able to inhibit the Ser9 phosphorylation of GSK3beta by PKC.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d1a3f51b-0cc4-414c-8a45-d9b5d9967822	1.0	PubMed	26972480	hnRNPK down-regulates the Ser9 phosphorylation of GSK3beta by PKC in H1299 cells.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
d1a3f51b-0cc4-414c-8a45-d9b5d9967822	1.0	PubMed	26972480	Therefore, we investigated if hnRNPK could inhibit the Ser9 phosphorylation of GSK3beta by PKC in H1299 cells.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
aaa4612f-f0eb-4841-b129-0ee900a684f0	1.0	PubMed	20357815	In addition, studies have reported that PKA and PKC, in addition to PKB and Akt, can phosphorylate GSK-3beta at serine 9 in some cell lines, leading to the inactivation of GSK-3beta activity (;).	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
aaa4612f-f0eb-4841-b129-0ee900a684f0	1.0	PubMed	20934407	Moreover, both PKC and AKT activity can phosphorylate GSK-3beta at Ser, indicating an overlap in these signaling pathways.	p(FPLX:PKC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
bd3716df-a7ef-4e7e-8167-5248370bc5ad	1.0	PubMed	25444918	Silencing of PKM2 expression enhanced ionizing radiation (IR)-induced apoptosis and autophagy in vitro and in vivo, accompanied by inhibiting AKT and PDK1 phosphorylation, but enhanced ERK and GSK3beta phosphorylation.	p(HGNC:PKM)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6ec95865-2518-41a4-849e-5b522f076bce	1.0	PubMed	PMC6635560	Inhibition of protein kinase C (PKC)s with GF109203X abrogated GSK-3beta phosphorylation by PLCgamma1.	p(HGNC:PLCG1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2bd9e3e0-792d-45c5-ad81-f28026155837	1.0	PubMed	24887096	The knockdown of PLK2 expression reduced GSK3B serine phosphorylation and nuclear NRF2 levels in both cell lines (XREF_FIG).	p(HGNC:PLK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
036d6f71-1178-4269-a540-eb625c20a9bc	1.0	PubMed	24887096	We next performed an in vitro phosphorylation assay using purified recombinant proteins and confirmed that the Ser 9 residue of GSK3B can be directly phosphorylated by PLK2 (XREF_FIG).	p(HGNC:PLK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7eb45c49-b1ba-4440-9b04-d9a11b1768e5	1.0	PubMed	23943160	PPAR beta and delta activation also resulted in decreased phosphorylation of AKT at Ser473 and decreased GSK3beta phosphorylation, whereas beta-catenin phosphorylation was markedly increased upon GW0742 treatment (XREF_FIG).	p(FPLX:PPAR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
058f099f-853f-4bc7-8f96-aae62f816a7a	1.0	PubMed	16987514	Inhibition of PP1 through I-2 overexpression increased the basal phosphorylation of GSK3alpha and GSK3beta, but only GSK3beta dephosphorylation induced by KCl treatment was blocked by I-2 overexpression.	p(FPLX:PPP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e6c41f20-a0c5-45ee-9695-dd89be53e670	1.0	PubMed	16987514	Therefore, inhibition of PP1 only modestly increases basal GSK3beta Ser9 phosphorylation compared to GSK3alpha Ser21 phosphorylation.	p(FPLX:PPP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
8abd76ab-a2de-4350-942a-5299dcacf431	1.0	PubMed	25219467	We found that overexpression of PP2Ac decreased Ser9 phosphorylation of GSK-3beta significantly (A and B).	p(FPLX:PPP2C)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
c3a4b152-1e91-4b23-b9b8-c230b7c0c4d9	1.0	PubMed	25219467	Upregulation of GSK-3beta promotes the methylation of PP2Ac and increases its phosphatase activity toward tau, whereas downregulation of PP2Ac elevates Ser9 phosphorylation of GSK-3beta and inhibits the kinase activity.	p(FPLX:PPP2C)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b253016a-6a3c-427b-92a4-69be3b18b2f8	1.0	PubMed	25219467	Inhibition of PP2A allowed enhancement of GSK-3beta phosphorylation at Ser9 and inhibited its activity.	p(FPLX:PPP2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b253016a-6a3c-427b-92a4-69be3b18b2f8	1.0	PubMed	25219467	Reduction of PP2A may lead to increase in Ser9 phosphorylation of GSK-3beta and decrease in GSK-3beta activity, which may further promote PP2A demethylation and decrease PP2A activity.	p(FPLX:PPP2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
403c2273-b139-4fbc-a796-7ba8917a602e	1.0	PubMed	18778410	Our result showed that Tg (PRDX3) mice have increased phosphorylation of GSK3beta and GSK3alpha.	p(HGNC:PRDX3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1940b0f8-5c38-4c5e-93a1-9c03f45def58	1.0	Other	sparser:Unknown	In addition, PE-induced GSK-3beta phosphorylation was reduced in Rat-1 cells treated with a cell-permeable PKCzeta pseudosubstrate peptide inhibitor.	p(HGNC:PREP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8eb59f13-4fdd-49bf-b7f8-dd88d8f3edff	1.0	PubMed	6009512	Treatment of these cells with either insulin or phenylephrine (PE), an alpha1-adrenergic receptor agonist, induced Ser 9 phosphorylation of GSK-3beta and inhibited GSK-3beta activity.	p(HGNC:PREP)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
bb1a91e5-bfa3-42a1-991b-566899a05c1a	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3alpha or ser9 in gsk3beta. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:PRKACA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
4be40a3d-2913-41ee-9b5b-b4994d39ca21	1.0	PubMed	19218353	The hypothesis tested was PKCalpha mediates the phosphorylation of glycogen synthetase kinase 3beta (GSK3beta) and that the GSK3beta inhibition modulates the response to tumor necrosis factor-alpha (TNF) in rat pulmonary microvessel endothelial cells (PMEC).	p(HGNC:PRKCA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4be40a3d-2913-41ee-9b5b-b4994d39ca21	1.0	PubMed	16984735	Although it was noted that PKCa and PKCb1 phosphorylate GSK-3b and GSK-3a [19], our results are largely consistent with a previous report by Goode et al. [18].	p(HGNC:PRKCA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c20401a2-dc3d-4dec-b7fa-776550c73be0	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3_ or ser9 in gsk3_. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:PRKCA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
6a8b1bb2-d274-4409-bae2-6fdd74a15eba	1.0	PubMed	21997316	Selective PKCbeta inhibition does not affect AKT activation but decreases phosphorylation of GSK3beta, ribosomal protein S6 and mTOR in AIDS-NHL cells.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6a8b1bb2-d274-4409-bae2-6fdd74a15eba	1.0	PubMed	20934407	This finding is in line with data showing that PKCbeta may directly phosphorylate GSK-3beta without involvement of AKT.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0869c0b3-5a3d-4ce2-95e7-419c1fd2b08e	1.0	PubMed	21997316	By contrast, PKCbeta selective inhibition dramatically reduced phosphorylation of GSK3beta, a serine threonine kinase originally identified for its role in glycogen metabolism but subsequently implicated in diverse cellular processes including proapoptotic signalling.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
9ced6f9c-df93-4165-9ba6-1b849ebbe3de	1.0	PubMed	21997316	By contrast, PKCbeta selective inhibition dramatically reduced phosphorylation of GSK3beta, a serine threonine kinase originally identified for its role in glycogen metabolism but subsequently implicated in diverse cellular processes including proapoptotic signalling.	p(HGNC:PRKCB)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Thr))
07aa3b0e-3f19-49c7-bc05-7845af15b245	1.0	PubMed	23349801	Intriguingly, functional gene analysis by RNA interference revealed that the phosphorylation of GSK-3beta was reduced by siRNA of PKCdelta, PKCepsilon, and zeta, the phosphorylation of ERK-1/2 was reduced by siRNA of PKCepsilon and zeta, and the phosphorylation of AKT was reduced by PKCepsilon in hPS cells.	p(HGNC:PRKCD)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ff0fdd48-fc75-4160-a5f6-0c1ef8fd5a9f	1.0	PubMed	23349801	Intriguingly, functional gene analysis by RNA interference revealed that the phosphorylation of GSK-3beta was reduced by siRNA of PKCdelta, PKCepsilon, and zeta, the phosphorylation of ERK-1/2 was reduced by siRNA of PKCepsilon and zeta, and the phosphorylation of AKT was reduced by PKCepsilon in hPS cells.	p(HGNC:PRKCE)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f31abb87-60b5-4164-8a61-a916c90904bd	1.0	PubMed	19836308	Gsk3 is different from most kinases in that it is constitutively partially active and the most common regulatory mechanism is inhibition by phosphorylation of ser21 in gsk3_ or ser9 in gsk3_. This inhibitory phosphorylation can be mediated by several kinases, such as akt/protein kinase b (pkb), protein kinase c (pkc) and protein kinase a (pka).	p(HGNC:PRKCH)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
cac191a0-8090-474b-8da9-8f2794fb808e	1.0	PubMed	14657655	Phospho-gsk3b-specific antibodies also revolved that lkb1 regulates gsk3b phosphorylation at a known inhibitory site, serine-9. This localized phosphorylation is cdc42 and pkc-zeta-dependent.	p(HGNC:PRKCZ)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
87f9d8ab-9a59-4281-8dc8-fe2e7dc861d3	1.0	PubMed	23727580	For example, mouse bone marrow macrophages isolated from heterozygous ROCK1 knockout mice exhibit enhanced phosphorylation of GSK3beta by cGMP dependent protein kinase II (cGKII) and Ca/calmodulin dependent protein kinase II (CaMKII) which inhibits GSK3beta activity, suggesting that ROCK1 may regulate the " destruction complex " assembly and activity.	p(HGNC:PRKG2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
879ac419-82ca-486f-bc52-29e7e06f5c8e	1.0	PubMed	26452025	As shown in Figure XREF_FIG, PTEN overexpression markedly reduced AKT and GSK-3beta phosphorylation in CNE2 cells, similar as the results caused by Hes1 silencing.	p(HGNC:PTEN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c6ecc589-920a-4e8e-a5d1-9774ac3574fc	1.0	PubMed	23765252	Constitutive activation of AKT by PI3K signaling, by PTEN and PI3K mutations, leads to the phosphorylation of GSK3beta targeting it for degradation, and thus allowing free beta-catenin to translocate to the nucleus 52.	p(HGNC:PTEN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c6ecc589-920a-4e8e-a5d1-9774ac3574fc	1.0	PubMed	23943160	After activation of PPARbeta and delta, increased PTEN generation leads to decreased phosphorylation of AKT and GSK3beta.	p(HGNC:PTEN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6c9207e1-a40d-4511-8803-c08c78e55507	1.0	PubMed	21952626	In the present study, we show that PTEN mediated PARP cleavage and apoptosis involves Cdc42 activity and may involve GSK3beta Ser9 phosphorylation.	p(HGNC:PTEN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
a861c565-2e51-4884-b5f7-284b6bb17038	1.0	PubMed	22126303	PGE2 also increases GSK-3beta phosphorylation through PI3K and AKT [XREF_BIBR] and protein kinase A signaling [XREF_BIBR].	p(HGNC:PTGER4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cb26ba42-9f92-47bc-b340-e4b25603e8be	1.0	PubMed	19584267	Analysis of the effect of PTHrP overexpression on downstream signaling molecules of the Akt pathway involved in cell survival revealed that wild-type PTHrP also induced phosphorylation of GSK-3beta in C4-2 cells, resulting in inhibition of its activity.	p(HGNC:PTHLH)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
652f8472-410f-47db-97d3-dd3bbd29b39b	1.0	PubMed	16452634	No evidence text.	p(HGNC:PTK2B, pmod(Ph, Tyr, 402))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 21))
652f8472-410f-47db-97d3-dd3bbd29b39b	1.0	PubMed	10601262	No evidence text.	p(HGNC:PTK2B, pmod(Ph, Tyr, 402))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 21))
118ff874-357a-426c-a9ce-7450b9c6781f	1.0	PubMed	16452634	No evidence text.	p(HGNC:PTK2B, pmod(Ph, Tyr, 402))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
118ff874-357a-426c-a9ce-7450b9c6781f	1.0	PubMed	10601262	No evidence text.	p(HGNC:PTK2B, pmod(Ph, Tyr, 402))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
425f3330-5994-4410-a381-6ab94b4f721b	1.0	PubMed	16452634	No evidence text.	p(HGNC:PTK2B, pmod(Ph, Tyr, 402))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
425f3330-5994-4410-a381-6ab94b4f721b	1.0	PubMed	10601262	No evidence text.	p(HGNC:PTK2B, pmod(Ph, Tyr, 402))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
e8651644-edd6-407b-8006-f71717bf2f67	1.0	PubMed	26274564	FAK and PYK2 promotes the Wnt and beta-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3beta.	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e8651644-edd6-407b-8006-f71717bf2f67	1.0	PubMed	5909931	In transfected CHO cells, it was demonstrated that PYK2 tyrosine phosphorylates GSK3beta in situ.	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e8651644-edd6-407b-8006-f71717bf2f67	1.0	PubMed	PMC5909931	In transfected CHO cells, it was demonstrated that PYK2 tyrosine phosphorylates GSK3beta in situ.	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
087e9143-f9cf-4f9f-8690-7b506f440241	1.0	PubMed	26274564	Our results indicate that phosphorylation of GSK3beta Y216 by FAK and PYK2 is a molecular determinant of GSK3beta recruitment of beta-TrCP, and is required for the activation of the Wnt and beta-catenin pathway and crucial for Wnt driven intestinal tumorigenesis.	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
087e9143-f9cf-4f9f-8690-7b506f440241	1.0	PubMed	26274564	FAK and PYK2 phosphorylate GSK3beta Y216.	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
087e9143-f9cf-4f9f-8690-7b506f440241	1.0	PubMed	26274564	In line with a prior report that GSK3beta Y216 can be phosphorylated by PYK2 (XREF_BIBR), we found that treatment of HEK293T cells with PF-562271, a dual inhibitor of FAK and PYK2, inhibited GSK3beta Y216 and GSK3alpha Y279 phosphorylation in the presence and absence of Wnt3a (XREF_FIG).	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
087e9143-f9cf-4f9f-8690-7b506f440241	1.0	PubMed	26274564	The result of in vitro kinase assay confirmed that FAK and PYK2 were able to directly phosphorylate GSK3beta Y216 in vitro (XREF_FIG).	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
087e9143-f9cf-4f9f-8690-7b506f440241	1.0	PubMed	26274564	Consistent with our finding that FAK and PYK2 function redundantly in phosphorylating GSK3, despite of suppressed FAK activity in FAK R454 and R454 MEFs, KD of PYK2 was required to inhibit GSK3beta Y216 phosphorylation.	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
087e9143-f9cf-4f9f-8690-7b506f440241	1.0	PubMed	26274564	Inhibition of FAK and PYK2 suppresses intestinal phosphorylation of GSK3beta Y216 and adenoma formation in APC min/+ mice.	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
37249891-eaf1-4fae-a2d1-4f1563f16e15	1.0	PubMed	5909931	In this report, we investigated the ability of the calcium dependent tyrosine kinase, proline rich tyrosine kinase 2 (PYK2) to tyrosine phosphorylate GSK3beta.	p(HGNC:PTK2B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
588920a3-b196-438c-9533-b0f33d633a77	1.0	PubMed	26274564	FAK and PYK2 promotes the Wnt and beta-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3beta.	p(HGNC:PTK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8e60ea6c-47dc-427e-95d9-16748dc3eb04	1.0	PubMed	26274564	Our results indicate that phosphorylation of GSK3beta Y216 by FAK and PYK2 is a molecular determinant of GSK3beta recruitment of beta-TrCP, and is required for the activation of the Wnt and beta-catenin pathway and crucial for Wnt driven intestinal tumorigenesis.	p(HGNC:PTK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
8e60ea6c-47dc-427e-95d9-16748dc3eb04	1.0	PubMed	26274564	FAK and PYK2 phosphorylate GSK3beta Y216.	p(HGNC:PTK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
8e60ea6c-47dc-427e-95d9-16748dc3eb04	1.0	PubMed	26274564	The result of in vitro kinase assay confirmed that FAK and PYK2 were able to directly phosphorylate GSK3beta Y216 in vitro (XREF_FIG).	p(HGNC:PTK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
8e60ea6c-47dc-427e-95d9-16748dc3eb04	1.0	PubMed	26274564	Inhibition of FAK and PYK2 suppresses intestinal phosphorylation of GSK3beta Y216 and adenoma formation in APC min/+ mice.	p(HGNC:PTK2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
34ca53e9-2ec1-45b7-9710-b08d29a9c2a1	1.0	PubMed	26238471	Alternatively it was proposed that Akt1 exerts its inhibitory effect by phosphorylating and inhibiting GSK3beta kinase activity on NFAT which is then degraded by proteasome resulting in an impaired migration.	p(FPLX:Proteasome)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
46609ddb-4d64-46bc-90d8-b8f9870c623a	1.0	PubMed	27481517	We investigated the role of Rab11a in the regulation of Wnt and beta-catenin signaling and we demonstrated that Rab11a overexpression upregulated GSK3beta phosphorylation and nuclear beta-catenin accumulation.	p(HGNC:RAB11A)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
be15745e-74e6-44ec-aa5b-bd850d4f60b7	1.0	PubMed	23068607	Intracellular coexpression showed that NDRG2 and PRA1 synergistically downregulate T-cell factor (TCF) promoter activity and GSK3beta phosphorylation.	p(HGNC:RABAC1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
75ba7739-a1a1-4775-ab32-526bd8ba6773	1.0	PubMed	22240482	Moreover, as shown in, although PKC is the first identified binding partner of RACK1, neither the agonist (PMA) nor the antagonist (GF109203X) of PKC could rescue the inhibitory effects of RACK1 on TOPflash reporter, suggesting that RACK1 inhibited Wnt and beta-catenin signaling in a PKC independent manner.The preceding finding that RACK1 enhances GSK3beta mediated phosphorylation and subsequent degradation of beta-catenin raises the possibility that RACK1 might be a member of the beta-catenin destruction complex.	p(HGNC:RACK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
31d3bb11-22ea-40fe-83f4-0328f24765c3	1.0	PubMed	26750098	Overexpression of RASSF1A inhibited the Wnt and beta-catenin activity, decreased phosphorylation of Akt and glycogen synthase kinase-3-beta (GSK3-beta), and increased phosphorylation of mammalian sterile 20 like kinase 1 (MST1).	p(HGNC:RASSF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
aecaa3fd-b2cd-479d-a579-47bf4bdcbcc3	1.0	PubMed	25762011	Conversely, downregulation of Ras activity by blocking its function with an antibody in oscillating cell cultures reduced protein levels and increased phosphorylation of GSK3beta and lengthened the period of BMAL1 promoter driven luciferase activity.	p(FPLX:RAS)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
6d828fbe-6743-4297-94ab-13295ac39ec8	1.0	PubMed	24151146	Therefore, to establish an association between Reg4 mediated increase in Akt kinase activity and GSK-3beta phosphorylation, we added rhR4 (200 nM) to different human CRC cell cultures for 0, 2, 5, 10, 20, 30 and 60 min.	p(HGNC:REG4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d8a7db42-81ff-488a-b1bc-7f4db2c3eb24	1.0	PubMed	23951306	In a cellular system, we study if an altered form of Reelin affects the Reelin signaling pathway, including Dab1, GSK3beta and ultimately tau phosphorylation.	p(HGNC:RELN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d8a7db42-81ff-488a-b1bc-7f4db2c3eb24	1.0	PubMed	24705369	In neurons with lower levels of cell surface ApoER2, resulting from SNX17 downregulation, an evident decrease in reelin mediated Dab1, AKT, and GSK3beta phosphorylation was observed.	p(HGNC:RELN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b85068d3-588a-4ef7-bfd5-33ab6e7a22ef	1.0	PubMed	21814183	It is fairly well established that the Reelin signaling pathway leads to Gsk-3beta phosphorylation at Ser9, thereby leading to its enzymatic inhibition (XREF_BIBR).	p(HGNC:RELN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
4b040940-39d3-4d46-ae1d-57da86f637f2	1.0	PubMed	21665151	ROCK activation increased GSK3beta Ser9 phosphorylation relative to control 4HT treated WT or KD : ER skin (XREF_FIG), accompanied by decreased beta-catenin phosphorylation on GSK3beta sites Ser37 and Thr41 (XREF_FIG).	p(FPLX:ROCK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
20a1c15c-343c-4a4f-8ba4-44505070a5cf	1.0	PubMed	25390651	Phosphorylation of GSK-3beta in mitochondria by nicorandil was inhibited by MPG (XREF_FIG), indicating that ROS generated by mK ATP channel activation XREF_BIBR, XREF_BIBR mediated GSK-3beta phosphorylation.	p(HGNC:ROS1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
35ac84fa-ad0b-4760-af0a-5ce69ab73435	1.0	PubMed	11584304	S6k then phosphorylates the same serine residue on gsk3 that is targeted by pkb/akt (fig. 1), thereby inhibiting its activity.	p(HGNC:RPS6KA1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
35ac84fa-ad0b-4760-af0a-5ce69ab73435	1.0	PubMed	PMC3557916	GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem.	p(HGNC:RPS6KA1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
8377ee15-aa25-4e24-99e4-b4519625959f	1.0	PubMed	7980435	GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem.	p(HGNC:RPS6KA1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
8377ee15-aa25-4e24-99e4-b4519625959f	1.0	PubMed	22615844	GSK-3 beta is phosphorylated in vitro at serine 9 by RSK1, resulting in its inhibition XREF_BIBR.	p(HGNC:RPS6KA1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
8377ee15-aa25-4e24-99e4-b4519625959f	1.0	PubMed	3557916	GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem.	p(HGNC:RPS6KA1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
b3b9b7da-64c1-445b-a4eb-8fa1edc79e4f	1.0	PubMed	23208494	MEK1 and RSK2 failed to augment the half-life of GLI2 lacking GSK-3beta phosphorylation sites, indicating that MEK-RSK stabilizes GLI2 by controlling targeting GSK-3beta-mediated phosphorylation and ubiquitination of GLI2.	p(HGNC:RPS6KA3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2c023346-7b61-4e86-a8e7-507b947ea920	1.0	PubMed	21422248	In addition, we were able to show the functional role of S6K1 in that inhibition of S6K1 abrogated the phosphorylation of GSK3-beta in LPS stimulated cells.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2c023346-7b61-4e86-a8e7-507b947ea920	1.0	PubMed	21422248	Inhibition of S6K1 abrogated the phosphorylation of GSK3-beta while increasing and decreasing the levels of IL-12 and IL-10, respectively, in LPS stimulated monocytes.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2c023346-7b61-4e86-a8e7-507b947ea920	1.0	PubMed	22491319	As shown in XREF_FIG, S. pneumoniae induced phosphorylation of Akt and GSK3beta, but not p70S6K, which represents another downstream target of PI3K pathway, suggesting the specific activation of Akt-GSK3beta by S. pneumoniae.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2c023346-7b61-4e86-a8e7-507b947ea920	1.0	PubMed	21127195	IB (XREF_FIG) showed that the ability of AKT to phosphorylate its direct or indirect substrates GSK3beta, p70S6K and elF4B decreased around 50%, 65% and 44%, respectively in KOM cells compared with KO cells under serum stimulation.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2c023346-7b61-4e86-a8e7-507b947ea920	1.0	PubMed	PMC3741895	MAPKAP kinase-1 and p70S6K phosphorylated the same tryptic peptide on GSK3 beta, and the site of phosphorylation was identified as the serine located nine residues from the N-terminus of the protein.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
03c14949-00c3-42d5-9004-3f5aaea318c4	1.0	PubMed	7980435	GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
03c14949-00c3-42d5-9004-3f5aaea318c4	1.0	PubMed	3557916	GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem.	p(HGNC:RPS6KB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
aaa12163-a002-47f4-816a-bb9ade7e9b93	1.0	PubMed	25078664	Consistent with the above results, we observed that combined knockdown of Galphai1 and Galphai3 in MEFs largely inhibited the phosphorylation of AKT (473S) and GSK-3beta (9S), as well as 4E-BP1 (65S) and S6 (235/236S) by KGF.	p(HGNC:RPS6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
94d242b9-a670-41ba-84e5-6b784437dd68	1.0	PubMed	25078664	Consistent with the above results, we observed that combined knockdown of Galphai1 and Galphai3 in MEFs largely inhibited the phosphorylation of AKT (473S) and GSK-3beta (9S), as well as 4E-BP1 (65S) and S6 (235/236S) by KGF.	p(HGNC:RPS6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 66))
1b27fa00-bdf8-4e28-964a-82da2f1bb581	1.0	PubMed	25078664	Consistent with the above results, we observed that combined knockdown of Galphai1 and Galphai3 in MEFs largely inhibited the phosphorylation of AKT (473S) and GSK-3beta (9S), as well as 4E-BP1 (65S) and S6 (235/236S) by KGF.	p(HGNC:RPS6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
2b8b7dfc-b09e-4939-bd58-22b962aab294	1.0	PubMed	7980435	GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem.	p(HGNC:RPS6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
2b8b7dfc-b09e-4939-bd58-22b962aab294	1.0	PubMed	3557916	GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem.	p(HGNC:RPS6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
a9c55e20-d5d1-422d-8f94-c7512c8cab70	1.0	PubMed	18280241	For example, RSK and Akt can phosphorylate GSK-3beta, tRNA methylase METTL1, andp27Kip1 at the same position ().	p(FPLX:RSK)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
be0ad1d4-55af-43fb-9008-529fac8b2d12	1.0	PubMed	21329734	Rapamycin inhibited the induction of both GSK3beta phosphorylation and beta-catenin expression by visfatin (A).	a(CHEBI:9168)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
90900f9f-e0cf-47ca-b620-a1d899d5f882	1.0	PubMed	26374165	To explore this possibility, we first showed that RvD1 and RvD2 induce Ser9 phosphorylation of GSK-3beta in an Akt dependent way (XREF_FIG).	a(PUBCHEM:16061135)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
4ff5432a-a17c-44a8-ae75-021a1f74d15c	1.0	PubMed	26374165	To explore this possibility, we first showed that RvD1 and RvD2 induce Ser9 phosphorylation of GSK-3beta in an Akt dependent way (XREF_FIG).	a(PUBCHEM:16061136)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
0d518068-d45b-464b-b29b-73b6b0b3fccb	1.0	PubMed	18494933	S100B caused a concentration dependent increase in GSK-3beta phosphorylation (as shown by increased immunoreactivity of p-Ser-9 bands, XREF_FIG), as well as a parallel degradation in beta-catenin expression in treated versus untreated cells (XREF_FIG).	p(HGNC:S100B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0d518068-d45b-464b-b29b-73b6b0b3fccb	1.0	PubMed	18494933	S100B induction of both DKK-1 and pppTau expression in neurons raises the possibility that S100B promotes DKK-1 expression, and thereby disrupts the canonical Wnt pathway (increased GSK-3beta phosphorylation and enhanced beta-catenin degradation), leading to tau protein hyperphosphorylation.	p(HGNC:S100B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0d518068-d45b-464b-b29b-73b6b0b3fccb	1.0	PubMed	18494933	As observed for differentiated NSCs, 5 muM S100B exposure significantly increased GSK-3beta phosphorylation and beta-catenin degradation by 24 hrs after stimulation.	p(HGNC:S100B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e55cac18-e48e-44af-8d0b-ba2df9a219a7	1.0	PubMed	25003810	Moreover, SB431542 or LDN193189 fully suppressed Smad1, Akt, and GSK3beta phosphorylation in CL1-5 cells.	a(PUBCHEM:4521392)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4c01097c-fdd4-44f6-9a33-6dfe4b77950b	1.0	PubMed	26899563	The results showed that suprabasin increased the phosphorylation of GSK3beta, while downregulation of suprabasin decreased expression of phosphorylated GSK3beta (XREF_SUPPLEMENTARY).	p(HGNC:SBSN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2b614bfd-a0c2-42f8-8dad-471f4925a5e0	1.0	PubMed	26822034	Since GSK3beta phosphorylation on Ser 389 was induced in B cells by CSR generated DSBs, we investigated the effect of inactivation of GSK3beta through this pathway on the in vivo humoral response.	p(HGNC:SCARA3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 389))
70d5605d-23a5-41f1-b9b0-dbfa2812f42f	1.0	PubMed	25881671	Another study also reported that treatment of PEDF in osteocytes induced phosphorylation of glycogen synthase kinase 3beta (GSK-3beta) and total beta-catenin levels [XREF_BIBR].	p(HGNC:SERPINF1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c9349627-f6cb-415b-bbdd-42acd8106860	1.0	PubMed	18570873	As for Akt, SGK phosphorylates bRaf, GSK3-beta, and FKHRL1 ().	p(HGNC:SGK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0a03303f-6f91-47b9-be52-6306a23e9233	1.0	PubMed	12054501	We demonstrated here that SGKL is able to phosphorylate GSK-3beta at serine 9 residues in vitro and its kinase activity is responsible for this phosphorylation.	p(HGNC:SGK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
0a03303f-6f91-47b9-be52-6306a23e9233	1.0	PubMed	12054501	Co-immunoprecipitation of SGKL and GSK-3beta in vivo coupled with in vitro SGKL kinase assay provides strong evidence that SGKL could phosphorylate GSK-3beta at serine 9 through intracellular interaction.	p(HGNC:SGK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
c5cc27f6-dd6c-45a8-90d9-85d1aa4c8f85	1.0	PubMed	25051360	Like Akt, SGK3 can phosphorylate GSK-3beta and TSC-2 which results in their inactivation and activation of mTORC1 and stimulation of protein translation [XREF_BIBR, XREF_BIBR].	p(HGNC:SGK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
c5cc27f6-dd6c-45a8-90d9-85d1aa4c8f85	1.0	PubMed	12054501	The special preference for lipid signals and the distinct subcellular localization of SGKL may contribute to such coordination by phosphorylating GSK-3beta in response to particular cell stimuli in different cellular compartments.	p(HGNC:SGK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
61e4b9a8-7401-430e-bd4a-a84745d7255f	1.0	PubMed	12054501	Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction	p(HGNC:SGK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
61e4b9a8-7401-430e-bd4a-a84745d7255f	1.0	PubMed	16543730	Phosphorylation of GSK3 by PKB or SGK1 inhibits GSK3 activity|estern blotting using an antibody specific for the PKB/SGK1 consensus phosphorylation site in GSK3a/beta (serine 21 and 9 respectively) revealed an increase in GSK3a/beta phosphorylation in human embryonic kidney 293 (HEK293) cells overexpressing wild type SGK1, constitutively active SGK1, but not catalytically inactive SGK1.|The effect of SGK1 was mimicked by PKB and SGK3.	p(HGNC:SGK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
0369652f-abb6-4db7-924f-c4c4441bc120	1.0	PubMed	12054501	We demonstrated here that SGKL is able to phosphorylate GSK-3beta at serine 9 residues in vitro and its kinase activity is responsible for this phosphorylation.	p(HGNC:SGK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
0369652f-abb6-4db7-924f-c4c4441bc120	1.0	PubMed	12054501	Co-immunoprecipitation of SGKL and GSK-3beta in vivo coupled with in vitro SGKL kinase assay provides strong evidence that SGKL could phosphorylate GSK-3beta at serine 9 through intracellular interaction.	p(HGNC:SGK3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
5d5421e4-40fa-4755-af02-0d257a5a585c	1.0	PubMed	20018240	Our data suggest that this signaling is mediated by integrin linked kinase (ILK), a substrate for beta1 integrin that regulates EMT (XREF_BIBR), which increases phosphorylation of Akt, GSK- 3beta, and IkappaB.	bp(GO:"GO:0001837")	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
76e7ec8d-58c7-4dc5-91fc-591331767448	1.0	PubMed	25003810	Inhibition of Smad1 by siRNA markedly decreased the expression of Akt and GSK3beta phosphorylation and repression of Nanog expression in CL1-5 cells.	p(HGNC:SMAD1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
42eebd21-7a89-495d-ada1-1c9cb0d32a97	1.0	PubMed	21050448	alpha-Synuclein expression increased GSK-3beta activity and Tau phosphorylation.	p(HGNC:SNCA)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ae786079-dadc-4ccf-a004-30ad03a0945f	1.0	PubMed	26226221	We found that LY294002 significantly inhibited the KLF14 stimulated 2-DG uptake (B) and the phosphorylation of Akt (G) and GSK3beta (H), suggesting that the effect of KLF14 on glucose uptake is mediated via PI3K and Akt activation.To imitate insulin resistance in cell level, Hepa1-6 cells were cultured in a medium with different glucose or insulin concentrations for 24h.	p(HGNC:SP6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
fe33f3e9-c140-420c-9852-0218de1cdaad	1.0	PubMed	19850036	OPN induces increased phosphorylation of GSK-3beta on serine 9, and this prompted us to investigate whether OPN affects beta-Catenin dynamics (XREF_FIG).	p(HGNC:SPP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
bd548367-3af5-48ed-b9e2-52a91f352a22	1.0	PubMed	19850036	OPN induces increased phosphorylation of GSK-3beta on serine 9, and this prompted us to investigate whether OPN affects beta-Catenin dynamics (XREF_FIG).	p(HGNC:SPP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
a7cc1c76-c025-46cb-a1d2-6c78684c2471	1.0	PubMed	17412687	Down-regulation of endogenous XB130 with siRNA reduced c-Src activity, IL-8 production, EGF induced phosphorylation of Akt and GSK3beta, and altered cell cycles in human lung epithelial cells.	p(HGNC:SRC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a7cc1c76-c025-46cb-a1d2-6c78684c2471	1.0	PubMed	26515729	This suggests polarized CD133 and integrin evoked Src activation (in cells cultured on collagen- or laminin coated dishes) enhanced phosphorylation of GSK3beta and its potential upstream regulator Akt as well as the subsequent increase and nuclear translocation of beta-catenin.	p(HGNC:SRC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a7cc1c76-c025-46cb-a1d2-6c78684c2471	1.0	PubMed	26515729	CD133 induced Src activation enhances the phosphorylation of GSK3beta and its potential upstream regulator, Akt.	p(HGNC:SRC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a7cc1c76-c025-46cb-a1d2-6c78684c2471	1.0	PubMed	23615537	In addition, knockdown of c-Src by siRNAs reduced cell proliferation and phosphorylation of ERK1/2, AKT, and GSK3beta.	p(HGNC:SRC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0358c53b-5ece-4e3c-8ce8-4701f62ccc7b	1.0	PubMed	23010592	In the present study, we report that NOK overexpression led to enhanced phosphorylation of GSK-3beta at its Ser9 residue via Akt phosphorylation at Thr308.	p(HGNC:STYK1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
4a7b00a4-024d-4426-aba2-99e5fa7446ce	1.0	PubMed	21040406	SULF2 expression also increased phosphorylation of the anti-apoptotic Akt substrate GSK3beta and stimulated Wnt and beta-catenin signalling (XREF_BIBR).	p(HGNC:SULF2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4a7b00a4-024d-4426-aba2-99e5fa7446ce	1.0	PubMed	21040406	We have previously shown that forced expression of SULF2 in SULF2 negative Hep3B cells increased phosphorylation of the Akt substrate GSK3beta (XREF_BIBR).	p(HGNC:SULF2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8e1ba125-0ec3-4863-9db3-5f732ece4cb8	1.0	PubMed	23348690	As shown in A, overexpression of TACC3 increased the phosphorylation of GSK3beta (Ser 9), whereas total GSK3beta levels remained unchanged, indicating the loss of GSK3beta activation.	p(HGNC:TACC3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
30442d18-88de-4a6e-821b-5b75d6b924fb	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:TCF4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
02d8436e-67b8-49f4-93ef-e5704f82f408	1.0	PubMed	16507111	Indeed we also observe that in primary human CD4+ T-cells recombinant Delta1-IgG4 fusion protein, or Notch-IC expression, blocks TCR mediated phosphorylation of Akt and GSK3beta (GM, BC, unpublished data).	p(FPLX:TCR)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9c78002f-6866-44a5-af38-db5583dc937c	1.0	PubMed	25935310	Whereas IGF-1 induced a significant increase in the phosphorylation of GSK3beta in control cardiomyocytes, overexpression of CHP3-GFP abolished the increased phosphorylation of GSK3beta (A).	p(HGNC:TESC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9c78002f-6866-44a5-af38-db5583dc937c	1.0	PubMed	25935310	We also observed that overexpression of CHP3-GFP inhibited a PE induced slight increase in GSK3beta phosphorylation, although the effect of PE was milder than that of IGF-1.	p(HGNC:TESC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9c78002f-6866-44a5-af38-db5583dc937c	1.0	PubMed	25935310	In this study, we observed that overexpression of CHP3 suppressed hormone (particularly IGF-1)-induced cardiomyocyte hypertrophy and inhibited phosphorylation of GSK3beta in NRVMs, suggesting a critical role of CHP3 as a negative regulator of hypertrophy, where CHP3 may balance the equilibrium of cardiac remodeling via regulation of GSK3beta activity.	p(HGNC:TESC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
811ac566-36e3-48b2-85c2-631d6821e469	1.0	PubMed	20190034	Unlike epidermal growth factor, BMP-4, TGF-beta1, 5-HT, and ET-1 each increased smooth muscle cell size, contractile protein expression, fractional cell shortening, and GSK-3beta phosphorylation.	p(HGNC:TGFB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
87029a07-6b6f-45d0-8aed-3c946ab69cf9	1.0	PubMed	21189258	We found that TGF-beta1 induced glycogen synthase kinase-3beta (GSK-3beta) phosphorylation on Ser 9 in HKC-8 cells, leading to its inactivation.	p(HGNC:TGFB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
5fc8b5b7-cc05-4213-8c06-8fc38d23b608	1.0	PubMed	18778410	Our result showed that Tg (PRDX3) mice have increased phosphorylation of GSK3beta and GSK3alpha.	p(HGNC:TG)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
265ac77a-de1a-4bf9-bcbd-8a6820bd0f9f	1.0	PubMed	17615157	Furthermore, the phosphorylations of GSK-3beta and Foxo1, well-known substrates of Akt, were increased by CTMP overexpression.	p(HGNC:THEM4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b51c12cf-133b-4506-84db-403c549ff2d1	1.0	PubMed	27354597	These results suggest that TLR4 induced GSK3beta and ERK phosphorylation independently controls cancer cell survival and regulation of GSK3beta and ERK after chemotherapy, making TLR4 a critical target for reducing drug resistance and metastasis in patients with colon cancer.	p(HGNC:TLR4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
20387026-291a-426e-b423-7a79f4c11d46	1.0	PubMed	21334395	Thus, cirrhotic monocytes have a defect in TLR4 and PI3K mediated phosphorylation of GSK3beta (Ser9) but not of GSK3alpha (Ser21) and this defect seems to be distal to PI3K.	p(HGNC:TLR4)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
b3beef15-2fd0-45d3-a327-4a1c88f69b22	1.0	PubMed	25218472	Here, we showed that downregulation of Tbeta4 by siRNA decreased the phosphorylation of GSK3beta, and decreased the expression and nuclear localization of beta-catenin.	p(HGNC:TMSB4X)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e8c3d924-185f-44c4-80a1-8c74bc38667c	1.0	PubMed	21405945	Indeed, TMZ phosphorylated and activated Akt led to phosphorylation and inactivation of GSK3beta which resulted in the stabilisation of c-Myc protein and subsequent modulation of the c-Myc target genes involved in the apoptotic processes.	a(CHEBI:72564, pmod(Ph))	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b1db3044-c276-45fe-871f-aa196f3fcbee	1.0	PubMed	26608463	OPG activated Akt and GSK3beta phosphorylation without notably affecting Erk1/2 activation.	p(HGNC:TNFRSF11B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
50c14d04-d6dd-41a3-a0ef-41fc87f5e1b9	1.0	PubMed	7053081	Importantly, TRAIL stimulation increased GSK-3beta tyrosine phosphorylation at Y216, suggesting that GSK-3beta is activated by TRAIL.	p(HGNC:TNFSF10)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
50c14d04-d6dd-41a3-a0ef-41fc87f5e1b9	1.0	PubMed	14617795	Importantly, TRAIL stimulation increased GSK-3beta tyrosine phosphorylation at Y216, suggesting that GSK-3beta is activated by TRAIL.	p(HGNC:TNFSF10)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr, 216))
cd54941f-d051-4198-8ac4-97d689716afe	1.0	PubMed	7053081	Importantly, TRAIL stimulation increased GSK-3beta tyrosine phosphorylation at Y216, suggesting that GSK-3beta is activated by TRAIL.	p(HGNC:TNFSF10)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
cd54941f-d051-4198-8ac4-97d689716afe	1.0	PubMed	14617795	Importantly, TRAIL stimulation increased GSK-3beta tyrosine phosphorylation at Y216, suggesting that GSK-3beta is activated by TRAIL.	p(HGNC:TNFSF10)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
309a8701-5718-4232-b7af-6d7367138d4f	1.0	PubMed	18443205	In primary cultures of human muscle, TNF-alpha exposure enhanced phosphorylation of GSK3beta.	p(HGNC:TNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
309a8701-5718-4232-b7af-6d7367138d4f	1.0	PubMed	19411070	We found that TNFalpha induced stabilization of Snail regardless of the phosphorylated status of GSK-3beta (XREF_FIG), suggesting that TNFalpha -mediated Snail stabilization is independent of GSK-3beta phosphorylation.	p(HGNC:TNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
309a8701-5718-4232-b7af-6d7367138d4f	1.0	PubMed	15026145	Further, The phosphorylation of GSK-3beta by TNF-alpha and insulin parallels those of PKB-alpha, indicating that downstream effects of TNF-alpha and insulin are mediated through this enzyme.	p(HGNC:TNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
309a8701-5718-4232-b7af-6d7367138d4f	1.0	PubMed	23911749	TNF-alpha induces the phosphorylation of glycogen synthase kinase 3beta (GSK3beta), i.e. inhibition of GSK3beta.	p(HGNC:TNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
309a8701-5718-4232-b7af-6d7367138d4f	1.0	PubMed	23911749	4) TNF-alpha induces hyper-phosphorylation of GSK3beta, i.e. the deactivated form of GSK3beta, which increases nuclear beta-catenin and Lef-1 accumulation, and eventually reduces the Runx2 associated osteogenesis in PDLSCs.	p(HGNC:TNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
309a8701-5718-4232-b7af-6d7367138d4f	1.0	PubMed	23911749	Based on these observations, we speculated that in the inflammatory microenvironment, TNF-alpha induces hyper-phosphorylation of GSK3beta, which increases nuclear beta-catenin and Lef-1 accumulation, and eventually reduces the Runx2 associated osteogenesis in PDLSCs.Yet, how were GSK3beta activities affected by TNF-alpha?	p(HGNC:TNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
309a8701-5718-4232-b7af-6d7367138d4f	1.0	PubMed	23911749	However, in-depth study is needed to investigate the mechanisms regulating GSK3beta activity in PDLSCs under inflammatory conditions.Our findings demonstrated that in the inflammatory microenvironments, TNF-alpha induced the phosphorylation of GSK3beta, and the p-GSK3beta subsequently resulted in nuclear beta-catenin accumulation and beta-catenin and Lef -1 complex formation, which inhibited Runx2 associated the osteogenesis of PDLSCs.	p(HGNC:TNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4c201b73-8fbd-4faa-a78f-d4f4f18b3602	1.0	PubMed	15026145	Both TNF-alpha and insulin increased the phosphorylation of Ser residue of GSK-3beta but the phosphorylation was significantly higher in the presence of insulin as compared to TNF-alpha.	p(HGNC:TNF)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
116d72e8-7cd2-4ead-bb8a-84cce92c0d67	1.0	PubMed	22710759	The knock-down of Tob1 using specific si-RNA increased the phosphorylation of Akt and GSK3beta (serine 9), resulting in the increased expression of beta-catenin and its target gene in AGS cells (XREF_FIG).	p(HGNC:TOB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
9847be80-9824-468d-9e70-92a91181b684	1.0	PubMed	22710759	Conversely, silencing of Tob1 induced the phosphorylation of Akt and GSK-3beta, and increased the expression of beta-catenin and its target genes.	p(HGNC:TOB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9847be80-9824-468d-9e70-92a91181b684	1.0	PubMed	22710759	As expected, Tob1 decreased the phosphorylation of Akt and GSK3beta (XREF_FIG).	p(HGNC:TOB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f68f38f9-0385-4092-99de-fb0c833d951f	1.0	PubMed	22710759	The knock-down of Tob1 using specific si-RNA increased the phosphorylation of Akt and GSK3beta (serine 9), resulting in the increased expression of beta-catenin and its target gene in AGS cells (XREF_FIG).	p(HGNC:TOB1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
0cc89733-b0b9-4121-ad04-b1f97cb042ef	1.0	PubMed	25629696	Furthermore, knockdown of TPD52L2 promoted GSK3beta phosphorylation in ZR-75-30 cells.	p(HGNC:TPD52L2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cf965952-459b-433e-92af-54186640e9ce	1.0	PubMed	24597671	Figure XREF_FIG A shows that HG/Pal decreased, and TPEN further decreased, Akt and GSK-3beta phosphorylation, which was restored or even further stimulated by Zn addition.	a(PUBCHEM:5519)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ef2525df-18a6-46c0-b25c-a2e0f382c201	1.0	PubMed	18804163	TPO induces phosphorylation of GSK-3beta.	p(HGNC:TPO)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ef2525df-18a6-46c0-b25c-a2e0f382c201	1.0	PubMed	18804163	We conclude that GSK-3beta is phosphorylated and inhibited by TPO induced Akt, promoting survival and proliferation in megakaryocytic cells through a pathway that does not involve beta-catenin.	p(HGNC:TPO)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ef2525df-18a6-46c0-b25c-a2e0f382c201	1.0	PubMed	18804163	Using a TPO dependent megakaryocytic cell line (UT-7 and TPO), we found that GSK-3beta is phosphorylated and inhibited by TPO and this requires PI3K activity.	p(HGNC:TPO)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ef2525df-18a6-46c0-b25c-a2e0f382c201	1.0	PubMed	18804163	Therefore, these experiments show that TPO treatment results in phosphorylation and inhibition of GSK-3beta, but only a modest accumulation of beta-catenin in comparison to inhibition of GSK-3beta using the chemical inhibitor BIO.	p(HGNC:TPO)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
4debe3ee-eb6b-4c66-8574-bc190b2797a1	1.0	PubMed	25483191	XREF_BIBR In prostate cancer cells, TRAF6 induced activation of p38 was also found to promote phosphorylation of GSK-3beta at Ser9, inhibiting its kinase activity and causing increased levels of both c-Jun, as well as of activated Smad 2 and Smad3 proteins, suggesting that TRAF6 both enhances and prolongs Smad dependent signals evoked by the canonical TGFbeta-Smad pathway, probably resulting in the formation of c-Jun homodimers.	p(HGNC:TRAF6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
8985dd55-554f-459b-adf2-dcf9eec110fc	1.0	PubMed	21435438	The TRB3 inhibits the phosphorylation of Akt and GSK3beta, leading to increased phosphorylation levels of glycogen synthase and reduced hepatic glycogen synthesis.	p(HGNC:TRIB3)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2b85155c-3e72-4795-bd8c-97e0959ede5e	1.0	PubMed	17052453	We found that endogenous S6K1 isolated from serum starved TSC2 deficient cells, but not control cells, could phosphorylate recombinant GSK3beta on S9 in vitro, and this activity is sensitive to pretreatment of the cells with rapamycin (B and 4C).	p(HGNC:TSC2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
866d3e87-05f5-44c0-bac4-32282d4326d5	1.0	PubMed	20302655	Treatment of SAS cells with AG1478 markedly suppressed the phosphorylation of GSK-3beta (Ser 9) and beta-catenin (tyrosine); treatment of OECM1 cells with EGF increased the phosphorylation of GSK-3beta (Ser 9) and beta-catenin (tyrosine).	p(HGNC:TSPAN31)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
10fe3f32-1fbc-47d3-9eb6-e34124522d20	1.0	PubMed	20302655	Treatment of SAS cells with AG1478 markedly suppressed the phosphorylation of GSK-3beta (Ser 9) and beta-catenin (tyrosine); treatment of OECM1 cells with EGF increased the phosphorylation of GSK-3beta (Ser 9) and beta-catenin (tyrosine).	p(HGNC:TSPAN31)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
41acc6ce-bb15-44fb-ba25-192f75e2cb06	1.0	PubMed	26781467	Mechanistically, TUFM knockdown activated AMPK and phosphorylated GSK3beta and increased the nuclear accumulation of beta-catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung cancer cells.	p(HGNC:TUFM)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
482400e1-24f3-4ecb-8c63-74f49d540b8c	1.0	PubMed	21284870	Consistent with these findings, we discovered that Akt was activated in Twist overexpressing cells, which lead to the phosphorylation and suppression of GSK-3beta and resulted in the significant protein stabilization of beta-catenin and Snail in these cells.	p(HGNC:TWIST1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
1e51a6be-5a20-404e-895f-69299df12dc8	1.0	PubMed	26325518	We found that overexpression of TXN increased the levels of Snail, Slug and Akt and GSK-3beta phosphorylation, whereas knockdown of TXN reduced the levels of Snail, Slug, Akt and GSK-3beta phosphorylation.	p(HGNC:TXN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e0651c6e-d5d7-4a7f-abe1-6d8aa86a50a8	1.0	PubMed	21156028	The granular component of vacuoles reacts with antibodies to tubulin [XREF_BIBR], abnormally phosphorylated tau [XREF_BIBR] and GSK-3beta [XREF_BIBR, XREF_BIBR] as well as to ubiquitin [XREF_BIBR].	p(FPLX:Tubulin)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
be573f3e-932a-4ef4-9376-b7cabbdd320f	1.0	PubMed	26320152	Similarly, GSK3beta phosphorylation was reduced by the MEK/ERK-1/2 inhibitor U0126, indicating involvement of the ERK1/2 pathway in the oxidant induced effect on GSK3beta in primary monocytes.	a(CHEBI:90693)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
90b3bd43-7f86-4e0b-a479-ba12c55025a4	1.0	PubMed	7222190	U0126, a MEK1/2 inhibitor, inhibited tyrosine phosphorylation of GSK-3beta, suggesting that MEK1/2 was involved in the phosphorylation of Tyr (216) in GSK-3beta.	a(CHEBI:90693)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
1a7bce4a-a2be-4e3d-b004-247d02ed301a	1.0	PubMed	25541373	Consistent with this, blocking the cAMP and PKA pathway resulted in reduced GSK-3beta, phosphorylation and increased cell death, further suggesting that Ucn 1 induced GSK-3beta phosphorylation dependent neuroprotection is mediated by a rise in intracellular levels of cAMP.	p(HGNC:UCN)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e4ad2c28-50ac-4564-b868-333183800150	1.0	PubMed	21559414	In cardiomyocytes, UII also increases phosphorylation of Akt and its downstream target GSK-3beta, a serine/threonine protein kinase discovered for its property to inhibit glycogen synthase that has been implicated in many disease states, among others tumorigenesis, diabetes or neurodegenerative diseases XREF_BIBR.	p(HGNC:UTS2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e8e89908-055e-47ea-a725-d7e0da912049	1.0	PubMed	21156028	The granular component of vacuoles reacts with antibodies to tubulin [XREF_BIBR], abnormally phosphorylated tau [XREF_BIBR] and GSK-3beta [XREF_BIBR, XREF_BIBR] as well as to ubiquitin [XREF_BIBR].	p(FPLX:Ubiquitin)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
aca0e2ae-0914-4342-85ed-f5f8e6b449ee	1.0	PubMed	23994577	VPA also caused phosphorylation of Akt and glycogen synthase kinase-3beta (GSK3beta) at concentrations ranging from 0.6 mM to 5mM in SH-SY5Y cells, suggesting activation of the PI3K pathway known to inhibit GSK3beta through Akt phosphorylation.	a(CHEBI:39867)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
2cbb59a2-4c41-4b92-9bb3-d18092790778	1.0	PubMed	25041379	Valproate and antipsychotic drugs increase GSK-3beta phosphorylation at Ser 9, thus providing evidence of direct inhibition of GSK-3beta activity by mood stabilizers and antipsychotics (XREF_BIBR, XREF_BIBR, XREF_BIBR).	a(PUBCHEM:3121)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
8178d46c-97bf-4524-9cbf-181683f15bac	1.0	PubMed	23920402	Our data demonstrate that knockdown of WDR62 could inhibit not only the expression of Akt, p38-MAPK and MDR1, but also the phosphorylation and activation of Akt, p38-MAPK and GSK-3beta, so as to potentially reverse GC MDR.	p(HGNC:WDR62)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f2929beb-da45-4dbc-ac7c-26a12eab2d37	1.0	PubMed	25749038	Furthermore, our study demonstrated that WISP1 promoted phosphorylation and inactivation of GSK3beta, a key enzyme that inhibits activation of Wnt and beta-catenin pathway.	p(HGNC:WISP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f2929beb-da45-4dbc-ac7c-26a12eab2d37	1.0	PubMed	25749038	Less active GSK3beta enhanced activation of Wnt and beta-catenin pathway and resultant WISP1 expression; in turn, increased WISP1 expression further led to phosphorylation and inactivation of GSK3beta, which eventuated in a strong positive feedback loop of WISP1 expression and concomitant refractory radioresistance.	p(HGNC:WISP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f2929beb-da45-4dbc-ac7c-26a12eab2d37	1.0	PubMed	20074638	Here we show that WISP1 induces GSK3beta phosphorylation, beta-catenin nuclear translocation, and the transcription of its own gene.	p(HGNC:WISP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f2929beb-da45-4dbc-ac7c-26a12eab2d37	1.0	PubMed	20074638	Since WISP1 induces GSK3beta phosphorylation, and thus targeting its degradation by the ubiquitin-proteasome system, we hypothesize that treatment with WISP1 favors cytoplasmic localization of Survivin.	p(HGNC:WISP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f2929beb-da45-4dbc-ac7c-26a12eab2d37	1.0	PubMed	20074638	Further, WISP1 stimulates PI3K-Akt-dependent GSK3beta phosphorylation and beta-catenin nuclear translocation.	p(HGNC:WISP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f2929beb-da45-4dbc-ac7c-26a12eab2d37	1.0	PubMed	20074638	WISP1 induces GSK3beta phosphorylation and beta-catenin nuclear translocation.	p(HGNC:WISP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f2929beb-da45-4dbc-ac7c-26a12eab2d37	1.0	PubMed	20074638	Results in XREF_FIG show that WISP1 indeed induced GSK3beta phosphorylation (Ser9) in a time dependent manner, an effect that was attenuated by the GSK3beta specific inhibitor SB-216763, and by LiCl (XREF_FIG).	p(HGNC:WISP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f2929beb-da45-4dbc-ac7c-26a12eab2d37	1.0	PubMed	20074638	These results indicate that WISP1 induces PI3K-Akt-dependent GSK3beta phosphorylation and beta-catenin nuclear translocation in cardiomyocytes (XREF_FIG).	p(HGNC:WISP1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
25ef5e6f-b220-40e9-9756-35dcd16541e0	1.0	PubMed	20826156	It remains to be determined whether Tyr phosphorylation of GSK3beta is down-regulated by Wnt10b and Wnt5a, in response to PG activated NF-kappaB.	p(HGNC:WNT10B)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
65af5bf2-4eb0-451d-ae6b-85d960df101f	1.0	PubMed	17289346	Through Akt1 dependent pathways, Wnt1 phosphorylates GSK-3beta and maintains beta-catenin integrity to insure its translocation from the cytoplasm to the nucleus to block apoptosis.	p(HGNC:WNT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
65af5bf2-4eb0-451d-ae6b-85d960df101f	1.0	PubMed	22270359	Leptin treatment also increases Wnt1 expression that contributes to GSK3beta phosphorylation.	p(HGNC:WNT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
65af5bf2-4eb0-451d-ae6b-85d960df101f	1.0	PubMed	25618247	Pretreatment with Dickkopf-1 inhibited Wnt1 stimulated differentiation of hPLFs by suppressing GSK-3beta phosphorylation, nuclear translocation of beta-catenin, and expression of the bone specific factors.	p(HGNC:WNT1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f4c62407-fcd7-45ac-9dcb-14b515ee4521	1.0	PubMed	26721203	The primary antibodies used for Western blot, immunohistochemistry and immunofluorescence analyses were mouse anti-human cytokeratin (CK AE1 and AE3), CK7, 8-OhdG, Ki-67, GAPDH (Santa Cruz Biotechnology, CA, USA) antibodies, rabbit anti-human Wnt2, beta-catenin, DVL, Gsk3beta, TCF4, LEF-1, CychinD1, and CDK4 antibodies, phosphorylated DVL and phosphorylated Gsk3beta monoclonal antibodies (Epitomics, CA, USA).	p(HGNC:WNT2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
60eeb90f-e268-4dc6-a260-1604207ae362	1.0	PubMed	23666756	Consequently, kallistatin pre-treatment reduced Wnt3a induced LRP6 and GSK-3beta phosphorylation and cytosolic non phosphorylated beta-catenin levels in MDA-MB-231 cells.	p(HGNC:WNT3A)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
60eeb90f-e268-4dc6-a260-1604207ae362	1.0	PubMed	19795391	Furthermore, when the WNT and beta-catenin pathway was activated in chondrocytic cells by WNT3a or SB216763, which inhibits the phosphorylation of GSK3beta, the mRNA levels of aggrecan and col2a1 were decreased, whereas that of mmp13 was increased.	p(HGNC:WNT3A)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
255dc1a2-3ac3-418c-b6fc-22dcf8590e43	1.0	PubMed	20826156	It remains to be determined whether Tyr phosphorylation of GSK3beta is down-regulated by Wnt10b and Wnt5a, in response to PG activated NF-kappaB.	p(HGNC:WNT5A)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
fea32d69-f602-4285-a80f-31ef10933490	1.0	PubMed	15126504	Remarkably knock-down of WOX1 expression by small interfering RNA in neuroblastoma SK-N-SH cells spontaneously induced Tau phosphorylation at Thr212 and Thr231 and Ser515 and Ser516, enhanced phosphorylation of glycogen synthase kinase 3beta (GSK-3beta) and ERK, and enhanced NFT formation.	p(HGNC:WWOX)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
807c62a3-fd61-4186-8e9c-2a9949195c8b	1.0	PubMed	26001136	Canonical Wnt signaling was repressed following miR-148a expression, as indicated by the marked reduction of Wnt1 protein (XREF_FIG, Day 0), increased phosphorylation of GSK-3beta (p-GSK-3beta) (XREF_FIG, Day 10), and reduced nuclear beta-catenin (XREF_FIG, Day 10).	p(FPLX:Wnt)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
807c62a3-fd61-4186-8e9c-2a9949195c8b	1.0	PubMed	19887570	Chemical inhibition of PI3K abolished Wnt dependent phosphorylation of AKT and GSK-3beta and trophoblast motility but did not affect appearance of activated beta-catenin or Wnt and TCF reporter activity.	p(FPLX:Wnt)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
807c62a3-fd61-4186-8e9c-2a9949195c8b	1.0	PubMed	25041379	Phosphorylation of GSK-3beta by the Wnt signaling pathway is one of the mechanisms regulating its activity.	p(FPLX:Wnt)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
807c62a3-fd61-4186-8e9c-2a9949195c8b	1.0	PubMed	25569101	XREF_BIBR, XREF_BIBR Many signaling events have been shown to be involved : among them, Wnt signaling inhibits GSK3beta mediated phosphorylation and degradation of beta-catenin.	p(FPLX:Wnt)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
807c62a3-fd61-4186-8e9c-2a9949195c8b	1.0	PubMed	21303971	Wnt stimulation prevents GSK-3beta mediated phosphorylation and degradation and instead leads to unique phosphorylation events on beta-catenin resulting in its translocation to the nucleus where it interacts with different transcription factors, most notably members of the TCF/LEF family, to control the expression of its target genes including c-jun, c-myc and cyclin D1 (XREF_BIBR, XREF_BIBR, XREF_BIBR).	p(FPLX:Wnt)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
807c62a3-fd61-4186-8e9c-2a9949195c8b	1.0	PubMed	19238201	Wnt pathway activation (e.g., through Frizzled receptor) leads to GSK-3beta phosphorylation, which subsequently inhibits beta-catenin degradation by the APC-complex XREF_BIBR, XREF_BIBR.	p(FPLX:Wnt)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
04ff43af-2b74-4a47-bfb5-2235d1f83f82	1.0	PubMed	25138042	Surprisingly, using a NF-kappaB luciferase reporter system, we find that Ser9 phosphorylation of GSK3beta promoted by 14-3-3zeta is critical for the activation of NF-kappaB pathway, which may thwart the pro apoptotic activity of GSK3beta.	p(HGNC:YWHAZ)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
04ff43af-2b74-4a47-bfb5-2235d1f83f82	1.0	PubMed	25138042	Inhibition of either NF-kappaB or GSK3beta significantly abolishes the anti-apoptotic effect of 14-3-3zeta and Ser9 phosphorylated GSK3beta, suggesting that Ser9 phosphorylated GSK3beta actively antagonizes cell apoptosis in a NF-kappaB dependent manner.	p(HGNC:YWHAZ)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
8dcd987e-a285-4cd6-8499-5a7722d3cde3	1.0	PubMed	24597671	Zn supplement prevented the effects of TPEN and also increased Akt and GSK-3beta phosphorylation with a decrease in Nrf2 nuclear exporter, Fyn.	a(PUBCHEM:23994)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8dcd987e-a285-4cd6-8499-5a7722d3cde3	1.0	PubMed	24597671	Figure XREF_FIG A shows that HG/Pal decreased, and TPEN further decreased, Akt and GSK-3beta phosphorylation, which was restored or even further stimulated by Zn addition.	a(PUBCHEM:23994)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8dcd987e-a285-4cd6-8499-5a7722d3cde3	1.0	PubMed	24597671	It has been suggested that Zn stimulation of Akt phosphorylation and, consequently, GSK-3beta phosphorylation, may result in the reduction in Fyn nuclear translocation to export Nrf2 to the cytosol.	a(PUBCHEM:23994)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8dcd987e-a285-4cd6-8499-5a7722d3cde3	1.0	PubMed	24597671	That is probably because alcohol feeding reduces the intracellular free Zn level that stimulates Fyn into nuclear to export Nrf2 to cytosolic degradation while Zn supplement might stimulate Akt and GSK-3beta phosphorylation that inhibits Fyn nuclear translocation, preventing Fyn mediated export of Nrf2 from nuclear that restores Nrf2 nuclear binding.	a(PUBCHEM:23994)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
20555937-201c-4fed-a362-80c0ab138b2f	1.0	PubMed	19332462	In addition, ALDH2 transgene significantly attenuated chronic alcohol intake induced myocardial fibrosis, protein carbonyl formation, apoptosis, enhanced NADPH oxidase p47 phox and calcineurin expression as well as phosphorylation of ASK-1, GSK-3beta, GATA4 and CREB.	a(CHEBI:16236)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
20555937-201c-4fed-a362-80c0ab138b2f	1.0	PubMed	19332462	As shown in XREF_FIG, chronic alcohol intake led to upregulated p47 phox (but not p67 phox, data not shown) and calcineurin A, as well as enhanced phosphorylation of ASK-1, GSK-3beta, GATA4 and CREB in FVB mice.	a(CHEBI:16236)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
20555937-201c-4fed-a362-80c0ab138b2f	1.0	PubMed	19332462	ALDH2 transgene ameliorates chronic alcohol intake induced hyper-phosphorylation of ASK-1, GSK-3beta, GATA4 and CREB, suggesting a possible role of these molecules in the cytoprotection of ALDH2.	a(CHEBI:16236)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e7903c25-cbe0-42b1-9a4f-805ab00d1657	1.0	PubMed	21315744	These results seem consistent with a previous study that has reported an amphetamine induced decrease in phosphorylation of AKT and GSK-3beta in the mouse striatum (XREF_BIBR).	a(PUBCHEM:3007)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
5444934b-74a2-4c09-9ce1-3a5f62810650	1.0	PubMed	18702828	Administration of amphetamine to mice increased Ser9 phosphorylation of GSK-3beta, resulting in a reduction of its activity in the frontal cortex and striatum [XREF_BIBR], and GSK-3 gene knockdown mice showed a reduced response to amphetamine [XREF_BIBR].	a(PUBCHEM:3007)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
5a949a30-6609-4b94-a578-f8627eef4dce	1.0	PubMed	18240292	We also found that apigenin inhibited Akt and GSK-3beta phosphorylation in PC3-M cells.	a(CHEBI:18388)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b56cf40a-6c72-4005-9486-2996a030497a	1.0	PubMed	26686692	MbetaCD and Cav-1 siRNA knockdown increased OM induced AMPK, Akt, GSK3beta, and CREB phosphorylation, which were reversed by Ara-A, a specific AMPK inhibitor.	p(UP:A0LT86)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
ea246094-5369-4972-a7f7-052bd78f3f83	1.0	PubMed	25869100	Our results revealed that capsaicin treatment decreased the phosphorylation of GSK-3beta at S9 and STAT-3 at Y705 and increased the phosphorylation of beta-catenin at S33/37/T41.	a(CHEBI:3374)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
42ff2b4a-8bf2-464a-88d3-8b58a690e471	1.0	PubMed	25869100	Our results revealed that capsaicin treatment decreased the phosphorylation of GSK-3beta at S9 and STAT-3 at Y705 and increased the phosphorylation of beta-catenin at S33/37/T41.	a(CHEBI:3374)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
688132de-fa6a-4b33-8a03-af268159ce09	1.0	PubMed	25733387	The direct interaction of beta-catenin and APC and indirect recruitment of the Axin, GSK3beta, CK1, SCF, beta, and TrCP complex to the IQGAP1 scaffold demonstrate that under steady state, casein kinase 1 (CK1) phosphorylates GSK3beta, which in turn constitutively phosphorylates beta-catenin and directs it for degradation.	p(PFAM:PF00363)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
688132de-fa6a-4b33-8a03-af268159ce09	1.0	PubMed	19251162	These results implicate the importance of beta-catenin in stem cell niche of human hair follicle tissue.At amino terminus of beta-catenin, there are several serine/threonine residues that are phosphorylated by casein kinase 1 (CK1) and glycogen synthase kinase-3beta (GSK-3beta), whose phosphorylation leads to the degradation of beta-catenin.	p(PFAM:PF00363)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
688132de-fa6a-4b33-8a03-af268159ce09	1.0	PubMed	22824791	5 The cytoplasmic tail of LRP6 is then phosphorylated by casein kinase 1alpha and GSK-3beta, which are recruited together with Axin from the ' beta-catenin destruction complex '.	p(PFAM:PF00363)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e2657538-01f6-4bfb-acad-baceadd6010d	1.0	PubMed	20015462	Administration of d-fenfluramine and clorgyline augmented 5-HT levels and increased the serine 9 phosphorylation of GSK3beta in the pre-frontal cortex, hippocampus, and striatum of mice ().	a(PUBCHEM:4380)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
f58055c6-c377-4fb8-b74c-e3dca728559e	1.0	PubMed	17097050	On the other hand, in accordance with its inhibitory effect on NF-AT (), compound C significantly inhibited phosphorylation of GSK-3beta, a critical NF-AT kinase, in PMA/Io activated Jurkat cells (B).	a(PUBCHEM:11524144)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
bec81207-0142-4027-a97d-64e1d0e3c75c	1.0	PubMed	24610780	We conclude that copper promotes APP trafficking by promoting a GSK3beta dependent phosphorylation in SH-SY5Y cells.	a(CHEBI:29036)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7b1f3ab2-f21c-4b1d-8cfe-5394d6c7f7f4	1.0	PubMed	24120917	DHA decreased GSK-3beta phosphorylation although it increased the total levels of GSK-3beta.	a(CHEBI:207229)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
9ebef4c1-6510-4fb1-9041-4750b2e6e208	1.0	PubMed	22087308	In accordance with this, etoposide or doxorubicin reduced the inhibitory phosphorylation of GSK3beta, which was inhibited by the PP2A inhibitor okadaic acid (XREF_FIG).	a(CHEBI:28748)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
35287c51-9439-458c-9e83-a029572f8a7f	1.0	PubMed	26822034	Interestingly, doxorubicin elicited the phosphorylation of GSK3beta on Ser 389 and this correlated with the activation of p38 MAPK (XREF_FIG) and the induction of DSBs as determined by the presence of gammaH2AX (XREF_FIG).	a(CHEBI:28748)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 389))
154d6fb7-8fe2-4bf3-9e9e-d1a26f44b2bb	1.0	PubMed	26252009	As treatment with LiCl did not recover embelin mediated decrease in GSK-3beta phosphorylation, LiCl may inhibit GSK-3beta activity but not change GSK-3beta phosphorylation.	a(CHEBI:4778)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
62da592c-ef8e-4d1e-939c-0209bea6bfea	1.0	PubMed	24157255	The concomitant presence of shRNA and emodin more potently inhibited Akt and GSK-3beta phosphorylation than did treatment with shRNA or emodin alone (C and D).	a(CHEBI:42223)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a3aad47d-409c-46f7-9ae1-f03f1c42a037	1.0	PubMed	20934407	In this report, we demonstrate for the first time that clinically achievable enzastaurin concentrations activate GSK-3beta in human NK cells by specifically suppressing GSK-3beta phosphorylation.	a(PUBCHEM:176167)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a3aad47d-409c-46f7-9ae1-f03f1c42a037	1.0	PubMed	20934407	However, enzastaurin concentrations between 0.625 muM and 2.5 muM inhibited dose-dependently GSK3beta phosphorylation in NK cells indicating an uncoupling of anti-proliferative effects of enzastaurin from effects on GSK3beta signaling.	a(PUBCHEM:176167)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a3aad47d-409c-46f7-9ae1-f03f1c42a037	1.0	PubMed	20934407	Similar observations were made in lymphoma cells treated with 2.5 muM enzastaurin which nearly completely abrogated GSK-3beta phosphorylation but did not influence cell proliferation.	a(PUBCHEM:176167)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a3aad47d-409c-46f7-9ae1-f03f1c42a037	1.0	PubMed	20934407	In addition, we show that enzastaurin selectively inhibits GSK-3beta phosphorylation (known to be involved in NK cell cytotoxicity) without affecting signaling molecules responsible for cell proliferation and survival (AKT, S6, p70S6K).	a(PUBCHEM:176167)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
8cb3313c-1704-4461-b884-860fc55d536e	1.0	PubMed	22253748	In addition, enzastaurin targets the phosphatidylinositol 3-kinase/AKT pathway, and inhibits phosphorylation of GSK3beta (Ser9) and ribosomal protein S6 (Ser240/244) XREF_BIBR.	a(PUBCHEM:176167)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
33fdc643-f421-458e-922d-e05b1829f2fa	1.0	PubMed	21334395	The finding that acute ethanol treatment decreases AKT phosphorylation and subsequent GSK3beta phosphorylation in murine cardiomyocytes suggests differences between cell types regarding the effect of alcohol.	a(CHEBI:16236)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
3c662f9c-fbf6-40f6-b10a-09fcad3f0959	1.0	PubMed	22087308	In accordance with this, etoposide or doxorubicin reduced the inhibitory phosphorylation of GSK3beta, which was inhibited by the PP2A inhibitor okadaic acid (XREF_FIG).	a(CHEBI:4911)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
3c662f9c-fbf6-40f6-b10a-09fcad3f0959	1.0	PubMed	22087308	Intriguingly, the inhibitory phosphorylation of GSK3beta was enhanced and was not inhibited by etoposide in cells expressing STAT5A1 * 6.	a(CHEBI:4911)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
04363e0b-a0ff-499f-adb2-907743fd58f1	1.0	PubMed	20357815	Phosphorylation of GSK-3beta at serine 9 was increased by forskolin at 15minutes and then reduced to the basal level at 30minutes post-treatment ().	a(PUBCHEM:47936)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, 9))
28762c46-f09e-409e-933e-65dcf4ba7acb	1.0	PubMed	20357815	Phosphorylation of GSK-3beta at serine 9 was increased by forskolin at 15minutes and then reduced to the basal level at 30minutes post-treatment ().	a(PUBCHEM:47936)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
4862f407-7131-47c6-95d5-8dda374f9b52	1.0	PubMed	5620652	Nerve growth factor withdrawal from differentiated PC12 cells and staurosporine treatment of SH-SY5Y cells led to increased phosphorylation at Y (216), GSK3beta activity, and cell death.	p(UP:Q776B5)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b5223b96-8ad2-4c64-9054-7fea138789ff	1.0	PubMed	7260269	Addition of guanosine caused a rapid phosphorylation of Akt and PKB, and glycogen synthase kinase-3beta (GSK-3beta) and induced an upregulation of Bcl-2 mRNA and protein expression.	a(PUBCHEM:6802)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
3b7b421c-3f42-4b18-a35f-81ff658694cd	1.0	PubMed	26284974	Furthermore, idebenone resulted in the phosphorylation of GSK3beta at Ser9 and the nuclear accumulation of beta-catenin of cells, which was associated with significantly the decrease of phosphorylated beta-catenin.	a(PUBCHEM:3686)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
2173c8bf-e97a-49db-bc21-b437d0725f43	1.0	PubMed	PMC6895213	Addition of SDF-1 to a human neuronal cell line induces phosphorylation of p44/p42 MAP kinase and GSK3beta.	p(UP:Q9WXE6)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a0c3666b-e750-433e-b20d-276dc54cb8be	1.0	PubMed	20454507	Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a0c3666b-e750-433e-b20d-276dc54cb8be	1.0	PubMed	18191226	Analysis of striatal extracts from WT mice confirmed that chronic lithium treatment enhances Akt and GSK3beta phosphorylation in neuronal tissues (A and 6B).	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
a0c3666b-e750-433e-b20d-276dc54cb8be	1.0	PubMed	23943160	We also observed that compared to the GW0742 treated samples, the combination of lithium and GW0742 restored the phosphorylation of both AKT (from 0.5 to 1.0, 0.6 to 1.2, and 0.8 to 1.2-fold increase in Ishikawa, RL-95 and Sawano cells lines, respectively) and GSK3beta (from 0.3 to 1.4, 0.5 to 0.9, 0.6 to 1.0-fold increase, in Ishikawa, RL-95, and Sawano cells, respectively) (XREF_FIG).	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
cd92a954-73d9-4eaa-bdd6-4a1dce89ed56	1.0	PubMed	19576885	Second, lithium can inhibit GSK-3beta activity by increasing the phosphorylation of the inhibitory serine (Ser 9) of GSK-3beta.	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
cd92a954-73d9-4eaa-bdd6-4a1dce89ed56	1.0	PubMed	19727391	Interestingly the selectivity of the synergistic interaction correlated with increased phosphorylation of an inhibitory residue (Ser 9) on GSK3beta induced by BIO or GSK3 inhibitor VIII, but not by lithium or Wnt-3a (XREF_FIG).	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
2da1b876-e77e-4494-9851-8689e2017f97	1.0	PubMed	19576885	Second, lithium can inhibit GSK-3beta activity by increasing the phosphorylation of the inhibitory serine (Ser 9) of GSK-3beta.	a(PUBCHEM:28486)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
345687e9-9626-4a2c-8528-07c2aa3c9cfa	1.0	PubMed	21239435	In addition, lithium chloride, which increases GSK3beta phosphorylation and the nuclear translocation of beta-catenin, increased MT1-MMP levels in these ovarian cancer cells.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
7a9659be-c3d2-46b9-80fc-2233b2323626	1.0	PubMed	24975844	As a GSK3beta inhibitor, lithium chloride stimulates the phosphorylation of GSK3beta at Ser9.	a(PUBCHEM:433294)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
a2ac8a37-dfc7-4428-ac5a-a84211d1681e	1.0	PubMed	21422248	However, it was unclear from these studies whether the ability of mTORC1 inhibition to attenuate the phosphorylation and inactivation of GSK3-beta is responsible for the inflammatory properties of rapamycin.	p(FPLX:mTORC1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f208966b-7099-4c84-b1fc-80edc7efa6a0	1.0	PubMed	21422248	Collectively, these results demonstrate that mTORC1 inhibition attenuates the ability of LPS to mediate the phosphorylation of GSK3-beta (S9) without any noticeable effect on the levels of phosphorylated Akt (S473 or T308).	p(FPLX:mTORC1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
f208966b-7099-4c84-b1fc-80edc7efa6a0	1.0	PubMed	21422248	We used immunoprecipitation studies to find out whether mTORC1 or an mTORC1 dependent kinase was mediating the phosphorylation of GSK3-beta (S9).	p(FPLX:mTORC1)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
ff0a556f-f890-4eaf-9235-2f7a9e6cffdc	1.0	PubMed	22488590	In BRCA1-KD MCF7 cells, treatment of PI-103, a PI3K and mTOR inhibitor, abolished phosphorylation of AKT and its substrate GSK3beta, in a dose dependent manner (XREF_FIG and XREF_SUPPLEMENTARY).	a(CHEBI:68481)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
24ec4516-8369-4721-b35a-78288561ce9b	1.0	PubMed	20553310	In addition, we have recently demonstrated that chronic memantine treatment markedly increased the inhibitory phosphorylation of GSK-3beta and consequently reduce the accumulation and phosphorylation of tau in the 3xTgAD mice [XREF_BIBR].	a(PUBCHEM:4054)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
e1a612f1-8f69-419e-b995-3d6154ad247f	1.0	PubMed	27517746	We showed that metformin did not inhibit GSK3beta phosphorylation in a dose dependent manner (XREF_SUPPLEMENTARY).	a(CHEBI:6801)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b4490f26-f803-4ac7-86ea-1f4ad4fa4cb5	1.0	PubMed	21524889	Since phosphorylation of GSK3beta is regulated by several kinases including PKA and PKB, we examined whether GSK3beta phosphorylation by minoxidil is mediated by PKA and PKB in human DPCs.	a(PUBCHEM:4201)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
b4490f26-f803-4ac7-86ea-1f4ad4fa4cb5	1.0	PubMed	21524889	We also found that minoxidil treatment increases the phosphorylation of GSK3beta and its upstream kinases PKA and PKB.	a(PUBCHEM:4201)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
fce11186-0c22-4b75-a1e0-9e4453e21c3b	1.0	PubMed	25889792	Imatinib, nilotinib, Akt inhibitor or IL-10 prevent phosphorylation of GSK3beta in moDC.	a(PUBCHEM:644241)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
edeb4164-da30-41e2-a02d-2ca8e05ed5ea	1.0	PubMed	26121043	GSK-3beta is phosphorylated and inactivated by Akt and p38 MAPK [XREF_BIBR, XREF_BIBR].	p(FPLX:p38)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
edeb4164-da30-41e2-a02d-2ca8e05ed5ea	1.0	PubMed	26320152	These redox sensitive p38 MAPK, ERK-1/2, and PI3K and Akt pathways can all induce GSK3beta phosphorylation (8, 15) and have been implicated in glucocorticoid insensitivity in COPD (5).	p(FPLX:p38)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
edeb4164-da30-41e2-a02d-2ca8e05ed5ea	1.0	PubMed	23123784	For instance, p38 can directly phosphorylate and inhibit GSK3beta to promote a beta-catenin-dependent pro survival cascade [XREF_BIBR].	p(FPLX:p38)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
89f228cf-8d3e-4ad6-99c8-d3dfb20c8b57	1.0	PubMed	23768967	p38 MAPK has been shown to inactivate GSK-3beta independent of serine 9 phosphorylation by phosphorylating GSK-3beta at serine 389, primarily in brain and thymocytes, offering an alternative mechanism for regulating beta-catenin levels through the inhibition of GSK-3beta.	p(FPLX:p38)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 389))
40027619-9584-408d-be16-3e62fc527808	1.0	PubMed	25483191	The stability of c-Jun protein is regulated by active GSK-3beta and therefore we investigated if p38 MAPK causes phosphorylation of GSK-3beta on Ser9, which is leading to its inhibition.	p(FPLX:p38)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
40027619-9584-408d-be16-3e62fc527808	1.0	PubMed	25483191	XREF_BIBR In prostate cancer cells, TRAF6 induced activation of p38 was also found to promote phosphorylation of GSK-3beta at Ser9, inhibiting its kinase activity and causing increased levels of both c-Jun, as well as of activated Smad 2 and Smad3 proteins, suggesting that TRAF6 both enhances and prolongs Smad dependent signals evoked by the canonical TGFbeta-Smad pathway, probably resulting in the formation of c-Jun homodimers.	p(FPLX:p38)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
0315d5fc-f4ad-4117-8839-657aaac188ad	1.0	PubMed	20190034	Unlike epidermal growth factor, BMP-4, TGF-beta1, 5-HT, and ET-1 each increased smooth muscle cell size, contractile protein expression, fractional cell shortening, and GSK-3beta phosphorylation.	a(PUBCHEM:5202)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
594d930f-de6d-45c4-8f00-30243d1d3846	1.0	PubMed	15132987	6-OHDA significantly inhibited phosphorylation of GSK3beta at Ser9, whereas it induced hyperphosphorylation of Tyr216 with little effect on GSK3beta expression in SH-SY5Y cells and PC12 cells (a rat dopamine cell line), as well as CGNs.	a(PUBCHEM:4624)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
594d930f-de6d-45c4-8f00-30243d1d3846	1.0	PubMed	25829335	Furthermore, investigation in different cell cultures have shown that besides triggering Tyr216 hyperphosphorylation, 6-OHDA also inhibits GSK-3beta phosphorylation at Ser9 and this GSK-3beta dephosphorylation at Ser9 disinhibits GSK-3beta, events which further activate GSK-3beta.	a(PUBCHEM:4624)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
041fcde7-3c7a-4277-ae1e-ca47cf2adc3e	1.0	PubMed	22728329	In HT-29 cells over expressing the EP4 receptor, PGE was linked predominantly to cAMP signaling, while in HEK293T cells programmed to ectopically express the EP2 receptor, PGE induced solely the phosphorylation of GSK-3beta activation of PKB and Akt.	p(UP:O42809)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0b8e05f7-e4c8-4c87-aaf8-e45e4634490a	1.0	PubMed	21239435	The phosphatidylinositol 3 kinase (PI3K)/Akt pathway is involved in beta-catenin-dependent signaling, and pretreatment of these human ovarian cancer cells with a PI3K and Akt inhibitor, LY294002, attenuated GnRH-II-stimulated phosphorylation of GSK3beta and inhibited GnRH-II-induced invasion.	a(PUBCHEM:53477912)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
0b8e05f7-e4c8-4c87-aaf8-e45e4634490a	1.0	PubMed	6009512	Insulin induced GSK-3beta phosphorylation is mediated by the phosphatidylinositol 3-kinase/Akt signaling pathway.	a(PUBCHEM:53477912)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
06569249-3f46-4111-aca2-4228cdf52d07	1.0	PubMed	19726098	In response to insulin stimulation, phosphatidylinositol 3-kinase-activated Akt phosphorylates GSK3beta at Ser, which leads to inactivation of GSK3beta and augmentation of beta-catenin-TCF and LEF -1 transcriptional activity.	a(PUBCHEM:53477912)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser))
90cab3f8-ef11-4bbc-86a2-3605e91d8af0	1.0	PubMed	7207834	Clozapine activates both Akt- and Dvl mediated phosphorylation of GSK-3beta through phosphorylation at Ser9, and increased total cellular and intranuclear levels of beta-catenin.	p(UP:P54644)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
90cab3f8-ef11-4bbc-86a2-3605e91d8af0	1.0	PubMed	14988008	Clozapine activates both Akt- and Dvl mediated phosphorylation of GSK-3beta through phosphorylation at Ser9, and increased total cellular and intranuclear levels of beta-catenin.	p(UP:P54644)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
90cab3f8-ef11-4bbc-86a2-3605e91d8af0	1.0	PubMed	24121026	On the other hand, we observed that T3 triggers a cascade of events that are PI3K dependent, since we demonstrated that pAKT induces a phosphorylation of glycogen synthase Kinase-3beta, GSK3beta, a main target of PI3K pathway.	p(UP:P54644)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
f6031e16-c6d8-49fb-b7ed-13fd94b66066	1.0	PubMed	23103626	Investigations of other types of cancers have shown that Gal-3 stimulates Akt phosphorylation and that pAkt phosphorylates GSK-3beta (a binding partner of beta-catenin) at Ser 9 and inactivates this protein XREF_BIBR, XREF_BIBR.	p(UP:P54644)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
444d1d69-60fc-4152-88b6-245a99c0a4c3	1.0	PubMed	15652488	aPKC can also phosphorylate GSK-3beta and inactivate its kinase activity, and GSK-3beta is important for polarization of migrating fibroblasts.	p(UP:Q19266)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
444d1d69-60fc-4152-88b6-245a99c0a4c3	1.0	PubMed	20152177	We thought that Dlg1 and GSK3beta are two good candidates for aPKC downstream effectors to be studied, though conflicting conclusions on the involvement of phosphorylated GSK3beta by aPKC in MTOC reorientation were drawn by different studies from Hall 's group ().	p(UP:Q19266)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
444d1d69-60fc-4152-88b6-245a99c0a4c3	1.0	PubMed	25756394	Furthermore, GSK-3beta is a substrate for aPKC, and inhibitory phosphorylation of GSK-3beta by aPKC induces APC recruitment to the microtubule plus end of migrating cells (XREF_BIBR).	p(UP:Q19266)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
857b114a-4dd5-4476-8f07-8b93ff6e7a99	1.0	PubMed	24986916	In murine models of mania (KCND2 and Kv4.2 knockout; ClockDelta19), genetic deletion or experimental manipulation of potassium currents attenuates physiological and behavioral correlates of mania and dose-dependently increases phosphorylation of GSK3beta in prefrontal cortex and hippocampus (XREF_BIBR).	a(PUBCHEM:813)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
dece6e95-77a0-4e5e-85c3-fd5d3e3fa877	1.0	PubMed	22837212	LMP2A also induced phosphorylation of the Akt target GSK3beta, a Wnt signaling mediator that has been shown to regulate the activity of focal adhesion kinase (FAK), a tyrosine kinase activated by clustering and ligand interaction of integrins.	p(UP:Q9DD33)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
634e2dfe-c25f-4211-a711-84d9297b56b6	1.0	PubMed	21422248	Because we showed that rapamycin inhibited the phosphorylation of both GSK3-beta and S6K1 and that direct inhibition of S6K1 reduced the phosphorylated levels of GSK3-beta, we next wanted to discover whether S6K1 inhibition would mimic the effects of rapamycin on the levels of IL-10 and IL-12 produced by LPS stimulated monocytes.	a(CHEBI:9168)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
634e2dfe-c25f-4211-a711-84d9297b56b6	1.0	PubMed	20008284	Similarly, the mTORC1 inhibitor, rapamycin, failed to block the phosphorylation of GSK3beta (S 9, Y 216) (XREF_FIG) despite a marked inhibition of GSK3beta (S 9 only) by the PI3K inhibitor wortmannin.	a(CHEBI:9168)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
5d7721a3-4516-49f3-be9e-1447d0f8ffb4	1.0	PubMed	21422248	Taken together, these results demonstrated that rapamycin induced inhibition of mTORC1 results in reduced phosphorylation of GSK3-beta (S9).	a(CHEBI:9168)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
5d7721a3-4516-49f3-be9e-1447d0f8ffb4	1.0	PubMed	21422248	Moreover, the data show that the ability of rapamycin to suppress the phosphorylation of GSK3-beta (S9) was not due to an effect on Rictor, because similar levels of GSK3-beta (S9) were observed in both wild-type and Rictor deficient cells stimulated with LPS.	a(CHEBI:9168)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
1f47d18e-d4db-48ee-a598-cffe9169cbd3	1.0	PubMed	20648061	Interestingly, it has been shown that retinoic acid decreases S9 phosphorylation of GSK3beta 53 and increases GSK3 expression 5, raising the intriguing possibility that retinoic acid signaling leads to the elevation of GSK3 activity above basal levels to control neurogenesis.	a(PUBCHEM:5282379)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
4d5d5917-12c7-4837-8603-2ea68d74e420	1.0	PubMed	20454507	Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.	a(PUBCHEM:923)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
d3d87ed1-733a-47fe-91a3-ca018e66c950	1.0	PubMed	22286758	Furthermore, sorafenib treatment suppressed Ser9 phosphorylation of GSK3beta, which inhibits its kinase activity (XREF_BIBR), in both WT and p53-KO HCT116 cells (XREF_FIG).	a(CHEBI:50924)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Ser, 9))
727e1f58-4592-4902-bf51-9aca3491e93e	1.0	PubMed	20454507	Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.	a(PUBCHEM:3121)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph))
21aa4015-166f-48d4-ad35-d660234ae3a5	1.0	PubMed	23768967	Autophosphorylation is not the only way that Tyr216 can be phosphorylated, with the zaphoid kinase-1 (ZAK-1) protein shown to catalyse tyrosine phosphorylation of GSK-3beta in.	p(UP:Q75JK0)	directlyIncreases	p(HGNC:GSK3B, pmod(Ph, Tyr))
1e1c7e35-74f0-4d78-aecd-b0c2cb202a2d	1.0	PubMed	21743491	In this context, it is interesting that GSK-3beta overexpression increased sumoylated EGR1 but decreased nonsumoylated EGR1; these findings suggest that GSK-3beta might inhibit beta-catenin activity through sumoylation of EGR1, which leads to reduction of nonsumoylated EGR1.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:EGR1)
b049abf5-9826-4133-9bb3-334ac0613e34	1.0	PubMed	26274564	We previously found that Wnt simulation induces monoubiquitination of GSK3beta by beta-TrCP, which is required for Wnt induced inhibition of beta-catenin recruitment of beta-TrCP and subsequent stabilization of beta-catenin (XREF_BIBR).	p(HGNC:BTRC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ub))
b049abf5-9826-4133-9bb3-334ac0613e34	1.0	PubMed	26274564	Our results has uncovered a previously unrealized role of GSK3beta Y216 phosphorylation : it triggers GSK3beta recruitment of beta-TrCP and subsequent GSK3beta monoubiquitination by beta-TrCP, an event required for Wnt induced inhibition of beta-catenin degradation, thus identifying phosphorylation of GSK3beta Y216 as an ' activator ' of the Wnt and beta-catenin pathway.	p(HGNC:BTRC)	directlyIncreases	p(HGNC:GSK3B, pmod(Ub))
c17becdb-4357-4d0a-b005-7e32f86fc47b	1.0	PubMed	21964756	Overall, these studies demonstrate that modulation of HIF-1alpha in hypoxia is a multi-step process involving both phosphorylation by GSK3beta and ubiquitination stimulated by FBW7.	p(HGNC:FBXW7)	directlyIncreases	p(HGNC:GSK3B, pmod(Ub))
0558f8c3-a8d7-4517-a58c-70321d3df650	1.0	PubMed	21964756	Expression of constitutively active GSK3beta reduced HIF-1alpha protein and transcriptional activity and increased ubiquitination of HIF-1alpha in hypoxia, whereas pharmacologic inhibition of GSK3 or expression of siGSK3beta promoted HIF-1alpha stabilization and activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:HIF1A, pmod(Ub))
30ff61be-1686-4b0b-ada6-cb13e16e578a	1.0	PubMed	14563837	Conversely, overexpression of GSK-3 alpha or GSK-3 beta enhances Thr 58 phosphorylation and ubiquitination of c-Myc.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ub))
30ff61be-1686-4b0b-ada6-cb13e16e578a	1.0	PubMed	7013582	Conversely, overexpression of GSK-3 alpha or GSK-3 beta enhances Thr 58 phosphorylation and ubiquitination of c-Myc.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYC, pmod(Ub))
8aba4905-e06a-4312-b358-ec0cb682b8e3	1.0	PubMed	25122124	GSK-3beta phosphorylation induces beta-TRCP-mediated ubiquitination, localization of Snail within the cytoplasm and subsequent proteasomal degradation of Snail XREF_BIBR.	p(HGNC:GSK3B, pmod(Ph))	directlyIncreases	p(HGNC:SNAI1, pmod(Ub))
8665c15a-c515-4d0f-8eec-8f04fb036f18	1.0	PubMed	24170547	Phosphorylation of Cyclin D1 by GSK3beta at threonine 286 enhances its ubiquitination and proteasomal degradation preventing its interaction with CDK4, and CDK4 dependent RB phosphorylation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CDK4, pmod(Ub))
d9ee0e21-3e4a-4770-b455-1ff348982116	1.0	PubMed	22641100	Thus, by inducing PECAM-1 tyrosine phosphorylation, CCL2 may regulate GSK-3beta -mediated ubiquitination of beta-catenin, thereby altering its cellular localization.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ub))
d9ee0e21-3e4a-4770-b455-1ff348982116	1.0	PubMed	20215423	Inactivation of GSK-3beta blocks beta-catenin ubiquitination by SCF-E3 ubiquitin ligase (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ub))
d9ee0e21-3e4a-4770-b455-1ff348982116	1.0	PubMed	19060929	The inactivation of GSK-3beta by phosphorylation has been shown to reduce the ubiquitination of beta-catenin, resulting in nuclear accumulation and transcriptional activity of beta-catenin (XREF_BIBR; XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ub))
d9ee0e21-3e4a-4770-b455-1ff348982116	1.0	PubMed	20519433	Sequential phosphorylation of beta-catenin by CKI and GSK3beta leads to ubiquitination and degradation of beta-catenin by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ub))
d9ee0e21-3e4a-4770-b455-1ff348982116	1.0	PubMed	24151146	In the absence of Wnt signaling, cytosolic beta-Catenin is phosphorylated by a protein complex composed of APC, Axin, and GSK-3beta that leads to a rapid ubiquitination and proteasomal degradation of beta-Catenin [XREF_BIBR - XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ub))
d9ee0e21-3e4a-4770-b455-1ff348982116	1.0	PubMed	16772034	Phosphorylation of beta-catenin by GSK-3beta leads to ubiquitination of beta-catenin and degradation in proteasomes [XREF_BIBR].	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ub))
d9ee0e21-3e4a-4770-b455-1ff348982116	1.0	PubMed	21411632	FAF1 induced beta-catenin ubiquitination was blocked by the GSK3beta kinase inhibitor SB216763 (XREF_FIG).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ub))
d9ee0e21-3e4a-4770-b455-1ff348982116	1.0	PubMed	20708603	Sequential phosphorylation of beta-catenin by CKI and GSK3beta leads to ubiquitination and degradation of beta-catenin by the proteasome.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:CTNNB1, pmod(Ub))
409c54fe-3f9a-4e35-9473-81d3ca51c14c	1.0	PubMed	5446509	Our results demonstrate that free cyclin D1 is ubiquitinated independently of its phosphorylation on threonine 286 by GSK-3beta, suggesting that, as has been shown for cyclin E, distinct pathways of ubiquitination lead to the degradation of free and CDK bound cyclin D1.	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Cyclin, pmod(Ub, Asp, 1))
8beb9110-aaa5-4c33-bae4-df56b0df2a86	1.0	PubMed	18367454	To summarize, our findings suggest that GSK3beta can promote the ubiquitination of E2F1 via physical interaction and thus inhibit its transcription activity in a kinase activity independent manner, which plays an important role in the NGF induced PC12 differentiation.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:E2F1, pmod(Ub))
34f8d966-8f1b-4703-bd74-4ab8accce94e	1.0	PubMed	20855292	We demonstrated that GSK-3beta mediates phosphorylation of GCM1 on Ser322, which is recognized by the F-box protein, FBW2, to promote GCM1 ubiquitination and degradation (XREF_BIBR, XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:GCM1, pmod(Ub))
0bb88bf7-d368-42eb-8d2a-663486bed28b	1.0	PubMed	22024133	For example, phosphorylation of Mcl-1 at T92 and T163 mediated by ERK prolongs the half-life of Mcl-1 protein (XREF_BIBR, XREF_BIBR), while phosphorylation of Mcl-1 at S159 mediated by GSK-3beta promotes Mcl-1 ubiquitination and degradation (XREF_BIBR).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MCL1, pmod(Ub))
50c6705c-78fd-40c9-8d2e-56b9c0552232	1.0	PubMed	21795403	We show here that in leukemia cells GSK3beta inactivation promotes the ubiquitination of c-Myb.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:MYB, pmod(Ub))
cb69195d-57dc-481e-9aea-112f9289c88a	1.0	PubMed	17574025	We next demonstrated that GSK3beta augmented SRC-3 ubiquitination (Di).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NCOA3, pmod(Ub))
cb69195d-57dc-481e-9aea-112f9289c88a	1.0	PubMed	17574025	The kinase activity of GSK3beta was required since kinase defective GSK3beta did not enhance SRC-3 ubiquitination (Dii).	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NCOA3, pmod(Ub))
d0630a4d-b15c-4de9-9d34-aa5005fe62a8	1.0	PubMed	19026640	Furthermore, activation of GSK3beta markedly enhanced NFATc4 ubiquitination and decreased its transactivation, whereas inhibition of GSK3beta had opposite effects.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFATC4, pmod(Ub))
f670483f-cf52-44cf-962d-9c85fde8d6e5	1.0	PubMed	25340789	Specifically, it has been shown that GSK-3beta mediates phosphorylation of certain serine residues on the Neh6 domain of Nrf2, increasing its affinity for another E3 ubiquitin ligase, beta-TrCP, which is believed to mediate Nrf2 ubiquitination and proteasomal degradation XREF_BIBR.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFE2L2, pmod(Ub))
f670483f-cf52-44cf-962d-9c85fde8d6e5	1.0	PubMed	25172557	The serine/threonine kinase GSK3beta has been shown to mediate ubiquitylation of Nrf2, resulting in decreased Nrf2 activity.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:NFE2L2, pmod(Ub))
885cef79-c79e-4bc4-8aba-13bb03488d3d	1.0	PubMed	26336990	To dissect whether the positive feedback between DAB2IP and Snail modulates Snail stability via proteasome dependent ubiquitination mediated by GSK3beta in SW480 cells, we treated Snail KD cells with LiCL (inhibitor of GSK-3beta) or MG132 (a proteasome inhibitor).	p(HGNC:GSK3B)	directlyIncreases	p(FPLX:Proteasome, pmod(Ub))
e0417290-cdb0-4810-8330-a827ca6132ad	1.0	PubMed	25088797	Thus, we hypothesized that the inhibition of GSK-3beta activity by bFGF might repress Snail ubiquitination and export from unclear.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ub))
e0417290-cdb0-4810-8330-a827ca6132ad	1.0	PubMed	25088797	GSK-3beta activity inhibition decreases the ubiquitination of Snail and increases Snail transcription.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNAI1, pmod(Ub))
48b80179-d5a2-493b-9533-d3fa637dd97f	1.0	PubMed	16174773	GSK3beta decreased the in vitro and in vivo ubiquitylation of synphilin-1 as well as its degradation promoted by SIAH.	p(HGNC:GSK3B)	directlyIncreases	p(HGNC:SNCAIP, pmod(Ub))
9bbb0548-b3e2-4c72-8d43-b915b28a9c44	1.0	PubMed	19276348	We found that glycogen synthase kinase 3beta (GSK3beta) mediates the recruitment of betaTrcp and receptor ubiquitination and degradation through phosphorylation of PRLr on Ser349.	p(HGNC:GSK3B)	directlyIncreases	p(UP:Q91854, pmod(Ub))
1dcbbede-6960-4b6a-983c-f3e000400e77	1.0	PubMed	19481076	These data suggest that i) Smurf2 induces GSK-3beta ubiquitination in chondrocytes; ii) the ubiquitinated GSK-3beta is degraded quickly in the proteasome, consistent with previous studies [XREF_BIBR, XREF_BIBR, XREF_BIBR].	p(HGNC:SMURF2)	directlyIncreases	p(HGNC:GSK3B, pmod(Ub))
d45cc730-7d96-4772-96ca-710d2165ae37	1.0	PubMed	21118991	To test whether EDD ubiquitinates beta-catenin or GSK-3beta, HEK293T cells were transfected with FLAG-EDD, HA-ubiquitin, and either GFP-beta-catenin or GFP-GSK-3beta (XREF_FIG).	p(HGNC:UBR5)	directlyIncreases	p(HGNC:GSK3B, pmod(Ub))
bb3bda64-1670-4d1b-a370-13bf4f79f26d	1.0	PubMed	24451375	We found that Wnt stimulation induced prolonged monoubiquitination of Gsk3beta and Gsk3beta-beta-TrCP interaction.	p(FPLX:Wnt)	directlyIncreases	p(HGNC:GSK3B, pmod(Ub))
78f987c7-ad56-44ef-96d6-27e33394dede	1.0	PubMed	25246272	No evidence text.	p(HGNC:GSK3B)	directlyIncreases	rxn(reactants(a(CHEBI:75771)), products(a(CHEBI:16856)))
